Psyllid ID: psy6905
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 527 | 2.2.26 [Sep-21-2011] | |||||||
| Q3U1V8 | 1077 | Mitogen-activated protein | yes | N/A | 0.927 | 0.454 | 0.569 | 1e-162 | |
| P80192 | 1104 | Mitogen-activated protein | yes | N/A | 0.927 | 0.442 | 0.569 | 1e-162 | |
| Q7T2V3 | 1005 | Mitogen-activated protein | N/A | N/A | 0.929 | 0.487 | 0.561 | 1e-159 | |
| Q66L42 | 940 | Mitogen-activated protein | no | N/A | 0.920 | 0.515 | 0.546 | 1e-153 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | N/A | 0.889 | 0.403 | 0.573 | 1e-151 | |
| Q02779 | 954 | Mitogen-activated protein | no | N/A | 0.922 | 0.509 | 0.543 | 1e-151 | |
| Q16584 | 847 | Mitogen-activated protein | no | N/A | 0.910 | 0.566 | 0.533 | 1e-147 | |
| Q80XI6 | 850 | Mitogen-activated protein | no | N/A | 0.910 | 0.564 | 0.531 | 1e-146 | |
| Q66HA1 | 850 | Mitogen-activated protein | no | N/A | 0.910 | 0.564 | 0.531 | 1e-146 | |
| Q8VDG6 | 1002 | Mitogen-activated protein | no | N/A | 0.969 | 0.509 | 0.524 | 1e-145 |
| >sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus GN=Map3k9 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 572 bits (1475), Expect = e-162, Method: Compositional matrix adjust.
Identities = 291/511 (56%), Positives = 371/511 (72%), Gaps = 22/511 (4%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV- 93
W A+++Y+A G DEL+LR GD+VEVLSKDS +SGD GWWTG++ +VGIFP+N+V
Sbjct: 50 WTAVFEYEAAGEDELTLRLGDVVEVLSKDSQVSGDEGWWTGQLN----QRVGIFPSNYVT 105
Query: 94 ------SSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKV 147
S + S ++L+EID+ +L E IG GGFGKVY+ + EVA+K
Sbjct: 106 PRSAFSSRCQPGAEDPSCYPPIQLLEIDFAELTLEEIIGIGGFGKVYRAFWAGDEVAVKA 165
Query: 148 AHPNPDENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL 204
A +PDE+I +ENV+QE KL + H NI++L GVCL+ P LCLVME+ARGGPLNRVL
Sbjct: 166 ARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL 225
Query: 205 AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264
+G++I PD+LV+WA+QIA GMNYLH +A + +IHRDLKSSN+L+ + +EN DL K LKI
Sbjct: 226 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 285
Query: 265 TDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI 324
TDFGLARE ++TT MSAAGTYAWMAPEVI+ S+FSK SDVWSYGV+LWELLTGE+P++ I
Sbjct: 286 TDFGLAREWHRTTKMSAAGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 345
Query: 325 NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384
+ AVAYGVA+NKL LPIPSTCP+ F LME CW D H RPSF +IL L I S F
Sbjct: 346 DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTSILDQLTTIEESGFF 405
Query: 385 QTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKELREREQAV 444
+ P +SFH +QD W+ EI+++ +LR KEKELR+ EEELT+A +QQK E+ LR REQ +
Sbjct: 406 EMPKDSFHCLQDDWKHEIQEMFDQLRAKEKELRTWEEELTRAALQQKNQEELLRRREQEL 465
Query: 445 AAREIDVLERELMIIL-QTAGPTPTPHKRGGKFNRSKLKVWKVHDISSPSDFRHTLTVQ- 502
A REID+LEREL II+ Q P KR GKF +S+LK+ + IS PSDF+H TVQ
Sbjct: 466 AEREIDILERELNIIIHQLCQEKPRVKKRKGKFRKSRLKLKDGNRISLPSDFQHKFTVQA 525
Query: 503 -PT--ERKS--RKATSPPGSPS-IPRLQAFK 527
PT +RKS +SPP SP+ IPRL+A +
Sbjct: 526 SPTMDKRKSLISNRSSPPASPTIIPRLRAIQ 556
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|P80192|M3K9_HUMAN Mitogen-activated protein kinase kinase kinase 9 OS=Homo sapiens GN=MAP3K9 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 571 bits (1471), Expect = e-162, Method: Compositional matrix adjust.
Identities = 291/511 (56%), Positives = 370/511 (72%), Gaps = 22/511 (4%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV- 93
W A+++Y+A G DEL+LR GD+VEVLSKDS +SGD GWWTG++ +VGIFP+N+V
Sbjct: 57 WTAVFEYEAAGEDELTLRLGDVVEVLSKDSQVSGDEGWWTGQLN----QRVGIFPSNYVT 112
Query: 94 ------SSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKV 147
S + S ++L+EID+ +L E IG GGFGKVY+ + EVA+K
Sbjct: 113 PRSAFSSRCQPGGEDPSCYPPIQLLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKA 172
Query: 148 AHPNPDENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL 204
A +PDE+I +ENV+QE KL + H NI++L GVCL+ P LCLVME+ARGGPLNRVL
Sbjct: 173 ARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL 232
Query: 205 AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264
+G++I PD+LV+WA+QIA GMNYLH +A + +IHRDLKSSN+L+ + +EN DL K LKI
Sbjct: 233 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 292
Query: 265 TDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI 324
TDFGLARE ++TT MSAAGTYAWMAPEVI+ S+FSK SDVWSYGV+LWELLTGE+P++ I
Sbjct: 293 TDFGLAREWHRTTKMSAAGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 352
Query: 325 NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384
+ AVAYGVA+NKL LPIPSTCP+ F LME CW D H RPSF IL L I S F
Sbjct: 353 DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTIEESGFF 412
Query: 385 QTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKELREREQAV 444
+ P +SFH +QD W+ EI+++ +LR KEKELR+ EEELT+A +QQK E+ LR REQ +
Sbjct: 413 EMPKDSFHCLQDNWKHEIQEMFDQLRAKEKELRTWEEELTRAALQQKNQEELLRRREQEL 472
Query: 445 AAREIDVLERELMIIL-QTAGPTPTPHKRGGKFNRSKLKVWKVHDISSPSDFRHTLTVQ- 502
A REID+LEREL II+ Q P KR GKF +S+LK+ + IS PSDF+H TVQ
Sbjct: 473 AEREIDILERELNIIIHQLCQEKPRVKKRKGKFRKSRLKLKDGNRISLPSDFQHKFTVQA 532
Query: 503 -PT--ERKS--RKATSPPGSPS-IPRLQAFK 527
PT +RKS +SPP SP+ IPRL+A +
Sbjct: 533 SPTMDKRKSLINSRSSPPASPTIIPRLRAIQ 563
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q7T2V3|M3K10_XENLA Mitogen-activated protein kinase kinase kinase 10 OS=Xenopus laevis GN=map3k10 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 563 bits (1451), Expect = e-159, Method: Compositional matrix adjust.
Identities = 284/506 (56%), Positives = 367/506 (72%), Gaps = 16/506 (3%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
LW A++DY+ +EL+LRRGD+VE+LSKDS +SGD GWWTGKI+ K VGIFP+N+V
Sbjct: 36 LWMAVFDYEPTAEEELTLRRGDLVEILSKDSTVSGDEGWWTGKIKDK----VGIFPSNYV 91
Query: 94 SSIEDINLVSSVINDVKL-VEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP 152
S + ++ L +EI++++L E IG GGFGKVYKG++ +EVA+K +P
Sbjct: 92 VSDDKYTTLTGAPKQCPLPLEIEFDELNLDEIIGVGGFGKVYKGLWRDEEVAVKAVRHDP 151
Query: 153 DENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKI 209
DE+I ENV+QE K+ + H NI++L GVCL+ P LCLVMEYARGGPL+R LAG+K+
Sbjct: 152 DEDINVTAENVRQEAKIFCMLCHPNIIALTGVCLKPPHLCLVMEYARGGPLHRALAGKKV 211
Query: 210 RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269
VLV+WA+QIA+GM YLH +A + +IHRDL SSN+L+ E EN+DL KTL ITDFGL
Sbjct: 212 PAHVLVNWAVQIAKGMTYLHNEAIVPIIHRDLGSSNILILEKAENDDLFNKTLNITDFGL 271
Query: 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAV 329
ARE KTT MSAAGTYAWMAPEVI+ S+FSK+SDVWS+GV+LWELLTGE+PY+ I+A AV
Sbjct: 272 AREWQKTTKMSAAGTYAWMAPEVIRLSLFSKSSDVWSFGVLLWELLTGEVPYREIDALAV 331
Query: 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHE 389
AYGVA+NKLTLPIPSTCP+ F ++EACW+ D H RP+F IL+ L I S Q P E
Sbjct: 332 AYGVAMNKLTLPIPSTCPEPFVRILEACWDPDPHSRPTFSCILEQLTTIEQSAMFQMPLE 391
Query: 390 SFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKELREREQAVAAREI 449
SFH +Q+ WR+EI+Q+ ELR KEKELRSREEEL +A +Q++ E L+ REQ +A REI
Sbjct: 392 SFHSLQEDWRLEIQQMFDELRTKEKELRSREEELVRAAEEQRILEDLLKRREQELAEREI 451
Query: 450 DVLERELMIIL-QTAGPTPTPHKRGGKFNRSKLKVWKVHDISSPSDFRHTLTVQPT---- 504
D++EREL II+ Q P KR G F +S+LK+ + IS PS F H +TVQ +
Sbjct: 452 DIVERELNIIMYQMYQEKPKVKKRKGNFKKSRLKLKDGNRISLPSGFEHKITVQASPMLD 511
Query: 505 --ERKSRKATSPPGSP-SIPRLQAFK 527
+ + + SPPGSP IPRL+A +
Sbjct: 512 KCKGQGTSSYSPPGSPLIIPRLRAIR 537
|
Activates the JUN N-terminal pathway. Essential for pronephros and cement gland development. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q66L42|M3K10_MOUSE Mitogen-activated protein kinase kinase kinase 10 OS=Mus musculus GN=Map3k10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 543 bits (1400), Expect = e-153, Method: Compositional matrix adjust.
Identities = 277/507 (54%), Positives = 363/507 (71%), Gaps = 22/507 (4%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+W A++DY+A+G +EL+LRRGD V+VLS+D A+SGD GWWTG++ +VG+FP+N+V
Sbjct: 20 VWTAVFDYEAVGDEELTLRRGDRVQVLSQDCAVSGDEGWWTGQLPSG---RVGVFPSNYV 76
Query: 94 SSIEDINLVSSVINDVKLV-EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP 152
+ + +D++L EI +++L E IG GGFGKVY+ ++ +EVA+K A +P
Sbjct: 77 APA-----APAAPSDLQLPQEIPFHELQLEEIIGVGGFGKVYRAVWRGEEVAVKAARLDP 131
Query: 153 DEN---ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKI 209
+ + E V+QE +L H NI++L G CL P LCLVMEYARGG L+RVLAGR++
Sbjct: 132 ERDPAVTAEQVRQEARLFGALQHPNIIALRGACLSPPNLCLVMEYARGGALSRVLAGRRV 191
Query: 210 RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269
P VLV+WA+Q+A GMNYLH AP+ +IHRDLKS N+L+ E IEN +L LKITDFGL
Sbjct: 192 PPHVLVNWAVQVARGMNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGL 251
Query: 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAV 329
ARE +KTT MSAAGTYAWMAPEVI+ S+FSK+SDVWS+GV+LWELLTGE+PY+ I+A AV
Sbjct: 252 AREWHKTTKMSAAGTYAWMAPEVIRLSLFSKSSDVWSFGVLLWELLTGEVPYREIDALAV 311
Query: 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHE 389
AYGVA+NKLTLPIPSTCP+ F L+E CW+ D H RP F +ILK L I S Q P E
Sbjct: 312 AYGVAMNKLTLPIPSTCPEPFARLLEECWDPDPHGRPDFGSILKQLEVIEQSALFQMPLE 371
Query: 390 SFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKELREREQAVAAREI 449
SFH +Q+ W++EI+ + +LR KEKELRSREEEL +A +Q+ E++LR REQ +A RE+
Sbjct: 372 SFHSLQEDWKLEIQHMFDDLRTKEKELRSREEELLRAAQEQRFQEEQLRRREQELAEREM 431
Query: 450 DVLERELMIIL-QTAGPTPTPHKRGGKFNRS---KLKVWKVHDISSPSDFRHTLTVQ--P 503
D++EREL +++ Q + P KR G F RS KL+ H IS PS F H +TVQ P
Sbjct: 432 DIVERELHLLMSQLSQEKPRVRKRKGNFKRSRLLKLREGSSH-ISLPSGFEHKITVQASP 490
Query: 504 T--ERKSRKATSPPGSPS-IPRLQAFK 527
T +RK SPP SPS IPRL+A +
Sbjct: 491 TLDKRKGSDGASPPASPSIIPRLRAIR 517
|
Activates the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 536 bits (1380), Expect = e-151, Method: Compositional matrix adjust.
Identities = 284/495 (57%), Positives = 346/495 (69%), Gaps = 26/495 (5%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
LW ALYDYDA G DEL+LRRG+IV VLS DS +SGDVGWWTGKI K VG+FP +FV
Sbjct: 60 LWTALYDYDAQGEDELTLRRGEIVVVLSTDSEVSGDVGWWTGKIGDK----VGVFPKDFV 115
Query: 94 SSIEDINL-VSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP 152
+ + + L VSS I D++ EI+YN+L E IG GGF KV++G Y+ +EVAIK+AH
Sbjct: 116 TDEDPLQLNVSSAIGDIQPHEIEYNELDIKEVIGSGGFCKVHRGYYDGEEVAIKIAHQTG 175
Query: 153 DENIL---ENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKI 209
++++ +NV QE KL W H NI +L GVCL + KLCLVMEYARGG LNR+LAG KI
Sbjct: 176 EDDMQRMRDNVLQEAKLFWALKHENIAALRGVCLNT-KLCLVMEYARGGSLNRILAG-KI 233
Query: 210 RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269
PDVLV+WAIQIA GMNYLH +AP+S+IHRDLKSSNVL+ E IE LQ KTLKITDFGL
Sbjct: 234 PPDVLVNWAIQIARGMNYLHNEAPMSIIHRDLKSSNVLIYEAIEGNHLQQKTLKITDFGL 293
Query: 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAV 329
ARE+Y T MSAAGTYAWM PEVI S +SK SDVWSYGV+LWEL+TGE PYK + +V
Sbjct: 294 AREMYNTQRMSAAGTYAWMPPEVISVSTYSKFSDVWSYGVLLWELITGETPYKGFDPLSV 353
Query: 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHE 389
AYGVAVN LTLPIP TCP+ + LM++CW+ D H RP FK ILK L +I S+F TP E
Sbjct: 354 AYGVAVNTLTLPIPKTCPETWGALMKSCWQTDPHKRPGFKEILKQLESIACSKFTLTPQE 413
Query: 390 SFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKELREREQAVAAREI 449
SFH MQ+ WR EI VLH+LR KEKELR++EE+L + Q +Q+ L+ REQ + RE
Sbjct: 414 SFHYMQECWRKEIAGVLHDLREKEKELRNKEEQLLRVQNEQREKANLLKIREQNLRERER 473
Query: 450 DVLERELMIILQTAGPTPTPHKRGGKFNRSKLKVWKVHDISSPSDFRHTLTVQPTERKSR 509
++EREL ++LQ P P+ K L+ IS P+ FRHT+T R
Sbjct: 474 VLIEREL-VMLQ---PVPSKRKHKKGKKNKPLQ------ISLPTGFRHTITA------VR 517
Query: 510 KATSPPGSPSIPRLQ 524
PGSPS L+
Sbjct: 518 DKAEQPGSPSFSGLR 532
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q02779|M3K10_HUMAN Mitogen-activated protein kinase kinase kinase 10 OS=Homo sapiens GN=MAP3K10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 536 bits (1380), Expect = e-151, Method: Compositional matrix adjust.
Identities = 275/506 (54%), Positives = 357/506 (70%), Gaps = 20/506 (3%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+W A++DY+A G +EL+LRRGD V+VLS+D A+SGD GWWTG++ +VG+FP+N+V
Sbjct: 20 VWTAVFDYEAAGDEELTLRRGDRVQVLSQDCAVSGDEGWWTGQLPSG---RVGVFPSNYV 76
Query: 94 SSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPD 153
+ + EI +++L E IG GGFGKVY+ ++ +EVA+K A +P+
Sbjct: 77 APGAPAAPAGLQLPQ----EIPFHELQLEEIIGVGGFGKVYRALWRGEEVAVKAARLDPE 132
Query: 154 EN---ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR 210
++ E V QE +L H NI++L G CL P LCLVMEYARGG L+RVLAGR++
Sbjct: 133 KDPAVTAEQVCQEARLFGALQHPNIIALRGACLNPPHLCLVMEYARGGALSRVLAGRRVP 192
Query: 211 PDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270
P VLV+WA+Q+A GMNYLH AP+ +IHRDLKS N+L+ E IEN +L LKITDFGLA
Sbjct: 193 PHVLVNWAVQVARGMNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLA 252
Query: 271 REVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVA 330
RE +KTT MSAAGTYAWMAPEVI+ S+FSK+SDVWS+GV+LWELLTGE+PY+ I+A AVA
Sbjct: 253 REWHKTTKMSAAGTYAWMAPEVIRLSLFSKSSDVWSFGVLLWELLTGEVPYREIDALAVA 312
Query: 331 YGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHES 390
YGVA+NKLTLPIPSTCP+ F L+E CW+ D H RP F +ILK L I S Q P ES
Sbjct: 313 YGVAMNKLTLPIPSTCPEPFARLLEECWDPDPHGRPDFGSILKRLEVIEQSALFQMPLES 372
Query: 391 FHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKELREREQAVAAREID 450
FH +Q+ W++EI+ + +LR KEKELRSREEEL +A +Q+ E++LR REQ +A RE+D
Sbjct: 373 FHSLQEDWKLEIQHMFDDLRTKEKELRSREEELLRAAQEQRFQEEQLRRREQELAEREMD 432
Query: 451 VLEREL-MIILQTAGPTPTPHKRGGKFNRS---KLKVWKVHDISSPSDFRHTLTVQ--PT 504
++EREL +++ Q + P KR G F RS KL+ H IS PS F H +TVQ PT
Sbjct: 433 IVERELHLLMCQLSQEKPRVRKRKGNFKRSRLLKLREGGSH-ISLPSGFEHKITVQASPT 491
Query: 505 --ERKSRKATSPPGSPS-IPRLQAFK 527
+RK SPP SPS IPRL+A +
Sbjct: 492 LDKRKGSDGASPPASPSIIPRLRAIR 517
|
Activates the JUN N-terminal pathway. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q16584|M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 523 bits (1348), Expect = e-147, Method: Compositional matrix adjust.
Identities = 269/504 (53%), Positives = 349/504 (69%), Gaps = 24/504 (4%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+W AL+DY+ G DEL+LR+GD VEVLS+D+AISGD GWW G++ G+ VGIFP+N+V
Sbjct: 45 VWTALFDYEPSGQDELALRKGDRVEVLSRDAAISGDEGWWAGQVGGQ----VGIFPSNYV 100
Query: 94 SSIEDINLVSSVINDVKLVEI-DYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP 152
S E+ + +L E IG GGFGKVY+G + + VA+K A +P
Sbjct: 101 SRG----------GGPPPCEVASFQELRLEEVIGIGGFGKVYRGSWRGELVAVKAARQDP 150
Query: 153 DENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKI 209
DE+I E+V+QE +L + H NI++L VCL+ P LCLVMEYA GGPL+R LAGR++
Sbjct: 151 DEDISVTAESVRQEARLFAMLAHPNIIALKAVCLEEPNLCLVMEYAAGGPLSRALAGRRV 210
Query: 210 RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269
P VLV+WA+QIA GM+YLHC+A + +IHRDLKS+N+LL +PIE++D++ KTLKITDFGL
Sbjct: 211 PPHVLVNWAVQIARGMHYLHCEALVPVIHRDLKSNNILLLQPIESDDMEHKTLKITDFGL 270
Query: 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAV 329
ARE +KTT MSAAGTYAWMAPEVIK S FSK SDVWS+GV+LWELLTGE+PY+ I+ AV
Sbjct: 271 AREWHKTTQMSAAGTYAWMAPEVIKASTFSKGSDVWSFGVLLWELLTGEVPYRGIDCLAV 330
Query: 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHE 389
AYGVAVNKLTLPIPSTCP+ F LM CW D H RP F +IL+ L + + P +
Sbjct: 331 AYGVAVNKLTLPIPSTCPEPFAQLMADCWAQDPHRRPDFASILQQLEALEAQVLREMPRD 390
Query: 390 SFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKELREREQAVAAREI 449
SFH MQ+GW+ EI+ + ELR KEKEL SREEELT+A +Q+ ++LR RE +A E+
Sbjct: 391 SFHSMQEGWKREIQGLFDELRAKEKELLSREEELTRAAREQRSQAEQLRRREHLLAQWEL 450
Query: 450 DVLERELMIILQTA-GPTPTPHKRGGKFNRSKLKVWKVHD-ISSPSDFRHTLTVQPTERK 507
+V EREL ++LQ P +R G F RSKL+ + IS P DF+H +TVQ +
Sbjct: 451 EVFERELTLLLQQVDRERPHVRRRRGTFKRSKLRARDGGERISMPLDFKHRITVQASPGL 510
Query: 508 SRKAT----SPPGSPSIPRLQAFK 527
R+ P SP+ PR +A +
Sbjct: 511 DRRRNVFEVGPGDSPTFPRFRAIQ 534
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q80XI6|M3K11_MOUSE Mitogen-activated protein kinase kinase kinase 11 OS=Mus musculus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1340), Expect = e-146, Method: Compositional matrix adjust.
Identities = 268/504 (53%), Positives = 347/504 (68%), Gaps = 24/504 (4%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+W AL+DY+ G DEL+LR+GD VEVLS+D+AISGD GWW G++ G+ VGIFP+N+V
Sbjct: 46 VWTALFDYEPNGQDELALRKGDRVEVLSRDAAISGDEGWWAGQVGGQ----VGIFPSNYV 101
Query: 94 SSIEDINLVSSVINDVKLVEI-DYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP 152
S E+ + +L E IG GGFGKVY+G + + VA+K A +P
Sbjct: 102 SRG----------GGPPPCEVASFQELRLEEVIGIGGFGKVYRGSWRGELVAVKAARQDP 151
Query: 153 DENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKI 209
DE+I E+V+QE +L + H NI++L VCL+ P LCLVMEYA GGPL+R LAGR++
Sbjct: 152 DEDISVTAESVRQEARLFAMLAHPNIIALKAVCLEEPNLCLVMEYAAGGPLSRALAGRRV 211
Query: 210 RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269
P VLV+WA+QIA GM+YLHC+A + +IHRDLKS+N+LL +PIE +D++ KTLKITDFGL
Sbjct: 212 PPHVLVNWAVQIARGMHYLHCEALVPVIHRDLKSNNILLLQPIEGDDMEHKTLKITDFGL 271
Query: 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAV 329
ARE +KTT MSAAGTYAWMAPEVIK S FSK SDVWS+GV+LWELLTGE+PY+ I+ AV
Sbjct: 272 AREWHKTTQMSAAGTYAWMAPEVIKASTFSKGSDVWSFGVLLWELLTGEVPYRGIDCLAV 331
Query: 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHE 389
AYGVAVNKLTLPIPSTCP+ F LM CW D H RP F +IL+ L + + P +
Sbjct: 332 AYGVAVNKLTLPIPSTCPEPFAQLMADCWAQDPHRRPDFASILQQLEALEAQVLREMPRD 391
Query: 390 SFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKELREREQAVAAREI 449
SFH MQ+GW+ EI+ + ELR KEKEL SREEELT+A +Q+ ++LR RE +A E+
Sbjct: 392 SFHSMQEGWKREIQGLFDELRAKEKELLSREEELTRAAREQRSQAEQLRRREHLLAQWEL 451
Query: 450 DVLERELMIILQTA-GPTPTPHKRGGKFNRSKLKVWKVHD-ISSPSDFRHTLTVQPTERK 507
+V EREL ++LQ P +R G F RSKL+ + IS P DF+H +TVQ +
Sbjct: 452 EVFERELTLLLQQVDRERPHVRRRRGTFKRSKLRARDGGERISMPLDFKHRITVQASPGL 511
Query: 508 SRKAT----SPPGSPSIPRLQAFK 527
R+ SP+ PR +A +
Sbjct: 512 DRRRNVFEVGAGDSPTFPRFRAIQ 535
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q66HA1|M3K11_RAT Mitogen-activated protein kinase kinase kinase 11 OS=Rattus norvegicus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1338), Expect = e-146, Method: Compositional matrix adjust.
Identities = 268/504 (53%), Positives = 347/504 (68%), Gaps = 24/504 (4%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+W AL+DY+ G DEL+LR+GD VEVLS+D+AISGD GWW G++ G+ VGIFP+N+V
Sbjct: 46 VWTALFDYEPNGQDELALRKGDRVEVLSRDAAISGDEGWWAGQVGGQ----VGIFPSNYV 101
Query: 94 SSIEDINLVSSVINDVKLVEI-DYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP 152
S E+ + +L E IG GGFGKVY+G + + VA+K A +P
Sbjct: 102 SRG----------GGPPPCEVASFQELRLEEVIGIGGFGKVYRGSWRGELVAVKAARQDP 151
Query: 153 DENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKI 209
DE+I E+V+QE +L + H NI++L VCL+ P LCLVMEYA GGPL+R LAGR++
Sbjct: 152 DEDISVTAESVRQEARLFAMLAHPNIIALKAVCLEEPNLCLVMEYAAGGPLSRALAGRRV 211
Query: 210 RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269
P VLV+WA+QIA GM+YLHC+A + +IHRDLKS+N+LL +PIE +D++ KTLKITDFGL
Sbjct: 212 PPHVLVNWAVQIARGMHYLHCEALVPVIHRDLKSNNILLLQPIEGDDMEHKTLKITDFGL 271
Query: 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAV 329
ARE +KTT MSAAGTYAWMAPEVIK S FSK SDVWS+GV+LWELLTGE+PY+ I+ AV
Sbjct: 272 AREWHKTTQMSAAGTYAWMAPEVIKASTFSKGSDVWSFGVLLWELLTGEVPYRGIDCLAV 331
Query: 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHE 389
AYGVAVNKLTLPIPSTCP+ F LM CW D H RP F +IL+ L + + P +
Sbjct: 332 AYGVAVNKLTLPIPSTCPEPFAQLMADCWAQDPHRRPDFASILQQLEALEAQVLREMPRD 391
Query: 390 SFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKELREREQAVAAREI 449
SFH MQ+GW+ EI+ + ELR KEKEL SREEELT+A +Q+ ++LR RE +A E+
Sbjct: 392 SFHSMQEGWKREIQGLFDELRAKEKELLSREEELTRAAREQRSQAEQLRRREHLLAQWEL 451
Query: 450 DVLERELMIILQTA-GPTPTPHKRGGKFNRSKLKVWKVHD-ISSPSDFRHTLTVQPTERK 507
+V EREL ++LQ P +R G F RSKL+ + IS P DF+H +TVQ +
Sbjct: 452 EVFERELTLLLQQVDRERPHVRRRRGTFKRSKLRARDGGERISMPLDFKHRITVQASPGL 511
Query: 508 SRKAT----SPPGSPSIPRLQAFK 527
R+ SP+ PR +A +
Sbjct: 512 DRRRNVFEVGAGDSPTFPRFRAIQ 535
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q8VDG6|M3KL4_MOUSE Mitogen-activated protein kinase kinase kinase MLK4 OS=Mus musculus GN=Mlk4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 516 bits (1330), Expect = e-145, Method: Compositional matrix adjust.
Identities = 283/540 (52%), Positives = 371/540 (68%), Gaps = 29/540 (5%)
Query: 13 QNEVDSDLLYGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGW 72
+ D+ L + + +W ALYDY+A G DELSLRRG +VEVLS+D+A+SGD GW
Sbjct: 7 EGTADTPLSPARDDSGSTSSGMWAALYDYEARGEDELSLRRGQLVEVLSQDAAVSGDEGW 66
Query: 73 WTGKIEGKIEYKVGIFPANFVSSIEDINLVSSVINDVKL-VEIDYNKLIFGEAIGEGGFG 131
W G+++ ++GIFPA++V+ + + V +D+ +L E IG GGFG
Sbjct: 67 WAGQVQ----RRLGIFPASYVAPCGPVPPPAPPPPRPCSPVHVDFERLELKELIGAGGFG 122
Query: 132 KVYKGIYEKQEVAIKVAHPNPDENIL---ENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188
+VY+ ++ QEVA+K A +P+++ E+V++E +L + H NI+ L GVCL+ P L
Sbjct: 123 QVYRATWQGQEVAVKAARRDPEQDAAAAAESVRREARLFAMLRHPNIIQLRGVCLRQPHL 182
Query: 189 CLVMEYARGGPLNRVLAGRK-------------IRPDVLVDWAIQIAEGMNYLHCQAPIS 235
CLV+E+ARGG LNR LA I P VLV+WA+QIA GM YLH +A +
Sbjct: 183 CLVLEFARGGALNRALAAAASDPRAPGPRRARRIPPQVLVNWAVQIARGMLYLHEEAVVP 242
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT 295
++HRDLKSSN+LL E IE++D+ KTLKITDFGLARE ++TT MSAAGTYAWMAPEVI++
Sbjct: 243 ILHRDLKSSNILLLEKIEHDDICNKTLKITDFGLAREWHRTTRMSAAGTYAWMAPEVIRS 302
Query: 296 SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLME 355
S+FSK SD+WSYGV+LWELLTGE+PY+ I+ AVAYGVAVNKLTLPIPSTCP+ F LM+
Sbjct: 303 SLFSKGSDIWSYGVLLWELLTGEVPYRGIDGLAVAYGVAVNKLTLPIPSTCPEPFAKLMK 362
Query: 356 ACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKE 415
CWE D H+RPSF IL+ L I + P ESFH MQ+ W++EI+Q+ ELR KEKE
Sbjct: 363 ECWEQDPHIRPSFALILQQLTAIEEAVLTNMPQESFHSMQEDWKLEIQQMFSELRTKEKE 422
Query: 416 LRSREEELTKAQMQQKLAEKELREREQAVAAREIDVLEREL-MIILQTAGPTPTPHKRGG 474
LRSREEEL++A +QQK E LR REQ +A REIDVLEREL ++I Q + P KR G
Sbjct: 423 LRSREEELSRAALQQKSQELLLRRREQQLAEREIDVLERELNVLIFQLSQEAPHVKKRKG 482
Query: 475 KFNRSKLKVWKVHDISSPSDFRHTLTVQ--PTERKSRKA----TSPPGSP-SIPRLQAFK 527
+F R +L++ H IS PSDF+H +TVQ PT K R + SPPGSP +PRL+A +
Sbjct: 483 RFRRGRLRLKDGHRISLPSDFQHKITVQASPTLDKRRSSDSGLCSPPGSPLMLPRLRAIQ 542
|
Activates the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 527 | ||||||
| 328784487 | 1610 | PREDICTED: hypothetical protein LOC41156 | 0.948 | 0.310 | 0.683 | 0.0 | |
| 340721197 | 1608 | PREDICTED: hypothetical protein LOC10064 | 0.948 | 0.310 | 0.683 | 0.0 | |
| 350399357 | 1608 | PREDICTED: hypothetical protein LOC10074 | 0.948 | 0.310 | 0.683 | 0.0 | |
| 383849938 | 1599 | PREDICTED: uncharacterized protein LOC10 | 0.948 | 0.312 | 0.681 | 0.0 | |
| 345490725 | 1556 | PREDICTED: hypothetical protein LOC10011 | 0.937 | 0.317 | 0.692 | 0.0 | |
| 307191858 | 983 | Mitogen-activated protein kinase kinase | 0.948 | 0.508 | 0.667 | 0.0 | |
| 332029638 | 1129 | Mitogen-activated protein kinase kinase | 0.948 | 0.442 | 0.671 | 0.0 | |
| 328699662 | 1103 | PREDICTED: mitogen-activated protein kin | 0.969 | 0.463 | 0.659 | 0.0 | |
| 270005270 | 710 | hypothetical protein TcasGA2_TC007298 [T | 0.986 | 0.732 | 0.648 | 0.0 | |
| 91081193 | 1113 | PREDICTED: similar to mixed lineage kina | 0.981 | 0.464 | 0.648 | 0.0 |
| >gi|328784487|ref|XP_395037.4| PREDICTED: hypothetical protein LOC411566 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/521 (68%), Positives = 409/521 (78%), Gaps = 21/521 (4%)
Query: 22 YGNHNRRNHRPD----LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI 77
+G H+ R D ++ AL+DY A G DELSL+RG+ VEVLSKDS ISGD GWWTGKI
Sbjct: 102 HGTHSSSQSRQDNSSTIFTALFDYVAQGEDELSLQRGETVEVLSKDSKISGDEGWWTGKI 161
Query: 78 EGKIEYKVGIFPANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGI 137
GK VGIFPANFV+ E I+ VSSVI+ V+ VEID+ +L E IG GGFGKVY+G
Sbjct: 162 HGK----VGIFPANFVAEAESIDQVSSVIDKVQPVEIDFEELQLEEVIGVGGFGKVYRGF 217
Query: 138 YEKQEVAIKVAHPNPDEN---ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194
++K EVA+K A +PDE LENV+QE KL WL H NIV L GVCL+ P +CLVMEY
Sbjct: 218 WQKHEVAVKAARQDPDEEPSVTLENVRQEAKLFWLLKHENIVQLEGVCLKMPNMCLVMEY 277
Query: 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254
ARGG LNRVL+GRKIRPDVLVDWAIQIA GM+YLH +APISLIHRDLKSSNVLLSEPIEN
Sbjct: 278 ARGGSLNRVLSGRKIRPDVLVDWAIQIARGMDYLHNKAPISLIHRDLKSSNVLLSEPIEN 337
Query: 255 EDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314
+DLQ+KTLKITDFGLAREVYKTT MSAAGTYAWMAPEVIK S FSKASDVWSYGV+LWEL
Sbjct: 338 DDLQYKTLKITDFGLAREVYKTTRMSAAGTYAWMAPEVIKKSTFSKASDVWSYGVLLWEL 397
Query: 315 LTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374
LTGE PYK I+A AVAYGVAVNKLTLPIPSTCPQ ++ LMEACW +DSH RP F IL A
Sbjct: 398 LTGETPYKGIDALAVAYGVAVNKLTLPIPSTCPQPWRFLMEACWASDSHSRPGFAEILVA 457
Query: 375 LNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAE 434
L+ V S F TPHESFH MQ+ WR+EIEQVLH LR+KEKELR REEELTKAQ+QQ+ E
Sbjct: 458 LDE-VRSAFAATPHESFHTMQEDWRLEIEQVLHGLRMKEKELRCREEELTKAQVQQRQHE 516
Query: 435 KELREREQAVAAREIDVLERELMIILQTAGPTPTPHKRGGKFNRSKLKVWKVH---DISS 491
+ LR+REQ +AAREID+LEREL +++ TPTP+KR GKF +S+LK+ K +IS+
Sbjct: 517 ENLRQREQELAAREIDLLERELTVMIIQQQNTPTPNKRRGKFKKSRLKLNKKEPGSNISA 576
Query: 492 PSDFRHTLTVQPTE------RKSRKATSPPGSPSIPRLQAF 526
PSDFRHT+TVQ T R + SPPGSPSIPRL+A
Sbjct: 577 PSDFRHTITVQHTALDRGKVRNPSRPNSPPGSPSIPRLRAI 617
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340721197|ref|XP_003399011.1| PREDICTED: hypothetical protein LOC100646749 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1817), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/521 (68%), Positives = 409/521 (78%), Gaps = 21/521 (4%)
Query: 22 YGNHNRRNHRPD----LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI 77
+G H+ R D ++ AL+DY A G DELSL+RG+ VEVLSKDS ISGD GWWTGKI
Sbjct: 102 HGTHSSSQSRQDNSSTIFTALFDYVAQGEDELSLQRGETVEVLSKDSKISGDEGWWTGKI 161
Query: 78 EGKIEYKVGIFPANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGI 137
GK VGIFPANFV+ E I+ VSSVI+ V+ VEID+ +L E IG GGFGKVY+G
Sbjct: 162 HGK----VGIFPANFVAEAESIDRVSSVIDKVQPVEIDFEELQLEEVIGVGGFGKVYRGF 217
Query: 138 YEKQEVAIKVAHPNPDEN---ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194
++K EVA+K A +PDE LENV+QE KL WL H NIV L GVCL+ P +CLVMEY
Sbjct: 218 WQKHEVAVKAARQDPDEEPSVTLENVRQEAKLFWLLKHENIVQLEGVCLKMPNMCLVMEY 277
Query: 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254
ARGG LNRVL+GRKIRPDVLVDWAIQIA GM+YLH +APISLIHRDLKSSNVLLSEPIEN
Sbjct: 278 ARGGSLNRVLSGRKIRPDVLVDWAIQIARGMDYLHNKAPISLIHRDLKSSNVLLSEPIEN 337
Query: 255 EDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314
+DLQ+KTLKITDFGLAREVYKTT MSAAGTYAWMAPEVIK S FSKASDVWSYGV+LWEL
Sbjct: 338 DDLQYKTLKITDFGLAREVYKTTRMSAAGTYAWMAPEVIKKSTFSKASDVWSYGVLLWEL 397
Query: 315 LTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374
LTGE PYK I+A AVAYGVAVNKLTLPIPSTCPQ ++ LMEACW +DSH RP F IL A
Sbjct: 398 LTGETPYKGIDALAVAYGVAVNKLTLPIPSTCPQPWRFLMEACWASDSHSRPGFAEILVA 457
Query: 375 LNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAE 434
L+ V S F TPHESFH MQ+ WR+EIEQVLH LR+KEKELR REEELTKAQ+QQ+ E
Sbjct: 458 LDE-VRSAFAATPHESFHTMQEDWRLEIEQVLHGLRMKEKELRCREEELTKAQVQQRQHE 516
Query: 435 KELREREQAVAAREIDVLERELMIILQTAGPTPTPHKRGGKFNRSKLKVWKVH---DISS 491
+ LR+REQ +AAREID+LEREL +++ TPTP+KR GKF +S+LK+ K +IS+
Sbjct: 517 ENLRQREQELAAREIDLLERELTVMIIQQQNTPTPNKRRGKFKKSRLKLNKKEPGSNISA 576
Query: 492 PSDFRHTLTVQPTE------RKSRKATSPPGSPSIPRLQAF 526
PSDFRHT+TVQ T R + SPPGSPSIPRL+A
Sbjct: 577 PSDFRHTITVQHTALDRGKVRNPSRPNSPPGSPSIPRLRAI 617
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350399357|ref|XP_003485498.1| PREDICTED: hypothetical protein LOC100743292 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1816), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/521 (68%), Positives = 409/521 (78%), Gaps = 21/521 (4%)
Query: 22 YGNHNRRNHRPD----LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI 77
+G H+ R D ++ AL+DY A G DELSL+RG+ VEVLSKDS ISGD GWWTGKI
Sbjct: 102 HGTHSSSQSRQDNSSTIFTALFDYVAQGEDELSLQRGETVEVLSKDSKISGDEGWWTGKI 161
Query: 78 EGKIEYKVGIFPANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGI 137
GK VGIFPANFV+ E I+ VSSVI+ V+ VEID+ +L E IG GGFGKVY+G
Sbjct: 162 HGK----VGIFPANFVAEAESIDRVSSVIDKVQPVEIDFEELQLEEVIGVGGFGKVYRGF 217
Query: 138 YEKQEVAIKVAHPNPDEN---ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194
++K EVA+K A +PDE LENV+QE KL WL H NIV L GVCL+ P +CLVMEY
Sbjct: 218 WQKHEVAVKAARQDPDEEPSVTLENVRQEAKLFWLLKHENIVQLEGVCLKMPNMCLVMEY 277
Query: 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254
ARGG LNRVL+GRKIRPDVLVDWAIQIA GM+YLH +APISLIHRDLKSSNVLLSEPIEN
Sbjct: 278 ARGGSLNRVLSGRKIRPDVLVDWAIQIARGMDYLHNKAPISLIHRDLKSSNVLLSEPIEN 337
Query: 255 EDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314
+DLQ+KTLKITDFGLAREVYKTT MSAAGTYAWMAPEVIK S FSKASDVWSYGV+LWEL
Sbjct: 338 DDLQYKTLKITDFGLAREVYKTTRMSAAGTYAWMAPEVIKKSTFSKASDVWSYGVLLWEL 397
Query: 315 LTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374
LTGE PYK I+A AVAYGVAVNKLTLPIPSTCPQ ++ LMEACW +DSH RP F IL A
Sbjct: 398 LTGETPYKGIDALAVAYGVAVNKLTLPIPSTCPQPWRFLMEACWASDSHSRPGFAEILVA 457
Query: 375 LNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAE 434
L+ V S F TPHESFH MQ+ WR+EIEQVLH LR+KEKELR REEELTKAQ+QQ+ E
Sbjct: 458 LDE-VRSAFAATPHESFHTMQEDWRLEIEQVLHGLRMKEKELRCREEELTKAQVQQRQHE 516
Query: 435 KELREREQAVAAREIDVLERELMIILQTAGPTPTPHKRGGKFNRSKLKVWKVH---DISS 491
+ LR+REQ +AAREID+LEREL +++ TPTP+KR GKF +S+LK+ K +IS+
Sbjct: 517 ENLRQREQELAAREIDLLERELTVMIIQQQNTPTPNKRRGKFKKSRLKLNKKEPGSNISA 576
Query: 492 PSDFRHTLTVQPTE------RKSRKATSPPGSPSIPRLQAF 526
PSDFRHT+TVQ T R + SPPGSPSIPRL+A
Sbjct: 577 PSDFRHTITVQHTALDRGKVRNPSRPNSPPGSPSIPRLRAI 617
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383849938|ref|XP_003700590.1| PREDICTED: uncharacterized protein LOC100876041 [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 703 bits (1814), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/521 (68%), Positives = 409/521 (78%), Gaps = 21/521 (4%)
Query: 22 YGNHNRRNHRPD----LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI 77
+G H+ R D ++ AL+DY A G DELSL+RG+ VEVLSKDS ISGD GWWTGKI
Sbjct: 102 HGTHSSSQSRQDNSSTIFTALFDYVAQGEDELSLQRGETVEVLSKDSKISGDEGWWTGKI 161
Query: 78 EGKIEYKVGIFPANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGI 137
GK VGIFPANFV+ + I+ VSSVI+ V+ VEID+ +L E IG GGFGKVY+G
Sbjct: 162 HGK----VGIFPANFVAEADSIDRVSSVIDKVQPVEIDFEELQLEEVIGVGGFGKVYRGF 217
Query: 138 YEKQEVAIKVAHPNPDEN---ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194
++K EVA+K A +PDE LENV+QE KL WL H NIV L GVCL+ P +CLVMEY
Sbjct: 218 WQKHEVAVKAARQDPDEEPSVTLENVRQEAKLFWLLKHENIVQLEGVCLKMPNMCLVMEY 277
Query: 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254
ARGG LNRVL+GRKIRPDVLVDWAIQIA GM+YLH +APISLIHRDLKSSNVLLSEPIEN
Sbjct: 278 ARGGSLNRVLSGRKIRPDVLVDWAIQIARGMDYLHNKAPISLIHRDLKSSNVLLSEPIEN 337
Query: 255 EDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314
+DLQ+KTLKITDFGLAREVYKTT MSAAGTYAWMAPEVIK S FSKASDVWSYGV+LWEL
Sbjct: 338 DDLQYKTLKITDFGLAREVYKTTRMSAAGTYAWMAPEVIKKSTFSKASDVWSYGVLLWEL 397
Query: 315 LTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374
LTGE PYK I+A AVAYGVAVNKLTLPIPSTCPQ ++ LMEACW +DSH RP F IL A
Sbjct: 398 LTGETPYKGIDALAVAYGVAVNKLTLPIPSTCPQPWRFLMEACWASDSHSRPGFAEILVA 457
Query: 375 LNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAE 434
L+ V S F TPHESFH MQ+ WR+EIEQVLH LR+KEKELR REEELTKAQ+QQ+ E
Sbjct: 458 LDE-VRSAFAATPHESFHTMQEDWRLEIEQVLHGLRMKEKELRCREEELTKAQVQQRQHE 516
Query: 435 KELREREQAVAAREIDVLERELMIILQTAGPTPTPHKRGGKFNRSKLKVWKVH---DISS 491
+ LR+REQ +AAREID+LEREL +++ TPTP+KR GKF +S+LK+ K +IS+
Sbjct: 517 ENLRQREQELAAREIDLLERELTVMIIQQQNTPTPNKRRGKFKKSRLKLNKKEPGSNISA 576
Query: 492 PSDFRHTLTVQPTE------RKSRKATSPPGSPSIPRLQAF 526
PSDFRHT+TVQ T R + SPPGSPSIPRL+A
Sbjct: 577 PSDFRHTITVQHTALDRGKVRNPSRPNSPPGSPSIPRLRAI 617
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345490725|ref|XP_001601792.2| PREDICTED: hypothetical protein LOC100117604 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/510 (69%), Positives = 404/510 (79%), Gaps = 16/510 (3%)
Query: 28 RNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGI 87
R+ L+ ALYDY A G DELSL+RG+ VEVLSKDS ISGD GWWTGKI GK VGI
Sbjct: 110 RHDSSTLFTALYDYVAQGEDELSLQRGETVEVLSKDSKISGDEGWWTGKIRGK----VGI 165
Query: 88 FPANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKV 147
FPANFV+ E I+ VSSVI V+ VEID+ +L E IG GGFGKVY+G + K+EVA+K
Sbjct: 166 FPANFVAEAETIDRVSSVIEQVQPVEIDFEELTLEEVIGVGGFGKVYRGFWNKKEVAVKA 225
Query: 148 AHPNPDEN---ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL 204
A +PDE L+NV+QE KL WL H NIV L GVCL+ P +CLVMEYARGG LNRVL
Sbjct: 226 ARQDPDEEPSATLQNVRQEAKLFWLLKHENIVQLEGVCLKMPNMCLVMEYARGGSLNRVL 285
Query: 205 AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264
+GRKIRPDVLVDWAIQIA GM+YLH +APISLIHRDLKSSNVLLSEPIEN+D Q+KTLKI
Sbjct: 286 SGRKIRPDVLVDWAIQIARGMDYLHNKAPISLIHRDLKSSNVLLSEPIENDDFQYKTLKI 345
Query: 265 TDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI 324
TDFGLAREVYKTT MSAAGTYAWMAPEVIK S FSKASDVWSYGV+LWELLTGE PYK I
Sbjct: 346 TDFGLAREVYKTTRMSAAGTYAWMAPEVIKKSTFSKASDVWSYGVLLWELLTGETPYKGI 405
Query: 325 NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384
+A AVAYGVAVNKLTLPIPSTCPQ ++ LMEACW +DSH RP F IL AL+ V S F
Sbjct: 406 DALAVAYGVAVNKLTLPIPSTCPQPWRCLMEACWLSDSHQRPGFAEILVALDE-VRSAFA 464
Query: 385 QTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKELREREQAV 444
TPHESFH MQ+ WR+EIEQVLH LR+KEKELR REEEL+KAQ+QQ+ E+ LR+RE+ +
Sbjct: 465 ATPHESFHTMQEDWRLEIEQVLHGLRMKEKELRCREEELSKAQVQQRQVEESLRQREKEL 524
Query: 445 AAREIDVLERELMI-ILQTAGPTPTPHKRGGKFNRSKLKVWKV-HDISSPSDFRHTLTVQ 502
AAREID+LEREL + I Q TPTP+ R GKF +SKL+ K+ + IS+PSDFRHT+TVQ
Sbjct: 525 AAREIDLLERELAVMITQQQSNTPTPNARRGKFKKSKLRSNKLGNKISAPSDFRHTITVQ 584
Query: 503 ---PTERKSR---KATSPPGSPSIPRLQAF 526
P KSR ++ SPP SPSIPRL+A
Sbjct: 585 NTAPDRVKSRNPSRSNSPPNSPSIPRLRAI 614
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307191858|gb|EFN75282.1| Mitogen-activated protein kinase kinase kinase 9 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1787), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/521 (66%), Positives = 406/521 (77%), Gaps = 21/521 (4%)
Query: 22 YGNHNRRNHRPD----LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI 77
+G H+ R D ++ AL+DY A G DELSL+RG+ VEVLSKDS ISGD GWWTGK+
Sbjct: 102 HGTHSSSQSRQDNSTTIFTALFDYVAQGEDELSLQRGETVEVLSKDSKISGDEGWWTGKV 161
Query: 78 EGKIEYKVGIFPANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGI 137
GK VGIFPANFV+ E I+ VSSVI+ V+ +EI++ +L E IG GGFGKVY+G
Sbjct: 162 HGK----VGIFPANFVAEAESIDRVSSVIDKVQPIEINFEELQLEEVIGVGGFGKVYRGF 217
Query: 138 YEKQEVAIKVAHPNPDEN---ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194
++ +EVA+K A +PDE LENV+QE KL WL H NIV L GVC++ P +CLVMEY
Sbjct: 218 WKGREVAVKAARQDPDEEPSVTLENVRQEAKLFWLLKHENIVQLEGVCIKMPNMCLVMEY 277
Query: 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254
ARGG LNRVL+GRKIRPDVLVDWAIQIA GM+YLH +APISLIHRDLKSSNVLLSEPIEN
Sbjct: 278 ARGGSLNRVLSGRKIRPDVLVDWAIQIARGMDYLHNKAPISLIHRDLKSSNVLLSEPIEN 337
Query: 255 EDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314
+DLQ+KTLKITDFGLAREVYKTT MSAAGTYAWMAPEVIK S FSKASDVWSYGV+LWEL
Sbjct: 338 DDLQYKTLKITDFGLAREVYKTTRMSAAGTYAWMAPEVIKKSTFSKASDVWSYGVLLWEL 397
Query: 315 LTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374
LTGEIPYK I+ A+AYGVAVNKLTLPIPSTCPQ ++ LME CW +DSH RP F IL A
Sbjct: 398 LTGEIPYKGIDTLAIAYGVAVNKLTLPIPSTCPQPWRYLMEECWASDSHARPGFAEILIA 457
Query: 375 LNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAE 434
L V F TPHESFH MQ+ WR+EIEQVLH LR+KEKELR REEELTKAQ+QQ+ E
Sbjct: 458 LEE-VRDAFAATPHESFHTMQEDWRLEIEQVLHGLRMKEKELRCREEELTKAQVQQRQHE 516
Query: 435 KELREREQAVAAREIDVLERELMIILQTAGPTPTPHKRGGKFNRSKLKVWKVH---DISS 491
+ LR+REQ +AAREID+LEREL +++ TPTP+KR GKF +S+LK+ K +IS+
Sbjct: 517 ENLRQREQELAAREIDLLERELTVMIIQQQNTPTPNKRRGKFKKSRLKLNKKEPGSNISA 576
Query: 492 PSDFRHTLTVQPTE------RKSRKATSPPGSPSIPRLQAF 526
PSDFRHT+TVQ T R + SPPGSPSIPRL+A
Sbjct: 577 PSDFRHTITVQHTALDRGKVRNPSRPNSPPGSPSIPRLRAI 617
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332029638|gb|EGI69527.1| Mitogen-activated protein kinase kinase kinase 9 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 691 bits (1784), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/521 (67%), Positives = 404/521 (77%), Gaps = 21/521 (4%)
Query: 22 YGNHNRRNHRPD----LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI 77
+G H+ R D ++ AL+DY A G DELSL+RG+ VEVLSKD+ ISGD GWWTGKI
Sbjct: 101 HGTHSSSQSRQDNSITIFTALFDYVAQGEDELSLQRGETVEVLSKDAKISGDEGWWTGKI 160
Query: 78 EGKIEYKVGIFPANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGI 137
GK VGIFPANFV+ E I+ VSSVI+ V+ +EID+ +L E IG GGFGKVY+G
Sbjct: 161 CGK----VGIFPANFVAEAESIDRVSSVIDKVQPIEIDFEELQLEEVIGVGGFGKVYRGF 216
Query: 138 YEKQEVAIKVAHPNPDEN---ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194
++K+EVA+K A + E LENV+QE KL WL H NIV L GVCL+ P +CLVMEY
Sbjct: 217 WKKREVAVKAARQDAGEEPSATLENVRQEAKLFWLLKHENIVQLEGVCLKMPNMCLVMEY 276
Query: 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254
ARGG LNRVL+GRKIRPDVLVDWAIQIA GM+YLH +APISLIHRDLKSSNVLLSEPIEN
Sbjct: 277 ARGGSLNRVLSGRKIRPDVLVDWAIQIARGMDYLHNKAPISLIHRDLKSSNVLLSEPIEN 336
Query: 255 EDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314
+D Q+KTLKITDFGLAREVYKTT MSAAGTYAWMAPEVIK S FSKASDVWSYGV+LWEL
Sbjct: 337 DDFQYKTLKITDFGLAREVYKTTRMSAAGTYAWMAPEVIKKSTFSKASDVWSYGVLLWEL 396
Query: 315 LTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374
LTGE PYK I+A AVAYGVAVNKLTLPIPSTCPQ + LMEACW +DSH RP F IL A
Sbjct: 397 LTGETPYKGIDALAVAYGVAVNKLTLPIPSTCPQPWSLLMEACWASDSHARPGFTDILIA 456
Query: 375 LNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAE 434
L+ V S F TPHESFH MQ+ WR EIEQVLH LR+KEKELR REEELTKAQ+QQ+ E
Sbjct: 457 LDE-VRSAFAATPHESFHTMQEDWRQEIEQVLHGLRMKEKELRCREEELTKAQVQQRQHE 515
Query: 435 KELREREQAVAAREIDVLERELMIILQTAGPTPTPHKRGGKFNRSKLKVWKVH---DISS 491
+ LR+REQ +AAREI +LEREL +++ TPTP+KR GKF +S+LK+ K +IS+
Sbjct: 516 ENLRQREQELAAREIAILERELTVMIIQQQNTPTPNKRRGKFKKSRLKLNKKEPGSNISA 575
Query: 492 PSDFRHTLTVQPTE------RKSRKATSPPGSPSIPRLQAF 526
PSDFRHT+TVQ T R + SPPGSPSIPRL+A
Sbjct: 576 PSDFRHTITVQDTALDRGKVRNPSRPNSPPGSPSIPRLRAI 616
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328699662|ref|XP_001944334.2| PREDICTED: mitogen-activated protein kinase kinase kinase 9-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/535 (65%), Positives = 415/535 (77%), Gaps = 24/535 (4%)
Query: 12 YQNEVDSDLLYGNHNRRNHRP-----DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAI 66
Y N S Y N H+ LW A+Y+Y+A G DELSL+RGDIVEVLS D+ I
Sbjct: 39 YANTTASSSYYKNKYTTQHQAAAANLPLWTAIYNYEAQGEDELSLKRGDIVEVLSTDAKI 98
Query: 67 SGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIG 126
SGD GWWTGK+ K VGIFPANFV+ + V++V+ + + EID+ +L E IG
Sbjct: 99 SGDEGWWTGKLGDK----VGIFPANFVTENNILENVTTVVGNAHITEIDFGELELEEVIG 154
Query: 127 EGGFGKVYKGIYEKQEVAIKVAHPNPDENILE---NVKQEGKLLWLFDHRNIVSLIGVCL 183
GGFGKVY+G + +EVA+K A +PDE+I E NVKQE L WL D+ NIVS++GVCL
Sbjct: 155 VGGFGKVYRGYWNNKEVAVKAARQDPDEDISETVKNVKQEANLFWLLDNENIVSMLGVCL 214
Query: 184 QSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKS 243
Q P LCL+MEYARGG LNRVL GRKIRPDVLVDWAIQIA GMNYLH APISLIHRDLKS
Sbjct: 215 QIPNLCLIMEYARGGSLNRVLMGRKIRPDVLVDWAIQIARGMNYLHNGAPISLIHRDLKS 274
Query: 244 SNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASD 303
SNVLL+E IEN DLQFKTLKITDFGLAREVYKTT MSAAGTYAWMAPEVIK SIFSKASD
Sbjct: 275 SNVLLNETIENNDLQFKTLKITDFGLAREVYKTTRMSAAGTYAWMAPEVIKKSIFSKASD 334
Query: 304 VWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSH 363
VWSYGV+LWELLTGE+PYK I+ AVAYGVAVNKLTLPIPSTCPQ F+ LMEACW +DSH
Sbjct: 335 VWSYGVLLWELLTGEMPYKGIDVLAVAYGVAVNKLTLPIPSTCPQPFRELMEACWHSDSH 394
Query: 364 MRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEEL 423
MRPSF+ IL +L++IVHS F QTPHESFH +QD W+VEIEQVL LR+KEKELR REEEL
Sbjct: 395 MRPSFEDILTSLDDIVHSAFTQTPHESFHTLQDVWKVEIEQVLDGLRMKEKELRCREEEL 454
Query: 424 TKAQMQQKLAEKELREREQAVAAREIDVLERELMIIL--QTAGPT-PTPHKRGGKFNRSK 480
++AQ+QQ++AEK L++RE+ + ARE+++L+ EL II+ Q A P PTP+KR G F +S
Sbjct: 455 SRAQVQQQIAEKHLKQRERDLEAREMELLKWELNIIMQQQQASPAIPTPNKRRGHFKKSN 514
Query: 481 -LKVWKVH----DISSPSDFRHTLTVQPT-ERKSRKAT---SPPGSPSIPRLQAF 526
LK+ K ISSPSDFRHT+TVQ T +RK+R A+ SPPGSP+IPRL+A
Sbjct: 515 ILKMLKKEPNQLPISSPSDFRHTITVQHTSDRKNRDASGPNSPPGSPNIPRLRAI 569
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270005270|gb|EFA01718.1| hypothetical protein TcasGA2_TC007298 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 677 bits (1746), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/543 (64%), Positives = 408/543 (75%), Gaps = 23/543 (4%)
Query: 1 MPPL------LDSMEHPYQNEVDSDLLYGNHNRRNHRP---DLWRALYDYDAIGLDELSL 51
MPPL L SME P ++ S + G R P LW ALYDYDA G DELSL
Sbjct: 1 MPPLVEHYHFLTSMEPPRNGDMVSSVHVGERTHRTANPITPALWTALYDYDAQGEDELSL 60
Query: 52 RRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDINLVSSVINDVKL 111
R+G IVEVLS+D+ ISGD GWWTGKI K VGIFP+NFV+ + IN V+S+I D+
Sbjct: 61 RKGQIVEVLSEDAKISGDEGWWTGKIGDK----VGIFPSNFVAYEDPINHVNSIIVDIHP 116
Query: 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENI---LENVKQEGKLLW 168
+EID+N+L E IG GGFGKVY+G++ EVA+K A +PD +I LENV +E KL
Sbjct: 117 IEIDFNELELEEVIGVGGFGKVYRGVWRGHEVAVKAARQDPDADISVTLENVVKEAKLFC 176
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYL 228
L H NIVSL GVCLQ P LCLV+EY RGG LNRVLAGRKIRPDVLVDWAIQIA GM+YL
Sbjct: 177 LLKHENIVSLEGVCLQEPNLCLVLEYCRGGSLNRVLAGRKIRPDVLVDWAIQIARGMDYL 236
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM 288
HC APISLIHRDLKSSNVLL E IEN+DL KTLKITDFGLAREVYKTT MS AGTYAWM
Sbjct: 237 HCGAPISLIHRDLKSSNVLLREAIENDDLLSKTLKITDFGLAREVYKTTRMSQAGTYAWM 296
Query: 289 APEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348
APEVIK S FS+ASDVWSYGVVLWELLTGE PYK I+ AVAYGVAVNKLTLPIPSTCPQ
Sbjct: 297 APEVIKNSTFSRASDVWSYGVVLWELLTGETPYKGIDTLAVAYGVAVNKLTLPIPSTCPQ 356
Query: 349 LFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHE 408
++ LME CW++D H+RPSF+ IL L I +S F QTPHESFHIMQD WR EIE+VL E
Sbjct: 357 PWRELMEKCWKSDPHLRPSFEQILFDLELIFNSSFTQTPHESFHIMQDDWRQEIEEVLLE 416
Query: 409 LRVKEKELRSREEELTKAQMQQKLAEKELREREQAVAAREIDVLERELMIILQTAGPTPT 468
LR KEKELR REE+L +AQM+Q++ E++LR++EQ + AREID+LEREL +++ TPT
Sbjct: 417 LRRKEKELRCREEDLNRAQMKQRMHEEQLRQKEQELQAREIDLLERELHFMIKQQ--TPT 474
Query: 469 PHKRGGKFNRSKLKVWKVH---DISSPSDFRHTLTVQPT--ERKSRKATSPPGSPSIPRL 523
P KR GKF RS+LK+ K +IS PSDFRHT+TVQ T + SPPGSP+I RL
Sbjct: 475 PIKRKGKFKRSRLKLLKKEPGSNISLPSDFRHTITVQHTLDHKAVISPHSPPGSPAITRL 534
Query: 524 QAF 526
+A
Sbjct: 535 RAI 537
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|91081193|ref|XP_975604.1| PREDICTED: similar to mixed lineage kinase [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 676 bits (1743), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/546 (64%), Positives = 410/546 (75%), Gaps = 29/546 (5%)
Query: 1 MPPL------LDSMEHPYQNEVDSDLLYGNHNRRNHR------PDLWRALYDYDAIGLDE 48
MPPL L SME P ++ S + G R HR P LW ALYDYDA G DE
Sbjct: 1 MPPLVEHYHFLTSMEPPRNGDMVSSVHVG---ERTHRTANPITPALWTALYDYDAQGEDE 57
Query: 49 LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDINLVSSVIND 108
LSLR+G IVEVLS+D+ ISGD GWWTGKI K VGIFP+NFV+ + IN V+S+I D
Sbjct: 58 LSLRKGQIVEVLSEDAKISGDEGWWTGKIGDK----VGIFPSNFVAYEDPINHVNSIIVD 113
Query: 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENI---LENVKQEGK 165
+ +EID+N+L E IG GGFGKVY+G++ EVA+K A +PD +I LENV +E K
Sbjct: 114 IHPIEIDFNELELEEVIGVGGFGKVYRGVWRGHEVAVKAARQDPDADISVTLENVVKEAK 173
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGM 225
L L H NIVSL GVCLQ P LCLV+EY RGG LNRVLAGRKIRPDVLVDWAIQIA GM
Sbjct: 174 LFCLLKHENIVSLEGVCLQEPNLCLVLEYCRGGSLNRVLAGRKIRPDVLVDWAIQIARGM 233
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTY 285
+YLHC APISLIHRDLKSSNVLL E IEN+DL KTLKITDFGLAREVYKTT MS AGTY
Sbjct: 234 DYLHCGAPISLIHRDLKSSNVLLREAIENDDLLSKTLKITDFGLAREVYKTTRMSQAGTY 293
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST 345
AWMAPEVIK S FS+ASDVWSYGVVLWELLTGE PYK I+ AVAYGVAVNKLTLPIPST
Sbjct: 294 AWMAPEVIKNSTFSRASDVWSYGVVLWELLTGETPYKGIDTLAVAYGVAVNKLTLPIPST 353
Query: 346 CPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRVEIEQV 405
CPQ ++ LME CW++D H+RPSF+ IL L I +S F QTPHESFHIMQD WR EIE+V
Sbjct: 354 CPQPWRELMEKCWKSDPHLRPSFEQILFDLELIFNSSFTQTPHESFHIMQDDWRQEIEEV 413
Query: 406 LHELRVKEKELRSREEELTKAQMQQKLAEKELREREQAVAAREIDVLERELMIILQTAGP 465
L ELR KEKELR REE+L +AQM+Q++ E++LR++EQ + AREID+LEREL +++
Sbjct: 414 LLELRRKEKELRCREEDLNRAQMKQRMHEEQLRQKEQELQAREIDLLERELHFMIKQQ-- 471
Query: 466 TPTPHKRGGKFNRSKLKVWKVH---DISSPSDFRHTLTVQPT--ERKSRKATSPPGSPSI 520
TPTP KR GKF RS+LK+ K +IS PSDFRHT+TVQ T + SPPGSP+I
Sbjct: 472 TPTPIKRKGKFKRSRLKLLKKEPGSNISLPSDFRHTITVQHTLDHKAVISPHSPPGSPAI 531
Query: 521 PRLQAF 526
RL+A
Sbjct: 532 TRLRAI 537
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 527 | ||||||
| ZFIN|ZDB-GENE-090312-24 | 1017 | si:ch211-120p12.3 "si:ch211-12 | 0.929 | 0.481 | 0.544 | 2.5e-136 | |
| UNIPROTKB|F1NCM2 | 992 | LOC425792 "Uncharacterized pro | 0.929 | 0.493 | 0.515 | 7.1e-132 | |
| ZFIN|ZDB-GENE-081113-5 | 1024 | map3k9 "mitogen-activated prot | 0.927 | 0.477 | 0.510 | 2.9e-131 | |
| UNIPROTKB|F1LRA7 | 1077 | Map3k9 "Protein Map3k9" [Rattu | 0.927 | 0.454 | 0.516 | 1.3e-130 | |
| UNIPROTKB|J3KPI6 | 1081 | MAP3K9 "Mitogen-activated prot | 0.927 | 0.452 | 0.516 | 4.5e-130 | |
| UNIPROTKB|P80192 | 1104 | MAP3K9 "Mitogen-activated prot | 0.927 | 0.442 | 0.516 | 4.5e-130 | |
| MGI|MGI:2449952 | 1077 | Map3k9 "mitogen-activated prot | 0.927 | 0.454 | 0.514 | 5.7e-130 | |
| ZFIN|ZDB-GENE-050419-112 | 1062 | map3k10 "mitogen-activated pro | 0.952 | 0.472 | 0.515 | 5.7e-130 | |
| UNIPROTKB|Q7T2V3 | 1005 | map3k10 "Mitogen-activated pro | 0.975 | 0.511 | 0.495 | 1.4e-129 | |
| UNIPROTKB|F1NI81 | 1060 | LOC425792 "Uncharacterized pro | 0.929 | 0.462 | 0.513 | 3.2e-129 |
| ZFIN|ZDB-GENE-090312-24 si:ch211-120p12.3 "si:ch211-120p12.3" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1317 (468.7 bits), Expect = 2.5e-136, Sum P(2) = 2.5e-136
Identities = 276/507 (54%), Positives = 346/507 (68%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
LW A++DY+A G DELSLRRGD+VEVLSKD+AISGD GWWTGKI ++VGIFP+N+V
Sbjct: 42 LWTAVFDYEASGEDELSLRRGDVVEVLSKDAAISGDEGWWTGKIN----HRVGIFPSNYV 97
Query: 94 SSIEDI-NLVSSVINDVKL-VEIDYNKLXXXXXXXXXXXXKVYKGIYEKQEVAIKVAHPN 151
+ I V + +D V I +++L KVY+G ++ QEVA+K A +
Sbjct: 98 TFQPVIYRAVGARESDPSAPVRIPFSELVLQEIIGVGGFGKVYRGTWKVQEVAVKAARQD 157
Query: 152 PDENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK 208
PDE+I ++VKQE KL + H NI+ L GVCL+ P LCLVMEYARGG LNR L GR+
Sbjct: 158 PDEDIKATADSVKQEAKLFSMLQHPNIIKLEGVCLEEPNLCLVMEYARGGTLNRALTGRR 217
Query: 209 IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268
I P +LV+WA+QIA GM YLH +A + +IHRDLKSSN+LL E IEN+D+ KTLKITDFG
Sbjct: 218 IPPHILVNWAVQIARGMQYLHEEAVVPIIHRDLKSSNILLLEKIENDDIGRKTLKITDFG 277
Query: 269 LAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINXXX 328
LARE +KTT MSAAGTY+WMAPEVIK+S+FSK SDVWSYGV+LWELLTGEIPY+ I+
Sbjct: 278 LAREWHKTTKMSAAGTYSWMAPEVIKSSLFSKGSDVWSYGVLLWELLTGEIPYRGIDGLA 337
Query: 329 XXXXXXXNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPH 388
NKLTLPIPSTCP+ F LME CWE D H+RPSF IL+ L I + P
Sbjct: 338 VAYGVAVNKLTLPIPSTCPEPFAKLMEECWEQDPHIRPSFAAILEQLTAIEEAVMATMPQ 397
Query: 389 ESFHIMQDGWRVEIEQVLHXXXXXXXXXXXXXXXXXXAQMQQKLAEKELREREQAVAARE 448
+SFH MQ+ WRVEI+++ A +QQK E+ L+ REQ +A RE
Sbjct: 398 DSFHSMQEDWRVEIQEMFDELRTKEKELRSREEELTRAALQQKSHEELLKRREQQLAERE 457
Query: 449 IDVLEREL-MIILQTAGPTPTPHKRGGKFNRSKLKVWKVHDISSPSDFRHTLTVQ--PT- 504
I+VLEREL ++I Q P KR GKF RS+LK+ + IS PSDF+H +TVQ PT
Sbjct: 458 INVLERELNILIFQQNKDKPNVKKRKGKFKRSRLKLKDGNRISLPSDFQHKITVQASPTM 517
Query: 505 -ERKSRKAT--SPPGSPS-IPRLQAFK 527
+R+S +T SPP SP+ IPRL+A +
Sbjct: 518 DKRRSLNSTNSSPPSSPTLIPRLRAIQ 544
|
|
| UNIPROTKB|F1NCM2 LOC425792 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1293 (460.2 bits), Expect = 7.1e-132, P = 7.1e-132
Identities = 261/506 (51%), Positives = 347/506 (68%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
LW A+++Y+A G DELSLR GD+V+VLS+DS +SGD GWWTG+I+ +VGIFP+N+V
Sbjct: 2 LWTAVFEYEACGEDELSLRPGDVVQVLSRDSQVSGDEGWWTGQID----QRVGIFPSNYV 57
Query: 94 SSIEDINLVSSVINDVKLV-EIDYNKLXXXXXXXXXXXXKVYKGIYEKQEVAIKVAHPNP 152
+ ++ + ++ L+ EID+++L KVY+ ++ EVA+K A +P
Sbjct: 58 LPCDSVSYTAVILKSSPLILEIDFSELVLEEIIGIGGFGKVYRAVWIGDEVAVKAARYDP 117
Query: 153 DENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKI 209
DE+I +ENV+QE KL + H NI++L GVCL+ P LCL+ME+ARGG LNRVL+G++I
Sbjct: 118 DEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLIMEFARGGSLNRVLSGKRI 177
Query: 210 RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269
PD+LV+WA+QIA+GMNYLH +A + +IHRDLKSSN+L+ E +EN DL K LKITDFGL
Sbjct: 178 PPDILVNWAVQIAKGMNYLHEEAIVPIIHRDLKSSNILILEKVENGDLSNKILKITDFGL 237
Query: 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINXXXX 329
ARE +KTT MSAAGTYAWMAPEVI++S+FSK SDVWSYGV+LWELLTGE+P++ I+
Sbjct: 238 AREWHKTTKMSAAGTYAWMAPEVIRSSMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV 297
Query: 330 XXXXXXNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHE 389
NKL LPIPSTCP+ F LME CW D H RPSF +IL L I S F + P +
Sbjct: 298 AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFASILGHLTAIEESGFFEMPKD 357
Query: 390 SFHIMQDGWRVEIEQVLHXXXXXXXXXXXXXXXXXXAQMQQKLAEKELREREQAVAAREI 449
SFH +Q+ W+ EI+++ A ++QK E+ LR REQ +A REI
Sbjct: 358 SFHSLQEDWKQEIQEMFDQLRAKEKELRTWEEELTRAAVEQKNHEELLRRREQELAEREI 417
Query: 450 DVLERELMIIL-QTAGPTPTPHKRGGKFNRSKLKVWKVHDISSPSDFRHTLTVQ--PT-- 504
D+LEREL II+ Q P KR GKF +S+LK+ ++IS PSDF+H TVQ PT
Sbjct: 418 DILERELNIIIHQLCQEKPRVKKRMGKFKKSRLKLKDGNNISLPSDFQHKFTVQASPTMD 477
Query: 505 ERKS--RKATSPPGSPSI-PRLQAFK 527
+RKS +SPP SP+I PRL+A +
Sbjct: 478 KRKSLISSCSSPPASPTIIPRLRAIQ 503
|
|
| ZFIN|ZDB-GENE-081113-5 map3k9 "mitogen-activated protein kinase kinase kinase 9" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1267 (451.1 bits), Expect = 2.9e-131, Sum P(2) = 2.9e-131
Identities = 263/515 (51%), Positives = 338/515 (65%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
W A++DY+A DELSLR+GD VEVLSKDS +SGD GWWTG IE + VGIFP+N+VS
Sbjct: 60 WTAVFDYEATAEDELSLRKGDRVEVLSKDSLVSGDEGWWTGMIEDR----VGIFPSNYVS 115
Query: 95 S------IEDI--NLVSSVINDVKLVEIDYNKLXXXXXXXXXXXXKVYKGIYEKQEVAIK 146
S I D + + + L++ID+++L KVY+ I+ QEVA+K
Sbjct: 116 SNGISEKIRDTPEDYCDYSVPPLHLLQIDFSELALEEMIGVGGFGKVYRAIWNGQEVAVK 175
Query: 147 VAHPNPDENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRV 203
A +PDE++ LE+V+QE KL + H NI++L+GVCLQ P LCLVMEYARGGPLNR
Sbjct: 176 AARRDPDEDVSQTLESVRQEAKLFAMLTHPNIMALLGVCLQEPNLCLVMEYARGGPLNRA 235
Query: 204 LAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263
LAG++I P LVDWA+QIA M YLHCQA + +IHRDLKSS VL+ E +EN+DL KTLK
Sbjct: 236 LAGKRIPPHTLVDWAVQIARAMLYLHCQAIVPVIHRDLKSSKVLILERVENDDLSNKTLK 295
Query: 264 ITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKS 323
+TDFGLARE ++TT MSAAGTYAWMAPEVI++S FSK SDVWSYGV+LWELLTGE+P++
Sbjct: 296 VTDFGLAREWHRTTKMSAAGTYAWMAPEVIRSSTFSKGSDVWSYGVLLWELLTGEVPFRG 355
Query: 324 INXXXXXXXXXXNKLTLPIPSTCPQLFKTLMEA---CWEADSHMRPSFKTILKALNNIVH 380
I+ NKL+LPIPSTCP+ F LMEA CW D H RP F +IL L I
Sbjct: 356 IDGLAVAYGVAMNKLSLPIPSTCPEPFARLMEAAVDCWNVDPHSRPPFTSILDQLTAIEE 415
Query: 381 SEFIQTPHESFHIMQDGWRVEIEQVLHXXXXXXXXXXXXXXXXXXAQMQQKLAEKELRER 440
S F + P ESF +QD W++E++++ A +QQK E+ LR R
Sbjct: 416 SGFFEMPAESFQSLQDDWKLEVQEMFDQLRAKEKELRSWEEELSRAALQQKYQEEALRRR 475
Query: 441 EQAVAAREIDVLERELMIIL-QTAGPTPTPHKRGGKFNRSKLKVWKVHDISSPSDFRHTL 499
EQ +A REI +LEREL +I+ Q P R GKF RS+LK+ + IS PSDF+H +
Sbjct: 476 EQELAEREIHILERELNVIIHQLYQEKPRVQHRHGKFRRSRLKLRDGNRISLPSDFQHKI 535
Query: 500 TVQPTERKSRKAT------SPPGSPSI-PRLQAFK 527
TVQ + R+ + +PP SP + PRL+A +
Sbjct: 536 TVQASPSLDRRRSLLGSNSTPPNSPPVLPRLRAIQ 570
|
|
| UNIPROTKB|F1LRA7 Map3k9 "Protein Map3k9" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1281 (456.0 bits), Expect = 1.3e-130, P = 1.3e-130
Identities = 264/511 (51%), Positives = 341/511 (66%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV- 93
W A+++Y+A G DEL+LR GD+VEVLSKDS +SGD GWWTG++ +VGIFP+N+V
Sbjct: 50 WTAVFEYEAAGEDELTLRLGDVVEVLSKDSQVSGDEGWWTGQLN----QRVGIFPSNYVT 105
Query: 94 ------SSIEDINLVSSVINDVKLVEIDYNKLXXXXXXXXXXXXKVYKGIYEKQEVAIKV 147
S + S ++L+EID+ +L KVY+ + EVA+K
Sbjct: 106 PRSAFSSRCQPGTEDPSCYPPIQLLEIDFAELTLEEIIGIGGFGKVYRAFWVGDEVAVKA 165
Query: 148 AHPNPDENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL 204
A +PDE+I +ENV+QE KL + H NI++L GVCL+ P LCLVME+ARGGPLNRVL
Sbjct: 166 ARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL 225
Query: 205 AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264
+G+++ PD+LV+WA+QIA GMNYLH +A + +IHRDLKSSN+L+ + +EN DL KTLKI
Sbjct: 226 SGKRVPPDILVNWAVQIARGMNYLHDEAIVPVIHRDLKSSNILILQKVENGDLSNKTLKI 285
Query: 265 TDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI 324
TDFGLARE ++TT MSAAGTYAWMAPEVI+ S+FSK SDVWSYGV+LWELLTGE+P++ I
Sbjct: 286 TDFGLAREWHRTTKMSAAGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 345
Query: 325 NXXXXXXXXXXNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384
+ NKL LPIPSTCP+ F LME CW D H RPSF +IL L I S F
Sbjct: 346 DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFSSILDQLTTIEESGFF 405
Query: 385 QTPHESFHIMQDGWRVEIEQVLHXXXXXXXXXXXXXXXXXXAQMQQKLAEKELREREQAV 444
+ P +SFH +QD W+ EI+++ A +QQK E+ LR REQ +
Sbjct: 406 EMPKDSFHCLQDDWKHEIQEMFDQLRAKEKELRTWEEELTRAALQQKNQEELLRRREQEL 465
Query: 445 AAREIDVLERELMIIL-QTAGPTPTPHKRGGKFNRSKLKVWKVHDISSPSDFRHTLTVQ- 502
A REID+LEREL II+ Q P KR GKF +S+LK+ + IS PSDF+H TVQ
Sbjct: 466 AEREIDILERELNIIIHQLCQEKPRVKKRKGKFRKSRLKLKDGNRISLPSDFQHKFTVQA 525
Query: 503 -PT--ERKS--RKATSPPGSPSI-PRLQAFK 527
PT +RKS +SPP SP+I PRL+A +
Sbjct: 526 SPTMDKRKSLISNRSSPPASPTIIPRLRAIQ 556
|
|
| UNIPROTKB|J3KPI6 MAP3K9 "Mitogen-activated protein kinase kinase kinase 9" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1276 (454.2 bits), Expect = 4.5e-130, P = 4.5e-130
Identities = 264/511 (51%), Positives = 339/511 (66%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV- 93
W A+++Y+A G DEL+LR GD+VEVLSKDS +SGD GWWTG++ +VGIFP+N+V
Sbjct: 57 WTAVFEYEAAGEDELTLRLGDVVEVLSKDSQVSGDEGWWTGQLN----QRVGIFPSNYVT 112
Query: 94 ------SSIEDINLVSSVINDVKLVEIDYNKLXXXXXXXXXXXXKVYKGIYEKQEVAIKV 147
S + S ++L+EID+ +L KVY+ + EVA+K
Sbjct: 113 PRSAFSSRCQPGGEDPSCYPPIQLLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKA 172
Query: 148 AHPNPDENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL 204
A +PDE+I +ENV+QE KL + H NI++L GVCL+ P LCLVME+ARGGPLNRVL
Sbjct: 173 ARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL 232
Query: 205 AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264
+G++I PD+LV+WA+QIA GMNYLH +A + +IHRDLKSSN+L+ + +EN DL K LKI
Sbjct: 233 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 292
Query: 265 TDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI 324
TDFGLARE ++TT MSAAGTYAWMAPEVI+ S+FSK SDVWSYGV+LWELLTGE+P++ I
Sbjct: 293 TDFGLAREWHRTTKMSAAGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 352
Query: 325 NXXXXXXXXXXNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384
+ NKL LPIPSTCP+ F LME CW D H RPSF IL L I S F
Sbjct: 353 DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTIEESGFF 412
Query: 385 QTPHESFHIMQDGWRVEIEQVLHXXXXXXXXXXXXXXXXXXAQMQQKLAEKELREREQAV 444
+ P +SFH +QD W+ EI+++ A +QQK E+ LR REQ +
Sbjct: 413 EMPKDSFHCLQDNWKHEIQEMFDQLRAKEKELRTWEEELTRAALQQKNQEELLRRREQEL 472
Query: 445 AAREIDVLERELMIIL-QTAGPTPTPHKRGGKFNRSKLKVWKVHDISSPSDFRHTLTVQ- 502
A REID+LEREL II+ Q P KR GKF +S+LK+ + IS PSDF+H TVQ
Sbjct: 473 AEREIDILERELNIIIHQLCQEKPRVKKRKGKFRKSRLKLKDGNRISLPSDFQHKFTVQA 532
Query: 503 -PT--ERKS--RKATSPPGSPSI-PRLQAFK 527
PT +RKS +SPP SP+I PRL+A +
Sbjct: 533 SPTMDKRKSLINSRSSPPASPTIIPRLRAIQ 563
|
|
| UNIPROTKB|P80192 MAP3K9 "Mitogen-activated protein kinase kinase kinase 9" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1276 (454.2 bits), Expect = 4.5e-130, P = 4.5e-130
Identities = 264/511 (51%), Positives = 339/511 (66%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV- 93
W A+++Y+A G DEL+LR GD+VEVLSKDS +SGD GWWTG++ +VGIFP+N+V
Sbjct: 57 WTAVFEYEAAGEDELTLRLGDVVEVLSKDSQVSGDEGWWTGQLN----QRVGIFPSNYVT 112
Query: 94 ------SSIEDINLVSSVINDVKLVEIDYNKLXXXXXXXXXXXXKVYKGIYEKQEVAIKV 147
S + S ++L+EID+ +L KVY+ + EVA+K
Sbjct: 113 PRSAFSSRCQPGGEDPSCYPPIQLLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKA 172
Query: 148 AHPNPDENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL 204
A +PDE+I +ENV+QE KL + H NI++L GVCL+ P LCLVME+ARGGPLNRVL
Sbjct: 173 ARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL 232
Query: 205 AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264
+G++I PD+LV+WA+QIA GMNYLH +A + +IHRDLKSSN+L+ + +EN DL K LKI
Sbjct: 233 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 292
Query: 265 TDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI 324
TDFGLARE ++TT MSAAGTYAWMAPEVI+ S+FSK SDVWSYGV+LWELLTGE+P++ I
Sbjct: 293 TDFGLAREWHRTTKMSAAGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 352
Query: 325 NXXXXXXXXXXNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384
+ NKL LPIPSTCP+ F LME CW D H RPSF IL L I S F
Sbjct: 353 DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTIEESGFF 412
Query: 385 QTPHESFHIMQDGWRVEIEQVLHXXXXXXXXXXXXXXXXXXAQMQQKLAEKELREREQAV 444
+ P +SFH +QD W+ EI+++ A +QQK E+ LR REQ +
Sbjct: 413 EMPKDSFHCLQDNWKHEIQEMFDQLRAKEKELRTWEEELTRAALQQKNQEELLRRREQEL 472
Query: 445 AAREIDVLERELMIIL-QTAGPTPTPHKRGGKFNRSKLKVWKVHDISSPSDFRHTLTVQ- 502
A REID+LEREL II+ Q P KR GKF +S+LK+ + IS PSDF+H TVQ
Sbjct: 473 AEREIDILERELNIIIHQLCQEKPRVKKRKGKFRKSRLKLKDGNRISLPSDFQHKFTVQA 532
Query: 503 -PT--ERKS--RKATSPPGSPSI-PRLQAFK 527
PT +RKS +SPP SP+I PRL+A +
Sbjct: 533 SPTMDKRKSLINSRSSPPASPTIIPRLRAIQ 563
|
|
| MGI|MGI:2449952 Map3k9 "mitogen-activated protein kinase kinase kinase 9" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1275 (453.9 bits), Expect = 5.7e-130, P = 5.7e-130
Identities = 263/511 (51%), Positives = 340/511 (66%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
W A+++Y+A G DEL+LR GD+VEVLSKDS +SGD GWWTG++ +VGIFP+N+V+
Sbjct: 50 WTAVFEYEAAGEDELTLRLGDVVEVLSKDSQVSGDEGWWTGQLN----QRVGIFPSNYVT 105
Query: 95 SIEDINLVS-------SVINDVKLVEIDYNKLXXXXXXXXXXXXKVYKGIYEKQEVAIKV 147
+ S ++L+EID+ +L KVY+ + EVA+K
Sbjct: 106 PRSAFSSRCQPGAEDPSCYPPIQLLEIDFAELTLEEIIGIGGFGKVYRAFWAGDEVAVKA 165
Query: 148 AHPNPDENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL 204
A +PDE+I +ENV+QE KL + H NI++L GVCL+ P LCLVME+ARGGPLNRVL
Sbjct: 166 ARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL 225
Query: 205 AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264
+G++I PD+LV+WA+QIA GMNYLH +A + +IHRDLKSSN+L+ + +EN DL K LKI
Sbjct: 226 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 285
Query: 265 TDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI 324
TDFGLARE ++TT MSAAGTYAWMAPEVI+ S+FSK SDVWSYGV+LWELLTGE+P++ I
Sbjct: 286 TDFGLAREWHRTTKMSAAGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 345
Query: 325 NXXXXXXXXXXNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384
+ NKL LPIPSTCP+ F LME CW D H RPSF +IL L I S F
Sbjct: 346 DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTSILDQLTTIEESGFF 405
Query: 385 QTPHESFHIMQDGWRVEIEQVLHXXXXXXXXXXXXXXXXXXAQMQQKLAEKELREREQAV 444
+ P +SFH +QD W+ EI+++ A +QQK E+ LR REQ +
Sbjct: 406 EMPKDSFHCLQDDWKHEIQEMFDQLRAKEKELRTWEEELTRAALQQKNQEELLRRREQEL 465
Query: 445 AAREIDVLERELMIIL-QTAGPTPTPHKRGGKFNRSKLKVWKVHDISSPSDFRHTLTVQ- 502
A REID+LEREL II+ Q P KR GKF +S+LK+ + IS PSDF+H TVQ
Sbjct: 466 AEREIDILERELNIIIHQLCQEKPRVKKRKGKFRKSRLKLKDGNRISLPSDFQHKFTVQA 525
Query: 503 -PT--ERKS--RKATSPPGSPSI-PRLQAFK 527
PT +RKS +SPP SP+I PRL+A +
Sbjct: 526 SPTMDKRKSLISNRSSPPASPTIIPRLRAIQ 556
|
|
| ZFIN|ZDB-GENE-050419-112 map3k10 "mitogen-activated protein kinase kinase kinase 10" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1275 (453.9 bits), Expect = 5.7e-130, P = 5.7e-130
Identities = 272/528 (51%), Positives = 351/528 (66%)
Query: 17 DSDLLYGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGK 76
DS L + +H N W A++DY+A +EL+LRRGD++EVLSKDS +SGD GWWTGK
Sbjct: 68 DSHLPH-HHESSN---TYWTAVFDYEATADEELTLRRGDLLEVLSKDSKVSGDEGWWTGK 123
Query: 77 IEGKIEYKVGIFPANFV----SSIEDINLVSSVINDVKLVEIDYNKLXXXXXXXXXXXXK 132
I+ K VGIFP N+V SS + + V D L EID+ +L K
Sbjct: 124 IQDK----VGIFPCNYVTQRDSSYPALPPEALVGGDSPL-EIDFLELRLEEVIGAGGFGK 178
Query: 133 VYKGIYEKQEVAIKVAHPNPDENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189
VYKG++ +EVA+K A +PDE+I ENV+QE +L W+ HRNI++L GVCL+ P LC
Sbjct: 179 VYKGVWRAEEVAVKAARQDPDEDISATAENVRQEARLFWMLRHRNIIALRGVCLREPNLC 238
Query: 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLS 249
LVMEYARGG LNR LAG+K+ P VLV+WA+QIA GM+YLH Q + +IHRDLKSSN+L+
Sbjct: 239 LVMEYARGGALNRALAGKKVPPRVLVNWAVQIATGMDYLHNQTFVPIIHRDLKSSNILIL 298
Query: 250 EPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGV 309
EP+E +DL KTLKITDFGLARE ++TT MSAAGTYAWMAPEVIK S+FSK+SDVWS+GV
Sbjct: 299 EPVERDDLSGKTLKITDFGLAREWHRTTKMSAAGTYAWMAPEVIKLSLFSKSSDVWSFGV 358
Query: 310 VLWELLTGEIPYKSINXXXXXXXXXXNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFK 369
+LWELLTGE+PY+ I+ NKLTLPIPSTCP+ F L+ CW + RP+F
Sbjct: 359 LLWELLTGEVPYREIDALAVAYGVAMNKLTLPIPSTCPEAFAQLLGECWCPNPRGRPAFG 418
Query: 370 TILKALNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHXXXXXXXXXXXXXXXXXXAQMQ 429
+ILK L +I S Q P ESFH +Q+ WR+EI+Q+ A +
Sbjct: 419 SILKRLEDIEQSAMFQMPLESFHSLQEDWRLEIQQMFDELRAKEKELRSWEEALARAAEE 478
Query: 430 QKLAEKELREREQAVAAREIDVLERELMIIL-QTAGPTPTPHKRGGKFNRSKL-KVWKVH 487
Q+ E+ LR REQ +A REID++EREL II+ Q P KR G F +S+L K+ +
Sbjct: 479 QREQEEHLRRREQELAEREIDIVERELNIIIHQMYQEKPQVKKRKGNFKKSRLLKLGRDS 538
Query: 488 D-ISSPSDFRHTLTVQ--PT--ERK--SRKATSPPGSPS-IPRLQAFK 527
+ IS PS F H +TVQ P+ +RK S ++T+PP SP IPRL+AF+
Sbjct: 539 NCISLPSGFEHKITVQASPSVDKRKCQSSESTTPPASPGVIPRLRAFR 586
|
|
| UNIPROTKB|Q7T2V3 map3k10 "Mitogen-activated protein kinase kinase kinase 10" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 1255 (446.8 bits), Expect = 1.4e-129, Sum P(2) = 1.4e-129
Identities = 266/537 (49%), Positives = 348/537 (64%)
Query: 4 LLDSMEHPYQNEVDSDLL-YGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSK 62
L S + +N V SD+ YG N P LW A++DY+ +EL+LRRGD+VE+LSK
Sbjct: 11 LWQSSKDNKENGVWSDVQSYGVSN-----P-LWMAVFDYEPTAEEELTLRRGDLVEILSK 64
Query: 63 DSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDINLVSSVINDVKL-VEIDYNKLXX 121
DS +SGD GWWTGKI+ K VGIFP+N+V S + ++ L +EI++++L
Sbjct: 65 DSTVSGDEGWWTGKIKDK----VGIFPSNYVVSDDKYTTLTGAPKQCPLPLEIEFDELNL 120
Query: 122 XXXXXXXXXXKVYKGIYEKQEVAIKVAHPNPDENI---LENVKQEGKLLWLFDHRNIVSL 178
KVYKG++ +EVA+K +PDE+I ENV+QE K+ + H NI++L
Sbjct: 121 DEIIGVGGFGKVYKGLWRDEEVAVKAVRHDPDEDINVTAENVRQEAKIFCMLCHPNIIAL 180
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238
GVCL+ P LCLVMEYARGGPL+R LAG+K+ VLV+WA+QIA+GM YLH +A + +IH
Sbjct: 181 TGVCLKPPHLCLVMEYARGGPLHRALAGKKVPAHVLVNWAVQIAKGMTYLHNEAIVPIIH 240
Query: 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIF 298
RDL SSN+L+ E EN+DL KTL ITDFGLARE KTT MSAAGTYAWMAPEVI+ S+F
Sbjct: 241 RDLGSSNILILEKAENDDLFNKTLNITDFGLAREWQKTTKMSAAGTYAWMAPEVIRLSLF 300
Query: 299 SKASDVWSYGVVLWELLTGEIPYKSINXXXXXXXXXXNKLTLPIPSTCPQLFKTLMEACW 358
SK+SDVWS+GV+LWELLTGE+PY+ I+ NKLTLPIPSTCP+ F ++EACW
Sbjct: 301 SKSSDVWSFGVLLWELLTGEVPYREIDALAVAYGVAMNKLTLPIPSTCPEPFVRILEACW 360
Query: 359 EADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHXXXXXXXXXXX 418
+ D H RP+F IL+ L I S Q P ESFH +Q+ WR+EI+Q+
Sbjct: 361 DPDPHSRPTFSCILEQLTTIEQSAMFQMPLESFHSLQEDWRLEIQQMFDELRTKEKELRS 420
Query: 419 XXXXXXXAQMQQKLAEKELREREQAVAAREIDVLERELMIIL-QTAGPTPTPHKRGGKFN 477
A +Q++ E L+ REQ +A REID++EREL II+ Q P KR G F
Sbjct: 421 REEELVRAAEEQRILEDLLKRREQELAEREIDIVERELNIIMYQMYQEKPKVKKRKGNFK 480
Query: 478 RSKLKVWKVHDISSPSDFRHTLTVQ--PTERKSR----KATSPPGSPSI-PRLQAFK 527
+S+LK+ + IS PS F H +TVQ P K + + SPPGSP I PRL+A +
Sbjct: 481 KSRLKLKDGNRISLPSGFEHKITVQASPMLDKCKGQGTSSYSPPGSPLIIPRLRAIR 537
|
|
| UNIPROTKB|F1NI81 LOC425792 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1268 (451.4 bits), Expect = 3.2e-129, P = 3.2e-129
Identities = 263/512 (51%), Positives = 349/512 (68%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
LW A+++Y+A G DELSLR GD+V+VLS+DS +SGD GWWTG+I+ +VGIFP+N+V
Sbjct: 2 LWTAVFEYEACGEDELSLRPGDVVQVLSRDSQVSGDEGWWTGQID----QRVGIFPSNYV 57
Query: 94 SS-IE----DINLVSSVINDVKLVEIDYNKLXXXXXXXXXXXXKVYKGIYEKQEVAIKVA 148
SS ++ ++ ++L+EID+++L KVY+ ++ EVA+K A
Sbjct: 58 SSGVQGGGPELRARYPPPPAIQLLEIDFSELVLEEIIGIGGFGKVYRAVWIGDEVAVKAA 117
Query: 149 HPNPDENI---LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA 205
+PDE+I +ENV+QE KL + H NI++L GVCL+ P LCL+ME+ARGG LNRVL+
Sbjct: 118 RYDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLIMEFARGGSLNRVLS 177
Query: 206 GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265
G++I PD+LV+WA+QIA+GMNYLH +A + +IHRDLKSSN+L+ E +EN DL K LKIT
Sbjct: 178 GKRIPPDILVNWAVQIAKGMNYLHEEAIVPIIHRDLKSSNILILEKVENGDLSNKILKIT 237
Query: 266 DFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
DFGLARE +KTT MSAAGTYAWMAPEVI++S+FSK SDVWSYGV+LWELLTGE+P++ I+
Sbjct: 238 DFGLAREWHKTTKMSAAGTYAWMAPEVIRSSMFSKGSDVWSYGVLLWELLTGEVPFRGID 297
Query: 326 XXXXXXXXXXNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
NKL LPIPSTCP+ F LME CW D H RPSF +IL L I S F +
Sbjct: 298 GLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFASILGHLTAIEESGFFE 357
Query: 386 TPHESFHIMQDGWRVEIEQVLHXXXXXXXXXXXXXXXXXXAQMQQKLAEKELREREQAVA 445
P +SFH +Q+ W+ EI+++ A ++QK E+ LR REQ +A
Sbjct: 358 MPKDSFHSLQEDWKQEIQEMFDQLRAKEKELRTWEEELTRAAVEQKNHEELLRRREQELA 417
Query: 446 AREIDVLERELMIIL-QTAGPTPTPHKRGGKFNRSKLKVWKVHDISSPS--DFRHTLTVQ 502
REID+LEREL II+ Q P KR GKF +S+LK+ ++IS PS DF+H TVQ
Sbjct: 418 EREIDILERELNIIIHQLCQEKPRVKKRMGKFKKSRLKLKDGNNISLPSVTDFQHKFTVQ 477
Query: 503 --PT--ERKS--RKATSPPGSPSI-PRLQAFK 527
PT +RKS +SPP SP+I PRL+A +
Sbjct: 478 ASPTMDKRKSLISSCSSPPASPTIIPRLRAIQ 509
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P80192 | M3K9_HUMAN | 2, ., 7, ., 1, 1, ., 2, 5 | 0.5694 | 0.9278 | 0.4429 | yes | N/A |
| Q3U1V8 | M3K9_MOUSE | 2, ., 7, ., 1, 1, ., 2, 5 | 0.5694 | 0.9278 | 0.4540 | yes | N/A |
| Q95UN8 | M3KSL_DROME | 2, ., 7, ., 1, 1, ., 2, 5 | 0.5737 | 0.8899 | 0.4039 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.10 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 527 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-93 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-93 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-81 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-77 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-62 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-55 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-52 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-52 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-50 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-49 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-49 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-48 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-48 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-47 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-46 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-46 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-46 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-46 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-46 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-45 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-45 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-43 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-43 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-42 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-41 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-41 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-41 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-40 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-40 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-40 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-40 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-40 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-40 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-39 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-38 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-38 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-38 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-38 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-38 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-37 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-37 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-37 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-37 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-37 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-37 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-37 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-37 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-36 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-36 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-36 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-36 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-36 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-36 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-36 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-36 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-35 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-34 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-34 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-34 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-34 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-34 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-34 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-34 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-34 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-33 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-33 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-33 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-33 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-33 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-32 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-32 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-32 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-31 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-31 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-31 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-31 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-31 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-30 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-30 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-30 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-30 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-30 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-28 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-27 | |
| cd12059 | 58 | cd12059, SH3_MLK1-3, Src Homology 3 domain of Mixe | 5e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-26 | |
| cd11876 | 58 | cd11876, SH3_MLK, Src Homology 3 domain of Mixed L | 3e-26 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-26 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-25 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-25 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-24 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-23 | |
| cd12058 | 58 | cd12058, SH3_MLK4, Src Homology 3 domain of Mixed | 2e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-23 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-23 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-23 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-23 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-23 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-22 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-22 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-21 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-20 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-20 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-19 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-19 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-18 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-17 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-16 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-16 | |
| cd00174 | 51 | cd00174, SH3, Src Homology 3 domain superfamily | 1e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-15 | |
| cd11875 | 55 | cd11875, SH3_CD2AP-like_3, Third Src Homology 3 do | 4e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-15 | |
| smart00326 | 56 | smart00326, SH3, Src homology 3 domains | 8e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-13 | |
| cd11827 | 53 | cd11827, SH3_MyoIe_If_like, Src homology 3 domain | 1e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-13 | |
| cd12056 | 57 | cd12056, SH3_CD2AP_3, Third Src Homology 3 domain | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd11805 | 53 | cd11805, SH3_GRB2_like_C, C-terminal Src homology | 3e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-12 | |
| cd12057 | 56 | cd12057, SH3_CIN85_3, Third Src Homology 3 domain | 6e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-12 | |
| cd12142 | 55 | cd12142, SH3_D21-like, Src Homology 3 domain of SH | 9e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-11 | |
| pfam00018 | 47 | pfam00018, SH3_1, SH3 domain | 2e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-11 | |
| cd11950 | 53 | cd11950, SH3_GRAP2_C, C-terminal Src homology 3 do | 3e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-11 | |
| cd11823 | 53 | cd11823, SH3_Nostrin, Src homology 3 domain of Nit | 5e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-10 | |
| cd11842 | 55 | cd11842, SH3_Ysc84p_like, Src homology 3 domain of | 2e-10 | |
| cd11826 | 52 | cd11826, SH3_Abi, Src homology 3 domain of Abl Int | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd11976 | 54 | cd11976, SH3_VAV1_2, C-terminal (or second) Src ho | 3e-10 | |
| cd11877 | 53 | cd11877, SH3_PIX, Src Homology 3 domain of Pak Int | 4e-10 | |
| cd11840 | 53 | cd11840, SH3_Intersectin_5, Fifth Src homology 3 d | 4e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-10 | |
| cd11874 | 53 | cd11874, SH3_CD2AP-like_2, Second Src Homology 3 d | 6e-10 | |
| cd11873 | 53 | cd11873, SH3_CD2AP-like_1, First Src Homology 3 do | 9e-10 | |
| cd11766 | 53 | cd11766, SH3_Nck_2, Second Src Homology 3 domain o | 9e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd11841 | 54 | cd11841, SH3_SH3YL1_like, Src homology 3 domain of | 1e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd11812 | 52 | cd11812, SH3_AHI-1, Src Homology 3 domain of Abels | 2e-09 | |
| cd11762 | 57 | cd11762, SH3_FCHSD_2, Second Src Homology 3 domain | 2e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd11843 | 53 | cd11843, SH3_PACSIN, Src homology 3 domain of Prot | 2e-09 | |
| cd11772 | 53 | cd11772, SH3_OSTF1, Src Homology 3 domain of metaz | 4e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-09 | |
| cd11820 | 54 | cd11820, SH3_STAM, Src homology 3 domain of Signal | 4e-09 | |
| cd11949 | 53 | cd11949, SH3_GRB2_C, C-terminal Src homology 3 dom | 4e-09 | |
| cd11830 | 54 | cd11830, SH3_VAV_2, C-terminal (or second) Src hom | 4e-09 | |
| cd11883 | 55 | cd11883, SH3_Sdc25, Src Homology 3 domain of Sdc25 | 5e-09 | |
| cd11951 | 53 | cd11951, SH3_GRAP_C, C-terminal Src homology 3 dom | 8e-09 | |
| cd11790 | 64 | cd11790, SH3_Amphiphysin, Src Homology 3 domain of | 8e-09 | |
| cd11969 | 55 | cd11969, SH3_PLCgamma2, Src homology 3 domain of P | 8e-09 | |
| cd11821 | 53 | cd11821, SH3_ASAP, Src homology 3 domain of ArfGAP | 9e-09 | |
| cd11819 | 54 | cd11819, SH3_Cortactin_like, Src homology 3 domain | 9e-09 | |
| cd11977 | 58 | cd11977, SH3_VAV2_2, C-terminal (or second) Src ho | 1e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-08 | |
| cd11844 | 56 | cd11844, SH3_CAS, Src homology 3 domain of CAS (Cr | 2e-08 | |
| cd11836 | 55 | cd11836, SH3_Intersectin_1, First Src homology 3 d | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-08 | |
| cd11771 | 60 | cd11771, SH3_Pex13p_fungal, Src Homology 3 domain | 3e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-08 | |
| cd11996 | 54 | cd11996, SH3_Intersectin2_5, Fifth Src homology 3 | 3e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-08 | |
| cd11763 | 55 | cd11763, SH3_SNX9_like, Src Homology 3 domain of S | 6e-08 | |
| cd12140 | 72 | cd12140, SH3_Amphiphysin_I, Src Homology 3 domain | 7e-08 | |
| cd11963 | 57 | cd11963, SH3_STAM2, Src homology 3 domain of Signa | 8e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-08 | |
| cd11839 | 58 | cd11839, SH3_Intersectin_4, Fourth Src homology 3 | 1e-07 | |
| cd11959 | 53 | cd11959, SH3_Cortactin, Src homology 3 domain of C | 1e-07 | |
| cd12052 | 53 | cd12052, SH3_CIN85_1, First Src Homology 3 domain | 1e-07 | |
| cd11995 | 54 | cd11995, SH3_Intersectin1_5, Fifth Src homology 3 | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd11825 | 54 | cd11825, SH3_PLCgamma, Src homology 3 domain of Ph | 1e-07 | |
| cd11778 | 51 | cd11778, SH3_Bzz1_2, Second Src Homology 3 domain | 2e-07 | |
| cd11856 | 53 | cd11856, SH3_p47phox_like, Src homology 3 domains | 2e-07 | |
| cd12073 | 55 | cd12073, SH3_HS1, Src homology 3 domain of Hematop | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd11894 | 56 | cd11894, SH3_FCHSD2_2, Second Src Homology 3 domai | 2e-07 | |
| cd11964 | 55 | cd11964, SH3_STAM1, Src homology 3 domain of Signa | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| cd11886 | 55 | cd11886, SH3_BOI, Src Homology 3 domain of fungal | 3e-07 | |
| cd11824 | 53 | cd11824, SH3_PSTPIP1, Src homology 3 domain of Pro | 4e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-07 | |
| cd11804 | 52 | cd11804, SH3_GRB2_like_N, N-terminal Src homology | 5e-07 | |
| cd11833 | 53 | cd11833, SH3_Stac_1, First C-terminal Src homology | 6e-07 | |
| cd11789 | 55 | cd11789, SH3_Nebulin_family_C, C-terminal Src Homo | 7e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-07 | |
| cd11780 | 55 | cd11780, SH3_Sorbs_3, Third (or C-terminal) Src Ho | 8e-07 | |
| cd11845 | 52 | cd11845, SH3_Src_like, Src homology 3 domain of Sr | 8e-07 | |
| cd11864 | 58 | cd11864, SH3_PEX13_eumet, Src Homology 3 domain of | 9e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-07 | |
| cd11987 | 55 | cd11987, SH3_Intersectin1_1, First Src homology 3 | 1e-06 | |
| cd11978 | 56 | cd11978, SH3_VAV3_2, C-terminal (or second) Src ho | 1e-06 | |
| cd12046 | 53 | cd12046, SH3_p67phox_C, C-terminal (or second) Src | 2e-06 | |
| cd12003 | 62 | cd12003, SH3_EFS, Src homology 3 domain of CAS (Cr | 2e-06 | |
| cd11858 | 55 | cd11858, SH3_Myosin-I_fungi, Src homology 3 domain | 2e-06 | |
| cd12000 | 57 | cd12000, SH3_CASS4, Src homology 3 domain of CAS ( | 2e-06 | |
| cd11866 | 53 | cd11866, SH3_SKAP1-like, Src Homology 3 domain of | 2e-06 | |
| pfam07653 | 53 | pfam07653, SH3_2, Variant SH3 domain | 3e-06 | |
| cd11918 | 58 | cd11918, SH3_Vinexin_3, Third (or C-terminal) Src | 3e-06 | |
| cd12047 | 53 | cd12047, SH3_Noxa1_C, C-terminal Src Homology 3 do | 3e-06 | |
| cd11991 | 52 | cd11991, SH3_Intersectin1_3, Third Src homology 3 | 3e-06 | |
| cd11828 | 53 | cd11828, SH3_ARHGEF9_like, Src homology 3 domain o | 3e-06 | |
| cd12053 | 56 | cd12053, SH3_CD2AP_1, First Src Homology 3 domain | 3e-06 | |
| cd12001 | 68 | cd12001, SH3_BCAR1, Src homology 3 domain of the C | 4e-06 | |
| cd11838 | 52 | cd11838, SH3_Intersectin_3, Third Src homology 3 d | 4e-06 | |
| cd11781 | 53 | cd11781, SH3_Sorbs_1, First Src Homology 3 domain | 4e-06 | |
| cd11988 | 57 | cd11988, SH3_Intersectin2_1, First Src homology 3 | 5e-06 | |
| cd11818 | 50 | cd11818, SH3_Eve1_5, Fifth Src homology 3 domain o | 5e-06 | |
| cd11998 | 56 | cd11998, SH3_PACSIN1-2, Src homology 3 domain of P | 5e-06 | |
| cd11961 | 53 | cd11961, SH3_Abp1_fungi_C2, Second C-terminal Src | 6e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-06 | |
| cd11870 | 53 | cd11870, SH3_p67phox-like_C, C-terminal Src Homolo | 6e-06 | |
| cd11916 | 59 | cd11916, SH3_Sorbs1_3, Third (or C-terminal) Src H | 8e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-06 | |
| cd11972 | 61 | cd11972, SH3_Abi2, Src homology 3 domain of Abl In | 1e-05 | |
| cd12033 | 61 | cd12033, SH3_MPP7, Src Homology 3 domain of Membra | 1e-05 | |
| cd12051 | 56 | cd12051, SH3_DOCK1_5_A, Src Homology 3 domain of C | 1e-05 | |
| cd11786 | 53 | cd11786, SH3_SH3RF_1, First Src Homology 3 domain | 1e-05 | |
| cd12061 | 54 | cd12061, SH3_betaPIX, Src Homology 3 domain of bet | 2e-05 | |
| cd12054 | 55 | cd12054, SH3_CD2AP_2, Second Src Homology 3 domain | 2e-05 | |
| cd11787 | 53 | cd11787, SH3_SH3RF_2, Second Src Homology 3 domain | 2e-05 | |
| cd12044 | 53 | cd12044, SH3_SKAP1, Src Homology 3 domain of Src K | 2e-05 | |
| cd11933 | 58 | cd11933, SH3_Nebulin_C, C-terminal Src Homology 3 | 2e-05 | |
| cd11773 | 57 | cd11773, SH3_Sla1p_1, First Src Homology 3 domain | 2e-05 | |
| cd11960 | 54 | cd11960, SH3_Abp1_eu, Src homology 3 domain of eum | 3e-05 | |
| cd11817 | 50 | cd11817, SH3_Eve1_4, Fourth Src homology 3 domain | 3e-05 | |
| cd11815 | 52 | cd11815, SH3_Eve1_2, Second Src homology 3 domain | 3e-05 | |
| cd11971 | 59 | cd11971, SH3_Abi1, Src homology 3 domain of Abl In | 4e-05 | |
| cd12139 | 72 | cd12139, SH3_Bin1, Src Homology 3 domain of Bridgi | 4e-05 | |
| cd12045 | 53 | cd12045, SH3_SKAP2, Src Homology 3 domain of Src K | 4e-05 | |
| cd11934 | 59 | cd11934, SH3_Lasp1_C, C-terminal Src Homology 3 do | 5e-05 | |
| cd11851 | 62 | cd11851, SH3_RIM-BP, Src homology 3 domains of Rab | 5e-05 | |
| cd12055 | 53 | cd12055, SH3_CIN85_2, Second Src Homology 3 domain | 5e-05 | |
| cd11895 | 58 | cd11895, SH3_FCHSD1_2, Second Src Homology 3 domai | 6e-05 | |
| cd11784 | 55 | cd11784, SH3_SH3RF2_3, Third Src Homology 3 domain | 6e-05 | |
| cd11855 | 55 | cd11855, SH3_Sho1p, Src homology 3 domain of High | 6e-05 | |
| cd11803 | 55 | cd11803, SH3_Endophilin_A, Src homology 3 domain o | 7e-05 | |
| cd11758 | 55 | cd11758, SH3_CRK_N, N-terminal Src Homology 3 doma | 8e-05 | |
| cd11935 | 58 | cd11935, SH3_Nebulette_C, C-terminal Src Homology | 8e-05 | |
| cd11970 | 60 | cd11970, SH3_PLCgamma1, Src homology 3 domain of P | 9e-05 | |
| cd11952 | 56 | cd11952, SH3_iASPP, Src Homology 3 (SH3) domain of | 1e-04 | |
| cd11965 | 57 | cd11965, SH3_ASAP1, Src homology 3 domain of ArfGA | 1e-04 | |
| cd11885 | 55 | cd11885, SH3_SH3TC, Src Homology 3 domain of SH3 d | 1e-04 | |
| cd11920 | 55 | cd11920, SH3_Sorbs2_1, First Src Homology 3 domain | 1e-04 | |
| cd11917 | 61 | cd11917, SH3_Sorbs2_3, Third (or C-terminal) Src H | 1e-04 | |
| cd11806 | 53 | cd11806, SH3_PRMT2, Src homology 3 domain of Prote | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| TIGR01843 | 423 | TIGR01843, type_I_hlyD, type I secretion membrane | 2e-04 | |
| cd12002 | 57 | cd12002, SH3_NEDD9, Src homology 3 domain of CAS ( | 2e-04 | |
| cd11992 | 52 | cd11992, SH3_Intersectin2_3, Third Src homology 3 | 2e-04 | |
| cd11816 | 51 | cd11816, SH3_Eve1_3, Third Src homology 3 domain o | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd12060 | 58 | cd12060, SH3_alphaPIX, Src Homology 3 domain of al | 3e-04 | |
| cd11782 | 53 | cd11782, SH3_Sorbs_2, Second Src Homology 3 domain | 3e-04 | |
| cd11947 | 52 | cd11947, SH3_GRAP2_N, N-terminal Src homology 3 do | 3e-04 | |
| cd11775 | 57 | cd11775, SH3_Sla1p_3, Third Src Homology 3 domain | 3e-04 | |
| cd11946 | 56 | cd11946, SH3_GRB2_N, N-terminal Src homology 3 dom | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd12080 | 62 | cd12080, SH3_MPP1, Src Homology 3 domain of Membra | 4e-04 | |
| cd11847 | 58 | cd11847, SH3_Brk, Src homology 3 domain of Brk (Br | 4e-04 | |
| cd12012 | 62 | cd12012, SH3_RIM-BP_2, Second Src homology 3 domai | 4e-04 | |
| cd11869 | 54 | cd11869, SH3_p40phox, Src Homology 3 domain of the | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd11999 | 56 | cd11999, SH3_PACSIN_like, Src homology 3 domain of | 5e-04 | |
| cd11832 | 50 | cd11832, SH3_Shank, Src homology 3 domain of SH3 a | 5e-04 | |
| cd11948 | 54 | cd11948, SH3_GRAP_N, N-terminal Src homology 3 dom | 5e-04 | |
| cd11997 | 56 | cd11997, SH3_PACSIN3, Src homology 3 domain of Pro | 5e-04 | |
| cd11911 | 55 | cd11911, SH3_CIP4-like, Src Homology 3 domain of C | 5e-04 | |
| cd11796 | 51 | cd11796, SH3_DNMBP_N3, Third N-terminal Src homolo | 6e-04 | |
| cd11889 | 53 | cd11889, SH3_Cyk3p-like, Src Homology 3 domain of | 6e-04 | |
| cd12035 | 62 | cd12035, SH3_MPP1-like, Src Homology 3 domain of M | 6e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 8e-04 | |
| cd11882 | 54 | cd11882, SH3_GRAF-like, Src Homology 3 domain of G | 9e-04 | |
| cd11966 | 56 | cd11966, SH3_ASAP2, Src homology 3 domain of ArfGA | 0.001 | |
| cd11956 | 55 | cd11956, SH3_srGAP4, Src homology 3 domain of Slit | 0.001 | |
| cd11807 | 57 | cd11807, SH3_ASPP, Src homology 3 domain of Apopto | 0.001 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.001 | |
| cd11887 | 60 | cd11887, SH3_Bbc1, Src Homology 3 domain of Bbc1 a | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd11884 | 56 | cd11884, SH3_MYO15, Src Homology 3 domain of Myosi | 0.001 | |
| cd11919 | 55 | cd11919, SH3_Sorbs1_1, First Src Homology 3 domain | 0.001 | |
| cd11932 | 57 | cd11932, SH3_SH3RF2_2, Second Src Homology 3 domai | 0.001 | |
| cd11901 | 55 | cd11901, SH3_Nck1_2, Second Src Homology 3 domain | 0.001 | |
| cd11791 | 59 | cd11791, SH3_UBASH3, Src homology 3 domain of Ubiq | 0.002 | |
| cd12081 | 62 | cd12081, SH3_CASK, Src Homology 3 domain of Calciu | 0.002 | |
| cd11912 | 55 | cd11912, SH3_Bzz1_1, First Src Homology 3 domain o | 0.002 | |
| cd11986 | 53 | cd11986, SH3_Stac3_1, First C-terminal Src homolog | 0.002 | |
| cd11862 | 61 | cd11862, SH3_MPP, Src Homology 3 domain of Membran | 0.002 | |
| cd11923 | 57 | cd11923, SH3_Sorbs2_2, Second Src Homology 3 domai | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 | |
| cd11813 | 53 | cd11813, SH3_SGSM3, Src Homology 3 domain of Small | 0.003 | |
| cd11793 | 55 | cd11793, SH3_ephexin1_like, Src homology 3 domain | 0.003 | |
| cd11872 | 56 | cd11872, SH3_DOCK_AB, Src Homology 3 domain of Cla | 0.003 | |
| cd12009 | 54 | cd12009, SH3_Blk, Src homology 3 domain of Blk Pro | 0.003 | |
| cd11783 | 55 | cd11783, SH3_SH3RF_3, Third Src Homology 3 domain | 0.004 | |
| cd11985 | 53 | cd11985, SH3_Stac2_C, C-terminal Src homology 3 do | 0.004 | |
| cd12039 | 62 | cd12039, SH3_MPP3, Src Homology 3 domain of Membra | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 285 bits (732), Expect = 1e-93
Identities = 99/270 (36%), Positives = 141/270 (52%), Gaps = 25/270 (9%)
Query: 119 LIFGEAIGEGGFGKVYKGIYE------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
L G+ +GEG FG+VYKG + + EVA+K + E +E +E +++ DH
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL---AGRKIRPDVLVDWAIQIAEGMNYLH 229
NIV L+GVC + L +VMEY GG L L +++ L+ +A+QIA GM YL
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---YA 286
+ + IHRDL + N L+ E +KI+DFGL+R++Y + G
Sbjct: 121 SK---NFIHRDLAARNCLVGEN--------LVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPST 345
WMAPE +K F+ SDVWS+GV+LWE+ T GE PY ++ V LP P
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV-LEYLKKGYRLPKPPN 228
Query: 346 CPQLFKTLMEACWEADSHMRPSFKTILKAL 375
CP LM CW D RP+F +++ L
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 284 bits (730), Expect = 2e-93
Identities = 101/269 (37%), Positives = 142/269 (52%), Gaps = 24/269 (8%)
Query: 119 LIFGEAIGEGGFGKVYKGIYE------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
L G+ +GEG FG+VYKG + K EVA+K + E +E +E +++ DH
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLHC 230
N+V L+GVC + L +VMEY GG L L K+ L+ +A+QIA GM YL
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---YAW 287
+ + IHRDL + N L+ E +KI+DFGL+R++Y + G W
Sbjct: 121 K---NFIHRDLAARNCLVGEN--------LVVKISDFGLSRDLYDDDYYRKRGGKLPIRW 169
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346
MAPE +K F+ SDVWS+GV+LWE+ T GE PY ++ V + N LP P C
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL-KNGYRLPQPPNC 228
Query: 347 PQLFKTLMEACWEADSHMRPSFKTILKAL 375
P LM CW D RP+F +++ L
Sbjct: 229 PPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 253 bits (649), Expect = 3e-81
Identities = 99/274 (36%), Positives = 139/274 (50%), Gaps = 33/274 (12%)
Query: 119 LIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
L G+ +GEG FG+VYKG + +VA+K E E +E ++ H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLHC 230
NIV L+GVC Q L +V EY GG L L G K+ L+ A+QIA+GM YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT----YA 286
+ + +HRDL + N L++E +KI+DFGL+R++Y+ + G
Sbjct: 121 K---NFVHRDLAARNCLVTEN--------LVVKISDFGLSRDIYEDDYYRKRGGGKLPIK 169
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT----LP 341
WMAPE +K F+ SDVWS+GV+LWE+ T GE PY ++ V + L LP
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-----LELLEDGYRLP 224
Query: 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
P CP LM CW D RP+F +++ L
Sbjct: 225 RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 4e-77
Identities = 99/274 (36%), Positives = 140/274 (51%), Gaps = 38/274 (13%)
Query: 125 IGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLI 179
+GEG FG+VYKG + EVA+K + E ++ +E +++ H N+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 180 GVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV------------LVDWAIQIAEGMNY 227
GVC + L LV+EY GG L L RK RP L+ +AIQIA+GM Y
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYL--RKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT--- 284
L + +HRDL + N L+ E +KI+DFGL+R+VY +
Sbjct: 121 LASK---KFVHRDLAARNCLVGED--------LVVKISDFGLSRDVYDDDYYRKKTGGKL 169
Query: 285 -YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK-LTLP 341
WMAPE +K IF+ SDVWS+GV+LWE+ T G PY ++ V + K LP
Sbjct: 170 PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE--YLRKGYRLP 227
Query: 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
P CP LM +CW+ D RP+F +++ L
Sbjct: 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 6e-65
Identities = 86/259 (33%), Positives = 121/259 (46%), Gaps = 17/259 (6%)
Query: 121 FGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
E +GEG FGKVY + VAIKV + E + +E K+L H NIV L
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLI 237
V KL LVMEY GG L +L ++ D + QI + YLH + ++
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK---GIV 119
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM-SAAGTYAWMAPEVIKTS 296
HRDLK N+LL E +K+ DFGLAR++ + + GT +MAPEV+
Sbjct: 120 HRDLKPENILLDED--------GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 297 IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLPIPS-TCPQLFKTLM 354
+ KA D+WS GV+L+ELLTG+ P+ + + K P P K L+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI 231
Query: 355 EACWEADSHMRPSFKTILK 373
D R + + L+
Sbjct: 232 RKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 5e-62
Identities = 85/267 (31%), Positives = 126/267 (47%), Gaps = 23/267 (8%)
Query: 119 LIFGEAIGEGGFGKVYKGIYEK--QEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNI 175
+G G FG VYK ++ + VA+K + + + ++E ++L H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 176 VSLIGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
V LI L LVMEY GG L L G + D A+QI G+ YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH--MSAAGTYAWMAPEV 292
+IHRDLK N+LL E +KI DFGLA+++ K++ + GT +MAPEV
Sbjct: 118 GIIHRDLKPENILLDENGV--------VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV 169
Query: 293 IKTSI-FSKASDVWSYGVVLWELLTGEIPY---KSINAYAVAYGVAVNKLTLPIPSTCP- 347
+ + DVWS GV+L+ELLTG+ P+ ++ + + L P
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG 229
Query: 348 -QLFKTLMEACWEADSHMRPSFKTILK 373
+ K L++ C D RP+ + IL+
Sbjct: 230 SEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 1e-57
Identities = 95/291 (32%), Positives = 139/291 (47%), Gaps = 45/291 (15%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGI-------YEKQEVAIKVAHPNP--DENILENVKQE 163
E+ K+ +G+G FG VY+G+ + VAIK + N E I E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNE 59
Query: 164 GKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV---------- 213
++ F+ ++V L+GV +VME G L L R RP+
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPT 117
Query: 214 ---LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270
+ A +IA+GM YL A +HRDL + N ++ EDL T+KI DFG+
Sbjct: 118 LQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMV-----AEDL---TVKIGDFGMT 166
Query: 271 REVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSI- 324
R++Y+T + G WMAPE +K +F+ SDVWS+GVVLWE+ T E PY+ +
Sbjct: 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226
Query: 325 NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
N + + + L LP CP LM CW+ + MRP+F I+ +L
Sbjct: 227 NEEVLKFVIDGGHLDLPE--NCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 4e-55
Identities = 85/258 (32%), Positives = 121/258 (46%), Gaps = 50/258 (19%)
Query: 125 IGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182
+GEGGFG VY ++VAIK+ ++LE + +E ++L +H NIV L GV
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 183 LQSPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240
L LVMEY GG L +L K+ D ++ +QI EG+ YLH +IHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY--KTTHMSAAGTYAWMAPEVIK-TSI 297
LK N+LL +K+ DFGL++ + K+ + GT A+MAPEV+
Sbjct: 118 LKPENILLDSDNGK-------VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 298 FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEAC 357
+S+ SD+WS GV+L+EL K L+
Sbjct: 171 YSEKSDIWSLGVILYEL---------------------------------PELKDLIRKM 197
Query: 358 WEADSHMRPSFKTILKAL 375
+ D RPS K IL+ L
Sbjct: 198 LQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 9e-54
Identities = 96/267 (35%), Positives = 127/267 (47%), Gaps = 41/267 (15%)
Query: 125 IGEGGFGKVYKGIYEKQ-----EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLI 179
+G G FG V KG+Y + EVA+K + +E ++ DH IV LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 180 GVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV-LVDWAIQIAEGMNYLHCQAPISLIH 238
GVC + L LVME A GPL + L R+ P L + A Q+A GM YL + +H
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVH 118
Query: 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR------EVYKTTHMSAAGTYA--WMAP 290
RDL + NVLL N KI+DFG++R + Y+ T AG + W AP
Sbjct: 119 RDLAARNVLL----VNRH----QAKISDFGMSRALGAGSDYYRAT---TAGRWPLKWYAP 167
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT-----LPIPS 344
E I FS SDVWSYGV LWE + G PY + G V + LP P
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK------GAEVIAMLESGERLPRPE 221
Query: 345 TCPQLFKTLMEACWEADSHMRPSFKTI 371
CPQ ++M +CW+ RP+F +
Sbjct: 222 ECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-52
Identities = 77/257 (29%), Positives = 121/257 (47%), Gaps = 22/257 (8%)
Query: 122 GEAIGEGGFGKVYKGIYEK--QEVAIKVAH-PNPDENILENVKQEGKLLWLFDHRNIVSL 178
GE +G G FG VY + + + +A+K E LE +++E ++L H NIV
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 179 IGVCLQSPK--LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
G K L + +EY GG L+ +L K+ V+ + QI EG+ YLH
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---G 121
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM----SAAGTYAWMAPE 291
++HRD+K +N+L+ +K+ DFG A+ + S GT WMAPE
Sbjct: 122 IVHRDIKGANILVDSD--------GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI-NAYAVAYGVAVNKLTLPIPSTCPQLF 350
VI+ + +A+D+WS G + E+ TG+ P+ + N A Y + + IP +
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA 233
Query: 351 KTLMEACWEADSHMRPS 367
K + C D RP+
Sbjct: 234 KDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 6e-52
Identities = 94/270 (34%), Positives = 132/270 (48%), Gaps = 19/270 (7%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
I+ +L G IG+G FG V G Y Q+VA+K D + E ++ H
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCL--KDDSTAAQAFLAEASVMTTLRH 59
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK---IRPDVLVDWAIQIAEGMNYLH 229
N+V L+GV LQ L +V EY G L L R I + +A+ + EGM YL
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMA 289
+ + +HRDL + NVL+SE DL K++DFGLA+E + S W A
Sbjct: 120 EK---NFVHRDLAARNVLVSE-----DL---VAKVSDFGLAKEASQG-QDSGKLPVKWTA 167
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348
PE ++ FS SDVWS+G++LWE+ + G +PY I V V + P CP
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPP 226
Query: 349 LFKTLMEACWEADSHMRPSFKTILKALNNI 378
+M+ CWE D RP+FK + + L I
Sbjct: 227 EVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 1e-50
Identities = 91/271 (33%), Positives = 138/271 (50%), Gaps = 26/271 (9%)
Query: 119 LIFGEAIGEGGFGKVYKGIYE------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
L + +G G FG VYKG++ K VAIKV + + E ++ DH
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEGMNYLHC 230
++V L+G+CL S ++ L+ + G L + K I L++W +QIA+GM+YL
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSAAGTYA-- 286
+ L+HRDL + NVL+ P + +KITDFGLA+ +V + + + G
Sbjct: 128 K---RLVHRDLAARNVLVKTP--------QHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPST 345
WMA E I I++ SDVWSYGV +WEL+T G PY+ I A + + LP P
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-DLLEKGERLPQPPI 235
Query: 346 CPQLFKTLMEACWEADSHMRPSFKTILKALN 376
C ++ CW D+ RP+FK ++ +
Sbjct: 236 CTIDVYMVLVKCWMIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 2e-49
Identities = 95/286 (33%), Positives = 134/286 (46%), Gaps = 39/286 (13%)
Query: 119 LIFGEAIGEGGFGKVYKG-------IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFD 171
++ +GEG FGKV+ G +K+ VA+K + ++ ++E +LL F
Sbjct: 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ 66
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL------AGRKIRPDV---------LVD 216
H NIV GVC + +V EY G LN+ L A PD L+
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 217 WAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT 276
A+QIA GM YL Q +HRDL + N L+ DL +KI DFG++R+VY T
Sbjct: 127 IAVQIASGMVYLASQ---HFVHRDLATRNCLVG-----YDL---VVKIGDFGMSRDVYTT 175
Query: 277 THMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAY 331
+ G WM PE I F+ SDVWS+GVVLWE+ T G+ P+ ++ V
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235
Query: 332 GVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
+ +L P TCP +M CW+ D R + K I + L
Sbjct: 236 CITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 2e-49
Identities = 96/276 (34%), Positives = 138/276 (50%), Gaps = 40/276 (14%)
Query: 125 IGEGGFGKVYKGIYEKQ------EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
+GEG FGKV Y+ +VA+K + + +E + ++E ++L DH NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 179 IGVC--LQSPKLCLVMEYARGGPLNRVLAGRKIRPDV--LVDWAIQIAEGMNYLHCQAPI 234
GVC L L+MEY G L L + + ++ L+ ++ QI +GM+YL Q
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ--- 128
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-----YKTTHMSAAGTYAWMA 289
IHRDL + N+L +E+EDL +KI+DFGLA+ + Y W A
Sbjct: 129 RYIHRDLAARNIL----VESEDL----VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVA---------VNKLT 339
PE ++TS FS ASDVWS+GV L+EL T G+ + G+A + L
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 340 ----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
LP P +CP LM+ CWEA+ RPSF +
Sbjct: 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-48
Identities = 85/263 (32%), Positives = 126/263 (47%), Gaps = 26/263 (9%)
Query: 123 EAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
+ +G+G FG V +G + + VA+K + +I+++ +E ++ DH N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRP---DVLVDWAIQIAEGMNYLHCQAPI 234
L GV L P L +V E A G L L + L D+A+QIA GM YL +
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR-----EVYKTTHMSAAGTYAWMA 289
IHRDL + N+LL+ +KI DFGL R E + +AW A
Sbjct: 117 RFIHRDLAARNILLASD--------DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348
PE ++T FS ASDVW +GV LWE+ T GE P+ ++ + + L P CPQ
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQ 228
Query: 349 LFKTLMEACWEADSHMRPSFKTI 371
+M CW + RP+F +
Sbjct: 229 DIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 6e-48
Identities = 94/261 (36%), Positives = 131/261 (50%), Gaps = 20/261 (7%)
Query: 123 EAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGV 181
E IG+G FG VYKG+ + EVA+K ++ QE ++L +DH NIV LIGV
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 182 CLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV--LVDWAIQIAEGMNYLHCQAPISLIHR 239
C+Q + +VME GG L L +K R V L+ ++ A GM YL + + IHR
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHR 117
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT----YAWMAPEVIKT 295
DL + N L+ E N LKI+DFG++RE + + G W APE +
Sbjct: 118 DLAARNCLVGE--NN------VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 296 SIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354
++ SDVWSYG++LWE + G+ PY ++ + +P P CP+ LM
Sbjct: 170 GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMPAPQLCPEEIYRLM 228
Query: 355 EACWEADSHMRPSFKTILKAL 375
CW D RPSF I L
Sbjct: 229 LQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 1e-47
Identities = 97/282 (34%), Positives = 141/282 (50%), Gaps = 24/282 (8%)
Query: 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVKQEGKL 166
EI + G IGEG FG VY+G+Y EK VA+K ++ E QE +
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV--LVDWAIQIAEG 224
+ FDH +IV LIGV ++P + +VME A G L L K D+ L+ ++ Q++
Sbjct: 61 MRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT 284
+ YL +HRD+ + NVL+S P +K+ DFGL+R + ++ A+
Sbjct: 120 LAYLE---SKRFVHRDIAARNVLVSSP--------DCVKLGDFGLSRYLEDESYYKASKG 168
Query: 285 ---YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340
WMAPE I F+ ASDVW +GV +WE+L G P++ + V G N L
Sbjct: 169 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGERL 227
Query: 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
P+P CP +LM CW D RP F + L++I+ E
Sbjct: 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-46
Identities = 99/311 (31%), Positives = 142/311 (45%), Gaps = 70/311 (22%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENIL-------E 158
E+ ++L G+ +GEG FG+V K E VA+K+ + E L E
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME 67
Query: 159 NVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDV---- 213
+K GK H+NI++L+GVC Q L +V+EYA G L L A R
Sbjct: 68 MMKMIGK------HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121
Query: 214 ------------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261
LV +A Q+A GM +L A IHRDL + NVL++E
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHV-------- 170
Query: 262 LKITDFGLAREV----YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT- 316
+KI DFGLAR++ Y + WMAPE + +++ SDVWS+GV+LWE+ T
Sbjct: 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 230
Query: 317 GEIPYKSINAYAVAYGVAVNKL--------TLPIPSTCPQLFKTLMEACWEADSHMRPSF 368
G PY G+ V +L + P C Q LM CW RP+F
Sbjct: 231 GGSPYP---------GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTF 281
Query: 369 KTILKALNNIV 379
K +++ L+ ++
Sbjct: 282 KQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 3e-46
Identities = 93/272 (34%), Positives = 135/272 (49%), Gaps = 27/272 (9%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHP---NPDENILENVKQEGKLLWL 169
ID ++L F + +G G FG V+ G + K +VAIK+ + D+ I +E K++
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFI-----EEAKVMMK 55
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEGMNY 227
H N+V L GVC + + +V EY G L L RK + + L+D + E M Y
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEY 115
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT--- 284
L IHRDL + N L+ E +K++DFGLAR V + S+ GT
Sbjct: 116 LESN---GFIHRDLAARNCLVGED--------NVVKVSDFGLARYVLDDQYTSSQGTKFP 164
Query: 285 YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343
W PEV S FS SDVWS+GV++WE+ + G++PY+ + V V+ L P
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRP 223
Query: 344 STCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
P T+M +CW RP+FK +L L
Sbjct: 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-46
Identities = 93/284 (32%), Positives = 140/284 (49%), Gaps = 36/284 (12%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKG---IYEKQE--VAIKVAHPNPDENILENVKQEGKLLW 168
ID + + + IG G FG+V +G + K+E VAIK + + E ++
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMG 60
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR--KIRPDVLVDWAIQIAEGMN 226
FDH NI+ L GV +S + ++ EY G L++ L K LV IA GM
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA 286
YL + ++ +HRDL + N+L+ N +L K++DFGL+R + + TY
Sbjct: 121 YL---SEMNYVHRDLAARNILV-----NSNLV---CKVSDFGLSRRL-----EDSEATYT 164
Query: 287 ---------WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVN 336
W APE I F+ ASDVWS+G+V+WE+++ GE PY ++ V AV
Sbjct: 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK--AVE 222
Query: 337 K-LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
LP P CP LM CW+ D + RP+F I+ L+ ++
Sbjct: 223 DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 5e-46
Identities = 75/261 (28%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 123 EAIGEGGFGKVYKG--IYEKQEVAIKVAH-PNPDENILENVKQEGKLLWLFDHRNIVSLI 179
+ IG+G FGKVY + + +K N E E+ E K+L +H NI+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 180 GVCLQSPKLCLVMEYARGGPLNRVL-----AGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
+ KLC+VMEYA GG L++ + G+ + ++DW +Q+ + YLH +
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTYAWMAPEV 292
++HRD+K N+ L+ +K+ DFG+++ + T + + GT +++PE+
Sbjct: 123 KILHRDIKPQNIFLTS--------NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKT 352
+ ++ SD+WS G VL+EL T + P++ N +A + + PIPS +
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-LKGQYPPIPSQYSSELRN 233
Query: 353 LMEACWEADSHMRPSFKTILK 373
L+ + + D RPS IL+
Sbjct: 234 LVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 6e-46
Identities = 91/267 (34%), Positives = 127/267 (47%), Gaps = 22/267 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFD 171
EI L +G G FG+V+ G + +VA+K P E QE +++
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLR 59
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL---AGRKIRPDVLVDWAIQIAEGMNYL 228
H +V L VC + + +V EY G L L G+K+R LVD A QIAEGM YL
Sbjct: 60 HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK---TTHMSAAGTY 285
+ + IHRDL + N+L+ E + KI DFGLAR + T A
Sbjct: 120 ESR---NYIHRDLAARNILVGENL--------VCKIADFGLARLIEDDEYTAREGAKFPI 168
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPS 344
W APE F+ SDVWS+G++L E++T G +PY + V V +P P
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPP 227
Query: 345 TCPQLFKTLMEACWEADSHMRPSFKTI 371
CP+ LM CW+ D RP+F+ +
Sbjct: 228 NCPEELYDLMLQCWDKDPEERPTFEYL 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 96/280 (34%), Positives = 127/280 (45%), Gaps = 41/280 (14%)
Query: 121 FGEAIGEGGFGKVYKG-------IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHR 173
F E +GEG FGKVYKG VAIK N + + + +QE +L+ H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV-----------------LVD 216
NIV L+GVC + C++ EY G L+ L DV +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 217 WAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT 276
AIQIA GM YL +HRDL + N L+ E + T+KI+DFGL+R++Y
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL--------TVKISDFGLSRDIYSA 177
Query: 277 THMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAY 331
+ WM PE I F+ SD+WS+GVVLWE+ + G PY + V
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237
Query: 332 GVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
+ +L LP P CP LM CW RP FK I
Sbjct: 238 MIRSRQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 90/274 (32%), Positives = 137/274 (50%), Gaps = 27/274 (9%)
Query: 123 EAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
IG+G FG VY G +K A+K + D +E +EG ++ F H N++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 178 LIGVCLQSPKLCLV-MEYARGGPLNRVLAGRKIRPDV--LVDWAIQIAEGMNYLHCQAPI 234
L+G+CL S LV + Y + G L + P V L+ + +Q+A+GM YL A
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT------THMSAAGTYAWM 288
+HRDL + N +L E T+K+ DFGLAR++Y H A WM
Sbjct: 118 KFVHRDLAARNCMLDESF--------TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 289 APEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347
A E ++T F+ SDVWS+GV+LWEL+T G PY ++++ + + + L P CP
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLLQPEYCP 228
Query: 348 QLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381
+M +CW MRP+F ++ + I +
Sbjct: 229 DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 4e-45
Identities = 92/262 (35%), Positives = 137/262 (52%), Gaps = 18/262 (6%)
Query: 118 KLIFGEAIGEGGFGKVYKGIYEK--QEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRN 174
G+ IG G FG VYKG+ + VAIK ++ E L+++ QE LL H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLV-DWAIQIAEGMNYLHCQAP 233
IV IG S L +++EYA G L +++ P+ LV + Q+ +G+ YLH Q
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ-- 118
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV--YKTTHMSAAGTYAWMAPE 291
+IHRD+K++N+L ++ +K+ DFG+A ++ S GT WMAPE
Sbjct: 119 -GVIHRDIKAANILTTKD--------GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFK 351
VI+ S S ASD+WS G + ELLTG PY +N A + + V P+P K
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI-VQDDHPPLPEGISPELK 228
Query: 352 TLMEACWEADSHMRPSFKTILK 373
+ C++ D ++RP+ K +LK
Sbjct: 229 DFLMQCFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 1e-43
Identities = 93/274 (33%), Positives = 133/274 (48%), Gaps = 28/274 (10%)
Query: 125 IGEGGFGKVYKGIY--------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIV 176
+G G FG+VY+G VA+K + + +E L+ F+H NIV
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV--------LVDWAIQIAEGMNYL 228
L+GVCL + ++ME GG L L ++ L+D + +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---- 284
+ IHRDL + N L+SE + D + +KI DFGLAR++YK+ + G
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDAD---RVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 285 YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343
WMAPE + F+ SDVWS+GV++WE+LT G+ PY ++N V V L P
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RLQKP 235
Query: 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
CP LM CW D RP+F I + L N
Sbjct: 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 89/266 (33%), Positives = 141/266 (53%), Gaps = 24/266 (9%)
Query: 122 GEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
+G G FG+V++G+++ + VAIK+ + D ++ ++E + L H++++SL
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-DLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLI 237
VC + ++ E G L L G+ + L+D A Q+AEGM YL Q + I
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSI 126
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR----EVYKTTHMSAAGTYAWMAPEVI 293
HRDL + N+L+ E + K+ DFGLAR +VY ++ Y W APE
Sbjct: 127 HRDLAARNILVGEDL--------VCKVADFGLARLIKEDVYLSS--DKKIPYKWTAPEAA 176
Query: 294 KTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKT 352
FS SDVWS+G++L+E+ T G++PY +N + V + +P P+ CPQ
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEIYK 235
Query: 353 LMEACWEADSHMRPSFKTILKALNNI 378
+M CW A+ RPSFK + + L+NI
Sbjct: 236 IMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 86/273 (31%), Positives = 134/273 (49%), Gaps = 19/273 (6%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
E++ + +G G +G+VY+G+++K + + V D +E +E ++ H
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDV-LVDWAIQIAEGMNYLH 229
N+V L+GVC + P ++ E+ G L L R+ V L+ A QI+ M YL
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---YA 286
+ + IHRDL + N L+ E +K+ DFGL+R + T+ + AG
Sbjct: 122 KK---NFIHRDLAARNCLVGEN--------HLVKVADFGLSRLMTGDTYTAHAGAKFPIK 170
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPST 345
W APE + + FS SDVW++GV+LWE+ T G PY I+ V Y + + P
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKGYRMERPEG 229
Query: 346 CPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
CP LM ACW+ + RPSF I +A +
Sbjct: 230 CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 94/298 (31%), Positives = 136/298 (45%), Gaps = 47/298 (15%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYK----GIYEKQE---VAIKVAHPNPDENILENVKQEGK 165
E N + + IG+G FG+V++ G+ + VA+K+ ++ + ++E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR--------------- 210
L+ FDH NIV L+GVC +CL+ EY G LN L R R
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 211 ----PDV----LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262
+ + A Q+A GM YL + +HRDL + N L+ E + +
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENM--------VV 169
Query: 263 KITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-G 317
KI DFGL+R +Y + A+ A WM PE I + ++ SDVW+YGVVLWE+ + G
Sbjct: 170 KIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 229
Query: 318 EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
PY + V Y V + L P CP LM CW RPSF +I + L
Sbjct: 230 MQPYYGMAHEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 85/262 (32%), Positives = 126/262 (48%), Gaps = 28/262 (10%)
Query: 123 EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E IG+GGFG+VYK + +EVAIKV E E + E ++L H NIV G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK-KEKIINEIQILKKCKHPNIVKYYG 64
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIA-------EGMNYLHCQAP 233
L+ +L +VME+ GG L +L QIA +G+ YLH
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES-----QIAYVCKELLKGLEYLHSN-- 117
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT-THMSAAGTYAWMAPEV 292
+IHRD+K++N+LL+ E +K+ DFGL+ ++ T + GT WMAPEV
Sbjct: 118 -GIIHRDIKAANILLTSDGE--------VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEV 168
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLFK 351
I + +D+WS G+ EL G+ PY + + +A N L P FK
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK 228
Query: 352 TLMEACWEADSHMRPSFKTILK 373
++ C + + RP+ + +LK
Sbjct: 229 DFLKKCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 98/308 (31%), Positives = 138/308 (44%), Gaps = 55/308 (17%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVY----KGIYEKQE--------------VAIKVAHPNPDE 154
E L F E +GEG FG+V+ G+ + E VA+KV P+ +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 155 NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL---------- 204
N E+ +E K+L NI L+GVC P LC++MEY G LN+ L
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 205 --AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262
+ + L+ A QIA GM YL ++ +HRDL + N L+ + T+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNY--------TI 169
Query: 263 KITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-- 316
KI DFG++R +Y + + G WMA E + F+ SDVW++GV LWE+LT
Sbjct: 170 KIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229
Query: 317 GEIPYKSI-------NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFK 369
E PY+ + NA LP P CP+ LM CW D RP+F+
Sbjct: 230 REQPYEHLTDQQVIENAGHFFRDDGRQIY-LPRPPNCPKDIYELMLECWRRDEEDRPTFR 288
Query: 370 TILKALNN 377
I L
Sbjct: 289 EIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 3e-41
Identities = 84/274 (30%), Positives = 136/274 (49%), Gaps = 32/274 (11%)
Query: 125 IGEGGFGKVY----KGIYEKQE---VAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
+G G FG+V+ KGI E+ V +K DEN+ ++E + H+N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVL----------VDWAIQIAEGMNY 227
L+G+C ++ +++EY G L + L K + + L V QIA GM++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA- 286
L + +HRDL + N L+S Q + +K++ L+++VY + +
Sbjct: 133 L---SNARFVHRDLAARNCLVSS-------QRE-VKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 287 --WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343
W+APE ++ FS SDVWS+GV++WE+ T GE+P+ ++ V + KL LP+P
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241
Query: 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
CP LM CW + RPSF ++ AL
Sbjct: 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 1e-40
Identities = 92/259 (35%), Positives = 137/259 (52%), Gaps = 25/259 (9%)
Query: 125 IGEGGFGKVYKGIYE---KQ-EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
+G G FG V KG+Y+ KQ +VAIKV ++++ + + +E +++ D+ IV +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238
VC ++ L LVME A GGPLN+ L+G+K I +V+ Q++ GM YL + + +H
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVH 118
Query: 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-----YKTTHMSAAGTYAWMAPEVI 293
RDL + NVLL + KI+DFGL++ + Y + W APE I
Sbjct: 119 RDLAARNVLL--------VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 294 KTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKT 352
FS SDVWSYG+ +WE + G+ PYK + V + K L P+ CP
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLDCPAECPPEMYA 229
Query: 353 LMEACWEADSHMRPSFKTI 371
LM+ CW RP+F +
Sbjct: 230 LMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 95/269 (35%), Positives = 131/269 (48%), Gaps = 35/269 (13%)
Query: 123 EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E IG G FG+V+ G + VA+K ++ QE ++L + H NIV LIG
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 181 VCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYL---HCQAPIS 235
VC Q + +VME +GG L G +++ L+ A GM YL HC
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----- 115
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT----YAWMAPE 291
IHRDL + N L++E LKI+DFG++RE + S G W APE
Sbjct: 116 -IHRDLAARNCLVTEK--------NVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166
Query: 292 VIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAY----AVAYGVAVNKLTLPIPSTC 346
+ +S SDVWS+G++LWE + G +PY +++ A+ GV LP P C
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV-----RLPCPELC 221
Query: 347 PQLFKTLMEACWEADSHMRPSFKTILKAL 375
P LME CWE D RPSF T+ + L
Sbjct: 222 PDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 98/283 (34%), Positives = 132/283 (46%), Gaps = 38/283 (13%)
Query: 125 IGEGGFGKVYKGIYEK------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
+GEG FGKV Y+ + VA+K + K+E +L H NIV
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 179 IGVCLQS--PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
G C + L L+MEY G L L K+ L+ +A QI EGM YLH Q
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HY 128
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-----YKTTHMSAAGTYAWMAPE 291
IHRDL + NVLL +N+ L +KI DFGLA+ V Y W A E
Sbjct: 129 IHRDLAARNVLL----DNDRL----VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA-YAVAYGVAVNKLT----------- 339
+K + FS ASDVWS+GV L+ELLT +S + G ++T
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240
Query: 340 --LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380
LP P CPQ LM+ CWE ++ RP+F++++ L + H
Sbjct: 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 85/269 (31%), Positives = 134/269 (49%), Gaps = 21/269 (7%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
I ++L + IG G FG V+ G + EK++VAIK E+ +E +++ H
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE--EDFIEEAQVMMKLSH 58
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEGMNYLHC 230
+V L GVC + +CLV E+ G L+ L ++ + L+ + + EGM YL
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---YAW 287
++IHRDL + N L+ E + +K++DFG+ R V + S+ GT W
Sbjct: 119 S---NVIHRDLAARNCLVGEN--------QVVKVSDFGMTRFVLDDQYTSSTGTKFPVKW 167
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346
+PEV S +S SDVWS+GV++WE+ + G+ PY++ + V + L P
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLA 226
Query: 347 PQLFKTLMEACWEADSHMRPSFKTILKAL 375
Q LM+ CW+ RPSF +L L
Sbjct: 227 SQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 5e-40
Identities = 90/275 (32%), Positives = 141/275 (51%), Gaps = 27/275 (9%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYK----GIYEKQ---EVAIKVAHPNPDENILENVKQEGK 165
E N L FG+ +G G FGKV + G+ + +VA+K+ P + E + E K
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 166 LL-WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK---IRPDVLVDWAIQI 221
++ L +H NIV+L+G C + ++ EY G L L ++ + + L+ ++ Q+
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150
Query: 222 AEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA 281
A+GM +L A + IHRDL + NVLL+ K +KI DFGLAR++ ++
Sbjct: 151 AKGMAFL---ASKNCIHRDLAARNVLLTHG--------KIVKICDFGLARDIMNDSNYVV 199
Query: 282 AGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVN 336
G WMAPE I +++ SDVWSYG++LWE+ + G PY + + Y +
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
Query: 337 KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
+ P P +M+ CW+AD RP+FK I
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 78/260 (30%), Positives = 126/260 (48%), Gaps = 26/260 (10%)
Query: 125 IGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182
+G+G G VYK ++ + A+K H + DE + + +E K L + +V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 183 LQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDL 241
+ ++ +V+EY GG L +L KI VL A QI +G++YLH + I IHRD+
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI--IHRDI 126
Query: 242 KSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIFS 299
K SN+L++ + E +KI DFG+++ + T + GT +M+PE I+ +S
Sbjct: 127 KPSNLLIN--SKGE------VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYS 178
Query: 300 KASDVWSYGVVLWELLTGEIPYKSINA-------YAVAYGVAVNKLTLPIPSTCPQLFKT 352
A+D+WS G+ L E G+ P+ A+ G +LP F+
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PPPSLP-AEEFSPEFRD 234
Query: 353 LMEACWEADSHMRPSFKTIL 372
+ AC + D RPS +L
Sbjct: 235 FISACLQKDPKKRPSAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 9e-40
Identities = 86/270 (31%), Positives = 132/270 (48%), Gaps = 28/270 (10%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHP---NPDENILENVKQEGKLLW 168
EID + +G G FG+V++G++ VA+K P +P + + E +++
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFL-----AEAQIMK 56
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL---AGRKIRPDVLVDWAIQIAEGM 225
H ++ L VC + +V E + G L L AGR ++ L+D A Q+A GM
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT- 284
YL Q + IHRDL + NVL+ E K+ DFGLAR + + + + G
Sbjct: 117 AYLEAQ---NYIHRDLAARNVLVGEN--------NICKVADFGLARVIKEDIYEAREGAK 165
Query: 285 --YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLP 341
W APE + FS SDVWS+G++L E++T G +PY + V V +P
Sbjct: 166 FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMP 224
Query: 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
P CP+ +M CW+ D RP+F+T+
Sbjct: 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 2e-39
Identities = 93/304 (30%), Positives = 137/304 (45%), Gaps = 52/304 (17%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVY----KGIYEKQE------------VAIKVAHPNPDENI 156
E +L E +GEG FG+V+ +G+ E VA+K+ + +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 157 LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR------ 210
+ +E K++ + NI+ L+GVC+ LC++ EY G LN+ L+ R+I
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 211 ---PDV----LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263
P V L+ A+QIA GM YL A ++ +HRDL + N L+ T+K
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHY--------TIK 169
Query: 264 ITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWEL--LTG 317
I DFG++R +Y + G WMA E I F+ ASDVW++GV LWE+ L
Sbjct: 170 IADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229
Query: 318 EIPYKSINAYAVAYGVAV------NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
E PY ++ V ++ L CP LM CW D RP+F I
Sbjct: 230 EQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289
Query: 372 LKAL 375
L
Sbjct: 290 HHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 103/317 (32%), Positives = 157/317 (49%), Gaps = 51/317 (16%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYK----GIYEKQE-----VAIKVAHPNPDENILENVKQE 163
E ++L+ G+ +GEG FG+V + GI + + VA+K+ N + L ++ E
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE 67
Query: 164 GKLLWLFD-HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK-----IRPDV---- 213
+L+ L H+NI++L+GVC Q L +++EYA G L L R+ D+
Sbjct: 68 MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 214 --------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265
LV A Q+A GM YL + IHRDL + NVL++E +N +KI
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTE--DN------VMKIA 176
Query: 266 DFGLAREV-----YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEI 319
DFGLAR V YK T + WMAPE + +++ SDVWS+G+++WE+ T G
Sbjct: 177 DFGLARGVHDIDYYKKTS-NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS 235
Query: 320 PYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI- 378
PY I + + + PS C LM CW A RP+FK +++AL+ +
Sbjct: 236 PYPGI-PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294
Query: 379 --VHSEF--IQTPHESF 391
V E+ + P E +
Sbjct: 295 AAVSEEYLDLSMPFEQY 311
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 94/303 (31%), Positives = 136/303 (44%), Gaps = 61/303 (20%)
Query: 119 LIFGEAIGEGGFGKVYK-GIYEKQE-----------------VAIKVAHPNPDENILENV 160
L+F E +GEG FG+V+ + Q+ VA+K+ P+ ++N +
Sbjct: 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDF 66
Query: 161 KQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK------------ 208
+E K+L NI+ L+GVC+ LC++ EY G LN+ L+
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 209 --------IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260
I L+ A+QIA GM YL + ++ +HRDL + N L+ E +
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENL-------- 175
Query: 261 TLKITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT 316
T+KI DFG++R +Y + G WMA E I F+ ASDVW++GV LWE+L
Sbjct: 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
Query: 317 --GEIPYKSINAYAVAYGVAV------NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSF 368
E PY + V ++ L P CPQ LM CW D RPSF
Sbjct: 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295
Query: 369 KTI 371
I
Sbjct: 296 SDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 2e-38
Identities = 94/299 (31%), Positives = 141/299 (47%), Gaps = 49/299 (16%)
Query: 118 KLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLF 170
L+ G+ +GEG FGKV K + VA+K+ N + L ++ E LL
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRP------------------ 211
+H +++ L G C Q L L++EYA+ G L L RK+ P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 212 ------DVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265
L+ +A QI+ GM YL A + L+HRDL + NVL++E + +KI+
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEG--------RKMKIS 169
Query: 266 DFGLAREVYKTTHMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIP 320
DFGL+R+VY+ WMA E + I++ SDVWS+GV+LWE++T G P
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
Query: 321 YKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
Y I A + + + P C + LM CW+ + RP+F I K L ++
Sbjct: 230 YPGI-APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-38
Identities = 99/271 (36%), Positives = 137/271 (50%), Gaps = 31/271 (11%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVK-----QEGKLLW 168
++ KL GE IGEG FG V +G Y Q+VA+K NI +V +E ++
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVK--------NIKCDVTAQAFLEETAVMT 54
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA--GRKIRPDV-LVDWAIQIAEGM 225
H+N+V L+GV L + L +VME G L L GR + + L+ +++ +AEGM
Sbjct: 55 KLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTY 285
YL + L+HRDL + N+L+SE D K++DFGLAR S
Sbjct: 114 EYLESK---KLVHRDLAARNILVSE-----DG---VAKVSDFGLARVGSMGVDNSKLPV- 161
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPS 344
W APE +K FS SDVWSYGV+LWE+ + G PY ++ V V P P
Sbjct: 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP-PE 220
Query: 345 TCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
CP LM +CWE + RPSF + + L
Sbjct: 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 6e-38
Identities = 91/281 (32%), Positives = 144/281 (51%), Gaps = 27/281 (9%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE---KQE--VAIKVAHPNPDENILENVKQEGKLL 167
EI + + + IG G FG+V++GI + ++E VAIK P E ++ E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR--KIRPDVLVDWAIQIAEGM 225
F H NI+ L GV + ++ EY G L++ L + LV IA GM
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGM 120
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY---KTTHMSAA 282
YL + ++ +HRDL + N+L++ +E K++DFGL+R + + T+ ++
Sbjct: 121 KYL---SDMNYVHRDLAARNILVNSNLE--------CKVSDFGLSRVLEDDPEGTYTTSG 169
Query: 283 GTYA--WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK-L 338
G W APE I F+ ASDVWS+G+V+WE+++ GE PY ++ + V A+N
Sbjct: 170 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMK--AINDGF 227
Query: 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
LP P CP LM CW+ D RP F I+ L+ ++
Sbjct: 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 1e-37
Identities = 88/296 (29%), Positives = 145/296 (48%), Gaps = 39/296 (13%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNPDENILENVK--QEGK 165
E+ K+ +G+G FG VY+G + E + V N ++ E ++ E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV------------ 213
++ F ++V L+GV + +VME G L L R +RP+
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQ 119
Query: 214 -LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272
++ A +IA+GM YL+ + +HRDL + N +++ T+KI DFG+ R+
Sbjct: 120 EMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDF--------TVKIGDFGMTRD 168
Query: 273 VYKTTHMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAY 327
+Y+T + G WMAPE +K +F+ +SD+WS+GVVLWE+ + E PY+ ++
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228
Query: 328 AVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383
V V ++ L P CP+ LM CW+ + MRP+F I+ L + +H F
Sbjct: 229 QVLKFV-MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 283
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 87/263 (33%), Positives = 129/263 (49%), Gaps = 31/263 (11%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E IG+G FG+VYK I ++ Q VAIKV E+ +E+++QE + L I G
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240
L+ KL ++MEY GG +L K+ + ++ G+ YLH + IHRD
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRD 123
Query: 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIF 298
+K++N+LLSE + +K+ DFG++ ++ T + GT WMAPEVIK S +
Sbjct: 124 IKAANILLSEEGD--------VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 299 SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL--------F 350
+ +D+WS G+ EL GE P ++ V L L + P L F
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRV--------LFLIPKNNPPSLEGNKFSKPF 227
Query: 351 KTLMEACWEADSHMRPSFKTILK 373
K + C D RPS K +LK
Sbjct: 228 KDFVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 92/281 (32%), Positives = 135/281 (48%), Gaps = 53/281 (18%)
Query: 125 IGEGGFGKVYKG-------IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
+GEG FGKV+ +K VA+K A E+ ++ ++E +LL + H++IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVK-ALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV------------------LVDWAI 219
GVC + L +V EY R G LNR L R PD ++ A
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 220 QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM 279
QIA GM YL A + +HRDL + N L+ + + +KI DFG++R++Y T +
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGL--------VVKIGDFGMSRDIYSTDYY 178
Query: 280 SAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVA 334
G WM PE I F+ SD+WS+GVVLWE+ T G+ P+ Y ++ A
Sbjct: 179 RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW-----YQLSNTEA 233
Query: 335 VNKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
+ +T L P TCP +M+ CW+ + R K I
Sbjct: 234 IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 95/288 (32%), Positives = 130/288 (45%), Gaps = 41/288 (14%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKG------IYEKQEVAIKVAHPNPDENILENVKQEGKL 166
E+ + + F E +GE FGK+YKG + Q VAIK + +QE L
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV------------- 213
+ H NIV L+GV Q +C++ EY G L+ L R DV
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 214 -----LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268
+ AIQIA GM YL + +H+DL + N+L+ E + +KI+D G
Sbjct: 121 LDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLH--------VKISDLG 169
Query: 269 LAREVYKTTHMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKS 323
L+RE+Y + WM PE I FS SD+WS+GVVLWE+ + G PY
Sbjct: 170 LSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229
Query: 324 INAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
+ V V +L LP CP +LM CW+ RP FK I
Sbjct: 230 FSNQEVIEMVRKRQL-LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 3e-37
Identities = 89/290 (30%), Positives = 144/290 (49%), Gaps = 39/290 (13%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVK--QEGK 165
E+ K+ +G+G FG VY+GI ++ E + + N ++ E ++ E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV------------ 213
++ F+ ++V L+GV Q ++ME G L L R +RP++
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLK 119
Query: 214 -LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272
++ A +IA+GM YL+ +HRDL + N +++E T+KI DFG+ R+
Sbjct: 120 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF--------TVKIGDFGMTRD 168
Query: 273 VYKTTHMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAY 327
+Y+T + G WM+PE +K +F+ SDVWS+GVVLWE+ T E PY+ ++
Sbjct: 169 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228
Query: 328 AVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
V V L L P CP + LM CW+ + MRPSF I+ ++
Sbjct: 229 QVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-37
Identities = 86/261 (32%), Positives = 129/261 (49%), Gaps = 21/261 (8%)
Query: 123 EAIGEGGFGKVYKG-IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGV 181
E +G+G FG+V+KG + +K VA+K + + + E ++L +DH NIV LIGV
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 182 CLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEGMNYLHCQAPISLIHR 239
C Q + +VME GG L +K ++ LV +A+ A GM YL + + IHR
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHR 117
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLARE----VYKTTHMSAAGTYAWMAPEVIKT 295
DL + N L+ E LKI+DFG++R+ +Y ++ + W APE +
Sbjct: 118 DLAARNCLVGEN--------NVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNY 168
Query: 296 SIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354
+S SDVWSYG++LWE + G PY + V + P CP +M
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVM 227
Query: 355 EACWEADSHMRPSFKTILKAL 375
+ CW+ RP F + K L
Sbjct: 228 QRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-37
Identities = 95/295 (32%), Positives = 141/295 (47%), Gaps = 41/295 (13%)
Query: 114 IDYNKLIFGEAIGEGGFGKV-----YKGIYEKQEVAIKVAH-PNPDENILENVKQEGKLL 167
I + ++ +GEG FGKV Y E+ ++ + V + +N ++ +E +LL
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV-------------- 213
H +IV GVC++ L +V EY + G LN+ L R PD
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL--RAHGPDAVLMAEGNRPAELTQ 119
Query: 214 --LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271
++ A QIA GM YL Q +HRDL + N L+ E + +KI DFG++R
Sbjct: 120 SQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL--------LVKIGDFGMSR 168
Query: 272 EVYKTTHMSAAG----TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINA 326
+VY T + G WM PE I F+ SDVWS GVVLWE+ T G+ P+ ++
Sbjct: 169 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
Query: 327 YAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381
V + ++ L P TCP+ LM CW+ + HMR + K I L N+ +
Sbjct: 229 NEVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-37
Identities = 87/286 (30%), Positives = 133/286 (46%), Gaps = 33/286 (11%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E+ + + A+G G FG+VY+G+Y + +VA+K + E + E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV----------LV 215
++ F+H+NIV LIGV + +++E GG L L R+ RP L+
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL--RENRPRPERPSSLTMKDLL 119
Query: 216 DWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275
A +A+G YL IHRD+ + N LL+ + KI DFG+AR++Y+
Sbjct: 120 FCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPG-----RVAKIADFGMARDIYR 171
Query: 276 TTHMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVA 330
++ G WM PE IF+ +DVWS+GV+LWE+ + G +PY V
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
Query: 331 YGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376
V L P CP +M CW+ RP+F TIL+ +
Sbjct: 232 EFV-TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 8e-37
Identities = 98/293 (33%), Positives = 141/293 (48%), Gaps = 46/293 (15%)
Query: 108 DVKLVEIDYNKLIFGEAIGEGGFGKVYKG---IYEKQE--VAIKVAHPNPDENILENVKQ 162
DV V+I+ E IG G FG+V +G + K+E VAIK E +
Sbjct: 2 DVSCVKIE-------EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS 54
Query: 163 EGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR--KIRPDVLVDWAIQ 220
E ++ FDH NI+ L GV +S + ++ E+ G L+ L + LV
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG 114
Query: 221 IAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR----EVYKT 276
IA GM YL + ++ +HRDL + N+L+ N +L K++DFGL+R +
Sbjct: 115 IAAGMKYL---SEMNYVHRDLAARNILV-----NSNL---VCKVSDFGLSRFLEDDTSDP 163
Query: 277 THMSAAG---TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPY------KSINA 326
T+ S+ G W APE I F+ ASDVWSYG+V+WE+++ GE PY INA
Sbjct: 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA 223
Query: 327 YAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
Y LP P CP LM CW+ D + RP F I+ L+ ++
Sbjct: 224 IEQDY-------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 90/301 (29%), Positives = 143/301 (47%), Gaps = 53/301 (17%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVY----KGIYEKQE--------------VAIKVAHPNPDE 154
E +L F E +GEG FG+V+ +G+ + + VA+K+ + ++
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 155 NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV- 213
N + +E K++ NI+ L+ VC+ S LC++ EY G LN+ L+ + +
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 214 -----------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262
L+ A QIA GM YL + ++ +HRDL + N L+ + T+
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNY--------TI 169
Query: 263 KITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-- 316
KI DFG++R +Y + G WM+ E I F+ ASDVW++GV LWE+LT
Sbjct: 170 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229
Query: 317 GEIPYKSINAYAVAYGVAV------NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKT 370
E PY ++ V ++ LP P+ CP LM +CW ++ RPSF+
Sbjct: 230 KEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQE 289
Query: 371 I 371
I
Sbjct: 290 I 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 87/283 (30%), Positives = 141/283 (49%), Gaps = 33/283 (11%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKLL 167
I +++ + + EG FG+++ GI +++EV +K + E + + QE LL
Sbjct: 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLL 62
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVME-YARGGPLNRVL---------AGRKIRPDVLVDW 217
+ H+NI+ ++ VC++ + V+ Y G L L + + LV
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 218 AIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT 277
AIQIA GM+YLH +IH+D+ + N ++ +E+LQ +KITD L+R+++
Sbjct: 123 AIQIACGMSYLH---KRGVIHKDIAARNCVI-----DEELQ---VKITDNALSRDLFPMD 171
Query: 278 -HMSAAGTY---AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYG 332
H WMA E + +S ASDVWS+GV+LWEL+T G+ PY I+ + +A
Sbjct: 172 YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY 231
Query: 333 VAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
+ L P CP +M CW D RPSF +++ L
Sbjct: 232 LKDGY-RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 88/273 (32%), Positives = 130/273 (47%), Gaps = 23/273 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFD 171
E+ L + +G G FG+V+ G Y +VAIK E E L+
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQ 59
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL---AGRKIRPDVLVDWAIQIAEGMNYL 228
H +V L V Q P + ++ EY G L L G K+ + L+D A QIAEGM ++
Sbjct: 60 HPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---Y 285
+ + IHRDL+++N+L+SE + KI DFGLAR + + + G
Sbjct: 119 ERK---NYIHRDLRAANILVSETL--------CCKIADFGLARLIEDNEYTAREGAKFPI 167
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPS 344
W APE I F+ SDVWS+G++L E++T G IPY + V + +P P
Sbjct: 168 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMPRPD 226
Query: 345 TCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
CP+ LM CW+ RP+F+ + L +
Sbjct: 227 NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 3e-36
Identities = 99/308 (32%), Positives = 151/308 (49%), Gaps = 62/308 (20%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYK----GIYEKQ-----EVAIKVAHPNPDENILENVKQE 163
E+ ++L+ G+ +GEG FG+V G+ +++ +VA+K+ + E L ++ E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 164 GKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK-------IRPDV-- 213
+++ + H+NI++L+G C Q L +++EYA G L L R+ P
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 214 --------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265
LV A Q+A GM YL A IHRDL + NVL++E +KI
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED--------NVMKIA 182
Query: 266 DFGLAREV-----YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEI 319
DFGLAR++ YK T + WMAPE + I++ SDVWS+GV+LWE+ T G
Sbjct: 183 DFGLARDIHHIDYYKKT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 241
Query: 320 PYKSINAYAVAYGVAVNKL--------TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
PY GV V +L + PS C +M CW A RP+FK +
Sbjct: 242 PYP---------GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292
Query: 372 LKALNNIV 379
++ L+ I+
Sbjct: 293 VEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 5e-36
Identities = 87/269 (32%), Positives = 133/269 (49%), Gaps = 21/269 (7%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
I+ ++L F + +G G FG V+ G + Q +VAIK N E+ +E K++ H
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAI--NEGAMSEEDFIEEAKVMMKLSH 58
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR--KIRPDVLVDWAIQIAEGMNYLHC 230
+V L GVC Q L +V E+ G L L R K+ D+L+ + EGM YL
Sbjct: 59 PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER 118
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---YAW 287
S IHRDL + N L+S +K++DFG+ R V + S++G W
Sbjct: 119 N---SFIHRDLAARNCLVSST--------GVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW 167
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346
PEV S +S SDVWS+GV++WE+ T G++P++ + Y V ++ L P
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLA 226
Query: 347 PQLFKTLMEACWEADSHMRPSFKTILKAL 375
+M +CW RP+F +L+A+
Sbjct: 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 83/261 (31%), Positives = 129/261 (49%), Gaps = 21/261 (8%)
Query: 123 EAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182
+ IG+G FG V G Y +VA+K ++ + E ++ H N+V L+GV
Sbjct: 12 QTIGKGEFGDVMLGDYRGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 183 LQSP-KLCLVMEYARGGPLNRVLAGRK---IRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238
++ L +V EY G L L R + D L+ +++ + E M YL + +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125
Query: 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIF 298
RDL + NVL+SE +N K++DFGL +E +T + W APE ++ F
Sbjct: 126 RDLAARNVLVSE--DN------VAKVSDFGLTKEA-SSTQDTGKLPVKWTAPEALREKKF 176
Query: 299 SKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEAC 357
S SDVWS+G++LWE+ + G +PY I V V + P CP + +M+ C
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQC 235
Query: 358 WEADSHMRPSFKTILKALNNI 378
W D+ RPSF + + L +I
Sbjct: 236 WHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 8e-36
Identities = 82/269 (30%), Positives = 120/269 (44%), Gaps = 30/269 (11%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN 174
E IGEG G+VYK +EVAIK E + E ++ H N
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEILIMKDCKHPN 76
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLH 229
IV L +L +VMEY GG L ++ +R + + I ++ +G+ YLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR---MNEPQIAYVCREVLQGLEYLH 133
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA----REVYKTTHMSAAGTY 285
Q ++IHRD+KS N+LLS + ++K+ DFG A +E K + GT
Sbjct: 134 SQ---NVIHRDIKSDNILLS--------KDGSVKLADFGFAAQLTKEKSKRNSV--VGTP 180
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPS 344
WMAPEVIK + D+WS G++ E+ GE PY + + + L P
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPE 240
Query: 345 TCPQLFKTLMEACWEADSHMRPSFKTILK 373
FK + C D RPS + +L+
Sbjct: 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 9e-36
Identities = 96/288 (33%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
EI+ + + F E +GE FGKVYKG + Q VAIK + + E K E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV------------ 213
+ H NIV L+GV + L ++ Y L+ L R DV
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 214 -----LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268
V QIA GM +L ++H+DL + NVL+ + + +KI+D G
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL--------NVKISDLG 169
Query: 269 LAREVYKTTHMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKS 323
L REVY + G WM+PE I FS SD+WSYGVVLWE+ + G PY
Sbjct: 170 LFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229
Query: 324 INAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
+ V + N+ LP P CP TLM CW RP FK I
Sbjct: 230 YSNQDVIEMIR-NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 98/302 (32%), Positives = 146/302 (48%), Gaps = 50/302 (16%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYK----GI-----YEKQEVAIKVAHPNPDENILENVKQE 163
E +KL G+ +GEG FG+V GI E VA+K+ + E L ++ E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 164 GKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRP-------DV-- 213
+++ + H+NI++L+G C Q L +++EYA G L L R RP D+
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYSYDIAR 128
Query: 214 ----------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263
LV Q+A GM YL Q IHRDL + NVL++E +K
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTEN--------NVMK 177
Query: 264 ITDFGLAREV-----YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-G 317
I DFGLAR+V YK T + WMAPE + +++ SDVWS+GV++WE+ T G
Sbjct: 178 IADFGLARDVNNIDYYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 236
Query: 318 EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
PY I + + + + P+ C +M CW A RP+FK +++ L+
Sbjct: 237 GSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295
Query: 378 IV 379
I+
Sbjct: 296 IL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 81/261 (31%), Positives = 131/261 (50%), Gaps = 26/261 (9%)
Query: 122 GEAIGEGGFGKVYKGI-YEKQEV-AIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
G IG G FGKVY + + E+ A+K + + D ++ + E K+L L H N+V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVD-WAIQIAEGMNYLHCQAPISLI 237
GV + K+ + MEY GG L +L +I + ++ + +Q+ EG+ YLH ++
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IV 121
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM------SAAGTYAWMAPE 291
HRD+K +N+ L +K+ DFG A ++ T S AGT A+MAPE
Sbjct: 122 HRDIKPANIFLDHN--------GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 292 VI---KTSIFSKASDVWSYGVVLWELLTGEIPYKSI-NAYAVAYGVAV-NKLTLPIPSTC 346
VI K +A+D+WS G V+ E+ TG+ P+ + N + + + V +K +P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL 233
Query: 347 PQLFKTLMEACWEADSHMRPS 367
K ++ C E+D RP+
Sbjct: 234 SPEGKDFLDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-34
Identities = 82/285 (28%), Positives = 137/285 (48%), Gaps = 38/285 (13%)
Query: 119 LIFGEAIGEGGFGKVYKGIYEKQE-----VAIKVAH-PNPDENILENVKQEGKLLWLFDH 172
L G+ +GEG FG V +G + + VA+K + +E E + FDH
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 173 RNIVSLIGVCLQS------PKLCLVMEYARGGPLNRVL-------AGRKIRPDVLVDWAI 219
N++ LIGVC ++ PK +++ + + G L+ L K+ L+ + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 220 QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY----- 274
IA GM YL + + IHRDL + N +L ED+ T+ + DFGL++++Y
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCML-----REDM---TVCVADFGLSKKIYSGDYY 169
Query: 275 KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGV 333
+ ++ W+A E + +++ SDVW++GV +WE+ T G+ PY + + + Y
Sbjct: 170 RQGRIAKMPV-KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI-YDY 227
Query: 334 AVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
+ L P C LM +CW AD RP+F + + L NI
Sbjct: 228 LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 91/256 (35%), Positives = 134/256 (52%), Gaps = 18/256 (7%)
Query: 123 EAIGEGGFGKVYKGI--YEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E IG+G FG+VYKGI K+ VAIK+ E+ +E+++QE +L D I G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240
L+ KL ++MEY GG +L + + +I +G++YLH + I HRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI---HRD 126
Query: 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--THMSAAGTYAWMAPEVIKTSIF 298
+K++NVLLSE + +K+ DFG+A ++ T + GT WMAPEVIK S +
Sbjct: 127 IKAANVLLSEQGD--------VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 299 SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPSTCPQLFKTLMEAC 357
+D+WS G+ EL GE P ++ V + + N TL + P FK +EAC
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKP--FKEFVEAC 236
Query: 358 WEADSHMRPSFKTILK 373
D RP+ K +LK
Sbjct: 237 LNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 94/281 (33%), Positives = 135/281 (48%), Gaps = 29/281 (10%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKG---IYEKQE--VAIKVAHPNPDENILENVKQEGKLLW 168
ID + + + IG G FG+V G + K+E VAIK E + E ++
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV--LVDWAIQIAEGMN 226
FDH NI+ L GV +S + +V EY G L+ L + V LV IA GM
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR-------EVYKTTHM 279
YL + + +HRDL + N+L+ N +L K++DFGL+R Y T
Sbjct: 121 YL---SDMGYVHRDLAARNILV-----NSNL---VCKVSDFGLSRVLEDDPEAAYTTR-- 167
Query: 280 SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338
W APE I F+ ASDVWSYG+V+WE+++ GE PY ++ V +
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGY 226
Query: 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
LP P CP LM CW+ D + RP F+ I+ L+ ++
Sbjct: 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-34
Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 22/273 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFD 171
EI + + +G G FG+V+ G Y +VA+K P ++ +E L+
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQ 59
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL---AGRKIRPDVLVDWAIQIAEGMNYL 228
H +V L V + + ++ EY G L L G K+ L+D++ QIAEGM Y+
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---Y 285
+ + IHRDL+++NVL+SE + KI DFGLAR + + + G
Sbjct: 120 ERK---NYIHRDLRAANVLVSESL--------MCKIADFGLARVIEDNEYTAREGAKFPI 168
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPS 344
W APE I F+ SDVWS+G++L+E++T G+IPY ++ V + +P
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRME 227
Query: 345 TCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
CP +M+ CW+ + RP+F + L++
Sbjct: 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 2e-34
Identities = 95/302 (31%), Positives = 146/302 (48%), Gaps = 50/302 (16%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYK----GIYEKQ-----EVAIKVAHPNPDENILENVKQE 163
E+ +L G+ +GEG FG+V GI + + VA+K+ + + L ++ E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 164 GKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRP----------- 211
+++ + H+NI++L+G C Q L +++EYA G L L R RP
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRAR--RPPGMDYSFDTCK 125
Query: 212 --------DVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263
LV A Q+A GM YL Q IHRDL + NVL++E +K
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTED--------NVMK 174
Query: 264 ITDFGLAREV-----YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-G 317
I DFGLAR+V YK T + WMAPE + +++ SDVWS+GV+LWE+ T G
Sbjct: 175 IADFGLARDVHNIDYYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 233
Query: 318 EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
PY I + + + + P+ C +M CW A RP+FK +++ L+
Sbjct: 234 GSPYPGIPVEEL-FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR 292
Query: 378 IV 379
++
Sbjct: 293 VL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 82/265 (30%), Positives = 128/265 (48%), Gaps = 25/265 (9%)
Query: 125 IGEGGFGKVYKGIYEKQEVAIKVA-----HPNPDENILENVKQEGKLLWLFDHRNIVSLI 179
+G G FG V KG+Y+ ++ VA + N D + + + +E ++ D+ IV +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 180 GVCLQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238
G+C ++ LVME A GPLN+ L + + + + Q++ GM YL + +H
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETNFVH 118
Query: 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA-----WMAPEVI 293
RDL + NVLL + KI+DFGL++ + + A T+ W APE +
Sbjct: 119 RDLAARNVLL--------VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 294 KTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKT 352
FS SDVWS+GV++WE + G+ PYK + V + + + P CP
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-RMECPQRCPPEMYD 229
Query: 353 LMEACWEADSHMRPSFKTILKALNN 377
LM+ CW RP F + L N
Sbjct: 230 LMKLCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 90/266 (33%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 125 IGEGGFGKVYKGIYE------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
+G G FG VYKGI+ K VAIKV N + + E ++ + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGMNYLHCQAPISLI 237
+G+CL S + G L+ V + +I L++W +QIA+GM+YL + L+
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLV 131
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSAAGTY--AWMAPEVI 293
HRDL + NVL+ P +KITDFGLAR ++ +T + + G WMA E I
Sbjct: 132 HRDLAARNVLVKSP--------NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 294 KTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKT 352
F+ SDVWSYGV +WEL+T G PY I A + + + LP P C
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RLPQPPICTIDVYM 242
Query: 353 LMEACWEADSHMRPSFKTILKALNNI 378
+M CW DS RP F+ ++ + +
Sbjct: 243 IMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-34
Identities = 95/286 (33%), Positives = 131/286 (45%), Gaps = 52/286 (18%)
Query: 119 LIFGEAIGEGGFGKVYKGIYEK------QEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
L F + +G+G FG V Y+ + VA+K + E+ L + ++E ++L H
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH-LRDFEREIEILKSLQH 64
Query: 173 RNIVSLIGVCLQS--PKLCLVMEYARGGPLNRVLAGRKIRPDV--LVDWAIQIAEGMNYL 228
NIV GVC + L LVMEY G L L + R D L+ +A QI +GM YL
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR------EVYKTTHMSAA 282
+ +HRDL + N+L +E+E+ +KI DFGL + E YK +
Sbjct: 125 GSK---RYVHRDLATRNIL----VESENR----VKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 283 GTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY----------G 332
+ W APE + S FS ASDVWS+GVVL+EL T Y + A G
Sbjct: 174 PIF-WYAPESLTESKFSVASDVWSFGVVLYELFT----YSDKSCSPPAEFMRMMGNDKQG 228
Query: 333 VAV---------NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFK 369
+ N LP P CP +M+ CW D RPSF
Sbjct: 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 82/268 (30%), Positives = 133/268 (49%), Gaps = 27/268 (10%)
Query: 122 GEAIGEGGFGKVYKGIYEK-QEVAIK--VAHPN---PDENILENVKQEGKLLWLFDHRNI 175
GE +G+G +G VY G+ + Q +A+K + E E +++E LL H NI
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 176 VSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPD-VLVDWAIQIAEGMNYLHCQAPI 234
V +G CL + + ME+ GG ++ +L P+ V + QI +G+ YLH
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN--- 121
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV----YKTTH----MSAAGTYA 286
++HRD+K +NV+L + +K+ DFG AR + TH S GT
Sbjct: 122 CVVHRDIKGNNVML--------MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP-IPST 345
WMAPEVI S + + SD+WS G ++E+ TG+ P S++ A + + ++ +P +P +
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDS 233
Query: 346 CPQLFKTLMEACWEADSHMRPSFKTILK 373
+ +C D H RPS +L+
Sbjct: 234 FSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 90/274 (32%), Positives = 133/274 (48%), Gaps = 27/274 (9%)
Query: 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE------KQEVAIKVAHPNPDENILENVKQEG 164
L E ++ K+ + +G G FG VYKG++ K VAIK + + E
Sbjct: 4 LKETEFKKI---KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 60
Query: 165 KLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR-KIRPDVLVDWAIQIAE 223
++ D+ ++ L+G+CL S + G L+ V + I L++W +QIA+
Sbjct: 61 YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 224 GMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV---YKTTHMS 280
GMNYL + L+HRDL + NVL+ P + +KITDFGLA+ + K H
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTP--------QHVKITDFGLAKLLGADEKEYHAE 169
Query: 281 AAGT-YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338
WMA E I I++ SDVWSYGV +WEL+T G PY I A ++ +
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGE 228
Query: 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTIL 372
LP P C +M CW D+ RP F+ ++
Sbjct: 229 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 91/291 (31%), Positives = 133/291 (45%), Gaps = 42/291 (14%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKG-------IYEKQEVAIKVAHPNPDENILENVKQEGKL 166
I ++ +GEG FGKV+ +K VA+K A +P ++ ++E +L
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK-ALKDPTLAARKDFQREAEL 60
Query: 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDW--------- 217
L H +IV GVC L +V EY + G LN+ L +LVD
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120
Query: 218 --------AIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269
A QIA GM YL Q +HRDL + N L+ + +KI DFG+
Sbjct: 121 GLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL--------LVKIGDFGM 169
Query: 270 AREVYKTTHMSAAG----TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSI 324
+R+VY T + G WM PE I F+ SDVWS+GV+LWE+ T G+ P+ +
Sbjct: 170 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229
Query: 325 NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
+ V + ++ L P CP+ +M CW+ + R + K I K L
Sbjct: 230 SNTEVIECITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-33
Identities = 88/284 (30%), Positives = 132/284 (46%), Gaps = 40/284 (14%)
Query: 125 IGEGGFGKVYKGIYEK------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
+GEG FGKV Y+ ++VA+K P N + ++K+E ++L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 179 IGVCLQSP--KLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEGMNYLHCQAPI 234
G+C + + L+ME+ G L L K I + +A+QI +GM+YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR--- 128
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-----YKTTHMSAAGTYAWMA 289
+HRDL + NVL +E+E +KI DFGL + + Y T W A
Sbjct: 129 QYVHRDLAARNVL----VESE----HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT--------- 339
PE + S F ASDVWS+GV L+ELLT + + + G ++T
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240
Query: 340 ----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
LP P CP+ LM CWE R +F+ +++ I+
Sbjct: 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 85/285 (29%), Positives = 137/285 (48%), Gaps = 37/285 (12%)
Query: 119 LIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENI-----LENVKQEGKLLWLFDHR 173
L G+ +GEG FG V +G + + +KVA I +E+ E + FDH
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 174 NIVSLIGVCLQS------PKLCLVMEYARGGPLNRVLAGRKI-------RPDVLVDWAIQ 220
N++ LIGVCLQ+ P +++ + + G L+ L ++ +LV +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 221 IAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS 280
IA GM YL + S IHRDL + N +L+E + + + DFGL++++Y +
Sbjct: 121 IASGMEYLSSK---SFIHRDLAARNCMLNENM--------NVCVADFGLSKKIYNGDYYR 169
Query: 281 ----AAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSI-NAYAVAYGVA 334
A W+A E + +++ SDVWS+GV +WE+ T G+ PY + N+ Y
Sbjct: 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229
Query: 335 VNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
N+L P C +LM +CW + RPSF+T+ L +
Sbjct: 230 GNRLKQ--PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-33
Identities = 79/256 (30%), Positives = 127/256 (49%), Gaps = 20/256 (7%)
Query: 125 IGEGGFGKVYKG--IYEKQEVAIKVAH-PNPDENILENVKQEGKLLWLFDHRNIVSLIGV 181
+G+G +G VYK + + Q A+K + + E+ E ++L +H NI+S
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 182 CLQSPKLCLVMEYARGGPLNRVLAGRK-----IRPDVLVDWAIQIAEGMNYLHCQAPISL 236
L KLC+VMEYA G L++ ++ RK I + IQ+ G+ LH Q +
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTS 296
+HRDLKS+N+LL +KI D G+++ + K + GT +MAPEV K
Sbjct: 125 LHRDLKSANILLVAN--------DLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 297 IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEA 356
+S SD+WS G +L+E+ T P+++ + + Y V K PIP Q + + +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRS 235
Query: 357 CWEADSHMRPSFKTIL 372
+ +RP+ IL
Sbjct: 236 MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 5e-33
Identities = 78/295 (26%), Positives = 118/295 (40%), Gaps = 36/295 (12%)
Query: 120 IFGEAIGEGGFGKVYKGIYEKQEVAIKVAHP--NPDENILENVKQEGKLL-WLFDHRNIV 176
+GEG FG+VY +++ VA+KV +E +E ++L L NIV
Sbjct: 3 RILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLNRVL----AGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
L L LVMEY GG L +L + + QI + YLH +
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK- 120
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV--------YKTTHMSAAGT 284
+IHRD+K N+LL +K+ DFGLA+ + ++ GT
Sbjct: 121 --GIIHRDIKPENILLDRDGRV-------VKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 285 YAWMAPEVIKTSIF---SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341
+MAPEV+ S +SD+WS G+ L+ELLTG P++ + L LP
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231
Query: 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQD 396
PS L + + +LK L + + + H +
Sbjct: 232 TPSLASPLSP-------SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 86/269 (31%), Positives = 135/269 (50%), Gaps = 27/269 (10%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHP---NPDENILENVKQEGKLLWL 169
ID L F + +G G FG V G + Q +VAIK+ + DE I +E K++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFI-----EEAKVMMK 55
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNY 227
H +V L GVC + + +V EY G L L G++ +P L++ + EGM Y
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT--- 284
L + IHRDL + N L+ ++ +K++DFGL+R V + S+ G+
Sbjct: 116 LESK---QFIHRDLAARNCLV-----DDQG---CVKVSDFGLSRYVLDDEYTSSVGSKFP 164
Query: 285 YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343
W PEV+ S FS SDVW++GV++WE+ + G++PY+ N V+ L L P
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRP 223
Query: 344 STCPQLFKTLMEACWEADSHMRPSFKTIL 372
+ +M +CW + RP+F+ +L
Sbjct: 224 HLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 91/282 (32%), Positives = 130/282 (46%), Gaps = 31/282 (10%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE---KQE--VAIKVAHPNPDENILENVKQEGKLL 167
E+D + +G G FG++ +G + K+E VAI + E L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK----IRPDVLVDWAIQIAE 223
FDH NIV L GV + + +V EY G L+ L RK + L+ +A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLAS 118
Query: 224 GMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE-----VYKTTH 278
GM YL + + +H+ L + VL+ N DL KI+ F +E +Y T
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLV-----NSDL---VCKISGFRRLQEDKSEAIYTT-- 165
Query: 279 MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK 337
MS W APE I+ FS ASDVWS+G+V+WE+++ GE PY ++ V V +
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DG 224
Query: 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
LP P CP L LM CW+ + RP F I L+ +V
Sbjct: 225 FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 96/264 (36%), Positives = 131/264 (49%), Gaps = 30/264 (11%)
Query: 123 EAIGEGGFGKVYKGIY--EKQEVAIKVA------HPNPDENILENVKQEGKLLWLFDHRN 174
+ +G G FG VYKGI+ E + V I VA P N+ E ++ DH +
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEGMNYLHCQA 232
+V L+GVCL SP + LV + G L + K I +L++W +QIA+GM YL +
Sbjct: 71 LVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER- 128
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSAAGTY--AWM 288
L+HRDL + NVL+ P +KITDFGLAR E + + + G WM
Sbjct: 129 --RLVHRDLAARNVLVKSP--------NHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 289 APEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347
A E I F+ SDVWSYGV +WEL+T G PY I + + + LP P C
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQPPICT 237
Query: 348 QLFKTLMEACWEADSHMRPSFKTI 371
+M CW D+ RP FK +
Sbjct: 238 IDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 9e-32
Identities = 85/258 (32%), Positives = 132/258 (51%), Gaps = 22/258 (8%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E IG+G FG+V+KGI + Q VAIK+ E+ +E+++QE +L D + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240
L+ KL ++MEY GG +L + +I +G++YLH + I HRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI---HRD 126
Query: 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIF 298
+K++NVLLSE + +K+ DFG+A ++ T + GT WMAPEVI+ S +
Sbjct: 127 IKAANVLLSEQGD--------VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 299 SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL---FKTLME 355
+D+WS G+ EL GE P ++ V + + N P+ + FK ++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN----NPPTLTGEFSKPFKEFID 234
Query: 356 ACWEADSHMRPSFKTILK 373
AC D RP+ K +LK
Sbjct: 235 ACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 82/276 (29%), Positives = 139/276 (50%), Gaps = 33/276 (11%)
Query: 118 KLIFGEAIGEGGFGKVYKGIYEK--QEVAIK-VAHPNPDEN-------ILENVKQEGKLL 167
K I G IG G FG VY G+ + +A+K V P+ + +L+ + +E LL
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLV-DWAIQIAEGMN 226
H NIV +G L + L + +EY GG + +L + LV ++ QI +G+N
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV--------YKTTH 278
YLH + +IHRD+K +N+L ++N+ +KI+DFG+++++
Sbjct: 121 YLHNR---GIIHRDIKGANIL----VDNKG----GIKISDFGISKKLEANSLSTKTNGAR 169
Query: 279 MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL 338
S G+ WMAPEV+K + +++ +D+WS G ++ E+LTG+ P+ + + +
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF--KIGEN 227
Query: 339 TLP-IPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
P IPS +E +E D + RP+ +LK
Sbjct: 228 ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 79/265 (29%), Positives = 121/265 (45%), Gaps = 30/265 (11%)
Query: 122 GEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNI 175
+ +G G FG V+KGI+ K VAIK + + + DH I
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 176 VSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEGMNYL--HCQ 231
V L+G+C L LV + + G L + + + P L++W +QIA+GM YL H
Sbjct: 72 VRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR- 129
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY----KTTHMSAAGTYAW 287
++HR+L + N+LL ++I DFG+A +Y K + W
Sbjct: 130 ----MVHRNLAARNILLKSDSI--------VQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346
MA E I ++ SDVWSYGV +WE+++ G PY + + V + L P C
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERLAQPQIC 236
Query: 347 PQLFKTLMEACWEADSHMRPSFKTI 371
+M CW D ++RP+FK +
Sbjct: 237 TIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 80/274 (29%), Positives = 129/274 (47%), Gaps = 35/274 (12%)
Query: 122 GEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSL 178
E IGEG +GKVYK ++K Q VAIK+ DE E +K+E +L + +H NI +
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE--EEIKEEYNILRKYSNHPNIATF 68
Query: 179 IGVCLQS------PKLCLVMEYARGGPLNRV-----LAGRKIRPDVLVDWAIQIAEGMNY 227
G ++ +L LVME GG + + G++++ + + + G+ Y
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTY 285
LH +IHRD+K N+LL++ E +K+ DFG++ ++ T + GT
Sbjct: 129 LHEN---KVIHRDIKGQNILLTKNAE--------VKLVDFGVSAQLDSTLGRRNTFIGTP 177
Query: 286 AWMAPEVI-----KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-T 339
WMAPEVI + + SDVWS G+ EL G+ P ++ + + N T
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237
Query: 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
L P + F + C + RP + +L+
Sbjct: 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 33/278 (11%)
Query: 118 KLIFGEAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDEN---------ILENVKQEGKL 166
K + GE IG+G +G+VY + + +A+K +++ ++ E +
Sbjct: 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGM 225
L DH NIV +G L + +EY GG + L + ++ + Q+ EG+
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL 121
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR---EVYKT-THMSA 281
YLH + ++HRDLK+ N+L+ D KI+DFG+++ ++Y +MS
Sbjct: 122 AYLHSK---GILHRDLKADNLLV-------DAD-GICKISDFGISKKSDDIYDNDQNMSM 170
Query: 282 AGTYAWMAPEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339
G+ WMAPEVI + +S D+WS G V+ E+ G P+ A A + + +
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230
Query: 340 LPIPS-TCPQLFKT---LMEACWEADSHMRPSFKTILK 373
PIP L + AC+ + RP+ + +L+
Sbjct: 231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-31
Identities = 84/286 (29%), Positives = 140/286 (48%), Gaps = 40/286 (13%)
Query: 119 LIFGEAIGEGGFGKVYKGIYEK-----QEVAIKV--AHPNPDENILENVKQEGKLLWLFD 171
G +G+G FG V + + Q+VA+K+ A +I E ++ E + FD
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFD 59
Query: 172 HRNIVSLIGVCLQS------PKLCLVMEYARGGPLNRVLAGRKIRPD-------VLVDWA 218
H N++ LIGV L+S P +++ + + G L+ L +I + LV +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 219 IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH 278
I IA GM YL + + IHRDL + N +L NE++ T+ + DFGL++++Y +
Sbjct: 120 IDIASGMEYLSSK---NFIHRDLAARNCML-----NENM---TVCVADFGLSKKIYSGDY 168
Query: 279 MSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSI-NAYAVAYG 332
W+A E + ++++ SDVW++GV +WE++T G+ PY + N+ Y
Sbjct: 169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
Query: 333 VAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
+ N+L P C + LM CW + RPSF+ + L I
Sbjct: 229 IKGNRLKQPP--DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 80/261 (30%), Positives = 124/261 (47%), Gaps = 27/261 (10%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E +GEG +G VYK I+++ Q VAIKV D L+ + +E +L D IV G
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYG 65
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLHCQAPIS 235
++ L +VMEY G ++ ++ KI L + I Q +G+ YLH
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLHSN---K 119
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTYAWMAPEVI 293
IHRD+K+ N+LL+E K+ DFG++ ++ T + GT WMAPEVI
Sbjct: 120 KIHRDIKAGNILLNEE--------GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPSTCPQLFKT 352
+ ++ +D+WS G+ E+ G+ PY I+ + + TL P F
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFND 231
Query: 353 LMEACWEADSHMRPSFKTILK 373
++ C D RPS +L+
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 89/267 (33%), Positives = 130/267 (48%), Gaps = 27/267 (10%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPN--PDENILENVKQEGKLLWL 169
EI L + +G G FG+V+ G + +VA+K P E+ LE E +++
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKK 57
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMN 226
H +V L V + P + +V EY G L L GR ++ LVD A Q+A GM
Sbjct: 58 LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT-- 284
Y+ ++ IHRDL+S+N+L+ + + KI DFGLAR + + + G
Sbjct: 117 YIE---RMNYIHRDLRSANILVGDGL--------VCKIADFGLARLIEDNEYTARQGAKF 165
Query: 285 -YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPI 342
W APE F+ SDVWS+G++L EL+T G +PY +N V V +P
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPC 224
Query: 343 PSTCPQLFKTLMEACWEADSHMRPSFK 369
P CP LM CW+ D RP+F+
Sbjct: 225 PQDCPISLHELMLQCWKKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 87/256 (33%), Positives = 134/256 (52%), Gaps = 18/256 (7%)
Query: 123 EAIGEGGFGKVYKGIYEKQE--VAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E IG+G FG+V+KGI + + VAIK+ E+ +E+++QE +L D + G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240
L+ KL ++MEY GG +L + + +I +G++YLH + I HRD
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI---HRD 126
Query: 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIF 298
+K++NVLLSE E +K+ DFG+A ++ T + GT WMAPEVIK S +
Sbjct: 127 IKAANVLLSEHGE--------VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 299 SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPSTCPQLFKTLMEAC 357
+D+WS G+ EL GE P+ ++ V + + N TL + P K +EAC
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP--LKEFVEAC 236
Query: 358 WEADSHMRPSFKTILK 373
+ RP+ K +LK
Sbjct: 237 LNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 75/262 (28%), Positives = 130/262 (49%), Gaps = 22/262 (8%)
Query: 122 GEAIGEGGFGKVYKGI-------YEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN 174
GE +G G FG VY+G+ + +EV++ E + + ++QE LL H N
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQ-LEQEIALLSKLQHPN 63
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVD-WAIQIAEGMNYLHCQAP 233
IV +G + L + +E GG L ++L P+ ++ + QI G+ YLH +
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR-- 121
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM-SAAGTYAWMAPEV 292
+ +HRD+K +N+L+ +K+ DFG+A++V + + S G+ WMAPEV
Sbjct: 122 -NTVHRDIKGANILVDTNGV--------VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV 172
Query: 293 I-KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFK 351
I + + A+D+WS G + E+ TG+ P+ + A + + +K PIP K
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAK 232
Query: 352 TLMEACWEADSHMRPSFKTILK 373
+ C + D +RP+ +L+
Sbjct: 233 DFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 1e-30
Identities = 75/267 (28%), Positives = 113/267 (42%), Gaps = 47/267 (17%)
Query: 120 IFGEAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILEN----VKQEGK-LLWLFDH 172
FG+ IGEG F V +E AIK+ + + I E VK E + L L H
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 173 RNIVSLIGVCLQSP-KLCLVMEYARGGPLNRVLAGRKIRPDVLVDW-AIQIAEGMNYLHC 230
I+ L Q L V+EYA G L + + + + A +I + YLH
Sbjct: 62 PGIIKLYY-TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH- 119
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR------------------- 271
+IHRDLK N+LL + +KITDFG A+
Sbjct: 120 --SKGIIHRDLKPENILLDKD--------MHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 272 ---EVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYA 328
E + S GT +++PE++ K+SD+W+ G +++++LTG+ P++ N Y
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 329 VAYGVAVNKLTLPIPSTCPQLFKTLME 355
+ KL P P K L+E
Sbjct: 230 TFQ--KILKLEYSFPPNFPPDAKDLIE 254
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-30
Identities = 95/291 (32%), Positives = 136/291 (46%), Gaps = 38/291 (13%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKGIYEKQ----EVAIKVAHPNPDENILENVKQEGKLLW- 168
+++N + F + IGEG FG+V K +K + AIK ++ + E ++L
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 63
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL------NRVL-----------AGRKIRP 211
L H NI++L+G C L L +EYA G L +RVL +
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 212 DVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271
L+ +A +A GM+YL + IHRDL + N+L+ E KI DFGL+R
Sbjct: 124 QQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY--------VAKIADFGLSR 172
Query: 272 --EVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328
EVY M WMA E + S+++ SDVWSYGV+LWE+++ G PY + A
Sbjct: 173 GQEVYVKKTMGRLPV-RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-A 230
Query: 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
Y L P C LM CW + RPSF IL +LN ++
Sbjct: 231 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 70/217 (32%), Positives = 108/217 (49%), Gaps = 40/217 (18%)
Query: 125 IGEGGFGKVY-------KGIY-----EKQEVAIK--VAHPNPDENILENVKQEGKLLWLF 170
+G+G FGKV +Y +K+++ + V H + NIL +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI---------- 50
Query: 171 DHRNIVSLIGVCLQSP-KLCLVMEYARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGMNYL 228
+H IV L Q+ KL LV+EYA GG L L+ + + +A +I + YL
Sbjct: 51 NHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYL 109
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH--MSAAGTYA 286
H +I+RDLK N+LL + D +K+TDFGLA+E+ + GT
Sbjct: 110 HSL---GIIYRDLKPENILL-----DADGH---IKLTDFGLAKELSSEGSRTNTFCGTPE 158
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKS 323
++APEV+ + KA D WS GV+L+E+LTG+ P+ +
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 86/265 (32%), Positives = 125/265 (47%), Gaps = 23/265 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFD 171
EI L +G+G FG+V+ G + VAIK P E QE +++
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLR 59
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYL 228
H +V L V + P + +V EY G L L G + +R LVD A QIA GM Y+
Sbjct: 60 HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---Y 285
++ +HRDL+++N+L+ E + K+ DFGLAR + + + G
Sbjct: 119 E---RMNYVHRDLRAANILVGENL--------VCKVADFGLARLIEDNEYTARQGAKFPI 167
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPS 344
W APE F+ SDVWS+G++L EL T G +PY + V V +P P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPP 226
Query: 345 TCPQLFKTLMEACWEADSHMRPSFK 369
CP+ LM CW + RP+F+
Sbjct: 227 ECPESLHDLMCQCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 9e-30
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 14/206 (6%)
Query: 125 IGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182
+G G G V K ++ + +A+K +E I + + +E +L + IV G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 183 LQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240
+ + + MEY GG L+++L +I +L A+ + +G+ YLH + I IHRD
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI--IHRD 126
Query: 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSK 300
+K SN+L++ + +K+ DFG++ ++ + + GT ++MAPE I+ + +S
Sbjct: 127 VKPSNILVNSRGQ--------IKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSV 178
Query: 301 ASDVWSYGVVLWELLTGEIPYKSINA 326
SD+WS G+ L EL TG PY N
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPEND 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 9e-30
Identities = 88/273 (32%), Positives = 134/273 (49%), Gaps = 23/273 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFD 171
EI L +G+G FG+V+ G + +VAIK P + E QE +++
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG--TMMPEAFLQEAQIMKKLR 59
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYL 228
H +V L V + P + +V E+ G L L G+ ++ LVD A QIA+GM Y+
Sbjct: 60 HDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---Y 285
++ IHRDL+++N+L+ + + KI DFGLAR + + + G
Sbjct: 119 E---RMNYIHRDLRAANILVGDNL--------VCKIADFGLARLIEDNEYTARQGAKFPI 167
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPS 344
W APE F+ SDVWS+G++L EL+T G +PY + V V +P P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQ 226
Query: 345 TCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
CP+ LM+ CW+ D RP+F+ I L +
Sbjct: 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-29
Identities = 84/273 (30%), Positives = 132/273 (48%), Gaps = 23/273 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFD 171
EI L + +G G FG+V+ Y K +VA+K P +E E ++
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQ 59
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYL 228
H +V L V + P + ++ E+ G L L G K L+D++ QIAEGM ++
Sbjct: 60 HDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---Y 285
+ + IHRDL+++N+L+S + KI DFGLAR + + + G
Sbjct: 119 EQR---NYIHRDLRAANILVSASL--------VCKIADFGLARVIEDNEYTAREGAKFPI 167
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPS 344
W APE I F+ SDVWS+G++L E++T G IPY ++ V + +P P
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPE 226
Query: 345 TCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
CP+ +M CW+ RP+F+ I L++
Sbjct: 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 9e-29
Identities = 71/267 (26%), Positives = 132/267 (49%), Gaps = 24/267 (8%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLW---LF 170
Y +L E IG G +G VY+G + + VA+K+ + + ++ + ++++E LL
Sbjct: 3 YQRL---ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQS 59
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHC 230
NI G L+ P+L ++MEYA GG + ++ I + ++ + Y+H
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH- 118
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWM 288
+ + IHRD+K++N+L++ +K+ DFG+A + + + + GT WM
Sbjct: 119 KVGV--IHRDIKAANILVTNT--------GNVKLCDFGVAALLNQNSSKRSTFVGTPYWM 168
Query: 289 APEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT-LPIPSTC 346
APEVI + +D+WS G+ ++E+ TG PY ++A+ + +K L
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYS 228
Query: 347 PQLFKTLMEACWEADSHMRPSFKTILK 373
L + + AC + + R S + +LK
Sbjct: 229 KLL-REFVAACLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 83/271 (30%), Positives = 122/271 (45%), Gaps = 35/271 (12%)
Query: 120 IFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
I GE +G+G FGKVYK + A K+ E LE+ E +L H NIV
Sbjct: 9 IIGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVG 66
Query: 178 LIGVCLQSPKLCLVMEYARGGPLN-------RVLAGRKIRPDVLVDWAIQIAEGMNYLHC 230
L KL +++E+ GG L+ R L +IR Q+ E +N+LH
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-----VCRQMLEALNFLHS 121
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--THMSAAGTYAWM 288
+IHRDLK+ N+LL+ +K+ DFG++ + T + GT WM
Sbjct: 122 H---KVIHRDLKAGNILLT--------LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWM 170
Query: 289 APEVIKTSIFSKA-----SDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPI 342
APEV+ F +D+WS G+ L EL E P+ +N V + ++ TL
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ 230
Query: 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
PS F +++C D RP+ +LK
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 76/271 (28%), Positives = 131/271 (48%), Gaps = 30/271 (11%)
Query: 118 KLIFGEAIGEGGFGKVY----KGIYEKQEVA----IKVAHPNPDENILENVKQEGKLLWL 169
+ I + +G+G FG VY K ++ + I V NP+E + N QE +LL
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN--QEAQLLSK 58
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL-----AGRKIRPDVLVDWAIQIAEG 224
DH IV L+ C++ EY G L+ L G+ + + + +W IQ+ G
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA-- 282
++Y+H + ++HRDLK+ N+ L + LKI DFG++R + + ++
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNL---------LKIGDFGVSRLLMGSCDLATTFT 166
Query: 283 GTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI 342
GT +M+PE +K + SD+WS G +L+E+ ++ N +V + V T +
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSL 225
Query: 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
P T + ++M++ D +RPS IL+
Sbjct: 226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 75/274 (27%), Positives = 122/274 (44%), Gaps = 43/274 (15%)
Query: 122 GEAIGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENILEN----VKQEGKLLWLFDHRNI 175
G+ +G+G FG+VY + +E+A+K +PD + ++ E +LL H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 176 VSLIGVCLQSP-KLCLVMEYARGG----------PLNRVLAGRKIRPDVLVDWAIQIAEG 224
V G CL+ L + MEY GG L + + R QI EG
Sbjct: 67 VQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR---------QILEG 116
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY----KTTHM- 279
+ YLH ++HRD+K +N+L +K+ DFG ++ + T M
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRD--------SAGNVKLGDFGASKRLQTICSSGTGMK 165
Query: 280 SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339
S GT WM+PEVI + + +DVWS G + E+LT + P+ A A + +A
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 225
Query: 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
+PS + + + ++ RPS + +L+
Sbjct: 226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 89/281 (31%), Positives = 128/281 (45%), Gaps = 38/281 (13%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGIYEKQ----EVAIKVAHPNPDENILENVKQEGKLLW-LF 170
+ + F + IGEG FG+V + + +K AIK+ EN + E ++L L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG 60
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPL------NRVL-----------AGRKIRPDV 213
H NI++L+G C L + +EYA G L +RVL +
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR-- 271
L+ +A +A GM YL + IHRDL + NVL+ E + + KI DFGL+R
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLAS--------KIADFGLSRGE 169
Query: 272 EVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVA 330
EVY M WMA E + S+++ SDVWS+GV+LWE+++ G PY + A
Sbjct: 170 EVYVKKTMGRLPV-RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AEL 227
Query: 331 YGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
Y + P C LM CW + RP F I
Sbjct: 228 YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 74/259 (28%), Positives = 126/259 (48%), Gaps = 20/259 (7%)
Query: 123 EAIGEGGFGKVYKGIY--EKQEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSLI 179
IG+G FG V+K + +K+ A+K + + E E ++L D I+
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 180 GVCLQSPKLCLVMEYARGGPLNRVL---AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
L KL +VMEYA G L+++L GR + D + + IQI G+ +LH + +
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KI 122
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA--GTYAWMAPEVIK 294
+HRD+KS N+ L + +KI D G+A+ + T+ + GT +++PE+ +
Sbjct: 123 LHRDIKSLNLFLDA--------YDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE 174
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354
+++ SDVW+ GVVL+E TG+ P+ + N A+ + P+ Q L+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-PVSQMYSQQLAQLI 233
Query: 355 EACWEADSHMRPSFKTILK 373
+ C D RP +L+
Sbjct: 234 DQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 35/217 (16%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIK-VAHPNPDENILENVKQEGKLLWLFDH 172
Y KL E +GEG +G VYK +K + VA+K + N +E I +E LL H
Sbjct: 1 YEKL---EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH 57
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAG------RKIRPDVLVDWAIQIAEGMN 226
NIV L+ V KL LV EY + L + P+++ Q+ G+
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEY-----CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE----VYKTTHMSAA 282
Y H ++HRDLK N+L++ + LK+ DFGLAR + TH
Sbjct: 113 YCHSH---RILHRDLKPQNILINR--DG------VLKLADFGLARAFGIPLRTYTHEVV- 160
Query: 283 GTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
T + APE++ + +S A D+WS G + E++TG+
Sbjct: 161 -TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|212992 cd12059, SH3_MLK1-3, Src Homology 3 domain of Mixed Lineage Kinases 1, 2, and 3 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-27
Identities = 40/62 (64%), Positives = 50/62 (80%), Gaps = 4/62 (6%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+W A++DY+A DEL+LRRGD VEVLSKDSA+SGD GWWTGKI +VGIFP+N+V
Sbjct: 1 VWTAVFDYEASAEDELTLRRGDRVEVLSKDSAVSGDEGWWTGKIND----RVGIFPSNYV 56
Query: 94 SS 95
+S
Sbjct: 57 TS 58
|
MLKs 1, 2, and 3 are Serine/Threonine Kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. MLKs act as mitogen-activated protein kinase kinase kinases (MAP3Ks, MKKKs, MAPKKKs), which phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MLKs play roles in immunity and inflammation, as well as in cell death, proliferation, and cell cycle regulation. Little is known about the specific function of MLK1, also called MAP3K9. It is capable of activating the c-Jun N-terminal kinase pathway. Mice lacking both MLK1 and MLK2 are viable, fertile, and have normal life spans. MLK2, also called MAP3K10, is abundant in brain, skeletal muscle, and testis. It functions upstream of the MAPK, c-Jun N-terminal kinase. It binds hippocalcin, a calcium-sensor protein that protects neurons against calcium-induced cell death. Both MLK2 and hippocalcin may be associated with the pathogenesis of Parkinson's disease. MLK3, also called MAP3K11, is highly expressed in breast cancer cells and its signaling through c-Jun N-terminal kinase has been implicated in the migration, invasion, and malignancy of cancer cells. It also functions as a negative regulator of Inhibitor of Nuclear Factor-KappaB Kinase (IKK) and thus, impacts inflammation and immunity. MLKs contain an SH3 domain, a catalytic kinase domain, a leucine zipper, a proline-rich region, and a CRIB domain that mediates binding to GTP-bound Cdc42 and Rac. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 58 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 79/282 (28%), Positives = 124/282 (43%), Gaps = 43/282 (15%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
DY +LI E IG G VY I ++VAIK + ++ +++E + + +H
Sbjct: 2 DY-ELI--EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH 58
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNY 227
N+V + +L LVM Y GG L ++ L + I ++ +G+ Y
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA------ 281
LH IHRD+K+ N+LL ED ++KI DFG++ + +
Sbjct: 118 LHSNG---QIHRDIKAGNILL-----GED---GSVKIADFGVSASLADGGDRTRKVRKTF 166
Query: 282 AGTYAWMAPEVIK--TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339
GT WMAPEV++ KA D+WS+G+ EL TG PY V + L
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKA-DIWSFGITAIELATGAAPYSKYPPMK----VLMLTLQ 221
Query: 340 LPIPS--------TCPQLFKTLMEACWEADSHMRPSFKTILK 373
PS + F+ ++ C + D RP+ + +LK
Sbjct: 222 NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 68/271 (25%), Positives = 128/271 (47%), Gaps = 31/271 (11%)
Query: 122 GEAIGEGGFGKVYKG-------IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN 174
G+ +G G F Y+ + ++V + E ++E +++E +L+ +H +
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGMNYLHCQAP 233
I+ ++G + L +E+ GG ++ +L+ + V++++ Q+ G++YLH
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA--------GTY 285
+IHRD+K +N+L+ D + L+I DFG A + + A GT
Sbjct: 123 -QIIHRDVKGANLLI-------DSTGQRLRIADFGAAARL--AAKGTGAGEFQGQLLGTI 172
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY---KSINAYAVAYGVAVNKLTLPI 342
A+MAPEV++ + ++ DVWS G V+ E+ T + P+ K N A+ + +A I
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232
Query: 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
P + + C E RP + +LK
Sbjct: 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 73/259 (28%), Positives = 129/259 (49%), Gaps = 19/259 (7%)
Query: 123 EAIGEGGFGKVY--KGIYEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSLI 179
+ IGEG FGK+Y K + + IK + E K+E LL H NIV+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 180 GVCLQSPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
++ +L +VMEY GG L + + G D ++ W +QI+ G+ ++H + +
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KI 122
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTYAWMAPEVIK 294
+HRD+KS N+ LS+ K+ DFG+AR++ + + + GT +++PE+ +
Sbjct: 123 LHRDIKSQNIFLSK-------NGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354
++ +D+WS G VL+EL T + P++ N + + + PI + ++L+
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLI 234
Query: 355 EACWEADSHMRPSFKTILK 373
++ RPS +ILK
Sbjct: 235 SQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 22/274 (8%)
Query: 112 VEIDYNKLIFGE--AIGEGGFGKVYKGIYEKQEVAIKVAH-PNPDENILENVKQEGKLLW 168
+E +Y GE +G+G +G VY +V I + P D ++ + +E L
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR----KIRPDVLVDWAIQIAEG 224
HRNIV +G ++ + ME GG L+ +L + K ++ + QI EG
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA-- 282
+ YLH ++HRD+K NVL+ + +KI+DFG ++ + +
Sbjct: 121 LKYLHDN---QIVHRDIKGDNVLV-------NTYSGVVKISDFGTSKRLAGINPCTETFT 170
Query: 283 GTYAWMAPEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYKSI-NAYAVAYGVAVNKLT 339
GT +MAPEVI + +D+WS G + E+ TG+ P+ + A + V + K+
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH 230
Query: 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
IP + K + C+E D R S +L+
Sbjct: 231 PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|212809 cd11876, SH3_MLK, Src Homology 3 domain of Mixed Lineage Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-26
Identities = 42/61 (68%), Positives = 49/61 (80%), Gaps = 4/61 (6%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
LW AL+DYDA G DEL+LRRG VEVLSKD+A+SGD GWWTGKI KVGIFP+N+V
Sbjct: 1 LWTALFDYDARGEDELTLRRGQPVEVLSKDAAVSGDEGWWTGKIGD----KVGIFPSNYV 56
Query: 94 S 94
+
Sbjct: 57 A 57
|
MLKs are Serine/Threonine Kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. MLKs act as mitogen-activated protein kinase kinase kinases (MAP3Ks, MKKKs, MAPKKKs), which phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MLKs play roles in immunity and inflammation, as well as in cell death, proliferation, and cell cycle regulation. Mammals have four MLKs (MLK1-4), mostly conserved in vertebrates, which contain an SH3 domain, a catalytic kinase domain, a leucine zipper, a proline-rich region, and a CRIB domain that mediates binding to GTP-bound Cdc42 and Rac. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 58 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 58/179 (32%), Positives = 90/179 (50%), Gaps = 26/179 (14%)
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273
L+ ++ Q+A GM +L A IHRDL + N+LLSE +KI DFGLAR++
Sbjct: 175 LISYSFQVARGMEFL---ASRKCIHRDLAARNILLSE--------NNVVKICDFGLARDI 223
Query: 274 YKTTHMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSIN--- 325
YK G WMAPE I +++ SDVWS+GV+LWE+ + G PY +
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283
Query: 326 --AYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
+ G + P +T P+++ M CW + RP+F +++ L +++
Sbjct: 284 EFCRRLKEGTRMRA---PEYAT-PEIYSI-MLDCWHNNPEDRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 93/282 (32%), Positives = 130/282 (46%), Gaps = 38/282 (13%)
Query: 123 EAIGEGGFGKVYKGIYEKQ----EVAIKVAHPNPDENILENVKQEGKLLW-LFDHRNIVS 177
+ IGEG FG+V K +K + AIK ++ + E ++L L H NI++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 178 LIGVCLQSPKLCLVMEYARGGPL------NRVL-----------AGRKIRPDVLVDWAIQ 220
L+G C L L +EYA G L +RVL + L+ +A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 221 IAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTH 278
+A GM+YL + IHRDL + N+L+ E KI DFGL+R EVY
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVA--------KIADFGLSRGQEVYVKKT 169
Query: 279 MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK 337
M WMA E + S+++ SDVWSYGV+LWE+++ G PY + A Y
Sbjct: 170 MGRLPV-RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 227
Query: 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
L P C LM CW + RPSF IL +LN ++
Sbjct: 228 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 83/263 (31%), Positives = 122/263 (46%), Gaps = 31/263 (11%)
Query: 123 EAIGEGGFGKVYKGI--YEKQEVAIKVAH--PNPDENILEN---VKQEGKLLWLFDHRNI 175
E IG+G G VY I QEVAIK + P + ++ N V +E K H NI
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK------HPNI 78
Query: 176 VSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
V+ + L +L +VMEY GG L V+ + + + + + +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---Q 135
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG----LAREVYKTTHMSAAGTYAWMAPE 291
+IHRD+KS N+LL ++K+TDFG + E K + M GT WMAPE
Sbjct: 136 VIHRDIKSDNILLGMD--------GSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPE 185
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLPIPSTCPQLF 350
V+ + D+WS G++ E++ GE PY + N Y +A N L P +F
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 245
Query: 351 KTLMEACWEADSHMRPSFKTILK 373
+ + C E D R S K +L+
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-25
Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 16/165 (9%)
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273
L+ ++ Q+A+GM++L A + IHRDL + N+LL+ + KI DFGLAR++
Sbjct: 216 LLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLT--------HGRITKICDFGLARDI 264
Query: 274 YKTTHMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328
++ G WMAPE I +++ SDVWSYG++LWE+ + G PY + +
Sbjct: 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324
Query: 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
Y + + P P +M++CW+AD RP+FK I++
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 73/292 (25%), Positives = 119/292 (40%), Gaps = 64/292 (21%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGI--------------Y------EKQEVAIKVAHPNPDE 154
DY L E IG+G FG V K Y EKQ++ +V
Sbjct: 1 DYEVL---ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV------- 50
Query: 155 NILENVKQEGKLLWLFDHRNIVSLIG--VCLQSPKLCLVMEYARGGPLNRVLA-----GR 207
NIL +K H NIV + + L +VMEY GG L +++ +
Sbjct: 51 NILRELK----------HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK 100
Query: 208 KIRPDVLVDWAIQIAEGMNYLHCQAPIS--LIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265
I + + Q+ + H ++ ++HRDLK +N+ L +K+
Sbjct: 101 YIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN--------NNVKLG 152
Query: 266 DFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
DFGLA+ + S A TY +M+PE + + + SD+WS G +++EL P+
Sbjct: 153 DFGLAKIL--GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210
Query: 322 KSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ N +A + K IP ++++ D RPS + +L+
Sbjct: 211 TARNQLQLASKIKEGKF-RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 67/213 (31%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKV--AHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
I +G +G+V+ K AIKV +N ++ V E +L +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 181 VCLQSPK-LCLVMEYARGGPLNRVLAGRKIRP-DVLVDWAIQIAEGMNYLHCQAPISLIH 238
Q K L LVMEY GG L +L DV + +I + YLH +IH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIH 116
Query: 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAA--------GTYAWM 288
RDLK N+L+ LK+TDFGL++ V + +++ GT ++
Sbjct: 117 RDLKPDNILID--------SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 289 APEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
APEVI SK D WS G +L+E L G P+
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPF 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 81/275 (29%), Positives = 124/275 (45%), Gaps = 42/275 (15%)
Query: 125 IGEGGFGKVYKG-IY---EKQEVAIK--VAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
IG G FGKV G + K V +K A PDE +L QE + +H N++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVLQC 60
Query: 179 IGVCLQSPKLCLVMEYARGGPL------NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
+G C++S LV+E+ G L NR + + + DVL A ++A G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA----WM 288
IH DL N L+ DL ++KI D+GLA E Y + +A W+
Sbjct: 118 QADFIHSDLALRNCQLTA-----DL---SVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169
Query: 289 APEV-------IKTSIFSKASDVWSYGVVLWELLT-GEIPYKSI-NAYAVAYGVAVNKLT 339
APE+ + +K S++WS GV +WEL T + PY + + + V +
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK 229
Query: 340 LPIPS---TCPQLFKTLMEACWEADSHMRPSFKTI 371
LP P + +M+ CW D RP+ + +
Sbjct: 230 LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 58/174 (33%), Positives = 93/174 (53%), Gaps = 18/174 (10%)
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273
L+ ++ Q+A+GM +L A IHRDL + N+LLSE +KI DFGLAR++
Sbjct: 181 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEN--------NVVKICDFGLARDI 229
Query: 274 YKTTHMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328
YK G WMAPE I +++ SDVWS+GV+LWE+ + G PY +
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289
Query: 329 VAYGVAVNKLTLPIPS-TCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381
+ P T P++++T+++ CW + RP+F +++ L N++ +
Sbjct: 290 EFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 64/257 (24%), Positives = 121/257 (47%), Gaps = 20/257 (7%)
Query: 125 IGEGGFGK--VYKGIYEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGV 181
+G+G FG+ +Y+ + V K V E + E +L L H NI++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 182 CLQSPKLCLVMEYARGGPLNRVLAGRK---IRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238
+ L + MEYA GG L + +K ++++ + QI ++Y+H ++H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILH 124
Query: 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTYAWMAPEVIKTS 296
RD+K+ N+ L++ L +K+ DFG+++ + M + GT +M+PE+ +
Sbjct: 125 RDIKTLNIFLTK----AGL----IKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV 176
Query: 297 IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEA 356
++ SD+W+ G VL+ELLT + + + N + + V P+ S +L+ +
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISLVHS 235
Query: 357 CWEADSHMRPSFKTILK 373
+ D RP+ +L
Sbjct: 236 LLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|212991 cd12058, SH3_MLK4, Src Homology 3 domain of Mixed Lineage Kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-23
Identities = 41/61 (67%), Positives = 51/61 (83%), Gaps = 4/61 (6%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
LW ALYDY+A G DELSLRRGD+VEVLS+D+A+SGD GWW GKI +++GIFPAN+V
Sbjct: 1 LWTALYDYEASGEDELSLRRGDVVEVLSQDAAVSGDDGWWA----GKIRHRLGIFPANYV 56
Query: 94 S 94
+
Sbjct: 57 T 57
|
MLK4 is a Serine/Threonine Kinase (STK), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. MLKs act as mitogen-activated protein kinase kinase kinases (MAP3Ks, MKKKs, MAPKKKs), which phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MLKs play roles in immunity and inflammation, as well as in cell death, proliferation, and cell cycle regulation. The specific function of MLK4 is yet to be determined. Mutations in the kinase domain of MLK4 have been detected in colorectal cancers. MLK4 contains an SH3 domain, a catalytic kinase domain, a leucine zipper, a proline-rich region, and a CRIB domain that mediates binding to GTP-bound Cdc42 and Rac. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 58 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 79/261 (30%), Positives = 123/261 (47%), Gaps = 27/261 (10%)
Query: 123 EAIGEGGFGKVYKG--IYEKQEVAIKVAH--PNPDENILEN---VKQEGKLLWLFDHRNI 175
E IG+G G VY I QEVAIK + P + ++ N V +E K + NI
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK------NPNI 78
Query: 176 VSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
V+ + L +L +VMEY GG L V+ + + + + +++LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---Q 135
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY--KTTHMSAAGTYAWMAPEVI 293
+IHRD+KS N+LL ++K+TDFG ++ ++ + GT WMAPEV+
Sbjct: 136 VIHRDIKSDNILLGMD--------GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLFKT 352
+ D+WS G++ E++ GE PY + N Y +A N L P +F+
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247
Query: 353 LMEACWEADSHMRPSFKTILK 373
+ C E D R S K +L+
Sbjct: 248 FLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 55/171 (32%), Positives = 91/171 (53%), Gaps = 16/171 (9%)
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273
LV ++ Q+A GM +L A + +HRDL + NVL+ E K +KI DFGLAR++
Sbjct: 241 LVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEG--------KLVKICDFGLARDI 289
Query: 274 YK-TTHMSAAGTY---AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328
+ + ++S T+ WMAPE I ++++ SDVWS+G++LWE+ T G PY +
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349
Query: 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
Y + P+ +M+ CWE +RP F ++ + +++
Sbjct: 350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 62/183 (33%), Positives = 97/183 (53%), Gaps = 38/183 (20%)
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273
L+ ++ Q+A GM +L A IHRDL + N+LLSE +KI DFGLAR++
Sbjct: 176 LICYSFQVARGMEFL---ASRKCIHRDLAARNILLSEN--------NVVKICDFGLARDI 224
Query: 274 YKTTHMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328
YK G+ WMAPE I +++ SDVWS+GV+LWE+ + G PY
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP------ 278
Query: 329 VAYGVAVN-----------KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
GV +N ++ P +T P++++ +M ACW+ D RP+F +++ L +
Sbjct: 279 ---GVQINEEFCQRLKDGTRMRAPENAT-PEIYR-IMLACWQGDPKERPTFSALVEILGD 333
Query: 378 IVH 380
++
Sbjct: 334 LLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 70/257 (27%), Positives = 119/257 (46%), Gaps = 24/257 (9%)
Query: 125 IGEGGFGKVYKGIYEKQEV--AIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182
+G G G V K + A KV H ++ + + +E +++ IVS G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 183 LQSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDL 241
L +C+ ME+ G L+R+ G I ++L A+ + EG+ YL+ I +HRD+
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRI--MHRDI 130
Query: 242 KSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKA 301
K SN+L++ + +K+ DFG++ E+ + + GT +M+PE I+ ++
Sbjct: 131 KPSNILVNSRGQ--------IKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 302 SDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL-------PIP----STCPQLF 350
SDVWS G+ + EL G+ P+ N + L L P P S P+
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL 242
Query: 351 KTLMEACWEADSHMRPS 367
+ ++AC D RP+
Sbjct: 243 RDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQ----EGKLLWLFDHR 173
G+ +GEG + VYK ++ + VAIK + + + E KLL H
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR---PDVLVDWAIQIAEGMNYLHC 230
NI+ L+ V + LV E+ L +V+ + I D+ + + G+ YLH
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFMETD-LEKVIKDKSIVLTPADI-KSYMLMTLRGLEYLHS 120
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV----YKTTHMSAAGTYA 286
++HRDLK +N+L++ LK+ DFGLAR K TH Y
Sbjct: 121 N---WILHRDLKPNNLLIAS--------DGVLKLADFGLARSFGSPNRKMTHQVVTRWY- 168
Query: 287 WMAPEVI-KTSIFSKASDVWSYGVVLWELLTGEIPY 321
APE++ + D+WS G + ELL +P+
Sbjct: 169 -RAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 54/163 (33%), Positives = 87/163 (53%), Gaps = 16/163 (9%)
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273
L+ ++ Q+A+GM++L A + IHRD+ + NVLL++ + KI DFGLAR++
Sbjct: 214 LLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDG--------RVAKICDFGLARDI 262
Query: 274 YKTTHMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328
++ G WMAPE I +++ SDVWSYG++LWE+ + G+ PY I +
Sbjct: 263 MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322
Query: 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
Y + + P P ++M+ CW + RP+F I
Sbjct: 323 KFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 60/173 (34%), Positives = 93/173 (53%), Gaps = 20/173 (11%)
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273
L+ + Q+A GM +L A + +HRDL + NVLL+ Q K +KI DFGLAR++
Sbjct: 239 LLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLA--------QGKIVKICDFGLARDI 287
Query: 274 -YKTTHMSAAGTY---AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328
+ + ++S T+ WMAPE I ++++ SDVWSYG++LWE+ + G PY + +
Sbjct: 288 MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347
Query: 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381
Y + + P Q +M CW ++ RPSF L++IV S
Sbjct: 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSF----LHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 8e-23
Identities = 70/213 (32%), Positives = 105/213 (49%), Gaps = 31/213 (14%)
Query: 123 EAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
+ IG G +G VYK I + VAIKV P ++ E ++QE +L H NIV+ G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF-EIIQQEISMLKECRHPNIVAYFG 67
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIA-------EGMNYLHCQAP 233
L+ KL +VMEY GG L + ++ L + +QIA +G+ YLH
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIY---QVTRGPLSE--LQIAYVCRETLKGLAYLHET-- 120
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWMAPE 291
IHRD+K +N+LL+E + +K+ DFG++ ++ T S GT WMAPE
Sbjct: 121 -GKIHRDIKGANILLTEDGD--------VKLADFGVSAQLTATIAKRKSFIGTPYWMAPE 171
Query: 292 VI---KTSIFSKASDVWSYGVVLWELLTGEIPY 321
V + + D+W+ G+ EL + P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 8e-23
Identities = 81/266 (30%), Positives = 130/266 (48%), Gaps = 25/266 (9%)
Query: 120 IFGEAIGEGGFGKVYKGIYEKQEV--AIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
I GE +G+G FGKVYK ++ A KV +E LE+ E ++L +H IV
Sbjct: 16 IIGE-LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDYMVEIEILATCNHPYIVK 73
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L+G KL +++E+ GG ++ ++ R + + Q+ E + YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---K 130
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTYAWMAPEVI 293
+IHRDLK+ NVLL+ + +K+ DFG++ + KT S GT WMAPEV+
Sbjct: 131 IIHRDLKAGNVLLTLDGD--------IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 294 -----KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPSTCP 347
K + + +D+WS G+ L E+ E P+ +N V +A ++ TL PS
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242
Query: 348 QLFKTLMEACWEADSHMRPSFKTILK 373
F+ ++ + RPS +L+
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 1e-22
Identities = 76/258 (29%), Positives = 121/258 (46%), Gaps = 21/258 (8%)
Query: 123 EAIGEGGFGKVYKG--IYEKQEVAIKVAH--PNPDENILENVKQEGKLLWLFDHRNIVSL 178
E IG+G G V+ + QEVAIK + P + ++ N E ++ + NIV+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN---EILVMKELKNPNIVNF 81
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238
+ L +L +VMEY GG L V+ + + + + + +LH +IH
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138
Query: 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY--KTTHMSAAGTYAWMAPEVIKTS 296
RD+KS NVLL ++K+TDFG ++ ++ + GT WMAPEV+
Sbjct: 139 RDIKSDNVLLGMD--------GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190
Query: 297 IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLFKTLME 355
+ D+WS G++ E++ GE PY + N Y +A N L P +F+ +
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN 250
Query: 356 ACWEADSHMRPSFKTILK 373
C E D R S K +L+
Sbjct: 251 RCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 81/270 (30%), Positives = 127/270 (47%), Gaps = 32/270 (11%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLI 179
E +G G +G+VYKG + K Q AIKV DE E +K E +L + HRNI +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE--EEIKLEINMLKKYSHHRNIATYY 79
Query: 180 GVCL-QSP-----KLCLVMEYARGGPLNRVL---AGRKIRPDVLVDWAIQIAEGMNYLHC 230
G + +SP +L LVME+ G + ++ G ++ D + +I G+ +LH
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA 139
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWM 288
+IHRD+K NVLL+E E +K+ DFG++ ++ +T + GT WM
Sbjct: 140 H---KVIHRDIKGQNVLLTENAE--------VKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188
Query: 289 APEVIKT-----SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP 343
APEVI + + SD+WS G+ E+ G P ++ + + N
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248
Query: 344 STCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ F +E C + RPS + +LK
Sbjct: 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 124 AIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILE-----NVKQEGKLLWLFDHRNIV 176
IG+G FGKV K+ A+K + + +E NV E ++L +H +V
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMN---KQKCVEKGSVRNVLNERRILQELNHPFLV 63
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR--PDVLVDWAIQIAEGMNYLHCQAPI 234
+L + LV++ GG L R +K++ + + W +I + YLH +
Sbjct: 64 NLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSK--- 119
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-YKTTHMSAAGTYAWMAPEVI 293
+IHRD+K N+LL E + ITDF +A +V T S +GT +MAPEV+
Sbjct: 120 GIIHRDIKPDNILLDEQ--------GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVL 171
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYK 322
+S A D WS GV +E L G+ PY+
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 45/218 (20%)
Query: 123 EAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQ--------EGKLLWLFDH 172
IGEG +G+VYK + VA+K + +EN K+ E KLL H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALK-------KIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 173 RNIVSLIGVCLQSPK--LCLVMEYARGGP--LNRVLA--GRKIRPDVLVDWAIQIAEGMN 226
NIV L + K + +V EY L +L K + + Q+ EG+
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYM---DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA 286
YLH ++HRD+K SN+L++ N+ LK+ DFGLAR T SA T
Sbjct: 115 YLHSNG---ILHRDIKGSNILIN----ND----GVLKLADFGLARPY--TKRNSADYTNR 161
Query: 287 ----WM-APEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
W PE++ + + D+WS G +L EL G+
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 75/279 (26%), Positives = 128/279 (45%), Gaps = 45/279 (16%)
Query: 123 EAIGEGGFGKVYKGIYEKQ------------EVAIKVAHPNPDENILENVKQEGKLLWLF 170
E +G+G F +YKG+ Q V +KV D + L+
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV--LGSDHRDSLAFFETASLMSQL 58
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDW----AIQIAEGMN 226
H+++V L GVC++ + +V EY + GPL+ L + + +V + W A Q+A ++
Sbjct: 59 SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFL--HREKNNVSLHWKLDVAKQLASALH 115
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA 286
YL + L+H ++ N+L++ NE +K++D G+ V
Sbjct: 116 YLEDK---KLVHGNVCGKNILVARYGLNEGYV-PFIKLSDPGIPITVLSREERVE--RIP 169
Query: 287 WMAPEVIK--TSIFSKASDVWSYGVVLWELLT-GEIPYKSINA------YAVAYGVAVNK 337
W+APE I+ + + A+D WS+G L E+ + GE P ++++ Y +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH------ 223
Query: 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376
LP+P C +L + + CW D RPSF+ IL+ LN
Sbjct: 224 -RLPMPD-CAELANLINQ-CWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-22
Identities = 76/261 (29%), Positives = 122/261 (46%), Gaps = 27/261 (10%)
Query: 123 EAIGEGGFGKVYKG--IYEKQEVAIKVAH--PNPDENILEN---VKQEGKLLWLFDHRNI 175
E IG+G G VY + QEVAI+ + P + ++ N V +E K + NI
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK------NPNI 79
Query: 176 VSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
V+ + L +L +VMEY GG L V+ + + + + + +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---Q 136
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY--KTTHMSAAGTYAWMAPEVI 293
+IHRD+KS N+LL ++K+TDFG ++ ++ + GT WMAPEV+
Sbjct: 137 VIHRDIKSDNILLGMD--------GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLFKT 352
+ D+WS G++ E++ GE PY + N Y +A N L P +F+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 353 LMEACWEADSHMRPSFKTILK 373
+ C + D R S K +L+
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 3e-22
Identities = 67/258 (25%), Positives = 125/258 (48%), Gaps = 24/258 (9%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENILENVKQ----EGKLLWLFDHRNIVSL 178
+G G FG V+ + +++ V IK P E + ++ + E ++L L H NI+
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQI---PVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVLAGRK---IRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L+ L +VMEYA GG L + R + D ++ + +QI ++++H +
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---L 121
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE-VYKTTHMSAAGTYAWMAPEVIK 294
++HRDLK+ N+LL D +KI DFG+++ K+ + GT +++PE+ +
Sbjct: 122 ILHRDLKTQNILL-------DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE 174
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354
+++ SD+W+ G VL+EL + + +++ N A+ + PI + L+
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-PISDRYSPDLRQLI 233
Query: 355 EACWEADSHMRPSFKTIL 372
+ D RP I+
Sbjct: 234 LSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 5e-22
Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 32/270 (11%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDH-RNIVSLI 179
E +G G +G+VYKG + K Q AIKV DE E +KQE +L + H RNI +
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE--EEIKQEINMLKKYSHHRNIATYY 69
Query: 180 GVCLQS------PKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHC 230
G ++ +L LVME+ G + ++ G ++ + + +I G+++LH
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWM 288
+IHRD+K NVLL+E E +K+ DFG++ ++ +T + GT WM
Sbjct: 130 H---KVIHRDIKGQNVLLTENAE--------VKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178
Query: 289 APEVIKT-----SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP 343
APEVI + + SD+WS G+ E+ G P ++ + + N
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238
Query: 344 STCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ F++ +E+C + RP+ + ++K
Sbjct: 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 5e-22
Identities = 75/267 (28%), Positives = 126/267 (47%), Gaps = 28/267 (10%)
Query: 122 GEAIGEGGFGKVY--KGIYEKQEVAIKVAHPNPDE----NILENVKQEGKLLWLFDHRNI 175
G+ +G+G FG+VY + +E+A K +P+ + ++ E +LL H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 176 VSLIGVCLQ---SPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
V G CL+ L + MEY GG + +++ A + V + QI EGM+YLH
Sbjct: 67 VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-----TTHMSAAGTYA 286
++HRD+K +N+L +K+ DFG ++ + T S GT
Sbjct: 126 M---IVHRDIKGANILRDSA--------GNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346
WM+PEVI + + +DVWS G + E+LT + P+ A A + +A +PS
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHI 234
Query: 347 PQLFKTLMEACWEADSHMRPSFKTILK 373
+ + + C ++ RPS + +L+
Sbjct: 235 SEHARDFL-GCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 7e-22
Identities = 70/259 (27%), Positives = 128/259 (49%), Gaps = 24/259 (9%)
Query: 125 IGEGGFGK---VYKGIYEKQEV--AIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLI 179
IGEG FGK V KQ V I ++ +P E E ++E +L H NIV
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER--EESRKEVAVLSNMKHPNIVQYQ 65
Query: 180 GVCLQSPKLCLVMEYARGGPLNRVLAGRK---IRPDVLVDWAIQIAEGMNYLHCQAPISL 236
++ L +VM+Y GG L + + ++ D ++DW +QI + ++H + +
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KI 122
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA--GTYAWMAPEVIK 294
+HRD+KS N+ L++ T+K+ DFG+AR + T ++ GT +++PE+ +
Sbjct: 123 LHRDIKSQNIFLTKD--------GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE 174
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354
++ SD+W+ G VL+E+ T + +++ N + + P+ S + L+
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-PVSSHYSYDLRNLV 233
Query: 355 EACWEADSHMRPSFKTILK 373
++ + RPS +IL+
Sbjct: 234 SQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 7e-22
Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 121 FGEAIGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENIL-----ENVKQEGKLLWLFDHR 173
F + +G G FG+V + + A+K+ I+ E+V E ++L H
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAK---IVKLKQVEHVLNEKRILQSIRHP 61
Query: 174 NIVSLIGVCLQSPK-LCLVMEYARGGPLNRVLAGRKIR---PDVLVDWAIQIAEGMNYLH 229
+V+L G Q L LVMEY GG L L RK V +A Q+ + YLH
Sbjct: 62 FLVNLYG-SFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLH 118
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMA 289
+++RDLK N+LL +KITDFG A+ V T+ GT ++A
Sbjct: 119 SL---DIVYRDLKPENLLLD--------SDGYIKITDFGFAKRVKGRTYT-LCGTPEYLA 166
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAV 329
PE+I + + KA D W+ G++++E+L G P+ N +
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 82/286 (28%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 104 SVINDVKLVEI----DYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKV-AHPNPD-ENIL 157
S IND+K +E Y ++ I E +YKGI+ +EV I+ + + ++
Sbjct: 7 SYINDIKCIESDDIDKYTSVL----IKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLI 62
Query: 158 ENVKQEGKLLWLFDHRNIVSLIG----VCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPD 212
+ + E K L D NI+ + G + P+L L++EY G L VL K +
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFK 122
Query: 213 VLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272
+D AI +G+ L+ + +++L S + L++E LKI GL
Sbjct: 123 TKLDMAIDCCKGLYNLY--KYTNKPYKNLTSVSFLVTEN--------YKLKIICHGL--- 169
Query: 273 VYKTTHMSAAGTYAWMA--PEVIKTSIFSK---ASDVWSYGVVLWELLTGEIPYKSINAY 327
K +M + IFS+ D++S GVVLWE+ TG+IP++++
Sbjct: 170 -EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-T 227
Query: 328 AVAYGVAVNK-LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTIL 372
Y + +NK +L +P CP K ++EAC DS RP+ K IL
Sbjct: 228 KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 34/271 (12%)
Query: 121 FGEAIGEGGFGKVY--KGIYEKQEVAIKVAHPNPDE-------NILENVKQEGKLLWLFD 171
G+ +G+G FG+VY +E+A+K +P+ N LE E +LL
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC---EIQLLKNLL 62
Query: 172 HRNIVSLIGVCLQSPK---LCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNY 227
H IV G CL+ P L + ME+ GG + +++ + + +V + QI EG++Y
Sbjct: 63 HERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-----TTHMSAA 282
LH ++HRD+K +N+L +K+ DFG ++ + T S
Sbjct: 122 LHSNM---IVHRDIKGANILRDSV--------GNVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 283 GTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI 342
GT WM+PEVI + + +D+WS G + E+LT + P+ A A + +A +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVL 230
Query: 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
P + ++ + ++ +RPS +L+
Sbjct: 231 PPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 73/243 (30%), Positives = 121/243 (49%), Gaps = 37/243 (15%)
Query: 115 DYNKLIFGEAIGEGGFGKVY----KGIYEKQEVAIKVAHPN---PDENILENVKQEGKLL 167
D+N F +G+G FGKV KG + AIK+ + D+++ E E ++L
Sbjct: 1 DFN---FLMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVIIQDDDV-ECTMVEKRVL 54
Query: 168 WLFDHRNIVSLIGVCLQSP-KLCLVMEYARGGPLN-RVLAGRKIRPDVLVDWAIQIAEGM 225
L ++ + C Q+ +L VMEY GG L + K + V +A +IA G+
Sbjct: 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGL 114
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAG 283
+LH + +I+RDLK NV+L +KI DFG+ +E T + G
Sbjct: 115 FFLHSKG---IIYRDLKLDNVMLD--------AEGHIKIADFGMCKENIFGGKTTRTFCG 163
Query: 284 TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP---------YKSINAYAVAYGVA 334
T ++APE+I + K+ D W++GV+L+E+L G+ P ++SI + V+Y +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS 223
Query: 335 VNK 337
++K
Sbjct: 224 LSK 226
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 85/269 (31%), Positives = 134/269 (49%), Gaps = 31/269 (11%)
Query: 120 IFGEAIGEGGFGKVYKGIYEKQEV--AIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
I GE +G+G FGKVYK ++ V A KV +E LE+ E +L DH NIV
Sbjct: 9 IIGE-LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHPNIVK 66
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIA-----EGMNYLHCQA 232
L+ L +++E+ GG ++ V+ + RP L + I++ E +NYLH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELE-RP--LTEPQIRVVCKQTLEALNYLHEN- 122
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTYAWMAP 290
+IHRDLK+ N+L + ++ + +K+ DFG++ + +T S GT WMAP
Sbjct: 123 --KIIHRDLKAGNILFT--LDGD------IKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 172
Query: 291 EVI-----KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPS 344
EV+ K + +DVWS G+ L E+ E P+ +N V +A ++ TL PS
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPS 232
Query: 345 TCPQLFKTLMEACWEADSHMRPSFKTILK 373
FK ++ C E + R + +L+
Sbjct: 233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 40/281 (14%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKV--AHPNPDENILENVKQEGKLLWLFDH 172
K++ +GEG G V K + A+K PNPD + + + +E ++
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD--LQKQILRELEINKSCKS 58
Query: 173 RNIVSLIGVCL--QSPKLCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGM 225
IV G L S + + MEY GG L+ + G +I VL A + +G+
Sbjct: 59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTY 285
+YLH + +IHRD+K SN+LL+ + +K+ DFG++ E+ + + GT
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQ--------VKLCDFGVSGELVNSLAGTFTGTS 167
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST 345
+MAPE I+ +S SDVWS G+ L E+ P+ + + L+ +
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG---PIELLSYIVNMP 224
Query: 346 CPQL-------------FKTLMEACWEADSHMRPSFKTILK 373
P+L FK ++ C E D RP+ +L+
Sbjct: 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 75/257 (29%), Positives = 117/257 (45%), Gaps = 21/257 (8%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENI--LENVKQEGKLLWLFDHRNIVSLIG 180
IG G FG VY + + + VAIK + ++ +++ +E + L H N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGMNYLHCQAPISLIHR 239
L+ LVMEY G + + +K ++ + +G+ YLH IHR
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHR 139
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVI---KTS 296
D+K+ N+LL+EP T+K+ DFG A V S GT WMAPEVI
Sbjct: 140 DIKAGNILLTEP--------GTVKLADFGSASLVSPAN--SFVGTPYWMAPEVILAMDEG 189
Query: 297 IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEA 356
+ DVWS G+ EL + P ++NA + Y +A N + F+ +++
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS 249
Query: 357 CWEADSHMRPSFKTILK 373
C + RPS + +LK
Sbjct: 250 CLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 122 GEAIGEGGFGKVYKGIYEK--QEVAIKVAH-PNPDENILENVKQEGKLLWLFDHRNIVSL 178
IGEG G V+K + + VA+K + I +E K L H +V L
Sbjct: 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR---PDVLVD-WAIQIAEGMNYLHCQAPI 234
+ V LVMEY L+ VL R P+ V + + +G+ Y+H
Sbjct: 65 LDVFPHGSGFVLVMEYM-PSDLSEVL--RDEERPLPEAQVKSYMRMLLKGVAYMHAN--- 118
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT------THMSAAGTYAWM 288
++HRDLK +N+L+S LKI DFGLAR ++ +H T +
Sbjct: 119 GIMHRDLKPANLLISAD--------GVLKIADFGLAR-LFSEEEPRLYSH--QVATRWYR 167
Query: 289 APEVIKTS-IFSKASDVWSYGVVLWELLTG 317
APE++ + + D+W+ G + ELL G
Sbjct: 168 APELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 9e-21
Identities = 79/274 (28%), Positives = 128/274 (46%), Gaps = 42/274 (15%)
Query: 122 GEAIGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENILENVKQ------EGKLLWLFDHR 173
G+ +G G FG+VY +E+A+K +PD E K+ E +LL H
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQ--ETSKEVNALECEIQLLKNLRHD 64
Query: 174 NIVSLIGVCLQSP---KLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLH 229
IV G CL+ P KL + +EY GG + +++ A + +V + QI +G++YLH
Sbjct: 65 RIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAG------ 283
++HRD+K +N+L +K+ DFG ++ + +T MS G
Sbjct: 124 SNM---IVHRDIKGANILRDSA--------GNVKLGDFGASKRI-QTICMSGTGIKSVTG 171
Query: 284 TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN--KLTLP 341
T WM+PEVI + + +DVWS + E+LT + P+ A A + +A K LP
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231
Query: 342 --IPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ C K + E RP+ + +L+
Sbjct: 232 DGVSDACRDFLKQIF--VEE---KRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 125 IGEGGFGKVYKG--IYEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGV 181
IGEG +G VYK + VAIK + E I + +E KLL +H NI+ L+ V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 182 CLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEGMNYLHCQAPISLIHR 239
L LV E+ L +++ R+ + ++ + Q+ +G+ + H I +HR
Sbjct: 67 FRHKGDLYLVFEFMDTD-LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-SHGI--LHR 122
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT----THMSAAGTYAWMAPEVIKT 295
DLK N+L++ LK+ DFGLAR TH T + APE++
Sbjct: 123 DLKPENLLINTE--------GVLKLADFGLARSFGSPVRPYTHYVV--TRWYRAPELLLG 172
Query: 296 S-IFSKASDVWSYGVVLWELLTG 317
+S D+WS G + ELL+
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 125 IGEGGFGKVYKGIYEKQEV-----AIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLI 179
+G GGFG+V + + +K H + E++ E ++L +H IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 180 GVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQ-----IAEGMNYLHCQAPI 234
+ ++MEY GG L +L R + ++ + + YLH +
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTIL--RDR--GLFDEYTARFYIACVVLAFEYLHNR--- 112
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY--KTTHMSAAGTYAWMAPEV 292
+I+RDLK N+LL +K+ DFG A+++ + T + GT ++APE+
Sbjct: 113 GIIYRDLKPENLLLDS--------NGYVKLVDFGFAKKLKSGQKTW-TFCGTPEYVAPEI 163
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGEIPY 321
I + + D WS G++L+ELLTG P+
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 74/267 (27%), Positives = 132/267 (49%), Gaps = 26/267 (9%)
Query: 115 DYNKLIFGEAIGEGGFGK--VYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
YN L +GEG FG+ + + + Q+ A+K + +E+ ++E LL H
Sbjct: 1 QYNVL---RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH 57
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLH 229
NIV+ L +VMEY GG L + + G+ D ++ W +Q+ G+ ++H
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA--- 286
+ ++HRD+KS N+ L+ Q +K+ DFG AR + T+ + A TY
Sbjct: 118 EK---RVLHRDIKSKNIFLT--------QNGKVKLGDFGSARLL--TSPGAYACTYVGTP 164
Query: 287 -WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST 345
++ PE+ + ++ SD+WS G +L+EL T + P+++ + + V P+PS
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSH 223
Query: 346 CPQLFKTLMEACWEADSHMRPSFKTIL 372
++L++ ++ + RPS TIL
Sbjct: 224 YSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 70/207 (33%), Positives = 94/207 (45%), Gaps = 27/207 (13%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKVAHPNPD---ENILENVKQEGK-LLWLFDHRNIVSL 178
I +G FG VY K AIKV D +N + NVK E ++ + + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVL-KKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQ-IAE---GMNYLHCQAPI 234
L LVMEY GG ++ P+ DWA Q IAE G+ LH +
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE---DWAKQYIAEVVLGVEDLHQRG-- 117
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIK 294
+IHRD+K N+L+ Q LK+TDFGL+R + GT ++APE I
Sbjct: 118 -IIHRDIKPENLLID--------QTGHLKLTDFGLSRNGLENKKFV--GTPDYLAPETIL 166
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIPY 321
K SD WS G V++E L G P+
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 75/273 (27%), Positives = 129/273 (47%), Gaps = 34/273 (12%)
Query: 123 EAIGEGGFGKVYKGIYE---------KQEVAIKV---AHPNPDENILENVKQEGKLLWLF 170
E++G+G F K++KGI K EV +KV +H N E+ E +L
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL---- 56
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNY-LH 229
H+++V GVC+ + +V EY + G L+ L +K + + + W +++A+ + + LH
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALH 114
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKT---LKITDFGLAREVYKTTHMSAAGTYA 286
L H ++ + NVLL I ED + +K++D G++ V +
Sbjct: 115 FLEDKGLTHGNVCAKNVLL---IREEDRKTGNPPFIKLSDPGISITVLPKEILLE--RIP 169
Query: 287 WMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV--NKLTLPIP 343
W+ PE I+ S A+D WS+G LWE+ +G K ++A + ++ LP P
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSG--GDKPLSALDSQKKLQFYEDRHQLPAP 227
Query: 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALN 376
L+ C + + RPSF+ I++ LN
Sbjct: 228 KWTE--LANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 31/264 (11%)
Query: 123 EAIGEGGFGKVYKGIYEKQE---VAIK---VAHPNPDENILENVKQEGKLL-------WL 169
E +G G FG VYK + +A+K V +P ++ E K G ++
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVD---WAI--QIAEG 224
H NIV L++ +L +VM+ G PL K + + W I Q+
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM-SAAG 283
+ YLH + I +HRDL +N++L E + ITDFGLA++ + + S G
Sbjct: 126 LRYLHKEKRI--VHRDLTPNNIMLGED--------DKVTITDFGLAKQKQPESKLTSVVG 175
Query: 284 TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP 343
T + PE++K + + +DVW++G +L+++ T + P+ S N ++A + V + P+P
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI-VEAVYEPLP 234
Query: 344 -STCPQLFKTLMEACWEADSHMRP 366
+ ++ +C D+ RP
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 125 IGEGGFGKVYKGIY-EKQE-VAIKV---AHPNPDENI-LENVKQEGKLLWLFDHRNIVSL 178
+G+G FG VY E E VAIK + +E + L VK L L +H NIV L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS---LRKLNEHPNIVKL 63
Query: 179 IGVCLQSPKLCLVMEYARGG--PLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
V ++ +L V EY G L + G+ V+ QI +G+ ++H
Sbjct: 64 KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---F 120
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-----YKTTHMSAAGTYAWMAPE 291
HRDLK N+L+S P + +KI DFGLARE+ Y T ++S T + APE
Sbjct: 121 FHRDLKPENLLVSGP--------EVVKIADFGLAREIRSRPPY-TDYVS---TRWYRAPE 168
Query: 292 VI-KTSIFSKASDVWSYGVVLWELLTGE 318
++ +++ +S D+W+ G ++ EL T
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 25/207 (12%)
Query: 125 IGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182
IG G G VYK I+ + A+KV + N ++ + + +E ++L +H N+V +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 183 LQSPKLCLVMEYARGGPLNRVLAGRKIRPD-VLVDWAIQIAEGMNYLHCQAPISLIHRDL 241
+ ++ +++E+ GG L G I + L D A QI G+ YLH + ++HRD+
Sbjct: 142 DHNGEIQVLLEFMDGGSLE----GTHIADEQFLADVARQILSGIAYLHRR---HIVHRDI 194
Query: 242 KSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH--MSAAGTYAWMAPEVIKTSIFS 299
K SN+L++ K +KI DFG++R + +T S+ GT A+M+PE I T +
Sbjct: 195 KPSNLLINSA--------KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNH 246
Query: 300 K-----ASDVWSYGVVLWELLTGEIPY 321
A D+WS GV + E G P+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLL-WLFDHRNIVSLI 179
E IG+G +GKV+K + +K + A+K+ P D I E ++ E +L L DH N+V
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFY 81
Query: 180 GVCLQS-----PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLH 229
G+ + +L LV+E GG + ++ G R + + + I + G+ +LH
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTYAW 287
IHRD+K +N+LL+ +K+ DFG++ ++ T ++ GT W
Sbjct: 142 VN---KTIHRDVKGNNILLTTE--------GGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190
Query: 288 MAPEVIKT-----SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLP 341
MAPEVI S + DVWS G+ EL G+ P ++ + + N TL
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250
Query: 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
P F + C D RP+ +L+
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 6e-20
Identities = 72/217 (33%), Positives = 107/217 (49%), Gaps = 41/217 (18%)
Query: 125 IGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQ---EGKLLWLFDHRNIVSLI 179
IG G +G V + ++ ++VAIK N ++ L + K+ E KLL H NI+ L+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-SNVFDD-LIDAKRILREIKLLRHLRHENIIGLL 65
Query: 180 GVCLQSPK------LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYL 228
+ L+ P + +V E L++V+ P L D I QI G+ YL
Sbjct: 66 DI-LRPPSPEDFNDVYIVTELM-ETDLHKVI----KSPQPLTDDHIQYFLYQILRGLKYL 119
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY----KTTHMSAAGT 284
H A + IHRDLK SN+L+ N + LKI DFGLAR V + ++
Sbjct: 120 H-SANV--IHRDLKPSNILV-----NSNC---DLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 285 YAWM-APEVIKTSI-FSKASDVWSYGVVLWELLTGEI 319
W APE++ +S ++KA D+WS G + ELLT +
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 30/215 (13%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGI--YEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFDH 172
Y L +G G +G+V ++VAIK ++ P + +E +LL DH
Sbjct: 17 YQNL---SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 173 RNIVSLIGVCLQSPKL------CLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMN 226
N++ L+ V + L LV G LN ++ +K+ D + QI G+
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLK 132
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSAAGT 284
Y+H A I IHRDLK SN+ + NED + LKI DFGLAR + T ++ T
Sbjct: 133 YIH-SAGI--IHRDLKPSNIAV-----NEDCE---LKILDFGLARHTDDEMTGYV---AT 178
Query: 285 YAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGE 318
+ APE++ + +++ D+WS G ++ ELLTG+
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 125 IGEGGFGKV----YKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
+G+G FGKV KG + A+KV + + Q+ + + +++L G
Sbjct: 3 LGKGSFGKVLLAELKG--TDELYAVKVLKK-------DVILQDDDVECTMTEKRVLALAG 53
Query: 181 ---------VCLQSP-KLCLVMEYARGGPLN-RVLAGRKIRPDVLVDWAIQIAEGMNYLH 229
C Q+ +L VMEY GG L + + +A +I G+ +LH
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 230 CQAPISLIHRDLKSSNVLL-SEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYA 286
+ +I+RDLK NVLL SE +KI DFG+ +E + T + GT
Sbjct: 114 ERG---IIYRDLKLDNVLLDSE---------GHIKIADFGMCKEGILGGVTTSTFCGTPD 161
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
++APE++ + A D W+ GV+L+E+L G+ P+
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 48/154 (31%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLH 229
+ H NIV + L +L +VME+ GG L ++ ++ + + + + + +++LH
Sbjct: 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLH 132
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAW 287
Q +IHRD+KS ++LL+ +K++DFG +V K S GT W
Sbjct: 133 AQG---VIHRDIKSDSILLTSD--------GRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 181
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
MAPEVI + D+WS G+++ E++ GE PY
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 31/215 (14%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIK-VAHPNPDENILENVKQEGKLLWLFD 171
DY K+ E IGEG +G VYKG +K Q VA+K + + +E + +E LL
Sbjct: 1 DYTKI---EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ 57
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYAR---GGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYL 228
H NIV L V +Q +L L+ E+ L+ + G+ + +++ + QI +G+ +
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR------EVYKTTHMSAA 282
H + ++HRDLK N+L I+N+ +K+ DFGLAR VY TH
Sbjct: 118 HSR---RVLHRDLKPQNLL----IDNKG----VIKLADFGLARAFGIPVRVY--TH--EV 162
Query: 283 GTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLT 316
T + APEV+ S +S D+WS G + E+ T
Sbjct: 163 VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 77/239 (32%), Positives = 110/239 (46%), Gaps = 44/239 (18%)
Query: 125 IGEGGFGKVYK-----GIYEKQEVAIKV-------------AHPNPDENILENVKQEGKL 166
+G+GG+GKV++ G + A+KV AH + NILE VK
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK----- 58
Query: 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKI-RPDVLVDWAIQIAEGM 225
H IV LI KL L++EY GG L L I D + +I+ +
Sbjct: 59 -----HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL 113
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY---KTTHMSAA 282
+LH Q +I+RDLK N+LL +K+TDFGL +E TH +
Sbjct: 114 EHLHQQG---IIYRDLKPENILLD--------AQGHVKLTDFGLCKESIHEGTVTH-TFC 161
Query: 283 GTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341
GT +MAPE++ S KA D WS G +++++LTG P+ + N + KL LP
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP 220
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 76/259 (29%), Positives = 122/259 (47%), Gaps = 21/259 (8%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIK-VAHPNPDEN-ILENVKQEGKLLWLFDHRNIVSLIG 180
IG G FG VY + + + VAIK +++ N +++ +E K L H N + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIA-EGMNYLHCQAPISLIHR 239
L+ LVMEY G + + +K +V + A +G+ YLH ++IHR
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHR 149
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVI---KTS 296
D+K+ N+LL+EP + +K+ DFG A S GT WMAPEVI
Sbjct: 150 DIKAGNILLTEPGQ--------VKLADFGSASIASPAN--SFVGTPYWMAPEVILAMDEG 199
Query: 297 IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEA 356
+ DVWS G+ EL + P ++NA + Y +A N+ + F+ +++
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 259
Query: 357 CWEADSHMRPSFKTILKAL 375
C + RP+ + +LK +
Sbjct: 260 CLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 74/266 (27%), Positives = 124/266 (46%), Gaps = 27/266 (10%)
Query: 120 IFGEAIGEGGFGKVYKGIYE---KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIV 176
F +G+G +G+V + KQ V K+ N + +QE +LL H NIV
Sbjct: 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 177 ----SLIGVCLQSPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLH 229
S G + L +VM + GG L L G+ + + +V+W +QIA + YLH
Sbjct: 63 AYRESWEG---EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA--GTYAW 287
+ ++HRDLK+ NV L+ +K+ D G+AR + M++ GT +
Sbjct: 120 EK---HILHRDLKTQNVFLTRT--------NIIKVGDLGIARVLENQCDMASTLIGTPYY 168
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347
M+PE+ ++ SDVW+ G ++E+ T + + + + ++ Y + KL P+P
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-PMPKDYS 227
Query: 348 QLFKTLMEACWEADSHMRPSFKTILK 373
L+ RPS K+IL+
Sbjct: 228 PELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 69/276 (25%), Positives = 117/276 (42%), Gaps = 59/276 (21%)
Query: 125 IGEGGFGKVY----KGIYEKQEVAIKVAHPNPDE--NILENVKQEGKLLWLFDHRNIVSL 178
+G+G G+V+ KG + A+KV N ++ V E ++L DH + +L
Sbjct: 9 LGKGDVGRVFLVRLKGT--GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 179 IGVCLQSPK-LCLVMEYARGGPLNRVL---AGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
Q+ LCLVM+Y GG L R+L G+ + +V +A ++ + YLH
Sbjct: 67 YAS-FQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG-- 123
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH---------------- 278
+++RDLK N+LL +E + ++DF L+++
Sbjct: 124 -IVYRDLKPENILL-----HESGH---IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 279 ---------------MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKS 323
S GT ++APEVI A D W+ G++L+E+L G P+K
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234
Query: 324 INAYAVAYGVAVNKLTLP----IPSTCPQLFKTLME 355
N + ++T P + S+ L + L+
Sbjct: 235 SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLV 270
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 75/257 (29%), Positives = 120/257 (46%), Gaps = 21/257 (8%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIK-VAHPNPDEN-ILENVKQEGKLLWLFDHRNIVSLIG 180
IG G FG VY + + + VAIK +++ N +++ +E + L H N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIA-EGMNYLHCQAPISLIHR 239
L+ LVMEY G + + +K +V + A +G+ YLH ++IHR
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHR 139
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVI---KTS 296
D+K+ N+LLSEP +K+ DFG A + GT WMAPEVI
Sbjct: 140 DVKAGNILLSEP--------GLVKLGDFGSASIMAPAN--XFVGTPYWMAPEVILAMDEG 189
Query: 297 IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEA 356
+ DVWS G+ EL + P ++NA + Y +A N+ + F+ +++
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 357 CWEADSHMRPSFKTILK 373
C + RP+ + +LK
Sbjct: 250 CLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 48/221 (21%)
Query: 125 IGEGGFGKV-----------YKGIYEKQEVAI---KVAHPNPDENILENVKQEGKLLWLF 170
+G+G FGKV Y K+EV I +VAH + +L+N +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR--------- 53
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPL------NRVLAGRKIRPDVLVDWAIQIAEG 224
H + +L +LC VMEYA GG L RV + + R + +I
Sbjct: 54 -HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-----FYGAEIVSA 107
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAA 282
+ YLH +++RDLK N++L + +KITDFGL +E T +
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLD--------KDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 283 GTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKS 323
GT ++APEV++ + + +A D W GVV++E++ G +P+ +
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 86/311 (27%), Positives = 133/311 (42%), Gaps = 49/311 (15%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAH----PNPDEN--ILENVKQEGKL 166
D N L IG G G+VYK ++K + V N +EN IL ++ +
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV---V 67
Query: 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEG 224
L D IV G + + + ME L+++L I D+L + I +
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKA 126
Query: 225 MNYL---HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA-REVYKTTHMS 280
++YL H +IHRD+K SN+LL +K+ DFG++ R V
Sbjct: 127 LHYLKEKH-----GVIHRDVKPSNILLDAS--------GNVKLCDFGISGRLVDSKAKTR 173
Query: 281 AAGTYAWMAPEVI----KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN 336
+AG A+MAPE I + +DVWS G+ L EL TG+ PYK+ + V
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---EFEVLTK 230
Query: 337 KLTLPIPSTCP-----QLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESF 391
L PS P F + ++ C D RP ++ +L+ H FI+ +E+
Sbjct: 231 ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ------H-PFIRR-YETA 282
Query: 392 HIMQDGWRVEI 402
+ GW ++
Sbjct: 283 EVDVAGWFQDV 293
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 16/203 (7%)
Query: 125 IGEGGFGKV--YKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182
IGEG G V + + ++VA+K+ + E + E ++ + H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 183 LQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLK 242
L +L ++ME+ +GG L +++ ++ + + + + + YLH Q +IHRD+K
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIK 144
Query: 243 SSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIFSK 300
S ++LL+ +K++DFG ++ K S GT WMAPEVI + +
Sbjct: 145 SDSILLTLD--------GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 301 ASDVWSYGVVLWELLTGEIPYKS 323
D+WS G+++ E++ GE PY S
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFS 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 70/215 (32%), Positives = 100/215 (46%), Gaps = 41/215 (19%)
Query: 122 GEAIGEGGFGKVYKGIYEKQE---VAIK-VAHPNPDENILENVKQEGKLLW---LFDHRN 174
IGEG +G VYK + VA+K V P +E I + +E LL F+H N
Sbjct: 4 LAEIGEGAYGTVYKA-RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 175 IVSLIGVCL-----QSPKLCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAI-----QIA 222
IV L+ VC + KL LV E+ ++ LA K L I Q+
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--- 279
G+++LH ++HRDLK N+L++ +KI DFGLAR +Y + M
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSD--------GQVKIADFGLAR-IY-SFEMALT 164
Query: 280 SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314
S T + APEV+ S ++ D+WS G + EL
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 123 EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E +G G G VYK + ++ +A+KV + + + + E ++L+ D I+ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240
++ + E+ GG L+ RKI VL A+ + +G+ YL + ++HRD
Sbjct: 67 AFFVENRISICTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLW---SLKILHRD 120
Query: 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSK 300
+K SN+L+ N Q +K+ DFG++ ++ + + GT A+MAPE I +
Sbjct: 121 VKPSNMLV-----NTRGQ---VKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 301 ASDVWSYGVVLWELLTGEIPYKSI 324
SDVWS G+ EL G PY I
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQI 196
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 125 IGEGGFGKVYKGI----YEKQEVAIK--VAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
IG G +G+VYK + +E AIK I ++ +E LL H N+VSL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 179 IGVCLQSPKLC--LVMEYARGGPL-----NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
+ V L+ L+ +YA +R I P ++ QI G++YLH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAG-----TYA 286
++HRDLK +N+L+ E + +KI D GLAR A T
Sbjct: 128 W---VLHRDLKPANILVM----GEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 287 WMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINA 326
+ APE++ + ++KA D+W+ G + ELLT E +K A
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 38/216 (17%)
Query: 125 IGEGGFGKVY------KGIYE-----KQEVAI---KVAHPNPDENILENVKQEGKLLWLF 170
+G+G FGKV G Y ++EV I +VAH + +L+N +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--------- 53
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKI-RPDVLVDWAIQIAEGMNYLH 229
H + +L +LC VMEYA GG L L+ ++ + + +I + YLH
Sbjct: 54 -HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 112
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAW 287
+ +++RD+K N++L + +KITDFGL +E T + GT +
Sbjct: 113 SR---DVVYRDIKLENLMLDKD--------GHIKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKS 323
+APEV++ + + +A D W GVV++E++ G +P+ +
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 125 IGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182
IGEG +G V ++ +VAIK P + + +E K+L F H NI+ ++ +
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDI- 71
Query: 183 LQSPKLC------LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
++ P +V E L +++ + + D + + QI G+ Y+H ++
Sbjct: 72 IRPPSFESFNDVYIVQELMETD-LYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA---NV 127
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR-----EVYKTTHMSAAGTYAWMAPE 291
+HRDLK SN+LL+ N DL KI DFGLAR + T + APE
Sbjct: 128 LHRDLKPSNLLLNT---NCDL-----KICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 292 VIKTS-IFSKASDVWSYGVVLWELLTGE 318
++ S ++KA D+WS G +L E+L+
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 35/214 (16%)
Query: 122 GEAIGEGGFGKV----YKG--------IYEKQEVAIKVAHPNPDENILENVKQEGKLLWL 169
GE +G G FG+V +KG +K+E+ +K+ +++V QE +L
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-LKMKQ-------VQHVAQEKSILME 74
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNY 227
H IV+++ ++ ++E+ GG L L AGR DV + ++ Y
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-FPNDVAKFYHAELVLAFEY 133
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAW 287
LH + +I+RDLK N+LL +K+TDFG A++V T + GT +
Sbjct: 134 LHSK---DIIYRDLKPENLLLD--------NKGHVKVTDFGFAKKVPDRTF-TLCGTPEY 181
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
+APEVI++ KA D W+ GV+L+E + G P+
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 28/273 (10%)
Query: 125 IGEGGFGKVYKGIYEKQEV--AIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182
+G G G V K ++ + A K+ H I + +E K+L + IV G
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 183 LQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240
++ + ME+ GG L++VL AGR I ++L +I + G+ YL + ++HRD
Sbjct: 69 YSDGEISICMEHMDGGSLDQVLKKAGR-IPENILGKISIAVLRGLTYL--REKHKIMHRD 125
Query: 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSK 300
+K SN+L++ E +K+ DFG++ ++ + S GT ++M+PE ++ + ++
Sbjct: 126 VKPSNILVNSRGE--------IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTV 177
Query: 301 ASDVWSYGVVLWELLTGE--IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACW 358
SD+WS G+ L E+ G IP +G V++
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS---------G 228
Query: 359 EADSHMRPSFKTILKALNNIVHSEFIQTPHESF 391
RP I + L+ IV+ + P +F
Sbjct: 229 HPPDSPRP--MAIFELLDYIVNEPPPKLPSGAF 259
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 34/267 (12%)
Query: 124 AIGEGGFGKVYKGI--YEKQEVAIKVAH--PNPDENILENVKQEGKLLWLFDHRNIVSLI 179
IG+G F VYK I + + VA+K D ++ +E LL DH N++ +
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 180 GVCLQSPKLCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
+++ +L +V+E A G L+R++ R I + + +Q+ + ++H +
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK--- 125
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY-KTTHM-SAAGTYAWMAPEV 292
++HRD+K +NV ++ +K+ D GL R KTT S GT +M+PE
Sbjct: 126 RIMHRDIKPANVFITAT--------GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGEIPYK--SINAYAVAYGVAVNKLTL----PIPST- 345
I + ++ SD+WS G +L+E+ + P+ +N Y++ K+ P+P+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-----CKKIEKCDYPPLPADH 232
Query: 346 CPQLFKTLMEACWEADSHMRPSFKTIL 372
+ + L+ C D RP +L
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 74/257 (28%), Positives = 117/257 (45%), Gaps = 21/257 (8%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIK-VAHPNPDEN-ILENVKQEGKLLWLFDHRNIVSLIG 180
IG G FG VY + + VA+K +++ N +++ +E K L H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIA-EGMNYLHCQAPISLIHR 239
L+ LVMEY G + + +K +V + A +G+ YLH +IHR
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHR 145
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVI---KTS 296
D+K+ N+LL+EP + +K+ DFG A + S GT WMAPEVI
Sbjct: 146 DIKAGNILLTEPGQ--------VKLADFGSASKSSPAN--SFVGTPYWMAPEVILAMDEG 195
Query: 297 IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEA 356
+ DVWS G+ EL + P ++NA + Y +A N + F+ ++
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255
Query: 357 CWEADSHMRPSFKTILK 373
C + RP+ +L+
Sbjct: 256 CLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 26/210 (12%)
Query: 125 IGEGGFGKVY-----KGIYEKQEVAIKVAHPNPDENILENV--KQEGKLLWLFDHRNIVS 177
+G+G FGKV+ G Q A+KV + + V K E +L +H IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLK-KATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 178 LIGVCLQSP-KLCLVMEYARGGPLNRVLAGRKI--RPDVLVDWAIQIAEGMNYLHCQAPI 234
L Q+ KL L++++ RGG L L+ + DV A ++A +++LH +
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLH---SL 117
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV--YKTTHMSAAGTYAWMAPEV 292
+I+RDLK N+LL E +K+TDFGL++E ++ S GT +MAPEV
Sbjct: 118 GIIYRDLKPENILLDEE--------GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGEIPYK 322
+ ++++D WS+GV+++E+LTG +P++
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 48/154 (31%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLH 229
+ H N+V + L +L +VME+ GG L ++ ++ + + + + ++YLH
Sbjct: 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH 135
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAW 287
Q +IHRD+KS ++LL+ +K++DFG +V K S GT W
Sbjct: 136 NQG---VIHRDIKSDSILLTSD--------GRIKLSDFGFCAQVSKEVPKRKSLVGTPYW 184
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
MAPEVI + D+WS G+++ E++ GE PY
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 77/277 (27%), Positives = 132/277 (47%), Gaps = 38/277 (13%)
Query: 123 EAIGEGGFGKVYKGI-------------YEKQ-EVAIKVAHPNPDENILENVKQEGKLLW 168
E +G G ++Y GI YEK+ +V +KV P+ +I + ++
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMR 59
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDW----AIQIAEG 224
H++IV L GVC++ + +V E+ GPL+ + RK + W A Q+A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD-LFMHRKSDV-LTTPWKFKVAKQLASA 117
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLS-EPIENEDLQFKTLKITDFGLAREVYKTTHMSAAG 283
++YL + L+H ++ + N+LL+ E I+ E F +K++D G+ V +
Sbjct: 118 LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVL--SRQECVE 170
Query: 284 TYAWMAPEVIK-TSIFSKASDVWSYGVVLWEL-LTGEIPYK--SINAYAVAYGVAVNKLT 339
W+APE ++ + S A+D WS+G LWE+ GEIP K ++ Y
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC---- 226
Query: 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376
+ + +C +L LM C D + RP F+ I++ +N
Sbjct: 227 MLVTPSCKELAD-LMTHCMNYDPNQRPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 47/219 (21%)
Query: 125 IGEGGFGKV-----------YKGIYEKQEVAI---KVAHPNPDENILENVKQEGKLLWLF 170
+G+G FGKV Y K+EV + +VAH + +L+N +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--------- 53
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPL------NRVLAGRKIRPDVLVDWAIQIAEG 224
H + +L +LC VMEYA GG L RV + + R + +I
Sbjct: 54 -HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-----FYGAEIVSA 107
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK--TTHMSAA 282
++YLH + ++++RDLK N++L + +KITDFGL +E K T +
Sbjct: 108 LDYLHSEK--NVVYRDLKLENLMLDKD--------GHIKITDFGLCKEGIKDGATMKTFC 157
Query: 283 GTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
GT ++APEV++ + + +A D W GVV++E++ G +P+
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 125 IGEGGFGKVYKGIYEK---QEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIG 180
+GEG +G V K K + VAIK + DE++ + +E K+L H NIV+L
Sbjct: 9 VGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGMNYLHCQAPISLIHR 239
+ +L LV EY L + A + PD + + Q+ + + Y H ++IHR
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHR 124
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAR------EVYKTTHMSAAGTYAWMAPEV- 292
D+K N+L+SE LK+ DFG AR T +++ T + APE+
Sbjct: 125 DIKPENILVSES--------GVLKLCDFGFARALRARPASPLTDYVA---TRWYRAPELL 173
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGE 318
+ + + K DVW+ G ++ ELL GE
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 78/272 (28%), Positives = 123/272 (45%), Gaps = 34/272 (12%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLL-WLFDHRNIVSLI 179
E IG+G +GKVYK +K A+K+ P D + E ++ E +L L +H N+V
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD--EEIEAEYNILQSLPNHPNVVKFY 85
Query: 180 GVCLQSPK-----LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIA-----EGMNYLH 229
G+ ++ K L LV+E GG + ++ G I L + I G+ +LH
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--THMSAAGTYAW 287
+IHRD+K +N+LL+ +K+ DFG++ ++ T ++ GT W
Sbjct: 146 NN---RIIHRDVKGNNILLTTE--------GGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194
Query: 288 MAPEVIKT-----SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLP 341
MAPEVI + DVWS G+ EL G+ P ++ + + N TL
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254
Query: 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
P + F + C D RPS +L+
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 75/246 (30%), Positives = 120/246 (48%), Gaps = 33/246 (13%)
Query: 115 DYNKLIFGEAIGEGGFGKVY----KGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLF 170
D+N F +G+G FGKV KG E + I ++ +E E ++L L
Sbjct: 1 DFN---FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 171 DHRNIVSLIGVCLQS-PKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNY 227
++ + C Q+ +L VMEY GG L + GR P V +A +IA G+ +
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHA-VFYAAEIAIGLFF 116
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY--KTTHMSAAGTY 285
LH + +I+RDLK NV+L +KI DFG+ +E T + GT
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSE--------GHIKIADFGMCKENMWDGVTTKTFCGTP 165
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP---------YKSINAYAVAYGVAVN 336
++APE+I + K+ D W++GV+L+E+L G+ P ++SI + VAY +++
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMS 225
Query: 337 KLTLPI 342
K + I
Sbjct: 226 KEAVAI 231
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 42/218 (19%)
Query: 125 IGEGGFGKV----YKGIYEKQEVAIKVAHPNPDENILEN-----VKQEGKLLWLFD---H 172
+G G FGKV YK + AIK +I+ + E ++ + H
Sbjct: 7 LGRGHFGKVLLAEYKK--TGELYAIKALK---KGDIIARDEVESLMCEKRIFETANSERH 61
Query: 173 RNIVSLIGVCLQSP-KLCLVMEYARGGPLNRVLAGRKIRPDVL-----VDWAIQIAEGMN 226
+V+L C Q+ +C VMEYA GG L I DV V +A + G+
Sbjct: 62 PFLVNLFA-CFQTEDHVCFVMEYAAGGDLMM-----HIHTDVFSEPRAVFYAACVVLGLQ 115
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV--YKTTHMSAAGT 284
YLH +++RDLK N+LL D + +KI DFGL +E + + GT
Sbjct: 116 YLHEN---KIVYRDLKLDNLLL-------DTE-GFVKIADFGLCKEGMGFGDRTSTFCGT 164
Query: 285 YAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYK 322
++APEV+ + +++A D W GV+++E+L GE P+
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 72/239 (30%), Positives = 118/239 (49%), Gaps = 28/239 (11%)
Query: 121 FGEAIGEGGFGKVY----KGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIV 176
F +G+G FGKV KG E + I ++ +E E ++L L D +
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63
Query: 177 SLIGVCLQS-PKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
+ + C Q+ +L VMEY GG L + K + V +A +I+ G+ +LH +
Sbjct: 64 TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG-- 121
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMAPEV 292
+I+RDLK NV+L +KI DFG+ +E V T + GT ++APE+
Sbjct: 122 -IIYRDLKLDNVMLDSE--------GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGEIP---------YKSINAYAVAYGVAVNKLTLPI 342
I + K+ D W+YGV+L+E+L G+ P ++SI + V+Y +++K + I
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSI 231
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 73/267 (27%), Positives = 112/267 (41%), Gaps = 45/267 (16%)
Query: 125 IGEGGFGKVYK-------GIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
+G+GGFG+V +Y +++ K E + N E K+L R IVS
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN---EKKILEKVSSRFIVS 57
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR----PDVLVDWAIQIAEGMNYLHCQAP 233
L LCLVM GG L + + +A QI G+ +LH +
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF-YAAQIICGLEHLHQR-- 114
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY--KTTHMSAAGTYAWMAPE 291
+++RDLK NVLL + ++I+D GLA E+ K AGT +MAPE
Sbjct: 115 -RIVYRDLKPENVLLDD--------HGNVRISDLGLAVELKGGKKIKGR-AGTPGYMAPE 164
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-----LTLPIPSTC 346
V++ ++ + D ++ G L+E++ G P++ V K TL +
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFR-------QRKEKVEKEELKRRTLEMAVEY 217
Query: 347 PQLF----KTLMEACWEADSHMRPSFK 369
P F K L EA + D R +
Sbjct: 218 PDKFSPEAKDLCEALLQKDPEKRLGCR 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 58/184 (31%), Positives = 84/184 (45%), Gaps = 36/184 (19%)
Query: 206 GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265
G I D+L A+ I + + YLH + +S+IHRD+K SNVL+ N + Q K+
Sbjct: 97 GLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLI-----NRNGQV---KLC 146
Query: 266 DFG----LAREVYKTTHMSAAGTYAWMAPEVI----KTSIFSKASDVWSYGVVLWELLTG 317
DFG L V KT AG +MAPE I + SDVWS G+ + EL TG
Sbjct: 147 DFGISGYLVDSVAKTID---AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
Query: 318 EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL--------FKTLMEACWEADSHMRPSFK 369
PY S + +L + PQL F+ + C + + RP++
Sbjct: 204 RFPYDS-------WKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP 256
Query: 370 TILK 373
+L+
Sbjct: 257 ELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 118 KLIFGEAI--GEGGFGKVYKGIYEKQEVAI---KVAHPNPDENILENVKQEGKLLWLFDH 172
K FG+ I E GK Y K+EV I +VAH + +L+N + H
Sbjct: 5 KGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR----------H 54
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKI-RPDVLVDWAIQIAEGMNYLHCQ 231
+ SL +LC VMEY GG L L+ ++ D + +I ++YLH
Sbjct: 55 PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMA 289
+++RDLK N++L + +KITDFGL +E T + GT ++A
Sbjct: 115 ---KIVYRDLKLENLMLDKD--------GHIKITDFGLCKEGITDAATMKTFCGTPEYLA 163
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
PEV++ + + +A D W GVV++E++ G +P+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 46/154 (29%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLH 229
+ H N+V + L +L +VME+ GG L ++ ++ + + + + + ++ LH
Sbjct: 74 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLH 133
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAW 287
Q +IHRD+KS ++LL+ +K++DFG +V K S GT W
Sbjct: 134 AQG---VIHRDIKSDSILLTHD--------GRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 182
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
MAPE+I + D+WS G+++ E++ GE PY
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 21/224 (9%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENI----LENVKQEGKLLWLFDHRNIVSL 178
+G G FG+V+ + + A+KV E I ++V E ++L H I+ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVM--AIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLI 237
L ++MEY GG L L + + +A +I + YLH + ++
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIV 123
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSI 297
+RDLK N+LL + +K+TDFG A+++ T + GT ++APEVI++
Sbjct: 124 YRDLKPENILLDKE--------GHIKLTDFGFAKKLRDRTW-TLCGTPEYLAPEVIQSKG 174
Query: 298 FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341
+KA D W+ G++++E+L G P+ N + + + KL P
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP 218
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 67/201 (33%), Positives = 99/201 (49%), Gaps = 22/201 (10%)
Query: 125 IGEGGFGKV--YKGIYEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGV 181
+G G FG V + Q VAIK + P + + +E KLL H NI+SL +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 182 CLQSPK--LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHR 239
+ SP + V E G L+R+L R + + + QI G+ Y+H ++HR
Sbjct: 78 FI-SPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHR 132
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA-AGTYAWMAPEVIKT-SI 297
DLK SN+L++ EN D LKI DFGLAR + M+ T + APE++ T
Sbjct: 133 DLKPSNILIN---ENCD-----LKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 298 FSKASDVWSYGVVLWELLTGE 318
+ D+WS G + E+L G+
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 79/273 (28%), Positives = 111/273 (40%), Gaps = 46/273 (16%)
Query: 125 IGEGGFGKVYKGI----YEKQEVAIK----VAHPNPDENILENVKQEGKLLWLFDHRNIV 176
IG G FGKV G Y +V +K A LE + L H N++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL----QHSNLL 58
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKI------RPDVLVDWAIQIAEGMNYLHC 230
+G C + LVME+ G L L + P L A +IA G+ +LH
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT----YA 286
+ IH DL N LL+ + T+KI D+GL+ YK +
Sbjct: 119 N---NFIHSDLALRNCLLTADL--------TVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167
Query: 287 WMAPEVIK-------TSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAV-AYGVAVNK 337
W+APE++ +K S+VWS GV +WEL G PY+ ++ V Y V +
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227
Query: 338 LTLPIPS---TCPQLFKTLMEACWEADSHMRPS 367
L LP P + +M+ CW RPS
Sbjct: 228 LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPS 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-17
Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 135 KGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194
+G K++V K N DE + E L DH IV KL L+MEY
Sbjct: 88 RGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 195 ARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLHCQAPISLIHRDLKSSNVLLS 249
GG LN+ + R ++ + QI ++ +H + ++HRDLKS+N+ L
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFL- 202
Query: 250 EPIENEDLQFKTLKITDFGLAREVYKTTHMSAA----GTYAWMAPEVIKTSIFSKASDVW 305
+ +K+ DFG +++ + + A GT ++APE+ + +SK +D+W
Sbjct: 203 -------MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255
Query: 306 SYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMR 365
S GV+L+ELLT P+K + + V K P P K L++ + +R
Sbjct: 256 SLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALR 314
Query: 366 PSFKTIL-----KALNNIV-----HSEFIQTPHESFHIMQ 395
P+ + +L K + N+ HSE I PH+ I++
Sbjct: 315 PTTQQLLHTEFLKYVANLFQDIVRHSETIS-PHDREEILR 353
|
Length = 478 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 123 EAIGEGGFGKVYKGI--YEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E +GEG + VYKGI Q VA+KV +E + +E LL H NIV L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238
+ L V EY L + + + P + + Q+ G+ Y+H Q ++H
Sbjct: 71 IIHTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILH 126
Query: 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSAAGTYAWMAPEVIKTS 296
RDLK N+L+S E LK+ DFGLAR + T+ S T + P+V+ +
Sbjct: 127 RDLKPQNLLISYLGE--------LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 297 I-FSKASDVWSYGVVLWELLTGE 318
+S A D+W G + E+L G+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 26/205 (12%)
Query: 125 IGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVK-QEGKLLWLFDHRNIVSLIGV 181
+GEG +G V K +++ Q VAIK + D+ +++ + +E ++L H N+V+LI V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 182 CLQSPKLCLVMEYARGGPLNRV-LAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240
+ +L LV E+ L+ + + + + QI G+ + H ++IHRD
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRD 125
Query: 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAR------EVYKTTHMSAAGTYAWMAPE-VI 293
+K N+L+S Q +K+ DFG AR EVY T +++ T + APE ++
Sbjct: 126 IKPENILVS--------QSGVVKLCDFGFARTLAAPGEVY-TDYVA---TRWYRAPELLV 173
Query: 294 KTSIFSKASDVWSYGVVLWELLTGE 318
+ + +A D+W+ G ++ E+LTGE
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 20/200 (10%)
Query: 123 EAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
+ +G G +G VYK ++ + A+K+ P ++ ++QE ++ H NIV+ G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD-FSLIQQEIFMVKECKHCNIVAYFG 73
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-QIAEGMNYLHCQAPISLIHR 239
L KL + MEY GG L + ++ + + + +G+ YLH + +HR
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHR 130
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--THMSAAGTYAWMAPEVI---K 294
D+K +N+LL+ +N D +K+ DFG+A ++ T S GT WMAPEV K
Sbjct: 131 DIKGANILLT---DNGD-----VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 295 TSIFSKASDVWSYGVVLWEL 314
+++ D+W+ G+ EL
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 123 EAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
+ IG G +G VYK + + AIKV P E+ V+QE ++ H NIV+ G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-QIAEGMNYLHCQAPISLIHR 239
L+ KL + ME+ GG L + + + + + +G+ YLH + +HR
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHR 130
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--THMSAAGTYAWMAPEVI---K 294
D+K +N+LL++ +K+ DFG++ ++ T S GT WMAPEV +
Sbjct: 131 DIKGANILLTDN--------GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIP 320
+++ D+W+ G+ EL + P
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 29/216 (13%)
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI----QIAEGMNY 227
H ++ + GVC++ + +V E+ GPL+ L RK + V V W I Q+A ++Y
Sbjct: 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL--RKEKGRVPVAWKITVAQQLASALSY 132
Query: 228 LHCQAPISLIHRDLKSSNVLLSEP-IENEDLQFKTLKITDFG-----LAREVYKTTHMSA 281
L + +L+H ++ + N+LL+ + F +K++D G L+RE
Sbjct: 133 LEDK---NLVHGNVCAKNILLARLGLAEGTSPF--IKLSDPGVSFTALSRE-------ER 180
Query: 282 AGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWEL-LTGEIPYKSINAYAVAYGVAVNKLT 339
W+APE + + S A+D WS+G L E+ GE+P K + K
Sbjct: 181 VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE-RTPSEKERFYEKKHR 239
Query: 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
LP PS C +L TL+ C + RPSF+TIL+ L
Sbjct: 240 LPEPS-CKEL-ATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKVAHPNPDE--NILENVKQEGKLLWLFDHRNIVSLIG 180
+G+GG+G+V+ K + VA+K + N + +V E +L +V L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 181 VCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHR 239
L L MEY GG +L + D + ++ E ++ LH + IHR
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH---ELGYIHR 125
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFS 299
DLK N L+ +K+TDFGL++ + + S G+ +MAPEV++ +
Sbjct: 126 DLKPENFLID--------ASGHIKLTDFGLSKGIVTYAN-SVVGSPDYMAPEVLRGKGYD 176
Query: 300 KASDVWSYGVVLWELLTGEIPY 321
D WS G +L+E L G P+
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 79/248 (31%), Positives = 120/248 (48%), Gaps = 35/248 (14%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENILENVKQEGK--------LLWLFDHRN 174
IG+G FGKV K + + A+KV + IL+ K+E K LL H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQ---KKAILK--KKEQKHIMAERNVLLKNVKHPF 57
Query: 175 IVSLIGVCLQSP-KLCLVMEYARGGPLNRVLAGRKIRPDVLVD-WAIQIAEGMNYLHCQA 232
+V L Q+ KL V++Y GG L L + P+ +A +IA + YLH
Sbjct: 58 LVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH--- 113
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMAP 290
+++I+RDLK N+LL D Q + +TDFGL +E + T + GT ++AP
Sbjct: 114 SLNIIYRDLKPENILL-------DSQ-GHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLP--IPSTCP 347
EV++ + + D W G VL+E+L G P+ S + A Y +NK L L I +
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-AEMYDNILNKPLRLKPNISVSAR 224
Query: 348 QLFKTLME 355
L + L++
Sbjct: 225 HLLEGLLQ 232
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 63/271 (23%), Positives = 125/271 (46%), Gaps = 42/271 (15%)
Query: 125 IGEGGFGKVYKG--IYEKQEVAIKVAH--PNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
IG G F +VY+ + +++ VA+K D ++ +E LL +H N++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 181 VCLQSPKLCLVMEYARGGPLNRVL----AGRKIRPDVLV-DWAIQIAEGMNYLHCQAPIS 235
++ +L +V+E A G L++++ +++ P+ V + +Q+ + ++H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSAAGTYAWMAPEVI 293
++HRD+K +NV ++ +K+ D GL R T S GT +M+PE I
Sbjct: 127 VMHRDIKPANVFITATGV--------VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL----------PIP 343
+ ++ SD+WS G +L+E+ + P+ YG +N +L P+P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF---------YGDKMNLFSLCQKIEQCDYPPLP 229
Query: 344 ST-CPQLFKTLMEACWEADSHMRPSFKTILK 373
+ + + L+ C D RP + +
Sbjct: 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-16
Identities = 70/250 (28%), Positives = 118/250 (47%), Gaps = 20/250 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQE---VAIKVAHPNP--DENILENVKQEGKLL 167
++ Y F +G G FG+V Y+ ++ VAIK + + +++V E K+L
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRP-DVLVDWAIQIAEGMN 226
+H V+L G L LV+E+ GG L K P DV +A QI
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE 145
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA 286
YL +++++RDLK N+LL + +K+TDFG A+ V T+ + GT
Sbjct: 146 YLQ---SLNIVYRDLKPENLLLDKD--------GFIKMTDFGFAKVVDTRTY-TLCGTPE 193
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPS 344
++APE++ KA+D W+ G+ ++E+L G P+ + + + + P + +
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDN 253
Query: 345 TCPQLFKTLM 354
C L K L+
Sbjct: 254 NCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|212690 cd00174, SH3, Src Homology 3 domain superfamily | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 1e-15
Identities = 28/57 (49%), Positives = 37/57 (64%), Gaps = 8/57 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
RALYDY+A DELS ++GDI+ VL KD GWW G++ G + G+FPAN+
Sbjct: 3 RALYDYEAQDDDELSFKKGDIITVLEKDDD-----GWWEGELNGG---REGLFPANY 51
|
Src Homology 3 (SH3) domains are protein interaction domains that bind proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. Thus, they are referred to as proline-recognition domains (PRDs). SH3 domains are less selective and show more diverse specificity compared to other PRDs. They have been shown to bind peptide sequences that lack the PxxP motif; examples include the PxxDY motif of Eps8 and the RKxxYxxY sequence in SKAP55. SH3 domain containing proteins play versatile and diverse roles in the cell, including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies, among others. Many members of this superfamily are adaptor proteins that associate with a number of protein partners, facilitating complex formation and signal transduction. Length = 51 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEKQEV--AIKVAHPNPDENILENVKQEGKLLWLFDHRN 174
+++ + +G+G +G VYK ++ V A+K DE+ + E +L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPLNRVLAG----RKIRPDVLVDWAIQIAEGMNYLHC 230
IV G + + MEY G L+++ AG I DVL + +G+ +L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAP 290
+ I IHRD+K +NVL++ +K+ DFG++ + + + G ++MAP
Sbjct: 121 EHNI--IHRDVKPTNVLVNGN--------GQVKLCDFGVSGNLVASLAKTNIGCQSYMAP 170
Query: 291 EVIKT------SIFSKASDVWSYGVVLWELLTGEIPY 321
E IK+ ++ SDVWS G+ + E+ G PY
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 66/242 (27%), Positives = 104/242 (42%), Gaps = 66/242 (27%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEG-------- 164
DY +GEG FG+VYK + VA+K IL + +++G
Sbjct: 9 DYE---ILGKLGEGTFGEVYKARQIKTGRVVALK--------KILMHNEKDGFPITALRE 57
Query: 165 -KLLWLFDHRNIVSLIGVCLQSPK--------LCLVMEYARGGPLNRVLAGRKIRPDVLV 215
K+L H N+V LI + ++ P + +V Y ++ L+G P V +
Sbjct: 58 IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPY-----MDHDLSGLLENPSVKL 112
Query: 216 DWA------IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269
+ +Q+ EG+NYLH ++HRD+K++N+L I+N+ LKI DFGL
Sbjct: 113 TESQIKCYMLQLLEGINYLHEN---HILHRDIKAANIL----IDNQG----ILKIADFGL 161
Query: 270 AR----EVYKTTHMSAAGT--YAWM-------APE-VIKTSIFSKASDVWSYGVVLWELL 315
AR GT Y + PE ++ ++ A D+W G V E+
Sbjct: 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
Query: 316 TG 317
T
Sbjct: 222 TR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 70/259 (27%), Positives = 131/259 (50%), Gaps = 37/259 (14%)
Query: 125 IGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG---- 180
IG GGFG+VY K + A D+ ++ ++G+ L L + R ++SL+
Sbjct: 2 IGRGGFGEVYG--CRKADTGKMYAMKCLDKKRIK--MKQGETLAL-NERIMLSLVSTGDC 56
Query: 181 ---VCL----QSP-KLCLVMEYARGGPLNRVLAGRKIRPDV-LVDWAIQIAEGMNYLHCQ 231
VC+ +P KLC +++ GG L+ L+ + + + +A +I G+ ++H +
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPE 291
+++RDLK +N+LL E ++I+D GLA + K ++ GT+ +MAPE
Sbjct: 117 F---VVYRDLKPANILLDE--------HGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 165
Query: 292 VI-KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLF 350
V+ K + + ++D +S G +L++LL G P++ + ++++TL + P F
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ---HKTKDKHEIDRMTLTVNVELPDSF 222
Query: 351 ----KTLMEACWEADSHMR 365
K+L+E + D R
Sbjct: 223 SPELKSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 123 EAIGEGGFGKVYKGI--YEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E +GEG + VYKG + VA+K H + +E +E L+ H NIV L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIR----PDVLVDWAIQIAEGMNYLHCQAPISL 236
V KL LV EY L + + +R P+ + + Q+ +G+ + H +
Sbjct: 66 VIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMAPEVIK 294
+HRDLK N+L+ N+ + LK+ DFGLAR + T + T + AP+V+
Sbjct: 122 LHRDLKPQNLLI-----NKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173
Query: 295 TS-IFSKASDVWSYGVVLWELLTG 317
S +S + D+WS G ++ E++TG
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 125 IGEGGFGKVYKGIYEKQEV--AIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182
+G G G V K ++ + A K+ H I + +E ++L + IV G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 183 LQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDL 241
++ + ME+ GG L++VL ++I ++L +I + G+ YL + I +HRD+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQI--MHRDV 130
Query: 242 KSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKA 301
K SN+L++ E +K+ DFG++ ++ + S GT ++M+PE ++ + +S
Sbjct: 131 KPSNILVNSRGE--------IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 302 SDVWSYGVVLWELLTGEIP 320
SD+WS G+ L EL G P
Sbjct: 183 SDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 69/213 (32%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGI-YEKQE-VAIK-VAHPNPDENILENVKQEGKLLWLFDH 172
Y KL E IGEG +G V+K E E VA+K V + DE + + +E LL H
Sbjct: 2 YEKL---EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLHC 230
+NIV L V KL LV EY L + I P+++ + Q+ +G+ + H
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQD-LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-YKTTHMSAAGTYAWM- 288
+++HRDLK N+L+++ E LK+ DFGLAR SA W
Sbjct: 118 H---NVLHRDLKPQNLLINKNGE--------LKLADFGLARAFGIPVRCYSAEVVTLWYR 166
Query: 289 APEVI-KTSIFSKASDVWSYGVVLWELLTGEIP 320
P+V+ ++S + D+WS G + EL P
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 67/253 (26%), Positives = 117/253 (46%), Gaps = 26/253 (10%)
Query: 188 LCLVMEYARGGPL-----NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLK 242
+ LV++YA G L +R R R IQ+ ++++H + +IHRD+K
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIK 170
Query: 243 SSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIF 298
S+N+LL +K+ DFG ++ T + GT ++APE+ + +
Sbjct: 171 SANILLCSN--------GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222
Query: 299 SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACW 358
SK +D++S GV+L+ELLT + P+ N V + + P+P + + ++ A
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLPPSISPEMQEIVTALL 281
Query: 359 EADSHMRPSFKTILKA----LNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRV-KE 413
+D RPS +L L E +QT ++D +I+Q L+V +
Sbjct: 282 SSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQQTKQLLQVERR 341
Query: 414 KELRSREEELTKA 426
+ +R EE L+ A
Sbjct: 342 RIVRQMEESLSTA 354
|
Length = 496 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 125 IGEGGFGKVYKGIYEK--QEVAIKVAH-PNPDENILENVKQEGKLLWLFDHRNIVSLIGV 181
+G G +G V I ++ ++VAIK P E + +E LL H N++ L+ V
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 182 CLQSPKL------CLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
+ LVM Y + L +++ G + D + Q+ G+ Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD-LQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAG--- 137
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM-APEVIK 294
+IHRDLK N+ + NED + LKI DFGLAR + M+ W APEVI
Sbjct: 138 IIHRDLKPGNLAV-----NEDCE---LKILDFGLAR--HADAEMTGYVVTRWYRAPEVIL 187
Query: 295 TSI-FSKASDVWSYGVVLWELLTGEIPYK 322
+ +++ D+WS G ++ E+LTG+ +K
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|212808 cd11875, SH3_CD2AP-like_3, Third Src Homology 3 domain (SH3C) of CD2-associated protein and similar proteins | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-15
Identities = 31/59 (52%), Positives = 38/59 (64%), Gaps = 7/59 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
R L+DY+A DEL+LR GDIV +LSKD D GWW G++ G K G+FP NFV
Sbjct: 3 RVLFDYEAENEDELTLREGDIVTILSKD---CEDKGWWKGELNG----KRGVFPDNFVE 54
|
This subfamily is composed of the third SH3 domain (SH3C) of CD2AP, CIN85 (Cbl-interacting protein of 85 kDa), and similar domains. CD2AP and CIN85 are adaptor proteins that bind to protein partners and assemble complexes that have been implicated in T cell activation, kidney function, and apoptosis of neuronal cells. They also associate with endocytic proteins, actin cytoskeleton components, and other adaptor proteins involved in receptor tyrosine kinase (RTK) signaling. CD2AP and the main isoform of CIN85 contain three SH3 domains, a proline-rich region, and a C-terminal coiled-coil domain. All of these domains enable CD2AP and CIN85 to bind various protein partners and assemble complexes that have been implicated in many different functions. SH3C of both proteins have been shown to bind to ubiquitin. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 71/258 (27%), Positives = 133/258 (51%), Gaps = 35/258 (13%)
Query: 125 IGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG---- 180
IG GGFG+VY K + A D+ ++ +KQ G+ L L + R ++SL+
Sbjct: 2 IGRGGFGEVYG--CRKADTGKMYAMKCLDKKRIK-MKQ-GETLAL-NERIMLSLVSTGDC 56
Query: 181 ---VCL----QSP-KLCLVMEYARGGPLNRVLAGRKIRPDV-LVDWAIQIAEGMNYLHCQ 231
VC+ +P KL +++ GG L+ L+ + + + +A +I G+ ++H +
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPE 291
+++RDLK +N+LL E ++I+D GLA + K ++ GT+ +MAPE
Sbjct: 117 F---VVYRDLKPANILLDE--------HGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 165
Query: 292 VIKTSI-FSKASDVWSYGVVLWELLTGEIPY---KSINAYAVAYGVAVNKLTLPIPSTCP 347
V++ + + ++D +S G +L++LL G P+ K+ + + + + LP S P
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP-DSFSP 224
Query: 348 QLFKTLMEACWEADSHMR 365
+L ++L+E + D + R
Sbjct: 225 EL-RSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 49/140 (35%), Positives = 70/140 (50%), Gaps = 15/140 (10%)
Query: 187 KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNV 246
KL L+++Y GG L L R+ + V + IAE + L + +I+RD+K N+
Sbjct: 79 KLHLILDYVNGGELFTHLYQREHFTESEV--RVYIAEIVLALDHLHQLGIIYRDIKLENI 136
Query: 247 LLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA---AGTYAWMAPEVIKT--SIFSKA 301
LL + +TDFGL++E A GT +MAPEVI+ KA
Sbjct: 137 LLDSE--------GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKA 188
Query: 302 SDVWSYGVVLWELLTGEIPY 321
D WS GV+ +ELLTG P+
Sbjct: 189 VDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 61/215 (28%), Positives = 111/215 (51%), Gaps = 18/215 (8%)
Query: 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQE--VAIKVAHPNPDENILENVKQEGKLL 167
+L + D+ K+ +G G G V+K ++ +A K+ H I + +E ++L
Sbjct: 1 ELKDDDFEKI---SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGM 225
+ IV G ++ + ME+ GG L++VL AG +I +L +I + +G+
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGL 116
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTY 285
YL + I +HRD+K SN+L++ E +K+ DFG++ ++ + S GT
Sbjct: 117 TYLREKHKI--MHRDVKPSNILVNSRGE--------IKLCDFGVSGQLIDSMANSFVGTR 166
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP 320
++M+PE ++ + +S SD+WS G+ L E+ G P
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|214620 smart00326, SH3, Src homology 3 domains | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 8e-15
Identities = 28/58 (48%), Positives = 36/58 (62%), Gaps = 8/58 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RALYDY A DELS ++GDI+ VL K D GWW G++ K G+FP+N+V
Sbjct: 6 RALYDYTAQDPDELSFKKGDIITVLEKS-----DDGWWKGRLGRG---KEGLFPSNYV 55
|
Src homology 3 (SH3) domains bind to target proteins through sequences containing proline and hydrophobic amino acids. Pro-containing polypeptides may bind to SH3 domains in 2 different binding orientations. Length = 56 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENIL--ENVKQEGKLLWLFDHRNIVSLIG 180
IG G FG V+ + + VA+K PN +N++ + V +E K+L F H N++S +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALK-KMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 181 VCLQSPKLCLVME-YARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLHCQAPI 234
+ LQ P + E Y + L + P L + QI G+ YLH A I
Sbjct: 67 I-LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH-SAGI 124
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSA-AGTYAWMAPE 291
+HRD+K N+L+ N + LKI DFGLAR E ++ HM+ T + APE
Sbjct: 125 --LHRDIKPGNLLV-----NSNCV---LKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 292 VIKTSI-FSKASDVWSYGVVLWELLTGEI 319
++ S ++ A D+WS G + ELL I
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGI--YEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHR 173
Y KL + +GEG + VYKG Q VA+K +E +E LL H
Sbjct: 7 YKKL---DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA------GRKIRPDVLVDWAIQIAEGMNY 227
NIV+L + L LV EY L+ L G + + + Q+ G+ Y
Sbjct: 64 NIVTLHDIIHTKKTLTLVFEY-----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSAAGTY 285
H + ++HRDLK N+L+SE E LK+ DFGLAR V T+ + T
Sbjct: 119 CHQR---RVLHRDLKPQNLLISERGE--------LKLADFGLARAKSVPSKTYSNEVVTL 167
Query: 286 AWMAPEVIKTSI-FSKASDVWSYGVVLWELLTG 317
+ P+V+ S +S + D+W G + +E+ TG
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 68/216 (31%), Positives = 99/216 (45%), Gaps = 36/216 (16%)
Query: 116 YNKLIFGEAIGEGGFGKVYKG--IYEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFDH 172
Y K+ E IGEG +G VYK + VA+K + DE + +E LL +H
Sbjct: 1 YQKV---EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH 57
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL-------AGRKIRPDVLVDWAIQIAEGM 225
NIV L+ V KL LV E+ L+ L + P ++ + Q+ +G+
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE----VYKTTHMSA 281
Y H ++HRDLK N+L I+ E LK+ DFGLAR V TH
Sbjct: 113 AYCHSH---RVLHRDLKPQNLL----IDREG----ALKLADFGLARAFGVPVRTYTHEVV 161
Query: 282 AGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLT 316
T + APE++ S +S D+WS G + E++
Sbjct: 162 --TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 63/256 (24%), Positives = 118/256 (46%), Gaps = 26/256 (10%)
Query: 125 IGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIG 180
IG G F +VY+ + VA+K D + +E LL +H N++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 181 VCLQSPKLCLVMEYARGGPLNRVL----AGRKIRPDVLV-DWAIQIAEGMNYLHCQAPIS 235
++ +L +V+E A G L+R++ +++ P+ V + +Q+ + ++H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---R 126
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSAAGTYAWMAPEVI 293
++HRD+K +NV ++ +K+ D GL R T S GT +M+PE I
Sbjct: 127 VMHRDIKPANVFITAT--------GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPY--KSINAYAVAYGVAVNKLTLPIPST-CPQLF 350
+ ++ SD+WS G +L+E+ + P+ +N Y++ + P+PS +
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPSDHYSEEL 237
Query: 351 KTLMEACWEADSHMRP 366
+ L+ C D RP
Sbjct: 238 RQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIG 180
+G+G FGKV + + A+KV + ++ +E E ++L L + ++ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 181 VCLQSP-KLCLVMEYARGGPLN-RVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238
C Q+P +L VME+ GG L + R+ +A +I + +LH + +I+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIY 119
Query: 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA--GTYAWMAPEVIKTS 296
RDLK NVLL K+ DFG+ +E ++ GT ++APE+++
Sbjct: 120 RDLKLDNVLLDHE--------GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 297 IFSKASDVWSYGVVLWELLTGEIPYKSIN 325
++ + D W+ GV+L+E+L G P+++ N
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 66/213 (30%), Positives = 108/213 (50%), Gaps = 27/213 (12%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVK-QEGKLLWLFDH 172
Y KL IGEG +G V+K + Q VAIK + D+ +++ + +E ++L H
Sbjct: 3 YEKL---SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-QIAEGMNYLHCQ 231
N+V+LI V + KL LV EY LN + + P+ L+ I Q + +N+ H
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR-----EVYKTTHMSAAGTYA 286
+ IHRD+K N+L+++ + + +K+ DFG AR T +++ T
Sbjct: 120 ---NCIHRDVKPENILITK--QGQ------IKLCDFGFARILTGPGDDYTDYVA---TRW 165
Query: 287 WMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
+ APE++ + + DVW+ G V ELLTG+
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 79/274 (28%), Positives = 122/274 (44%), Gaps = 43/274 (15%)
Query: 123 EAIGEGGFGKVYKGIYEKQEV--AIKV------------AHPNPDENIL-ENVKQEGKLL 167
+ IG+G FGKV ++ +E A+KV H + N+L +NVK
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK------ 54
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEGM 225
H +V L + KL V++Y GG L L + + P +A +IA +
Sbjct: 55 ----HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASAL 109
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAG 283
YLH +++++RDLK N+LL D Q + +TDFGL +E + T + G
Sbjct: 110 GYLH---SLNIVYRDLKPENILL-------DSQGHIV-LTDFGLCKENIEHNGTTSTFCG 158
Query: 284 TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP 343
T ++APEV+ + + D W G VL+E+L G P+ S N A Y +NK L +
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNK-PLQLK 216
Query: 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
+ L+E + D R K + N
Sbjct: 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 123 EAIGEGGFGKVYKGIYEKQ--EVAIKVAH-PNPDENILENVKQEGKLLWLFDHRNIVSLI 179
+ +G G +G V + + +VAIK + P E + +E +LL H N++ L+
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 180 GVCLQSPKL------CLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAP 233
V L LVM + G L +++ K+ D + Q+ +G+ Y+H
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG- 138
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM-APEV 292
+IHRDLK N+ ++E E LKI DFGLAR+ + M+ W APEV
Sbjct: 139 --IIHRDLKPGNLAVNEDCE--------LKILDFGLARQT--DSEMTGYVVTRWYRAPEV 186
Query: 293 IKTSI-FSKASDVWSYGVVLWELLTGEIPYK 322
I + +++ D+WS G ++ E+LTG+ +K
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 69/228 (30%), Positives = 104/228 (45%), Gaps = 25/228 (10%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENILENVKQE------GKLLWLFDHRNIV 176
IG+G FGKV K + A+KV + IL+ +Q LL H +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQ---KKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L + KL V++Y GG L L R +A ++A + YLH +
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---N 116
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--THMSAAGTYAWMAPEVI 293
+I+RDLK N+LL D Q + +TDFGL +E + T + GT ++APEV+
Sbjct: 117 IIYRDLKPENILL-------DSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL 168
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341
+ + + D W G VL+E+L G P+ S + + + L LP
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 66/230 (28%), Positives = 97/230 (42%), Gaps = 53/230 (23%)
Query: 125 IGEGGFGKVYKGI--YEKQEVAIK----VAHPNPDENILENVKQEG---------KLLWL 169
+GEG +GKV K + VAIK + N + V G K++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEG 224
H NI+ L+ V ++ + LVM+ L +V+ RKIR L + + QI G
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV-DRKIR---LTESQVKCILLQILNG 131
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR---------EVYK 275
+N LH +HRDL +N+ ++ KI DFGLAR + K
Sbjct: 132 LNVLHKW---YFMHRDLSPANIFINS--------KGICKIADFGLARRYGYPPYSDTLSK 180
Query: 276 TTHM-------SAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTG 317
M S T + APE++ + + A D+WS G + ELLTG
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLI 179
E IGEG +G VYK + + VA+K + + E + +E LL +H NIV L+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 180 GVCLQSPKLCLVMEYARGGPLNRVL-------AGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
V KL LV E+ L++ L I ++ + Q+ +G+ + H
Sbjct: 66 DVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH- 119
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMAP 290
++HRDLK N+L+ N + +K+ DFGLAR V T+ T + AP
Sbjct: 120 --RVLHRDLKPQNLLI-----NTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169
Query: 291 EV-IKTSIFSKASDVWSYGVVLWELLT 316
E+ + +S A D+WS G + E++T
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 163 EGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL---AGRKIRPDVLVDWAI 219
E ++L + IV+L LCLVM GG L + R + + ++ ++
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 220 QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-TTH 278
QI G+ +LH + +++RD+K NVLL + +++D GLA E+ T
Sbjct: 103 QITCGILHLH---SMDIVYRDMKPENVLLDD--------QGNCRLSDLGLAVELKDGKTI 151
Query: 279 MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYK 322
AGT +MAPE++K +S D ++ G ++E++ G P+K
Sbjct: 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 35/212 (16%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSLI 179
E IG G +G V I + ++VAIK + H + + +E K+L F H NI+++
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 180 GVCLQSPK-----LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-QIAEGMNYLHCQAP 233
+ L+ P + +VM+ L+ ++ + + + + + Q+ G+ Y+H A
Sbjct: 71 DI-LRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH-SAN 127
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV---------YKTTHMSAAGT 284
+ IHRDLK SN+L+ NED L+I DFG+AR + + T +++ T
Sbjct: 128 V--IHRDLKPSNLLV-----NEDC---ELRIGDFGMARGLSSSPTEHKYFMTEYVA---T 174
Query: 285 YAWMAPEVIKTSI-FSKASDVWSYGVVLWELL 315
+ APE++ + ++ A D+WS G + E+L
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 43/217 (19%)
Query: 125 IGEGGFGKVY----KGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
+G+G FGKV KG + AIK + +LE+ E ++ R +++L
Sbjct: 3 LGKGSFGKVMLAELKG--TNEFFAIKALK---KDVVLEDDDVECTMV----ERRVLAL-- 51
Query: 181 VCLQSPKLC-------------LVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMN 226
+ P L VMEY GG L + + + +A +I G+
Sbjct: 52 -AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQ 110
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGT 284
+LH + +I+RDLK NVLL + +KI DFG+ +E + + GT
Sbjct: 111 FLHKK---GIIYRDLKLDNVLLDKD--------GHIKIADFGMCKENMNGEGKASTFCGT 159
Query: 285 YAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
++APE++K ++++ D WS+GV+L+E+L G+ P+
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 64/239 (26%), Positives = 108/239 (45%), Gaps = 27/239 (11%)
Query: 125 IGEGGFGKVYKGIYEKQE---VAIKVAHPNPDEN--ILENVKQEGKLLWL--FDHRNIVS 177
IGEG +GKV+K K VA+K E L +++ L L F+H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 178 LIGVCLQS-----PKLCLVMEYARGGPLNRV--LAGRKIRPDVLVDWAIQIAEGMNYLHC 230
L VC S KL LV E+ + + + + + D Q+ G+++LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR-EVYKTTHMSAAGTYAWMA 289
++HRDLK N+L++ + +K+ DFGLAR ++ S T + A
Sbjct: 129 H---RVVHRDLKPQNILVTSSGQ--------IKLADFGLARIYSFQMALTSVVVTLWYRA 177
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348
PEV+ S ++ D+WS G + E+ + ++ ++ G ++ + LP P+
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG-SSDVDQLGKILDVIGLPGEEDWPR 235
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHR 173
Y KL E +GEG + VYKG + + VA+KV +E +E LL H
Sbjct: 7 YEKL---EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGP---LNRVLAGRKIRPDVLVDWAIQIAEGMNYLHC 230
NIV L + L LV EY +++ G + P+ + + Q+ G++Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG--LHPENVKLFLFQLLRGLSYIHQ 121
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSAAGTYAWM 288
+ ++HRDLK N+L+S+ E LK+ DFGLAR V T+ + T +
Sbjct: 122 R---YILHRDLKPQNLLISDTGE--------LKLADFGLARAKSVPSHTYSNEVVTLWYR 170
Query: 289 APEVIKTSI-FSKASDVWSYGVVLWELLTG 317
P+V+ S +S D+W G + E++ G
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 125 IGEGGFGKVYKGIYEK--QEVAIKVAHPNP---DENILENVKQEGKLLWL-FDHRNIVSL 178
+G+G FGKV+ + Q AIK + D+++ E E ++L L ++H + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV-ECTMVEKRVLSLAWEHPFLTHL 61
Query: 179 IGVCLQSPKLCLVMEYARGGPLN-RVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLI 237
L VMEY GG L + + K +A +I G+ +LH + ++
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IV 118
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMAPEVIKT 295
+RDLK N+LL +KI DFG+ +E + + GT ++APE++
Sbjct: 119 YRDLKLDNILLDTD--------GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 296 SIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
++ + D WS+GV+L+E+L G+ P+ +
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|212761 cd11827, SH3_MyoIe_If_like, Src homology 3 domain of Myosins Ie, If, and similar proteins | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-13
Identities = 28/58 (48%), Positives = 37/58 (63%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ALY YDA DELS GDI+E+L +D + GWWTG++ G K G+FP N+V
Sbjct: 3 KALYAYDAQDTDELSFNEGDIIEILKEDPS-----GWWTGRLRG----KEGLFPGNYV 51
|
Myosins Ie (MyoIe) and If (MyoIf) are nonmuscle, unconventional, long tailed, class I myosins containing an N-terminal motor domain and a myosin tail with TH1, TH2, and SH3 domains. MyoIe interacts with the endocytic proteins, dynamin and synaptojanin-1, through its SH3 domain; it may play a role in clathrin-dependent endocytosis. In the kidney, MyoIe is critical for podocyte function and normal glomerular filtration. Mutations in MyoIe is associated with focal segmental glomerulosclerosis, a disease characterized by massive proteinuria and progression to end-stage kidney disease. MyoIf is predominantly expressed in the immune system; it plays a role in immune cell motility and innate immunity. Mutations in MyoIf may be associated with the loss of hearing. The MyoIf gene has also been found to be fused to the MLL (Mixed lineage leukemia) gene in infant acute myeloid leukemias (AML). SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 71/253 (28%), Positives = 103/253 (40%), Gaps = 66/253 (26%)
Query: 115 DYNKLIFGEAIGEGGFGKVY--KGIYEKQEVAIKVA-----HPNPDENILENVKQEGKLL 167
D+ + + IG G FG+V+ + Q A+KV +V+ E +L
Sbjct: 2 DFEVI---KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQI---AHVRAERDIL 55
Query: 168 WLFDHRNIVSLIGVCLQSPK-LCLVMEYARGGPLNRVLAGRKIRPDVLV-DWA-IQIAE- 223
D IV L Q + L LVMEY GG L +L IR DV + A IAE
Sbjct: 56 ADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL----IRKDVFPEETARFYIAEL 110
Query: 224 --GMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA--------REV 273
++ +H IHRD+K N+L+ +K+ DFGL RE
Sbjct: 111 VLALDSVHKLG---FIHRDIKPDNILIDAD--------GHIKLADFGLCKKMNKAKDREY 159
Query: 274 Y---------------------KTTHM--SAAGTYAWMAPEVIKTSIFSKASDVWSYGVV 310
Y + S GT ++APEV++ + + D WS GV+
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVI 219
Query: 311 LWELLTGEIPYKS 323
L+E+L G P+ S
Sbjct: 220 LYEMLYGFPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 35/215 (16%)
Query: 123 EAIGEGGFGKVYKG-IYEKQEVAIKV-----AHPNPDENILENVKQEGKLLWLFDHRNIV 176
+ IG G FGKV IY VA V A+ + E Q+G + H NI+
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNIL 58
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLNRVLAG-----RKIRPDVLVDWAIQIAEGMNYLHCQ 231
+G C+++ LV EY G L L+ R + +L A +IA G+ ++H
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-- 116
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA----REVYKTTHMSAAGTYAW 287
+ +H DL N L+ DL T+K+ D+G+ +E Y T W
Sbjct: 117 -KHNFLHSDLALRNCFLTS-----DL---TVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 288 MAPEVIK-------TSIFSKASDVWSYGVVLWELL 315
+APE++ T+ +K S+VW+ GV LWEL
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 67/228 (29%), Positives = 94/228 (41%), Gaps = 46/228 (20%)
Query: 116 YNKLIFGEAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDH 172
Y KL E IGEG +GKVYK + VA+K D E I +E LL +
Sbjct: 3 YEKL---EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 173 RN-IVSLIGV-----CLQSPKLCLVMEY-----------ARGGPLNRVLAGRKIRPDVLV 215
IV L+ V P L LV EY GP GR + +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGP------GRPLPAKTIK 113
Query: 216 DWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--- 272
+ Q+ +G+ + H ++HRDLK N+L+ + LKI D GL R
Sbjct: 114 SFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKG-------LLKIADLGLGRAFSI 163
Query: 273 -VYKTTHMSAAGTYAWMAPEV-IKTSIFSKASDVWSYGVVLWELLTGE 318
V TH T + APEV + ++ +S D+WS G + E+ +
Sbjct: 164 PVKSYTHEIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 72/214 (33%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 125 IGEGGFGKVYKG--IYEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSL--- 178
IGEG +G VY+ + VA+K V N + I + +E LL H NIV L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 179 -IGVCLQSPKLCLVMEYARGGPLNRVLAGRKI---RPDVLVDWAIQIAEGMNYLHCQAPI 234
+G L S + LVMEY L +L V +Q+ G+ YLH
Sbjct: 75 VVGKHLDS--IFLVMEYCEQD-LASLLDNMPTPFSESQVKC-LMLQLLRGLQYLHENF-- 128
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-YKTTHMSAAGTYAWM-APEV 292
+IHRDLK SN+LL+ LKI DFGLAR M+ W APE+
Sbjct: 129 -IIHRDLKVSNLLLT--------DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL 179
Query: 293 I-KTSIFSKASDVWSYGVVLWELLTGE--IPYKS 323
+ + ++ A D+W+ G +L ELL + +P KS
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 35/210 (16%)
Query: 125 IGEGGFGKVYKG--IYEKQEVAIK-VAHPNPDENI-LENVKQEG--KLLWLFDHRNIVSL 178
IG G +G VYK + VA+K V ++ + L V++ K L FDH NIV L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 179 IGVCL-----QSPKLCLVMEYARGGPLNRVLAGRKIRP-----DVLVDWAIQIAEGMNYL 228
+ VC + K+ LV E+ L L K+ P + + D Q G+++L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLD--KVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS---AAGTY 285
H ++HRDLK N+L++ +K+ DFGLAR +Y + M+ T
Sbjct: 125 HANC---IVHRDLKPENILVTSG--------GQVKLADFGLAR-IY-SCQMALTPVVVTL 171
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELL 315
+ APEV+ S ++ D+WS G + E+
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 125 IGEGGFGKVYKGIYEKQEVAIKVAH-PNPDENIL--ENVKQEGKLLWLFDHRNIVSLIGV 181
+G G +G V K + + V P ++I+ + +E +LL H N++ L+ V
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 182 CLQSPKL-----CLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
+ L ++ + G LN ++ +K+ D + QI G+ Y+H +
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DI 141
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM-APEVIKT 295
IHRDLK SN+ ++E E LKI DFGLAR + M+ W APE++
Sbjct: 142 IHRDLKPSNLAVNEDCE--------LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 191
Query: 296 SI-FSKASDVWSYGVVLWELLTG 317
+ +++ D+WS G ++ ELLTG
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 15/156 (9%)
Query: 163 EGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI--Q 220
E LL +H +++ + + C+V+ + L L R + I Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSD-LYTYLTKRSRPLPIDQALIIEKQ 165
Query: 221 IAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR-EVYKTTHM 279
I EG+ YLH Q +IHRD+K+ N+ I + D + I D G A+ V +
Sbjct: 166 ILEGLRYLHAQ---RIIHRDVKTENIF----INDVD----QVCIGDLGAAQFPVVAPAFL 214
Query: 280 SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELL 315
AGT APEV+ ++ +D+WS G+VL+E+L
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 123 EAIGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENILEN---VKQEGKLLWLFDHRNIVS 177
+ IG+G FGKV K + + A+KV N E + + LL H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVD-WAIQIAEGMNYLHCQAPISL 236
L + KL V+++ GG L L + P+ +A +IA + YLH I++
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINI 117
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMAPEVIK 294
++RDLK N+LL + +TDFGL +E T + GT ++APEVI+
Sbjct: 118 VYRDLKPENILLD--------SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIPYKS 323
+ D W G VL+E+L G P+
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 65/235 (27%), Positives = 113/235 (48%), Gaps = 24/235 (10%)
Query: 125 IGEGGFGKVYKGIYE--KQEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGV 181
+GEG +G V K ++ K+ VAIK +E + E +E K+L NIV L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 182 CLQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240
+ KL LV EY L + + P+ + + Q+ + +++ H ++HRD
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRD 125
Query: 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT---HMSAAGTYAWMAPEVIKTSI 297
+K N+L+S + D+ LK+ DFG AR + + + + T + +PE++ +
Sbjct: 126 IKPENLLIS----HNDV----LKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 298 FSKASDVWSYGVVLWELLTGE--IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLF 350
+ KA D+WS G +L EL G+ P +S + + K+ P+P+ +LF
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGES----EIDQLFTIQKVLGPLPAEQMKLF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 52/275 (18%)
Query: 91 NFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVY--KGIYEKQEVAIKVA 148
NF+S E + I +++ D++ + + IG G FG+V + KQ A+K+
Sbjct: 23 NFLSRYEK---AAEKITKLRMKAEDFDVI---KVIGRGAFGEVQLVRHKSSKQVYAMKLL 76
Query: 149 HPNPDENILENVKQEGKLLW----LFDHRN---IVSLIGVCLQSPK-LCLVMEYARGGPL 200
+ E I + + W + H N IV L Q K L +VMEY GG L
Sbjct: 77 --SKFEMI---KRSDSAFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDL 130
Query: 201 NRVLAGRKIRPDVLVDWAI----QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENED 256
+++ D+ WA ++ ++ +H + IHRD+K N+LL
Sbjct: 131 VNLMSNY----DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLD------- 176
Query: 257 LQFKTLKITDFGLAREVYKTTHM---SAAGTYAWMAPEVIKT----SIFSKASDVWSYGV 309
+ LK+ DFG ++ + +A GT +++PEV+K+ + + D WS GV
Sbjct: 177 -KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235
Query: 310 VLWELLTGEIPYKSINAYAVAYGVAV---NKLTLP 341
L+E+L G+ P+ + ++ Y + N LT P
Sbjct: 236 FLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFP 269
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 43/224 (19%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENILENVKQ----EGKLLWLFDHRNIVSL 178
I G +G VY + +Q A+K N IL N Q E +L ++ +VS+
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMK--KINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWA-IQIAE---GMNYLHCQAPI 234
LC+VMEY GG +L P VD A + AE + YLH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIGALP---VDMARMYFAETVLALEYLHNYG-- 121
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHM------------- 279
++HRDLK N+L++ +K+TDFGL++ + TT++
Sbjct: 122 -IVHRDLKPDNLLIT--------SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 280 --SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
GT ++APEVI + K D W+ G++L+E L G +P+
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 67/216 (31%), Positives = 95/216 (43%), Gaps = 35/216 (16%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGI--YEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFDH 172
Y K+ E IGEG +G VYK + +A+K + DE + +E LL H
Sbjct: 4 YEKV---EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR-------KIRPDVLVDWAIQIAEGM 225
NIV L V +L LV EY L+ L P ++ + QI G+
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE----VYKTTHMSA 281
Y H ++HRDLK N+L+ D + LK+ DFGLAR V TH
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLI-------DRRTNALKLADFGLARAFGIPVRTFTHEVV 165
Query: 282 AGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLT 316
T + APE++ S +S D+WS G + E++
Sbjct: 166 --TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|212989 cd12056, SH3_CD2AP_3, Third Src Homology 3 domain (SH3C) of CD2-associated protein | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-12
Identities = 25/59 (42%), Positives = 38/59 (64%), Gaps = 7/59 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+AL+ Y+ DEL + G+I+ ++SKD +G+ GWW G++ G K G+FP NFVS
Sbjct: 5 KALFHYEGTNEDELDFKEGEIILIISKD---TGEPGWWKGELNG----KEGVFPDNFVS 56
|
CD2AP, also called CMS (Cas ligand with Multiple SH3 domains) or METS1 (Mesenchyme-to-Epithelium Transition protein with SH3 domains), is a cytosolic adaptor protein that plays a role in regulating the cytoskeleton. It is critical in cell-to-cell union necessary for kidney function. It also stabilizes the contact between a T cell and antigen-presenting cells. It is primarily expressed in podocytes at the cytoplasmic face of the slit diaphragm and serves as a linker anchoring podocin and nephrin to the actin cytoskeleton. CD2AP contains three SH3 domains, a proline-rich region, and a C-terminal coiled-coil domain. All of these domains enable CD2AP to bind various protein partners and assemble complexes that have been implicated in many different functions. This alignment model represents the third SH3 domain (SH3C) of CD2AP. SH3C has been shown to bind ubiquitin. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 57 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 125 IGEGGFGKV-------YKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
+G+GGFG+V +Y + + K E++ N KQ +L + + +V+
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ---ILEKVNSQFVVN 64
Query: 178 LIGVCLQSPKLCLVMEYARGGPLN---RVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
L LCLV+ GG L + + + +A +I G+ LH +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE--- 121
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA-AGTYAWMAPEVI 293
+ ++RDLK N+LL + + ++I+D GLA ++ + + GT +MAPEV+
Sbjct: 122 NTVYRDLKPENILLDD--------YGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL 173
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYKS 323
++ + D W G +++E++ G+ P++
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 125 IGEGGFGKVY----KGIYEKQEV-AIKVAHPN---PDENILENVKQEGKLLWLFDHRNIV 176
+G+G FGKV KG EV AIKV + D+++ + E ++L L +
Sbjct: 3 LGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDV-DCTMTEKRILALAAKHPFL 58
Query: 177 SLIGVCLQSP-KLCLVMEYARGGPLN-RVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
+ + C Q+ +L VMEY GG L ++ RK +A ++ + +LH
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG-- 116
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMAPEV 292
+I+RDLK N+LL K+ DFG+ +E + T + GT ++APE+
Sbjct: 117 -VIYRDLKLDNILLD--------AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI 167
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
++ + + D W+ GV+++E++ G+ P+++ N
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 43/220 (19%)
Query: 125 IGEGGFGKVY---------KGIYEKQEVAIKVA---------HPNPDENILENVKQEGKL 166
+G G +GKV+ G +V K A H + N+LE+V+Q L
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGM 225
V+L KL L+++Y GG + L R D + ++ +I +
Sbjct: 68 ---------VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY---KTTHMSAA 282
+LH + +++RD+K N+LL + +TDFGL++E K S
Sbjct: 119 EHLH---KLGIVYRDIKLENILLDSE--------GHVVLTDFGLSKEFLSEEKERTYSFC 167
Query: 283 GTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPY 321
GT +MAPE+I+ KA D WS G++++ELLTG P+
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 48/220 (21%)
Query: 125 IGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQ--------EGKLLWLFDHRN 174
IG+G FG+V+K KQ VA+K + ++EN K+ E K+L L H N
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALK-------KVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 175 IVSLIGVCLQSPK--------LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI--QIAEG 224
+V+LI +C LV E+ L +L+ + ++ + + + G
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT 284
+ Y+H ++HRD+K++N+L+++ LK+ DFGLAR + + S
Sbjct: 132 LYYIHRN---KILHRDMKAANILITKD--------GILKLADFGLAR-AFSLSKNSKPNR 179
Query: 285 YA------WM-APEV-IKTSIFSKASDVWSYGVVLWELLT 316
Y W PE+ + + D+W G ++ E+ T
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 79/295 (26%), Positives = 115/295 (38%), Gaps = 68/295 (23%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHR 173
L IG G FG V K +++ +A+K ++E K L L D
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-------STVDEKEQKRL-LMDLD 54
Query: 174 ---------NIVSLIG---------VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLV 215
IV G +C++ + L Y + VL I ++L
Sbjct: 55 VVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKY---VYEVLKSV-IPEEILG 110
Query: 216 DWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG----LAR 271
A+ + +NYL + + +IHRD+K SN+LL D +K+ DFG L
Sbjct: 111 KIAVATVKALNYL--KEELKIIHRDVKPSNILL-------DRN-GNIKLCDFGISGQLVD 160
Query: 272 EVYKTTHMSAAGTYAWMAPEVIKTSIFSK---ASDVWSYGVVLWELLTGEIPYKSINAY- 327
+ KT AG +MAPE I S SDVWS G+ L+E+ TG+ PY N+
Sbjct: 161 SIAKTRD---AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF 217
Query: 328 ----AVAYGVAVNKLTLPIPSTCPQL-----FKTLMEACWEADSHMRPSFKTILK 373
V G PI S + F + C D RP +K +L+
Sbjct: 218 DQLTQVVKGDP------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 40/208 (19%)
Query: 125 IGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILEN-VKQEGKLLWLFDHRNIVSLIGVCL 183
I G G YKG K + V N +I + + GKL H NIV LIG+C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKL----QHPNIVKLIGLCR 753
Query: 184 QSPKLCLVMEYARGGPLNRVLAG------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLI 237
L+ EY G L+ VL RKI AI IA+ + +LHC+ +++
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRNLSWERRRKI--------AIGIAKALRFLHCRCSPAVV 805
Query: 238 HRDLKSSNVLLSEPIENED-----LQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEV 292
+L ++ I+ +D L L TD +S+A ++APE
Sbjct: 806 VGNLSPEKII----IDGKDEPHLRLSLPGLLCTDT--------KCFISSA----YVAPET 849
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGEIP 320
+T ++ SD++ +G++L ELLTG+ P
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 125 IGEGGFGKVYK-------GIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
+G+GGFG+V +Y +++ K E + N KQ +L + R +VS
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ---ILEKVNSRFVVS 64
Query: 178 LIGVCLQSPKLCLVMEYARGGPL-----NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
L LCLV+ GG L N G + V +A +I G+ LH +
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLHRE- 121
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA-AGTYAWMAPE 291
+++RDLK N+LL + + ++I+D GLA E+ + + GT +MAPE
Sbjct: 122 --RIVYRDLKPENILLDD--------YGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE 171
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYK 322
V+K ++ + D W G +++E++ G+ P++
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 125 IGEGGFGKV-------YKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
+G+GGFG+V +Y +++ K E++ N KQ +L + R +VS
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ---ILEKVNSRFVVS 64
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVL-----AGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
L LCLV+ GG L + AG + V +A +I G+ LH +
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF--YAAEICCGLEDLHQE- 121
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-TTHMSAAGTYAWMAPE 291
+++RDLK N+LL + ++I+D GLA V + T GT +MAPE
Sbjct: 122 --RIVYRDLKPENILLDD--------HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 171
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYK 322
V+K ++ + D W+ G +L+E++ G+ P++
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 68/262 (25%), Positives = 124/262 (47%), Gaps = 32/262 (12%)
Query: 125 IGEGGFGKVYKGIYEKQE--VAIKVAHP---NPDENILENVKQEGKLLWLFDHRNIVSLI 179
IG G + KV +K E A+KV N DE+I + V+ E + + + +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDI-DWVQTEKHVFEQASNHPFLVGL 61
Query: 180 GVCLQS-PKLCLVMEYARGGPLN-RVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLI 237
C Q+ +L V+EY GG L + RK+ + ++ +I+ +NYLH + +I
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---II 118
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA--AGTYAWMAPEVIKT 295
+RDLK NVLL +K+TD+G+ +E + ++ GT ++APE+++
Sbjct: 119 YRDLKLDNVLLDSE--------GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 296 SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLME 355
+ + D W+ GV+++E++ G P+ + G + N P +T LF+ ++E
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIV-------GSSDN----PDQNTEDYLFQVILE 219
Query: 356 ACWEADSHMRPSFKTILKALNN 377
+ ++LK+ N
Sbjct: 220 KQIRIPRSLSVKAASVLKSFLN 241
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 31/214 (14%)
Query: 125 IGEGGFGKVY-------KGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
IG G + KV IY + V ++ H + D + ++ K +F+ +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKH------VFEQASSNP 56
Query: 178 -LIGV--CLQS-PKLCLVMEYARGGPLN-RVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
L+G+ C Q+ +L LV+EY GG L + RK+ + +A +I +N+LH +
Sbjct: 57 FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK--TTHMSAAGTYAWMAP 290
+I+RDLK NVLL +K+TD+G+ +E T + GT ++AP
Sbjct: 117 ---IIYRDLKLDNVLLD--------ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAP 165
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI 324
E+++ + + D W+ GV+++E++ G P+ I
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 123 EAIGEGGFGKVYKGIYEKQE--VAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
+ +GEG + VYKG + + VA+K +E +E LL H NIV+L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 181 VCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238
+ L LV EY L + L G I + + Q+ G+NY H + ++H
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLH 127
Query: 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSAAGTYAWMAPEVIKTS 296
RDLK N+L++E E LK+ DFGLAR + T+ + T + P+++ S
Sbjct: 128 RDLKPQNLLINERGE--------LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 297 I-FSKASDVWSYGVVLWELLTG 317
+S D+W G + +E+ TG
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|212739 cd11805, SH3_GRB2_like_C, C-terminal Src homology 3 domain of Growth factor receptor-bound protein 2 (GRB2) and related proteins | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-12
Identities = 26/59 (44%), Positives = 34/59 (57%), Gaps = 9/59 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+ALYD++ EL RRGDI+ VL D WW G++ G +VGIFPAN+V
Sbjct: 3 QALYDFNPQEPGELEFRRGDIITVLDSS-----DPDWWKGELRG----RVGIFPANYVQ 52
|
This family includes the adaptor protein GRB2 and related proteins including Drosophila melanogaster Downstream of receptor kinase (DRK), Caenorhabditis elegans Sex muscle abnormal protein 5 (Sem-5), GRB2-related adaptor protein (GRAP), GRAP2, and similar proteins. Family members contain an N-terminal SH3 domain, a central SH2 domain, and a C-terminal SH3 domain. GRB2/Sem-5/DRK is a critical signaling molecule that regulates the Ras pathway by linking tyrosine kinases to the Ras guanine nucleotide releasing protein Sos (son of sevenless), which converts Ras to the active GTP-bound state. GRAP2 plays an important role in T cell receptor (TCR) signaling by promoting the formation of the SLP-76:LAT complex, which couples the TCR to the Ras pathway. GRAP acts as a negative regulator of T cell receptor (TCR)-induced lymphocyte proliferation by downregulating the signaling to the Ras/ERK pathway. The C-terminal SH3 domains (SH3c) of GRB2 and GRAP2 have been shown to bind to classical PxxP motif ligands, as well as to non-classical motifs. GRB2 SH3c binds Gab2 (Grb2-associated binder 2) through epitopes containing RxxK motifs, while the SH3c of GRAP2 binds to the phosphatase-like protein HD-PTP via a RxxxxK motif. SH3 domains are protein interaction domains that typically bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 40/218 (18%)
Query: 123 EAIGEGGFGKVYKGI--YEKQEVAIKVAHPNPDENILENVK------QEGKLLWLFDHRN 174
E IG+G +G V I + ++VAIK + ++ E+V +E KLL L H +
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKIN-----DVFEHVSDATRILREIKLLRLLRHPD 60
Query: 175 IVSLIGVCLQSPK-----LCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYL 228
IV + + L + + +V E L++V+ A + P+ + Q+ + Y+
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA-----AG 283
H ++ HRDLK N+L N D + LKI DFGLAR + T +
Sbjct: 120 HTA---NVFHRDLKPKNIL-----ANADCK---LKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 284 TYAWMAPEVIKTSIFSK---ASDVWSYGVVLWELLTGE 318
T + APE+ S FSK A D+WS G + E+LTG+
Sbjct: 169 TRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 64/217 (29%), Positives = 94/217 (43%), Gaps = 46/217 (21%)
Query: 125 IGEGGFGKV--YKGIYEKQEVAIKVAHPNPDENILENVK------QEGKLLWLFDHRNIV 176
IG G +G V K ++VAIK N +N +E KLL DH N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIA-----NAFDNRIDAKRTLREIKLLRHLDHENVI 67
Query: 177 SLIGVCLQSPK-----LCLVMEYARGGPLNRVLAGRKIR-PDVLVD-----WAIQIAEGM 225
++ + + + +V E L + IR L D + Q+ G+
Sbjct: 68 AIKDIMPPPHREAFNDVYIVYE------LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH---MSAA 282
Y+H +++HRDLK SN+LL+ N D LKI DFGLAR
Sbjct: 122 KYIHSA---NVLHRDLKPSNLLLN---ANCD-----LKICDFGLAR-TTSEKGDFMTEYV 169
Query: 283 GTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
T + APE++ S ++ A DVWS G + ELL +
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|212990 cd12057, SH3_CIN85_3, Third Src Homology 3 domain (SH3C) of Cbl-interacting protein of 85 kDa | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-12
Identities = 25/58 (43%), Positives = 37/58 (63%), Gaps = 7/58 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ L+ Y+A DEL+++ GDIV ++SKD D GWW G++ G + G+FP NFV
Sbjct: 3 KVLFPYEAQNEDELTIKEGDIVTLISKDCI---DAGWWEGELNG----RRGVFPDNFV 53
|
CIN85, also called SH3 domain-containing kinase-binding protein 1 (SH3KBP1) or CD2-binding protein 3 (CD2BP3) or Ruk, is an adaptor protein that is involved in the downregulation of receptor tyrosine kinases by facilitating endocytosis through interaction with endophilin-associated ubiquitin ligase Cbl proteins. It is also important in many other cellular processes including vesicle-mediated transport, cytoskeletal remodelling, apoptosis, cell adhesion and migration, and viral infection, among others. CIN85 exists as multiple variants from alternative splicing; the main variant contains three SH3 domains, a proline-rich region, and a C-terminal coiled-coil domain. All of these domains enable CIN85 to bind various protein partners and assemble complexes that have been implicated in many different functions. This alignment model represents the third SH3 domain (SH3C) of CIN85. SH3C has been shown to bind ubiquitin. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 48/217 (22%)
Query: 125 IGEGGFGKVYKGIYEKQE--VAIKVAHPNPDENILENVKQ--------EGKLLWLFDHRN 174
I EG +G VY+ +K VA+K + +E K+ E +L H N
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALK-------KLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 175 IVSLIGVCLQSP--KLCLVMEYA----RGGPLNRVLAGRKIRPDV--LVDWAIQIAEGMN 226
IV++ V + S K+ +VMEY + L + ++ +V L+ +Q+ G+
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEHDLKS--LMETMKQPFLQSEVKCLM---LQLLSGVA 120
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV----YKTTHMSAA 282
+LH ++HRDLK+SN+LL+ LKI DFGLARE T +
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGI--------LKICDFGLAREYGSPLKPYTQLVV- 168
Query: 283 GTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
T + APE++ +S A D+WS G + ELLT +
Sbjct: 169 -TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVA----HPNPDENILENVKQEGKLLWLFD 171
Y K+ + GK+Y K+ ++ A H + +LE+++Q L
Sbjct: 13 YGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL----- 67
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGMNYLHC 230
V+L KL L+++Y GG L L+ R + + + ++ +I + +LH
Sbjct: 68 ----VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH- 122
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA---AGTYAW 287
+ +I+RD+K N+LL + +TDFGL++E ++ A GT +
Sbjct: 123 --KLGIIYRDIKLENILLDSN--------GHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 288 MAPEVIK--TSIFSKASDVWSYGVVLWELLTGEIPY 321
MAP++++ KA D WS GV+++ELLTG P+
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 7e-12
Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 61/286 (21%)
Query: 125 IGEGGFGKV------------------YKGI--YEKQEVAIKVAHPNPDENILENVKQEG 164
IG G FG+V Y+G+ EK ++ I+V NV +E
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEV-----------NVMREL 69
Query: 165 KLLWLFDHRNIVSLIGVCLQ--SPKLCLVMEYARGGPLNRVLAG-----RKIRPDVLVDW 217
K H+NIV I L + KL ++ME+ G L+R + KI +VD
Sbjct: 70 K------HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123
Query: 218 AIQIAEGMNYLHC--QAPIS--LIHRDLKSSNVLLSEPIEN--------EDLQFKTL-KI 264
Q+ + Y H P ++HRDLK N+ LS I + +L + + KI
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 265 TDFGLAREV-YKTTHMSAAGTYAWMAPEVI--KTSIFSKASDVWSYGVVLWELLTGEIPY 321
DFGL++ + ++ S GT + +PE++ +T + SD+W+ G +++EL +G+ P+
Sbjct: 184 GDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 322 KSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPS 367
N ++ LPI +L L++ + RPS
Sbjct: 244 HKANNFSQLISELKRGPDLPIKGKSKEL-NILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 67/222 (30%), Positives = 93/222 (41%), Gaps = 52/222 (23%)
Query: 125 IGEGGFGKV----YKGIYEKQEVAIKVAHPNPDENIL-ENVKQEGKLLWLF-DHRNIVSL 178
+G+G +G V E++ VAIK + IL + +E KLL F H+NI L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRV----------LAGRKIRPDV-LVDWAI-----QIA 222
M+ G N + L + IR L D QI
Sbjct: 68 YD-----------MDIVFPGNFNELYLYEELMEADLH-QIIRSGQPLTDAHFQSFIYQIL 115
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR-----EVYKTT 277
G+ Y+H +++HRDLK N+L+ N D + LKI DFGLAR
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLV-----NADCE---LKICDFGLARGFSENPGENAG 164
Query: 278 HMSAAGTYAWM-APEV-IKTSIFSKASDVWSYGVVLWELLTG 317
M+ W APE+ + ++KA DVWS G +L ELL
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|213018 cd12142, SH3_D21-like, Src Homology 3 domain of SH3 domain-containing protein 21 (SH3D21) and similar proteins | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-12
Identities = 26/58 (44%), Positives = 40/58 (68%), Gaps = 7/58 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
R L+DY+ + DEL+L++GD++EV+SK+ + D GWW G++ G + G FP NFV
Sbjct: 3 RVLFDYNPVAPDELALKKGDVIEVISKE---TEDEGWWEGELNG----RRGFFPDNFV 53
|
N-terminal SH3 domain of the uncharacterized protein SH3 domain-containing protein 21, and similar uncharacterized domains, it belongs to the CD2AP-like_3 subfamily of proteins. The CD2AP-like_3 subfamily is composed of the third SH3 domain (SH3C) of CD2AP, CIN85 (Cbl-interacting protein of 85 kDa), and similar domains. CD2AP and CIN85 are adaptor proteins that bind to protein partners and assemble complexes that have been implicated in T cell activation, kidney function, and apoptosis of neuronal cells. They also associate with endocytic proteins, actin cytoskeleton components, and other adaptor proteins involved in receptor tyrosine kinase (RTK) signaling. CD2AP and the main isoform of CIN85 contain three SH3 domains, a proline-rich region, and a C-terminal coiled-coil domain. All of these domains enable CD2AP and CIN85 to bind various protein partners and assemble complexes that have been implicated in many different functions. SH3C of both proteins have been shown to bind to ubiquitin. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 125 IGEGGFGKVYKGIYEKQE--VAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182
+GEG + V+KG + E VA+K +E +E LL H NIV+L +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 183 LQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240
L LV EY L + L G + + + Q+ G++Y H + ++HRD
Sbjct: 73 HTERCLTLVFEYLDSD-LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRD 128
Query: 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSAAGTYAWMAPEVIKTSI- 297
LK N+L++E E LK+ DFGLAR V T+ + T + P+V+ S
Sbjct: 129 LKPQNLLINEKGE--------LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 298 FSKASDVWSYGVVLWELLTG 317
+S D+W G +L+E+ TG
Sbjct: 181 YSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 70/264 (26%), Positives = 112/264 (42%), Gaps = 36/264 (13%)
Query: 125 IGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEG--------KLLWLFDHRNIV 176
+G+GGFG+V Q A + N K++G ++L R IV
Sbjct: 1 LGKGGFGEVSAC----QMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIV 56
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLN-RVLAGRKIRPDV----LVDWAIQIAEGMNYLHCQ 231
SL LCLVM GG L + + P + QI G+ +LH +
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY--KTTHMSAAGTYAWMA 289
+I+RDLK NVLL +N+ ++I+D GLA E+ ++ AGT +MA
Sbjct: 117 ---RIIYRDLKPENVLL----DNDG----NVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349
PE+++ + + D ++ GV L+E++ P+++ + + L T P
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--VENKELKQRILNDSVTYPDK 223
Query: 350 F----KTLMEACWEADSHMRPSFK 369
F K+ EA D R F+
Sbjct: 224 FSPASKSFCEALLAKDPEKRLGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 125 IGEGGFGKVYKG--IYEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGV 181
+G G +G V +Q+VA+K ++ P +E +LL H N++ L+ V
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 182 CLQSPKL-----CLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
+ + ++ G LN ++ +K+ + + Q+ G+ Y+H +
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---I 139
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM-APEVIKT 295
IHRDLK SNV ++E E L+I DFGLAR+ M+ W APE++
Sbjct: 140 IHRDLKPSNVAVNEDCE--------LRILDFGLARQA--DDEMTGYVATRWYRAPEIMLN 189
Query: 296 SI-FSKASDVWSYGVVLWELLTGEI 319
+ +++ D+WS G ++ ELL G+
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 31/176 (17%)
Query: 162 QEGKLLWLFDHRNIV--------------SLIGVCLQSPKLCLVMEYARGGPLNRVLAGR 207
+E K++ DH NIV +G + + +V EY L VL
Sbjct: 51 REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQG 109
Query: 208 KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267
+ + + Q+ G+ Y+H +++HRDLK +NV I EDL LKI DF
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVF----INTEDL---VLKIGDF 159
Query: 268 GLAR----EVYKTTHMSAAGTYAWM-APE-VIKTSIFSKASDVWSYGVVLWELLTG 317
GLAR ++S W +P ++ + ++KA D+W+ G + E+LTG
Sbjct: 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|215659 pfam00018, SH3_1, SH3 domain | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 2e-11
Identities = 25/55 (45%), Positives = 33/55 (60%), Gaps = 8/55 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPA 90
ALYDY A DELS ++GDI+ VL K D GWW G+++G K G+ P+
Sbjct: 1 VALYDYTAREPDELSFKKGDIIIVLEKS-----DDGWWKGRLKGG---KEGLIPS 47
|
SH3 (Src homology 3) domains are often indicative of a protein involved in signal transduction related to cytoskeletal organisation. First described in the Src cytoplasmic tyrosine kinase. The structure is a partly opened beta barrel. Length = 47 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 42/150 (28%), Positives = 82/150 (54%), Gaps = 17/150 (11%)
Query: 178 LIGV--CLQSP-KLCLVMEYARGGPLN-RVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAP 233
L+G+ C Q+ +L V+E+ GG L + RK+ + ++ +I+ +N+LH +
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA--GTYAWMAPE 291
+I+RDLK NVLL +K+TD+G+ +E + ++ GT ++APE
Sbjct: 117 --IIYRDLKLDNVLLDAE--------GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPE 166
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
+++ + + D W+ GV+++E++ G P+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 123 EAIGEGGFGKVY----KGIYEKQEV-AIKVAHPNPDENILENVKQEGKLLWL-FDHRNIV 176
+ +G+G FGKV KG E V A+K D+++ E E ++L L +++ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV-ECTMVEKRVLALAWENPFLT 59
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVL--VDWAIQIAEGMNYLHCQAPI 234
L L VME+ GG L + K R D+ +A +I G+ +LH +
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQ-DKGRFDLYRATFYAAEIVCGLQFLHSKG-- 116
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE-VYKTTHMSA-AGTYAWMAPEV 292
+I+RDLK NV+L +KI DFG+ +E V+ S GT ++APE+
Sbjct: 117 -IIYRDLKLDNVMLDRD--------GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGEIPY 321
++ ++ + D WS+GV+L+E+L G+ P+
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 45/145 (31%), Positives = 75/145 (51%), Gaps = 26/145 (17%)
Query: 188 LCLVMEYARGGPLNRVLAGRKIRPDVLVDWA----IQIAEGMNYLHCQAPISLIHRDLKS 243
L +VMEY GG L +++ DV WA ++ ++ +H + LIHRD+K
Sbjct: 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKP 170
Query: 244 SNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM---SAAGTYAWMAPEVIKTS---- 296
N+LL + LK+ DFG ++ +T + +A GT +++PEV+K+
Sbjct: 171 DNMLLD--------KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 297 IFSKASDVWSYGVVLWELLTGEIPY 321
+ + D WS GV L+E+L G+ P+
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|212883 cd11950, SH3_GRAP2_C, C-terminal Src homology 3 domain of GRB2-related adaptor protein 2 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-11
Identities = 26/58 (44%), Positives = 37/58 (63%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RALYD++A+ DEL GD++EVL S + WW G++ GK+ G+FPAN+V
Sbjct: 3 RALYDFEALEDDELGFNSGDVIEVLD-----SSNPSWWKGRLHGKL----GLFPANYV 51
|
GRAP2 is also called GADS (GRB2-related adapter downstream of Shc), GrpL, GRB2L, Mona, or GRID (Grb2-related protein with insert domain). It is expressed specifically in the hematopoietic system. It plays an important role in T cell receptor (TCR) signaling by promoting the formation of the SLP-76:LAT complex, which couples the TCR to the Ras pathway. It also has roles in antigen-receptor and tyrosine kinase mediated signaling. GRAP2 is unique from other GRB2-like adaptor proteins in that it can be regulated by caspase cleavage. It contains an N-terminal SH3 domain, a central SH2 domain, and a C-terminal SH3 domain. The C-terminal SH3 domain of GRAP2 binds to different motifs found in substrate peptides including the typical PxxP motif in hematopoietic progenitor kinase 1 (HPK1), the RxxK motif in SLP-76 and HPK1, and the RxxxxK motif in phosphatase-like protein HD-PTP. SH3 domains are protein interaction domains that typically bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 123 EAIGEGGFGKVYKGIYEKQE--VAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E +GEG + V+KG + E VA+K +E +E LL H NIV+L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 181 VCLQSPKLCLVMEYARGGPLNRVL------AGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
+ L LV EY L++ L G + + + QI G+ Y H +
Sbjct: 72 IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR--- 123
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHMSAAGTYAWMAPEV 292
++HRDLK N+L++E E LK+ DFGLAR V T+ + T + P+V
Sbjct: 124 KVLHRDLKPQNLLINERGE--------LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 293 -IKTSIFSKASDVWSYGVVLWELLTG 317
+ +S +S D+W G + +E+ +G
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 54/164 (32%), Positives = 81/164 (49%), Gaps = 32/164 (19%)
Query: 169 LFDHRNIVSLIGV--CLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QI 221
L DH NIV L+ V + LV EY L+ V IR ++L D Q+
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYMETD-LHAV-----IRANILEDVHKRYIMYQL 116
Query: 222 AEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--THM 279
+ + Y+H ++IHRDLK SN+LL N D + +K+ DFGLAR + +
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILL-----NSDCR---VKLADFGLARSLSELEENPE 165
Query: 280 SAAGTY----AWM-APEV-IKTSIFSKASDVWSYGVVLWELLTG 317
+ T W APE+ + ++ ++K D+WS G +L E+L G
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|212757 cd11823, SH3_Nostrin, Src homology 3 domain of Nitric Oxide Synthase TRaffic INducer | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-11
Identities = 29/58 (50%), Positives = 35/58 (60%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ALY Y A DELSL+ GDI+EV K D GWW G++ G K GIFPA +V
Sbjct: 3 KALYSYTANREDELSLQPGDIIEVHEKQ-----DDGWWLGELNG----KKGIFPATYV 51
|
Nostrin is expressed in endothelial and epithelial cells and is involved in the regulation, trafficking and targeting of endothelial NOS (eNOS). It facilitates the endocytosis of eNOS by coordinating the functions of dynamin and the Wiskott-Aldrich syndrome protein (WASP). Increased expression of Nostrin may be correlated to preeclampsia. Nostrin contains an N-terminal F-BAR domain and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 8e-11
Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 28/239 (11%)
Query: 125 IGEGGFGKV---YKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGV 181
IG G G V Y + ++ K++ P ++ + +E L+ +H+NI+SL+ V
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 182 CLQSPKL------CLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L LVME L +V+ ++ + + Q+ G+ +LH
Sbjct: 85 FTPQKSLEEFQDVYLVMELMDAN-LCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG--- 139
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA-AGTYAWMAPEVIK 294
+IHRDLK SN+++ TLKI DFGLAR + M+ T + APEVI
Sbjct: 140 IIHRDLKPSNIVVKSDC--------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTL 353
+ + D+WS G ++ E++ +I + + Y + + +L P CP+ K L
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTP----CPEFMKKL 245
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 125 IGEGGFGKVYK-------GIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
+G+GGFG+V +Y +++ K E + N E ++L + R +VS
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN---EKRILEKVNSRFVVS 64
Query: 178 LIGVCLQSPKLCLVMEYARGGPLN---RVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
L LCLV+ GG L + + +A ++ G+ L +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE--- 121
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-TTHMSAAGTYAWMAPEVI 293
+++RDLK N+LL + ++I+D GLA ++ + T GT +MAPEVI
Sbjct: 122 RIVYRDLKPENILLDDR--------GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI 173
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYK 322
++ + D W G +++E++ G+ P++
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 64/239 (26%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 125 IGEGGFGKV---YKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGV 181
IG G G V Y I E+ K++ P ++ + +E L+ +H+NI+ L+ V
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 182 CLQSPKL------CLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L +VME L +V+ ++ + + Q+ G+ +LH
Sbjct: 92 FTPQKSLEEFQDVYIVMELMDAN-LCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG--- 146
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA-AGTYAWMAPEVIK 294
+IHRDLK SN+++ TLKI DFGLAR + M+ T + APEVI
Sbjct: 147 IIHRDLKPSNIVVKSDC--------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTL 353
+ + D+WS G ++ E++ G + + + + + + +L P CP+ K L
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTP----CPEFMKKL 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 68/251 (27%), Positives = 113/251 (45%), Gaps = 46/251 (18%)
Query: 91 NFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKV--YKGIYEKQEVAIKVA 148
NF++ +D + I D+++ DY + + IG G FG+V + ++ A+K+
Sbjct: 23 NFLNRYKD---TINKIRDLRMKAEDYEVV---KVIGRGAFGEVQLVRHKSTRKVYAMKLL 76
Query: 149 HPNPDENILENVKQ-EGKLLWLFDHRNI---------VSLIGVCLQSPKLCLVMEYARGG 198
E +K+ + W + R+I V L L +VMEY GG
Sbjct: 77 SK------FEMIKRSDSAFFW--EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 128
Query: 199 PLNRVLAGRKIRPDVLVDWA-IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDL 257
L +++ DV WA AE + L + IHRD+K N+LL +
Sbjct: 129 DLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS------ 178
Query: 258 QFKTLKITDFGLAREVYKTTHM---SAAGTYAWMAPEVIKTS----IFSKASDVWSYGVV 310
LK+ DFG ++ K + +A GT +++PEV+K+ + + D WS GV
Sbjct: 179 --GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236
Query: 311 LWELLTGEIPY 321
L+E+L G+ P+
Sbjct: 237 LYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|212776 cd11842, SH3_Ysc84p_like, Src homology 3 domain of Ysc84p and similar fungal proteins | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-10
Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 7/58 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALYD+ +L+ ++GDI+ +L K S D WWTG+I G + GIFPAN+V
Sbjct: 3 VALYDFAGEQPGDLAFQKGDIITILKK-SDSQND--WWTGRIGG----REGIFPANYV 53
|
This family is composed of the Saccharomyces cerevisiae proteins, Ysc84p (also called LAS17-binding protein 4, Lsb4p) and Lsb3p, and similar fungal proteins. They contain an N-terminal SYLF domain (also called DUF500) and a C-terminal SH3 domain. Ysc84p localizes to actin patches and plays an important in actin polymerization during endocytosis. The N-terminal domain of both Ysc84p and Lsb3p can bind and bundle actin filaments. A study of the yeast SH3 domain interactome predicts that the SH3 domains of Lsb3p and Lsb4p may function as molecular hubs for the assembly of endocytic complexes. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212760 cd11826, SH3_Abi, Src homology 3 domain of Abl Interactor proteins | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-10
Identities = 25/58 (43%), Positives = 32/58 (55%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALYDY A DELS + GDI+ V K+ D GW+ G + G G+FP N+V
Sbjct: 3 VALYDYTADKDDELSFQEGDIIYVTKKN-----DDGWYEGVLNG----VTGLFPGNYV 51
|
Abl interactor (Abi) proteins are adaptor proteins serving as binding partners and substrates of Abl tyrosine kinases. They are involved in regulating actin cytoskeletal reorganization and play important roles in membrane-ruffling, endocytosis, cell motility, and cell migration. They localize to sites of actin polymerization in epithelial adherens junction and immune synapses, as well as to the leading edge of lamellipodia. Vertebrates contain two Abi proteins, Abi1 and Abi2. Abi1 displays a wide expression pattern while Abi2 is highly expressed in the eye and brain. Abi proteins contain a homeobox homology domain, a proline-rich region, and a SH3 domain. The SH3 domain of Abi binds to a PxxP motif in Abl. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 52 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 59/188 (31%), Positives = 91/188 (48%), Gaps = 21/188 (11%)
Query: 140 KQEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL------CLVM 192
Q VAIK ++ P + + +E L+ L +H+NI+ L+ V L LVM
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100
Query: 193 EYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPI 252
E L +V+ + + + Q+ G+ +LH A I IHRDLK SN+++
Sbjct: 101 ELMDAN-LCQVIQ-MDLDHERMSYLLYQMLCGIKHLH-SAGI--IHRDLKPSNIVV---- 151
Query: 253 ENEDLQFKTLKITDFGLAREVYKTTHMSA-AGTYAWMAPEVIKTSIFSKASDVWSYGVVL 311
D TLKI DFGLAR + M+ T + APEVI + + D+WS G ++
Sbjct: 152 -KSDC---TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207
Query: 312 WELLTGEI 319
E++ G +
Sbjct: 208 GEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 60/257 (23%), Positives = 98/257 (38%), Gaps = 81/257 (31%)
Query: 125 IGEGGFGKVY-------KGIY-----EKQEVAIK--VAHPNPDENILENVKQEGKLLWLF 170
IG G FG+V +Y K +V ++ AH VK E +L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH----------VKAERDILAEA 58
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-QIAEGMNYLH 229
D+ +V L L VM+Y GG + +L I + L + I ++ + +H
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH 118
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL-------------------- 269
+ IHRD+K N+L+ + +K+TDFGL
Sbjct: 119 ---KMGFIHRDIKPDNILID--------RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167
Query: 270 -------------------------AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDV 304
R+ + S GT ++APEV+ + +++ D
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227
Query: 305 WSYGVVLWELLTGEIPY 321
WS GV+L+E+L G+ P+
Sbjct: 228 WSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 22/163 (13%)
Query: 163 EGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRP--DVLVDWAIQ 220
E +L +H +I+ L G + CL++ + L LA ++ D+L AI+
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD-LYCYLAAKRNIAICDIL---AIE 188
Query: 221 --IAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA---REVYK 275
+ + YLH +IHRD+K+ N+ ++ P + + + DFG A ++
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGD--------VCLGDFGAACFPVDINA 237
Query: 276 TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGE 318
+ AGT A APE++ + A D+WS G+VL+E+ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|212909 cd11976, SH3_VAV1_2, C-terminal (or second) Src homology 3 domain of VAV1 protein | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-10
Identities = 27/58 (46%), Positives = 37/58 (63%), Gaps = 8/58 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+A YD+ A ELSL+ GDI+++L+K G GWW G+I G +VG FPAN+V
Sbjct: 3 KARYDFCARDRSELSLKEGDIIKILNK----KGQQGWWRGEIYG----RVGWFPANYV 52
|
VAV1 is expressed predominantly in the hematopoietic system and it plays an important role in the development and activation of B and T cells. It is activated by tyrosine phosphorylation to function as a guanine nucleotide exchange factor (GEF) for Rho GTPases following cell surface receptor activation, triggering various effects such as cytoskeletal reorganization, transcription regulation, cell cycle progression, and calcium mobilization. It also serves as a scaffold protein and has been shown to interact with Ku70, Socs1, Janus kinase 2, SIAH2, S100B, Abl gene, ZAP-70, SLP76, and Syk, among others. VAV proteins contain several domains that enable their function: N-terminal calponin homology (CH), acidic, RhoGEF (also called Dbl-homologous or DH), Pleckstrin Homology (PH), C1 (zinc finger), SH2, and two SH3 domains. The C-terminal SH3 domain of Vav1 interacts with a wide variety of proteins including cytoskeletal regulators (zyxin), RNA-binding proteins (Sam68), transcriptional regulators, viral proteins, and dynamin 2. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|212810 cd11877, SH3_PIX, Src Homology 3 domain of Pak Interactive eXchange factors | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-10
Identities = 22/58 (37%), Positives = 32/58 (55%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RA ++++ DELS +GDI+ V + G GWW G + G K G FP+N+V
Sbjct: 3 RAKFNFEGTNEDELSFDKGDIITVTQV---VEG--GWWEGTLNG----KTGWFPSNYV 51
|
PIX proteins are Rho guanine nucleotide exchange factors (GEFs), which activate small GTPases by exchanging bound GDP for free GTP. They act as GEFs for both Cdc42 and Rac 1, and have been implicated in cell motility, adhesion, neurite outgrowth, and cell polarity. Vertebrates contain two proteins from the PIX subfamily, alpha-PIX and beta-PIX. Alpha-PIX, also called ARHGEF6, is localized in dendritic spines where it regulates spine morphogenesis. Mutations in the ARHGEF6 gene cause X-linked intellectual disability in humans. Beta-PIX play roles in regulating neuroendocrine exocytosis, focal adhesion maturation, cell migration, synaptic vesicle localization, and insulin secretion. PIX proteins contain an N-terminal SH3 domain followed by RhoGEF (also called Dbl-homologous or DH) and Pleckstrin Homology (PH) domains, and a C-terminal leucine-zipper domain for dimerization. The SH3 domain of PIX binds to an atypical PxxxPR motif in p21-activated kinases (PAKs) with high affinity. The binding of PAKs to PIX facilitate the localization of PAKs to focal complexes and also localizes PAKs to PIX targets Cdc43 and Rac, leading to the activation of PAKs. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212774 cd11840, SH3_Intersectin_5, Fifth Src homology 3 domain (or SH3E) of Intersectin | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-10
Identities = 26/58 (44%), Positives = 36/58 (62%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
AL+ Y A DELS ++GDI+ VLSKD D WW G++ G + G+FP+N+V
Sbjct: 3 IALFPYTAQNEDELSFQKGDIINVLSKD-----DPDWWRGELNG----QTGLFPSNYV 51
|
Intersectins (ITSNs) are adaptor proteins that function in exo- and endocytosis, actin cytoskeletal reorganization, and signal transduction. They are essential for initiating clathrin-coated pit formation. They bind to many proteins through their multidomain structure and facilitate the assembly of multimeric complexes. Vertebrates contain two ITSN proteins, ITSN1 and ITSN2, which exist in alternatively spliced short and long isoforms. The short isoforms contain two Eps15 homology domains (EH1 and EH2), a coiled-coil region and five SH3 domains (SH3A-E), while the long isoforms, in addition, contain RhoGEF (also called Dbl-homologous or DH), Pleckstrin homology (PH) and C2 domains. ITSN1 and ITSN2 are both widely expressed, with variations depending on tissue type and stage of development. The fifth SH3 domain (or SH3E) of ITSN1 has been shown to bind many protein partners including SGIP1, Sos1, dynamin1/2, CIN85, c-Cbl, SHIP2, N-WASP, and synaptojanin-1, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 125 IGEGGFGKVYK-------GIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
IG+G FGKV + IY + I+ AH + + E +L + IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALK--TIRKAHIVSRSEVTHTLA-ERTVLAQVNCPFIVP 57
Query: 178 LIGVCLQSP-KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
L QSP KL LV+ + GG L L R+ R D L AE + L ++
Sbjct: 58 L-KFSFQSPEKLYLVLAFINGGELFHHLQ-REGRFD-LSRARFYTAELLCALENLHKFNV 114
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA--GTYAWMAPEVIK 294
I+RDLK N+LL D Q + + DFGL + K + GT ++APE++
Sbjct: 115 IYRDLKPENILL-------DYQ-GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIPY 321
++KA D W+ GV+L+E+LTG P+
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|212807 cd11874, SH3_CD2AP-like_2, Second Src Homology 3 domain (SH3B) of CD2-associated protein and similar proteins | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 6e-10
Identities = 25/58 (43%), Positives = 34/58 (58%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ L+ Y DEL L+ GD +EVL + + GWW GK+ GK VG+FP+NFV
Sbjct: 3 KVLFSYTPQNEDELELKVGDTIEVLGEV-----EEGWWEGKLNGK----VGVFPSNFV 51
|
This subfamily is composed of the second SH3 domain (SH3B) of CD2AP, CIN85 (Cbl-interacting protein of 85 kDa), and similar domains. CD2AP and CIN85 are adaptor proteins that bind to protein partners and assemble complexes that have been implicated in T cell activation, kidney function, and apoptosis of neuronal cells. They also associate with endocytic proteins, actin cytoskeleton components, and other adaptor proteins involved in receptor tyrosine kinase (RTK) signaling. CD2AP and the main isoform of CIN85 contain three SH3 domains, a proline-rich region, and a C-terminal coiled-coil domain. All of these domains enable CD2AP and CIN85 to bind various protein partners and assemble complexes that have been implicated in many different functions. SH3B of both proteins have been shown to bind to Cbl. In the case of CD2AP, its SH3B binds to Cbl at a site distinct from the c-Cbl/SH3A binding site. The CIN85 SH3B also binds ubiquitin. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212806 cd11873, SH3_CD2AP-like_1, First Src Homology 3 domain (SH3A) of CD2-associated protein and similar proteins | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 9e-10
Identities = 24/57 (42%), Positives = 32/57 (56%), Gaps = 9/57 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+DYDA DEL+L+ GDI+ + K + GWW G + G K G+FP NFV
Sbjct: 4 VEFDYDAEEPDELTLKVGDIITNVKKM-----EEGWWEGTLNG----KRGMFPDNFV 51
|
This subfamily is composed of the first SH3 domain (SH3A) of CD2AP, CIN85 (Cbl-interacting protein of 85 kDa), and similar domains. CD2AP and CIN85 are adaptor proteins that bind to protein partners and assemble complexes that have been implicated in T cell activation, kidney function, and apoptosis of neuronal cells. They also associate with endocytic proteins, actin cytoskeleton components, and other adaptor proteins involved in receptor tyrosine kinase (RTK) signaling. CD2AP and the main isoform of CIN85 contain three SH3 domains, a proline-rich region, and a C-terminal coiled-coil domain. All of these domains enable CD2AP and CIN85 to bind various protein partners and assemble complexes that have been implicated in many different functions. SH3A of both proteins bind to an atypical PXXXPR motif at the C-terminus of Cbl and the cytoplasmic domain of the cell adhesion protein CD2. CIN85 SH3A binds to internal proline-rich motifs within the proline-rich region; this intramolecular interaction serves as a regulatory mechanism to keep CIN85 in a closed conformation, preventing the recruitment of other proteins. CIN85 SH3A has also been shown to bind ubiquitin. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212700 cd11766, SH3_Nck_2, Second Src Homology 3 domain of Nck adaptor proteins | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 9e-10
Identities = 26/59 (44%), Positives = 35/59 (59%), Gaps = 9/59 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
++Y+A DELSLR+GD V VL K S GWW G+ G +VG FP+N+V+
Sbjct: 3 VVKFNYEAQREDELSLRKGDRVLVLEKSSD-----GWWRGECNG----QVGWFPSNYVT 52
|
Nck adaptor proteins regulate actin cytoskeleton dynamics by linking proline-rich effector molecules to protein tyrosine kinases and phosphorylated signaling intermediates. They contain three SH3 domains and a C-terminal SH2 domain. They function downstream of the PDGFbeta receptor and are involved in Rho GTPase signaling and actin dynamics. Vertebrates contain two Nck adaptor proteins: Nck1 (also called Nckalpha) and Nck2 (also called Nckbeta or Growth factor receptor-bound protein 4, Grb4), which show partly overlapping functions but also bind distinct targets. Their SH3 domains are involved in recruiting downstream effector molecules, such as the N-WASP/Arp2/3 complex, which when activated induces actin polymerization that results in the production of pedestals, or protrusions of the plasma membrane. The second SH3 domain of Nck appears to prefer ligands containing the APxxPxR motif. SH3 domains are protein interaction domains that usually bind to proline-rich ligands with moderate affinity and selectivity, preferentially a PxxP motif. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 102 VSSVINDVKLVEIDYN-KLIFGEAIGEGGFGKVY---KGIYEKQEV--AIKVAHPNPDEN 155
+S ++ +K EI KLI +G FGKV +K V IK + N E
Sbjct: 6 LSELVQFLKNCEIVKKLKLI------DGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIE- 58
Query: 156 ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK-LCLVMEYARGGPL-NRVLAGRKIRPDV 213
V Q K D+ N + L + + K L+M+Y + G L + + K+
Sbjct: 59 --PMVHQLMK-----DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAE 110
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273
+ Q+ E +N LH +IH D+K NVL + + D+GL + +
Sbjct: 111 VKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAK-------DRIYLCDYGLCKII 160
Query: 274 YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYK 322
+ GT + +PE IK + + D W+ GV+ +ELLTG+ P+K
Sbjct: 161 GTPSCYD--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 44/212 (20%)
Query: 125 IGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQ--EGKLL-WLFDHRNIVSLI 179
IGEG F +V K + AIK LE V E + L L H NI+ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 180 GVCLQSP--KLCLVME--------YARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLH 229
V +L LV E +G R L ++++ + Q+ + ++++H
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELIKG--RKRPLPEKRVK-----SYMYQLLKSLDHMH 117
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK----TTHMSAAGTY 285
+ HRD+K N+L+ + LK+ DFG R +Y T ++S T
Sbjct: 118 ---RNGIFHRDIKPENILI---------KDDILKLADFGSCRGIYSKPPYTEYIS---TR 162
Query: 286 AWMAPEVIKTS-IFSKASDVWSYGVVLWELLT 316
+ APE + T + D+W+ G V +E+L+
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|212775 cd11841, SH3_SH3YL1_like, Src homology 3 domain of SH3 domain containing Ysc84-like 1 (SH3YL1) protein | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-09
Identities = 22/58 (37%), Positives = 34/58 (58%), Gaps = 7/58 (12%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
ALY ++ +LS + GD + VL++ + WW G++ G+ VGIFPAN+VS
Sbjct: 4 ALYSFEGQQPCDLSFQAGDRITVLTRTDS---QFDWWEGRLRGR----VGIFPANYVS 54
|
SH3YL1 localizes to the plasma membrane and is required for dorsal ruffle formation. It binds phosphoinositides (PIs) with high affinity through its N-terminal SYLF domain (also called DUF500). In addition, SH3YL1 contains a C-terminal SH3 domain which has been reported to bind to N-WASP, dynamin 2, and SHIP2 (a PI 5-phosphatase). SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 54/187 (28%), Positives = 89/187 (47%), Gaps = 20/187 (10%)
Query: 146 KVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL------CLVMEYARGGP 199
K++ P ++ + +E LL +H+NI+SL+ V L LVME
Sbjct: 53 KLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN- 111
Query: 200 LNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259
L +V+ ++ + + Q+ G+ +LH +IHRDLK SN+++
Sbjct: 112 LCQVIH-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC------- 160
Query: 260 KTLKITDFGLAREVYKTTHMSA-AGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGE 318
TLKI DFGLAR M+ T + APEVI + + D+WS G ++ EL+ G
Sbjct: 161 -TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGS 219
Query: 319 IPYKSIN 325
+ ++ +
Sbjct: 220 VIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 45/218 (20%)
Query: 125 IGEGGFGKVYKGI--YEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGV 181
IGEG +G+VYK + VA+K V N E +E K+L +HRNIV+L +
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 182 CL----------QSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWA--------IQIAE 223
LV EY ++ L G + LV ++ Q+ E
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEY-----MDHDLMG--LLESGLVHFSEDHIKSFMKQLLE 127
Query: 224 GMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY----KTTHM 279
G+NY H + + +HRD+K SN+LL+ + +K+ DFGLAR +Y +
Sbjct: 128 GLNYCHKK---NFLHRDIKCSNILLNNKGQ--------IKLADFGLAR-LYNSEESRPYT 175
Query: 280 SAAGTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLT 316
+ T + PE++ + A DVWS G +L EL T
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 53/154 (34%), Positives = 77/154 (50%), Gaps = 20/154 (12%)
Query: 125 IGEGGFGKVYKGI--YEKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIG 180
I G FGKVY G + A+KV ++N++ V+ E L L IV L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY- 70
Query: 181 VCLQSP-KLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLI 237
LQS + LVMEY GG + +L G ++ V + ++A ++YLH +I
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRH---GII 126
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271
HRDLK N+L+S NE +K+TDFGL++
Sbjct: 127 HRDLKPDNMLIS----NEG----HIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|212746 cd11812, SH3_AHI-1, Src Homology 3 domain of Abelson helper integration site-1 (AHI-1) | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-09
Identities = 26/57 (45%), Positives = 34/57 (59%), Gaps = 8/57 (14%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALYDY A DEL++ RGDI+ VL KD+ WW G + + + G FPAN+V
Sbjct: 4 ALYDYTANRSDELTIHRGDIIRVLYKDND-----NWWFGSL---VNGQQGYFPANYV 52
|
AHI-1, also called Jouberin, is expressed in high levels in the brain, gonad tissues, and skeletal muscle. It is an adaptor protein that interacts with the small GTPase Rab8a and regulates it distribution and function, affecting cilium formation and vesicle transport. Mutations in the AHI-1 gene can cause Joubert syndrome, a disorder characterized by brainstem malformations, cerebellar aplasia/hypoplasia, and retinal dystrophy. AHI-1 variation is also associated with susceptibility to schizophrenia and type 2 diabetes mellitus progression. AHI-1 contains WD40 and SH3 domains. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 52 |
| >gnl|CDD|212696 cd11762, SH3_FCHSD_2, Second Src Homology 3 domain of FCH and double SH3 domains proteins | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-09
Identities = 27/60 (45%), Positives = 35/60 (58%), Gaps = 5/60 (8%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
L RALYDY+A +ELS G I+ +L KD D GWW G+ G +VG+FP+ V
Sbjct: 1 LVRALYDYEAQSDEELSFPEGAIIRILRKDDN-GVDDGWWEGEFNG----RVGVFPSLVV 55
|
This group is composed of FCH and double SH3 domains protein 1 (FCHSD1) and FCHSD2. These proteins have a common domain structure consisting of an N-terminal F-BAR (FES-CIP4 Homology and Bin/Amphiphysin/Rvs), two SH3, and C-terminal proline-rich domains. They have only been characterized in silico and their functions remain unknown. This group also includes the insect protein, nervous wreck, which acts as a regulator of synaptic growth signaling. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 57 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 20/159 (12%)
Query: 162 QEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVD---WA 218
E +LL H +++L+ V + CLV+ R L L G ++RP L A
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD-LYTYL-GARLRPLGLAQVTAVA 266
Query: 219 IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG---LAREVYK 275
Q+ ++Y+H + +IHRD+K+ NVL++ P ED+ + DFG AR +
Sbjct: 267 RQLLSAIDYIHGEG---IIHRDIKTENVLVNGP---EDIC-----LGDFGAACFARGSWS 315
Query: 276 T-THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWE 313
T H AGT APEV+ ++ + D+WS G+V++E
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 67/272 (24%), Positives = 110/272 (40%), Gaps = 64/272 (23%)
Query: 125 IGEGGFGKVYKGIYEKQE----VAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSL 178
IG G FG+V + +K++ A+K + ++ + +V+ E +L D+ +V L
Sbjct: 9 IGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 179 IGVCLQSPK-LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQ--IAEGMNYLHCQAPIS 235
Q L L+MEY GG + +L ++ D + + IAE + + +
Sbjct: 67 Y-YSFQDENYLYLIMEYLPGGDMMTLL----MKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT------------------- 276
IHRD+K N+LL +K++DFGL + K+
Sbjct: 122 YIHRDIKPDNLLLD--------AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 277 ---THM------------------SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELL 315
M S GT ++APEV + ++K D WS GV+++E+L
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 316 TGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347
G P+ S N + K TL P P
Sbjct: 234 VGYPPFCSDNPQETYRKIINWKETLQFPDEVP 265
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|212777 cd11843, SH3_PACSIN, Src homology 3 domain of Protein kinase C and Casein kinase Substrate in Neurons (PACSIN) proteins | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-09
Identities = 24/58 (41%), Positives = 37/58 (63%), Gaps = 8/58 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RALYDY+ DELS + GDI+ L ++ + GW G+++G +VG++PAN+V
Sbjct: 3 RALYDYEGQESDELSFKAGDILTKLEEED----EQGWCKGRLDG----RVGLYPANYV 52
|
PACSINs, also called Synaptic dynamin-associated proteins (Syndapins), act as regulators of cytoskeletal and membrane dynamics. They bind both dynamin and Wiskott-Aldrich syndrome protein (WASP), and may provide direct links between the actin cytoskeletal machinery through WASP and dynamin-dependent endocytosis. Vetebrates harbor three isoforms with distinct expression patterns and specific functions. PACSINs contain an N-terminal F-BAR domain and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212706 cd11772, SH3_OSTF1, Src Homology 3 domain of metazoan osteoclast stimulating factor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-09
Identities = 23/58 (39%), Positives = 30/58 (51%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RALYDY+A DELS GD++ + K D WW G K G+ P+N+V
Sbjct: 3 RALYDYEAQHPDELSFEEGDLLYISDKS-----DPNWWKATCGG----KTGLIPSNYV 51
|
OSTF1, also named OSF or SH3P2, is a signaling protein containing SH3 and ankyrin-repeat domains. It acts through a Src-related pathway to enhance the formation of osteoclasts and bone resorption. It also acts as a negative regulator of cell motility. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 53/193 (27%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 141 QEVAIKVA---HPNPDENILENVKQEGKLLWLFDHRNIVSLI--GVCLQSPKLCLVMEYA 195
EVAIK+ P +E+ ++E L H NIV+L+ G L V EY
Sbjct: 4 HEVAIKLLRTDAPE-EEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 196 RGGPLNRVLAGRKIRPDV-LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254
G L VLA P +Q+ + + H Q ++HRDLK N+++S+
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ---- 114
Query: 255 EDLQFKTLKITDFGL------AREVYKTTHMSAA---GTYAWMAPEVIKTSIFSKASDVW 305
++ K+ DFG+ R+ T GT + APE ++ + SD++
Sbjct: 115 TGVR-PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 306 SYGVVLWELLTGE 318
++G++ E LTG+
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|212754 cd11820, SH3_STAM, Src homology 3 domain of Signal Transducing Adaptor Molecules | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-09
Identities = 25/60 (41%), Positives = 35/60 (58%), Gaps = 9/60 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYD++A +EL+ + G+I+ VL DS D WW G G+FPANFV++
Sbjct: 4 RALYDFEAAEDNELTFKAGEIITVLD-DS----DPNWWKGSNHRGE----GLFPANFVTA 54
|
STAMs were discovered as proteins that are highly phosphorylated following cytokine and growth factor stimulation. They function in cytokine signaling and surface receptor degradation, as well as regulate Golgi morphology. They associate with many proteins including Jak2 and Jak3 tyrosine kinases, Hrs, AMSH, and UBPY. STAM adaptor proteins contain VHS (Vps27, Hrs, STAM homology), ubiquitin interacting (UIM), and SH3 domains. There are two vertebrate STAMs, STAM1 and STAM2, which may be functionally redundant; vertebrate STAMs contain ITAM motifs. They are part of the endosomal sorting complex required for transport (ESCRT-0). STAM2 deficiency in mice did not cause any obvious abnormality, while STAM1 deficiency resulted in growth retardation. Loss of both STAM1 and STAM2 in mice proved lethal, indicating that STAMs are important for embryonic development. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|212882 cd11949, SH3_GRB2_C, C-terminal Src homology 3 domain of Growth factor receptor-bound protein 2 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-09
Identities = 22/59 (37%), Positives = 32/59 (54%), Gaps = 9/59 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+AL+D+D EL RRGD +EV+ + D WW G G+ G+FP N+V+
Sbjct: 3 QALFDFDPQEDGELGFRRGDFIEVMD-----NSDPNWWKGACHGQT----GMFPRNYVT 52
|
GRB2 is a critical signaling molecule that regulates the Ras pathway by linking tyrosine kinases to the Ras guanine nucleotide releasing protein Sos (son of sevenless), which converts Ras to the active GTP-bound state. It is ubiquitously expressed in all tissues throughout development and is important in cell cycle progression, motility, morphogenesis, and angiogenesis. In lymphocytes, GRB2 is associated with antigen receptor signaling components. GRB2 contains an N-terminal SH3 domain, a central SH2 domain, and a C-terminal SH3 domain. The C-terminal SH3 domain of GRB2 binds to Gab2 (Grb2-associated binder 2) through epitopes containing RxxK motifs, as well as to the proline-rich C-terminus of FGRF2. SH3 domains are protein interaction domains that typically bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212764 cd11830, SH3_VAV_2, C-terminal (or second) Src homology 3 domain of VAV proteins | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-09
Identities = 24/57 (42%), Positives = 35/57 (61%), Gaps = 8/57 (14%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A YD+ A + ELSL+ GD+V++ +K G GWW G+I G+I G FP+ +V
Sbjct: 4 ARYDFCARDMRELSLKEGDVVKIYNK----KGQQGWWRGEINGRI----GWFPSTYV 52
|
VAV proteins function both as cytoplasmic guanine nucleotide exchange factors (GEFs) for Rho GTPases and scaffold proteins and they play important roles in cell signaling by coupling cell surface receptors to various effector functions. They play key roles in processes that require cytoskeletal reorganization including immune synapse formation, phagocytosis, cell spreading, and platelet aggregation, among others. Vertebrates have three VAV proteins (VAV1, VAV2, and VAV3). VAV proteins contain several domains that enable their function: N-terminal calponin homology (CH), acidic, RhoGEF (also called Dbl-homologous or DH), Pleckstrin Homology (PH), C1 (zinc finger), SH2, and two SH3 domains. The SH3 domain of VAV is involved in the localization of proteins to specific sites within the cell, by interacting with proline-rich sequences within target proteins. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|212816 cd11883, SH3_Sdc25, Src Homology 3 domain of Sdc25/Cdc25 guanine nucleotide exchange factors | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-09
Identities = 23/58 (39%), Positives = 33/58 (56%), Gaps = 6/58 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGK-IEGKIEYKVGIFPANF 92
ALYD+ ++LS + GDI+ VL+KD + GWW G I + K G FP+N+
Sbjct: 3 VALYDFTPKSKNQLSFKAGDIIYVLNKDPS-----GWWDGVIISSSGKVKRGWFPSNY 55
|
This subfamily is composed of the Saccharomyces cerevisiae guanine nucleotide exchange factors (GEFs) Sdc25 and Cdc25, and similar proteins. These GEFs regulate Ras by stimulating the GDP/GTP exchange on Ras. Cdc25 is involved in the Ras/PKA pathway that plays an important role in the regulation of metabolism, stress responses, and proliferation, depending on available nutrients and conditions. Proteins in this subfamily contain an N-terminal SH3 domain as well as REM (Ras exchanger motif) and RasGEF domains at the C-terminus. SH3 domains bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs; they play a role in the regulation of enzymes by intramolecular interactions, changing the subcellular localization of signal pathway components and mediate multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212884 cd11951, SH3_GRAP_C, C-terminal Src homology 3 domain of GRB2-related adaptor protein | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-09
Identities = 26/58 (44%), Positives = 33/58 (56%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+A YD+ A +LS RRGDI+EVL D WW G+I G +VG FP N+V
Sbjct: 3 QAQYDFSAEDPSQLSFRRGDIIEVLD-----CPDPNWWRGRISG----RVGFFPRNYV 51
|
GRAP is a GRB-2 like adaptor protein that is highly expressed in lymphoid tissues. It acts as a negative regulator of T cell receptor (TCR)-induced lymphocyte proliferation by downregulating the signaling to the Ras/ERK pathway. It has been identified as a regulator of TGFbeta signaling in diabetic kidney tubules and may have a role in the pathogenesis of the disease. GRAP contains an N-terminal SH3 domain, a central SH2 domain, and a C-terminal SH3 domain. The C-terminal SH3 domains (SH3c) of the related proteins, GRB2 and GRAP2, have been shown to bind to classical PxxP motif ligands, as well as to non-classical motifs. GRB2 SH3c binds Gab2 (Grb2-associated binder 2) through epitopes containing RxxK motifs, while the SH3c of GRAP2 binds to the phosphatase-like protein HD-PTP via a RxxxxK motif. SH3 domains are protein interaction domains that typically bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212724 cd11790, SH3_Amphiphysin, Src Homology 3 domain of Amphiphysin and related domains | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 8e-09
Identities = 23/61 (37%), Positives = 30/61 (49%), Gaps = 2/61 (3%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA +DY A DEL+ +GD++ V+ D D GW G E G+FP NF
Sbjct: 6 RATHDYTAEDTDELTFEKGDVILVIPFDDPEEQDEGWLMGVKES--TGCRGVFPENFTER 63
Query: 96 I 96
I
Sbjct: 64 I 64
|
Amphiphysins function primarily in endocytosis and other membrane remodeling events. They exist in several isoforms and mammals possess two amphiphysin proteins from distinct genes. Amphiphysin I proteins, enriched in the brain and nervous system, contain domains that bind clathrin, Adaptor Protein complex 2 (AP2), dynamin, and synaptojanin. They function in synaptic vesicle endocytosis. Human autoantibodies to amphiphysin I hinder GABAergic signaling and contribute to the pathogenesis of paraneoplastic stiff-person syndrome. Some amphiphysin II isoforms, also called Bridging integrator 1 (Bin1), are localized in many different tissues and may function in intracellular vesicle trafficking. In skeletal muscle, Bin1 plays a role in the organization and maintenance of the T-tubule network. Mutations in Bin1 are associated with autosomal recessive centronuclear myopathy. Amphiphysins contain an N-terminal BAR domain with an additional N-terminal amphipathic helix (an N-BAR), a variable central domain, and a C-terminal SH3 domain. The SH3 domain of amphiphysins bind proline-rich motifs present in binding partners such as dynamin, synaptojanin, and nsP3. It also belongs to a subset of SH3 domains that bind ubiquitin in a site that overlaps with the peptide binding site. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 64 |
| >gnl|CDD|212902 cd11969, SH3_PLCgamma2, Src homology 3 domain of Phospholipase C (PLC) gamma 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-09
Identities = 23/61 (37%), Positives = 36/61 (59%), Gaps = 8/61 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ALYDY A DELS +G ++ +SK++ GWW G GK+++ FP+N+V
Sbjct: 3 KALYDYRAKRSDELSFCKGALIHNVSKETG-----GWWKGDYGGKVQH---YFPSNYVED 54
Query: 96 I 96
+
Sbjct: 55 V 55
|
PLCgamma2 is primarily expressed in haematopoietic cells, specifically in B cells. It is activated by tyrosine phosphorylation by B cell receptor (BCR) kinases and is recruited to the plasma membrane where its substrate is located. It is required in pre-BCR signaling and in the maturation of B cells. PLCs catalyze the hydrolysis of phosphatidylinositol (4,5)-bisphosphate [PtdIns(4,5)P2] to produce Ins(1,4,5)P3 and diacylglycerol (DAG). Ins(1,4,5)P3 initiates the calcium signaling cascade while DAG functions as an activator of PKC. PLCgamma contains a Pleckstrin homology (PH) domain followed by an elongation factor (EF) domain, two catalytic regions of PLC domains that flank two tandem SH2 domains, followed by a SH3 domain and C2 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212755 cd11821, SH3_ASAP, Src homology 3 domain of ArfGAP with SH3 domain, ankyrin repeat and PH domain containing proteins | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-09
Identities = 23/57 (40%), Positives = 30/57 (52%), Gaps = 6/57 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
RALYD A DEL+ G+I+ V + D WW G IEG + G+FP +F
Sbjct: 3 RALYDCQADNDDELTFSEGEIIVVTGE-----EDDEWWEGHIEGDPSRR-GVFPVSF 53
|
ASAPs are Arf GTPase activating proteins (GAPs) and they function in regulating cell growth, migration, and invasion. They contain an N-terminal BAR domain, followed by a Pleckstrin homology (PH) domain, an Arf GAP domain, ankyrin (ANK) repeats, and a C-terminal SH3 domain. Vertebrates contain at least three members, ASAP1, ASAP2, and ASAP3, but some ASAP3 proteins do not seem to harbor a C-terminal SH3 domain. ASAP1 and ASAP2 show GTPase activating protein (GAP) activity towards Arf1 and Arf5. They do not show GAP activity towards Arf6, but are able to mediate Arf6 signaling by binding stably to GTP-Arf6. ASAP3 is an Arf6-specific GAP. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212753 cd11819, SH3_Cortactin_like, Src homology 3 domain of Cortactin and related proteins | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-09
Identities = 22/59 (37%), Positives = 31/59 (52%), Gaps = 8/59 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+ALYDY A +E+S GDI+ + + D GWW G + G+FPAN+V
Sbjct: 3 KALYDYQAAEDNEISFVEGDIITQIEQI-----DEGWWLGVNAKG---QKGLFPANYVE 53
|
This subfamily includes cortactin, Abp1 (actin-binding protein 1), hematopoietic lineage cell-specific protein 1 (HS1), and similar proteins. These proteins are involved in regulating actin dynamics through direct or indirect interaction with the Arp2/3 complex, which is required to initiate actin polymerization. They all contain at least one C-terminal SH3 domain. Cortactin and HS1 bind Arp2/3 and actin through an N-terminal region that contains an acidic domain and several copies of a repeat domain found in cortactin and HS1. Abp1 binds actin via an N-terminal actin-depolymerizing factor (ADF) homology domain. Yeast Abp1 binds Arp2/3 directly through two acidic domains. Mammalian Abp1 does not directly interact with Arp2/3; instead, it regulates actin dynamics indirectly by interacting with dynamin and WASP family proteins. The C-terminal region of these proteins acts as an adaptor or scaffold that can connect membrane trafficking and signaling proteins that bind the SH3 domain within the actin network. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|212910 cd11977, SH3_VAV2_2, C-terminal (or second) Src homology 3 domain of VAV2 protein | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-08
Identities = 25/57 (43%), Positives = 35/57 (61%), Gaps = 7/57 (12%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A Y++ A + ELSLR GD+V + S+ I GD GWW G+ G+I G FP+ +V
Sbjct: 5 ARYNFAARDMRELSLREGDVVRIYSR---IGGDQGWWKGETNGRI----GWFPSTYV 54
|
VAV2 is widely expressed and functions as a guanine nucleotide exchange factor (GEF) for RhoA, RhoB and RhoG and also activates Rac1 and Cdc42. It is implicated in many cellular and physiological functions including blood pressure control, eye development, neurite outgrowth and branching, EGFR endocytosis and degradation, and cell cluster morphology, among others. It has been reported to associate with Nek3. VAV proteins contain several domains that enable their function: N-terminal calponin homology (CH), acidic, RhoGEF (also called Dbl-homologous or DH), Pleckstrin Homology (PH), C1 (zinc finger), SH2, and two SH3 domains. The SH3 domain of VAV is involved in the localization of proteins to specific sites within the cell, by interacting with proline-rich sequences within target proteins. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 58 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
N+V L + + LV+++A GG L + + I + + WA ++ ++ LH +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG 105
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEV 292
++ RDL +N+LL +++T F EV + A + APEV
Sbjct: 106 ---IVCRDLNPNNILLD--------DRGHIQLTYFSRWSEVEDSCDGEAVENM-YCAPEV 153
Query: 293 IKTSIFSKASDVWSYGVVLWELLTG 317
S ++A D WS G +L+ELLTG
Sbjct: 154 GGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|212778 cd11844, SH3_CAS, Src homology 3 domain of CAS (Crk-Associated Substrate) scaffolding proteins | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-08
Identities = 27/58 (46%), Positives = 34/58 (58%), Gaps = 6/58 (10%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
L RALYD A DEL+ RRGDI+ VL +++A G GWW + G + GI P N
Sbjct: 1 LARALYDNVAESPDELAFRRGDILTVLEQNTA--GLEGWWLCSLRG----RQGIAPGN 52
|
CAS proteins function as molecular scaffolds to regulate protein complexes that are involved in many cellular processes including migration, chemotaxis, apoptosis, differentiation, and progenitor cell function. They mediate the signaling of integrins at focal adhesions where they localize, and thus, regulate cell invasion and survival. Over-expression of these proteins is implicated in poor prognosis, increased metastasis, and resistance to chemotherapeutics in many cancers such as breast, lung, melanoma, and glioblastoma. CAS proteins have also been linked to the pathogenesis of inflammatory disorders, Alzheimer's, Parkinson's, and developmental defects. They share a common domain structure that includes an N-terminal SH3 domain, an unstructured substrate domain that contains many YxxP motifs, a serine-rich four-helix bundle, and a FAT-like C-terminal domain. Vertebrates contain four CAS proteins: BCAR1 (or p130Cas), NEDD9 (or HEF1), EFS (or SIN), and CASS4 (or HEPL). The SH3 domain of CAS proteins binds to diverse partners including FAK, FRNK, Pyk2, PTP-PEST, DOCK180, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|212770 cd11836, SH3_Intersectin_1, First Src homology 3 domain (or SH3A) of Intersectin | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-08
Identities = 24/60 (40%), Positives = 36/60 (60%), Gaps = 7/60 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+RALY ++A DE+S + GDI++V A + GW G+++G K G FPAN+V
Sbjct: 2 YRALYAFEARNPDEISFQPGDIIQVDESQVA---EPGWLAGELKG----KTGWFPANYVE 54
|
Intersectins (ITSNs) are adaptor proteins that function in exo- and endocytosis, actin cytoskeletal reorganization, and signal transduction. They are essential for initiating clathrin-coated pit formation. They bind to many proteins through their multidomain structure and facilitate the assembly of multimeric complexes. Vertebrates contain two ITSN proteins, ITSN1 and ITSN2, which exist in alternatively spliced short and long isoforms. The short isoforms contain two Eps15 homology domains (EH1 and EH2), a coiled-coil region and five SH3 domains (SH3A-E), while the long isoforms, in addition, contain RhoGEF (also called Dbl-homologous or DH), Pleckstrin homology (PH) and C2 domains. ITSN1 and ITSN2 are both widely expressed, with variations depending on tissue type and stage of development. The first SH3 domain (or SH3A) of ITSN1 has been shown to bind many proteins including Sos1, dynamin1/2, CIN85, c-Cbl, PI3K-C2, SHIP2, N-WASP, and CdGAP, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 125 IGEGGFGKVYKGIYEKQE---VAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVSLI 179
+G G FG+V + + EK A+KV + + + ++E +L + + I L
Sbjct: 9 VGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 180 GVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQ--IAEGMNYLHCQAPISLI 237
L LVMEY GG L +L + D + Q +AE + +H + +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQMGYV 124
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA---AGTYAWMAPEVIK 294
HRD+K NVL+ + +K+ DFG A + +++ GT ++APEV+
Sbjct: 125 HRDIKPENVLID--------RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 295 T-SIFSKAS-----DVWSYGVVLWELLTGEIPY 321
T + K + D WS GV+ +E++ G P+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|212705 cd11771, SH3_Pex13p_fungal, Src Homology 3 domain of fungal peroxisomal membrane protein Pex13p | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-08
Identities = 28/62 (45%), Positives = 39/62 (62%), Gaps = 8/62 (12%)
Query: 36 RALYDY--DAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI-EGKIEYKVGIFPANF 92
RALYD+ + + ELSL++GDIV VLSK + D WW G+ +G+I G FP+N+
Sbjct: 3 RALYDFTPENPEM-ELSLKKGDIVAVLSKTDPLGRDSEWWKGRTRDGRI----GWFPSNY 57
Query: 93 VS 94
V
Sbjct: 58 VE 59
|
Pex13p, located in the peroxisomal membrane, contains two transmembrane regions and a C-terminal SH3 domain. It binds to the peroxisomal targeting type I (PTS1) receptor Pex5p and the docking factor Pex14p through its SH3 domain. It is essential for both PTS1 and PTS2 protein import pathways into the peroxisomal matrix. Pex13p binds Pex14p, which contains a PxxP motif, in a classical fashion to the proline-rich ligand binding site of its SH3 domain. It binds the WxxxF/Y motif of Pex5p in a novel site that does not compete with Pex14p binding. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 63/264 (23%), Positives = 105/264 (39%), Gaps = 62/264 (23%)
Query: 153 DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPD 212
+ N + +VK E +L D+ +V L L VM+Y GG + +L ++ P+
Sbjct: 41 NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPE 100
Query: 213 VLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL--- 269
VL + IAE + + IHRD+K N+L+ DL +K+TDFGL
Sbjct: 101 VLARF--YIAELTLAIESVHKMGFIHRDIKPDNILI-------DLD-GHIKLTDFGLCTG 150
Query: 270 ------AREVYKTTHM----------------------------------------SAAG 283
++ K +H+ S G
Sbjct: 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVG 210
Query: 284 TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP 343
T ++APEV+ +++ D WS GV+L+E+L G+ P+ + V + TL IP
Sbjct: 211 TPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIP 270
Query: 344 ST---CPQLFKTLMEACWEADSHM 364
P+ + + C A+ +
Sbjct: 271 PQVKLSPEAVDLITKLCCSAEERL 294
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|212929 cd11996, SH3_Intersectin2_5, Fifth Src homology 3 domain (or SH3E) of Intersectin-2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-08
Identities = 25/57 (43%), Positives = 34/57 (59%), Gaps = 9/57 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A+YDY A DELS +G ++ VL+KD D WW G+I G G+FP+N+V
Sbjct: 5 AMYDYTANNEDELSFSKGQLINVLNKD-----DPDWWQGEING----VTGLFPSNYV 52
|
Intersectin-2 (ITSN2) is an adaptor protein that functions in exo- and endocytosis, actin cytoskeletal reorganization, and signal transduction. It plays a role in clathrin-coated pit (CCP) formation. It binds to many proteins through its multidomain structure and facilitate the assembly of multimeric complexes. ITSN2 also functions as a specific GEF for Cdc42 activation in epithelial morphogenesis, and is required in mitotic spindle orientation. It exists in alternatively spliced short and long isoforms. The short isoform contains two Eps15 homology domains (EH1 and EH2), a coiled-coil region and five SH3 domains (SH3A-E), while the long isoform, in addition, contains RhoGEF (also called Dbl-homologous or DH), Pleckstrin homology (PH) and C2 domains. The fifth SH3 domain (or SH3E) of ITSN2 is expected to bind protein partners, similar to ITSN1 which has been shown to bind many protein partners including SGIP1, Sos1, dynamin1/2, CIN85, c-Cbl, SHIP2, N-WASP, and synaptojanin-1, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 64/279 (22%), Positives = 104/279 (37%), Gaps = 72/279 (25%)
Query: 155 NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVL 214
N + +VK E +L D+ +V L L VM+Y GG + +L I P+ L
Sbjct: 43 NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL 102
Query: 215 VDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL----- 269
+ IAE + + IHRD+K N+L+ +K+TDFGL
Sbjct: 103 ARF--YIAELTCAVESVHKMGFIHRDIKPDNILIDRD--------GHIKLTDFGLCTGFR 152
Query: 270 --------------------------------------------AREVYKTTHMSAAGTY 285
AR+ + S GT
Sbjct: 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTP 212
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST 345
++APEV+ + +++ D WS GV+L+E+L G+ P+ + V + +L IP
Sbjct: 213 NYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ 272
Query: 346 C---PQLFKTLMEACWEADSHM----------RPSFKTI 371
P+ +++ C + + P FKTI
Sbjct: 273 AKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTI 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 76/283 (26%), Positives = 112/283 (39%), Gaps = 85/283 (30%)
Query: 123 EAIGEGGFGKVY------------KGIYEKQEVAIK--VAHPNPDENILENVKQEG---- 164
+ IG G FG+V I K ++ K VAH + +IL V+ +G
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDIL--VEADGAWVV 64
Query: 165 KLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQ--I 221
K+ + F D RN L L+ME+ GG + +L ++ D L + A Q I
Sbjct: 65 KMFYSFQDKRN-------------LYLIMEFLPGGDMMTLL----MKKDTLSEEATQFYI 107
Query: 222 AEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--------EV 273
AE + + + IHRD+K N+LL +K++DFGL E
Sbjct: 108 AETVLAIDAIHQLGFIHRDIKPDNLLLDAK--------GHVKLSDFGLCTGLKKAHRTEF 159
Query: 274 YKT-TH----------------------------MSAAGTYAWMAPEVIKTSIFSKASDV 304
Y+ TH S GT ++APEV + ++K D
Sbjct: 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDW 219
Query: 305 WSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347
WS GV+++E+L G P+ S V K TL P P
Sbjct: 220 WSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 49/235 (20%)
Query: 125 IGEGGFGKVYKGIYEK---QEVAIKVAHPNPDENILENVK--QEGKLLWLFDHRNIVSLI 179
IG+GG G+VY Y+ + VA+K + EN L + +E K+ H IV +
Sbjct: 10 IGKGGMGEVYLA-YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 180 GVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQ------------IAEGMNY 227
+C + M Y G L +L + + + A + I + Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR------------EVYK 275
+H + ++HRDLK N+LL F + I D+G A +V +
Sbjct: 129 VHSKG---VLHRDLKPDNILLG--------LFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 276 TTHMSA--------AGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYK 322
+ GT +MAPE + S+++D+++ GV+L+++LT PY+
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
|
Length = 932 |
| >gnl|CDD|212697 cd11763, SH3_SNX9_like, Src Homology 3 domain of Sorting Nexin 9 and similar proteins | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-08
Identities = 23/58 (39%), Positives = 36/58 (62%), Gaps = 7/58 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RALYD+D+ ELSLR G+++ + +D GD GW G+ +VG+FP+++V
Sbjct: 3 RALYDFDSQPSGELSLRAGEVLTITRQD---VGD-GWLEGR---NSRGEVGLFPSSYV 53
|
Sorting nexins (SNXs) are Phox homology (PX) domain containing proteins that are involved in regulating membrane traffic and protein sorting in the endosomal system. SNXs differ from each other in their lipid-binding specificity, subcellular localization and specific function in the endocytic pathway. This subfamily consists of SH3 domain containing SNXs including SNX9, SNX18, SNX33, and similar proteins. SNX9 is localized to plasma membrane endocytic sites and acts primarily in clathrin-mediated endocytosis, while SNX18 is localized to peripheral endosomal structures, and acts in a trafficking pathway that is clathrin-independent but relies on AP-1 and PACS1. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|213016 cd12140, SH3_Amphiphysin_I, Src Homology 3 domain of Amphiphysin I | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-08
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 6/61 (9%)
Query: 38 LYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGK------IEYKVGIFPAN 91
L+D++A DEL L+RGDIV V+ ++A D GW TG E G+FP N
Sbjct: 8 LHDFEAANSDELELKRGDIVLVVPSETAADQDAGWLTGVKESDWLQYRDASAYKGLFPEN 67
Query: 92 F 92
F
Sbjct: 68 F 68
|
Amphiphysins function primarily in endocytosis and other membrane remodeling events. They exist in several isoforms and mammals possess two amphiphysin proteins from distinct genes. Amphiphysin I proteins, enriched in the brain and nervous system, contain domains that bind clathrin, Adaptor Protein complex 2 (AP2), dynamin, and synaptojanin. They function in synaptic vesicle endocytosis. Human autoantibodies to amphiphysin I hinder GABAergic signaling and contribute to the pathogenesis of paraneoplastic stiff-person syndrome. Amphiphysins contain an N-terminal BAR domain with an additional N-terminal amphipathic helix (an N-BAR), a variable central domain, and a C-terminal SH3 domain. The SH3 domain of amphiphysins bind proline-rich motifs present in binding partners such as dynamin, synaptojanin, and nsP3. It also belongs to a subset of SH3 domains that bind ubiquitin in a site that overlaps with the peptide binding site. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 72 |
| >gnl|CDD|212896 cd11963, SH3_STAM2, Src homology 3 domain of Signal Transducing Adaptor Molecule 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-08
Identities = 25/60 (41%), Positives = 39/60 (65%), Gaps = 9/60 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYD++A+ +EL+ + G+I+ VL DS D WW +G+ VG+FP+NFV++
Sbjct: 5 RALYDFEAVEDNELTFKHGEIIIVLD-DS----DANWW----KGENHRGVGLFPSNFVTT 55
|
STAM2, also called EAST (Epidermal growth factor receptor-associated protein with SH3 and TAM domain) or Hbp (Hrs binding protein), is part of the endosomal sorting complex required for transport (ESCRT-0). It plays a role in sorting mono-ubiquinated endosomal cargo for trafficking to the lysosome for degradation. It is also involved in the regulation of exocytosis. STAMs were discovered as proteins that are highly phosphorylated following cytokine and growth factor stimulation. They function in cytokine signaling and surface receptor degradation, as well as regulate Golgi morphology. They associate with many proteins including Jak2 and Jak3 tyrosine kinases, Hrs, AMSH, and UBPY. STAM adaptor proteins contain VHS (Vps27, Hrs, STAM homology), ubiquitin interacting (UIM), and SH3 domains. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 57 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 67/273 (24%), Positives = 110/273 (40%), Gaps = 65/273 (23%)
Query: 123 EAIGEGGFGKVYKGIYEKQEV----AIKVAHPNPDENILE-----NVKQEGKLLWLFDHR 173
+ IG G FG+V + +K++ A+K+ ++LE +++ E +L D
Sbjct: 7 KVIGRGAFGEVR--LVQKKDTGHVYAMKILR---KADMLEKEQVGHIRAERDILVEADSL 61
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQ--IAEGMNYLHCQ 231
+V + L L+ME+ GG + +L ++ D L + Q IAE + +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL----MKKDTLTEEETQFYIAETVLAIDSI 117
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--------EVYKTTH----- 278
+ IHRD+K N+LL +K++DFGL E Y+ +
Sbjct: 118 HQLGFIHRDIKPDNLLLDSK--------GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 279 ------------------------MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314
S GT ++APEV + ++K D WS GV+++E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 315 LTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347
L G P+ S V K TL P P
Sbjct: 230 LIGYPPFCSETPQETYKKVMNWKETLIFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|212773 cd11839, SH3_Intersectin_4, Fourth Src homology 3 domain (or SH3D) of Intersectin | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-07
Identities = 18/59 (30%), Positives = 33/59 (55%), Gaps = 6/59 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGK-IEYKVGIFPANFV 93
+ + + A ++LSL G +V V K + GWW G+++ + + ++G FPAN+V
Sbjct: 3 QVIAPFTATAENQLSLAVGQLVLVRKKSPS-----GWWEGELQARGKKRQIGWFPANYV 56
|
Intersectins (ITSNs) are adaptor proteins that function in exo- and endocytosis, actin cytoskeletal reorganization, and signal transduction. They are essential for initiating clathrin-coated pit formation. They bind to many proteins through their multidomain structure and facilitate the assembly of multimeric complexes. Vertebrates contain two ITSN proteins, ITSN1 and ITSN2, which exist in alternatively spliced short and long isoforms. The short isoforms contain two Eps15 homology domains (EH1 and EH2), a coiled-coil region and five SH3 domains (SH3A-E), while the long isoforms, in addition, contain RhoGEF (also called Dbl-homologous or DH), Pleckstrin homology (PH) and C2 domains. ITSN1 and ITSN2 are both widely expressed, with variations depending on tissue type and stage of development. The fourth SH3 domain (or SH3D) of ITSN1 has been shown to bind SHIP2, Numb, CdGAP, and N-WASP. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 58 |
| >gnl|CDD|212892 cd11959, SH3_Cortactin, Src homology 3 domain of Cortactin | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-07
Identities = 24/57 (42%), Positives = 29/57 (50%), Gaps = 9/57 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALYDY A DE+S DI+ + D GWW G G K G+FPAN+V
Sbjct: 4 ALYDYQAADDDEISFDPDDIITNIEMI-----DEGWWRGVCRG----KYGLFPANYV 51
|
Cortactin was originally identified as a substrate of Src kinase. It is an actin regulatory protein that binds to the Arp2/3 complex and stabilizes branched actin filaments. It is involved in cellular processes that affect cell motility, adhesion, migration, endocytosis, and invasion. It is expressed ubiquitously except in hematopoietic cells, where the homolog hematopoietic lineage cell-specific 1 (HS1) is expressed instead. Cortactin contains an N-terminal acidic domain, several copies of a repeat domain found in cortactin and HS1, a proline-rich region, and a C-terminal SH3 domain. The N-terminal region interacts with the Arp2/3 complex and F-actin, and is crucial in regulating branched actin assembly. Cortactin also serves as a scaffold and provides a bridge to the actin cytoskeleton for membrane trafficking and signaling proteins that bind to its SH3 domain. Binding partners for the SH3 domain of cortactin include dynamin2, N-WASp, MIM, FGD1, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212985 cd12052, SH3_CIN85_1, First Src Homology 3 domain (SH3A) of Cbl-interacting protein of 85 kDa | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-07
Identities = 24/55 (43%), Positives = 33/55 (60%), Gaps = 9/55 (16%)
Query: 39 YDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+DY A DEL++ GDI+ + KD D GWW G+I+G + G+FP NFV
Sbjct: 6 FDYKAQHEDELTITVGDIITKIKKD-----DGGWWEGEIKG----RRGLFPDNFV 51
|
CIN85, also called SH3 domain-containing kinase-binding protein 1 (SH3KBP1) or CD2-binding protein 3 (CD2BP3) or Ruk, is an adaptor protein that is involved in the downregulation of receptor tyrosine kinases by facilitating endocytosis through interaction with endophilin-associated ubiquitin ligase Cbl proteins. It is also important in many other cellular processes including vesicle-mediated transport, cytoskeletal remodelling, apoptosis, cell adhesion and migration, and viral infection, among others. CIN85 exists as multiple variants from alternative splicing; the main variant contains three SH3 domains, a proline-rich region, and a C-terminal coiled-coil domain. All of these domains enable CIN85 to bind various protein partners and assemble complexes that have been implicated in many different functions. This alignment model represents the first SH3 domain (SH3A) of CIN85; SH3A binds to internal proline-rich motifs within the proline-rich region. This intramolecular interaction serves as a regulatory mechanism to keep CIN85 in a closed conformation, preventing the recruitment of other proteins. SH3A has also been shown to bind ubiquitin and to an atypical PXXXPR motif at the C-terminus of Cbl and the cytoplasmic end of the cell adhesion protein CD2. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212928 cd11995, SH3_Intersectin1_5, Fifth Src homology 3 domain (or SH3E) of Intersectin-1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-07
Identities = 23/57 (40%), Positives = 35/57 (61%), Gaps = 9/57 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+YDY A DEL+ +G I+ VL+K+ D WW G++ G +VG+FP+N+V
Sbjct: 5 GMYDYTAQNDDELAFSKGQIINVLNKE-----DPDWWKGELNG----QVGLFPSNYV 52
|
Intersectin-1 (ITSN1) is an adaptor protein that functions in exo- and endocytosis, actin cytoskeletal reorganization, and signal transduction. It plays a role in clathrin-coated pit (CCP) formation. It binds to many proteins through its multidomain structure and facilitate the assembly of multimeric complexes. ITSN1 localizes in membranous organelles, CCPs, the Golgi complex, and may be involved in the cell membrane trafficking system. It exists in alternatively spliced short and long isoforms. The short isoform contains two Eps15 homology domains (EH1 and EH2), a coiled-coil region and five SH3 domains (SH3A-E), while the long isoform, in addition, contains RhoGEF (also called Dbl-homologous or DH), Pleckstrin homology (PH) and C2 domains. The fifth SH3 domain (or SH3E) of ITSN1 has been shown to bind many protein partners including SGIP1, Sos1, dynamin1/2, CIN85, c-Cbl, SHIP2, N-WASP, and synaptojanin-1, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 41/183 (22%)
Query: 159 NVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGG-----------PLNRVLAGR 207
+E +L HR I++LI +C+VM + PL + + +
Sbjct: 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQ 191
Query: 208 KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267
+ ++ E + YLH + +IHRD+K+ N+ L EP EN L DF
Sbjct: 192 R-----------RLLEALAYLHGRG---IIHRDVKTENIFLDEP-ENAVL-------GDF 229
Query: 268 GLAREVYKTTHMSAAGTYAWM------APEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
G A ++ H Y W +PE++ + +D+WS G+VL+E+ +
Sbjct: 230 GAACKL--DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
Query: 322 KSI 324
Sbjct: 288 FGK 290
|
Length = 392 |
| >gnl|CDD|212759 cd11825, SH3_PLCgamma, Src homology 3 domain of Phospholipase C (PLC) gamma | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-07
Identities = 25/58 (43%), Positives = 31/58 (53%), Gaps = 8/58 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ALYDY A DELS + I+ + K+ D GWW G GK K FPAN+V
Sbjct: 3 KALYDYRAQRPDELSFCKHAIITNVEKE-----DGGWWRGDYGGK---KQKWFPANYV 52
|
PLC catalyzes the hydrolysis of phosphatidylinositol (4,5)-bisphosphate [PtdIns(4,5)P2] to produce Ins(1,4,5)P3 and diacylglycerol (DAG) in response to various receptors. Ins(1,4,5)P3 initiates the calcium signaling cascade while DAG functions as an activator of PKC. PLCgamma catalyzes this reaction in tyrosine kinase-dependent signaling pathways. It is activated and recruited to its substrate at the membrane. Vertebrates contain two forms of PLCgamma, PLCgamma1, which is widely expressed, and PLCgamma2, which is primarily found in haematopoietic cells. PLCgamma contains a Pleckstrin homology (PH) domain followed by an elongation factor (EF) domain, two catalytic regions of PLC domains that flank two tandem SH2 domains, followed by a SH3 domain and C2 domain. The SH3 domain of PLCgamma1 directly interacts with dynamin-1 and can serve as a guanine nucleotide exchange factor (GEF). It also interacts with Cbl, inhibiting its phosphorylation and activity. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|212712 cd11778, SH3_Bzz1_2, Second Src Homology 3 domain of Bzz1 and similar domains | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-07
Identities = 24/56 (42%), Positives = 33/56 (58%), Gaps = 8/56 (14%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
ALYDY+A G DE+S+R GD + V+ D SG WT G+I G+FP ++
Sbjct: 4 ALYDYEAQGDDEISIRVGDRIAVIRGDDG-SG----WT---YGEINGVKGLFPTSY 51
|
Bzz1 (or Bzz1p) is a WASP/Las17-interacting protein involved in endocytosis and trafficking to the vacuole. It physically interacts with type I myosins and functions in the early steps of endocytosis. Together with other proteins, it induces membrane scission in yeast. Bzz1 contains an N-terminal F-BAR (FES-CIP4 Homology and Bin/Amphiphysin/Rvs), a central coiled-coil, and two C-terminal SH3 domains. This model represents the second C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 51 |
| >gnl|CDD|212790 cd11856, SH3_p47phox_like, Src homology 3 domains of the p47phox subunit of NADPH oxidase and similar domains | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 2e-07
Identities = 22/57 (38%), Positives = 33/57 (57%), Gaps = 9/57 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
A+ DY+A G DE+SL+ G++VEVL K+ + GWW + K G PA++
Sbjct: 3 VAIADYEAQGDDEISLQEGEVVEVLEKNDS-----GWWYVRKGD----KEGWVPASY 50
|
This family is composed of the tandem SH3 domains of p47phox subunit of NADPH oxidase and Nox Organizing protein 1 (NoxO1), the four SH3 domains of Tks4 (Tyr kinase substrate with four SH3 domains), the five SH3 domains of Tks5, the SH3 domain of obscurin, Myosin-I, and similar domains. Most members of this group also contain Phox homology (PX) domains, except for obscurin and Myosin-I. p47phox and NoxO1 are regulators of the phagocytic NADPH oxidase complex (also called Nox2 or gp91phox) and nonphagocytic NADPH oxidase Nox1, respectively. They play roles in the activation of their respective NADPH oxidase, which catalyzes the transfer of electrons from NADPH to molecular oxygen to form superoxide. Tks proteins are Src substrates and scaffolding proteins that play important roles in the formation of podosomes and invadopodia, the dynamic actin-rich structures that are related to cell migration and cancer cell invasion. Obscurin is a giant muscle protein that plays important roles in the organization and assembly of the myofibril and the sarcoplasmic reticulum. Type I myosins (Myosin-I) are actin-dependent motors in endocytic actin structures and actin patches. They play roles in membrane traffic in endocytic and secretory pathways, cell motility, and mechanosensing. Myosin-I contains an N-terminal actin-activated ATPase, a phospholipid-binding TH1 (tail homology 1) domain, and a C-terminal extension which includes an F-actin-binding TH2 domain, an SH3 domain, and an acidic peptide that participates in activating the Arp2/3complex. The SH3 domain of myosin-I is required for myosin-I-induced actin polymerization. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|213006 cd12073, SH3_HS1, Src homology 3 domain of Hematopoietic lineage cell-specific protein 1 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-07
Identities = 22/60 (36%), Positives = 29/60 (48%), Gaps = 15/60 (25%)
Query: 37 ALYDYDAIGLDELSLRRGDI---VEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALYDY G DE+S + +E++ D GWW G G G+FPAN+V
Sbjct: 5 ALYDYQGEGDDEISFDPQETITDIEMV--------DEGWWKGTCHG----HRGLFPANYV 52
|
HS1, also called HCLS1 (hematopoietic cell-specific Lyn substrate 1), is a cortactin homolog expressed specifically in hematopoietic cells. It is an actin regulatory protein that binds the Arp2/3 complex and stabilizes branched actin filaments. It is required for cell spreading and signaling in lymphocytes. It regulates cytoskeletal remodeling that controls lymphocyte trafficking, and it also affects tissue invasion and infiltration of leukemic B cells. Like cortactin, HS1 contains an N-terminal acidic domain, several copies of a repeat domain found in cortactin and HS1, a proline-rich region, and a C-terminal SH3 domain. The N-terminal region binds the Arp2/3 complex and F-actin, while the C-terminal region acts as an adaptor or scaffold that can connect varied proteins that bind the SH3 domain within the actin network. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 122 GEAIGEGGFGKVYKGIY----EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
G +G G +G VYK +++E A+K I + +E LL H N+++
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIE---GTGISMSACREIALLRELKHPNVIA 62
Query: 178 LIGVCLQSP--KLCLVMEYARGGPLNRVLAGRKIR--------PDVLVDWAI-QIAEGMN 226
L V L K+ L+ +YA + + R + P +V + QI +G++
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAG--- 283
YLH ++HRDLK +N+L + E + +KI D G AR ++ + A
Sbjct: 123 YLHANW---VLHRDLKPANIL----VMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDP 174
Query: 284 ---TYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
T+ + APE++ ++KA D+W+ G + ELLT E
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|212827 cd11894, SH3_FCHSD2_2, Second Src Homology 3 domain of FCH and double SH3 domains protein 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-07
Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 6/58 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ALYDY+ DELS G I+ +L+K++ D G+W G+ G+I G+FP+ V
Sbjct: 3 KALYDYEGQTDDELSFPEGAIIRILNKEN--QDDDGFWEGEFNGRI----GVFPSVLV 54
|
FCHSD2 has a domain structure consisting of an N-terminal F-BAR (FES-CIP4 Homology and Bin/Amphiphysin/Rvs), two SH3, and C-terminal proline-rich domains. It has only been characterized in silico and its function is unknown. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|212897 cd11964, SH3_STAM1, Src homology 3 domain of Signal Transducing Adaptor Molecule 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-07
Identities = 23/60 (38%), Positives = 37/60 (61%), Gaps = 9/60 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA+YD++A +EL+ + GDI+ +L DS D WW +G+ G+FP+NFV++
Sbjct: 4 RAIYDFEAAEDNELTFKAGDIITILD-DS----DPNWW----KGETPQGTGLFPSNFVTA 54
|
STAM1 is part of the endosomal sorting complex required for transport (ESCRT-0) and is involved in sorting ubiquitinated cargo proteins from the endosome. It may also be involved in the regulation of IL2 and GM-CSF mediated signaling, and has been implicated in neural cell survival. STAMs were discovered as proteins that are highly phosphorylated following cytokine and growth factor stimulation. They function in cytokine signaling and surface receptor degradation, as well as regulate Golgi morphology. They associate with many proteins including Jak2 and Jak3 tyrosine kinases, Hrs, AMSH, and UBPY. STAM adaptor proteins contain VHS (Vps27, Hrs, STAM homology), ubiquitin interacting (UIM), and SH3 domains. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 40/237 (16%)
Query: 125 IGEGGFGKVY-------------KGIYEKQEVAIK-VAHPNPDENILENVKQEGKLLWLF 170
IG+G FG+VY K + +K+ VA K VAH + NIL L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL-------LD 53
Query: 171 DHRNIVSLIGVCLQSP-KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-QIAEGMNYL 228
+ IV L Q+ L LV +Y GG L L + + I ++ + +L
Sbjct: 54 ESPFIVGL-KFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHL 112
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR---EVYKTTHMSAAGTY 285
H +++RDLK N+LL + + DFGL++ KTT+ + GT
Sbjct: 113 HKY---DIVYRDLKPENILLDAT--------GHIALCDFGLSKANLTDNKTTN-TFCGTT 160
Query: 286 AWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341
++APEV+ ++K D WS GV+++E+ G P+ + + + +A K+ P
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP 217
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 41/223 (18%)
Query: 122 GEAIGEGGFGKVYKGIY----EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
G +G G +G VYK + ++ A+K I + +E LL H N++S
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVIS 62
Query: 178 LIGVCLQSP--KLCLVMEYA-----------RGGPLNR--VLAGRKIRPDVLVDWAIQIA 222
L V L K+ L+ +YA R N+ V R + +L QI
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY----QIL 118
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA 282
+G++YLH ++HRDLK +N+L + E + +KI D G AR ++ + A
Sbjct: 119 DGIHYLHANW---VLHRDLKPANIL----VMGEGPERGRVKIADMGFAR-LFNSPLKPLA 170
Query: 283 G------TYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
T+ + APE++ ++KA D+W+ G + ELLT E
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|212819 cd11886, SH3_BOI, Src Homology 3 domain of fungal BOI-like proteins | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-07
Identities = 20/59 (33%), Positives = 33/59 (55%), Gaps = 4/59 (6%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
L ++D++A DEL+L+ GD +E++ D GD GW+ G+ + G+FP F
Sbjct: 1 LLIVIHDFNARSEDELTLKPGDKIELIEDDEEF-GD-GWYLGR--NLRTGETGLFPVVF 55
|
This subfamily includes the Saccharomyces cerevisiae proteins BOI1 and BOI2, and similar proteins. They contain an N-terminal SH3 domain, a Sterile alpha motif (SAM), and a Pleckstrin homology (PH) domain at the C-terminus. BOI1 and BOI2 interact with the SH3 domain of Bem1p, a protein involved in bud formation. They promote polarized cell growth and participates in the NoCut signaling pathway, which is involved in the control of cytokinesis. SH3 domains bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs; they play a role in the regulation of enzymes by intramolecular interactions, changing the subcellular localization of signal pathway components and mediate multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212758 cd11824, SH3_PSTPIP1, Src homology 3 domain of Proline-Serine-Threonine Phosphatase-Interacting Protein 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-07
Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 9/59 (15%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ LYDY A DELS+ +GD+V V+ K G+ GWWT + G+ G+ P ++
Sbjct: 2 YSVLYDYTAQEDDELSISKGDVVAVIEK-----GEDGWWTVERNGQK----GLVPGTYL 51
|
PSTPIP1, also called CD2 Binding Protein 1 (CD2BP1), is mainly expressed in hematopoietic cells. It is a binding partner of the cell surface receptor CD2 and PTP-PEST, a tyrosine phosphatase which functions in cell motility and Rac1 regulation. It also plays a role in the activation of the Wiskott-Aldrich syndrome protein (WASP), which couples actin rearrangement and T cell activation. Mutations in the gene encoding PSTPIP1 cause the autoinflammatory disorder known as PAPA (pyogenic sterile arthritis, pyoderma gangrenosum, and acne) syndrome. PSTPIP1 contains an N-terminal F-BAR domain, PEST motifs, and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 22/159 (13%)
Query: 188 LCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSN 245
L LVM+Y GG L +L+ ++ D+ + ++ ++ +H + +HRD+K N
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDN 132
Query: 246 VLLSEPIENEDLQFKTLKITDFGLAREVYKT-THMS--AAGTYAWMAPEVIK-----TSI 297
VLL D +++ DFG + T S A GT +++PE+++
Sbjct: 133 VLL-------DKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 298 FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN 336
+ D WS GV ++E+L GE P+ + + YG +N
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|212738 cd11804, SH3_GRB2_like_N, N-terminal Src homology 3 domain of Growth factor receptor-bound protein 2 (GRB2) and related proteins | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-07
Identities = 18/58 (31%), Positives = 33/58 (56%), Gaps = 8/58 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A +D+ A DELS ++G I++VL+ + D W+ +++G K G+ P N++
Sbjct: 3 VAKHDFKATAEDELSFKKGSILKVLNMED----DPNWYKAELDG----KEGLIPKNYI 52
|
This family includes the adaptor protein GRB2 and related proteins including Drosophila melanogaster Downstream of receptor kinase (DRK), Caenorhabditis elegans Sex muscle abnormal protein 5 (Sem-5), GRB2-related adaptor protein (GRAP), GRAP2, and similar proteins. Family members contain an N-terminal SH3 domain, a central SH2 domain, and a C-terminal SH3 domain. GRB2/Sem-5/DRK is a critical signaling molecule that regulates the Ras pathway by linking tyrosine kinases to the Ras guanine nucleotide releasing protein Sos (son of sevenless), which converts Ras to the active GTP-bound state. GRAP2 plays an important role in T cell receptor (TCR) signaling by promoting the formation of the SLP-76:LAT complex, which couples the TCR to the Ras pathway. GRAP acts as a negative regulator of T cell receptor (TCR)-induced lymphocyte proliferation by downregulating the signaling to the Ras/ERK pathway. The N-terminal SH3 domain of GRB2 binds to Sos and Sos-derived proline-rich peptides. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 52 |
| >gnl|CDD|212767 cd11833, SH3_Stac_1, First C-terminal Src homology 3 domain of SH3 and cysteine-rich domain-containing (Stac) proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-07
Identities = 22/57 (38%), Positives = 30/57 (52%), Gaps = 9/57 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALY + ++L +R GD + +L + WW GKIE + VG FPANFV
Sbjct: 4 ALYKFKPQENEDLEMRPGDKITLLD-----DSNEDWWKGKIEDR----VGFFPANFV 51
|
Stac proteins are putative adaptor proteins that contain a cysteine-rich C1 domain and one or two SH3 domains at the C-terminus. There are three mammalian members (Stac1, Stac2, and Stac3) of this family. Stac1 and Stac3 contain two SH3 domains while Stac2 contains a single SH3 domain at the C-terminus. This model represents the first C-terminal SH3 domain of Stac1 and Stac3, and the single C-terminal SH3 domain of Stac2. Stac1 and Stac2 have been found to be expressed differently in mature dorsal root ganglia (DRG) neurons. Stac1 is mainly expressed in peptidergic neurons while Stac2 is found in a subset of nonpeptidergic and all trkB+ neurons. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212723 cd11789, SH3_Nebulin_family_C, C-terminal Src Homology 3 domain of the Nebulin family of proteins | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 7e-07
Identities = 22/60 (36%), Positives = 32/60 (53%), Gaps = 9/60 (15%)
Query: 35 WRALYDYDAIGLDELSLRRGD-IVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+RA+YDY A DE+S + GD I+ V D GW G ++ + G+ PAN+V
Sbjct: 2 YRAMYDYAAADDDEVSFQEGDVIINVEIIDD------GWMEGTVQRTGQS--GMLPANYV 53
|
Nebulin family proteins contain multiple nebulin repeats, and may contain an N-terminal LIM domain and/or a C-terminal SH3 domain. They have molecular weights ranging from 34 to 900 kD, depending on the number of nebulin repeats, and they all bind actin. They are involved in the regulation of actin filament architecture and function as stabilizers and scaffolds for cytoskeletal structures with which they associate, such as long actin filaments or focal adhesions. Nebulin family proteins that contain a C-terminal SH3 domain include the giant filamentous protein nebulin, nebulette, Lasp1, and Lasp2. Lasp2, also called LIM-nebulette, is an alternatively spliced variant of nebulette. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYK----GIYEKQ---EVAIKVAHPNPDENILENVKQEGK 165
E + L FG+ +G G FGKV + G+ ++ VA+K+ + + E + E K
Sbjct: 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELK 93
Query: 166 LL-WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200
+L L H+NIV+L+G C + ++ EY G L
Sbjct: 94 ILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|212714 cd11780, SH3_Sorbs_3, Third (or C-terminal) Src Homology 3 domain of Sorbin and SH3 domain containing (Sorbs) proteins and similar domains | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 8e-07
Identities = 27/61 (44%), Positives = 31/61 (50%), Gaps = 11/61 (18%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIE--GKIEYKVGIFPANF 92
+RALY Y DEL LR GDIV V+ K D GW+ G E G G FP N+
Sbjct: 2 YRALYSYTPQNEDELELREGDIVYVMEK-----CDDGWFVGTSERTGLF----GTFPGNY 52
Query: 93 V 93
V
Sbjct: 53 V 53
|
This family, also called the vinexin family, is composed predominantly of adaptor proteins containing one sorbin homology (SoHo) and three SH3 domains. Members include the third SH3 domains of Sorbs1 (or ponsin), Sorbs2 (or ArgBP2), Vinexin (or Sorbs3), and similar domains. They are involved in the regulation of cytoskeletal organization, cell adhesion, and growth factor signaling. Members of this family bind multiple partners including signaling molecules like c-Abl, c-Arg, Sos, and c-Cbl, as well as cytoskeletal molecules such as vinculin and afadin. They may have overlapping functions. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212779 cd11845, SH3_Src_like, Src homology 3 domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 8e-07
Identities = 24/63 (38%), Positives = 33/63 (52%), Gaps = 19/63 (30%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWW------TGKIEGKIEYKVGIFP 89
ALYDY+A D+LS ++GD +++L GD WW TGK EG I P
Sbjct: 3 VALYDYEARTDDDLSFKKGDRLQILDDS---DGD--WWLARHLSTGK-EGYI-------P 49
Query: 90 ANF 92
+N+
Sbjct: 50 SNY 52
|
Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, Yes, and Brk. Src (or c-Src) proteins are cytoplasmic (or non-receptor) PTKs which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). However, Brk lacks the N-terminal myristoylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells, and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, Lyn, and Brk show a limited expression pattern. This subfamily also includes Drosophila Src42A, Src oncogene at 42A (also known as Dsrc41) which accumulates at sites of cell-cell or cell-matrix adhesion, and participates in Drosphila development and wound healing. It has been shown to promote tube elongation in the tracheal system, is essential for proper cell-cell matching during dorsal closure, and regulates cell-cell contacts in developing Drosophila eyes. The SH3 domain of Src kinases contributes to substrate recruitment by binding adaptor proteins/substrates, and regulation of kinase activity through an intramolecular interaction. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 52 |
| >gnl|CDD|212798 cd11864, SH3_PEX13_eumet, Src Homology 3 domain of eumetazoan Peroxisomal biogenesis factor 13 | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 9e-07
Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 6/59 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDV-GWWTGKIEGKIEYKVGIFPANFV 93
RA YD+ A DELS R GD + + K+ + V GW ++G+ K+G+ PAN+V
Sbjct: 3 RAEYDFVAESEDELSFRAGDKLRLAPKE--LQPRVRGWLLATVDGQ---KIGLVPANYV 56
|
PEX13 is a peroxin and is required for protein import into the peroxisomal matrix and membrane. It is an integral membrane protein that is essential for the localization of PEX14 and the import of proteins containing the peroxisome matrix targeting signals, PTS1 and PTS2. Mutations of the PEX13 gene in humans lead to a wide range of peroxisome biogenesis disorders (PBDs), the most severe of which is known as Zellweger syndrome (ZS), a severe multisystem disorder characterized by hypotonia, psychomotor retardation, and neuronal migration defects. PEX13 contains two transmembrane regions and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 58 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 45/143 (31%), Positives = 72/143 (50%), Gaps = 19/143 (13%)
Query: 188 LCLVMEYARGGPLNRVLAGRKIRPDVLVDWA-IQIAEGMNYLHCQAPISLIHRDLKSSNV 246
L LVM+Y GG L +L+ K + D A IAE + +H + +HRD+K NV
Sbjct: 76 LYLVMDYYVGGDLLTLLS--KFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 247 LLSEPIENEDLQFKTLKITDFGLAREVYK--TTHMSAA-GTYAWMAPEVIKT-----SIF 298
LL D+ +++ DFG ++ + T S A GT +++PE+++ +
Sbjct: 134 LL-------DMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 185
Query: 299 SKASDVWSYGVVLWELLTGEIPY 321
D WS GV ++E+L GE P+
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|212920 cd11987, SH3_Intersectin1_1, First Src homology 3 domain (or SH3A) of Intersectin-1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-06
Identities = 24/58 (41%), Positives = 38/58 (65%), Gaps = 7/58 (12%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
+RALY ++A DE++++ GDIV V D + +G+ GW G+++G K G FPAN+
Sbjct: 2 YRALYPFEARSHDEITIQPGDIVMV---DESQTGEPGWLGGELKG----KTGWFPANY 52
|
Intersectin-1 (ITSN1) is an adaptor protein that functions in exo- and endocytosis, actin cytoskeletal reorganization, and signal transduction. It plays a role in clathrin-coated pit (CCP) formation. It binds to many proteins through its multidomain structure and facilitate the assembly of multimeric complexes. ITSN1 localizes in membranous organelles, CCPs, the Golgi complex, and may be involved in the cell membrane trafficking system. It exists in alternatively spliced short and long isoforms. The short isoform contains two Eps15 homology domains (EH1 and EH2), a coiled-coil region and five SH3 domains (SH3A-E), while the long isoform, in addition, contains RhoGEF (also called Dbl-homologous or DH), Pleckstrin homology (PH) and C2 domains. The first SH3 domain (or SH3A) of ITSN1 has been shown to bind many proteins including Sos1, dynamin1/2, CIN85, c-Cbl, PI3K-C2, SHIP2, N-WASP, and CdGAP, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212911 cd11978, SH3_VAV3_2, C-terminal (or second) Src homology 3 domain of VAV3 protein | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-06
Identities = 22/57 (38%), Positives = 34/57 (59%), Gaps = 8/57 (14%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A YD+ A + ELSL +GD+V++ +K GWW G++ G +VG FP+ +V
Sbjct: 5 ARYDFCARDMRELSLLKGDVVKIYTK----MSTNGWWRGEVNG----RVGWFPSTYV 53
|
VAV3 is ubiquitously expressed and functions as a phosphorylation-dependent guanine nucleotide exchange factor (GEF) for RhoA, RhoG, and Rac1. It has been implicated to function in the hematopoietic, bone, cerebellar, and cardiovascular systems. VAV3 is essential in axon guidance in neurons that control blood pressure and respiration. It is overexpressed in prostate cancer cells and it plays a role in regulating androgen receptor transcriptional activity. VAV proteins contain several domains that enable their function: N-terminal calponin homology (CH), acidic, RhoGEF (also called Dbl-homologous or DH), Pleckstrin Homology (PH), C1 (zinc finger), SH2, and two SH3 domains. The SH3 domain of VAV is involved in the localization of proteins to specific sites within the cell, by interacting with proline-rich sequences within target proteins. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|212979 cd12046, SH3_p67phox_C, C-terminal (or second) Src Homology 3 domain of the p67phox subunit of NADPH oxidase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-06
Identities = 23/57 (40%), Positives = 36/57 (63%), Gaps = 9/57 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
AL+ Y+A ++L ++GD++ VLSK ++ D W G+ +GKI GIFP+ FV
Sbjct: 4 ALFSYEASQPEDLEFQKGDVILVLSK---VNED--WLEGQCKGKI----GIFPSAFV 51
|
p67phox, also called Neutrophil cytosol factor 2 (NCF-2), is a cytosolic subunit of the phagocytic NADPH oxidase complex (also called Nox2 or gp91phox) which plays a crucial role in the cellular response to bacterial infection. NADPH oxidase catalyzes the transfer of electrons from NADPH to oxygen during phagocytosis forming superoxide and reactive oxygen species. p67phox plays a regulatory role and contains N-terminal TPR, first SH3 (or N-terminal or central SH3), PB1, and C-terminal SH3 domains. It binds, via its C-terminal SH3 domain, to a proline-rich region of p47phox and upon activation, this complex assembles with flavocytochrome b558, the Nox2-p22phox heterodimer. Concurrently, RacGTP translocates to the membrane and interacts with the TPR domain of p67phox, which leads to the activation of NADPH oxidase. The PB1 domain of p67phox binds to its partner PB1 domain in p40phox, and this facilitates the assembly of p47phox-p67phox at the membrane. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212936 cd12003, SH3_EFS, Src homology 3 domain of CAS (Crk-Associated Substrate) scaffolding protein family member, Embryonal Fyn-associated Substrate | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-06
Identities = 25/58 (43%), Positives = 33/58 (56%), Gaps = 6/58 (10%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
L +ALYD A +ELS RRGD++ VL ++ S GWW + G + GI PAN
Sbjct: 2 LAKALYDNAAESPEELSFRRGDVLMVLKREHG-SLP-GWWLCSLHG----QQGIAPAN 53
|
EFS is also called HEFS, CASS3 (Cas scaffolding protein family member 3) or SIN (Src-interacting protein). It was identified based on interactions with the Src kinases, Fyn and Yes. It plays a role in thymocyte development and acts as a negative regulator of T cell proliferation. CAS proteins function as molecular scaffolds to regulate protein complexes that are involved in many cellular processes. They share a common domain structure that includes an N-terminal SH3 domain, an unstructured substrate domain that contains many YxxP motifs, a serine-rich four-helix bundle, and a FAT-like C-terminal domain. The SH3 domain of CAS proteins binds to diverse partners including FAK, FRNK, Pyk2, PTP-PEST, DOCK180, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 62 |
| >gnl|CDD|212792 cd11858, SH3_Myosin-I_fungi, Src homology 3 domain of Type I fungal Myosins | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-06
Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 7/59 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
++ALYD+ +ELSL++ DIV ++ K+ D GWW K E K G PA ++
Sbjct: 2 YKALYDFAGSVANELSLKKDDIVYIVQKE-----DNGWWLAKKLD--ESKEGWVPAAYL 53
|
Type I myosins (myosin-I) are actin-dependent motors in endocytic actin structures and actin patches. They play roles in membrane traffic in endocytic and secretory pathways, cell motility, and mechanosensing. Saccharomyces cerevisiae has two myosins-I, Myo3 and Myo5, which are involved in endocytosis and the polarization of the actin cytoskeleton. Myosin-I contains an N-terminal actin-activated ATPase, a phospholipid-binding TH1 (tail homology 1) domain, and a C-terminal extension which includes an F-actin-binding TH2 domain, an SH3 domain, and an acidic peptide that participates in activating the Arp2/3complex. The SH3 domain of myosin-I is required for myosin-I-induced actin polymerization. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212933 cd12000, SH3_CASS4, Src homology 3 domain of CAS (Crk-Associated Substrate) scaffolding protein family member 4 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-06
Identities = 26/58 (44%), Positives = 34/58 (58%), Gaps = 6/58 (10%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
L RALYD A DEL+ RRGDI+ VL ++ + G GWW + G + G+ PAN
Sbjct: 2 LARALYDNKADCSDELAFRRGDILTVLEQN--VPGSEGWWKCLLHG----RQGLAPAN 53
|
CASS4, also called HEPL (HEF1-EFS-p130Cas-like), localizes to focal adhesions and plays a role in regulating FAK activity, focal adhesion integrity, and cell spreading. It is most abundant in blood cells and lung tissue, and is also found in high levels in leukemia and ovarian cell lines. CAS proteins function as molecular scaffolds to regulate protein complexes that are involved in many cellular processes. They share a common domain structure that includes an N-terminal SH3 domain, an unstructured substrate domain that contains many YxxP motifs, a serine-rich four-helix bundle, and a FAT-like C-terminal domain. The SH3 domain of CAS proteins binds to diverse partners including FAK, FRNK, Pyk2, PTP-PEST, DOCK180, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 57 |
| >gnl|CDD|212800 cd11866, SH3_SKAP1-like, Src Homology 3 domain of Src Kinase-Associated Phosphoprotein 1 and similar proteins | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-06
Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 7/59 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ L+D DELS +RGD++ ++SK+ GWW G++ G KVG+ P +++
Sbjct: 2 YMGLWDCSGNEPDELSFKRGDLIYIISKEYDS---FGWWVGELNG----KVGLVPKDYL 53
|
This subfamily is composed of SKAP1, SKAP2, and similar proteins. SKAP1 and SKAP2 are immune cell-specific adaptor proteins that play roles in T- and B-cell adhesion, respectively, and are thus important in the migration of T- and B-cells to sites of inflammation and for movement during T-cell conjugation with antigen-presenting cells. Both SKAP1 and SKAP2 bind to ADAP (adhesion and degranulation-promoting adaptor protein), among many other binding partners. They contain a pleckstrin homology (PH) domain, a C-terminal SH3 domain, and several tyrosine phosphorylation sites. The SH3 domain of SKAP1 is necessary for its ability to regulate T-cell conjugation with antigen-presenting cells and the formation of LFA-1 clusters. SKAP1 binds primarily to a proline-rich region of ADAP through its SH3 domain; its degradation is regulated by ADAP. A secondary interaction occurs via the ADAP SH3 domain and the RKxxYxxY motif in SKAP1. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|219499 pfam07653, SH3_2, Variant SH3 domain | Back alignment and domain information |
|---|
Score = 44.0 bits (105), Expect = 3e-06
Identities = 24/59 (40%), Positives = 37/59 (62%), Gaps = 9/59 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
R ++DY A +ELSL++GD+V+VL KD D GWW EG+ + G+ P+++V
Sbjct: 3 RVIFDYVATDPNELSLKKGDVVKVLDKD-----DNGWW----EGERGGRRGLVPSSYVE 52
|
SH3 (Src homology 3) domains are often indicative of a protein involved in signal transduction related to cytoskeletal organisation. First described in the Src cytoplasmic tyrosine kinase. The structure is a partly opened beta barrel. Length = 53 |
| >gnl|CDD|212851 cd11918, SH3_Vinexin_3, Third (or C-terminal) Src Homology 3 domain of Vinexin, also called Sorbin and SH3 domain containing 3 (Sorbs3) | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-06
Identities = 22/62 (35%), Positives = 32/62 (51%), Gaps = 7/62 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
++A+Y Y DEL LR GD V+V+ + D GW+ G K G FP N+V+
Sbjct: 4 YKAVYQYRPQNEDELELREGDRVDVMQQ-----CDDGWFVGVSRRT--QKFGTFPGNYVA 56
Query: 95 SI 96
+
Sbjct: 57 PV 58
|
Vinexin is also called Sorbs3, SH3P3, and SH3-containing adapter molecule 1 (SCAM-1). It is an adaptor protein containing one sorbin homology (SoHo) and three SH3 domains. Vinexin was first identified as a vinculin binding protein; it is co-localized with vinculin at cell-ECM and cell-cell adhesion sites. There are several splice variants of vinexin: alpha, which contains the SoHo and three SH3 domains and displays tissue-specific expression; and beta, which contains only the three SH3 domains and is widely expressed. Vinexin alpha stimulates the accumulation of F-actin at focal contact sites. Vinexin also promotes keratinocyte migration and wound healing. The SH3 domains of vinexin have been reported to bind a number of ligands including vinculin, WAVE2, DLG5, Abl, and Cbl. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 58 |
| >gnl|CDD|212980 cd12047, SH3_Noxa1_C, C-terminal Src Homology 3 domain of NADPH oxidase activator 1 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-06
Identities = 19/58 (32%), Positives = 32/58 (55%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A +DY A G ++L +GD +++LS+ ++ + W G +G+I GIFP F
Sbjct: 3 VAQHDYSAQGPEDLEFSQGDTIDILSE---VNQE--WLEGHCDGRI----GIFPKCFA 51
|
Noxa1 is a homolog of p67phox and is a cytosolic subunit of the nonphagocytic NADPH oxidase complex Nox1, which catalyzes the transfer of electrons from NADPH to molecular oxygen to form superoxide. Noxa1 is co-expressed with Nox1 in colon, stomach, uterus, prostate, and vascular smooth muscle cells, consistent with its regulatory role. It does not interact with p40phox, unlike p67phox, making Nox1 activity independent of p40phox, unlike Nox2. Noxa1 contains TPR, PB1, and C-terminal SH3 domains, but lacks the central SH3 domain that is present in p67phox. The TPR domain binds activated GTP-bound Rac. The C-terminal SH3 domain binds the polyproline motif found at the C-terminus of Noxo1, a homolog of p47phox. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212924 cd11991, SH3_Intersectin1_3, Third Src homology 3 domain (or SH3C) of Intersectin-1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-06
Identities = 21/57 (36%), Positives = 34/57 (59%), Gaps = 10/57 (17%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A+Y Y++ +L+ ++GD++ V KD GD WWTG + K G+FP+N+V
Sbjct: 4 AMYTYESNEQGDLTFQQGDVILVTKKD----GD--WWTGTVGDKT----GVFPSNYV 50
|
Intersectin-1 (ITSN1) is an adaptor protein that functions in exo- and endocytosis, actin cytoskeletal reorganization, and signal transduction. It plays a role in clathrin-coated pit (CCP) formation. It binds to many proteins through its multidomain structure and facilitate the assembly of multimeric complexes. ITSN1 localizes in membranous organelles, CCPs, the Golgi complex, and may be involved in the cell membrane trafficking system. It exists in alternatively spliced short and long isoforms. The short isoform contains two Eps15 homology domains (EH1 and EH2), a coiled-coil region and five SH3 domains (SH3A-E), while the long isoform, in addition, contains RhoGEF (also called Dbl-homologous or DH), Pleckstrin homology (PH) and C2 domains. The third SH3 domain (or SH3C) of ITSN1 has been shown to bind many proteins including dynamin1/2, CIN85, c-Cbl, SHIP2, Reps1, synaptojanin-1, and WNK, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 52 |
| >gnl|CDD|212762 cd11828, SH3_ARHGEF9_like, Src homology 3 domain of ARHGEF9-like Rho guanine nucleotide exchange factors | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-06
Identities = 21/57 (36%), Positives = 30/57 (52%), Gaps = 9/57 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
AL+D+ + +EL + GD++EVL D WW G I + G FPA+FV
Sbjct: 4 ALWDHVTMDPEELGFKAGDVIEVLD-----MSDKDWWWGSIRD----EEGWFPASFV 51
|
Members of this family contain a SH3 domain followed by RhoGEF (also called Dbl-homologous or DH) and Pleckstrin Homology (PH) domains. They include the Rho guanine nucleotide exchange factors ARHGEF9, ASEF (also called ARHGEF4), ASEF2, and similar proteins. GEFs activate small GTPases by exchanging bound GDP for free GTP. ARHGEF9 specifically activates Cdc42, while both ASEF and ASEF2 can activate Rac1 and Cdc42. ARHGEF9 is highly expressed in the brain and it interacts with gephyrin, a postsynaptic protein associated with GABA and glycine receptors. ASEF plays a role in angiogenesis and cell migration. ASEF2 is important in cell migration and adhesion dynamics. ASEF exists in an autoinhibited form and is activated upon binding of the tumor suppressor APC (adenomatous polyposis coli), leading to the activation of Rac1 or Cdc42. In its autoinhibited form, the SH3 domain of ASEF forms an extensive interface with the DH and PH domains, blocking the Rac binding site. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212986 cd12053, SH3_CD2AP_1, First Src Homology 3 domain (SH3A) of CD2-associated protein | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-06
Identities = 23/59 (38%), Positives = 36/59 (61%), Gaps = 8/59 (13%)
Query: 39 YDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97
YDYDA+ DEL++R G+I+ + K + GW +EG++ + G+FP NFV I+
Sbjct: 6 YDYDAVHEDELTIRVGEIIRNVKKLE----EEGW----LEGELNGRRGMFPDNFVKEIK 56
|
CD2AP, also called CMS (Cas ligand with Multiple SH3 domains) or METS1 (Mesenchyme-to-Epithelium Transition protein with SH3 domains), is a cytosolic adaptor protein that plays a role in regulating the cytoskeleton. It is critical in cell-to-cell union necessary for kidney function. It also stabilizes the contact between a T cell and antigen-presenting cells. It is primarily expressed in podocytes at the cytoplasmic face of the slit diaphragm and serves as a linker anchoring podocin and nephrin to the actin cytoskeleton. CD2AP contains three SH3 domains, a proline-rich region, and a C-terminal coiled-coil domain. All of these domains enable CD2AP to bind various protein partners and assemble complexes that have been implicated in many different functions. This alignment model represents the first SH3 domain (SH3A) of CD2AP. SH3A binds to the PXXXPR motif present in c-Cbl and the cytoplasmic domain of cell adhesion protein CD2. Its interaction with CD2 anchors CD2 at sites of cell contact. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|212934 cd12001, SH3_BCAR1, Src homology 3 domain of the CAS (Crk-Associated Substrate) scaffolding protein family member, Breast Cancer Anti-estrogen Resistance 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-06
Identities = 26/58 (44%), Positives = 33/58 (56%), Gaps = 6/58 (10%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
L +ALYD A DELS R+GDI+ VL +D+ G GWW + G + GI P N
Sbjct: 4 LAKALYDNVAESPDELSFRKGDIMTVLERDT--QGLDGWWLCSLHG----RQGIVPGN 55
|
BCAR1, also called p130cas or CASS1, is the founding member of the CAS family of scaffolding proteins and was originally identified through its ability to associate with Crk. The name BCAR1 was designated because the human gene was identified in a screen for genes that promote resistance to tamoxifen. It is widely expressed and its deletion is lethal in mice. It plays a role in regulating cell motility, survival, proliferation, transformation, cancer progression, and bacterial pathogenesis. CAS proteins function as molecular scaffolds to regulate protein complexes that are involved in many cellular processes. They share a common domain structure that includes an N-terminal SH3 domain, an unstructured substrate domain that contains many YxxP motifs, a serine-rich four-helix bundle, and a FAT-like C-terminal domain. The SH3 domain of CAS proteins binds to diverse partners including FAK, FRNK, Pyk2, PTP-PEST, DOCK180, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 68 |
| >gnl|CDD|212772 cd11838, SH3_Intersectin_3, Third Src homology 3 domain (or SH3C) of Intersectin | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-06
Identities = 22/57 (38%), Positives = 32/57 (56%), Gaps = 10/57 (17%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALY Y++ +L+ GD++ V KD G+ WWTG I + GIFP+N+V
Sbjct: 4 ALYPYESNEPGDLTFNAGDVILVTKKD----GE--WWTGTIGDR----TGIFPSNYV 50
|
Intersectins (ITSNs) are adaptor proteins that function in exo- and endocytosis, actin cytoskeletal reorganization, and signal transduction. They are essential for initiating clathrin-coated pit formation. They bind to many proteins through their multidomain structure and facilitate the assembly of multimeric complexes. Vertebrates contain two ITSN proteins, ITSN1 and ITSN2, which exist in alternatively spliced short and long isoforms. The short isoforms contain two Eps15 homology domains (EH1 and EH2), a coiled-coil region and five SH3 domains (SH3A-E), while the long isoforms, in addition, contain RhoGEF (also called Dbl-homologous or DH), Pleckstrin homology (PH) and C2 domains. ITSN1 and ITSN2 are both widely expressed, with variations depending on tissue type and stage of development. The third SH3 domain (or SH3C) of ITSN1 has been shown to bind many proteins including dynamin1/2, CIN85, c-Cbl, SHIP2, Reps1, synaptojanin-1, and WNK, among others. The SH3C of ITSN2 has been shown to bind the K15 protein of Kaposi's sarcoma-associated herpesvirus. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 52 |
| >gnl|CDD|212715 cd11781, SH3_Sorbs_1, First Src Homology 3 domain of Sorbin and SH3 domain containing (Sorbs) proteins and similar domains | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-06
Identities = 23/58 (39%), Positives = 34/58 (58%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RALY + A ELSL++GDI+ + + D W+ G+ G +VGIFPA++V
Sbjct: 3 RALYPFKAQSAKELSLKKGDIIYIRRQI-----DKNWYEGEHNG----RVGIFPASYV 51
|
This family, also called the vinexin family, is composed predominantly of adaptor proteins containing one sorbin homology (SoHo) and three SH3 domains. Members include the first SH3 domains of Sorbs1 (or ponsin), Sorbs2 (or ArgBP2), Vinexin (or Sorbs3), and similar domains. They are involved in the regulation of cytoskeletal organization, cell adhesion, and growth factor signaling. Members of this family bind multiple partners including signaling molecules like c-Abl, c-Arg, Sos, and c-Cbl, as well as cytoskeletal molecules such as vinculin and afadin. They may have overlapping functions. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212921 cd11988, SH3_Intersectin2_1, First Src homology 3 domain (or SH3A) of Intersectin-2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-06
Identities = 23/59 (38%), Positives = 32/59 (54%), Gaps = 7/59 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+RALY ++A DE+S GDI++V D G+ GW G +G G FP N+V
Sbjct: 4 YRALYPFEARNHDEMSFNAGDIIQV---DEKTVGEPGWLYGSFQG----NFGWFPCNYV 55
|
Intersectin-2 (ITSN2) is an adaptor protein that functions in exo- and endocytosis, actin cytoskeletal reorganization, and signal transduction. It plays a role in clathrin-coated pit (CCP) formation. It binds to many proteins through its multidomain structure and facilitate the assembly of multimeric complexes. ITSN2 also functions as a specific GEF for Cdc42 activation in epithelial morphogenesis, and is required in mitotic spindle orientation. It exists in alternatively spliced short and long isoforms. The short isoform contains two Eps15 homology domains (EH1 and EH2), a coiled-coil region and five SH3 domains (SH3A-E), while the long isoform, in addition, contains RhoGEF (also called Dbl-homologous or DH), Pleckstrin homology (PH) and C2 domains. The first SH3 domain (or SH3A) of ITSN2 is expected to bind many protein partners, similar to ITSN1 which has been shown to bind Sos1, dynamin1/2, CIN85, c-Cbl, PI3K-C2, SHIP2, N-WASP, and CdGAP, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 57 |
| >gnl|CDD|212752 cd11818, SH3_Eve1_5, Fifth Src homology 3 domain of ADAM-binding protein Eve-1 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-06
Identities = 25/57 (43%), Positives = 31/57 (54%), Gaps = 9/57 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
RALYD+ DELS + GDI+ L S D W +G++ G K GIFP NF
Sbjct: 3 RALYDFTGENEDELSFKAGDIITELE-----SIDEEWMSGELRG----KSGIFPKNF 50
|
Eve-1, also called SH3 domain-containing protein 19 (SH3D19) or EEN-binding protein (EBP), exists in multiple alternatively spliced isoforms. The longest isoform contains five SH3 domain in the C-terminal region and seven proline-rich motifs in the N-terminal region. It is abundantly expressed in skeletal muscle and heart, and may be involved in regulating the activity of ADAMs (A disintegrin and metalloproteases). Eve-1 interacts with EEN, an endophilin involved in endocytosis and may be the target of the MLL-EEN fusion protein that is implicated in leukemogenesis. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 50 |
| >gnl|CDD|212931 cd11998, SH3_PACSIN1-2, Src homology 3 domain of Protein kinase C and Casein kinase Substrate in Neurons 1 (PACSIN1) and PACSIN 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-06
Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 7/60 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYDYD DELS + GD + L + + GW G+++ +VG++PAN+V
Sbjct: 4 RALYDYDGQEQDELSFKAGDELTKLEDED----EQGWCKGRLDSG---QVGLYPANYVEP 56
|
PACSIN 1 or Syndapin I (Synaptic dynamin-associated protein I) is expressed specifically in the brain and is localized in neurites and synaptic boutons. It binds the brain-specific proteins dynamin I, synaptojanin, synapsin I, and neural Wiskott-Aldrich syndrome protein (nWASP), and functions as a link between the cytoskeletal machinery and synaptic vesicle endocytosis. PACSIN 1 interacts with huntingtin and may be implicated in the neuropathology of Huntington's disease. PACSIN 2 or Syndapin II is expressed ubiquitously and is involved in the regulation of tubulin polymerization. It associates with Golgi membranes and forms a complex with dynamin II which is crucial in promoting vesicle formation from the trans-Golgi network. PACSINs act as regulators of cytoskeletal and membrane dynamics. Vetebrates harbor three isoforms with distinct expression patterns and specific functions. PACSINs contain an N-terminal F-BAR domain and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|212894 cd11961, SH3_Abp1_fungi_C2, Second C-terminal Src homology 3 domain of Fungal Actin-binding protein 1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-06
Identities = 22/62 (35%), Positives = 30/62 (48%), Gaps = 15/62 (24%)
Query: 36 RALYDYDAIGLDELSLRRGDI---VEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
+ALYDYDA +ELS D +E + D WW G+ G G+FP+N+
Sbjct: 3 KALYDYDAAEDNELSFFENDKIINIEFVDDD--------WWLGECHG----SRGLFPSNY 50
Query: 93 VS 94
V
Sbjct: 51 VE 52
|
Abp1 is an adaptor protein that functions in receptor-mediated endocytosis and vesicle trafficking. It contains an N-terminal actin-binding module, the actin-depolymerizing factor (ADF) homology domain, a central proline-rich region, and a C-terminal SH3 domain (many yeast Abp1 proteins contain two C-terminal SH3 domains). Yeast Abp1 also contains two acidic domains that bind directly to the Arp2/3 complex, which is required to initiate actin polymerization. The SH3 domain of yeast Abp1 binds and localizes the kinases, Ark1p and Prk1p, which facilitate actin patch disassembly following vesicle internalization. It also mediates the localization to the actin patch of the synaptojanin-like protein, Sjl2p, which plays a key role in endocytosis. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 73/290 (25%), Positives = 120/290 (41%), Gaps = 58/290 (20%)
Query: 62 KDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE----DINLVSSVINDVKLVEIDYN 117
KD I D+ + K + G F N E N ++ K+++ D N
Sbjct: 2 KDWPIDEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDIN 61
Query: 118 K-----LIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF 170
+ G IG G FG VY+ I ++VAIK +P + +E ++
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNL 116
Query: 171 DHRNIVSLIGV----CLQSPK----LCLVME------------YARGGPLNRVLAGRKIR 210
+H NI+ L C + + L +VME YAR N L
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN---NHAL------ 167
Query: 211 PDVLVD-WAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269
P LV ++ Q+ + Y+H + + HRDLK N+L+ D TLK+ DFG
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLI-------DPNTHTLKLCDFGS 217
Query: 270 AREVYKTTH-MSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTG 317
A+ + +S + + APE++ + ++ D+WS G ++ E++ G
Sbjct: 218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|212803 cd11870, SH3_p67phox-like_C, C-terminal Src Homology 3 domain of the p67phox subunit of NADPH oxidase and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-06
Identities = 22/57 (38%), Positives = 33/57 (57%), Gaps = 9/57 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
AL+ Y+A G ++L R GD ++VLS+ + W +EG + +VGIFP FV
Sbjct: 4 ALHRYEAQGPEDLGFREGDTIDVLSE-----VNEAW----LEGHSDGRVGIFPKCFV 51
|
This subfamily is composed of p67phox, NADPH oxidase activator 1 (Noxa1), and similar proteins. p67phox, also called Neutrophil cytosol factor 2 (NCF-2), and Noxa1 are homologs and are the cytosolic subunits of the phagocytic (Nox2) and nonphagocytic (Nox1) NADPH oxidase complexes, respectively. NADPH oxidase catalyzes the transfer of electrons from NADPH to oxygen during phagocytosis forming superoxide and reactive oxygen species. p67phox and Noxa1 play regulatory roles. p67phox contains N-terminal TPR, first SH3 (or N-terminal or central SH3), PB1, and C-terminal SH3 domains. Noxa1 has a similar domain architecture except it is lacking the N-terminal SH3 domain. The TPR domain of both binds activated GTP-bound Rac, while the C-terminal SH3 domain of p67phox and Noxa1 binds the polyproline motif found at the C-terminus of p47phox and Noxo1, respectively. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212849 cd11916, SH3_Sorbs1_3, Third (or C-terminal) Src Homology 3 domain of Sorbin and SH3 domain containing 1 (Sorbs1), also called ponsin | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 8e-06
Identities = 24/59 (40%), Positives = 32/59 (54%), Gaps = 7/59 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
++ALY Y DEL LR GDIV+V+ K D GW+ G + + G FP N+V
Sbjct: 4 YQALYSYAPQNDDELELRDGDIVDVMEK-----CDDGWFVGT--SRRTKQFGTFPGNYV 55
|
Sorbs1 is also called ponsin, SH3P12, or CAP (c-Cbl associated protein). It is an adaptor protein containing one sorbin homology (SoHo) and three SH3 domains. It binds Cbl and plays a major role in regulating the insulin signaling pathway by enhancing insulin-induced phosphorylation of Cbl. Sorbs1, like vinexin, localizes at cell-ECM and cell-cell adhesion sites where it binds vinculin, paxillin, and afadin. It may function in the control of cell motility. Other interaction partners of Sorbs1 include c-Abl, Sos, flotillin, Grb4, ataxin-7, filamin C, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 59 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 63/303 (20%), Positives = 117/303 (38%), Gaps = 67/303 (22%)
Query: 143 VAIKVAH-PNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLN 201
V +++ N E L+ ++ E L F H NI++ V L ++ + G N
Sbjct: 28 VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87
Query: 202 RVLAGRKIRPDVLVDWAIQ-----IAEGMNYLHCQAPISLIHRDLKSSNVLLSEP--IEN 254
+L + P+ + + I G+NYLH IHR++K+S++L+S +
Sbjct: 88 SLL--KTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSL 142
Query: 255 EDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSI--FSKASDVWSYGVVLW 312
L + + A+ VY S + W++PE+++ + ++ SD++S G+
Sbjct: 143 SGLSHLYSLVRNGQKAKVVYDFPQFSTS-VLPWLSPELLRQDLYGYNVKSDIYSVGITAC 201
Query: 313 ELLTGEIPY---------------------------------------------KSINAY 327
EL TG +P+ +S+ A
Sbjct: 202 ELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAA 261
Query: 328 AVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTP 387
+ + +L P T F+ L+E C + D RPS ++L H+ F Q
Sbjct: 262 GMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS------HAFFKQVK 315
Query: 388 HES 390
++
Sbjct: 316 EQT 318
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 40/223 (17%)
Query: 125 IGEGGFGKVYKGIYEKQE--VAIKVAHPNP----DENI----LENVKQ---EGKLLWLFD 171
+GEG FGKV + K++ A+K+ P D I +E V+Q + +
Sbjct: 137 LGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKI 196
Query: 172 HRNIVSLIG-VCLQSPKL--CLVMEYARGGPLN-RVLAGRKIRPDVLVDWAIQIAEGMNY 227
R + G +C+ PK CL+ + GP + R LA Q ++Y
Sbjct: 197 QRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLA----------QIIFQTGVALDY 246
Query: 228 LHCQAPISLIHRDLKSSNVLLS------EPIENEDLQFKT--LKITDFG-LAREVYKTTH 278
H + + L+H DLK N+L+ +P+ N L ++I D G E + T
Sbjct: 247 FHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRT- 303
Query: 279 MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
+ T + +PEV+ + ++D+WS G +++EL TG++ Y
Sbjct: 304 -AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345
|
Length = 467 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 48/185 (25%), Positives = 90/185 (48%), Gaps = 20/185 (10%)
Query: 161 KQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR-PDVLVDWAI 219
++E +L D++ I +L L LVM+Y GG L +L+ + R P+ + +
Sbjct: 49 REERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-- 106
Query: 220 QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK--TT 277
+AE + + + +HRD+K N+L+ D+ +++ DFG ++ + T
Sbjct: 107 YLAEMVIAIDSVHQLHYVHRDIKPDNILM-------DMN-GHIRLADFGSCLKLMEDGTV 158
Query: 278 HMSAA-GTYAWMAPEVIKT-----SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY 331
S A GT +++PE+++ + D WS GV ++E+L GE P+ + + Y
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETY 217
Query: 332 GVAVN 336
G +N
Sbjct: 218 GKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|212905 cd11972, SH3_Abi2, Src homology 3 domain of Abl Interactor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-05
Identities = 24/60 (40%), Positives = 33/60 (55%), Gaps = 9/60 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96
A+YDY DELS + G I+ V+ K+ D GW+ G + G G+FP N+V SI
Sbjct: 7 AIYDYTKDKEDELSFQEGAIIYVIKKN-----DDGWYEGVMNG----VTGLFPGNYVESI 57
|
Abi2 is highly expressed in the brain and eye. It regulates actin cytoskeletal reorganization at adherens junctions and dendritic spines, which is important in cell morphogenesis, migration, and cognitive function. Mice deficient with Abi2 show defects in orientation and migration of lens fibers, neuronal migration, dendritic spine morphology, as well as deficits in learning and memory. Abi proteins are adaptor proteins serving as binding partners and substrates of Abl tyrosine kinases. They are involved in regulating actin cytoskeletal reorganization and play important roles in membrane-ruffling, endocytosis, cell motility, and cell migration. Abi proteins contain a homeobox homology domain, a proline-rich region, and a SH3 domain. The SH3 domain of Abi binds to a PxxP motif in Abl. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 61 |
| >gnl|CDD|212966 cd12033, SH3_MPP7, Src Homology 3 domain of Membrane Protein, Palmitoylated 7 (or MAGUK p55 subfamily member 7) | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-05
Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 12/62 (19%)
Query: 36 RALYDYD-----AIGLDE--LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIF 88
+AL+DY+ AI E LS ++GDI++++S+D D WW K EG + G+
Sbjct: 3 KALFDYNPNEDKAIPCKEAGLSFKKGDILQIMSQD-----DATWWQAKHEGDANPRAGLI 57
Query: 89 PA 90
P+
Sbjct: 58 PS 59
|
MPP7 is a scaffolding protein that binds to DLG1 and promotes tight junction formation and epithelial cell polarity. Mutations in the MPP7 gene may be associated with the pathogenesis of diabetes and extreme bone mineral density. It is one of seven vertebrate homologs of the Drosophila Stardust protein, which is required in establishing cell polarity, and it contains two L27 domains followed by the core of three domains characteristic of MAGUK (membrane-associated guanylate kinase) proteins: PDZ, SH3, and guanylate kinase (GuK). The GuK domain in MAGUK proteins is enzymatically inactive; instead, the domain mediates protein-protein interactions and associates intramolecularly with the SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 61 |
| >gnl|CDD|212984 cd12051, SH3_DOCK1_5_A, Src Homology 3 domain of Class A Dedicator of Cytokinesis proteins 1 and 5 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-05
Identities = 25/57 (43%), Positives = 34/57 (59%), Gaps = 7/57 (12%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A+Y+YDA G DELSL+ GD V +L GW+ G K + K GIFPA+++
Sbjct: 4 AIYNYDARGPDELSLQIGDTVHILETYE------GWYRGYTLRK-KSKKGIFPASYI 53
|
Dock1, also called Dock180, and Dock5 are class A DOCKs and are atypical guanine nucleotide exchange factors (GEFs) that lack the conventional Dbl homology (DH) domain. Dock1 interacts with the scaffold protein Elmo and the resulting complex functions upstream of Rac in many biological events including phagocytosis of apoptotic cells, cell migration and invasion. Dock5 functions upstream of Rac1 to regulate osteoclast function. All DOCKs contain two homology domains: the DHR-1 (Dock homology region-1), also called CZH1 (CED-5, Dock180, and MBC-zizimin homology 1), and DHR-2 (also called CZH2 or Docker). The DHR-1 domain binds phosphatidylinositol-3,4,5-triphosphate while DHR-2 contains the catalytic activity for Rac and/or Cdc42. Class A DOCKs also contain an SH3 domain at the N-terminal region and a PxxP motif at the C-terminus; they are specific GEFs for Rac. The SH3 domain of Dock1 binds to DHR-2 in an autoinhibitory manner; binding of Elmo to the SH3 domain of Dock1 exposes the DHR-2 domain and promotes GEF activity. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|212720 cd11786, SH3_SH3RF_1, First Src Homology 3 domain of SH3 domain containing ring finger proteins | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 1e-05
Identities = 21/58 (36%), Positives = 33/58 (56%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ALY+Y+ +LS ++GDI+ +L K D W+ G+ GK G FPA++V
Sbjct: 3 KALYNYEGKEPGDLSFKKGDII-LLRKRI----DENWYHGECNGKQ----GFFPASYV 51
|
This model represents the first SH3 domain of SH3RF1 (or POSH), SH3RF2 (or POSHER), SH3RF3 (POSH2), and similar domains. Members of this family are scaffold proteins that function as E3 ubiquitin-protein ligases. They all contain an N-terminal RING finger domain and multiple SH3 domains; SH3RF1 and SH3RF3 have four SH3 domains while SH3RF2 has three. SH3RF1 plays a role in calcium homeostasis through the control of the ubiquitin domain protein Herp. It may also have a role in regulating death receptor mediated and JNK mediated apoptosis. SH3RF3 interacts with p21-activated kinase 2 (PAK2) and GTP-loaded Rac1. It may play a role in regulating JNK mediated apoptosis in certain conditions. SH3RF2 acts as an anti-apoptotic regulator of the JNK pathway by binding to and promoting the degradation of SH3RF1. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212994 cd12061, SH3_betaPIX, Src Homology 3 domain of beta-Pak Interactive eXchange factor | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-05
Identities = 20/61 (32%), Positives = 31/61 (50%), Gaps = 9/61 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA +++ DELS +GD++ V + + GWW G G + G FP+N+V
Sbjct: 3 RAKFNFQQTNEDELSFSKGDVIHVTRVE-----EGGWWEGTHNG----RTGWFPSNYVRE 53
Query: 96 I 96
I
Sbjct: 54 I 54
|
Beta-PIX, also called Rho guanine nucleotide exchange factor 7 (ARHGEF7) or Cool (Cloned out of Library)-1, activates small GTPases by exchanging bound GDP for free GTP. It acts as a GEF for both Cdc42 and Rac 1, and plays important roles in regulating neuroendocrine exocytosis, focal adhesion maturation, cell migration, synaptic vesicle localization, and insulin secretion. PIX proteins contain an N-terminal SH3 domain followed by RhoGEF (also called Dbl-homologous or DH) and Pleckstrin Homology (PH) domains, and a C-terminal leucine-zipper domain for dimerization. The SH3 domain of PIX binds to an atypical PxxxPR motif in p21-activated kinases (PAKs) with high affinity. The binding of PAKs to PIX facilitate the localization of PAKs to focal complexes and also localizes PAKs to PIX targets Cdc43 and Rac, leading to the activation of PAKs. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|212987 cd12054, SH3_CD2AP_2, Second Src Homology 3 domain (SH3B) of CD2-associated protein | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-05
Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 9/61 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ L++Y DEL L+ GDI+++ + + GWW+G + GK G+FP+NFV
Sbjct: 4 KVLFEYVPQNEDELELKVGDIIDINEE-----VEEGWWSGTLNGKS----GLFPSNFVKE 54
Query: 96 I 96
+
Sbjct: 55 L 55
|
CD2AP, also called CMS (Cas ligand with Multiple SH3 domains) or METS1 (Mesenchyme-to-Epithelium Transition protein with SH3 domains), is a cytosolic adaptor protein that plays a role in regulating the cytoskeleton. It is critical in cell-to-cell union necessary for kidney function. It also stabilizes the contact between a T cell and antigen-presenting cells. It is primarily expressed in podocytes at the cytoplasmic face of the slit diaphragm and serves as a linker anchoring podocin and nephrin to the actin cytoskeleton. CD2AP contains three SH3 domains, a proline-rich region, and a C-terminal coiled-coil domain. All of these domains enable CD2AP to bind various protein partners and assemble complexes that have been implicated in many different functions. This alignment model represents the second SH3 domain (SH3B) of CD2AP. SH3B binds to c-Cbl in a site (TPSSRPLR is the core binding motif) distinct from the c-Cbl/SH3A binding site. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212721 cd11787, SH3_SH3RF_2, Second Src Homology 3 domain of SH3 domain containing ring finger proteins | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-05
Identities = 20/60 (33%), Positives = 34/60 (56%), Gaps = 12/60 (20%)
Query: 36 RALYDYDAIGLDE---LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
+ALYD++ DE L+ ++GD++ V+ + D W EG++ K+GIFP +F
Sbjct: 3 KALYDFEMKDEDEKDCLTFKKGDVITVIRRV-----DENW----AEGRLGDKIGIFPISF 53
|
This model represents the second SH3 domain of SH3RF1 (or POSH), SH3RF2 (or POSHER), SH3RF3 (POSH2), and similar domains. Members of this family are scaffold proteins that function as E3 ubiquitin-protein ligases. They all contain an N-terminal RING finger domain and multiple SH3 domains; SH3RF1 and SH3RF3 have four SH3 domains while SH3RF2 has three. SH3RF1 plays a role in calcium homeostasis through the control of the ubiquitin domain protein Herp. It may also have a role in regulating death receptor mediated and JNK mediated apoptosis. SH3RF3 interacts with p21-activated kinase 2 (PAK2) and GTP-loaded Rac1. It may play a role in regulating JNK mediated apoptosis in certain conditions. SH3RF2 acts as an anti-apoptotic regulator of the JNK pathway by binding to and promoting the degradation of SH3RF1. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212977 cd12044, SH3_SKAP1, Src Homology 3 domain of Src Kinase-Associated Phosphoprotein 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-05
Identities = 21/59 (35%), Positives = 35/59 (59%), Gaps = 7/59 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
++ L+D DELS +RGD++ +LSK+ + GWW G++ G VGI P +++
Sbjct: 2 YQGLWDCFGDNPDELSFQRGDLIYILSKEYNM---YGWWVGELNG----IVGIVPKDYL 53
|
SKAP1, also called SKAP55 (Src kinase-associated protein of 55kDa), is an immune cell-specific adaptor protein that plays an important role in T-cell adhesion, migration, and integrin clustering. It is expressed exclusively in T-lymphocytes, mast cells, and macrophages. Binding partners include ADAP (adhesion and degranulation-promoting adaptor protein), Fyn, Riam, RapL, and RasGRP. It contains a pleckstrin homology (PH) domain, a C-terminal SH3 domain, and several tyrosine phosphorylation sites. The SH3 domain of SKAP1 is necessary for its ability to regulate T-cell conjugation with antigen-presenting cells and the formation of LFA-1 clusters. SKAP1 binds primarily to a proline-rich region of ADAP through its SH3 domain; its degradation is regulated by ADAP. A secondary interaction occurs via the ADAP SH3 domain and the RKxxYxxY motif in SKAP1. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212866 cd11933, SH3_Nebulin_C, C-terminal Src Homology 3 domain of Nebulin | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-05
Identities = 25/62 (40%), Positives = 34/62 (54%), Gaps = 9/62 (14%)
Query: 36 RALYDYDAIGLDELSLRRGD-IVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
RA+YDY A DE+S + GD IV V + D GW G ++ K G+ PAN+V
Sbjct: 5 RAMYDYRAADDDEVSFKDGDTIVNVQTIDE------GWMYGTVQRT--GKTGMLPANYVE 56
Query: 95 SI 96
+I
Sbjct: 57 AI 58
|
Nebulin is a giant filamentous protein (600-900 kD) that is expressed abundantly in skeletal muscle. It binds to actin thin filaments and regulates its assembly and function. Nebulin was thought to be part of a molecular ruler complex that is critical in determining the lengths of actin thin filaments in skeletal muscle since its length, which varies due to alternative splicing, correlates with the length of thin filaments in various muscle types. Recent studies indicate that nebulin regulates thin filament length by stabilizing the filaments and preventing depolymerization. Mutations in nebulin can cause nemaline myopathy, characterized by muscle weakness which can be severe and can lead to neonatal lethality. Nebulin contains an N-terminal LIM domain, many nebulin repeats/super repeats, and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 58 |
| >gnl|CDD|212707 cd11773, SH3_Sla1p_1, First Src Homology 3 domain of the fungal endocytic adaptor protein Sla1p | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-05
Identities = 20/62 (32%), Positives = 34/62 (54%), Gaps = 8/62 (12%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEG---KIEYKVGIFPA 90
+++ALYDY+ DEL+++ DI+ +L K D WW K++ + VG+ PA
Sbjct: 1 VYKALYDYEPQTEDELTIQEDDILYLLEKS-----DDDWWKVKLKVNSSDDDEPVGLVPA 55
Query: 91 NF 92
+
Sbjct: 56 TY 57
|
Sla1p facilitates endocytosis by playing a role as an adaptor protein in coupling components of the actin cytoskeleton to the endocytic machinery. It interacts with Abp1p, Las17p and Pan1p, which are activator proteins of actin-related protein 2/3 (Arp2/3). Sla1p contains multiple domains including three SH3 domains, a SAM (sterile alpha motif) domain, and a Sla1 homology domain 1 (SHD1), which binds to the NPFXD motif that is found in many integral membrane proteins such as the Golgi-localized Arf-binding protein Lsb5p and the P4-ATPases, Drs2p and Dnf1p. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 57 |
| >gnl|CDD|212893 cd11960, SH3_Abp1_eu, Src homology 3 domain of eumetazoan Actin-binding protein 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-05
Identities = 24/61 (39%), Positives = 30/61 (49%), Gaps = 14/61 (22%)
Query: 36 RALYDYDAIGLDELSLRRGDI---VEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
RALYDY A E+S GDI +E + D GWW G + G+FPAN+
Sbjct: 3 RALYDYQAADDTEISFDPGDIITDIEQI--------DEGWWRGTGP---DGTYGLFPANY 51
Query: 93 V 93
V
Sbjct: 52 V 52
|
Abp1, also called drebrin-like protein, is an adaptor protein that functions in receptor-mediated endocytosis and vesicle trafficking. It contains an N-terminal actin-binding module, the actin-depolymerizing factor (ADF) homology domain, a helical domain, and a C-terminal SH3 domain. Mammalian Abp1, unlike yeast Abp1, does not contain an acidic domain that interacts with the Arp2/3 complex. It regulates actin dynamics indirectly by interacting with dynamin and WASP family proteins. Abp1 deficiency causes abnormal organ structure and function of the spleen, heart, and lung of mice. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|212751 cd11817, SH3_Eve1_4, Fourth Src homology 3 domain of ADAM-binding protein Eve-1 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-05
Identities = 19/56 (33%), Positives = 27/56 (48%), Gaps = 9/56 (16%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
ALYD+ ++LS +RGD + V D W G++ G + GIFP F
Sbjct: 4 ALYDFTGETEEDLSFQRGDRILVTEHL-----DAEWSRGRLNG----REGIFPRAF 50
|
Eve-1, also called SH3 domain-containing protein 19 (SH3D19) or EEN-binding protein (EBP), exists in multiple alternatively spliced isoforms. The longest isoform contains five SH3 domain in the C-terminal region and seven proline-rich motifs in the N-terminal region. It is abundantly expressed in skeletal muscle and heart, and may be involved in regulating the activity of ADAMs (A disintegrin and metalloproteases). Eve-1 interacts with EEN, an endophilin involved in endocytosis and may be the target of the MLL-EEN fusion protein that is implicated in leukemogenesis. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 50 |
| >gnl|CDD|212749 cd11815, SH3_Eve1_2, Second Src homology 3 domain of ADAM-binding protein Eve-1 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-05
Identities = 23/56 (41%), Positives = 30/56 (53%), Gaps = 9/56 (16%)
Query: 38 LYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
L+D+ A D+LSL G+IV +L K D W+ GK + GIFPAN V
Sbjct: 5 LHDFPAEHSDDLSLNSGEIVYLLEKI-----DTEWYRGKCKNTT----GIFPANHV 51
|
Eve-1, also called SH3 domain-containing protein 19 (SH3D19) or EEN-binding protein (EBP), exists in multiple alternatively spliced isoforms. The longest isoform contains five SH3 domain in the C-terminal region and seven proline-rich motifs in the N-terminal region. It is abundantly expressed in skeletal muscle and heart, and may be involved in regulating the activity of ADAMs (A disintegrin and metalloproteases). Eve-1 interacts with EEN, an endophilin involved in endocytosis and may be the target of the MLL-EEN fusion protein that is implicated in leukemogenesis. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 52 |
| >gnl|CDD|212904 cd11971, SH3_Abi1, Src homology 3 domain of Abl Interactor 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-05
Identities = 24/60 (40%), Positives = 31/60 (51%), Gaps = 9/60 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96
A+YDY DELS G I+ V+ K+ D GW+ G G G+FP N+V SI
Sbjct: 4 AIYDYSKDKDDELSFMEGAIIYVIKKN-----DDGWYEGVCNG----VTGLFPGNYVESI 54
|
Abi1, also called e3B1, is a central regulator of actin cytoskeletal reorganization through interactions with many protein complexes. It is part of WAVE, a nucleation-promoting factor complex, that links Rac 1 activation to actin polymerization causing lamellipodia protrusion at the plasma membrane. Abi1 interact with formins to promote protrusions at the leading edge of motile cells. It also is a target of alpha4 integrin, regulating membrane protrusions at sites of integrin engagement. Abi proteins are adaptor proteins serving as binding partners and substrates of Abl tyrosine kinases. They are involved in regulating actin cytoskeletal reorganization and play important roles in membrane-ruffling, endocytosis, cell motility, and cell migration. Abi proteins contain a homeobox homology domain, a proline-rich region, and a SH3 domain. The SH3 domain of Abi binds to a PxxP motif in Abl. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 59 |
| >gnl|CDD|213015 cd12139, SH3_Bin1, Src Homology 3 domain of Bridging integrator 1 (Bin1), also called Amphiphysin-2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-05
Identities = 24/63 (38%), Positives = 32/63 (50%), Gaps = 6/63 (9%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEG------KIEYKVGIFP 89
+A +DY A DEL L+ GD+V V+ + D GW G E K+E G+FP
Sbjct: 6 QAQHDYTATDTDELQLKAGDVVLVIPFQNPEEQDEGWLMGVKESDWNQHKKLEKCRGVFP 65
Query: 90 ANF 92
NF
Sbjct: 66 ENF 68
|
Bin1 isoforms are localized in many different tissues and may function in intracellular vesicle trafficking. It plays a role in the organization and maintenance of the T-tubule network in skeletal muscle. Mutations in Bin1 are associated with autosomal recessive centronuclear myopathy. Bin1 contains an N-terminal BAR domain with an additional N-terminal amphipathic helix (an N-BAR) and a C-terminal SH3 domain. The SH3 domain of Bin1 forms transient complexes with actin, myosin filaments, and CDK5, to facilitate sarcomere organization and myofiber maturation. It also binds dynamin and prevents its self-assembly. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 72 |
| >gnl|CDD|212978 cd12045, SH3_SKAP2, Src Homology 3 domain of Src Kinase-Associated Phosphoprotein 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-05
Identities = 20/59 (33%), Positives = 33/59 (55%), Gaps = 7/59 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
++ L+D DELS +RGD + +LSK+ GWW G+++G I G+ P ++
Sbjct: 2 YQGLWDCTGDQPDELSFKRGDTIYILSKEYNR---FGWWVGEMKGTI----GLVPKAYI 53
|
SKAP2, also called SKAP55-Related (SKAP55R) or SKAP55 homolog (SKAP-HOM or SKAP55-HOM), is an immune cell-specific adaptor protein that plays an important role in adhesion and migration of B-cells and macrophages. Binding partners include ADAP (adhesion and degranulation-promoting adaptor protein), YopH, SHPS1, and HPK1. SKAP2 has also been identified as a substrate for lymphoid-specific tyrosine phosphatase (Lyp), which has been implicated in a wide variety of autoimmune diseases. It contains a pleckstrin homology (PH) domain, a C-terminal SH3 domain, and several tyrosine phosphorylation sites. Like SKAP1, SKAP2 is expected to bind primarily to a proline-rich region of ADAP through its SH3 domain; its degradation may be regulated by ADAP. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212867 cd11934, SH3_Lasp1_C, C-terminal Src Homology 3 domain of LIM and SH3 domain protein 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-05
Identities = 25/63 (39%), Positives = 35/63 (55%), Gaps = 9/63 (14%)
Query: 35 WRALYDYDAIGLDELSLRRGD-IVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+RA+YDY+A DE+S + GD IV V D GW G +E + G+ PAN+V
Sbjct: 5 YRAVYDYNAADEDEVSFQDGDTIVNVQQIDD------GWMYGTVERTGD--TGMLPANYV 56
Query: 94 SSI 96
+I
Sbjct: 57 EAI 59
|
Lasp1 is a cytoplasmic protein that binds focal adhesion proteins and is involved in cell signaling, migration, and proliferation. It is overexpressed in several cancer cells including breast, ovarian, bladder, and liver. In cancer cells, it can be found in the nucleus; its degree of nuclear localization correlates with tumor size and poor prognosis. Lasp1 is a 36kD protein containing an N-terminal LIM domain, two nebulin repeats, and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 59 |
| >gnl|CDD|212785 cd11851, SH3_RIM-BP, Src homology 3 domains of Rab3-interacting molecules (RIMs) binding proteins | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 5e-05
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 16/70 (22%)
Query: 34 LWRALYDYDAIGL-------DELSLRRGDIVEVL-SKDSAISGDVGWWTGKIEGKIEYKV 85
L ALYDY+ + +ELS GD+V V D + G++ G++EG +
Sbjct: 1 LMVALYDYNPETMSPNDDPEEELSFHAGDVVRVYGPMD-----EDGFYYGELEGG---RK 52
Query: 86 GIFPANFVSS 95
G+ P+NFV
Sbjct: 53 GLVPSNFVQE 62
|
RIMs binding proteins (RBPs, RIM-BPs) associate with calcium channels present in photoreceptors, neurons, and hair cells; they interact simultaneously with specific calcium channel subunits, and active zone proteins, RIM1 and RIM2. RIMs are part of the matrix at the presynaptic active zone and are associated with synaptic vesicles through their interaction with the small GTPase Rab3. RIM-BPs play a role in regulating synaptic transmission by serving as adaptors and linking calcium channels with the synaptic vesicle release machinery. RIM-BPs contain three SH3 domains and two to three fibronectin III repeats. Invertebrates contain one, while vertebrates contain at least two RIM-BPs, RIM-BP1 and RIM-BP2. RIM-BP1 is also called peripheral-type benzodiazapine receptor associated protein 1 (PRAX-1). Mammals contain a third protein, RIM-BP3. RIM-BP1 and RIM-BP2 are predominantly expressed in the brain where they display overlapping but distinct expression patterns, while RIM-BP3 is almost exclusively expressed in the testis and is essential in spermiogenesis. The SH3 domains of RIM-BPs bind to the PxxP motifs of RIM1, RIM2, and L-type (alpha1D) and N-type (alpha1B) calcium channel subunits. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 62 |
| >gnl|CDD|212988 cd12055, SH3_CIN85_2, Second Src Homology 3 domain (SH3B) of Cbl-interacting protein of 85 kDa | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-05
Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 9/47 (19%)
Query: 47 DELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
DEL L+ GDI+EV+ + + GWW G + G K G+FP+NF+
Sbjct: 14 DELELKVGDIIEVVGE-----VEEGWWEGVLNG----KTGMFPSNFI 51
|
CIN85, also called SH3 domain-containing kinase-binding protein 1 (SH3KBP1) or CD2-binding protein 3 (CD2BP3) or Ruk, is an adaptor protein that is involved in the downregulation of receptor tyrosine kinases by facilitating endocytosis through interaction with endophilin-associated ubiquitin ligase Cbl proteins. It is also important in many other cellular processes including vesicle-mediated transport, cytoskeletal remodelling, apoptosis, cell adhesion and migration, and viral infection, among others. CIN85 exists as multiple variants from alternative splicing; the main variant contains three SH3 domains, a proline-rich region, and a C-terminal coiled-coil domain. All of these domains enable CIN85 to bind various protein partners and assemble complexes that have been implicated in many different functions. This alignment model represents the second SH3 domain (SH3B) of CIN85. SH3B has been shown to bind Cbl proline-rich peptides and ubiquitin. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212828 cd11895, SH3_FCHSD1_2, Second Src Homology 3 domain of FCH and double SH3 domains protein 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-05
Identities = 21/63 (33%), Positives = 33/63 (52%), Gaps = 5/63 (7%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
L RALY Y +ELS G ++ +L + + D G+W G+ G +VG+FP+ V
Sbjct: 1 LARALYSYTGQSPEELSFPEGALIRLLPR-AQDGVDDGFWRGEFGG----RVGVFPSLLV 55
Query: 94 SSI 96
+
Sbjct: 56 EEL 58
|
FCHSD1 has a domain structure consisting of an N-terminal F-BAR (FES-CIP4 Homology and Bin/Amphiphysin/Rvs), two SH3, and C-terminal proline-rich domains. It has only been characterized in silico and its function is unknown. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 58 |
| >gnl|CDD|212718 cd11784, SH3_SH3RF2_3, Third Src Homology 3 domain of SH3 domain containing ring finger 2 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 6e-05
Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 7/58 (12%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
AL+ Y A +EL L++G+ V VL K GW G + +VGIFP+N+VS
Sbjct: 4 ALHSYSAHRPEELELQKGEGVRVLGKFQE-----GWLRGL--SLVTGRVGIFPSNYVS 54
|
SH3RF2 is also called POSHER (POSH-eliminating RING protein) or HEPP1 (heart protein phosphatase 1-binding protein). It acts as an anti-apoptotic regulator of the JNK pathway by binding to and promoting the degradation of SH3RF1 (or POSH), a scaffold protein that is required for pro-apoptotic JNK activation. It may also play a role in cardiac functions together with protein phosphatase 1. SH3RF2 contains an N-terminal RING finger domain and three SH3 domains. This model represents the third SH3 domain, located in the middle, of SH3RF2. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212789 cd11855, SH3_Sho1p, Src homology 3 domain of High osmolarity signaling protein Sho1p | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 6e-05
Identities = 25/60 (41%), Positives = 33/60 (55%), Gaps = 11/60 (18%)
Query: 36 RALYDYDAIGLD--ELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RALY YDA D ELS +G+I+EV S SG WW + K + GI P+N++
Sbjct: 3 RALYPYDASPDDPNELSFEKGEILEV----SDTSGK--WWQAR---KSNGETGICPSNYL 53
|
Sho1p (or Sho1), also called SSU81 (Suppressor of SUA8-1 mutation), is a yeast membrane protein that regulates adaptation to high salt conditions by activating the HOG (high-osmolarity glycerol) pathway. High salt concentrations lead to the localization to the membrane of the MAPKK Pbs2, which is then activated by the MAPKK Ste11 and in turn, activates the MAPK Hog1. Pbs2 is localized to the membrane though the interaction of its PxxP motif with the SH3 domain of Sho1p. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212737 cd11803, SH3_Endophilin_A, Src homology 3 domain of Endophilin-A | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 7e-05
Identities = 19/61 (31%), Positives = 31/61 (50%), Gaps = 9/61 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYD++ EL + GDI+ + ++ D W+ G + G + G FP N+V
Sbjct: 4 RALYDFEPENEGELGFKEGDIITLTNQI-----DENWYEGMVNG----QSGFFPVNYVEV 54
Query: 96 I 96
+
Sbjct: 55 L 55
|
Endophilins play roles in synaptic vesicle formation, virus budding, mitochondrial morphology maintenance, receptor-mediated endocytosis inhibition, and endosomal sorting. They are classified into two types, A and B. Vertebrates contain three endophilin-A isoforms (A1, A2, and A3). Endophilin-A proteins are enriched in the brain and play multiple roles in receptor-mediated endocytosis. They tubulate membranes and regulate calcium influx into neurons to trigger the activation of the endocytic machinery. They are also involved in the sorting of plasma membrane proteins, actin filament assembly, and the uncoating of clathrin-coated vesicles for fusion with endosomes. Endophilins contain an N-terminal N-BAR domain (BAR domain with an additional N-terminal amphipathic helix), followed by a variable region containing proline clusters, and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212692 cd11758, SH3_CRK_N, N-terminal Src Homology 3 domain of Ct10 Regulator of Kinase adaptor proteins | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 8e-05
Identities = 17/60 (28%), Positives = 30/60 (50%), Gaps = 10/60 (16%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGK-IEGKIEYKVGIFPANFVS 94
RAL+D+ ++L ++G+I+ V+ K + WW + EGK G+ P +V
Sbjct: 4 RALFDFPGNDDEDLPFKKGEILTVIRKP-----EEQWWNARNSEGKT----GMIPVPYVE 54
|
CRK adaptor proteins consists of SH2 and SH3 domains, which bind tyrosine-phosphorylated peptides and proline-rich motifs, respectively. They function downstream of protein tyrosine kinases in many signaling pathways started by various extracellular signals, including growth and differentiation factors. Cellular CRK (c-CRK) contains a single SH2 domain, followed by N-terminal and C-terminal SH3 domains. It is involved in the regulation of many cellular processes including cell growth, motility, adhesion, and apoptosis. CRK has been implicated in the malignancy of various human cancers. The N-terminal SH3 domain of CRK binds a number of target proteins including DOCK180, C3G, SOS, and cABL. The CRK family includes two alternatively spliced protein forms, CRKI and CRKII, that are expressed by the CRK gene, and the CRK-like (CRKL) protein, which is expressed by a distinct gene (CRKL). SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212868 cd11935, SH3_Nebulette_C, C-terminal Src Homology 3 domain of Nebulette and LIM-nebulette (or Lasp2) | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-05
Identities = 20/62 (32%), Positives = 32/62 (51%), Gaps = 7/62 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+RA+YDY A DE+S R GD + + D GW G ++ + G+ PAN++
Sbjct: 3 YRAMYDYSAQDEDEVSFRDGDYIVNVQPI-----DEGWMYGTVQRT--GRTGMLPANYIE 55
Query: 95 SI 96
+
Sbjct: 56 FV 57
|
Nebulette is a cardiac-specific protein that localizes to the Z-disc. It interacts with tropomyosin and is important in stabilizing actin thin filaments in cardiac muscles. Polymorphisms in the nebulette gene are associated with dilated cardiomyopathy, with some mutations resulting in severe heart failure. Nebulette is a 107kD protein that contains an N-terminal acidic region, multiple nebulin repeats, and a C-terminal SH3 domain. LIM-nebulette, also called Lasp2 (LIM and SH3 domain protein 2), is an alternatively spliced variant of nebulette. Although it shares a gene with nebulette, Lasp2 is not transcribed from a muscle-specific promoter, giving rise to its multiple tissue expression pattern with highest amounts in the brain. It can crosslink actin filaments and it affects cell spreading. Lasp2 is a 34kD protein containing an N-terminal LIM domain, three nebulin repeats, and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 58 |
| >gnl|CDD|212903 cd11970, SH3_PLCgamma1, Src homology 3 domain of Phospholipase C (PLC) gamma 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 9e-05
Identities = 22/61 (36%), Positives = 32/61 (52%), Gaps = 8/61 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+AL+DY A DEL+ + I++ + K + GWW G GK K FP+N+V
Sbjct: 7 KALFDYKAQREDELTFTKNAIIQNVEKQ-----EGGWWRGDYGGK---KQLWFPSNYVEE 58
Query: 96 I 96
I
Sbjct: 59 I 59
|
PLCgamma1 is widely expressed and is essential in growth and development. It is activated by the TrkA receptor tyrosine kinase and functions as a key regulator of cell differentiation. It is also the predominant PLCgamma in T cells and is required for T cell and NK cell function. PLCs catalyze the hydrolysis of phosphatidylinositol (4,5)-bisphosphate [PtdIns(4,5)P2] to produce Ins(1,4,5)P3 and diacylglycerol (DAG). Ins(1,4,5)P3 initiates the calcium signaling cascade while DAG functions as an activator of PKC. PLCgamma contains a Pleckstrin homology (PH) domain followed by an elongation factor (EF) domain, two catalytic regions of PLC domains that flank two tandem SH2 domains, followed by a SH3 domain and C2 domain. The SH3 domain of PLCgamma1 directly interacts with dynamin-1 and can serve as a guanine nucleotide exchange factor (GEF). It also interacts with Cbl, inhibiting its phosphorylation and activity. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 60 |
| >gnl|CDD|212885 cd11952, SH3_iASPP, Src Homology 3 (SH3) domain of Inhibitor of ASPP protein (iASPP) | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 1e-04
Identities = 22/56 (39%), Positives = 28/56 (50%), Gaps = 7/56 (12%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
AL+DY A DELS + GD+V VL KD WW + G + G P N+
Sbjct: 5 ALWDYSAEFPDELSFKEGDMVTVLRKDGE---GTDWWWASLCG----REGYVPRNY 53
|
iASPP, also called RelA-associated inhibitor (RAI), is an oncoprotein that inhibits the apoptotic transactivation potential of p53. It is upregulated in human breast cancers expressing wild-type p53, in acute leukemias regardless of the p53 mutation status, as well as in ovarian cancer where it is associated with poor patient outcome and chemoresistance. iASPP is also a binding partner and negative regulator of p65RelA, which promotes cell proliferation and inhibits apoptosis; p65RelA has the opposite effect on cell growth compared to the p53 family. It contains a proline-rich region, four ankyrin (ANK) repeats, and an SH3 domain at its C-terminal half. The SH3 domain and the ANK repeats of iASPP contribute to the p53 binding site; they bind to the DNA binding domain of p53. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|212898 cd11965, SH3_ASAP1, Src homology 3 domain of ArfGAP with SH3 domain, ankyrin repeat and PH domain containing protein 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 1e-04
Identities = 22/58 (37%), Positives = 33/58 (56%), Gaps = 6/58 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ +YD A DEL+ G+++ V ++ D WW G IEG+ E K G+FP +FV
Sbjct: 3 KTIYDCQADNDDELTFVEGEVIIVTGEE-----DQEWWIGHIEGQPERK-GVFPVSFV 54
|
ASAP1 is also called DDEF1 (Development and Differentiation Enhancing Factor 1), AMAP1, centaurin beta-4, or PAG2. an Arf GTPase activating protein (GAP) with activity towards Arf1 and Arf5 but not Arf6. However, it has been shown to bind GTP-Arf6 stably without GAP activity. It has been implicated in cell growth, migration, and survival, as well as in tumor invasion and malignancy. It binds paxillin and cortactin, two components of invadopodia which are essential for tumor invasiveness. It also binds focal adhesion kinase (FAK) and the SH2/SH3 adaptor CrkL. ASAP1 contains an N-terminal BAR domain, followed by a Pleckstrin homology (PH) domain, an Arf GAP domain, ankyrin (ANK) repeats, and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 57 |
| >gnl|CDD|212818 cd11885, SH3_SH3TC, Src Homology 3 domain of SH3 domain and tetratricopeptide repeat-containing (SH3TC) proteins and similar domains | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 1e-04
Identities = 17/62 (27%), Positives = 29/62 (46%), Gaps = 13/62 (20%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVG----WWTGKIEGKIEYKVGIFPAN 91
A D++ + ELS R+GD +E++ GD+ W+ G+ + +VG P N
Sbjct: 3 TAKMDFEGVEPGELSFRQGDSIEII-------GDLIPGLQWFVGRSKS--SGRVGFVPTN 53
Query: 92 FV 93
Sbjct: 54 HF 55
|
This subfamily is composed of vertebrate SH3TC proteins and hypothetical fungal proteins containing BAR and SH3 domains. Mammals contain two SH3TC proteins, SH3TC1 and SH3TC2. The function of SH3TC1 is unknown. SH3TC2 is localized in Schwann cells in the peripheral nervous system, where it interacts with Rab11 and plays a role in peripheral nerve myelination. Mutations in SH3TC2 are associated with Charcot-Marie-Tooth disease type 4C, a severe hereditary peripheral neuropathy with symptoms that include progressive scoliosis, delayed age of walking, muscular atrophy, distal weakness, and reduced nerve conduction velocity. SH3 domains bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs; they play a role in the regulation of enzymes by intramolecular interactions, changing the subcellular localization of signal pathway components and mediate multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212853 cd11920, SH3_Sorbs2_1, First Src Homology 3 domain of Sorbin and SH3 domain containing 2 (Sorbs2), also called Arg-binding protein 2 (ArgBP2) | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 1e-04
Identities = 23/61 (37%), Positives = 34/61 (55%), Gaps = 9/61 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA+YD+ A ELS ++GD V +L K D W+ G+ G +VGIFP ++V
Sbjct: 4 RAVYDFKAQTSKELSFKKGDTVYILRKI-----DQNWYEGEHHG----RVGIFPISYVEK 54
Query: 96 I 96
+
Sbjct: 55 L 55
|
Sorbs2 or ArgBP2 is an adaptor protein containing one sorbin homology (SoHo) and three SH3 domains. It regulates actin-dependent processes including cell adhesion, morphology, and migration. It is expressed in many tissues and is abundant in the heart. Like vinexin, it is found in focal adhesion where it interacts with vinculin and afadin. It also localizes in epithelial cell stress fibers and in cardiac muscle cell Z-discs. Sorbs2 has been implicated to play roles in the signaling of c-Arg, Akt, and Pyk2. Other interaction partners of Sorbs2 include c-Abl, flotillin, spectrin, dynamin 1/2, synaptojanin, PTP-PEST, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212850 cd11917, SH3_Sorbs2_3, Third (or C-terminal) Src Homology 3 domain of Sorbin and SH3 domain containing 2 (Sorbs2), also called Arg-binding protein 2 (ArgBP2) | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 1e-04
Identities = 22/62 (35%), Positives = 33/62 (53%), Gaps = 7/62 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
++ALY+Y DEL LR GD+++V+ K D GW+ G + G FP N+V
Sbjct: 7 FQALYNYMPRNEDELELREGDVIDVMEK-----CDDGWFVGT--SRRTKFFGTFPGNYVK 59
Query: 95 SI 96
+
Sbjct: 60 RL 61
|
Sorbs2 or ArgBP2 is an adaptor protein containing one sorbin homology (SoHo) and three SH3 domains. It regulates actin-dependent processes including cell adhesion, morphology, and migration. It is expressed in many tissues and is abundant in the heart. Like vinexin, it is found in focal adhesion where it interacts with vinculin and afadin. It also localizes in epithelial cell stress fibers and in cardiac muscle cell Z-discs. Sorbs2 has been implicated to play roles in the signaling of c-Arg, Akt, and Pyk2. Other interaction partners of Sorbs2 include c-Abl, flotillin, spectrin, dynamin 1/2, synaptojanin, PTP-PEST, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 61 |
| >gnl|CDD|212740 cd11806, SH3_PRMT2, Src homology 3 domain of Protein arginine N-methyltransferase 2 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 1e-04
Identities = 17/59 (28%), Positives = 24/59 (40%), Gaps = 9/59 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A+ D+ A +LS GD + VL K S WW + G Y PA+ +
Sbjct: 4 AIADFVATDDSQLSFESGDKLLVLRKPSVD-----WWWAEHNGCCGY----IPASHLHQ 53
|
PRMT2, also called HRMT1L1, belongs to the arginine methyltransferase protein family. It functions as a coactivator to both estrogen receptor alpha (ER-alpha) and androgen receptor (AR), presumably through arginine methylation. The ER-alpha transcription factor is involved in cell proliferation, differentiation, morphogenesis, and apoptosis, and is also implicated in the development and progression of breast cancer. PRMT2 and its variants are upregulated in breast cancer cells and may be involved in modulating the ER-alpha signaling pathway during formation of breast cancer. PRMT2 also plays a role in regulating the function of E2F transcription factors, which are critical cell cycle regulators, by binding to the retinoblastoma gene product (RB). It contains an N-terminal SH3 domain and an AdoMet binding domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYK----GIYEKQE---VAIKVAHPNPDENILENVKQEGK 165
E N+L FG+ +G G FGKV + G+++ VA+K+ P+ E + E K
Sbjct: 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELK 90
Query: 166 LL-WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200
+L +L +H NIV+L+G C ++ EY G L
Sbjct: 91 VLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDL 126
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|130902 TIGR01843, type_I_hlyD, type I secretion membrane fusion protein, HlyD family | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 31/117 (26%), Positives = 48/117 (41%), Gaps = 19/117 (16%)
Query: 359 EADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKELRS 418
EADS F L + + E I+ F + R ++E +L +++ E EL
Sbjct: 103 EADSQAAIEFPDDLLSAEDPAVPELIKGQQSLFESRKSTLRAQLELILAQIKQLEAELAG 162
Query: 419 REEELTKA-----------QMQQKLAEKEL--------REREQAVAAREIDVLEREL 456
+ +L + ++KL EK L ERE+A A E+ LE EL
Sbjct: 163 LQAQLQALRQQLEVISEELEARRKLKEKGLVSRLELLELERERAEAQGELGRLEAEL 219
|
Type I secretion is an ABC transport process that exports proteins, without cleavage of any signal sequence, from the cytosol to extracellular medium across both inner and outer membranes. The secretion signal is found in the C-terminus of the transported protein. This model represents the adaptor protein between the ATP-binding cassette (ABC) protein of the inner membrane and the outer membrane protein, and is called the membrane fusion protein. This model selects a subfamily closely related to HlyD; it is defined narrowly and excludes, for example, colicin V secretion protein CvaA and multidrug efflux proteins [Protein fate, Protein and peptide secretion and trafficking]. Length = 423 |
| >gnl|CDD|212935 cd12002, SH3_NEDD9, Src homology 3 domain of CAS (Crk-Associated Substrate) scaffolding protein family member, Neural precursor cell Expressed, Developmentally Down-regulated 9 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 2e-04
Identities = 21/56 (37%), Positives = 31/56 (55%), Gaps = 6/56 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
RALYD +EL+ R+GDI+ V+ +++ G GWW + G + GI P N
Sbjct: 3 RALYDNVPECAEELAFRKGDILTVIEQNT--GGLEGWWLCSLHG----RQGIAPGN 52
|
NEDD9 is also called human enhancer of filamentation 1 (HEF1) or CAS-L (Crk-associated substrate in lymphocyte). It was first described as a gene predominantly expressed in early embryonic brain, and was also isolated from a screen of human proteins that regulate filamentous budding in yeast, and as a tyrosine phosphorylated protein in lymphocytes. It promotes metastasis in different solid tumors. NEDD9 localizes in focal adhesions and associates with FAK and Abl kinase. It also interacts with SMAD3 and the proteasomal machinery which allows its rapid turnover; these interactions are not shared by other CAS proteins. CAS proteins function as molecular scaffolds to regulate protein complexes that are involved in many cellular processes. They share a common domain structure that includes an N-terminal SH3 domain, an unstructured substrate domain that contains many YxxP motifs, a serine-rich four-helix bundle, and a FAT-like C-terminal domain. The SH3 domain of CAS proteins binds to diverse partners including FAK, FRNK, Pyk2, PTP-PEST, DOCK180, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 57 |
| >gnl|CDD|212925 cd11992, SH3_Intersectin2_3, Third Src homology 3 domain (or SH3C) of Intersectin-2 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 2e-04
Identities = 21/57 (36%), Positives = 29/57 (50%), Gaps = 10/57 (17%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALY Y + +L+ G+ + V KD WWTG IE + GIFP+N+V
Sbjct: 4 ALYPYSSSEPGDLTFNEGEEILVTQKDGE------WWTGSIEDR----TGIFPSNYV 50
|
Intersectin-2 (ITSN2) is an adaptor protein that functions in exo- and endocytosis, actin cytoskeletal reorganization, and signal transduction. It plays a role in clathrin-coated pit (CCP) formation. It binds to many proteins through its multidomain structure and facilitate the assembly of multimeric complexes. ITSN2 also functions as a specific GEF for Cdc42 activation in epithelial morphogenesis, and is required in mitotic spindle orientation. It exists in alternatively spliced short and long isoforms. The short isoform contains two Eps15 homology domains (EH1 and EH2), a coiled-coil region and five SH3 domains (SH3A-E), while the long isoform, in addition, contains RhoGEF (also called Dbl-homologous or DH), Pleckstrin homology (PH) and C2 domains. The third SH3 domain (SH3C) of ITSN2 has been shown to bind the K15 protein of Kaposi's sarcoma-associated herpesvirus. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 52 |
| >gnl|CDD|212750 cd11816, SH3_Eve1_3, Third Src homology 3 domain of ADAM-binding protein Eve-1 | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 2e-04
Identities = 22/60 (36%), Positives = 30/60 (50%), Gaps = 13/60 (21%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVG--WWTGKIEGKIEYKVGIFPANFV 93
A +D++ DELS GD++ + VG W G++ GKI GIFP NFV
Sbjct: 3 VARFDFEGEQEDELSFSEGDVITLKEY-------VGEEWAKGELNGKI----GIFPLNFV 51
|
Eve-1, also called SH3 domain-containing protein 19 (SH3D19) or EEN-binding protein (EBP), exists in multiple alternatively spliced isoforms. The longest isoform contains five SH3 domain in the C-terminal region and seven proline-rich motifs in the N-terminal region. It is abundantly expressed in skeletal muscle and heart, and may be involved in regulating the activity of ADAMs (A disintegrin and metalloproteases). Eve-1 interacts with EEN, an endophilin involved in endocytosis and may be the target of the MLL-EEN fusion protein that is implicated in leukemogenesis. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 51 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 62/262 (23%), Positives = 101/262 (38%), Gaps = 75/262 (28%)
Query: 125 IGEGGFGKVY-------KGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
IG+G FG+V IY + + +K D+ L +VK E +L D +VS
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQ--LAHVKAERDVLAESDSPWVVS 65
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQ--IAEGMNYLHCQAPIS 235
L + L L+ME+ GG L +L I+ D + + +AE + + +
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTML----IKYDTFSEDVTRFYMAECVLAIEAVHKLG 121
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA-------------- 281
IHRD+K N+L+ +K++DFGL+ +K H SA
Sbjct: 122 FIHRDIKPDNILIDRG--------GHIKLSDFGLSTGFHK-QHDSAYYQKLLQGKSNKNR 172
Query: 282 ------------------------------------AGTYAWMAPEVIKTSIFSKASDVW 305
GT ++APE+ + + D W
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232
Query: 306 SYGVVLWELLTGEIPYKSINAY 327
S G +++E L G P+ S N++
Sbjct: 233 SLGAIMFECLIGWPPFCSENSH 254
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|212993 cd12060, SH3_alphaPIX, Src Homology 3 domain of alpha-Pak Interactive eXchange factor | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 3e-04
Identities = 21/62 (33%), Positives = 34/62 (54%), Gaps = 9/62 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+A +++ DELS+ +GDI+ V + + GWW G + GK G FP+N+V
Sbjct: 5 KARFNFKQTNEDELSVCKGDIIYVTRVE-----EGGWWEGTLNGK----TGWFPSNYVRE 55
Query: 96 IE 97
I+
Sbjct: 56 IK 57
|
Alpha-PIX, also called Rho guanine nucleotide exchange factor 6 (ARHGEF6) or Cool (Cloned out of Library)-2, activates small GTPases by exchanging bound GDP for free GTP. It acts as a GEF for both Cdc42 and Rac 1, and is localized in dendritic spines where it regulates spine morphogenesis. It controls dendritic length and spine density in the hippocampus. Mutations in the ARHGEF6 gene cause X-linked intellectual disability in humans. PIX proteins contain an N-terminal SH3 domain followed by RhoGEF (also called Dbl-homologous or DH) and Pleckstrin Homology (PH) domains, and a C-terminal leucine-zipper domain for dimerization. The SH3 domain of PIX binds to an atypical PxxxPR motif in p21-activated kinases (PAKs) with high affinity. The binding of PAKs to PIX facilitate the localization of PAKs to focal complexes and also localizes PAKs to PIX targets Cdc43 and Rac, leading to the activation of PAKs. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 58 |
| >gnl|CDD|212716 cd11782, SH3_Sorbs_2, Second Src Homology 3 domain of Sorbin and SH3 domain containing (Sorbs) proteins and similar domains | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 3e-04
Identities = 20/58 (34%), Positives = 33/58 (56%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RA Y+++A ELS R+GD++ + + D W+ EG+I + GIFP ++V
Sbjct: 3 RAKYNFNADTGVELSFRKGDVITLTRRV-----DENWY----EGRIGGRQGIFPVSYV 51
|
This family, also called the vinexin family, is composed predominantly of adaptor proteins containing one sorbin homology (SoHo) and three SH3 domains. Members include the second SH3 domains of Sorbs1 (or ponsin), Sorbs2 (or ArgBP2), Vinexin (or Sorbs3), and similar domains. They are involved in the regulation of cytoskeletal organization, cell adhesion, and growth factor signaling. Members of this family bind multiple partners including signaling molecules like c-Abl, c-Arg, Sos, and c-Cbl, as well as cytoskeletal molecules such as vinculin and afadin. They may have overlapping functions. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212880 cd11947, SH3_GRAP2_N, N-terminal Src homology 3 domain of GRB2-related adaptor protein 2 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 3e-04
Identities = 20/58 (34%), Positives = 32/58 (55%), Gaps = 10/58 (17%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
R +D+ A G DELS ++GD++++LS D W+ ++ G + G P NFV
Sbjct: 3 RGKFDFTASGEDELSFKKGDVLKILSSDDI------WFKAELNG----EEGYVPKNFV 50
|
GRAP2 is also called GADS (GRB2-related adapter downstream of Shc), GrpL, GRB2L, Mona, or GRID (Grb2-related protein with insert domain). It is expressed specifically in the hematopoietic system. It plays an important role in T cell receptor (TCR) signaling by promoting the formation of the SLP-76:LAT complex, which couples the TCR to the Ras pathway. It also have roles in antigen-receptor and tyrosine kinase mediated signaling. GRAP2 is unique from other GRB2-like adaptor proteins in that it can be regulated by caspase cleavage. It contains an N-terminal SH3 domain, a central SH2 domain, and a C-terminal SH3 domain. The N-terminal SH3 domain of the related protein GRB2 binds to Sos and Sos-derived proline-rich peptides. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 52 |
| >gnl|CDD|212709 cd11775, SH3_Sla1p_3, Third Src Homology 3 domain of the fungal endocytic adaptor protein Sla1p | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 3e-04
Identities = 22/62 (35%), Positives = 34/62 (54%), Gaps = 14/62 (22%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVL----SKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
+ LYD+DA DEL+++ GD+V +L SKD WW +E K G+ PA+
Sbjct: 4 KVLYDFDAQSDDELTVKEGDVVYILDDKKSKD--------WW--MVENVSTGKEGVVPAS 53
Query: 92 FV 93
++
Sbjct: 54 YI 55
|
Sla1p facilitates endocytosis by playing a role as an adaptor protein in coupling components of the actin cytoskeleton to the endocytic machinery. It interacts with Abp1p, Las17p and Pan1p, which are activator proteins of actin-related protein 2/3 (Arp2/3). Sla1p contains multiple domains including three SH3 domains, a SAM (sterile alpha motif) domain, and a Sla1 homology domain 1 (SHD1), which binds to the NPFXD motif that is found in many integral membrane proteins such as the Golgi-localized Arf-binding protein Lsb5p and the P4-ATPases, Drs2p and Dnf1p. The third SH3 domain of Sla1p can bind ubiquitin while retaining the ability to bind proline-rich ligands; monoubiquitination of target proteins signals internalization and sorting through the endocytic pathway. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 57 |
| >gnl|CDD|212879 cd11946, SH3_GRB2_N, N-terminal Src homology 3 domain of Growth factor receptor-bound protein 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 3e-04
Identities = 21/57 (36%), Positives = 33/57 (57%), Gaps = 8/57 (14%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A YD+ A DELS +RGDI++VL+++ D W+ ++ G K G P N++
Sbjct: 5 AKYDFKATADDELSFKRGDILKVLNEEC----DQNWYKAELNG----KDGFIPKNYI 53
|
GRB2 is a critical signaling molecule that regulates the Ras pathway by linking tyrosine kinases to the Ras guanine nucleotide releasing protein Sos (son of sevenless), which converts Ras to the active GTP-bound state. It is ubiquitously expressed in all tissues throughout development and is important in cell cycle progression, motility, morphogenesis, and angiogenesis. In lymphocytes, GRB2 is associated with antigen receptor signaling components. GRB2 contains an N-terminal SH3 domain, a central SH2 domain, and a C-terminal SH3 domain. Its N-terminal SH3 domain binds to Sos and Sos-derived proline-rich peptides. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYK----GIYEKQ---EVAIKVAHPNPDENILENVKQEGK 165
E+ + L+ G +G G FG+V + G+ Q +VA+K+ + + + E K
Sbjct: 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELK 92
Query: 166 LL-WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200
++ L H NIV+L+G C + + ++ EY R G L
Sbjct: 93 IMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDL 128
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|213013 cd12080, SH3_MPP1, Src Homology 3 domain of Membrane Protein, Palmitoylated 1 (or MAGUK p55 subfamily member 1) | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 4e-04
Identities = 22/62 (35%), Positives = 33/62 (53%), Gaps = 12/62 (19%)
Query: 36 RALYDYDA-----IGLDE--LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIF 88
RA +DYD I E L + GDI+++++KD D WW G++EG E G+
Sbjct: 3 RAQFDYDPKKDNLIPCKEAGLKFQTGDIIQIINKD-----DSNWWQGRVEGSGEESAGLI 57
Query: 89 PA 90
P+
Sbjct: 58 PS 59
|
MPP1, also called 55 kDa erythrocyte membrane protein (p55), is a ubiquitously-expressed scaffolding protein that plays roles in regulating neutrophil polarity, cell shape, hair cell development, and neural development and patterning of the retina. It was originally identified as an erythrocyte protein that stabilizes the actin cytoskeleton to the plasma membrane by forming a complex with 4.1R protein and glycophorin C. MPP1 is one of seven vertebrate homologs of the Drosophila Stardust protein, which is required in establishing cell polarity, and it contains the three domains characteristic of MAGUK (membrane-associated guanylate kinase) proteins: PDZ, SH3, and guanylate kinase (GuK). In addition, it also contains the Hook (Protein 4.1 Binding) motif in between the SH3 and GuK domains. The GuK domain in MAGUK proteins is enzymatically inactive; instead, the domain mediates protein-protein interactions and associates intramolecularly with the SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 62 |
| >gnl|CDD|212781 cd11847, SH3_Brk, Src homology 3 domain of Brk (Breast tumor kinase) Protein Tyrosine Kinase (PTK), also called PTK6 | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 4e-04
Identities = 20/63 (31%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKV--GIFPAN 91
+++AL+D+ A G +ELS + GD + + SGD WWT + V G P N
Sbjct: 1 IYKALWDFKARGDEELSFQAGDQFRIAER----SGD--WWTALKLDRAGGVVAQGFVPNN 54
Query: 92 FVS 94
+++
Sbjct: 55 YLA 57
|
Brk is a cytoplasmic (or non-receptor) PTK with limited homology to Src kinases. It has been found to be overexpressed in a majority of breast tumors. It plays roles in normal cell differentiation, proliferation, survival, migration, and cell cycle progression. Brk substrates include RNA-binding proteins (SLM-1/2, Sam68), transcription factors (STAT3/5), and signaling molecules (Akt, paxillin, IRS-4). Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). However, Brk lacks the N-terminal myristoylation site. The SH3 domain of Src kinases contributes to substrate recruitment by binding adaptor proteins/substrates, and regulation of kinase activity through an intramolecular interaction. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 58 |
| >gnl|CDD|212945 cd12012, SH3_RIM-BP_2, Second Src homology 3 domain of Rab3-interacting molecules (RIMs) binding proteins | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 4e-04
Identities = 21/67 (31%), Positives = 34/67 (50%), Gaps = 18/67 (26%)
Query: 37 ALYDYDAIGL--------DELSLRRGDIVEVL-SKDSAISGDVGWWTGKIEGKIEYKVGI 87
AL+DYD + + +EL + G +++V KD D G++ G+I G+ G+
Sbjct: 4 ALFDYDPLTMSPNPDAAEEELPFKEGQLIKVYGDKD----AD-GFYLGEINGRR----GL 54
Query: 88 FPANFVS 94
P N VS
Sbjct: 55 VPCNMVS 61
|
RIMs binding proteins (RBPs, RIM-BPs) associate with calcium channels present in photoreceptors, neurons, and hair cells; they interact simultaneously with specific calcium channel subunits, and active zone proteins, RIM1 and RIM2. RIMs are part of the matrix at the presynaptic active zone and are associated with synaptic vesicles through their interaction with the small GTPase Rab3. RIM-BPs play a role in regulating synaptic transmission by serving as adaptors and linking calcium channels with the synaptic vesicle release machinery. RIM-BPs contain three SH3 domains and two to three fibronectin III repeats. Invertebrates contain one, while vertebrates contain at least two RIM-BPs, RIM-BP1 and RIM-BP2. RIM-BP1 is also called peripheral-type benzodiazapine receptor associated protein 1 (PRAX-1). Mammals contain a third protein, RIM-BP3. RIM-BP1 and RIM-BP2 are predominantly expressed in the brain where they display overlapping but distinct expression patterns, while RIM-BP3 is almost exclusively expressed in the testis and is essential in spermiogenesis. The SH3 domains of RIM-BPs bind to the PxxP motifs of RIM1, RIM2, and L-type (alpha1D) and N-type (alpha1B) calcium channel subunits. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 62 |
| >gnl|CDD|212802 cd11869, SH3_p40phox, Src Homology 3 domain of the p40phox subunit of NADPH oxidase | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 4e-04
Identities = 20/60 (33%), Positives = 33/60 (55%), Gaps = 9/60 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96
AL+D+ EL+ + GD++ +LS+ ++ D W +EG + GIFP +FV I
Sbjct: 4 ALFDFTGNSKLELNFKAGDVIFLLSR---VNKD--W----LEGTVRGATGIFPLSFVKII 54
|
p40phox, also called Neutrophil cytosol factor 4 (NCF-4), is a cytosolic subunit of the phagocytic NADPH oxidase complex (also called Nox2 or gp91phox) which plays a crucial role in the cellular response to bacterial infection. NADPH oxidase catalyzes the transfer of electrons from NADPH to oxygen during phagocytosis forming superoxide and reactive oxygen species. p40phox positively regulates NADPH oxidase in both phosphatidylinositol-3-phosphate (PI3P)-dependent and PI3P-independent manner. It contains an N-terminal PX domain, a central SH3 domain, and a C-terminal PB1 domain that interacts with p67phox. The SH3 domain of p40phox binds to canonical polyproline and noncanonical motifs at the C-terminus of p47phox. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKG----IYEKQ---EVAIKVAHPNPDENILENVKQEGK 165
E + L+ G +G G FGKV +G + Q +VA+K+ P + + + E K
Sbjct: 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELK 92
Query: 166 LL-WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200
++ L H NIV+L+G C +S + ++ EY G L
Sbjct: 93 IMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDL 128
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|212932 cd11999, SH3_PACSIN_like, Src homology 3 domain of an unknown subfamily of proteins with similarity to Protein kinase C and Casein kinase Substrate in Neurons (PACSIN) proteins | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 5e-04
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RA+YDY DELS + G+ + + + + GW G +G VG++PAN+V
Sbjct: 5 RAVYDYTGQEPDELSFKAGEELLKVEDED----EQGWCKGVTDGG---AVGLYPANYV 55
|
PACSINs, also called Synaptic dynamin-associated proteins (Syndapins), act as regulators of cytoskeletal and membrane dynamics. They bind both dynamin and Wiskott-Aldrich syndrome protein (WASP), and may provide direct links between the actin cytoskeletal machinery through WASP and dynamin-dependent endocytosis. Vetebrates harbor three isoforms with distinct expression patterns and specific functions. PACSINs contain an N-terminal F-BAR domain and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|212766 cd11832, SH3_Shank, Src homology 3 domain of SH3 and multiple ankyrin repeat domains (Shank) proteins | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 5e-04
Identities = 19/54 (35%), Positives = 28/54 (51%), Gaps = 9/54 (16%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPA 90
A+ Y E+SL +GD V+VLS G+ G+W G + G+ G FP+
Sbjct: 4 AVKSYSPQEEGEISLHKGDRVKVLS-----IGEGGFWEGSVRGRT----GWFPS 48
|
Shank proteins carry scaffolding functions through multiple sites of protein-protein interaction in its domain architecture, including ankyrin (ANK) repeats, a long proline rich region, as well as SH3, PDZ, and SAM domains. They bind a variety of membrane and cytosolic proteins, and exist in alternatively spliced isoforms. They are highly enriched in postsynaptic density (PSD) where they interact with the cytoskeleton and with postsynaptic membrane receptors including NMDA and glutamate receptors. They are crucial in the construction and organization of the PSD and dendritic spines of excitatory synapses. There are three members of this family (Shank1, Shank2, Shank3) which show distinct and cell-type specific patterns of expression. Shank1 is brain-specific; Shank2 is found in neurons, glia, endocrine cells, liver, and kidney; Shank3 is widely expressed. The SH3 domain of Shank binds GRIP, a scaffold protein that binds AMPA receptors and Eph receptors/ligands. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 50 |
| >gnl|CDD|212881 cd11948, SH3_GRAP_N, N-terminal Src homology 3 domain of GRB2-related adaptor protein | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 5e-04
Identities = 17/58 (29%), Positives = 32/58 (55%), Gaps = 8/58 (13%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
ALY + A DEL ++GDI+++L+ + D W+ +++G + G P N++
Sbjct: 4 ALYSFQATESDELPFQKGDILKILNMED----DQNWYKAELQG----REGYIPKNYIK 53
|
GRAP is a GRB-2 like adaptor protein that is highly expressed in lymphoid tissues. It acts as a negative regulator of T cell receptor (TCR)-induced lymphocyte proliferation by downregulating the signaling to the Ras/ERK pathway. It has been identified as a regulator of TGFbeta signaling in diabetic kidney tubules and may have a role in the pathogenesis of the disease. GRAP contains an N-terminal SH3 domain, a central SH2 domain, and a C-terminal SH3 domain. The N-terminal SH3 domain of the related protein GRB2 binds to Sos and Sos-derived proline-rich peptides. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|212930 cd11997, SH3_PACSIN3, Src homology 3 domain of Protein kinase C and Casein kinase Substrate in Neurons 3 (PACSIN3) | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 5e-04
Identities = 19/58 (32%), Positives = 33/58 (56%), Gaps = 7/58 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RALYDY DELS + G+ + + ++ + GW G++ ++G++PAN+V
Sbjct: 5 RALYDYTGQEADELSFKAGEELLKIGEED----EQGWCKGRLLSG---RIGLYPANYV 55
|
PACSIN 3 or Syndapin III (Synaptic dynamin-associated protein III) is expressed ubiquitously and regulates glucose uptake in adipocytes through its role in GLUT1 trafficking. It also modulates the subcellular localization and stimulus-specific function of the cation channel TRPV4. PACSINs act as regulators of cytoskeletal and membrane dynamics. Vetebrates harbor three isoforms with distinct expression patterns and specific functions. PACSINs contain an N-terminal F-BAR domain and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|212844 cd11911, SH3_CIP4-like, Src Homology 3 domain of Cdc42-Interacting Protein 4 | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 5e-04
Identities = 16/38 (42%), Positives = 21/38 (55%), Gaps = 4/38 (10%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGW 72
ALYD+D LS+ G+I+ VL +D GD GW
Sbjct: 2 CTALYDFDGTSEGTLSMEEGEILLVLEED---GGD-GW 35
|
This subfamily is composed of Cdc42-Interacting Protein 4 (CIP4), Formin Binding Protein 17 (FBP17), FormiN Binding Protein 1-Like (FNBP1L), and similar proteins. CIP4 and FNBP1L are Cdc42 effectors that bind Wiskott-Aldrich syndrome protein (WASP) and function in endocytosis. CIP4 and FBP17 bind to the Fas ligand and may be implicated in the inflammatory response. CIP4 may also play a role in phagocytosis. It functions downstream of Cdc42 in PDGF-dependent actin reorganization and cell migration, and also regulates the activity of PDGFRbeta. It uses Src as a substrate in regulating the invasiveness of breast tumor cells. CIP4 may also play a role in the pathogenesis of Huntington's disease. Members of this subfamily typically contain an N-terminal F-BAR (FES-CIP4 Homology and Bin/Amphiphysin/Rvs) domain, a central Cdc42-binding HR1 domain, and a C-terminal SH3 domain. The SH3 domain of CIP4 associates with Gapex-5, a Rab31 GEF. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212730 cd11796, SH3_DNMBP_N3, Third N-terminal Src homology 3 domain of Dynamin Binding Protein, also called Tuba | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 6e-04
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
R L D A +EL LR GD+V + D GW+ G++ G+ GIFP FV
Sbjct: 3 RVLQDLSAQLDEELDLREGDVVTITG-----ILDKGWFRGELNGR----RGIFPEGFV 51
|
DNMBP or Tuba is a cdc42-specific guanine nucleotide exchange factor (GEF) that contains four N-terminal SH3 domains, a central RhoGEF [or Dbl homology (DH)] domain followed by a Bin/Amphiphysin/Rvs (BAR) domain, and two C-terminal SH3 domains. It provides a functional link between dynamin and key regulatory proteins of the actin cytoskeleton. It plays an important role in regulating cell junction configuration. The four N-terminal SH3 domains of DNMBP binds the GTPase dynamin, which plays an important role in the fission of endocytic vesicles. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 51 |
| >gnl|CDD|212822 cd11889, SH3_Cyk3p-like, Src Homology 3 domain of Cytokinesis protein 3 and similar proteins | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 6e-04
Identities = 22/58 (37%), Positives = 32/58 (55%), Gaps = 7/58 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+A+Y + +L GD++EVLS GD WW+GK+ + GIFP+NFV
Sbjct: 3 KAVYSWAGETEGDLGFLEGDLIEVLS-----IGDGSWWSGKL--RRNGAEGIFPSNFV 53
|
Cytokinesis protein 3 (Cyk3 or Cyk3p) is a component of the actomyosin ring independent cytokinesis pathway in yeast. It interacts with Inn1 and facilitates its recruitment to the bud neck, thereby promoting cytokinesis. Cyk3p contains an N-terminal SH3 domain and a C-terminal transglutaminase-like domain. The Cyk3p SH3 domain binds to the C-terminal proline-rich region of Inn1. SH3 domains bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs; they play a role in the regulation of enzymes by intramolecular interactions, changing the subcellular localization of signal pathway components and mediate multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212968 cd12035, SH3_MPP1-like, Src Homology 3 domain of Membrane Protein, Palmitoylated 1 (or MAGUK p55 subfamily member 1)-like proteins | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 6e-04
Identities = 18/62 (29%), Positives = 30/62 (48%), Gaps = 12/62 (19%)
Query: 36 RALYDYDAIGLD-------ELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIF 88
RA +DYD D ++ + GDI++++SKD D WW + G + G+
Sbjct: 3 RAQFDYDPSKDDLIPCQQAGIAFKTGDILQIISKD-----DHNWWQARKPGASKEPAGLI 57
Query: 89 PA 90
P+
Sbjct: 58 PS 59
|
This subfamily includes MPP1, CASK (Calcium/calmodulin-dependent Serine protein Kinase), Caenorhabditis elegans lin-2, and similar proteins. MPP1 and CASK are scaffolding proteins from the MAGUK (membrane-associated guanylate kinase) protein family, which is characterized by the presence of a core of three domains: PDZ, SH3, and guanylate kinase (GuK). In addition, they also have the Hook (Protein 4.1 Binding) motif in between the SH3 and GuK domains. The GuK domain in MAGUK proteins is enzymatically inactive; instead, the domain mediates protein-protein interactions and associates intramolecularly with the SH3 domain. CASK and lin-2 also contain an N-terminal calmodulin-dependent kinase (CaMK)-like domain and two L27 domains. MPP1 is ubiquitously-expressed and plays roles in regulating neutrophil polarity, cell shape, hair cell development, and neural development and patterning of the retina. CASK is highly expressed in the mammalian nervous system and plays roles in synaptic protein targeting, neural development, and gene expression regulation. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 62 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 24/107 (22%)
Query: 217 WAI--QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274
WA+ Q + LH QA KS N+LL D K G V
Sbjct: 20 WAVCLQCLGALRELHRQA---------KSGNILL-----TWDGLLKL-----DG---SVA 57
Query: 275 KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321
T + +MAPEVI+ +++ +D++S G+ L+E L E+PY
Sbjct: 58 FKTPEQSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPY 104
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|212815 cd11882, SH3_GRAF-like, Src Homology 3 domain of GTPase Regulator Associated with Focal adhesion kinase and similar proteins | Back alignment and domain information |
|---|
Score = 37.3 bits (87), Expect = 9e-04
Identities = 19/59 (32%), Positives = 26/59 (44%), Gaps = 8/59 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
RALY A ELS G I+ + S + GW G + G + G+ P N+V
Sbjct: 3 RALYACKAEDESELSFEPGQII----TNVQPSDEPGWLEGTLNG----RTGLIPENYVE 53
|
This subfamily is composed of Rho GTPase activating proteins (GAPs) with similarity to GRAF. Members contain an N-terminal BAR domain, followed by a Pleckstrin homology (PH) domain, a Rho GAP domain, and a C-terminal SH3 domain. Although vertebrates harbor four Rho GAPs in the GRAF subfamily including GRAF, GRAF2, GRAF3, and Oligophrenin-1 (OPHN1), only three are included in this model. OPHN1 contains the BAR, PH and GAP domains, but not the C-terminal SH3 domain. GRAF and GRAF2 show GAP activity towards RhoA and Cdc42. GRAF influences Rho-mediated cytoskeletal rearrangements and binds focal adhesion kinase. GRAF2 regulates caspase-activated p21-activated protein kinase-2. The SH3 domain of GRAF and GRAF2 binds PKNbeta, a target of the small GTPase Rho. SH3 domains bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs; they play a role in the regulation of enzymes by intramolecular interactions, changing the subcellular localization of signal pathway components and mediate multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|212899 cd11966, SH3_ASAP2, Src homology 3 domain of ArfGAP with SH3 domain, ankyrin repeat and PH domain containing protein 2 | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.001
Identities = 21/58 (36%), Positives = 32/58 (55%), Gaps = 6/58 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ALY+ A DEL+ G+I+ V ++ D WW G I+G+ + G FP +FV
Sbjct: 3 KALYNCVADNPDELTFSEGEIIIVDGEE-----DKEWWIGHIDGEPTRR-GAFPVSFV 54
|
ASAP2 is also called DDEF2 (Development and Differentiation Enhancing Factor 2), AMAP2, centaurin beta-3, or PAG3. It mediates the functions of Arf GTPases vial dual mechanisms: it exhibits GTPase activating protein (GAP) activity towards class I (Arf1) and II (Arf5) Arfs; and it binds class III Arfs (GTP-Arf6) stably without GAP activity. It binds paxillin and is implicated in Fcgamma receptor-mediated phagocytosis in macrophages and in cell migration. ASAP2 contains an N-terminal BAR domain, followed by a Pleckstrin homology (PH) domain, an Arf GAP domain, ankyrin (ANK) repeats, and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|212889 cd11956, SH3_srGAP4, Src homology 3 domain of Slit-Robo GTPase Activating Protein 4 | Back alignment and domain information |
|---|
Score = 37.1 bits (86), Expect = 0.001
Identities = 20/58 (34%), Positives = 29/58 (50%), Gaps = 9/58 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
A +DY ELS +RGD++ + SK S D WW G+ G G+ P ++S
Sbjct: 6 ACFDYTGRTAQELSFKRGDVLLLHSKA---SSD--WWRGEHNGMR----GLIPHKYIS 54
|
srGAP4, also called ARHGAP4, is highly expressed in hematopoietic cells and may play a role in lymphocyte differentiation. It is able to stimulate the GTPase activity of Rac1, Cdc42, and RhoA. In the nervous system, srGAP4 has been detected in differentiating neurites and may be involved in axon and dendritic growth. srGAPs are Rho GAPs that interact with Robo1, the transmembrane receptor of Slit proteins. Slit proteins are secreted proteins that control axon guidance and the migration of neurons and leukocytes. srGAPs contain an N-terminal F-BAR domain, a Rho GAP domain, and a C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212741 cd11807, SH3_ASPP, Src homology 3 domain of Apoptosis Stimulating of p53 proteins (ASPP) | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.001
Identities = 19/47 (40%), Positives = 25/47 (53%), Gaps = 2/47 (4%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEY 83
AL+DY+A DELS R GD + VL K + WW ++ K Y
Sbjct: 5 ALFDYEAENGDELSFREGDELTVLRKGDDDETE--WWWARLNDKEGY 49
|
The ASPP family of proteins bind to important regulators of apoptosis (p53, Bcl-2, and RelA) and cell growth (APCL, PP1). They share similarity at their C-termini, where they harbor a proline-rich region, four ankyrin (ANK) repeats, and an SH3 domain. Vertebrates contain three members of the family: ASPP1, ASPP2, and iASPP. ASPP1 and ASPP2 activate the apoptotic function of the p53 family of tumor suppressors (p53, p63, and p73), while iASPP is an oncoprotein that specifically inhibits p53-induced apoptosis. The expression of ASPP proteins is altered in tumors; ASPP1 and ASPP2 are downregulated whereas iASPP is upregulated is some cancer types. ASPP proteins also bind and regulate protein phosphatase 1 (PP1), and this binding is competitive with p53 binding. The SH3 domain and the ANK repeats of ASPP contribute to the p53 binding site; they bind to the DNA binding domain of p53. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 57 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 46/225 (20%), Positives = 90/225 (40%), Gaps = 42/225 (18%)
Query: 121 FGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLW---LFDHRNIVS 177
G+ + + K VA+K N D E++K + + H NI+
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKI--NLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLHCQA 232
+ + +L +V G +L + P+ L + AI + ++Y+H +
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHSKG 121
Query: 233 PISLIHRDLKSSNVLLSE-------------PIENEDLQFKTLKITDFGLAREVYKTTHM 279
IHR +K+S++LLS + + + DF
Sbjct: 122 ---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG--KRQRVVHDFPK---------- 166
Query: 280 SAAGTYAWMAPEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYK 322
S+ W++PEV++ ++ +++ SD++S G+ EL G +P+K
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|212820 cd11887, SH3_Bbc1, Src Homology 3 domain of Bbc1 and similar domains | Back alignment and domain information |
|---|
Score = 36.9 bits (86), Expect = 0.001
Identities = 19/59 (32%), Positives = 32/59 (54%), Gaps = 6/59 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGK-IEGKIEYKVGIFPANFV 93
+ALY Y++ D+L+ G ++ V ++ D W+ G+ ++ K GIFP NFV
Sbjct: 5 KALYPYESDHEDDLNFDVGQLITVTEEE-----DADWYFGEYVDSNGNTKEGIFPKNFV 58
|
This subfamily is composed of Saccharomyces cerevisiae Bbc1p, also called Mti1p (Myosin tail region-interacting protein), and similar proteins. Bbc1p interacts with and regulates type I myosins in yeast, Myo3p and Myo5p, which are involved in actin cytoskeletal reorganization. It also binds and inhibits Las17, a WASp family protein that functions as an activator of the Arp2/3 complex. Bbc1p contains an N-terminal SH3 domain. SH3 domains bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs; they play a role in the regulation of enzymes by intramolecular interactions, changing the subcellular localization of signal pathway components and mediate multiprotein complex assemblies. Length = 60 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 29/103 (28%), Positives = 50/103 (48%), Gaps = 14/103 (13%)
Query: 220 QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT-- 277
Q+ + Y+H + LIHRD+K N+ L N D + + DFG A K
Sbjct: 275 QLLCAVEYIHDKK---LIHRDIKLENIFL-----NCD---GKIVLGDFGTAMPFEKEREA 323
Query: 278 -HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEI 319
GT A +PE++ + + +D+WS G++L ++L+ +
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|212817 cd11884, SH3_MYO15, Src Homology 3 domain of Myosin XV | Back alignment and domain information |
|---|
Score = 36.9 bits (86), Expect = 0.001
Identities = 15/45 (33%), Positives = 26/45 (57%), Gaps = 6/45 (13%)
Query: 49 LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
LS +GD++++L K+ + D GW G ++G+ G FP +V
Sbjct: 16 LSFHKGDVIKLLPKEGPL--DPGWLFGTLDGR----SGAFPKEYV 54
|
This subfamily is composed of proteins with similarity to Myosin XVa. Myosin XVa is an unconventional myosin that is critical for the normal growth of mechanosensory stereocilia of inner ear hair cells. Mutations in the myosin XVa gene are associated with nonsyndromic hearing loss. Myosin XVa contains a unique N-terminal extension followed by a motor domain, light chain-binding IQ motifs, and a tail consisting of a pair of MyTH4-FERM tandems separated by a SH3 domain, and a PDZ domain. SH3 domains bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs; they play a role in the regulation of enzymes by intramolecular interactions, changing the subcellular localization of signal pathway components and mediate multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|212852 cd11919, SH3_Sorbs1_1, First Src Homology 3 domain of Sorbin and SH3 domain containing 1 (Sorbs1), also called ponsin | Back alignment and domain information |
|---|
Score = 36.9 bits (85), Expect = 0.001
Identities = 21/61 (34%), Positives = 34/61 (55%), Gaps = 9/61 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA +D+ A L EL L++GDIV + + D W+ G+ G +VGIFP +++
Sbjct: 4 RAKFDFKAQTLKELPLQKGDIVYIYKQI-----DQNWYEGEHHG----RVGIFPRSYIEL 54
Query: 96 I 96
+
Sbjct: 55 L 55
|
Sorbs1 is also called ponsin, SH3P12, or CAP (c-Cbl associated protein). It is an adaptor protein containing one sorbin homology (SoHo) and three SH3 domains. It binds Cbl and plays a major role in regulating the insulin signaling pathway by enhancing insulin-induced phosphorylation of Cbl. Sorbs1, like vinexin, localizes at cell-ECM and cell-cell adhesion sites where it binds vinculin, paxillin, and afadin. It may function in the control of cell motility. Other interaction partners of Sorbs1 include c-Abl, Sos, flotillin, Grb4, ataxin-7, filamin C, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212865 cd11932, SH3_SH3RF2_2, Second Src Homology 3 domain of SH3 domain containing ring finger 2 | Back alignment and domain information |
|---|
Score = 36.7 bits (85), Expect = 0.001
Identities = 23/66 (34%), Positives = 33/66 (50%), Gaps = 15/66 (22%)
Query: 34 LWRALYDYDAIGLDE------LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGI 87
L RALY++D + L ++ DI+ V+S+ D W EGK+ +VGI
Sbjct: 1 LCRALYNFDLKEKNREESKDCLKFQKDDIITVISR-----VDENW----AEGKLGDQVGI 51
Query: 88 FPANFV 93
FP FV
Sbjct: 52 FPILFV 57
|
SH3RF2 is also called POSHER (POSH-eliminating RING protein) or HEPP1 (heart protein phosphatase 1-binding protein). It acts as an anti-apoptotic regulator of the JNK pathway by binding to and promoting the degradation of SH3RF1 (or POSH), a scaffold protein that is required for pro-apoptotic JNK activation. It may also play a role in cardiac functions together with protein phosphatase 1. SH3RF2 contains an N-terminal RING finger domain and three SH3 domains. This model represents the second SH3 domain, located C-terminal of the first SH3 domain at the N-terminal half, of SH3RF2. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 57 |
| >gnl|CDD|212834 cd11901, SH3_Nck1_2, Second Src Homology 3 domain of Nck1 adaptor protein | Back alignment and domain information |
|---|
Score = 36.6 bits (84), Expect = 0.001
Identities = 23/56 (41%), Positives = 31/56 (55%), Gaps = 9/56 (16%)
Query: 39 YDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
++Y A DELSL +G V V+ K S GWW G G +VG FP+N+V+
Sbjct: 8 FNYTAEREDELSLVKGTKVIVMEKCSD-----GWWRGSYNG----QVGWFPSNYVT 54
|
Nck1 (also called Nckalpha) plays a crucial role in connecting signaling pathways of tyrosine kinase receptors and important effectors in actin dynamics and cytoskeletal remodeling. It binds and activates RasGAP, resulting in the downregulation of Ras. It is also involved in the signaling of endothilin-mediated inhibition of cell migration. Nck adaptor proteins regulate actin cytoskeleton dynamics by linking proline-rich effector molecules to protein tyrosine kinases and phosphorylated signaling intermediates. They contain three SH3 domains and a C-terminal SH2 domain. They function downstream of the PDGFbeta receptor and are involved in Rho GTPase signaling and actin dynamics. Vertebrates contain two Nck adaptor proteins: Nck1 (also called Nckalpha) and Nck2, which show partly overlapping functions but also bind distinct targets. The second SH3 domain of Nck appears to prefer ligands containing the APxxPxR motif. SH3 domains are protein interaction domains that usually bind to proline-rich ligands with moderate affinity and selectivity, preferentially a PxxP motif. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212725 cd11791, SH3_UBASH3, Src homology 3 domain of Ubiquitin-associated and SH3 domain-containing proteins, also called TULA (T cell Ubiquitin LigAnd) family of proteins | Back alignment and domain information |
|---|
Score = 36.5 bits (85), Expect = 0.002
Identities = 19/63 (30%), Positives = 24/63 (38%), Gaps = 13/63 (20%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGW-----WTGKIEGKIEYKVGIFPA 90
R LY Y DEL L GD + V ++ S D GW W G+ P
Sbjct: 3 RVLYPYTPQEEDELELVPGDYIYVSPEELDSSSD-GWVEGTSWLTGCS-------GLLPE 54
Query: 91 NFV 93
N+
Sbjct: 55 NYT 57
|
UBASH3 or TULA proteins are also referred to as Suppressor of T cell receptor Signaling (STS) proteins. They contain an N-terminal UBA domain, a central SH3 domain, and a C-terminal histidine phosphatase domain. They bind c-Cbl through the SH3 domain and to ubiquitin via UBA. In some vertebrates, there are two TULA family proteins, called UBASH3A (also called TULA or STS-2) and UBASH3B (also called TULA-2 or STS-1), which show partly overlapping as well as distinct functions. UBASH3B is widely expressed while UBASH3A is only found in lymphoid cells. UBASH3A facilitates apoptosis induced in T cells through its interaction with the apoptosis-inducing factor AIF. UBASH3B is an active phosphatase while UBASH3A is not. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 59 |
| >gnl|CDD|213014 cd12081, SH3_CASK, Src Homology 3 domain of Calcium/calmodulin-dependent Serine protein Kinase | Back alignment and domain information |
|---|
Score = 36.4 bits (84), Expect = 0.002
Identities = 20/63 (31%), Positives = 31/63 (49%), Gaps = 14/63 (22%)
Query: 36 RALYDYDAIGLDEL--------SLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGI 87
RA ++YD + D+L R GDI++++SKD D WW K+E G+
Sbjct: 3 RAQFEYDPLK-DDLIPCKQAGIRFRVGDILQIISKD-----DHNWWQAKLENSKNGTAGL 56
Query: 88 FPA 90
P+
Sbjct: 57 IPS 59
|
CASK is a scaffolding protein that is highly expressed in the mammalian nervous system and plays roles in synaptic protein targeting, neural development, and gene expression regulation. CASK interacts with many different binding partners including parkin, neurexin, syndecans, calcium channel proteins, caskin, among others, to perform specific functions in different subcellular locations. Disruption of the CASK gene in mice results in neonatal lethality while mutations in the human gene have been associated with X-linked mental retardation. Drosophila CASK is associated with both pre- and postsynaptic membranes and is crucial in synaptic transmission and vesicle cycling. CASK contains an N-terminal calmodulin-dependent kinase (CaMK)-like domain, two L27 domains, followed by the core of three domains characteristic of MAGUK (membrane-associated guanylate kinase) proteins: PDZ, SH3, and guanylate kinase (GuK). In addition, it also contains the Hook (Protein 4.1 Binding) motif in between the SH3 and GuK domains. The GuK domain in MAGUK proteins is enzymatically inactive; instead, the domain mediates protein-protein interactions and associates intramolecularly with the SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 62 |
| >gnl|CDD|212845 cd11912, SH3_Bzz1_1, First Src Homology 3 domain of Bzz1 and similar domains | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.002
Identities = 18/39 (46%), Positives = 22/39 (56%), Gaps = 5/39 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWT 74
+ LYDY A G DE+S+ G+ V VL D SG WT
Sbjct: 3 KVLYDYTASGDDEVSISEGEEVTVLEPDDG-SG----WT 36
|
Bzz1 (or Bzz1p) is a WASP/Las17-interacting protein involved in endocytosis and trafficking to the vacuole. It physically interacts with type I myosins and functions in the early steps of endocytosis. Together with other proteins, it induces membrane scission in yeast. Bzz1 contains an N-terminal F-BAR (FES-CIP4 Homology and Bin/Amphiphysin/Rvs), a central coiled-coil, and two C-terminal SH3 domains. This model represents the first C-terminal SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212919 cd11986, SH3_Stac3_1, First C-terminal Src homology 3 domain of SH3 and cysteine-rich domain-containing protein 3 (Stac3) | Back alignment and domain information |
|---|
Score = 36.0 bits (83), Expect = 0.002
Identities = 21/57 (36%), Positives = 29/57 (50%), Gaps = 9/57 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALY + A+ D+L G+ + V+ DS + WW GKI K G FP NF+
Sbjct: 4 ALYRFKALEKDDLDFHPGERITVID-DS----NEEWW----RGKIGEKTGYFPMNFI 51
|
Stac proteins are putative adaptor proteins that contain a cysteine-rich C1 domain and one or two SH3 domains at the C-terminus. There are three mammalian members (Stac1, Stac2, and Stac3) of this family. Stac1 and Stac3 contain two SH3 domains while Stac2 contains a single SH3 domain at the C-terminus. Stac1 and Stac2 have been found to be expressed differently in mature dorsal root ganglia (DRG) neurons. Stac1 is mainly expressed in peptidergic neurons while Stac2 is found in a subset of nonpeptidergic and all trkB+ neurons. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212796 cd11862, SH3_MPP, Src Homology 3 domain of Membrane Protein, Palmitoylated (or MAGUK p55 subfamily member) proteins | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.002
Identities = 18/62 (29%), Positives = 31/62 (50%), Gaps = 12/62 (19%)
Query: 36 RALYDYDAIGLDE-------LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIF 88
RAL+DYD LS ++GDI++++++D D WW + G + G+
Sbjct: 3 RALFDYDPEEDPLIPCKEAGLSFKKGDILQIVNQD-----DPNWWQARKVGDPNGRAGLI 57
Query: 89 PA 90
P+
Sbjct: 58 PS 59
|
The MPP/p55 subfamily of MAGUK (membrane-associated guanylate kinase) proteins includes at least eight vertebrate members (MPP1-7 and CASK), four Drosophila proteins (Stardust, Varicose, CASK and Skiff), and other similar proteins; they all contain one each of the core of three domains characteristic of MAGUK proteins: PDZ, SH3, and guanylate kinase (GuK). In addition, most members except for MPP1 contain N-terminal L27 domains and some also contain a Hook (Protein 4.1 Binding) motif in between the SH3 and GuK domains. CASK has an additional calmodulin-dependent kinase (CaMK)-like domain at the N-terminus. Members of this subfamily are scaffolding proteins that play important roles in regulating and establishing cell polarity, cell adhesion, and synaptic targeting and transmission, among others. The GuK domain in MAGUK proteins is enzymatically inactive; instead, the domain mediates protein-protein interactions and associates intramolecularly with the SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 61 |
| >gnl|CDD|212856 cd11923, SH3_Sorbs2_2, Second Src Homology 3 domain of Sorbin and SH3 domain containing 2 (Sorbs2), also called Arg-binding protein 2 (ArgBP2) | Back alignment and domain information |
|---|
Score = 36.0 bits (83), Expect = 0.002
Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 7/60 (11%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96
A Y+++A ELSLR+GD V +L + D W+ GKI G + GIFP ++V I
Sbjct: 5 AKYNFNADTNVELSLRKGDRVVLLKQ-----VDQNWYEGKIPGT--NRQGIFPVSYVEVI 57
|
Sorbs2 or ArgBP2 is an adaptor protein containing one sorbin homology (SoHo) and three SH3 domains. It regulates actin-dependent processes including cell adhesion, morphology, and migration. It is expressed in many tissues and is abundant in the heart. Like vinexin, it is found in focal adhesion where it interacts with vinculin and afadin. It also localizes in epithelial cell stress fibers and in cardiac muscle cell Z-discs. Sorbs2 has been implicated to play roles in the signaling of c-Arg, Akt, and Pyk2. Other interaction partners of Sorbs2 include c-Abl, flotillin, spectrin, dynamin 1/2, synaptojanin, PTP-PEST, among others. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 57 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 40/167 (23%), Positives = 79/167 (47%), Gaps = 15/167 (8%)
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQ-IAEGM-- 225
LF+H NIV + +L +V + G ++ + D + + AI I +G+
Sbjct: 55 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM--DGMSELAIAYILQGVLK 112
Query: 226 --NYLHCQAPISLIHRDLKSSNVLLSE--PIENEDLQFKTLKITDFGLAREVYKTTHMSA 281
+Y+H + +HR +K+S++L+S + L+ L + + G V +
Sbjct: 113 ALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLR-SNLSMINHGQRLRVVHDFPKYS 168
Query: 282 AGTYAWMAPEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYKSINA 326
W++PEV++ ++ + SD++S G+ EL G +P+K + A
Sbjct: 169 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|212747 cd11813, SH3_SGSM3, Src Homology 3 domain of Small G protein Signaling Modulator 3 | Back alignment and domain information |
|---|
Score = 35.9 bits (83), Expect = 0.003
Identities = 20/58 (34%), Positives = 30/58 (51%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+AL D++ DEL R+ DI+ ++S+ D W G++ G G FPA FV
Sbjct: 3 KALLDFERHDDDELGFRKNDIITIISQK-----DEHCWVGELNG----LRGWFPAKFV 51
|
SGSM3 is also called Merlin-associated protein (MAP), RUN and SH3 domain-containing protein (RUSC3), RUN and TBC1 domain-containing protein 3 (RUTBC3), Rab GTPase-activating protein 5 (RabGAP5), or Rab GAP-like protein (RabGAPLP). It is expressed ubiquitously and functions as a regulator of small G protein RAP- and RAB-mediated neuronal signaling. It is involved in modulating NGF-mediated neurite outgrowth and differentiation. It also interacts with the tumor suppressor merlin and may play a role in the merlin-associated suppression of cell growth. SGSM3 contains TBC, SH3, and RUN domains. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212727 cd11793, SH3_ephexin1_like, Src homology 3 domain of ephexin-1-like SH3 domain containing Rho guanine nucleotide exchange factors | Back alignment and domain information |
|---|
Score = 35.8 bits (83), Expect = 0.003
Identities = 19/57 (33%), Positives = 29/57 (50%), Gaps = 7/57 (12%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
++ Y A DEL+L GD+V VL K GW+ G E + + G FP+++
Sbjct: 4 CVHAYTAQQPDELTLEEGDVVNVLRKMPD-----GWYEG--ERLRDGERGWFPSSYT 53
|
Members of this family contain RhoGEF (also called Dbl-homologous or DH), Pleckstrin Homology (PH), and C-terminal SH3 domains. They include the Rho guanine nucleotide exchange factors ARHGEF5, ARHGEF16, ARHGEF19, ARHGEF26, ARHGEF27 (also called ephexin-1), and similar proteins, and are also called ephexins because they interact directly with ephrin A receptors. GEFs interact with Rho GTPases via their DH domains to catalyze nucleotide exchange by stabilizing the nucleotide-free GTPase intermediate. They play important roles in neuronal development. The SH3 domains of ARHGEFs play an autoinhibitory role through intramolecular interactions with a proline-rich region N-terminal to the DH domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212805 cd11872, SH3_DOCK_AB, Src Homology 3 domain of Class A and B Dedicator of Cytokinesis proteins | Back alignment and domain information |
|---|
Score = 35.6 bits (83), Expect = 0.003
Identities = 19/57 (33%), Positives = 30/57 (52%), Gaps = 7/57 (12%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A+Y++ G +LSL+ GD V++L + GW+ G K GIFP ++V
Sbjct: 4 AIYNFQGDGEHQLSLQVGDTVQILEECE------GWYRGFSLRNKSLK-GIFPKSYV 53
|
DOCK proteins are atypical guanine nucleotide exchange factors (GEFs) that lack the conventional Dbl homology (DH) domain. They are divided into four classes (A-D) based on sequence similarity and domain architecture: class A includes Dock1, 2 and 5; class B includes Dock3 and 4; class C includes Dock6, 7, and 8; and class D includes Dock9, 10 and 11. All DOCKs contain two homology domains: the DHR-1 (Dock homology region-1), also called CZH1 (CED-5, Dock180, and MBC-zizimin homology 1), and DHR-2 (also called CZH2 or Docker). The DHR-1 domain binds phosphatidylinositol-3,4,5-triphosphate while DHR-2 contains the catalytic activity for Rac and/or Cdc42. This subfamily includes only Class A and B DOCKs, which also contain an SH3 domain at the N-terminal region and a PxxP motif at the C-terminus. Class A/B DOCKs are mostly specific GEFs for Rac, except Dock4 which activates the Ras family GTPase Rap1, probably indirectly through interaction with Rap regulatory proteins. The SH3 domain of class A/B DOCKs have been shown to bind Elmo, a scaffold protein that promotes GEF activity of DOCKs by releasing DHR-2 autoinhibition by the intramolecular SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 56 |
| >gnl|CDD|212942 cd12009, SH3_Blk, Src homology 3 domain of Blk Protein Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 35.6 bits (82), Expect = 0.003
Identities = 18/59 (30%), Positives = 30/59 (50%), Gaps = 10/59 (16%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGK-IEGKIEYKVGIFPANFVS 94
A YD+ +L L++G+ ++VL D G+ WW K + E G P+N+V+
Sbjct: 4 AQYDFVPSNERDLQLKKGEKLQVLKSD----GE--WWLAKSLTTGKE---GYIPSNYVA 53
|
Blk is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) PTKs. It is expressed specifically in B-cells and is involved in pre-BCR (B-cell receptor) signaling. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). The SH3 domain of Src kinases contributes to substrate recruitment by binding adaptor proteins/substrates, and regulation of kinase activity through an intramolecular interaction. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 54 |
| >gnl|CDD|212717 cd11783, SH3_SH3RF_3, Third Src Homology 3 domain of SH3 domain containing ring finger 1 (SH3RF1), SH3RF3, and similar domains | Back alignment and domain information |
|---|
Score = 35.4 bits (82), Expect = 0.004
Identities = 22/63 (34%), Positives = 29/63 (46%), Gaps = 15/63 (23%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSK--DSAISGDVGWWTGK--IEGKIEYKVGIFPANF 92
ALY Y DEL LR+G++ V K D GW+ G G+ G+FP N+
Sbjct: 4 ALYPYKPQKPDELELRKGEMYTVTEKCQD-------GWFKGTSLRTGQS----GVFPGNY 52
Query: 93 VSS 95
V
Sbjct: 53 VQP 55
|
SH3RF1 (or POSH) and SH3RF3 (or POSH2) are scaffold proteins that function as E3 ubiquitin-protein ligases. They contain an N-terminal RING finger domain and four SH3 domains. This model represents the third SH3 domain, located in the middle of SH3RF1 and SH3RF3, and similar domains. SH3RF1 plays a role in calcium homeostasis through the control of the ubiquitin domain protein Herp. It may also have a role in regulating death receptor mediated and JNK mediated apoptosis. SH3RF3 interacts with p21-activated kinase 2 (PAK2) and GTP-loaded Rac1. It may play a role in regulating JNK mediated apoptosis in certain conditions. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 55 |
| >gnl|CDD|212918 cd11985, SH3_Stac2_C, C-terminal Src homology 3 domain of SH3 and cysteine-rich domain-containing protein 2 (Stac2) | Back alignment and domain information |
|---|
Score = 35.3 bits (81), Expect = 0.004
Identities = 23/57 (40%), Positives = 30/57 (52%), Gaps = 9/57 (15%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALY + ++L L+ GD V V+ DS + WW GK + VG FPANFV
Sbjct: 4 ALYKFLPQENNDLPLQPGDRVMVVD-DS----NEDWWKGKSGDR----VGFFPANFV 51
|
Stac proteins are putative adaptor proteins that contain a cysteine-rich C1 domain and one or two SH3 domains at the C-terminus. There are three mammalian members (Stac1, Stac2, and Stac3) of this family. Stac2 contains a single SH3 domain at the C-terminus unlike Stac1 and Stac3, which contain two C-terminal SH3 domains. Stac1 and Stac2 have been found to be expressed differently in mature dorsal root ganglia (DRG) neurons. Stac1 is mainly expressed in peptidergic neurons while Stac2 is found in a subset of nonpeptidergic and all trkB+ neurons. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 53 |
| >gnl|CDD|212972 cd12039, SH3_MPP3, Src Homology 3 domain of Membrane Protein, Palmitoylated 3 (or MAGUK p55 subfamily member 3) | Back alignment and domain information |
|---|
Score = 35.7 bits (82), Expect = 0.004
Identities = 23/62 (37%), Positives = 32/62 (51%), Gaps = 12/62 (19%)
Query: 36 RALYDYD-----AIGLDE--LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIF 88
RAL+DY+ AI E L +R DI+EV+S+D D WW K G + G+
Sbjct: 3 RALFDYNPYEDRAIPCQEAGLPFKRRDILEVVSQD-----DPTWWQAKRVGDTNLRAGLI 57
Query: 89 PA 90
P+
Sbjct: 58 PS 59
|
MPP3 is a scaffolding protein that colocalizes with MPP5 and CRB1 at the subdpical region adjacent to adherens junctions and may function in photoreceptor polarity. It interacts with some nectins and regulates their trafficking and processing. Nectins are cell-cell adhesion proteins involved in the establishment apical-basal polarity at cell adhesion sites. It is one of seven vertebrate homologs of the Drosophila Stardust protein, which is required in establishing cell polarity, and it contains two L27 domains followed by the core of three domains characteristic of MAGUK (membrane-associated guanylate kinase) proteins: PDZ, SH3, and guanylate kinase (GuK). The GuK domain in MAGUK proteins is enzymatically inactive; instead, the domain mediates protein-protein interactions and associates intramolecularly with the SH3 domain. SH3 domains are protein interaction domains that bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs. They play versatile and diverse roles in the cell including the regulation of enzymes, changing the subcellular localization of signaling pathway components, and mediating the formation of multiprotein complex assemblies. Length = 62 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 527 | |||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG4721|consensus | 904 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0200|consensus | 609 | 100.0 | ||
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025|consensus | 1177 | 100.0 | ||
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| KOG1035|consensus | 1351 | 100.0 | ||
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG2052|consensus | 513 | 100.0 | ||
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1024|consensus | 563 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0984|consensus | 282 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027|consensus | 903 | 100.0 | ||
| KOG0576|consensus | 829 | 99.98 | ||
| KOG0668|consensus | 338 | 99.97 | ||
| KOG0664|consensus | 449 | 99.97 | ||
| KOG1290|consensus | 590 | 99.97 | ||
| KOG1152|consensus | 772 | 99.97 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0665|consensus | 369 | 99.97 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1163|consensus | 341 | 99.96 | ||
| KOG1345|consensus | 378 | 99.96 | ||
| KOG1165|consensus | 449 | 99.96 | ||
| KOG1164|consensus | 322 | 99.96 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1167|consensus | 418 | 99.95 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0195|consensus | 448 | 99.94 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0590|consensus | 601 | 99.89 | ||
| KOG1023|consensus | 484 | 99.88 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG0603|consensus | 612 | 99.87 | ||
| KOG1240|consensus | 1431 | 99.87 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1166|consensus | 974 | 99.85 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG4158|consensus | 598 | 99.84 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0606|consensus | 1205 | 99.79 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG1033|consensus | 516 | 99.73 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0590|consensus | 601 | 99.66 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.48 | |
| KOG0601|consensus | 524 | 99.46 | ||
| KOG0601|consensus | 524 | 99.45 | ||
| KOG1243|consensus | 690 | 99.43 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| PF14604 | 49 | SH3_9: Variant SH3 domain; PDB: 2CRE_A 2E5K_A 2CT3 | 99.41 | |
| KOG1266|consensus | 458 | 99.4 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| KOG0606|consensus | 1205 | 99.26 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG3087|consensus | 229 | 99.24 | ||
| KOG2199|consensus | 462 | 99.21 | ||
| PF00018 | 48 | SH3_1: SH3 domain; InterPro: IPR001452 SH3 (src Ho | 99.15 | |
| PF07653 | 55 | SH3_2: Variant SH3 domain; InterPro: IPR011511 SH3 | 99.13 | |
| KOG1118|consensus | 366 | 99.1 | ||
| KOG3741|consensus | 655 | 99.08 | ||
| KOG1029|consensus | 1118 | 99.06 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.93 | |
| KOG2856|consensus | 472 | 98.91 | ||
| KOG2137|consensus | 700 | 98.9 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.88 | |
| KOG0162|consensus | 1106 | 98.88 | ||
| KOG2070|consensus | 661 | 98.87 | ||
| cd00174 | 54 | SH3 Src homology 3 domains; SH3 domains bind to pr | 98.85 | |
| smart00326 | 58 | SH3 Src homology 3 domains. Src homology 3 (SH3) d | 98.85 | |
| KOG4226|consensus | 379 | 98.82 | ||
| KOG4348|consensus | 627 | 98.77 | ||
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.77 | |
| KOG4792|consensus | 293 | 98.72 | ||
| KOG4348|consensus | 627 | 98.69 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| KOG2996|consensus | 865 | 98.65 | ||
| KOG4225|consensus | 489 | 98.63 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.62 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.58 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| KOG4226|consensus | 379 | 98.53 | ||
| KOG4225|consensus | 489 | 98.51 | ||
| KOG1235|consensus | 538 | 98.51 | ||
| PRK09902 | 216 | hypothetical protein; Provisional | 98.45 | |
| KOG0576|consensus | 829 | 98.42 | ||
| KOG0515|consensus | 752 | 98.4 | ||
| KOG3875|consensus | 362 | 98.39 | ||
| KOG1843|consensus | 473 | 98.38 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.37 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.32 | |
| KOG1029|consensus | 1118 | 98.27 | ||
| KOG3601|consensus | 222 | 98.26 | ||
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.26 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.26 | |
| KOG3655|consensus | 484 | 98.26 | ||
| KOG2546|consensus | 483 | 98.26 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.21 | |
| KOG1264|consensus | 1267 | 98.2 | ||
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.1 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.06 | |
| KOG1702|consensus | 264 | 98.0 | ||
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.99 | |
| KOG1035|consensus | 1351 | 97.98 | ||
| PRK10593 | 297 | hypothetical protein; Provisional | 97.88 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.61 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.53 |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-63 Score=502.90 Aligned_cols=329 Identities=33% Similarity=0.599 Sum_probs=287.1
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCE-EEEeecCCCCCCCCceeEEEecCcccceecccccCccccc------ccccc---
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDI-VEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI------EDINL--- 101 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~-~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~------~~~~~--- 101 (527)
..+++|+|||++...++|+|++||. ..+++. .+..||.++.... +..|++|.|||... ..++.
T Consensus 11 ~~~~valyd~~s~~~~dLsf~~Gd~~~~~~~~-----~~~~Ww~ar~~~~--~~~g~ip~N~v~~~~~~~~~~~l~~~~W 83 (468)
T KOG0197|consen 11 ETIVVALYDYASRTPEDLSFRKGDVVLILLET-----TNGDWWRARSLQL--GQEGYIPSNYVARNRGSPAFIKLSDEPW 83 (468)
T ss_pred cceEEEeccccCCCccccccccCceEEEeecc-----CChhHHHHHHhhc--CCCCcCcCceeeccccCCCccccccCCc
Confidence 4689999999999999999999999 667665 3789999885432 78899999999965 22110
Q ss_pred -------------------------eee-------------------------------------e--e-----------
Q psy6905 102 -------------------------VSS-------------------------------------V--I----------- 106 (527)
Q Consensus 102 -------------------------~~~-------------------------------------~--~----------- 106 (527)
+.. . +
T Consensus 84 f~~~isR~~ae~~ll~p~~~~G~flvR~se~~~g~yslsv~~~~~~~~~~~v~hyri~~~~~~~~~~~~~~~~~F~~l~~ 163 (468)
T KOG0197|consen 84 FFGKISREEAERQLLAPENKEGAFLVRESESDKGDYSLSVREGDSGGLGAKVKHYRIRQLDGGGLYPYIDERELFSSLQQ 163 (468)
T ss_pred hhccccHHHHHHhhcCCCCCccceeeecccCCcCCeeEEEEeccccCCccceeeeeeeEcCCCCeecCCCHHHhhhhHHH
Confidence 000 0 0
Q ss_pred -------------------------------c-CceeeEEeCCceeeeeeeccCCceEEEEeeEcCc-eEEEEEcCCCCC
Q psy6905 107 -------------------------------N-DVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPD 153 (527)
Q Consensus 107 -------------------------------~-~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~-~vaiK~~~~~~~ 153 (527)
. ....|+|+++.+++++.||+|.||.||.|.|++. .||+|.++....
T Consensus 164 lv~~~~~~~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m 243 (468)
T KOG0197|consen 164 LVNYYSKNADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM 243 (468)
T ss_pred HHhhhhccCcchhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc
Confidence 0 0345999999999999999999999999999986 899999987633
Q ss_pred hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHh
Q psy6905 154 ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHC 230 (527)
Q Consensus 154 ~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~ 230 (527)
. .+.|.+|+.+|++|+|+|||++||+|..+..+|||||||..|+|.++|+. ..+...+++.++.|||+||+||++
T Consensus 244 ~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes 321 (468)
T KOG0197|consen 244 S--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES 321 (468)
T ss_pred C--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh
Confidence 2 46788999999999999999999999998899999999999999999984 678999999999999999999999
Q ss_pred cCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccccccCC---CccccccccccccCCCCcccchHHH
Q psy6905 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA---GTYAWMAPEVIKTSIFSKASDVWSY 307 (527)
Q Consensus 231 ~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~---gt~~y~aPE~l~~~~~~~ksDvwSl 307 (527)
+ ++|||||.++||||+++ ..|||+|||||+...+..+.... -++.|+|||++..+.|+.|||||||
T Consensus 322 ~---~~IHRDLAARNiLV~~~--------~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSF 390 (468)
T KOG0197|consen 322 K---NYIHRDLAARNILVDED--------LVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSF 390 (468)
T ss_pred C---CccchhhhhhheeeccC--------ceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeeh
Confidence 9 59999999999999986 69999999999966555444333 4689999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 308 GVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 308 Gv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
||+||||+| |+.||+++++.+++..+. .++++|.|..||++++++|..||+.+|++||||..+...|+++...
T Consensus 391 GVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 391 GVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred hhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 999999999 999999999999998886 6899999999999999999999999999999999999998887654
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-57 Score=455.19 Aligned_cols=332 Identities=32% Similarity=0.594 Sum_probs=291.3
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccccccee------
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDINLVS------ 103 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~~~~------ 103 (527)
+++++++|||||.+.+++.|++.+||.+.|+... .+..|..++.. .-.|++|+||+++...++..+
T Consensus 88 ndpNLFVALYDFvasGdntLSitKGeklRvLGYN----~NgEWcEartK----NGqGWVPSNyItPvNSLeKhsWYHGpv 159 (1157)
T KOG4278|consen 88 NDPNLFVALYDFVASGDNTLSITKGEKLRVLGYN----KNGEWCEARTK----NGQGWVPSNYITPVNSLEKHSWYHGPV 159 (1157)
T ss_pred CCCceeEeeeeeeccccceeeeecCceEEEeeec----CCCcceeeccc----CCCccccccccccccchhhcccccCcc
Confidence 4667999999999999999999999999999874 45667777742 234999999999887765200
Q ss_pred ----------e---------------------------------------------------------------------
Q psy6905 104 ----------S--------------------------------------------------------------------- 104 (527)
Q Consensus 104 ----------~--------------------------------------------------------------------- 104 (527)
+
T Consensus 160 SRsaaEy~LsSgInGSFLVRESEsSpgQ~sISlRyeGRVyHYRINt~~dgK~yvt~EsrF~TLaELVHHHStvADGLitt 239 (1157)
T KOG4278|consen 160 SRSAAEYILSSGINGSFLVRESESSPGQYSISLRYEGRVYHYRINTDNDGKMYVTQESRFRTLAELVHHHSTVADGLITT 239 (1157)
T ss_pred ccchhhhhhhcCcccceEEeeccCCCcceeEEEEecceEEEEEeeccCCccEEEeehhhhhHHHHHHhhccccccceeEe
Confidence 0
Q ss_pred ---------------eecCceeeEEeCCceeeeeeeccCCceEEEEeeEcC--ceEEEEEcCCCCChhHHHHHHHHHHHH
Q psy6905 105 ---------------VINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLL 167 (527)
Q Consensus 105 ---------------~~~~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l 167 (527)
+....+.||+++.++....+||-|.||.||.|+|+. ..||||.++.+.. ..++|+.|+.+|
T Consensus 240 LhYPApK~nKptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvM 317 (1157)
T KOG4278|consen 240 LHYPAPKKNKPTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVM 317 (1157)
T ss_pred eeccCccCCCCceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHH
Confidence 001124699999999999999999999999999975 5799999887643 478999999999
Q ss_pred HhCCCCccceEEEEEEeCCeEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q psy6905 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSS 244 (527)
Q Consensus 168 ~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~ 244 (527)
+.++|||+|+++|+|.....+|||+|||..|+|.++|+ +..++.-.++.++.||..||+||..+ ++|||||.++
T Consensus 318 KeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAAR 394 (1157)
T KOG4278|consen 318 KEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAAR 394 (1157)
T ss_pred HhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhh
Confidence 99999999999999999999999999999999999998 34577778899999999999999998 6999999999
Q ss_pred ceecCCCCcccccccceeEEeccCcchhhhccccccCCC---ccccccccccccCCCCcccchHHHHHHHHHHHh-CCCC
Q psy6905 245 NVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAG---TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIP 320 (527)
Q Consensus 245 NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~g---t~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~P 320 (527)
||||+++ ..||++||||++.+...++..+.| .+.|+|||-+..+.|+.|+|||+|||+|||+.| |-.|
T Consensus 395 NCLVgEn--------hiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsP 466 (1157)
T KOG4278|consen 395 NCLVGEN--------HIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 466 (1157)
T ss_pred hcccccc--------ceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCC
Confidence 9999986 689999999999998777766665 689999999999999999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhccc
Q psy6905 321 YKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383 (527)
Q Consensus 321 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~ 383 (527)
|++.+..+++ ....+++++.-|+.||+.++.||+.||+++|.+||+|.++-+.|+.++++..
T Consensus 467 YPGidlSqVY-~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 467 YPGIDLSQVY-GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred CCCccHHHHH-HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 9999877765 5566899999999999999999999999999999999999999998887543
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-57 Score=452.09 Aligned_cols=302 Identities=43% Similarity=0.776 Sum_probs=271.2
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
...|+|+|+.+.-++-||+|+.|.||+|...+..||||.++.- -..+++.|++|+||||+.|.|+|...+.+
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 4579999999999999999999999999999999999976532 23578889999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|||||||..|-|..+|+ ++.++...+.+|..+|+.||.|||.+ +|||||||.-||||+.+ ..|||+||
T Consensus 188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~--------d~VKIsDF 256 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYD--------DVVKISDF 256 (904)
T ss_pred EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeecc--------ceEEeccc
Confidence 99999999999999998 67899999999999999999999999 69999999999999986 58999999
Q ss_pred Ccchhhhc-cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 268 GLAREVYK-TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 268 Gla~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
|-++...+ .+.++++||..|||||++++.+.+.|+|||||||+||||+||..||...+...+++++-.+.+.+|.|..|
T Consensus 257 GTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstc 336 (904)
T KOG4721|consen 257 GTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTC 336 (904)
T ss_pred cchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccC
Confidence 99998754 56678999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhccccCCCCcchhhcchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKA 426 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~ 426 (527)
|+.|+-||++||+..|..||+|.+|+.||+ |.......++.+.++..+..|+.++...+.+....-+-+.++++++.+.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~Hld-Ia~pell~~tee~yf~sq~swrEevk~h~~~it~~gt~ih~~eeelirr 415 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLD-IASPELLSTTEETYFKSQASWREEVKLHFEKITSEGTCIHRLEEELIRR 415 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHh-hcCHHHhcccHHHHHHHHHHHHHHHHHhhhhhccCcchHHHHHHHHHHH
Confidence 999999999999999999999999999985 5566677788888999999999988887777665555555555555544
Q ss_pred HHHH
Q psy6905 427 QMQQ 430 (527)
Q Consensus 427 ~~~~ 430 (527)
..++
T Consensus 416 R~ee 419 (904)
T KOG4721|consen 416 RREE 419 (904)
T ss_pred HHHH
Confidence 4433
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=431.74 Aligned_cols=278 Identities=44% Similarity=0.752 Sum_probs=246.5
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEcCce-EEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQE-VAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~-vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
...|+|+..++.+.+.||+|+||+||+|.|.|+. ||||++.... +....+.|.+|+.+|..++|||||+|+|+|.+..
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3568899999999999999999999999999988 9999988753 2223678999999999999999999999999988
Q ss_pred -eEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 187 -KLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 187 -~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
.++|||||+++|+|.+++.+ +.++...++.|+.||+.||+|||++++ ||||||||+||||+.+. .++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~-------~~~ 183 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKG-------KTL 183 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCC-------CEE
Confidence 79999999999999999964 689999999999999999999999953 99999999999999862 389
Q ss_pred EEeccCcchhhhcc--ccccCCCccccccccccc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Q psy6905 263 KITDFGLAREVYKT--THMSAAGTYAWMAPEVIK--TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 263 kL~DFGla~~~~~~--~~~~~~gt~~y~aPE~l~--~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
||+|||+++..... ......||+.|||||++. ...|+.|+||||||+++|||+||+.||.+....+++..+..++.
T Consensus 184 KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~ 263 (362)
T KOG0192|consen 184 KIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL 263 (362)
T ss_pred EECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence 99999999877543 333468999999999999 56899999999999999999999999999999999999999999
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhccccCCCCcchhhcc
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQ 395 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~~~~~~~~~~~~~ 395 (527)
+.++|..|++.+..||..||+.||..||+|.+++..|+.+........+........
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~~~~~~~ 320 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPEDSADSDS 320 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCccccccccc
Confidence 999999999999999999999999999999999999998877665544444444333
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=395.15 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=221.3
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEE-EEEeCCe-EE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIG-VCLQSPK-LC 189 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~-~~~~~~~-~~ 189 (527)
...+|+++++||.|+||+||++.+ +|..+|.|-+.-. .+....+.+..|+.+|++|+|||||++|+ .+.+++. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 456799999999999999999875 6789999987754 35666788999999999999999999999 4555544 89
Q ss_pred EEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCC-CceeecCCCCCceecCCCCcccccccceeE
Q psy6905 190 LVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAP-ISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~-~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
||||||.+|+|..+++ ++.+++.+++.++.|++.||..||+.-+ ..|+||||||.||+|+.+ |.||
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~--------gvvK 168 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN--------GVVK 168 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC--------Ccee
Confidence 9999999999999986 5679999999999999999999998322 138999999999999986 7999
Q ss_pred EeccCcchhhhccccc--cCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 264 ITDFGLAREVYKTTHM--SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 264 L~DFGla~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
|+|||+++.+...... +.+|||.||+||.+.+.+|+.+|||||+||++|||+.-.+||.+.+-.+...+|..+.+. |
T Consensus 169 LGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~-~ 247 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP-P 247 (375)
T ss_pred eccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC-C
Confidence 9999999998665443 568999999999999999999999999999999999999999999999998888876543 5
Q ss_pred CC-CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 342 IP-STCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 342 ~p-~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
+| ..+|.++..|+..|+..||+.||+...++..+..
T Consensus 248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 77 7889999999999999999999996666655543
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-53 Score=408.74 Aligned_cols=250 Identities=30% Similarity=0.487 Sum_probs=227.3
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe-EEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK-LCL 190 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~-~~i 190 (527)
+..++++.++.||+|..|+||++.++ ++.+|+|++....+....+++.+|+++++..+||+||.+||+|..... ++|
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 55567888899999999999999985 678999999888788888999999999999999999999999999985 999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
+||||+||||++++. -+++++..+-.++.+|++||.|||+.. +||||||||+||||+.+ |.|||||||.
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNsk--------GeVKicDFGV 225 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSK--------GEVKICDFGV 225 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccC--------CCEEeccccc
Confidence 999999999999988 578999999999999999999999632 69999999999999986 7999999999
Q ss_pred chhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCccCCCCC
Q psy6905 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI-----NAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 270 a~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~ 344 (527)
++.+.+....+++||..|||||.+.+..|+.++||||||++++|+++|+.||... +..+....|. .+....+|.
T Consensus 226 S~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~ 304 (364)
T KOG0581|consen 226 SGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPE 304 (364)
T ss_pred cHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCc
Confidence 9998777777899999999999999999999999999999999999999999874 5566666666 455666777
Q ss_pred C-ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 345 T-CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 345 ~-~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. +|++|++++..||..||.+|||+.+|+.|
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 6 99999999999999999999999999885
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-51 Score=414.92 Aligned_cols=247 Identities=29% Similarity=0.461 Sum_probs=226.3
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
....|..++.||+|||+.||++.+ .|..||+|++.... .....+.+.+|+++.+.|+|||||++|++|++.+++||
T Consensus 16 ~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 16 RSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred CcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 346799999999999999999987 57899999987642 33457789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|.|+|..|+|..+++ .+.+++.++..++.||+.||.|||+++ |||||||..|+|++++ -+|||+||||
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~--------~~VKIgDFGL 164 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNEN--------MNVKIGDFGL 164 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCc--------CcEEecccce
Confidence 999999999999998 678999999999999999999999994 9999999999999987 4899999999
Q ss_pred chhhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCcc
Q psy6905 270 AREVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 270 a~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 347 (527)
|..+.. ....+.||||.|.|||++....++..+||||+||+||-|++|++||+..+-.+.+..|..+.+.+ |..++
T Consensus 165 At~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~--P~~ls 242 (592)
T KOG0575|consen 165 ATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM--PSHLS 242 (592)
T ss_pred eeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc--ccccC
Confidence 998853 45668899999999999999999999999999999999999999999999999999998877765 55899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.++||.++|..||.+|||+++++.+
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999999999985
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-52 Score=402.04 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=217.3
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCCh------hHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDE------NILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~------~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
-.+.|.+.+.||+|+||.|-+|.. +++.||||+++..... .....+.+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 457789999999999999999986 4689999998764311 12344679999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
..||||||++||+|.+.+- ++.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+.++ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~-----~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAED-----CLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcc-----eEEEec
Confidence 9999999999999987765 778899999999999999999999996 9999999999999876432 589999
Q ss_pred ccCcchhhhccccc-cCCCccccccccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCccC
Q psy6905 266 DFGLAREVYKTTHM-SAAGTYAWMAPEVIKTSI---FSKASDVWSYGVVLWELLTGEIPYKSINAYA-VAYGVAVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~~~~~-~~~gt~~y~aPE~l~~~~---~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~-~~~~i~~~~~~~ 340 (527)
|||+|+.......+ +.|||+.|.|||++.+.. +..++|+|||||+||-+++|.+||.+..... ...+|..+.+.+
T Consensus 322 DFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 322 DFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred ccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 99999988654443 679999999999997664 3458899999999999999999998876665 777888877765
Q ss_pred CCC--CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 PIP--STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 ~~p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+ ..++++..+||.+||..||++|||+.+++++
T Consensus 402 ~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 402 GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 433 5689999999999999999999999999873
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=391.05 Aligned_cols=253 Identities=30% Similarity=0.497 Sum_probs=221.3
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.+|.+.+.||+|+||+||+|+++ +..||||.+.... .....+.+..|+.+|+.++|||||.+++++..++.+|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 57888899999999999999984 5789999887764 55567788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||+||+|.++++ .+.+++.++..++.||+.||++||++ +||||||||.||||+....+.. ...+||+|||+|+.
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~--~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDT--SPVLKIADFGFARF 164 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCC--CceEEecccchhhh
Confidence 999999999998 55899999999999999999999999 5999999999999998522211 15799999999998
Q ss_pred hhcccc-ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC-CCCCccHHH
Q psy6905 273 VYKTTH-MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP-IPSTCPQLF 350 (527)
Q Consensus 273 ~~~~~~-~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~~~~~ 350 (527)
+..... .+.+|++.|||||++....|+.|+|+||+|+++|++++|+.||...+..+....+..+....+ +|..++...
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 864433 367899999999999999999999999999999999999999999999888887776665544 445667778
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+|+...+..+|..|.++.+...+
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhh
Confidence 899999999999999998877654
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=425.06 Aligned_cols=262 Identities=37% Similarity=0.700 Sum_probs=239.3
Q ss_pred CceeeEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEE
Q psy6905 108 DVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180 (527)
Q Consensus 108 ~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~ 180 (527)
+.+..+|.+.+..+.+.||+|+||+||+|...+ ..||||.++...+.....+|++|+.++..|+|||||+|+|
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 345678999999999999999999999998532 4699999999888878999999999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHhc-----------CCC----CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCc
Q psy6905 181 VCLQSPKLCLVMEYARGGPLNRVLA-----------GRK----IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSN 245 (527)
Q Consensus 181 ~~~~~~~~~iv~Ey~~ggsL~~~l~-----------~~~----~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~N 245 (527)
+|.+++.+|||+|||..|+|.++|. +.. ++..+.+.|+.||+.||.||-++ .+|||||..+|
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRN 633 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRN 633 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhh
Confidence 9999999999999999999999985 112 77889999999999999999999 59999999999
Q ss_pred eecCCCCcccccccceeEEeccCcchhhhccccccCC----CccccccccccccCCCCcccchHHHHHHHHHHHh-CCCC
Q psy6905 246 VLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA----GTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIP 320 (527)
Q Consensus 246 ILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~----gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~P 320 (527)
|||+++ -.|||+||||++.++...+.... -+++|||||.+..++|+.+||||||||+|||+++ |+.|
T Consensus 634 CLVge~--------l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QP 705 (774)
T KOG1026|consen 634 CLVGEN--------LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQP 705 (774)
T ss_pred ceeccc--------eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCc
Confidence 999987 58999999999999876665443 4689999999999999999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 321 YKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 321 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
|.+.++.+++..+..+.. ++.|+.||.++++||..||+.+|.+||+|.+|-..|+.....
T Consensus 706 y~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 706 YYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 999999999999987777 999999999999999999999999999999999999876543
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=378.05 Aligned_cols=248 Identities=29% Similarity=0.439 Sum_probs=220.2
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+..++|+++++||+|+||+||.+.. +++.||+|++++.. .....+...+|..+|..++||.||+++-.|.+...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 4567899999999999999999985 56789999988753 2234678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+|+||+.||.|...|. .+.|++..+.-++..|+.||.|||+.| ||||||||+|||++.+ |.|+|+|||
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~--------GHi~LtDFg 170 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQ--------GHIKLTDFG 170 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCC--------CcEEEeccc
Confidence 9999999999999888 788999999999999999999999995 9999999999999986 899999999
Q ss_pred cchhhhcc--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 269 LAREVYKT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 269 la~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
|++..... ...+.+||+.|||||++.+..|+..+|+||||+++|||++|.+||.+.+.......+..++ ....|..+
T Consensus 171 L~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~l 249 (357)
T KOG0598|consen 171 LCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYL 249 (357)
T ss_pred cchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccC
Confidence 99966433 4446799999999999999999999999999999999999999999999999988888655 23456669
Q ss_pred cHHHHHHHHHhhhhCCCCCC----CHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRP----SFKTILK 373 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RP----s~~~ll~ 373 (527)
+.+.+++++.+|..||++|. ++.+|.+
T Consensus 250 s~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 250 SEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred CHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 99999999999999999995 4555443
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=393.71 Aligned_cols=262 Identities=32% Similarity=0.615 Sum_probs=235.0
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEcC-----ce-EEEEEcCC--CCChhHHHHHHHHHHHHHhCCCCccceEEE
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-----QE-VAIKVAHP--NPDENILENVKQEGKLLWLFDHRNIVSLIG 180 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~-vaiK~~~~--~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~ 180 (527)
...|++..++..+.++||+|+||.||+|.+.- .. ||||.... ........++.+|+++|++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45699999999999999999999999998632 23 89998885 245566889999999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHhcCC--CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccc
Q psy6905 181 VCLQSPKLCLVMEYARGGPLNRVLAGR--KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258 (527)
Q Consensus 181 ~~~~~~~~~iv~Ey~~ggsL~~~l~~~--~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~ 258 (527)
++....++|||||+|.||+|.++|++. .++..+.+.++.+.+.||+|||++ ++|||||.++|||++.+
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~------- 298 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKK------- 298 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCC-------
Confidence 999999999999999999999999843 499999999999999999999999 69999999999999985
Q ss_pred cceeEEeccCcchhhhccccc--cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q psy6905 259 FKTLKITDFGLAREVYKTTHM--SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAV 335 (527)
Q Consensus 259 ~~~vkL~DFGla~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~ 335 (527)
+.+||+|||+++........ ...-+.+|+|||.+....|+.++|||||||++||+++ |..||.+....++...|..
T Consensus 299 -~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 299 -GVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred -CeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 57899999998765321111 2235789999999999999999999999999999999 8999999999999999988
Q ss_pred CCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 336 NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 336 ~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
++++++.|...|.++..++.+||..+|+.||++.++.+.|+.+...
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999999999999998877654
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=416.45 Aligned_cols=257 Identities=39% Similarity=0.716 Sum_probs=234.0
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS 185 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~ 185 (527)
++++...++...||+|.||.||.|...+ ..||||.+....+.....+|.+|+.+|+.++|||||+++|++.+.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 4778999999999999999999998743 249999999888888899999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhcCC--------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccc
Q psy6905 186 PKLCLVMEYARGGPLNRVLAGR--------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDL 257 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~~~--------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~ 257 (527)
...+|++|||.||+|..+|++. .++...++.++.||++|++|||++ ++|||||.++||||+..
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~------ 838 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDER------ 838 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeeccc------
Confidence 9999999999999999999843 478889999999999999999999 59999999999999986
Q ss_pred ccceeEEeccCcchhhhccccccCC----CccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6905 258 QFKTLKITDFGLAREVYKTTHMSAA----GTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYG 332 (527)
Q Consensus 258 ~~~~vkL~DFGla~~~~~~~~~~~~----gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~ 332 (527)
..|||+|||+|+.++...+.... -..+|||||.+....|+.|+|||||||+|||++| |..||++.++.++...
T Consensus 839 --r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~ 916 (1025)
T KOG1095|consen 839 --RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD 916 (1025)
T ss_pred --CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH
Confidence 69999999999987665554333 3479999999999999999999999999999999 9999999999999988
Q ss_pred HHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 333 VAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 333 i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
+..++ +++.|..||+.++++|.+||+.+|++||+|..|++.+..+...
T Consensus 917 ~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 917 VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 87777 9999999999999999999999999999999999988776653
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=383.24 Aligned_cols=247 Identities=29% Similarity=0.462 Sum_probs=220.9
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~ 189 (527)
...+|.+++.||.|+|++|++|+. .++.||||++.+.- .+...+.+..|-..|.+| .||.|++||-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 357899999999999999999987 46799999876531 222245677899999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+|+||+++|+|.++|+ -+.|++.....++.+|+.||+|||++| ||||||||+||||+.+ +.+||+|||
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~d--------mhikITDFG 219 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKD--------GHIKITDFG 219 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCC--------CcEEEeecc
Confidence 9999999999999998 578999999999999999999999996 9999999999999987 799999999
Q ss_pred cchhhhcc---------------ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6905 269 LAREVYKT---------------THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGV 333 (527)
Q Consensus 269 la~~~~~~---------------~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i 333 (527)
.|+.+... ...+++||..|.+||++.++..++.+|||+|||+||.|+.|.+||.+.+..-....|
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI 299 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI 299 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence 99876321 013478999999999999999999999999999999999999999999999999888
Q ss_pred HhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 334 AVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 334 ~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. +.+++|...|+.+.+|++++|..||.+|++..+|.+|
T Consensus 300 ~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 QA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 74 4557889999999999999999999999999999886
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=375.21 Aligned_cols=249 Identities=29% Similarity=0.516 Sum_probs=213.6
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC--eEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP--KLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~--~~~iv 191 (527)
..+|..++.||+|+||.||++.+. +...|||.+....... .+.+.+|+.+|++|+|||||+++|...... .++|.
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 456788899999999999999985 5889999877664333 677899999999999999999999854443 69999
Q ss_pred EeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 192 MEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||+.+|+|.+++.+ +.+++..+..+..||++||+|||++| ||||||||+||||+.. .+.+||+|||+
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~-------~~~~KlaDFG~ 164 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPS-------NGDVKLADFGL 164 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCC-------CCeEEeccCcc
Confidence 999999999999983 26999999999999999999999995 9999999999999972 16899999999
Q ss_pred chhhhc-----cccccCCCccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCccCCC
Q psy6905 270 AREVYK-----TTHMSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKS-INAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 270 a~~~~~-----~~~~~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~ 342 (527)
++.... .......||+.|||||++.++. ..+++|||||||++.||+||+.||.. ....+....+.......++
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~i 244 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEI 244 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCC
Confidence 987752 2233567999999999999643 34699999999999999999999998 4555555666666666689
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
|..+|.+.+++|..|+..||.+|||+.+++++.
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 999999999999999999999999999999864
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=354.98 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=211.9
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
+.|+.+.++|+|+||.||+|++ +|+.||||.+....+ ....+-.++|+++|++|+|||+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4688889999999999999987 578999998876654 5556677999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||+..-|.++-. ...++.+.+..++.|++.|+.|||++ ++|||||||+||||+.+ +.+||||||+|+.
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~--------gvvKLCDFGFAR~ 150 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQN--------GVVKLCDFGFART 150 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecC--------CcEEeccchhhHh
Confidence 998877776655 56789999999999999999999999 69999999999999986 7999999999998
Q ss_pred hhc--cccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Q psy6905 273 VYK--TTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV-------------- 335 (527)
Q Consensus 273 ~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~-------------- 335 (527)
+.. ..+...+.|..|+|||.+.+ ..|+..+||||+||++.||++|.+.|++.+.....+.|..
T Consensus 151 L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 151 LSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred hcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 863 23345678999999999988 5699999999999999999999999999988777665532
Q ss_pred -----CCccCCCCC----------CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 -----NKLTLPIPS----------TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 -----~~~~~~~p~----------~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.++|.|. ..+..+.+||+.||..||++|++.++++.+
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 133444432 345678899999999999999999999873
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=380.39 Aligned_cols=258 Identities=32% Similarity=0.613 Sum_probs=217.3
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCL 183 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~ 183 (527)
|.|+.++|++.+.||+|+||.||+|.+. +..||||++...........+.+|+.++..+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 7889999999999999999999999742 2479999987655444567788999999999 8999999999987
Q ss_pred eC-CeEEEEEeccCCCCHHHHhcC--------------------------------------------------------
Q psy6905 184 QS-PKLCLVMEYARGGPLNRVLAG-------------------------------------------------------- 206 (527)
Q Consensus 184 ~~-~~~~iv~Ey~~ggsL~~~l~~-------------------------------------------------------- 206 (527)
.. ..+|+|||||++|+|.+++..
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 468999999999999988862
Q ss_pred -------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcccc-
Q psy6905 207 -------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH- 278 (527)
Q Consensus 207 -------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~- 278 (527)
..++...++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.......
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~--------~~~kl~DfG~a~~~~~~~~~ 230 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSEN--------NVVKICDFGLARDIYKDPDY 230 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCC--------CcEEEeecccccccccCcch
Confidence 13667788999999999999999995 9999999999999875 6899999999986532211
Q ss_pred ---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 279 ---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 279 ---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+........+.....|..+++.+.+|+
T Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 310 (338)
T cd05102 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIM 310 (338)
T ss_pred hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 12345688999999998889999999999999999997 99999886654444444445555667788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 355 EACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 355 ~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.+||+.||.+|||+.+|++.|+.++.
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=383.08 Aligned_cols=247 Identities=32% Similarity=0.513 Sum_probs=223.8
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
...|...++||+|+.|.||.|.. +++.||||.+...... ..+-+.+|+.+|+.++|+|||+|++.|..++.+|+|||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 46788889999999999999986 4578999988765433 25678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 194 YARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 194 y~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|++||+|.+++....+++.++..++..++.||+|||.+| |||||||.+|||++.+ +.|||+|||++..+
T Consensus 351 ym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~--------g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMD--------GSVKLTDFGFCAQI 419 (550)
T ss_pred ecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccC--------CcEEEeeeeeeecc
Confidence 999999999999889999999999999999999999995 9999999999999986 78999999999887
Q ss_pred hcc--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCCCCCccHHH
Q psy6905 274 YKT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLF 350 (527)
Q Consensus 274 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~~ 350 (527)
... ...+.+|||.|||||++....|+++.||||||++++||+-|++||-..+.....+.+..++. .+..|..+|+.|
T Consensus 420 ~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~ 499 (550)
T KOG0578|consen 420 SEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPEL 499 (550)
T ss_pred ccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHH
Confidence 543 34467899999999999999999999999999999999999999998888888888876544 567789999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++++.+||..|+.+|+++.+||+|
T Consensus 500 kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 500 KDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHhhcchhcCCCHHHHhcC
Confidence 999999999999999999999985
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=394.97 Aligned_cols=259 Identities=34% Similarity=0.609 Sum_probs=238.3
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--C---ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--K---QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
.||+.+..+|.++||.|.||.|++|..+ + ..||||.++..-.+....+|+.|+.||-+++||||++|.|+.....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 4899999999999999999999999874 2 4699999999888888999999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.++||+|||++|+|+.+|+ .++|+..++..+++.|+.||+||-+. ++|||||.++||||+.+ -.+|+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsn--------LvCKV 772 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSN--------LVCKV 772 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhheeeccc--------eEEEe
Confidence 9999999999999999998 56799999999999999999999998 59999999999999987 58999
Q ss_pred eccCcchhhhccccc--cCC-C--ccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCc
Q psy6905 265 TDFGLAREVYKTTHM--SAA-G--TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 265 ~DFGla~~~~~~~~~--~~~-g--t~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
+||||++.+.+.... +.. | +++|+|||++...+|+.+||||||||+|||.++ |+.||..+++.+++..|. .++
T Consensus 773 sDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gy 851 (996)
T KOG0196|consen 773 SDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGY 851 (996)
T ss_pred ccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hcc
Confidence 999999977544322 222 2 589999999999999999999999999999998 999999999999998887 589
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
++|.|-+||..+++||..||+.|-.+||.|.+|+..|++++..+
T Consensus 852 RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 852 RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 99999999999999999999999999999999999999987664
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=385.33 Aligned_cols=259 Identities=37% Similarity=0.664 Sum_probs=225.8
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
..|+|..+++.+++.||+|.||+||+|.|.| .||||+++... ..+.++.|++|+..+++-+|.||+-|.|+|...+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 6799999999999999999999999999988 59999988753 44568999999999999999999999999998876
Q ss_pred EEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 189 CLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
.||+.+|+|.+|..+|. ..+|....+++|+.||++||.|||.+ +|||||||..|||+.++ +.|||+|
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~--------~kVkIgD 531 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHED--------LKVKIGD 531 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccC--------CcEEEec
Confidence 99999999999999987 56788999999999999999999999 69999999999999985 6999999
Q ss_pred cCcchhhh----ccccccCCCcccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-
Q psy6905 267 FGLAREVY----KTTHMSAAGTYAWMAPEVIKT---SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL- 338 (527)
Q Consensus 267 FGla~~~~----~~~~~~~~gt~~y~aPE~l~~---~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~- 338 (527)
|||+..-. ........|...|||||+++. .+|++.+|||||||++|||++|..||...+.+++++.+-.+-.
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~ 611 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM 611 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC
Confidence 99985431 122234468899999999964 4699999999999999999999999997777777777665422
Q ss_pred --cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 339 --TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 339 --~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
...+-..|++++++|+..||..++++||.|.+|+..|+.+..+
T Consensus 612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1223478999999999999999999999999999988888774
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=380.40 Aligned_cols=258 Identities=34% Similarity=0.658 Sum_probs=231.0
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcC----c--eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK----Q--EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCL 183 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~----~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~ 183 (527)
..+++.++.+.+.++||.|.||.||+|++.. . .||||..+.+...+..+.|.+|+.+|++++|||||+++|+|.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3578999999999999999999999999742 2 599999998877777899999999999999999999999998
Q ss_pred eCCeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 184 QSPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 184 ~~~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
+. .++||||+++-|.|..+|+ +..++...+.-++.||+.||.|||+. ++|||||.++||||+.. ..
T Consensus 462 e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp--------~C 529 (974)
T KOG4257|consen 462 EQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSP--------QC 529 (974)
T ss_pred cc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCc--------ce
Confidence 76 5899999999999999998 45688888999999999999999999 69999999999999986 57
Q ss_pred eEEeccCcchhhhccccccC-C--CccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Q psy6905 262 LKITDFGLAREVYKTTHMSA-A--GTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK 337 (527)
Q Consensus 262 vkL~DFGla~~~~~~~~~~~-~--gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~ 337 (527)
|||+|||+++.+....+... . -++.|||||-++...|+.+||||.|||++||++. |..||.+..+..++-.+. ++
T Consensus 530 VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nG 608 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NG 608 (974)
T ss_pred eeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CC
Confidence 99999999998866554422 2 3688999999999999999999999999999998 999999988877765554 68
Q ss_pred ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 338 ~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
-++|.|+.||+.++.||.+||..+|.+||.|.+|...|.++..
T Consensus 609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 8999999999999999999999999999999999998877765
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=347.79 Aligned_cols=238 Identities=29% Similarity=0.438 Sum_probs=217.9
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
....+|++.+.||.|+||.|.+++. ++..||+|++.... .....+...+|..+|+.+.||+++++++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 4567889999999999999999986 46789999987653 2234677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|||||.+||.|..+++ .++|++..+..++.||+.||+|||+. .|++|||||+|||++.+ |.+||+|||
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~--------G~iKitDFG 189 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQN--------GHIKITDFG 189 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccC--------CcEEEEecc
Confidence 9999999999999998 57899999999999999999999999 49999999999999986 899999999
Q ss_pred cchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 269 LAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 269 la~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
+|+.+... ..+.||||.|+|||++....|..++|.|||||++|||+.|.+||.+.+....+.+|..+++. .|..++.
T Consensus 190 FAK~v~~r-T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--fP~~fs~ 266 (355)
T KOG0616|consen 190 FAKRVSGR-TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--FPSYFSS 266 (355)
T ss_pred ceEEecCc-EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--CCcccCH
Confidence 99988655 66789999999999999999999999999999999999999999999999999999977765 5788999
Q ss_pred HHHHHHHHhhhhCCCCC
Q psy6905 349 LFKTLMEACWEADSHMR 365 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~R 365 (527)
++++|++.+++.|-.+|
T Consensus 267 ~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 267 DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHHHHHhhhhHhh
Confidence 99999999999999988
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=377.21 Aligned_cols=245 Identities=29% Similarity=0.450 Sum_probs=219.9
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
-|++++.||.|+.|.|.+|.+ +|+.+|||++.... .+.....+.+|+.+|+.+.||||+++|++|++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 367889999999999999997 68999999987652 23335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|++||.|.+++- ++.+++.+...++.||+.|+.|||.. +|+||||||+|+||+.+ +++||+|||+|..
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~--------~nIKIADFGMAsL 161 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVK--------NNIKIADFGMASL 161 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcc--------cCEeeeccceeec
Confidence 999999988765 88999999999999999999999999 59999999999999986 5699999999975
Q ss_pred hhcc-ccccCCCccccccccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHH
Q psy6905 273 VYKT-THMSAAGTYAWMAPEVIKTSIFS-KASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLF 350 (527)
Q Consensus 273 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~-~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 350 (527)
-... .-.+.||.+.|.|||++.|.+|+ .++||||.|||||.|++|++||++.+....+.++..+.+. +|..+|.+.
T Consensus 162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~--MPs~Is~ea 239 (786)
T KOG0588|consen 162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE--MPSNISSEA 239 (786)
T ss_pred ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc--CCCcCCHHH
Confidence 4332 23467999999999999999885 8999999999999999999999999999999999877665 569999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
.+||.+|+..||..|.|..+|++|-
T Consensus 240 QdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 240 QDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHHHHHHhccCccccccHHHHhhCc
Confidence 9999999999999999999999973
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=362.44 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=221.9
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
..|-++.++|++.+.||.|..++||+|++ .+..||||++..+......+.+.+|+..|+.++||||++++..|..+..
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 34667889999999999999999999987 5678999999988766668999999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 188 LCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
+|+||.||.+||+.++++ ...+++..+..|++++++||.|||.+| .||||||+.||||+.+ |.|||
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~d--------G~VkL 167 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSD--------GTVKL 167 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCC--------CcEEE
Confidence 999999999999999987 456999999999999999999999996 9999999999999986 89999
Q ss_pred eccCcchhhhccc-----c-ccCCCccccccccccc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6905 265 TDFGLAREVYKTT-----H-MSAAGTYAWMAPEVIK--TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN 336 (527)
Q Consensus 265 ~DFGla~~~~~~~-----~-~~~~gt~~y~aPE~l~--~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~ 336 (527)
+|||.+..+.... . ..++||++|||||++. ...|+.|+||||||++..||.+|..||..+....+......+
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn 247 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN 247 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9999886653321 1 3568999999999964 345999999999999999999999999999988887766654
Q ss_pred CccCCC--------CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 KLTLPI--------PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ~~~~~~--------p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+. ...++..|+.++..||..||.+|||+.+++++
T Consensus 248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 432111 12356689999999999999999999999985
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=373.80 Aligned_cols=248 Identities=31% Similarity=0.499 Sum_probs=217.8
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC----ChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP----DENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~ 186 (527)
.....|.+++.||+|+||+|+.|.+ ++..||+|++.... .....+.+.+|+.+++.+. ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999987 56899999876641 1133556778999999998 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.+|+|||||.||+|.+++. .+++.+..+..++.|++.|++|||++| |+||||||+|||++.+ .+++||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~-------~~~~Kl~ 163 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGN-------EGNLKLS 163 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCC-------CCCEEEe
Confidence 9999999999999999887 588999999999999999999999995 9999999999999985 1589999
Q ss_pred ccCcchhhh--ccccccCCCccccccccccccCC-CC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 266 DFGLAREVY--KTTHMSAAGTYAWMAPEVIKTSI-FS-KASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 266 DFGla~~~~--~~~~~~~~gt~~y~aPE~l~~~~-~~-~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
|||++.... .....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+.......+..+ .+.
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~--~~~ 241 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG--EFK 241 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC--Ccc
Confidence 999998772 34445789999999999999877 75 8999999999999999999999998877777776544 456
Q ss_pred CCCCc-cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 342 IPSTC-PQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 342 ~p~~~-~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
+|..+ +.+++.|+.+|+..||.+|+++.+|+.
T Consensus 242 ~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 242 IPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 77777 999999999999999999999999985
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=362.50 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=220.3
Q ss_pred eEEeCCceeee--eeeccCCceEEEEeeEcCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe---
Q psy6905 112 VEIDYNKLIFG--EAIGEGGFGKVYKGIYEKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--- 184 (527)
Q Consensus 112 ~~i~~~~~~~~--~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--- 184 (527)
..|+.++++.. ..||+|++|.||+|.++++.||||.+.... .....+.+.+|+.+|+.++||||++++|++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 44555555555 689999999999999999999999987643 22335778899999999999999999999877
Q ss_pred -CCeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 185 -SPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 185 -~~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
...+++|||||+||+|.+++. .+.++....+.++.|++.||.|||+.. +++||||||+|||++.+ +.+
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~--------~~~ 162 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTEN--------YKL 162 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCC--------CcE
Confidence 457899999999999999987 456888899999999999999999852 48899999999999986 689
Q ss_pred EEeccCcchhhhccccccCCCcccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 263 KITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT--SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 263 kL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+...+...
T Consensus 163 kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 241 (283)
T PHA02988 163 KIICHGLEKILSSP-PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL 241 (283)
T ss_pred EEcccchHhhhccc-cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99999999865332 234568999999999976 678999999999999999999999999988877777776666777
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
+.|..+|+.+.+||.+||+.||.+|||+.++++.|+.+
T Consensus 242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 78878999999999999999999999999999988764
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=373.11 Aligned_cols=246 Identities=35% Similarity=0.563 Sum_probs=216.7
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
..|...+.||+|.||.||+|.+. ++.||+|++.....++..+.+.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34566689999999999999984 5789999999987777789999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCC-ChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLAGRKI-RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~~~~~-~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|.||++.++++-+.+ .+..+.-++++++.||.|||.+ +.+|||||+.|||+..+ +.|||+|||.+...
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~--------g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSES--------GDVKLADFGVAGQL 161 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEecc--------CcEEEEecceeeee
Confidence 999999999995554 8888999999999999999999 59999999999999985 79999999999877
Q ss_pred hccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHH
Q psy6905 274 YKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFK 351 (527)
Q Consensus 274 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 351 (527)
.... ..+++||+.|||||++....|+.|+||||||++.+||.+|.+||.......+...|..+. ...+...+++.|+
T Consensus 162 ~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~-PP~L~~~~S~~~k 240 (467)
T KOG0201|consen 162 TNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA-PPRLDGDFSPPFK 240 (467)
T ss_pred echhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC-CCccccccCHHHH
Confidence 5433 257899999999999999899999999999999999999999999887755554443322 2223357899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 352 TLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++|..||..||+.||++.+|+++
T Consensus 241 EFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 241 EFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHhhcCcccCcCHHHHhhh
Confidence 99999999999999999999985
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=373.23 Aligned_cols=244 Identities=33% Similarity=0.546 Sum_probs=219.3
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|.+.+.||+|+||.||||+.+ .+.||+|.+.+. ..+..++.+.+|+++++.|+|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57899999999999999999865 468999987664 455668889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||.| +|..+|. .+.++++.+..++.+++.||.|||++ .|+|||+||.|||+... +.+|+||||+|+.
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~--------~~~KlcdFg~Ar~ 149 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKG--------GTLKLCDFGLARA 149 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCC--------Cceeechhhhhhh
Confidence 9966 9999997 78899999999999999999999999 59999999999999986 7999999999998
Q ss_pred hhccccc--cCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHH
Q psy6905 273 VYKTTHM--SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLF 350 (527)
Q Consensus 273 ~~~~~~~--~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 350 (527)
+...+.. +..|||.|||||++.+.+|+..+|+|||||++||+++|++||...+-.+....|.... ...|...+..|
T Consensus 150 m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~--v~~p~~~S~~f 227 (808)
T KOG0597|consen 150 MSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP--VKPPSTASSSF 227 (808)
T ss_pred cccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC--CCCcccccHHH
Confidence 7554333 4579999999999999999999999999999999999999999888877777776443 34556899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.++++..|..||..|.++.+++.|
T Consensus 228 ~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 228 VNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHHhhcChhhcccHHHHhcC
Confidence 999999999999999999999875
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=367.50 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=218.8
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
.+..++|+++++||+|+||.||+|.- +|..||+|+++... ..+..+.++.|-.+|...++|+||++|-.|.+..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45778999999999999999999985 67899999998763 234477899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+||||++||++..+|. .+.+++..+..++.+++.|++.||..| +|||||||+|+||+.. |.+||+||
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~--------GHiKLSDF 285 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAK--------GHIKLSDF 285 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCC--------CCEeeccc
Confidence 99999999999999887 678999999999999999999999995 9999999999999986 89999999
Q ss_pred Ccchhhhc-------------------------cc------------------------cccCCCccccccccccccCCC
Q psy6905 268 GLAREVYK-------------------------TT------------------------HMSAAGTYAWMAPEVIKTSIF 298 (527)
Q Consensus 268 Gla~~~~~-------------------------~~------------------------~~~~~gt~~y~aPE~l~~~~~ 298 (527)
||+..+.. .. ..+.+|||.|+|||++.+..|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 99853210 00 013469999999999999999
Q ss_pred CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--cCCCCCCccHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q psy6905 299 SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL--TLPIPSTCPQLFKTLMEACWEADSHMRPS---FKTILK 373 (527)
Q Consensus 299 ~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~~~~li~~~l~~dp~~RPs---~~~ll~ 373 (527)
+..+|+||||||+|||+.|.+||.+.+..+....|..-.. ..|.-..++++.++||.+|+. ||+.|.. +.||.+
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 9999999999999999999999999999999998886654 444446678999999999999 9999974 677765
Q ss_pred H
Q psy6905 374 A 374 (527)
Q Consensus 374 ~ 374 (527)
|
T Consensus 445 H 445 (550)
T KOG0605|consen 445 H 445 (550)
T ss_pred C
Confidence 3
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=365.26 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=210.6
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCC-eEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSP-KLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~-~~~ 189 (527)
+..++|.+.++||.|.||.||+|.. .+..||||.++.....-..-.-.+|+..|++|+ |||||++.+++.+.+ .+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3457899999999999999999986 567899998877543211223368999999998 999999999998877 999
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+||||| ..+|.++++ ++.|++..+..|+.||++||+|+|.+| +.|||+||+||||..+ ..|||+||
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~--------~~iKiaDF 154 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGN--------DVIKIADF 154 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEeccc--------ceeEeccc
Confidence 999999 567988887 567999999999999999999999996 9999999999999964 48999999
Q ss_pred Ccchhhhccc-cccCCCccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Q psy6905 268 GLAREVYKTT-HMSAAGTYAWMAPEVIK-TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV---------- 335 (527)
Q Consensus 268 Gla~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~---------- 335 (527)
|+||.+.... +...+.|..|+|||++. .+.|+.+.|+||+||+++|+++-++.|+|.+..+.+++|+.
T Consensus 155 GLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 155 GLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred ccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 9999986544 44567899999999975 56799999999999999999999999999998887777652
Q ss_pred ---------CCccCC---------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 ---------NKLTLP---------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ---------~~~~~~---------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.++.+| +-..++.++.+||.+|+.+||.+|||+.+++++
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 122222 013478899999999999999999999999985
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=351.32 Aligned_cols=253 Identities=32% Similarity=0.574 Sum_probs=218.5
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc-----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
|+.++|++.+.||+|+||.||+|.++ +..||+|.+...........+.+|+.+++.++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 67788999999999999999999763 3579999988765555566788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 189 CLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
|+||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++| ++||||||+|||++.+ +.++++|
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~--------~~~~l~d 150 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSD--------LVCKISG 150 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCC--------CcEEECC
Confidence 999999999999999873 46899999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 267 FGLAREVYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 267 FGla~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
||.+....... .....++..|+|||.+.+..++.++|||||||++||+++ |..||.+.+.......+. .+...+.
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 229 (266)
T cd05064 151 FRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPA 229 (266)
T ss_pred CcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCC
Confidence 99876542211 112335678999999999999999999999999999876 999999888777666554 4456678
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
|..+|..+.+++.+||..+|.+||++.+|++.|.++
T Consensus 230 ~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 230 PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 889999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=359.23 Aligned_cols=250 Identities=30% Similarity=0.415 Sum_probs=216.0
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-------------hhHHHHHHHHHHHHHhCCCCccceEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-------------ENILENVKQEGKLLWLFDHRNIVSLI 179 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~hpnIv~~~ 179 (527)
..+.|++.+.||+|.||.|-+|.+ .++.||||++..... ..-.+.+++|+.+|++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 357899999999999999999997 468999999865321 11146889999999999999999999
Q ss_pred EEEEe--CCeEEEEEeccCCCCHHHHhcCCC-CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccc
Q psy6905 180 GVCLQ--SPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENED 256 (527)
Q Consensus 180 ~~~~~--~~~~~iv~Ey~~ggsL~~~l~~~~-~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~ 256 (527)
.+..+ .+.+|||+|||..|.+...-..+. +++.++..++.+++.||+|||.+| ||||||||+|+||+.+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~----- 246 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD----- 246 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC-----
Confidence 99865 567999999999998876655555 999999999999999999999995 9999999999999986
Q ss_pred cccceeEEeccCcchhhhcc-------ccccCCCccccccccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCC
Q psy6905 257 LQFKTLKITDFGLAREVYKT-------THMSAAGTYAWMAPEVIKTSI----FSKASDVWSYGVVLWELLTGEIPYKSIN 325 (527)
Q Consensus 257 ~~~~~vkL~DFGla~~~~~~-------~~~~~~gt~~y~aPE~l~~~~----~~~ksDvwSlGv~l~elltg~~Pf~~~~ 325 (527)
|+|||+|||.+...... .-...+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-+..
T Consensus 247 ---g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 247 ---GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred ---CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 79999999998755221 112367999999999987632 3589999999999999999999999999
Q ss_pred HHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 326 AYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 326 ~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
..+...+|....+.+|.-..+.+.+++||++||..||+.|.+..+|..|.
T Consensus 324 ~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 99999999987777777677899999999999999999999999998764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=371.35 Aligned_cols=257 Identities=33% Similarity=0.623 Sum_probs=219.0
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGV 181 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~ 181 (527)
..|.++.++|.+.+.||+|+||.||+|.+. +..||||++.........+.+.+|+.++..+ +||||++++++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 458888999999999999999999999742 3479999987655444466788999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHhcCC------------------------------------------------------
Q psy6905 182 CLQSPKLCLVMEYARGGPLNRVLAGR------------------------------------------------------ 207 (527)
Q Consensus 182 ~~~~~~~~iv~Ey~~ggsL~~~l~~~------------------------------------------------------ 207 (527)
|.+....|+|||||+||+|.+++...
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 99999999999999999999887521
Q ss_pred ----------------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 208 ----------------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 208 ----------------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~--------~~~kl~ 256 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHG--------RITKIC 256 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECC--------CcEEEe
Confidence 3567788899999999999999994 9999999999999875 589999
Q ss_pred ccCcchhhhccccc----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 266 DFGLAREVYKTTHM----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
|||+++........ ...++..|+|||++.+..++.++|||||||++|+|++ |..||...............+...
T Consensus 257 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 336 (375)
T cd05104 257 DFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM 336 (375)
T ss_pred cCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC
Confidence 99999765432221 1234678999999999999999999999999999998 999998876665555555566666
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
..|..++.++.+|+..||+.||++||++.++++.|+.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 6777889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=370.80 Aligned_cols=260 Identities=32% Similarity=0.595 Sum_probs=221.8
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEE
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIG 180 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~ 180 (527)
...|.++.++|++.+.||+|+||.||+|.+. +..||||++...........+.+|+.+++.+ +|+||+++++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 4468889999999999999999999998852 1469999998765555567788999999999 8999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHhcC------------------------------------------------------
Q psy6905 181 VCLQSPKLCLVMEYARGGPLNRVLAG------------------------------------------------------ 206 (527)
Q Consensus 181 ~~~~~~~~~iv~Ey~~ggsL~~~l~~------------------------------------------------------ 206 (527)
+|.....+|+|||||.+|+|.+++..
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 99999999999999999999988742
Q ss_pred -----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 207 -----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 207 -----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
..++...++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~--------~~~kL~DfGl 258 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDG--------RVAKICDFGL 258 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCC--------CeEEEeecee
Confidence 13667788999999999999999995 9999999999999865 6899999999
Q ss_pred chhhhccccc----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 270 AREVYKTTHM----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 270 a~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
++........ ...+++.|+|||++.+..++.++|||||||++|+|++ |+.||.....................|.
T Consensus 259 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 338 (374)
T cd05106 259 ARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPD 338 (374)
T ss_pred eeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCC
Confidence 9765332221 1235678999999998889999999999999999997 9999988766555555555666667777
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~ 379 (527)
.+|+++.+++.+||+.||.+|||+.++++.|++++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 88999999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=359.41 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=211.9
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
+..++|++.+.||+|+||.||++.+. +..||+|++...........+.+|+.+++.++||||+++++++..++.+++|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 55688999999999999999999985 5689999988765555567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||||++|+|.+++. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.+ +.+||+|||++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~--------~~~kl~Dfg~~ 151 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSR--------GEIKLCDFGVS 151 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCC--------CcEEEccCccc
Confidence 99999999999987 456899999999999999999999864 59999999999999875 68999999999
Q ss_pred hhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------------
Q psy6905 271 REVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA---------------- 334 (527)
Q Consensus 271 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~---------------- 334 (527)
............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.
T Consensus 152 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 152 GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence 8765444445679999999999999899999999999999999999999997655433221110
Q ss_pred -----------------------------hCCccCCC-CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 335 -----------------------------VNKLTLPI-PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 335 -----------------------------~~~~~~~~-p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
........ ...+++++.+||.+||..||++|||+.+|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00001111 12468899999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=365.07 Aligned_cols=247 Identities=28% Similarity=0.467 Sum_probs=222.0
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe-EEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK-LCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~-~~iv 191 (527)
.+.|..++.+|+|+||.++.+.++ ++.|++|.+.... .+...+...+|+.++++++|||||.|++.|.+++. +|||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357889999999999999988774 4689999877653 33345577899999999999999999999999887 9999
Q ss_pred EeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 192 MEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|+||+||+|.+.+. +..|+++.++.|+.|++.|+.|||++ .|+|||||+.|||++.+ +.|+|+|||
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~--------~~VkLgDfG 151 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKD--------KKVKLGDFG 151 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhcccc--------Cceeecchh
Confidence 99999999999987 34689999999999999999999988 59999999999999986 678999999
Q ss_pred cchhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 269 LAREVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 269 la~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
+|+...... ..+..||+.|++||++.+.+|..|+|||||||++|||++-+++|.+.+......++.... -.|+|..+
T Consensus 152 laK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~y 230 (426)
T KOG0589|consen 152 LAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMY 230 (426)
T ss_pred hhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccc
Confidence 999886553 345689999999999999999999999999999999999999999999999998887655 56899999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+++.||+.|+..+|..||++.+|+.+
T Consensus 231 s~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 231 SSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 9999999999999999999999999985
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=372.06 Aligned_cols=250 Identities=34% Similarity=0.615 Sum_probs=224.2
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc---Cc--eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE---KQ--EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~---~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
--|..+++.+.++||+|.||.|++|.|+ |+ .||||+++.+........|++|+.+|.+|+|||+++|||+..+ .
T Consensus 105 clIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 105 CLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred eeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 3577788999999999999999999995 33 6999999987655578999999999999999999999999988 6
Q ss_pred eEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 187 KLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
.+.||||+|..|+|.+.|++ ..|-...+.+++.||+.||.||.++ .+|||||.++|+|+... ..||
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasp--------rtVK 252 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASP--------RTVK 252 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheeccc--------ceee
Confidence 78999999999999999974 4577888999999999999999999 49999999999999874 5899
Q ss_pred EeccCcchhhhccccc-c----CCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Q psy6905 264 ITDFGLAREVYKTTHM-S----AAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK 337 (527)
Q Consensus 264 L~DFGla~~~~~~~~~-~----~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~ 337 (527)
|+||||.+.+...... . ..-.+.|+|||.++...|+.+||||+|||+||||++ |+.||.+.....++..+. .+
T Consensus 253 I~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~ 331 (1039)
T KOG0199|consen 253 ICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AG 331 (1039)
T ss_pred eecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-cc
Confidence 9999999987543322 1 124678999999999999999999999999999999 999999999999999888 78
Q ss_pred ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 ~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+++.|..||++++++|+.||..+|.+||+|..|.+.
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 8899999999999999999999999999999999744
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=370.25 Aligned_cols=243 Identities=26% Similarity=0.419 Sum_probs=218.3
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCe
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~ 187 (527)
.+..++|.++++||+|.||+|+++..+ ++.||||++++.. ..+..+..+.|.+++... +||.+++++..|....+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 456788999999999999999999985 4689999998863 334577888999999887 59999999999999999
Q ss_pred EEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 188 LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+|+||||+.||++..+.+.+.|++..+..++..|+.||.|||++| |||||||.+|||++.. |.+||+||
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~e--------Gh~kiADF 512 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTE--------GHVKIADF 512 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEccc--------CcEEeccc
Confidence 999999999999666666789999999999999999999999995 9999999999999986 89999999
Q ss_pred Ccchhhh--ccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCC
Q psy6905 268 GLAREVY--KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST 345 (527)
Q Consensus 268 Gla~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 345 (527)
|+++..- .....+.+||+.|||||++.+..|+..+|.|||||+||||+.|..||++.+..++...|.... ...|..
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--~~yP~~ 590 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRF 590 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCCc
Confidence 9998763 445567899999999999999999999999999999999999999999999999999987554 456778
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSF 368 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~ 368 (527)
+|.+..+||+++|..+|++|...
T Consensus 591 ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 591 LSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ccHHHHHHHHHHhccCcccccCC
Confidence 99999999999999999999754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=362.36 Aligned_cols=245 Identities=26% Similarity=0.444 Sum_probs=213.0
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
..++|.+.+.||+|+||.||+|.+. ++.||+|++.... .......+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 4578999999999999999999984 5789999986532 22235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||||.||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~--------~~~kl~Dfg~ 164 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNK--------GHVKVTDFGF 164 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCC--------CCEEEeeccC
Confidence 999999999998886 567899999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 270 a~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ..+.|..++..
T Consensus 165 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~ 241 (329)
T PTZ00263 165 AKKVPDR-TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWFDGR 241 (329)
T ss_pred ceEcCCC-cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCCCHH
Confidence 9766332 23457999999999999999999999999999999999999999988877776666543 34667788999
Q ss_pred HHHHHHHhhhhCCCCCCC-----HHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPS-----FKTILK 373 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs-----~~~ll~ 373 (527)
+.+||.+||..||.+||+ +.+++.
T Consensus 242 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 242 ARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 999999999999999997 577665
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=367.55 Aligned_cols=261 Identities=31% Similarity=0.576 Sum_probs=222.4
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEE
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIG 180 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~ 180 (527)
...|+++.++|.+++.||+|+||.||+|.+.+ ..||||++.........+.+.+|+.+++.+. ||||+++++
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 35699999999999999999999999998632 3599999977655555678899999999996 999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHhcC------------------------------------------------------
Q psy6905 181 VCLQSPKLCLVMEYARGGPLNRVLAG------------------------------------------------------ 206 (527)
Q Consensus 181 ~~~~~~~~~iv~Ey~~ggsL~~~l~~------------------------------------------------------ 206 (527)
+|.+...+|||||||++|+|.+++..
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 99999999999999999999887742
Q ss_pred -------------------------------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q psy6905 207 -------------------------------------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKS 243 (527)
Q Consensus 207 -------------------------------------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp 243 (527)
..++...++.++.||+.||.|||+++ |+||||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp 265 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAA 265 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCh
Confidence 13566778899999999999999994 99999999
Q ss_pred CceecCCCCcccccccceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CC
Q psy6905 244 SNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GE 318 (527)
Q Consensus 244 ~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~ 318 (527)
+|||++.+ +.+||+|||+++...... .....++..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 266 ~Nill~~~--------~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~ 337 (400)
T cd05105 266 RNVLLAQG--------KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337 (400)
T ss_pred HhEEEeCC--------CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999875 589999999997653221 123346788999999998889999999999999999997 99
Q ss_pred CCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 319 IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 319 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.||...............+..++.+..++..+.++|.+||..||++||++.+|.+.|+.++.
T Consensus 338 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 338 TPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 99988765555555555566677788899999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=356.60 Aligned_cols=244 Identities=27% Similarity=0.400 Sum_probs=212.6
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||+|+||.||+|.+. ++.||+|++.... .......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999985 6789999886432 2223566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||+.+|+|.+++. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~--------~~~kl~Dfg~~~ 149 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKE--------GHIKLTDFGFAK 149 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCC--------CCEEEEecCcch
Confidence 9999999999886 567899999999999999999999995 9999999999999875 689999999998
Q ss_pred hhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHH
Q psy6905 272 EVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFK 351 (527)
Q Consensus 272 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 351 (527)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ...|..++..+.
T Consensus 150 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 226 (291)
T cd05612 150 KLRDR-TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLDLYAK 226 (291)
T ss_pred hccCC-cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cCCCccCCHHHH
Confidence 66432 234579999999999999889999999999999999999999999988777777666543 456777899999
Q ss_pred HHHHHhhhhCCCCCCC-----HHHHHHH
Q psy6905 352 TLMEACWEADSHMRPS-----FKTILKA 374 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs-----~~~ll~~ 374 (527)
+||++||..||.+||+ +.+++++
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 9999999999999995 8888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=354.15 Aligned_cols=252 Identities=37% Similarity=0.636 Sum_probs=209.6
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc------------------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCcc
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE------------------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNI 175 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~------------------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnI 175 (527)
++..+|.+.+.||+|+||.||+|.+. +..||+|++...........+.+|+.++..++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 45678999999999999999999752 236999998876555556788999999999999999
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCCHHHHhcCC--------------------CCChhHHHHHHHHHHHHHHHHHhcCCCc
Q psy6905 176 VSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR--------------------KIRPDVLVDWAIQIAEGMNYLHCQAPIS 235 (527)
Q Consensus 176 v~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~~--------------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~ 235 (527)
+++++++.+.+..|+|||||.+|+|.+++... .++...++.++.||+.||.|||+.|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--- 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--- 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99999999999999999999999999988532 2566778999999999999999995
Q ss_pred eeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHH
Q psy6905 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVL 311 (527)
Q Consensus 236 iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l 311 (527)
|+||||||+|||++.+ +.+||+|||+++....... ....++..|+|||++.+..++.++|||||||++
T Consensus 159 ivH~dlkp~Nill~~~--------~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 230 (304)
T cd05096 159 FVHRDLATRNCLVGEN--------LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL 230 (304)
T ss_pred ccccCcchhheEEcCC--------ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence 9999999999999875 6899999999976533221 123457899999999888899999999999999
Q ss_pred HHHHh--CCCCCCCCCHHHHHHHHHh------CCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 312 WELLT--GEIPYKSINAYAVAYGVAV------NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 312 ~ellt--g~~Pf~~~~~~~~~~~i~~------~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
|+|++ +..||.+.+.......+.. .......|..+|..+.+||.+||..||.+|||+.+|.+.|+
T Consensus 231 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 99987 6789988776555443321 11123346678999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=336.51 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=221.1
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
+.|.+.+.||+|.|+.||++.+ +|+.+|+|++.... .....+.+.+|+.+-+.|+|||||++.+.+......|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 5788999999999999999987 57889999887642 22246788899999999999999999999999999999999
Q ss_pred ccCCCCHH-HHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLN-RVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~-~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
++.||+|. ++..+--+++..+-.++.||+++|.|||.++ |||||+||.|+|+....++ .-|||+|||+|..
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~-----A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKG-----AAVKLADFGLAIE 162 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCC-----CceeecccceEEE
Confidence 99999985 5555656788888899999999999999994 9999999999999876433 5799999999998
Q ss_pred hhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCccHH
Q psy6905 273 VYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQL 349 (527)
Q Consensus 273 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~ 349 (527)
+.... ....+|||.|||||+++..+|+..+|||+.||+||-|+.|.+||.+.+....+.+|..+.+.++.| +.++++
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 86322 235689999999999999999999999999999999999999999999999999999998887765 678999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.++|+++||..||.+|.|+.|.+++
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCC
Confidence 9999999999999999999999873
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.28 Aligned_cols=244 Identities=38% Similarity=0.699 Sum_probs=208.9
Q ss_pred eeeeeeccCCceEEEEeeEc------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 120 IFGEAIGEGGFGKVYKGIYE------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 120 ~~~~~iG~G~fg~Vy~~~~~------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.+.+.||.|.||.||+|.+. +..|+||.+.........+.+.+|++.+++++||||++++|++......++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999987 468999999776566567889999999999999999999999998888999999
Q ss_pred ccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 194 YARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 194 y~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||++|+|.+++.. ..++...+..|+.||+.||.|||++ +++|+||+++|||++.+ +.+||+|||++
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~--------~~~Kl~~f~~~ 150 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSN--------GQVKLSDFGLS 150 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETT--------TEEEEESTTTG
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc--------ccccccccccc
Confidence 9999999999884 4789999999999999999999999 59999999999999986 69999999999
Q ss_pred hhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCC
Q psy6905 271 REVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPST 345 (527)
Q Consensus 271 ~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 345 (527)
....... .....+...|+|||.+.+..++.++||||||+++|||++ |+.||...+.......+ ......+.|..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (259)
T PF07714_consen 151 RPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDN 229 (259)
T ss_dssp EETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccc
Confidence 8762211 123347789999999998889999999999999999999 78999999888877777 45666778889
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
++..+.++|..||+.||.+|||+.+|++.|
T Consensus 230 ~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 230 CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999999999999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=346.01 Aligned_cols=247 Identities=25% Similarity=0.429 Sum_probs=221.4
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
...+|++.+.||+|.||.|-+|.. .|+.||||.++.+. ++..+-.+.+|+++|..|+||||+.+|.+|++.+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 346899999999999999999986 57899999988763 44456778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
||||..+|.|.+++. .+.+++.+...+++||..|+.|||.+ .+||||||.+|||++.| +++||+|||+
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N--------~NiKIADFGL 199 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQN--------NNIKIADFGL 199 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCC--------CCeeeeccch
Confidence 999999999999998 77899999999999999999999999 49999999999999987 7999999999
Q ss_pred chhhhcccc-ccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCcc
Q psy6905 270 AREVYKTTH-MSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 270 a~~~~~~~~-~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 347 (527)
+..+.+... .++||++.|.+||++++.+| ++.+|.|||||+||-|+.|..||++.+....+.+|..+.|+-|. -|
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~P 276 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TP 276 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CC
Confidence 987755433 47899999999999999987 48999999999999999999999999999999999888776432 23
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
.+..-||+.||..||++|.|+.+|..+-
T Consensus 277 SdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 277 SDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 4567899999999999999999998874
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=327.23 Aligned_cols=246 Identities=26% Similarity=0.431 Sum_probs=221.6
Q ss_pred CCceeeeeeeccCCceEEEEeeEcC--ceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~~--~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
.++|.+++.||.|-||.||.|+.+. -.||+|++.... ......++.+|+++-..|+||||+++|++|.++..+|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3678899999999999999999754 579999987653 222356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 192 MEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+||..+|+|...|. ..++++.....++.|++.||.|||.. +||||||||+|+|++.. +.+||+|||
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~--------~~lkiAdfG 169 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSA--------GELKIADFG 169 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCC--------CCeeccCCC
Confidence 99999999998887 45699999999999999999999999 69999999999999986 689999999
Q ss_pred cchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 269 LAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 269 la~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
-+.........+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...+..+.+..+... ....|..++.
T Consensus 170 wsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--~~~~p~~is~ 247 (281)
T KOG0580|consen 170 WSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--DLKFPSTISG 247 (281)
T ss_pred ceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--cccCCcccCh
Confidence 99877666777889999999999999999999999999999999999999999999988888887644 4556699999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...++|.+|+..+|.+|....+++++
T Consensus 248 ~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 248 GAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred hHHHHHHHHhccCccccccHHHHhhh
Confidence 99999999999999999999999875
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=353.13 Aligned_cols=247 Identities=29% Similarity=0.396 Sum_probs=208.5
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--CeEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS--PKLC 189 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~ 189 (527)
..+.|+.+++||+|.||.||+|++ +|+.||+|.+..+. .+.......+|+.+|++|+||||+++.++..+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 346788899999999999999997 56789999887664 445567788999999999999999999999876 6899
Q ss_pred EEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
||+|||+. +|.-++.. -+|++.++..++.||+.||+|||++| |+|||||.+||||+.+ |.+||+||
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~--------G~LKiaDF 262 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNN--------GVLKIADF 262 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCC--------CCEEeccc
Confidence 99999964 67777764 47999999999999999999999995 9999999999999986 79999999
Q ss_pred Ccchhhhccc---cccCCCccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Q psy6905 268 GLAREVYKTT---HMSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------- 336 (527)
Q Consensus 268 Gla~~~~~~~---~~~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------- 336 (527)
|||+.+.... ..+.+.|..|+|||++.+.. |+.++|+||.||||.||++|++.|++.+..+....|..-
T Consensus 263 GLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 263 GLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred cceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 9999764432 34557899999999998864 999999999999999999999999999887776665421
Q ss_pred ---CccCC-----CC------------CCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 337 ---KLTLP-----IP------------STCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 337 ---~~~~~-----~p------------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
...+| .| ..+|....+|+..+|..||++|.|+.+.+.
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00111 00 235677889999999999999999999886
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=347.57 Aligned_cols=252 Identities=38% Similarity=0.689 Sum_probs=217.7
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
++.++|++.+.||+|+||.||+|.+.+ ..||+|.+...........+.+|+.++..++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 456789999999999999999998643 4699999887655556677899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecC
Q psy6905 187 KLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLS 249 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~ 249 (527)
..|++|||+++|+|.+++.. ..++...++.++.||+.||.|||++| ++||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEc
Confidence 99999999999999998862 44778889999999999999999995 99999999999998
Q ss_pred CCCcccccccceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q psy6905 250 EPIENEDLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSI 324 (527)
Q Consensus 250 ~~~~~~~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~ 324 (527)
.+ +.++|+|||+++...... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 159 ~~--------~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 159 EG--------LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred CC--------CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 75 689999999997653322 123356789999999988889999999999999999998 99999988
Q ss_pred CHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 325 NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 325 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
+..+....+. .....+.|..+|+.+.+|+.+||+.||.+||++.+|+++|.+
T Consensus 231 ~~~~~~~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 231 SNQEVIEMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 8777666554 344556788899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=357.93 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=211.1
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999974 6789999987532 2233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||+||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~--------~~~kL~Dfg~a~ 149 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDAS--------GHIKLTDFGLSK 149 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCC--------CCEEEEeCcCCc
Confidence 9999999999987 567899999999999999999999995 9999999999999875 689999999997
Q ss_pred hhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC------C
Q psy6905 272 EVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS------T 345 (527)
Q Consensus 272 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~------~ 345 (527)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.........|. .
T Consensus 150 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 228 (333)
T cd05600 150 GIVT-YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN 228 (333)
T ss_pred cccc-ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccc
Confidence 6543 23356799999999999999999999999999999999999999998877666555543222222221 4
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++++.++|.+||..+|.+||++.+++++
T Consensus 229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 229 LSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 68999999999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=357.61 Aligned_cols=238 Identities=28% Similarity=0.448 Sum_probs=205.3
Q ss_pred eeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCC
Q psy6905 123 EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGG 198 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~gg 198 (527)
+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++...+.+|+|||||.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 46789999987532 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc--
Q psy6905 199 PLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-- 275 (527)
Q Consensus 199 sL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~-- 275 (527)
+|.+++. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~--------~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKD--------GHIKITDFGLCKEGISDG 149 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCC--------CCEEEeeCCCCcccccCC
Confidence 9988886 567899999999999999999999995 9999999999999875 6899999999875422
Q ss_pred cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHH
Q psy6905 276 TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLME 355 (527)
Q Consensus 276 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~ 355 (527)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+... ...+|..+++++.+||.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~ 227 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLA 227 (323)
T ss_pred CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHH
Confidence 2223456999999999999999999999999999999999999999988776666655543 34567889999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHH
Q psy6905 356 ACWEADSHMRP-----SFKTILK 373 (527)
Q Consensus 356 ~~l~~dp~~RP-----s~~~ll~ 373 (527)
+||..||.+|| ++.++++
T Consensus 228 ~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 228 GLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHccCCHHHcCCCCCCCHHHHHc
Confidence 99999999999 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=374.75 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=222.5
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc-C-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEE-e-
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-K-QEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCL-Q- 184 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~-~- 184 (527)
..++|...++++.+.|.+|||+.||.|.+. + ..||+|.+... ++..++.+.+|+.+|+.|. |+|||.|++... .
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 357788889999999999999999999984 3 78999998877 7778999999999999996 999999999432 1
Q ss_pred -----CCeEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccc
Q psy6905 185 -----SPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENED 256 (527)
Q Consensus 185 -----~~~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~ 256 (527)
.-.++|.||||.||.|-+++. ...|++.+++.|+.|+++|+.+||...+ +|||||||-+||||+.+
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls~~----- 182 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLSAD----- 182 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEcCC-----
Confidence 124789999999999999987 4469999999999999999999999965 79999999999999986
Q ss_pred cccceeEEeccCcchhhhcccc-----------ccCCCcccccccccc---ccCCCCcccchHHHHHHHHHHHhCCCCCC
Q psy6905 257 LQFKTLKITDFGLAREVYKTTH-----------MSAAGTYAWMAPEVI---KTSIFSKASDVWSYGVVLWELLTGEIPYK 322 (527)
Q Consensus 257 ~~~~~vkL~DFGla~~~~~~~~-----------~~~~gt~~y~aPE~l---~~~~~~~ksDvwSlGv~l~elltg~~Pf~ 322 (527)
+.+||||||.|........ ....-|+.|+|||++ .+...+.|+|||+|||+||-||....||+
T Consensus 183 ---g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe 259 (738)
T KOG1989|consen 183 ---GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE 259 (738)
T ss_pred ---CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence 7899999999865422111 122468999999997 56778999999999999999999999998
Q ss_pred CCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 323 SINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 323 ~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
..... .|...+|.+|..+.++..+++||+.||..||.+||++.+++..+..+....
T Consensus 260 ~sg~l----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 260 ESGKL----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred cCcce----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 76433 455678888888899999999999999999999999999999988877654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.89 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=209.7
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
|+..++|++.+.||.|+||.||++.+. +..+|+|++...........+.+|+.+++.++||||++++++|.+++.+|+
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 356789999999999999999999985 568999988766555556778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||||.+|+|.+++. .+.+++..+..++.|++.||.|||+.+ +++||||||+|||++.+ +.+||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~--------~~~kL~Dfg~ 150 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSR--------GEIKLCDFGV 150 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCC--------CCEEEeeCCc
Confidence 999999999999987 456888999999999999999999853 59999999999999875 6899999999
Q ss_pred chhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----------------
Q psy6905 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGV---------------- 333 (527)
Q Consensus 270 a~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i---------------- 333 (527)
+............||..|+|||++.+..++.++|||||||++|+|++|+.||...........+
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 151 SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred chhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 9866444444557899999999999888999999999999999999999999765432221110
Q ss_pred ---------------------------HhCCccCCCC-CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 334 ---------------------------AVNKLTLPIP-STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 334 ---------------------------~~~~~~~~~p-~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.........+ ...+.++.+||.+||+.||.+|||+.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0011111111 2357889999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=359.52 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=215.8
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcC---ceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS 185 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~---~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~ 185 (527)
...+..++|++.+.||+|+||.||+|.+.+ ..||+|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 355677899999999999999999998643 479999875431 223356788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 186 PKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
..+|+|||||.||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~--------~~ikL 172 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKD--------GFIKM 172 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCC--------CCEEE
Confidence 99999999999999999986 567899999999999999999999995 9999999999999875 68999
Q ss_pred eccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 265 TDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 265 ~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ...|.
T Consensus 173 ~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~ 249 (340)
T PTZ00426 173 TDFGFAKVVDT-RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--IYFPK 249 (340)
T ss_pred ecCCCCeecCC-CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCCCC
Confidence 99999976532 2335679999999999999889999999999999999999999999888776666665433 34677
Q ss_pred CccHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RP-----s~~~ll~~ 374 (527)
.+++.+.++|++||..||.+|+ ++.+++++
T Consensus 250 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 8899999999999999999995 88888764
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=357.87 Aligned_cols=257 Identities=37% Similarity=0.640 Sum_probs=228.4
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
..|++++.+.++++||+|.||.|.+|...+ ..||+|.++..........|.+|+++|.+|+|||||+++|+|..++.++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 468999999999999999999999999876 8999999999887777899999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCC---ChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 190 LVMEYARGGPLNRVLAGRKI---RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~---~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
++|||+++|+|..++..... .-....+|+.||+.||+||.+. ++|||||.+.|||++.+ .++||+|
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e--------~~iKiad 680 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGE--------FTIKIAD 680 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCc--------ccEEecC
Confidence 99999999999999985532 3456778999999999999998 79999999999999987 5999999
Q ss_pred cCcchhhhccccccC----CCccccccccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHh-----
Q psy6905 267 FGLAREVYKTTHMSA----AGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT--GEIPYKSINAYAVAYGVAV----- 335 (527)
Q Consensus 267 FGla~~~~~~~~~~~----~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt--g~~Pf~~~~~~~~~~~i~~----- 335 (527)
||+++.++...+... +-+++|||||.+..++|+.+||||+||+++||+++ ...||......++......
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~ 760 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQ 760 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCC
Confidence 999998876555433 35789999999999999999999999999999886 8899999988887765432
Q ss_pred -CCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 336 -NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 336 -~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
...-++.|..||..++++|..||..+..+||+|++|...|++.
T Consensus 761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1234567899999999999999999999999999999888654
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=343.42 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=223.9
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcC--ceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~--~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
...+..+.|++++.||.|.-|+||++...+ +.+|+|++.... ..+....+..|.+||..++||.++.+|+.|+.+.
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 345677889999999999999999999866 689999998753 2334667888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 187 KLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
..|+|||||.||+|..+++ ++.|++..+..++..|+-||+|||..| ||+|||||+||||.++ |.|.
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvred--------GHIM 219 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVRED--------GHIM 219 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecC--------CcEE
Confidence 9999999999999999887 567999999999999999999999996 9999999999999986 8999
Q ss_pred EeccCcchhhh----------------------------------c-c-----------------------ccccCCCcc
Q psy6905 264 ITDFGLAREVY----------------------------------K-T-----------------------THMSAAGTY 285 (527)
Q Consensus 264 L~DFGla~~~~----------------------------------~-~-----------------------~~~~~~gt~ 285 (527)
|+||.|+.... . . ..++++||-
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 99999873210 0 0 012456999
Q ss_pred ccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCC
Q psy6905 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMR 365 (527)
Q Consensus 286 ~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~R 365 (527)
.|+|||++.+...+.++|+|+|||++|||+.|..||.|.++.+....|......+|-....+..+++||+++|..||.+|
T Consensus 300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence 99999999999999999999999999999999999999999999999998888887777888999999999999999999
Q ss_pred CC----HHHHHHH
Q psy6905 366 PS----FKTILKA 374 (527)
Q Consensus 366 Ps----~~~ll~~ 374 (527)
.. +.+|.+|
T Consensus 380 lg~~rGA~eIK~H 392 (459)
T KOG0610|consen 380 LGSKRGAAEIKRH 392 (459)
T ss_pred hccccchHHhhcC
Confidence 98 7777764
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=354.80 Aligned_cols=258 Identities=31% Similarity=0.603 Sum_probs=217.0
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCL 183 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~ 183 (527)
|+++.++|++.+.||.|+||.||+|.+. ++.||+|++...........+..|+.++..+ +|+||++++++|.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 8889999999999999999999999742 2579999987654444456778899999999 8999999999886
Q ss_pred e-CCeEEEEEeccCCCCHHHHhcC--------------------------------------------------------
Q psy6905 184 Q-SPKLCLVMEYARGGPLNRVLAG-------------------------------------------------------- 206 (527)
Q Consensus 184 ~-~~~~~iv~Ey~~ggsL~~~l~~-------------------------------------------------------- 206 (527)
. +..++++|||+++|+|.+++..
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 5 4678999999999999988742
Q ss_pred ------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccc---
Q psy6905 207 ------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--- 277 (527)
Q Consensus 207 ------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~--- 277 (527)
..++...+..++.||+.||+|||++| |+||||||+|||++.+ +.++|+|||+++.+....
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~--------~~vkL~DfG~a~~~~~~~~~~ 230 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSEN--------NVVKICDFGLARDIYKDPDYV 230 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCC--------CcEEEeccccchhcccCcchh
Confidence 25678889999999999999999994 9999999999999875 689999999998763321
Q ss_pred -cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHH
Q psy6905 278 -HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLME 355 (527)
Q Consensus 278 -~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~ 355 (527)
.....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+..............|..+++++.+++.
T Consensus 231 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 310 (337)
T cd05054 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIML 310 (337)
T ss_pred hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHH
Confidence 112345778999999999999999999999999999998 999998765444444444445555667788999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 356 ACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 356 ~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
+||+.+|++||++.+++++|..++.
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=339.19 Aligned_cols=252 Identities=33% Similarity=0.623 Sum_probs=218.1
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
|+|+.++|++.+.||+|+||.||+|.+. +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+....|+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 6788999999999999999999999874 46799998765432 25678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 191 VMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+|||+.+|+|.+++. ...++...++.++.|++.||.|||+.+ ++||||||+||+++.+ +.++|+||
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~--------~~~~l~df 147 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSES--------LMCKIADF 147 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCC--------CcEEECCC
Confidence 999999999999886 345788899999999999999999984 9999999999999875 68999999
Q ss_pred Ccchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 268 GLAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 268 Gla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|++........ ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+. .....+.+
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 226 (261)
T cd05072 148 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRM 226 (261)
T ss_pred ccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 99986643221 22346778999999998889999999999999999998 999999887766665554 34556666
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
..++..+.+++.+||..+|++||++.++.+.|++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 7899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=338.50 Aligned_cols=253 Identities=33% Similarity=0.600 Sum_probs=218.7
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
|+++..+|.+.+.||.|+||.||+|.+. ++.||+|++.... .....+.+|+.+++.++||||+++++++..++.++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 6788899999999999999999999974 5789999887542 22567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 190 LVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
++|||+++|+|.+++.. ..+++..++.++.|++.||+|||++| ++||||||+|||++.+ +.+||+|
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~--------~~~kl~d 147 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGEN--------HLVKVAD 147 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCC--------CcEEeCC
Confidence 99999999999999862 35788899999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccccc---cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 267 FGLAREVYKTTHM---SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 267 FGla~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
||++......... ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.......+. .....+.
T Consensus 148 f~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~ 226 (263)
T cd05052 148 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMER 226 (263)
T ss_pred CccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCC
Confidence 9999766432221 2234678999999998899999999999999999998 999999877666554443 4556677
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
|..+|..+.+++.+||..||++||++.++++.|+++
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 888999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.73 Aligned_cols=242 Identities=27% Similarity=0.423 Sum_probs=205.5
Q ss_pred eeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHH---HhCCCCccceEEEEEEeCCeEEEE
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLL---WLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l---~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
|.+.+.||+|+||.||+|.+. ++.||||++.... .....+.+..|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999874 5789999987532 222345566666655 566899999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 192 MEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||||.||+|...+..+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~--------~~~kL~Dfg~~~ 149 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTE--------GFVKIADFGLCK 149 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCC--------CcEEeCcccCCc
Confidence 99999999999998888999999999999999999999995 9999999999999875 689999999987
Q ss_pred hhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 272 EVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 272 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
.... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ...|..++..
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~ 227 (324)
T cd05589 150 EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSRE 227 (324)
T ss_pred cCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHH
Confidence 5422 22234579999999999999999999999999999999999999999988777776665443 3466788999
Q ss_pred HHHHHHHhhhhCCCCCC-----CHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRP-----SFKTILK 373 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RP-----s~~~ll~ 373 (527)
+.++|.+||..||.+|| ++.++++
T Consensus 228 ~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 228 AISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 99999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=323.91 Aligned_cols=246 Identities=27% Similarity=0.377 Sum_probs=207.5
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.+|...+.||+|.||.||+|.+ +|+.||||.++.... +.......+|++.|+.++|+||+.++++|.....+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678889999999999999998 578999998877642 2334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|+ ..+|..+++. ..+++..+..|+.++++||+|||++ .|+||||||.|+||+.+ |.+||+|||+|+
T Consensus 82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~--------g~lKiADFGLAr 149 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSD--------GQLKIADFGLAR 149 (318)
T ss_pred ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCC--------CcEEeecccchh
Confidence 99 5679999984 4589999999999999999999999 49999999999999986 799999999999
Q ss_pred hhhccccc--cCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Q psy6905 272 EVYKTTHM--SAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK----------- 337 (527)
Q Consensus 272 ~~~~~~~~--~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~----------- 337 (527)
.+...... ..+.|..|+|||.+-|. .|+..+|+||.||++.||+-|.+-|+|.+..+....+...-
T Consensus 150 ~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 150 FFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred ccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence 88543332 23689999999999775 49999999999999999999999999988776665543210
Q ss_pred --------cc-CCCC------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 --------LT-LPIP------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 --------~~-~~~p------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+. .|.| ..++.+..+||..||..||.+|+++.+.+++
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00 1111 2356778999999999999999999999884
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=345.29 Aligned_cols=245 Identities=22% Similarity=0.338 Sum_probs=203.3
Q ss_pred eeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 119 LIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
|++.+.||+|+||.||+|.+ +++.||+|.+.... .......+.+|+.++..++|+||+++++++.+++.+|+||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67889999999999999987 46799999876532 112234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 195 ARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 195 ~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|.+|+|..++. ...+++..+..++.|++.||+|||+.| |+||||||+|||++.+ +.++|+|||++.
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~--------~~~kl~Dfg~~~ 150 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDR--------GHIRISDLGLAV 150 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCC--------CCEEEeeCCCcE
Confidence 99999987764 335889999999999999999999995 9999999999999875 689999999997
Q ss_pred hhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCccCCCCCCccH
Q psy6905 272 EVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA--VNKLTLPIPSTCPQ 348 (527)
Q Consensus 272 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~~~ 348 (527)
...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+. ........+..++.
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 230 (285)
T cd05631 151 QIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSE 230 (285)
T ss_pred EcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCH
Confidence 653322 234578999999999999999999999999999999999999998765432221111 12233456677899
Q ss_pred HHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPS-----FKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs-----~~~ll~~ 374 (527)
.+.+|+++||+.||.+||+ +.+++++
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 231 DAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999999997 7777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=359.78 Aligned_cols=246 Identities=26% Similarity=0.361 Sum_probs=209.1
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.++..++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999987 46789999986532 2233566788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||.||+|.+++. ++.+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.++|+|||++.
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~--------~~~kl~Dfg~~~ 149 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAK--------GHIKLSDFGLCT 149 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCC--------CCEEEeecccce
Confidence 9999999999886 567899999999999999999999995 9999999999999875 689999999986
Q ss_pred hhhccc----------------------------------------cccCCCccccccccccccCCCCcccchHHHHHHH
Q psy6905 272 EVYKTT----------------------------------------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVL 311 (527)
Q Consensus 272 ~~~~~~----------------------------------------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l 311 (527)
.+.... ..+.+||+.|+|||++.+..++.++|||||||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 542110 0124699999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC--CccHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q psy6905 312 WELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS--TCPQLFKTLMEACWEADSHMRPS---FKTILKA 374 (527)
Q Consensus 312 ~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~~~~li~~~l~~dp~~RPs---~~~ll~~ 374 (527)
|+|++|..||.+.+..+....+.........|. .+++++.+||.+|+. +|.+|++ +.+++.+
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999999998887777666654444444443 568999999999996 9999998 8887763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=358.47 Aligned_cols=259 Identities=31% Similarity=0.604 Sum_probs=221.7
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGV 181 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~ 181 (527)
..|+++.++|.+.+.||+|+||.||+|.+.+ ..||||++...........+.+|+.++..+. ||||++++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4599999999999999999999999998643 4799999987644444567889999999997 9999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHhcCC------------------------------------------------------
Q psy6905 182 CLQSPKLCLVMEYARGGPLNRVLAGR------------------------------------------------------ 207 (527)
Q Consensus 182 ~~~~~~~~iv~Ey~~ggsL~~~l~~~------------------------------------------------------ 207 (527)
|.....+|+|||||.+|+|.+++...
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 99999999999999999999988521
Q ss_pred ---------------------------------------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q psy6905 208 ---------------------------------------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLK 242 (527)
Q Consensus 208 ---------------------------------------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlk 242 (527)
.++...++.++.||+.||.|||+. +++|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCC
Confidence 245566788999999999999998 49999999
Q ss_pred CCceecCCCCcccccccceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-C
Q psy6905 243 SSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-G 317 (527)
Q Consensus 243 p~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g 317 (527)
|+|||++.+ +.+||+|||+++...... .....+++.|+|||.+.+..++.++|||||||++|||++ |
T Consensus 267 p~NiLl~~~--------~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g 338 (401)
T cd05107 267 ARNVLICEG--------KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLG 338 (401)
T ss_pred cceEEEeCC--------CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcC
Confidence 999999875 689999999997653211 123456789999999998889999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q psy6905 318 EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379 (527)
Q Consensus 318 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~ 379 (527)
..||......+........+.+.+.|..++..+.+|+.+||..+|..||++.+|++.|+.++
T Consensus 339 ~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 339 GTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 99998877666655655566677788889999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=359.37 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=215.4
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
.+.+..++|++.+.||+|+||.||+|.+. +..||+|++.... .......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 45567789999999999999999999874 5789999986421 1222455778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 187 KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
.+|+|||||.||+|.+++.+..+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~--------~~~kL~D 185 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--------GHLKLAD 185 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCC--------CCEEEEe
Confidence 9999999999999999998888999999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc---cccCCCccccccccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 267 FGLAREVYKTT---HMSAAGTYAWMAPEVIKTS----IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 267 FGla~~~~~~~---~~~~~gt~~y~aPE~l~~~----~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
||++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+......
T Consensus 186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 265 (370)
T cd05596 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS 265 (370)
T ss_pred ccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc
Confidence 99997654322 2245699999999998653 4789999999999999999999999998877777776654444
Q ss_pred CCCCC--CccHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q psy6905 340 LPIPS--TCPQLFKTLMEACWEADSHM--RPSFKTILKA 374 (527)
Q Consensus 340 ~~~p~--~~~~~~~~li~~~l~~dp~~--RPs~~~ll~~ 374 (527)
...|. .+|.++.+||..||..+|.+ ||++.+++++
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 44443 57999999999999999987 9999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=336.55 Aligned_cols=252 Identities=33% Similarity=0.602 Sum_probs=218.2
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
|+++.++|.+.+.||.|+||.||+|.++ ++.||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 6788899999999999999999999874 46799999875432 24568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 191 VMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
||||+.+++|.+++.. ..++...+..++.|++.||.|||+.| ++||||||+||+++.+ +.++|+||
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~--------~~~~l~df 147 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGEN--------NICKVADF 147 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCC--------CCEEECCc
Confidence 9999999999999863 35889999999999999999999995 9999999999999875 68999999
Q ss_pred CcchhhhccccccCC---CccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 268 GLAREVYKTTHMSAA---GTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 268 Gla~~~~~~~~~~~~---gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|+++........... ++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+.......+. .....+.+
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 226 (261)
T cd05068 148 GLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCP 226 (261)
T ss_pred ceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 999876433222222 3457999999998889999999999999999999 999999888776666554 34556677
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
..++..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 8899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=340.59 Aligned_cols=253 Identities=34% Similarity=0.614 Sum_probs=218.8
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
|+++.++|.+.+.||.|+||.||+|.+.+ ..||+|.............+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 67889999999999999999999998743 56999998766544445678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhcC-----------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCc
Q psy6905 185 SPKLCLVMEYARGGPLNRVLAG-----------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIE 253 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~~-----------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~ 253 (527)
....|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||+.+ ++||||||+|||++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~-- 155 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAED-- 155 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCC--
Confidence 9999999999999999998852 13567788999999999999999984 9999999999999975
Q ss_pred ccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy6905 254 NEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328 (527)
Q Consensus 254 ~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~ 328 (527)
+.+||+|||+++....... ....++..|+|||.+.+..++.++|||||||++|++++ |..||.+.+...
T Consensus 156 ------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 229 (277)
T cd05032 156 ------LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE 229 (277)
T ss_pred ------CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH
Confidence 6899999999986643322 12346789999999988889999999999999999998 999999888777
Q ss_pred HHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 329 ~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
....+. .+...+.|..++..+.+++.+||..+|++|||+.++++.|+
T Consensus 230 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 230 VLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 666555 44556778889999999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=357.98 Aligned_cols=246 Identities=27% Similarity=0.391 Sum_probs=212.3
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+..|+.++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999985 7899999987532 1233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||.+|+|.+++. .+.+++..+..++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~--------~~~kL~Dfg~~~ 149 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDAD--------GHIKLADFGLCK 149 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCC--------CCEEeecCCCCc
Confidence 9999999999987 457899999999999999999999985 9999999999999875 689999999997
Q ss_pred hhhccc-------------------------------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCC
Q psy6905 272 EVYKTT-------------------------------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP 320 (527)
Q Consensus 272 ~~~~~~-------------------------------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~P 320 (527)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence 654322 2234689999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHh--CCccCCCCCCccHHHHHHHHHhhhhCCCCCCC-HHHHHHH
Q psy6905 321 YKSINAYAVAYGVAV--NKLTLPIPSTCPQLFKTLMEACWEADSHMRPS-FKTILKA 374 (527)
Q Consensus 321 f~~~~~~~~~~~i~~--~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs-~~~ll~~ 374 (527)
|.+.+.......+.. .....+....+++.+.+||..||. ||.+||+ +.+++++
T Consensus 230 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 230 FYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 998887776666665 333344444569999999999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=351.89 Aligned_cols=239 Identities=27% Similarity=0.448 Sum_probs=205.2
Q ss_pred eeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCC
Q psy6905 123 EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGG 198 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~gg 198 (527)
+.||+|+||.||++.+ ++..||+|++.... .......+.+|+.+++.++||||+++++++...+.+|+|||||.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999987 46789999987532 2233556778999999999999999999999999999999999999
Q ss_pred CHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc-
Q psy6905 199 PLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT- 276 (527)
Q Consensus 199 sL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~- 276 (527)
+|..++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~--------~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKD--------GHIKITDFGLCKEGISDG 149 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCC--------CCEEecccHHhccccCCC
Confidence 9988876 557899999999999999999999995 9999999999999875 68999999998754221
Q ss_pred -ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHH
Q psy6905 277 -THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLME 355 (527)
Q Consensus 277 -~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~ 355 (527)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ...|..+++.+.++|.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~ 227 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLA 227 (323)
T ss_pred CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHH
Confidence 2224569999999999999999999999999999999999999999887776666655433 3567789999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHHH
Q psy6905 356 ACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 356 ~~l~~dp~~RP-----s~~~ll~~ 374 (527)
.||..||.+|| ++.+++++
T Consensus 228 ~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 228 GLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHccCCHHHhCCCCCCCHHHHHcC
Confidence 99999999998 78888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=358.42 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=205.0
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.|.+++.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999987 45789999986532 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||+||+|.+++. .+.+++..+..++.||+.||.|||+.| ||||||||+||||+.+ +.+||+|||+++.
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~--------~~~kL~DFGl~~~ 150 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLD--------GHIKLTDFGLCTG 150 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCC--------CCEEEeeCcCCcc
Confidence 999999999886 566889999999999999999999995 9999999999999875 6899999999753
Q ss_pred hhcc-------------------------------------------------ccccCCCccccccccccccCCCCcccc
Q psy6905 273 VYKT-------------------------------------------------THMSAAGTYAWMAPEVIKTSIFSKASD 303 (527)
Q Consensus 273 ~~~~-------------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~ksD 303 (527)
.... ...+.+||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence 2100 001346999999999999888999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--cCCCCCCccHHHHHHHHHhh--hhCCCCCCCHHHHHHH
Q psy6905 304 VWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL--TLPIPSTCPQLFKTLMEACW--EADSHMRPSFKTILKA 374 (527)
Q Consensus 304 vwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~~~~li~~~l--~~dp~~RPs~~~ll~~ 374 (527)
||||||++|||++|..||...+.......+..... ..+....+++++.+||.+|+ ..++..||++.+++.+
T Consensus 231 iwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred eeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999999999999998776666555543332 33334468999999999854 5566669999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=335.94 Aligned_cols=252 Identities=34% Similarity=0.622 Sum_probs=218.1
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc-----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+.++|++.+.||+|+||.||+|.+. ...||||.+...........+.+|+.+++.++||||+++++++......+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 4578999999999999999999874 24799999877655555678889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+||||+.+|+|.+++. .+.++...+..++.|++.||.|||+++ |+||||||+|||++.+ +.++|+||
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~--------~~~~l~df 150 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSN--------LVCKVSDF 150 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC--------CCEEECcc
Confidence 9999999999999986 346899999999999999999999984 9999999999999875 68999999
Q ss_pred Ccchhhhc--ccc--ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 268 GLAREVYK--TTH--MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 268 Gla~~~~~--~~~--~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
|+++.... ... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+. .....+.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 229 (266)
T cd05033 151 GLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPP 229 (266)
T ss_pred chhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence 99987641 111 12235678999999998889999999999999999998 999998877766655554 3455677
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
+..+++.+.+++.+||+.+|++||++.+++++|..+
T Consensus 230 ~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=355.75 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=205.6
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||+|+||.||+|.+. ++.||||++.... .......+..|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999874 6789999986532 2233567788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||+||+|.+++. .+.+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+++
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~--------~~vkL~DFGla~ 149 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSK--------GHVKLSDFGLCT 149 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCC--------CCEEEeeccCcc
Confidence 9999999999886 567999999999999999999999995 9999999999999875 689999999987
Q ss_pred hhhccc-------------------------------------cccCCCccccccccccccCCCCcccchHHHHHHHHHH
Q psy6905 272 EVYKTT-------------------------------------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314 (527)
Q Consensus 272 ~~~~~~-------------------------------------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~el 314 (527)
...... ....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 229 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence 542110 1234799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCccHHHHHHHHHhhh--hCCCCCCCHHHHHH
Q psy6905 315 LTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQLFKTLMEACWE--ADSHMRPSFKTILK 373 (527)
Q Consensus 315 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~~~~li~~~l~--~dp~~RPs~~~ll~ 373 (527)
++|+.||.+.+..+....+.........| ..+++++.++|.+|+. .++..||++.+|++
T Consensus 230 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 230 LIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 99999999888777777666533333344 3468899999998654 23335689999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=349.97 Aligned_cols=236 Identities=26% Similarity=0.352 Sum_probs=202.5
Q ss_pred eccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCH
Q psy6905 125 IGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200 (527)
Q Consensus 125 iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL 200 (527)
||+|+||.||+|.+. +..||+|++.... .......+.+|+.++..++||||+++++++.+.+.+|+|||||.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999974 5689999886531 223356778899999999999999999999999999999999999999
Q ss_pred HHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc--c
Q psy6905 201 NRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--T 277 (527)
Q Consensus 201 ~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~--~ 277 (527)
.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++..... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~--------~~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQ--------GHIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCC--------CcEEEEECcccccCccCCCc
Confidence 98886 567899999999999999999999995 9999999999999875 68999999999754322 1
Q ss_pred cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHh
Q psy6905 278 HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEAC 357 (527)
Q Consensus 278 ~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~ 357 (527)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... ....|..+++.+.++|.+|
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~ 227 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGL 227 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHH
Confidence 22356999999999999999999999999999999999999999988877776666543 3456778999999999999
Q ss_pred hhhCCCCCCC---HHHHHH
Q psy6905 358 WEADSHMRPS---FKTILK 373 (527)
Q Consensus 358 l~~dp~~RPs---~~~ll~ 373 (527)
|..||.+||+ +.+++.
T Consensus 228 L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 228 LSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred cCCCHHHcCCCCCHHHHHc
Confidence 9999999986 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=344.25 Aligned_cols=261 Identities=34% Similarity=0.633 Sum_probs=221.1
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcC---------ceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK---------QEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLI 179 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~---------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~ 179 (527)
+.|++..++|.+.+.||+|+||.||++.+.+ ..+|+|.+...........+..|+.+++.+ +||||++++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 4588889999999999999999999997632 369999988654444456788899999999 799999999
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHhcCC-----------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q psy6905 180 GVCLQSPKLCLVMEYARGGPLNRVLAGR-----------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLK 242 (527)
Q Consensus 180 ~~~~~~~~~~iv~Ey~~ggsL~~~l~~~-----------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlk 242 (527)
+++......|+|||||.+|+|.+++... .++...++.++.||+.||+|||++| ++|||||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlk 167 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLA 167 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---ccccccc
Confidence 9999999999999999999999998632 3677889999999999999999985 9999999
Q ss_pred CCceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-C
Q psy6905 243 SSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-G 317 (527)
Q Consensus 243 p~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g 317 (527)
|+|||++.+ +.+||+|||+++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 168 p~Nill~~~--------~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g 239 (307)
T cd05098 168 ARNVLVTED--------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 239 (307)
T ss_pred HHheEEcCC--------CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999875 6899999999876532211 11224578999999998889999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 318 EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 318 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
..||.+.+..+....+. .....+.|..++.++.+|+.+||..+|.+||++.++++.|+.++...
T Consensus 240 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 240 GSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred CCCCCcCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 99998877655554443 44556777889999999999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=359.30 Aligned_cols=246 Identities=26% Similarity=0.333 Sum_probs=205.8
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|.+.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688999999999999999987 46789999876431 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||.||+|.+++. .+.+++..+..++.|++.||+|||+.| |+||||||+|||++.+ +.+||+|||+++
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~--------~~~kl~DfGla~ 149 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRG--------GHIKLSDFGLST 149 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCC--------CCEEEeeccccc
Confidence 9999999999886 567899999999999999999999995 9999999999999875 689999999986
Q ss_pred hhhccc-------------------------------------------------cccCCCccccccccccccCCCCccc
Q psy6905 272 EVYKTT-------------------------------------------------HMSAAGTYAWMAPEVIKTSIFSKAS 302 (527)
Q Consensus 272 ~~~~~~-------------------------------------------------~~~~~gt~~y~aPE~l~~~~~~~ks 302 (527)
.+.... ..+.+||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 229 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence 331100 0124699999999999998999999
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCccHHHHHHHHHhhhhCCCCC---CCHHHHHHH
Q psy6905 303 DVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQLFKTLMEACWEADSHMR---PSFKTILKA 374 (527)
Q Consensus 303 DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~~~~li~~~l~~dp~~R---Ps~~~ll~~ 374 (527)
|||||||++|||++|..||.+.+.......+.........| ..++.++.+||.+|+. +|.+| +++.+++.+
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999999999999887766666555433333444 3578999999999997 77765 589888873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=339.87 Aligned_cols=251 Identities=36% Similarity=0.645 Sum_probs=214.0
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
++.++|++.+.||+|+||.||+|.+ .+..||+|.+...........+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 4567899999999999999999985 2357999998765544556778899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhcC------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecC
Q psy6905 188 LCLVMEYARGGPLNRVLAG------------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLS 249 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~------------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~ 249 (527)
.|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++| ++||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEc
Confidence 9999999999999998841 23677888999999999999999995 99999999999998
Q ss_pred CCCcccccccceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q psy6905 250 EPIENEDLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSI 324 (527)
Q Consensus 250 ~~~~~~~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~ 324 (527)
.+ +.+||+|||+++...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 159 ~~--------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 159 EQ--------LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred CC--------CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 75 589999999997653221 123346778999999988889999999999999999998 99999887
Q ss_pred CHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 325 NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 325 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
+.......+. ....++.+..++..+.+++.+||+.||.+||++.+|+++|.
T Consensus 231 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 231 SNQEVIEMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred CHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 7665555444 34455678889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=351.72 Aligned_cols=242 Identities=30% Similarity=0.472 Sum_probs=213.8
Q ss_pred eeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 119 LIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
|.-+..||.|+||.||-|.+ +...||||.+.... ......++..|+..|.++.|||+|.|-|+|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 34456799999999999987 45689999876543 233467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
| -|+-.|++. ++++.+.++..|+.+.+.||.|||+. +.||||||+.|||+++. |.|||+|||.|..
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~--------g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEP--------GLVKLADFGSASI 175 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCC--------Ceeeeccccchhh
Confidence 9 677778876 77899999999999999999999999 59999999999999986 7999999999976
Q ss_pred hhccccccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 273 VYKTTHMSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 273 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
.. .-.+++|||.|||||++. .+.|+-++||||||++..||...++|+-.++.....+.|+.+....-....++..
T Consensus 176 ~~--PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~ 253 (948)
T KOG0577|consen 176 MA--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 253 (948)
T ss_pred cC--chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHH
Confidence 53 345789999999999985 4679999999999999999999999999999999999999776554445678999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
|+.++..||..-|.+|||..+++++
T Consensus 254 F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 254 FRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHHhhCcccCCcHHHHhhc
Confidence 9999999999999999999999885
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.84 Aligned_cols=239 Identities=28% Similarity=0.444 Sum_probs=205.1
Q ss_pred eeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCC
Q psy6905 123 EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGG 198 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~gg 198 (527)
+.||+|+||.||++.+ +++.||+|++.... .......+.+|+.+++.++||||+++++++...+.+|+|||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 46789999987532 2233567788999999999999999999999999999999999999
Q ss_pred CHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc--
Q psy6905 199 PLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-- 275 (527)
Q Consensus 199 sL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~-- 275 (527)
+|...+. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~--------~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKD--------GHIKITDFGLCKEGITDA 149 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCC--------CcEEEecCcCCccCCCcc
Confidence 9988876 557899999999999999999999995 9999999999999875 6899999999875422
Q ss_pred cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHH
Q psy6905 276 TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLME 355 (527)
Q Consensus 276 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~ 355 (527)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+... ...+|..++.++.++|.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~ 227 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DIKFPRTLSADAKSLLS 227 (328)
T ss_pred cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--CccCCCCCCHHHHHHHH
Confidence 1222456999999999999989999999999999999999999999887776665555433 34567889999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHHH
Q psy6905 356 ACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 356 ~~l~~dp~~RP-----s~~~ll~~ 374 (527)
+||..||.+|| ++.+++++
T Consensus 228 ~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 228 GLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHcCCCHHHcCCCCCCCHHHHhcC
Confidence 99999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=343.00 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=203.7
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|++.+.||+|+||.||+|.++ ++.||+|++.... .......+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999984 5689999887543 22335677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||.++++..+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~--------~~~kl~Dfg~~~~ 149 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHN--------DVLKLCDFGFARN 149 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCC--------CcEEEeeccCccc
Confidence 999887776654 456899999999999999999999994 9999999999999875 6899999999987
Q ss_pred hhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Q psy6905 273 VYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------------- 336 (527)
Q Consensus 273 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------------- 336 (527)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 63322 12346899999999999888999999999999999999999999987654433322210
Q ss_pred ------CccCCC-----------CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ------KLTLPI-----------PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ------~~~~~~-----------p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+. ...+|..+.+||++||..||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000110 12367889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=339.29 Aligned_cols=253 Identities=34% Similarity=0.606 Sum_probs=214.0
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
|++..++|++.+.||+|+||.||+|.+.+ ..||||.+...........+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 67788899999999999999999988643 46999988655444445678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhcCC-----------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCc
Q psy6905 185 SPKLCLVMEYARGGPLNRVLAGR-----------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIE 253 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~~~-----------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~ 253 (527)
....++||||+.+|+|.+++... .++...++.++.|++.||.|||+.| ++||||||+|||++.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~-- 155 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED-- 155 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCC--
Confidence 99999999999999999988631 2456778899999999999999985 9999999999999975
Q ss_pred ccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy6905 254 NEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328 (527)
Q Consensus 254 ~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~ 328 (527)
+.++|+|||+++....... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+...
T Consensus 156 ------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~ 229 (277)
T cd05062 156 ------FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229 (277)
T ss_pred ------CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 6899999999876533221 12345788999999998889999999999999999999 799999887766
Q ss_pred HHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 329 ~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
....+... ...+.+..++..+.+++.+||..||++|||+.++++.|+
T Consensus 230 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 VLRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 65555433 334667889999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=345.14 Aligned_cols=256 Identities=33% Similarity=0.613 Sum_probs=217.1
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--Cc----eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQ----EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
+...+|++.+.||+|+||.||+|.+. +. .||+|++...........+.+|+.+++.++||||++++|++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 45578999999999999999999863 33 48999987655555567888999999999999999999999765 5
Q ss_pred EEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.++++||+.+|+|.+++.. ..++...++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~--------~~~kl~ 151 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTP--------QHVKIT 151 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCC--------CcEEEc
Confidence 6899999999999998873 35788899999999999999999994 9999999999999875 689999
Q ss_pred ccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 266 DFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
|||+++....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+.. .+...+...
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~ 230 (316)
T cd05108 152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERL 230 (316)
T ss_pred cccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCC
Confidence 9999987643221 12234678999999999999999999999999999998 99999887765543 444456667
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
+.|..++..+.+++..||..+|.+||++.+++..|..+....
T Consensus 231 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 778889999999999999999999999999999998877544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=361.16 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=213.0
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC----
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP---- 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~---- 186 (527)
...++|.+.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.++..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 4557999999999999999999987 56899999986543 3444567889999999999999999998775432
Q ss_pred ----eEEEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccc
Q psy6905 187 ----KLCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDL 257 (527)
Q Consensus 187 ----~~~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~ 257 (527)
.+++||||+.+|+|.+++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~------ 179 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSN------ 179 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCC------
Confidence 3789999999999999885 246889999999999999999999994 9999999999999875
Q ss_pred ccceeEEeccCcchhhhcc----ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6905 258 QFKTLKITDFGLAREVYKT----THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGV 333 (527)
Q Consensus 258 ~~~~vkL~DFGla~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i 333 (527)
+.+||+|||+++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+
T Consensus 180 --~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 180 --GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred --CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 68999999999765321 123457999999999999999999999999999999999999999988877776666
Q ss_pred HhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 334 AVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 334 ~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.... ..+.|..+++++.+++..||+.||.+||++.+++.+
T Consensus 258 ~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 5433 346788899999999999999999999999999875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=342.48 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=201.7
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|.+.+.||.|+||.||+|.+. +..||+|++...........+.+|+.+++.++||||+++++++......|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 467999999999999999999874 578999988754433334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|+. |+|.+++. +..++...+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 84 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~--------~~~kl~DfG~~~ 151 (288)
T cd07871 84 YLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEK--------GELKLADFGLAR 151 (288)
T ss_pred CCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCC--------CCEEECcCccee
Confidence 996 48888775 345788899999999999999999995 9999999999999875 689999999987
Q ss_pred hhhcc--ccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Q psy6905 272 EVYKT--THMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------------ 336 (527)
Q Consensus 272 ~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------------ 336 (527)
..... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 152 AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred eccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 65322 1223468999999999865 56899999999999999999999999887765544333210
Q ss_pred -------CccCC---------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 -------KLTLP---------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 -------~~~~~---------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+ ....++.++.+||.+||..||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 112467889999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=348.78 Aligned_cols=238 Identities=29% Similarity=0.427 Sum_probs=204.2
Q ss_pred eeeccCCceEEEEeeE-----cCceEEEEEcCCCC---ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 123 EAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNP---DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+.||+|+||.||++.. .++.||||++.... .......+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999875 35689999886531 222345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
+.||+|.+++. .+.+.+..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~--------~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQ--------GHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCC--------CCEEEeeCcCCeec
Confidence 99999999886 566788899999999999999999995 9999999999999875 68999999998754
Q ss_pred hccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHH
Q psy6905 274 YKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFK 351 (527)
Q Consensus 274 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 351 (527)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+... ...+|..+++.+.
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 228 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEAR 228 (323)
T ss_pred ccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHH
Confidence 2221 22346999999999999888999999999999999999999999988877766666543 3467788999999
Q ss_pred HHHHHhhhhCCCCCC-----CHHHHHH
Q psy6905 352 TLMEACWEADSHMRP-----SFKTILK 373 (527)
Q Consensus 352 ~li~~~l~~dp~~RP-----s~~~ll~ 373 (527)
++|.+||..||++|| ++.++++
T Consensus 229 ~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 229 DLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 999999999999999 7888776
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=341.37 Aligned_cols=245 Identities=27% Similarity=0.440 Sum_probs=220.4
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
-|.+.+.||+|-|+.|-+|.+ +|..||||++.... +.-....+.+|++.|+.++|||||++|.+......+|+|+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 377888999999999999874 89999999998764 444567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
-++|+|.++|- ...+.++....++.||+.|+.|||.. .+|||||||+||.+.+. .|.|||+|||++..
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEK-------lGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEK-------LGLVKLTDFGFSNK 168 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeee-------cCceEeeecccccc
Confidence 99999999986 56799999999999999999999998 49999999999999886 38999999999987
Q ss_pred hhcccc-ccCCCccccccccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHH
Q psy6905 273 VYKTTH-MSAAGTYAWMAPEVIKTSIFS-KASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLF 350 (527)
Q Consensus 273 ~~~~~~-~~~~gt~~y~aPE~l~~~~~~-~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 350 (527)
+..... .+.||...|-|||++.+..|+ +++|||||||+||-|++|++||+..+.-+....|..++| ..|..++.+.
T Consensus 169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS~eC 246 (864)
T KOG4717|consen 169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVSKEC 246 (864)
T ss_pred CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhhHHH
Confidence 754433 467999999999999999887 799999999999999999999999998888888887776 4678899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++||..||..||.+|.+.++|...
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhcc
Confidence 999999999999999999998764
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=353.17 Aligned_cols=246 Identities=29% Similarity=0.454 Sum_probs=203.6
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
...++|.+.+.||+|+||.||+|.+. ++.||||++...........+.+|+.+++.++|+||+++++++.+.+.+|+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 34567888899999999999999874 6799999987665555567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 192 MEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||||.+|+|... ....+..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 151 ~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~--------~~~kL~DfG~~~ 216 (353)
T PLN00034 151 LEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSA--------KNVKIADFGVSR 216 (353)
T ss_pred EecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCC--------CCEEEcccccce
Confidence 999999998653 23567788899999999999999995 9999999999999875 689999999998
Q ss_pred hhhccc--cccCCCcccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCccCC
Q psy6905 272 EVYKTT--HMSAAGTYAWMAPEVIKT-----SIFSKASDVWSYGVVLWELLTGEIPYKSINAY---AVAYGVAVNKLTLP 341 (527)
Q Consensus 272 ~~~~~~--~~~~~gt~~y~aPE~l~~-----~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~---~~~~~i~~~~~~~~ 341 (527)
...... .....||..|+|||++.. ...+.++|||||||++|||++|+.||...... .....+ .......
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 295 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-CMSQPPE 295 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hccCCCC
Confidence 664322 234579999999999843 23457999999999999999999999743221 122222 1233445
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+..++.++.+||.+||..||++||++.+++++
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 667889999999999999999999999999984
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=348.34 Aligned_cols=238 Identities=27% Similarity=0.428 Sum_probs=204.1
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCC-ccceEEEEEEeCCeEEEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHR-NIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hp-nIv~~~~~~~~~~~~~iv~ 192 (527)
+|.+.+.||+|+||.||+|.+. ++.||||++.... .....+.+..|..++..+.|+ +|+.+++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999875 4689999987532 223356678899999998765 6889999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||+||+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~--------~~~kL~Dfg~~~ 149 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAE--------GHIKIADFGMCK 149 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCC--------CCEEEeecCcce
Confidence 9999999998886 567899999999999999999999995 9999999999999875 689999999987
Q ss_pred hhh--ccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 272 EVY--KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 272 ~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+... ....|..++..
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 227 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKE 227 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHH
Confidence 532 22223456999999999999999999999999999999999999999998887777666543 34567789999
Q ss_pred HHHHHHHhhhhCCCCCCCH
Q psy6905 350 FKTLMEACWEADSHMRPSF 368 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~ 368 (527)
+.+++.+||..||.+|++.
T Consensus 228 ~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 228 AVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHHHHhhcCHHHcCCC
Confidence 9999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=359.44 Aligned_cols=244 Identities=27% Similarity=0.412 Sum_probs=210.9
Q ss_pred CceeeeeeeccCCceEEEEeeEc---CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE---KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
..|.+.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.+++.++|||||++++++..++.+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 34889999999999999999863 4578889775543 3335567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 194 YARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 194 y~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
||+||+|.+++. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.+ +.+||+|||
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~--------~~~kL~DFg 214 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPT--------GIIKLGDFG 214 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCC--------CcEEEEeCc
Confidence 999999988764 345888999999999999999999994 9999999999999875 689999999
Q ss_pred cchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 269 LAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 269 la~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
+++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..+.. .+.|.
T Consensus 215 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-~~~~~ 293 (478)
T PTZ00267 215 FSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-DPFPC 293 (478)
T ss_pred CceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCc
Confidence 998664322 2245699999999999999999999999999999999999999998888777776665433 35677
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.++..+.++|..||..||++||++.+++.
T Consensus 294 ~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 294 PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 89999999999999999999999999976
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=345.14 Aligned_cols=252 Identities=29% Similarity=0.412 Sum_probs=222.5
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh--hHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE--NILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~i 190 (527)
...|.+.+.||.|.||.||+|... |+.+|+|++...... .....+.+|+.+|+++. |||||.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 457888999999999999999974 678999998775432 23578899999999998 9999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 191 VMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||+|.||.|.+.+....+++..+..++.||+.+++|||+.| ||||||||+|+|+....++ .+.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~----~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEG----SGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCC----CCcEEEeeCCCc
Confidence 999999999988876435999999999999999999999995 9999999999999875321 258999999999
Q ss_pred hhhhcc-ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCcc
Q psy6905 271 REVYKT-THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCP 347 (527)
Q Consensus 271 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~ 347 (527)
...... .....+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+.......+....+.++.+ ..++
T Consensus 187 ~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 187 KFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred eEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 887652 2335689999999999999999999999999999999999999999999888888888887765544 6779
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..++++++.|+..||..|+++.++++|
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 999999999999999999999999984
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=340.55 Aligned_cols=252 Identities=37% Similarity=0.613 Sum_probs=215.7
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
|+..+|.+.+.||.|+||.||+|.+. +..||||++...........+.+|+.++..++||||+++++++....
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 56678999999999999999999863 25799999986655555677889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecC
Q psy6905 187 KLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLS 249 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~ 249 (527)
..++++||+.+++|.+++.. ..++...+..++.|++.||.|||++| ++||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence 99999999999999998741 24677888999999999999999995 99999999999998
Q ss_pred CCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q psy6905 250 EPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSI 324 (527)
Q Consensus 250 ~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~ 324 (527)
.+ +.+||+|||+++....... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 159 ~~--------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 159 DK--------LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred CC--------CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 75 5899999999886533222 12345789999999988889999999999999999998 99999988
Q ss_pred CHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 325 NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 325 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
........+... ...+.|..++..+.+|+..||+.+|.+||++.+|+..|+.
T Consensus 231 ~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 231 SNQDVIEMIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 877766666543 3446778899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=332.09 Aligned_cols=248 Identities=33% Similarity=0.599 Sum_probs=212.6
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++.++|++.+.||+|+||.||++.++. ..+|+|.+..... ....+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 356789999999999999999998854 5899998765432 2356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||+++|+|.+++. ...+++..++.++.|++.||.|||++| ++||||+|+||+++.+ +.+||+|||++
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~--------~~~kl~d~g~~ 147 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSST--------GVVKVSDFGMT 147 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCC--------CeEEECCCCCc
Confidence 9999999999886 345889999999999999999999995 9999999999999875 68999999998
Q ss_pred hhhhccccc---cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 271 REVYKTTHM---SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 271 ~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
+........ ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+.......+.. +.....|...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~ 226 (256)
T cd05114 148 RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLA 226 (256)
T ss_pred cccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCC
Confidence 765332221 2235678999999998889999999999999999999 9999998887777666654 3344567778
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
+..+.+++.+||..+|.+||++.++++.|
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 89999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=354.89 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=212.5
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
..+..++|++.+.||+|+||.||++.+. ++.||+|++.... .......+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 4556789999999999999999999974 5789999886421 22234567789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 188 LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+|+|||||+||+|.+++....+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+||
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~--------~~~kL~DF 186 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKH--------GHLKLADF 186 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCC--------CCEEEEec
Confidence 999999999999999998878999999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhccc---cccCCCccccccccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 268 GLAREVYKTT---HMSAAGTYAWMAPEVIKTS----IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 268 Gla~~~~~~~---~~~~~gt~~y~aPE~l~~~----~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
|++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence 9998653322 1245799999999999754 37899999999999999999999999888777777776554444
Q ss_pred CCCC--CccHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q psy6905 341 PIPS--TCPQLFKTLMEACWEADSHM--RPSFKTILKA 374 (527)
Q Consensus 341 ~~p~--~~~~~~~~li~~~l~~dp~~--RPs~~~ll~~ 374 (527)
..|. .++..+++++..|+..++.+ |+++.+++++
T Consensus 267 ~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 4444 56899999999999855543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=332.36 Aligned_cols=251 Identities=36% Similarity=0.637 Sum_probs=219.0
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
|.++.++|++.+.||.|+||.||+|...++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+....|+|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 456778999999999999999999999999999999876543 457788999999999999999999999988999999
Q ss_pred EeccCCCCHHHHhcCC---CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 192 MEYARGGPLNRVLAGR---KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~~~---~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|||+++++|.+++... .+++..++.++.|++.||.|||++| ++||||||+|||++.+ +.++|+|||
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~--------~~~~l~d~g 147 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSED--------LVAKVSDFG 147 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCC--------CCEEEcccc
Confidence 9999999999998732 5899999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCcc
Q psy6905 269 LAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 269 la~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 347 (527)
+++...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+. .+.....|..+|
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (256)
T cd05039 148 LAKEASQGQ-DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCP 225 (256)
T ss_pred ccccccccc-ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCC
Confidence 998763322 23345678999999988889999999999999999998 999998887666555444 344556677889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
+.+.+++.+||..+|.+||++.++++.|++
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=338.42 Aligned_cols=260 Identities=32% Similarity=0.584 Sum_probs=218.4
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
|+++.++|++.+.||+|+||.||+|.++ +..||+|.+...........+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 7889999999999999999999998753 237999988765444445567889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhcC-----------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCc
Q psy6905 185 SPKLCLVMEYARGGPLNRVLAG-----------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIE 253 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~~-----------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~ 253 (527)
....|+||||+.+|+|.+++.. ..++...+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~-- 155 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHD-- 155 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCC--
Confidence 9999999999999999999862 12345678889999999999999995 9999999999999875
Q ss_pred ccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy6905 254 NEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328 (527)
Q Consensus 254 ~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~ 328 (527)
+.++|+|||+++....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+...
T Consensus 156 ------~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~ 229 (288)
T cd05061 156 ------FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229 (288)
T ss_pred ------CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 6899999999986533221 12235678999999998889999999999999999999 899998877766
Q ss_pred HHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhccc
Q psy6905 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383 (527)
Q Consensus 329 ~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~ 383 (527)
....+.. ....+.+..+++.+.+++.+||+.||.+|||+.++++.|.+..+..+
T Consensus 230 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~ 283 (288)
T cd05061 230 VLKFVMD-GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 283 (288)
T ss_pred HHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCC
Confidence 5554443 33345677889999999999999999999999999999988776544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=338.97 Aligned_cols=257 Identities=35% Similarity=0.652 Sum_probs=220.6
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVC 182 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~ 182 (527)
.|+++.++|++.+.||+|+||.||++.+.+ ..+|+|.+...........+.+|+.++..+ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 578899999999999999999999998642 469999988655444456788999999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCc
Q psy6905 183 LQSPKLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSN 245 (527)
Q Consensus 183 ~~~~~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~N 245 (527)
..+..++++|||+.+|+|..++.. ..+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 999999999999999999998842 35788889999999999999999984 9999999999
Q ss_pred eecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCC
Q psy6905 246 VLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIP 320 (527)
Q Consensus 246 ILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~P 320 (527)
||++.+ +.+||+|||+++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 163 il~~~~--------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 234 (293)
T cd05053 163 VLVTED--------HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234 (293)
T ss_pred EEEcCC--------CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCC
Confidence 999875 6899999999987643221 12235678999999988889999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q psy6905 321 YKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379 (527)
Q Consensus 321 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~ 379 (527)
|.+.+..+....+. .+...+.|..++..+.+|+.+||..||.+|||+.++++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 235 YPGIPVEELFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 99887766655443 44556677889999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=349.00 Aligned_cols=258 Identities=31% Similarity=0.591 Sum_probs=215.5
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE-------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCL 183 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~ 183 (527)
|+++.++|++.+.||.|+||.||+|.+ .++.||||++...........+.+|+.++..+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 788899999999999999999999974 24679999987655444566788999999999 7899999999886
Q ss_pred e-CCeEEEEEeccCCCCHHHHhcCC-------------------------------------------------------
Q psy6905 184 Q-SPKLCLVMEYARGGPLNRVLAGR------------------------------------------------------- 207 (527)
Q Consensus 184 ~-~~~~~iv~Ey~~ggsL~~~l~~~------------------------------------------------------- 207 (527)
. +..+++|||||++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 5 45689999999999999887521
Q ss_pred -------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 208 -------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 208 -------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
.++...+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~--------~~~kl~dfg~~~~~~ 230 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEN--------NVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCC--------CcEEEEecccccccc
Confidence 2566777889999999999999995 9999999999999875 689999999997653
Q ss_pred cccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 275 KTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 275 ~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
.... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||...............+...+.|..+++.
T Consensus 231 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (343)
T cd05103 231 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE 310 (343)
T ss_pred cCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHH
Confidence 2211 12335678999999988889999999999999999997 999998765444444444455566677778899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
+.+++..||+.||.+||++.+|+++|+.++.
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=356.49 Aligned_cols=246 Identities=25% Similarity=0.333 Sum_probs=205.2
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 46899999999999999999874 5789999986431 1223466789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||+||+|.+++. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++.
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~--------~~ikL~DFG~a~ 149 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRD--------GHIKLTDFGLCT 149 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCC--------CCEEEEeCCCCc
Confidence 9999999999987 456788899999999999999999995 9999999999999875 689999999974
Q ss_pred hhhc---------------------------------------------cccccCCCccccccccccccCCCCcccchHH
Q psy6905 272 EVYK---------------------------------------------TTHMSAAGTYAWMAPEVIKTSIFSKASDVWS 306 (527)
Q Consensus 272 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwS 306 (527)
.+.. ......+||+.|+|||++.+..++.++||||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 229 (376)
T cd05598 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229 (376)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence 3210 0001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC--CCCCCccHHHHHHHHHhhhhCCCCCC---CHHHHHHH
Q psy6905 307 YGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL--PIPSTCPQLFKTLMEACWEADSHMRP---SFKTILKA 374 (527)
Q Consensus 307 lGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~~~~~li~~~l~~dp~~RP---s~~~ll~~ 374 (527)
|||++|+|++|+.||.+.+.......+....... +....+++.+.++|.+|+ .+|.+|+ ++.+++++
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999999999999887766655554333333 333468899999999976 5999999 88888763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=337.45 Aligned_cols=251 Identities=35% Similarity=0.631 Sum_probs=215.4
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
+...+|.+.+.||+|+||.||+|.+. +..||||.+...........+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 34567899999999999999999763 25799999877655545678999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcC---------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCC
Q psy6905 187 KLCLVMEYARGGPLNRVLAG---------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEP 251 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~ 251 (527)
..|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++| ++||||||+|||++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCC
Confidence 99999999999999999862 23678889999999999999999995 9999999999999875
Q ss_pred CcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCH
Q psy6905 252 IENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINA 326 (527)
Q Consensus 252 ~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~ 326 (527)
+.++|+|||+++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 159 --------~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 159 --------LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred --------CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 6899999999976533221 12345788999999999999999999999999999998 9999988877
Q ss_pred HHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 327 YAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 327 ~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
......+.. +.....+..++..+.+++.+||..||.+||++.++++.|+
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 231 EEVIECITQ-GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 776666553 3334556789999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=346.34 Aligned_cols=238 Identities=27% Similarity=0.445 Sum_probs=199.9
Q ss_pred eeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHh-CCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWL-FDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~-l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+. ++.||||++.... .......+..|..++.. ++||||+++++++.....+|+|||||.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 4689999987532 12224455566666664 4899999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc-
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK- 275 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~- 275 (527)
|+|..++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~--------~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKD--------GHIKIADFGMCKENMNG 149 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCC--------CCEEEccCcCCeECCCC
Confidence 99998886 567999999999999999999999995 9999999999999875 6899999999975422
Q ss_pred -cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 276 -TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 276 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.. .....|..++.++.++|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ll 227 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCL 227 (316)
T ss_pred CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 222345799999999999998999999999999999999999999999887777666543 34456788999999999
Q ss_pred HHhhhhCCCCCCCHH-HHHH
Q psy6905 355 EACWEADSHMRPSFK-TILK 373 (527)
Q Consensus 355 ~~~l~~dp~~RPs~~-~ll~ 373 (527)
.+||..||.+||++. ++++
T Consensus 228 ~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 228 SKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHccCCHHHcCCChHHHHc
Confidence 999999999999875 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=355.04 Aligned_cols=244 Identities=25% Similarity=0.347 Sum_probs=204.9
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.|.+++.||+|+||.||+|.+ .++.||+|++.... .......+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999987 45789999886532 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||+||+|.+++. .+.+++..+..++.||+.||.|||++| ||||||||+|||++.+ +.+||+|||++..
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~--------g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRD--------GHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC--------CCEEEeECCCCcc
Confidence 999999999886 456889999999999999999999995 9999999999999875 6899999999753
Q ss_pred hhcc-------------------------------------------------ccccCCCccccccccccccCCCCcccc
Q psy6905 273 VYKT-------------------------------------------------THMSAAGTYAWMAPEVIKTSIFSKASD 303 (527)
Q Consensus 273 ~~~~-------------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~ksD 303 (527)
.... ...+.+||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence 2100 001246899999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC--CCCccHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q psy6905 304 VWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI--PSTCPQLFKTLMEACWEADSHMRPS---FKTILK 373 (527)
Q Consensus 304 vwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~~~~li~~~l~~dp~~RPs---~~~ll~ 373 (527)
||||||++|||++|+.||.+.+..+....+......... ...+++++.++|.+|+ .+|.+|++ +.+++.
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 231 WWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred EEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999999999999988877766666543333333 3567899999998876 59999997 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=347.53 Aligned_cols=235 Identities=27% Similarity=0.432 Sum_probs=200.9
Q ss_pred eeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.++ ++.||||++.... .......+..|..++..+ +||||+++++++...+.+|+|||||+|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 5789999886531 223355667888888776 799999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc-
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK- 275 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~- 275 (527)
|+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~--------~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHE--------GHCKLADFGMCKEGIFN 149 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCC--------CcEEEeeCCCCeecCcC
Confidence 99998886 567999999999999999999999995 9999999999999875 6899999999875422
Q ss_pred -cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 276 -TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 276 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ...|..++.++.++|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li 227 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLSQDAVDIL 227 (320)
T ss_pred CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHH
Confidence 22234569999999999999899999999999999999999999999988877776665433 356677899999999
Q ss_pred HHhhhhCCCCCCCHHH
Q psy6905 355 EACWEADSHMRPSFKT 370 (527)
Q Consensus 355 ~~~l~~dp~~RPs~~~ 370 (527)
.+||..||.+||++.+
T Consensus 228 ~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 228 KAFMTKNPTMRLGSLT 243 (320)
T ss_pred HHHcccCHHHCCCCCC
Confidence 9999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=337.52 Aligned_cols=252 Identities=36% Similarity=0.646 Sum_probs=214.8
Q ss_pred ceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
+|++.+.||+|+||.||+|.... ..+++|.+...........+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998632 46899988776555556788899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcC-------------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCc
Q psy6905 191 VMEYARGGPLNRVLAG-------------------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSN 245 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~-------------------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~N 245 (527)
+|||+.+|+|.+++.. ..++...++.++.|++.||+|||+++ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999998752 23677888999999999999999984 9999999999
Q ss_pred eecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCC
Q psy6905 246 VLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIP 320 (527)
Q Consensus 246 ILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~P 320 (527)
||++.+ +.+||+|||+++....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 158 ill~~~--------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 229 (290)
T cd05045 158 VLVAEG--------RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229 (290)
T ss_pred EEEcCC--------CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCC
Confidence 999875 6899999999976532211 12345778999999988889999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 321 YKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 321 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
|.+.........+ ......+.|..++..+.+++..||+.+|.+||++.++++.|+++..+
T Consensus 230 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 230 YPGIAPERLFNLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCCCHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 9887766554433 34556677888999999999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=339.79 Aligned_cols=257 Identities=34% Similarity=0.621 Sum_probs=219.7
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVC 182 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~ 182 (527)
.|.+..++|.+.+.||+|+||.||+|.+. +..||+|++.........+.+.+|+.+++.+ +||||+++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 47788889999999999999999999752 2369999987665455567789999999999 799999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHhcCC---CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 183 LQSPKLCLVMEYARGGPLNRVLAGR---KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 183 ~~~~~~~iv~Ey~~ggsL~~~l~~~---~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
...+..|+||||+.+|+|.+++... .++...++.++.||+.||.|||+++ ++|+||||+|||++.+
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~-------- 177 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHG-------- 177 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCC--------
Confidence 9999999999999999999998632 3789999999999999999999994 9999999999999865
Q ss_pred ceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy6905 260 KTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVA 334 (527)
Q Consensus 260 ~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~ 334 (527)
+.++|+|||+++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...........
T Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~ 257 (302)
T cd05055 178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI 257 (302)
T ss_pred CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH
Confidence 6899999999976533221 12345788999999999889999999999999999998 999998877665555555
Q ss_pred hCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 335 VNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 335 ~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
..+.....+...++.+.+++.+||..+|++||++.++++.|.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 55555666777899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=342.87 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=196.9
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|.+.+.||.|+||.||+|.+ +++.||||++...........+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 36799999999999999999997 4678999998765433334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||. ++|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~--------~~~kl~Dfg~~~ 151 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDT--------GELKLADFGLAR 151 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC--------CCEEECCCCcce
Confidence 995 56766665 356889999999999999999999995 9999999999999875 689999999987
Q ss_pred hhhcc--ccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC-----------
Q psy6905 272 EVYKT--THMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYA-VAYGVAVN----------- 336 (527)
Q Consensus 272 ~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~-~~~~i~~~----------- 336 (527)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 152 AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred eccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 54321 2234568999999999865 457899999999999999999999998764322 11111100
Q ss_pred ----------CccCCCC---------CCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 337 ----------KLTLPIP---------STCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 337 ----------~~~~~~p---------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.+....| ..+++.+.+|+..||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000001 123567899999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=319.23 Aligned_cols=260 Identities=23% Similarity=0.391 Sum_probs=215.8
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC-
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP- 186 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~- 186 (527)
..+-|+.++|.+.+.||.|||+.||++.. ++..||+|.+.-... +..+..++|++.-++++|||+++++++...+.
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~-~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ-EDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch-HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 45678999999999999999999999874 678899997765543 34678899999999999999999998875433
Q ss_pred ----eEEEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccc
Q psy6905 187 ----KLCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDL 257 (527)
Q Consensus 187 ----~~~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~ 257 (527)
..||++.|...|+|.+.+. +..+++.+++.|+.+|++||++||+..+ +++||||||.|||++++
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~------ 165 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDS------ 165 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCC------
Confidence 4899999999999998875 4468999999999999999999999965 69999999999999985
Q ss_pred ccceeEEeccCcchhhhcccc-----------ccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCC
Q psy6905 258 QFKTLKITDFGLAREVYKTTH-----------MSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKS 323 (527)
Q Consensus 258 ~~~~vkL~DFGla~~~~~~~~-----------~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~elltg~~Pf~~ 323 (527)
+.++|.|||.++...-... .....|..|+|||.+. +...+.++|||||||+||.|+.|..||+.
T Consensus 166 --~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 166 --GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred --CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 6899999999976532111 1234789999999985 44578999999999999999999999964
Q ss_pred CC--HHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q psy6905 324 IN--AYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379 (527)
Q Consensus 324 ~~--~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~ 379 (527)
.- ...++..+....+..|....+|+.+.++++.|++.||.+||++.+++.+++++.
T Consensus 244 ~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 244 IYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 32 222333444456666766779999999999999999999999999999987653
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=331.07 Aligned_cols=250 Identities=33% Similarity=0.636 Sum_probs=214.9
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEE-eCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCL-QSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~-~~~~~~i 190 (527)
|-++..+|++.+.||+|+||.||++...+..||+|...... ..+.+.+|+.+++.++|+||+++++++. .+...|+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 55778899999999999999999999999999999986542 2456889999999999999999999764 4567899
Q ss_pred EEeccCCCCHHHHhcCC---CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 191 VMEYARGGPLNRVLAGR---KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~~---~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+|||+++|+|.+++... .+++..++.++.||+.||.|||++| ++||||||+|||++.+ +.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~--------~~~kl~df 146 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSED--------NVAKVSDF 146 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCC--------CcEEecCC
Confidence 99999999999998632 3788899999999999999999995 9999999999999875 68999999
Q ss_pred CcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 268 GLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 268 Gla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
|+++...... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+. .......+..+
T Consensus 147 g~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 224 (256)
T cd05082 147 GLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGC 224 (256)
T ss_pred ccceeccccC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCC
Confidence 9987653322 23345678999999998889999999999999999998 999998877666655554 34555677889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
|..+.+++.+||..+|++|||+.++++.|+.
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 9999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=334.24 Aligned_cols=253 Identities=34% Similarity=0.617 Sum_probs=218.9
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
||....+|++.+.||.|+||.||+|.+. +..+|+|++..... .....+..|+.+++.++||||+++++++.+....++
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 3455678999999999999999999985 46899999876543 235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 191 VMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
||||+++|+|.+++.. ..++...+..++.||+.||.|||++| ++||||+|+|||++.+ +.+||+||
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~--------~~~kl~d~ 148 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGED--------LVCKVADF 148 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCC--------ceEEEccc
Confidence 9999999999999863 45888999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhcccc--ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 268 GLAREVYKTTH--MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 268 Gla~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
|++........ ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+. .....+.|.
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 227 (261)
T cd05148 149 GLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPA 227 (261)
T ss_pred cchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCC
Confidence 99976533221 13346788999999998889999999999999999998 899999888776666655 455667788
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
.+++.+.++|.+||..||.+|||+.+|++.|++
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=348.99 Aligned_cols=239 Identities=28% Similarity=0.458 Sum_probs=204.1
Q ss_pred eeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCC
Q psy6905 123 EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGG 198 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~gg 198 (527)
+.||+|+||.||++.+ ++..||+|++.... .......+..|+.++..++||||+++++++...+.+|+|||||.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 46789999987532 2233456778999999999999999999999999999999999999
Q ss_pred CHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc
Q psy6905 199 PLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHC-QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT 276 (527)
Q Consensus 199 sL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~-~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~ 276 (527)
+|..++. .+.+++..+..++.||+.||.|||+ . +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~--------~~~kL~Dfg~~~~~~~~ 149 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKD--------GHIKITDFGLCKEGIKD 149 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCC--------CCEEEecCCCCeecCCC
Confidence 9998886 5678999999999999999999997 5 49999999999999875 68999999998754221
Q ss_pred --ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 277 --THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 277 --~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ...+|..+++++.++|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li 227 (325)
T cd05594 150 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLL 227 (325)
T ss_pred CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHH
Confidence 222356999999999999999999999999999999999999999888776665555433 3456778999999999
Q ss_pred HHhhhhCCCCCC-----CHHHHHHH
Q psy6905 355 EACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 355 ~~~l~~dp~~RP-----s~~~ll~~ 374 (527)
.+||..||.+|+ ++.+++++
T Consensus 228 ~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 228 SGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 999999999996 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=347.29 Aligned_cols=254 Identities=35% Similarity=0.554 Sum_probs=203.3
Q ss_pred CceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC-eEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-KLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-~~~iv~Ey 194 (527)
+.|.-...||+|+||.||+|...+ ..||||.+....... ..+|.+|+.++.+++|||+|+++|||.+.+ ..++|+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy 153 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY 153 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence 345555789999999999999865 899999877765432 456999999999999999999999999988 59999999
Q ss_pred cCCCCHHHHhcCC---CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 195 ARGGPLNRVLAGR---KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 195 ~~ggsL~~~l~~~---~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+.+|+|.+.|.+. .+++...+.|+.++|.||+|||...+.+||||||||+|||+|++ .+.||+|||+|+
T Consensus 154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~--------~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED--------FNAKLSDFGLAK 225 (361)
T ss_pred cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC--------CCEEccCccCcc
Confidence 9999999999843 67999999999999999999999876679999999999999987 488999999997
Q ss_pred hhhc-ccccc-C-CCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-c---
Q psy6905 272 EVYK-TTHMS-A-AGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN------AYAVAYGVAVNK-L--- 338 (527)
Q Consensus 272 ~~~~-~~~~~-~-~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~------~~~~~~~i~~~~-~--- 338 (527)
.... ..... . .||.+|+|||.+..+..+.|+|||||||+|.||+||+.|..... ....+......+ .
T Consensus 226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei 305 (361)
T KOG1187|consen 226 LGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI 305 (361)
T ss_pred cCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence 6653 32222 2 79999999999999899999999999999999999998876432 111111121111 1
Q ss_pred -cCCCC-CCcc--H---HHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q psy6905 339 -TLPIP-STCP--Q---LFKTLMEACWEADSHMRPSFKTILKALNNIV 379 (527)
Q Consensus 339 -~~~~p-~~~~--~---~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~ 379 (527)
...+. ...+ . .+..+...|++.+|..||++.++++.|+.+.
T Consensus 306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 11111 2222 2 2556778999999999999999998885544
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=336.80 Aligned_cols=255 Identities=36% Similarity=0.643 Sum_probs=217.2
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
|+..+|.+.+.||.|+||.||++.+. +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 56778999999999999999999741 2458999886543 334667889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcCC--------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCC
Q psy6905 187 KLCLVMEYARGGPLNRVLAGR--------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPI 252 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~--------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~ 252 (527)
.+++||||+.+|+|.+++... .+++..++.++.||+.||+|||++| ++||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~- 156 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN- 156 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC-
Confidence 999999999999999988622 3788999999999999999999995 9999999999999875
Q ss_pred cccccccceeEEeccCcchhhhccccc----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHH
Q psy6905 253 ENEDLQFKTLKITDFGLAREVYKTTHM----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAY 327 (527)
Q Consensus 253 ~~~~~~~~~vkL~DFGla~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~ 327 (527)
+.++|+|||+++........ ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..
T Consensus 157 -------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~ 229 (288)
T cd05093 157 -------LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229 (288)
T ss_pred -------CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 68999999999865432211 2235778999999998889999999999999999998 99999988777
Q ss_pred HHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 328 AVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 328 ~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.....+.. +...+.+..++..+.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 230 ~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 230 EVIECITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHHc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 66666654 334456778899999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=331.48 Aligned_cols=251 Identities=34% Similarity=0.606 Sum_probs=215.7
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
|+|..++|++.++||+|+||.||+|.. .++.||+|.+...... ...+.+|+.+++.++|+||+++++++. ....|+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 678899999999999999999999987 4578999988765332 457889999999999999999999875 456899
Q ss_pred EEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 191 VMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+|||+.+|+|.+++. +..++...+..++.|++.||+|||+.| ++||||||+||+++.+ +.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~--------~~~~l~df 146 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSET--------LCCKIADF 146 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCC--------CCEEEccC
Confidence 999999999999875 346888899999999999999999985 9999999999999875 68999999
Q ss_pred Ccchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 268 GLAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 268 Gla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|++........ ....++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+.......+. .....+.+
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 225 (260)
T cd05067 147 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRP 225 (260)
T ss_pred cceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCC
Confidence 99976542221 12346788999999998889999999999999999999 999999887766655543 45566778
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
..++..+.+++.+||..+|++||++.+++..|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 8899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=331.60 Aligned_cols=248 Identities=33% Similarity=0.630 Sum_probs=212.5
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEcCc-eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~-~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
|+.++|.+.+.||+|+||.||+|.+.+. .||+|.+..... ....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 3567899999999999999999988654 699998775432 2356889999999999999999999999988999999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||+.+|+|.+++. ...+++..++.++.||+.||.|||+.| ++|+||||+|||++.+ +.+||+|||++
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~--------~~~kl~d~g~~ 147 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQ--------GCVKVSDFGLS 147 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCC--------CCEEECCCccc
Confidence 9999999999986 346899999999999999999999995 9999999999999875 68999999998
Q ss_pred hhhhccccc---cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 271 REVYKTTHM---SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 271 ~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+. .+...+.+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 226 (256)
T cd05113 148 RYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLA 226 (256)
T ss_pred eecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCC
Confidence 765433222 2335678999999998889999999999999999999 999998887766665554 34455667778
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
+..+.+++.+||..+|.+||++.+|+..|
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 99999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=352.31 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=212.0
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
...+..++|++.+.||+|+||.||+|.+. ++.||+|++.... .......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 35667789999999999999999999874 5789999986421 2223456778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 187 KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
.+|+|||||+||+|.+++....+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~--------~~ikL~D 185 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--------GHLKLAD 185 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCC--------CCEEEEe
Confidence 9999999999999999998888999999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc---cccCCCccccccccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 267 FGLAREVYKTT---HMSAAGTYAWMAPEVIKTS----IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 267 FGla~~~~~~~---~~~~~gt~~y~aPE~l~~~----~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
||+++...... .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+......
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 99997653321 2245699999999998754 3789999999999999999999999998877777766654433
Q ss_pred --CCCCCCccHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q psy6905 340 --LPIPSTCPQLFKTLMEACWEADSHM--RPSFKTILKA 374 (527)
Q Consensus 340 --~~~p~~~~~~~~~li~~~l~~dp~~--RPs~~~ll~~ 374 (527)
.+.+..++..++++|..|+..++.+ |+++.+++++
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 3444568999999999999843332 6788888875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=335.00 Aligned_cols=254 Identities=33% Similarity=0.593 Sum_probs=213.5
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
+..++|.+.+.||+|+||.||+|.+.+ ..||+|.............+.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 455789999999999999999998743 5789998876555545567889999999999999999999999988
Q ss_pred eEEEEEeccCCCCHHHHhcCC--------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccc
Q psy6905 187 KLCLVMEYARGGPLNRVLAGR--------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~--------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~ 258 (527)
..|+||||+.||+|.+++... .+++..++.++.||+.||+|||+++ ++||||||+|||++.+.+
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~----- 154 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGP----- 154 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCC-----
Confidence 999999999999999998632 4788899999999999999999995 999999999999986421
Q ss_pred cceeEEeccCcchhhhccccc----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy6905 259 FKTLKITDFGLAREVYKTTHM----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGV 333 (527)
Q Consensus 259 ~~~vkL~DFGla~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i 333 (527)
...+||+|||+++........ ...++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~ 234 (277)
T cd05036 155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234 (277)
T ss_pred CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 136899999999876332211 1223568999999998889999999999999999997 99999987776655544
Q ss_pred HhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 334 AVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 334 ~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
. .......|..+|..+.+++.+||..+|++||++.+++++|.
T Consensus 235 ~-~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 T-GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 3 33445667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=345.35 Aligned_cols=238 Identities=26% Similarity=0.427 Sum_probs=203.7
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
+|.+.+.||+|+||.||+|.+. ++.||||++.... .......+..|..++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999875 4689999887542 122344566777887776 6899999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||++|+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~--------~~~kL~DfG~~~ 149 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSE--------GHIKIADFGMCK 149 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCC--------CcEEEccCCCce
Confidence 9999999998876 567899999999999999999999995 9999999999999876 689999999987
Q ss_pred hhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 272 EVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 272 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.... ...|..++.+
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~ 227 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKE 227 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCcCCHH
Confidence 5421 22234579999999999999999999999999999999999999999988877777666443 4566789999
Q ss_pred HHHHHHHhhhhCCCCCCCH
Q psy6905 350 FKTLMEACWEADSHMRPSF 368 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~ 368 (527)
+.+++.+||..||.+|++.
T Consensus 228 ~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 228 AVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHHHHcccCHHhcCCC
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=338.98 Aligned_cols=259 Identities=34% Similarity=0.620 Sum_probs=220.5
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc---------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE---------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIG 180 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~ 180 (527)
.|++...+|.+.+.||+|+||.||+|.+. +..||+|.............+.+|+.+++.+ +||||+++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 47888899999999999999999999742 2369999987654444567889999999999 8999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q psy6905 181 VCLQSPKLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKS 243 (527)
Q Consensus 181 ~~~~~~~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp 243 (527)
++......|+||||+.+|+|.+++.. ..++...++.++.||+.||.|||++| ++||||||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp 165 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAA 165 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeeccccc
Confidence 99999999999999999999999863 23567788999999999999999995 99999999
Q ss_pred CceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CC
Q psy6905 244 SNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GE 318 (527)
Q Consensus 244 ~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~ 318 (527)
+|||++.+ +.+||+|||+++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 166 ~Nili~~~--------~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~ 237 (304)
T cd05101 166 RNVLVTEN--------NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 237 (304)
T ss_pred ceEEEcCC--------CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 99999875 6899999999986643221 12345678999999998889999999999999999998 89
Q ss_pred CCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 319 IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 319 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.||.+.+..+....+. .......|..++..+.+|+.+||..+|.+||++.++++.|+.+...
T Consensus 238 ~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 238 SPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 9999887776665554 4445567788999999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=339.58 Aligned_cols=259 Identities=35% Similarity=0.644 Sum_probs=220.0
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc---------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE---------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIG 180 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~ 180 (527)
.|+++.++|.+.+.||+|+||.||+|.+. ...||+|++...........+.+|+.+++.+ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 57888899999999999999999999752 2469999988655445567788999999999 6999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q psy6905 181 VCLQSPKLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKS 243 (527)
Q Consensus 181 ~~~~~~~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp 243 (527)
++.+...+|++|||+.+|+|.+++.. ..++...++.++.||+.||.|||++| ++||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp 162 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAA 162 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccc
Confidence 99999999999999999999999853 23777888999999999999999995 99999999
Q ss_pred CceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CC
Q psy6905 244 SNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GE 318 (527)
Q Consensus 244 ~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~ 318 (527)
+|||++.+ +.+||+|||+++....... ....++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 163 ~Nill~~~--------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~ 234 (314)
T cd05099 163 RNVLVTED--------NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234 (314)
T ss_pred eeEEEcCC--------CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCC
Confidence 99999875 6899999999986643211 11234568999999998889999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 319 IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 319 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.||.+.+.......+. .......|..++..+.+++.+||..+|++||++.++++.|..+...
T Consensus 235 ~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 235 SPYPGIPVEELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred CCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 9998887766555544 3445567788999999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=345.93 Aligned_cols=238 Identities=25% Similarity=0.409 Sum_probs=202.6
Q ss_pred eeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+. ++.||||++.... .......+..|..++..+ +||||+++++++...+.+|+|||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 5689999987532 223345667888888765 899999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc-
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK- 275 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~- 275 (527)
|+|...+. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~--------~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAE--------GHCKLADFGMCKEGILN 149 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCC--------CCEEEeecccceecccC
Confidence 99988876 567899999999999999999999995 9999999999999875 6899999999875422
Q ss_pred -cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 276 -TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 276 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ...|..++.++.++|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll 227 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--VLYPVWLSKEAVSIL 227 (321)
T ss_pred CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Confidence 12234568999999999999899999999999999999999999999988877777766443 345667899999999
Q ss_pred HHhhhhCCCCCC-------CHHHHHH
Q psy6905 355 EACWEADSHMRP-------SFKTILK 373 (527)
Q Consensus 355 ~~~l~~dp~~RP-------s~~~ll~ 373 (527)
..||..||++|| ++.++++
T Consensus 228 ~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 228 KAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 999999999999 6666665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=346.30 Aligned_cols=243 Identities=27% Similarity=0.397 Sum_probs=202.1
Q ss_pred ceeeeeeeccCCceEEEEeeE-----cCceEEEEEcCCCC---ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNP---DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~ 188 (527)
+|.+.+.||+|+||.||++.. .++.||+|++.... .....+.+..|+.++..+ +||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999875 35789999886431 223356678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+|||||.+|+|.+++. ++.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+||
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~--------~~~kl~Df 149 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSE--------GHVVLTDF 149 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCC--------CCEEEeeC
Confidence 99999999999998886 567899999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhcc---ccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCcc
Q psy6905 268 GLAREVYKT---THMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSIN----AYAVAYGVAVNKLT 339 (527)
Q Consensus 268 Gla~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~----~~~~~~~i~~~~~~ 339 (527)
|+++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .......+. ...
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~ 227 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KCD 227 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cCC
Confidence 999765322 12245799999999999865 47899999999999999999999997532 222222232 334
Q ss_pred CCCCCCccHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q psy6905 340 LPIPSTCPQLFKTLMEACWEADSHMRP-----SFKTILK 373 (527)
Q Consensus 340 ~~~p~~~~~~~~~li~~~l~~dp~~RP-----s~~~ll~ 373 (527)
.++|..++..+.+++.+||..||++|| ++.++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 567778999999999999999999999 6777776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=336.33 Aligned_cols=254 Identities=32% Similarity=0.572 Sum_probs=214.1
Q ss_pred CceeeeeeeccCCceEEEEeeEcC----ceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYEK----QEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv 191 (527)
++|++.+.||.|+||.||+|.+.. ..+++|.+.........+.+.+|+.++.++ +||||+++++++.....+|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998743 247888887544444466788999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHhcCC-----------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcc
Q psy6905 192 MEYARGGPLNRVLAGR-----------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~~~-----------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~ 254 (527)
|||+++|+|.+++... .++...++.++.||+.||+|||++| ++||||||+|||++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~--- 155 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGEN--- 155 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCC---
Confidence 9999999999998632 3778889999999999999999985 9999999999999875
Q ss_pred cccccceeEEeccCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6905 255 EDLQFKTLKITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYG 332 (527)
Q Consensus 255 ~~~~~~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~ 332 (527)
+.+||+|||++....... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.......
T Consensus 156 -----~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~ 230 (297)
T cd05089 156 -----LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230 (297)
T ss_pred -----CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 689999999986432211 111233567999999998889999999999999999998 9999998877666555
Q ss_pred HHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 333 VAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 333 i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
+. .+...+.|..++..+.+|+.+||..+|.+||++.++++.|..+....
T Consensus 231 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 LP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred Hh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 54 34556677889999999999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=349.04 Aligned_cols=245 Identities=22% Similarity=0.343 Sum_probs=208.0
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|.+.+.||+|+||.||+|.+ +++.||+|++.... .......+..|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688999999999999999987 46789999987542 2234566788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||++|+|.+++.. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~--------~~~kL~Dfg~a 149 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRT--------GHIKLADFGSA 149 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCC--------CCEEeccCCCC
Confidence 99999999999873 57899999999999999999999995 9999999999999875 68999999999
Q ss_pred hhhhcccc---ccCCCccccccccccc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--c
Q psy6905 271 REVYKTTH---MSAAGTYAWMAPEVIK------TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL--T 339 (527)
Q Consensus 271 ~~~~~~~~---~~~~gt~~y~aPE~l~------~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~--~ 339 (527)
........ ....||+.|+|||++. ...++.++|||||||++|+|++|..||...+.......+..... .
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 229 (330)
T cd05601 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229 (330)
T ss_pred eECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC
Confidence 76543221 2346899999999986 45678999999999999999999999998877776666654332 2
Q ss_pred CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 340 ~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.+....++..+.+|+..||. +|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 33334678999999999998 9999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=328.10 Aligned_cols=242 Identities=36% Similarity=0.685 Sum_probs=206.6
Q ss_pred eeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCH
Q psy6905 123 EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL 200 (527)
+.||+|+||.||+|.+ +++.||+|.+......+....+.+|+.+++.++||||+++++++......|+||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999987 46789999887655555667889999999999999999999999999999999999999999
Q ss_pred HHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcccc
Q psy6905 201 NRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH 278 (527)
Q Consensus 201 ~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~ 278 (527)
.+++.. ..+++..++.++.|++.||.|||++| ++||||||+|||++.+ +.+||+|||++........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~--------~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEK--------NVLKISDFGMSREEEDGVY 149 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCC--------CcEEECccccCcccccccc
Confidence 999863 45889999999999999999999995 9999999999999875 6899999999875432211
Q ss_pred cc----CCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHH
Q psy6905 279 MS----AAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTL 353 (527)
Q Consensus 279 ~~----~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~l 353 (527)
.. ..++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+. .....+.|..++..+.++
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 228 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRL 228 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHH
Confidence 11 123467999999998889999999999999999998 999998877665544443 344557778899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 354 MEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 354 i~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
+.+||..+|++|||+.++++.|.
T Consensus 229 i~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHcCCChhhCcCHHHHHHHHh
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=328.45 Aligned_cols=242 Identities=33% Similarity=0.638 Sum_probs=206.1
Q ss_pred eeccCCceEEEEeeE----cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCC
Q psy6905 124 AIGEGGFGKVYKGIY----EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGG 198 (527)
Q Consensus 124 ~iG~G~fg~Vy~~~~----~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~gg 198 (527)
.||+|+||.||+|.+ ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.. ...++||||+.+|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999975 34689999987543 33446778999999999999999999998854 5679999999999
Q ss_pred CHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccc
Q psy6905 199 PLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT 277 (527)
Q Consensus 199 sL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~ 277 (527)
+|.+++. ...+++..+..++.|++.||.|||++| ++||||||.|||++.+ +.+||+|||+++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~--------~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQ--------HYAKISDFGLSKALGADE 149 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCC--------CeEEECCCccccccCCCC
Confidence 9999986 457899999999999999999999995 9999999999999875 689999999997663322
Q ss_pred c-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHH
Q psy6905 278 H-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFK 351 (527)
Q Consensus 278 ~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 351 (527)
. ....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+.......+. .+...+.|..+++++.
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~ 228 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMY 228 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHH
Confidence 1 12234679999999988889999999999999999998 999999887766666554 3445677888999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 352 TLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
++|.+||+.||.+||++.+|...|++.
T Consensus 229 ~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 229 DLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=330.34 Aligned_cols=253 Identities=34% Similarity=0.604 Sum_probs=215.6
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--C---ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--K---QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
|+..+|++.+.||+|+||.||+|.+. + ..+|+|.+...........+.+|+.+++.++||||+++++++..++..
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 35678999999999999999999863 2 369999987655445567889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 189 CLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
|+||||+++|+|.+++.. ..++...+..++.|++.||.|||+++ ++||||||+|||++.+ +.++|+|
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~--------~~~~l~d 149 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSN--------LVCKVSD 149 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCC--------CeEEeCC
Confidence 999999999999999873 46788999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 267 FGLAREVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 267 FGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
||++........ ....++..|+|||.+.+..++.++|||||||++|++++ |..||...+..+....+. .....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~ 228 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRL 228 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcC
Confidence 999986633211 11223568999999998889999999999999999887 999998877666555544 34566
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
+.+..+|+.+.+++.+||+.+|.+||++.++++.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 77778899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.59 Aligned_cols=238 Identities=26% Similarity=0.428 Sum_probs=199.8
Q ss_pred eeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHh-CCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWL-FDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~-l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+. +..||+|++.... ..........|..++.. ++||||+++++++.+.+.+|+|||||.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999984 5789999987532 11224556677777765 4899999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh--
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY-- 274 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~-- 274 (527)
|+|..++. +..+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++...
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~--------~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRD--------GHIKIADFGMCKENVFG 149 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCC--------CCEEeCccCCCeecccC
Confidence 99988886 567899999999999999999999995 9999999999999875 689999999987532
Q ss_pred ccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 275 KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 275 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ....|..++.++.++|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 227 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESKDIL 227 (316)
T ss_pred CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHH
Confidence 22223457999999999999999999999999999999999999999988877666555432 3345677899999999
Q ss_pred HHhhhhCCCCCCCHH-HHHH
Q psy6905 355 EACWEADSHMRPSFK-TILK 373 (527)
Q Consensus 355 ~~~l~~dp~~RPs~~-~ll~ 373 (527)
.+||..||.+||++. ++++
T Consensus 228 ~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 228 EKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHccCCHHHcCCChHHHHc
Confidence 999999999999974 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=342.92 Aligned_cols=238 Identities=26% Similarity=0.447 Sum_probs=200.4
Q ss_pred eeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHh-CCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWL-FDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~-l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+. ++.||||++.... .......+..|..++.. ++||||+++++++.+.+.+|+|||||+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999974 4689999887542 11224455667777775 5999999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh--
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY-- 274 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~-- 274 (527)
|+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~--------~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTD--------GHIKIADFGMCKENMLG 149 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCC--------CCEEEccCCcceECCCC
Confidence 99999887 457899999999999999999999995 9999999999999875 689999999987532
Q ss_pred ccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 275 KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 275 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.... ...|..++.++.+++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li 227 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAKDIL 227 (316)
T ss_pred CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHH
Confidence 122234579999999999999899999999999999999999999999888777666655433 345667899999999
Q ss_pred HHhhhhCCCCCCCHH-HHHH
Q psy6905 355 EACWEADSHMRPSFK-TILK 373 (527)
Q Consensus 355 ~~~l~~dp~~RPs~~-~ll~ 373 (527)
.+||..||.+||++. +++.
T Consensus 228 ~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 228 VKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHhccCHhhcCCChHHHHc
Confidence 999999999999996 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=327.97 Aligned_cols=242 Identities=36% Similarity=0.662 Sum_probs=206.3
Q ss_pred eeccCCceEEEEeeEc----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCC
Q psy6905 124 AIGEGGFGKVYKGIYE----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGP 199 (527)
Q Consensus 124 ~iG~G~fg~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggs 199 (527)
.||+|+||.||+|.+. +..||+|+..........+.+.+|+.+++.++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 34699999877655555677899999999999999999999885 457899999999999
Q ss_pred HHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccc
Q psy6905 200 LNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT 277 (527)
Q Consensus 200 L~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~ 277 (527)
|.+++. ...+++..++.++.||+.||.|||++| ++||||||+|||++.+ +.+||+|||++.......
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~--------~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQ--------HYAKISDFGLSKALGADD 149 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCC--------CcEEeccCCccccccCCc
Confidence 999986 456899999999999999999999995 9999999999999875 689999999997553221
Q ss_pred c-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHH
Q psy6905 278 H-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFK 351 (527)
Q Consensus 278 ~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 351 (527)
. ....+++.|+|||.+.+..++.++|||||||++|++++ |..||.+.........+. .+...+.|..+++++.
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 228 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMY 228 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHH
Confidence 1 11224578999999988889999999999999999996 999999887776655554 3455677888999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 352 TLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
++|..||..+|++||++.++.+.|+.+
T Consensus 229 ~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 229 ALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.70 Aligned_cols=238 Identities=26% Similarity=0.435 Sum_probs=202.9
Q ss_pred eeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+. ++.||||++.... .......+..|..++..+ +||||+++++++...+.+|+|||||.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999884 5689999987532 223355667888888877 799999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc-
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK- 275 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~- 275 (527)
|+|..++. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~--------~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSE--------GHIKIADFGMCKEGILG 149 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCC--------CcEEecccCCCeecCcC
Confidence 99998886 457999999999999999999999994 9999999999999875 6899999999875321
Q ss_pred -cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 276 -TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 276 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ...|..++..+.+||
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li 227 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--VRYPRWLSKEAKSIL 227 (318)
T ss_pred CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCcCCHHHHHHH
Confidence 22223468999999999999999999999999999999999999999888777666655433 346678899999999
Q ss_pred HHhhhhCCCCCCCH-----HHHHH
Q psy6905 355 EACWEADSHMRPSF-----KTILK 373 (527)
Q Consensus 355 ~~~l~~dp~~RPs~-----~~ll~ 373 (527)
++||..||.+||++ .++++
T Consensus 228 ~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 228 KSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHccCCHHHcCCCCCCCHHHHhc
Confidence 99999999999999 66665
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=332.11 Aligned_cols=256 Identities=32% Similarity=0.618 Sum_probs=218.2
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEcC------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe-C
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ-S 185 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~ 185 (527)
.++.++|++.+.||+|+||.||+|.+.. ..|++|.+...........+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4678899999999999999999999743 67999998766555667788999999999999999999998776 5
Q ss_pred CeEEEEEeccCCCCHHHHhcC---------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccc
Q psy6905 186 PKLCLVMEYARGGPLNRVLAG---------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENED 256 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~~---------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~ 256 (527)
...++++||+.+|+|.+++.. ..++...++.++.||+.||+|||++ +++||||||+|||++.+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~----- 153 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEE----- 153 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCC-----
Confidence 678999999999999998863 4578999999999999999999998 49999999999999875
Q ss_pred cccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy6905 257 LQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAY 331 (527)
Q Consensus 257 ~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~ 331 (527)
+.+||+|||+++.+..... ....++..|+|||++.+..++.++|||||||++|++++ |+.||...+......
T Consensus 154 ---~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 230 (280)
T cd05043 154 ---LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA 230 (280)
T ss_pred ---CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 6899999999986532211 12346778999999988889999999999999999999 999998877666544
Q ss_pred HHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 332 GVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 332 ~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.+. .....+.+..+|+.+.+++.+||..||++|||+.++++.|.++..
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 231 YLK-DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 433 455556667789999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=328.42 Aligned_cols=252 Identities=36% Similarity=0.618 Sum_probs=218.4
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
|+++.++|.+.+.||+|+||.||+|.+.+ ..||||.+..... ....+.+|+.+++.++|+||+++++++......++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 67899999999999999999999998754 6799998876432 24678899999999999999999999999889999
Q ss_pred EEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 191 VMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
||||+++++|.+++.. ..++...+..++.||+.||.|||+++ ++|+||+|+||+++.+ +.++|+||
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~--------~~~~l~d~ 147 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGEN--------LVCKIADF 147 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCC--------CCEEECcc
Confidence 9999999999999863 46889999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 268 GLAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 268 Gla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|++........ ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+.......+. ..+..+.|
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 226 (261)
T cd05034 148 GLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRP 226 (261)
T ss_pred ccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 99876532211 12335678999999998889999999999999999999 999999887766665554 45566778
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
..+|..+.+++.+||..+|.+||++.++++.|++
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 8889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=329.79 Aligned_cols=253 Identities=34% Similarity=0.579 Sum_probs=214.7
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
|+++.++|.+.+.||.|+||.||+|.+.+ ..||+|++..... ....+.+|+.+++.++||||+++++++.+ ...|+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence 67888999999999999999999998754 4799999876432 13567889999999999999999998754 55799
Q ss_pred EEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 191 VMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
||||+.+|+|.+++.. ..++...+..++.|++.||.|||+.+ ++||||||+||+++.+ +.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~--------~~~~L~df 146 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN--------LVCKVADF 146 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCC--------CcEEeccC
Confidence 9999999999999863 35788899999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhccccc---cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 268 GLAREVYKTTHM---SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 268 Gla~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|+++........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+. .....+.+
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 225 (262)
T cd05071 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCP 225 (262)
T ss_pred CceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCc
Confidence 999765432221 2346778999999988889999999999999999999 899999887766655554 34445667
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~ 379 (527)
..++..+.+++.+||+.||.+||++.++++.|+..+
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 788999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=332.87 Aligned_cols=250 Identities=37% Similarity=0.565 Sum_probs=206.2
Q ss_pred eeeeeeeccCCceEEEEeeE------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--CeEEE
Q psy6905 119 LIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS--PKLCL 190 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~i 190 (527)
|++.+.||.|+||+||++.+ .+..||+|++...........+.+|+.+++.++||||+++++++... ..+|+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48899999999999988653 34679999987664444456788999999999999999999988653 46899
Q ss_pred EEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 191 VMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
+|||+.+|+|.+++....+++..++.++.|++.||.|||++| ++||||||+|||++.+ +.++|+|||++
T Consensus 86 v~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~--------~~~~l~dfg~~ 154 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDND--------RLVKIGDFGLA 154 (283)
T ss_pred EecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCC--------CcEEEeecccc
Confidence 999999999999998778999999999999999999999995 9999999999999875 68999999999
Q ss_pred hhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH--------------HHHH
Q psy6905 271 REVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY--------------AVAY 331 (527)
Q Consensus 271 ~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~--------------~~~~ 331 (527)
+....... ....++..|+|||.+.+..++.++|||||||++|+|++|..||...... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 76543221 1223567799999998888999999999999999999999998653211 0111
Q ss_pred HHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q psy6905 332 GVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379 (527)
Q Consensus 332 ~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~ 379 (527)
.........+.|..++..+.+++.+||..+|++|||+.+++..|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 112223344567788999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=368.73 Aligned_cols=256 Identities=36% Similarity=0.649 Sum_probs=228.7
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc---------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE---------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIG 180 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~ 180 (527)
.|+++.+.+.+.+.||+|.||.|++|... ...||||..+........+.+..|+.+|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 79999999999999999999999999743 2469999998876667788999999999998 6999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHhcCCC-----------------CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q psy6905 181 VCLQSPKLCLVMEYARGGPLNRVLAGRK-----------------IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKS 243 (527)
Q Consensus 181 ~~~~~~~~~iv~Ey~~ggsL~~~l~~~~-----------------~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp 243 (527)
+|..+..+++|+|||..|+|..+++..+ ++...++.++.||+.||+||++. ++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998655 88899999999999999999999 599999999
Q ss_pred CceecCCCCcccccccceeEEeccCcchhhhcccccc---CCC--ccccccccccccCCCCcccchHHHHHHHHHHHh-C
Q psy6905 244 SNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS---AAG--TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-G 317 (527)
Q Consensus 244 ~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~---~~g--t~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g 317 (527)
+|||+..+ ..+||+|||+|+......... ..| ...|||||.+....|+.++|||||||+||||++ |
T Consensus 447 RNVLi~~~--------~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG 518 (609)
T KOG0200|consen 447 RNVLITKN--------KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLG 518 (609)
T ss_pred hhEEecCC--------CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCC
Confidence 99999986 689999999999765443332 222 466999999999999999999999999999999 9
Q ss_pred CCCCCCCC-HHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 318 EIPYKSIN-AYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 318 ~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
..||++.. ..++ ......+.++..|..|+++++++|+.||+.+|++||+|.++.+.|...
T Consensus 519 ~~PYp~~~~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 519 GTPYPGIPPTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCCCCCCCcHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 99999977 4444 556778999999999999999999999999999999999999988764
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=337.90 Aligned_cols=257 Identities=33% Similarity=0.594 Sum_probs=214.5
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--Cc--eEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQ--EVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~ 188 (527)
+..++|++.+.||.|+||.||+|.+. +. .+|+|.+...........+.+|+.++..+ +||||+++++++..++.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 45678999999999999999999874 33 46888776544445567788999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCC
Q psy6905 189 CLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEP 251 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~ 251 (527)
|+||||+++|+|.+++.. ..+++..++.++.||+.||+|||++| ++||||||+|||++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCC
Confidence 999999999999998862 24678899999999999999999995 9999999999999875
Q ss_pred CcccccccceeEEeccCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy6905 252 IENEDLQFKTLKITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAV 329 (527)
Q Consensus 252 ~~~~~~~~~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~ 329 (527)
+.+||+|||++....... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 161 --------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 232 (303)
T cd05088 161 --------YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232 (303)
T ss_pred --------CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH
Confidence 689999999986432111 112234678999999988889999999999999999998 9999988776665
Q ss_pred HHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 330 ~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
...+. .....+.|..++..+.+|+.+||+.+|++||++.+++..|..+....
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 233 YEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHHh-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 54443 34455667778999999999999999999999999999988776544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=329.42 Aligned_cols=248 Identities=35% Similarity=0.622 Sum_probs=211.7
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
|+..+|.+.+.||+|+||.||+|.+.+ ..+|+|++...... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred CChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 355678999999999999999998754 47999988654321 346778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||++|++|.+++. ...+++..++.++.||+.||.|||+.| ++||||||+|||++.+ +.+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~--------~~~kl~dfg~~ 147 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGED--------NVVKVSDFGLA 147 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCC--------CcEEECCcccc
Confidence 9999999999986 346889999999999999999999995 9999999999999875 68999999999
Q ss_pred hhhhccccccC---CCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 271 REVYKTTHMSA---AGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 271 ~~~~~~~~~~~---~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
+.......... .++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .....+.|..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 226 (256)
T cd05059 148 RYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLA 226 (256)
T ss_pred eecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCC
Confidence 76543322222 24568999999998889999999999999999999 899998877666655554 45566777889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
|..+.+++.+||..+|++|||+.++++.|
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=331.63 Aligned_cols=253 Identities=31% Similarity=0.568 Sum_probs=212.3
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCc----eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQ----EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
...+|++.+.||.|+||.||+|.+ .+. .+++|.+...........+..|+..+..++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 456788999999999999999987 333 4788887655444455678888889999999999999998754 457
Q ss_pred EEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 189 CLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
++++||+.+|+|.+++. .+.+++..++.|+.||+.||.|||++| ++||||||+|||++.+ +.+||+|
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~--------~~~kl~D 152 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSD--------SIVQIAD 152 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCC--------CcEEEcC
Confidence 89999999999999986 456899999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 267 FGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 267 FGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
||+++...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+ ..+...+
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~ 231 (279)
T cd05111 153 FGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLA 231 (279)
T ss_pred CccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCC
Confidence 99997653221 112346788999999998889999999999999999998 99999887765544333 3455566
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.+..++..+..++.+||..||..|||+.++++.|..+..
T Consensus 232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 778899999999999999999999999999998877664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=329.31 Aligned_cols=255 Identities=35% Similarity=0.658 Sum_probs=217.5
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEcC-----ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK-----QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
++...+|.+.+.||.|+||.||+|.+.. ..||||...........+.+.+|+.+++.++||||+++++++.+. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~ 80 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P 80 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-C
Confidence 5677889999999999999999998632 368999887766555677889999999999999999999998764 5
Q ss_pred EEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.|+||||+++|+|.+++.. ..++...++.++.||+.||.|||+.| ++||||||+|||++.+ +.++|+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~--------~~~~l~ 149 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSP--------DCVKLG 149 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecC--------CCeEEc
Confidence 7899999999999999873 35889999999999999999999984 9999999999999875 689999
Q ss_pred ccCcchhhhccccc---cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 266 DFGLAREVYKTTHM---SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 266 DFGla~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
|||+++........ ...++..|+|||.+....++.++|||||||++|++++ |..||.+.+..+....+. .....+
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~ 228 (270)
T cd05056 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLP 228 (270)
T ss_pred cCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCC
Confidence 99998765332211 2234568999999988889999999999999999997 999999887766655554 344557
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.|..+|..+.++|.+||..+|.+|||+.++++.|+++..
T Consensus 229 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 788899999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=350.84 Aligned_cols=245 Identities=26% Similarity=0.376 Sum_probs=205.3
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||+|+||.||+|.+. ++.||||++.... .......+..|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999874 6789999986431 2234567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||+||+|.+++. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~--------~~vkL~DfG~~~ 149 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAK--------GHVKLSDFGLCT 149 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCC--------CCEEEeeccCCc
Confidence 9999999999886 567899999999999999999999995 9999999999999875 689999999986
Q ss_pred hhhccc-------------------------------------cccCCCccccccccccccCCCCcccchHHHHHHHHHH
Q psy6905 272 EVYKTT-------------------------------------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314 (527)
Q Consensus 272 ~~~~~~-------------------------------------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~el 314 (527)
...... ....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel 229 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence 442110 1134699999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCccHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q psy6905 315 LTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQLFKTLMEACWEADSHMRPS---FKTILK 373 (527)
Q Consensus 315 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~~~~li~~~l~~dp~~RPs---~~~ll~ 373 (527)
++|+.||.+.+.......+.........| ..+++++.+||.+|+ .||.+|++ +.++++
T Consensus 230 ~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 230 LIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 99999999888777766665433333333 347889999999976 49999985 556554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=354.64 Aligned_cols=246 Identities=31% Similarity=0.526 Sum_probs=215.5
Q ss_pred CceeeeeeeccCCceEEEEeeEcCc--eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYEKQ--EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+.|.|+..||.|+||.||+|..+.. ..|-|++.... +..++.++-|+.||..++||+||++++.|..++.++|+.||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 4466777899999999999998653 45778776554 34588999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|.||-++.++- ++.+++.++..+|+|++.||.|||++ +|||||||+.|||++-+ |.++|+|||.+..
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~Tld--------GdirLADFGVSAK 179 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLD--------GDIRLADFGVSAK 179 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEec--------CcEeeeccccccc
Confidence 99999987765 78899999999999999999999999 69999999999999976 7999999999865
Q ss_pred hhc--cccccCCCcccccccccc-----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCCCC
Q psy6905 273 VYK--TTHMSAAGTYAWMAPEVI-----KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPS 344 (527)
Q Consensus 273 ~~~--~~~~~~~gt~~y~aPE~l-----~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~ 344 (527)
... ....++.|||+|||||+. ...+|+.++||||||++|.||..+.+|....+...++..|..... .+-.|.
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS 259 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPS 259 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcc
Confidence 432 233478899999999986 456799999999999999999999999999999999888875433 445688
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.++..|.++++.||..||..||++.+|++|
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 899999999999999999999999999884
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=343.62 Aligned_cols=234 Identities=25% Similarity=0.444 Sum_probs=194.9
Q ss_pred eeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+. ++.||+|++.... .......+..|..++..+ +||||+++++++.+...+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999874 5789999987542 223356678899999888 799999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc-
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK- 275 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~- 275 (527)
|+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~--------~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAE--------GHIKLTDYGMCKEGIRP 149 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCC--------CCEEECcCccccccccC
Confidence 99988875 567999999999999999999999995 9999999999999875 6899999999875322
Q ss_pred -cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCccCCCCCCc
Q psy6905 276 -TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN--------AYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 276 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~--------~~~~~~~i~~~~~~~~~p~~~ 346 (527)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......... .....+|..+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~ 228 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-EKQIRIPRSL 228 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-cCCCCCCCCC
Confidence 22234579999999999999999999999999999999999999996321 1112222221 2334677889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSF 368 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~ 368 (527)
+..+.++|.+||..||.+||++
T Consensus 229 ~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 229 SVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CHHHHHHHHHHhccCHHHcCCC
Confidence 9999999999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=352.53 Aligned_cols=240 Identities=31% Similarity=0.523 Sum_probs=209.6
Q ss_pred eeeccCCceEEEEeeEcC--ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCH
Q psy6905 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL 200 (527)
-+||+|.||+||.|++.. ...|||.+....++ ..+-+..|+.+-+.|+|.|||+|+|.+.+++++-|.||-++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 379999999999999855 36799988665433 356788999999999999999999999999999999999999999
Q ss_pred HHHhc--CCCC--ChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc
Q psy6905 201 NRVLA--GRKI--RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT 276 (527)
Q Consensus 201 ~~~l~--~~~~--~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~ 276 (527)
..+|+ .+++ ++.++-.+..||++||.|||++ .|||||||-+|+||+.- .|.+||+|||-++.+...
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTy-------SGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTY-------SGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeec-------cceEEecccccchhhccC
Confidence 99998 5666 7888899999999999999999 59999999999999763 489999999999988553
Q ss_pred c--cccCCCccccccccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCccCCCCCCccHHHH
Q psy6905 277 T--HMSAAGTYAWMAPEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYKSINA-YAVAYGVAVNKLTLPIPSTCPQLFK 351 (527)
Q Consensus 277 ~--~~~~~gt~~y~aPE~l~~~~--~~~ksDvwSlGv~l~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~~~~~~ 351 (527)
. ..++.||..|||||++..+. |+.++|||||||++.||.||++||-.... .....++-.-+...++|..++.+.+
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak 809 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAK 809 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHH
Confidence 3 34678999999999997654 89999999999999999999999987644 4444566556778899999999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q psy6905 352 TLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.+|.+|+.+||..||++.+++.
T Consensus 810 ~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 810 NFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHcCCCcccCccHHHhcc
Confidence 9999999999999999999986
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=324.76 Aligned_cols=246 Identities=28% Similarity=0.342 Sum_probs=205.3
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh-hHHHHHHHHHHHHHhCCCCccceEEEEEEe--CCeEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE-NILENVKQEGKLLWLFDHRNIVSLIGVCLQ--SPKLCLV 191 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~iv 191 (527)
++|+.++.|++|.||.||+|.++ +..||+|.++...+. .+--...+|+.+|.+++|||||.+-.+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 57888999999999999999985 568999998876432 233445799999999999999999998765 3569999
Q ss_pred EeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 192 MEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
||||+ -+|..++. ..+|...++..+..|++.|++|||.+. |+||||||+|+|++.. |.+||+|||+
T Consensus 156 Me~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~--------G~lKiaDFGL 223 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHK--------GILKIADFGL 223 (419)
T ss_pred HHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccC--------CcEEecccch
Confidence 99995 46888887 568999999999999999999999995 9999999999999986 7999999999
Q ss_pred chhhhccc--cccCCCccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Q psy6905 270 AREVYKTT--HMSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN---------- 336 (527)
Q Consensus 270 a~~~~~~~--~~~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~---------- 336 (527)
|+.+.... ....+.|..|+|||.+.+.. |+...|+||+|||+.||+++++.|+|.+.......|...
T Consensus 224 AR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 224 AREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred hhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 99886542 23456899999999998765 999999999999999999999999998887776665421
Q ss_pred ---------CccC----------CCCCC-ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ---------KLTL----------PIPST-CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ---------~~~~----------~~p~~-~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+ .++.. +++.-.+|+..+|..||.+|.|+.+.+++
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0111 01111 55778999999999999999999999874
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=345.73 Aligned_cols=235 Identities=29% Similarity=0.430 Sum_probs=202.1
Q ss_pred eeeccCCceEEEEeeE-----cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccC
Q psy6905 123 EAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYAR 196 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ 196 (527)
+.||+|+||.||++.. .++.||+|++..... ......+..|+.+++.++||||+++++++.+.+.+|+|||||.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 357899999875321 1223456789999999999999999999999999999999999
Q ss_pred CCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 197 GGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 197 ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
+|+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~--------~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEE--------GHIKLTDFGLSKESID 150 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCC--------CcEEEeeccCCcccCC
Confidence 999999886 556899999999999999999999995 9999999999999875 6899999999876533
Q ss_pred c--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHH
Q psy6905 276 T--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTL 353 (527)
Q Consensus 276 ~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~l 353 (527)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ...|..+++.+.+|
T Consensus 151 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~l 228 (318)
T cd05582 151 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSL 228 (318)
T ss_pred CCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHH
Confidence 2 2234579999999999998889999999999999999999999999888777776665443 45677899999999
Q ss_pred HHHhhhhCCCCCCCHHH
Q psy6905 354 MEACWEADSHMRPSFKT 370 (527)
Q Consensus 354 i~~~l~~dp~~RPs~~~ 370 (527)
|++||+.||.+||++.+
T Consensus 229 i~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 229 LRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHhhcCHhHcCCCCC
Confidence 99999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=328.16 Aligned_cols=251 Identities=23% Similarity=0.427 Sum_probs=208.6
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC--CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||.|+||.||+|.+ +++.||||.+... ........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999987 4679999987542 23344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 193 EYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 193 Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
||+++|+|.+++. ...+++..+..++.||+.||.|||+++ ++|+||||+|||++.+ +.++|+||
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~--------~~~~l~d~ 150 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITAT--------GVVKLGDL 150 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCC--------CCEEECcc
Confidence 9999999998874 345788899999999999999999994 9999999999999875 68999999
Q ss_pred Ccchhhhcccc--ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCccCCCC
Q psy6905 268 GLAREVYKTTH--MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN--AYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 268 Gla~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~--~~~~~~~i~~~~~~~~~p 343 (527)
|++........ ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+.........+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT 230 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCCh
Confidence 99876533221 23468899999999988889999999999999999999999996543 233333333323222223
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
..++..+.++|.+||..+|++||++.++++.|+.+
T Consensus 231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 46788999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=343.02 Aligned_cols=234 Identities=29% Similarity=0.430 Sum_probs=196.8
Q ss_pred eeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHH-HHHhCCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGK-LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~-~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+ +++.||||++.... .......+..|.. +++.++||||+++++++.+.+.+|+|||||.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999998 46789999986532 1122334444544 56789999999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc-
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK- 275 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~- 275 (527)
|+|..++. ++.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~--------~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQ--------GHVVLTDFGLCKEGIEH 149 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCC--------CcEEEeccCCCcccccC
Confidence 99998886 567899999999999999999999995 9999999999999875 6899999999875422
Q ss_pred -cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 276 -TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 276 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.... ...+..++..+.++|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li 227 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--LRLKPNISVSARHLL 227 (323)
T ss_pred CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Confidence 22224569999999999999999999999999999999999999999888777766665433 345567899999999
Q ss_pred HHhhhhCCCCCCCHH
Q psy6905 355 EACWEADSHMRPSFK 369 (527)
Q Consensus 355 ~~~l~~dp~~RPs~~ 369 (527)
.+||..||.+||++.
T Consensus 228 ~~~l~~~p~~R~~~~ 242 (323)
T cd05575 228 EGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHhhcCHHhCCCCC
Confidence 999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=335.55 Aligned_cols=252 Identities=35% Similarity=0.592 Sum_probs=209.6
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEcC----------------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccce
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYEK----------------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~ 177 (527)
++.++|.+.+.||+|+||.||+|.+.+ ..||+|.+...........+.+|+++++.++|+||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 556789999999999999999987632 2489999887655555677899999999999999999
Q ss_pred EEEEEEeCCeEEEEEeccCCCCHHHHhcCC-------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q psy6905 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGR-------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSS 244 (527)
Q Consensus 178 ~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~~-------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~ 244 (527)
+++++......++|||||.+++|.+++... .++...++.++.|++.||.|||++| ++||||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChh
Confidence 999999999999999999999999988532 2577788999999999999999995 999999999
Q ss_pred ceecCCCCcccccccceeEEeccCcchhhhccccc----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh--CC
Q psy6905 245 NVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT--GE 318 (527)
Q Consensus 245 NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt--g~ 318 (527)
|||++.+ +.+||+|||++......... ...++..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 159 Nill~~~--------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~ 230 (295)
T cd05097 159 NCLVGNH--------YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE 230 (295)
T ss_pred hEEEcCC--------CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCC
Confidence 9999875 58999999999765332211 2235778999999998889999999999999999998 77
Q ss_pred CCCCCCCHHHHHHHHHh------CCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 319 IPYKSINAYAVAYGVAV------NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 319 ~Pf~~~~~~~~~~~i~~------~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
.||...+.......+.. .......+..+|+.+.+|+.+||..||++|||+.++++.|.
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 231 QPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 89988776555443321 11123345678899999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=327.69 Aligned_cols=247 Identities=29% Similarity=0.510 Sum_probs=213.4
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC----hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD----ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
+.|.+.+.||.|+||.||+|.. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.++..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999986 467899998765421 1224568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|+||+++++|.+++. .+.+++..+..++.|++.||.|||+.| ++||||+|+||+++.+ +.++|+|||+
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~--------~~~~l~dfg~ 150 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSA--------GNVKLGDFGA 150 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC--------CCEEEeeccc
Confidence 999999999999886 556889999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 270 AREVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 270 a~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
++....... ....|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+.........|.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPS 230 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCc
Confidence 875532111 234578899999999998899999999999999999999999988777666666665556667888
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.++..+.++|.+||..+|.+||++.+++++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 231 HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 899999999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=328.91 Aligned_cols=252 Identities=35% Similarity=0.604 Sum_probs=215.9
Q ss_pred eCCceeeeeeeccCCceEEEEeeEcC-----ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYEK-----QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+..+|++.+.||+|+||.||+|.+.. ..||||++...........+..|+.+++.++||||+++++++.++...+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 45678999999999999999998742 2599999877655556778999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+||||+.+|+|.+++. .+.++...++.++.|++.||.|||++| ++||||||+|||++.+ +.++|+||
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~--------~~~kl~df 150 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSN--------LVCKVSDF 150 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCC--------CcEEECCC
Confidence 9999999999999986 356889999999999999999999995 9999999999999865 68999999
Q ss_pred Ccchhhhcccc----ccCC---CccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 268 GLAREVYKTTH----MSAA---GTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 268 Gla~~~~~~~~----~~~~---gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
|++........ .... .+..|+|||.+.+..++.++|||||||++||+++ |..||...+.......+. ....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~ 229 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYR 229 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCc
Confidence 99876532211 1111 2457999999998889999999999999999887 999998887776666554 4456
Q ss_pred CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 340 ~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
.+.+..+|..+.+++.+||..+|.+||++.+++..|+.+
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 677788999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=356.20 Aligned_cols=245 Identities=22% Similarity=0.354 Sum_probs=197.1
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC------
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS------ 185 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------ 185 (527)
....+|.+++.||+|+||.||+|.+ .++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3456899999999999999999987 45789999875432 2234799999999999999999987432
Q ss_pred --CeEEEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccc
Q psy6905 186 --PKLCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258 (527)
Q Consensus 186 --~~~~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~ 258 (527)
..+++|||||.+ +|.+++. +..+++..+..++.||+.||.|||++| ||||||||+||||+.+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~------- 206 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPN------- 206 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCC-------
Confidence 247799999965 5665543 457899999999999999999999995 9999999999999864
Q ss_pred cceeEEeccCcchhhhcc-ccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6905 259 FKTLKITDFGLAREVYKT-THMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN 336 (527)
Q Consensus 259 ~~~vkL~DFGla~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~ 336 (527)
.+.+||+|||+++.+... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+.......+...
T Consensus 207 ~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 207 THTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred CCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 247999999999876432 22345789999999998764 6899999999999999999999999987665544433211
Q ss_pred ---------------------------CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ---------------------------KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ---------------------------~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+...+|..+|+++.+||.+||..||.+|||+.+++.+
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00111345678899999999999999999999999875
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=329.79 Aligned_cols=255 Identities=35% Similarity=0.602 Sum_probs=214.5
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--Cc----eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQ----EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
+...+|++.+.||.|+||.||+|.+. +. .||+|++...........+.+|+.+++.++||||+++++++... .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 34578899999999999999999863 33 48999987665555567888999999999999999999998754 5
Q ss_pred EEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.++++||+++|+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~--------~~~kL~ 151 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSP--------NHVKIT 151 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCC--------CcEEEC
Confidence 7899999999999999863 46899999999999999999999994 9999999999999865 579999
Q ss_pred ccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 266 DFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
|||+++....... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+. .+...
T Consensus 152 dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~ 230 (279)
T cd05109 152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERL 230 (279)
T ss_pred CCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcC
Confidence 9999986642221 12235678999999998889999999999999999998 999998776665554433 44555
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
+.+..++..+.+++..||..||+.||++.++++.|..+...
T Consensus 231 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 67788999999999999999999999999999988766543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=334.39 Aligned_cols=252 Identities=36% Similarity=0.633 Sum_probs=209.4
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc------------------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCcc
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE------------------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNI 175 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~------------------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnI 175 (527)
++.++|++.+.||+|+||.||++.+. ...||+|++...........+.+|+.+++.++|+||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 45678999999999999999998542 235899998866555556788999999999999999
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCCHHHHhcCC------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q psy6905 176 VSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKS 243 (527)
Q Consensus 176 v~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~~------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp 243 (527)
+++++++..++..|+||||+.+|+|.+++... .++...+..++.||+.||.|||+.| ++||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp 158 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLAT 158 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCh
Confidence 99999999999999999999999999988632 3556789999999999999999995 99999999
Q ss_pred CceecCCCCcccccccceeEEeccCcchhhhccccc----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh--C
Q psy6905 244 SNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT--G 317 (527)
Q Consensus 244 ~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt--g 317 (527)
+|||++.+ +.++|+|||+++........ ...+++.|+|||...+..++.++|||||||++|||++ |
T Consensus 159 ~Nili~~~--------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~ 230 (296)
T cd05095 159 RNCLVGKN--------YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK 230 (296)
T ss_pred heEEEcCC--------CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence 99999875 68999999999865432211 2234678999999888889999999999999999998 7
Q ss_pred CCCCCCCCHHHHHHHHHh------CCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 318 EIPYKSINAYAVAYGVAV------NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 318 ~~Pf~~~~~~~~~~~i~~------~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
..||...+..+....... .....+.|..++..+.+|+.+||..||.+||++.+|++.|+
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 899987766554433211 12234566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=327.95 Aligned_cols=251 Identities=34% Similarity=0.596 Sum_probs=214.6
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
|+++.++|++.+.||+|+||.||+|.+. +..||+|.+...... ...+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI 77 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence 6788889999999999999999999875 467999988764332 3568899999999999999999998854 56799
Q ss_pred EEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 191 VMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+|||+.+++|.+++.. ..+++..+..++.|++.||.|||++| ++||||||+||+++.+ +.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~--------~~~~l~df 146 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDG--------LVCKIADF 146 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCC--------ceEEeCCc
Confidence 9999999999999863 35888999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 268 GLAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 268 Gla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|++........ ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+. .....+.+
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 225 (260)
T cd05070 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCP 225 (260)
T ss_pred eeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 99976533221 12345678999999988889999999999999999999 999999887776665554 34566778
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
..++..+.+|+.+||..+|.+|||+.++.+.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 8899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=332.31 Aligned_cols=244 Identities=25% Similarity=0.451 Sum_probs=212.8
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+-|.++++||+|+||.||+|++ .|+.+|||.+.... .++++.+|+.+|.+++.|++|+|||.+.....++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 3467889999999999999998 46889999877653 378899999999999999999999999988899999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|..|++.++++ ++.+++.++..++...+.||+|||.. .-||||||+.|||++.+ |..||+|||.|..
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~--------G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTD--------GIAKLADFGVAGQ 178 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEccc--------chhhhhhccccch
Confidence 99999999987 77899999999999999999999988 57999999999999876 7999999999987
Q ss_pred hhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CccCCCCCCccHH
Q psy6905 273 VYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLPIPSTCPQL 349 (527)
Q Consensus 273 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~ 349 (527)
+.++. ..+..||+.|||||++..-.|+.++||||||++..||..|++||...-....+.-+-.+ ...+..|..++.+
T Consensus 179 LTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~ 258 (502)
T KOG0574|consen 179 LTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSE 258 (502)
T ss_pred hhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhH
Confidence 75432 34567999999999999999999999999999999999999999876554443333222 2234567788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
|.+++++||-.+|++|-|+.+|+++
T Consensus 259 F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 259 FNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 9999999999999999999999885
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=339.94 Aligned_cols=260 Identities=33% Similarity=0.620 Sum_probs=221.2
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcC---------ceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK---------QEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLI 179 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~---------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~ 179 (527)
..|++...+|++++.||+|+||.||+|.+.+ ..||+|++...........+.+|+.+++++ +||||++++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 4588899999999999999999999997521 268999888655455567889999999999 899999999
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q psy6905 180 GVCLQSPKLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLK 242 (527)
Q Consensus 180 ~~~~~~~~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlk 242 (527)
+++.....+|++|||+.+|+|.+++.. ..++...++.++.||+.||.|||++| ++|||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlk 161 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLA 161 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccc
Confidence 999999999999999999999998863 13566788899999999999999995 9999999
Q ss_pred CCceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-C
Q psy6905 243 SSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-G 317 (527)
Q Consensus 243 p~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g 317 (527)
|+|||++.+ +.+||+|||+++....... ....++..|+|||++.+..++.++|||||||++|||++ |
T Consensus 162 p~Nill~~~--------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 233 (334)
T cd05100 162 ARNVLVTED--------NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 233 (334)
T ss_pred cceEEEcCC--------CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcC
Confidence 999999875 6899999999976543221 11234578999999999899999999999999999998 8
Q ss_pred CCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 318 EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 318 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
..||.+.+.......+. .....+.|..++..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 234 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 234 GSPYPGIPVEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred CCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 99999887766655554 4455667788999999999999999999999999999999887743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=342.35 Aligned_cols=245 Identities=28% Similarity=0.418 Sum_probs=196.0
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC-----CeEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-----PKLC 189 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 189 (527)
+|++.+.||+|+||.||+|.+ ++..||||.+.... .......+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999987 46789999886432 222345678999999999999999999998643 3589
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+||||| +++|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~--------~~~kL~Dfg 148 (338)
T cd07859 81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANAD--------CKLKICDFG 148 (338)
T ss_pred EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCC--------CcEEEccCc
Confidence 999999 568888776 567999999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhccc-----cccCCCcccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------
Q psy6905 269 LAREVYKTT-----HMSAAGTYAWMAPEVIKT--SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV------ 335 (527)
Q Consensus 269 la~~~~~~~-----~~~~~gt~~y~aPE~l~~--~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~------ 335 (527)
+++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 997653211 123468999999999876 5789999999999999999999999987654332211100
Q ss_pred --------------------CCccCCCC---CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 --------------------NKLTLPIP---STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 --------------------~~~~~~~p---~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....+.+ ..+++.+.++|.+||..||++|||+.+++++
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000110 2467788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.37 Aligned_cols=248 Identities=32% Similarity=0.621 Sum_probs=209.3
Q ss_pred eeeeeeeccCCceEEEEeeEcC-----ceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe-----
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYEK-----QEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK----- 187 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~~-----~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~----- 187 (527)
|++++.||+|+||.||+|.+.. ..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998632 569999887643 23345678899999999999999999999876544
Q ss_pred -EEEEEeccCCCCHHHHhc-------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 188 -LCLVMEYARGGPLNRVLA-------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 188 -~~iv~Ey~~ggsL~~~l~-------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
.+++|||+.+|+|..++. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~-------- 149 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLRED-------- 149 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCC--------
Confidence 799999999999998874 135788899999999999999999994 9999999999999875
Q ss_pred ceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy6905 260 KTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVA 334 (527)
Q Consensus 260 ~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~ 334 (527)
+.+||+|||+++....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~ 229 (273)
T cd05035 150 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR 229 (273)
T ss_pred CeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 6899999999986643221 12235678999999988889999999999999999999 999999888777665554
Q ss_pred hCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 335 VNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 335 ~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
.+.....|..++..+.+++.+||..||.+||++.++++.|+++
T Consensus 230 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 -HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3445567888999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=343.24 Aligned_cols=237 Identities=29% Similarity=0.417 Sum_probs=197.1
Q ss_pred eeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHH-HHHHHhCCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQE-GKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e-~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+. ++.||+|++.... .......+..| ..+++.++||||+++++++...+.+|+|||||.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999874 4679999986532 11112333344 4456789999999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc-
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK- 275 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~- 275 (527)
|+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~--------~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQ--------GHIVLTDFGLCKENIEH 149 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCC--------CCEEEccCCCCcccccC
Confidence 99999887 566888999999999999999999995 9999999999999875 6899999999975422
Q ss_pred -cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 276 -TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 276 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... ....+..++..+.+++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li 227 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLL 227 (325)
T ss_pred CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CcCCCCCCCHHHHHHH
Confidence 2223456999999999999999999999999999999999999999988877766665533 2345567899999999
Q ss_pred HHhhhhCCCCCCCHHHHH
Q psy6905 355 EACWEADSHMRPSFKTIL 372 (527)
Q Consensus 355 ~~~l~~dp~~RPs~~~ll 372 (527)
.+||..||.+||++.+.+
T Consensus 228 ~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 228 EGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHcccCHHHCCCCCCCH
Confidence 999999999999977543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=334.23 Aligned_cols=246 Identities=23% Similarity=0.350 Sum_probs=204.0
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.|++.+.||+|+||.||++.+ +++.||+|++.... .......+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 377889999999999999987 46789999886532 12223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 194 YARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 194 y~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||.+|+|.+++. ...+++..+..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~--------~~~~l~Dfg~~ 149 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDY--------GHIRISDLGLA 149 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCC--------CCEEEeeCCCc
Confidence 999999988774 346899999999999999999999995 9999999999999875 68999999998
Q ss_pred hhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCccCCCCCCcc
Q psy6905 271 REVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV--NKLTLPIPSTCP 347 (527)
Q Consensus 271 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~ 347 (527)
....... .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.. .......+..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFS 229 (285)
T ss_pred eecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccC
Confidence 7653322 2345789999999999988899999999999999999999999987654332222211 122334566789
Q ss_pred HHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RP-----s~~~ll~~ 374 (527)
..+.+||.+||..||.+|| ++.+++++
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999999999 78888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.83 Aligned_cols=251 Identities=34% Similarity=0.594 Sum_probs=213.1
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
|+++.++|.+.+.||+|+||.||+|.+.+ ..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.. ...|+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYI 77 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEE
Confidence 67788899999999999999999998755 4799998765432 24567889999999999999999998854 56899
Q ss_pred EEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 191 VMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
||||+.+|+|.+++.. ..++...+..++.|++.||.|||+.| ++|+||+|+|||++.+ +.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~--------~~~~l~df 146 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDN--------LVCKIADF 146 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCC--------CeEEECCC
Confidence 9999999999999863 34788889999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 268 GLAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 268 Gla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|++........ ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+. .....+.+
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 225 (260)
T cd05069 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCP 225 (260)
T ss_pred ccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 99976533221 12346778999999988889999999999999999999 999999877766555544 44556677
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
...+..+.+++.+||..||.+||++.++++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 8899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=325.26 Aligned_cols=245 Identities=28% Similarity=0.473 Sum_probs=211.5
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
+|++.+.||.|+||.||++.+ .+..||+|.+.........+.+.+|+.+++.++|+||+++++++.+++.+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 478899999999999999987 457899998865444445677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 196 RGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 196 ~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
++|+|.+++. ...+++..++.++.||+.||.|||++| ++|+||||+|||++.+ +.++|+|||++..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~--------~~~~l~dfg~~~~ 149 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQN--------GKVKLGDFGSARL 149 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCC--------CcEEEcccCccee
Confidence 9999988875 345789999999999999999999995 9999999999999875 6899999999876
Q ss_pred hhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHH
Q psy6905 273 VYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLF 350 (527)
Q Consensus 273 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 350 (527)
..... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.. +...+.|..++..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 228 (255)
T cd08219 150 LTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ-GSYKPLPSHYSYEL 228 (255)
T ss_pred ecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc-CCCCCCCcccCHHH
Confidence 54322 2235689999999999988899999999999999999999999998776666555543 33445777889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.++|.+||+.||.+||++.+++..
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=327.26 Aligned_cols=246 Identities=29% Similarity=0.379 Sum_probs=203.3
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCC-CCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe-----CCeE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHP-NPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ-----SPKL 188 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~-~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-----~~~~ 188 (527)
..|...+.||.|+||.|..+.+ +|..||||.+.. ....-..+...+|+.+|+.++|+||+.+++++.. -+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 3455578999999999999987 467899997763 3444557888999999999999999999999865 3568
Q ss_pred EEEEeccCCCCHHHHhcCCC-CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~~~-~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+|+|+| +.+|..+++.+. ++...+..++.||+.||+|+|+. +|+||||||.|+|++.+ ..+||+||
T Consensus 102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~--------c~lKI~DF 169 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNAD--------CDLKICDF 169 (359)
T ss_pred EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccC--------CCEEeccc
Confidence 9999999 788999999666 99999999999999999999998 59999999999999987 57899999
Q ss_pred Ccchhhhc---ccc-ccCCCccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------
Q psy6905 268 GLAREVYK---TTH-MSAAGTYAWMAPEVIK-TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV------- 335 (527)
Q Consensus 268 Gla~~~~~---~~~-~~~~gt~~y~aPE~l~-~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~------- 335 (527)
|+|+.... ... ...+.|..|.|||++. ...|+...||||+||++.||++|++.|+|.+.......+..
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 99998853 222 3456799999999975 45699999999999999999999999999775443333211
Q ss_pred -----------------CCccCCCC-----CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 -----------------NKLTLPIP-----STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 -----------------~~~~~~~p-----~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....+.| ..+++...+|+.+||..||.+|+|+++.+.+
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111111 3567889999999999999999999999986
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=332.36 Aligned_cols=251 Identities=35% Similarity=0.625 Sum_probs=214.0
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
++.++|++.+.||.|+||.||+|.+. +..||+|++...........+.+|+.+++.++||||+++++++.++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 46678999999999999999999863 46799999877655555677889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcC-----------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q psy6905 187 KLCLVMEYARGGPLNRVLAG-----------------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKS 243 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~-----------------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp 243 (527)
..|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||+++ ++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccH
Confidence 99999999999999999852 13567788999999999999999995 99999999
Q ss_pred CceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CC
Q psy6905 244 SNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GE 318 (527)
Q Consensus 244 ~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~ 318 (527)
+|||++.+ +.++|+|||++........ ....+++.|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 159 ~nil~~~~--------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~ 230 (288)
T cd05050 159 RNCLVGEN--------MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM 230 (288)
T ss_pred hheEecCC--------CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCC
Confidence 99999875 6899999999876533221 12235678999999998889999999999999999998 88
Q ss_pred CCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 319 IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 319 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
.||.+.+..+....+.. ....+.|..++..+.+|+.+||+.||.+|||+.++++.|+
T Consensus 231 ~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 231 QPYYGMAHEEVIYYVRD-GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 99988877776655543 3344567788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=333.31 Aligned_cols=252 Identities=37% Similarity=0.640 Sum_probs=212.5
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEcC------------------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCcc
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYEK------------------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNI 175 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~~------------------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnI 175 (527)
+...+|.+.+.||+|+||.||+|.+.+ ..||+|.+...........+.+|+.+++.++||||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 345789999999999999999987632 35899998876555567788999999999999999
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCCHHHHhcCC------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q psy6905 176 VSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKS 243 (527)
Q Consensus 176 v~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~~------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp 243 (527)
+++++++..++..+++|||+.+++|.+++... .+++..++.++.|++.||.|||++| ++||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccch
Confidence 99999999999999999999999999998632 5888999999999999999999995 99999999
Q ss_pred CceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh--C
Q psy6905 244 SNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT--G 317 (527)
Q Consensus 244 ~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt--g 317 (527)
+|||++.+ +.++|+|||+++....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |
T Consensus 159 ~Nili~~~--------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 230 (296)
T cd05051 159 RNCLVGKN--------YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230 (296)
T ss_pred hceeecCC--------CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCC
Confidence 99999875 6899999999976533221 23346788999999988889999999999999999998 7
Q ss_pred CCCCCCCCHHHHHHHHHhC------CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 318 EIPYKSINAYAVAYGVAVN------KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 318 ~~Pf~~~~~~~~~~~i~~~------~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
..||...+.......+... ....+.+..+|.++.+++.+||+.||.+|||+.+|++.|+
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 231 EQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 8899887766554444321 1223455678899999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=329.85 Aligned_cols=244 Identities=26% Similarity=0.479 Sum_probs=203.1
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|++.+.||+|+||.||+|.+ +++.||+|++...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999987 46789999887654444566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 195 ~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
+++|+|..+ ..+++..+..++.|++.||.|||+.| |+|+||||+|||++.+ +.++|+|||++....
T Consensus 81 ~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~--------~~~~l~dfg~~~~~~ 146 (279)
T cd06619 81 MDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTR--------GQVKLCDFGVSTQLV 146 (279)
T ss_pred CCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCC--------CCEEEeeCCcceecc
Confidence 999999765 35788889999999999999999995 9999999999999875 689999999998765
Q ss_pred ccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCccCCCCCCcc
Q psy6905 275 KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY-------AVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 275 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~ 347 (527)
........||..|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.............+
T Consensus 147 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (279)
T cd06619 147 NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226 (279)
T ss_pred cccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCC
Confidence 44444567999999999999988999999999999999999999999753221 11222211111111224578
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++.++|.+||..+|.+||++.+++++
T Consensus 227 ~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 227 EKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=327.08 Aligned_cols=247 Identities=32% Similarity=0.629 Sum_probs=205.4
Q ss_pred eeeeeeccCCceEEEEeeEcC--c--eEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC------CeE
Q psy6905 120 IFGEAIGEGGFGKVYKGIYEK--Q--EVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS------PKL 188 (527)
Q Consensus 120 ~~~~~iG~G~fg~Vy~~~~~~--~--~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~~~ 188 (527)
.+++.||+|+||.||+|.+.. . .||+|.+.... .......+..|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467899999999999998743 2 58999887642 334467788999999999999999999987532 246
Q ss_pred EEEEeccCCCCHHHHhc-------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 189 CLVMEYARGGPLNRVLA-------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
+++|||+.+|+|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~--------~~ 150 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNEN--------MN 150 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCC--------CC
Confidence 89999999999988763 234788899999999999999999984 9999999999999875 68
Q ss_pred eEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Q psy6905 262 LKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVN 336 (527)
Q Consensus 262 vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~ 336 (527)
+||+|||+++....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+. .
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~ 229 (272)
T cd05075 151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-Q 229 (272)
T ss_pred EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-c
Confidence 99999999987643221 12246778999999999889999999999999999999 899999877766555554 3
Q ss_pred CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 337 KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 337 ~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
+...+.+..++..+.++|.+||..||++|||+.+|++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 344456778999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.40 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=206.1
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|++.+.||+|+||.||++.+. +..||+|.+...........+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999874 5679999887654455567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
++||+|.+++. .+.+++..+..++.||+.||.|||+.. +++||||||+|||++.+ +.++|+|||++...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~--------~~~~l~dfg~~~~~ 150 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSR--------GEIKLCDFGVSGQL 150 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecC--------CcEEEccCCCcccc
Confidence 99999999986 567899999999999999999999842 59999999999999875 68999999998766
Q ss_pred hccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------
Q psy6905 274 YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN----------------- 336 (527)
Q Consensus 274 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~----------------- 336 (527)
.........|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+...........
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 151 IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred cccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 444344567899999999998888999999999999999999999999765433322111100
Q ss_pred ------------------CccCCCC-CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ------------------KLTLPIP-STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ------------------~~~~~~p-~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
......| ..++.++.++|.+||..+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111 2367889999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=324.56 Aligned_cols=241 Identities=39% Similarity=0.738 Sum_probs=213.2
Q ss_pred eeeccCCceEEEEeeEc-----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+. +..|++|++...........+.+|+.++..++|+||+++++++..+..+++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999875 6689999998765544567889999999999999999999999999999999999999
Q ss_pred CCHHHHhcC----------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 198 GPLNRVLAG----------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 198 gsL~~~l~~----------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+|.+++.. ..+++..+..++.|++.||+|||++| ++||||+|+||+++.+ +.++|+||
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~--------~~~~l~df 149 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGED--------LVVKISDF 149 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCC--------CcEEEccc
Confidence 999999874 56899999999999999999999994 9999999999999986 68999999
Q ss_pred Ccchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 268 GLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 268 Gla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
|.+....... .....+++.|+|||.+....++.++|||||||++|+|++ |..||...+.......+.. +...+.
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 228 (262)
T cd00192 150 GLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPK 228 (262)
T ss_pred ccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCC
Confidence 9998775432 223457899999999988889999999999999999999 6999999877776666653 556678
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
|..+|..+.+++.+||..+|.+|||+.+++++|
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 229 PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 888999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=333.22 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=196.4
Q ss_pred CceeeeeeeccCCceEEEEeeEc---CceEEEEEcCCCCC-hhHHHHHHHHHHHHHhC---CCCccceEEEEEEe-----
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE---KQEVAIKVAHPNPD-ENILENVKQEGKLLWLF---DHRNIVSLIGVCLQ----- 184 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~---~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l---~hpnIv~~~~~~~~----- 184 (527)
.+|.+.+.||+|+||.||+|.+. +..||+|.+..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999872 46799998765432 22233455677766655 79999999999852
Q ss_pred CCeEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
...+++||||+. ++|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~--------~~ 148 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS--------GQ 148 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCC--------CC
Confidence 456899999995 68888875 345889999999999999999999995 9999999999999875 68
Q ss_pred eEEeccCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 262 LKITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 262 vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.......+.... ..
T Consensus 149 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~-~~ 227 (290)
T cd07862 149 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-GL 227 (290)
T ss_pred EEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CC
Confidence 9999999997653322 224568999999999998889999999999999999999999999887666555443210 00
Q ss_pred C--------------------------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 P--------------------------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 ~--------------------------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+ ....+++.+.+|+.+||+.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 113467788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=339.21 Aligned_cols=238 Identities=27% Similarity=0.436 Sum_probs=203.0
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv~ 192 (527)
+|.+.+.||+|+||.||+|.+. ++.||+|++.... .....+.+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999874 6789999887532 2223456778888888875 577889999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||+||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~--------~~ikL~Dfg~~~ 149 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSE--------GHIKIADFGMCK 149 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCC--------CCEEEecccccc
Confidence 9999999999887 467999999999999999999999995 9999999999999875 689999999987
Q ss_pred hhhcc--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 272 EVYKT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 272 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ...|..++..
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~ 227 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKE 227 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHH
Confidence 54222 2234569999999999999889999999999999999999999999988877777666443 3567788999
Q ss_pred HHHHHHHhhhhCCCCCCCH
Q psy6905 350 FKTLMEACWEADSHMRPSF 368 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~ 368 (527)
+.+++.+||..+|.+|++.
T Consensus 228 ~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 228 AVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHHHcccCHhhCCCC
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=340.27 Aligned_cols=234 Identities=26% Similarity=0.446 Sum_probs=194.1
Q ss_pred eeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+. ++.||+|++.... .......+..|+.++..+ +||||+++++++...+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999874 5689999987642 223355677888888776 899999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc-
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK- 275 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~- 275 (527)
|+|..++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~--------~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSE--------GHIKLTDYGMCKEGLRP 149 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCC--------CCEEEeeCCccccccCC
Confidence 99988876 567999999999999999999999995 9999999999999875 6899999999875422
Q ss_pred -cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCccCCCCCCc
Q psy6905 276 -TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN--------AYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 276 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~--------~~~~~~~i~~~~~~~~~p~~~ 346 (527)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ......... ......+|..+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-~~~~~~~p~~~ 228 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIRIPRSL 228 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-hcCCCCCCCCC
Confidence 12234579999999999999999999999999999999999999995311 111222222 12344677889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSF 368 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~ 368 (527)
+..+.++|.+||..||.+||++
T Consensus 229 ~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 229 SVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CHHHHHHHHHHhcCCHHHcCCC
Confidence 9999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=326.03 Aligned_cols=253 Identities=33% Similarity=0.609 Sum_probs=215.8
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--C---ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--K---QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
|..++|+..+.||+|+||.||+|... + ..+|+|.+...........+.+|+.+++.++||||+++++++...+..
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 45567888999999999999999873 2 269999987765455567788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 189 CLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
|+||||+.+++|.+++. .+.+++..+..++.|++.||.|||+.| ++||||||+|||++.+ +.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~--------~~~kl~d 150 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSN--------LECKVSD 150 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCC--------CcEEECC
Confidence 99999999999999986 356899999999999999999999994 9999999999999875 6899999
Q ss_pred cCcchhhhccccc-----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 267 FGLAREVYKTTHM-----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 267 FGla~~~~~~~~~-----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
||++......... ....++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+. .....
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~ 229 (268)
T cd05063 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRL 229 (268)
T ss_pred CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCC
Confidence 9998765332211 1123467999999998889999999999999999998 999998877766665554 34455
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
+.+..++..+.+++.+||..+|.+||++.++++.|+++
T Consensus 230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 66778899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=323.62 Aligned_cols=243 Identities=37% Similarity=0.620 Sum_probs=206.8
Q ss_pred eeeccCCceEEEEeeEcC-----ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYEK-----QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+.. ..||+|.+...........+.+|+.+++.++||||+++++++. .+..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998632 5799999887654445677889999999999999999999876 4468999999999
Q ss_pred CCHHHHhcC-CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc
Q psy6905 198 GPLNRVLAG-RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT 276 (527)
Q Consensus 198 gsL~~~l~~-~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~ 276 (527)
|+|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.+ +.+||+|||+++.....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~--------~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNR--------HQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCC--------CcEEeccccccceeecC
Confidence 999999974 45899999999999999999999995 9999999999999875 68999999999866332
Q ss_pred ccc-----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHH
Q psy6905 277 THM-----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLF 350 (527)
Q Consensus 277 ~~~-----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 350 (527)
... ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .....+.|..++..+
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 227 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEI 227 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHH
Confidence 211 1123568999999998889999999999999999998 999998887766655554 344567788899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
.++|.+||..+|.+||++.++++.|+++
T Consensus 228 ~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 228 YSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=330.47 Aligned_cols=255 Identities=33% Similarity=0.591 Sum_probs=215.9
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
+...+|.+.+.||.|+||.||+|.+. +..+++|.+..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 45678999999999999999999752 24588998765432 23467889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecC
Q psy6905 187 KLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLS 249 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~ 249 (527)
..++||||+++++|.+++.. ..+++..++.++.||+.||.|||++| ++||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence 99999999999999999853 23788899999999999999999995 99999999999998
Q ss_pred CCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q psy6905 250 EPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSI 324 (527)
Q Consensus 250 ~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~ 324 (527)
.+ +.++|+|||++........ ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 158 ~~--------~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 158 AN--------LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred cC--------CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 75 6899999999976543221 22346788999999999899999999999999999999 99999888
Q ss_pred CHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 325 NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 325 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
+.......+. .+.....+..+|..+.+++.+||..+|.+||++.++++.|+++...
T Consensus 230 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 230 SNTEVIECIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CHHHHHHHHh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 7766655544 3444456677899999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=332.37 Aligned_cols=236 Identities=27% Similarity=0.379 Sum_probs=195.5
Q ss_pred eccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCH
Q psy6905 125 IGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200 (527)
Q Consensus 125 iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL 200 (527)
||+|+||+||++.+ +++.||+|.+.... .....+.+..|+.+++.++|+||+++++++.....+|+|||||+||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999987 46789999886532 122345677899999999999999999999999999999999999999
Q ss_pred HHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 201 NRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 201 ~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
..++. +..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.++|+|||++.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~--------~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDND--------GNVRISDLGLAVELKD 149 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC--------CCEEEeeCccceecCC
Confidence 87763 346899999999999999999999995 9999999999999875 6899999999976533
Q ss_pred cc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCccCCCCCCccHH
Q psy6905 276 TT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY----AVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 276 ~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+. ......|..++..
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 227 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL--NDSVTYPDKFSPA 227 (280)
T ss_pred CCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc--ccCCCCcccCCHH
Confidence 22 22346899999999999999999999999999999999999999865432 1222221 2233556778999
Q ss_pred HHHHHHHhhhhCCCCCC-----CHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRP-----SFKTILK 373 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RP-----s~~~ll~ 373 (527)
+.+++.+||+.||++|| ++.++++
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 99999999999999999 5666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=323.65 Aligned_cols=251 Identities=32% Similarity=0.599 Sum_probs=214.8
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
|++..++|.+.+.||+|+||.||++.+. +..+|+|.+.... .....+.+|+.+++.++|+||+++++++.+ ...|+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 7889999999999999999999999864 4579999887542 235678899999999999999999999887 67899
Q ss_pred EEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 191 VMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+|||+++|+|.+++.. ..++...+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~--------~~~~l~d~ 146 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSAS--------LVCKIADF 146 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCC--------CcEEECCC
Confidence 9999999999999863 34677888999999999999999985 9999999999999875 68999999
Q ss_pred Ccchhhhccccc---cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 268 GLAREVYKTTHM---SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 268 Gla~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|++......... ...++..|+|||.+....++.++|+|||||++|++++ |..||.+.+.......+. .....+.+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 225 (260)
T cd05073 147 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRP 225 (260)
T ss_pred cceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCc
Confidence 998765332211 2235678999999998889999999999999999999 999999887766555443 45566677
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
...+..+.+++.+||..+|.+||++.++.+.|++
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 8889999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=329.27 Aligned_cols=250 Identities=34% Similarity=0.622 Sum_probs=212.1
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE-------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
|+..+|.+.+.||+|+||.||++.. .+..+|+|.+.... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 5677899999999999999999864 23478999876543 344678899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCC
Q psy6905 187 KLCLVMEYARGGPLNRVLAG----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSE 250 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~ 250 (527)
..+++|||+.+|+|.+++.. ..+++..++.++.||+.||+|||+.| ++||||||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcC
Confidence 99999999999999998863 24788899999999999999999995 999999999999987
Q ss_pred CCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q psy6905 251 PIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSIN 325 (527)
Q Consensus 251 ~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~ 325 (527)
+ +.+||+|||++........ ....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||....
T Consensus 158 ~--------~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 158 G--------LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred C--------CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 5 6899999999875532221 12335788999999998899999999999999999998 999998877
Q ss_pred HHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 326 AYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 326 ~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
.......+.. ......|..+|+.+.+++.+||..||.+||++.+|++.|.
T Consensus 230 ~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 230 NTEAIECITQ-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHHHc-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 7666655543 3445667889999999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.97 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=208.1
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe--CC
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--SP 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~ 186 (527)
.+....+|.+++.||.|+||.||+|.+. +..||+|++.... .......+..|+.+++.|+|||||+++++|.+ ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 4456678999999999999999999974 4679999886542 33446778899999999999999999999865 45
Q ss_pred eEEEEEeccCCCCHHHHhcC-----CCCChhHHHHHHHHHHHHHHHHHhcCC----CceeecCCCCCceecCCCCcc---
Q psy6905 187 KLCLVMEYARGGPLNRVLAG-----RKIRPDVLVDWAIQIAEGMNYLHCQAP----ISLIHRDLKSSNVLLSEPIEN--- 254 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~-----~~~~~~~~~~i~~qi~~~L~yLH~~g~----~~iiHrDlkp~NILl~~~~~~--- 254 (527)
.+|||||||.+|+|.++|.. ..+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.....
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 68999999999999998862 568999999999999999999998531 149999999999999753110
Q ss_pred ------cccccceeEEeccCcchhhhccc-cccCCCcccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q psy6905 255 ------EDLQFKTLKITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKT--SIFSKASDVWSYGVVLWELLTGEIPYKSIN 325 (527)
Q Consensus 255 ------~~~~~~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~--~~~~~ksDvwSlGv~l~elltg~~Pf~~~~ 325 (527)
.......+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||+||+|++|..||...+
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 00012458999999998663322 224579999999999864 458899999999999999999999998766
Q ss_pred HHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 326 AYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 326 ~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
..............++. ..++.++.+||..||..+|.+||++.+++.
T Consensus 248 ~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 55544444333333222 357899999999999999999999999985
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=328.43 Aligned_cols=249 Identities=25% Similarity=0.447 Sum_probs=205.5
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
...+|++.+.||+|+||.||+|.+ +++.||+|++...... ....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 456799999999999999999987 4578999988754322 2456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||+.+|+|.+++. ...+++..+..++.|++.||.|||+.| |+||||+|+||+++.+ +.++|+|||++.
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~--------~~~~l~dfg~~~ 154 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDN--------GDVKLADFGVAA 154 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCC--------CCEEECcCccce
Confidence 9999999999886 567899999999999999999999994 9999999999999875 689999999998
Q ss_pred hhhccc--cccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC---C
Q psy6905 272 EVYKTT--HMSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI---P 343 (527)
Q Consensus 272 ~~~~~~--~~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~---p 343 (527)
...... .....|++.|+|||.+. ...++.++|||||||++|+|++|..||...+.......+.......+. +
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06646 155 KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234 (267)
T ss_pred eecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccc
Confidence 653221 22346889999999984 345788999999999999999999999766544333333222222222 2
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
..++..+.++|.+||..+|++||++.+++++|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 35688999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=331.32 Aligned_cols=248 Identities=26% Similarity=0.465 Sum_probs=208.7
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|++.+.||+|+||.||++.+. +..||+|.+...........+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999985 6789999887654444567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC----CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 195 ARGGPLNRVLAGR----KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 195 ~~ggsL~~~l~~~----~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|++++|..++... .+++..+..++.||+.||.|||+.. +|+||||||+|||++.+ +.++|+|||++
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~--------~~~~l~dfg~~ 150 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGN--------GQVKLCDFGVS 150 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCC--------CCEEEeecCCc
Confidence 9999999988753 7899999999999999999999742 49999999999999875 68999999999
Q ss_pred hhhhccccccCCCccccccccccccC------CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCccCCC
Q psy6905 271 REVYKTTHMSAAGTYAWMAPEVIKTS------IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA--VNKLTLPI 342 (527)
Q Consensus 271 ~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~--~~~~~~~~ 342 (527)
............+++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+. ........
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd06622 151 GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230 (286)
T ss_pred ccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC
Confidence 76644444445688999999998554 35789999999999999999999997655443332221 12333456
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
|..++.++.++|.+||..+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 77799999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=325.28 Aligned_cols=245 Identities=34% Similarity=0.600 Sum_probs=205.7
Q ss_pred eeeccCCceEEEEeeEcC--c--eEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYEK--Q--EVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~--~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+.+ . .+++|.............+.+|+.++..+ +||||+++++++......|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999998743 2 47889887654445567788999999999 899999999999999999999999999
Q ss_pred CCHHHHhcCC-----------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccc
Q psy6905 198 GPLNRVLAGR-----------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260 (527)
Q Consensus 198 gsL~~~l~~~-----------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~ 260 (527)
|+|.+++... .++...++.++.|++.||+|||++| ++||||||+|||++.+ +
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~--------~ 149 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN--------Y 149 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCC--------C
Confidence 9999998632 3678889999999999999999985 9999999999999875 6
Q ss_pred eeEEeccCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCc
Q psy6905 261 TLKITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 261 ~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
.+||+|||++....... ......+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+. ...
T Consensus 150 ~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~ 228 (270)
T cd05047 150 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 228 (270)
T ss_pred eEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCC
Confidence 89999999986432111 112234677999999988889999999999999999997 999998877666555443 345
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~ 379 (527)
..+.+..++.++.+++.+||..||.+|||+.+++..|..++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 55677788999999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=327.30 Aligned_cols=252 Identities=31% Similarity=0.621 Sum_probs=217.1
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
++.++|.+...||.|+||.||+|... ...|++|.............+.+|+.+++.++|+||+++++++.+..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 45678999999999999999999863 24699998876655546778999999999999999999999999988
Q ss_pred eEEEEEeccCCCCHHHHhcC-C---------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccc
Q psy6905 187 KLCLVMEYARGGPLNRVLAG-R---------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENED 256 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~-~---------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~ 256 (527)
..|+||||+++|+|.+++.. . .+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~----- 153 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQ----- 153 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCC-----
Confidence 99999999999999999862 2 4889999999999999999999995 9999999999999875
Q ss_pred cccceeEEeccCcchhhhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6905 257 LQFKTLKITDFGLAREVYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYG 332 (527)
Q Consensus 257 ~~~~~vkL~DFGla~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~ 332 (527)
+.++|+|||++....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 154 ---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~ 230 (275)
T cd05046 154 ---REVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR 230 (275)
T ss_pred ---CcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH
Confidence 689999999986543221 123346788999999988888999999999999999999 8999988777777666
Q ss_pred HHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 333 VAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 333 i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
+.......+.+..+|..+.+++.+||..+|.+||++.++++.|.
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 66556566677889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=325.30 Aligned_cols=255 Identities=34% Similarity=0.627 Sum_probs=218.0
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--C----ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--K----QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
+...+|++.+.||+|+||.||+|.+. + ..||+|.............+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 45678999999999999999999863 2 25899988776555556788899999999999999999999987 68
Q ss_pred EEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.++||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++| ++||||||+|||++.+ +.+||+
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~--------~~~kL~ 151 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTP--------QHVKIT 151 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCC--------CeEEEC
Confidence 8999999999999999873 46889999999999999999999984 9999999999999875 689999
Q ss_pred ccCcchhhhccccc----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 266 DFGLAREVYKTTHM----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
|||+++........ ...++..|+|||.+....++.++|||||||++||+++ |+.||.+....+....+. .+...
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~ 230 (279)
T cd05057 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERL 230 (279)
T ss_pred CCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCC
Confidence 99999866422111 1224678999999988889999999999999999998 999999887776665554 44556
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
+.|..++..+.+++.+||..||..||++.++++.|..+...
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 77888999999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.11 Aligned_cols=247 Identities=23% Similarity=0.355 Sum_probs=203.7
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCC--CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||+|+||.||++.+. ++.||+|++... ........+.+|..++..++|+||+++++++.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999874 578999998642 12223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||.||+|.+++. ...+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~--------~~~kl~Dfg~~ 149 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKN--------GHIRLADFGSC 149 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCC--------CCEEEEECCce
Confidence 9999999999986 457899999999999999999999995 9999999999999875 68999999998
Q ss_pred hhhhcccc---ccCCCcccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 271 REVYKTTH---MSAAGTYAWMAPEVIKT-----SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 271 ~~~~~~~~---~~~~gt~~y~aPE~l~~-----~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
........ ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+....+.........
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF 229 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence 76533222 12468999999999863 45788999999999999999999999988776666666543333333
Q ss_pred C---CCccHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q psy6905 343 P---STCPQLFKTLMEACWEADSHM--RPSFKTILKA 374 (527)
Q Consensus 343 p---~~~~~~~~~li~~~l~~dp~~--RPs~~~ll~~ 374 (527)
| ..+++.++++|++|+..++.. ||++.+++++
T Consensus 230 ~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 3 347899999999988654443 7888888874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=323.35 Aligned_cols=248 Identities=37% Similarity=0.637 Sum_probs=211.8
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
|-++..+|++.+.||+|+||.||++...++.||+|...... ....+.+|+.+++.++||||+++++++..+ ..|+|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 34566789999999999999999999888999999886542 245678999999999999999999998765 47999
Q ss_pred EeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 192 MEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|||+.+|+|.+++.. ..++...++.++.|++.||.|||+.| ++||||||+|||++.+ +.+||+|||
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~--------~~~kl~Dfg 145 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSED--------GVAKVSDFG 145 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCC--------CcEEECCCc
Confidence 999999999999863 34788899999999999999999985 9999999999999875 689999999
Q ss_pred cchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCcc
Q psy6905 269 LAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 269 la~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 347 (527)
++...... ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.......+. .+...+.+..+|
T Consensus 146 ~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 223 (254)
T cd05083 146 LARVGSMG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCP 223 (254)
T ss_pred cceecccc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCC
Confidence 98754322 122344678999999998889999999999999999998 999999887766655544 345556677889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
..+.+++.+||+.+|..||++.+++..|+
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 99999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=319.50 Aligned_cols=242 Identities=35% Similarity=0.657 Sum_probs=207.0
Q ss_pred eeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCHH
Q psy6905 123 EAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLN 201 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~ 201 (527)
+.||+|+||.||+|... +..||+|++...........+.+|+.+++.++||||+++++++......++||||+.+|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999864 56899999887655555567889999999999999999999999999999999999999999
Q ss_pred HHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccccc
Q psy6905 202 RVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM 279 (527)
Q Consensus 202 ~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~ 279 (527)
+++. ...+++..+..++.|++.||.|||++| ++||||+|+||+++.+ +.+||+|||++.........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~--------~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGEN--------NVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCC--------CeEEECCCccceeccccccc
Confidence 9886 345788999999999999999999995 9999999999999875 68999999998754322111
Q ss_pred ---cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHH
Q psy6905 280 ---SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLME 355 (527)
Q Consensus 280 ---~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~ 355 (527)
...+++.|+|||++.+..++.++||||||+++|++++ |..||...........+. .......+..++..+.+++.
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 228 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQ 228 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHH
Confidence 1234678999999998889999999999999999998 999999887766655554 44555667789999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHh
Q psy6905 356 ACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 356 ~~l~~dp~~RPs~~~ll~~L~ 376 (527)
+||..+|++||++.++++.|.
T Consensus 229 ~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 229 RCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHcccCcccCCCHHHHHHHhc
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=338.48 Aligned_cols=234 Identities=29% Similarity=0.412 Sum_probs=196.2
Q ss_pred eeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHH-HHHHhCCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEG-KLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~-~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+ .++.||+|++.... .......+..|. .+++.++||||+++++++.+.+.+|+|||||+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999997 45789999986532 112233444554 467889999999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc-
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK- 275 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~- 275 (527)
|+|...+. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~--------~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQ--------GHVVLTDFGLCKEGVEP 149 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCC--------CCEEEccCCCCccCCCC
Confidence 99988776 567889999999999999999999995 9999999999999875 6899999999875322
Q ss_pred -cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 276 -TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 276 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ....|...+..+.+++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li 227 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAACDLL 227 (321)
T ss_pred CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHH
Confidence 1222456899999999999988999999999999999999999999988776666666533 3456778899999999
Q ss_pred HHhhhhCCCCCCCHH
Q psy6905 355 EACWEADSHMRPSFK 369 (527)
Q Consensus 355 ~~~l~~dp~~RPs~~ 369 (527)
.+||+.||.+||++.
T Consensus 228 ~~~l~~~p~~R~~~~ 242 (321)
T cd05603 228 VGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHccCCHhhcCCCC
Confidence 999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=339.56 Aligned_cols=236 Identities=28% Similarity=0.404 Sum_probs=197.6
Q ss_pred eeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHH-HHHhCCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGK-LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~-~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+ +++.||+|++.... .......+..|.. +++.++||||+++++++..++.+|+|||||.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999987 46789999986532 1222344455544 56779999999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc-
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK- 275 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~- 275 (527)
|+|..++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~--------~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQ--------GHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCC--------CCEEEeecCCcccCCCC
Confidence 99988876 567899999999999999999999995 9999999999999875 6899999999875422
Q ss_pred -cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 276 -TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 276 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ...+...+..+.++|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll 227 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--LVLRPGASLTAWSIL 227 (325)
T ss_pred CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--ccCCCCCCHHHHHHH
Confidence 22234569999999999999999999999999999999999999999888777766665433 344556889999999
Q ss_pred HHhhhhCCCCCCCHHHH
Q psy6905 355 EACWEADSHMRPSFKTI 371 (527)
Q Consensus 355 ~~~l~~dp~~RPs~~~l 371 (527)
..|+..+|.+||++.+.
T Consensus 228 ~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 228 EELLEKDRQRRLGAKED 244 (325)
T ss_pred HHHhccCHHhcCCCCCC
Confidence 99999999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=321.84 Aligned_cols=246 Identities=35% Similarity=0.685 Sum_probs=203.8
Q ss_pred eeeccCCceEEEEeeEc-----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEE-eCCeEEEEEeccC
Q psy6905 123 EAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCL-QSPKLCLVMEYAR 196 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~-~~~~~~iv~Ey~~ 196 (527)
+.||+|+||.||+|.+. ...||+|.+...........+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36999999999999863 24699998865544445678889999999999999999999875 4556899999999
Q ss_pred CCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 197 GGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 197 ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
+|+|.+++.. ...+...++.++.||+.||.|||+. +++||||||+|||++.+ +.+||+|||+++...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~--------~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDES--------FTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCC--------CcEEECCcccccccc
Confidence 9999999863 3456777889999999999999998 49999999999999875 689999999997653
Q ss_pred ccc------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCcc
Q psy6905 275 KTT------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 275 ~~~------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 347 (527)
... .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+.......+. .+...+.+..+|
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 228 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCP 228 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCC
Confidence 321 112346778999999988889999999999999999999 677888777666555443 344455677789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
..+.+++.+||..+|++||++.++++.|+++..
T Consensus 229 ~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 229 DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=338.88 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=208.2
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcC-ceEEEE-EcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCC
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIK-VAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSP 186 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK-~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~ 186 (527)
..+.|+...|++++.||+||.+.||++...+ +.||+| +.....+...+..+.+|+.+|.+| .|.+||++|+|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 4678999999999999999999999998754 456665 444456677789999999999999 5999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcCCCC--ChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLAGRKI--RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~~~--~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.+||||||- ..+|..+|+.+.. ..-.+..+..||+.+++++|.+| |||.||||+|+|+-. |.+||
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk---------G~LKL 500 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK---------GRLKL 500 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe---------eeEEe
Confidence 999999985 5689999985443 33478889999999999999995 999999999999986 79999
Q ss_pred eccCcchhhhcccc----ccCCCccccccccccccCC-----------CCcccchHHHHHHHHHHHhCCCCCCCCCH-HH
Q psy6905 265 TDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSI-----------FSKASDVWSYGVVLWELLTGEIPYKSINA-YA 328 (527)
Q Consensus 265 ~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~-----------~~~ksDvwSlGv~l~elltg~~Pf~~~~~-~~ 328 (527)
+|||+|..+...+. .+.+||+.||+||++.... .++++|||||||+||+|+.|++||....+ ..
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a 580 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA 580 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH
Confidence 99999988865433 3678999999999985322 56899999999999999999999987653 33
Q ss_pred HHHHHHhCCccCCCCCCccHH-HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 329 VAYGVAVNKLTLPIPSTCPQL-FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 329 ~~~~i~~~~~~~~~p~~~~~~-~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+..-+...++|..-+.. +.++|+.||..||.+||++.+||++
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 444444333445566544433 9999999999999999999999874
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=337.32 Aligned_cols=235 Identities=27% Similarity=0.440 Sum_probs=196.3
Q ss_pred eeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+. ++.||+|++.... .......+..|+.++..+ +||||+.+++++.+.+.+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999874 5789999987642 223356678899998888 699999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc-
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK- 275 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~- 275 (527)
|+|..++. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~--------~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDAD--------GHIKLTDYGMCKEGLGP 149 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCC--------CCEEEeccccceeccCC
Confidence 99988876 567999999999999999999999995 9999999999999875 6899999999875322
Q ss_pred -cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCccCCCCCCccH
Q psy6905 276 -TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI------NAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 276 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~------~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||... +.......... .....+|..++.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~ 228 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-EKPIRIPRFLSV 228 (327)
T ss_pred CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-hCCCCCCCCCCH
Confidence 2223457999999999999999999999999999999999999999642 22223333322 234457788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFK 369 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~ 369 (527)
.+.+++.+||..||.+|+++.
T Consensus 229 ~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHHHHHhccCHHHcCCCC
Confidence 999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=329.74 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=209.8
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
+..++|++.+.||+|+||+||++.+. ++.||+|++...........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 45678999999999999999999975 6789999887655455567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||+++|+|.+++. .+.++...+..++.+++.||.|||+.. +++||||+|+||+++.+ +.++|+|||++
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~--------~~~~l~d~gl~ 151 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSR--------GQIKLCDFGVS 151 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCC--------CcEEEccCCcc
Confidence 99999999999887 456899999999999999999999742 49999999999999875 68999999998
Q ss_pred hhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhCCcc
Q psy6905 271 REVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY-----------AVAYGVAVNKLT 339 (527)
Q Consensus 271 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~-----------~~~~~i~~~~~~ 339 (527)
............|+..|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+.. ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 230 (284)
T cd06620 152 GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPP 230 (284)
T ss_pred cchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccC
Confidence 765433334457899999999998888999999999999999999999999865442 12222221 112
Q ss_pred CCCCC-CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 LPIPS-TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ~~~p~-~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..++. .++..+.+|+.+||..||++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 22232 378899999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=337.90 Aligned_cols=246 Identities=22% Similarity=0.347 Sum_probs=203.9
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|.+.+.||+|+||.||++.+. ++.||+|++.... .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999874 5689999886421 2223455778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||.||+|.+++. +..+++..+..++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~--------~~~kl~DfG~a 149 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMN--------GHIRLADFGSC 149 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCC--------CCEEEEeccce
Confidence 9999999999986 357899999999999999999999995 9999999999999875 68999999999
Q ss_pred hhhhcccc---ccCCCcccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 271 REVYKTTH---MSAAGTYAWMAPEVIKT-----SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 271 ~~~~~~~~---~~~~gt~~y~aPE~l~~-----~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.......+.
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05624 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 229 (331)
T ss_pred eeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC
Confidence 76543222 12469999999999875 46789999999999999999999999988877776666554444444
Q ss_pred CC---CccHHHHHHHHHhhhhCCCC--CCCHHHHHH
Q psy6905 343 PS---TCPQLFKTLMEACWEADSHM--RPSFKTILK 373 (527)
Q Consensus 343 p~---~~~~~~~~li~~~l~~dp~~--RPs~~~ll~ 373 (527)
|. .+++.+.+++.+|+..++.+ |+++.++++
T Consensus 230 p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 230 PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 43 46899999999999865543 457777765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=322.91 Aligned_cols=247 Identities=29% Similarity=0.394 Sum_probs=206.2
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCc-cceEEEEEEeCC-----
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRN-IVSLIGVCLQSP----- 186 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpn-Iv~~~~~~~~~~----- 186 (527)
...|..+++||+|+||+||+|+. +|+.||+|.+....+ +.......+|+.+++.|+|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45677888999999999999987 578999999887654 344566789999999999999 999999998877
Q ss_pred -eEEEEEeccCCCCHHHHhcC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccc
Q psy6905 187 -KLCLVMEYARGGPLNRVLAG-----RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260 (527)
Q Consensus 187 -~~~iv~Ey~~ggsL~~~l~~-----~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~ 260 (527)
.+++|+||+ .-+|..++.. ..++...+..++.||+.||+|||+++ |+||||||.||||+.+ +
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~--------G 157 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSS--------G 157 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCC--------C
Confidence 899999999 5689888872 35777889999999999999999995 9999999999999985 7
Q ss_pred eeEEeccCcchhhhc--cccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Q psy6905 261 TLKITDFGLAREVYK--TTHMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN- 336 (527)
Q Consensus 261 ~vkL~DFGla~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~- 336 (527)
.+||+|||+|+...- ......++|..|+|||++.+. .|+...||||+||+++||++++..|++.+.......|...
T Consensus 158 ~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 158 VLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred cEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 999999999997642 223456799999999999887 6999999999999999999999999999887766665421
Q ss_pred ---------------CccCCC-----CC-------CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ---------------KLTLPI-----PS-------TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ---------------~~~~~~-----p~-------~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+..+. |. ..++...+++..|++.+|.+|.|+...+.+
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111011 11 112478899999999999999999999875
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=321.16 Aligned_cols=242 Identities=35% Similarity=0.641 Sum_probs=209.9
Q ss_pred eeeccCCceEEEEeeEcC---c--eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIYEK---Q--EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~---~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||+|+||.||+|.+.. + .||||.+.........+.+.+|+.++++++||||+++++++.+ ..+++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 469999999999998732 2 6899999876554557788999999999999999999999988 889999999999
Q ss_pred CCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 198 GPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 198 gsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
|+|.+++.. ..+++..+..++.|++.||.|||++| ++|+||+|+|||++.+ +.+||+|||+++...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~--------~~~kl~dfg~~~~~~ 148 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASD--------DKVKIGDFGLMRALP 148 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecC--------CEEEecccccccccc
Confidence 999999864 35888999999999999999999995 9999999999999875 689999999998763
Q ss_pred ccc-----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 275 KTT-----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 275 ~~~-----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.......+.|..+|.
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
T cd05040 149 QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQ 228 (257)
T ss_pred ccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCH
Confidence 311 112346789999999998889999999999999999998 99999888877777666655556667788899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
.+.+++.+||..+|++||++.++++.|.
T Consensus 229 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=339.05 Aligned_cols=246 Identities=26% Similarity=0.330 Sum_probs=197.0
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC------
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP------ 186 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------ 186 (527)
.++|++.+.||+|+||.||+|.+ .+..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46799999999999999999987 46789999886542 3334567789999999999999999999986543
Q ss_pred eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 187 KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
.+|+||||+.+ +|...+. ..++...+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~--------~~~kl~D 166 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD--------CTLKILD 166 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCC--------CCEEEec
Confidence 57999999965 4555553 35788899999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Q psy6905 267 FGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV---------- 335 (527)
Q Consensus 267 FGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~---------- 335 (527)
||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 167 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99997653322 2245689999999999999999999999999999999999999987654332211110
Q ss_pred ------------CCccC------------------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 ------------NKLTL------------------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ------------~~~~~------------------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..... ..+...++.+++||.+||..||++|||+.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0112346788999999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=345.26 Aligned_cols=246 Identities=30% Similarity=0.497 Sum_probs=210.8
Q ss_pred eeeeeeeccCCceEEEEeeEcC--ceEE---EEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe--EEEE
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYEK--QEVA---IKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK--LCLV 191 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~~--~~va---iK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~--~~iv 191 (527)
.++.++||+|+|-+||+|.+.. -.|| ||+-........++.++.|+.+|+.|+|||||++|++|.+..+ +-+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 4667899999999999999854 3443 3444444455667899999999999999999999999988655 8899
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
+|.+..|+|..|++ .++++...+..|++||++||.|||++.| +|||||||-+||||+.+ .|.|||+|+|||
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~-------~G~VKIGDLGLA 193 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGN-------LGEVKIGDLGLA 193 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCC-------cCceeecchhHH
Confidence 99999999999987 6789999999999999999999999976 89999999999999987 489999999999
Q ss_pred hhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 271 REVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKS-INAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 271 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
+........+..|||.|||||+.. ..|+..+||||||+++.||+|+..||.. .+..+++.++..+...-.+...-.++
T Consensus 194 tl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe 272 (632)
T KOG0584|consen 194 TLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE 272 (632)
T ss_pred HHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence 988776666778999999999987 5689999999999999999999999975 55666666666554443444445788
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++++|.+|+.. ..+|||+.+||++
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhC
Confidence 99999999999 9999999999974
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=319.77 Aligned_cols=245 Identities=30% Similarity=0.485 Sum_probs=210.5
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|.+.+.||+|+||.||+|.+ ++..|++|.+... ........+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999987 4678999987653 2334467788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 195 ARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 195 ~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+.|++|.+++.. ..++...+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.++|+|||+++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~--------~~~~l~df~~~~ 149 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAY--------DNVKIGDLGVAK 149 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCC--------CCEEEcccccce
Confidence 999999999863 46888999999999999999999985 9999999999999875 689999999987
Q ss_pred hhhcccc--ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 272 EVYKTTH--MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 272 ~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
....... ....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.. ....+++..++..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 228 (256)
T cd08529 150 LLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFPPVSQMYSQQ 228 (256)
T ss_pred eccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHH
Confidence 6543221 234688999999999998899999999999999999999999998876665555543 3344566688999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHhhC
Confidence 9999999999999999999999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=332.48 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=200.3
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|.+.+.||+|+||.||+|.+. +..||+|.+...........+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 367999999999999999999874 568999988765433334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|+.+ +|.+++. +..++...+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~--------~~~kl~Dfg~~~ 152 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINER--------GELKLADFGLAR 152 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC--------CCEEECccccce
Confidence 9965 7777765 345788899999999999999999995 9999999999999875 689999999987
Q ss_pred hhhccc--cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Q psy6905 272 EVYKTT--HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------------ 336 (527)
Q Consensus 272 ~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------------ 336 (527)
...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 153 AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred ecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 543221 223467899999999865 45889999999999999999999999887654433322110
Q ss_pred -------CccC---------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 -------KLTL---------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 -------~~~~---------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.... .....+++++.+||.+||..||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000 0113468889999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=336.93 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=205.3
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|.+.+.||+|+||.||++.++ ++.||+|++.... .......+..|..++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999875 4689999886421 1223455788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||.+|+|.+++.. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||++
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~--------~~~kL~DfG~a 149 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMN--------GHIRLADFGSC 149 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCC--------CCEEEeecchh
Confidence 99999999999973 57899999999999999999999995 9999999999999875 68999999998
Q ss_pred hhhhcccc---ccCCCccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 271 REVYKTTH---MSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 271 ~~~~~~~~---~~~~gt~~y~aPE~l~-----~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
........ ....||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+....+.......+.
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (332)
T cd05623 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 229 (332)
T ss_pred eecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC
Confidence 76532221 2346999999999986 345789999999999999999999999998887777777655444444
Q ss_pred C---CCccHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q psy6905 343 P---STCPQLFKTLMEACWEADSHM--RPSFKTILKA 374 (527)
Q Consensus 343 p---~~~~~~~~~li~~~l~~dp~~--RPs~~~ll~~ 374 (527)
| ..++.++.+||.+|+..++.. |+++.+++++
T Consensus 230 p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 4 357999999999999665444 6888888763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=328.06 Aligned_cols=247 Identities=30% Similarity=0.497 Sum_probs=210.3
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
..+|.+.+.||+|+||.||+|.+ .++.||+|.+....... ...+.+|+.+++.+.||||+++++.+..+...|+|||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 35788999999999999999986 46789999887654332 4668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 194 YARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 194 y~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|+.|++|.+++....++..++..++.|++.||.|||+.| |+||||||+|||++.+ +.++|+|||++...
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~--------~~~kl~dfg~~~~~ 166 (296)
T cd06654 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMD--------GSVKLTDFGFCAQI 166 (296)
T ss_pred ccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCC--------CCEEECccccchhc
Confidence 999999999998778899999999999999999999995 9999999999999875 68999999998765
Q ss_pred hccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-ccCCCCCCccHHH
Q psy6905 274 YKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPSTCPQLF 350 (527)
Q Consensus 274 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~~ 350 (527)
.... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+............ ...+.+..++..+
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (296)
T cd06654 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (296)
T ss_pred cccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence 3222 223468899999999998889999999999999999999999998776544443333222 2234456788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.++|.+||..+|.+||++.+++++
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhC
Confidence 999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.98 Aligned_cols=243 Identities=26% Similarity=0.343 Sum_probs=195.1
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
.+....|.+.+.||+|+||.||+|.+. ++.||||... ...+.+|+.+++.++||||+++++++......|+
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 355678999999999999999999874 5789999753 2346789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||++. ++|..++. ...++...++.++.||+.||.|||++| ||||||||+|||++.+ +.+||+|||+
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~--------~~vkL~DFG~ 228 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHP--------GDVCLGDFGA 228 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCC--------CCEEEEeCCc
Confidence 999994 67877765 567899999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhc---cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH------
Q psy6905 270 AREVYK---TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA-------YAVAYGV------ 333 (527)
Q Consensus 270 a~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~-------~~~~~~i------ 333 (527)
++.... .......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+
T Consensus 229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 229 ACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred ccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 965322 222345799999999999998999999999999999999999987643210 0000000
Q ss_pred --------------------HhCCccCC--CC-----CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 334 --------------------AVNKLTLP--IP-----STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 334 --------------------~~~~~~~~--~p-----~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.......+ .| ..++.++.+||.+||+.||.+|||+.+++++
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 01 1246689999999999999999999999874
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=324.90 Aligned_cols=248 Identities=26% Similarity=0.453 Sum_probs=205.2
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
+.++|.+.+.||+|+||.||+|.+ +++.||+|++...... ....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 446889999999999999999987 4578999998765332 2456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||.+++|.+++. .+.+++..++.++.|++.||.|||++| ++|+||||+|||++.+ +.++|+|||++.
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~--------~~~~l~dfg~~~ 154 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDN--------GHVKLADFGVSA 154 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC--------CCEEECcceeee
Confidence 9999999999886 567899999999999999999999995 9999999999999875 689999999987
Q ss_pred hhhccc--cccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC---C
Q psy6905 272 EVYKTT--HMSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI---P 343 (527)
Q Consensus 272 ~~~~~~--~~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~---p 343 (527)
...... .....|++.|+|||++. ...++.++|||||||++|+|++|..||...................+. .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06645 155 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK 234 (267)
T ss_pred EccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccccc
Confidence 553221 22346899999999974 455889999999999999999999999766544433333322222221 1
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..++..+.+++.+||..+|++||++.+|+++
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 2477889999999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=324.92 Aligned_cols=252 Identities=34% Similarity=0.550 Sum_probs=206.8
Q ss_pred CCceeeeeeeccCCceEEEEeeE------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--Ce
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS--PK 187 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~ 187 (527)
..-|++.+.||+|+||.||+|.+ .+..||+|.+...........+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 34578899999999999999874 24679999987665555567889999999999999999999998775 56
Q ss_pred EEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.++||||++|++|.+++.. ..++...++.++.||+.||+|||++| ++||||||+|||++.+ +.++|+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~--------~~~~l~ 151 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE--------HQVKIG 151 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCC--------CCEEEC
Confidence 8999999999999999863 35788999999999999999999995 9999999999999875 689999
Q ss_pred ccCcchhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--------------H
Q psy6905 266 DFGLAREVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN--------------A 326 (527)
Q Consensus 266 DFGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~--------------~ 326 (527)
|||+++....... ....++..|+|||++.+..++.++|||||||++|+|+++..|+.... .
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05079 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT 231 (284)
T ss_pred CCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccccc
Confidence 9999986643211 13346778999999988889999999999999999999776643210 1
Q ss_pred HHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 327 YAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 327 ~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
..........+...+.+..++..+.+|+.+||+.+|.+||++.++++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111122233445566788999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=323.77 Aligned_cols=246 Identities=34% Similarity=0.548 Sum_probs=211.7
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|.+.+.||.|+||.||+|.+ .++.||+|++...........+.+|+.+++.++|+||+++++++.++..+|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3688889999999999999987 45789999987654444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 195 ~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
+.+++|.+++....+++..+..++.|++.||.|||+++ ++||||+|+||+++.+ +.++|+|||+++...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~--------~~~~l~d~g~~~~~~ 149 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEE--------GDVKLADFGVSGQLT 149 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCC--------CCEEEcccccceeec
Confidence 99999999998778999999999999999999999995 9999999999999985 689999999998764
Q ss_pred cc--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCC-ccHHHH
Q psy6905 275 KT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST-CPQLFK 351 (527)
Q Consensus 275 ~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~~~~~~ 351 (527)
.. ......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+... .....+.. ++..+.
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 228 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKFSKPFK 228 (274)
T ss_pred ccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccccCHHHH
Confidence 33 222456888999999999888999999999999999999999999887765554444432 22333344 889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 352 TLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++.+||..+|++||++.+++++
T Consensus 229 ~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 229 DFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHHHhhCChhhCcCHHHHhhC
Confidence 99999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=322.37 Aligned_cols=251 Identities=24% Similarity=0.432 Sum_probs=208.2
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||.|+||.||+|.+ ++..||||.+.... +......+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999996 56789999776432 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 193 EYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 193 Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
||+.+++|.+++. ...+++..++.++.||+.||.|||++| ++|+||+|+||+++.+ +.++|+||
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~--------~~~~l~df 150 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITAT--------GVVKLGDL 150 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCC--------CCEEECcc
Confidence 9999999999875 345788999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhcccc--ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCccCCCC
Q psy6905 268 GLAREVYKTTH--MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA--YAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 268 Gla~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~p 343 (527)
|++........ ....|+..|+|||.+.+..++.++||||||+++|+|++|..||.+... ......+.........+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS 230 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCc
Confidence 99876533221 234688999999999988899999999999999999999999976543 22223332222222233
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
..++..+.+++.+||..||.+|||+.+|++.+.++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 56889999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=326.17 Aligned_cols=238 Identities=24% Similarity=0.338 Sum_probs=193.4
Q ss_pred eccCCceEEEEeeEc--CceEEEEEcCCCCC--hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCH
Q psy6905 125 IGEGGFGKVYKGIYE--KQEVAIKVAHPNPD--ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200 (527)
Q Consensus 125 iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL 200 (527)
||+|+||.||++... ++.||+|.+..... ......+..|+.+++.++||||+++++++..+..+|+||||+.||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999874 67899998864321 11233456799999999999999999999999999999999999999
Q ss_pred HHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccc
Q psy6905 201 NRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT 277 (527)
Q Consensus 201 ~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~ 277 (527)
.+++. ...++...+..++.||+.||.|||+.| |+||||||+|||++.+ +.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~--------~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQ--------GNCRLSDLGLAVELKDGK 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCC--------CCEEEeeceeeeecCCCc
Confidence 88775 235788888999999999999999995 9999999999999875 689999999987654322
Q ss_pred c-ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCccCCCCCCccHHHHH
Q psy6905 278 H-MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA----YAVAYGVAVNKLTLPIPSTCPQLFKT 352 (527)
Q Consensus 278 ~-~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~~~~~~ 352 (527)
. ....|+..|+|||++.+..++.++|||||||++|+|++|..||..... ..+.......... .....+++++.+
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 228 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKD 228 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHH
Confidence 2 235689999999999988899999999999999999999999976533 2222222222221 122468899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q psy6905 353 LMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 353 li~~~l~~dp~~RPs~~~ll~~ 374 (527)
||..||..||.+||++.++++.
T Consensus 229 li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 229 ICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHhccCHhhCCCCccchhh
Confidence 9999999999999999777643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=318.83 Aligned_cols=250 Identities=26% Similarity=0.470 Sum_probs=209.5
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCC--CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||.|+||.||+|.+. ++.||+|.+... .+......+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999984 788999987642 23334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 193 EYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 193 Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
||+++|+|..++. +..++...++.++.|++.||.|||+.| ++||||+|+||+++.+ +.++|+||
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~--------~~~~l~d~ 150 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITAT--------GVVKLGDL 150 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCC--------CcEEEecc
Confidence 9999999998875 345788999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCccCCCC
Q psy6905 268 GLAREVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN--AYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 268 Gla~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~--~~~~~~~i~~~~~~~~~p 343 (527)
|++....... .....|++.|+|||.+.+..++.++|||||||++|+|++|..||.... .......+.. +...+.|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (267)
T cd08224 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLP 229 (267)
T ss_pred ceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCC
Confidence 9987653322 223468899999999998889999999999999999999999996543 2233333322 2233444
Q ss_pred C-CccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 344 S-TCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 344 ~-~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
. .++..+.++|.+||..+|.+||++.+|++.|+.+
T Consensus 230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 4 7888999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.20 Aligned_cols=246 Identities=31% Similarity=0.503 Sum_probs=211.8
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
..|++.+.||.|+||.||+|.+ .++.|++|.+..... ...+.+.+|+.+++.++||||+++++++.....+|+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4689999999999999999986 567899998865432 2356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 195 ~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
+.+++|..++....+++..+..++.|++.||+|||++| ++||||+|+||+++.+ +.++|+|||++....
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~--------~~~kl~dfg~~~~~~ 166 (296)
T cd06655 98 LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMD--------GSVKLTDFGFCAQIT 166 (296)
T ss_pred cCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC--------CCEEEccCccchhcc
Confidence 99999999998778999999999999999999999995 9999999999999875 689999999987653
Q ss_pred cccc--ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-ccCCCCCCccHHHH
Q psy6905 275 KTTH--MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPSTCPQLFK 351 (527)
Q Consensus 275 ~~~~--~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~~~ 351 (527)
.... ....|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+.... .....|..+++.+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246 (296)
T ss_pred cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 3222 23468899999999998889999999999999999999999998877665554443322 23345677899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 352 TLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++|.+||..||.+||++.+++++
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhC
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=317.81 Aligned_cols=248 Identities=33% Similarity=0.622 Sum_probs=211.0
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++..+|++.+.||.|+||.||+|.+. +..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred CChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 35678999999999999999999875 678999988754322 346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||+.+|+|.+++. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.+ +.++|+|||++
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~--------~~~~l~d~g~~ 147 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGEN--------QVVKVSDFGMT 147 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCC--------CeEEECCCcce
Confidence 9999999999986 345888999999999999999999995 9999999999999865 68999999998
Q ss_pred hhhhccccc---cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 271 REVYKTTHM---SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 271 ~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
+........ ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.. +.....|...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (256)
T cd05112 148 RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLYKPRLA 226 (256)
T ss_pred eecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-CCCCCCCCCC
Confidence 765332221 2235678999999998889999999999999999998 9999988776666655543 3344556778
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
+..+.+|+.+||..+|++||++.++++.|
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 99999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=324.28 Aligned_cols=245 Identities=32% Similarity=0.561 Sum_probs=203.2
Q ss_pred eeeeeeeccCCceEEEEeeEcC--ceEEEEEcCCCCChhH-HHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENI-LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~~--~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
|++++.||+|+||.||++.+.+ +.||+|++........ .....+|+.+++.++||||+++++++.+....++|||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 7889999999999999999854 5799999887643322 233456999999999999999999999999999999999
Q ss_pred CCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh-
Q psy6905 196 RGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV- 273 (527)
Q Consensus 196 ~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~- 273 (527)
.+++|.+++. ...++...++.++.||+.||.|||+++ ++|+||||+|||++.+ +.++|+|||++...
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~--------~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDEN--------GEVKLIDFGSSVKLS 149 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTT--------SEEEESSGTTTEEST
T ss_pred cccccccccccccccccccccccccccccccccccccc---cccccccccccccccc--------ccccccccccccccc
Confidence 9999999997 788999999999999999999999994 9999999999999975 68999999998753
Q ss_pred -hccccccCCCccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCccCCC--CCCc
Q psy6905 274 -YKTTHMSAAGTYAWMAPEVIK-TSIFSKASDVWSYGVVLWELLTGEIPYKSINA---YAVAYGVAVNKLTLPI--PSTC 346 (527)
Q Consensus 274 -~~~~~~~~~gt~~y~aPE~l~-~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~--p~~~ 346 (527)
.........++..|+|||++. +..++.++||||||+++|+|++|..||..... ................ ....
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREK 229 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchh
Confidence 223333567899999999998 78899999999999999999999999998732 2222222221111111 1223
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+..+.++|..||+.||.+||++.+++++
T Consensus 230 ~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 230 SEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4899999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.87 Aligned_cols=246 Identities=29% Similarity=0.470 Sum_probs=209.2
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|++.+.||.|+||.||+|.+. ++.+++|++...... ....+.+|+.+++.++||||+++++++.+...+|++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 467999999999999999999874 568999998765433 45778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|+.+++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~--------~~~~l~d~g~~~ 149 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTED--------GDVKLADFGVSA 149 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCC--------CCEEECccccch
Confidence 9999999998863 67999999999999999999999994 9999999999999975 689999999987
Q ss_pred hhhccc--cccCCCccccccccccccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC---CCC
Q psy6905 272 EVYKTT--HMSAAGTYAWMAPEVIKTS---IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL---PIP 343 (527)
Q Consensus 272 ~~~~~~--~~~~~gt~~y~aPE~l~~~---~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~---~~p 343 (527)
...... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+....+.. ..+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd06613 150 QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDK 229 (262)
T ss_pred hhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccch
Confidence 664322 2234688899999999776 78999999999999999999999998877666555544433222 223
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
..++.++.++|.+||..+|..|||+.+++.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 456788999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=323.88 Aligned_cols=246 Identities=34% Similarity=0.568 Sum_probs=212.0
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
..|+..+.||.|+||.||+|.+. +..||||++...........+.+|+.+++.+.||||+++++++.++...|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778889999999999999874 5789999987654445567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 195 ~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
+.||+|.+++..+.+++..+..++.|++.||.|||++ +++|+||+|+||+++.+ +.++|+|||++....
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~--------~~~~l~dfg~~~~~~ 152 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQ--------GDVKLADFGVAGQLT 152 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCC--------CCEEEcccccceecc
Confidence 9999999999888899999999999999999999998 49999999999999875 689999999997653
Q ss_pred ccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHH
Q psy6905 275 KTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKT 352 (527)
Q Consensus 275 ~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 352 (527)
... .....++..|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .......+..++..+.+
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 231 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKE 231 (277)
T ss_pred CCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHH
Confidence 322 123457889999999998889999999999999999999999998877665554432 23334455678899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q psy6905 353 LMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 353 li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.+||..+|.+||++.+++.+
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 232 FIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHcccCcccCcCHHHHHhC
Confidence 9999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=325.48 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=201.8
Q ss_pred eeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
|++.+.||+|+||.||++.+. ++.||+|.+.... .......+.+|+.+++.++|+||+.+++.+.+++.+|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999884 5789999876532 222245577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 195 ARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 195 ~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+.||+|.+++. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.+ +.++|+|||++.
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~--------~~~~l~Dfg~~~ 150 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDH--------GHIRISDLGLAV 150 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCC--------CCEEEeecccee
Confidence 99999998875 235889999999999999999999984 9999999999999875 689999999987
Q ss_pred hhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCccCCCCCCcc
Q psy6905 272 EVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY---AVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 272 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~~ 347 (527)
...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||...... ....... .......+..++
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 229 (285)
T cd05630 151 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFS 229 (285)
T ss_pred ecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCC
Confidence 653322 22357899999999999989999999999999999999999999875432 1122211 122334567789
Q ss_pred HHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPS-----FKTILKA 374 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs-----~~~ll~~ 374 (527)
+++.+|+..||..||.+||| +.+++++
T Consensus 230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 99999999999999999999 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.26 Aligned_cols=243 Identities=29% Similarity=0.432 Sum_probs=210.3
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||+|+||.||++.+. ++.||+|++.... .......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46899999999999999999874 5789999886532 2233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||+.+|+|.+++. ...+++..+..++.||+.||.|||+.| ++|+||+|+|||++.+ +.+||+|||++.
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~--------~~~kl~dfg~~~ 149 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSD--------GYIKITDFGFAK 149 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCC--------CCEEEeeCCCcc
Confidence 9999999999986 567899999999999999999999985 9999999999999875 689999999998
Q ss_pred hhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHH
Q psy6905 272 EVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFK 351 (527)
Q Consensus 272 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 351 (527)
..... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. ...++|..++..+.
T Consensus 150 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~ 226 (290)
T cd05580 150 RVKGR-TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GKVRFPSFFSPDAK 226 (290)
T ss_pred ccCCC-CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCccCCccCCHHHH
Confidence 76443 3345689999999999888889999999999999999999999988776555555542 34567778899999
Q ss_pred HHHHHhhhhCCCCCC-----CHHHHHH
Q psy6905 352 TLMEACWEADSHMRP-----SFKTILK 373 (527)
Q Consensus 352 ~li~~~l~~dp~~RP-----s~~~ll~ 373 (527)
+++.+||..||.+|+ ++.++++
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHc
Confidence 999999999999999 7777765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=323.95 Aligned_cols=245 Identities=32% Similarity=0.480 Sum_probs=206.6
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
.|++.+.||.|+||.||+|.+. +..+++|.+.... ......+.+|+.+++.++||||+++++++..+...|+||||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 3678899999999999999985 4678999886543 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 196 RGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 196 ~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
.+|+|..++. ...+++..+..++.||+.||.|||+.| ++||||||+|||++.+ +.+||+|||++...
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~--------~~~kl~dfg~~~~~ 153 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLD--------GDIKLADFGVSAKN 153 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccC--------CCEEEccccccccc
Confidence 9999988775 456899999999999999999999995 9999999999999875 68999999998765
Q ss_pred hccc--cccCCCccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CccCCCCCC
Q psy6905 274 YKTT--HMSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLPIPST 345 (527)
Q Consensus 274 ~~~~--~~~~~gt~~y~aPE~l~-----~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~ 345 (527)
.... .....|+..|+|||++. +..++.++|||||||++|+|++|..||...+.......+... ......|..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd06643 154 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 233 (282)
T ss_pred cccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccc
Confidence 3221 22346899999999984 345788999999999999999999999988776665555432 223455677
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++..+.++|.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 234 WSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999998874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.89 Aligned_cols=245 Identities=32% Similarity=0.587 Sum_probs=207.7
Q ss_pred ceeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCC-----ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNP-----DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
+|++.+.||.|+||.||+|.. ++..+|+|.+.... .......+.+|+.+++.++|+||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999986 56789999876532 122345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||+.|++|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~--------~~~~l~dfg~~ 149 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPN--------GIIKLIDFGCA 149 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCC--------CeEEeccchhh
Confidence 99999999999987 467889999999999999999999985 9999999999999865 68999999998
Q ss_pred hhhhcc--------ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CccCC
Q psy6905 271 REVYKT--------THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLP 341 (527)
Q Consensus 271 ~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~ 341 (527)
...... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+... ....+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06631 150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229 (265)
T ss_pred HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence 765211 112345889999999999888999999999999999999999999887765554444332 23345
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.+..++..+.++|.+||..+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 67789999999999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=322.92 Aligned_cols=241 Identities=27% Similarity=0.365 Sum_probs=197.6
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--C---eEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS--P---KLCL 190 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~---~~~i 190 (527)
.|.-.+++|+|+||.||+|... +..||||..-++.. .--+|+.+|+.++|||||++.-+|... . .+.+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3556789999999999999874 57899997766532 223799999999999999999888642 2 4578
Q ss_pred EEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 191 VMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
||||+ ..+|.++++ +.+++.-.+.-+.+||++||.|||+. +|+||||||.|+|++.+ .+.+|||
T Consensus 100 Vleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~-------tg~LKic 168 (364)
T KOG0658|consen 100 VLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPD-------TGVLKIC 168 (364)
T ss_pred HHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCC-------CCeEEec
Confidence 99999 467888887 67888889999999999999999998 59999999999999986 5899999
Q ss_pred ccCcchhhhcccc-ccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Q psy6905 266 DFGLAREVYKTTH-MSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------- 336 (527)
Q Consensus 266 DFGla~~~~~~~~-~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------- 336 (527)
|||.|+.+..... .+...|..|+|||.+.+. .|+.+.||||.||++.||+.|++-|+|.+....+..+..-
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999998855443 355678999999999875 4999999999999999999999999998776555544320
Q ss_pred -----Cc---cCC------------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 -----KL---TLP------------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 -----~~---~~~------------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+. ... .....+++..+|+.+++..+|.+|.++.+++.+
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00 000 224568899999999999999999999999875
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.00 Aligned_cols=244 Identities=31% Similarity=0.587 Sum_probs=207.8
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC--------hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD--------ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
+|.+...||.|+||.||+|.+ .++.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477888999999999999987 457899998765321 1234668899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
.++||||+++++|.+++. .+.++...+..++.|++.||.|||++| ++||||+|+|||++.+ +.++|+|
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~--------~~~~l~d 149 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNK--------GGIKISD 149 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCC--------CCEEecc
Confidence 999999999999999987 456888999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc--------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Q psy6905 267 FGLAREVYKTT--------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 267 FGla~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
||+++...... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.. ..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~ 228 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NA 228 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cC
Confidence 99987664211 1123578899999999988899999999999999999999999998776655554433 33
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
....|..++..+.++|.+||+.||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 44667788999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=324.60 Aligned_cols=249 Identities=31% Similarity=0.483 Sum_probs=208.0
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
.+.+.|++++.||.|+||.||+|.+. +..|++|++.... ......+.+|+.+++.++||||+++++++..+..+|+|
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 45577999999999999999999874 5789999987553 33467788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 192 MEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||+++++|..++. ...+++..+..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||+
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~--------~~~kl~dfg~ 156 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLD--------GDIKLADFGV 156 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCC--------CCEEEccCcc
Confidence 99999999988775 456899999999999999999999984 9999999999999865 6899999999
Q ss_pred chhhhcc--ccccCCCccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCC
Q psy6905 270 AREVYKT--THMSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLP 341 (527)
Q Consensus 270 a~~~~~~--~~~~~~gt~~y~aPE~l~-----~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~ 341 (527)
+...... ......+++.|+|||.+. ...++.++|||||||++|+|++|..||...+.......+..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T cd06644 157 SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236 (292)
T ss_pred ceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCC
Confidence 8754322 122346889999999984 34578899999999999999999999988766555444432222 234
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+..++..+.++|.+||..+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 466788999999999999999999999999873
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=325.64 Aligned_cols=246 Identities=35% Similarity=0.575 Sum_probs=210.6
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+.|+..+.||+|+||.||+|.+. +..||+|.+...........+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35677889999999999999873 5689999987655445567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 195 ~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
+++++|.+++..+.+++..+..++.||+.||.|||++| ++|+||+|+||+++.+ +.++|+|||++....
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~--------~~~~l~dfg~~~~~~ 152 (277)
T cd06642 84 LGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQ--------GDVKLADFGVAGQLT 152 (277)
T ss_pred cCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCC--------CCEEEcccccccccc
Confidence 99999999998888999999999999999999999994 9999999999999875 689999999997654
Q ss_pred ccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHH
Q psy6905 275 KTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKT 352 (527)
Q Consensus 275 ~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 352 (527)
... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...........+.. ......+..++..+.+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 231 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-NSPPTLEGQYSKPFKE 231 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-CCCCCCCcccCHHHHH
Confidence 322 1234588999999999998899999999999999999999999987665554443322 2233345668889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q psy6905 353 LMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 353 li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.+||..+|.+||++.+++.+
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 232 FVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHccCCcccCcCHHHHHHh
Confidence 9999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=324.83 Aligned_cols=248 Identities=31% Similarity=0.484 Sum_probs=210.5
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
+.++|++.+.||.|+||.||+|.+. +..||+|++.... ......+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 3467999999999999999999874 5789999987543 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||+++|+|.+++. +..+++..+..++.|++.||.|||++| |+|+||+|+||+++.+ +.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~--------~~~~l~d~g~~ 150 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLD--------GDVKLADFGVS 150 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCC--------CCEEEccCccc
Confidence 9999999999986 356899999999999999999999995 9999999999999875 68999999998
Q ss_pred hhhhccc--cccCCCccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCC
Q psy6905 271 REVYKTT--HMSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPI 342 (527)
Q Consensus 271 ~~~~~~~--~~~~~gt~~y~aPE~l~-----~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~ 342 (527)
....... .....|++.|+|||.+. ...++.++|||||||++|+|++|+.||...+.......+..... ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ 230 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCC
Confidence 7653221 22346899999999975 34577899999999999999999999998877666655543322 3345
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
|..++.++.++|..||..+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 67789999999999999999999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=339.28 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=199.5
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC-----eEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-----KLC 189 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 189 (527)
+|++.+.||+|+||.||+|.+ +++.||||.+.... .......+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467889999999999999986 46899999886532 2234567889999999999999999999998776 789
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+||||+. ++|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~--------~~~kL~Dfg 148 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSN--------CVLKICDFG 148 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCC--------CCEEecccc
Confidence 9999996 56766664 667999999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhccc---cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Q psy6905 269 LAREVYKTT---HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV--------- 335 (527)
Q Consensus 269 la~~~~~~~---~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~--------- 335 (527)
+++...... .....+|..|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 997653221 1234578999999999874 478999999999999999999999988765443332211
Q ss_pred --------------CCccC-------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 --------------NKLTL-------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 --------------~~~~~-------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..... .....+++++.+||.+||..||.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 01111 1234567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=339.46 Aligned_cols=244 Identities=29% Similarity=0.418 Sum_probs=205.3
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CC-----ccceEEEEEEeCCeEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HR-----NIVSLIGVCLQSPKLC 189 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hp-----nIv~~~~~~~~~~~~~ 189 (527)
+|.+.+.||+|.||.|.+|.+. ++.||||+++... ....+...|+.+|..|+ |. |||+++++|...+++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 8899999999999999999984 5789999998653 45677788999999996 53 8999999999999999
Q ss_pred EEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 190 LVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
||+|.+ .-+|.++++. ..++...+..++.||+.||.+||..| |||+||||+||||..-. ...|||+|
T Consensus 265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~------r~~vKVID 334 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPK------RSRIKVID 334 (586)
T ss_pred eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCC------cCceeEEe
Confidence 999999 7789999984 35788999999999999999999994 99999999999998643 24899999
Q ss_pred cCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Q psy6905 267 FGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN---------- 336 (527)
Q Consensus 267 FGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~---------- 336 (527)
||+|.......+ +...+..|+|||++.+.+|+.+.|+||||||++||++|.+.|+|.+..+....|..-
T Consensus 335 FGSSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 335 FGSSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred cccccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 999988766554 667788999999999999999999999999999999999999998876655443210
Q ss_pred ----------C------------------------------ccCCCCC-----------CccHHHHHHHHHhhhhCCCCC
Q psy6905 337 ----------K------------------------------LTLPIPS-----------TCPQLFKTLMEACWEADSHMR 365 (527)
Q Consensus 337 ----------~------------------------------~~~~~p~-----------~~~~~~~~li~~~l~~dp~~R 365 (527)
. .....|. .-...|.++|++||..||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 0 0000120 112458999999999999999
Q ss_pred CCHHHHHHH
Q psy6905 366 PSFKTILKA 374 (527)
Q Consensus 366 Ps~~~ll~~ 374 (527)
+|..+.++|
T Consensus 494 ~tp~qal~H 502 (586)
T KOG0667|consen 494 ITPAQALNH 502 (586)
T ss_pred CCHHHHhcC
Confidence 999999885
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=337.51 Aligned_cols=237 Identities=24% Similarity=0.372 Sum_probs=194.5
Q ss_pred eccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC---CCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 125 IGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF---DHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 125 iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l---~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
||+|+||.||+|.+. ++.||||++.... ..........|..++..+ +||||+++++++.+...+|+|||||.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999874 6789999986431 112233445566666654 799999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc-
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK- 275 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~- 275 (527)
|+|..++. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~--------~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDAT--------GHIALCDFGLSKANLTD 149 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCC--------CCEEEecCCcCcCCCCC
Confidence 99988876 567999999999999999999999995 9999999999999875 6899999999875422
Q ss_pred -cccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHH
Q psy6905 276 -TTHMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTL 353 (527)
Q Consensus 276 -~~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~l 353 (527)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......++. ..+++.+.++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~l 228 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK-NVLSDEGRQF 228 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC-ccCCHHHHHH
Confidence 222345799999999998764 4789999999999999999999999988877776666554443332 3578999999
Q ss_pred HHHhhhhCCCCCCC----HHHHHH
Q psy6905 354 MEACWEADSHMRPS----FKTILK 373 (527)
Q Consensus 354 i~~~l~~dp~~RPs----~~~ll~ 373 (527)
+++||..||.+||+ +.++++
T Consensus 229 i~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 229 VKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHcCCCHHHCCCCCCCHHHHhc
Confidence 99999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=323.36 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=202.3
Q ss_pred eeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
|...+.||.|+||.||+|.+. ++.||+|.+.... .......+.+|+.+++.++|+||+.+++++..++..|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999874 6789999886542 122234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 195 ARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 195 ~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+.+|+|.+++. ...+++..+..++.|++.||.|||+.| |+||||||+||+++.+ +.++|+|||++.
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~--------~~~kl~Dfg~~~ 150 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDY--------GHIRISDLGLAV 150 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCC--------CCEEEecCCcce
Confidence 99999988775 236899999999999999999999995 9999999999999875 589999999986
Q ss_pred hhhcc-ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCccCCCCCCccH
Q psy6905 272 EVYKT-THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV--NKLTLPIPSTCPQ 348 (527)
Q Consensus 272 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~ 348 (527)
..... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.+.........+.. .......+..++.
T Consensus 151 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd05632 151 KIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSE 230 (285)
T ss_pred ecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCH
Confidence 54322 22345689999999999988899999999999999999999999988765443333221 1222345667889
Q ss_pred HHHHHHHHhhhhCCCCCCC-----HHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPS-----FKTILK 373 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs-----~~~ll~ 373 (527)
.+.+|+..||..||++||+ +.+++.
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 231 EAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 9999999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=311.43 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=216.1
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-------ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCC
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-------DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSP 186 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~ 186 (527)
..|.-.+.||.|..+.|.+|.. +++.+|+|++.... .....+.-.+|+.+|+++ .||+|+.+.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4566677899999999999987 46789999775432 122355667899999998 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.+++|+|.|+.|.|.++|. .-.+++.....|+.|+++|++|||.+ +||||||||+|||++++ -++||+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn--------~~i~is 165 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDN--------MNIKIS 165 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccc--------cceEEe
Confidence 9999999999999999998 45799999999999999999999999 69999999999999987 589999
Q ss_pred ccCcchhhhccccc-cCCCcccccccccccc------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Q psy6905 266 DFGLAREVYKTTHM-SAAGTYAWMAPEVIKT------SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 266 DFGla~~~~~~~~~-~~~gt~~y~aPE~l~~------~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
|||+++.+...... ..||||+|+|||.+.. ..|+..+|+|++||+||-|+.|.+||......-....+..+++
T Consensus 166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence 99999988655443 5689999999999853 3588899999999999999999999998888778888888888
Q ss_pred cCCCC--CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 TLPIP--STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 ~~~~p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+..| .+++...++||.+||..||.+|.|+.+.+.|
T Consensus 246 qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 246 QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 77666 6789999999999999999999999999875
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=321.37 Aligned_cols=245 Identities=30% Similarity=0.525 Sum_probs=202.8
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeC------Ce
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQS------PK 187 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~------~~ 187 (527)
+.|.+.+.||.|+||.||+|.+. ++.||+|++...... ...+.+|+.++..+ +|+||+++++++... ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc--HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 56788899999999999999874 578999988654322 35677899999988 799999999998753 46
Q ss_pred EEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 188 LCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
+|+|||||.+|+|.+++.. ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.+ +.++|
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~--------~~~~l 152 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTEN--------AEVKL 152 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCC--------CCEEE
Confidence 8999999999999998873 35889999999999999999999994 9999999999999875 68999
Q ss_pred eccCcchhhhcc--ccccCCCccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy6905 265 TDFGLAREVYKT--THMSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK 337 (527)
Q Consensus 265 ~DFGla~~~~~~--~~~~~~gt~~y~aPE~l~-----~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~ 337 (527)
+|||++...... ......|++.|+|||++. +..++.++|||||||++|+|++|..||................
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~ 232 (272)
T cd06637 153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 232 (272)
T ss_pred ccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC
Confidence 999998765322 223456899999999986 3457889999999999999999999998766555544444333
Q ss_pred ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 ~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 233 APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 3444456788999999999999999999999999873
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=315.90 Aligned_cols=244 Identities=40% Similarity=0.752 Sum_probs=211.2
Q ss_pred eeeeeeccCCceEEEEeeEcC------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 120 IFGEAIGEGGFGKVYKGIYEK------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 120 ~~~~~iG~G~fg~Vy~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++.+.||.|+||.||+|.+.. ..||+|.+...........+..|+.++..++|+||+++++++.+.+..|++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 567889999999999999854 67999999776555456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCC-C--CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 194 YARGGPLNRVLAGR-K--IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 194 y~~ggsL~~~l~~~-~--~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|+.+++|.+++... . +++..+..++.|++.||+|||+.+ ++|+||+|+||+++.+ +.++|+|||++
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~--------~~~~l~dfg~~ 150 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGEN--------LVVKISDFGLS 150 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccC--------CeEEEcccCCc
Confidence 99999999998732 2 899999999999999999999995 9999999999999875 68999999999
Q ss_pred hhhhccccc---cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 271 REVYKTTHM---SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 271 ~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
......... ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+.. ....+.+..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 229 (258)
T smart00219 151 RDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENC 229 (258)
T ss_pred eecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcC
Confidence 766433111 1236789999999988889999999999999999998 8999988777776665543 4455677789
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
+..+.+++.+||..||.+|||+.++++.|
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 230 PPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 99999999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=314.68 Aligned_cols=242 Identities=37% Similarity=0.694 Sum_probs=207.2
Q ss_pred eeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCHH
Q psy6905 123 EAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLN 201 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~ 201 (527)
++||.|+||.||+|.+. ++.||+|.+...........+.+|+.++++++|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999875 68899998876654445678899999999999999999999999999999999999999999
Q ss_pred HHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccccc
Q psy6905 202 RVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM 279 (527)
Q Consensus 202 ~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~ 279 (527)
+++. ...++...++.++.+++.||.|||+++ ++||||+|+|||++.+ +.++|+|||++.........
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~--------~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGEN--------NVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCC--------CcEEEeeccccccccCCcce
Confidence 9985 345788899999999999999999995 9999999999999875 68999999999765321111
Q ss_pred ----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHH
Q psy6905 280 ----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 280 ----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li 354 (527)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+. .....+.|..+|..+.+++
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 228 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLM 228 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHH
Confidence 1223567999999998889999999999999999999 899998877655554443 3445667788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHh
Q psy6905 355 EACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 355 ~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
.+||..+|.+||++.++++.|+
T Consensus 229 ~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 229 LQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHhccChhhCcCHHHHHHHhh
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.95 Aligned_cols=246 Identities=26% Similarity=0.316 Sum_probs=197.6
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC------C
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS------P 186 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~ 186 (527)
.++|++.+.||+|+||.||+|.+ .++.||||.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 46899999999999999999987 46789999887542 333456778899999999999999999998643 3
Q ss_pred eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 187 KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
..|+|||||++ +|...+. ..++...+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 96 ~~~lv~e~~~~-~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~--------~~~kl~D 162 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD--------CTLKILD 162 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCC--------CCEEEee
Confidence 57999999965 5666554 35888899999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Q psy6905 267 FGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN--------- 336 (527)
Q Consensus 267 FGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~--------- 336 (527)
||+++...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 163 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred CcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99998654322 23456899999999999989999999999999999999999999887644332221110
Q ss_pred -------------C-----cc-------------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 -------------K-----LT-------------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 -------------~-----~~-------------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. .. ...+...+..+.+||.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 00 00112235678999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=324.85 Aligned_cols=247 Identities=27% Similarity=0.363 Sum_probs=200.7
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|.+.+.||.|+||.||+|.+. ++.||+|.+...........+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 467999999999999999999874 578999988755433334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|+. ++|..++. ...+++..+..++.||+.||.|||++| ++||||||+|||++.+ +.++|+|||++.
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~--------~~~kl~dfg~~~ 152 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINER--------GELKLADFGLAR 152 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCC--------CcEEECcCcchh
Confidence 996 58888775 456888999999999999999999995 9999999999999875 689999999987
Q ss_pred hhhccc--cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Q psy6905 272 EVYKTT--HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------------ 336 (527)
Q Consensus 272 ~~~~~~--~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------------ 336 (527)
...... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 153 AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred ccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 643221 2234578999999998654 4788999999999999999999999887654433222110
Q ss_pred -------CccCC---------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 -------KLTLP---------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 -------~~~~~---------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+ ....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 113468889999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=325.21 Aligned_cols=255 Identities=35% Similarity=0.611 Sum_probs=212.8
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--Cc----eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQ----EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
..++|+..+.||+|+||.||+|.+. +. .||+|.+...........+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 4567888999999999999999873 33 47999887665545456788999999999999999999998754 46
Q ss_pred EEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 189 CLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
++++||+++|+|.+++.. ..++...++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~--------~~~kL~D 152 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSP--------NHVKITD 152 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCC--------CceEEcc
Confidence 899999999999999863 35788899999999999999999994 9999999999999865 5899999
Q ss_pred cCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 267 FGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 267 FGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
||+++....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+......... ...+...+
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~ 231 (303)
T cd05110 153 FGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-LEKGERLP 231 (303)
T ss_pred ccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHCCCCCC
Confidence 999986532211 12345778999999998889999999999999999998 9999988765544333 33455666
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
.+..++..+.+++..||..+|++||++.++++.|..+....
T Consensus 232 ~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 232 QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 77788999999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.22 Aligned_cols=246 Identities=25% Similarity=0.315 Sum_probs=198.8
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC------C
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS------P 186 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~ 186 (527)
.++|.+.+.||+|+||.||+|.+ .++.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46799999999999999999987 45789999887542 233456778999999999999999999987543 3
Q ss_pred eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 187 KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
.+|+||||+.+ +|...+. ..++...+..++.|++.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~--------~~~kL~D 169 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD--------CTLKILD 169 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCC--------CcEEEEe
Confidence 57999999965 6666664 35788899999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc------
Q psy6905 267 FGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT------ 339 (527)
Q Consensus 267 FGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~------ 339 (527)
||+++...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...-..
T Consensus 170 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99998654322 22456899999999999999999999999999999999999999987765544433211000
Q ss_pred ------------------------------C----CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 ------------------------------L----PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ------------------------------~----~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. ......+..+.+||.+||..||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0011134578999999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=320.90 Aligned_cols=251 Identities=35% Similarity=0.552 Sum_probs=204.1
Q ss_pred CCceeeeeeeccCCceEEEEeeE------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe--CCe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--SPK 187 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~ 187 (527)
..+|++.+.||+|+||.||+|.+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 45788999999999999999874 35689999987553 3345678899999999999999999998754 456
Q ss_pred EEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
+++||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++| ++||||||+|||++.+ +.+||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~--------~~~~l~ 150 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESE--------NRVKIG 150 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCC--------CeEEEC
Confidence 8999999999999999863 45889999999999999999999995 9999999999999875 689999
Q ss_pred ccCcchhhhccccc-----cCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH------------
Q psy6905 266 DFGLAREVYKTTHM-----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYA------------ 328 (527)
Q Consensus 266 DFGla~~~~~~~~~-----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~------------ 328 (527)
|||+++........ ...++..|+|||.+.+..++.++|||||||++|||++|..|+.......
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQM 230 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccccc
Confidence 99999866432211 1123456999999998889999999999999999999877764332110
Q ss_pred ---HHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 329 ---VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 329 ---~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
............+.+..++..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 01122233445566778999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=334.84 Aligned_cols=246 Identities=27% Similarity=0.373 Sum_probs=200.3
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeC------C
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQS------P 186 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~ 186 (527)
.++|.+.+.||.|+||.||+|.+ .++.||||.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 36799999999999999999987 456899998875432 22345677899999999999999999987543 4
Q ss_pred eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 187 KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
..|+++|++ +++|.+++..+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~--------~~~kl~D 161 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNED--------CELRILD 161 (343)
T ss_pred cEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCC--------CCEEEcC
Confidence 579999998 889999998888999999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Q psy6905 267 FGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-------- 337 (527)
Q Consensus 267 FGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~-------- 337 (527)
||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 162 fg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 162 FGLARQADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred CccceecCCC-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9999865432 234578999999999876 568899999999999999999999998766544333221100
Q ss_pred --------------cc-CC------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 --------------LT-LP------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 --------------~~-~~------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. .+ ....+++.+.+|+.+||..||.+|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00 012356678899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=317.77 Aligned_cols=240 Identities=31% Similarity=0.523 Sum_probs=194.5
Q ss_pred eeccCCceEEEEeeEc----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCC
Q psy6905 124 AIGEGGFGKVYKGIYE----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGP 199 (527)
Q Consensus 124 ~iG~G~fg~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggs 199 (527)
.||+|+||.||+|... ...+|+|.+...........+.+|+.+++.++||||+++++++.....+|+||||+.+|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5999999999999752 246889987655444455678899999999999999999999999999999999999999
Q ss_pred HHHHhcCC------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 200 LNRVLAGR------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 200 L~~~l~~~------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|.+++... ..++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~--------~~~kl~dfg~~~~~ 150 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTAD--------LSVKIGDYGLALEQ 150 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCC--------CcEEEecccccccc
Confidence 99998632 2356778899999999999999994 9999999999999875 68999999998654
Q ss_pred hccc----cccCCCcccccccccccc-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-ccC
Q psy6905 274 YKTT----HMSAAGTYAWMAPEVIKT-------SIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK-LTL 340 (527)
Q Consensus 274 ~~~~----~~~~~gt~~y~aPE~l~~-------~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~ 340 (527)
.... .....+++.|+|||++.. ..++.++|||||||++|||++ |..||...........+.... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 230 (269)
T cd05042 151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL 230 (269)
T ss_pred ccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC
Confidence 2211 122346778999999743 356889999999999999999 889998877666555443322 222
Q ss_pred C---CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 341 P---IPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 341 ~---~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
+ .+..++..+.+++..|| .||++||++.++++.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 231 PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 2 33567899999999999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=321.30 Aligned_cols=252 Identities=37% Similarity=0.611 Sum_probs=210.5
Q ss_pred CCceeeeeeeccCCceEEEEeeEc------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe--CCe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--SPK 187 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~ 187 (527)
...|++.+.||+|+||.||+|.+. +..||||++...........+.+|+.+++.+.||||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 467888899999999999999863 468999998876544346788999999999999999999999887 567
Q ss_pred EEEEEeccCCCCHHHHhcCC--CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLAGR--KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~--~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.++||||+++++|.+++... .++...+..++.|++.||+|||++| ++|+||||+|||++.+ +.++|+
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~--------~~~~l~ 151 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESE--------DLVKIS 151 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCC--------CCEEEc
Confidence 89999999999999999744 4899999999999999999999995 9999999999999875 689999
Q ss_pred ccCcchhhhccccc-----cCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-------------
Q psy6905 266 DFGLAREVYKTTHM-----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY------------- 327 (527)
Q Consensus 266 DFGla~~~~~~~~~-----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~------------- 327 (527)
|||++......... ...++..|+|||.+.+..++.++|||||||++|+|++|..||......
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI 231 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccccc
Confidence 99999876422111 123466799999998888999999999999999999999998654221
Q ss_pred -HHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 328 -AVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 328 -~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
.............+.+..++..+.+++.+||..+|.+||++.++++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 112223334455666788899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=326.23 Aligned_cols=247 Identities=27% Similarity=0.411 Sum_probs=210.2
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh--hHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE--NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||+|+||.||+|... ++.||+|.+...... .....+..|+.+++.++||||+++++.+.++...|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36889999999999999999874 578999988765322 24567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 193 EYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 193 Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
||+.|++|.+++.. ..+++..+..++.||+.||.|||+.| ++|+||||+|||++.+ +.++|+|||+
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~--------~~~~l~dfg~ 149 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHES--------GHIMLSDFDL 149 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCC--------CCEEEeecch
Confidence 99999999999863 46899999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhccc-------------------------------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCC
Q psy6905 270 AREVYKTT-------------------------------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGE 318 (527)
Q Consensus 270 a~~~~~~~-------------------------------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~ 318 (527)
+....... .....||..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 86542111 01235788999999999888999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCC----HHHHHHH
Q psy6905 319 IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPS----FKTILKA 374 (527)
Q Consensus 319 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs----~~~ll~~ 374 (527)
.||.+.+.......+.......+.....+..+.++|.+||..||++||+ +.+++.+
T Consensus 230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 230 TPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 9999888777666665544444444447999999999999999999999 7777763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=317.15 Aligned_cols=246 Identities=29% Similarity=0.506 Sum_probs=205.6
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC----ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe--CCeE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP----DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--SPKL 188 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~ 188 (527)
.+|++.+.||+|+||.||+|.+ .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999986 46789999876432 22335678899999999999999999999875 3678
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+++|||+.+++|.+++. ...++....+.++.|++.||.|||+.+ ++||||+|+||+++.+ +.++|+||
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~--------~~~~l~df 150 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSA--------GNVKLGDF 150 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCC--------CCEEEccC
Confidence 99999999999999886 456889999999999999999999984 9999999999999875 58999999
Q ss_pred Ccchhhhcc-----ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 268 GLAREVYKT-----THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 268 Gla~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
|+++..... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.....................
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (266)
T cd06651 151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL 230 (266)
T ss_pred CCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCC
Confidence 998755321 112245889999999999888999999999999999999999999887766655555444444556
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
|..+++.+.+++ .||..+|++||++.+++++
T Consensus 231 ~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 231 PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 777889999999 6788899999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=319.54 Aligned_cols=246 Identities=37% Similarity=0.650 Sum_probs=205.1
Q ss_pred eeccCCceEEEEeeEcC--------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 124 AIGEGGFGKVYKGIYEK--------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 124 ~iG~G~fg~Vy~~~~~~--------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
.||+|+||.||+|.+.. ..+|||.+...........+.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 59999999999998642 4689998766543344667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcC--------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 196 RGGPLNRVLAG--------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 196 ~ggsL~~~l~~--------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
++|+|.+++.. ..++...++.++.||+.||.|||+.+ ++|+||+|+|||++.+..+ ....++|+||
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~---~~~~~~l~df 155 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYD---ADRVVKIGDF 155 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCC---CCcceEECCc
Confidence 99999998852 23677889999999999999999984 9999999999999875211 1137999999
Q ss_pred Ccchhhhccccc----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 268 GLAREVYKTTHM----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 268 Gla~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
|+++........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+. .+.....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~ 234 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQK 234 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCC
Confidence 999765332211 2245788999999999899999999999999999998 999998877766655543 3445566
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
+..+|..+.++|.+||..+|.+||++.++++.|+
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7788999999999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=315.90 Aligned_cols=246 Identities=27% Similarity=0.499 Sum_probs=205.6
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC----ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--CeE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP----DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS--PKL 188 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~ 188 (527)
.+|.+.+.||+|+||.||+|.+. +..||||.+.... .......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999873 5789999875321 123356788999999999999999999998763 568
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+++|||+++|+|.+++. ...+++..++.++.|++.||.|||+++ ++|+||+|+|||++.+ +.++|+||
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~--------~~~~l~Df 150 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSV--------GNVKLGDF 150 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCC--------CCEEECcC
Confidence 89999999999999886 456888999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhcc-----ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 268 GLAREVYKT-----THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 268 Gla~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
|+++..... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.................
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd06652 151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVL 230 (265)
T ss_pred ccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCC
Confidence 998755321 122346889999999998888999999999999999999999999887665555554444444556
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
|...+..+.+++.+||. +|..||++.+++++
T Consensus 231 ~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 231 PPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 77788889999999994 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=313.35 Aligned_cols=246 Identities=26% Similarity=0.432 Sum_probs=210.3
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|.+.+.||.|+||.||++.. .++.+|+|.+.... .......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478899999999999999887 45789999876542 233467788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 195 ARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 195 ~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+++++|.+++.. ..+++..+..++.|++.||.|||++| ++|+||+|+||+++.+ .+.++|+|||++.
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~-------~~~~~l~d~~~~~ 150 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKH-------KMVVKIGDFGISK 150 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC-------CCEEEEccCCCce
Confidence 999999999863 34788999999999999999999994 9999999999999764 2468999999998
Q ss_pred hhhcccc-ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHH
Q psy6905 272 EVYKTTH-MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLF 350 (527)
Q Consensus 272 ~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 350 (527)
....... ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+... ...+++..++..+
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 229 (256)
T cd08220 151 ILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-TFAPISDRYSPDL 229 (256)
T ss_pred ecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-CCCCCCCCcCHHH
Confidence 6643322 2346889999999999888899999999999999999999999887766665555433 3346677899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+++.+||..+|.+|||+.+++.+
T Consensus 230 ~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 230 RQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=325.59 Aligned_cols=246 Identities=31% Similarity=0.499 Sum_probs=208.9
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
.+|.+.+.||.|+||.||+|.+ .++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++..+...|+||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 6789999999999999999986 4689999988654332 246678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 195 ~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
+++++|.+++....+++..+..++.|++.||.|||+.| ++||||||+|||++.+ +.++|+|||++....
T Consensus 98 ~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~--------~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMD--------GSVKLTDFGFCAQIT 166 (297)
T ss_pred cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC--------CCEEECcCccceEcc
Confidence 99999999998778899999999999999999999995 9999999999999875 689999999987653
Q ss_pred cccc--ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-ccCCCCCCccHHHH
Q psy6905 275 KTTH--MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPSTCPQLFK 351 (527)
Q Consensus 275 ~~~~--~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~~~ 351 (527)
.... ....+++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+...+ .....|..++..+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFR 246 (297)
T ss_pred CCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHH
Confidence 2221 23468899999999998889999999999999999999999998765544333332222 12234567889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 352 TLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++.+||..+|++||++.+++++
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.81 Aligned_cols=246 Identities=30% Similarity=0.523 Sum_probs=208.6
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|++.+.||.|+||.||++.+. ++.||+|.+...........+.+|+.+++.++||||+++++++..+...|+++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999985 6789999887765555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 195 ARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHC-QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 195 ~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~-~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+.+++|.+++.. ..+++..+..++.|++.||+|||+ . +++|+||+|+||+++.+ +.++|+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~--------~~~~l~d~g~~~ 149 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSR--------GQIKLCDFGVSG 149 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCC--------CCEEEeecccch
Confidence 999999999873 678899999999999999999999 7 49999999999999985 689999999987
Q ss_pred hhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCccCCCCCC-
Q psy6905 272 EVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN-----AYAVAYGVAVNKLTLPIPST- 345 (527)
Q Consensus 272 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~-----~~~~~~~i~~~~~~~~~p~~- 345 (527)
...........++..|+|||.+.+..++.++||||||+++|+|++|..||...+ .......+. .......+..
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (265)
T cd06605 150 QLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGK 228 (265)
T ss_pred hhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhh
Confidence 664433333678999999999999899999999999999999999999997652 222222222 2223334444
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++..+.++|.+||..||.+|||+.+++.+
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 88999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=313.53 Aligned_cols=245 Identities=24% Similarity=0.424 Sum_probs=210.7
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|++.+.||.|+||.||.+.. +++.+++|.+.... .......+.+|+.++++++|+||+++++++.+...++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 488899999999999988776 46789999876542 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 195 ARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 195 ~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|++|+|.+++.. ..+++..+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.+||+|||++.
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~--------~~~kl~d~~~~~ 149 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKA--------GLIKLGDFGISK 149 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCC--------CCEEECcCcceE
Confidence 999999999863 35889999999999999999999984 9999999999999875 689999999987
Q ss_pred hhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 272 EVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 272 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+...... +.+..++..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 228 (256)
T cd08221 150 ILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVYSSE 228 (256)
T ss_pred EcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCccccCHH
Confidence 653322 22346899999999998888899999999999999999999999988777766666544433 455778999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+++.+||..+|.+||++.+++++
T Consensus 229 ~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 229 LISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHHHHcccCcccCCCHHHHhhC
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.59 Aligned_cols=244 Identities=26% Similarity=0.467 Sum_probs=196.5
Q ss_pred eeeccCCceEEEEeeEcC---------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 123 EAIGEGGFGKVYKGIYEK---------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~---------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
+.||.|+||.||+|.+.. ..||+|...... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 469999999999998632 248888775432 2335678889999999999999999999999899999999
Q ss_pred ccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||.+|+|..++.. ..+++..++.++.||+.||+|||+.| |+||||||+|||++.+........+.++++|||++.
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999999873 35788999999999999999999995 999999999999987532211223458999999986
Q ss_pred hhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 272 EVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTG-EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 272 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++| ..||...+...... ... .....|...+.+
T Consensus 157 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~ 231 (258)
T cd05078 157 TVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPAPKWTE 231 (258)
T ss_pred ccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH--ccccCCCCCcHH
Confidence 5532 223467889999999986 4578999999999999999998 57776655544322 221 233566677789
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
+.++|.+||+.||++|||+.+|++.|
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHhc
Confidence 99999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=318.54 Aligned_cols=245 Identities=33% Similarity=0.559 Sum_probs=211.2
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
-|++.+.||.|+||.||+|.+ .+..||||+............+.+|+.++..++||||+++++++.++...|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 467788999999999999986 457899998876544455677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 196 RGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 196 ~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
.+|+|.+++....++...+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~--------~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEH--------GEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCC--------CCEEEeecccceeccc
Confidence 9999999998888999999999999999999999985 9999999999999875 6899999999876533
Q ss_pred cc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHH
Q psy6905 276 TT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTL 353 (527)
Q Consensus 276 ~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~l 353 (527)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.. ......+..++.++.++
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (277)
T cd06641 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEF 232 (277)
T ss_pred chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCcccCHHHHHH
Confidence 21 2234688899999999888889999999999999999999999988776555554432 33334566789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q psy6905 354 MEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 354 i~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+||..+|.+||++.+++.+
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 233 VEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHccCChhhCcCHHHHHhC
Confidence 999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=328.04 Aligned_cols=243 Identities=20% Similarity=0.360 Sum_probs=195.2
Q ss_pred eeeeeccC--CceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 121 FGEAIGEG--GFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 121 ~~~~iG~G--~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
++++||+| +||+||++.+ +++.||+|.+.... .......+.+|+.+++.++||||+++++++..++..|+|||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7889999987 46789999987653 2344567788999999999999999999999999999999999
Q ss_pred CCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 196 RGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 196 ~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
++|+|.+++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.++++|||.+..
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~--------~~~~l~~~~~~~~ 150 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVD--------GKVYLSGLRSNLS 150 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecC--------CcEEEcccchhhc
Confidence 9999999986 245889999999999999999999995 9999999999999875 6899999987544
Q ss_pred hhccc---------cccCCCcccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc--
Q psy6905 273 VYKTT---------HMSAAGTYAWMAPEVIKT--SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT-- 339 (527)
Q Consensus 273 ~~~~~---------~~~~~gt~~y~aPE~l~~--~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~-- 339 (527)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||..................
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (327)
T cd08227 151 MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 230 (327)
T ss_pred cccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccc
Confidence 32110 112346788999999976 45889999999999999999999999876544433222111000
Q ss_pred ------------------------------------------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 ------------------------------------------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ------------------------------------------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+....+++.+.+|+.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 01122356789999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=353.57 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=206.0
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|.+.+.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999874 6789999987542 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhcC------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccc
Q psy6905 193 EYARGGPLNRVLAG------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260 (527)
Q Consensus 193 Ey~~ggsL~~~l~~------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~ 260 (527)
|||+||+|.+++.. ..++...++.++.||+.||.|||++| |+||||||+|||++.+ +
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~d--------g 150 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLF--------G 150 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCC--------C
Confidence 99999999998752 12445677889999999999999995 9999999999999875 6
Q ss_pred eeEEeccCcchhhhcc--------------------ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCC
Q psy6905 261 TLKITDFGLAREVYKT--------------------THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP 320 (527)
Q Consensus 261 ~vkL~DFGla~~~~~~--------------------~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~P 320 (527)
.++|+|||+++..... .....+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 8999999999765110 00123689999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhC-CccCCCCCCccHHHHHHHHHhhhhCCCCCC-CHHHHHHHHhhhhhc
Q psy6905 321 YKSINAYAVAYGVAVN-KLTLPIPSTCPQLFKTLMEACWEADSHMRP-SFKTILKALNNIVHS 381 (527)
Q Consensus 321 f~~~~~~~~~~~i~~~-~~~~~~p~~~~~~~~~li~~~l~~dp~~RP-s~~~ll~~L~~~~~~ 381 (527)
|...+........... .........+|+.+.+++.+||..||.+|| ++.++++.|+.....
T Consensus 231 F~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 231 YRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9876544333221111 111112246789999999999999999996 567777777776653
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=315.90 Aligned_cols=241 Identities=31% Similarity=0.495 Sum_probs=193.5
Q ss_pred eeccCCceEEEEeeEcC----ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCC
Q psy6905 124 AIGEGGFGKVYKGIYEK----QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGP 199 (527)
Q Consensus 124 ~iG~G~fg~Vy~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggs 199 (527)
.||+|+||.||+|.+.+ ..+|+|.+...........+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 59999999999998642 46899988766544445678889999999999999999999999889999999999999
Q ss_pred HHHHhcC------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 200 LNRVLAG------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 200 L~~~l~~------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|.+++.. ...+...+..++.|++.||+|||+.+ ++||||||+||+++.+ +.+||+|||++...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~--------~~~kL~dfg~~~~~ 150 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTAD--------LTVKIGDYGLSHNK 150 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCC--------CcEEECCccccccc
Confidence 9998862 13456677889999999999999995 9999999999999875 68999999998754
Q ss_pred hccc----cccCCCccccccccccccC-------CCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH-hCCccC
Q psy6905 274 YKTT----HMSAAGTYAWMAPEVIKTS-------IFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVA-VNKLTL 340 (527)
Q Consensus 274 ~~~~----~~~~~gt~~y~aPE~l~~~-------~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~-~~~~~~ 340 (527)
.... .....++..|+|||++.+. .++.++|||||||++|||++ |..||......+...... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (269)
T cd05087 151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL 230 (269)
T ss_pred cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC
Confidence 3221 1123578889999998642 35789999999999999997 999998776655443322 222222
Q ss_pred CCC---CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 341 PIP---STCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 341 ~~p---~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
+.| ..+++.+.++|..|| .+|++|||+.+|+..|.
T Consensus 231 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 323 356888999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=313.03 Aligned_cols=245 Identities=27% Similarity=0.467 Sum_probs=206.9
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe-CCeEEEEEe
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ-SPKLCLVME 193 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~~~iv~E 193 (527)
.|++.+.||.|+||.||++.+. ++.||+|.+.... .....+.+.+|+.+++.++|+|++++++.+.. +..+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999874 5689999886542 23345678899999999999999999998864 456899999
Q ss_pred ccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 194 YARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 194 y~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||++++|.+++. ...+++.+++.++.|++.||.|||++| ++||||+|+||+++.+ +.++|+|||++
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~--------~~~~l~df~~~ 149 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRT--------NIIKVGDLGIA 149 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecC--------CcEEEecccce
Confidence 999999998886 345899999999999999999999995 9999999999999875 68999999998
Q ss_pred hhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 271 REVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 271 ~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
....... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... ...+.+..+++
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG-KLPPMPKDYSP 228 (257)
T ss_pred EEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCccccCH
Confidence 7653322 12346889999999999988999999999999999999999999887766665555433 33356677899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.+++.+||+.||.+||++.+++.+
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcC
Confidence 99999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=314.36 Aligned_cols=246 Identities=30% Similarity=0.532 Sum_probs=209.9
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC----ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP----DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
+|+..+.||+|+||.||+|.+. +..|++|.+.... .....+.+.+|+.+++.++|+||+++++++.++..+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999974 6789999875532 123457788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||+++++|.+++. ...+++..+..++.||+.||.|||+.| ++|+||+|+||+++.+ +.+||+|||++
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~--------~~~kl~d~~~~ 149 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTN--------GVVKLADFGMA 149 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC--------CCEEEccCccc
Confidence 99999999999987 445889999999999999999999995 9999999999999875 68999999998
Q ss_pred hhhhccc-cccCCCccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 271 REVYKTT-HMSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 271 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
....... .....|+..|+|||.+.... ++.++|+|||||++|+|++|..||...........+........+|..+++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence 7653332 23456899999999987766 899999999999999999999999887765555555443444456778899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.+++.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 99999999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=316.43 Aligned_cols=243 Identities=26% Similarity=0.454 Sum_probs=193.4
Q ss_pred eeeccCCceEEEEeeEcC--------------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 123 EAIGEGGFGKVYKGIYEK--------------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
+.||+|+||.||+|.+.. ..|++|++.... ......+.+|+.+++.++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 369999999999997521 258899876543 23456778899999999999999999999999899
Q ss_pred EEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 189 CLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
++||||+++|+|..++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+... ......++++|
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~-~~~~~~~~l~d 155 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGID-GECGPFIKLSD 155 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCcc-CCCCceeEeCC
Confidence 99999999999998886 356899999999999999999999995 9999999999999764211 01113489999
Q ss_pred cCcchhhhccccccCCCccccccccccc-cCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 267 FGLAREVYKTTHMSAAGTYAWMAPEVIK-TSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 267 FGla~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
||++..... .....++..|+|||.+. +..++.++|||||||++|+|++ |..||......+... ..... .....
T Consensus 156 ~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~--~~~~~ 230 (262)
T cd05077 156 PGIPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQ--CMLVT 230 (262)
T ss_pred CCCCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcC--ccCCC
Confidence 999865532 22346788999999986 4668999999999999999985 999998765443322 11122 22333
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
..+.++.+||.+||+.||.+||++.+|++.|
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 4567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=318.56 Aligned_cols=242 Identities=25% Similarity=0.431 Sum_probs=193.9
Q ss_pred eeccCCceEEEEeeEc--------------------------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccce
Q psy6905 124 AIGEGGFGKVYKGIYE--------------------------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177 (527)
Q Consensus 124 ~iG~G~fg~Vy~~~~~--------------------------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~ 177 (527)
.||+|+||.||+|.+. ...||+|++..... .....+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 5999999999998741 12488998865432 33466888999999999999999
Q ss_pred EEEEEEeCCeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccc
Q psy6905 178 LIGVCLQSPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENE 255 (527)
Q Consensus 178 ~~~~~~~~~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~ 255 (527)
+++++.+....|+|||||++|+|..++. .+.+++..++.++.||+.||+|||+++ |+||||||+|||++.....
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~- 156 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA- 156 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc-
Confidence 9999999999999999999999999886 456899999999999999999999994 9999999999999764211
Q ss_pred ccccceeEEeccCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHH-hCCCCCCCCCHHHHHHHH
Q psy6905 256 DLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELL-TGEIPYKSINAYAVAYGV 333 (527)
Q Consensus 256 ~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~ell-tg~~Pf~~~~~~~~~~~i 333 (527)
+.....+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.+..........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred cCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 111245899999998654221 22457889999998865 56899999999999999995 599999877654433222
Q ss_pred HhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 334 AVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 334 ~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
.. ....|...++.+.++|.+||..+|++|||+.++++.|
T Consensus 235 -~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 235 -EK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -Hh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11 2234455667899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=315.00 Aligned_cols=244 Identities=31% Similarity=0.541 Sum_probs=208.5
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|++.+.||+|+||.||+|.+. +..|++|.+..... ...+.+|+.+++.++||||+++++++.....+|+++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 367899999999999999999985 57899999865422 6788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|+.+++|.+++. +..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.+ +.++|+|||++.
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~--------~~~~l~dfg~~~ 147 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEE--------GQAKLADFGVSG 147 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCC--------CcEEEcccccch
Confidence 999999999986 556899999999999999999999995 9999999999999875 689999999998
Q ss_pred hhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CccCCCCCCccH
Q psy6905 272 EVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLPIPSTCPQ 348 (527)
Q Consensus 272 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~ 348 (527)
...... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+... ......+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd06612 148 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSP 227 (256)
T ss_pred hcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCH
Confidence 764332 22345889999999999888999999999999999999999999877665544333221 112334556788
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.+.++|.+||..||.+|||+.+++.
T Consensus 228 ~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 228 EFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHHHhcChhhCcCHHHHhc
Confidence 9999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=320.62 Aligned_cols=245 Identities=27% Similarity=0.356 Sum_probs=193.4
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh-hHHHHHHHHHHHHHhC---CCCccceEEEEEEe-----CC
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE-NILENVKQEGKLLWLF---DHRNIVSLIGVCLQ-----SP 186 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l---~hpnIv~~~~~~~~-----~~ 186 (527)
+|.+.+.||+|+||.||+|.+. ++.||+|.+...... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788999999999999999874 678999988653211 1123445666666554 79999999999864 34
Q ss_pred eEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 187 KLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
.+++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.+ +.+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~--------~~~k 148 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSG--------GQVK 148 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC--------CCEE
Confidence 5899999996 578877753 35899999999999999999999995 9999999999999875 6899
Q ss_pred EeccCcchhhhcccc-ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----
Q psy6905 264 ITDFGLAREVYKTTH-MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK----- 337 (527)
Q Consensus 264 L~DFGla~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~----- 337 (527)
|+|||+++....... ....||..|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 149 LADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred ECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 999999976643222 23468999999999998889999999999999999999999998776554443332100
Q ss_pred ------ccC--------------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 ------LTL--------------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 ------~~~--------------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
... .....++..+.+++.+||+.||.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0113467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=321.96 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=206.4
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC--hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD--ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||+|+||.||++.+. ++.|++|.+..... ......+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999874 46899998865431 233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||+.||+|.+++. .+.+++..+..++.|++.||.|||++| ++||||||+|||++.+ +.++|+|||+++
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~--------~~~~l~dfg~~~ 149 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSM--------GHIKLTDFGLSK 149 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCC--------CCEEEeeCCCcc
Confidence 9999999999987 466889999999999999999999994 9999999999999875 689999999986
Q ss_pred hhhcc-----------------ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6905 272 EVYKT-----------------THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA 334 (527)
Q Consensus 272 ~~~~~-----------------~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 334 (527)
..... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 32100 0012357889999999988889999999999999999999999999887777666655
Q ss_pred hCCccCCC-CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 335 VNKLTLPI-PSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 335 ~~~~~~~~-p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
......+. +..+|.++.++|.+||+.||.+||++.++.+.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 230 SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred hcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 44333332 235789999999999999999999965555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=318.28 Aligned_cols=246 Identities=26% Similarity=0.451 Sum_probs=195.9
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHH-HHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKL-LWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|.+.+.||+|+||.||+|.+. +..||||.+...........+..|..+ ++.++||||+++++++..+..+|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999984 678999988765433333445555554 667799999999999999999999999
Q ss_pred ccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 194 YARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 194 y~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|++ |+|.+++. +..+++..+..++.||+.||.|||++. +++||||||+|||++.+ +.+||+|||
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~--------~~~kl~dfg 149 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRN--------GQVKLCDFG 149 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCC--------CCEEEeecc
Confidence 995 67877664 246889999999999999999999872 49999999999999875 689999999
Q ss_pred cchhhhcccc-ccCCCcccccccccccc----CCCCcccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCccCCC
Q psy6905 269 LAREVYKTTH-MSAAGTYAWMAPEVIKT----SIFSKASDVWSYGVVLWELLTGEIPYKSIN-AYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 269 la~~~~~~~~-~~~~gt~~y~aPE~l~~----~~~~~ksDvwSlGv~l~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~ 342 (527)
++........ ....|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.... ..+....+.. ......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 228 (283)
T cd06617 150 ISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQL 228 (283)
T ss_pred cccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCC
Confidence 9986543222 22468899999998865 446889999999999999999999997543 2233333322 222233
Q ss_pred C-CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 343 P-STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 343 p-~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
| ..+|.++.++|.+||..+|.+||++.+++.+
T Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3 4578999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=343.30 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=194.0
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCC------CccceEEEEEEe
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH------RNIVSLIGVCLQ 184 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h------pnIv~~~~~~~~ 184 (527)
++...+|++.+.||+|+||.||+|.+ .++.||||++.... ........|+.++..+.| .+|+++++++..
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 34467899999999999999999987 45789999986432 223445566777666544 568899998876
Q ss_pred C-CeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccc------
Q psy6905 185 S-PKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENED------ 256 (527)
Q Consensus 185 ~-~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~------ 256 (527)
. .++|+|||++ |++|.+++. .+.+++..+..++.||+.||.|||++. +||||||||+|||++.+....+
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccccc
Confidence 4 5789999998 777877765 567999999999999999999999742 4999999999999986421100
Q ss_pred --cccceeEEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6905 257 --LQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA 334 (527)
Q Consensus 257 --~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 334 (527)
.....+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred cCCCCceEEECCCCccccCc-cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 011359999999886432 22335679999999999999999999999999999999999999998876554433221
Q ss_pred hCCccCC--------------------------CC--------------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 335 VNKLTLP--------------------------IP--------------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 335 ~~~~~~~--------------------------~p--------------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....++ .| ...++.+.+||..||..||.+|||+.++++|
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 1100000 00 0113567899999999999999999999984
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=319.11 Aligned_cols=245 Identities=28% Similarity=0.376 Sum_probs=198.6
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|.+.+.||+|+||.||+|.+ ++..||||.+.... .......+.+|+.+++.++||||+++++++.++..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478899999999999999987 46789999886542 222346678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhc----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 195 ARGGPLNRVLA----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 195 ~~ggsL~~~l~----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
+. ++|.+++. +..+++..+..++.||+.||.|||++| ++||||+|+|||++.+ +.++|+|||++
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~--------~~~~l~dfg~~ 148 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNK--------GVIKLADFGLA 148 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCC--------CcEEECcccce
Confidence 96 67877775 256899999999999999999999994 9999999999999875 68999999998
Q ss_pred hhhhccc--cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Q psy6905 271 REVYKTT--HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN----------- 336 (527)
Q Consensus 271 ~~~~~~~--~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~----------- 336 (527)
....... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 149 RAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred eecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 7543221 1234578999999998654 4789999999999999999999999877654433322110
Q ss_pred ----------------CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ----------------KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ----------------~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.........+++++.++|.+||..||.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00001123578899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=313.29 Aligned_cols=247 Identities=28% Similarity=0.496 Sum_probs=208.3
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|++.+.||.|+||.||+|.+ ++..+|+|++...........+.+|+.+++.++|+||+++++.+..+...|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688999999999999999987 45689999987654334567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC----CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 195 ARGGPLNRVLAG----RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 195 ~~ggsL~~~l~~----~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
+.+++|.+++.. ..+++..+..++.|++.||.|||++| ++||||+|+||+++.+ +.++|+|||++
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~--------~~~~l~df~~~ 149 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGED--------GSVKIADFGVS 149 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCC--------CCEEEcccchH
Confidence 999999999863 45889999999999999999999995 9999999999999875 68999999998
Q ss_pred hhhhcccc------ccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCC
Q psy6905 271 REVYKTTH------MSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPI 342 (527)
Q Consensus 271 ~~~~~~~~------~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~ 342 (527)
........ ....|+..|+|||++... .++.++|+|||||++|+|++|+.||...+............. ..+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLET 229 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCC
Confidence 76643221 234688999999998776 789999999999999999999999988776655554443221 1111
Q ss_pred C---CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 343 P---STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 343 p---~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. ..+++.+.+++..||..||++||++.+|+++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1 3578899999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=318.73 Aligned_cols=246 Identities=30% Similarity=0.511 Sum_probs=201.5
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEe------C
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQ------S 185 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~------~ 185 (527)
..+.|++.+.||.|+||.||+|.+ .++.||+|+..... .....+..|+.+++.+ +|+||+++++++.. .
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 346788899999999999999997 45789999876542 2345677899999888 79999999999853 4
Q ss_pred CeEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 186 PKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
..+|++||||.+|+|.+++. ...+++..+..++.||+.||.|||+.| ++|+||+|+||+++.+ +.+
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~--------~~~ 160 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTEN--------AEV 160 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC--------CCE
Confidence 57899999999999999886 345788889999999999999999995 9999999999999875 689
Q ss_pred EEeccCcchhhhcc--ccccCCCccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6905 263 KITDFGLAREVYKT--THMSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV 335 (527)
Q Consensus 263 kL~DFGla~~~~~~--~~~~~~gt~~y~aPE~l~-----~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 335 (527)
+|+|||++...... ......|++.|+|||.+. +..++.++|||||||++|+|++|..||...........+..
T Consensus 161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 240 (282)
T cd06636 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240 (282)
T ss_pred EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence 99999998765322 223456899999999986 34578899999999999999999999987665544443333
Q ss_pred CCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 336 NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 336 ~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.......+..++..+.++|.+||+.||.+||++.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 22222334568999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=317.19 Aligned_cols=245 Identities=27% Similarity=0.540 Sum_probs=205.9
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC---CCccceEEEEEEeCCeEEEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFD---HRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~~~~~~~~~~~~~iv~ 192 (527)
.|++.+.||.|+||.||+|.+ .+..||+|++...........+.+|+.+++.++ |||++++++++.++...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477888999999999999997 467899999876544445667889999999986 999999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 193 EYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 193 Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||+.|++|.+++..+.+++..++.++.|++.||.|||+.| ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~--------~~~~l~dfg~~~~ 150 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNT--------GNVKLCDFGVAAL 150 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCC--------CCEEEccCCceee
Confidence 9999999999998778999999999999999999999995 9999999999999975 6899999999876
Q ss_pred hhccc--cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC-CccH
Q psy6905 273 VYKTT--HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS-TCPQ 348 (527)
Q Consensus 273 ~~~~~--~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~ 348 (527)
..... .....|+..|+|||.+.++ .++.++|||||||++|+|++|..||.+.........+... ....++. .++.
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 229 (277)
T cd06917 151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSK 229 (277)
T ss_pred cCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCH
Confidence 64322 2234689999999998754 4789999999999999999999999887655444333222 1122333 3788
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.++|.+||..||++||++.+++.+
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 99999999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=318.20 Aligned_cols=247 Identities=30% Similarity=0.536 Sum_probs=201.7
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEE-----eCC
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCL-----QSP 186 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~-----~~~ 186 (527)
..++|++.+.||+|+||.||+|.+ .++.||+|+...... ....+.+|+.+++.+ +||||+++++++. .++
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 457889999999999999999987 457899998765322 235677899999998 7999999999884 345
Q ss_pred eEEEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 187 KLCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
.+|+||||++||+|.+++. +..+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~--------~~ 162 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTE--------GG 162 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCC--------CC
Confidence 7899999999999998764 346788889999999999999999994 9999999999999875 57
Q ss_pred eEEeccCcchhhhcc--ccccCCCcccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6905 262 LKITDFGLAREVYKT--THMSAAGTYAWMAPEVIKT-----SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA 334 (527)
Q Consensus 262 vkL~DFGla~~~~~~--~~~~~~gt~~y~aPE~l~~-----~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 334 (527)
++|+|||+++..... ......|++.|+|||++.. ..++.++|||||||++|+|++|+.||.............
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 999999998765332 2223468999999999853 447889999999999999999999998776544433332
Q ss_pred hCC-ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 335 VNK-LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 335 ~~~-~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
... .....|..++..+.++|.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 211 1233456678899999999999999999999999885
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.38 Aligned_cols=245 Identities=27% Similarity=0.455 Sum_probs=210.1
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|++.+.||+|+||.||++.. .++.||+|.+.... .......+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 488899999999999999987 46789999876432 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 195 ARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 195 ~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+.+++|.+++.. ..+++..++.|+.|++.||.|||++| ++|+||+|+|||++.+ +.++|+|||++.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~--------~~~~l~d~~~~~ 149 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKD--------GTIKLGDFGIAR 149 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCC--------CCEEEeecccee
Confidence 999999988863 35788999999999999999999995 9999999999999875 589999999997
Q ss_pred hhhcccc--ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 272 EVYKTTH--MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 272 ~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
....... ....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.. +...+.|..++.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 228 (256)
T cd08218 150 VLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSYPPVSSHYSYD 228 (256)
T ss_pred ecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc-CCCCCCcccCCHH
Confidence 6533221 134588899999999988899999999999999999999999988777766666653 3344567788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.++|.+||+.+|.+||++.+++++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 229 LRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhhC
Confidence 9999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=317.90 Aligned_cols=247 Identities=29% Similarity=0.407 Sum_probs=202.5
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|++.+.||+|+||.||+|.+. ++.||+|++..... ....+.+.+|+.+++.++||||+++++++..+..+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999974 67899998764422 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|+++++|..++. ...+++..+..++.||+.||.|||+.| ++||||||+||+++.+ +.++|+|||++..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~--------~~~~l~dfg~~~~ 149 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQ--------GQIKLCDFGFARI 149 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCC--------CcEEECcccccee
Confidence 999999988875 456899999999999999999999984 9999999999999875 6899999999986
Q ss_pred hhccc--cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Q psy6905 273 VYKTT--HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------------- 336 (527)
Q Consensus 273 ~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------------- 336 (527)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 150 LTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred cCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 64322 223457889999999876 45789999999999999999999999987765544332210
Q ss_pred ------CccCCCC----------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ------KLTLPIP----------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ------~~~~~~p----------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+.+ ...+..+.+|+.+||..+|++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0011111 2457889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=303.76 Aligned_cols=250 Identities=27% Similarity=0.452 Sum_probs=211.5
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~ 189 (527)
..+.++++++..||+|..|.|+++.+. |...|||.+....+.+..+.++..+.++... ++|.||+.+|+|..+..++
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 345677788899999999999999985 4789999998877666677888888877666 4999999999999999999
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|.||.| ...+..+++ .+.+++..+-.+...++.||.||..+. +|||||+||+|||+++. |++|||||
T Consensus 168 IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~--------GniKlCDF 236 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDER--------GNIKLCDF 236 (391)
T ss_pred HHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccC--------CCEEeecc
Confidence 999998 455666665 567888888899999999999999887 79999999999999986 89999999
Q ss_pred Ccchhhh-ccccccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCccCCC
Q psy6905 268 GLAREVY-KTTHMSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSI-NAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 268 Gla~~~~-~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~ 342 (527)
|++-.+- ...+...+|-+.|||||.+. ...|+.++||||||++++||.||..||.+- ..+++...+... ....+
T Consensus 237 GIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-ePP~L 315 (391)
T KOG0983|consen 237 GISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-EPPLL 315 (391)
T ss_pred cccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-CCCCC
Confidence 9997663 34455678999999999985 446899999999999999999999999985 456777777653 32333
Q ss_pred C--CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 343 P--STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 343 p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
| ..+|++|.+++..||..|+.+||.+.+|+++
T Consensus 316 ~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 3 3489999999999999999999999999885
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.74 Aligned_cols=240 Identities=27% Similarity=0.491 Sum_probs=193.1
Q ss_pred eeccCCceEEEEeeEc-C---ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCC
Q psy6905 124 AIGEGGFGKVYKGIYE-K---QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGP 199 (527)
Q Consensus 124 ~iG~G~fg~Vy~~~~~-~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggs 199 (527)
.||+|+||.||+|... + ..+++|.............+.+|+.+++.++||||+++++.+.+....|+|||||.+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999753 2 24677776655444456788999999999999999999999999999999999999999
Q ss_pred HHHHhcC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 200 LNRVLAG-----RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 200 L~~~l~~-----~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
|.+++.. ..++...+..++.||+.||+|||+.+ ++||||||+|||++.+ +.++|+|||++....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~--------~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSD--------LTVKVGDYGIGPSRY 150 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCC--------ccEEecccccccccC
Confidence 9998863 23556677899999999999999984 9999999999999875 689999999986432
Q ss_pred cc----ccccCCCcccccccccccc-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-c---
Q psy6905 275 KT----THMSAAGTYAWMAPEVIKT-------SIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK-L--- 338 (527)
Q Consensus 275 ~~----~~~~~~gt~~y~aPE~l~~-------~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~-~--- 338 (527)
.. ......++..|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+.... .
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T cd05086 151 KEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF 230 (268)
T ss_pred cchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccC
Confidence 21 1223467899999999743 235789999999999999997 688998877666555543322 1
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
....+..+++.+.+++..|| .+|++||++.++++.|
T Consensus 231 ~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 231 KPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 22334557889999999999 6899999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=322.26 Aligned_cols=246 Identities=26% Similarity=0.436 Sum_probs=205.9
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+.|.....||.|+||.||++.+ ++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..|+||||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 3445567799999999999987 46789999876543 23356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 195 ~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
+++++|.+++..+.+++..+..++.||+.||.|||+++ ++||||||+||+++.+ +.++|+|||++....
T Consensus 101 ~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~--------~~~kL~dfg~~~~~~ 169 (292)
T cd06658 101 LEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSD--------GRIKLSDFGFCAQVS 169 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCC--------CCEEEccCcchhhcc
Confidence 99999999998778999999999999999999999994 9999999999999875 689999999987653
Q ss_pred ccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CccCCCCCCccHHHH
Q psy6905 275 KTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLPIPSTCPQLFK 351 (527)
Q Consensus 275 ~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~~~ 351 (527)
... .....|+..|+|||.+.+..++.++||||||+++|||++|..||...+.......+... ....+.+..++..+.
T Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (292)
T cd06658 170 KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLR 249 (292)
T ss_pred cccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHH
Confidence 222 12346889999999998888999999999999999999999999887765554433221 112223345788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 352 TLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++..||..||.+|||+.+++++
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhC
Confidence 99999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=312.83 Aligned_cols=249 Identities=24% Similarity=0.457 Sum_probs=207.0
Q ss_pred ceeeeeeeccCCceEEEEeeEcC---ceEEEEEcCCC---------CChhHHHHHHHHHHHHHh-CCCCccceEEEEEEe
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPN---------PDENILENVKQEGKLLWL-FDHRNIVSLIGVCLQ 184 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~~---~~vaiK~~~~~---------~~~~~~~~~~~e~~~l~~-l~hpnIv~~~~~~~~ 184 (527)
.|++.+.||+|+||.||+|.+.+ +.+|+|.+... ........+.+|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788999999999999999854 67999977532 122335567788888865 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
++..|++|||+.|++|.+++. ...+++..++.++.|++.||.|||+.+ +++|+||+|+|||++.+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~-------- 150 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGED-------- 150 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCC--------
Confidence 999999999999999988863 346889999999999999999999643 59999999999999875
Q ss_pred ceeEEeccCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Q psy6905 260 KTLKITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 260 ~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
+.++|+|||++....... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.....
T Consensus 151 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 230 (269)
T cd08528 151 DKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY 230 (269)
T ss_pred CcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC
Confidence 689999999997654332 2345689999999999988899999999999999999999999988776666655554443
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
.......+++.+.++|.+||..||++||++.++..++.
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 32223367899999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=312.61 Aligned_cols=241 Identities=29% Similarity=0.527 Sum_probs=193.2
Q ss_pred eeeccCCceEEEEeeEcCc------------eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 123 EAIGEGGFGKVYKGIYEKQ------------EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~~------------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
+.||+|+||.||+|.+... .+++|+....... ...+.+|+.+++.++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 4699999999999998543 3788877654322 5678899999999999999999999988 77899
Q ss_pred EEeccCCCCHHHHhcC-C-CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 191 VMEYARGGPLNRVLAG-R-KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~-~-~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
||||+.+|+|.+++.. . .++...++.++.||+.||.|||++ +|+||||||+|||++.+... +.....+||+|||
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~-~~~~~~~kl~Dfg 153 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLN-EGYVPFIKLSDPG 153 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccc-cCCceeEEeCCCC
Confidence 9999999999999873 3 588999999999999999999998 49999999999999875311 1112379999999
Q ss_pred cchhhhccccccCCCccccccccccccC--CCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCC
Q psy6905 269 LAREVYKTTHMSAAGTYAWMAPEVIKTS--IFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPST 345 (527)
Q Consensus 269 la~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 345 (527)
++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+......... .....+.|
T Consensus 154 ~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~-- 228 (259)
T cd05037 154 IPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP-- 228 (259)
T ss_pred ccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC--
Confidence 9986543 2234577889999999876 78999999999999999999 688887765433322222 22222222
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
....+.++|.+||..+|.+||++.++++.|
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 337899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=310.79 Aligned_cols=246 Identities=30% Similarity=0.504 Sum_probs=211.4
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|.+.+.||.|+||.||+|.+. ++.|++|.+...........+.+|+..+..++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999874 6789999987765434567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHC-QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~-~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
+++++|.+++. ...+++..++.++.|++.||.|||+ .+ ++||||+|+||+++.+ +.++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~--------~~~~l~df~~~~~ 149 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSK--------GEVKIADFGISKV 149 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCC--------CCEEEccCcccee
Confidence 99999999987 4778999999999999999999999 84 9999999999999875 6899999999986
Q ss_pred hhccccc--cCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCccCCCCCC-c
Q psy6905 273 VYKTTHM--SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN---AYAVAYGVAVNKLTLPIPST-C 346 (527)
Q Consensus 273 ~~~~~~~--~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~-~ 346 (527)
....... ...++..|+|||.+.+..++.++||||||+++|+|++|..||.... ..+....+. .......+.. +
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 228 (264)
T cd06623 150 LENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEF 228 (264)
T ss_pred cccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccC
Confidence 6433222 3457899999999998889999999999999999999999998774 333333333 3344455666 8
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+..+.++|.+||..+|++||++.+++++
T Consensus 229 ~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 229 SPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.50 Aligned_cols=238 Identities=26% Similarity=0.409 Sum_probs=205.8
Q ss_pred eccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCH
Q psy6905 125 IGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200 (527)
Q Consensus 125 iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL 200 (527)
||.|+||.||+|.+. ++.||+|++.... .....+.+.+|+.+++.++||||+++++++.++..+|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999986 6799999987543 223457789999999999999999999999999999999999999999
Q ss_pred HHHhcC-CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccc-c
Q psy6905 201 NRVLAG-RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT-H 278 (527)
Q Consensus 201 ~~~l~~-~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~-~ 278 (527)
.+++.+ ..++...+..++.||+.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~--------~~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSN--------GYVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCC--------CCEEEeeCCcccccCccccc
Confidence 999874 56899999999999999999999984 9999999999999875 689999999998764432 2
Q ss_pred ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCccCCCCCCccHHHHHHHHH
Q psy6905 279 MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN--AYAVAYGVAVNKLTLPIPSTCPQLFKTLMEA 356 (527)
Q Consensus 279 ~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~ 356 (527)
....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+.........|..+++++.++|.+
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 229 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ 229 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHH
Confidence 23468899999999988889999999999999999999999998776 5555555554445566777789999999999
Q ss_pred hhhhCCCCCCC-----HHHHHH
Q psy6905 357 CWEADSHMRPS-----FKTILK 373 (527)
Q Consensus 357 ~l~~dp~~RPs-----~~~ll~ 373 (527)
||..+|.+||+ +.++++
T Consensus 230 ~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 230 LLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HccCChhhCcCCcccCHHHHhc
Confidence 99999999999 888876
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=319.18 Aligned_cols=250 Identities=15% Similarity=0.239 Sum_probs=190.8
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcC-----ceEEEEEcCCCCChhHH----------HHHHHHHHHHHhCCCCcc
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-----QEVAIKVAHPNPDENIL----------ENVKQEGKLLWLFDHRNI 175 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~vaiK~~~~~~~~~~~----------~~~~~e~~~l~~l~hpnI 175 (527)
..++...+|++.+.||+|+||.||+|.+.+ ..+|+|+.......... .....+...+..+.|+||
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 345677899999999999999999998743 35777765433221111 112233445566799999
Q ss_pred ceEEEEEEeCC----eEEEEEeccCCCCHHHHhcC-CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCC
Q psy6905 176 VSLIGVCLQSP----KLCLVMEYARGGPLNRVLAG-RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSE 250 (527)
Q Consensus 176 v~~~~~~~~~~----~~~iv~Ey~~ggsL~~~l~~-~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~ 250 (527)
+++++++.... ..++++|++ ..++.+++.. ...++..+..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 99999876543 457889988 4567666653 3467888999999999999999999 4999999999999986
Q ss_pred CCcccccccceeEEeccCcchhhhcc---------ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q psy6905 251 PIENEDLQFKTLKITDFGLAREVYKT---------THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321 (527)
Q Consensus 251 ~~~~~~~~~~~vkL~DFGla~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf 321 (527)
+ +.++|+|||+|+..... ......||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 162 ~--------~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~ 233 (294)
T PHA02882 162 N--------NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW 233 (294)
T ss_pred C--------CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 5 68999999999765321 112346999999999999999999999999999999999999999
Q ss_pred CCCCHHHH-H--------HHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 322 KSINAYAV-A--------YGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 322 ~~~~~~~~-~--------~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
.+.+.... . ..+...+ ..+..+++.+.++++.||..+|++||++.+|++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 234 KGFGHNGNLIHAAKCDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CccccchHHHHHhHHHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 87743221 1 1121111 12346789999999999999999999999999865
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=309.94 Aligned_cols=245 Identities=25% Similarity=0.406 Sum_probs=208.4
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe--CCeEEEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--SPKLCLVM 192 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~iv~ 192 (527)
+|++.+.||.|+||.||++.+ .++.||+|++.... .....+.+..|+.+++.++||||+++++++.. ....|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999987 45789999886542 33445678899999999999999999998764 45689999
Q ss_pred eccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHH-----hcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 193 EYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLH-----CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 193 Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH-----~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
||+++++|.+++. ...+++..++.++.||+.||.||| +. +++|+||+|+||+++.+ +.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~--------~~~ 149 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDAN--------NNV 149 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecC--------CCE
Confidence 9999999998885 356889999999999999999999 66 59999999999999875 689
Q ss_pred EEeccCcchhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 263 KITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 263 kL~DFGla~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
||+|||++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.. +...
T Consensus 150 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~ 228 (265)
T cd08217 150 KLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-GKFR 228 (265)
T ss_pred EEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc-CCCC
Confidence 999999998764433 2234689999999999988899999999999999999999999998876555555543 3334
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..|..++..+.+++.+||..+|.+||++.+|+++
T Consensus 229 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 5677889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=313.25 Aligned_cols=246 Identities=29% Similarity=0.568 Sum_probs=203.7
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC---------ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP---------DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
+|.+.+.||.|+||.||+|.. +++.||+|.+.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578889999999999999986 46789999875321 1112456788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
..++||||+.+|+|.+++. .+.++...+..++.||+.||.|||+++ ++||||+|+||+++.+ +.++|+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~--------~~~~l~ 150 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDAD--------GICKIS 150 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCC--------CeEEEe
Confidence 9999999999999999987 467889999999999999999999984 9999999999999875 689999
Q ss_pred ccCcchhhhcc----ccccCCCccccccccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 266 DFGLAREVYKT----THMSAAGTYAWMAPEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 266 DFGla~~~~~~----~~~~~~gt~~y~aPE~l~~~~--~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
|||++...... ......|+..|+|||.+.... ++.++|+||||+++|++++|..||...+.......+......
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 230 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence 99998765321 122345889999999987654 789999999999999999999999876665554444333333
Q ss_pred CCCC----CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 LPIP----STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ~~~p----~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+ ..++..+.++|.+||..+|..||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3333 2468899999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=315.24 Aligned_cols=244 Identities=29% Similarity=0.419 Sum_probs=207.3
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.|++.+.||.|+||.||+|.+. ++.||+|++.... .....+.+.+|+.+++.++||||+++++++.++..+|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999985 6789999887542 22346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCC-CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~~~-~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|+.|++|.+++... .+++..+..++.||+.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~--------~~~~l~d~~~~~~ 149 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQ--------GHVHITDFNIATK 149 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCC--------CCEEEeecccccc
Confidence 99999999998744 8999999999999999999999994 9999999999999875 6899999999876
Q ss_pred hhcc-ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCccCCCCCCccHH
Q psy6905 273 VYKT-THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA--YAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 273 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
.... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+. ......... ......|..++..
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 228 (258)
T cd05578 150 VTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-TADVLYPATWSTE 228 (258)
T ss_pred cCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-cccccCcccCcHH
Confidence 6433 22345688999999999988899999999999999999999999987763 222222221 1445667788999
Q ss_pred HHHHHHHhhhhCCCCCCCH--HHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSF--KTILK 373 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~--~~ll~ 373 (527)
+.++|.+||..||.+||++ .++++
T Consensus 229 ~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 229 AIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHHHHHccCChhHcCCccHHHHhc
Confidence 9999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=309.76 Aligned_cols=246 Identities=26% Similarity=0.475 Sum_probs=208.4
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC----CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--CeE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN----PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS--PKL 188 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~ 188 (527)
.+|.+.+.||+|+||.||+|.+ ++..||+|.+... ........+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5789999999999999999987 4678999987532 1223456788999999999999999999998764 468
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+++|||+++++|.+++. ...+++..+..++.||+.||.|||++| ++|+||+|+||+++.+ +.++|+||
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~--------~~~~l~df 150 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSA--------GNVKLGDF 150 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCC--------CCEEECcc
Confidence 99999999999999886 456889999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhcc-----ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 268 GLAREVYKT-----THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 268 Gla~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
|+++..... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+........+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (264)
T cd06653 151 GASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML 230 (264)
T ss_pred ccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCC
Confidence 999765321 112345889999999999888999999999999999999999999887766666665554555567
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
|..+++.+.+++.+||. +|..||++.+++.+
T Consensus 231 p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 231 PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 88899999999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=312.47 Aligned_cols=247 Identities=26% Similarity=0.512 Sum_probs=206.4
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-----ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-----DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
+|+..+.||+|+||.||++.. +++.||+|++.... .......+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 377788999999999999986 46789999886532 12245778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
||||+.|++|.+++. .+.+++..+..++.||+.||.|||++| ++|+||+|+||+++.+ ...++|+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~-------~~~~~l~dfg~ 150 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDST-------GQRLRIADFGA 150 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC-------CCEEEEccccc
Confidence 999999999999987 467889999999999999999999995 9999999999999764 14699999999
Q ss_pred chhhhccc------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCccC
Q psy6905 270 AREVYKTT------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA---YAVAYGVAVNKLTL 340 (527)
Q Consensus 270 a~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~i~~~~~~~ 340 (527)
+....... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...+. ......+.......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC
Confidence 87664321 1123578899999999888899999999999999999999999975442 22233333334455
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..|..+++++.+++.+||..+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 6677789999999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=339.50 Aligned_cols=251 Identities=36% Similarity=0.610 Sum_probs=221.2
Q ss_pred ceeeeeeeccCCceEEEEeeE--cC----ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EK----QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
..+..++||+|+||+||+|.| ++ -+||||++..........++..|+-.|..++|||+++++|+|..+. +.||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 445568999999999999998 33 3799999988777777889999999999999999999999998776 8899
Q ss_pred EeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 192 MEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
++|+++|+|.++++ +..+....++.|+.||++||.|||.+ .+|||||.++||||..- +.|||+|||+
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP--------~hvkitdfgl 844 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSP--------NHVKITDFGL 844 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCC--------CeEEEEecch
Confidence 99999999999998 56788999999999999999999999 59999999999999874 6899999999
Q ss_pred chhhhccccc----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 270 AREVYKTTHM----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 270 a~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
++........ ...-.+.|||-|.+....|+.++|||||||++||++| |..||.++...++-.-+. .+.+++.|+
T Consensus 845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqPp 923 (1177)
T KOG1025|consen 845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQPP 923 (1177)
T ss_pred hhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCCC
Confidence 9887433221 1234688999999999999999999999999999999 999999999888765554 566699999
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.|+.+++-+|.+||..|+..||+|+++...+......
T Consensus 924 iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 924 ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999988776543
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=320.23 Aligned_cols=245 Identities=26% Similarity=0.437 Sum_probs=206.6
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
.|.....||.|+||.||+|.+ .++.||+|++...... ....+.+|+.++..++||||+++++++..++..|+||||+
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 344456799999999999987 4678999998654322 3466789999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 196 RGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 196 ~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
++++|..++....+++..+..++.|++.||.|||++| ++||||+|+|||++.+ +.++|+|||++.....
T Consensus 101 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~--------~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 101 QGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLD--------GRVKLSDFGFCAQISK 169 (297)
T ss_pred CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccC--------CcEEEeechhHhhccc
Confidence 9999999988888999999999999999999999994 9999999999999875 6899999999876533
Q ss_pred cc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCCCCCccHHHHH
Q psy6905 276 TT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLFKT 352 (527)
Q Consensus 276 ~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~~~~ 352 (527)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... ....+..++..+.+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 249 (297)
T cd06659 170 DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRD 249 (297)
T ss_pred ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHH
Confidence 22 2235689999999999988899999999999999999999999987776655544432211 12234567889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q psy6905 353 LMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 353 li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+|.+||..+|.+||++.+++++
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 250 FLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhC
Confidence 9999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=311.22 Aligned_cols=250 Identities=28% Similarity=0.478 Sum_probs=202.8
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
++.+.......||+|+||.||+|.+. +..||+|.+...... ..+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34444445568999999999999874 467999987665433 356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcC--CCC--ChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 192 MEYARGGPLNRVLAG--RKI--RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~~--~~~--~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+||+.+++|.+++.. ..+ +...+..++.||+.||.|||++| |+||||||+||+++.+ .+.++|+||
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~-------~~~~~l~df 153 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTY-------SGVVKISDF 153 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCC-------CCeEEEecc
Confidence 999999999998873 345 77888899999999999999994 9999999999999763 258999999
Q ss_pred Ccchhhhccc--cccCCCccccccccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCccCCC
Q psy6905 268 GLAREVYKTT--HMSAAGTYAWMAPEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYKSINAY-AVAYGVAVNKLTLPI 342 (527)
Q Consensus 268 Gla~~~~~~~--~~~~~gt~~y~aPE~l~~~~--~~~ksDvwSlGv~l~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~ 342 (527)
|++....... .....|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...... ..............+
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06624 154 GTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233 (268)
T ss_pred hhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC
Confidence 9987653221 22345889999999986643 789999999999999999999999765432 222222222334456
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
|..+++++.+++.+||+.+|.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 77889999999999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.18 Aligned_cols=243 Identities=22% Similarity=0.342 Sum_probs=196.7
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+...+|.+.+.||.|+||.||+|... +..||+|.+... ....+|+.+++.++||||+++++++.....+|
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 34567999999999999999999753 357999987653 23457999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+||||+. ++|.+++. ...+++..++.++.||+.||.|||++| ||||||||+|||++.+ +.++|+|||
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~--------~~~~l~DfG 230 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEP--------ENAVLGDFG 230 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCC--------CCEEEccCc
Confidence 9999995 67777775 567999999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh------
Q psy6905 269 LAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY---AVAYGVAV------ 335 (527)
Q Consensus 269 la~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~---~~~~~i~~------ 335 (527)
+++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+..
T Consensus 231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~ 310 (392)
T PHA03207 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310 (392)
T ss_pred cccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence 997653322 12356999999999999999999999999999999999999999764321 11111110
Q ss_pred -------------------CCcc--CCCC-----CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 -------------------NKLT--LPIP-----STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 -------------------~~~~--~~~p-----~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+ ...| ..++.++.++|.+||..||.+||++.+++.+
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 1111 2346788999999999999999999999984
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=309.08 Aligned_cols=244 Identities=33% Similarity=0.608 Sum_probs=204.8
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|++.+.||+|+||.||+|.+ .++.|++|.+..... ......+..|+.+++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 488899999999999999987 467899999876543 24577889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC-CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLAG-RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~~-~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
+.+++|.+++.. ..+++..+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.+||+|||++...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~--------~~~kl~d~g~~~~~ 149 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHN--------GVIKLGDFGCAVKL 149 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC--------CCEEEccccccccc
Confidence 999999999874 45788899999999999999999995 9999999999999875 68999999998766
Q ss_pred hcccc------ccCCCccccccccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCccCCCC
Q psy6905 274 YKTTH------MSAAGTYAWMAPEVIKTSI---FSKASDVWSYGVVLWELLTGEIPYKSIN-AYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 274 ~~~~~------~~~~gt~~y~aPE~l~~~~---~~~ksDvwSlGv~l~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~p 343 (527)
..... ....+++.|+|||++.+.. ++.++||||||+++|++++|..||...+ .......+.. ......|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 228 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIP 228 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCC
Confidence 43221 1245789999999998766 8899999999999999999999997663 3333333332 3333344
Q ss_pred C--CccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 344 S--TCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 344 ~--~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
. .++..+.+++..||+.+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 4 34899999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=329.99 Aligned_cols=246 Identities=28% Similarity=0.426 Sum_probs=217.9
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
...|.+.+.||+|.|+.|.+|.+ ++..||||++.+.. +......+.+|+.+|+.|+|||||++|.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 35688899999999999999987 57899999998764 3344566899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||+.+|.+.+++. .+++.+.....++.|+..|++|||++ .|||||||++||||+.+ -++||+|||++.
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~--------mnikIaDfgfS~ 203 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDEN--------MNIKIADFGFST 203 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccc--------cceeeeccccce
Confidence 9999999999987 67788899999999999999999999 59999999999999987 369999999998
Q ss_pred hhhc-cccccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 272 EVYK-TTHMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 272 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
.+.. ....+.+|++.|.|||++.+..| .+.+|+||+|++||-|++|.+||++.+..+....+...+++.+ -.++.+
T Consensus 204 ~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp--~~ms~d 281 (596)
T KOG0586|consen 204 FFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP--FYMSCD 281 (596)
T ss_pred eecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc--ceeech
Confidence 7753 33447899999999999998876 4899999999999999999999999988888778877777655 446677
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+||+++|-.+|.+|++.+++.++
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhhh
Confidence 8999999999999999999999875
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.09 Aligned_cols=247 Identities=32% Similarity=0.504 Sum_probs=208.2
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
..+|.+.+.||+|+||.||++.. ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 46788999999999999999986 4578999988654322 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 194 YARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 194 y~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|+++++|.+++....++...+..++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+|||++...
T Consensus 97 ~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~--------~~~kL~dfg~~~~~ 165 (293)
T cd06647 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMD--------GSVKLTDFGFCAQI 165 (293)
T ss_pred cCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCC--------CCEEEccCcceecc
Confidence 999999999998878899999999999999999999995 9999999999999875 68999999998755
Q ss_pred hccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CccCCCCCCccHHH
Q psy6905 274 YKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLPIPSTCPQLF 350 (527)
Q Consensus 274 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~~ 350 (527)
.... .....|++.|+|||.+.+..++.++|||||||++|++++|+.||...+.......+... ......+..++..+
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 245 (293)
T ss_pred cccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHH
Confidence 3322 12346889999999998888999999999999999999999999877654443332222 22233445678889
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.++|.+||..+|.+||++.+++.+
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 246 RDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=313.19 Aligned_cols=246 Identities=28% Similarity=0.464 Sum_probs=201.9
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe--CCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--SPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~iv~ 192 (527)
++|...+.||.|++|.||+|.+ .++.||+|.+...........+.+|+++++.++||||+++++++.+ ...+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3678889999999999999998 4578999998766544556778999999999999999999999865 34689999
Q ss_pred eccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 193 EYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 193 Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
||++|++|.+++. ...+++..+..++.||+.||.|||+.| ++|+||+|+||+++.+ +.++|+||
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~--------~~~~l~df 149 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRK--------GQVKLCDF 149 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecC--------CeEEEeec
Confidence 9999999988764 345788899999999999999999995 9999999999999875 68999999
Q ss_pred CcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCccCCC
Q psy6905 268 GLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN-----AYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 268 Gla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~-----~~~~~~~i~~~~~~~~~ 342 (527)
|++............++..|+|||.+.+..++.++|||||||++|+|++|..||.... ..+....+.. ......
T Consensus 150 g~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 228 (287)
T cd06621 150 GVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPEL 228 (287)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhh
Confidence 9987654333334567889999999998889999999999999999999999998652 2233222221 111111
Q ss_pred C------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 343 P------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 343 p------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+ ..+++.+.++|.+||..+|.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1 2356789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=310.99 Aligned_cols=248 Identities=31% Similarity=0.595 Sum_probs=204.6
Q ss_pred eeeeeeeccCCceEEEEeeEc-----CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC------
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP------ 186 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~-----~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------ 186 (527)
|.+.+.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999863 4689999887643 3334667889999999999999999999986532
Q ss_pred eEEEEEeccCCCCHHHHhcC-------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 187 KLCLVMEYARGGPLNRVLAG-------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~-------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
..+++++|+.+|+|.+++.. ..++...++.++.||+.||+|||++| |+||||||+|||++.+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~-------- 149 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNEN-------- 149 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCC--------
Confidence 24789999999999887641 14678889999999999999999995 9999999999999865
Q ss_pred ceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy6905 260 KTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVA 334 (527)
Q Consensus 260 ~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~ 334 (527)
+.+||+|||+++...... .....+++.|++||.+.+..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 229 (273)
T cd05074 150 MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI 229 (273)
T ss_pred CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence 689999999998653221 112345678999999998889999999999999999999 999998887766555544
Q ss_pred hCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 335 VNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 335 ~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
. ......+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ~-~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 K-GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred c-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3 333455567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=316.20 Aligned_cols=245 Identities=31% Similarity=0.469 Sum_probs=204.3
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
...|.+.+.||+|+||.||+|.+ .++.||+|.+.... .......+.+|+.+++.++||||+++++++.++...|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35688899999999999999987 46789999876432 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 192 MEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||+. |+|.+++. ...+++..+..++.||+.||.|||+.| ++||||+|+||+++.+ +.++|+|||+
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~--------~~~kL~dfg~ 161 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEP--------GTVKLADFGS 161 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCC--------CCEEEeecCc
Confidence 99996 56666654 456899999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhccccccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 270 AREVYKTTHMSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 270 a~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
+..... .....+++.|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.........+..+
T Consensus 162 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (307)
T cd06607 162 ASLVSP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW 239 (307)
T ss_pred ceecCC--CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhh
Confidence 865432 22356889999999874 4568899999999999999999999998887766655554433322234557
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+..+.++|.+||..+|++||++.+++.+
T Consensus 240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 240 SDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 8899999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=315.84 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=198.5
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv~ 192 (527)
.++|...+.||+|+||.||++.+. ++.||+|.+...........+.+|+.++..+. |+||+++++++..+...+++|
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 456777889999999999999874 57899998876544455667889999999996 999999999999999999999
Q ss_pred eccCCCCHHHHhc------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 193 EYARGGPLNRVLA------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 193 Ey~~ggsL~~~l~------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
||+. ++|.++.. ...+++..+..++.|++.||+|||+.. +++||||||+|||++.+ +.++|+|
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~--------~~~kl~d 151 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRN--------GNIKLCD 151 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccC--------CcEEEee
Confidence 9995 45544321 456899999999999999999999752 49999999999999875 6899999
Q ss_pred cCcchhhhccc-cccCCCccccccccccccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCc-cC
Q psy6905 267 FGLAREVYKTT-HMSAAGTYAWMAPEVIKTS---IFSKASDVWSYGVVLWELLTGEIPYKSINAY-AVAYGVAVNKL-TL 340 (527)
Q Consensus 267 FGla~~~~~~~-~~~~~gt~~y~aPE~l~~~---~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~-~~~~~i~~~~~-~~ 340 (527)
||+++...... .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... +....+..... ..
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd06616 152 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL 231 (288)
T ss_pred cchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcC
Confidence 99997654322 2234688999999999776 6899999999999999999999999876522 22222221111 11
Q ss_pred --CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 --PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 --~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+..++..+.+||.+||+.+|++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223578999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.25 Aligned_cols=245 Identities=33% Similarity=0.532 Sum_probs=209.1
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|+-+..||.|.||.||-|+. +|...|+|-+... ........+.+|..++..++|||+|+|||+-.+.+.++|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 466678899999999999986 5678899976543 2344466788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCC-ChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLAGRKI-RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~~~~~-~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|.||+|.+++..++. ++.....+..|++.|+.|||++| ||||||||+|||++.+ |.+|++|||.|..+
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~--------g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFN--------GLIKYGDFGSAVKI 1384 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecC--------CcEEeecccceeEe
Confidence 999999999986554 45555666789999999999996 9999999999999986 79999999999877
Q ss_pred hccc------cccCCCccccccccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCccCCCC
Q psy6905 274 YKTT------HMSAAGTYAWMAPEVIKTSI---FSKASDVWSYGVVLWELLTGEIPYKSIN-AYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 274 ~~~~------~~~~~gt~~y~aPE~l~~~~---~~~ksDvwSlGv~l~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~p 343 (527)
.... -....||+.|||||++.+.. ...++|||||||++.||+||+.||...+ +.++.+.+. .+....+|
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P 1463 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIP 1463 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCc
Confidence 5432 12457999999999997643 5679999999999999999999998765 556667776 46677899
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..++.+-+++|..||..||+.|.++.+|+++
T Consensus 1464 ~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1464 ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 9999999999999999999999999988875
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=311.61 Aligned_cols=246 Identities=29% Similarity=0.515 Sum_probs=202.7
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeC-----Ce
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQS-----PK 187 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~-----~~ 187 (527)
.++|.+.+.||+|+||.||++.. .++.||+|++..... ....+.+|+.++..+ +||||+++++++... ..
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence 46799999999999999999987 457899999865432 245677889999988 899999999998753 35
Q ss_pred EEEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 188 LCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
.|+||||+++|+|.+++. +..+++..+..++.|++.||+|||+.| ++||||||+||+++.+ +.+
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~--------~~~ 167 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTE--------GGV 167 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCC--------CCE
Confidence 899999999999998874 456899999999999999999999994 9999999999999875 679
Q ss_pred EEeccCcchhhhccc--cccCCCccccccccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6905 263 KITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTS-----IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV 335 (527)
Q Consensus 263 kL~DFGla~~~~~~~--~~~~~gt~~y~aPE~l~~~-----~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 335 (527)
||+|||++....... .....|+..|+|||.+... .++.++|||||||++|+|++|+.||...+.......+..
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 999999987654322 2234688999999998643 368899999999999999999999988776555554433
Q ss_pred CCc-cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 NKL-TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ~~~-~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
... ....+..++..+.++|.+||..+|++||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 221 223455677889999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=316.02 Aligned_cols=247 Identities=28% Similarity=0.421 Sum_probs=201.6
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh-hHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE-NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|++.+.||+|+||.||+|.+. ++.||+|.+...... ...+.+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999984 578999987654322 234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|+++++|..+.. ...+++..++.++.||+.||.|||+.| ++||||+|+||+++.+ +.++|+|||++..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~--------~~~~l~dfg~~~~ 149 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQS--------GVVKLCDFGFART 149 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCC--------CcEEEEeeeeeee
Confidence 999999988775 446899999999999999999999995 9999999999999875 6899999999876
Q ss_pred hhcccc--ccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Q psy6905 273 VYKTTH--MSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------------- 336 (527)
Q Consensus 273 ~~~~~~--~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------------- 336 (527)
...... ....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 150 LAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred ccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence 533222 23457899999999875 34788999999999999999999999876654332222110
Q ss_pred ------CccCC----------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ------KLTLP----------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ------~~~~~----------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+ .+..++..+.+++.+||..+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 123568889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=314.73 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=204.9
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeC
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQS 185 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~ 185 (527)
...|.++.++|.+.+.||+|+||.||+|.+. ++.||||.+...........+..|+.++..+ .||||+++++++.++
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 3456778899999999999999999999986 7899999987654333455566677766666 599999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 186 PKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
...|++|||+ +++|.+++. ...+++..+..++.||+.||.|||+.. +|+||||+|+||+++.+ +.+|
T Consensus 87 ~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~--------~~~k 155 (296)
T cd06618 87 SDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDAS--------GNVK 155 (296)
T ss_pred CeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCC--------CCEE
Confidence 9999999998 557777765 456889999999999999999999742 49999999999999875 6899
Q ss_pred EeccCcchhhhccc-cccCCCccccccccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC
Q psy6905 264 ITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSI----FSKASDVWSYGVVLWELLTGEIPYKSINA-YAVAYGVAVNK 337 (527)
Q Consensus 264 L~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~----~~~ksDvwSlGv~l~elltg~~Pf~~~~~-~~~~~~i~~~~ 337 (527)
|+|||++....... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+....+....
T Consensus 156 L~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 235 (296)
T cd06618 156 LCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE 235 (296)
T ss_pred ECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC
Confidence 99999987654322 22345788999999987553 78899999999999999999999976433 33333333222
Q ss_pred -ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 -LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 -~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+....++..+.+|+.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2223334578999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.04 Aligned_cols=239 Identities=25% Similarity=0.366 Sum_probs=188.9
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
..|.+.+.||+|+||.||+|.+. +..||+|+.... ....|+.+++.++||||+++++++......|+||||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 46899999999999999999985 458999985433 224689999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
+. |+|.+++. ...+++..+..|+.||+.||.|||++| ||||||||+|||++.+ +.+||+|||+++.
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~--------~~~kl~DfG~a~~ 206 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDV--------DQVCIGDLGAAQF 206 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC--------CCEEEecCccccc
Confidence 94 67777765 456899999999999999999999995 9999999999999875 6899999999975
Q ss_pred hhc-cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhC-CCCCCCCCHH---------HHHHHHHh-CCc-c
Q psy6905 273 VYK-TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTG-EIPYKSINAY---------AVAYGVAV-NKL-T 339 (527)
Q Consensus 273 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg-~~Pf~~~~~~---------~~~~~i~~-~~~-~ 339 (527)
... .......||+.|+|||++.+..++.++|||||||++|||+++ ..+|...... .....+.. .+. .
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 207 PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred cccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 422 222345799999999999998999999999999999999984 4455432211 00111100 000 0
Q ss_pred CCCC------------------------------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 LPIP------------------------------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ~~~p------------------------------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...| ..++.++.+||.+||+.||.+|||+.+++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000 1346677889999999999999999999874
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=312.12 Aligned_cols=245 Identities=28% Similarity=0.380 Sum_probs=202.2
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|++.+.||.|+||.||+|.+ .+..||+|++..... ......+.+|+.+++.++||||+++++++..+...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 488999999999999999997 467899998876532 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
+ +++|.+++. ...+++..+..++.||+.||.|||+.| ++|+||||+||+++.+ +.++|+|||++..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~--------~~~~l~dfg~~~~ 148 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISAD--------GVLKIADFGLARL 148 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCC--------CcEEEeeeeeccc
Confidence 9 999999885 456899999999999999999999995 9999999999999875 6899999999987
Q ss_pred hhccc---cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Q psy6905 273 VYKTT---HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------------ 336 (527)
Q Consensus 273 ~~~~~---~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------------ 336 (527)
..... .....|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 149 FSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred ccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhc
Confidence 64432 2345689999999998654 4689999999999999999999999876654433332210
Q ss_pred -------CccCC---------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 -------KLTLP---------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 -------~~~~~---------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+ .....+..+.+++.+||..+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 112457889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=312.81 Aligned_cols=246 Identities=29% Similarity=0.436 Sum_probs=203.3
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|++.+.||+|+||.||+|.+. ++.||+|.+.... .......+.+|+.+++.++|+||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36899999999999999999874 5789999887542 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|++++++..+.. ...+++..+..++.||+.||.|||.++ ++||||+|+||+++.+ +.+||+|||++..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~--------~~~kl~d~g~~~~ 149 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSES--------GVLKLCDFGFARA 149 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCC--------CCEEEEeeecccc
Confidence 999887776665 456899999999999999999999995 9999999999999875 6899999999887
Q ss_pred hhccc---cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Q psy6905 273 VYKTT---HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------------ 336 (527)
Q Consensus 273 ~~~~~---~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------------ 336 (527)
..... .....++..|+|||++.+. .++.++||||||+++|+|++|..||.+.+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred cCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 64432 2234678899999999888 7899999999999999999999999876554433322110
Q ss_pred -------Ccc-----------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 337 -------KLT-----------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 337 -------~~~-----------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
... ...+..++.++.++|++||..+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0123345889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=318.63 Aligned_cols=242 Identities=24% Similarity=0.329 Sum_probs=183.8
Q ss_pred eeeeccCCceEEEEeeEc----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe--CCeEEEEEecc
Q psy6905 122 GEAIGEGGFGKVYKGIYE----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--SPKLCLVMEYA 195 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~iv~Ey~ 195 (527)
+.+||+|+||.||+|.+. ++.||+|.+..... ...+.+|+.+++.++||||+++++++.. +..+|++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 458999999999999863 36799998865432 2346789999999999999999999864 45689999999
Q ss_pred CCCCHHHHhcC----------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 196 RGGPLNRVLAG----------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 196 ~ggsL~~~l~~----------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
. ++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||+..+.. ..+.+||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~----~~~~~kl~ 154 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP----ERGRVKIA 154 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCC----CcCcEEEe
Confidence 5 577777641 24788899999999999999999995 999999999999954311 13689999
Q ss_pred ccCcchhhhccc-----cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHH---------HHH
Q psy6905 266 DFGLAREVYKTT-----HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAY---------AVA 330 (527)
Q Consensus 266 DFGla~~~~~~~-----~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~---------~~~ 330 (527)
|||+++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.... ...
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHH
Confidence 999998653321 123568999999999976 45899999999999999999999999753321 001
Q ss_pred HHHHh-CC----------------------ccC-------------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 331 YGVAV-NK----------------------LTL-------------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 331 ~~i~~-~~----------------------~~~-------------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+.. .+ +.. ......+..+.+||.+||..||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11100 00 000 0001224568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=312.20 Aligned_cols=239 Identities=26% Similarity=0.395 Sum_probs=191.1
Q ss_pred eeccCCceEEEEeeEc--CceEEEEEcCCCCC--hhHHHHHHHHHH---HHHhCCCCccceEEEEEEeCCeEEEEEeccC
Q psy6905 124 AIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD--ENILENVKQEGK---LLWLFDHRNIVSLIGVCLQSPKLCLVMEYAR 196 (527)
Q Consensus 124 ~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~--~~~~~~~~~e~~---~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ 196 (527)
.||+|+||.||++.+. ++.||+|++..... ......+.+|.. ++...+||||+.+++++...+..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 57899998865421 111222334443 3344589999999999999999999999999
Q ss_pred CCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 197 GGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 197 ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
+|+|.+++. .+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.+ +.++|+|||++.....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~--------~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEH--------GHVRISDLGLACDFSK 149 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCC--------CCEEEccCCcceeccc
Confidence 999998886 567899999999999999999999995 9999999999999875 6899999999876544
Q ss_pred cccccCCCccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCccCCCCCCccHHHHH
Q psy6905 276 TTHMSAAGTYAWMAPEVIK-TSIFSKASDVWSYGVVLWELLTGEIPYKSINAY--AVAYGVAVNKLTLPIPSTCPQLFKT 352 (527)
Q Consensus 276 ~~~~~~~gt~~y~aPE~l~-~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~~~~~ 352 (527)
.......|+..|+|||.+. +..++.++|||||||++|+|++|..||...... ...... ........|..++.++.+
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 228 (279)
T cd05633 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKS 228 (279)
T ss_pred cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHH
Confidence 3333457899999999986 456899999999999999999999999764321 111111 123344567788999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHHHH
Q psy6905 353 LMEACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 353 li~~~l~~dp~~RP-----s~~~ll~~ 374 (527)
+|.+||..||.+|| ++.+++++
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 229 LLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 99999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=309.12 Aligned_cols=246 Identities=31% Similarity=0.545 Sum_probs=202.7
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCC------
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSP------ 186 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~------ 186 (527)
.++|++.+.||.|+||.||+|.+. ++.|++|++..... ....+.+|+.+++.+ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 468999999999999999999984 46899998876533 246788999999998 7999999999997644
Q ss_pred eEEEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 187 KLCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
.+|+||||+.+++|.+++. +..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~--------~~ 151 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKN--------AE 151 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccC--------Ce
Confidence 4899999999999998875 356899999999999999999999995 9999999999999875 68
Q ss_pred eEEeccCcchhhhccc--cccCCCcccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6905 262 LKITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKT-----SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA 334 (527)
Q Consensus 262 vkL~DFGla~~~~~~~--~~~~~gt~~y~aPE~l~~-----~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 334 (527)
++|+|||++....... .....|+..|+|||++.. ..++.++|||||||++|+|++|..||...........+.
T Consensus 152 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 231 (275)
T cd06608 152 VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP 231 (275)
T ss_pred EEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh
Confidence 9999999987653221 223568999999998753 346789999999999999999999998766555544444
Q ss_pred hCCc-cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 335 VNKL-TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 335 ~~~~-~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.... ....+..++..+.++|.+||..||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 3222 223334578899999999999999999999999873
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=311.02 Aligned_cols=245 Identities=27% Similarity=0.429 Sum_probs=205.6
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
.|.-.+.||.|+||.||++.+ .++.|++|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 344457899999999999986 357899998764432 23456789999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 196 RGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 196 ~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
.|++|.+++....++...+..++.|++.||.|||++| ++||||+|+||+++.+ +.++|+|||++.....
T Consensus 99 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~--------~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 99 EGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSD--------GRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCC--------CcEEEcccccchhhcc
Confidence 9999999998888999999999999999999999995 9999999999999875 6899999999876533
Q ss_pred cc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCCCCCccHHHHH
Q psy6905 276 TT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLFKT 352 (527)
Q Consensus 276 ~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~~~~ 352 (527)
.. .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+..... ....+..++..+.+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRS 247 (285)
T ss_pred CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHH
Confidence 22 2234689999999999988899999999999999999999999988776655554443211 12223447899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q psy6905 353 LMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 353 li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+|.+||+.+|.+||++.+++++
T Consensus 248 li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 248 FLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHcccChhhCcCHHHHccC
Confidence 9999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=330.79 Aligned_cols=240 Identities=24% Similarity=0.328 Sum_probs=191.3
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
...|.+.+.||+|+||.||+|.+. ++.||||.... ..+.+|+.+++.++|+|||++++++..+...|+|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457999999999999999999984 46899996432 235689999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
++ .++|..++. .+.+++..++.|+.||+.||.|||++| ||||||||+||||+.+ +.+||+|||+++
T Consensus 241 ~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~--------~~vkL~DFGla~ 308 (461)
T PHA03211 241 KY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGP--------EDICLGDFGAAC 308 (461)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCC--------CCEEEcccCCce
Confidence 99 467877775 346899999999999999999999995 9999999999999875 689999999997
Q ss_pred hhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCcc
Q psy6905 272 EVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN--------AYAVAYGVAVNKLT 339 (527)
Q Consensus 272 ~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~--------~~~~~~~i~~~~~~ 339 (527)
...... .....||+.|+|||++.+..++.++|||||||+||||++|..|+-... ..+....+......
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 653221 123569999999999999999999999999999999999776543211 11222211111110
Q ss_pred -CCCC-------------------------------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 -LPIP-------------------------------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 -~~~p-------------------------------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+ ...+.++.+||..||..||.+|||+.+++++
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 1235578999999999999999999999984
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=312.98 Aligned_cols=246 Identities=28% Similarity=0.373 Sum_probs=193.8
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
.+|.+.+.||+|+||.||+|.+ ++..||+|++...........+.+|+.+++.++|+||+++++++..+...|+||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 5789999999999999999986 46789999987654333334567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
+. ++|.+.+. ...+++..+..++.||+.||.|||+.| |+|+||||+|||++.+ +.++|+|||+++.
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~--------~~~~l~Dfg~~~~ 152 (291)
T cd07870 85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYL--------GELKLADFGLARA 152 (291)
T ss_pred cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCC--------CcEEEeccccccc
Confidence 95 66665554 345788889999999999999999995 9999999999999875 6899999999875
Q ss_pred hhcc--ccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh-CC----------
Q psy6905 273 VYKT--THMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAY-AVAYGVAV-NK---------- 337 (527)
Q Consensus 273 ~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~-~~~~~i~~-~~---------- 337 (527)
.... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.. +....+.. -+
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 153 KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred cCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhh
Confidence 4322 12234578999999998764 4788999999999999999999999876532 11111100 00
Q ss_pred -----c-----cCCCC---------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 -----L-----TLPIP---------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 -----~-----~~~~p---------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+ ....+ -..+..+.+++.+|+..||.+|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 00000 0125678999999999999999999998863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=303.33 Aligned_cols=245 Identities=30% Similarity=0.530 Sum_probs=212.6
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|.+.+.||.|+||.||++.+. +..|++|++.... .......+.+|+.+++.++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999985 6789999887653 234466788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 195 ARGGPLNRVLAG-----RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 195 ~~ggsL~~~l~~-----~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
+++++|.+++.. ..++...+..++.+++.||.|||++| ++|+||+|+||+++.+ +.++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~--------~~~~l~d~~~ 149 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSN--------GLVKLGDFGI 149 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCC--------CcEEECCccc
Confidence 999999998863 66899999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCcc
Q psy6905 270 AREVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 270 a~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 347 (527)
+....... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+........... ...++|..++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 228 (258)
T cd08215 150 SKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG-QYPPIPSQYS 228 (258)
T ss_pred eeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC-CCCCCCCCCC
Confidence 97664332 22346889999999998888999999999999999999999999888766665555433 3456777899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+.+++.+||..+|++||++.+++++
T Consensus 229 ~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 229 SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.35 Aligned_cols=245 Identities=27% Similarity=0.392 Sum_probs=194.4
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|++.+.||.|+||.||+|.+ ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+...+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999998 46789999886542 222235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|. ++|.+++. ...+++..+..++.||+.||.|||++| ++||||||+|||++.+ +.++|+|||+++.
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~--------~~~~l~dfg~~~~ 148 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKN--------GELKLADFGLARA 148 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCC--------CcEEECccchhhc
Confidence 96 56777664 467899999999999999999999995 9999999999999875 6899999999976
Q ss_pred hhccc--cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhC------------
Q psy6905 273 VYKTT--HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPY-KSINAYAVAYGVAVN------------ 336 (527)
Q Consensus 273 ~~~~~--~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf-~~~~~~~~~~~i~~~------------ 336 (527)
..... .....++..|+|||++.+. .++.++|||||||++|+|++|..|| .+.+.......+...
T Consensus 149 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 149 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred cCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 53221 1234578999999998764 4789999999999999999988875 444333222221100
Q ss_pred ----Cc-c----------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ----KL-T----------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ----~~-~----------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. . ......+++++.++|.+||..||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 0 01113467889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=312.77 Aligned_cols=246 Identities=26% Similarity=0.361 Sum_probs=194.7
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|.+.+.||.|+||.||+|.+ .++.||||.+...........+.+|+.+++.++|+||+++++++.++...|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 36789999999999999999987 4678999988754332223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|+. ++|.+++. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.+ +.+||+|||+++
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~--------~~~kl~dfg~~~ 151 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISER--------GELKLADFGLAR 151 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCC--------CCEEECcccccc
Confidence 997 58988876 346889999999999999999999994 9999999999999875 689999999987
Q ss_pred hhhcc--ccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh------------
Q psy6905 272 EVYKT--THMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINA-YAVAYGVAV------------ 335 (527)
Q Consensus 272 ~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~-~~~~~~i~~------------ 335 (527)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+... .+....+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 152 AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred ccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 54221 1122346889999999875 4578999999999999999999999976552 111111100
Q ss_pred -------CCccCC----C-----CCCcc--HHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 336 -------NKLTLP----I-----PSTCP--QLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 336 -------~~~~~~----~-----p~~~~--~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.....+ . ....+ ..+.+++.+||+.+|++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0 01233 77889999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=305.55 Aligned_cols=246 Identities=29% Similarity=0.500 Sum_probs=207.0
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|.+.+.||+|+||.||+|.++ +..||+|.+.... .....+.+.+|+.+++.++|+||+++++.+..+...|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788999999999999999984 5789999876532 112345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 195 ARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 195 ~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+.+++|.+++.. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.+. ..++|+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~-------~~~~l~d~~~~~ 150 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNG-------MVAKLGDFGIAR 150 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCC-------CeEEecccccch
Confidence 999999998863 24788999999999999999999984 99999999999998751 357999999987
Q ss_pred hhhcccc--ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 272 EVYKTTH--MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 272 ~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
....... ....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. ....+.+..++..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (257)
T cd08225 151 QLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-GYFAPISPNFSRD 229 (257)
T ss_pred hccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-ccCCCCCCCCCHH
Confidence 6643222 123588999999999888899999999999999999999999988776665555443 3333556678899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.++|.+||..+|++|||+.+++++
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 230 LRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHHHhccChhhCcCHHHHhhC
Confidence 9999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=305.55 Aligned_cols=241 Identities=29% Similarity=0.460 Sum_probs=212.7
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
.+..++|.++++||+|.||+|.+|.- .++.||||+++... ..+....-..|-++|+..+||.+..+--.|...+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 35568899999999999999999986 46889999988752 333455667899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+||||.+||.|.-.|. .+.|++.....+...|+.||.|||++ +||.||||.+|+|++.+ |.+||+||
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkD--------GHIKitDF 312 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKD--------GHIKITDF 312 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccC--------CceEeeec
Confidence 99999999999987776 56799999999999999999999998 69999999999999986 89999999
Q ss_pred Ccchhhh--ccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCC
Q psy6905 268 GLAREVY--KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST 345 (527)
Q Consensus 268 Gla~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 345 (527)
|+++.-. .....++||||.|+|||++....|+..+|.|.+||++|||++|++||...+......-|..... ..|..
T Consensus 313 GLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--kFPr~ 390 (516)
T KOG0690|consen 313 GLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--KFPRT 390 (516)
T ss_pred ccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--cCCcc
Confidence 9998753 3344578999999999999999999999999999999999999999999888777777765544 56788
Q ss_pred ccHHHHHHHHHhhhhCCCCCC
Q psy6905 346 CPQLFKTLMEACWEADSHMRP 366 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RP 366 (527)
++++.+.|+..+|..||.+|.
T Consensus 391 ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 391 LSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CCHHHHHHHHHHhhcChHhhc
Confidence 999999999999999999995
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=301.10 Aligned_cols=245 Identities=33% Similarity=0.581 Sum_probs=208.6
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
+|.+.+.||+|+||.||++.+. +..+++|++..... .....+.+|+.+++.++|+||+++++++..+...++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4778899999999999999985 67899999877643 34678889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 196 RGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 196 ~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
++++|.+++.. ..+++..+..++.|++.||.|||.. +++||||+|+||+++.+ +.++|+|||.+...
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~--------~~~~l~d~~~~~~~ 148 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSD--------GEVKLIDFGLSAQL 148 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccC--------CeEEEeeccccccc
Confidence 99999999874 4789999999999999999999998 49999999999999875 68999999999776
Q ss_pred hccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCCCCCccHHHH
Q psy6905 274 YKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLFK 351 (527)
Q Consensus 274 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~~~ 351 (527)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+............. ..+.+..++..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (253)
T cd05122 149 SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK 228 (253)
T ss_pred cccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHH
Confidence 4433 3345688999999999988899999999999999999999999988755554444332222 2223334489999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 352 TLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++.+||..||.+|||+.+++++
T Consensus 229 ~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 229 DFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=305.97 Aligned_cols=245 Identities=31% Similarity=0.489 Sum_probs=211.8
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|++.+.||.|+||.||++.+ .+..+|+|.+.... .......+.+|+.+++.++|+||+++++++.+....|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478899999999999999987 45689999887543 233456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 195 ARGGPLNRVLAG-----RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 195 ~~ggsL~~~l~~-----~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
+++++|.+++.. ..+++..+..++.|++.||.|||+.| ++|+||+|.||+++.+ +.+||+|||+
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~--------~~~kl~d~g~ 149 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVAN--------DLVKIGDLGI 149 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecC--------CcEEEeeccc
Confidence 999999998763 56888999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 270 a~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
+............+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ...+.+..++.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 228 (256)
T cd08530 150 SKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG-KYPPIPPIYSQD 228 (256)
T ss_pred hhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCchhhCHH
Confidence 9877554333456889999999999988999999999999999999999999988876665555433 333566688999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+++.+||..+|++||++.+++++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcC
Confidence 9999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=310.21 Aligned_cols=247 Identities=30% Similarity=0.460 Sum_probs=207.2
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
..|...+.||+|+||.||++.+ .+..||+|.+.... .......+.+|+.+++.++|||++++++++.++...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3477788999999999999987 45789999876432 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||+. |+|.+++. ...+++..+..++.||+.||.|||++| ++||||+|+||+++.+ +.++|+|||++
T Consensus 105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~--------~~~kl~dfg~~ 172 (317)
T cd06635 105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEP--------GQVKLADFGSA 172 (317)
T ss_pred eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCC--------CCEEEecCCCc
Confidence 9996 57777664 556889999999999999999999995 9999999999999875 68999999998
Q ss_pred hhhhccccccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCcc
Q psy6905 271 REVYKTTHMSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 271 ~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 347 (527)
..... .....|++.|+|||.+. ...++.++|||||||++|+|++|..||...+.......+.........+..++
T Consensus 173 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (317)
T cd06635 173 SIASP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS 250 (317)
T ss_pred cccCC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCcccc
Confidence 65432 22456889999999974 45688999999999999999999999988777666666655554444456788
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
+.+.+++.+||+.+|.+||++.++++++..
T Consensus 251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 999999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=306.51 Aligned_cols=238 Identities=28% Similarity=0.388 Sum_probs=195.3
Q ss_pred eeeccCCceEEEEeeE--cCceEEEEEcCCCCC--hhHHHHHHHHHHH-HHhCCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD--ENILENVKQEGKL-LWLFDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~--~~~~~~~~~e~~~-l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.||.|+||.||+|.+ .++.||+|++..... ......+..|..+ ...++|+||+++++++..++.+|+|||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999987 467899999865421 1222334445444 4456899999999999999999999999999
Q ss_pred CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc
Q psy6905 198 GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT 276 (527)
Q Consensus 198 gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~ 276 (527)
++|.+++. .+.+++..+..++.||+.||.|||+. +++||||+|+|||++.+ +.++|+|||+++....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~--------~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQT--------GHLKLTDFGLSRNGLE- 149 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC--------CcEEEeecccceeccc-
Confidence 99999987 46789999999999999999999999 49999999999999875 6899999999875432
Q ss_pred ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC--CCCCCccHHHHHHH
Q psy6905 277 THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL--PIPSTCPQLFKTLM 354 (527)
Q Consensus 277 ~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~~~~~li 354 (527)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+....... ..+..+++.+.+++
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 228 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI 228 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHH
Confidence 223468899999999988888999999999999999999999999887776665554433322 23456899999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q psy6905 355 EACWEADSHMRPSFKTILK 373 (527)
Q Consensus 355 ~~~l~~dp~~RPs~~~ll~ 373 (527)
.+||..+|++||++.++.+
T Consensus 229 ~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 229 NRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HHHccCCHHHccCCCcHHH
Confidence 9999999999997654444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=302.05 Aligned_cols=246 Identities=31% Similarity=0.563 Sum_probs=212.6
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--CeEEEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQS--PKLCLVM 192 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~iv~ 192 (527)
+|++.+.||+|+||.||+|.+. +..|++|++..... ....+.+.+|+.+++.++||||+++++.+.+. ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999985 67899998876532 23467888999999999999999999999988 8899999
Q ss_pred eccCCCCHHHHhcC-CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLAG-RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~~-~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||+.+++|.+++.. ..+++..+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.++|+|||.+.
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~--------~~~~l~d~~~~~ 149 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSD--------GVVKLADFGCAK 149 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCC--------CCEEEcccccEE
Confidence 99999999999874 47899999999999999999999984 9999999999999975 689999999998
Q ss_pred hhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCccCCCCCCc
Q psy6905 272 EVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN-AYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 272 ~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~ 346 (527)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+ .......+........+|..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHL 229 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCccc
Confidence 775443 234568899999999988889999999999999999999999998776 334444444334555678888
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+..+.+++.+||..+|.+||++.+++.+
T Consensus 230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 230 SEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 9999999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=309.54 Aligned_cols=245 Identities=33% Similarity=0.517 Sum_probs=208.6
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+.|.+.+.||.|+||.||+|.+. +..|++|++..... ....+.+|+.+++.++|+||+++++++......|+|+||
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 45778889999999999999985 67899999876533 356778999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC--CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLAGR--KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~~~--~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
++|++|.+++... .++...+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~--------~~~~l~d~~~~~~ 165 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKD--------GSVKLADFGFAAQ 165 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCC--------CCEEECccchhhh
Confidence 9999999999854 7899999999999999999999984 9999999999999875 6899999999865
Q ss_pred hhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCCCCCccHH
Q psy6905 273 VYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQL 349 (527)
Q Consensus 273 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~ 349 (527)
..... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+..... ....+..++..
T Consensus 166 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd06614 166 LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPE 245 (286)
T ss_pred hccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHH
Confidence 53221 1234578899999999988899999999999999999999999988776655554443322 22233448899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.++|.+||+.+|..||++.+++.+
T Consensus 246 l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 246 FKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHHHHhccChhhCcCHHHHhhC
Confidence 9999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=308.70 Aligned_cols=237 Identities=25% Similarity=0.384 Sum_probs=192.8
Q ss_pred eeccCCceEEEEeeE--cCceEEEEEcCCCCC--hhHHHHHHHH---HHHHHhCCCCccceEEEEEEeCCeEEEEEeccC
Q psy6905 124 AIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD--ENILENVKQE---GKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYAR 196 (527)
Q Consensus 124 ~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~--~~~~~~~~~e---~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ 196 (527)
.||+|+||.||+|.+ .++.||+|++..... ......+..| ..++....||||+.+++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999987 457899998765321 1111122333 344555689999999999999999999999999
Q ss_pred CCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 197 GGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 197 ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
||+|.+++. .+.+++..+..++.|++.||+|||+.+ ++||||||+||+++.+ +.++|+|||++.....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~--------~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEH--------GHVRISDLGLACDFSK 149 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCC--------CCEEEccCcCccccCc
Confidence 999998886 556899999999999999999999994 9999999999999875 6899999999976644
Q ss_pred cccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCccCCCCCCccHHHH
Q psy6905 276 TTHMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSIN---AYAVAYGVAVNKLTLPIPSTCPQLFK 351 (527)
Q Consensus 276 ~~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~~~~~~~ 351 (527)
.......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||.+.. ........ .......|..++..+.
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~ 227 (278)
T cd05606 150 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELR 227 (278)
T ss_pred cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHH
Confidence 444456799999999999754 58999999999999999999999998762 22222222 2334567778899999
Q ss_pred HHHHHhhhhCCCCCC-----CHHHHHH
Q psy6905 352 TLMEACWEADSHMRP-----SFKTILK 373 (527)
Q Consensus 352 ~li~~~l~~dp~~RP-----s~~~ll~ 373 (527)
+++.+||..+|.+|| ++.++++
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=318.01 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=198.3
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC-----CeEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-----PKLC 189 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 189 (527)
++|++.+.||+|+||.||+|.+ +++.||||.+...........+.+|+.+++.++||||+++++++... ..+|
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 5799999999999999999987 46789999987544444456778899999999999999999987654 3589
Q ss_pred EEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
+|+||+. ++|..++..+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 85 lv~e~~~-~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~--------~~~kl~dfg~ 152 (336)
T cd07849 85 IVQELME-TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTN--------CDLKICDFGL 152 (336)
T ss_pred EEehhcc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCC--------CCEEECcccc
Confidence 9999995 58888888888999999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhcccc-----ccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------
Q psy6905 270 AREVYKTTH-----MSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV-------- 335 (527)
Q Consensus 270 a~~~~~~~~-----~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~-------- 335 (527)
+........ ....||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 876532211 12468899999998754 5688999999999999999999999987654322211110
Q ss_pred ------------------CCccCC---CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 ------------------NKLTLP---IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ------------------~~~~~~---~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....+ .....+..+.++|.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 012356789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=306.20 Aligned_cols=238 Identities=29% Similarity=0.422 Sum_probs=202.0
Q ss_pred eccCCceEEEEeeEc--CceEEEEEcCCCCC--hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCH
Q psy6905 125 IGEGGFGKVYKGIYE--KQEVAIKVAHPNPD--ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200 (527)
Q Consensus 125 iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL 200 (527)
||.|+||.||++.+. ++.|++|++..... ......+.+|+.+++.++||||+++++.+..+...|++|||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 699999999999984 68999999875432 23466788999999999999999999999999999999999999999
Q ss_pred HHHhcC-CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc---
Q psy6905 201 NRVLAG-RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--- 276 (527)
Q Consensus 201 ~~~l~~-~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~--- 276 (527)
.+++.. +.+++..+..++.||+.||.|||.+| ++||||+|+||+++.+ +.++|+|||++......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~--------~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSN--------GHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCC--------CCEEEEecccchhcccCccc
Confidence 999873 57899999999999999999999995 9999999999999875 68999999998765332
Q ss_pred -------ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCc--c
Q psy6905 277 -------THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC--P 347 (527)
Q Consensus 277 -------~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~--~ 347 (527)
......++..|+|||.+.+..++.++||||||+++|+|++|..||...........+..... +.|..+ +
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 227 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI--EWPEDVEVS 227 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc--CCCccccCC
Confidence 11234578899999999888899999999999999999999999998887777666654333 344444 9
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
..+.+++.+||+.+|.+||++..+.+.|
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 228 DEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 9999999999999999999995444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.49 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=198.6
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC------C
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS------P 186 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~ 186 (527)
..+|++.+.||+|+||.||+|.+ .++.||||++... ........+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46799999999999999999987 4678999988653 2333456677899999999999999999998643 3
Q ss_pred eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 187 KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
..|+|||||. ++|.+.+... ++...+..++.|++.||+|||++| |+||||||+|||++.+ +.+||+|
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~--------~~~kL~D 161 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD--------CTLKILD 161 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCC--------CCEEEcc
Confidence 5799999995 5788877644 889999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhcccc-ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Q psy6905 267 FGLAREVYKTTH-MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN--------- 336 (527)
Q Consensus 267 FGla~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~--------- 336 (527)
||+++....... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 162 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 162 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred CccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 999986543322 2346889999999999999999999999999999999999999877654332222110
Q ss_pred -------------Ccc--------------CC-----CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 -------------KLT--------------LP-----IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 -------------~~~--------------~~-----~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
... .+ .+...++.+.++|.+||..||.+|||+.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00 012346678999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=299.37 Aligned_cols=244 Identities=36% Similarity=0.605 Sum_probs=211.1
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|.+.+.||+|+||.||++.+. ++.|++|.+..... ......+.+|+++++.++|||++++++++.++...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999874 57899998876532 23467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
+.+++|.+++. ...+++..+..++.|++.||.|||++| ++||||+|+||+++.+ +.++|+|||++...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~--------~~~~l~d~~~~~~~ 149 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKD--------GVVKLADFGVATKL 149 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCC--------CCEEEeccccceec
Confidence 99999999887 467899999999999999999999995 9999999999999875 68999999999876
Q ss_pred hcccc--ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHH
Q psy6905 274 YKTTH--MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFK 351 (527)
Q Consensus 274 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 351 (527)
..... ....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......... ....+.|..++..+.
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 228 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELK 228 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCCHHHH
Confidence 43322 235688999999999888889999999999999999999999988776555555443 334467778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q psy6905 352 TLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs~~~ll~ 373 (527)
+++.+||..+|++||++.+++.
T Consensus 229 ~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 229 DFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHhCChhhCcCHHHHhc
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.83 Aligned_cols=238 Identities=28% Similarity=0.385 Sum_probs=195.3
Q ss_pred eccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCH
Q psy6905 125 IGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200 (527)
Q Consensus 125 iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL 200 (527)
||+|+||.||+|.+. ++.||+|++.... .......+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 799999999999864 6789999886532 122345567899999999999999999999999999999999999999
Q ss_pred HHHhcC-C--CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccc
Q psy6905 201 NRVLAG-R--KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT 277 (527)
Q Consensus 201 ~~~l~~-~--~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~ 277 (527)
.+++.. . .+++..+..++.|++.||.|||+.| ++||||+|+|||++.+ +.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~--------~~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDH--------GNVRISDLGLAVELKGGK 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCC--------CCEEEccCcchhhhccCC
Confidence 988862 3 5899999999999999999999995 9999999999999875 689999999987654322
Q ss_pred -cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCccCCCCCCccHHHHHHH
Q psy6905 278 -HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV--NKLTLPIPSTCPQLFKTLM 354 (527)
Q Consensus 278 -~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~~~~~li 354 (527)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.. .......|..+++.+.++|
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 229 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC 229 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHH
Confidence 2234678899999999888899999999999999999999999977543211111111 1234456677899999999
Q ss_pred HHhhhhCCCCCC-----CHHHHHH
Q psy6905 355 EACWEADSHMRP-----SFKTILK 373 (527)
Q Consensus 355 ~~~l~~dp~~RP-----s~~~ll~ 373 (527)
.+||..||.+|| ++.+++.
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 230 EALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHccCChhHccCCCcccHHHHHh
Confidence 999999999999 6666655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.56 Aligned_cols=247 Identities=28% Similarity=0.341 Sum_probs=200.1
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--CeEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQS--PKLCL 190 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~i 190 (527)
.++|++.+.||.|+||.||+|.+. ++.+|+|.+..... ......+.+|+.+++.++||||+++++++... ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357889999999999999999985 57899998865432 22234567899999999999999999999877 88999
Q ss_pred EEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 191 VMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
||||+. ++|.+++. ...+++..++.++.||+.||.|||++| ++|+||+|+|||++.+ +.++|+|||
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~--------~~~~l~d~g 151 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNR--------GILKICDFG 151 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCC--------CcEEEeecC
Confidence 999996 58988876 335899999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhcc--ccccCCCccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Q psy6905 269 LAREVYKT--THMSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN--------- 336 (527)
Q Consensus 269 la~~~~~~--~~~~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~--------- 336 (527)
++...... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 152 LAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred ceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 99866432 122345788999999987644 689999999999999999999999877655444332210
Q ss_pred --------------------CccCCCCCC-ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 --------------------KLTLPIPST-CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 --------------------~~~~~~p~~-~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
......+.. +++.+.++|++||+.+|++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001112222 57889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=308.49 Aligned_cols=245 Identities=27% Similarity=0.377 Sum_probs=197.9
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|++.+.||.|+||.||+|.+ +++.||||.+.... .......+.+|+.+++.++||||+++++++.++...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 377889999999999999987 46789999886543 222345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 195 ARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 195 ~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+. ++|..++. +..+++..+..++.||+.||+|||+.+ ++||||+|+||+++.+ +.+||+|||++.
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~--------~~~~l~dfg~~~ 148 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTE--------GAIKLADFGLAR 148 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC--------CCEEEeeccchh
Confidence 95 67888775 356889999999999999999999995 9999999999999875 689999999987
Q ss_pred hhhccc--cccCCCccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc---------
Q psy6905 272 EVYKTT--HMSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT--------- 339 (527)
Q Consensus 272 ~~~~~~--~~~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~--------- 339 (527)
...... .....++..|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.+.......+......
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 149 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred hcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 653221 12335788999999987644 688999999999999999999999877654433332210000
Q ss_pred ------------------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 ------------------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ------------------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
......++..++++|.+||+.||.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 01123467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=308.34 Aligned_cols=245 Identities=30% Similarity=0.486 Sum_probs=209.8
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv 191 (527)
++|.+.+.||+|+||.||+|.+ +++.||+|++.... .......+..|+.+++.+. ||||+++++++..+...++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4789999999999999999987 46899999987532 2233567888999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||+.+++|.+++. .+.+++..+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.++|+|||++
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~--------~~~~l~df~~~ 149 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKD--------MHIKITDFGTA 149 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCC--------CCEEecCCccc
Confidence 99999999999987 447999999999999999999999995 9999999999999875 68999999998
Q ss_pred hhhhcccc----------------------ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6905 271 REVYKTTH----------------------MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYA 328 (527)
Q Consensus 271 ~~~~~~~~----------------------~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~ 328 (527)
........ ....++..|+|||++.+..++.++||||||+++|++++|..||...+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 76533211 12347899999999988889999999999999999999999999887666
Q ss_pred HHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCH----HHHHHH
Q psy6905 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSF----KTILKA 374 (527)
Q Consensus 329 ~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~----~~ll~~ 374 (527)
....+. ......|..+++.+.+++.+||+.+|.+||++ .+++++
T Consensus 230 ~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 TFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 655554 33445677889999999999999999999999 777763
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=315.76 Aligned_cols=242 Identities=25% Similarity=0.350 Sum_probs=182.4
Q ss_pred eeeeccCCceEEEEeeEc----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe--CCeEEEEEecc
Q psy6905 122 GEAIGEGGFGKVYKGIYE----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--SPKLCLVMEYA 195 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~iv~Ey~ 195 (527)
+.+||+|+||.||+|.+. +..||+|.+..... ...+.+|+.+++.++||||+++++++.. +..+|+||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 357999999999999863 35799998865432 2356789999999999999999999854 56789999999
Q ss_pred CCCCHHHHhc----------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 196 RGGPLNRVLA----------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 196 ~ggsL~~~l~----------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
. ++|.+++. ...+++..+..++.||+.||.|||+.| |+||||||+|||+..+.. ..+.+||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~----~~~~~kl~ 154 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP----ERGRVKIA 154 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCC----CCCcEEEe
Confidence 6 46766653 124778889999999999999999995 999999999999954311 13689999
Q ss_pred ccCcchhhhccc-----cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHH---------HHH
Q psy6905 266 DFGLAREVYKTT-----HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAY---------AVA 330 (527)
Q Consensus 266 DFGla~~~~~~~-----~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~---------~~~ 330 (527)
|||+++...... .....||+.|+|||++.+ ..++.++|||||||++|||+||++||...... ...
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence 999998653321 123468999999999876 45889999999999999999999999753321 000
Q ss_pred HHHHh-CC----------------------c---cC----------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 331 YGVAV-NK----------------------L---TL----------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 331 ~~i~~-~~----------------------~---~~----------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+.. .+ . .. ......+..+.+||.+||..||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 00 0 00 0011234568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=308.16 Aligned_cols=241 Identities=27% Similarity=0.424 Sum_probs=203.6
Q ss_pred eeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCC
Q psy6905 122 GEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGP 199 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggs 199 (527)
...||+|+||.||++.. ++..||||.+.... ......+.+|+.+++.++|+||+++++++...+..|+||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 46799999999999987 46789999875433 2335668899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccc--
Q psy6905 200 LNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT-- 277 (527)
Q Consensus 200 L~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~-- 277 (527)
|.+++....+++..+..++.|++.||+|||++| ++||||+|+||+++.+ +.++|+|||++.......
T Consensus 104 L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~--------~~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 104 LTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHD--------GRVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC--------CCEEEcccccceeccccccc
Confidence 999988778999999999999999999999995 9999999999999875 689999999987653322
Q ss_pred cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-ccCCCCCCccHHHHHHHHH
Q psy6905 278 HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPSTCPQLFKTLMEA 356 (527)
Q Consensus 278 ~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~~~~li~~ 356 (527)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+.... ........++..+.+++.+
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR 252 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence 223468899999999988888999999999999999999999998876655544333221 1222345678899999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q psy6905 357 CWEADSHMRPSFKTILKA 374 (527)
Q Consensus 357 ~l~~dp~~RPs~~~ll~~ 374 (527)
||..+|.+||++.+++.+
T Consensus 253 ~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 253 LLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHhCCcccCcCHHHHhcC
Confidence 999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=345.08 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=218.5
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
..+..++|.++++||+|+||.|..++.+ ++.||+|++.... .......|..|-.+|..-+.+-|+.++-+|.++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 4567899999999999999999999874 5789999987631 11224678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhcCC-CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~-~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|+||||++||+|..++.+- ++++..+..++..|..||.-||+.| +|||||||+||||+.. |.+||+|
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~--------GHikLAD 218 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKS--------GHIKLAD 218 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEeccc--------CcEeecc
Confidence 99999999999999999844 5999999999999999999999996 9999999999999986 8999999
Q ss_pred cCcchhhhcccc---ccCCCccccccccccc----c-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Q psy6905 267 FGLAREVYKTTH---MSAAGTYAWMAPEVIK----T-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 267 FGla~~~~~~~~---~~~~gt~~y~aPE~l~----~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
||.+-.+...+. ...+|||-|.+||++. + +.|+..+|.||+||++|||+.|..||...+..+.+.+|...+-
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE 298 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh
Confidence 999987754433 2467999999999995 3 5689999999999999999999999999999999999987755
Q ss_pred cCCCC--CCccHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q psy6905 339 TLPIP--STCPQLFKTLMEACWEADSHMRPS---FKTILKA 374 (527)
Q Consensus 339 ~~~~p--~~~~~~~~~li~~~l~~dp~~RPs---~~~ll~~ 374 (527)
.+.+| ..+|++.++||.+.+ .+|+.|.. +.++..|
T Consensus 299 ~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 299 SLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 66666 568999999998876 46788877 8888876
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=305.09 Aligned_cols=243 Identities=23% Similarity=0.325 Sum_probs=193.5
Q ss_pred eeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeC--CeEEEEEe
Q psy6905 119 LIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQS--PKLCLVME 193 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~--~~~~iv~E 193 (527)
|++.+.||+|+||.||+|.+ +++.||+|.+.............+|+.++..+. |+||+++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 57788999999999999987 467899998876432222234457888888885 99999999999987 88999999
Q ss_pred ccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|+. |+|.+.+. ...+++..+..++.||+.||.|||+.| ++||||+|+||+++. +.+||+|||+++
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~---------~~~kl~dfg~~~ 147 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD---------DILKLADFGSCR 147 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC---------CCeEEEeccccc
Confidence 996 57777665 346899999999999999999999995 999999999999986 489999999998
Q ss_pred hhhcccc-ccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Q psy6905 272 EVYKTTH-MSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------------- 336 (527)
Q Consensus 272 ~~~~~~~-~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------------- 336 (527)
....... ....++..|+|||.+.. ..++.++|||||||++|||++|..||.+.+..+....+...
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 7643322 23457899999997654 55789999999999999999999999887654433322110
Q ss_pred ---CccCCC-----------CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ---KLTLPI-----------PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ---~~~~~~-----------p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...... ...++..+.++|.+||..+|++||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000111 13568899999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=306.23 Aligned_cols=244 Identities=27% Similarity=0.405 Sum_probs=198.7
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
+|++.+.||.|++|.||+|.+ ++..||||++...........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 478899999999999999997 467899998876543333456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcC----CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 196 RGGPLNRVLAG----RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 196 ~ggsL~~~l~~----~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
.+ +|.+++.. ..+++..+..++.||+.||.|||+.| ++||||+|+||+++.+ +.++|+|||++.
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~--------~~~~l~d~g~~~ 148 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKR--------GELKLADFGLAR 148 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCC--------CcEEEeecchhh
Confidence 75 78877752 35899999999999999999999995 9999999999999875 689999999997
Q ss_pred hhhccc--cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Q psy6905 272 EVYKTT--HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------------ 336 (527)
Q Consensus 272 ~~~~~~--~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------------ 336 (527)
...... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07836 149 AFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI 228 (284)
T ss_pred hhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence 653221 2234578899999998654 5789999999999999999999999877655443332210
Q ss_pred ----CccCC-----------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 337 ----KLTLP-----------IPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 337 ----~~~~~-----------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.+... ....++..+.+++..||+.||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00001 11245778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=310.54 Aligned_cols=248 Identities=27% Similarity=0.349 Sum_probs=199.4
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--CeEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQS--PKLC 189 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~ 189 (527)
+.++|++.+.||.|+||.||+|.+. +..||+|.+..... ......+.+|+.+++.++|+||+++++++.+. +.+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 4567999999999999999999974 67899998865422 22233456799999999999999999998765 5689
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+||||+. ++|.+++. ...+++..+..++.||+.||.|||+.| ++||||||+|||++.+ +.+||+||
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~--------~~~kL~df 152 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDK--------GCLKIADF 152 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC--------CCEEECcc
Confidence 9999996 57887776 356899999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhccc--cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc------
Q psy6905 268 GLAREVYKTT--HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL------ 338 (527)
Q Consensus 268 Gla~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~------ 338 (527)
|++....... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 153 GLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred ceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 9998664321 122345788999999865 4578999999999999999999999998877666554432100
Q ss_pred -----------cCCCC-----------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 -----------TLPIP-----------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 -----------~~~~p-----------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+ ...++.+.++|.+||..||++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00011 1247888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=308.85 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=199.0
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC----hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD----ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
+|++.+.||.|+||.||+|.+. ++.||||.+..... ......+..|+.+++.++|+||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999974 67899998876432 22245567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCC--CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 192 MEYARGGPLNRVLAGR--KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~~~--~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||+ +|+|.+++... .+++..++.++.||+.||.|||++| ++|+||+|+|||++.+ +.++|+|||+
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~--------~~~~l~dfg~ 148 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASD--------GVLKLADFGL 148 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCC--------CCEEEcccee
Confidence 9999 99999999744 5899999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhccc--cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Q psy6905 270 AREVYKTT--HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK--------- 337 (527)
Q Consensus 270 a~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~--------- 337 (527)
++...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 149 ARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred eeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 97664321 122356788999999865 457899999999999999999988888766544333322100
Q ss_pred -------c-----cCC-----CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 -------L-----TLP-----IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 -------~-----~~~-----~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. ..+ .....+..+.++|.+||..||.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 000 113457789999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=309.48 Aligned_cols=245 Identities=29% Similarity=0.459 Sum_probs=203.7
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC--CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
...|...+.||.|+||.||+|.+ .+..+|+|.+... ........+.+|+.+++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34577788999999999999997 4578999987642 2233456778899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 192 MEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||+. |+|.+++. ...+++..+..++.|++.||.|||+.+ ++||||+|+|||++.+ +.++|+|||+
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~--------~~~kl~dfg~ 161 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEP--------GLVKLGDFGS 161 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCC--------CcEEECCccc
Confidence 99996 57777664 556889999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhccccccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 270 AREVYKTTHMSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 270 a~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
+..... .....|++.|+|||.+. ...++.++|||||||++|+|++|..||...+.......+.........+..+
T Consensus 162 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (308)
T cd06634 162 ASIMAP--ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239 (308)
T ss_pred ceeecC--cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccc
Confidence 875532 22356889999999974 3457889999999999999999999998877666655555443333334578
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+..+.+||.+||..+|.+||++.+++.+
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 8999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=295.31 Aligned_cols=244 Identities=27% Similarity=0.453 Sum_probs=204.1
Q ss_pred Cceeee-eeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEe----CCeE
Q psy6905 117 NKLIFG-EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQ----SPKL 188 (527)
Q Consensus 117 ~~~~~~-~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~----~~~~ 188 (527)
++|.+. ++||-|-.|.|-.|.++ ++.+|+|++... ...++|+++-... .|||||.++++|.+ ...+
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 344443 68999999999999874 678999998754 3345777776655 79999999999865 3568
Q ss_pred EEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 189 CLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.||||.|+||.|...+. ...|++.++..|..||+.|+.|||+. +|.||||||+|+|...+.. +..+||+
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~-----na~lKLt 206 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSP-----NAPLKLT 206 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCC-----CcceEec
Confidence 99999999999988876 34599999999999999999999999 7999999999999987643 3689999
Q ss_pred ccCcchhhhc-cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCccC
Q psy6905 266 DFGLAREVYK-TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY----AVAYGVAVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~----~~~~~i~~~~~~~ 340 (527)
|||+|+.... ..-.+.+.|+.|.|||++....|+..+|+||+||++|-|++|.+||...... ....+|..+.+.+
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 9999987653 3344678899999999999999999999999999999999999999876543 2344566677777
Q ss_pred CCC--CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 PIP--STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 ~~p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
|-| +.+|+..+++|+.+|..+|++|.|+.+++++
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 766 5679999999999999999999999999874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=310.91 Aligned_cols=245 Identities=21% Similarity=0.345 Sum_probs=197.5
Q ss_pred eeeeeeeccCCceEEEEeeEcCceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
+.+++.+|.|+++.||++..+++.||||++... ........+.+|+.+++.++|+||+++++++.+....|++||||.+
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 456677788888888888888899999998765 3444567899999999999999999999999999999999999999
Q ss_pred CCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 198 GPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 198 gsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||.+....
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~--------~~~kl~d~~~~~~~~ 152 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGD--------GKVVLSGLRYSVSMI 152 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecC--------CceEEecCccceeec
Confidence 999999873 45888999999999999999999994 9999999999999875 689999999986553
Q ss_pred ccc---------cccCCCccccccccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------
Q psy6905 275 KTT---------HMSAAGTYAWMAPEVIKTS--IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK------ 337 (527)
Q Consensus 275 ~~~---------~~~~~gt~~y~aPE~l~~~--~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~------ 337 (527)
... .....++..|+|||++... .++.++|||||||++|+|++|..||...+............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD 232 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccc
Confidence 211 1223477889999998763 57899999999999999999999998765443332211100
Q ss_pred --------------------------ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 --------------------------LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 --------------------------~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....+..++..+.++|..||..||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0011112335678999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=311.04 Aligned_cols=241 Identities=23% Similarity=0.412 Sum_probs=193.5
Q ss_pred eeeccC--CceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 123 EAIGEG--GFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 123 ~~iG~G--~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
..||.| +||+||++.+ .++.||+|+..... .....+.+.+|+.+++.++||||++++++|..++..|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 9999999987 57899999987643 334457788999999999999999999999999999999999999
Q ss_pred CCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 198 GPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 198 gsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
|+|.+++.. ..+++..+..++.||+.||.|||++| ++||||||+|||++.+ +.++++|||.+....
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~--------~~~~~~~~~~~~~~~ 152 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGD--------GLVSLSGLSHLYSLV 152 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCC--------CcEEEechHHHhhhh
Confidence 999998873 35888999999999999999999985 9999999999999875 689999998654332
Q ss_pred cccc---------ccCCCccccccccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------
Q psy6905 275 KTTH---------MSAAGTYAWMAPEVIKTS--IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK------ 337 (527)
Q Consensus 275 ~~~~---------~~~~gt~~y~aPE~l~~~--~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~------ 337 (527)
.... ....++..|+|||++.+. .++.++|||||||++|+|++|..||.+..............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 2111 012346779999999764 47899999999999999999999998776544332221110
Q ss_pred ---------------------------------------ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 ---------------------------------------LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 ---------------------------------------~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+.+..+++.+.+||.+||..||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0112234467889999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=305.78 Aligned_cols=247 Identities=27% Similarity=0.343 Sum_probs=195.8
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCe-----
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPK----- 187 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~----- 187 (527)
++|++.+.||.|+||.||+|.+ +++.||||.+..... ......+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688999999999999999987 467899998765432 22245677899999999 46999999999987665
Q ss_pred EEEEEeccCCCCHHHHhc------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 188 LCLVMEYARGGPLNRVLA------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
.|+|||||.+ +|.+++. +..+++..++.++.||+.||.|||++| ++||||+|+|||++.+ .+.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~-------~~~ 149 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQ-------KGL 149 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecC-------CCe
Confidence 8999999975 7877764 235789999999999999999999995 9999999999999873 268
Q ss_pred eEEeccCcchhhhcc--ccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Q psy6905 262 LKITDFGLAREVYKT--THMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 262 vkL~DFGla~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
+||+|||++...... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+...-.
T Consensus 150 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 150 LKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred EEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999998765322 1123357889999998865 4578999999999999999999999988766554433321000
Q ss_pred -----c------------CC---------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 -----T------------LP---------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 -----~------------~~---------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. .+ ....++..+.++|.+||..||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00 012467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=307.05 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=193.7
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC-----
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP----- 186 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~----- 186 (527)
+.++|++.+.||+|+||.||+|.+. ++.||||.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457999999999999999999974 6789999876532 2222345568999999999999999999987643
Q ss_pred ---eEEEEEeccCCCCHHHHhcCC--CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 187 ---KLCLVMEYARGGPLNRVLAGR--KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 187 ---~~~iv~Ey~~ggsL~~~l~~~--~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
..|+|||||. ++|.+++... .+++.++..++.||+.||.|||++| ++|+||||+|||++.+ +.
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~--------~~ 157 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKD--------GI 157 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCC--------Cc
Confidence 4599999995 5787777633 6899999999999999999999995 9999999999999875 68
Q ss_pred eEEeccCcchhhhcccc------ccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6905 262 LKITDFGLAREVYKTTH------MSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA 334 (527)
Q Consensus 262 vkL~DFGla~~~~~~~~------~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 334 (527)
+||+|||++........ ....++..|+|||.+.+. .++.++||||||+++|+|++|..||.+.+.......+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~ 237 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999976533211 123578899999988664 37889999999999999999999998776543322211
Q ss_pred hC--Ccc---------------CCCC-------------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 335 VN--KLT---------------LPIP-------------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 335 ~~--~~~---------------~~~p-------------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. ... ...| ...+..+.++|.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 10 000 0011 1235677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=324.00 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=201.0
Q ss_pred eeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC------eEEEEE
Q psy6905 121 FGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP------KLCLVM 192 (527)
Q Consensus 121 ~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------~~~iv~ 192 (527)
..+.||+||||.||+|++ .|..||||.++......-.+...+|+++|++|+|+|||+++++-.+.. ...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 446799999999999996 578999999887554444667789999999999999999999865433 458999
Q ss_pred eccCCCCHHHHhc----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 193 EYARGGPLNRVLA----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 193 Ey~~ggsL~~~l~----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|||.||||..++. ...+++.+++.++.+++.||.|||++| ||||||||.||++-...+ .....||+|||
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Ged----gq~IyKLtDfG 169 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGED----GQSIYKLTDFG 169 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCC----CceEEeeeccc
Confidence 9999999999997 356999999999999999999999994 999999999999865321 12467999999
Q ss_pred cchhhhcccc-ccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHh-------
Q psy6905 269 LAREVYKTTH-MSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSIN----AYAVAYGVAV------- 335 (527)
Q Consensus 269 la~~~~~~~~-~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~----~~~~~~~i~~------- 335 (527)
.|+.+.+... .+.+||..|++||++.. ..|+..+|.|||||++|+..||..||.... +.++.+.+..
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9999866544 46789999999999984 889999999999999999999999996532 2334443321
Q ss_pred ------------CCccCCCCCCccHH----HHHHHHHhhhhCCCCCC--CHHHHHHHHhhhhhc
Q psy6905 336 ------------NKLTLPIPSTCPQL----FKTLMEACWEADSHMRP--SFKTILKALNNIVHS 381 (527)
Q Consensus 336 ------------~~~~~~~p~~~~~~----~~~li~~~l~~dp~~RP--s~~~ll~~L~~~~~~ 381 (527)
....+|.|..++.. +-..+..++..+|.+|- .+.+....+.++++.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 12234555555544 34567788899999998 666666655555443
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.71 Aligned_cols=242 Identities=29% Similarity=0.477 Sum_probs=200.6
Q ss_pred eeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 119 LIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
|...+.||+|+||.||+|.+ .+..|++|.+.... .......+.+|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999987 46789999876532 233456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|. |+|.+++. ...+++..+..++.||+.||.|||++| ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~--------~~~kL~dfg~~~~ 170 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEP--------GQVKLADFGSASK 170 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCC--------CCEEEeecCCCcc
Confidence 95 56766664 456889999999999999999999995 9999999999999875 6899999999864
Q ss_pred hhccccccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 273 VYKTTHMSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 273 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
.. ......|+..|+|||.+. ...++.++|||||||++|+|++|..||...+.......+............++..
T Consensus 171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
T cd06633 171 SS--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDS 248 (313)
T ss_pred cC--CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHH
Confidence 32 222456889999999984 4568899999999999999999999998877666665555443333333457788
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+++.+||+.+|.+||++.+++.+
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=301.17 Aligned_cols=238 Identities=23% Similarity=0.337 Sum_probs=189.5
Q ss_pred ceeeeeee--ccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHh-CCCCccceEEEEEEeCCeEEEEE
Q psy6905 118 KLIFGEAI--GEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWL-FDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 118 ~~~~~~~i--G~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~-l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
+|.+.+.+ |.|+||.||++.. .+..+|+|+........ .|+..... .+||||+++++.+...+..|+||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 44555555 9999999999986 45789999876532111 12222221 27999999999999999999999
Q ss_pred eccCCCCHHHHhcC-CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLAG-RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~~-~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||+++|+|.+++.. ..+++..+..++.||+.||.|||+.| ++||||||+||+++.+. +.++|+|||++.
T Consensus 89 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~-------~~~~l~dfg~~~ 158 (267)
T PHA03390 89 DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAK-------DRIYLCDYGLCK 158 (267)
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCC-------CeEEEecCccce
Confidence 99999999999874 47899999999999999999999995 99999999999998751 289999999987
Q ss_pred hhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HH-hCCccCCCCCCccHH
Q psy6905 272 EVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG-VA-VNKLTLPIPSTCPQL 349 (527)
Q Consensus 272 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~-i~-~~~~~~~~p~~~~~~ 349 (527)
.... .....|+..|+|||++.+..++.++|||||||++|+|++|..||........... .. ......+.+..+++.
T Consensus 159 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 159 IIGT--PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred ecCC--CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 6532 2234689999999999988899999999999999999999999986543322111 11 112233555678999
Q ss_pred HHHHHHHhhhhCCCCCCC-HHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPS-FKTILK 373 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs-~~~ll~ 373 (527)
+.++|.+||+.+|.+||+ ++++++
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhc
Confidence 999999999999999995 688886
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=304.86 Aligned_cols=243 Identities=27% Similarity=0.414 Sum_probs=199.0
Q ss_pred ceeeeeeeccCCceEEEEeeE-----cCceEEEEEcCCCC---ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNP---DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~ 188 (527)
.|++.+.||.|+||.||+|.. ++..||+|++.... .....+.+.+|+.++..+ +|+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999886 46789999986532 122346678899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+||||+++++|.+++. ...+++..+..++.||+.||.|||+.| ++||||+|+|||++.+ +.+||+||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~--------~~~kl~df 149 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSN--------GHVVLTDF 149 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCC--------CCEEEeeC
Confidence 99999999999999886 566889999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhccc---cccCCCccccccccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCc
Q psy6905 268 GLAREVYKTT---HMSAAGTYAWMAPEVIKTS--IFSKASDVWSYGVVLWELLTGEIPYKSINA----YAVAYGVAVNKL 338 (527)
Q Consensus 268 Gla~~~~~~~---~~~~~gt~~y~aPE~l~~~--~~~~ksDvwSlGv~l~elltg~~Pf~~~~~----~~~~~~i~~~~~ 338 (527)
|++....... .....|+..|+|||.+.+. .++.++||||||+++|+|++|..||..... ......+. ..
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~ 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KS 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh--cc
Confidence 9997653321 1234689999999998753 467899999999999999999999974322 22222222 22
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRP-----SFKTILK 373 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RP-----s~~~ll~ 373 (527)
..+.|..++..+.+++.+||..||++|| ++.+++.
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 3456778899999999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=301.51 Aligned_cols=244 Identities=30% Similarity=0.558 Sum_probs=202.3
Q ss_pred ceeeeeeeccCCceEEEEeeEcC--ceEEEEEcCCCC----ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP----DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~~--~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
+|.+.+.||+|+||.||++.+.. ..+++|+.+... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999998753 446666654321 122234566789999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 192 MEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
|||+.+++|.+++. ...+++..++.++.|++.||.|||+.| ++|+||+|+||+++. +.++|+|
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~---------~~~~l~d 148 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN---------NLLKIGD 148 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec---------CCEeecc
Confidence 99999999998774 356899999999999999999999995 999999999999975 3699999
Q ss_pred cCcchhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 267 FGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 267 FGla~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
||++....... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.. ......+.
T Consensus 149 ~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 227 (260)
T cd08222 149 FGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPE 227 (260)
T ss_pred cCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCcc
Confidence 99987653322 2234588999999999888889999999999999999999999987766665555443 33334567
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.++.++.++|.+||..+|++||++.+++++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=317.44 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=225.0
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEcCce--EEEEEcCCC--CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQE--VAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~--vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
.+..++++.+..||-||||.|-++..+++. +|+|+++.. -+....+.+..|-++|..++.|.||++|..|.++.++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 355677888899999999999998877654 799988764 2445567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
||+||-|-||.|..+|+ ++.|...+...++.-+++|++|||++| ||+|||||+|+|++.+ |-+||.||
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~--------Gy~KLVDF 564 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNR--------GYLKLVDF 564 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccC--------CceEEeeh
Confidence 99999999999999998 678999999999999999999999995 9999999999999986 79999999
Q ss_pred Ccchhhhcc-ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 268 GLAREVYKT-THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 268 Gla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
|+|+.+... ...++|||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.+....+..|..+--.+..|..+
T Consensus 565 GFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I 644 (732)
T KOG0614|consen 565 GFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRI 644 (732)
T ss_pred hhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccccc
Confidence 999988554 4458899999999999999999999999999999999999999999999999988888776677889999
Q ss_pred cHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPS-----FKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs-----~~~ll~~ 374 (527)
+....+||+++...+|.+|.. +.+|.+|
T Consensus 645 ~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 645 TKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred chhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 999999999999999999975 5566654
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=303.31 Aligned_cols=244 Identities=27% Similarity=0.377 Sum_probs=197.3
Q ss_pred eeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 119 LIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
|++.+.||.|++|.||+|.+ ++..||+|++..... ......+.+|+.+++.++||||+++++++.+++..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999987 468899998865432 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC---CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 196 RGGPLNRVLAGR---KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 196 ~ggsL~~~l~~~---~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
+++|.+++... .+++..++.++.|++.||.|||++ +++||||+|+|||++.+ +.++|+|||++..
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~--------~~~~l~df~~~~~ 148 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDRE--------GALKLADFGLARA 148 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCC--------CcEEEeecccccc
Confidence 46898888633 589999999999999999999998 49999999999999875 6899999999975
Q ss_pred hhccc--cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Q psy6905 273 VYKTT--HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK------------ 337 (527)
Q Consensus 273 ~~~~~--~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~------------ 337 (527)
..... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 149 FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred cCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence 53221 1233568899999988664 57899999999999999999999998776544333321100
Q ss_pred -----------cc----CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 -----------LT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 -----------~~----~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. ......++..+.+++.+||+.||.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 01124567889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=307.45 Aligned_cols=249 Identities=29% Similarity=0.375 Sum_probs=193.3
Q ss_pred ceeeeeeeccCCceEEEEeeE----cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--CeEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY----EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS--PKLC 189 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~----~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~ 189 (527)
+|.+.+.||+|+||.||+|.+ .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 478889999999999999997 35789999887632 122345677899999999999999999999988 8899
Q ss_pred EEEeccCCCCHHHHhc------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 190 LVMEYARGGPLNRVLA------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
+||||+.+ +|.+++. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.+.. ..+.+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~----~~~~~k 152 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGP----ERGVVK 152 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCC----ccceEE
Confidence 99999965 5665553 136788999999999999999999995 999999999999987211 137899
Q ss_pred EeccCcchhhhcccc-----ccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---------
Q psy6905 264 ITDFGLAREVYKTTH-----MSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYA--------- 328 (527)
Q Consensus 264 L~DFGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~--------- 328 (527)
|+|||++........ ....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.....
T Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 232 (316)
T cd07842 153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232 (316)
T ss_pred ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHH
Confidence 999999986533221 234578899999988764 57899999999999999999999998654321
Q ss_pred HHHHHH------------------------hCCccCCCC-----------CCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 329 VAYGVA------------------------VNKLTLPIP-----------STCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 329 ~~~~i~------------------------~~~~~~~~p-----------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
....+. ........+ ...+..+.+++.+||..||++|||+.+++.
T Consensus 233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000001111 145678999999999999999999999986
Q ss_pred H
Q psy6905 374 A 374 (527)
Q Consensus 374 ~ 374 (527)
+
T Consensus 313 ~ 313 (316)
T cd07842 313 H 313 (316)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=309.81 Aligned_cols=245 Identities=28% Similarity=0.352 Sum_probs=202.8
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC-----eEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-----KLC 189 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 189 (527)
+|++.+.||.|+||.||+|.+. +..||||.+..... ....+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788999999999999999974 57899998876432 334567889999999999999999999998775 789
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+||||+. ++|.+++. +..+++..+..++.||+.||.|||++| |+||||||.|||++.+ +.++|+|||
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~--------~~~~L~dfg 148 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSN--------CDLKICDFG 148 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC--------CCEEEcccC
Confidence 9999996 57888876 457899999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhccc-----cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC--
Q psy6905 269 LAREVYKTT-----HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL-- 340 (527)
Q Consensus 269 la~~~~~~~-----~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~-- 340 (527)
++....... .....++..|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 228 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence 998764432 2234578899999999887 78999999999999999999999998877655444332210000
Q ss_pred ---------------------------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 ---------------------------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 ---------------------------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....++..+.++|.+||+.+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0113367889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.43 Aligned_cols=247 Identities=27% Similarity=0.390 Sum_probs=197.0
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|++.+.||.|+||.||+|.+. ++.||+|.+.... .......+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999874 5789999886542 22334667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 194 YARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 194 y~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|++ ++|.+.+.. ..+++..+..++.||+.||+|||+++ ++||||+|+||+++.+ .+.+||+|||++
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~-------~~~~kl~dfg~~ 150 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRR-------TNALKLADFGLA 150 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECC-------CCEEEEcccccc
Confidence 995 577766642 23577888899999999999999994 9999999999999853 257999999999
Q ss_pred hhhhccc--cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-C---------
Q psy6905 271 REVYKTT--HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-K--------- 337 (527)
Q Consensus 271 ~~~~~~~--~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-~--------- 337 (527)
....... .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+... +
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 7553221 1234578999999998764 5789999999999999999999999877655444332210 0
Q ss_pred ----------c-cCC------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 ----------L-TLP------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 ----------~-~~~------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. ..+ .....++.+.+++.+|++.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 123467889999999999999999999999873
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=295.80 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=209.7
Q ss_pred CceeeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHH-hCCCCccceEEEEEEe
Q psy6905 108 DVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLW-LFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 108 ~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~hpnIv~~~~~~~~ 184 (527)
+...|++...+++-+..||.|+||+|++-.++ |+..|||.++....+....+++.|.+... .-+.||||+|||++..
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 34568888888988999999999999998874 67899999998877666677777766554 4589999999999988
Q ss_pred CCeEEEEEeccCCCCHHHHhc------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccc
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~ 258 (527)
++..||.||+| ..||+.+.+ +..+++..+-.|..-...||.||...- +|||||+||+|||++..
T Consensus 135 EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~------- 204 (361)
T KOG1006|consen 135 EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRH------- 204 (361)
T ss_pred CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecC-------
Confidence 88899999999 567776643 567999998899999999999999875 79999999999999986
Q ss_pred cceeEEeccCcchhhhcc-ccccCCCcccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Q psy6905 259 FKTLKITDFGLAREVYKT-THMSAAGTYAWMAPEVIKT--SIFSKASDVWSYGVVLWELLTGEIPYKSINA-YAVAYGVA 334 (527)
Q Consensus 259 ~~~vkL~DFGla~~~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~-~~~~~~i~ 334 (527)
|.|||||||++-.+.+. .....+|-..|||||.+.. ..|+.+|||||||++|||+.||..||.+++. .+.+..+.
T Consensus 205 -G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv 283 (361)
T KOG1006|consen 205 -GDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV 283 (361)
T ss_pred -CCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH
Confidence 79999999999876443 2334578899999999953 3589999999999999999999999998765 33344444
Q ss_pred hCCcc-CCCCCC---ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 335 VNKLT-LPIPST---CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 335 ~~~~~-~~~p~~---~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+... +..+.. ++..+..+|.-|+..|-..||.+.+|+++
T Consensus 284 ~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 33322 222333 67889999999999999999999999873
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=337.87 Aligned_cols=240 Identities=29% Similarity=0.481 Sum_probs=193.3
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe----------
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ---------- 184 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~---------- 184 (527)
.+|+.++.||+||||.||+++. +|+.||||.+...........+.+|+.+|.+|+|||||+||..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4567788999999999999986 6899999998887666667889999999999999999999976520
Q ss_pred --------------------------------------------------------------------C-----------
Q psy6905 185 --------------------------------------------------------------------S----------- 185 (527)
Q Consensus 185 --------------------------------------------------------------------~----------- 185 (527)
.
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0
Q ss_pred ------------------------------CeEEEEEeccCCCCHHHHhcCCCCC--hhHHHHHHHHHHHHHHHHHhcCC
Q psy6905 186 ------------------------------PKLCLVMEYARGGPLNRVLAGRKIR--PDVLVDWAIQIAEGMNYLHCQAP 233 (527)
Q Consensus 186 ------------------------------~~~~iv~Ey~~ggsL~~~l~~~~~~--~~~~~~i~~qi~~~L~yLH~~g~ 233 (527)
-.+||.||||+..+|.+++....+. ...+++++++|++||.|+|++|
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g- 717 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG- 717 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc-
Confidence 1269999999999999999866664 7788999999999999999996
Q ss_pred CceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh------c--------------cccccCCCcccccccccc
Q psy6905 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY------K--------------TTHMSAAGTYAWMAPEVI 293 (527)
Q Consensus 234 ~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~------~--------------~~~~~~~gt~~y~aPE~l 293 (527)
||||||||.|||++.+ +.|||+|||+|+... . ....+.+||.-|+|||++
T Consensus 718 --iIHRDLKP~NIFLd~~--------~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 718 --IIHRDLKPRNIFLDSR--------NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred --eeeccCCcceeEEcCC--------CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 9999999999999975 699999999998721 0 012345799999999999
Q ss_pred ccCC---CCcccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCccCCCC-----CCccHHHHHHHHHhhhhCCCC
Q psy6905 294 KTSI---FSKASDVWSYGVVLWELLTGEIPYKS-INAYAVAYGVAVNKLTLPIP-----STCPQLFKTLMEACWEADSHM 364 (527)
Q Consensus 294 ~~~~---~~~ksDvwSlGv~l~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~p-----~~~~~~~~~li~~~l~~dp~~ 364 (527)
.+.. |+.|+|+|||||+|+||+. ||.. +....+...+. ...+|.| ..++. -..+|++|++.||.+
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP~~~~f~~~~~~~-e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIPEPADFFDPEHPE-EASLIRWLLSHDPSK 861 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCCCCcccccccchH-HHHHHHHHhcCCCcc
Confidence 7654 9999999999999999985 4643 33333333333 2333443 22333 467999999999999
Q ss_pred CCCHHHHHH
Q psy6905 365 RPSFKTILK 373 (527)
Q Consensus 365 RPs~~~ll~ 373 (527)
|||+.+||.
T Consensus 862 RPtA~eLL~ 870 (1351)
T KOG1035|consen 862 RPTATELLN 870 (1351)
T ss_pred CCCHHHHhh
Confidence 999999987
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.99 Aligned_cols=249 Identities=27% Similarity=0.377 Sum_probs=202.1
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC--
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-- 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-- 186 (527)
|++ .++|++.+.||+|+||.||+|.+ .+..||||.+.... .......+.+|+.+++.++||||+++++++..+.
T Consensus 11 ~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 11 WEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 444 45699999999999999999987 46789999886532 2333556789999999999999999999987653
Q ss_pred ----eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 187 ----KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 187 ----~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
.+|+||||+ |++|.+++....+++..+..++.||+.||.|||+.| |+||||||+|||++.+ +.+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~--------~~~ 157 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNED--------CEL 157 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC--------CCE
Confidence 469999999 889999988888999999999999999999999995 9999999999999875 689
Q ss_pred EEeccCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc--
Q psy6905 263 KITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT-- 339 (527)
Q Consensus 263 kL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~-- 339 (527)
+|+|||++..... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 158 kl~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 158 KILDFGLARQTDS-EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred EEeeccccccccc-CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999999976532 2233467899999999876 45789999999999999999999999876654333322111000
Q ss_pred ---------------------------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 ---------------------------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ---------------------------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
......++..+.++|.+|+..||.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01124567889999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.69 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=196.9
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC-----CeE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-----PKL 188 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~~~ 188 (527)
++|.+.+.||.|+||.||+|.+ +++.||||.+.... .......+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4689999999999999999987 46789999876532 222245667899999999999999999988653 358
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+|+||+. ++|.+++. .+.+++..+..++.||+.||.|||+++ ++||||||+|||++.+ +.+||+||
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~--------~~~kL~Df 152 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNAN--------CDLKICDF 152 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCC--------CCEEECcC
Confidence 99999995 67888776 567999999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhccc--cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Q psy6905 268 GLAREVYKTT--HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV--------- 335 (527)
Q Consensus 268 Gla~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~--------- 335 (527)
|++....... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 9998664321 123467899999998865 4688999999999999999999999987654322211110
Q ss_pred --------------CCc---c---CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 --------------NKL---T---LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 --------------~~~---~---~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
... . ......+++.+.++|.+||+.+|.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000 0 01124578899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=306.31 Aligned_cols=252 Identities=27% Similarity=0.451 Sum_probs=207.9
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC------hhHHHHHHHHHHHHHhCCCCccceEEEEEE-eCC
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD------ENILENVKQEGKLLWLFDHRNIVSLIGVCL-QSP 186 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~-~~~ 186 (527)
.++|-++.+||+|||+.||+|.+ ..+.||+|+-..+.+ ++..+...+|..+-+.|+||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 46788999999999999999987 456899998766543 234566788999999999999999999996 456
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.+|-|+|||+|.+|+-+|+ .+.+++.++..|+.||+.||.||.+..+ +|||-||||.|||+.... ..|.+||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNILLv~Gt-----acGeIKIT 615 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNILLVNGT-----ACGEIKIT 615 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccEEEecCc-----ccceeEee
Confidence 7899999999999999998 5678999999999999999999998865 799999999999997642 24789999
Q ss_pred ccCcchhhhccccc---------cCCCccccccccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy6905 266 DFGLAREVYKTTHM---------SAAGTYAWMAPEVIKTS----IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG 332 (527)
Q Consensus 266 DFGla~~~~~~~~~---------~~~gt~~y~aPE~l~~~----~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 332 (527)
||||++.+....+. ...||+.|++||.+.-+ ..+.|+||||+||++|..+.|+.||......+.+..
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 99999988554332 24699999999998533 478999999999999999999999987643332221
Q ss_pred ----HHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 333 ----VAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 333 ----i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
+......+|.-+.++.+.+++|++||.+.-++|.+..+|..
T Consensus 696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 12234456666778999999999999999999999888765
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.67 Aligned_cols=244 Identities=27% Similarity=0.350 Sum_probs=198.3
Q ss_pred eeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--CeEEEEEe
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS--PKLCLVME 193 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~~~iv~E 193 (527)
|++.+.||.|+||.||+|.+. ++.+|+|.+.... .......+.+|+.+++.++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 577899999999999999874 5789999987653 223346678899999999999999999999988 88999999
Q ss_pred ccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|++ ++|.+++.. ..+++..++.++.||+.||+|||+.| ++|+||+|+|||++.+ +.++|+|||++.
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~--------~~~~l~d~g~~~ 148 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINND--------GVLKLADFGLAR 148 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCC--------CCEEEcccccee
Confidence 996 588888764 47899999999999999999999985 9999999999999985 689999999998
Q ss_pred hhhccc---cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---------
Q psy6905 272 EVYKTT---HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL--------- 338 (527)
Q Consensus 272 ~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~--------- 338 (527)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 149 PYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred eccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccc
Confidence 664432 223456889999998765 4578999999999999999999999988765444333221000
Q ss_pred ------------cC--------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 ------------TL--------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 ------------~~--------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. .....++..+.+++.+||..+|.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 0112247889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.17 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=201.5
Q ss_pred ceeeeeeeccCCceEEEEeeE-----cCceEEEEEcCCCC---ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNP---DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~ 188 (527)
+|++.+.||.|+||.||++.+ ++..||||++.... .......+.+|+.++..+ +||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999875 34679999886432 122345678899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+||||+.+|+|.+++. ...+++..+..++.|++.||.|||+.+ ++||||+|.||+++.+ +.++|+||
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~--------~~~~l~df 149 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSE--------GHVVLTDF 149 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCC--------CCEEEEEC
Confidence 99999999999998886 456889999999999999999999984 9999999999999875 68999999
Q ss_pred Ccchhhhccc---cccCCCccccccccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCc
Q psy6905 268 GLAREVYKTT---HMSAAGTYAWMAPEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYKSINA----YAVAYGVAVNKL 338 (527)
Q Consensus 268 Gla~~~~~~~---~~~~~gt~~y~aPE~l~~~~--~~~ksDvwSlGv~l~elltg~~Pf~~~~~----~~~~~~i~~~~~ 338 (527)
|+++...... .....|+..|+|||.+.+.. .+.++||||||+++|+|++|..||..... ......+. ..
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~ 227 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--KS 227 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH--cc
Confidence 9987653322 12345889999999987654 78899999999999999999999964322 22222222 23
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
..+.|..++..+.+++.+||+.||++|||+.++.+.|+
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 34677788999999999999999999999887776554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.70 Aligned_cols=243 Identities=28% Similarity=0.326 Sum_probs=194.8
Q ss_pred eeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChh-------------HHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 120 IFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDEN-------------ILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 120 ~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
.+.+.||.|+||.||+|.+ .++.||||.+....... ....+.+|+.+++.++|+||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 4567899999999999986 46789999876542211 01246789999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
.+..|+||||+. |+|.+++. ...+++..+..++.||+.||.|||+.| ++||||+|+|||++.+ +.++
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~--------~~~k 159 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSK--------GICK 159 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCC--------CCEE
Confidence 999999999996 68888876 457899999999999999999999995 9999999999999875 6899
Q ss_pred EeccCcchhhhc----------------cccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCH
Q psy6905 264 ITDFGLAREVYK----------------TTHMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINA 326 (527)
Q Consensus 264 L~DFGla~~~~~----------------~~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~ 326 (527)
|+|||++..... .......++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999876531 111123467889999998764 468999999999999999999999998776
Q ss_pred HHHHHHHHhCC---c----------------cC-------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 327 YAVAYGVAVNK---L----------------TL-------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 327 ~~~~~~i~~~~---~----------------~~-------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
......+.... . .. .....++..+.+++..||..+|++||++.+++.+
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 55443322100 0 00 0113457889999999999999999999999873
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.02 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=197.9
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--------
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-------- 185 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-------- 185 (527)
..+|.+.+.||.|+||.||+|.+. ++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 368999999999999999999874 57899998765543 3356788899999999999999999876543
Q ss_pred ------CeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 186 ------PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 186 ------~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
...|+||||+. ++|.+++....+++..+..++.||+.||.|||+.| |+||||||+|||++.. .
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~-------~ 151 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTE-------D 151 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCC-------C
Confidence 35799999996 68988888778999999999999999999999995 9999999999999754 2
Q ss_pred ceeEEeccCcchhhhccc-----cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6905 260 KTLKITDFGLAREVYKTT-----HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGV 333 (527)
Q Consensus 260 ~~vkL~DFGla~~~~~~~-----~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i 333 (527)
+.++|+|||+++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 578999999987653211 112357889999998754 56789999999999999999999999876654433322
Q ss_pred HhC-----------------------CccC-----CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 334 AVN-----------------------KLTL-----PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 334 ~~~-----------------------~~~~-----~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
... .... .....++.++.++|.+||..||.+|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 110 0000 0113467889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=328.18 Aligned_cols=247 Identities=19% Similarity=0.271 Sum_probs=184.3
Q ss_pred CCceeeeeeeccCCceEEEEeeEcC---ceEEEEEcC--------------C--CCChhHHHHHHHHHHHHHhCCCCccc
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYEK---QEVAIKVAH--------------P--NPDENILENVKQEGKLLWLFDHRNIV 176 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~~---~~vaiK~~~--------------~--~~~~~~~~~~~~e~~~l~~l~hpnIv 176 (527)
..+|.+++.||+|+||.||+|.++. ..+++|.+. . .........+.+|+.+++.++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987532 112222110 0 01122355678999999999999999
Q ss_pred eEEEEEEeCCeEEEEEeccCCCCHHHHhcCC------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCC
Q psy6905 177 SLIGVCLQSPKLCLVMEYARGGPLNRVLAGR------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSE 250 (527)
Q Consensus 177 ~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~~------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~ 250 (527)
++++++...+..|+|+|++. ++|..++... ......+..++.||+.||.|||++| ||||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 99999999999999999994 5666665422 2335567889999999999999995 999999999999987
Q ss_pred CCcccccccceeEEeccCcchhhhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCC-CCCCCC-
Q psy6905 251 PIENEDLQFKTLKITDFGLAREVYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEI-PYKSIN- 325 (527)
Q Consensus 251 ~~~~~~~~~~~vkL~DFGla~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~-Pf~~~~- 325 (527)
+ +.+||+|||+++.+.... .....||+.|+|||++.+..++.++|||||||++|||++|.. ||....
T Consensus 303 ~--------~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 303 D--------GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred C--------CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 5 689999999998664322 224579999999999999999999999999999999999775 454322
Q ss_pred -HHHHHHHHHhC----CccCC-----------------CC---------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 326 -AYAVAYGVAVN----KLTLP-----------------IP---------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 326 -~~~~~~~i~~~----~~~~~-----------------~p---------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.......+... ...++ .+ ..++..+.++|.+||..||.+|||+.+++.+
T Consensus 375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111111100 00000 00 1345678888999999999999999999873
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=294.54 Aligned_cols=236 Identities=31% Similarity=0.431 Sum_probs=203.3
Q ss_pred eccCCceEEEEeeEc--CceEEEEEcCCCCC--hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCH
Q psy6905 125 IGEGGFGKVYKGIYE--KQEVAIKVAHPNPD--ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200 (527)
Q Consensus 125 iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL 200 (527)
||.|+||.||++.+. ++.||+|++..... ......+..|+.+++.++||||+++++.+..+...|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999974 67899998876432 23456788999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc--c
Q psy6905 201 NRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--T 277 (527)
Q Consensus 201 ~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~--~ 277 (527)
.+++. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~--------~~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDAD--------GHIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCC--------CcEEEeecCcceecccCCCc
Confidence 99987 44789999999999999999999998 49999999999999875 68999999999776443 2
Q ss_pred cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHh
Q psy6905 278 HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEAC 357 (527)
Q Consensus 278 ~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~ 357 (527)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.. ...+.|...+..+.++|++|
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~ 227 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGL 227 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHH
Confidence 2345688999999999888889999999999999999999999988776555555543 44577888899999999999
Q ss_pred hhhCCCCCCCH---HHHHH
Q psy6905 358 WEADSHMRPSF---KTILK 373 (527)
Q Consensus 358 l~~dp~~RPs~---~~ll~ 373 (527)
|..||++||++ .++++
T Consensus 228 l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 228 LQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred hcCCHhhCCCcccHHHHHh
Confidence 99999999999 55544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.49 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=197.3
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEe----CCeEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQ----SPKLC 189 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----~~~~~ 189 (527)
++|.+.+.||.|+||.||+|.. ++..||+|++..... ......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6788999999999999999987 467899998876432 2335667789999999999999999998753 45689
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+||||+. |+|.+++. ++.+++..+..++.||+.||.|||++| ++||||||+|||++.+ +.+||+|||
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~--------~~~kl~dfg 152 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNED--------CELRIGDFG 152 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCC--------CcEEecccc
Confidence 9999995 68888886 566899999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhcccc------ccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------
Q psy6905 269 LAREVYKTTH------MSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV------ 335 (527)
Q Consensus 269 la~~~~~~~~------~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~------ 335 (527)
++........ ....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~ 232 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence 9876532211 13468899999999865 4588999999999999999999999987654332211110
Q ss_pred ------------------CCccCCC-----CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 ------------------NKLTLPI-----PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ------------------~~~~~~~-----p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....+. ....++.+.++|.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0001111 13468899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.27 Aligned_cols=246 Identities=25% Similarity=0.350 Sum_probs=197.2
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCC-CChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeC--CeEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN-PDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQS--PKLCL 190 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~--~~~~i 190 (527)
++|++.+.||+|+||.||+|.+. ++.||+|.+... ........+.+|+.+++.+ +||||+++++++... ..+|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 57889999999999999999874 578999987543 1222345677899999999 999999999998653 46899
Q ss_pred EEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 191 VMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||||+. ++|..++..+.+++.....++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||++
T Consensus 87 v~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~--------~~~kl~d~g~~ 154 (337)
T cd07852 87 VFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSD--------CRVKLADFGLA 154 (337)
T ss_pred Eecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCC--------CcEEEeeccch
Confidence 999996 58999888668888889999999999999999984 9999999999999876 68999999999
Q ss_pred hhhhcccc-------ccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----
Q psy6905 271 REVYKTTH-------MSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK----- 337 (527)
Q Consensus 271 ~~~~~~~~-------~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~----- 337 (527)
........ ....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 86633221 12358899999998755 457899999999999999999999998765443322221110
Q ss_pred ---------------------cc---CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 ---------------------LT---LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 ---------------------~~---~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. ......++..+.++|.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 01112368899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=302.45 Aligned_cols=242 Identities=28% Similarity=0.431 Sum_probs=211.8
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEcC--ceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCe
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~--~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~ 187 (527)
-|...+|.++.+||+|+||.|.+|..+| ..||||+++.+- ..+..+.-+.|-++|... +-|.++.++..|..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4666788999999999999999998876 479999988752 112244556777788766 57889999999999999
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|+||||++||+|-..++ -+++.+..+..++..|+-||-+||++| ||.||||.+|||++.+ |.+||+|
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~e--------GHiKi~D 493 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSE--------GHIKIAD 493 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccC--------CceEeee
Confidence 999999999999977766 578999999999999999999999996 9999999999999986 7999999
Q ss_pred cCcchhh--hccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 267 FGLAREV--YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 267 FGla~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
||+++.. ...+..+.+||+.|+|||++...+|+..+|.|||||+||||+.|++||.+.+..++...|...+. ..|.
T Consensus 494 FGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--syPK 571 (683)
T KOG0696|consen 494 FGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--SYPK 571 (683)
T ss_pred cccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--cCcc
Confidence 9999864 34455578999999999999999999999999999999999999999999999999998876554 5678
Q ss_pred CccHHHHHHHHHhhhhCCCCCCC
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPS 367 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs 367 (527)
.+|.+..++.+..+...|.+|..
T Consensus 572 slSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 572 SLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cccHHHHHHHHHHhhcCCccccC
Confidence 89999999999999999999964
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=304.58 Aligned_cols=246 Identities=28% Similarity=0.384 Sum_probs=198.4
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe-CCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ-SPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~~~iv 191 (527)
.++|.+.+.||.|+||.||+|.+ +++.||+|.+.... .......+..|+.+++.++||||+++++++.. ....|++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 35699999999999999999986 46789999875432 22335667889999999999999999999865 5678999
Q ss_pred EeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 192 MEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||+ +++|..++....+++..+..++.||+.||.|||+.+ ++||||+|.|||++.+ +.++|+|||++.
T Consensus 89 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~--------~~~~l~dfg~~~ 156 (328)
T cd07856 89 TELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINEN--------CDLKICDFGLAR 156 (328)
T ss_pred eehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCC--------CCEEeCcccccc
Confidence 9999 678999998778899999999999999999999995 9999999999999875 689999999987
Q ss_pred hhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------
Q psy6905 272 EVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV--------------- 335 (527)
Q Consensus 272 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~--------------- 335 (527)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 157 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 157 IQDP-QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred ccCC-CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 5432 2234467889999999866 5689999999999999999999999987654222111100
Q ss_pred ---------CCccCCCC-----CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 ---------NKLTLPIP-----STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ---------~~~~~~~p-----~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....+.| ..+++.+.++|.+||..+|++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00001111 3467899999999999999999999999774
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=305.87 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=207.8
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
-+..+.|..-++||+||||.||-|.. +|+.||.|.+.... ...-.....+|..+|..++.+.||.+--+|...+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 45567788889999999999998764 67889998765432 111134567899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 189 CLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
|+|+..|+||+|.-.|. +..|++..++.++.+|+.||++||+. .||.|||||+|||+|+. |+|.|+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~--------GhvRIS 329 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDH--------GHVRIS 329 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccC--------CCeEee
Confidence 99999999999987665 34799999999999999999999999 59999999999999986 899999
Q ss_pred ccCcchhhhccccc-cCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCccC
Q psy6905 266 DFGLAREVYKTTHM-SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY----AVAYGVAVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~----~~~~~i~~~~~~~ 340 (527)
|+|||..+...... +.+||.+|||||++.+..|+...|.|||||+||||+.|+.||...... ++-..+.. ...
T Consensus 330 DLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ 407 (591)
T KOG0986|consen 330 DLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPE 407 (591)
T ss_pred ccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chh
Confidence 99999988665544 448999999999999999999999999999999999999999865432 33333332 233
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPS-----FKTILKA 374 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs-----~~~ll~~ 374 (527)
..|+..|++.++|.+..|..||.+|.. +.++.+|
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 567899999999999999999999964 4455543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=307.42 Aligned_cols=250 Identities=27% Similarity=0.379 Sum_probs=203.3
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
.|++ .++|.+...||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred eecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 3444 457999999999999999999984 5789999876532 22334667789999999999999999998876554
Q ss_pred ------EEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 188 ------LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 188 ------~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
+|+|+||+ +++|.+++....+++..+..++.||+.||.|||+.| |+||||+|+||+++.+ +.
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~--------~~ 156 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNED--------CE 156 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCC--------CC
Confidence 89999999 779999998888999999999999999999999995 9999999999999875 68
Q ss_pred eEEeccCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc-
Q psy6905 262 LKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT- 339 (527)
Q Consensus 262 vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~- 339 (527)
++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 157 ~kL~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~ 235 (343)
T cd07851 157 LKILDFGLARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235 (343)
T ss_pred EEEcccccccccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence 999999999765332 233467889999999865 36789999999999999999999999877665444333211000
Q ss_pred ----------------------C------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 ----------------------L------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ----------------------~------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. .....+++.+.++|.+||+.||.+|||+.+|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 0112458889999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.10 Aligned_cols=243 Identities=27% Similarity=0.407 Sum_probs=203.4
Q ss_pred eeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCC
Q psy6905 122 GEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGG 198 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~gg 198 (527)
.+.||+|.||+||-|.+ +|+.||||++.+.. .......+++|+.+|.+++||.||.+.-.|+..+.+++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 37899999999999987 57899999987642 2233477889999999999999999999999999999999999766
Q ss_pred CHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc
Q psy6905 199 PLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT 276 (527)
Q Consensus 199 sL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~ 276 (527)
-|.-+|. .+++++.....++.||+.||.|||-+ +|||+||||+|||+.... ...++||||||+|+.+...
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~-----~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASAS-----PFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCC-----CCCceeeccccceeecchh
Confidence 6666665 67899988889999999999999999 699999999999998753 2468999999999988543
Q ss_pred -ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--cCCCCCCccHHHHHH
Q psy6905 277 -THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL--TLPIPSTCPQLFKTL 353 (527)
Q Consensus 277 -~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~~~~l 353 (527)
...+.+||+.|+|||++++..|...-|+||.||++|--++|..||....... .+|....+ .......++++..+|
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAaFMyPp~PW~eis~~Aidl 798 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAAFMYPPNPWSEISPEAIDL 798 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhccccccCCCchhhcCHHHHHH
Confidence 3447789999999999999999999999999999999999999997654332 23332222 222336788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q psy6905 354 MEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 354 i~~~l~~dp~~RPs~~~ll~~ 374 (527)
|..+|+..-.+|.|.+..+.+
T Consensus 799 In~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 799 INNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHHHHhcchHhhccc
Confidence 999999999999998877664
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=307.31 Aligned_cols=245 Identities=27% Similarity=0.356 Sum_probs=198.5
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC------Ce
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS------PK 187 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~~ 187 (527)
++|.+.+.||+|+||.||+|.+ +++.||+|.+.... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 6799999999999999999986 46789999887542 222345677899999999999999999988643 34
Q ss_pred EEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 188 LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
.|++++++ |++|.+++....+++..+..++.||+.||.|||+.| |+||||||+||+++.+ +.+||+||
T Consensus 97 ~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~--------~~~kl~df 164 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED--------CELKILDF 164 (345)
T ss_pred EEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC--------CCEEEecc
Confidence 78899988 889999988778999999999999999999999995 9999999999999875 68999999
Q ss_pred CcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--------
Q psy6905 268 GLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-------- 338 (527)
Q Consensus 268 Gla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-------- 338 (527)
|+++.... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 165 g~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 165 GLARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred cccccccc-cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 99876532 2233468899999999866 4688999999999999999999999987665443322211000
Q ss_pred ---------------cCC------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 ---------------TLP------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 ---------------~~~------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+ .....++.+.++|.+|++.||.+||++.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 012357789999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=299.76 Aligned_cols=244 Identities=26% Similarity=0.374 Sum_probs=199.8
Q ss_pred eeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCCh-hHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 119 LIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDE-NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
|.+.+.||.|++|.||+|.+ +++.+++|.+...... .....+..|+.+++.++|+||+++++++..+...|+||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56678999999999999987 4678999987765322 34567788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 196 RGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 196 ~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
.+ +|..++.. ..+++..+..++.||+.||.|||.++ ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~--------~~~~l~df~~~~~~ 148 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTE--------GVLKLADFGLARSF 148 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCC--------CcEEEeeeeeeEec
Confidence 65 78777763 47899999999999999999999994 9999999999999875 68999999998766
Q ss_pred hccc--cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc------------
Q psy6905 274 YKTT--HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL------------ 338 (527)
Q Consensus 274 ~~~~--~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~------------ 338 (527)
.... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 149 GSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred CCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 4432 2234578899999998776 689999999999999999999999988776554333221100
Q ss_pred -------c------C---CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 -------T------L---PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 -------~------~---~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. . .....++..+.++|.+||..||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 0 0123467889999999999999999999999873
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=299.25 Aligned_cols=253 Identities=31% Similarity=0.557 Sum_probs=204.1
Q ss_pred CCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHH--hCCCCccceEEEEEEeCC----eEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLW--LFDHRNIVSLIGVCLQSP----KLC 189 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~--~l~hpnIv~~~~~~~~~~----~~~ 189 (527)
..++.+.+.||+|.||.||+|.|.|..||||++....+. ...+|.++.. .|+|+||+.|+++-..+. .++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~----SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDER----SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccchh----hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 357889999999999999999999999999999875433 3345666665 469999999998854433 489
Q ss_pred EEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHh-----cCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHC-----QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~-----~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
+|++|.+.|||.|+|....++....+.++..++.||++||. +|...|.|||||..||||..+ +.+.|
T Consensus 286 LvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn--------~~C~I 357 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN--------GTCCI 357 (513)
T ss_pred EeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC--------CcEEE
Confidence 99999999999999999999999999999999999999994 466679999999999999986 79999
Q ss_pred eccCcchhhhcc------ccccCCCccccccccccccCC----CC--cccchHHHHHHHHHHHh-----C-----CCCCC
Q psy6905 265 TDFGLAREVYKT------THMSAAGTYAWMAPEVIKTSI----FS--KASDVWSYGVVLWELLT-----G-----EIPYK 322 (527)
Q Consensus 265 ~DFGla~~~~~~------~~~~~~gt~~y~aPE~l~~~~----~~--~ksDvwSlGv~l~ellt-----g-----~~Pf~ 322 (527)
+|+|||...... .....+||.+|||||++.... |. ..+||||||.++||++. | ++||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999765432 223457999999999996542 22 57999999999999884 2 57886
Q ss_pred CC----CH-HHHHHHHHhCCccCCCCCCcc-----HHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 323 SI----NA-YAVAYGVAVNKLTLPIPSTCP-----QLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 323 ~~----~~-~~~~~~i~~~~~~~~~p~~~~-----~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
+. .. .+...-+...+++..+|..+. ..+..||+.||..+|..|-|+-.|.+.|.++..
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 53 22 333334456677777775442 346789999999999999999999998877654
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=302.16 Aligned_cols=248 Identities=28% Similarity=0.375 Sum_probs=197.3
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC-----
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP----- 186 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~----- 186 (527)
..++|++.+.||.|+||.||+|.+. ++.||+|.+..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3467899999999999999999984 67899998865432 222346678999999999999999999987654
Q ss_pred -----eEEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 187 -----KLCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 187 -----~~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
.+|+|+||+++ +|..++.. ..+++..+..++.||+.||.|||++| |+||||+|+||+++.+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~-------- 152 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNK-------- 152 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC--------
Confidence 78999999976 66666653 46899999999999999999999995 9999999999999875
Q ss_pred ceeEEeccCcchhhhcccc---ccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6905 260 KTLKITDFGLAREVYKTTH---MSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV 335 (527)
Q Consensus 260 ~~vkL~DFGla~~~~~~~~---~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 335 (527)
+.+||+|||++........ ....++..|+|||.+.+. .++.++|||||||++|+|++|++||...+.......+..
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 153 GQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred CcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 6899999999976643221 123467889999988653 478999999999999999999999987665444333221
Q ss_pred C-Ccc---------------------------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 N-KLT---------------------------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ~-~~~---------------------------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. +.. ......+|..+.+++..||..||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 000 00122468899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=308.00 Aligned_cols=249 Identities=28% Similarity=0.408 Sum_probs=198.4
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-- 185 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-- 185 (527)
.|++ ..+|.+.+.||+|+||.||+|.+ ++..||||.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 10 VWEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 3555 35799999999999999999986 46789999886532 223345678999999999999999999998754
Q ss_pred ----CeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 186 ----PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 186 ----~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
..+|+||||+. ++|..++ +..+++..+..++.|++.||.|||++| ++||||||+|||++.+ +.
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~--------~~ 155 (342)
T cd07879 89 GDEFQDFYLVMPYMQ-TDLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNED--------CE 155 (342)
T ss_pred CCCCceEEEEecccc-cCHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC--------CC
Confidence 34699999995 5777665 356899999999999999999999995 9999999999999875 68
Q ss_pred eEEeccCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---
Q psy6905 262 LKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK--- 337 (527)
Q Consensus 262 vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~--- 337 (527)
++|+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 156 ~kL~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (342)
T cd07879 156 LKILDFGLARHADA-EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 234 (342)
T ss_pred EEEeeCCCCcCCCC-CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999999876532 2233467889999999876 458899999999999999999999998876544333222100
Q ss_pred -------------------c-cCC------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 -------------------L-TLP------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 -------------------~-~~~------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. ..+ ....++..+.++|.+||+.||.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000 012467789999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=298.80 Aligned_cols=244 Identities=27% Similarity=0.387 Sum_probs=195.5
Q ss_pred eeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEEEecc
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
|++.+.||.|+||.||+|.+. ++.|+||.+.............+|+..++.++ ||||+++++++.+++..|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 577889999999999999984 57899998765432222233457889999998 999999999999999999999999
Q ss_pred CCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 196 RGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 196 ~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
+|+|.+++.. ..+++..++.++.|++.+|.|||++| ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~--------~~~~l~d~~~~~~ 148 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGP--------EVVKIADFGLARE 148 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCC--------CCEEEeeccccee
Confidence 8889887763 36899999999999999999999994 9999999999999975 6899999999976
Q ss_pred hhcccc-ccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Q psy6905 273 VYKTTH-MSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-------------- 336 (527)
Q Consensus 273 ~~~~~~-~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-------------- 336 (527)
...... ....++..|+|||++.. ..++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 149 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 149 IRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred ccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 643222 23468899999998854 45789999999999999999999999877654443332210
Q ss_pred ---CccCC-----------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ---KLTLP-----------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ---~~~~~-----------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..... .....+..+.+++..||..+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000 011226789999999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.75 Aligned_cols=145 Identities=32% Similarity=0.523 Sum_probs=129.7
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
.++|.+.+.||.|+||.||+|.+. ++.||||++.... .......+..|+.++..++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 467999999999999999999985 6799999987542 334457788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||||.||+|.+++. .+.+++..++.|+.||+.||.|||.++ ||||||||+||||+.+ +.+||+|||++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~--------g~vkL~DFGls 151 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNE--------GHIKLTDFGLS 151 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCC--------CCEEEEeCCCC
Confidence 99999999999987 456889999999999999999999994 9999999999999875 68999999987
Q ss_pred h
Q psy6905 271 R 271 (527)
Q Consensus 271 ~ 271 (527)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=293.83 Aligned_cols=244 Identities=28% Similarity=0.357 Sum_probs=194.8
Q ss_pred eeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh-hHHHHHHHHHHHHHhC---CCCccceEEEEEEeCCe-----
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE-NILENVKQEGKLLWLF---DHRNIVSLIGVCLQSPK----- 187 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l---~hpnIv~~~~~~~~~~~----- 187 (527)
|++.+.||.|+||.||+|.+. ++.||+|++...... .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 577889999999999999984 678999998754322 2234556777777655 69999999999988776
Q ss_pred EEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 188 LCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
++++|||+. ++|.+++.. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.+ +.++|
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~--------~~~~l 148 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSD--------GQVKI 148 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccC--------CCEEE
Confidence 999999996 578887753 35899999999999999999999994 9999999999999986 68999
Q ss_pred eccCcchhhhcccc-ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-----
Q psy6905 265 TDFGLAREVYKTTH-MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL----- 338 (527)
Q Consensus 265 ~DFGla~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~----- 338 (527)
+|||++........ ....++..|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 149 ADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence 99999876633222 234578899999999988899999999999999999999999988776554443322100
Q ss_pred cCC--------------------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 TLP--------------------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 ~~~--------------------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+ .....+..+.++|.+||+.||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000 001345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=287.66 Aligned_cols=244 Identities=27% Similarity=0.458 Sum_probs=201.9
Q ss_pred eeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEEeccCCC
Q psy6905 122 GEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARGG 198 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~Ey~~gg 198 (527)
.+.||+|+||.|--|+. ++.+||||++.+... .....+.+|++++.++ .|+||+.++++|+++..+|+|||-|.||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc-hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 36899999999998874 788999999987633 3467889999999998 5999999999999999999999999999
Q ss_pred CHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccc
Q psy6905 199 PLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT 277 (527)
Q Consensus 199 sL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~ 277 (527)
+|...|. .+.|++.++-.+..+|+.||.|||.+| |.||||||+|||..... .-.-||||||.+...+..+.
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn-----~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPN-----KVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCC-----CcCceeeeccccccccccCC
Confidence 9877765 678999999999999999999999996 99999999999987531 11358999999876543221
Q ss_pred ---------cccCCCccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCC---------------HHH
Q psy6905 278 ---------HMSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGVVLWELLTGEIPYKSIN---------------AYA 328 (527)
Q Consensus 278 ---------~~~~~gt~~y~aPE~l~-----~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~---------------~~~ 328 (527)
-.+.+|+..|||||+.. ...|+.++|.|||||++|-|++|.+||.+.= ...
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 313 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence 12456889999999863 3458999999999999999999999997642 123
Q ss_pred HHHHHHhCCccCCCC--CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 329 VAYGVAVNKLTLPIP--STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 329 ~~~~i~~~~~~~~~p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....|..+++.+|-- ..+|.+.++++..++..|+..|.++..++.+
T Consensus 314 LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 314 LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 444566677765533 4578999999999999999999999888763
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=315.36 Aligned_cols=245 Identities=32% Similarity=0.560 Sum_probs=210.2
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEe-----CCeE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQ-----SPKL 188 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~-----~~~~ 188 (527)
..|+|.+.||.|.+|.||++.. +++.+|+|+.....+. -+++..|.++++.+ +|||++.+||+|.- ++.+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 4577889999999999999875 6789999998877554 35677888898877 79999999999864 5679
Q ss_pred EEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 189 CLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
|+|||||.|||..|+++ +.++.+..+..|++.++.||.+||.+ .+||||||-.|||++.+ +.|||+
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e--------~~VKLv 165 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTEN--------AEVKLV 165 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEecc--------CcEEEe
Confidence 99999999999999987 67899999999999999999999999 59999999999999986 799999
Q ss_pred ccCcchhhhcc--ccccCCCcccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Q psy6905 266 DFGLAREVYKT--THMSAAGTYAWMAPEVIKT-----SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 266 DFGla~~~~~~--~~~~~~gt~~y~aPE~l~~-----~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
|||.+..+..+ ...+..||+.|||||++.. ..|+.++|+||||++..||.-|.+|+-.+-.......+-.+..
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP 245 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 245 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence 99999887554 3446789999999999953 3478999999999999999999999988877666666654432
Q ss_pred -cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 -TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 -~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+..|..++++|.++|..||..|.+.||+..+++++
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 233467889999999999999999999999999874
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=300.23 Aligned_cols=245 Identities=28% Similarity=0.394 Sum_probs=192.9
Q ss_pred ceeeeeeeccCCceEEEEeeEc----CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeC----Ce
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE----KQEVAIKVAHPNP-DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQS----PK 187 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~----~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~----~~ 187 (527)
+|.+.+.||+|+||.||++.+. +..||+|.+.... .......+.+|+.+++.+ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999974 4589999876532 222355678899999998 599999999975432 45
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|+++||+. ++|.+++. ...+++..+..++.||+.||.|||++| ++||||||+|||++.+ +.+||+|
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~--------~~~kl~D 148 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNAD--------CELKICD 148 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCC--------CCEEeCc
Confidence 789999995 68888775 667899999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc------cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---
Q psy6905 267 FGLAREVYKTT------HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN--- 336 (527)
Q Consensus 267 FGla~~~~~~~------~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~--- 336 (527)
||+++...... .....||..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence 99997653211 123468999999998765 46889999999999999999999999876543332221110
Q ss_pred ----------------------Cc-cCC---CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ----------------------KL-TLP---IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ----------------------~~-~~~---~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. ..+ ....++..+.+++.+||+.||.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 000 112357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.63 Aligned_cols=247 Identities=25% Similarity=0.335 Sum_probs=192.9
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeC-------
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQS------- 185 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------- 185 (527)
.++|.+.+.||.|+||.||+|.+. ++.||||.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999974 57899998754322 11234567899999999999999999987543
Q ss_pred -CeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 186 -PKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 186 -~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
..+|+||||+.+ +|...+. ...+++..+..++.||+.||.|||++| ++|+||||+|||++.+ +.+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~--------~~~ 154 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQ--------GIL 154 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC--------CCE
Confidence 347999999964 5666654 457999999999999999999999995 9999999999999875 689
Q ss_pred EEeccCcchhhhcccc-------------ccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6905 263 KITDFGLAREVYKTTH-------------MSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYA 328 (527)
Q Consensus 263 kL~DFGla~~~~~~~~-------------~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~ 328 (527)
+|+|||+++....... ....+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+...
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999976532211 122467889999988654 57899999999999999999999998776654
Q ss_pred HHHHHHhCCcc---------------------CCCC-------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 329 VAYGVAVNKLT---------------------LPIP-------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 329 ~~~~i~~~~~~---------------------~~~p-------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+...... ...+ ..+++.+.+++.+||..||.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 43332210000 0000 2344678899999999999999999998863
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.92 Aligned_cols=244 Identities=30% Similarity=0.420 Sum_probs=198.9
Q ss_pred eeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
|.+.+.||+|+||.||+|... ++.||+|++.... .......+..|+.+++.++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999974 6789999887653 2233566778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC--CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 196 RGGPLNRVLAGR--KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 196 ~ggsL~~~l~~~--~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
. ++|.+++... .+++..+..++.|++.||.|||++| |+||||+|+||+++.+ +.++|+|||+++..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~--------~~~~l~d~g~~~~~ 148 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRD--------GVLKLADFGLARAF 148 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCC--------CCEEEecCCccccc
Confidence 7 5899988743 7899999999999999999999995 9999999999999885 68999999999766
Q ss_pred hccc--cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Q psy6905 274 YKTT--HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-------------- 336 (527)
Q Consensus 274 ~~~~--~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-------------- 336 (527)
.... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 149 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 149 GIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred CCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 3322 2233467889999998776 7899999999999999999999999887654443322110
Q ss_pred ----CccCC---------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ----KLTLP---------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ----~~~~~---------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+ .....+..+.++|.+||..||++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 011347789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.76 Aligned_cols=239 Identities=29% Similarity=0.423 Sum_probs=198.5
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHH-HhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLL-WLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l-~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
..+|.+...||.|+|+.|..+.+ +++..++|++..... +..+|+.++ ..-+||||+++.+++.++.+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 67889999999999999999987 467899999876521 222455343 3448999999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 193 EYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 193 Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|++.||-|.+.+...+.....+..|+.+|+.++.|||++| +|||||||+|||+..+ .++++|+|||.++.
T Consensus 396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~-------~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGS-------AGHLRLTYFGFWSE 465 (612)
T ss_pred hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCC-------CCcEEEEEechhhh
Confidence 9999998877776555444778889999999999999995 9999999999999521 27899999999987
Q ss_pred hhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCccCCCCCCccHHHH
Q psy6905 273 VYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY-AVAYGVAVNKLTLPIPSTCPQLFK 351 (527)
Q Consensus 273 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~~~ 351 (527)
.... ..+.+-|..|.|||++....|+.++|+||||++||+|++|+.||...... +....+.. .+....+|+..+
T Consensus 466 ~~~~-~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~----~~~s~~vS~~AK 540 (612)
T KOG0603|consen 466 LERS-CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM----PKFSECVSDEAK 540 (612)
T ss_pred Cchh-hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC----CccccccCHHHH
Confidence 7544 44557789999999999999999999999999999999999999877665 33322321 223378899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 352 TLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+|+..||+.||.+||++.++..+
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHHHhccCChhhCcChhhhccC
Confidence 99999999999999999999874
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=296.42 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=207.6
Q ss_pred CCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHh--CCCCccceEEEEEEeCC----eEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWL--FDHRNIVSLIGVCLQSP----KLC 189 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~~~~~~~~~~----~~~ 189 (527)
...+++.++||+|.||.||+|.++++.||||++... ..+.+.+|-+|... +.|+||++|+++-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 456788899999999999999999999999998753 35677888888875 48999999999876554 789
Q ss_pred EEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCC------CceeecCCCCCceecCCCCcccccccceeE
Q psy6905 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAP------ISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~------~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
||+||.+.|+|.++|+...++...+.+++..+++||+|||+.-+ ..|+|||||..||||..+ .++.
T Consensus 285 LVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D--------lTcc 356 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND--------LTCC 356 (534)
T ss_pred EEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC--------CcEE
Confidence 99999999999999999999999999999999999999997532 369999999999999986 6999
Q ss_pred EeccCcchhhhcccc----ccCCCccccccccccccCC-C-----CcccchHHHHHHHHHHHhCCC------------CC
Q psy6905 264 ITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSI-F-----SKASDVWSYGVVLWELLTGEI------------PY 321 (527)
Q Consensus 264 L~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~-~-----~~ksDvwSlGv~l~elltg~~------------Pf 321 (527)
|+|||+|..+..... ...+||.+|||||++.+.. + -.+.||||+|.+||||++.-. ||
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 999999987743222 2468999999999996543 2 147999999999999997422 33
Q ss_pred CC-----CCHHHHHHHHHhCCccCCCCCCc-----cHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhccc
Q psy6905 322 KS-----INAYAVAYGVAVNKLTLPIPSTC-----PQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383 (527)
Q Consensus 322 ~~-----~~~~~~~~~i~~~~~~~~~p~~~-----~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~ 383 (527)
.. .+-.++...+...+.+..+|..+ ...+++.+..||..||+.|.|+.=+-+.+.++.+...
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 31 12233444455556666666543 5678999999999999999999988888877776553
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=283.86 Aligned_cols=251 Identities=27% Similarity=0.347 Sum_probs=194.3
Q ss_pred CCceeeeeeeccCCceEEEEeeEcC------ceEEEEEcCCCCCh-hHHHHHHHHHHHHHhCCCCccceEEEEEEe-CCe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYEK------QEVAIKVAHPNPDE-NILENVKQEGKLLWLFDHRNIVSLIGVCLQ-SPK 187 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~~------~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~ 187 (527)
...|++...||+|.||.||+|+.++ ..+|||.++...+. .......+|+.+++.++||||+.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568889999999999999996422 36999988775432 233456789999999999999999999987 888
Q ss_pred EEEEEeccCCCCHHHHhc------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 188 LCLVMEYARGGPLNRVLA------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
+++++||.+. +|..+++ .+.++...+..|++||+.|++|||++- |+||||||+||||..+.+ ..|.
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgp----erG~ 174 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGP----ERGR 174 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCC----ccCe
Confidence 9999999965 5667765 346888999999999999999999995 999999999999987532 3589
Q ss_pred eEEeccCcchhhhcccc-----ccCCCccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCH---------
Q psy6905 262 LKITDFGLAREVYKTTH-----MSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINA--------- 326 (527)
Q Consensus 262 vkL~DFGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~elltg~~Pf~~~~~--------- 326 (527)
|||+|||+++.+...-. ...+.|+.|+|||.+.+.. |+.+.|||+.||++.||+|-++.|.+...
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 99999999998854322 2345799999999998865 89999999999999999999888866321
Q ss_pred HHHHHHHHh---------------------------CCccCCC--------CCCccHHHHHHHHHhhhhCCCCCCCHHHH
Q psy6905 327 YAVAYGVAV---------------------------NKLTLPI--------PSTCPQLFKTLMEACWEADSHMRPSFKTI 371 (527)
Q Consensus 327 ~~~~~~i~~---------------------------~~~~~~~--------p~~~~~~~~~li~~~l~~dp~~RPs~~~l 371 (527)
......|.. ..+..+. -..-++...+|+..+|..||.+|.|+.+.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 011111110 0000000 01123447899999999999999999999
Q ss_pred HHH
Q psy6905 372 LKA 374 (527)
Q Consensus 372 l~~ 374 (527)
+++
T Consensus 335 leh 337 (438)
T KOG0666|consen 335 LEH 337 (438)
T ss_pred hcc
Confidence 875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=284.59 Aligned_cols=217 Identities=24% Similarity=0.306 Sum_probs=180.0
Q ss_pred CCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCHHHHhc
Q psy6905 128 GGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA 205 (527)
Q Consensus 128 G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~ 205 (527)
|.||.||++.+ +++.||+|.+.... .+..|...+....||||+++++++.+....|+||||+.||+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 89999999997 46789999987642 22344455556679999999999999999999999999999998876
Q ss_pred -CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccccccCCCc
Q psy6905 206 -GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT 284 (527)
Q Consensus 206 -~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~gt 284 (527)
...+++..+..++.|++.||.|||+.| ++||||||+||+++.+ +.++|+|||++...... .....++
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~--------~~~~l~df~~~~~~~~~-~~~~~~~ 145 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDR--------GHIQLTYFSRWSEVEDS-CDGEAVE 145 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCC--------CCEEEecccchhccccc-cccCCcC
Confidence 456899999999999999999999995 9999999999999975 68999999988665332 2234567
Q ss_pred cccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCC
Q psy6905 285 YAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHM 364 (527)
Q Consensus 285 ~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~ 364 (527)
..|+|||.+.+..++.++|||||||++|+|++|..||....... .......+|..+++.++++|.+||+.||.+
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 219 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNIPEWVSEEARSLLQQLLQFNPTE 219 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCCcccCCHHHHHHHHHHccCCHHH
Confidence 78999999988889999999999999999999999876432210 112234567788999999999999999999
Q ss_pred CCCH
Q psy6905 365 RPSF 368 (527)
Q Consensus 365 RPs~ 368 (527)
||++
T Consensus 220 R~~~ 223 (237)
T cd05576 220 RLGA 223 (237)
T ss_pred hcCC
Confidence 9986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.24 Aligned_cols=255 Identities=29% Similarity=0.568 Sum_probs=220.8
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
..+.+.++++...+-+|.||.||.|+|.. +.|.+|..+....+-....+..|.-++..+.|||+..+.+++.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 45667788899999999999999997742 35788888877666667889999999999999999999999865
Q ss_pred -CCeEEEEEeccCCCCHHHHhc---------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcc
Q psy6905 185 -SPKLCLVMEYARGGPLNRVLA---------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254 (527)
Q Consensus 185 -~~~~~iv~Ey~~ggsL~~~l~---------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~ 254 (527)
....++++.++.-|+|..+|. .+.++..++..++.|++.||+|||++| +||.||.++|++|++.
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~--- 432 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ--- 432 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh---
Confidence 456788899999999999986 123666788899999999999999995 9999999999999986
Q ss_pred cccccceeEEeccCcchhhhccccc----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy6905 255 EDLQFKTLKITDFGLAREVYKTTHM----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAV 329 (527)
Q Consensus 255 ~~~~~~~vkL~DFGla~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~ 329 (527)
-+|||+|=.+++.+....+. ....+..||+||.+.+..|+.++|||||||+||||+| |+.||-..+.+++
T Consensus 433 -----LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 433 -----LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred -----eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 58999999999877433221 2345789999999999999999999999999999999 9999999999998
Q ss_pred HHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 330 ~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
..-+. .++++..|-+||+++..+|..||..+|++||+|.++..-|.++
T Consensus 508 ~~ylk-dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 508 EHYLK-DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHHHh-ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 76665 6899999999999999999999999999999999998877554
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=260.79 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=202.4
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+|.-.++||+|.||+||+|... +..||+|..+.+. ++.......+|+-+++.++|.|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666789999999999999864 5689999887754 444566778999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
| ..+|..+.. ++.+..+.+..++.|++.||.|+|++ ++.||||||.|+||+.+ |.+||+|||+++.
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~n--------gelkladfglara 150 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRN--------GELKLADFGLARA 150 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccC--------CcEEecccchhhh
Confidence 9 567887776 78899999999999999999999999 69999999999999986 7999999999997
Q ss_pred hhccc--cccCCCccccccccccccCC-CCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCcc-----C---
Q psy6905 273 VYKTT--HMSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT-----L--- 340 (527)
Q Consensus 273 ~~~~~--~~~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~-----~--- 340 (527)
+.-.. ....+.|..|.+|.++-+.. |+...|+||.||++.|+.. |++.|++.+.......+...-.. .
T Consensus 151 fgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred cCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 74332 23456799999999998765 8999999999999999998 99999998877666665421000 0
Q ss_pred -------CCC------------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 -------PIP------------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 -------~~p------------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.| ..++..-++|++..+..+|..|.+++..+++
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 011 1112235799999999999999999988773
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=334.52 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=188.7
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
.+...+.||+|+||.||+|.+ .+..||||.+...... ...|+..+++++|||||+++|+|.+....|+|||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 345567899999999999986 4678999988654321 124578899999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 196 RGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 196 ~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
++|+|.+++. .+++.....++.||+.||+|||.....+|+||||||+||+++.+ ...++. ||.......
T Consensus 766 ~~g~L~~~l~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~--------~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 766 EGKNLSEVLR--NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK--------DEPHLR-LSLPGLLCT 834 (968)
T ss_pred CCCcHHHHHh--cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC--------CceEEE-ecccccccc
Confidence 9999999996 47888999999999999999995433369999999999999875 244443 555433221
Q ss_pred cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC---------Cc--c
Q psy6905 276 TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA-----YAVAYGVAVN---------KL--T 339 (527)
Q Consensus 276 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~-----~~~~~~i~~~---------~~--~ 339 (527)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .. .
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 2234688999999999999999999999999999999999999854211 1111100000 00 0
Q ss_pred CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 340 ~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.+.+.....++.+++.+||+.||++||++.++++.|+.+...
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 011112234577899999999999999999999999887654
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=274.66 Aligned_cols=245 Identities=24% Similarity=0.416 Sum_probs=206.7
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCC--CChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeC
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN--PDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQS 185 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~ 185 (527)
.|.+...+|.++.+||+|+|++|..+.+. .+.||+|+++.. ++.+...-+..|..++.+. +||.+|-++.+|...
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 47788899999999999999999998874 568999998764 2222345566777777665 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 186 PKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
..+++|.||++||+|--.++ .++++++.+..+...|+.||.|||+.| ||.||||.+|+|++.. +.+||
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldae--------ghikl 392 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAE--------GHIKL 392 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccC--------Cceee
Confidence 99999999999999965554 678999999999999999999999996 9999999999999986 79999
Q ss_pred eccCcchhhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHh
Q psy6905 265 TDFGLAREVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKS-------INAYAVAYGVAV 335 (527)
Q Consensus 265 ~DFGla~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~-------~~~~~~~~~i~~ 335 (527)
+|||+++.... ....+++||+.|.|||++++..|...+|.|+|||+++||+.|+.||.- .+......++..
T Consensus 393 tdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil 472 (593)
T KOG0695|consen 393 TDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL 472 (593)
T ss_pred cccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh
Confidence 99999987643 344567999999999999999999999999999999999999999952 334444445443
Q ss_pred CCccCCCCCCccHHHHHHHHHhhhhCCCCCCC
Q psy6905 336 NKLTLPIPSTCPQLFKTLMEACWEADSHMRPS 367 (527)
Q Consensus 336 ~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs 367 (527)
.....+|..++-....+++.-|+.||.+|..
T Consensus 473 -ekqiriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 473 -EKQIRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -hhcccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 2345678888888889999999999999953
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=269.97 Aligned_cols=234 Identities=36% Similarity=0.505 Sum_probs=196.2
Q ss_pred CceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCHHHHhcC
Q psy6905 129 GFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAG 206 (527)
Q Consensus 129 ~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~ 206 (527)
+||.||+|.+. ++.+|+|++...........+.+|+..++.++|+||+++++++......++++||+.+++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999985 4789999988765433367889999999999999999999999999999999999999999999874
Q ss_pred C-CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc-ccccCCCc
Q psy6905 207 R-KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT-THMSAAGT 284 (527)
Q Consensus 207 ~-~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~-~~~~~~gt 284 (527)
. .++...+..++.+++.+|.|||..+ ++|+||+|.||+++.+ +.++|+|||.+...... ......++
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~--------~~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDED--------GHVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCC--------CcEEEccccceeeeccccccccccCC
Confidence 3 3889999999999999999999994 9999999999999875 68999999999876443 23345688
Q ss_pred cccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCccCCCCCC-ccHHHHHHHHHhhhhCC
Q psy6905 285 YAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI-NAYAVAYGVAVNKLTLPIPST-CPQLFKTLMEACWEADS 362 (527)
Q Consensus 285 ~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~-~~~~~~~li~~~l~~dp 362 (527)
..|++||.+.+..++.++||||||+++|+|++|..||... +.................... ++..+.+++.+||..+|
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCc
Confidence 9999999998888899999999999999999999999874 333333333322222222222 88999999999999999
Q ss_pred CCCCCHHHHHH
Q psy6905 363 HMRPSFKTILK 373 (527)
Q Consensus 363 ~~RPs~~~ll~ 373 (527)
.+||++.++++
T Consensus 230 ~~Rp~~~~~~~ 240 (244)
T smart00220 230 EKRLTAEEALQ 240 (244)
T ss_pred hhccCHHHHhh
Confidence 99999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=257.13 Aligned_cols=213 Identities=27% Similarity=0.417 Sum_probs=178.1
Q ss_pred eEEeCCceeeeeeeccCCceEEEEee--EcCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGI--YEKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~ 188 (527)
.+++.+++.-+..||+|+||.|-+-+ .+|+..|+|.+...-.....+....|+++.... .+|.+|.|||...+...+
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 67777888888999999999986555 478899999888765555567777888776654 899999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 189 CLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
+|.||.| ..||+.+.+ ++.+++..+-.|+..|..||.|||++- ++||||+||+||||+.. |+||
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~--------GqVK 189 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYD--------GQVK 189 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccC--------CcEE
Confidence 9999999 567776643 677999999999999999999999985 89999999999999986 8999
Q ss_pred EeccCcchhhhcccccc-CCCccccccccccc----cCCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHh
Q psy6905 264 ITDFGLAREVYKTTHMS-AAGTYAWMAPEVIK----TSIFSKASDVWSYGVVLWELLTGEIPYKSI-NAYAVAYGVAV 335 (527)
Q Consensus 264 L~DFGla~~~~~~~~~~-~~gt~~y~aPE~l~----~~~~~~ksDvwSlGv~l~elltg~~Pf~~~-~~~~~~~~i~~ 335 (527)
+||||++-.+.+..-.+ ..|--.|||||.+. ...|+-+|||||||+++.||.+++.||+.. +.++...++..
T Consensus 190 iCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 190 ICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred EcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 99999997765443333 56888999999985 346899999999999999999999999875 55666666553
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=271.48 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=197.8
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCC-CCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe-----
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHP-NPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ----- 184 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~-~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----- 184 (527)
-+..+.|.-..+||+|.||.||+|..+ ++.||+|...- +..+..-....+|+.+|..|+|+|++.++.+|..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 345567777889999999999999864 56788875433 2233344566799999999999999999988743
Q ss_pred ---CCeEEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 185 ---SPKLCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 185 ---~~~~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
...+|+|+.+|+ -+|.-+|.+ .+++..++..++.+++.||.|+|++ .|+|||+||+|+||+.+
T Consensus 93 ~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~d-------- 160 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKD-------- 160 (376)
T ss_pred ccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCC--------
Confidence 234899999995 468888874 5799999999999999999999999 69999999999999986
Q ss_pred ceeEEeccCcchhhhccc------cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy6905 260 KTLKITDFGLAREVYKTT------HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG 332 (527)
Q Consensus 260 ~~vkL~DFGla~~~~~~~------~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 332 (527)
+.+||+|||+++.+.... +...+.|..|++||.+.+. .|+++.|||..||++.||++|.+-|.+.++......
T Consensus 161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~ 240 (376)
T KOG0669|consen 161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL 240 (376)
T ss_pred ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence 799999999998764322 2234569999999999875 489999999999999999999999999887665544
Q ss_pred HHh--CCcc------------------CCCCC-------------CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 333 VAV--NKLT------------------LPIPS-------------TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 333 i~~--~~~~------------------~~~p~-------------~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
|.. +... .|+|. .-+++..+||..++..||.+|+++++.+.+
T Consensus 241 Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 241 ISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 321 1000 01221 113467899999999999999999999885
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=290.64 Aligned_cols=243 Identities=26% Similarity=0.403 Sum_probs=198.9
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
-..+.+-|..++.||-|+||+|.++.. +...||+|.+.+.. ..+....+..|-.||..-+.+-||+||-.|.+++.
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 356777888999999999999999864 55689999887653 33446678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|+||+|++||++-.+|- -+-|.+..+..++..+..|+++.|..| +|||||||+||||+.+ |.+||+|
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrd--------GHIKLTD 772 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRD--------GHIKLTD 772 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccC--------Cceeeee
Confidence 999999999999987765 566788888888999999999999996 9999999999999986 8999999
Q ss_pred cCcchhh--------hc-cc-----------------------------------cccCCCccccccccccccCCCCccc
Q psy6905 267 FGLAREV--------YK-TT-----------------------------------HMSAAGTYAWMAPEVIKTSIFSKAS 302 (527)
Q Consensus 267 FGla~~~--------~~-~~-----------------------------------~~~~~gt~~y~aPE~l~~~~~~~ks 302 (527)
|||+.-+ +. .. .-+.+||+.|+|||++....|+.-+
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c 852 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC 852 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence 9998532 00 00 0023599999999999999999999
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCccCCCCCCccHHHHHHHHHhhhhCCCCCC
Q psy6905 303 DVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV--NKLTLPIPSTCPQLFKTLMEACWEADSHMRP 366 (527)
Q Consensus 303 DvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~~~~~li~~~l~~dp~~RP 366 (527)
|.||.|||||||+.|++||-.....+...++.. +.+.++.-..++.+..+||.++. .+++.|.
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 999999999999999999988776666555432 33444555778999998887643 4555664
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=277.76 Aligned_cols=253 Identities=26% Similarity=0.313 Sum_probs=199.1
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-C-C----ccceEEEEEEeC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFD-H-R----NIVSLIGVCLQS 185 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h-p----nIv~~~~~~~~~ 185 (527)
+-.++|.++..+|+|.||.|-.+.+. +..||||+++.. ....+..+-|+++|.++. + | -+|.+.++|.-.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 44688999999999999999999985 468999998764 234556678999999983 2 2 378888889999
Q ss_pred CeEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCc-------c-
Q psy6905 186 PKLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIE-------N- 254 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~-------~- 254 (527)
+++|||+|.+ |-|+.+++.. ..++...+..|+.|++.+++|||+. +++|-||||+|||+..+.. .
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999 7799999984 3588899999999999999999999 5999999999999965421 0
Q ss_pred ----cccccceeEEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy6905 255 ----EDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVA 330 (527)
Q Consensus 255 ----~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~ 330 (527)
.......|+|+|||.|+..... +...+.|-.|.|||++.+-.++..+||||+||||+|+++|...|+..++.+-.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 1122456999999999865433 34567899999999999999999999999999999999999999887654421
Q ss_pred ---HHHHh-----------------CCccCC-----------------CC--------CCccHHHHHHHHHhhhhCCCCC
Q psy6905 331 ---YGVAV-----------------NKLTLP-----------------IP--------STCPQLFKTLMEACWEADSHMR 365 (527)
Q Consensus 331 ---~~i~~-----------------~~~~~~-----------------~p--------~~~~~~~~~li~~~l~~dp~~R 365 (527)
..+.- .+ ++. .| +..-.++.+||+.||..||.+|
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 11110 00 111 11 0011358899999999999999
Q ss_pred CCHHHHHHH
Q psy6905 366 PSFKTILKA 374 (527)
Q Consensus 366 Ps~~~ll~~ 374 (527)
+|+.|++.+
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=294.91 Aligned_cols=246 Identities=19% Similarity=0.230 Sum_probs=167.5
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEE-----
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGV----- 181 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~----- 181 (527)
.+..++|.+.+.||+|+||.||+|.+. +..||||.+....... ....+ .+....+.+++.++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e---~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE---IWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH---HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 456789999999999999999999973 5689999876432211 11111 1122223333322221
Q ss_pred -EEeCCeEEEEEeccCCCCHHHHhcCCCC---------------------ChhHHHHHHHHHHHHHHHHHhcCCCceeec
Q psy6905 182 -CLQSPKLCLVMEYARGGPLNRVLAGRKI---------------------RPDVLVDWAIQIAEGMNYLHCQAPISLIHR 239 (527)
Q Consensus 182 -~~~~~~~~iv~Ey~~ggsL~~~l~~~~~---------------------~~~~~~~i~~qi~~~L~yLH~~g~~~iiHr 239 (527)
...+..+++||||+.+++|.+++....+ ....+..++.||+.||+|||+++ ||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 2356679999999999999998864322 12345678999999999999994 9999
Q ss_pred CCCCCceecCCCCcccccccceeEEeccCcchhhhcc---ccccCCCccccccccccccC--------------------
Q psy6905 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT---THMSAAGTYAWMAPEVIKTS-------------------- 296 (527)
Q Consensus 240 Dlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~---~~~~~~gt~~y~aPE~l~~~-------------------- 296 (527)
||||+|||++.+ .+.+||+|||+++.+... ......+|+.|+|||.+...
T Consensus 280 DLKP~NILl~~~-------~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~ 352 (566)
T PLN03225 280 DVKPQNIIFSEG-------SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 352 (566)
T ss_pred cCCHHHEEEeCC-------CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhc
Confidence 999999999853 258999999999865322 12345789999999976422
Q ss_pred --CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc-------------------CCCCCCccHHHHHHHH
Q psy6905 297 --IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT-------------------LPIPSTCPQLFKTLME 355 (527)
Q Consensus 297 --~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~-------------------~~~p~~~~~~~~~li~ 355 (527)
.++.++|||||||+||||+++..|+... .......+...+.. +.+....+....+||.
T Consensus 353 ~~~~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 353 QLNLPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred cccCCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 1345679999999999999977665421 11111111111110 0011112334568999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q psy6905 356 ACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 356 ~~l~~dp~~RPs~~~ll~~ 374 (527)
+||..||.+|||+.++++|
T Consensus 432 ~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHccCCcccCCCHHHHhCC
Confidence 9999999999999999984
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=280.93 Aligned_cols=250 Identities=25% Similarity=0.313 Sum_probs=204.5
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCC------CccceEEEEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDH------RNIVSLIGVCL 183 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h------pnIv~~~~~~~ 183 (527)
.|+--.+|.+....|+|-|++|.+|.+. ++.||||++..+ +-..+.=+.|+.+|+.|+. -|+++|+..|.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 3556678999999999999999999974 679999999865 3345666789999999953 48999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHhc----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 184 QSPKLCLVMEYARGGPLNRVLA----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 184 ~~~~~~iv~Ey~~ggsL~~~l~----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
..+++|||+|-+ .-+|.++|+ +-.+....+..++.|++.||..|... +|+|.||||+||||+++ .
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~-------k 573 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES-------K 573 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC-------c
Confidence 999999999998 678999997 23577788999999999999999988 49999999999999986 3
Q ss_pred ceeEEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 260 KTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 260 ~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
+.+||||||.|.......-.....+-.|.|||++.|-+|+...|+||.||+||||+||+..|+|.++..++.-....+..
T Consensus 574 ~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred ceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 68999999999877665544445567799999999999999999999999999999999999998766554432211111
Q ss_pred CC----------------------------------------CC-----------CCcc-------HHHHHHHHHhhhhC
Q psy6905 340 LP----------------------------------------IP-----------STCP-------QLFKTLMEACWEAD 361 (527)
Q Consensus 340 ~~----------------------------------------~p-----------~~~~-------~~~~~li~~~l~~d 361 (527)
+| .| +.+| ..|++|+..||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 11 01 0111 35889999999999
Q ss_pred CCCCCCHHHHHHH
Q psy6905 362 SHMRPSFKTILKA 374 (527)
Q Consensus 362 p~~RPs~~~ll~~ 374 (527)
|++|.|..+.|.|
T Consensus 734 P~KRit~nqAL~H 746 (752)
T KOG0670|consen 734 PEKRITVNQALKH 746 (752)
T ss_pred hhhcCCHHHHhcC
Confidence 9999999988874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=285.72 Aligned_cols=250 Identities=20% Similarity=0.276 Sum_probs=182.3
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE------------------cCceEEEEEcCCCCChh-------------HHHHHHH
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY------------------EKQEVAIKVAHPNPDEN-------------ILENVKQ 162 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~------------------~~~~vaiK~~~~~~~~~-------------~~~~~~~ 162 (527)
+..++|.+.++||+|+||.||+|.+ .++.||||.+....... ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4678999999999999999999964 23579999876543211 0122334
Q ss_pred HHHHHHhCCCCcc-----ceEEEEEEe--------CCeEEEEEeccCCCCHHHHhcCC----------------------
Q psy6905 163 EGKLLWLFDHRNI-----VSLIGVCLQ--------SPKLCLVMEYARGGPLNRVLAGR---------------------- 207 (527)
Q Consensus 163 e~~~l~~l~hpnI-----v~~~~~~~~--------~~~~~iv~Ey~~ggsL~~~l~~~---------------------- 207 (527)
|+..+..++|.++ ++++++|.. ....++||||+.+|+|.+++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666777766554 677777753 34689999999999999887521
Q ss_pred ---CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccccc---cC
Q psy6905 208 ---KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM---SA 281 (527)
Q Consensus 208 ---~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~---~~ 281 (527)
.++...+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||++......... ..
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~--------~~~kL~DFGla~~~~~~~~~~~~~g 370 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVD--------GQVKIIDFGAAVDMCTGINFNPLYG 370 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCC--------CcEEEEeCcCccccccCCccCcccc
Confidence 1244567889999999999999994 9999999999999875 58999999999765322211 12
Q ss_pred CCccccccccccccCC--------------------C--CcccchHHHHHHHHHHHhCCC-CCCCCCHHHHH--------
Q psy6905 282 AGTYAWMAPEVIKTSI--------------------F--SKASDVWSYGVVLWELLTGEI-PYKSINAYAVA-------- 330 (527)
Q Consensus 282 ~gt~~y~aPE~l~~~~--------------------~--~~ksDvwSlGv~l~elltg~~-Pf~~~~~~~~~-------- 330 (527)
.+|+.|+|||.+.... | ..+.||||+||++|+|++|.. ||.+.......
T Consensus 371 ~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~ 450 (507)
T PLN03224 371 MLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDL 450 (507)
T ss_pred CCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchH
Confidence 3578999999985432 1 134799999999999999875 77643221111
Q ss_pred ---HHHHhCCccCCCCCCccHHHHHHHHHhhhhCC---CCCCCHHHHHHH
Q psy6905 331 ---YGVAVNKLTLPIPSTCPQLFKTLMEACWEADS---HMRPSFKTILKA 374 (527)
Q Consensus 331 ---~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp---~~RPs~~~ll~~ 374 (527)
..+....+.++....+++..++|+.+|+..+| .+|+|+.++++|
T Consensus 451 ~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 451 NRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11122344455556788999999999999766 689999999884
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=292.06 Aligned_cols=242 Identities=27% Similarity=0.407 Sum_probs=191.3
Q ss_pred eeeeeeccCCceE-EEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 120 IFGEAIGEGGFGK-VYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 120 ~~~~~iG~G~fg~-Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
.-.+++|.|+-|+ ||+|.+.++.||||.+-.. ......+|+.+|+.. .|||||++|+.-.+....||..|.| .
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeCCceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 3346899999886 6999999999999987653 345667999999988 6999999999999999999999999 6
Q ss_pred CCHHHHhcCC--CCCh---hHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 198 GPLNRVLAGR--KIRP---DVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 198 gsL~~~l~~~--~~~~---~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
-+|.+++... .+.. ...+..+.|++.||++||+. +||||||||.||||+....+ ....++|+|||+++.
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~---~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSAD---GTLRAKISDFGLSKK 660 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCC---cceeEEecccccccc
Confidence 7899999853 2111 33577889999999999998 59999999999999873211 125789999999998
Q ss_pred hhccc-----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCC-CCC
Q psy6905 273 VYKTT-----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPI-PST 345 (527)
Q Consensus 273 ~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~ 345 (527)
+.... ..+..||.+|+|||++....-+.++|||||||++|+.++ |..||...-..+ ..|..+.+.+.. ...
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPL 738 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccC
Confidence 75432 234569999999999999888889999999999999999 699997643332 234334333211 111
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
-..+..+||.+|++.+|..||++.+++.|
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11178999999999999999999999874
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-33 Score=288.34 Aligned_cols=248 Identities=25% Similarity=0.465 Sum_probs=210.8
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
+..+|.++..+|+|.||.||++++ ++...|+|+++.....+ ..-+.+|+-+++..+|||||.|+|.+...+.++|.|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 467899999999999999999997 46789999998876544 566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||.||+|+++.. .+.+++.++...++..+.||+|||+.| =+|||||-.|||+++. +.||++|||.+.
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~--------gDvklaDfgvsa 160 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDE--------GDVKLADFGVSA 160 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeeccc--------CceeecccCchh
Confidence 9999999999987 678999999999999999999999996 6999999999999986 799999999987
Q ss_pred hhhc--cccccCCCcccccccccc---ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC---CCC
Q psy6905 272 EVYK--TTHMSAAGTYAWMAPEVI---KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL---PIP 343 (527)
Q Consensus 272 ~~~~--~~~~~~~gt~~y~aPE~l---~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~---~~p 343 (527)
.+.. ....++.||+.|||||+. +.+.|...+|||++|++..|+-.-++|-...-......-....++.. .-+
T Consensus 161 qitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 161 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK 240 (829)
T ss_pred hhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence 6633 233467899999999986 45678999999999999999988887755544444444443334332 334
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+++.|.++++.|+..+|.+||+++.++.+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 6789999999999999999999999987753
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=243.62 Aligned_cols=244 Identities=19% Similarity=0.390 Sum_probs=197.3
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeC--CeEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQS--PKLC 189 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~--~~~~ 189 (527)
+.++|++.+++|+|.|+.||.|.. ++..++||++++.. .+.+.+|+.+|..|. ||||++++++..+. ....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 457899999999999999999984 66789999998753 567889999999996 99999999998763 4578
Q ss_pred EEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
+++||+++.+...+.. .++.-.+..++.+++.||.|||+.| |+|||+||.|++|+.. ...++|+|+|+
T Consensus 112 LiFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~-------~rkLrlIDWGL 179 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHE-------LRKLRLIDWGL 179 (338)
T ss_pred hHhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechh-------hceeeeeecch
Confidence 9999999998887764 5778889999999999999999996 9999999999999975 36899999999
Q ss_pred chhhhccccc-cCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHh-----------
Q psy6905 270 AREVYKTTHM-SAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPY-KSINAYAVAYGVAV----------- 335 (527)
Q Consensus 270 a~~~~~~~~~-~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf-~~~~~~~~~~~i~~----------- 335 (527)
|......... ..+.+..|--||.+.. ..|+..-|+|||||++..|+..+.|| .|.++......++.
T Consensus 180 AEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 180 AEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred HhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 9877554433 3356677899999864 56899999999999999999988876 45444433333321
Q ss_pred CCccCCCC------------------------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 NKLTLPIP------------------------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ~~~~~~~p------------------------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++.+.++ ...+++..+|+..+|..|-.+|+|+.|.+.+
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 12222111 2346789999999999999999999998764
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-33 Score=255.90 Aligned_cols=242 Identities=27% Similarity=0.408 Sum_probs=190.7
Q ss_pred eeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC-----eEEEEEe
Q psy6905 122 GEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-----KLCLVME 193 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-----~~~iv~E 193 (527)
.+.||-|+||.||.+.+ +|+.||+|.+.... .-...+.+.+|+.+|..++|.|++..+++..... .+|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 45799999999999887 57889998765432 2234577889999999999999999998865432 3688999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
.| ..+|..++- -..++.+.+.-++.||++||+|||+. +|.||||||.|+|++.| ..+||||||+++.
T Consensus 138 Lm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSN--------CvLKICDFGLARv 205 (449)
T KOG0664|consen 138 LM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSN--------CILKICDFGLART 205 (449)
T ss_pred HH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccC--------ceEEecccccccc
Confidence 99 677877765 67799999999999999999999999 59999999999999987 6899999999987
Q ss_pred hhccc--cc-cCCCccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------
Q psy6905 273 VYKTT--HM-SAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA-------------- 334 (527)
Q Consensus 273 ~~~~~--~~-~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~-------------- 334 (527)
..... ++ ..+.|-.|.|||++.+.. |+.+.||||.||++.||+..+..|...+..+...-|.
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 64322 22 235688999999998764 8999999999999999999999998766544433221
Q ss_pred ---------hCCccCC---------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 335 ---------VNKLTLP---------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 335 ---------~~~~~~~---------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
+...+.| .|..-..+...++..++..||++|.+..+.+.++
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111 1122334667889999999999999999888764
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=259.03 Aligned_cols=255 Identities=27% Similarity=0.370 Sum_probs=194.3
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-----C---CccceEEEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFD-----H---RNIVSLIGVCL 183 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----h---pnIv~~~~~~~ 183 (527)
++..+|.+.++||-|.|++||+|.+. .+.||+|+.+.. +...+....|+.+|+++. | .+||+|++.|.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 34578999999999999999999984 468999998875 334567789999999872 3 36999999996
Q ss_pred e----CCeEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcc--
Q psy6905 184 Q----SPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN-- 254 (527)
Q Consensus 184 ~----~~~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~-- 254 (527)
. +.++|||+|++ |.+|..+|. -+.++...+..|+.||+.||.|||... +|||-||||+|||+..+..+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~ 229 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA 229 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence 5 56899999999 788888876 456899999999999999999999997 89999999999998532000
Q ss_pred --------------------------------------------------------------------------------
Q psy6905 255 -------------------------------------------------------------------------------- 254 (527)
Q Consensus 255 -------------------------------------------------------------------------------- 254 (527)
T Consensus 230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~ 309 (590)
T KOG1290|consen 230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI 309 (590)
T ss_pred hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence
Q ss_pred ---------------------------cc-------------------------------------------------cc
Q psy6905 255 ---------------------------ED-------------------------------------------------LQ 258 (527)
Q Consensus 255 ---------------------------~~-------------------------------------------------~~ 258 (527)
.. ..
T Consensus 310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~ 389 (590)
T KOG1290|consen 310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC 389 (590)
T ss_pred CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence 00 00
Q ss_pred cceeEEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHH
Q psy6905 259 FKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN-------AYAVAY 331 (527)
Q Consensus 259 ~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~-------~~~~~~ 331 (527)
.-.|||+|||.|.-+... ......|..|+|||++.+..|+..+||||++|++|||+||...|...+ ...++.
T Consensus 390 di~vKIaDlGNACW~~kh-FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVHKH-FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred ceeEEEeeccchhhhhhh-hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 114788888888755332 223456899999999999999999999999999999999999885322 111111
Q ss_pred HH----------HhC-Ccc----------------------------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHH
Q psy6905 332 GV----------AVN-KLT----------------------------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTIL 372 (527)
Q Consensus 332 ~i----------~~~-~~~----------------------------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll 372 (527)
-+ +.. ++. +..+..-..+|.+++.-||..+|++|||+.+.+
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 11 100 000 001122235689999999999999999999998
Q ss_pred HH
Q psy6905 373 KA 374 (527)
Q Consensus 373 ~~ 374 (527)
++
T Consensus 549 ~h 550 (590)
T KOG1290|consen 549 KH 550 (590)
T ss_pred cC
Confidence 74
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=272.19 Aligned_cols=198 Identities=27% Similarity=0.412 Sum_probs=173.2
Q ss_pred eCCceeeeeeeccCCceEEEEeeEcC--ceEEEEEcCCCCC-------hhHHHHHHHHHHHHHhCC---CCccceEEEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPD-------ENILENVKQEGKLLWLFD---HRNIVSLIGVC 182 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~~--~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~---hpnIv~~~~~~ 182 (527)
.+.+|...+.+|.|+||.|+.|+++. ..|+||.+.+..- ...+-.+-.|+.+|..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 46779999999999999999999854 5899998876520 001233557999999997 99999999999
Q ss_pred EeCCeEEEEEeccC-CCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccc
Q psy6905 183 LQSPKLCLVMEYAR-GGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260 (527)
Q Consensus 183 ~~~~~~~iv~Ey~~-ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~ 260 (527)
++++++||+||-.. |-+|.+++. +..+++.+...|+.||+.|+++||++| |||||||-+|+.++.+ |
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~--------g 707 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSN--------G 707 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecC--------C
Confidence 99999999999864 448899998 678999999999999999999999995 9999999999999986 7
Q ss_pred eeEEeccCcchhhhccccccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCC
Q psy6905 261 TLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKS 323 (527)
Q Consensus 261 ~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~ 323 (527)
-+||+|||.|..........++||..|.|||++.+..| +..-|||+||++||.++..+.||..
T Consensus 708 ~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999998887777778899999999999999876 5789999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=240.36 Aligned_cols=206 Identities=40% Similarity=0.673 Sum_probs=183.0
Q ss_pred eccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCHHH
Q psy6905 125 IGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNR 202 (527)
Q Consensus 125 iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~ 202 (527)
||+|++|.||++... ++.+++|+............+.+|+..++.+.|++|+++++++......++++||+.|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999986 789999998876543245678899999999999999999999999899999999999999999
Q ss_pred HhcCC--CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCC-CCcccccccceeEEeccCcchhhhccc--
Q psy6905 203 VLAGR--KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSE-PIENEDLQFKTLKITDFGLAREVYKTT-- 277 (527)
Q Consensus 203 ~l~~~--~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~-~~~~~~~~~~~vkL~DFGla~~~~~~~-- 277 (527)
++... .++...+..++.+++.+|.|||+.| ++|+||+|.||+++. + +.++|+|||.+.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~--------~~~~l~d~~~~~~~~~~~~~ 149 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDN--------GKVKLADFGLSKLLTSDKSL 149 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCC--------CcEEEecCCceEEccCCcch
Confidence 99854 7899999999999999999999994 999999999999987 3 589999999998664433
Q ss_pred cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHH
Q psy6905 278 HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEA 356 (527)
Q Consensus 278 ~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~ 356 (527)
.....+...|++||.+... .++.++|+|+||+++++| ..+.+++..
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~ 196 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRK 196 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHH
Confidence 3345678899999999887 788999999999999999 568899999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q psy6905 357 CWEADSHMRPSFKTILKA 374 (527)
Q Consensus 357 ~l~~dp~~RPs~~~ll~~ 374 (527)
|+..+|.+||++.+++++
T Consensus 197 ~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 197 MLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HhhCCcccCcCHHHHhhC
Confidence 999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=251.47 Aligned_cols=244 Identities=27% Similarity=0.360 Sum_probs=192.2
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC------e
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP------K 187 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------~ 187 (527)
.+|.-+..+|.|.- .|--+.+ .++.||+|..... ......+...+|..++..++|+||++++.+|.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778999988 6666665 5788999866553 23344677889999999999999999999996543 4
Q ss_pred EEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 188 LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
.|+||||| .++|..++. -.+.-..+..++.|++.|++|||+.| |+||||||+||++..+ +.+||.||
T Consensus 96 ~y~v~e~m-~~nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~--------~~lKi~df 162 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSD--------CTLKILDF 162 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecch--------hheeeccc
Confidence 79999999 677877765 45667788999999999999999995 9999999999999986 68999999
Q ss_pred Ccchhhhcc-ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Q psy6905 268 GLAREVYKT-THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV----------- 335 (527)
Q Consensus 268 Gla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~----------- 335 (527)
|+|+..... .....+.|..|.|||++.+..|...+||||+||++.||++|...|+|.+......++..
T Consensus 163 g~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 163 GLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred hhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 999876544 22345689999999999998899999999999999999999999998654332222110
Q ss_pred -----------C-----CccC--CCC-----------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 -----------N-----KLTL--PIP-----------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 -----------~-----~~~~--~~p-----------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+ +..+ ..| ..-+...++++.+||-.||++|.|++++|.|
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 0000 011 1123457899999999999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=239.24 Aligned_cols=209 Identities=35% Similarity=0.528 Sum_probs=176.5
Q ss_pred eeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccC
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYAR 196 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ 196 (527)
|.+.+.||.|++|.||++... ++.+|+|.+...........+.+|+..+..++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 467789999999999999985 478999998876443246788899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCC-C-CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 197 GGPLNRVLAGR-K-IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 197 ggsL~~~l~~~-~-~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
+++|.+++... . ++...+..++.+++.+|.|||..+ ++|+||+|.||+++.+ +.++|+|||++....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~--------~~~~l~d~g~~~~~~ 149 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMD--------GLVKLADFGLARFIH 149 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC--------CCEEEeeCceeeEec
Confidence 99999998743 3 889999999999999999999994 9999999999999875 689999999988764
Q ss_pred cc---ccccCCCcccccccccc-ccCCCCcccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc
Q psy6905 275 KT---THMSAAGTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGEIPYKS-INAYAVAYGVAVNKL 338 (527)
Q Consensus 275 ~~---~~~~~~gt~~y~aPE~l-~~~~~~~ksDvwSlGv~l~elltg~~Pf~~-~~~~~~~~~i~~~~~ 338 (527)
.. ......++..|++||.+ ....++.++|||+||+++++|++|+.||.. .+...........+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 43 22344678899999998 666788899999999999999999999987 455544444444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=223.69 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=213.9
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCC-CccceEEEEEEeCCeEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH-RNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~~~~~~~~~~~~~ 189 (527)
.|-..+|.++++||+|+||.+|.|.. .|..||||+...... .-.+.-|..+...|++ ..|..+..+..+..+-.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 35668899999999999999999986 678999999876532 2345678888888864 67888888888988999
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+||+.+ |-+|.++.. .+.|+..+++-++-|++.-++|+|.++ +|||||||+|+|.+-+. ..+.+.|+||
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgr-----h~~kl~LIDF 158 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGR-----HCNKLYLIDF 158 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeecccc-----ccceEEEEec
Confidence 999999 899999987 788999999999999999999999995 99999999999997542 2368999999
Q ss_pred Ccchhhhcccc---------ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh
Q psy6905 268 GLAREVYKTTH---------MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA---YAVAYGVAV 335 (527)
Q Consensus 268 Gla~~~~~~~~---------~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~i~~ 335 (527)
|+|+.+.+... ....||.+|.+-.++.+...+.+.|+-|+|++|..+.-|.+||++... .+.+..|..
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 99988754322 245699999999999888889999999999999999999999998754 444556665
Q ss_pred CCccCCCC---CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 336 NKLTLPIP---STCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 336 ~~~~~~~p---~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.+...++. ..+|.+|.-.+..|-..--++-|++.-|.+.+.-++..
T Consensus 239 kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 239 KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 55555544 45689999999999999999999999988877666554
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=232.89 Aligned_cols=241 Identities=21% Similarity=0.367 Sum_probs=185.8
Q ss_pred CceeeeeeeccCCceEEEEeeEcC--ceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEE-EEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGV-CLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~-~~~~~~~~iv~ 192 (527)
+.|.+.+.||+|.||.+-+|.+++ +.+++|.+.... ....+|.+|..---.| .|.||+.-|++ |...+.+++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 468889999999999999999865 689999887653 2367888888776666 68999988865 66677889999
Q ss_pred eccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 193 EYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 193 Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|||+.|+|..-+....+.+.....++.|++.||.|+|++ ++||||||.+||||-... ...|||||||+.+.
T Consensus 102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~d------f~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDAD------FYRVKLCDFGLTRK 172 (378)
T ss_pred ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCC------ccEEEeeecccccc
Confidence 999999999998878888999999999999999999999 799999999999996531 35899999999876
Q ss_pred hhccccccCCCcccccccccccc---CC--CCcccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCccCCCCC
Q psy6905 273 VYKTTHMSAAGTYAWMAPEVIKT---SI--FSKASDVWSYGVVLWELLTGEIPYKSINA---YAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 273 ~~~~~~~~~~gt~~y~aPE~l~~---~~--~~~ksDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~p~ 344 (527)
...... ...-+..|.+||.... .. ..+.+|||.||+++|.++||.+||+...- .-..+..-.++..+..|.
T Consensus 173 ~g~tV~-~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 173 VGTTVK-YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred cCceeh-hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 532221 1234667999998643 22 46899999999999999999999985321 111111122333444554
Q ss_pred ---CccHHHHHHHHHhhhhCCCCCCCHH
Q psy6905 345 ---TCPQLFKTLMEACWEADSHMRPSFK 369 (527)
Q Consensus 345 ---~~~~~~~~li~~~l~~dp~~RPs~~ 369 (527)
.+++.+..+.++-+..++++|--..
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~ 279 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIW 279 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhH
Confidence 3567778888888899988884333
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-28 Score=228.60 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=219.0
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~ 189 (527)
.+-.-.|.++++||.|+||..+.|.. +++.||||......+ .-++..|.+..+.| ..++|...|-+..++.+-.
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 35556799999999999999999974 889999998766543 23455677777777 5799999999988998899
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+|+|++ |-||.|+.. +++|+..+++.++.|++.-++|+|++ .+|.|||||+|+||+... ....+.|.|+||
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~---~k~~n~IhiiDF 173 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPG---TKDANVIHIIDF 173 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCC---CCCCceEEEEec
Confidence 999999 899999987 88999999999999999999999999 699999999999998642 233468999999
Q ss_pred Ccchhhhccc---------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh
Q psy6905 268 GLAREVYKTT---------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI---NAYAVAYGVAV 335 (527)
Q Consensus 268 Gla~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~---~~~~~~~~i~~ 335 (527)
|+|+.+.+.. +.+..||.+||+-..+.+...+.+.|+-|||-++.+.+-|.+||.+. +..+.+.+|-.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 9999874432 23567999999999999999999999999999999999999999985 45566666665
Q ss_pred CCccCCCC---CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 336 NKLTLPIP---STCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 336 ~~~~~~~p---~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.+...++. ..+|.+|...|+..-..+-.+-|+++-+...+.+++..
T Consensus 254 ~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 254 TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 55555543 55799999999999999999999999999988887765
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-27 Score=241.33 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=203.6
Q ss_pred ceeeeeeeccCCceEEEEeeEcC---ceEEEEEcCCCCChhHHHHHHHHHHHHHhCC----CCccceEEEEE-EeCCeEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNPDENILENVKQEGKLLWLFD----HRNIVSLIGVC-LQSPKLC 189 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~----hpnIv~~~~~~-~~~~~~~ 189 (527)
.|.+.+.||+|+||.||.|.+.. ..+|+|+.......... .+..|+.++..+. ..++..+++.. ......|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 79999999999999999999754 36999988765322212 5667888888876 36899999999 5777889
Q ss_pred EEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 190 LVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
|||+.+ |.+|.++.. .+.++..+++.++.|++.+|++||+.| +|||||||+|++++.... .....++|.|
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~---~~~~~~~llD 170 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSR---SEVRTLYLLD 170 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCC---cccceEEEEe
Confidence 999999 899999875 368999999999999999999999996 999999999999987520 0114799999
Q ss_pred cCcch--hhhccc----------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6905 267 FGLAR--EVYKTT----------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA 334 (527)
Q Consensus 267 FGla~--~~~~~~----------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 334 (527)
||+++ ...... .....||.+|+++.++.+...+.+.|+||+++++.+++.|..||.+.........+.
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99998 321111 123459999999999999999999999999999999999999998766433333222
Q ss_pred hCCcc--CC-CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 335 VNKLT--LP-IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 335 ~~~~~--~~-~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
..... .. ....++.++..++..+-..+...+|.+..+...|.......
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 21111 11 33456788999999988999999999999999987776653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=271.17 Aligned_cols=197 Identities=20% Similarity=0.178 Sum_probs=144.4
Q ss_pred CC-CccceEEEEE-------EeCCeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecC
Q psy6905 171 DH-RNIVSLIGVC-------LQSPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240 (527)
Q Consensus 171 ~h-pnIv~~~~~~-------~~~~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrD 240 (527)
.| +||++++++| .....+++++||+ +++|.+++. ...+++.+++.++.||+.||.|||++| |||||
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrD 105 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVHN 105 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 45 5888888877 3345678889987 779999996 345899999999999999999999995 99999
Q ss_pred CCCCceecCCCCc-----------ccccccceeEEeccCcchhhhcc------------------ccccCCCcccccccc
Q psy6905 241 LKSSNVLLSEPIE-----------NEDLQFKTLKITDFGLAREVYKT------------------THMSAAGTYAWMAPE 291 (527)
Q Consensus 241 lkp~NILl~~~~~-----------~~~~~~~~vkL~DFGla~~~~~~------------------~~~~~~gt~~y~aPE 291 (527)
|||+||||+.... ......+.+||+|||+++..... ......||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999964210 00011357899999998743110 001135889999999
Q ss_pred ccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHH
Q psy6905 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371 (527)
Q Consensus 292 ~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~l 371 (527)
++.+..|+.++|||||||+||||++|..||..... ....+... ...+.+.........++..||..+|.+||++.++
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR-VLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh-hcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 99999999999999999999999999988764321 11111111 1111111123456789999999999999999999
Q ss_pred HHH
Q psy6905 372 LKA 374 (527)
Q Consensus 372 l~~ 374 (527)
+++
T Consensus 263 l~h 265 (793)
T PLN00181 263 LQS 265 (793)
T ss_pred hhc
Confidence 874
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=236.52 Aligned_cols=244 Identities=26% Similarity=0.395 Sum_probs=190.4
Q ss_pred CCceeeeeeeccCCceEEEEeeEc-----CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~ 189 (527)
.+.|.++++||.|.|++||++.+. ...||+|.+..... ...+.+|+++|..+ .+.||+++.+++...+..+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 356888999999999999999752 35799998877643 45688999999998 6999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
+|+||++.....+++. .++..++..+++.++.||.++|.+| ||||||||+|+|.+.. .+.-.|+|||+
T Consensus 112 ivlp~~~H~~f~~l~~--~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~-------t~rg~LvDFgL 179 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR--SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRR-------TQRGVLVDFGL 179 (418)
T ss_pred EEecccCccCHHHHHh--cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccc-------cCCceEEechh
Confidence 9999999999999886 4668889999999999999999996 9999999999999875 36789999999
Q ss_pred chhhhc--------c--------------------------------------ccccCCCcccccccccccc-CCCCccc
Q psy6905 270 AREVYK--------T--------------------------------------THMSAAGTYAWMAPEVIKT-SIFSKAS 302 (527)
Q Consensus 270 a~~~~~--------~--------------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~ks 302 (527)
|..... . .....+||++|.|||++.. ...++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 862100 0 0012249999999999854 4578899
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCH-H-HHHH-----------HHH--hCC------------------c-cC--------
Q psy6905 303 DVWSYGVVLWELLTGEIPYKSINA-Y-AVAY-----------GVA--VNK------------------L-TL-------- 340 (527)
Q Consensus 303 DvwSlGv~l~elltg~~Pf~~~~~-~-~~~~-----------~i~--~~~------------------~-~~-------- 340 (527)
||||.||++..+++++.||-.-.. . .... +.+ .+. + ..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999999999843211 0 0000 000 000 0 00
Q ss_pred -------C-CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 -------P-IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 -------~-~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. -.+..|..+.+|+.+|+..||.+|.|+++.|++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 002234578999999999999999999999884
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=215.18 Aligned_cols=159 Identities=23% Similarity=0.294 Sum_probs=125.7
Q ss_pred CCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 198 GPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 198 gsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
|+|.+++. +..+++..++.|+.||+.||.|||+++ ||+|||++.+ +.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~--------~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWD--------GLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCc--------cceee--ccceEeecc
Confidence 78999987 456999999999999999999999883 9999999875 57888 999876533
Q ss_pred cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCccC-----CCCCCccH-
Q psy6905 276 TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAV-AYGVAVNKLTL-----PIPSTCPQ- 348 (527)
Q Consensus 276 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~-~~~i~~~~~~~-----~~p~~~~~- 348 (527)
. ...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+....... +.+..++.
T Consensus 62 ~---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 62 E---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred c---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhh
Confidence 2 23689999999999999999999999999999999999999976543222 22222111111 11223344
Q ss_pred -HHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 349 -LFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 349 -~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
.+.++|.+||..+|.+||++.++++++...
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 699999999999999999999999987554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=220.47 Aligned_cols=254 Identities=27% Similarity=0.539 Sum_probs=212.8
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
..|+..++.+..+|.....|..|+|.|.|..++.|++.... .....+.|..|.-.|+.+.||||+.++|.|...+++.+
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred cCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 35777888889999999999999999999999999877543 23345678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCC---CChhHHHHHHHHHHHHHHHHHhcCCCcee-ecCCCCCceecCCCCcccccccceeEEec
Q psy6905 191 VMEYARGGPLNRVLAGRK---IRPDVLVDWAIQIAEGMNYLHCQAPISLI-HRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~~~---~~~~~~~~i~~qi~~~L~yLH~~g~~~ii-HrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+..||+.|+|..+|.++. ....++.+++.+|+.||+|||+..+ +| ---|....++|+++.. ..+-.+|
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedlt------arismad 336 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLT------ARISMAD 336 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhh------hheeccc
Confidence 999999999999998543 5677899999999999999999863 44 4468888999998642 2344444
Q ss_pred cCcchhhhccccccCCCccccccccccccCCCC---cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 267 FGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFS---KASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 267 FGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
--++- ........+.||+||.++..+-+ .++|+|||++++|||.|.+.||...+..+.-.+++..+++..+|
T Consensus 337 ~kfsf-----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip 411 (448)
T KOG0195|consen 337 TKFSF-----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP 411 (448)
T ss_pred ceeee-----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC
Confidence 32221 11223457899999999876533 68999999999999999999999999999999999999999999
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
...+.-+..||.-|.+.||.+||.|+.++-.|++.
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 99999999999999999999999999998887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-24 Score=212.11 Aligned_cols=244 Identities=31% Similarity=0.451 Sum_probs=200.1
Q ss_pred eeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChh--HHHHHHHHHHHHHhCCCC-ccceEEEEEEeCCeEEEEEecc
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDEN--ILENVKQEGKLLWLFDHR-NIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~hp-nIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
|.+.+.||.|+||.||++.+. ..+++|.+....... ....+.+|+.++..+.|+ +|+++++++......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 677889999999999999988 788999887764333 477889999999999988 7999999998777789999999
Q ss_pred CCCCHHHHhcCC----CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccc-eeEEeccCcc
Q psy6905 196 RGGPLNRVLAGR----KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK-TLKITDFGLA 270 (527)
Q Consensus 196 ~ggsL~~~l~~~----~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~-~vkL~DFGla 270 (527)
.++++.+++... .+.......++.|++.++.|+|+.+ ++||||||+||+++.. + .++++|||++
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~--------~~~~~l~dfg~~ 149 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRD--------GRVVKLIDFGLA 149 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCC--------CCeEEEeccCcc
Confidence 999999777743 6889999999999999999999995 9999999999999975 3 6999999999
Q ss_pred hhhhccc--------cccCCCcccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh
Q psy6905 271 REVYKTT--------HMSAAGTYAWMAPEVIKT---SIFSKASDVWSYGVVLWELLTGEIPYKSINA----YAVAYGVAV 335 (527)
Q Consensus 271 ~~~~~~~--------~~~~~gt~~y~aPE~l~~---~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~----~~~~~~i~~ 335 (527)
+...... .....||..|+|||.+.+ ..++...|+||+|++++++++|..||..... ......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 7553322 245679999999999987 5788999999999999999999999887763 333333333
Q ss_pred CCcc-C--CCCCCc----cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 NKLT-L--PIPSTC----PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ~~~~-~--~~p~~~----~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.... . ...... ...+.+++..|+..+|..|.+.......
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 3322 1 122222 2578999999999999999998877764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=221.41 Aligned_cols=171 Identities=19% Similarity=0.207 Sum_probs=130.0
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc---CceEEEEEcCCCC----ChhHHHHHHHHHHHHHhCCCCccce-EEEEEEeC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE---KQEVAIKVAHPNP----DENILENVKQEGKLLWLFDHRNIVS-LIGVCLQS 185 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~---~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~hpnIv~-~~~~~~~~ 185 (527)
.-...|.+.+.||+|+||+||+|.+. ++.||||...... .......+.+|+.+|+.++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34567999999999999999999873 5668999865331 2234567899999999999999985 5442
Q ss_pred CeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCC-CCCceecCCCCcccccccceeEE
Q psy6905 186 PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDL-KSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDl-kp~NILl~~~~~~~~~~~~~vkL 264 (527)
...|+|||||+|++|...... . ...++.|++.||.|||++| |+|||| ||+|||++.+ +.+||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~--------~~ikL 153 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLARPH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPD--------GEAAV 153 (365)
T ss_pred CCcEEEEEccCCCCHHHhCcc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCC--------CCEEE
Confidence 457999999999999733111 1 2567899999999999995 999999 9999999764 58999
Q ss_pred eccCcchhhhcccc----------ccCCCccccccccccccCC------CCcccchH
Q psy6905 265 TDFGLAREVYKTTH----------MSAAGTYAWMAPEVIKTSI------FSKASDVW 305 (527)
Q Consensus 265 ~DFGla~~~~~~~~----------~~~~gt~~y~aPE~l~~~~------~~~ksDvw 305 (527)
+|||+|+.+..... ....+++.|+|||.+.... .+..+|-|
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99999986533221 1345788899999985332 33456666
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-24 Score=229.41 Aligned_cols=242 Identities=24% Similarity=0.356 Sum_probs=184.5
Q ss_pred eeeeeeccCCceEEEEeeEc--CceEEEEEcC----CC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 120 IFGEAIGEGGFGKVYKGIYE--KQEVAIKVAH----PN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 120 ~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~----~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
.....+|.|++|.|+.+... ...++.|... .. ........+..|+.+-..|.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977766542 2223333221 22 22223333778888888999999988887777766666669
Q ss_pred eccCCCCHHHHhcCC-CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~~~-~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||++ +|..++... .++..++..++.|++.|+.|||+.| |.|||||++|+++..+ +.+||+|||.+.
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~--------g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTEN--------GILKIIDFGAAS 468 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecC--------CceEEeecCcce
Confidence 99999 999888754 8999999999999999999999996 9999999999999986 699999999987
Q ss_pred hhhcc------ccccCCCccccccccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhCCc----
Q psy6905 272 EVYKT------THMSAAGTYAWMAPEVIKTSIFS-KASDVWSYGVVLWELLTGEIPYKSINAYAVA--YGVAVNKL---- 338 (527)
Q Consensus 272 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~~-~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~--~~i~~~~~---- 338 (527)
..... .....+|+..|+|||++.+..|+ ...||||.|++++.|.+|+.||......... ........
T Consensus 469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~ 548 (601)
T KOG0590|consen 469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFE 548 (601)
T ss_pred eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccccc
Confidence 65321 22356799999999999999887 5799999999999999999999764333221 11000000
Q ss_pred -cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 339 -TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 339 -~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
...+-..+|..-+.+|.+||+.||.+|.|+.+|++
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11222456788899999999999999999999986
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=205.75 Aligned_cols=205 Identities=28% Similarity=0.513 Sum_probs=161.5
Q ss_pred HHhCCCCccceEEEEEEeCCeEEEEEeccCCCCHHHHhcCCC--CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q psy6905 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSS 244 (527)
Q Consensus 167 l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~~~--~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~ 244 (527)
|+.+.|.|+.+++|.+.+++.+++|.+||..|+|.+++.... ++......++.+|+.||.|||+.. . ..|+.|++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeeccc
Confidence 356899999999999999999999999999999999998644 555566778889999999999873 1 289999999
Q ss_pred ceecCCCCcccccccceeEEeccCcchhhhcc----ccccCCCccccccccccccCC-------CCcccchHHHHHHHHH
Q psy6905 245 NVLLSEPIENEDLQFKTLKITDFGLAREVYKT----THMSAAGTYAWMAPEVIKTSI-------FSKASDVWSYGVVLWE 313 (527)
Q Consensus 245 NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~----~~~~~~gt~~y~aPE~l~~~~-------~~~ksDvwSlGv~l~e 313 (527)
|++++.. ..+||+|||+....... ......-...|.|||.+++.. .+.+.||||||++++|
T Consensus 79 nClvd~~--------w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 79 NCLVDSR--------WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred cceeeee--------EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 9999987 48999999998765321 111112346799999997642 4678999999999999
Q ss_pred HHhCCCCCCCC----CHHHHHHHHHhCCccCCCCC-----CccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 314 LLTGEIPYKSI----NAYAVAYGVAVNKLTLPIPS-----TCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 314 lltg~~Pf~~~----~~~~~~~~i~~~~~~~~~p~-----~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
+++...||... +..+.+..+...+.....|. .+++++..+++.||..+|..||++..+...++.+...
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred HHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99999999763 23455555554233333332 3456789999999999999999999999988776654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=192.04 Aligned_cols=172 Identities=17% Similarity=0.132 Sum_probs=133.2
Q ss_pred eCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCC--ChhHHHH------HHHHHHHHHhCCCCccceEEEEEEeC-
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP--DENILEN------VKQEGKLLWLFDHRNIVSLIGVCLQS- 185 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~--~~~~~~~------~~~e~~~l~~l~hpnIv~~~~~~~~~- 185 (527)
-..+|.+.+.||.|+||.||++..++..+|||++.... .+..... +.+|+..+..+.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 45789999999999999999977777789999997653 2222223 57899999999999999999886643
Q ss_pred -------CeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccc
Q psy6905 186 -------PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258 (527)
Q Consensus 186 -------~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~ 258 (527)
...++||||++|.+|.++.. +++ ....+|+.+|..||..| ++||||+|+||+++.+
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~------- 171 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN------- 171 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC-------
Confidence 35799999999999988742 333 34569999999999995 9999999999999864
Q ss_pred cceeEEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHH
Q psy6905 259 FKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELL 315 (527)
Q Consensus 259 ~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ell 315 (527)
+ ++|+|||..+......... ..+....|+.++|+||||+++..+.
T Consensus 172 -g-i~liDfg~~~~~~e~~a~d----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 -G-LRIIDLSGKRCTAQRKAKD----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -C-EEEEECCCcccccchhhHH----------HHHHHhHhcccccccceeEeehHHH
Confidence 5 9999999886542211110 0333445668999999999987654
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-23 Score=213.34 Aligned_cols=224 Identities=29% Similarity=0.412 Sum_probs=184.9
Q ss_pred eeccCCceEEEEee-----EcCceEEEEEcCCCCCh-hHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEEEeccC
Q psy6905 124 AIGEGGFGKVYKGI-----YEKQEVAIKVAHPNPDE-NILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLVMEYAR 196 (527)
Q Consensus 124 ~iG~G~fg~Vy~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv~Ey~~ 196 (527)
.+|.|.||.|+++. +.+..||+|+.+..... ........|..++...+ ||.+|+++-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999754 34567999987664211 11114456777787776 9999999999999999999999999
Q ss_pred CCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 197 GGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 197 ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
||.|...+. ...+.+.....+...++-+++++|..| ++|||+|++||+++.+ |.+++.|||+++..-.
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~--------Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLE--------GHIKLTDFGLSKEAVK 149 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeeccc--------CccccCCchhhhHhHh
Confidence 999988776 445677777888889999999999995 9999999999999986 7999999999987754
Q ss_pred cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHH
Q psy6905 276 TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLME 355 (527)
Q Consensus 276 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~ 355 (527)
.... |||..|||||+++ .....+|.||||++++||++|..||.+ ++...|. +..++.|...+....+++.
T Consensus 150 ~~~~--cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il--~~~~~~p~~l~~~a~~~~~ 219 (612)
T KOG0603|consen 150 EKIA--CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL--KAELEMPRELSAEARSLFR 219 (612)
T ss_pred hhhc--ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh--hhccCCchhhhHHHHHHHH
Confidence 3332 9999999999998 457899999999999999999999987 4444444 3456788999999999999
Q ss_pred HhhhhCCCCCCCH
Q psy6905 356 ACWEADSHMRPSF 368 (527)
Q Consensus 356 ~~l~~dp~~RPs~ 368 (527)
.++..+|..|--.
T Consensus 220 ~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 220 QLFKRNPENRLGA 232 (612)
T ss_pred HHHhhCHHHHhcc
Confidence 9999999999754
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-23 Score=225.27 Aligned_cols=242 Identities=21% Similarity=0.239 Sum_probs=178.6
Q ss_pred ceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHH---HHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVK---QEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~---~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++...+.||++.|=+|.+|.+....|+||++-...+.-.+..+. .|++ ....+|||++.|.-+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 67788899999999999999877779999876654332233333 3344 4556999999999887777788999999
Q ss_pred cCCCCHHHHhcCCC-CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~~~~-~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
. .-+|.|.+..++ +..-+...|+.|++.||..+|..| |+|||||.+||||+. .+.+.|+||..-+..
T Consensus 103 v-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTS--------WNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITS--------WNWLYLTDFASFKPT 170 (1431)
T ss_pred H-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEee--------echhhhhcccccCCc
Confidence 9 567888887554 566777888999999999999995 999999999999987 478999999887654
Q ss_pred hcccc----c-----cCCCccccccccccccC----------C-CCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6905 274 YKTTH----M-----SAAGTYAWMAPEVIKTS----------I-FSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYG 332 (527)
Q Consensus 274 ~~~~~----~-----~~~gt~~y~aPE~l~~~----------~-~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~ 332 (527)
+-... + +...-.+|.|||.+... . .+++.||||+||++.||++ |++||.-....+.
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aY--- 247 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAY--- 247 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhH---
Confidence 32111 1 11234679999988541 2 5789999999999999999 9999852111100
Q ss_pred HHhCCc---cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 333 VAVNKL---TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 333 i~~~~~---~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
..++. ...+-.--+..++.|+..|++.||++|.++++.++.-.
T Consensus 248 -r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 248 -RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred -hccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 00000 00000111346899999999999999999999998733
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=185.02 Aligned_cols=138 Identities=22% Similarity=0.214 Sum_probs=108.2
Q ss_pred eeeeccCCceEEEEeeE-cCceEEEEEcCCCCCh--h-----------------------HHHHHHHHHHHHHhCCCCcc
Q psy6905 122 GEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDE--N-----------------------ILENVKQEGKLLWLFDHRNI 175 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~--~-----------------------~~~~~~~e~~~l~~l~hpnI 175 (527)
...||+|+||.||+|.+ +|+.||||+++..... . .......|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999987 5789999998764210 0 01123459999999988887
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCCHHHH-hcCCCCChhHHHHHHHHHHHHHHHH-HhcCCCceeecCCCCCceecCCCCc
Q psy6905 176 VSLIGVCLQSPKLCLVMEYARGGPLNRV-LAGRKIRPDVLVDWAIQIAEGMNYL-HCQAPISLIHRDLKSSNVLLSEPIE 253 (527)
Q Consensus 176 v~~~~~~~~~~~~~iv~Ey~~ggsL~~~-l~~~~~~~~~~~~i~~qi~~~L~yL-H~~g~~~iiHrDlkp~NILl~~~~~ 253 (527)
...+.+.... .+||||||+|+++... +....++...+..++.|++.+|.|| |+.| |+||||||+|||++.
T Consensus 82 ~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~--- 153 (190)
T cd05147 82 PCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD--- 153 (190)
T ss_pred CCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC---
Confidence 5544433222 3899999998877654 5567889999999999999999999 6874 999999999999974
Q ss_pred ccccccceeEEeccCcchhh
Q psy6905 254 NEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 254 ~~~~~~~~vkL~DFGla~~~ 273 (527)
+.++|+|||+|...
T Consensus 154 ------~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 ------GKLYIIDVSQSVEH 167 (190)
T ss_pred ------CcEEEEEccccccC
Confidence 47999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-21 Score=209.38 Aligned_cols=248 Identities=19% Similarity=0.285 Sum_probs=183.6
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC---CCccceEEEEEEeCC
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDENILENVKQEGKLLWLFD---HRNIVSLIGVCLQSP 186 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~~~~~~~~~~ 186 (527)
..++..+.|.|.+.||.|+||.||+|.. +++.||||+.++...++.. --.+++.+|+ -+.|..+..++.-.+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY----I~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY----ICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee----ehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 4677889999999999999999999986 5789999999988765532 2223333443 345666666666666
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.-++|+||.+.|+|.+++. .+.+++..++.++.|++..++.||..+ ||||||||+|+||.....+ +.....++|+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~-~~~~~~l~lI 843 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICA-DSDSKGLYLI 843 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCC-CCcccceEEE
Confidence 7799999999999999998 566888889999999999999999995 9999999999999765432 2335679999
Q ss_pred ccCcchhhh---cc-ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 266 DFGLAREVY---KT-THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 266 DFGla~~~~---~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
|||.+..+. +. .....++|-.+-++|+..|..++..+|.|.|+-+++-|+.|+.- + ..++....
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-----------q-~~~g~~~~ 911 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-----------E-VKNGSSWM 911 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-----------H-hcCCccee
Confidence 999986552 22 33356789999999999999999999999999999999999742 1 12222222
Q ss_pred CCCCcc----H-HHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 342 IPSTCP----Q-LFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 342 ~p~~~~----~-~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
.+..++ . ....++..+|+.|-..=|...+|...|+..
T Consensus 912 ~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 912 VKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred ccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 222222 2 234566666665544446666666555443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-21 Score=177.73 Aligned_cols=138 Identities=21% Similarity=0.205 Sum_probs=109.9
Q ss_pred eeeeccCCceEEEEeeE-cCceEEEEEcCCCCCh-------------------------hHHHHHHHHHHHHHhCCCCcc
Q psy6905 122 GEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDE-------------------------NILENVKQEGKLLWLFDHRNI 175 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~-------------------------~~~~~~~~e~~~l~~l~hpnI 175 (527)
...||+|+||.||+|.+ +|+.||||++...... .....+..|...+..+.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987 4889999998765210 001234578999999999988
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCCHH-HHhcCCCCChhHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCceecCCCCc
Q psy6905 176 VSLIGVCLQSPKLCLVMEYARGGPLN-RVLAGRKIRPDVLVDWAIQIAEGMNYLHC-QAPISLIHRDLKSSNVLLSEPIE 253 (527)
Q Consensus 176 v~~~~~~~~~~~~~iv~Ey~~ggsL~-~~l~~~~~~~~~~~~i~~qi~~~L~yLH~-~g~~~iiHrDlkp~NILl~~~~~ 253 (527)
.....+.... .|+||||++|+++. ..+....++......++.|++.+|.+||. .| |+||||||+|||++ +
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~-- 153 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D-- 153 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C--
Confidence 6555544433 38999999988553 34556678888999999999999999999 74 99999999999998 3
Q ss_pred ccccccceeEEeccCcchhh
Q psy6905 254 NEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 254 ~~~~~~~~vkL~DFGla~~~ 273 (527)
+.++|+|||+++..
T Consensus 154 ------~~~~liDFG~a~~~ 167 (190)
T cd05145 154 ------GKPYIIDVSQAVEL 167 (190)
T ss_pred ------CCEEEEEcccceec
Confidence 58999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=175.77 Aligned_cols=183 Identities=16% Similarity=0.089 Sum_probs=138.1
Q ss_pred eeeeeccCCceEEEEeeEcCceEEEEEcCCCCCh---hHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEEEeccC
Q psy6905 121 FGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDE---NILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLVMEYAR 196 (527)
Q Consensus 121 ~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv~Ey~~ 196 (527)
+...|++|+||+||.+...+..++.+.+...... -+...+.+|+++|++|. |++|++++++ +..|++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 4568999999999988777788887776655331 11235789999999995 5889999886 34699999999
Q ss_pred CCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCC-CCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 197 GGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDL-KSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 197 ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDl-kp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
|.+|...+... ...++.|++.+|.++|++| |||||| ||+|||++.+ +.++|+|||+|.....
T Consensus 82 G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~--------g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 82 GAAMYQRPPRG------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQED--------GSPAVIDFQLAVRGNP 144 (218)
T ss_pred CccHHhhhhhh------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCC--------CCEEEEECCCceecCC
Confidence 99987654321 2457789999999999995 999999 7999999864 6899999999975432
Q ss_pred cccc---------------cCCCccccccccccccC-CCC-cccchHHHHHHHHHHHhCCCCCCCC
Q psy6905 276 TTHM---------------SAAGTYAWMAPEVIKTS-IFS-KASDVWSYGVVLWELLTGEIPYKSI 324 (527)
Q Consensus 276 ~~~~---------------~~~gt~~y~aPE~l~~~-~~~-~ksDvwSlGv~l~elltg~~Pf~~~ 324 (527)
.... -...++.|++|+...-- ..+ ...+.++.|+-+|.++|+..|+-+.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 2210 01256778888754322 233 6788999999999999998887554
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.6e-21 Score=184.85 Aligned_cols=199 Identities=24% Similarity=0.296 Sum_probs=153.1
Q ss_pred CCCccceEEEEEEeC---------------------------CeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHH
Q psy6905 171 DHRNIVSLIGVCLQS---------------------------PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAE 223 (527)
Q Consensus 171 ~hpnIv~~~~~~~~~---------------------------~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~ 223 (527)
.|||||++.++|.++ ..+|+||... .-+|..++-.+..+.-...-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCCCchHHHHHHHHHHHH
Confidence 699999999987532 2489999988 568999998778888888889999999
Q ss_pred HHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc--------cccccCCCcccccccccccc
Q psy6905 224 GMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK--------TTHMSAAGTYAWMAPEVIKT 295 (527)
Q Consensus 224 ~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~--------~~~~~~~gt~~y~aPE~l~~ 295 (527)
|+.|||.+| |.|||+|.+||||.-+.+ ....+.|+|||++-.-.. ......-|.-.-||||+...
T Consensus 353 av~hL~~hg---vAhRDlKSDNiL~ElddD----~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 353 AVTHLHKHG---VAHRDLKSDNILLELDDD----EIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHcc---chhhcccccceEEEecCC----CCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999995 999999999999976521 235789999998743211 12223457888999999864
Q ss_pred CC------CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHH
Q psy6905 296 SI------FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFK 369 (527)
Q Consensus 296 ~~------~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~ 369 (527)
.+ --.++|.|+.|-+.||+++...||.+......-........-.++|+.||+.+++++..+|+.||++|++..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 32 125899999999999999999999873322221111222334578899999999999999999999999977
Q ss_pred HHHHHHhh
Q psy6905 370 TILKALNN 377 (527)
Q Consensus 370 ~ll~~L~~ 377 (527)
-....|+-
T Consensus 506 iAANvl~L 513 (598)
T KOG4158|consen 506 IAANVLNL 513 (598)
T ss_pred HHHhHHHH
Confidence 66555543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=175.00 Aligned_cols=138 Identities=18% Similarity=0.172 Sum_probs=106.6
Q ss_pred eeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-----CCCccceEEEEEEeCC---eEE-EEE
Q psy6905 122 GEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLF-----DHRNIVSLIGVCLQSP---KLC-LVM 192 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~hpnIv~~~~~~~~~~---~~~-iv~ 192 (527)
.+.||+|+||.||....... .+||++...... ..+.+.+|+.+++.+ +||||+++||++.++. .++ +||
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEECCCCcC-eEEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46799999999996222333 368987664322 356789999999999 6799999999998863 434 789
Q ss_pred ec--cCCCCHHHHhcCCCCChhHHHHHHHHHHHHH-HHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 193 EY--ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGM-NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 193 Ey--~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L-~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|| +.+|+|.+++....+++. ..++.|++.++ +|||+++ ||||||||+|||++...++ ...++|+||+.
T Consensus 85 e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~----~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISES----EVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCC----CCcEEEEECCC
Confidence 99 557999999987666666 46678888888 9999995 9999999999999753211 24799999554
Q ss_pred c
Q psy6905 270 A 270 (527)
Q Consensus 270 a 270 (527)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=182.90 Aligned_cols=229 Identities=22% Similarity=0.329 Sum_probs=145.2
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCC----------CccceEEEEEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDH----------RNIVSLIGVCL 183 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h----------pnIv~~~~~~~ 183 (527)
.+..++.||.|+|+.||.+.+. ++.+|+|+..... .....+.+.+|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4566789999999999999985 5899999765433 22335666666544444322 12333333321
Q ss_pred ---------eCC--------eEEEEEeccCCCCHHHHhc----CCCC--C--hhHHHHHHHHHHHHHHHHHhcCCCceee
Q psy6905 184 ---------QSP--------KLCLVMEYARGGPLNRVLA----GRKI--R--PDVLVDWAIQIAEGMNYLHCQAPISLIH 238 (527)
Q Consensus 184 ---------~~~--------~~~iv~Ey~~ggsL~~~l~----~~~~--~--~~~~~~i~~qi~~~L~yLH~~g~~~iiH 238 (527)
... +.+++|.-+ .++|.+++. .... . ....+.+..|+++.+++||+.| +||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 246788877 678887754 1111 1 2223455679999999999996 999
Q ss_pred cCCCCCceecCCCCcccccccceeEEeccCcchhhhccccccCCCcccccccccccc--------CCCCcccchHHHHHH
Q psy6905 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT--------SIFSKASDVWSYGVV 310 (527)
Q Consensus 239 rDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~ksDvwSlGv~ 310 (527)
+||+|+|+|++.+ |.++|+||+........... ...+..|.+||.... -.++.+.|.|+||++
T Consensus 169 gdi~~~nfll~~~--------G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 169 GDIKPENFLLDQD--------GGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp ST-SGGGEEE-TT--------S-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred cccceeeEEEcCC--------CCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 9999999999986 89999999987665443332 345678999998743 247889999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCC
Q psy6905 311 LWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMR 365 (527)
Q Consensus 311 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~R 365 (527)
+|.|.+|..||........... .+. ... ..|+.++.||..+|..||.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~----~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW----DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG----GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc----cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999986543222110 111 222 678999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.4e-19 Score=166.76 Aligned_cols=135 Identities=24% Similarity=0.368 Sum_probs=113.3
Q ss_pred eeeccCCceEEEEeeEcCceEEEEEcCCCCC--hh-----HHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 123 EAIGEGGFGKVYKGIYEKQEVAIKVAHPNPD--EN-----ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~--~~-----~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
+.||+|++|.||+|.+.+..|++|+...... .. ....+.+|+.++..+.|++|.....++.+....+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999888999998664321 11 1345778999999999999988887777777889999999
Q ss_pred CCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 196 RGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 196 ~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
+|++|.+++..... ....++.+++.+|.+||..| ++|||++|.|||++. +.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~~---------~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGM---EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILSG---------GKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEEC---------CCEEEEECCcccC
Confidence 99999999864322 77889999999999999995 999999999999983 5799999998753
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-19 Score=194.43 Aligned_cols=201 Identities=27% Similarity=0.444 Sum_probs=151.2
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|..++.|-.|+||.||.+.++ .+.+|+|+-+++ ..++. ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~---lilRn------ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN---LILRN------ILTFAGNPFVV------------------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc---hhhhc------cccccCCccee------------------
Confidence 45667788999999999999876 678998654332 11111 22222333333
Q ss_pred cCCCCHHHHhcC-CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLAG-RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~~-~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|+-...+++ +.++... +.+++|||+-| |+|||+||+|.||..- |.+|++|||+++..
T Consensus 136 ---gDc~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~m--------GhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSM--------GHIKLTDFGLSKKG 193 (1205)
T ss_pred ---chhhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeec--------ccccccchhhhhhh
Confidence 555555553 3343332 77899999995 9999999999999974 79999999998754
Q ss_pred hcc-----------------ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6905 274 YKT-----------------THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN 336 (527)
Q Consensus 274 ~~~-----------------~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~ 336 (527)
... .....+||+.|.|||++....|...+|+|++|+++||.+.|..||.+.+..+....+...
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd 273 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 273 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence 210 112347999999999999999999999999999999999999999999988888776654
Q ss_pred CccC-CCCCCccHHHHHHHHHhhhhCCCCCC
Q psy6905 337 KLTL-PIPSTCPQLFKTLMEACWEADSHMRP 366 (527)
Q Consensus 337 ~~~~-~~p~~~~~~~~~li~~~l~~dp~~RP 366 (527)
.... +-...++++.++++.++|..+|..|-
T Consensus 274 ~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 274 DIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 3332 23355788999999999999999995
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=163.12 Aligned_cols=131 Identities=24% Similarity=0.375 Sum_probs=107.2
Q ss_pred eeccCCceEEEEeeEcCceEEEEEcCCCC--Ch-----hHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccC
Q psy6905 124 AIGEGGFGKVYKGIYEKQEVAIKVAHPNP--DE-----NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYAR 196 (527)
Q Consensus 124 ~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~--~~-----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ 196 (527)
.||+|+||.||+|.+.+..|++|...... .. .....+.+|+.++..+.|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 48999999999999999999999865432 11 113567789999999998877665556666667799999999
Q ss_pred CCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 197 GGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 197 ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|++|.+++..... .++.+++.+|.+||+.| ++|||++|.|||++. +.++++|||++..
T Consensus 81 g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~~---------~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVRD---------DKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEEC---------CcEEEEECCCCcC
Confidence 9999988763321 78899999999999995 999999999999983 5899999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=167.46 Aligned_cols=141 Identities=22% Similarity=0.234 Sum_probs=109.0
Q ss_pred ceeeeeeeccCCceEEEEee-E--cCceEEEEEcCCCCCh-----------------------hHHHHHHHHHHHHHhCC
Q psy6905 118 KLIFGEAIGEGGFGKVYKGI-Y--EKQEVAIKVAHPNPDE-----------------------NILENVKQEGKLLWLFD 171 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~-~--~~~~vaiK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~ 171 (527)
-|.+.+.||+|+||.||+|. + +|+.||||++...... .....+..|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 3 5789999988754210 01233568999999997
Q ss_pred CCc--cceEEEEEEeCCeEEEEEeccCCCCHHHHh-cCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceec
Q psy6905 172 HRN--IVSLIGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLL 248 (527)
Q Consensus 172 hpn--Iv~~~~~~~~~~~~~iv~Ey~~ggsL~~~l-~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl 248 (527)
+.+ +.++++. . ..++||||+.|++|.... .+..+....+..++.||+.+|.+||.+| .++||||||+|||+
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEE
Confidence 533 4444443 2 348999999998886654 4455666677899999999999999994 39999999999999
Q ss_pred CCCCcccccccceeEEeccCcchhh
Q psy6905 249 SEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 249 ~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
+ + +.++|+|||++...
T Consensus 183 ~-~--------~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-D--------GKVVIIDVSQSVEL 198 (237)
T ss_pred E-C--------CCEEEEEChhhhcc
Confidence 8 3 57999999998643
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.3e-18 Score=181.61 Aligned_cols=134 Identities=26% Similarity=0.364 Sum_probs=110.6
Q ss_pred eeeeeeccCCceEEEEeeEcCceEEEEEcCCC--CC-----hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 120 IFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPN--PD-----ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 120 ~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~--~~-----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
...+.||+|+||.||+|.+.+..+++|..... .. ......+.+|+.++..++|++|+..+.++.+....++||
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 45789999999999999987766666543221 11 112356889999999999999998888887777789999
Q ss_pred eccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 193 EYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 193 Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||++|++|.+++. ....++.+++.+|.|||+.| ++||||||+|||++. +.++|+|||+++.
T Consensus 416 E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl~~---------~~~~liDFGla~~ 476 (535)
T PRK09605 416 EYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIVRD---------DRLYLIDFGLGKY 476 (535)
T ss_pred EecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEEEC---------CcEEEEeCccccc
Confidence 9999999998875 35678999999999999995 999999999999943 5899999999864
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-18 Score=175.95 Aligned_cols=166 Identities=30% Similarity=0.438 Sum_probs=126.4
Q ss_pred CeEEEEEeccCCCCHHHHhcCC----CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 186 PKLCLVMEYARGGPLNRVLAGR----KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~~~----~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
.++||.|++|..++|.++|.++ ..+...++.|+.|++.|++| + +.+|+|+||.||+...+ ..
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d--------~q 394 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDD--------DQ 394 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccc--------hh
Confidence 3589999999999999999743 35667889999999999999 5 49999999999999875 58
Q ss_pred eEEeccCcchhhhccc--------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6905 262 LKITDFGLAREVYKTT--------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYG 332 (527)
Q Consensus 262 vkL~DFGla~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~ 332 (527)
+||+|||+........ +....||..||+||.+.+..|+.++||||||++|+|+++ -..+|........
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d--- 471 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTD--- 471 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhh---
Confidence 9999999987764433 234579999999999999999999999999999999998 4444432211111
Q ss_pred HHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHH
Q psy6905 333 VAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFK 369 (527)
Q Consensus 333 i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~ 369 (527)
+..+.+....-...|. -+.|+.+++...|.+||++.
T Consensus 472 ~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 472 IRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHH
Confidence 1111111112233443 36899999999999999443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.9e-17 Score=154.38 Aligned_cols=135 Identities=22% Similarity=0.216 Sum_probs=105.2
Q ss_pred eeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCCCh---------------------hHHHHHHHHHHHHHhCCCCc--
Q psy6905 119 LIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDE---------------------NILENVKQEGKLLWLFDHRN-- 174 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~---------------------~~~~~~~~e~~~l~~l~hpn-- 174 (527)
|.+.+.||+|+||.||++.+ +++.||||++...... ........|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 67788999999999999987 5789999986643200 01123567888888888774
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcc
Q psy6905 175 IVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254 (527)
Q Consensus 175 Iv~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~ 254 (527)
++..++. ...++||||++|++|..+... .....++.+++.++.++|..| ++||||+|+||+++.+
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~--- 161 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD--- 161 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC---
Confidence 4455442 345899999999999776431 345678899999999999984 9999999999999864
Q ss_pred cccccceeEEeccCcchhh
Q psy6905 255 EDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 255 ~~~~~~~vkL~DFGla~~~ 273 (527)
+.++|+|||++...
T Consensus 162 -----~~~~liDfg~~~~~ 175 (198)
T cd05144 162 -----EKIYIIDWPQMVST 175 (198)
T ss_pred -----CcEEEEECCccccC
Confidence 68999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.1e-16 Score=148.85 Aligned_cols=135 Identities=16% Similarity=0.139 Sum_probs=105.3
Q ss_pred eeec-cCCceEEEEeeEcCceEEEEEcCCCC------------ChhHHHHHHHHHHHHHhCCCCcc--ceEEEEEEeCCe
Q psy6905 123 EAIG-EGGFGKVYKGIYEKQEVAIKVAHPNP------------DENILENVKQEGKLLWLFDHRNI--VSLIGVCLQSPK 187 (527)
Q Consensus 123 ~~iG-~G~fg~Vy~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~l~~l~hpnI--v~~~~~~~~~~~ 187 (527)
..|| .||.|+||.+...+..++||.+.... .......+.+|+.++..|.|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 3587 89999999988888899999775321 01123567889999999998885 677776543222
Q ss_pred ----EEEEEeccCC-CCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 188 ----LCLVMEYARG-GPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 188 ----~~iv~Ey~~g-gsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
.++||||++| .+|.+++....++... +.+|+.+|.+||..| |+||||||+|||++.+ +.+
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~--------~~v 181 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAG---VYHADLNAHNILLDPD--------GKF 181 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCC---CCCCCCCchhEEEcCC--------CCE
Confidence 3599999997 6999998766666543 568999999999995 9999999999999864 579
Q ss_pred EEeccCcchh
Q psy6905 263 KITDFGLARE 272 (527)
Q Consensus 263 kL~DFGla~~ 272 (527)
+|+|||.+..
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999998864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.8e-16 Score=136.82 Aligned_cols=135 Identities=23% Similarity=0.250 Sum_probs=112.8
Q ss_pred eeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCC--CccceEEEEEEeCCeEEEEEeccCCC
Q psy6905 121 FGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH--RNIVSLIGVCLQSPKLCLVMEYARGG 198 (527)
Q Consensus 121 ~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~~~~~~~~~~~~~iv~Ey~~gg 198 (527)
+.+.||.|.++.||++...+..+++|....... ...+..|+.++..+.| .++++++++....+..+++|||+.|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 356799999999999999888999999876533 4567889999999976 58999999888878899999999988
Q ss_pred CHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 199 PLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 199 sL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
.+..+ +......++.+++.+|.+||......++|+||+|+|||++.. +.++++|||+++.
T Consensus 79 ~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~--------~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG--------KILGIIDWEYAGY 138 (155)
T ss_pred ecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC--------cEEEEEecccccC
Confidence 77654 455667788999999999998532249999999999999863 5899999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.3e-18 Score=181.07 Aligned_cols=248 Identities=25% Similarity=0.343 Sum_probs=194.2
Q ss_pred CCceeeeeeeccCCceEEEEeeEc---CceEEEEEcCCC-CChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE---KQEVAIKVAHPN-PDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~---~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~i 190 (527)
...|.+.+.||+|+|+.|-..... ...+|+|.+... ...........|..+-..+. |+|++.+++...+....++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 456777888999999999877653 245677766554 24445566667888877886 9999999999999999999
Q ss_pred EEeccCCCCHHHHh-c-CC-CCChhHHHHHHHHHHHHHHHHH-hcCCCceeecCCCCCceecCCCCcccccccc-eeEEe
Q psy6905 191 VMEYARGGPLNRVL-A-GR-KIRPDVLVDWAIQIAEGMNYLH-CQAPISLIHRDLKSSNVLLSEPIENEDLQFK-TLKIT 265 (527)
Q Consensus 191 v~Ey~~ggsL~~~l-~-~~-~~~~~~~~~i~~qi~~~L~yLH-~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~-~vkL~ 265 (527)
+++|..||++.+.+ . .. ..+....-.++.|+..++.|+| ..+ +.|+||||+|.+++.+ + .++++
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s--------~~~l~~~ 167 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDES--------GSALKIA 167 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccC--------CCcccCC
Confidence 99999999998888 4 22 5677788899999999999999 774 9999999999999986 4 79999
Q ss_pred ccCcchhhhc-ccc----ccCCC-ccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhC-
Q psy6905 266 DFGLAREVYK-TTH----MSAAG-TYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVA-YGVAVN- 336 (527)
Q Consensus 266 DFGla~~~~~-~~~----~~~~g-t~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~-~~i~~~- 336 (527)
|||+|..+.. ... ...+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||......... ......
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~ 247 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK 247 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc
Confidence 9999987644 221 23468 9999999999884 5578999999999999999999999764433221 111111
Q ss_pred -CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 -KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 -~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..........+....+++..++..+|..|.+..++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 248 GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 11234456677888999999999999999998887653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.8e-16 Score=143.97 Aligned_cols=135 Identities=24% Similarity=0.266 Sum_probs=95.4
Q ss_pred eeeeccCCceEEEEeeEc-CceEEEEEcCCCCCh--hHHH---------------------HHHHHHHHHHhCCCCc--c
Q psy6905 122 GEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDE--NILE---------------------NVKQEGKLLWLFDHRN--I 175 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~--~~~~---------------------~~~~e~~~l~~l~hpn--I 175 (527)
.+.||+|+||.||+|.+. ++.||||++...... .... ....|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 567999999999999875 789999987754211 0011 1134555565554433 4
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCCHHH-HhcCCCCChhHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCceecCCCCc
Q psy6905 176 VSLIGVCLQSPKLCLVMEYARGGPLNR-VLAGRKIRPDVLVDWAIQIAEGMNYLHC-QAPISLIHRDLKSSNVLLSEPIE 253 (527)
Q Consensus 176 v~~~~~~~~~~~~~iv~Ey~~ggsL~~-~l~~~~~~~~~~~~i~~qi~~~L~yLH~-~g~~~iiHrDlkp~NILl~~~~~ 253 (527)
.+.+++ ...++||||++|+.+.. .+...... .....++.+++.++.++|. . +|+||||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~-- 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D-- 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C--
Confidence 455543 23599999999854321 12111111 6678899999999999999 7 599999999999998 3
Q ss_pred ccccccceeEEeccCcchhh
Q psy6905 254 NEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 254 ~~~~~~~~vkL~DFGla~~~ 273 (527)
+.++|+|||.+...
T Consensus 151 ------~~~~liDfg~a~~~ 164 (187)
T cd05119 151 ------GKVYIIDVPQAVEI 164 (187)
T ss_pred ------CcEEEEECcccccc
Confidence 58999999999755
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.9e-14 Score=147.04 Aligned_cols=140 Identities=20% Similarity=0.282 Sum_probs=94.4
Q ss_pred eeeccCCceEEEEeeE-cCceEEEEEcCCCCChhHHH---------------------------------------HHHH
Q psy6905 123 EAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDENILE---------------------------------------NVKQ 162 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~~~~~---------------------------------------~~~~ 162 (527)
+.||+|++|.||+|+. +|+.||||+.++........ ++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999997 67899999987753211100 1334
Q ss_pred HHHHHHhC----CCCccceEEEEEE-eCCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHH-HHHHHHhcCCCce
Q psy6905 163 EGKLLWLF----DHRNIVSLIGVCL-QSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAE-GMNYLHCQAPISL 236 (527)
Q Consensus 163 e~~~l~~l----~hpnIv~~~~~~~-~~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~-~L~yLH~~g~~~i 236 (527)
|+..+..+ .|.+-+.+-.++. .....++||||++|++|.++........ ....++.+++. .+..+|..| +
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g---~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDG---F 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCC---c
Confidence 44444443 2332233222222 2334699999999999988764211111 23445555555 467889885 9
Q ss_pred eecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 237 iHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
+|+|++|.||+++.+ +.++|+|||++..+.
T Consensus 279 ~H~D~hPgNilv~~~--------g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKD--------GKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCC--------CcEEEEeCCCeeECC
Confidence 999999999999875 689999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.2e-12 Score=139.00 Aligned_cols=144 Identities=16% Similarity=0.237 Sum_probs=92.1
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh---------------------------------hHHHH-
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE---------------------------------NILEN- 159 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~---------------------------------~~~~~- 159 (527)
+.+|.. +.||+|++|.||+|... |+.||||+.++.... +..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 556666 78999999999999973 789999999865311 11122
Q ss_pred -----HHHHHHHHHhC----CCCccceEEEEEEe-CCeEEEEEeccCCCCHHHH--hcCCCC-----ChhHHHHHHHHHH
Q psy6905 160 -----VKQEGKLLWLF----DHRNIVSLIGVCLQ-SPKLCLVMEYARGGPLNRV--LAGRKI-----RPDVLVDWAIQIA 222 (527)
Q Consensus 160 -----~~~e~~~l~~l----~hpnIv~~~~~~~~-~~~~~iv~Ey~~ggsL~~~--l~~~~~-----~~~~~~~i~~qi~ 222 (527)
+.+|+..+.++ .+.+.+.+-.++.+ ....+||||||.|+.+.++ +..... .+..+..++.||+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 22333333333 24433443333332 3445899999999999875 333222 2333333444443
Q ss_pred HHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 223 ~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
.. +++|+|+||+||+++.+.. ..+.++++|||++..+.
T Consensus 278 -------~~---GffHaDpHPGNIlv~~~g~----~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RD---GFFHADMHPGNIFVSYDPP----ENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hC---CeeeCCCChHHeEEecCCC----CCCeEEEEecceEEECC
Confidence 45 4999999999999987521 12489999999987663
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.46 E-value=4e-14 Score=146.64 Aligned_cols=242 Identities=18% Similarity=0.223 Sum_probs=177.4
Q ss_pred Cceeeeeeecc--CCceEEEEeeE----cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeE
Q psy6905 117 NKLIFGEAIGE--GGFGKVYKGIY----EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 117 ~~~~~~~~iG~--G~fg~Vy~~~~----~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~ 188 (527)
..+.+.+.+|. |++|.||.+.. .+..+|+|.-+.... ......-++|+.-.+.+ .|+|.++.+..+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 44556678999 99999999876 346789886433211 11122234566666666 599999999999999999
Q ss_pred EEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHH----HHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 189 CLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAE----GMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~----~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
|+-+|+| +.+|..+.. ...++...+...+.+... ||.++|+. +++|-|+||+||++..++ ..+
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~-------~s~ 262 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDW-------TSC 262 (524)
T ss_pred eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccc-------cee
Confidence 9999999 577877765 344788888889999888 99999999 599999999999998863 578
Q ss_pred EEeccCcchhhhcccc-------ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC--CHHHHHHHH
Q psy6905 263 KITDFGLAREVYKTTH-------MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI--NAYAVAYGV 333 (527)
Q Consensus 263 kL~DFGla~~~~~~~~-------~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~--~~~~~~~~i 333 (527)
+++|||+...+..... ....|...|++||.+++ .++..+|+|+||.++.+..+|..++... +.....
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--- 338 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--- 338 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---
Confidence 9999999987754321 12257889999999876 4688999999999999999876655332 111111
Q ss_pred HhCCc-cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 334 AVNKL-TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 334 ~~~~~-~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.+ ....-...+..+...+..|+..+|..|+++..+..+
T Consensus 339 -r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 339 -RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred -ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1111 111112335556678999999999999999888763
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.1e-14 Score=145.31 Aligned_cols=244 Identities=18% Similarity=0.167 Sum_probs=175.1
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc---CceEEEEEcCCCCChhHH-HHHHHHHHHHHhC-CCCccceEEEEEEeCCeEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE---KQEVAIKVAHPNPDENIL-ENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~---~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~ 189 (527)
...++.++..||.|.|+.|+.+..+ +..|++|..........- ..-..|+.+...+ .|.+++.++..|......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457788999999999999987643 578999876554321111 1112344444333 6999999999999988999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|-.|||+++++...+. ...+.+...+.+..|++.++.++|+. .++|+|+||.||++..++ ...++.|||
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~-------~~~~~~~~~ 412 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDG-------FFSKLGDFG 412 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccch-------hhhhccccc
Confidence 9999999998866553 44577888899999999999999998 599999999999998752 477999999
Q ss_pred cchhhhccccccCCCcccc-ccccccccCCCCcccchHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 269 LAREVYKTTHMSAAGTYAW-MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP-YKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 269 la~~~~~~~~~~~~gt~~y-~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~P-f~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
....+.........++..| .++.......+..+.|++|||..+.+..+|..- ..+.....+ ..+ ..+.....
T Consensus 413 ~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i-----~~~-~~p~~~~~ 486 (524)
T KOG0601|consen 413 CWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI-----RSG-DTPNLPGL 486 (524)
T ss_pred cccccceecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceee-----ecc-cccCCCch
Confidence 9875322111112233334 355555566688999999999999999997643 322221111 112 23444444
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.++..+.+.+...++..||.+.++..+
T Consensus 487 ~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 487 KLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred HHhhhhhhhhhcCCccccchhhhhhccc
Confidence 5888999999999999999999888764
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.9e-12 Score=131.87 Aligned_cols=163 Identities=23% Similarity=0.302 Sum_probs=122.8
Q ss_pred cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHH
Q psy6905 139 EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWA 218 (527)
Q Consensus 139 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~ 218 (527)
.+.+|.|........ .......+-+..|+.++||||++|++.+..++.+|||+|.+ -.|..+++. +....+..-+
T Consensus 36 ~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~--l~~~~v~~Gl 110 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE--LGKEEVCLGL 110 (690)
T ss_pred cCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH--hHHHHHHHHH
Confidence 355677776665544 33455677888999999999999999999999999999998 456677652 2355666678
Q ss_pred HHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcccc--ccCCCccccccccccccC
Q psy6905 219 IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH--MSAAGTYAWMAPEVIKTS 296 (527)
Q Consensus 219 ~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~--~~~~gt~~y~aPE~l~~~ 296 (527)
.||+.||.|||+.+ +++|++|.-+.|+|+.. |..||++|-++........ ....--..|..|+.+...
T Consensus 111 ~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~--------GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 111 FQILAALSFLNDDC--NLVHGNVCKDSVFVNES--------GEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHhccC--CeeeccEeeeeEEEcCC--------CcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence 89999999999887 79999999999999986 7999999988865433221 011112335666655333
Q ss_pred CCCcccchHHHHHHHHHHHhCC
Q psy6905 297 IFSKASDVWSYGVVLWELLTGE 318 (527)
Q Consensus 297 ~~~~ksDvwSlGv~l~elltg~ 318 (527)
. -..|.|-|||++++++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 2 3469999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.5e-13 Score=120.80 Aligned_cols=130 Identities=20% Similarity=0.183 Sum_probs=96.8
Q ss_pred eeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCcc-ceEEEEEEeCCeEEEEEeccCCCCH
Q psy6905 122 GEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNI-VSLIGVCLQSPKLCLVMEYARGGPL 200 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~~~~~~~~~~~~~iv~Ey~~ggsL 200 (527)
.+.|+.|.++.||++...+..|++|+....... ...+..|+.++..+.+.++ .+++.+.. ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 357899999999999988889999997665321 2345688888888865554 45555433 234899999999887
Q ss_pred HHHhcCCCCChhHHHHHHHHHHHHHHHHHhcC--CCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 201 NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA--PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 201 ~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g--~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
... .. ....++.+++.+|..||..+ +..++|+|++|.||+++. +.++++|||.+.
T Consensus 79 ~~~----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~---------~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD---------GRLWLIDWEYAG 135 (170)
T ss_pred ccc----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC---------CeEEEEeccccc
Confidence 543 11 11345678999999999885 123699999999999984 478999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF14604 SH3_9: Variant SH3 domain; PDB: 2CRE_A 2E5K_A 2CT3_A 2DE0_X 2D8H_A 2DA9_A 2X3X_E 2X3W_D 2KRN_A 2ED0_A | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-13 Score=97.16 Aligned_cols=49 Identities=53% Similarity=1.068 Sum_probs=43.6
Q ss_pred EcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccc
Q psy6905 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94 (527)
Q Consensus 37 alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~ 94 (527)
|+|||.++.++||+|++||+|.|+.+. +++||.|++. ++.|+||+|||+
T Consensus 1 Al~~y~~~~~dELs~~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yV~ 49 (49)
T PF14604_consen 1 ALYDYEAQDPDELSFKKGDVITVLEKS-----DDGWWYGRNT----GRTGLFPANYVE 49 (49)
T ss_dssp ESSCBCSSSTTB-EB-TTEEEEEEEES-----STSEEEEEET----TEEEEEEGGGEE
T ss_pred CCccCCCCCcCEeeEcCCCEEEEEEeC-----CCCEEEEEEC----CEEEEECHHhCC
Confidence 799999999999999999999999874 7899999984 899999999985
|
... |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=4e-13 Score=128.92 Aligned_cols=197 Identities=22% Similarity=0.344 Sum_probs=140.0
Q ss_pred HHHHHhCCCCccceEEEEEEeC-----CeEEEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCC
Q psy6905 164 GKLLWLFDHRNIVSLIGVCLQS-----PKLCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAP 233 (527)
Q Consensus 164 ~~~l~~l~hpnIv~~~~~~~~~-----~~~~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~ 233 (527)
..-+-++.|.|||+++.||.+. ....+++||+..|+|..+|+ ...+......+|+-||+.||.|||+..|
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 3445566899999999998654 45789999999999999987 3457788889999999999999999876
Q ss_pred CceeecCCCCCceecCCCCcccccccceeEEeccCcchh---h---hccccccCCCccccccccccccCCCCcccchHHH
Q psy6905 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE---V---YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSY 307 (527)
Q Consensus 234 ~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~---~---~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSl 307 (527)
.|+|+++..+-|++..+ +-+|++--.-... + .........+-++|.|||.=.....+..+|||+|
T Consensus 198 -piihgnlTc~tifiq~n--------gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f 268 (458)
T KOG1266|consen 198 -PIIHGNLTCDTIFIQHN--------GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF 268 (458)
T ss_pred -ccccCCcchhheeecCC--------ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence 79999999999999875 5666542111100 0 0011112246789999998666666789999999
Q ss_pred HHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 308 GVVLWELLTGEIP-YKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 308 Gv~l~elltg~~P-f~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
|.+..+|..|..- -.+.+...+...+...-..+ -...-+.++..|+...|..||++.+++.|
T Consensus 269 gmcAlemailEiq~tnseS~~~~ee~ia~~i~~l-----en~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 269 GMCALEMAILEIQSTNSESKVEVEENIANVIIGL-----ENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred hHHHHHHHHheeccCCCcceeehhhhhhhheeec-----cCccccCcCcccccCCCCCCcchhhhhcC
Confidence 9999999987653 33333222222222111111 11223568899999999999999998865
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.1e-11 Score=114.74 Aligned_cols=136 Identities=21% Similarity=0.189 Sum_probs=99.4
Q ss_pred eeeeccCCceEEEEeeEc--------CceEEEEEcCCCC------------C---------hhHHHHHH----HHHHHHH
Q psy6905 122 GEAIGEGGFGKVYKGIYE--------KQEVAIKVAHPNP------------D---------ENILENVK----QEGKLLW 168 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~--------~~~vaiK~~~~~~------------~---------~~~~~~~~----~e~~~l~ 168 (527)
...||.|-=+.||.|... +..+|||+.+... + .+....+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357999999999999753 3689999765321 0 01122333 8999999
Q ss_pred hCCC--CccceEEEEEEeCCeEEEEEeccCCCCH-HHHhcCCCCChhHHHHHHHHHHHHHHHH-HhcCCCceeecCCCCC
Q psy6905 169 LFDH--RNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYL-HCQAPISLIHRDLKSS 244 (527)
Q Consensus 169 ~l~h--pnIv~~~~~~~~~~~~~iv~Ey~~ggsL-~~~l~~~~~~~~~~~~i~~qi~~~L~yL-H~~g~~~iiHrDlkp~ 244 (527)
++.. -++...+++ ..-+|||||+.++.+ ...++...++...+..+..+++.+|..| |.. ++|||||++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 8853 466677765 345899999976544 2234444556666778889999999999 777 4999999999
Q ss_pred ceecCCCCcccccccceeEEeccCcchhh
Q psy6905 245 NVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 245 NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|||+.. +.++|+|||.+...
T Consensus 155 NIL~~~---------~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWHD---------GKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEEC---------CcEEEEECCCceeC
Confidence 999975 47999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.9e-11 Score=108.37 Aligned_cols=132 Identities=24% Similarity=0.315 Sum_probs=102.6
Q ss_pred eeeccCCceEEEEeeEcCceEEEEEcCCCC------Chh-HHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 123 EAIGEGGFGKVYKGIYEKQEVAIKVAHPNP------DEN-ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~------~~~-~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
..|++|+-+.+|.+.+.+..+++|.-.+.. ++. ....-.+|+.++..+.--.|.-.+=+..+.+...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 358899999999998888778888543321 121 1345678999999987666665555666777779999999
Q ss_pred CCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 196 RGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 196 ~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
+|-.|.+++... ...++..|-.-+.-||..| |||+||.++||++... .+.++||||+..
T Consensus 82 ~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~---------~i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG---------RIYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCC---------cEEEEECCcccc
Confidence 999999888744 2456677777788899995 9999999999999873 699999999863
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.8e-12 Score=140.99 Aligned_cols=246 Identities=21% Similarity=0.266 Sum_probs=181.3
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC--hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD--ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
....+.+.+.+-+-+|.|+.++.+.-. +...++|+...... ....+....+-.++-...+|-++...-.+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 355677788889999999999987643 33344444332210 01122233333344334567777666556667789
Q ss_pred EEEEeccCCCCHHHHhcCCC-CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~~~-~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+++++|..|++|...+.+-. .+.+-....+..+..+++|||+. .++|+|++|.|+|+..+ +..+++||
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~--------gh~~l~~~ 948 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYD--------GHRPLTDF 948 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhccc--------CCcccCcc
Confidence 99999999999988887433 55556666777888999999987 58999999999999886 68899999
Q ss_pred Ccchhhhc---------------------------------cccccCCCccccccccccccCCCCcccchHHHHHHHHHH
Q psy6905 268 GLAREVYK---------------------------------TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314 (527)
Q Consensus 268 Gla~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~el 314 (527)
|....... .......||+.|.+||.+.+......+|+|++|++++|.
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEV 1028 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhh
Confidence 84322100 001123589999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCccCC-CCCCccHHHHHHHHHhhhhCCCCCCCHH
Q psy6905 315 LTGEIPYKSINAYAVAYGVAVNKLTLP-IPSTCPQLFKTLMEACWEADSHMRPSFK 369 (527)
Q Consensus 315 ltg~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~~~~~~~li~~~l~~dp~~RPs~~ 369 (527)
++|.+||.......+...+.......+ -|...+....+++...+..+|.+|-.+.
T Consensus 1029 l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1029 LTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999999988888877765544433 2456788899999999999999998765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.4e-11 Score=113.28 Aligned_cols=144 Identities=19% Similarity=0.244 Sum_probs=109.1
Q ss_pred eeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCC--ccceEEEEEEeC---CeEEEEEeccC
Q psy6905 123 EAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHR--NIVSLIGVCLQS---PKLCLVMEYAR 196 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~~~~~~~~~---~~~~iv~Ey~~ 196 (527)
+.||.|.++.||++...+ ..+++|+............+..|+.++..+.+. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999998765 789999987653222345678899999998763 457778776654 25689999999
Q ss_pred CCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q psy6905 197 GGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA-------------------------------------------- 232 (527)
Q Consensus 197 ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g-------------------------------------------- 232 (527)
|+++...+....+++.....++.+++.+|.+||+..
T Consensus 84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (223)
T cd05154 84 GRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW 163 (223)
T ss_pred CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence 998877654345677777888888888888888421
Q ss_pred ---------CCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 233 ---------PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 233 ---------~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
+..++|+|++|.|||++.+. .+.+.|+||+.+..
T Consensus 164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~------~~~~~iID~e~~~~ 206 (223)
T cd05154 164 LEAHLPADSRPGLVHGDYRLGNVLFHPDE------PRVVAVLDWELATL 206 (223)
T ss_pred HHhhCCCCCCcEEEECCCCcccEEEcCCC------CcEEEEEecccccc
Confidence 23579999999999998730 14689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.1e-10 Score=104.15 Aligned_cols=143 Identities=25% Similarity=0.299 Sum_probs=108.2
Q ss_pred eeeeeccCCceEEEEeeEcCceEEEEEcCCCC------Ch-hHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 121 FGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP------DE-NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 121 ~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~------~~-~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
....|-+|+-+.|+++.+.|+.+.||.-.... +. -......+|+++|.++.--.|.-..=++.+...-+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 45678899999999999999998998543321 11 124567889999998876666655556666666799999
Q ss_pred ccCCC-CHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 194 YARGG-PLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 194 y~~gg-sL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|++|- ++.+++. ...........++.+|-+.+.-||.+ .|||+||..+||++..+.+. ..+.|+|||+
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~-----~~~~lIdfgl 162 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQ-----ITPILIDFGL 162 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCc-----CceEEEeecc
Confidence 99773 6777765 22333344478899999999999999 49999999999999876422 3459999999
Q ss_pred ch
Q psy6905 270 AR 271 (527)
Q Consensus 270 a~ 271 (527)
+.
T Consensus 163 s~ 164 (229)
T KOG3087|consen 163 SS 164 (229)
T ss_pred hh
Confidence 74
|
|
| >KOG2199|consensus | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.1e-12 Score=124.48 Aligned_cols=58 Identities=41% Similarity=0.792 Sum_probs=52.5
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.....|+|||||++.+++||+|++||+|+|++. .+.+||.|.+. +..|+||+|||+..
T Consensus 213 ~~~rkVRALYDFeAaE~nELsFkaGdIItVLd~-----s~~~WWKG~~~----~~~GlFPsnfVT~~ 270 (462)
T KOG2199|consen 213 TVVRKVRALYDFEAAEDNELSFKAGDIITVLDD-----SDPNWWKGENH----RGIGLFPSNFVTAD 270 (462)
T ss_pred ccchhhhhhhcccccCCCccceecCcEEEEccc-----CCcchhccccC----Ccccccchhhhhhh
Confidence 444679999999999999999999999999997 48999999987 67999999999974
|
|
| >PF00018 SH3_1: SH3 domain; InterPro: IPR001452 SH3 (src Homology-3) domains are small protein modules containing approximately 50 amino acid residues [, ] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4e-11 Score=84.94 Aligned_cols=48 Identities=54% Similarity=0.934 Sum_probs=42.6
Q ss_pred EEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceeccccc
Q psy6905 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPA 90 (527)
Q Consensus 36 ~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~ 90 (527)
+|+|||+++.++||+|++||.|.|+++. +.+||.++...+ ++.|+||+
T Consensus 1 ~Alydf~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~~~~~~~--~~~G~vP~ 48 (48)
T PF00018_consen 1 RALYDFDAEDPDELSFKKGDIIEVLEKS-----DDGWWKVRNEST--GKEGWVPS 48 (48)
T ss_dssp EESSCBETSSTTBSEB-TTEEEEEEEES-----SSSEEEEEETTT--TEEEEEEG
T ss_pred CCCeeeCCCCCCEEeEECCCEEEEEEec-----CCCEEEEEECCC--CcEEEeeC
Confidence 6999999999999999999999999985 679999998754 68999995
|
They are found in a great variety of intracellular or membrane-associated proteins [, , ] for example, in a variety of proteins with enzymatic activity, in adaptor proteins that lack catalytic sequences and in cytoskeletal proteins, such as fodrin and yeast actin binding protein ABP-1. The SH3 domain has a characteristic fold which consists of five or six beta-strands arranged as two tightly packed anti-parallel beta sheets. The linker regions may contain short helices []. The surface of the SH3-domain bears a flat, hydrophobic ligand-binding pocket which consists of three shallow grooves defined by conservative aromatic residues in which the ligand adopts an extended left-handed helical arrangement. The ligand binds with low affinity but this may be enhanced by multiple interactions. The region bound by the SH3 domain is in all cases proline-rich and contains PXXP as a core-conserved binding motif. The function of the SH3 domain is not well understood but they may mediate many diverse processes such as increasing local concentration of proteins, altering their subcellular location and mediating the assembly of large multiprotein complexes []. The crystal structure of the SH3 domain of the cytoskeletal protein spectrin, and the solution structures of SH3 domains of phospholipase C (PLC-y) and phosphatidylinositol 3-kinase p85 alpha-subunit, have been determined [, , ]. In spite of relatively limited sequence similarity, their overall structures are similar. The domains belong to the alpha+beta structural class, with 5 to 8 beta-strands forming 2 tightly-packed, anti-parallel beta-sheets arranged in a barrel-like structure, and intervening loops sometimes forming helices. Conserved aliphatic and aromatic residues form a hydrophobic core (A11, L23, A29, V34, W42, L52 and V59 in PLC-y []) and a hydrophobic pocket on the molecular surface (L12, F13, W53 and P55 in PLC-y). The conserved core is believed to stabilise the fold, while the pocket is thought to serve as a binding site for target proteins. Conserved carboxylic amino acids located in the loops, on the periphery of the pocket (D14 and E22), may be involved in protein-protein interactions via proline-rich regions. The N- and C-termini are packed in close proximity, indicating that they are independent structural modules.; GO: 0005515 protein binding; PDB: 1UHF_A 1W1F_A 1WA7_A 1SEM_A 1KFZ_A 2SEM_B 1K76_A 3SEM_B 1X2Q_A 2J06_B .... |
| >PF07653 SH3_2: Variant SH3 domain; InterPro: IPR011511 SH3 (src Homology-3) domains are small protein modules containing approximately 50 amino acid residues [, ] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.2e-11 Score=86.97 Aligned_cols=53 Identities=47% Similarity=0.962 Sum_probs=46.0
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEe-ecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVL-SKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~-~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
+++|++||.+..+++|+|++||+|.|+ +++ +++||.++.. ++.|+||.+||+.
T Consensus 1 ~~~a~~d~~~~~~~~Ls~~~Gd~i~v~~~~~-----~~~ww~~~~~----g~~G~~P~~~v~~ 54 (55)
T PF07653_consen 1 YYRAIFDYVAEDPDELSFKKGDVIEVLGEKD-----DDGWWLGENN----GRRGWFPSSYVEE 54 (55)
T ss_dssp EEEESSSBESSSTTB-EB-TTEEEEEEEEEC-----STSEEEEEET----TEEEEEEGGGEEE
T ss_pred CEEEeEEECCCCCCceEEecCCEEEEEEeec-----CCCEEEEEEC----CcEEEEcHHHEEE
Confidence 479999999999999999999999999 664 6799999995 7899999999975
|
They are found in a great variety of intracellular or membrane-associated proteins [, , ] for example, in a variety of proteins with enzymatic activity, in adaptor proteins that lack catalytic sequences and in cytoskeletal proteins, such as fodrin and yeast actin binding protein ABP-1. The SH3 domain has a characteristic fold which consists of five or six beta-strands arranged as two tightly packed anti-parallel beta sheets. The linker regions may contain short helices []. The surface of the SH3-domain bears a flat, hydrophobic ligand-binding pocket which consists of three shallow grooves defined by conservative aromatic residues in which the ligand adopts an extended left-handed helical arrangement. The ligand binds with low affinity but this may be enhanced by multiple interactions. The region bound by the SH3 domain is in all cases proline-rich and contains PXXP as a core-conserved binding motif. The function of the SH3 domain is not well understood but they may mediate many diverse processes such as increasing local concentration of proteins, altering their subcellular location and mediating the assembly of large multiprotein complexes []. This entry represents a variant of the SH3 domain.; PDB: 1I1J_B 1K0X_A 1HJD_A 2KEA_A 1KJW_A 1JXM_A 1JXO_B 2EBP_A 2DL3_A 2EYX_A .... |
| >KOG1118|consensus | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.5e-11 Score=112.10 Aligned_cols=77 Identities=26% Similarity=0.462 Sum_probs=61.4
Q ss_pred CcccccccccCCCCCC--CCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceeccccc
Q psy6905 13 QNEVDSDLLYGNHNRR--NHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPA 90 (527)
Q Consensus 13 ~~~~~~~~~~~~~~~~--~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~ 90 (527)
+..-.++-.++.++.. ..+.+.|+|+|||++++.+||.|++||+|+++++. |++||.|... |..|+||.
T Consensus 285 s~~~is~~p~~~p~rs~s~~~~p~cralYdFepenEgEL~fkeGDlI~l~~QI-----denWyeG~~~----g~sG~FPv 355 (366)
T KOG1118|consen 285 SPSNISPKPPSTPNRSASQMDQPCCRALYDFEPENEGELDFKEGDLITLTNQI-----DENWYEGEKH----GESGMFPV 355 (366)
T ss_pred CcccCCCCCCCCCCcccCcccchhheeeeccCCCCCCccCcccCceeeehhhc-----Ccchhhheec----CccCcccc
Confidence 3334444444444433 24457899999999999999999999999999986 8999999998 67999999
Q ss_pred Cccccccc
Q psy6905 91 NFVSSIED 98 (527)
Q Consensus 91 ~yv~~~~~ 98 (527)
|||+.+-+
T Consensus 356 nYv~vlvp 363 (366)
T KOG1118|consen 356 NYVEVLVP 363 (366)
T ss_pred ceeEEecc
Confidence 99987544
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-08 Score=103.48 Aligned_cols=210 Identities=18% Similarity=0.232 Sum_probs=150.7
Q ss_pred CceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEE----eCCeEEEEEeccCCC-CHH
Q psy6905 129 GFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCL----QSPKLCLVMEYARGG-PLN 201 (527)
Q Consensus 129 ~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~----~~~~~~iv~Ey~~gg-sL~ 201 (527)
.-.+.|++.. +|..|++|.++...+.. ......-++.++++.|+|||+|.++|. .+..+++|++|.++. +|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3456788875 57889999985543322 222335578899999999999999986 356789999998764 676
Q ss_pred HHhc----------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 202 RVLA----------------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 202 ~~l~----------------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
++.- +.+.++..++.++.|+..||.++|+.| +.-+-|.|.+||++.+ .+++|+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~--------~RIriS 435 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGK--------MRIRIS 435 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCc--------ceEEEe
Confidence 6531 234677899999999999999999996 8889999999999975 378888
Q ss_pred ccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCC-CCCCCHHHH-HHHHHhCCccCCCC
Q psy6905 266 DFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP-YKSINAYAV-AYGVAVNKLTLPIP 343 (527)
Q Consensus 266 DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~P-f~~~~~~~~-~~~i~~~~~~~~~p 343 (527)
..|....+.... . +-+.. -.+-|.=.||.++..|.||..- +......+. .. .+-
T Consensus 436 ~C~i~Dvl~~d~----------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~---------~I~ 491 (655)
T KOG3741|consen 436 GCGIMDVLQEDP----------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT---------RIT 491 (655)
T ss_pred cccceeeecCCC----------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH---------Hhh
Confidence 777765443221 1 11111 2467899999999999998543 222222111 11 223
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
..++.++++++......++.+ -++.+++.++
T Consensus 492 ~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 492 TTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred hhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 567889999999999999887 6788887754
|
|
| >KOG1029|consensus | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.4e-11 Score=122.25 Aligned_cols=55 Identities=45% Similarity=0.866 Sum_probs=50.9
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
..++|+|||.|+++|||+|++||+|.|++++ +++||.|.++ |..|+||+|||...
T Consensus 1054 ~qviamYdY~AqndDELsF~kgdiI~Vlnkd-----epeWW~Ge~n----g~sGLFPSNYV~k~ 1108 (1118)
T KOG1029|consen 1054 CQVIAMYDYEAQNDDELSFKKGDIINVLNKD-----EPEWWSGERN----GKSGLFPSNYVQKQ 1108 (1118)
T ss_pred ceeEEeeccccCCcccccccCCCEEEecCCC-----Chhhhccccc----CccccCcccccccc
Confidence 5678999999999999999999999999996 8999999998 78999999999653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.9e-09 Score=101.10 Aligned_cols=137 Identities=13% Similarity=0.109 Sum_probs=94.5
Q ss_pred eEEEEeeEcCceEEEEEcCCCCChhHHH----------HHHHHHHHHHhCCCCcc--ceEEEEEEe-----CCeEEEEEe
Q psy6905 131 GKVYKGIYEKQEVAIKVAHPNPDENILE----------NVKQEGKLLWLFDHRNI--VSLIGVCLQ-----SPKLCLVME 193 (527)
Q Consensus 131 g~Vy~~~~~~~~vaiK~~~~~~~~~~~~----------~~~~e~~~l~~l~hpnI--v~~~~~~~~-----~~~~~iv~E 193 (527)
..|++..+.|+.|.||...........+ .+.+|+..+..|..-+| +...++... ...-++|||
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 3466777788889999664432111112 36788888887744333 344444433 234689999
Q ss_pred ccCCC-CHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 194 YARGG-PLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 194 y~~gg-sL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
++++. +|.+++. ....+......++.+++..+.-||..| |+|+|+++.|||++.+... ......+.|+||+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~-~~~~~~~~LIDl~r 191 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPG-REEDLKLSVIDLHR 191 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccC-CCCCceEEEEECCc
Confidence 99876 8988875 234556677789999999999999995 9999999999999752000 00125799999998
Q ss_pred ch
Q psy6905 270 AR 271 (527)
Q Consensus 270 a~ 271 (527)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 74
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.8e-09 Score=95.50 Aligned_cols=125 Identities=28% Similarity=0.343 Sum_probs=81.7
Q ss_pred EEEEeeE-cCceEEEEEcCCCC------------------------C-hhHHHHHHHHHHHHHhCCCC--ccceEEEEEE
Q psy6905 132 KVYKGIY-EKQEVAIKVAHPNP------------------------D-ENILENVKQEGKLLWLFDHR--NIVSLIGVCL 183 (527)
Q Consensus 132 ~Vy~~~~-~~~~vaiK~~~~~~------------------------~-~~~~~~~~~e~~~l~~l~hp--nIv~~~~~~~ 183 (527)
.||.|.. .+..+|||+.+... . ........+|++.|..+..- ++.+.+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3888886 57789999764321 0 11134567899999999766 46677655
Q ss_pred eCCeEEEEEeccC--CCCHHHHhcCCCCChhHHHHHHHHHHHHHHH-HHhcCCCceeecCCCCCceecCCCCcccccccc
Q psy6905 184 QSPKLCLVMEYAR--GGPLNRVLAGRKIRPDVLVDWAIQIAEGMNY-LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260 (527)
Q Consensus 184 ~~~~~~iv~Ey~~--ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~y-LH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~ 260 (527)
.. -+|||||++ |..+..+.. ..++......++.+++..+.. +|.. +|||+||.+.|||++. +
T Consensus 79 ~~--~~ivME~I~~~G~~~~~l~~-~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~---------~ 143 (188)
T PF01163_consen 79 NR--NVIVMEYIGEDGVPLPRLKD-VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDD---------G 143 (188)
T ss_dssp ET--TEEEEE--EETTEEGGCHHH-CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEET---------T
T ss_pred eC--CEEEEEecCCCccchhhHHh-ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeec---------c
Confidence 23 379999998 555554433 223355667778888886655 5677 4999999999999987 3
Q ss_pred eeEEeccCcchhh
Q psy6905 261 TLKITDFGLAREV 273 (527)
Q Consensus 261 ~vkL~DFGla~~~ 273 (527)
.+.|+|||.+...
T Consensus 144 ~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 KVYIIDFGQAVDS 156 (188)
T ss_dssp CEEE--GTTEEET
T ss_pred eEEEEecCcceec
Confidence 7999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2856|consensus | Back alignment and domain information |
|---|
Probab=98.91 E-value=4.2e-10 Score=108.46 Aligned_cols=57 Identities=42% Similarity=0.792 Sum_probs=51.4
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
..++|||||.+++.|||+|++||.++++... ++.||..|+++. |++|++|+|||+..
T Consensus 415 v~vraLYDY~gqE~DElsfkaGd~l~kl~ee----DeqGWC~Grl~~---G~vGLyPAnYVe~~ 471 (472)
T KOG2856|consen 415 VRVRALYDYAGQEGDELSFKAGDELEKLEEE----DEQGWCKGRLDS---GRVGLYPANYVECI 471 (472)
T ss_pred eeEEeeeccCcccccchhhccccHhhhcCCc----cccccccccccC---Ccccccchhhhhcc
Confidence 5589999999999999999999999998875 577999999885 89999999999864
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.90 E-value=5.5e-10 Score=117.74 Aligned_cols=144 Identities=19% Similarity=0.340 Sum_probs=107.9
Q ss_pred HHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccccc-----------cCCCcccc
Q psy6905 219 IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM-----------SAAGTYAW 287 (527)
Q Consensus 219 ~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~-----------~~~gt~~y 287 (527)
.+++.||.|+|... ++||++|.|++|.++.+ +..||+.|+.+......... -..-...|
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~--------~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f 175 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNAN--------GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNF 175 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccC--------cceeeccchhhhccCCCCccccccCCCCCChhhccCccc
Confidence 45569999999887 89999999999999986 78999999998655432111 01235689
Q ss_pred ccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHH--HHhCCccCCCCCCccHHHHHHHHHhhhhCCCC
Q psy6905 288 MAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYG--VAVNKLTLPIPSTCPQLFKTLMEACWEADSHM 364 (527)
Q Consensus 288 ~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~--i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~ 364 (527)
.|||++.+...+.++|+|||||++|-++. |+.-+.+.+....... ...+-.....+..+|.++++-|.+++..++..
T Consensus 176 ~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~ 255 (700)
T KOG2137|consen 176 LAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAV 255 (700)
T ss_pred ccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCccc
Confidence 99999999888999999999999999995 6666654432222111 11112233455788999999999999999999
Q ss_pred CCCHHHHH
Q psy6905 365 RPSFKTIL 372 (527)
Q Consensus 365 RPs~~~ll 372 (527)
||++..+.
T Consensus 256 rp~~~~l~ 263 (700)
T KOG2137|consen 256 RPTLDLLL 263 (700)
T ss_pred Ccchhhhh
Confidence 99776664
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=6.8e-08 Score=96.48 Aligned_cols=243 Identities=21% Similarity=0.289 Sum_probs=154.3
Q ss_pred eeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccce--------EEEEEEeCCeEEEE
Q psy6905 120 IFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS--------LIGVCLQSPKLCLV 191 (527)
Q Consensus 120 ~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~--------~~~~~~~~~~~~iv 191 (527)
..+..||+|+-+.+|-.---+ ..+-|++....... ..+ .-..+-..-.||-+-. ++|-- .+..+.+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Pppa~-~aq--k~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPPAA-QAQ--KVAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchhh-chhheeecCCCchH-HHH--HHHHhccCCCCcchhhhhcccHHHhhCCC-ccceeEEe
Confidence 356679999999999532212 23446665543221 111 1122222335664332 11111 12236788
Q ss_pred EeccCCC-CHHHHhc----CC---CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 192 MEYARGG-PLNRVLA----GR---KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 192 ~Ey~~gg-sL~~~l~----~~---~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
|..+.|. ....+++ ++ .+.+..+++.++.++.+.+-||..| .+-+|+.++|+|++++ +.|.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~--------~~V~ 157 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDD--------SKVV 157 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecC--------ceEE
Confidence 8888765 3444544 11 3567889999999999999999996 8999999999999986 6788
Q ss_pred EeccCcchhh-hccccccCCCccccccccccc-----cCCCCcccchHHHHHHHHHHHh-CCCCCCCCCH-------HH-
Q psy6905 264 ITDFGLAREV-YKTTHMSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGVVLWELLT-GEIPYKSINA-------YA- 328 (527)
Q Consensus 264 L~DFGla~~~-~~~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~-------~~- 328 (527)
|.|=...... ....+...+|...|++||.-+ +-.-+...|.|.||+++++++. |+.||.+... .+
T Consensus 158 LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 158 LVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred EEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 8874432221 222333457899999999865 2334678999999999999998 5999987531 11
Q ss_pred -HHHH-----HHhCCccCCCC-----CCccHHHHHHHHHhhhh--CCCCCCCHHHHHHHHhhh
Q psy6905 329 -VAYG-----VAVNKLTLPIP-----STCPQLFKTLMEACWEA--DSHMRPSFKTILKALNNI 378 (527)
Q Consensus 329 -~~~~-----i~~~~~~~~~p-----~~~~~~~~~li~~~l~~--dp~~RPs~~~ll~~L~~~ 378 (527)
+... -..+....+.| .-+++.+..|..+|+.. ++.-|||++..+..|..+
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 1111 00111111222 34578899999999975 367899999887776554
|
|
| >KOG0162|consensus | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.6e-09 Score=111.25 Aligned_cols=54 Identities=46% Similarity=1.010 Sum_probs=50.7
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
+.|.|+|||.++..+||+|++||+|+|+.++ ..|||.|+.+ ++.|+||.|||+.
T Consensus 1052 p~~~A~Y~y~gq~~dEls~~~~diIei~~ed-----pSGWw~gk~~----~keG~~P~~Yv~~ 1105 (1106)
T KOG0162|consen 1052 PVCEALYDYPGQDVDELSFKKGDIIEIMRED-----PSGWWLGKLN----GKEGLFPGNYVTE 1105 (1106)
T ss_pred cceeeeccCCCCCcccccccCCCEEEEeccC-----CCcchhhccC----Ccccccccccccc
Confidence 7899999999999999999999999999986 6799999987 7899999999975
|
|
| >KOG2070|consensus | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.3e-09 Score=108.98 Aligned_cols=59 Identities=34% Similarity=0.790 Sum_probs=53.7
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
..+..++|-|.|.+.+.|||+|.|||+|+|.... +.|||.|.++ |+.|+||+|||..+.
T Consensus 15 ~~pLvvrAkf~F~gsNnDELsf~KgDvItVTq~e-----eGGWWEGTln----g~TGWFPsnYV~eik 73 (661)
T KOG2070|consen 15 NNPLVVRAKFNFQGSNNDELSFSKGDVITVTQVE-----EGGWWEGTLN----GRTGWFPSNYVREIK 73 (661)
T ss_pred CCceEEEEEeecccCCCceeccccCCEEEEEEec-----cCcceecccc----CccCccchHHHHHHh
Confidence 3457899999999999999999999999999874 8899999999 789999999998765
|
|
| >cd00174 SH3 Src homology 3 domains; SH3 domains bind to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs; they play a role in the regulation of enzymes by intramolecular interactions, changing the subcellular localization of signal pathway components and mediate multiprotein complex assemblies | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.6e-09 Score=76.04 Aligned_cols=52 Identities=60% Similarity=1.114 Sum_probs=46.9
Q ss_pred EEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccc
Q psy6905 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94 (527)
Q Consensus 35 ~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~ 94 (527)
++|+|||.+..+++|+|++||.|.++... ++|||.++..+ ++.|+||.+||+
T Consensus 2 ~~a~~~~~~~~~~~l~~~~Gd~v~v~~~~-----~~~w~~~~~~~---~~~G~vP~~~v~ 53 (54)
T cd00174 2 VRALYDYDARDPDELSFKKGDIIEVLEKS-----DDGWWEGRLLG---GKRGLFPSNYVE 53 (54)
T ss_pred EEEEEeeCCCCCCCCCCCCCCEEEEEEcC-----CCCeEEEEECC---CCEEEEccccCc
Confidence 68999999999999999999999999873 78999999874 389999999986
|
|
| >smart00326 SH3 Src homology 3 domains | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.4e-09 Score=77.31 Aligned_cols=55 Identities=51% Similarity=0.961 Sum_probs=49.4
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
..++|+|||.+..+++|+|++||.|.+++.+ +.+||.++... ++.|+||.+||+.
T Consensus 3 ~~~~a~~~~~~~~~~~l~~~~Gd~v~v~~~~-----~~~w~~~~~~~---~~~G~vP~~~v~~ 57 (58)
T smart00326 3 PQVRALYDYTAQDPDELSFKKGDIITVLEKS-----DDGWWKGRLGR---GKEGLFPSNYVEE 57 (58)
T ss_pred cEEEEeeeeCCCCCCCCCCCCCCEEEEEEcC-----CCCeEEEEeCC---CCEEEEchHHEEE
Confidence 5789999999999999999999999999884 78999999764 6899999999864
|
Src homology 3 (SH3) domains bind to target proteins through sequences containing proline and hydrophobic amino acids. Pro-containing polypeptides may bind to SH3 domains in 2 different binding orientations. |
| >KOG4226|consensus | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.8e-09 Score=100.13 Aligned_cols=60 Identities=30% Similarity=0.658 Sum_probs=53.8
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+++|||.|.+.+++||+|++||+++|+++. ..|++||.+++.. |.+|++|.|||+.+.+
T Consensus 192 ~vVvaLYsFsssndeELsFeKGerleivd~P---e~DPdWwkarn~~---G~vGLVPrNYv~vl~d 251 (379)
T KOG4226|consen 192 HVVVALYSFSSSNDEELSFEKGERLEIVDKP---ENDPDWWKARNAR---GQVGLVPRNYVVVLSD 251 (379)
T ss_pred EEEEEEecccCCChhhcccccCceeEeccCC---CCCchHHhhcccC---CccceeecceEEEecc
Confidence 4699999999999999999999999999985 4689999999764 8999999999987654
|
|
| >KOG4348|consensus | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.2e-09 Score=103.66 Aligned_cols=61 Identities=38% Similarity=0.847 Sum_probs=55.6
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
....+|+.+|-|+++++|||+|+.||+|..+.++ +++.|||.|.++ |+.|.||.|||..+.
T Consensus 259 KtKeycrv~F~Ye~qndDELt~KEgdil~lItK~---cgdaGWweGELn----Gk~GvFPDNFv~lv~ 319 (627)
T KOG4348|consen 259 KTKEYCRVKFVYEPQNDDELTLKEGDILILITKN---CGDAGWWEGELN----GKKGVFPDNFVELVQ 319 (627)
T ss_pred hhhhheeeeeeecCCCccceeeccccEEEEeccc---ccccceeeeeec----CccccCCchhhhhcC
Confidence 3447899999999999999999999999999987 589999999999 689999999998765
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.1e-07 Score=97.35 Aligned_cols=139 Identities=19% Similarity=0.284 Sum_probs=92.4
Q ss_pred eeeccCCceEEEEeeEc-CceEEEEEcCCCCChhH---------------------------------HH------HHHH
Q psy6905 123 EAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENI---------------------------------LE------NVKQ 162 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~---------------------------------~~------~~~~ 162 (527)
+.|++++-|.||+|+.. |+.||||+.+++-.+.. .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999986 89999999877632111 11 1233
Q ss_pred HHHHHHhC----C-CCccceEEEEEEeCCeEEEEEeccCCCCHHHH--hcCCCCChhHHHHHHHHHHHHHHHHHhcCCCc
Q psy6905 163 EGKLLWLF----D-HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRV--LAGRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235 (527)
Q Consensus 163 e~~~l~~l----~-hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~~--l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~ 235 (527)
|+.-+..+ + .+++.-..=++.-...-.++|||++|-.+.++ ++...++...+...+.++.--.-+-| +
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~d-----g 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRD-----G 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhc-----C
Confidence 44433333 2 33332222222334456899999999999887 44555665555554444433333333 4
Q ss_pred eeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 236 iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
+.|.|.+|.||++..+ +.+.+.|||+...+.
T Consensus 286 ffHaDpHpGNi~v~~~--------g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVRSD--------GRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEecC--------CcEEEEcCcceecCC
Confidence 9999999999999986 799999999986653
|
|
| >KOG4792|consensus | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.2e-09 Score=95.28 Aligned_cols=59 Identities=24% Similarity=0.619 Sum_probs=53.2
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
.+++|+|||.+...+||.|++||+++|++++ ++.||.+++.. |+.|++|.+||+.....
T Consensus 125 ~~vr~~fdF~G~deeDLPFkkGeiL~I~~K~-----eeqWW~Arns~---Gk~GmIPvpYVe~~~~~ 183 (293)
T KOG4792|consen 125 EYVRALFDFNGNDEEDLPFKKGEILRIRDKP-----EEQWWNARNSE---GKRGMIPVPYVEKYRPA 183 (293)
T ss_pred hheeeeeccCCCccccCCcccCcEEEEecCc-----HHHhhhhhccC---CcccceechHHHhhhhh
Confidence 5688999999999999999999999999996 88999999875 89999999999975443
|
|
| >KOG4348|consensus | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.9e-09 Score=104.80 Aligned_cols=57 Identities=40% Similarity=0.842 Sum_probs=52.6
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..|+++|.|-++++|||.|+.||+|++++.. ++|||.|.++ |++|+||+|||.....
T Consensus 101 r~c~v~f~Y~pqndDELelkVGDiIeli~eV-----EeGWw~G~Ln----gk~GmFPsNFVkel~~ 157 (627)
T KOG4348|consen 101 RICVVTFAYSPQNDDELELKVGDIIELISEV-----EEGWWKGKLN----GKVGMFPSNFVKELPT 157 (627)
T ss_pred eeEEEEEeecCCCCceeeeeeccHHHhhhHh-----hhhhhhceec----CcccccchhhceecCC
Confidence 6899999999999999999999999999885 8899999999 7899999999987543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.6e-07 Score=89.45 Aligned_cols=134 Identities=22% Similarity=0.244 Sum_probs=93.3
Q ss_pred eeeeeeccCCceEEEEeeE-cCceEEEEEcCCCC-------------------C--hhHHHHHHHHHHHHHhCCCC--cc
Q psy6905 120 IFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNP-------------------D--ENILENVKQEGKLLWLFDHR--NI 175 (527)
Q Consensus 120 ~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~-------------------~--~~~~~~~~~e~~~l~~l~hp--nI 175 (527)
.++..||.|-=+.||.|.+ ++.++|||.-+... + .-......+|..+|..|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4678999999999999998 58899999643221 1 01133467899999988655 67
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccc
Q psy6905 176 VSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENE 255 (527)
Q Consensus 176 v~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~ 255 (527)
.+.+++ +...+||||++|-.|..+- ++....-.++..|+.-+.-+-.. +|||+|+.+-|||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d---- 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED---- 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC----
Confidence 777654 4568999999987765442 12333333444444444333345 39999999999999986
Q ss_pred ccccceeEEeccCcchh
Q psy6905 256 DLQFKTLKITDFGLARE 272 (527)
Q Consensus 256 ~~~~~~vkL~DFGla~~ 272 (527)
|.++++||-.+..
T Consensus 239 ----g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 ----GDIVVIDWPQAVP 251 (304)
T ss_pred ----CCEEEEeCccccc
Confidence 6899999976643
|
|
| >KOG2996|consensus | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.7e-08 Score=101.44 Aligned_cols=56 Identities=39% Similarity=0.786 Sum_probs=49.9
Q ss_pred EEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 35 ~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.+|-|||.|.+-.||||+.||+|.|+++- ++|.|||.|..+ |++|+||++||++..
T Consensus 808 AvarYdf~ard~~eLSlk~GDvV~i~~k~---g~d~GWWkGevn----grvGwFPstYVee~~ 863 (865)
T KOG2996|consen 808 AVARYDFCARDMRELSLKEGDVVKIYDKV---GEDQGWWKGEVN----GRVGWFPSTYVEEDD 863 (865)
T ss_pred eeeccccCCCchhhcccccCCEEEEehhc---cccCceecceec----CcccccccccccccC
Confidence 56779999999999999999999999874 567999999998 799999999998743
|
|
| >KOG4225|consensus | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.8e-08 Score=97.57 Aligned_cols=57 Identities=40% Similarity=0.729 Sum_probs=52.5
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
...+|+|||.+++..||+|.+||+|.|+.+. |.+|+.|..+ |++|+||.|||+.+..
T Consensus 231 ~~aralf~F~~qt~kEL~~~kGDIVyI~rkv-----D~nWyeGEhh----Gr~GifP~sYvE~~~~ 287 (489)
T KOG4225|consen 231 RAARALFDFEAQTPKELPFNKGDIVYILRKV-----DQNWYEGEHH----GRVGIFPASYVEILTP 287 (489)
T ss_pred chhhheeccccCCccccccCCCCEEEEEeec-----cCceeeeeec----ceecceechheeecCc
Confidence 4478999999999999999999999999994 8999999999 7899999999998765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.5e-07 Score=87.34 Aligned_cols=107 Identities=19% Similarity=0.188 Sum_probs=81.0
Q ss_pred HHHHHHHHHHHhCCCCc--cceEEEEEEeC----CeEEEEEeccCCC-CHHHHhcC-CCCChhHHHHHHHHHHHHHHHHH
Q psy6905 158 ENVKQEGKLLWLFDHRN--IVSLIGVCLQS----PKLCLVMEYARGG-PLNRVLAG-RKIRPDVLVDWAIQIAEGMNYLH 229 (527)
Q Consensus 158 ~~~~~e~~~l~~l~hpn--Iv~~~~~~~~~----~~~~iv~Ey~~gg-sL~~~l~~-~~~~~~~~~~i~~qi~~~L~yLH 229 (527)
....+|+..+..|..-+ ..+.+++.... ...++|||++++. +|.+++.. ...+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 35667777777664333 45666665542 2358999999885 79998874 33666777889999999999999
Q ss_pred hcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 230 ~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
..| |+|+|+++.|||+..+. ....+.|+||+.++.
T Consensus 136 ~~g---i~H~Dl~~~NILv~~~~-----~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAG---IYHGDLNPSNILVDPDD-----GQYRFYLIDLDRMRF 170 (206)
T ss_pred HCc---CCCCCCCcccEEEeCCC-----CceeEEEEcchhcee
Confidence 995 99999999999999862 123799999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.1e-06 Score=82.22 Aligned_cols=138 Identities=18% Similarity=0.149 Sum_probs=91.7
Q ss_pred CCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCCh--hH---------HHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDE--NI---------LENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~--~~---------~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
..+|.+.+.+-......|.+-..+++.+++|........ .. ..........+....--....++.+...
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 456777788888888888888888899999987664311 11 1111122222222233334444444332
Q ss_pred -----CCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 185 -----SPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 185 -----~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
....+++|||++|..|.++.. +++ .+...|.++|.-||..| +.|+|+.|.|++++.+
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-------- 171 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-------- 171 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC--------
Confidence 234578999999998876643 222 24456778899999996 9999999999999864
Q ss_pred ceeEEeccCcchh
Q psy6905 260 KTLKITDFGLARE 272 (527)
Q Consensus 260 ~~vkL~DFGla~~ 272 (527)
.++++||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 699999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.2e-06 Score=83.76 Aligned_cols=72 Identities=22% Similarity=0.251 Sum_probs=55.4
Q ss_pred eeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCc--cceEEEEEEeCCeEEEEEeccCCCC
Q psy6905 123 EAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN--IVSLIGVCLQSPKLCLVMEYARGGP 199 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~~~~~~~~~~~~~iv~Ey~~ggs 199 (527)
..||+|..+.||+. .+..+++|+...... ...+.+|.+++..+..-+ +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57999999999984 355688998876432 345678999998886433 4678888888888899999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG4226|consensus | Back alignment and domain information |
|---|
Probab=98.53 E-value=6.8e-08 Score=89.86 Aligned_cols=55 Identities=40% Similarity=0.691 Sum_probs=49.5
Q ss_pred EEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 35 ~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+.-|+|.|+.+|||++-+|+.|.|+++. .+|||.|.-+ |.+|+||+|||++..+
T Consensus 110 AvVKf~Y~a~~eDELsLtKGtrv~vmEKs-----sDGWWrG~~n----g~VGWFPSNYv~E~~d 164 (379)
T KOG4226|consen 110 AVVKFNYVAEREDELSLTKGTRVTVMEKS-----SDGWWRGSYN----GQVGWFPSNYVTEEVD 164 (379)
T ss_pred eEEEEeeccccccccccccCcEEEEEEec-----cCcceecccC----Ceeccccccceehhcc
Confidence 66789999999999999999999999994 7899999987 7899999999997544
|
|
| >KOG4225|consensus | Back alignment and domain information |
|---|
Probab=98.51 E-value=8.1e-08 Score=95.29 Aligned_cols=56 Identities=45% Similarity=0.793 Sum_probs=49.3
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
.-++|||.|.++++|||.|+.||+|.|+++- |+||..|....+ +.+|+||.|||+.
T Consensus 433 l~yrAly~Y~pqnedeLEl~egDii~VmeKc-----ddgWfvGts~rt--g~fGtFPgnyV~~ 488 (489)
T KOG4225|consen 433 LKYRALYSYRPQNEDELELREGDIIDVMEKC-----DDGWFVGTSRRT--GKFGTFPGNYVKR 488 (489)
T ss_pred ccceeccccCCCCchhheeccCCEEeeeecc-----cCcceeccceec--ccccccCcccccc
Confidence 4489999999999999999999999999994 789999953333 7899999999975
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.9e-07 Score=95.46 Aligned_cols=142 Identities=23% Similarity=0.316 Sum_probs=95.5
Q ss_pred eeeccCCceEEEEeeE-cCceEEEEEcCCCCChh------------------------------HHHH------HHHHHH
Q psy6905 123 EAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDEN------------------------------ILEN------VKQEGK 165 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~~------------------------------~~~~------~~~e~~ 165 (527)
+.||.-+.|.||+|+. .|+.||||+-++.-... ..+. |.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999997 46789999977653111 1111 222222
Q ss_pred ----HHHhCCCCc------cceEEEEEEeCCeEEEEEeccCCCCHHHH--hcCCCCChhHHHHHHHHHHHHHHHHHhcCC
Q psy6905 166 ----LLWLFDHRN------IVSLIGVCLQSPKLCLVMEYARGGPLNRV--LAGRKIRPDVLVDWAIQIAEGMNYLHCQAP 233 (527)
Q Consensus 166 ----~l~~l~hpn------Iv~~~~~~~~~~~~~iv~Ey~~ggsL~~~--l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~ 233 (527)
+.+.+.|-+ |.++|--+ .....++||||+|..+.++ +....++...+..-+.+...-+-+.|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~---- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT---- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc----
Confidence 223344555 33443322 3345899999999987654 56777888877766666555444444
Q ss_pred CceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 234 ~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
+++|+|=+|.||++..+.+ ....+.+.|||+...+..
T Consensus 321 -GffHaDPHPGNilv~~~~~----~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 -GFFHADPHPGNILVRPNPE----GDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -CCccCCCCCCcEEEecCCC----CCccEEEEcccccccccH
Confidence 4999999999999995421 136899999999876643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.4e-06 Score=79.62 Aligned_cols=138 Identities=11% Similarity=0.009 Sum_probs=97.4
Q ss_pred eccCCceEEEEeeEcCceEEEEEcCCCCC-----hhHHHHHHHHHHHHHhCCCCc--cceEEEEEE-e----CCeEEEEE
Q psy6905 125 IGEGGFGKVYKGIYEKQEVAIKVAHPNPD-----ENILENVKQEGKLLWLFDHRN--IVSLIGVCL-Q----SPKLCLVM 192 (527)
Q Consensus 125 iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~l~hpn--Iv~~~~~~~-~----~~~~~iv~ 192 (527)
-|.||-+-|++..+.|+.+-+|....... ..-...|.+|+..+..|..-+ +.+.. ++. . .-.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 46789999999888887888886431100 011356788988888874332 34444 222 1 12358999
Q ss_pred eccCC-CCHHHHhcCCC---CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 193 EYARG-GPLNRVLAGRK---IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 193 Ey~~g-gsL~~~l~~~~---~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|-+.| -+|.+++.... .+......++.+|+..+.-||..| +.|+|+.+.|||++.+. .-.|.++||-
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g------~~~v~lIDlE 175 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEG------KAEAGFLDLE 175 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCC------CeeEEEEEhh
Confidence 98754 48888887544 356666789999999999999995 99999999999998541 1259999997
Q ss_pred cchh
Q psy6905 269 LARE 272 (527)
Q Consensus 269 la~~ 272 (527)
-++.
T Consensus 176 k~r~ 179 (216)
T PRK09902 176 KSRR 179 (216)
T ss_pred ccch
Confidence 7654
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.9e-08 Score=102.15 Aligned_cols=181 Identities=20% Similarity=0.180 Sum_probs=135.6
Q ss_pred eeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCc-cceEEEEEEeCCeEEEEEeccCC
Q psy6905 120 IFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN-IVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 120 ~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
....-+++|++++++|.+... +....+++... ....-++++|.+++||| .+.+++-+..++..+++++||.+
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 344568899999999988654 33335555433 33446788999999999 88888888888899999999988
Q ss_pred C-CHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 198 G-PLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 198 g-sL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
| +...... .-.+..-+...+++.-.++++|+|+. .=+|+| ||+..+ +.++.+||+....+.
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~---------~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE---------EEVKLLDFAVPPQLT 382 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc---------cccccccccCCcccC
Confidence 8 3222221 22234445556677778999999986 248999 888876 478999999987764
Q ss_pred cc-ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCC
Q psy6905 275 KT-THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYK 322 (527)
Q Consensus 275 ~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~ 322 (527)
.. ...+..+|+.|+|||+...+.+....|+|++|+--.++.-|-+|-.
T Consensus 383 ~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 383 RTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 43 2345679999999999999999999999999987777776766643
|
|
| >KOG0515|consensus | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.2e-07 Score=95.93 Aligned_cols=70 Identities=30% Similarity=0.584 Sum_probs=55.6
Q ss_pred cccCCCCCCC--CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 20 LLYGNHNRRN--HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 20 ~~~~~~~~~~--~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
++.|-+++.+ +.| .+-|||||+++..|||+|+.||.++|+.+++. .+.+||.++++ |+.|++|.||+...
T Consensus 670 yL~~vqesmG~mN~G-~vYAlwdYeaqf~DELsf~eGd~lTvirr~d~--~eteWWwa~ln----g~eGyVPRnylgLy 741 (752)
T KOG0515|consen 670 YLYGVQESMGSMNKG-VVYALWDYEAQFEDELSFDEGDELTVIRRDDE--VETEWWWARLN----GEEGYVPRNYLGLY 741 (752)
T ss_pred HHHHHHHhhcccccc-eeEEeecccccccccccccCCceeEEEecCCc--chhhhhhHhhc----CcccccchhhhhcC
Confidence 4444444433 233 57799999999999999999999999998654 35689999988 78999999998654
|
|
| >KOG3875|consensus | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.7e-08 Score=92.74 Aligned_cols=63 Identities=33% Similarity=0.525 Sum_probs=54.5
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEE-ecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGK-IEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~-~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+++|+|||.+.++.||+|++||++.|+.++.+..-+..||..+ .++ +..|++|.|||+.+..
T Consensus 269 ~~arA~YdF~a~np~ElSlk~Gdml~ia~K~dq~~~~~~gW~lat~dg---~~tG~iP~NYvkIi~r 332 (362)
T KOG3875|consen 269 EFARALYDFVARNPVELSLKKGDMLAIASKEDQQGVRCEGWLLATRDG---GTTGLIPINYVKIIGR 332 (362)
T ss_pred HHHHHHhhhhcCCHHHhhhhcCchhhcccccccCCCCCcceeeeeccC---Ceeeeeehhhhhhhhc
Confidence 78999999999999999999999999999987766666788776 445 7999999999987544
|
|
| >KOG1843|consensus | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.7e-07 Score=92.12 Aligned_cols=58 Identities=40% Similarity=0.774 Sum_probs=51.9
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
.+..++|+|+|.++.+++|+|++||+|+|+++.+ ..+.||+|+.+ +..|+||+|||..
T Consensus 415 ~~n~a~a~ysfage~~GDl~f~kgDii~il~ks~---s~~dwwtgr~~----~~egifPanyv~~ 472 (473)
T KOG1843|consen 415 EPNIATALYSFAGEQPGDLSFQKGDIITILKKSD---SANDWWTGRGN----GYEGIFPANYVSL 472 (473)
T ss_pred CcceeeeeehhccCCCCCcccccCceEEEecCCc---chhhHHHhhcc----ccccccccceecc
Confidence 4569999999999999999999999999999853 46789999988 7899999999974
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.8e-06 Score=78.49 Aligned_cols=78 Identities=19% Similarity=0.316 Sum_probs=57.8
Q ss_pred eeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCC--ccceEEEEEEe---CCeEEEEEeccC
Q psy6905 122 GEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHR--NIVSLIGVCLQ---SPKLCLVMEYAR 196 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~~~~~~~~---~~~~~iv~Ey~~ 196 (527)
++.|+.|..+.||+....+..+++|+.... .....+..|..++..+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 357999999999999987789999997654 3456777888888887433 35677764433 345799999999
Q ss_pred CCCHHH
Q psy6905 197 GGPLNR 202 (527)
Q Consensus 197 ggsL~~ 202 (527)
|..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 988776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.3e-06 Score=75.61 Aligned_cols=130 Identities=25% Similarity=0.376 Sum_probs=93.6
Q ss_pred ceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccc-eEEEEEEeCCeEEEEEeccC
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIV-SLIGVCLQSPKLCLVMEYAR 196 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv-~~~~~~~~~~~~~iv~Ey~~ 196 (527)
.....+.||+|.+|.||+|.|.+..+|+|+-..+.. ...+..|+++|..+...++- ++|.+..+ ++.|||++
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 345567899999999999999999999999887643 56778999999998877765 55554332 46699999
Q ss_pred CCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCC--CceecCCCCcccccccceeEEeccCcchh
Q psy6905 197 GGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKS--SNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 197 ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp--~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|-.|.+.-... +...++ .+++.---|... +|-|+.|.- .||++.. +.+.|+||..|+.
T Consensus 96 G~~L~~~~~~~--~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~---------~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG--DRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVND---------RDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc--cHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecC---------CcEEEEEccchhh
Confidence 98887765532 333333 344443344444 488888853 4677765 4799999998863
|
|
| >KOG1029|consensus | Back alignment and domain information |
|---|
Probab=98.27 E-value=5e-07 Score=95.03 Aligned_cols=65 Identities=35% Similarity=0.707 Sum_probs=56.5
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDINL 101 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~~ 101 (527)
++-..|+|||.|++++.||++|..||+|.|-.+. .+++||-.|.++ |++|+||.|||+.+...+.
T Consensus 691 ~~~vkyrAly~FeaRs~dEisf~pGDII~V~esq---~aEPGWlaGel~----gktGWFPenyvEki~~~e~ 755 (1118)
T KOG1029|consen 691 HDTVKYRALYPFEARSHDEISFEPGDIIIVFESQ---AAEPGWLAGELR----GKTGWFPENYVEKIPAVET 755 (1118)
T ss_pred cceEEEeeecccccCCcccccccCCCEEEEehhc---cCCcccccceec----cccCcCcHHHHhhcccCCC
Confidence 4557799999999999999999999999986554 478999999998 7899999999998776653
|
|
| >KOG3601|consensus | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.6e-07 Score=80.90 Aligned_cols=59 Identities=32% Similarity=0.619 Sum_probs=52.8
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
....+..|+|||+++.+++|.|++||.++|++. ++..||.|... |+.|+||++||....
T Consensus 161 ~~~~yqQa~~df~~~pp~ql~f~~gq~~~v~~~-----ss~~ww~Gs~l----g~agiFpagyv~p~d 219 (222)
T KOG3601|consen 161 PTNYYQQALYDFQPQPPGQLAFRRGQQIQVLDS-----SSPFWWFGSKL----GRAGIFPAGYVAPSD 219 (222)
T ss_pred ccchhhhhcCCCCCCCchhhccccCCcceeecC-----CCcchhhcccc----CceeeecCccccccc
Confidence 344678999999999999999999999999998 48999999987 789999999998754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.3e-05 Score=77.62 Aligned_cols=75 Identities=17% Similarity=0.218 Sum_probs=54.1
Q ss_pred eeccCCc-eEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEEEeccCCCCHH
Q psy6905 124 AIGEGGF-GKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLVMEYARGGPLN 201 (527)
Q Consensus 124 ~iG~G~f-g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~ 201 (527)
.|-.|.. ..||+....+..+.||+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 7899987766788999876542 234567888887773 344668888877766779999999998775
Q ss_pred H
Q psy6905 202 R 202 (527)
Q Consensus 202 ~ 202 (527)
.
T Consensus 81 ~ 81 (244)
T cd05150 81 A 81 (244)
T ss_pred H
Confidence 4
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.26 E-value=9e-06 Score=76.95 Aligned_cols=137 Identities=21% Similarity=0.188 Sum_probs=92.9
Q ss_pred eeeeccCCceEEEEeeE-cCceEEEEEcCCCCCh---------------------h--HHHHHHHHHHHHHhCC--CCcc
Q psy6905 122 GEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDE---------------------N--ILENVKQEGKLLWLFD--HRNI 175 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~---------------------~--~~~~~~~e~~~l~~l~--hpnI 175 (527)
...|.+|--+.||+|.. .+..+|+|+.+..... . ...-..+|..-|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34788888889999986 5789999987653210 0 0112345666666653 3445
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCC-HHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcc
Q psy6905 176 VSLIGVCLQSPKLCLVMEYARGGP-LNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254 (527)
Q Consensus 176 v~~~~~~~~~~~~~iv~Ey~~ggs-L~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~ 254 (527)
.+.+++. +-.+||||+.... -.-.|+.-.+...+...+..++++.|.-|-..+ ++||+||..=|||+..
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~~---- 202 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVHD---- 202 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEEC----
Confidence 5555553 3379999995441 122233334445467777888999998887744 6999999999999995
Q ss_pred cccccceeEEeccCcchhh
Q psy6905 255 EDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 255 ~~~~~~~vkL~DFGla~~~ 273 (527)
+.+.|+|||-|...
T Consensus 203 -----~~p~iID~~QaV~~ 216 (268)
T COG1718 203 -----GEPYIIDVSQAVTI 216 (268)
T ss_pred -----CeEEEEECcccccc
Confidence 58999999988654
|
|
| >KOG3655|consensus | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.4e-07 Score=89.82 Aligned_cols=58 Identities=43% Similarity=0.789 Sum_probs=52.0
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.+...+|+|||+|..+.|++|-.+|.|..++.- ++|||.|.... |.+|+||+|||..+
T Consensus 426 ~~q~A~A~~dyqAAddtEisf~p~d~it~Id~v-----degww~g~~pd---G~~glfPaNyV~li 483 (484)
T KOG3655|consen 426 EPQTARALYDYQAADDTEISFDPPDAITLIDQV-----DEGWWTGQGPD---GEVGLFPANYVELI 483 (484)
T ss_pred cCCCccccccccccCCcccccCCcccccccccc-----CCccccccCCC---CCcCcccccccccC
Confidence 556789999999999999999999999999985 78999999754 89999999999753
|
|
| >KOG2546|consensus | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-06 Score=87.02 Aligned_cols=55 Identities=42% Similarity=0.721 Sum_probs=50.3
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
-++|+|||++..++||+|.+|-+|.|+.++ |+|||.|-.+ +-.|+||.|||+...
T Consensus 425 kVv~iydy~~~KddeLsf~E~ailyv~kkn-----ddgw~EgV~~----~VTglFpgnyve~~~ 479 (483)
T KOG2546|consen 425 KVVAIYDYTADKDDELSFAEGAILYVLKKN-----DDGWYEGVQD----GVTGLFPGNYVEPLK 479 (483)
T ss_pred HHHhhcccccccccccccccccEEEEEEec-----CCcchhheec----CcceeccCccccccc
Confidence 388999999999999999999999999995 8999999887 579999999998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.9e-05 Score=73.08 Aligned_cols=126 Identities=21% Similarity=0.305 Sum_probs=91.2
Q ss_pred CceeeeeeeccCCc-eEEEEeeEcCceEEEEEcCC---CC--------C--h-------hHHHHHHHHHHHHHhC---CC
Q psy6905 117 NKLIFGEAIGEGGF-GKVYKGIYEKQEVAIKVAHP---NP--------D--E-------NILENVKQEGKLLWLF---DH 172 (527)
Q Consensus 117 ~~~~~~~~iG~G~f-g~Vy~~~~~~~~vaiK~~~~---~~--------~--~-------~~~~~~~~e~~~l~~l---~h 172 (527)
.++++++.||.|.- |.||++...|+.||+|+... .. . . ....-|..|.+...+| .+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67889999999999 99999999999999999221 10 0 0 1234577788877766 45
Q ss_pred Ccc--ceEEEEEEeC------------------CeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcC
Q psy6905 173 RNI--VSLIGVCLQS------------------PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA 232 (527)
Q Consensus 173 pnI--v~~~~~~~~~------------------~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g 232 (527)
.++ |+.+|+..-. ....||.||..... .++.. -+.+|.+-|..+|..|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~----~~~~~~~dl~~~~k~g 184 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIR----DIPQMLRDLKILHKLG 184 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchh----HHHHHHHHHHHHHHCC
Confidence 566 9999997322 12467888776543 12222 3456777888999995
Q ss_pred CCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 233 ~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|+-+|+++.|..=+ +|+|||.+
T Consensus 185 ---I~~~Dv~~~ny~~G-------------~lvDfs~~ 206 (207)
T PF13095_consen 185 ---IVPRDVKPRNYRGG-------------KLVDFSSS 206 (207)
T ss_pred ---eeeccCccccccCC-------------EEEecccC
Confidence 99999999998721 89999965
|
|
| >KOG1264|consensus | Back alignment and domain information |
|---|
Probab=98.20 E-value=6.2e-07 Score=94.91 Aligned_cols=58 Identities=41% Similarity=0.749 Sum_probs=52.3
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..|.|||||.|+.+|||+|-+|-+|+++.++ +.|||.|.-.| ...++||+|||+.+..
T Consensus 775 vt~kAL~~Yka~r~DELSFpk~aiItnv~ke-----eg~wWrGdYGg---~iq~wfPsnyVeei~~ 832 (1267)
T KOG1264|consen 775 VTVKALYDYKAKRSDELSFPKGAIITNVSKE-----EGGWWRGDYGG---RIQQWFPSNYVEEIST 832 (1267)
T ss_pred hhhhhhhccccCCcccccccccceeEeeecc-----CCceeeccccc---ceeeeccHHHhhhhcc
Confidence 6799999999999999999999999999995 67899999876 4679999999998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.1e-05 Score=72.21 Aligned_cols=137 Identities=21% Similarity=0.295 Sum_probs=94.5
Q ss_pred eeeeccCCceEEEEeeEcCceEEEEEcCCCC---------------ChhHHHHHHHHHHHHHhCC------CCccceEEE
Q psy6905 122 GEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP---------------DENILENVKQEGKLLWLFD------HRNIVSLIG 180 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~e~~~l~~l~------hpnIv~~~~ 180 (527)
...||+|+.=.||.-- .+....||+..... .....++..+|+.....+. +.+|.++||
T Consensus 6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 3479999999999633 23456788877654 0112345556665555554 889999999
Q ss_pred EEEeCCeEEEEEeccCC--C----CHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcc
Q psy6905 181 VCLQSPKLCLVMEYARG--G----PLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254 (527)
Q Consensus 181 ~~~~~~~~~iv~Ey~~g--g----sL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~ 254 (527)
+...+-...+|+|.+.. | +|.+++..+.++. .+...+.++. .||-.+ .|+.+||+|.||++....+.
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~L~~f~---~~l~~~---~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQALDEFK---RYLLDH---HIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHHHHHHH---HHHHHc---CCeecCCCcccEEEEecCCC
Confidence 99999999999998643 2 5788888777777 4444444443 455555 49999999999999876332
Q ss_pred cccccceeEEec-cCcc
Q psy6905 255 EDLQFKTLKITD-FGLA 270 (527)
Q Consensus 255 ~~~~~~~vkL~D-FGla 270 (527)
...+.|+| ||..
T Consensus 158 ----~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 158 ----EFRLVLIDGLGEK 170 (199)
T ss_pred ----ceEEEEEeCCCCc
Confidence 12577777 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.3e-05 Score=88.00 Aligned_cols=78 Identities=15% Similarity=0.241 Sum_probs=57.0
Q ss_pred eeeeccCCceEEEEeeEcC----ceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCcc--ceEEEEEEeC---CeEEEE
Q psy6905 122 GEAIGEGGFGKVYKGIYEK----QEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNI--VSLIGVCLQS---PKLCLV 191 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnI--v~~~~~~~~~---~~~~iv 191 (527)
.+.|+.|.++.+|+..+.+ ..+++|.............+.+|+.+++.+. |.++ .+++.+|.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4578999999999977644 4678887655332122356789999999985 6665 7888887664 357899
Q ss_pred EeccCCCC
Q psy6905 192 MEYARGGP 199 (527)
Q Consensus 192 ~Ey~~ggs 199 (527)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.1e-05 Score=72.92 Aligned_cols=100 Identities=21% Similarity=0.170 Sum_probs=80.0
Q ss_pred HHHHHHHhCCC-CccceEEEEEEeCCeEEEEEeccCCCCHHH----HhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCce
Q psy6905 162 QEGKLLWLFDH-RNIVSLIGVCLQSPKLCLVMEYARGGPLNR----VLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236 (527)
Q Consensus 162 ~e~~~l~~l~h-pnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~----~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~i 236 (527)
.|..+++.+.+ +++.+++|+|- .++|+||...+++.. +..-...++....+|+.++++.+++|+..-...+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57888888876 69999999993 378999998776642 1122346788999999999999999998544468
Q ss_pred eecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 237 iHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
.-.|++|+|+-++.+ +.+|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~--------~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDD--------GRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCC--------CcEEEEechhcchh
Confidence 889999999999975 68999999887544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1702|consensus | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.5e-06 Score=74.62 Aligned_cols=59 Identities=32% Similarity=0.552 Sum_probs=49.7
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
..+..++|.|||.|+..+|++|..||.|.-+... ++||..|...-+ |..|..|+||++.
T Consensus 205 ~~gktyra~ydysaqdedevsF~dgd~ivnvq~i-----ddGWmygtv~rt--g~tGmlpaNyie~ 263 (264)
T KOG1702|consen 205 CTGKTYRAFYDYSAQDEDEVSFVDGDYIVNVQSI-----DDGWMYGTVVRT--GWTGMLPANYIEF 263 (264)
T ss_pred CCCccchhhccCcccCcceeEEecCCeEEEEEec-----cCCceeeEEEec--cccCCCchhheee
Confidence 4557899999999999999999999998766554 678988885533 7899999999974
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.5e-05 Score=73.53 Aligned_cols=73 Identities=14% Similarity=0.244 Sum_probs=47.3
Q ss_pred eeeccCCce-EEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCC---ccceEEEEEEeC---CeEEEEEecc
Q psy6905 123 EAIGEGGFG-KVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHR---NIVSLIGVCLQS---PKLCLVMEYA 195 (527)
Q Consensus 123 ~~iG~G~fg-~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hp---nIv~~~~~~~~~---~~~~iv~Ey~ 195 (527)
+.|+.|+.. .||+. +..+++|+..... ....+.+|+.++..+... -+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 468877777 48875 3467888765432 245678899999887532 344555544332 2348899999
Q ss_pred CCCCHH
Q psy6905 196 RGGPLN 201 (527)
Q Consensus 196 ~ggsL~ 201 (527)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.1e-05 Score=85.83 Aligned_cols=199 Identities=22% Similarity=0.183 Sum_probs=136.7
Q ss_pred HHHHHHHHHHHhCCCCccceEEEEEEeCCeE----EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcC
Q psy6905 158 ENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL----CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQA 232 (527)
Q Consensus 158 ~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~----~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g 232 (527)
.....|...+..+.|+|++.++.+..+.... .+..|||.+.++...+. -+..+...++.+..++.+||.|+|+.
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 3444566677788999999999998765433 34568999988888877 46678888999999999999999987
Q ss_pred CCceeecCCCCCceecCCCCcccccccceeEEe--ccCcchhhhccccc-cCCCccccccccccccCCCCc--ccchHHH
Q psy6905 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT--DFGLAREVYKTTHM-SAAGTYAWMAPEVIKTSIFSK--ASDVWSY 307 (527)
Q Consensus 233 ~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~--DFGla~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~--ksDvwSl 307 (527)
...|.-+...-..-.. ....+.+.++ ||+.+......... +..-+..|.++|......+.. ..|+|.+
T Consensus 306 --~l~~v~L~~s~~~~~~-----~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 306 --SLEHVVLSASSSKEST-----VDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred --ccceeEEecccccccc-----cCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHH
Confidence 3555544443211111 1112456666 89888776543332 334566788899887766554 4799999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 308 GVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 308 Gv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
|.++..+..|..+-.... +. ..-.+..+.....+.+..|+..++++|+++.+++.+.
T Consensus 379 gll~~~~~~~~~i~~~~~---~~--------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA---VP--------VSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HHHHhhhhhcCccccccc---ch--------hhhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 999999998765421110 00 0012233333678889999999999999999998864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00031 Score=70.23 Aligned_cols=77 Identities=17% Similarity=0.132 Sum_probs=57.4
Q ss_pred eeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCC---CccceEEEEEEe---CCeEEEEEec
Q psy6905 121 FGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH---RNIVSLIGVCLQ---SPKLCLVMEY 194 (527)
Q Consensus 121 ~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h---pnIv~~~~~~~~---~~~~~iv~Ey 194 (527)
-.+.||.|..+.||+....+..+++|+.+.... ...+..|+..|+.|.- -.+.++++++.. .+..++|||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGNPMPLMARSFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCCCEEEEEeccccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 356799999999999876555688888543211 2467789999988843 367888988754 3558999999
Q ss_pred cCCCCH
Q psy6905 195 ARGGPL 200 (527)
Q Consensus 195 ~~ggsL 200 (527)
++|+++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0016 Score=67.25 Aligned_cols=75 Identities=19% Similarity=0.200 Sum_probs=52.7
Q ss_pred eeeccCCceEEEEeeEcC--ceEEEEEcCCCC----C--hhHHHHHHHHHHHHHhC---CCCccceEEEEEEeCCeEEEE
Q psy6905 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP----D--ENILENVKQEGKLLWLF---DHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~--~~vaiK~~~~~~----~--~~~~~~~~~e~~~l~~l---~hpnIv~~~~~~~~~~~~~iv 191 (527)
+.||.|.+..||++...+ +.|+||...+.. . ....+....|+..|..+ ...++.++|.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 569999999999998854 389999754221 1 11345667788888775 23467788877 33456899
Q ss_pred EeccCCCC
Q psy6905 192 MEYARGGP 199 (527)
Q Consensus 192 ~Ey~~ggs 199 (527)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00093 Score=66.66 Aligned_cols=138 Identities=20% Similarity=0.172 Sum_probs=81.9
Q ss_pred eeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCC--ccceEEEE------EEeCCeEEEEEe
Q psy6905 122 GEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHR--NIVSLIGV------CLQSPKLCLVME 193 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~~~~~------~~~~~~~~iv~E 193 (527)
.+.|..|....+|+....+..+++|+.... . ...+..|+.++..|.+- .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~-~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV-S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC-C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456888888899998776678999987652 1 23455677777766432 24454432 233456789999
Q ss_pred ccCCCCHHH-----------Hhc-----CCCCCh--------hHHHH------------HHHHHHHHHHHHHh----cCC
Q psy6905 194 YARGGPLNR-----------VLA-----GRKIRP--------DVLVD------------WAIQIAEGMNYLHC----QAP 233 (527)
Q Consensus 194 y~~ggsL~~-----------~l~-----~~~~~~--------~~~~~------------i~~qi~~~L~yLH~----~g~ 233 (527)
|++|..+.. .+. ...+.. ..... ....+..++.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998876421 110 001100 00000 11112334444443 122
Q ss_pred CceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 234 ~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
..++|+|+.|.|||++.+ +.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~--------~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGD--------ELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCC--------ceEEEeehhhhc
Confidence 359999999999999874 456899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 527 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-90 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-33 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-33 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-31 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-31 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-30 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-30 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-30 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-30 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-30 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-30 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-30 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-30 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-30 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-30 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-30 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-30 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-30 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-30 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-30 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-30 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-29 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-29 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-29 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-29 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-29 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-29 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-29 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-29 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-29 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-29 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-29 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-29 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-29 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-29 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-29 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-29 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-29 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-29 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-29 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-29 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-29 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-29 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-29 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-29 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-29 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-29 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-29 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-29 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-29 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-29 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-29 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-29 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-29 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-29 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-29 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-29 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-29 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-29 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-29 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-29 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-29 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-29 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-29 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-29 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-29 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-29 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-29 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-28 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-28 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-28 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-28 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-28 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-28 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-28 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-28 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-28 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-28 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-28 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-28 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-28 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-28 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-28 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-28 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-28 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-28 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-28 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-28 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-28 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-28 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-28 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-28 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-28 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-28 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-28 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-28 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-27 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-27 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-27 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-27 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-27 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-27 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-27 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-27 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-27 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-27 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-27 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-27 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-27 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-27 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-27 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-27 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-27 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-27 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-27 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-27 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-27 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-27 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-27 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-27 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-27 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-27 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-27 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-27 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-27 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-27 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-27 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-27 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-27 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-27 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-27 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-27 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-26 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-26 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-26 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-26 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-26 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-26 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-26 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-26 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-26 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-26 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-26 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-26 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-26 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-26 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-26 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-26 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-26 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-26 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-26 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-26 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-26 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-26 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-26 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-26 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-26 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-26 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-26 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-26 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-26 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-26 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-25 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-25 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-25 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-25 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-25 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-25 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-25 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-25 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-25 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-25 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-25 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-25 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-25 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-25 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-25 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-25 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-25 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-25 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-25 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-25 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-25 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-25 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-25 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-25 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-25 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-25 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-25 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-25 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-25 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-25 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-25 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-25 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-25 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-25 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-25 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-25 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-25 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-25 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-25 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-25 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-25 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-25 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-25 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-25 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-25 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-25 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-25 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-25 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-25 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-25 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-25 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-25 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-25 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-25 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-25 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-25 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-25 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-25 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-25 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-25 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-25 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-25 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-25 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-25 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-25 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-25 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-25 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-25 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-25 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-25 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-25 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-25 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-25 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-25 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-25 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-25 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-25 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-25 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-24 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-24 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-24 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-24 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-24 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-24 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-24 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-24 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-24 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-24 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-24 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-24 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-24 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-24 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-24 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-24 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-24 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-24 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-24 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-24 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-24 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-24 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-24 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-24 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-24 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-24 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-24 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-23 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-23 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-23 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-23 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-23 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-23 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-23 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-23 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-23 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-23 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-23 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-23 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-23 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-23 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-23 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-23 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-23 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-23 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-22 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-22 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-22 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-22 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-22 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-22 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-22 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-19 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-18 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-18 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-17 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-17 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-17 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-17 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-16 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-16 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-16 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-16 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 2rf0_A | 89 | Crystal Structure Of Human Mixed Lineage Kinase Map | 4e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-14 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-14 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-14 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-14 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-08 | ||
| 1h3h_A | 60 | Structural Basis For Specific Recognition Of An Rxx | 5e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 1uti_A | 58 | MonaGADS SH3C IN COMPLEX WITH HPK DERIVED PEPTIDE L | 7e-08 | ||
| 1oeb_A | 62 | MonaGADS SH3C DOMAIN Length = 62 | 7e-08 | ||
| 2d0n_A | 59 | Crystal Structure Of The C-Terminal Sh3 Domain Of T | 7e-08 | ||
| 2xmf_A | 60 | Myosin 1e Sh3 Length = 60 | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 2da9_A | 70 | Solution Structure Of The Third Sh3 Domain Of Sh3-D | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 2k9g_A | 73 | Solution Structure Of The Third Sh3 Domain Of The C | 3e-07 | ||
| 3jv3_A | 283 | Structure Of Sh3e-Dh Unit Of Murine Intersectin-1l | 3e-07 | ||
| 2jte_A | 64 | Third Sh3 Domain Of Cd2ap Length = 64 | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-07 | ||
| 2ydl_A | 69 | Crystal Structure Of Sh3c From Cin85 Length = 69 | 5e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2RF0|A Chain A, Crystal Structure Of Human Mixed Lineage Kinase Map3k10 Sh3 Domain Length = 89 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1H3H|A Chain A, Structural Basis For Specific Recognition Of An Rxxk-Containing Slp-76 Peptide By The Gads C-Terminal Sh3 Domain Length = 60 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1UTI|A Chain A, MonaGADS SH3C IN COMPLEX WITH HPK DERIVED PEPTIDE Length = 58 | Back alignment and structure |
|
| >pdb|1OEB|A Chain A, MonaGADS SH3C DOMAIN Length = 62 | Back alignment and structure |
|
| >pdb|2D0N|A Chain A, Crystal Structure Of The C-Terminal Sh3 Domain Of The Adaptor Protein Gads In Complex With Slp-76 Motif Peptide Reveals A Unique Sh3-Sh3 Interaction Length = 59 | Back alignment and structure |
|
| >pdb|2XMF|A Chain A, Myosin 1e Sh3 Length = 60 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2DA9|A Chain A, Solution Structure Of The Third Sh3 Domain Of Sh3-Domain Kinase Binding Protein 1 (Regulator Of Ubiquitous Kinase, Ruk) Length = 70 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2K9G|A Chain A, Solution Structure Of The Third Sh3 Domain Of The Cin85 Adapter Protein Length = 73 | Back alignment and structure |
|
| >pdb|3JV3|A Chain A, Structure Of Sh3e-Dh Unit Of Murine Intersectin-1l Length = 283 | Back alignment and structure |
|
| >pdb|2JTE|A Chain A, Third Sh3 Domain Of Cd2ap Length = 64 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2YDL|A Chain A, Crystal Structure Of Sh3c From Cin85 Length = 69 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 404 bits (1041), Expect = e-140
Identities = 172/271 (63%), Positives = 211/271 (77%), Gaps = 3/271 (1%)
Query: 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENI---LENVKQEGKLL 167
L+EID+ +L E IG GGFGKVY+ + EVA+K A +PDE+I +ENV+QE KL
Sbjct: 1 LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNY 227
+ H NI++L GVCL+ P LCLVME+ARGGPLNRVL+G++I PD+LV+WA+QIA GMNY
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNY 120
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAW 287
LH +A + +IHRDLKSSN+L+ + +EN DL K LKITDFGLARE ++TT MSAAG YAW
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW 180
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347
MAPEVI+ S+FSK SDVWSYGV+LWELLTGE+P++ I+ AVAYGVA+NKL LPIPSTCP
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240
Query: 348 QLFKTLMEACWEADSHMRPSFKTILKALNNI 378
+ F LME CW D H RPSF IL L I
Sbjct: 241 EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 362 bits (931), Expect = e-123
Identities = 98/298 (32%), Positives = 150/298 (50%), Gaps = 17/298 (5%)
Query: 100 NLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAH-PNPDENILE 158
NL D ++I + L E IG G FG V++ + +VA+K+ + +
Sbjct: 20 NLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVN 79
Query: 159 NVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL----AGRKIRPDVL 214
+E ++ H NIV +G Q P L +V EY G L R+L A ++
Sbjct: 80 EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 215 VDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274
+ A +A+GMNYLH + P ++HR+LKS N+L+ + T+K+ DFGL+R
Sbjct: 140 LSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDK--------KYTVKVCDFGLSRLKA 190
Query: 275 KT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG 332
T + SAAGT WMAPEV++ ++ SDV+S+GV+LWEL T + P+ ++N V
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250
Query: 333 VAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHES 390
V L IP ++E CW + RPSF TI+ L ++ S + P+ S
Sbjct: 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS-AVPPPNRS 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-122
Identities = 107/314 (34%), Positives = 155/314 (49%), Gaps = 23/314 (7%)
Query: 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLF 170
L IDY ++ E +G G FG V K + ++VAIK E+ + E + L
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE---SESERKAFIVELRQLSRV 58
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV----LVDWAIQIAEGMN 226
+H NIV L G CL +CLVMEYA GG L VL G + P + W +Q ++G+
Sbjct: 59 NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA 286
YLH P +LIHRDLK N+LL LKI DFG A ++ +T + G+ A
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLL-------VAGGTVLKICDFGTACDI-QTHMTNNKGSAA 168
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPST 345
WMAPEV + S +S+ DV+S+G++LWE++T P+ I A AV+ P+
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN 228
Query: 346 CPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS-----EFIQTPHESFHIMQDGWRV 400
P+ ++LM CW D RPS + I+K + +++ E +Q P + + RV
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRV 288
Query: 401 EIEQVLHELRVKEK 414
E E
Sbjct: 289 EPYVDFAEFYRLWS 302
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-113
Identities = 84/292 (28%), Positives = 140/292 (47%), Gaps = 21/292 (7%)
Query: 101 LVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDEN--- 155
+ S +L + N++ + + IG+GGFG V+KG K VAIK E
Sbjct: 3 MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 156 ---ILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK--IR 210
+ ++E ++ +H NIV L G+ P +VME+ G L L + I+
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIK 120
Query: 211 PDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270
V + + IA G+ Y+ Q P ++HRDL+S N+ L EN + K+ DFGL+
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPV---CAKVADFGLS 176
Query: 271 REVYKTTHMSAAGTYAWMAPEVIKT--SIFSKASDVWSYGVVLWELLTGEIPYKSINAYA 328
++ + G + WMAPE I +++ +D +S+ ++L+ +LTGE P+ +
Sbjct: 177 QQSVHSV-SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
Query: 329 VAYGVAV--NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
+ + + L IP CP + ++E CW D RP F I+K L+ +
Sbjct: 236 IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 335 bits (861), Expect = e-113
Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 21/275 (7%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHP-NPDENILENVKQEGKLLWLFD 171
ID+ +L F + E G+++KG ++ ++ +KV + + +E L +F
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 172 HRNIVSLIGVCLQSP--KLCLVMEYARGGPLNRVL---AGRKIRPDVLVDWAIQIAEGMN 226
H N++ ++G C P L+ + G L VL + V +A+ +A GM
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA 286
+LH P+ + L S +V++ E T +I+ + M A
Sbjct: 126 FLHTLEPL-IPRHALNSRSVMIDE--------DMTARISMADVKFSFQSPGRM---YAPA 173
Query: 287 WMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP 343
W+APE ++ +++D+WS+ V+LWEL+T E+P+ ++ + VA+ L IP
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233
Query: 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
LM+ C D RP F I+ L +
Sbjct: 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-109
Identities = 79/285 (27%), Positives = 125/285 (43%), Gaps = 32/285 (11%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHP-NPDENILENVKQEGKLLWLFD 171
+I + +L GE IG+G FG+VY G + EVAI++ +E+ L+ K+E
Sbjct: 29 DIPFEQLEIGELIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPD--VLVDWAIQIAEGMNYLH 229
H N+V +G C+ P L ++ +G L V+ KI D A +I +GM YLH
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE-------VYKTTHMSAA 282
+ I +H+DLKS NV + ITDFGL +
Sbjct: 148 AK-GI--LHKDLKSKNVFYDN---------GKVVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 283 GTYAWMAPEVIKTSI---------FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGV 333
G +APE+I+ FSK SDV++ G + +EL E P+K+ A A+ + +
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255
Query: 334 AVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
+ ++ CW + RP+F ++ L +
Sbjct: 256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 5e-98
Identities = 97/280 (34%), Positives = 143/280 (51%), Gaps = 27/280 (9%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHP-NPDENILENVKQEGKLLWLFD 171
EI ++ G+ IG G FG VYKG + +VA+K+ + P L+ K E +L
Sbjct: 20 EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLH 229
H NI+ +G P+L +V ++ G L L + K L+D A Q A GM+YLH
Sbjct: 79 HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT----THMSAAGTY 285
+ S+IHRDLKS+N+ L E T+KI DFGLA E + +G+
Sbjct: 138 AK---SIIHRDLKSNNIFLHE--------DNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 286 AWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL---- 338
WMAPEVI+ ++ +S SDV+++G+VL+EL+TG++PY +IN +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
+ S CP+ K LM C + RPSF IL + +
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 7e-93
Identities = 78/296 (26%), Positives = 124/296 (41%), Gaps = 33/296 (11%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF 170
+ LI GE +G+G FG+ K + + + +K DE +E K++
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI-RFDEETQRTFLKEVKVMRCL 64
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYL 228
+H N++ IGV + +L + EY +GG L ++ + V +A IA GM YL
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV--------------- 273
H ++IHRDL S N L+ E+ + + DFGLAR +
Sbjct: 125 HSM---NIIHRDLNSHNCLV-----RENK---NVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 274 -YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG 332
+ + G WMAPE+I + + DV+S+G+VL E++ + +G
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 333 VAVNK-LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTP 387
+ V L P CP F + C + D RPSF + L + P
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 1e-79
Identities = 91/300 (30%), Positives = 137/300 (45%), Gaps = 39/300 (13%)
Query: 107 NDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENV 160
N L + + + +G G FG VYKG++ K VAIK + +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 64
Query: 161 KQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWA 218
E ++ D+ ++ L+G+CL S + L+ + G L + I L++W
Sbjct: 65 LDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 219 IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK--T 276
+QIA+GMNYL + L+HRDL + NVL+ P + +KITDFGLA+ +
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTP--------QHVKITDFGLAKLLGAEEK 172
Query: 277 THMSAAGTY--AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGV 333
+ + G WMA E I I++ SDVWSYGV +WEL+T G PY I A +
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---- 228
Query: 334 AVNKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHE 389
+ L LP P C +M CW D+ RP F+ ++ S+ + P
Sbjct: 229 -SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEF-----SKMARDPQR 282
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-79
Identities = 87/285 (30%), Positives = 139/285 (48%), Gaps = 32/285 (11%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVKQEGKLL 167
I ++ +GEG FG+VY+G+Y EK VA+K + + E E ++
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGM 225
DH +IV LIG+ + P ++ME G L L ++ LV +++QI + M
Sbjct: 68 KNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT- 284
YL I+ +HRD+ N+L++ P +K+ DFGL+R + + A+ T
Sbjct: 127 AYL---ESINCVHRDIAVRNILVASPE--------CVKLGDFGLSRYIEDEDYYKASVTR 175
Query: 285 --YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT-- 339
WM+PE I F+ ASDVW + V +WE+L+ G+ P+ + V + L
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-----IGVLEKG 230
Query: 340 --LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
LP P CP + TLM CW+ D RP F ++ +L+++ E
Sbjct: 231 DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 2e-79
Identities = 72/301 (23%), Positives = 122/301 (40%), Gaps = 51/301 (16%)
Query: 119 LIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
+ E +G+G +G+V++G ++ + VA+K+ + DE + E + H NI+
Sbjct: 10 ITLLECVGKGRYGEVWRGSWQGENVAVKI-FSSRDEKSWFR-ETELYNTVMLRHENILGF 67
Query: 179 IGVCL----QSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
I + S +L L+ Y G L L + + + IA G+ +LH +
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 235 SL-----IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM------SAAG 283
+ HRDLKS N+L+ ++ I D GLA ++T+ G
Sbjct: 128 TQGKPAIAHRDLKSKNILV-----KKNG---QCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 284 TYAWMAPEVIKTSI------FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG----- 332
T +MAPEV+ +I K D+W++G+VLWE+ + + Y +
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 333 ----------VAVNKLTLPIPST-----CPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
V V++ IP+ LM+ CW + R + I K L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 378 I 378
I
Sbjct: 300 I 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 3e-79
Identities = 71/314 (22%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
++ + IG+G +G+V+ G + ++VA+KV E + E L H
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFF--TTEEASWFRETEIYQTVLMRH 90
Query: 173 RNIVSLIGVCLQS----PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYL 228
NI+ I ++ +L L+ +Y G L L + ++ A G+ +L
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHL 150
Query: 229 HCQAPISL-----IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----- 278
H + + HRDLKS N+L+ ++ T I D GLA + T+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILV-----KKNG---TCCIADLGLAVKFISDTNEVDIP 202
Query: 279 -MSAAGTYAWMAPEVIKTSI------FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY 331
+ GT +M PEV+ S+ +D++S+G++LWE+ + + Y + Y
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 332 ---------------GVAVNKLTLPIPST-----CPQLFKTLMEACWEADSHMRPSFKTI 371
V + KL P+ C + LM CW + R + +
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 372 LKALNNIVHSEFIQ 385
K L + S+ I+
Sbjct: 323 KKTLAKMSESQDIK 336
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 4e-78
Identities = 92/294 (31%), Positives = 140/294 (47%), Gaps = 32/294 (10%)
Query: 107 NDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVK 161
+ + EI ++ G IGEG FG V++GIY VAIK +++ E
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 162 QEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAI 219
QE + FDH +IV LIGV ++P + ++ME G L L + L+ +A
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 220 QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM 279
Q++ + YL +HRD+ + NVL+S +K+ DFGL+R + +T+
Sbjct: 124 QLSTALAYL---ESKRFVHRDIAARNVLVSSND--------CVKLGDFGLSRYMEDSTYY 172
Query: 280 SAAGT---YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAV 335
A+ WMAPE I F+ ASDVW +GV +WE+L G P++ + V +
Sbjct: 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----I 227
Query: 336 NKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
++ LP+P CP +LM CW D RP F + L+ I+ E Q
Sbjct: 228 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 281
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 5e-78
Identities = 92/294 (31%), Positives = 140/294 (47%), Gaps = 35/294 (11%)
Query: 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVKQEGK 165
++ + F E IG G FG VY G +K A+K + D + EG
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 166 LLWLFDHRNIVSLIGVCLQS-PKLCLVMEYARGGPLNRVLAGRKIRPDV--LVDWAIQIA 222
++ F H N++SL+G+CL+S +V+ Y + G L + P V L+ + +Q+A
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 138
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA 282
+GM YL A +HRDL + N +L E T+K+ DFGLAR++Y + S
Sbjct: 139 KGMKYL---ASKKFVHRDLAARNCMLDEK--------FTVKVADFGLARDMYDKEYYSVH 187
Query: 283 GTYA------WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAV 335
WMA E ++T F+ SDVWS+GV+LWEL+T G PY +N + +
Sbjct: 188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----T 242
Query: 336 NKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
L L P CP +M CW + MRPSF ++ ++ I + +
Sbjct: 243 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 1e-77
Identities = 93/279 (33%), Positives = 134/279 (48%), Gaps = 21/279 (7%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF 170
+++ L+ GE IG G FG+V+ G + VA+K ++ QE ++L +
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYL 228
H NIV LIGVC Q + +VME +GG L G ++R L+ A GM YL
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA-- 286
+ IHRDL + N L++E LKI+DFG++RE + ++ G
Sbjct: 230 ESK---CCIHRDLAARNCLVTEK--------NVLKISDFGMSREEADGVYAASGGLRQVP 278
Query: 287 --WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343
W APE + +S SDVWS+G++LWE + G PY +++ V LP P
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCP 337
Query: 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
CP LME CW + RPSF TI + L +I
Sbjct: 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 3e-77
Identities = 88/303 (29%), Positives = 141/303 (46%), Gaps = 47/303 (15%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E+ K+ +G+G FG VY+G+ + VAIK + E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV------------ 213
++ F+ ++V L+GV Q ++ME G L L R +RP +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLAPPSLS 138
Query: 214 -LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272
++ A +IA+GM YL+ +HRDL + N +++E T+KI DFG+ R+
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED--------FTVKIGDFGMTRD 187
Query: 273 VYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAY 327
+Y+T + G WM+PE +K +F+ SDVWS+GVVLWE+ T E PY+ ++
Sbjct: 188 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247
Query: 328 AVAYGVAVNKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383
V + + L P CP + LM CW+ + MRPSF I+ ++ + F
Sbjct: 248 QV-----LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302
Query: 384 IQT 386
+
Sbjct: 303 REV 305
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 3e-77
Identities = 84/283 (29%), Positives = 130/283 (45%), Gaps = 35/283 (12%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
++ +L + IG+G FG V G Y +VA+K + + E ++ H
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA---QAFLAEASVMTQLRH 73
Query: 173 RNIVSLIGVCLQS-PKLCLVMEYARGGPLN---RVLAGRKIRPDVLVDWAIQIAEGMNYL 228
N+V L+GV ++ L +V EY G L R + D L+ +++ + E M YL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---Y 285
+ +HRDL + NVL+SE K++DFGL +E T
Sbjct: 134 EGN---NFVHRDLAARNVLVSED--------NVAKVSDFGLTKEASSTQD----TGKLPV 178
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT----L 340
W APE ++ FS SDVWS+G++LWE+ + G +PY I V V ++ +
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGYKM 233
Query: 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383
P CP +M+ CW D+ MRPSF + + L +I E
Sbjct: 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 276
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 1e-76
Identities = 98/316 (31%), Positives = 156/316 (49%), Gaps = 43/316 (13%)
Query: 97 EDINLVSSVINDVKLVEI--DYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAH 149
D++ S+++ +VK V I + IG+G FG VY G Y + + AIK
Sbjct: 1 RDLD--SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS 58
Query: 150 PNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-PKLCLVMEYARGGPLNRVLAGRK 208
+ +E +EG L+ +H N+++LIG+ L +++ Y G L + + +
Sbjct: 59 RITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ 118
Query: 209 IRPDV--LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266
P V L+ + +Q+A GM YL A +HRDL + N +L E T+K+ D
Sbjct: 119 RNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDES--------FTVKVAD 167
Query: 267 FGLAREVYKTTHMSAAGTYA------WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEI 319
FGLAR++ + S W A E ++T F+ SDVWS+GV+LWELLT G
Sbjct: 168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227
Query: 320 PYKSINAYAVAYGVAVNKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
PY+ I+ + + + L LP P CP +M+ CWEAD +RP+F+ ++ +
Sbjct: 228 PYRHIDPFDL-----THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282
Query: 376 NNIVHS----EFIQTP 387
IV + ++Q P
Sbjct: 283 EQIVSALLGDHYVQLP 298
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 2e-76
Identities = 96/302 (31%), Positives = 126/302 (41%), Gaps = 38/302 (12%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKL 166
L +GEG FGKV Y + VA+K + KQE +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 167 LWLFDHRNIVSLIGVCLQSPK--LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEG 224
L H +I+ G C + L LVMEY G L L I L+ +A QI EG
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEG 146
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT 284
M YLH Q IHRDL + NVLL + +KI DFGLA+ V +
Sbjct: 147 MAYLHAQ---HYIHRDLAARNVLLDND--------RLVKIGDFGLAKAVPEGHEYYRVRE 195
Query: 285 YA-----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAY-----GV 333
W APE +K F ASDVWS+GV L+ELLT + + +
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255
Query: 334 AVNKLT--------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
V +LT LP P CP LM+ CWE ++ RP+F+ ++ L + Q
Sbjct: 256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315
Query: 386 TP 387
P
Sbjct: 316 AP 317
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 5e-76
Identities = 91/292 (31%), Positives = 138/292 (47%), Gaps = 35/292 (11%)
Query: 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVKQEGK 165
++ + F E IG G FG VY G +K A+K + D + EG
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 166 LLWLFDHRNIVSLIGVCLQS-PKLCLVMEYARGGPLNRVLAGRKIRPDV--LVDWAIQIA 222
++ F H N++SL+G+CL+S +V+ Y + G L + P V L+ + +Q+A
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 202
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA 282
+GM +L A +HRDL + N +L E T+K+ DFGLAR++Y S
Sbjct: 203 KGMKFL---ASKKFVHRDLAARNCMLDEK--------FTVKVADFGLARDMYDKEFDSVH 251
Query: 283 GTYA------WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAV 335
WMA E ++T F+ SDVWS+GV+LWEL+T G PY +N + +
Sbjct: 252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----T 306
Query: 336 NKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383
L L P CP +M CW + MRPSF ++ ++ I +
Sbjct: 307 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 5e-76
Identities = 88/342 (25%), Positives = 148/342 (43%), Gaps = 54/342 (15%)
Query: 96 IEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHP 150
++ + + + ++ V I + G +G+G FG V + +VA+K+
Sbjct: 2 LDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61
Query: 151 N-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS------PKLCLVMEYARGGPLNRV 203
+ + +E +E + FDH ++ L+GV L+S P +++ + + G L+
Sbjct: 62 DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121
Query: 204 LAGRKIRPDV---------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254
L R LV + + IA GM YL + + IHRDL + N +L+E
Sbjct: 122 L--LASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAED--- 173
Query: 255 EDLQFKTLKITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVV 310
T+ + DFGL+R++Y + W+A E + ++++ SDVW++GV
Sbjct: 174 -----MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228
Query: 311 LWELLT-GEIPYKSINAYAVAYGVAVNKLT----LPIPSTCPQLFKTLMEACWEADSHMR 365
+WE++T G+ PY I + N L L P C + LM CW AD R
Sbjct: 229 MWEIMTRGQTPYAGIENAEI-----YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQR 283
Query: 366 PSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLH 407
PSF + L NI+ QD + IE+ H
Sbjct: 284 PSFTCLRMELENILGHL------SVLSTSQDPLYINIERAHH 319
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 5e-76
Identities = 75/302 (24%), Positives = 138/302 (45%), Gaps = 38/302 (12%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY---------EKQEVAIKV---AHPNPDENILENV 160
+I LIF E++G+G F K++KG+ + EV +KV AH N E+
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFF--- 60
Query: 161 KQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWA 218
+ ++ H+++V GVC+ + LV E+ + G L+ L I ++ A
Sbjct: 61 -EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119
Query: 219 IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH 278
Q+A M++L +LIH ++ + N+LL + + +K++D G++ V
Sbjct: 120 KQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 279 MSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVN 336
+ W+ PE I+ + A+D WS+G LWE+ + G+ P ++++ +
Sbjct: 177 LQER--IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-----LQ 229
Query: 337 KLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ--TPHES 390
LP P L L+ C + + RPSF+ I++ LN++ + + + H
Sbjct: 230 FYEDRHQLPAPKAAE-LAN-LINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHH 287
Query: 391 FH 392
H
Sbjct: 288 HH 289
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 8e-76
Identities = 82/282 (29%), Positives = 129/282 (45%), Gaps = 35/282 (12%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
++ +L + IG+G FG V G Y +VA+K + + E ++ H
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA---QAFLAEASVMTQLRH 245
Query: 173 RNIVSLIGVCLQS-PKLCLVMEYARGGPLN---RVLAGRKIRPDVLVDWAIQIAEGMNYL 228
N+V L+GV ++ L +V EY G L R + D L+ +++ + E M YL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---Y 285
+ +HRDL + NVL+SE K++DFGL +E T
Sbjct: 306 EGN---NFVHRDLAARNVLVSEDN--------VAKVSDFGLTKEASSTQD----TGKLPV 350
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT----L 340
W APE ++ FS SDVWS+G++LWE+ + G +PY I V V ++ +
Sbjct: 351 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGYKM 405
Query: 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
P CP +M+ CW D+ RP+F + + L +I E
Sbjct: 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 15/68 (22%), Positives = 29/68 (42%), Gaps = 7/68 (10%)
Query: 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
A Y++ +L +GD++ +++ + D W+ K + GI PAN+
Sbjct: 12 TECIAKYNFHGTAEQDLPFCKGDVLTIVAV----TKDPNWYKAK---NKVGREGIIPANY 64
Query: 93 VSSIEDIN 100
V E +
Sbjct: 65 VQKREGVK 72
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 9e-76
Identities = 85/302 (28%), Positives = 131/302 (43%), Gaps = 39/302 (12%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKL 166
+L + +G G FG V+KG++ K V IKV + V
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEG 224
+ DH +IV L+G+C S L LV +Y G L + + + P +L++W +QIA+G
Sbjct: 69 IGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT-THMSAAG 283
M YL ++HR+L + NVLL P +++ DFG+A + + +
Sbjct: 128 MYYLEEH---GMVHRNLAARNVLLKSP--------SQVQVADFGVADLLPPDDKQLLYSE 176
Query: 284 T---YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT 339
WMA E I ++ SDVWSYGV +WEL+T G PY + V + L
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-----PDLLE 231
Query: 340 ----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQ 395
L P C +M CW D ++RP+FK + + + P I +
Sbjct: 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF-----TRMARDPPRYLVIKR 286
Query: 396 DG 397
+
Sbjct: 287 ES 288
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 9e-76
Identities = 88/287 (30%), Positives = 124/287 (43%), Gaps = 33/287 (11%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVKQEGKLL 167
EI+ +++ + IG G G+V G VAIK E + E ++
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGM 225
FDH NI+ L GV + +V EY G L+ L + LV + GM
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK---TTHMSAA 282
YL +HRDL + NVL+ K++DFGL+R + + +
Sbjct: 165 RYLSDL---GYVHRDLAARNVLVDSN--------LVCKVSDFGLSRVLEDDPDAAYTTTG 213
Query: 283 GTYA--WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT 339
G W APE I FS ASDVWS+GVV+WE+L GE PY ++ V ++ +
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----ISSVE 268
Query: 340 ----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
LP P CP LM CW D RP F I+ L+ ++ S
Sbjct: 269 EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-75
Identities = 89/291 (30%), Positives = 129/291 (44%), Gaps = 27/291 (9%)
Query: 107 NDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNP--DENILEN 159
I L E +G+G FG V +G + + VA+K P+ +++
Sbjct: 8 LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 160 VKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDW 217
+E + DHRN++ L GV L P + +V E A G L L L +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 218 AIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY--- 274
A+Q+AEGM YL + IHRDL + N+LL+ +KI DFGL R +
Sbjct: 127 AVQVAEGMGYLESK---RFIHRDLAARNLLLATR--------DLVKIGDFGLMRALPQND 175
Query: 275 KTTHMSAAGT--YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAY 331
M +AW APE +KT FS ASD W +GV LWE+ T G+ P+ +N + +
Sbjct: 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235
Query: 332 GVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
+ LP P CPQ +M CW RP+F + L ++
Sbjct: 236 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-75
Identities = 88/292 (30%), Positives = 128/292 (43%), Gaps = 33/292 (11%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E+ + +G G FG+VY+G +VA+K E + E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV----------LV 215
++ F+H+NIV IGV LQS ++ME GG L L R+ RP L+
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL--RETRPRPSQPSSLAMLDLL 143
Query: 216 DWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275
A IA G YL IHRD+ + N LL+ P + KI DFG+AR++Y+
Sbjct: 144 HVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPG-----RVAKIGDFGMARDIYR 195
Query: 276 TTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVA 330
++ G WM PE IF+ +D WS+GV+LWE+ + G +PY S + V
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255
Query: 331 YGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
V + P CP +M CW+ RP+F IL+ +
Sbjct: 256 EFVTSGGR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 3e-75
Identities = 87/282 (30%), Positives = 134/282 (47%), Gaps = 29/282 (10%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFD 171
ID ++L F + IG G FG V+ G + + +VAIK E+ +E +++
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLS 61
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLH 229
H +V L GVCL+ +CLV E+ G L+ L + L+ + + EGM YL
Sbjct: 62 HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL- 120
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---YA 286
+IHRDL + N L+ E +K++DFG+ R V + S+ GT
Sbjct: 121 --EEACVIHRDLAARNCLVGENQ--------VIKVSDFGMTRFVLDDQYTSSTGTKFPVK 170
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT----LP 341
W +PEV S +S SDVWS+GV++WE+ + G+IPY++ + V V ++ L
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLY 225
Query: 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383
P +M CW RP+F +L+ L I S
Sbjct: 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 3e-75
Identities = 89/293 (30%), Positives = 135/293 (46%), Gaps = 34/293 (11%)
Query: 107 NDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENV 160
N L + + + +G G FG VYKG++ K VAIK + +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 64
Query: 161 KQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWA 218
E ++ D+ ++ L+G+CL S + L+ + G L + I L++W
Sbjct: 65 LDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 219 IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK--T 276
+QIA+GMNYL + L+HRDL + NVL+ P + +KITDFGLA+ +
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTP--------QHVKITDFGLAKLLGAEEK 172
Query: 277 THMSAAGTY--AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGV 333
+ + G WMA E I I++ SDVWSYGV +WEL+T G PY I A +
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---- 228
Query: 334 AVNKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
+ L LP P C +M CW D+ RP F+ ++ + +
Sbjct: 229 -SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 4e-75
Identities = 77/314 (24%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
++ E+IG+G FG+V++G + +EVA+K+ +E + E + H
Sbjct: 38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS-REERSWFR-EAEIYQTVMLRH 95
Query: 173 RNIVSLIGVCLQ----SPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYL 228
NI+ I + +L LV +Y G L L + + ++ A+ A G+ +L
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 155
Query: 229 HCQAPISL-----IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM---- 279
H + + HRDLKS N+L+ + T I D GLA T
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKN--------GTCCIADLGLAVRHDSATDTIDIA 207
Query: 280 --SAAGTYAWMAPEVIKTSI------FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY 331
GT +MAPEV+ SI K +D+++ G+V WE+ Y + Y
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267
Query: 332 G---------------VAVNKLTLPIPST-----CPQLFKTLMEACWEADSHMRPSFKTI 371
V KL IP+ ++ +M CW A+ R + I
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327
Query: 372 LKALNNIVHSEFIQ 385
K L+ + E I+
Sbjct: 328 KKTLSQLSQQEGIK 341
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 5e-75
Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 29/281 (10%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFD 171
E+ ++ + +G G FG V G ++ Q +VA+K+ + QE + +
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLS 61
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLH 229
H +V GVC + + +V EY G L L G+ + P L++ + EGM +L
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---YA 286
IHRDL + N L+ +K++DFG+ R V ++S+ GT
Sbjct: 122 SH---QFIHRDLAARNCLVDRD--------LCVKVSDFGMTRYVLDDQYVSSVGTKFPVK 170
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT----LP 341
W APEV +S SDVW++G+++WE+ + G++PY V V K++ L
Sbjct: 171 WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-----VLKVSQGHRLY 225
Query: 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
P +M +CW RP+F+ +L ++ + +
Sbjct: 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 8e-75
Identities = 87/292 (29%), Positives = 127/292 (43%), Gaps = 33/292 (11%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E+ + +G G FG+VY+G +VA+K E + E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV----------LV 215
++ F+H+NIV IGV LQS +++E GG L L R+ RP L+
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLL 184
Query: 216 DWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275
A IA G YL IHRD+ + N LL+ P + KI DFG+AR++Y+
Sbjct: 185 HVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPG-----RVAKIGDFGMARDIYR 236
Query: 276 TTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVA 330
+ G WM PE IF+ +D WS+GV+LWE+ + G +PY S + V
Sbjct: 237 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296
Query: 331 YGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
V + P CP +M CW+ RP+F IL+ +
Sbjct: 297 EFVTSGGR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 2e-74
Identities = 88/294 (29%), Positives = 133/294 (45%), Gaps = 26/294 (8%)
Query: 112 VEIDYNKLIFGE-AIGEGGFGKVYKGIY----EKQEVAIKVAHPN-PDENILENVKQEGK 165
V +D L + +G G FG V KG Y + VA+K+ D + + + E
Sbjct: 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 70
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEG 224
++ D+ IV +IG+C LVME A GPLN+ L R ++ +++ Q++ G
Sbjct: 71 VMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 129
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK---TTHMSA 281
M YL + +HRDL + NVLL KI+DFGL++ +
Sbjct: 130 MKYLEES---NFVHRDLAARNVLLVTQ--------HYAKISDFGLSKALRADENYYKAQT 178
Query: 282 AGTY--AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338
G + W APE I FS SDVWS+GV++WE + G+ PY+ + V + +
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 238
Query: 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFH 392
+ P+ CP+ LM CW D RP F + L N + + H H
Sbjct: 239 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH 291
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 2e-74
Identities = 81/311 (26%), Positives = 139/311 (44%), Gaps = 47/311 (15%)
Query: 101 LVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHP-NPDE 154
+ N ++ V ID N LI G+ +GEG FG V +G +VA+K N +
Sbjct: 18 GSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ 77
Query: 155 NILENVKQEGKLLWLFDHRNIVSLIGVCLQS-----PKLCLVMEYARGGPLNRVLAGRKI 209
+E E + F H N++ L+GVC++ PK +++ + + G L+ L
Sbjct: 78 REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL--LYS 135
Query: 210 RPDV---------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260
R + L+ + + IA GM YL + + +HRDL + N +L +
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDD--------M 184
Query: 261 TLKITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT 316
T+ + DFGL++++Y + W+A E + +++ SDVW++GV +WE+ T
Sbjct: 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
Query: 317 -GEIPYKSINAYAVAYGVAVNKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
G PY + + + + L L P C +M +CW D RP+F +
Sbjct: 245 RGMTPYPGVQNHEM-----YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVL 299
Query: 372 LKALNNIVHSE 382
L ++ S
Sbjct: 300 RLQLEKLLESL 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 2e-74
Identities = 85/296 (28%), Positives = 126/296 (42%), Gaps = 40/296 (13%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKL 166
+ L +GEG FGKV Y ++VA+K P N + ++K+E ++
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 167 LWLFDHRNIVSLIGVCLQSPK--LCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIA 222
L H NIV G+C + + L+ME+ G L L K I + +A+QI
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA 282
+GM+YL + +HRDL + NVL+ +KI DFGL + +
Sbjct: 137 KGMDYLGSR---QYVHRDLAARNVLVESE--------HQVKIGDFGLTKAIETDKEYYTV 185
Query: 283 GTYA-----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAY----- 331
W APE + S F ASDVWS+GV L ELLT + + +
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245
Query: 332 GVAVNKLT--------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
+ V +L LP P CP LM CWE R SF+ +++ ++
Sbjct: 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-74
Identities = 87/288 (30%), Positives = 137/288 (47%), Gaps = 34/288 (11%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKL 166
EI + + + IG G FG+VYKG+ ++ VAIK E + E +
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEG 224
+ F H NI+ L GV + + ++ EY G L++ L + LV IA G
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV---YKTTHMSA 281
M YL + +HRDL + N+L++ K++DFGL+R + + T+ ++
Sbjct: 160 MKYLANM---NYVHRDLAARNILVNSN--------LVCKVSDFGLSRVLEDDPEATYTTS 208
Query: 282 AGTYA--WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338
G W APE I F+ ASDVWS+G+V+WE++T GE PY ++ + V + +
Sbjct: 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MKAI 263
Query: 339 T----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
LP P CP LM CW+ + RP F I+ L+ ++ +
Sbjct: 264 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 3e-74
Identities = 98/302 (32%), Positives = 129/302 (42%), Gaps = 45/302 (14%)
Query: 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQ 162
KL EI + + F E +GE FGKVYKG + Q VAIK + + E +
Sbjct: 2 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61
Query: 163 EGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV--------- 213
E L H N+V L+GV + L ++ Y G L+ L P
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL--VMRSPHSDVGSTDDDR 119
Query: 214 ----------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263
V QIA GM YL + ++H+DL + NVL+ + L +K
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLV-----YDKL---NVK 168
Query: 264 ITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GE 318
I+D GL REVY + G WMAPE I FS SD+WSYGVVLWE+ + G
Sbjct: 169 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228
Query: 319 IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
PY + V + ++ LP P CP LM CW RP FK I L
Sbjct: 229 QPYCGYSNQDVVEMIRNRQV-LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
Query: 379 VH 380
+
Sbjct: 288 GN 289
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 3e-74
Identities = 95/288 (32%), Positives = 142/288 (49%), Gaps = 32/288 (11%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVKQEGKLL 167
EI ++ G IGEG FG V++GIY VAIK +++ E QE +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV--LVDWAIQIAEGM 225
FDH +IV LIGV ++P + ++ME G L L RK D+ L+ +A Q++ +
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT- 284
YL +HRD+ + NVL+S +K+ DFGL+R + +T+ A+
Sbjct: 505 AYL---ESKRFVHRDIAARNVLVSSN--------DCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 285 --YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT-- 339
WMAPE I F+ ASDVW +GV +WE+L G P++ + V + ++
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENG 608
Query: 340 --LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
LP+P CP +LM CW D RP F + L+ I+ E +Q
Sbjct: 609 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 4e-74
Identities = 85/282 (30%), Positives = 133/282 (47%), Gaps = 31/282 (10%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFD 171
E+ L E +G G FG+V+ G Y +VA+K + E L+
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQ 66
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLN---RVLAGRKIRPDVLVDWAIQIAEGMNYL 228
H+ +V L V Q P + ++ EY G L + +G K+ + L+D A QIAEGM ++
Sbjct: 67 HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---Y 285
+ + IHRDL+++N+L+S+ + + KI DFGLAR + + + G
Sbjct: 126 EER---NYIHRDLRAANILVSDTL--------SCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT----L 340
W APE I F+ SDVWS+G++L E++T G IPY + V + L +
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----IQNLERGYRM 229
Query: 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
P CP+ LM CW+ RP+F + L + +
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 6e-74
Identities = 91/291 (31%), Positives = 137/291 (47%), Gaps = 34/291 (11%)
Query: 113 EIDYNKLIFGEA-IGEGGFGKVYKGIY----EKQEVAIKVAHPNPDENILENVKQEGKLL 167
+ + L+ + +G G FG V +G+Y ++ +VAIKV ++ E + +E +++
Sbjct: 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 64
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGM 225
D+ IV LIGVC L LVME A GGPL++ L +I + + Q++ GM
Sbjct: 65 HQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK---TTHMSAA 282
YL + +HRDL + NVLL KI+DFGL++ + +A
Sbjct: 124 KYL---EEKNFVHRDLAARNVLLVNR--------HYAKISDFGLSKALGADDSYYTARSA 172
Query: 283 GTY--AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT 339
G + W APE I FS SDVWSYGV +WE L+ G+ PYK + V + +
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----MAFIE 227
Query: 340 ----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQT 386
+ P CP LM CW RP F T+ + + +S +
Sbjct: 228 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 7e-74
Identities = 78/281 (27%), Positives = 131/281 (46%), Gaps = 29/281 (10%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFD 171
EID L F + +G G FG V G + Q +VAIK+ + +E K++
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLS 77
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLH 229
H +V L GVC + + ++ EY G L L + + L++ + E M YL
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL- 136
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---YA 286
+HRDL + N L+++ +K++DFGL+R V + S+ G+
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQG--------VVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT----LP 341
W PEV+ S FS SD+W++GV++WE+ + G++PY+ + L
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----AEHIAQGLRLY 241
Query: 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
P + T+M +CW + RP+FK +L + +++ E
Sbjct: 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-73
Identities = 91/305 (29%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E N+L FG+ +G G FGKV + VA+K+ P+ E + E K
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 166 LL-WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV----------- 213
+L +L +H NIV+L+G C ++ EY G L L R+ R
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIME 136
Query: 214 ----------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263
L+ ++ Q+A+GM +L A + IHRDL + N+LL+ + K
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHG--------RITK 185
Query: 264 ITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GE 318
I DFGLAR++ ++ G WMAPE I +++ SDVWSYG+ LWEL + G
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 319 IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
PY + + Y + + P P +M+ CW+AD RP+FK I++ +
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 379 VHSEF 383
+
Sbjct: 306 ISEST 310
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-73
Identities = 93/313 (29%), Positives = 140/313 (44%), Gaps = 61/313 (19%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E L+ G+ +GEG FGKV K VA+K+ N + L ++ E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV------------ 213
+L +H +++ L G C Q L L++EYA+ G L L R+ R
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNS 136
Query: 214 ---------------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258
L+ +A QI++GM YL A + L+HRDL + N+L++E
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEG------- 186
Query: 259 FKTLKITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWEL 314
+ +KI+DFGL+R+VY+ WMA E + I++ SDVWS+GV+LWE+
Sbjct: 187 -RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 315 LT-GEIPYKSINAYAVAYGVAVNKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFK 369
+T G PY I + N L + P C + LM CW+ + RP F
Sbjct: 246 VTLGGNPYPGIPPERL-----FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300
Query: 370 TILKALNNIVHSE 382
I K L ++
Sbjct: 301 DISKDLEKMMVKR 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 235 bits (600), Expect = 3e-73
Identities = 80/337 (23%), Positives = 129/337 (38%), Gaps = 67/337 (19%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
+D + L E IG G +G VYKG +++ VA+KV + N ++ + L +H
Sbjct: 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF-SFANRQNFIN-EKNIYRVPLMEH 66
Query: 173 RNIVSLIGVCL-----QSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNY 227
NI I + LVMEY G L + L+ A + G+ Y
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAY 126
Query: 228 LHCQAPISL------IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT----- 276
LH + P HRDL S NVL+ D T I+DFGL+ +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLV-----KNDG---TCVISDFGLSMRLTGNRLVRP 178
Query: 277 -----THMSAAGTYAWMAPEVIKTSI-------FSKASDVWSYGVVLWELL---TGEIPY 321
+S GT +MAPEV++ ++ K D+++ G++ WE+ T P
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 322 KSINAYAVAYG---------------VAVNKLTLPIPSTC------PQLFKTLMEACWEA 360
+S+ Y +A+ V+ K P + K +E CW+
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 361 DSHMRPSFKTILKALNNIVHS-----EFIQTPHESFH 392
D+ R + + + + ++ T H H
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHH 335
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 3e-73
Identities = 80/307 (26%), Positives = 119/307 (38%), Gaps = 41/307 (13%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKL 166
+ L + +G+G FG V Y VA+K + + + ++E ++
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQI 77
Query: 167 LWLFDHRNIVSLIGVCLQSPK--LCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIA 222
L IV GV + L LVMEY G L L + + L+ ++ QI
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA 282
+GM YL + +HRDL + N+L+ +KI DFGLA+ +
Sbjct: 138 KGMEYLGSR---RCVHRDLAARNILVESE--------AHVKIADFGLAKLLPLDKDYYVV 186
Query: 283 GTYA-----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVN 336
W APE + +IFS+ SDVWS+GVVL+EL T + + G +
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246
Query: 337 KLT-------------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383
LP P CP LM+ CW RPSF + L+ +
Sbjct: 247 VPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306
Query: 384 IQTPHES 390
H
Sbjct: 307 GCETHAF 313
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 3e-73
Identities = 91/307 (29%), Positives = 139/307 (45%), Gaps = 48/307 (15%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY---------EKQEVAIKVAHPNPDENILENVKQE 163
E +KL G+ +GEG FG+V E VA+K+ + E L ++ E
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 164 GKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV--------- 213
+++ + H+NI++L+G C Q L +++EYA G L L R RP
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINR 194
Query: 214 ----------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263
LV Q+A GM YL Q IHRDL + NVL++E +K
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN--------NVMK 243
Query: 264 ITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GE 318
I DFGLAR++ + WMAPE + +++ SDVWS+GV++WE+ T G
Sbjct: 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 319 IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
PY I + + + P+ C +M CW A RP+FK +++ L+ I
Sbjct: 304 SPYPGIPVEELFKLLKEGHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
Query: 379 VHSEFIQ 385
+ +
Sbjct: 363 LTLTTNE 369
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 4e-73
Identities = 84/282 (29%), Positives = 134/282 (47%), Gaps = 31/282 (10%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFD 171
EI L + +G G FG+V+ Y K +VA+K P +E E ++
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQ 241
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLN---RVLAGRKIRPDVLVDWAIQIAEGMNYL 228
H +V L V + P + ++ E+ G L + G K L+D++ QIAEGM ++
Sbjct: 242 HDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---Y 285
+ + IHRDL+++N+L+S + KI DFGLAR + + + G
Sbjct: 301 EQR---NYIHRDLRAANILVSASL--------VCKIADFGLARVIEDNEYTAREGAKFPI 349
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT----L 340
W APE I F+ SDVWS+G++L E++T G IPY ++ V + L +
Sbjct: 350 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-----IRALERGYRM 404
Query: 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
P P CP+ +M CW+ RP+F+ I L++ +
Sbjct: 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 21/64 (32%), Positives = 34/64 (53%), Gaps = 8/64 (12%)
Query: 37 ALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96
ALYDY+AI ++LS ++GD + VL + WW K K G P+N+V+ +
Sbjct: 13 ALYDYEAIHHEDLSFQKGDQMVVLEESG------EWW--KARSLATRKEGYIPSNYVARV 64
Query: 97 EDIN 100
+ +
Sbjct: 65 DSLE 68
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 8e-73
Identities = 94/309 (30%), Positives = 133/309 (43%), Gaps = 53/309 (17%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E N + + IGEG FG+V++ VA+K+ ++ + ++E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV------------ 213
L+ FD+ NIV L+GVC +CL+ EY G LN L R + P
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL--RSMSPHTVCSLSHSDLSTR 160
Query: 214 ---------------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258
+ A Q+A GM YL + +HRDL + N L+ E
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGEN------- 210
Query: 259 FKTLKITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWEL 314
+KI DFGL+R +Y + A G A WM PE I + ++ SDVW+YGVVLWE+
Sbjct: 211 -MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269
Query: 315 LT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ G PY + V Y V + L P CP LM CW RPSF +I +
Sbjct: 270 FSYGLQPYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328
Query: 374 ALNNIVHSE 382
L +
Sbjct: 329 ILQRMCERA 337
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-72
Identities = 91/307 (29%), Positives = 139/307 (45%), Gaps = 48/307 (15%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY---------EKQEVAIKVAHPNPDENILENVKQE 163
E +KL G+ +GEG FG+V E VA+K+ + E L ++ E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 164 GKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV--------- 213
+++ + H+NI++L+G C Q L +++EYA G L L R RP
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINR 148
Query: 214 ----------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263
LV Q+A GM YL A IHRDL + NVL++E +K
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN--------NVMK 197
Query: 264 ITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GE 318
I DFGLAR++ + WMAPE + +++ SDVWS+GV++WE+ T G
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257
Query: 319 IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
PY I + + + P+ C +M CW A RP+FK +++ L+ I
Sbjct: 258 SPYPGIPVEELFKLLKEGHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
Query: 379 VHSEFIQ 385
+ +
Sbjct: 317 LTLTTNE 323
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 4e-72
Identities = 91/300 (30%), Positives = 137/300 (45%), Gaps = 46/300 (15%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
I ++ +GEG FGKV+ +K VA+K +P ++ ++E +
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAE 69
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV------------ 213
LL H +IV GVC L +V EY + G LN+ L R PD
Sbjct: 70 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL--RAHGPDAMILVDGQPRQAK 127
Query: 214 -------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266
++ A QIA GM YL A +HRDL + N L+ +L +KI D
Sbjct: 128 GELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGA-----NL---LVKIGD 176
Query: 267 FGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPY 321
FG++R+VY T + G WM PE I F+ SDVWS+GV+LWE+ T G+ P+
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236
Query: 322 KSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381
++ V + ++ L P CP+ +M CW+ + R + K I K L+ + +
Sbjct: 237 FQLSNTEVIECITQGRV-LERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 4e-72
Identities = 87/287 (30%), Positives = 132/287 (45%), Gaps = 33/287 (11%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVKQEGKLL 167
E+D + + +G G FG+V G ++ VAIK E + E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGM 225
FDH NI+ L GV +S + +V EY G L+ L + LV IA GM
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK---TTHMSAA 282
YL +HRDL + N+L++ + K++DFGL R + + +
Sbjct: 161 KYLSDM---GYVHRDLAARNILINSNL--------VCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 283 GTYA--WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT 339
G W +PE I F+ ASDVWSYG+VLWE+++ GE PY ++ V + +
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-----IKAVD 264
Query: 340 ----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
LP P CP LM CW+ D + RP F+ I+ L+ ++ +
Sbjct: 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 4e-72
Identities = 87/301 (28%), Positives = 130/301 (43%), Gaps = 52/301 (17%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKL 166
+ + L F + +G+G FG V Y + VA+K + +E+ L + ++E ++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-LRDFEREIEI 64
Query: 167 LWLFDHRNIVSLIGVCLQSPK--LCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIA 222
L H NIV GVC + + L L+MEY G L L K I L+ + QI
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA 282
+GM YL + IHRDL + N+L+ +KI DFGL + + +
Sbjct: 125 KGMEYLGTK---RYIHRDLATRNILVENE--------NRVKIGDFGLTKVLPQDKEFFKV 173
Query: 283 GTYA-----WMAPEVIKTSIFSKASDVWSYGVVLWELLT----------------GEIPY 321
W APE + S FS ASDVWS+GVVL+EL T G
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 322 KSINAYAVAYGVAVNKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
+ + + + L LP P CP +M CW + + RPSF+ + ++
Sbjct: 234 GQMIVFHL-----IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 378 I 378
I
Sbjct: 289 I 289
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 4e-72
Identities = 84/306 (27%), Positives = 135/306 (44%), Gaps = 46/306 (15%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E ++L G+ +G G FG+V + + VA+K+ + + E K
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 166 LLWLFD-HRNIVSLIGVCLQSPK-LCLVMEYARGGPLNRVLAGRKIRPDV---------- 213
+L H N+V+L+G C + L +++E+ + G L+ L R R +
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDL 140
Query: 214 ---------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264
L+ ++ Q+A+GM +L A IHRDL + N+LLSE +KI
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEK--------NVVKI 189
Query: 265 TDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEI 319
DFGLAR++YK G WMAPE I +++ SDVWS+GV+LWE+ + G
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 320 PYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
PY + + P M CW + RP+F +++ L N++
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309
Query: 380 HSEFIQ 385
+ Q
Sbjct: 310 QANAQQ 315
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 6e-72
Identities = 87/301 (28%), Positives = 130/301 (43%), Gaps = 52/301 (17%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKL 166
+ + L F + +G+G FG V Y + VA+K + +E+ L + ++E ++
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-LRDFEREIEI 95
Query: 167 LWLFDHRNIVSLIGVCLQSPK--LCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIA 222
L H NIV GVC + + L L+MEY G L L K I L+ + QI
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA 282
+GM YL + IHRDL + N+L+ +KI DFGL + + +
Sbjct: 156 KGMEYLGTK---RYIHRDLATRNILVENE--------NRVKIGDFGLTKVLPQDKEYYKV 204
Query: 283 GTYA-----WMAPEVIKTSIFSKASDVWSYGVVLWELLT----------------GEIPY 321
W APE + S FS ASDVWS+GVVL+EL T G
Sbjct: 205 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264
Query: 322 KSINAYAVAYGVAVNKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377
+ + + + L LP P CP +M CW + + RPSF+ + ++
Sbjct: 265 GQMIVFHL-----IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
Query: 378 I 378
I
Sbjct: 320 I 320
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 8e-72
Identities = 90/300 (30%), Positives = 133/300 (44%), Gaps = 45/300 (15%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
I ++ +GEG FGKV+ +K VA+K + + + E +
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR-EAE 95
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV------------ 213
LL + H++IV GVC + L +V EY R G LNR L R PD
Sbjct: 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKLLAGGEDVAPG 153
Query: 214 ------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267
L+ A Q+A GM YL A + +HRDL + N L+ + L +KI DF
Sbjct: 154 PLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLV-----GQGL---VVKIGDF 202
Query: 268 GLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYK 322
G++R++Y T + G WM PE I F+ SDVWS+GVVLWE+ T G+ P+
Sbjct: 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262
Query: 323 SINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
++ + + L P CP +M CW+ + R S K + L + +
Sbjct: 263 QLSNTEAIDCITQGRE-LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 8e-72
Identities = 86/282 (30%), Positives = 138/282 (48%), Gaps = 23/282 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQE--VAIKVAHPNPDENILENVKQEGKLLWLF 170
E++ + +G G +G+VY+G+++K VA+K D +E +E ++
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEI 273
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLN---RVLAGRKIRPDVLVDWAIQIAEGMNY 227
H N+V L+GVC + P ++ E+ G L R +++ VL+ A QI+ M Y
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT--- 284
L + + IHR+L + N L+ E +K+ DFGL+R + T+ + AG
Sbjct: 334 LEKK---NFIHRNLAARNCLVGENH--------LVKVADFGLSRLMTGDTYTAHAGAKFP 382
Query: 285 YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343
W APE + + FS SDVW++GV+LWE+ T G PY I+ V + + + P
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-MERP 441
Query: 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
CP+ LM ACW+ + RPSF I +A + I
Sbjct: 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 483
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 17/70 (24%), Positives = 35/70 (50%), Gaps = 8/70 (11%)
Query: 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPA 90
P+L+ ALYD+ A G + LS+ +G+ + VL + + W + + G P+
Sbjct: 42 DPNLFVALYDFVASGDNTLSITKGEKLRVLGY----NHNGEWCEAQTKNGQ----GWVPS 93
Query: 91 NFVSSIEDIN 100
N+++ + +
Sbjct: 94 NYITPVNSLE 103
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-71
Identities = 89/292 (30%), Positives = 134/292 (45%), Gaps = 32/292 (10%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFD 171
EI L +G+G FG+V+ G + VAIK P E QE +++
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLR 237
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLN---RVLAGRKIRPDVLVDWAIQIAEGMNYL 228
H +V L V + P + +V EY G L + G+ +R LVD A QIA GM Y+
Sbjct: 238 HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---Y 285
+ +HRDL+++N+L+ E K+ DFGLAR + + + G
Sbjct: 297 ERM---NYVHRDLRAANILVGEN--------LVCKVADFGLARLIEDNEYTARQGAKFPI 345
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT----L 340
W APE F+ SDVWS+G++L EL T G +PY + V ++++ +
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERGYRM 400
Query: 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ-TPHESF 391
P P CP+ LM CW + RP+F+ + L + S Q P E+
Sbjct: 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 15/67 (22%), Positives = 33/67 (49%), Gaps = 7/67 (10%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ ALYDY++ +LS ++G+ +++++ + WW + G P+N+V
Sbjct: 4 TFVALYDYESRTETDLSFKKGERLQIVNNT-----EGDWW--LAHSLSTGQTGYIPSNYV 56
Query: 94 SSIEDIN 100
+ + I
Sbjct: 57 APSDSIQ 63
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-71
Identities = 88/286 (30%), Positives = 137/286 (47%), Gaps = 31/286 (10%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQE--VAIKVAHPNPDENILENVKQEGKLLWLF 170
E++ + +G G +G+VY+G+++K VA+K + E +E +E ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEI 66
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLN---RVLAGRKIRPDVLVDWAIQIAEGMNY 227
H N+V L+GVC + P ++ E+ G L R +++ VL+ A QI+ M Y
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT--- 284
L + IHRDL + N L+ E +K+ DFGL+R + T+ + AG
Sbjct: 127 L---EKKNFIHRDLAARNCLVGEN--------HLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 285 YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT---- 339
W APE + + FS SDVW++GV+LWE+ T G PY I+ V L
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELLEKDYR 230
Query: 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
+ P CP+ LM ACW+ + RPSF I +A + I
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-71
Identities = 92/309 (29%), Positives = 134/309 (43%), Gaps = 52/309 (16%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E L FG+ +G G FGKV +VA+K+ D + E + E K
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 166 LLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV----------- 213
++ H NIV+L+G C S + L+ EY G L L R R
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL--RSKREKFSEDEIEYENQK 158
Query: 214 ---------------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258
L+ +A Q+A+GM +L S +HRDL + NVL++
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHG------- 208
Query: 259 FKTLKITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWEL 314
K +KI DFGLAR++ ++ G WMAPE + I++ SDVWSYG++LWE+
Sbjct: 209 -KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
Query: 315 LT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ G PY I A Y + N + P + +M++CW DS RPSF +
Sbjct: 268 FSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327
Query: 374 ALNNIVHSE 382
L +
Sbjct: 328 FLGCQLADA 336
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 3e-71
Identities = 88/312 (28%), Positives = 139/312 (44%), Gaps = 61/312 (19%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E N L FG+ +G G FGKV + +VA+K+ + E + E K
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 166 LL-WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV----------- 213
++ L H NIV+L+G C + ++ EY G L L R+ +
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANS 159
Query: 214 ------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267
L+ ++ Q+A+GM +L A + IHRD+ + NVLL+ KI DF
Sbjct: 160 TASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTN--------GHVAKIGDF 208
Query: 268 GLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYK 322
GLAR++ ++ G WMAPE I +++ SDVWSYG++LWE+ + G PY
Sbjct: 209 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY- 267
Query: 323 SINAYAVAYGVAVN-----KLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
G+ VN + + P+ P+ ++M+ACW + RP+F+ I
Sbjct: 268 --------PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319
Query: 374 ALNNIVHSEFIQ 385
L + +
Sbjct: 320 FLQEQAQEDRRE 331
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 6e-71
Identities = 97/306 (31%), Positives = 135/306 (44%), Gaps = 60/306 (19%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQE----VAIKVAHPNPDENILENVKQEGKLL- 167
+D+N + F + IGEG FG+V K +K AIK ++ + E ++L
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV-------------- 213
L H NI++L+G C L L +EYA G L L RK R
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTAST 138
Query: 214 -----LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268
L+ +A +A GM+YL + IHRDL + N+L+ E KI DFG
Sbjct: 139 LSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGEN--------YVAKIADFG 187
Query: 269 LAR--EVYKTTHMSAAGTYA-----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIP 320
L+R EVY M WMA E + S+++ SDVWSYGV+LWE+++ G P
Sbjct: 188 LSRGQEVYVKKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
Query: 321 YKSINAYAVAYGVAVNKLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376
Y + + KL L P C LM CW + RPSF IL +LN
Sbjct: 242 YCGMTCAEL-----YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296
Query: 377 NIVHSE 382
++
Sbjct: 297 RMLEER 302
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 9e-71
Identities = 87/285 (30%), Positives = 131/285 (45%), Gaps = 31/285 (10%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQ-EVAIKVAHPNPDENILENVKQEGKLLWLFD 171
EI L +G+G FG+V+ G + VAIK P E QE +++
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLR 320
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLN---RVLAGRKIRPDVLVDWAIQIAEGMNYL 228
H +V L V + P + +V EY G L + G+ +R LVD A QIA GM Y+
Sbjct: 321 HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT---Y 285
+ +HRDL+++N+L+ E K+ DFGLAR + + + G
Sbjct: 380 ERM---NYVHRDLRAANILVGEN--------LVCKVADFGLARLIEDNEYTARQGAKFPI 428
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT----L 340
W APE F+ SDVWS+G++L EL T G +PY + V ++++ +
Sbjct: 429 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERGYRM 483
Query: 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
P P CP+ LM CW + RP+F+ + L + S Q
Sbjct: 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 15/71 (21%), Positives = 33/71 (46%), Gaps = 7/71 (9%)
Query: 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFP 89
+ ALYDY++ +LS ++G+ +++++ + WW + G P
Sbjct: 83 GGVTTFVALYDYESRTETDLSFKKGERLQIVNNT-----EGDWW--LAHSLSTGQTGYIP 135
Query: 90 ANFVSSIEDIN 100
+N+V+ + I
Sbjct: 136 SNYVAPSDSIQ 146
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 4e-70
Identities = 93/307 (30%), Positives = 143/307 (46%), Gaps = 48/307 (15%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY---------EKQEVAIKVAHPNPDENILENVKQE 163
E+ ++L+ G+ +GEG FG+V +VA+K+ + E L ++ E
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 164 GKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV--------- 213
+++ + H+NI++L+G C Q L +++EYA G L L + RP
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSH 182
Query: 214 ----------LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263
LV A Q+A GM YL A IHRDL + NVL++E +K
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED--------NVMK 231
Query: 264 ITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLT-GE 318
I DFGLAR+++ + WMAPE + I++ SDVWS+GV+LWE+ T G
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
Query: 319 IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
PY + + + + PS C +M CW A RP+FK +++ L+ I
Sbjct: 292 SPYPGVPVEELFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
Query: 379 VHSEFIQ 385
V Q
Sbjct: 351 VALTSNQ 357
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 8e-69
Identities = 76/321 (23%), Positives = 117/321 (36%), Gaps = 51/321 (15%)
Query: 103 SSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQ 162
S V + + L E G FG V+K + VA+K+ D+ +N +
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ-DKQSWQN-EY 67
Query: 163 EGKLLWLFDHRNIVSLIGVCLQSPK----LCLVMEYARGGPLNRVLAGRKIRPDVLVDWA 218
E L H NI+ IG + L L+ + G L+ L + + L A
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 219 IQIAEGMNYLHCQAPISL-------IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271
+A G+ YLH P HRD+KS NVLL + T I DFGLA
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL--------TACIADFGLAL 179
Query: 272 --EVYKTTH--MSAAGTYAWMAPEVIKTSI-----FSKASDVWSYGVVLWELLTGEIPYK 322
E K+ GT +MAPEV++ +I D+++ G+VLWEL +
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 323 SIN-AYAVAYG---------------VAVNKLTLPIPSTCP-----QLFKTLMEACWEAD 361
Y + + V K + + +E CW+ D
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299
Query: 362 SHMRPSFKTILKALNNIVHSE 382
+ R S + + + +
Sbjct: 300 AEARLSAGCVGERITQMQRLT 320
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-68
Identities = 90/290 (31%), Positives = 137/290 (47%), Gaps = 34/290 (11%)
Query: 110 KLVEIDYNKLIFGEA-IGEGGFGKVYKGIY----EKQEVAIKVAHPNPDENILENVKQEG 164
K + + + L+ + +G G FG V +G+Y ++ +VAIKV ++ E + +E
Sbjct: 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 387
Query: 165 KLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIA 222
+++ D+ IV LIGVC L LVME A GGPL++ L +I + + Q++
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-----TT 277
GM YL + + +HR+L + NVLL KI+DFGL++ + T
Sbjct: 447 MGMKYLEEK---NFVHRNLAARNVLLVNR--------HYAKISDFGLSKALGADDSYYTA 495
Query: 278 HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVN 336
+ W APE I FS SDVWSYGV +WE L+ G+ PYK + V +
Sbjct: 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----MA 550
Query: 337 KLT----LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
+ + P CP LM CW RP F T+ + + +S
Sbjct: 551 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-55
Identities = 66/267 (24%), Positives = 130/267 (48%), Gaps = 23/267 (8%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKG--IYEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFD 171
Y +L + IGEG FGK + ++ IK + E ++E +L
Sbjct: 25 KYVRL---QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK 81
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRP---DVLVDWAIQIAEGMNYL 228
H NIV ++ L +VM+Y GG L + + +K D ++DW +QI + ++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTYA 286
H + ++HRD+KS N+ L++ T+++ DFG+AR + T + + GT
Sbjct: 142 HDR---KILHRDIKSQNIFLTKD--------GTVQLGDFGIARVLNSTVELARACIGTPY 190
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346
+++PE+ + ++ SD+W+ G VL+EL T + +++ + + + ++ P+
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-ISGSFPPVSLHY 249
Query: 347 PQLFKTLMEACWEADSHMRPSFKTILK 373
++L+ ++ + RPS +IL+
Sbjct: 250 SYDLRSLVSQLFKRNPRDRPSVNSILE 276
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-55
Identities = 72/262 (27%), Positives = 114/262 (43%), Gaps = 18/262 (6%)
Query: 121 FGEAIGEGGFGKVYKGI--YEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
F IG G F VYKG+ EVA + ++ + K+E ++L H NIV
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 178 LIGVCLQSPK----LCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
+ K + LV E G L L + ++ VL W QI +G+ +LH +
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEV 292
P +IHRDLK N+ ++ P + +KI D GLA + + GT +MAPE+
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGS-------VKIGDLGLATLKRASFAKAVIGTPEFMAPEM 201
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPSTCPQLFK 351
+ + ++ DV+++G+ + E+ T E PY A Y + K
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260
Query: 352 TLMEACWEADSHMRPSFKTILK 373
++E C + R S K +L
Sbjct: 261 EIIEGCIRQNKDERYSIKDLLN 282
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 5e-54
Identities = 82/367 (22%), Positives = 138/367 (37%), Gaps = 44/367 (11%)
Query: 103 SSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIK-VAHPNPDENILENV 160
SS + + Y+ + IG GG KV++ + E KQ AIK V D L++
Sbjct: 45 SSANECISVKGRIYSI---LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSY 101
Query: 161 KQEGKLLWLFDH--RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDW 217
+ E L I+ L + + +VME LN L +K I P +
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSY 160
Query: 218 AIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT 277
+ E ++ +H ++H DLK +N L+ + LK+ DFG+A ++ T
Sbjct: 161 WKNMLEAVHTIHQH---GIVHSDLKPANFLIVD---------GMLKLIDFGIANQMQPDT 208
Query: 278 HM----SAAGTYAWMAPEVIK-----------TSIFSKASDVWSYGVVLWELLTGEIPYK 322
S G +M PE IK S S SDVWS G +L+ + G+ P++
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
Query: 323 SI-NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381
I N + + + + P + + +++ C + D R S +L H
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA------H- 321
Query: 382 EFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKELRERE 441
++Q + M G E++ VL +L + T + +
Sbjct: 322 PYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSK 381
Query: 442 QAVAARE 448
R
Sbjct: 382 TFEKKRG 388
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 9e-54
Identities = 82/349 (23%), Positives = 136/349 (38%), Gaps = 45/349 (12%)
Query: 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIK-VAHPNPDENILENVKQEGKL 166
+ + Y+ + IG GG KV++ + E KQ AIK V D L++ + E
Sbjct: 4 ISVKGRIYSI---LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 60
Query: 167 LWLFDH--RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAE 223
L I+ L + + +VME LN L +K I P + + E
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLE 119
Query: 224 GMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM---- 279
++ +H ++H DLK +N L+ + LK+ DFG+A ++ T
Sbjct: 120 AVHTIHQH---GIVHSDLKPANFLIVD---------GMLKLIDFGIANQMQPDTTSVVKD 167
Query: 280 SAAGTYAWMAPEVIK-----------TSIFSKASDVWSYGVVLWELLTGEIPYKSI-NAY 327
S GT +M PE IK S S SDVWS G +L+ + G+ P++ I N
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227
Query: 328 AVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTP 387
+ + + + P + + +++ C + D R S +L H ++Q
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA------H-PYVQIQ 280
Query: 388 HESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKE 436
+ M G E++ VL +L V S + E
Sbjct: 281 THPVNQMAKGTTEEMKYVLGQL-VGLNSPNSILKAAKTLYEHYSGGESH 328
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-52
Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 37/292 (12%)
Query: 103 SSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIK-VAHPNPDENILENV 160
+ + + Y+ + IG GG KV++ + E KQ AIK V D L++
Sbjct: 17 NLYFQSMSVKGRIYSI---LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSY 73
Query: 161 KQEGKLLWLFDHRN--IVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDW 217
+ E L + I+ L + + +VME LN L +K I P +
Sbjct: 74 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSY 132
Query: 218 AIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT 277
+ E ++ +H ++H DLK +N L+ + LK+ DFG+A ++ T
Sbjct: 133 WKNMLEAVHTIHQH---GIVHSDLKPANFLIVD---------GMLKLIDFGIANQMQPDT 180
Query: 278 HM----SAAGTYAWMAPEVIK-----------TSIFSKASDVWSYGVVLWELLTGEIPYK 322
S GT +M PE IK S S SDVWS G +L+ + G+ P++
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240
Query: 323 SI-NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
I N + + + + P + + +++ C + D R S +L
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-52
Identities = 73/313 (23%), Positives = 128/313 (40%), Gaps = 46/313 (14%)
Query: 110 KLVEIDYNKLIFGEAIGEGGFGKVY--KGIYEKQEVAIK-VAHPNPDENILENVKQEGKL 166
+V ID +F + +GEGGF V +G+++ A+K + + E ++E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADM 79
Query: 167 LWLFDHRNIVSLIGVCLQSP----KLCLVMEYARGGPLNRVLAGRKIRPDVL-----VDW 217
LF+H NI+ L+ CL+ + L++ + + G L + K + + L +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 218 AIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT 277
+ I G+ +H + HRDLK +N+LL + + D G +
Sbjct: 140 LLGICRGLEAIHAK-GY--AHRDLKPTNILLGDE--------GQPVLMDLGSMNQACIHV 188
Query: 278 HMSAA-----------GTYAWMAPEVIKT---SIFSKASDVWSYGVVLWELLTGEIPYKS 323
S T ++ APE+ + + +DVWS G VL+ ++ GE PY
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 324 INAYAVAYGVAV-NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
+ + +AV N+L++P L+ + D H RP +L E
Sbjct: 249 VFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS------QLE 302
Query: 383 FIQTPHESFHIMQ 395
+Q P H Q
Sbjct: 303 ALQPPAPGQHTTQ 315
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 6e-52
Identities = 65/292 (22%), Positives = 123/292 (42%), Gaps = 29/292 (9%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKG--IYEKQEVAIKV--AHPNPDENILENVKQEGKLLWLF 170
++ + IG G F +VY+ + + VA+K D + +E LL
Sbjct: 33 NFRIE---KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL-----AGRKIRPDVLVDWAIQIAEGM 225
+H N++ ++ +L +V+E A G L+R++ R I + + +Q+ +
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAG 283
++H + ++HRD+K +NV ++ +K+ D GL R T S G
Sbjct: 150 EHMHSR---RVMHRDIKPANVFITAT--------GVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 284 TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY--KSINAYAVAYGVAVNKLTLP 341
T +M+PE I + ++ SD+WS G +L+E+ + P+ +N Y++ + P
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPP 257
Query: 342 IPSTC-PQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFH 392
+PS + + L+ C D RP + + H H
Sbjct: 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-51
Identities = 77/295 (26%), Positives = 132/295 (44%), Gaps = 29/295 (9%)
Query: 107 NDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEG 164
+D+ + +Y++ +G+G +G VY G +AIK P D + + +E
Sbjct: 12 SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI-PERDSRYSQPLHEEI 70
Query: 165 KLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR----KIRPDVLVDWAIQ 220
L H+NIV +G ++ + + ME GG L+ +L + K + + Q
Sbjct: 71 ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130
Query: 221 IAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV--YKTTH 278
I EG+ YLH ++HRD+K NVL+ + LKI+DFG ++ +
Sbjct: 131 ILEGLKYLHDN---QIVHRDIKGDNVLI-------NTYSGVLKISDFGTSKRLAGINPCT 180
Query: 279 MSAAGTYAWMAPEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYKSI-NAYAVAYGVAV 335
+ GT +MAPE+I + KA+D+WS G + E+ TG+ P+ + A + V +
Sbjct: 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM 240
Query: 336 NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHES 390
K+ IP + K + C+E D R +L EF++ +
Sbjct: 241 FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV------D-EFLKVSSKK 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-51
Identities = 66/273 (24%), Positives = 115/273 (42%), Gaps = 26/273 (9%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKG--IYEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFD 171
DY L IG G +G+ K + + + K + + + E + + E LL
Sbjct: 7 DYEVL---YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 63
Query: 172 HRNIVSLIG--VCLQSPKLCLVMEYARGGPLNRVL-----AGRKIRPDVLVDWAIQIAEG 224
H NIV + + L +VMEY GG L V+ + + + ++ Q+
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 225 MNYLH--CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--S 280
+ H +++HRDLK +NV L + +K+ DFGLAR + T +
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK--------QNVKLGDFGLARILNHDTSFAKT 175
Query: 281 AAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL 340
GT +M+PE + +++ SD+WS G +L+EL P+ + + +A +
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFR 234
Query: 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
IP ++ + RPS + IL+
Sbjct: 235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 9e-50
Identities = 79/206 (38%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 125 IGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQ---EGKLLWLFDHRNIVSLIGV 181
+GEGGFG VYKG VA+K D E +Q E K++ H N+V L+G
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 182 CLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDW------AIQIAEGMNYLHCQAPIS 235
LCLV Y G L L+ P L W A A G+N+LH
Sbjct: 99 SSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PL-SWHMRCKIAQGAANGINFLHEN---H 153
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSA--AGTYAWMAPE 291
IHRD+KS+N+LL D F T KI+DFGLAR + T M++ GT A+MAPE
Sbjct: 154 HIHRDIKSANILL-------DEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTG 317
+ + SD++S+GVVL E++TG
Sbjct: 206 AL-RGEITPKSDIYSFGVVLLEIITG 230
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-50
Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 49/282 (17%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKG--IYEKQEVAIK-VAHPNPDENILENVKQEGKLLWLFD 171
D+ ++ E IG GGFG+V+K + + IK V + N E ++E K L D
Sbjct: 12 DFKEI---ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLD 62
Query: 172 HRNIVSLIG----------------VCLQSPKLCLVMEYARGGPLNRVLAGRKIRP---D 212
H NIV G ++ L + ME+ G L + + R+
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 213 VLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272
+ ++ QI +G++Y+H + LI+RDLK SN+ L + K +KI DFGL
Sbjct: 123 LALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT--------KQVKIGDFGLVTS 171
Query: 273 VYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY 331
+ + GT +M+PE I + + K D+++ G++L ELL +
Sbjct: 172 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----- 226
Query: 332 GVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ I + KTL++ RP+ IL+
Sbjct: 227 -FFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-49
Identities = 59/288 (20%), Positives = 105/288 (36%), Gaps = 27/288 (9%)
Query: 97 EDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDE 154
E + L + + + + +G G FG+V++ ++ + A+K
Sbjct: 38 EGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV------ 91
Query: 155 NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDV 213
+ +E IV L G + P + + ME GG L +++ + D
Sbjct: 92 RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR 151
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273
+ + Q EG+ YLH + ++H D+K+ NVLL + DFG A +
Sbjct: 152 ALYYLGQALEGLEYLHTR---RILHGDVKADNVLL-------SSDGSRAALCDFGHALCL 201
Query: 274 YK-------TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA 326
T GT MAPEV+ D+WS ++ +L G P+
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261
Query: 327 YAVAYGVAVN-KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ +A IP +C L ++ + R S + +
Sbjct: 262 GPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRR 309
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-48
Identities = 58/274 (21%), Positives = 104/274 (37%), Gaps = 32/274 (11%)
Query: 122 GEAIGEGGFGKVYKGIY--EKQEVAIK-VAHPNPDENILENVKQE-GKLLWLFDHRNIVS 177
E IG G FG V+K + + AIK P +N +E L H ++V
Sbjct: 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRP-----DVLVDWAIQIAEGMNYLHCQA 232
+ + + EY GG L ++ L D +Q+ G+ Y+H
Sbjct: 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM- 134
Query: 233 PISLIHRDLKSSNVLLSE-----------PIENEDLQFKTLKITDFGLAREVYKTTHMSA 281
SL+H D+K SN+ +S ++ KI D G + ++
Sbjct: 135 --SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI--SSPQVE 190
Query: 282 AGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL 340
G ++A EV++ + +D+++ + + E ++ + + + + L
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH-----EIRQGRL 245
Query: 341 P-IPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
P IP Q F L++ D RPS ++K
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 8e-47
Identities = 51/280 (18%), Positives = 101/280 (36%), Gaps = 33/280 (11%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKV--AHPNPDENILENVKQEGKLLWLF 170
+ +L +G G +G+V+K + + A+K + ++ + + G +
Sbjct: 58 SFQRL---SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYL 228
H V L + L L E G L + G + + + + +L
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM-SAAGTYAW 287
H Q L+H D+K +N+ L K+ DFGL E+ G +
Sbjct: 174 HSQ---GLVHLDVKPANIFLG--------PRGRCKLGDFGLLVELGTAGAGEVQEGDPRY 222
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347
MAPE+++ S + A+DV+S G+ + E+ + L +
Sbjct: 223 MAPELLQGS-YGTAADVFSLGLTILEVACNMELPHGGEGWQQLR---QGYLPPEFTAGLS 278
Query: 348 QLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTP 387
++++ E D +R + + +L ++ P
Sbjct: 279 SELRSVLVMMLEPDPKLRATAEALLA------LP-VLRQP 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 87/284 (30%), Positives = 133/284 (46%), Gaps = 39/284 (13%)
Query: 125 IGEGGFGKVYKG-IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCL 183
IG G FGKVYKG + + +VA+K P + I E + E + L H ++VSLIG C
Sbjct: 47 IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSLIGFCD 105
Query: 184 QSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDW------AIQIAEGMNYLHCQAPISLI 237
+ ++ L+ +Y G L R L G + + W I A G++YLH +A +I
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSM-SWEQRLEICIGAARGLHYLHTRA---II 161
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMS--AAGTYAWMAPEVI 293
HRD+KS N+LL +E+ KITDFG++++ TH+S GT ++ PE
Sbjct: 162 HRDVKSINILL-----DENF---VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF 213
Query: 294 KTSIFSKASDVWSYGVVLWELLTG------EIPYKSIN--AYAVAY-------GVAVNKL 338
++ SDV+S+GVVL+E+L +P + +N +AV + L
Sbjct: 214 IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273
Query: 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
I + F C S RPS +L L + +
Sbjct: 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 66/306 (21%), Positives = 121/306 (39%), Gaps = 58/306 (18%)
Query: 121 FGEAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
+G+G FG+V K + + AIK E L + E LL +H+ +V
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 179 IGV-------------CLQSPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAE 223
+ L + MEY G L ++ + D QI E
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 224 GMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM---- 279
++Y+H Q +IHRDLK N+ + E + +KI DFGLA+ V+++ +
Sbjct: 128 ALSYIHSQ---GIIHRDLKPMNIFIDES--------RNVKIGDFGLAKNVHRSLDILKLD 176
Query: 280 ------------SAAGTYAWMAPEVIK-TSIFSKASDVWSYGVVLWELLTGEIPYKSINA 326
SA GT ++A EV+ T +++ D++S G++ +E++ +
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMER 234
Query: 327 YAVAYGVAVNKLTLP--IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384
+ + + P ++ K ++ + D + RP +T+L S ++
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN-------SGWL 287
Query: 385 QTPHES 390
H+
Sbjct: 288 PVKHQD 293
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-45
Identities = 67/285 (23%), Positives = 124/285 (43%), Gaps = 16/285 (5%)
Query: 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLL 167
K+ E+ + +G G G V+K ++ +A K+ H I + +E ++L
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMN 226
+ IV G ++ + ME+ GG L++VL +I +L +I + +G+
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 145
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA 286
YL + I +HRD+K SN+L++ E +K+ DFG++ ++ + S GT +
Sbjct: 146 YLREKHKI--MHRDVKPSNILVNSRGE--------IKLCDFGVSGQLIDSMANSFVGTRS 195
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346
+M+PE ++ + +S SD+WS G+ L E+ G P +A + +
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
Query: 347 PQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESF 391
+ DS I + L+ IV+ + P F
Sbjct: 256 RPRTPGRPLNKFGMDSR---PPMAIFELLDYIVNEPPPKLPSGVF 297
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-45
Identities = 67/304 (22%), Positives = 111/304 (36%), Gaps = 56/304 (18%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
D+ + + +G GGFG V++ + AIK E E V +E K L +H
Sbjct: 6 DFEPI---QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 62
Query: 173 RNIVSLIGVCL------------QSPKLCLVMEYARGGPLNRVLAGRKIRP----DVLVD 216
IV L L + M+ R L + GR V +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 217 WAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT 276
+QIAE + +LH + L+HRDLK SN+ + +K+ DFGL + +
Sbjct: 123 IFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTM--------DDVVKVGDFGLVTAMDQD 171
Query: 277 T--------------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYK 322
H GT +M+PE I + +S D++S G++L+ELL P+
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228
Query: 323 SINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
+ N P+ + +++ RP I++ +
Sbjct: 229 TQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE-------NA 281
Query: 383 FIQT 386
+
Sbjct: 282 VFED 285
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-43
Identities = 69/311 (22%), Positives = 121/311 (38%), Gaps = 49/311 (15%)
Query: 110 KLVEIDYNKLIFGEAIGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENILENVKQEGKLL 167
+ VE+ +L + EGGF VY + + +E A+K N +E + QE +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFM 79
Query: 168 -WLFDHRNIVSLIGVCLQSPK--------LCLVMEYARGG---PLNRVLAGRKIRPDVLV 215
L H NIV + L+ E +G L ++ + + D ++
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL 139
Query: 216 DWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275
Q + ++H Q P +IHRDLK N+LLS T+K+ DFG A +
Sbjct: 140 KIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQ--------GTIKLCDFGSATTISH 190
Query: 276 TTHMSAA--------------GTYAWMAPEVIKTSIFSKA-----SDVWSYGVVLWELLT 316
S + T + PE+I ++S D+W+ G +L+ L
Sbjct: 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEII--DLYSNFPIGEKQDIWALGCILYLLCF 248
Query: 317 GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376
+ P++ + G K ++P T +F +L+ A + + R S ++ L
Sbjct: 249 RQHPFEDGAKLRIVNG----KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
Query: 377 NIVHSEFIQTP 387
I + +
Sbjct: 305 EIAAARNVNPK 315
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-43
Identities = 72/374 (19%), Positives = 136/374 (36%), Gaps = 57/374 (15%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
+ + +G+G V++G ++K AIKV + ++ +E ++L +H+NIV
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 178 LIGV--CLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI----QIAEGMNYLHCQ 231
L + + L+ME+ G L VL + + + GMN+L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM-SAAGTYAWMAP 290
++HR++K N++ + + K+TDFG ARE+ S GT ++ P
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQ----SVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 291 EVIKTSI--------FSKASDVWSYGVVLWELLTGEIP--------------YKSIN--- 325
++ + ++ + D+WS GV + TG +P YK I
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 326 ------AYAVAYGVAVNKLTLPIPSTCPQLFKTLMEA----CWEADSHMRPSFKTILKAL 375
G +P+ + + + L+ EAD F
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 376 NNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEK 435
++I+H I +Q +I + EL ++ + + Q+ + E
Sbjct: 305 SDILHRMVIHVFS-----LQQMTAHKIYIHSYNTATIFHELVYKQTK-IISSNQELIYEG 358
Query: 436 ELREREQAVAAREI 449
E A+
Sbjct: 359 RRLVLEPGRLAQHF 372
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 9e-43
Identities = 63/305 (20%), Positives = 115/305 (37%), Gaps = 51/305 (16%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
+ + +G+G V++G ++K AIKV + ++ +E ++L +H+NIV
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 178 LIGV--CLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI----QIAEGMNYLHCQ 231
L + + L+ME+ G L VL + + + GMN+L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM-SAAGTYAWMAP 290
++HR++K N++ + + K+TDFG ARE+ S GT ++ P
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQ----SVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 291 EVIKTSI--------FSKASDVWSYGVVLWELLTGEIP--------------YKSIN--- 325
++ + ++ + D+WS GV + TG +P YK I
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 326 ------AYAVAYGVAVNKLTLP----IPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
G +P + L ++ EAD F
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 376 NNIVH 380
++I+H
Sbjct: 305 SDILH 309
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 72/211 (34%), Positives = 106/211 (50%), Gaps = 35/211 (16%)
Query: 125 IGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGK--------LLWLFDHRNI 175
+G GGFGKVYKG VA+K + E Q G+ ++ + HRN+
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKR--------LKEERTQGGELQFQTEVEMISMAVHRNL 89
Query: 176 VSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDW------AIQIAEGMNYLH 229
+ L G C+ + LV Y G + L R L DW A+ A G+ YLH
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL-DWPKRQRIALGSARGLAYLH 148
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-YKTTHMS--AAGTYA 286
+IHRD+K++N+LL +E+ + + DFGLA+ + YK TH++ GT
Sbjct: 149 DHCDPKIIHRDVKAANILL-----DEEFE---AVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTG 317
+APE + T S+ +DV+ YGV+L EL+TG
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-42
Identities = 77/263 (29%), Positives = 116/263 (44%), Gaps = 31/263 (11%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E IG+G G VY + QEVAI+ + E + E ++ + NIV+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-ELIINEILVMRENKNPNIVNYLD 84
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIA-------EGMNYLHCQAP 233
L +L +VMEY GG L V+ + QIA + + +LH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHSN-- 135
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH--MSAAGTYAWMAPE 291
+IHRD+KS N+LL +K+TDFG ++ + GT WMAPE
Sbjct: 136 -QVIHRDIKSDNILLGMDGS--------VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLF 350
V+ + D+WS G++ E++ GE PY + N Y +A N L P +F
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 351 KTLMEACWEADSHMRPSFKTILK 373
+ + C E D R S K +L+
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELLQ 269
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 90/285 (31%), Positives = 140/285 (49%), Gaps = 37/285 (12%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E IG+G FG+V+KGI + + VAIK+ E+ +E+++QE +L D + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240
L+ KL ++MEY GG +L + + +I +G++YLH + IHRD
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRD 144
Query: 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIF 298
+K++NVLLSE E +K+ DFG+A ++ T + GT WMAPEVIK S +
Sbjct: 145 IKAANVLLSEHGE--------VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 196
Query: 299 SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL-------FK 351
+D+WS G+ EL GE P+ ++ V + + N P P L K
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---P-----PTLEGNYSKPLK 248
Query: 352 TLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQD 396
+EAC + RP+ K +LK H +FI + + +
Sbjct: 249 EFVEACLNKEPSFRPTAKELLK------H-KFILRNAKKTSYLTE 286
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-41
Identities = 76/266 (28%), Positives = 125/266 (46%), Gaps = 30/266 (11%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
+G+G FGKVYK ++ A KV +E + E+ E ++L DH IV L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL-EDYIVEIEILATCDHPYIVKLLG 83
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLHCQAPIS 235
KL +++E+ GG ++ ++ L + I Q+ E +N+LH +
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSK---R 137
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWMAPEVI 293
+IHRDLK+ NVL++ + +++ DFG++ + KT S GT WMAPEV+
Sbjct: 138 IIHRDLKAGNVLMTLEGD--------IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 294 KTSIFSKAS-----DVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCP 347
D+WS G+ L E+ E P+ +N V +A + TL PS
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249
Query: 348 QLFKTLMEACWEADSHMRPSFKTILK 373
F+ ++ + + RPS +L+
Sbjct: 250 VEFRDFLKIALDKNPETRPSAAQLLE 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-41
Identities = 67/263 (25%), Positives = 120/263 (45%), Gaps = 31/263 (11%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
IGEG G V + ++VA+K+ + E + E ++ + H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR-ELLFNEVVIMRDYQHFNVVEMYK 109
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIA-------EGMNYLHCQAP 233
L +L ++ME+ +GG L +++ ++ + QIA + + YLH Q
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEE-------QIATVCEAVLQALAYLHAQ-- 160
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWMAPE 291
+IHRD+KS ++LL+ +K++DFG ++ K S GT WMAPE
Sbjct: 161 -GVIHRDIKSDSILLTLDGR--------VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLF 350
VI S+++ D+WS G+++ E++ GE PY S + + + L +
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVL 271
Query: 351 KTLMEACWEADSHMRPSFKTILK 373
+ +E D R + + +L
Sbjct: 272 RDFLERMLVRDPQERATAQELLD 294
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 8e-41
Identities = 72/359 (20%), Positives = 124/359 (34%), Gaps = 59/359 (16%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
E +G GGFG V + I++ ++VAIK E E +++ +H N+VS
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 178 LIGV------CLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMN 226
V + L MEY GG L + L + L + I I+ +
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALR 135
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM-SAAGTY 285
YLH +IHRDLK N++L + KI D G A+E+ + GT
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQR-----LIHKIIDLGYAKELDQGELCTEFVGTL 187
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP-- 343
++APE+++ ++ D WS+G + +E +TG P+ +G K I
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 344 -------------------STCPQ-LFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383
S + ++ R +
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP----------- 296
Query: 384 IQTPHESFHIMQDGWRVEIEQVLHELRVKEKELRSREEELTKAQMQQKLAEKELREREQ 442
F + +++ V++ + + E E + + + E EQ
Sbjct: 297 ---NVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQ 352
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 55/175 (31%), Positives = 84/175 (48%), Gaps = 16/175 (9%)
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273
L+ ++ Q+A+GM +L + IHRDL + N+LLSE +KI DFGLAR++
Sbjct: 195 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK--------NVVKICDFGLARDI 243
Query: 274 YKTTHMSAAGT----YAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328
YK G WMAPE I +++ SDVWS+GV+LWE+ + G PY +
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303
Query: 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383
+ P M CW + RP+F +++ L N++ +
Sbjct: 304 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 31/147 (21%), Positives = 61/147 (41%), Gaps = 15/147 (10%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E ++L G+ +G G FG+V + + VA+K+ + + E K
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77
Query: 166 LLWLFD-HRNIVSLIGVCLQSPK-LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAE 223
+L H N+V+L+G C + L +++E+ + G L+ L ++ + +
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQ 137
Query: 224 GMNYLHCQAPISLIHRDLKSSNVLLSE 250
G +Y+ I DLK ++
Sbjct: 138 GKDYV------GAIPVDLKRRLDSITS 158
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-40
Identities = 89/327 (27%), Positives = 144/327 (44%), Gaps = 56/327 (17%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLW-LFDHRNIVSLI 179
E +G G +G+VYKG + K Q AIKV DE E +KQE +L HRNI +
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYY 87
Query: 180 G------VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYL 228
G +L LVME+ G + ++ K L + I +I G+++L
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT--LKEEWIAYICREILRGLSHL 145
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYA 286
H +IHRD+K NVLL+E E +K+ DFG++ ++ +T + GT
Sbjct: 146 HQH---KVIHRDIKGQNVLLTENAE--------VKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 287 WMAPEVIKTSIFSKAS-----DVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341
WMAPEVI A+ D+WS G+ E+ G P ++ + + N P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----P 250
Query: 342 IPSTCP----QLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDG 397
P + F++ +E+C + RP+ + ++K H FI+ +
Sbjct: 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK------H-PFIRDQPNERQV---- 299
Query: 398 WRVEIEQVLHELRVKEKELRSREEELT 424
R++++ + + K E E E +
Sbjct: 300 -RIQLKDHIDRTKKKRGEKDETEYEYS 325
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 63/276 (22%), Positives = 111/276 (40%), Gaps = 27/276 (9%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGK-LLWL 169
E+ + L +G G +G V K + Q +A+K + + + + +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT 62
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEG 224
D V+ G + + + ME L++ G+ I D+L A+ I +
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT-THMSAAG 283
+ +LH + + IHRD+K SNVL++ + +K+ DFG++ + AG
Sbjct: 122 LEHLHSKLSV--IHRDVKPSNVLINALGQ--------VKMCDFGISGYLVDDVAKDIDAG 171
Query: 284 TYAWMAPEVIKTSIFSKA----SDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL- 338
+MAPE I + K SD+WS G+ + EL PY S V +
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231
Query: 339 -TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
LP F C + +S RP++ +++
Sbjct: 232 PQLP-ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 40/231 (17%), Positives = 85/231 (36%), Gaps = 37/231 (16%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEKQEVAIKV----------------AHPNPDENILENV 160
N + +G F K+ + + A+K ++ ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 161 KQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL---------NRVLAGRKIRP 211
K E +++ + ++ G+ ++ ++ EY + I
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 212 DVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271
V+ + +Y+H + I HRD+K SN+L+ + +K++DFG +
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDK--------NGRVKLSDFGESE 200
Query: 272 EVYKTTHMSAAGTYAWMAPEVI--KTSIFSKASDVWSYGVVLWELLTGEIP 320
+ + GTY +M PE ++S D+WS G+ L+ + +P
Sbjct: 201 YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 63/302 (20%), Positives = 117/302 (38%), Gaps = 30/302 (9%)
Query: 108 DVKLVEIDYNKLIFGEAIGEGGFGK-VYKGIYEKQEVAIKVAHPNPDENILENVKQEGKL 166
+ +V + + +G G G VY+G+++ ++VA+K P +E +L
Sbjct: 15 ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE----CFSFADREVQL 70
Query: 167 L-WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-QIAEG 224
L +H N++ + +E V + + Q G
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-----TTHM 279
+ +LH +++HRDLK N+L+S P + ++ I+DFGL +++ +
Sbjct: 131 LAHLHSL---NIVHRDLKPHNILISMPNAHGKIK---AMISDFGLCKKLAVGRHSFSRRS 184
Query: 280 SAAGTYAWMAPEVIKTSIF---SKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAV 335
GT W+APE++ + D++S G V + +++ G P+ +
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244
Query: 336 NKLTLPIP-STCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIM 394
L P + + L+E D RPS K +LK H F + +
Sbjct: 245 CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK------HP-FFWSLEKQLQFF 297
Query: 395 QD 396
QD
Sbjct: 298 QD 299
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 65/273 (23%), Positives = 114/273 (41%), Gaps = 22/273 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGK-LLWL 169
+ + N L +G G G+V+K + +A+K + ++ + + + +L
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS 80
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYL 228
D IV G + + + + ME I +L + I + + YL
Sbjct: 81 HDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT-THMSAAGTYAW 287
+ + IHRD+K SN+LL E + +K+ DFG++ + +AG A+
Sbjct: 141 KEKHGV--IHRDVKPSNILLDERGQ--------IKLCDFGISGRLVDDKAKDRSAGCAAY 190
Query: 288 MAPEVIKTSIFSKA-----SDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK--LTL 340
MAPE I +K +DVWS G+ L EL TG+ PYK+ + + L
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250
Query: 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
P F++ ++ C D RP + +L+
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 82/309 (26%), Positives = 145/309 (46%), Gaps = 40/309 (12%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
E +GEG +G VYK I+++ Q VAIK D L+ + +E ++ D ++V G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYG 91
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLHCQAPIS 235
++ L +VMEY G ++ ++ ++R L + I +G+ YLH
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFM---R 145
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH--MSAAGTYAWMAPEVI 293
IHRD+K+ N+LL+ K+ DFG+A ++ T + GT WMAPEVI
Sbjct: 146 KIHRDIKAGNILLNTEGH--------AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLFKT 352
+ ++ +D+WS G+ E+ G+ PY I+ + + N T P F
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257
Query: 353 LMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVK 412
++ C R + +L+ H F+++ + I++D I + + ++++K
Sbjct: 258 FVKQCLVKSPEQRATATQLLQ------H-PFVRSA-KGVSILRD----LINEAM-DVKLK 304
Query: 413 EKELRSREE 421
+E + REE
Sbjct: 305 RQESQQREE 313
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-39
Identities = 62/258 (24%), Positives = 116/258 (44%), Gaps = 18/258 (6%)
Query: 121 FGEAIGEGGFGKVY--KGIYEKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIV 176
G +G+G FG VY + K +A+KV + +++E ++ H NI+
Sbjct: 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L G + ++ L++EYA G + R L K + ++A ++Y H +
Sbjct: 73 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---R 129
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT 295
+IHRD+K N+LL LKI DFG + + GT ++ PE+I+
Sbjct: 130 VIHRDIKPENLLLGS--------AGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 296 SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLME 355
+ + D+WS GV+ +E L G+ P+++ Y ++++ P + + L+
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YK-RISRVEFTFPDFVTEGARDLIS 239
Query: 356 ACWEADSHMRPSFKTILK 373
+ + RP + +L+
Sbjct: 240 RLLKHNPSQRPMLREVLE 257
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 70/287 (24%), Positives = 114/287 (39%), Gaps = 31/287 (10%)
Query: 106 INDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQE 163
I+ + + L IG G +G V K +++ Q +A+K DE + + +
Sbjct: 11 ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD 70
Query: 164 GK-LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL------AGRKIRPDVLVD 216
++ D IV G + + ME ++ I ++L
Sbjct: 71 LDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS-FDKFYKYVYSVLDDVIPEEILGK 129
Query: 217 WAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT 276
+ + +N+L I IHRD+K SN+LL +K+ DFG++ ++ +
Sbjct: 130 ITLATVKALNHLKENLKI--IHRDIKPSNILLDRSGN--------IKLCDFGISGQLVDS 179
Query: 277 THMS-AAGTYAWMAPEVIKTSIFSKA----SDVWSYGVVLWELLTGEIPYKSINA----- 326
+ AG +MAPE I S + SDVWS G+ L+EL TG PY N+
Sbjct: 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239
Query: 327 YAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
V G +L+ F + C D RP +K +LK
Sbjct: 240 TQVVKG-DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-38
Identities = 67/239 (28%), Positives = 101/239 (42%), Gaps = 47/239 (19%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKV-------------------------AH 149
N+ + IG+G +G V E A+KV
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 150 PNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP---KLCLVMEYARGGPLNRVLAG 206
+E V QE +L DH N+V L+ V L P L +V E GP+ V
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 207 RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266
+ + D + + +G+ YLH Q +IHRD+K SN+L+ E +KI D
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGE--------DGHIKIAD 180
Query: 267 FGLAREVYKTTHM--SAAGTYAWMAPEVIKTSIFS---KASDVWSYGVVLWELLTGEIP 320
FG++ E + + + GT A+MAPE + + KA DVW+ GV L+ + G+ P
Sbjct: 181 FGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-38
Identities = 74/289 (25%), Positives = 118/289 (40%), Gaps = 47/289 (16%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
DY E IG G V K++VAIK + + ++ + +E + + H
Sbjct: 16 DYELQ---EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI----QIA------ 222
NIVS + +L LVM+ GG + ++ + I + IA
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDII--KHIVAKGEHKSGVLDESTIATILREV 130
Query: 223 -EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA 281
EG+ YLH IHRD+K+ N+LL E +++I DFG++ + ++
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGED--------GSVQIADFGVSAFLATGGDITR 179
Query: 282 -------AGTYAWMAPEVIKTSIF--SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG 332
GT WMAPEV++ KA D+WS+G+ EL TG PY V
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKA-DIWSFGITAIELATGAAPYHKYPPMKVLML 238
Query: 333 VAVN---KLTLPIPSTCP-----QLFKTLMEACWEADSHMRPSFKTILK 373
N L + + F+ ++ C + D RP+ +L+
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 25/216 (11%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK---QEVAIKV-------AHPNPDENILENVKQEGKLLWL 169
I + +G G G+V E+ ++VAI++ + + NV+ E ++L
Sbjct: 138 IMSKTLGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYL 228
+H I+ + + +V+E GG L ++V+ ++++ + Q+ + YL
Sbjct: 197 LNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAW 287
H +IHRDLK NVLLS E+ +KITDFG ++ + +T+ M GT +
Sbjct: 256 HEN---GIIHRDLKPENVLLSSQEED-----CLIKITDFGHSKILGETSLMRTLCGTPTY 307
Query: 288 MAPEVIKTSIF---SKASDVWSYGVVLWELLTGEIP 320
+APEV+ + ++A D WS GV+L+ L+G P
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 83/330 (25%), Positives = 132/330 (40%), Gaps = 65/330 (19%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKV--AHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
IG G FG VY + + VAIK +++ +E + L H N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLHCQAP 233
G L+ LVMEY G + + ++ L + I +G+ YLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLL----EVHKKPLQEVEIAAVTHGALQGLAYLHSH-- 173
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVI 293
++IHRD+K+ N+LLSEP +K+ DFG A + GT WMAPEVI
Sbjct: 174 -NMIHRDVKAGNILLSEPGL--------VKLGDFGSASIMAPANSF--VGTPYWMAPEVI 222
Query: 294 ---KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL- 349
+ DVWS G+ EL + P ++NA + Y +A N+ P L
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--------SPALQ 274
Query: 350 -------FKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRVEI 402
F+ +++C + RP+ + +LK H F+
Sbjct: 275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK------H-RFVLRERPP------------ 315
Query: 403 EQVLHELRVKEKELRSREEELTKAQMQQKL 432
V+ +L + K+ + L +M++ L
Sbjct: 316 -TVIMDLIQRTKDAVRELDNLQYRKMKKIL 344
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 71/259 (27%), Positives = 114/259 (44%), Gaps = 20/259 (7%)
Query: 122 GEAIGEGGFGKVYKG--IYEKQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVS 177
G +G+GGF K ++ K+ A K+ + + E + E + H+++V
Sbjct: 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 79
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGMNYLHCQAPISL 236
G + + +V+E R L + RK + + QI G YLH +
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWMAPEVIK 294
IHRDLK N+ L NEDL+ +KI DFGLA +V GT ++APEV+
Sbjct: 137 IHRDLKLGNLFL-----NEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 188
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLM 354
S DVWS G +++ LL G+ P+++ Y + K IP + +L+
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-LKETYL-RIKKNEYSIPKHINPVAASLI 246
Query: 355 EACWEADSHMRPSFKTILK 373
+ + D RP+ +L
Sbjct: 247 QKMLQTDPTARPTINELLN 265
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-37
Identities = 51/232 (21%), Positives = 85/232 (36%), Gaps = 35/232 (15%)
Query: 122 GEAIGEGGFGKVYKG---IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
I GG G +Y + V +K + D E + L H +IV +
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 179 I-----GVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAP 233
P +VMEY G L R + + + + ++I ++YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-LPVAEAIAYLLEILPALSYLHSI-- 201
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA-GTYAWMAPEV 292
L++ DLK N++L+E + LK+ D G + GT + APE+
Sbjct: 202 -GLVYNDLKPENIMLTE---------EQLKLIDLGAVSRI---NSFGYLYGTPGFQAPEI 248
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344
++T + A+D+++ G L L G V+ L P
Sbjct: 249 VRTGP-TVATDIYTVGRTLAALTLDLPTRN---------GRYVDGLPEDDPV 290
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-37
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 19/218 (8%)
Query: 122 GEAIGEGGFGKVYKG--IYEKQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVS 177
+ +G GG VY +VAIK E L+ ++E H+NIVS
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
+I V + LVMEY G L+ + + D +++ QI +G+ + H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA---GTYAWMAPEVI 293
+HRD+K N+L+ KTLKI DFG+A+ + +T+ GT + +PE
Sbjct: 133 VHRDIKPQNILIDSN--------KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY 331
K + +D++S G+VL+E+L GE P+ A ++A
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 72/268 (26%), Positives = 111/268 (41%), Gaps = 38/268 (14%)
Query: 122 GEAIGEGGFGKVYKG--IYEKQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVS 177
G +G+GGF K ++ K+ A K+ + + E + E + H+++V
Sbjct: 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGMNYLHCQAPISL 236
G + + +V+E R L + RK + + QI G YLH +
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWMAPEVIK 294
IHRDLK N+ L NEDL+ +KI DFGLA +V GT ++APEV+
Sbjct: 163 IHRDLKLGNLFL-----NEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIP---------YKSINAYAVAYGVAVNKLTLPIPST 345
S DVWS G +++ LL G+ P Y I K IP
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-----------KKNEYSIPKH 263
Query: 346 CPQLFKTLMEACWEADSHMRPSFKTILK 373
+ +L++ + D RP+ +L
Sbjct: 264 INPVAASLIQKMLQTDPTARPTINELLN 291
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 41/254 (16%), Positives = 84/254 (33%), Gaps = 24/254 (9%)
Query: 88 FPANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIY-------EK 140
P + + + I ++ + +GEG F +VY+ K
Sbjct: 36 KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95
Query: 141 QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL 200
Q+ +KV P + Q + L + L LV E G L
Sbjct: 96 QKFVLKVQKP-ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
Query: 201 NRVLAGRKIRPDVLVD------WAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254
+ K P+ ++ +A+++ + +H +IH D+K N +L
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211
Query: 255 EDLQF---KTLKITDFGLAREV----YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSY 307
+D + L + D G + ++ T + T + E++ ++ D +
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271
Query: 308 GVVLWELLTGEIPY 321
++ +L G
Sbjct: 272 AATVYCMLFGTYMK 285
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 25/213 (11%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK---QEVAIKV-------AHPNPDENILENVKQEGKLLWL 169
I + +G G G+V E+ ++VAIK+ + + NV+ E ++L
Sbjct: 13 IMSKTLGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYL 228
+H I+ + + +V+E GG L ++V+ ++++ + Q+ + YL
Sbjct: 72 LNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAW 287
H +IHRDLK NVLLS E+ +KITDFG ++ + +T+ M GT +
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEED-----CLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 288 MAPEVIKTSI---FSKASDVWSYGVVLWELLTG 317
+APEV+ + +++A D WS GV+L+ L+G
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 70/334 (20%), Positives = 135/334 (40%), Gaps = 47/334 (14%)
Query: 104 SVINDVKLVEIDYNKL-IFGEAIGEGGFGKV-YKGIYEKQEVAIKVAHPNPDENILENVK 161
S I ++ E L + + +G G G V ++G ++ + VA+K + +
Sbjct: 1 SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIAL 56
Query: 162 QEGKLLW-LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI- 219
E KLL DH N++ L + +E + V + ++ +
Sbjct: 57 MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYN 116
Query: 220 ------QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT-----LKITDFG 268
QIA G+ +LH +IHRDLK N+L+S Q + I+DFG
Sbjct: 117 PISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 269 LAREV------YKTTHMSAAGTYAWMAPEVIKTSIF-------SKASDVWSYGVVLWELL 315
L +++ ++T + +GT W APE+++ S +++ D++S G V + +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 316 T-GEIPY--KSINAYAVAYGV-AVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371
+ G+ P+ K + G+ +++++ + L+ + D RP+ +
Sbjct: 234 SKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
Query: 372 LKALNNIVHSEFIQTPHESFHIMQD-GWRVEIEQ 404
L+ H + + R+EIE
Sbjct: 294 LR------H-PLFWPKSKKLEFLLKVSDRLEIEN 320
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-36
Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 122 GEAIGEGGFGKVY--KGIYEKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVS 177
G +G+G FG VY + K +A+KV + E + +++E ++ H NI+
Sbjct: 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
+ ++ L++E+A G L + L + + ++A+ ++Y H + +
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KV 135
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTS 296
IHRD+K N+L+ +L KI DFG + + GT ++ PE+I+
Sbjct: 136 IHRDIKPENLLMGY---KGEL-----KIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGK 187
Query: 297 IFSKASDVWSYGVVLWELLTGEIPYKSIN 325
+ D+W GV+ +E L G P+ S +
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPS 216
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 25/224 (11%)
Query: 122 GEAIGEGGFGKVYKG--IYEKQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVS 177
GE +G GG +V+ + + ++VA+KV + D + ++E + +H IV+
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 178 L--IGVCLQSPKLC--LVMEYARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGMNYLHCQA 232
+ G +VMEY G L ++ + P ++ + +N+ H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM-----SAAGTYAW 287
+IHRD+K +N+++S +K+ DFG+AR + + + + GT +
Sbjct: 136 --GIIHRDVKPANIMISAT--------NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY 331
++PE + SDV+S G VL+E+LTGE P+ + +VAY
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 31/218 (14%)
Query: 122 GEAIGEGGFGKVYKG--IYEKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVS 177
G +G+G F VY+ I+ EVAIK+ +++ V+ E K+ H +I+
Sbjct: 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L S + LV+E G +NR L + + + QI GM YLH
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---G 132
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA--------GTYAW 287
++HRDL SN+LL+ +KI DFGLA T + GT +
Sbjct: 133 ILHRDLTLSNLLLTR--------NMNIKIADFGLA------TQLKMPHEKHYTLCGTPNY 178
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
++PE+ S SDVWS G + + LL G P+ +
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-35
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKV---AHPNPDENILENVKQEGKLLWLFDHRN 174
E +G+G F V + + K E A K+ + + + +++E ++ H N
Sbjct: 10 VKEELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPN 66
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAP 233
IV L + LV + GG L ++A QI E + Y H
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN-- 124
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAPEV 292
++HR+LK N+LL+ + + K+ DFGLA EV + AGT +++PEV
Sbjct: 125 -GIVHRNLKPENLLLASKAKGAAV-----KLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 178
Query: 293 IKTSIFSKASDVWSYGVVLWELLTG 317
+K +SK D+W+ GV+L+ LL G
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVG 203
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGI--YEKQEVAIKVAHPNPDENILENVKQEGKLLWLFD- 171
Y+ + + +GEG F K + Q A+K+ + + N ++E L L +
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII----SKRMEANTQKEITALKLCEG 64
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVL---------AGRKIRPDVLVDWAIQI 221
H NIV L V LVME GG L R+ A +R ++
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR---------KL 115
Query: 222 AEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH--M 279
++++H ++HRDLK N+L ++ +N ++ KI DFG AR
Sbjct: 116 VSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEI-----KIIDFGFARLKPPDNQPLK 167
Query: 280 SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTG 317
+ T + APE++ + + ++ D+WS GV+L+ +L+G
Sbjct: 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 120 IFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
+ +GEG +G+V + ++ VA+K+ + EN+K+E + + +H N+V
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 178 LIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
G + L +EY GG L +R+ + + Q+ G+ YLH +
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GI 126
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM----SAAGTYAWMAPEV 292
HRD+K N+LL E LKI+DFGLA GT ++APE+
Sbjct: 127 THRDIKPENLLLDE--------RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 293 IKTSIFS-KASDVWSYGVVLWELLTGEIP 320
+K F + DVWS G+VL +L GE+P
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK--QEVAIKV---AHPNPDENILENVKQEGKLLWLFDHRN 174
+ G+ +GEG +GKV + + + A+K+ N NVK+E +LL H+N
Sbjct: 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 175 IVSLIGVCLQ--SPKLCLVMEYARGGP---LNRVLAGRKIRPDVLVDWAIQIAEGMNYLH 229
++ L+ V K+ +VMEY G L+ V R + Q+ +G+ YLH
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEYLH 126
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR--EVYKTTHM--SAAGTY 285
Q ++H+D+K N+LL+ TLKI+ G+A + ++ G+
Sbjct: 127 SQ---GIVHKDIKPGNLLLTT--------GGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 286 AWMAPEVIKTS-IFS-KASDVWSYGVVLWELLTGEIPY 321
A+ PE+ FS D+WS GV L+ + TG P+
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKV-----AHPNPDENILENVKQEGKLLWLFDH 172
GE +G G F V K EK E A K + + E +++E +L H
Sbjct: 16 IGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
N+++L V + L++E GG L + + + + + QI +G+NYLH +
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAP 290
+ H DLK N++L + +K+ DFGLA E+ GT ++AP
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPI----PHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGEIP 320
E++ +D+WS GV+ + LL+G P
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKV-----AHPNPDENILENVKQEGKLLWLFDH 172
GE +G G F V K EK E A K + + E +++E +L H
Sbjct: 16 IGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
NI++L V + L++E GG L + + + + + QI +G+NYLH +
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAP 290
+ H DLK N++L ++++ +K+ DFGLA E+ GT ++AP
Sbjct: 135 ---KIAHFDLKPENIMLL----DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGEIP 320
E++ +D+WS GV+ + LL+G P
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 47/319 (14%), Positives = 83/319 (26%), Gaps = 66/319 (20%)
Query: 118 KLIFGEAIGEGGFGKVYKGI--YEKQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHR 173
KL E + G V+ ++ A+KV + LE + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 174 NIVSLIGVC--------------------------LQSPKLCLVMEYARG--GPLNRVLA 205
+ L+M A L L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 206 GRKIRPDVLVDWA-----IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260
+ A Q+ L + L+H N+ + D +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMP-----DGR-- 232
Query: 261 TLKITDFGLAREVYKTTHMSAAGTYAWMAPEVI---KTSIFSKASDVWSYGVVLWELLTG 317
L + D +V T A+ AP T+ F+ A + W G+ ++ +
Sbjct: 233 -LMLGDVSALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289
Query: 318 EIPY-------KSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKT 370
+P+ K + L + P KTL+ D R
Sbjct: 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349
Query: 371 ILKALNNIVHSEFIQTPHE 389
++ EF+Q +E
Sbjct: 350 AME------TPEFLQLQNE 362
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK---QEVAIKV---AHPNPDENILENVKQEGKLLWLFDHR 173
+G+G FG+V K ++ QE A+KV A + + +E +LL DH
Sbjct: 25 NIVCMLGKGSFGEVLKCK-DRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHP 81
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
NI+ L + S +V E GG L + ++ ++ Q+ G+ Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH- 140
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAPE 291
+++HRDLK N+LL ++ +KI DFGL+ + T M GT ++APE
Sbjct: 141 --NIVHRDLKPENILLESKEKD-----CDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIP 320
V++ + + + DVWS GV+L+ LL+G P
Sbjct: 194 VLRGT-YDEKCDVWSAGVILYILLSGTPP 221
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 44/216 (20%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNPDENIL---ENVKQEGKLLW-LFDHR 173
E IG G + + I K E A+K+ I + +E ++L H
Sbjct: 26 VKEDIGVGSYSVCKRCI-HKATNMEFAVKI--------IDKSKRDPTEEIEILLRYGQHP 76
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGPL-NRVL---------AGRKIRPDVLVDWAIQIAE 223
NI++L V + +V E +GG L +++L A + I +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF---------TITK 127
Query: 224 GMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH--MSA 281
+ YLH Q ++HRDLK SN+L + N + +++I DFG A+++ M+
Sbjct: 128 TVEYLHAQ---GVVHRDLKPSNILYVDESGNPE----SIRICDFGFAKQLRAENGLLMTP 180
Query: 282 AGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTG 317
T ++APEV++ + A D+WS GV+L+ +LTG
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 51/219 (23%), Positives = 87/219 (39%), Gaps = 20/219 (9%)
Query: 122 GEAIGEGGFGKVYKGIYEK--QEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVS 177
+G GG G VY+ + VA+K+ D +++E + ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
+ +L + M G L +L + + P V QI ++ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---A 155
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR---EVYKTTHMSAAGTYAWMAPEVI 293
HRD+K N+L+S + DFG+A + T + GT +MAPE
Sbjct: 156 THRDVKPENILVSAD--------DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG 332
S + +D+++ VL+E LTG PY+ + +V
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGA 245
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 46/248 (18%), Positives = 97/248 (39%), Gaps = 37/248 (14%)
Query: 100 NLVSSVINDVKLVEIDYNKLIFGEAIGEG--GFGKVYKGIYEK--QEVAIKVAHP-NPDE 154
NL ++ Y L IG+G V Y+ + V ++ +
Sbjct: 11 NLYFQGMSSFLPEGGCYELL---TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 155 NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVL 214
++ ++ E + LF+H NIV + +L +V + G ++ D +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGM 125
Query: 215 VDWAI-----QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269
+ AI + + ++Y+H +HR +K+S++L+S + ++
Sbjct: 126 NELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVD--------GKVYLSGLRS 174
Query: 270 A---------REVYKTTHMSAAGTYAWMAPEVIKTSI--FSKASDVWSYGVVLWELLTGE 318
+ V + W++PEV++ ++ + SD++S G+ EL G
Sbjct: 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
Query: 319 IPYKSINA 326
+P+K + A
Sbjct: 235 VPFKDMPA 242
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKV---AHPNPDENILENVKQEGKLLWLFDHRN 174
E +G+G F V + + K E A K+ + + + +++E ++ H N
Sbjct: 33 VKEELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPN 89
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAP 233
IV L + LV + GG L ++A QI E + Y H
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN-- 147
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAPEV 292
++HR+LK N+LL+ + + K+ DFGLA EV + AGT +++PEV
Sbjct: 148 -GIVHRNLKPENLLLASKAKGAAV-----KLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 201
Query: 293 IKTSIFSKASDVWSYGVVLWELLTG 317
+K +SK D+W+ GV+L+ LL G
Sbjct: 202 LKKDPYSKPVDIWACGVILYILLVG 226
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 120 IFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
+ +GEG +G+V + ++ VA+K+ + EN+K+E + + +H N+V
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 178 LIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
G + L +EY GG L +R+ + + Q+ G+ YLH +
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GI 126
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA--------REVYKTTHMSAAGTYAWM 288
HRD+K N+LL E LKI+DFGLA + GT ++
Sbjct: 127 THRDIKPENLLLDE--------RDNLKISDFGLATVFRYNNRERLLNKM----CGTLPYV 174
Query: 289 APEVIKTSIFS-KASDVWSYGVVLWELLTGEIP 320
APE++K F + DVWS G+VL +L GE+P
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 120 IFGEAIGEGGFGKVYKGIYE--KQEVAIKVAH-PNPDENILENVKQEGKLLWLFDHRNIV 176
+ IG+G F KV + +EVAIK+ + L+ + +E +++ + +H NIV
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 177 SLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L V L L+MEYA GG + + ++A +++ QI + Y H +
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---R 134
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA-GTYAWMAPEVIK 294
++HRDLK+ N+LL +KI DFG + E + A G + APE+ +
Sbjct: 135 IVHRDLKAENLLLDAD--------MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ 186
Query: 295 TSIFS-KASDVWSYGVVLWELLTGEIPYKSIN 325
+ DVWS GV+L+ L++G +P+ N
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIV 176
IF E +G G F +V+ ++ + A+K +P +++ E +L H NIV
Sbjct: 12 IFMEVLGSGAFSEVFLVK-QRLTGKLFALKCIKKSPAFRD-SSLENEIAVLKKIKHENIV 69
Query: 177 SLIGVCLQSPKLCLVMEYARGGPL-NRVL---------AGRKIRPDVLVDWAIQIAEGMN 226
+L + + LVM+ GG L +R+L A I+ Q+ +
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ---------QVLSAVK 120
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA 286
YLH ++HRDLK N+L P EN + ITDFGL++ +A GT
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKI-----MITDFGLSKMEQNGIMSTACGTPG 172
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTG 317
++APEV+ +SKA D WS GV+ + LL G
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 68/206 (33%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 122 GEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLI 179
+ IG G FG + K+ VA+K I ENV++E H NIV
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 180 GVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238
V L L ++MEYA GG L R+ + D + Q+ G++Y H + H
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICH 139
Query: 239 RDLKSSNVLL-SEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTYAWMAPEVIKT 295
RDLK N LL P LKI DFG ++ S GT A++APEV+
Sbjct: 140 RDLKLENTLLDGSPAPR-------LKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLR 191
Query: 296 SIFS-KASDVWSYGVVLWELLTGEIP 320
+ K +DVWS GV L+ +L G P
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-33
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKV-----AHPNPDENILENVKQEGKLLWLFDH 172
GE +G G F V K +K +E A K + E +++E +L H
Sbjct: 9 MGEELGSGQFAIVRKCR-QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
NI++L + + L++E GG L + + + D + QI +G++YLH +
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAP 290
+ H DLK N++L ++++ +K+ DFG+A ++ GT ++AP
Sbjct: 128 ---RIAHFDLKPENIMLL----DKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGEIP 320
E++ +D+WS GV+ + LL+G P
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 121 FGEAIGEGGFGKVYKGIYEK--QEVAIKV---AHPNPDENILENVKQEGKLLWLFDHRNI 175
+ +G G +G+V + E AIK+ + + +E +L L DH NI
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS--NSKLLEEVAVLKLLDHPNI 98
Query: 176 VSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
+ L LVME +GG L + ++ K Q+ G+ YLH
Sbjct: 99 MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH--- 155
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAPEVI 293
+++HRDLK N+LL ++ +KI DFGL+ M GT ++APEV+
Sbjct: 156 NIVHRDLKPENLLLESKEKDAL-----IKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL 210
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYK 322
+ + + DVWS GV+L+ LL G P+
Sbjct: 211 RKK-YDEKCDVWSIGVILFILLAGYPPFG 238
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
IG G +G+V + + A K E++ + KQE +++ DH NI+
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-DRFKQEIEIMKSLDHPNIIR 70
Query: 178 LIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
L + + LVME GG L RV+ R R + + Y H ++
Sbjct: 71 LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NV 127
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAPEVIKT 295
HRDLK N L + LK+ DFGLA M GT +++P+V++
Sbjct: 128 AHRDLKPENFLFLTDSPD-----SPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 182
Query: 296 SIFSKASDVWSYGVVLWELLTGEIP 320
+ D WS GV+++ LL G P
Sbjct: 183 L-YGPECDEWSAGVMMYVLLCGYPP 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
IF +G G FG V+ E IK + + + +E ++ E ++L DH NI+
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 178 LIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVL-----VDWAIQIAEGMNYLHCQ 231
+ V + +VME GG L R+++ + R L + Q+ + Y H Q
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVS-AQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAP 290
++H+DLK N+L + + +KI DFGLA H + AAGT +MAP
Sbjct: 144 ---HVVHKDLKPENILFQDTSPH-----SPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGEIP 320
EV K + D+WS GVV++ LLTG +P
Sbjct: 196 EVFKRD-VTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 64/217 (29%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK--QEVAIKV------------AHPNPDENILENVKQEGK 165
+G G +G+V + E AIKV E E + E
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEG 224
LL DH NI+ L V LV E+ GG L +++ K + QI G
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAG 283
+ YLH +++HRD+K N+LL +KI DFGL+ K + G
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLL-----NIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 284 TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP 320
T ++APEV+K +++ DVWS GV+++ LL G P
Sbjct: 211 TAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPP 246
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK---QEVAIKV----AHPNPDENILENVKQEGKLLWLFDH 172
E IG+G F V + I + Q+ A+K+ + E++K+E + + H
Sbjct: 27 ELCEVIGKGPFSVVRRCI-NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVL-----VDWAIQIAEGMN 226
+IV L+ L +V E+ G L ++ R V + QI E +
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQILEALR 144
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGT 284
Y H ++IHRD+K VLL+ + +K+ FG+A ++ ++ + GT
Sbjct: 145 YCHDN---NIIHRDVKPHCVLLASKENS-----APVKLGGFGVAIQLGESGLVAGGRVGT 196
Query: 285 YAWMAPEVIKTSIFSKASDVWSYGVVLWELLTG 317
+MAPEV+K + K DVW GV+L+ LL+G
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 121 FGEAIGEGGFGKVYKGIYEK--QEVAIKV--AHPNPDENILENVKQEGKLLWLFDHRNIV 176
+G+G FG+V + QE A+KV + E++ +E +LL DH NI+
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 177 SLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L LV E GG L + +++ ++ Q+ G+ Y+H
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---K 146
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAPEVIK 294
++HRDLK N+LL ++ ++I DFGL+ + M GT ++APEV+
Sbjct: 147 IVHRDLKPENLLLESKSKDA-----NIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH 201
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
+ + + DVWS GV+L+ LL+G P+ N
Sbjct: 202 GT-YDEKCDVWSTGVILYILLSGCPPFNGAN 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 44/218 (20%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNPDENILENVKQEGKLLW-LFDHRNI 175
+ + +G G GKV + + Q+ A+K+ + +P +QE W +I
Sbjct: 32 LSKQVLGLGVNGKVLECF-HRRTGQKCALKLLYDSPK------ARQEVDHHWQASGGPHI 84
Query: 176 VSLIGVC----LQSPKLCLVMEYARGGPL-NRVL-----------AGRKIRPDVLVDWAI 219
V ++ V L ++ME GG L +R+ A +R
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR--------- 135
Query: 220 QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM 279
I + +LH ++ HRD+K N+L + ++ LK+TDFG A+E +
Sbjct: 136 DIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKD-----AVLKLTDFGFAKETTQNALQ 187
Query: 280 SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTG 317
+ T ++APEV+ + K+ D+WS GV+++ LL G
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 6e-33
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKV-----AHPNPDENILENVKQEGKLLWLFDH 172
GE +G G F V K EK + A K + E++++E +L H
Sbjct: 15 TGEELGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
N+++L V + L++E GG L + + + + ++ QI G+ YLH
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAP 290
+ H DLK N++L + ++ +KI DFGLA ++ GT ++AP
Sbjct: 134 ---QIAHFDLKPENIMLL----DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGEIP 320
E++ +D+WS GV+ + LL+G P
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
E +G G FG V++ + EK + K + + VK E ++ H +++
Sbjct: 55 ILEELGSGAFGVVHRCV-EKATGRVFVAKFINTPYPLDK-YTVKNEISIMNQLHHPKLIN 112
Query: 178 LIGVCLQSPKLCLVMEYARGGPL-NRVL----------AGRKIRPDVLVDWAIQIAEGMN 226
L ++ L++E+ GG L +R+ +R Q EG+
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR---------QACEGLK 163
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTY 285
++H S++H D+K N++ + +KI DFGLA ++ + T
Sbjct: 164 HMHEH---SIVHLDIKPENIMCETKKASS------VKIIDFGLATKLNPDEIVKVTTATA 214
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP 320
+ APE++ +D+W+ GV+ + LL+G P
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 121 FGEAIGEGGFGKVYKGI--YEKQEVAIKV---AHPNPDENILENVKQEGKLLWLFDHRNI 175
+G+G FG+V K +QE A+KV A + + +E +LL DH NI
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNI 83
Query: 176 VSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
+ L + S +V E GG L + ++ ++ Q+ G+ Y+H
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH--- 140
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAPEVI 293
+++HRDLK N+LL ++ +KI DFGL+ + T M GT ++APEV+
Sbjct: 141 NIVHRDLKPENILLESKEKDC-----DIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIP 320
+ + + + DVWS GV+L+ LL+G P
Sbjct: 196 RGT-YDEKCDVWSAGVILYILLSGTPP 221
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
E +G G FG V++ E+ A K + + E V++E + + + H +V+
Sbjct: 161 IHEELGTGAFGVVHRVT-ERATGNNFAAKFVMTPHESDK-ETVRKEIQTMSVLRHPTLVN 218
Query: 178 LIGVCLQSPKLCLVMEYARGGPL-NRVLAGR-KIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L ++ ++ E+ GG L +V K+ D V++ Q+ +G+ ++H +
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---N 275
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAPEVIK 294
+H DLK N++ + N LK+ DFGL + + GT + APEV +
Sbjct: 276 YVHLDLKPENIMFTTKRSN------ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIP 320
+D+WS GV+ + LL+G P
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 49/206 (23%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS 177
E +G G FG V++ + E + K + VK+E +L + HRNI+
Sbjct: 9 IAEDLGRGEFGIVHRCV-ETSSKKTYMAKFVKVKGTDQ--VLVKKEISILNIARHRNILH 65
Query: 178 LIGVCLQSPKLCLVMEYARGGPL-NRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L +L ++ E+ G + R+ ++ +V + Q+ E + +LH +
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---N 122
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAWMAPEVIK 294
+ H D++ N++ + +KI +FG AR++ + + APEV +
Sbjct: 123 IGHFDIRPENIIYQTRRSST------IKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 295 TSIFSKASDVWSYGVVLWELLTGEIP 320
+ S A+D+WS G +++ LL+G P
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 120 IFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNI 175
+ G+ +G G FGKV G ++ +VA+K+ + +++ +K+E + L LF H +I
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 176 VSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
+ L V +VMEY GG L + + ++ QI ++Y H
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH--- 130
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTYAWMAPEV 292
++HRDLK NVLL KI DFGL+ + ++ G+ + APEV
Sbjct: 131 MVVHRDLKPENVLLDA--------HMNAKIADFGLSN-MMSDGEFLRTSCGSPNYAAPEV 181
Query: 293 IKTSIFS-KASDVWSYGVVLWELLTGEIPY 321
I +++ D+WS GV+L+ LL G +P+
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPF 211
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNPDENILENVKQEGKLLWLFD 171
+ + E +G G FG+V+K E ++A K+ ++ E VK E ++ D
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCE-ETATGLKLAAKIIKTRGMKDK-EEVKNEISVMNQLD 144
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVL----------AGRKIRPDVLVDWAIQ 220
H N++ L + LVMEY GG L +R++ ++ Q
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---------Q 195
Query: 221 IAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS 280
I EG+ ++H ++H DLK N+L + +KI DFGLAR +
Sbjct: 196 ICEGIRHMHQM---YILHLDLKPENILCVNRDAKQ------IKIIDFGLARRYKPREKLK 246
Query: 281 -AAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP 320
GT ++APEV+ S +D+WS GV+ + LL+G P
Sbjct: 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 35/212 (16%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIV 176
+G G VY+ +K + A+KV D+ + V+ E +L H NI+
Sbjct: 56 EVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDK---KIVRTEIGVLLRLSHPNII 111
Query: 177 SLIGVCLQSPKLCLVMEYARGGPL-NRVL---------AGRKIRPDVLVDWAIQIAEGMN 226
L + ++ LV+E GG L +R++ A ++ QI E +
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK---------QILEAVA 162
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTY 285
YLH ++HRDLK N+L + P + LKI DFGL++ V M GT
Sbjct: 163 YLHEN---GIVHRDLKPENLLYATPAPD-----APLKIADFGLSKIVEHQVLMKTVCGTP 214
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTG 317
+ APE+++ + D+WS G++ + LL G
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK---QEVAIKV---AHPNPDENILENVKQEGKLLWLFDHR 173
+ + +G G F V + I K QE A K D + E +L L
Sbjct: 32 LTSKELGRGKFAVVRQCI-SKSTGQEYAAKFLKKRRRGQDC--RAEILHEIAVLELAKSC 88
Query: 174 -NIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIR---PDVLVDWAIQIAEGMNYL 228
+++L V + ++ L++EYA GG + + L DV + QI EG+ YL
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV-IRLIKQILEGVYYL 147
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAW 287
H +++H DLK N+LLS D+ KI DFG++R++ + GT +
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDI-----KIVDFGMSRKIGHACELREIMGTPEY 199
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP 320
+APE++ + A+D+W+ G++ + LLT P
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 53/225 (23%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKV-------AHPNPDENILENVKQEGKLL-WL 169
+ IG G V + + + E A+K+ P E + E ++E +L +
Sbjct: 98 PKDVIGRGVSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVL---------AGRKIRPDVLVDWAI 219
H +I++LI S + LV + R G L + + +R
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR--------- 207
Query: 220 QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM 279
+ E +++LH +++HRDLK N+LL + ++++DFG + + +
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDN--------MQIRLSDFGFSCHLEPGEKL 256
Query: 280 S-AAGTYAWMAPEVIKTSIF------SKASDVWSYGVVLWELLTG 317
GT ++APE++K S+ K D+W+ GV+L+ LL G
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 67/256 (26%), Positives = 99/256 (38%), Gaps = 66/256 (25%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKV----AHPNPDENILENVKQEGKLLWLFDHR 173
AIG+G +G V I E AIK+ + +E +K E +L+ H
Sbjct: 30 LKGAIGQGSYGVVRVAI-ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAI------------- 219
NI L V +CLVME GG L +++ +
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 220 ---------------------------QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPI 252
QI ++YLH Q + HRD+K N L S
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTN- 204
Query: 253 ENEDLQFKTLKITDFGLAREVYKTTH------MSAAGTYAWMAPEVIKTSI--FSKASDV 304
+ + +K+ DFGL++E YK + + AGT ++APEV+ T+ + D
Sbjct: 205 --KSFE---IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 305 WSYGVVLWELLTGEIP 320
WS GV+L LL G +P
Sbjct: 260 WSAGVLLHLLLMGAVP 275
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKV---AHPNPDENILENVKQEGKLLWLFDHRN 174
E +G+G F V + + + QE A + + ++ + +++E ++ L H N
Sbjct: 15 LFEELGKGAFSVVRRCV-KVLAGQEYAAMIINTKKLSARDH--QKLEREARICRLLKHPN 71
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAP 233
IV L + L+ + GG L ++A QI E + + H
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM-- 129
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTYAWMAPE 291
++HR+LK N+LL+ ++ + K+ DFGLA EV AGT +++PE
Sbjct: 130 -GVVHRNLKPENLLLASKLKGAAV-----KLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTG 317
V++ + K D+W+ GV+L+ LL G
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVG 209
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 43/218 (19%)
Query: 120 IFGEAIGEGGFGKVYKGI--YEKQEVAIKVAHPNPDENILENVKQEGKLLW-LFDHRNIV 176
+ + +G G GKV + +++ A+K+ P ++E +L W +IV
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQCPHIV 118
Query: 177 SLIGVC----LQSPKLCLVMEYARGGPL-NRVL-----------AGRKIRPDVLVDWAIQ 220
++ V L +VME GG L +R+ A ++
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---------S 169
Query: 221 IAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS 280
I E + YLH ++ HRD+K N+L + N LK+TDFG A+E ++
Sbjct: 170 IGEAIQYLHSI---NIAHRDVKPENLLYTSKRPN-----AILKLTDFGFAKETTSHNSLT 221
Query: 281 -AAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTG 317
T ++APEV+ + K+ D+WS GV+++ LL G
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 45/225 (20%)
Query: 120 IFGEAIGEGGFGKVYKGI--YEKQEVAIKVAHPNPDENILENVKQEGKLLW-LFDHRNIV 176
+ + +GEG +V I QE A+K+ P V +E ++L+ HRN++
Sbjct: 16 LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR-SRVFREVEMLYQCQGHRNVL 74
Query: 177 SLIGVCLQSPKLCLVMEYARGGPL-NRVL---------AGRKIRPDVLVDWAIQIAEGMN 226
LI + + LV E RGG + + + A ++ +A ++
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---------DVASALD 125
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA 286
+LH + + HRDLK N+L P + +KI DF L + S T
Sbjct: 126 FLHNK---GIAHRDLKPENILCEHPNQVSP-----VKICDFDLGSGIKLNGDCSPISTPE 177
Query: 287 W---------MAPEVIK-----TSIFSKASDVWSYGVVLWELLTG 317
MAPEV++ SI+ K D+WS GV+L+ LL+G
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKV--------AHPNPDENILENVKQEGKLL-W 168
E +G G V + I K +E A+K+ + + E +E +L
Sbjct: 21 PKEILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNY 227
+ H NI+ L + LV + + G L + + + + E +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 139
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYA 286
LH +++HRDLK N+LL + +K+TDFG + ++ + GT +
Sbjct: 140 LHKL---NIVHRDLKPENILLDDD--------MNIKLTDFGFSCQLDPGEKLREVCGTPS 188
Query: 287 WMAPEVIKTSIF------SKASDVWSYGVVLWELLTG 317
++APE+I+ S+ K D+WS GV+++ LL G
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 56/225 (24%), Positives = 86/225 (38%), Gaps = 48/225 (21%)
Query: 121 FGEAIGEGGFGKVYKGIYE--KQEVAIKVA-----HPNPDENILENVKQEGKLLWLFDHR 173
G +G GGFG VY GI VAIK + V E LL
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 174 --NIVSLIGVCLQSPKLCLVMEYARG-----------GPLNRVLAGRKIRPDVLVDWAIQ 220
++ L+ + L++E G L LA Q
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW---------Q 157
Query: 221 IAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA----REVYKT 276
+ E + + H ++HRD+K N+L+ DL LK+ DFG VY
Sbjct: 158 VLEAVRHCHNC---GVLHRDIKDENILI-------DLNRGELKLIDFGSGALLKDTVYTD 207
Query: 277 THMSAAGTYAWMAPEVIKTSIFS-KASDVWSYGVVLWELLTGEIP 320
GT + PE I+ + +++ VWS G++L++++ G+IP
Sbjct: 208 F----DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 120 IFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNI 175
I G+ +G G FGKV G +E +VA+K+ + +++ +++E + L LF H +I
Sbjct: 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 176 VSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
+ L V + +VMEY GG L + + ++ QI G++Y H
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH--- 135
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA-GTYAWMAPEVI 293
++HRDLK NVLL KI DFGL+ + + + G+ + APEVI
Sbjct: 136 MVVHRDLKPENVLLDA--------HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 187
Query: 294 KTSIFS-KASDVWSYGVVLWELLTGEIP 320
+++ D+WS GV+L+ LL G +P
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 32/217 (14%)
Query: 122 GEAIGEGGFGKVYKGIYE--KQEVAIKVA-----HPNPDENILENVKQEGKLLWLFD--- 171
G +G+GGFG V+ G + +VAIKV + E LLW
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 172 -HRNIVSLIGVCLQSPKLCLVMEYA-RGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYL 228
H ++ L+ LV+E L + + + + Q+ + +
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA----REVYKTTHMSAAGT 284
H + ++HRD+K N+L+ DL+ K+ DFG E Y GT
Sbjct: 156 HSR---GVVHRDIKDENILI-------DLRRGCAKLIDFGSGALLHDEPYTDF----DGT 201
Query: 285 YAWMAPEVIKTSIFS-KASDVWSYGVVLWELLTGEIP 320
+ PE I + + VWS G++L++++ G+IP
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 122 GEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVS 177
E +GEG FGKV + +Q+VA+K ++ V++E L L H +I+
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 178 LIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
L V + +V+EYA GG L + ++ +++ D + QI + Y H +
Sbjct: 74 LYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KI 129
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--SAAGTYAWMAPEVIK 294
+HRDLK N+LL + +KI DFGL+ + + ++ G+ + APEVI
Sbjct: 130 VHRDLKPENLLLDDN--------LNVKIADFGLSN-IMTDGNFLKTSCGSPNYAAPEVIN 180
Query: 295 TSIFS-KASDVWSYGVVLWELLTGEIP 320
+++ DVWS G+VL+ +L G +P
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 24/247 (9%)
Query: 121 FGEAIGEGGFGKVY--KGIYEKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIV 176
FG+ +GEG F V + + +E AIK+ EN + V +E ++ DH V
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 177 SLIGVCLQSP-KLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
L Q KL + YA+ G L + + + +I + YLH +
Sbjct: 94 KLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK--- 149
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA----GTYAWMAP 290
+IHRDLK N+LL + ++ITDFG A+ + + + A GT +++P
Sbjct: 150 GIIHRDLKPENILL-------NEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPSTCPQ 348
E++ K+SD+W+ G ++++L+ G P+++ N Y + + + P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 349 LFKTLME 355
L + L+
Sbjct: 262 LVEKLLV 268
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 120 IFGEAIGEGGFGKVYKGIYE--KQEVAIKV-------AHPNPDENILENVKQEGKLLWLF 170
+G G FG V+ + + +EV +K ++ L V E +L
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 171 DHRNIVSLIGVCLQSPKLCLVME-YARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYL 228
+H NI+ ++ + LVME + G L + ++ + Q+ + YL
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS-AAGTYAW 287
+ +IHRD+K N++++E T+K+ DFG A + + GT +
Sbjct: 147 RLK---DIIHRDIKDENIVIAE--------DFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 288 MAPEVIKTSIFS-KASDVWSYGVVLWELLTGEIPY 321
APEV+ + + ++WS GV L+ L+ E P+
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 61/348 (17%), Positives = 110/348 (31%), Gaps = 101/348 (29%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKG--IYEKQEVAI-----------------------KVAH 149
D+ + + +G GGFG V++ + AI K+ H
Sbjct: 7 DFEPI---QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 63
Query: 150 PNP----------------------------------DENILENVKQEGKLLWLFDHRNI 175
P + ++ + + + F +N
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 176 VSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK----IRPDVLVDWAIQIAEGMNYLHCQ 231
V + L + M+ R L + R V + IQIAE + +LH +
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV--------------YKTT 277
L+HRDLK SN+ + +K+ DFGL + T
Sbjct: 184 ---GLMHRDLKPSNIFFTMD--------DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 278 HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK 337
H GT +M+PE I + +S D++S G++L+ELL + + N
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNL 289
Query: 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
+ + +++ RP I++ + +
Sbjct: 290 KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE-------NAIFE 330
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 32/305 (10%), Positives = 88/305 (28%), Gaps = 68/305 (22%)
Query: 118 KLIFGEAIGEGGFGKVYKG--IYEKQEVAIKVAH--PNPDENILENVKQEGKLLWLF--- 170
L+ G +G+ + + + V + P N ++ +K+E L L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 171 ----------------------DHRNIVSLIGVC--LQSPKLCLVMEYARGGPL------ 200
+ ++ + + + +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 201 -NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259
+ + + + +Q+ + LH L+H L+ +++L +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQ--------R 242
Query: 260 KTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT-----------SIFSKASDVWSYG 308
+ +T F + ++ + + PE+ ++ + + D W+ G
Sbjct: 243 GGVFLTGFEHLVRD--GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300
Query: 309 VVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSF 368
+V++ + ++P A + + PQ + L+E R
Sbjct: 301 LVIYWIWCADLPITKDAALGGS------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLP 354
Query: 369 KTILK 373
++
Sbjct: 355 LQAME 359
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 4e-29
Identities = 39/305 (12%), Positives = 84/305 (27%), Gaps = 63/305 (20%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKV--AHPNPDENILENVKQEGKLL---- 167
L+ G +G+ + ++ + + V P N ++ +K+E L
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 168 ------------------WLFDHRNIVSLIGVCLQ-----SPKLCLVMEYARG--GPLNR 202
L +I V L + +
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 203 VLAGRKIRPDVLVDWA-----IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDL 257
VL LV A +Q+ + LH L+H L+ +++L +
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLD-----QRG 248
Query: 258 QFKTLKITDFGLAR---EVYKTTHMSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGV 309
+ +T F + A ++ ++ + A D W+ G+
Sbjct: 249 G---VFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305
Query: 310 VLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFK 369
++ + ++P A + + PQ + L+E R
Sbjct: 306 AIYWIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPL 359
Query: 370 TILKA 374
++
Sbjct: 360 QAMET 364
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 36/218 (16%)
Query: 125 IGEGGFGKVY-------KGIY-----EKQEVAIK--VAHPNPDENILENVKQEGKLLWLF 170
IG GGFG+VY +Y +K+ + +K + +L V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG------- 249
Query: 171 DHRNIVSLIGVCLQSP-KLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYL 228
D IV + +P KL +++ GG L + + +A +I G+ ++
Sbjct: 250 DCPFIVCMSY-AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM 288
H + +++RDLK +N+LL D ++I+D GLA + K ++ GT+ +M
Sbjct: 309 HNR---FVVYRDLKPANILL-------DEH-GHVRISDLGLACDFSKKKPHASVGTHGYM 357
Query: 289 APEVI-KTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
APEV+ K + ++D +S G +L++LL G P++
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 36/215 (16%)
Query: 124 AIGEGGFGKVY-------KGIYEKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRN 174
AIG+G FGKV K +Y A+K + + N + NV +E +++ +H
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMY-----AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 175 IVSLIGVCLQSP-KLCLVMEYARGGPLNRVLAGRKIR---PDVLVDWAIQIAEGMNYLHC 230
+V+L Q + +V++ GG L R + + V + + ++ ++YL
Sbjct: 77 LVNLWY-SFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKL-FICELVMALDYLQN 133
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-YKTTHMSAAGTYAWMA 289
Q +IHRD+K N+LL D + ITDF +A + +T + AGT +MA
Sbjct: 134 Q---RIIHRDMKPDNILL-------DEH-GHVHITDFNIAAMLPRETQITTMAGTKPYMA 182
Query: 290 PEVIKTSIF---SKASDVWSYGVVLWELLTGEIPY 321
PE+ + S A D WS GV +ELL G PY
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 54/221 (24%), Positives = 86/221 (38%), Gaps = 64/221 (28%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNPDENILENVKQEGKLLW-LFDHRNI 175
+ + +G G GKV + K ++ A+K+ P ++E +L W +I
Sbjct: 21 VTSQVLGLGINGKVLQIF-NKRTQEKFALKMLQDCPK------ARREVELHWRASQCPHI 73
Query: 176 VSLIGVC----LQSPKLCLVMEYARGGPL-NRVL-----------AGRKIRPDVLVDWAI 219
V ++ V L +VME GG L +R+ A ++
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK--------- 124
Query: 220 QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM 279
I E + YLH ++ HRD+K N+L + N LK+TDFG
Sbjct: 125 SIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPN-----AILKLTDFGF---------- 166
Query: 280 SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP 320
A E + K+ D+WS GV+++ LL G P
Sbjct: 167 ---------AKETTGEK-YDKSCDMWSLGVIMYILLCGYPP 197
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-27
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 125 IGEGGFGKVY-------KGIYEKQEVAIKV---AHPNPDENILENVKQEGKLLWLFDHRN 174
+G GGFG+V+ +Y A K + + E K+L R
Sbjct: 193 LGRGGFGEVFACQMKATGKLY-----ACKKLNKKRLKKRKGY-QGAMVEKKILAKVHSRF 246
Query: 175 IVSLIGVCLQSP-KLCLVMEYARGGPL-----NRVLAGRKIRPDVLVDWAIQIAEGMNYL 228
IVSL ++ LCLVM GG + N + + + QI G+ +L
Sbjct: 247 IVSLAY-AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV--YKTTHMSAAGTYA 286
H + ++I+RDLK NVLL D ++I+D GLA E+ +T AGT
Sbjct: 306 HQR---NIIYRDLKPENVLL-------DDD-GNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
+MAPE++ + + D ++ GV L+E++ P+++
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 125 IGEGGFGKVY-------KGIYEKQEVAIKV---AHPNPDENILENVKQEGKLLWL-FDHR 173
IG G + KV IY A+KV N DE+I + V+ E + +H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIY-----AMKVVKKELVNDDEDI-DWVQTEKHVFEQASNHP 70
Query: 174 NIVSLIGVCLQSP-KLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
+V L C Q+ +L V+EY GG L + RK+ + ++ +I+ +NYLH +
Sbjct: 71 FLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMA 289
+I+RDLK NVLL D + +K+TD+G+ +E T + GT ++A
Sbjct: 130 ---GIIYRDLKLDNVLL-------DSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL 338
PE+++ + + D W+ GV+++E++ G P+ + + + L
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-26
Identities = 70/318 (22%), Positives = 120/318 (37%), Gaps = 45/318 (14%)
Query: 29 NHRPDLWRALYDYDAI--GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEY-KV 85
+ R R L G D + +V ++ + EY V
Sbjct: 96 DKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSV 155
Query: 86 GIFPANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVY-------KGIY 138
F S + L + + + + + +G+GGFG+V +Y
Sbjct: 156 APFADYLDSIYFNRFLQWKWLERQPVTKNTFRQY---RVLGKGGFGEVCACQVRATGKMY 212
Query: 139 EKQEVAIKV---AHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-KLCLVMEY 194
A K + E ++L + R +VSL ++ LCLV+
Sbjct: 213 -----ACKKLEKKRIKKRKGE-AMALNEKQILEKVNSRFVVSLAY-AYETKDALCLVLTL 265
Query: 195 ARGGPLN---RVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEP 251
GG L + V +A +I G+ LH + +++RDLK N+LL +
Sbjct: 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDH 322
Query: 252 --IENEDLQFKTLKITDFGLAREVY--KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSY 307
I +I+D GLA V +T GT +MAPEV+K ++ + D W+
Sbjct: 323 GHI----------RISDLGLAVHVPEGQTIK-GRVGTVGYMAPEVVKNERYTFSPDWWAL 371
Query: 308 GVVLWELLTGEIPYKSIN 325
G +L+E++ G+ P++
Sbjct: 372 GCLLYEMIAGQSPFQQRK 389
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIG 180
+G G FG+V K A+K+ +E+ E ++L + +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 VCLQSP-KLCLVMEYARGGPLNRVLAGRKIR---PDVLVDWAIQIAEGMNYLHCQAPISL 236
+ L +VMEY GG + L R+I +A QI YLH L
Sbjct: 109 -SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSL---DL 162
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTS 296
I+RDLK N+L+ Q +++TDFG A+ V T + GT +APE+I +
Sbjct: 163 IYRDLKPENLLID--------QQGYIQVTDFGFAKRVKGRTW-TLCGTPEALAPEIILSK 213
Query: 297 IFSKASDVWSYGVVLWELLTGEIPY 321
++KA D W+ GV+++E+ G P+
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 125 IGEGGFGKVY-------KGIYEKQEVAIKV---AHPNPDENILENVKQEGKLLWLFDHRN 174
+G+G FGKV Y A+K+ + + + E ++L H
Sbjct: 156 LGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAKDEV-AHTLTENRVLQNSRHPF 209
Query: 175 IVSLIGVCLQSP-KLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
+ +L Q+ +LC VMEYA GG L + R D + +I ++YLH +
Sbjct: 210 LTALKY-SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMAP 290
+ ++RDLK N++L D +KITDFGL +E T + GT ++AP
Sbjct: 269 NV--VYRDLKLENLML-------DKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
EV++ + + +A D W GVV++E++ G +P+ + +
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 59/251 (23%), Positives = 100/251 (39%), Gaps = 50/251 (19%)
Query: 94 SSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPN 151
S+ +N ++ + + G+G FG V G + VAIK
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVE---RMAGQGTFGTVQLGKEKSTGMSVAIK----- 54
Query: 152 PDENILENVK------QEGKLLWLFDHRNIVSLIGVCLQSPK--------LCLVMEYARG 197
++++ + Q + L + H NIV L + L +VMEY
Sbjct: 55 ---KVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSY-FYTLGERDRRDIYLNVVMEYV-P 109
Query: 198 GPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPI 252
L+R R I Q+ + LH + +++ HRD+K NVL+
Sbjct: 110 DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLV---- 164
Query: 253 ENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA---WM-APEVIKTSI-FSKASDVWSY 307
+ TLK+ DFG A+++ + A Y + APE+I + ++ A D+WS
Sbjct: 165 ---NEADGTLKLCDFGSAKKLSPSEPNVA---YICSRYYRAPELIFGNQHYTTAVDIWSV 218
Query: 308 GVVLWELLTGE 318
G + E++ GE
Sbjct: 219 GCIFAEMMLGE 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 63/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 125 IGEGGFGKVY-------KGIYEKQEVAIKV---AHPNPDENILENVKQEGKLLWL-FDHR 173
IG G + KV IY A++V N DE+I + V+ E + +H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIY-----AMRVVKKELVNDDEDI-DWVQTEKHVFEQASNHP 113
Query: 174 NIVSLIGVCLQSP-KLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
+V L C Q+ +L V+EY GG L + RK+ + ++ +I+ +NYLH +
Sbjct: 114 FLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMA 289
+I+RDLK NVLL D + +K+TD+G+ +E T + GT ++A
Sbjct: 173 ---GIIYRDLKLDNVLL-------DSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL 338
PE+++ + + D W+ GV+++E++ G P+ + + + L
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 65/278 (23%), Positives = 118/278 (42%), Gaps = 50/278 (17%)
Query: 90 ANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVY-------KGIY---- 138
NF+S +D + I D+++ DY + + IG G FG+V + +Y
Sbjct: 48 DNFLSRYKD---TINKIRDLRMKAEDYEVV---KVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 139 -EKQEVAIK--VAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-KLCLVMEY 194
K E+ + A + +I+ + +V L Q L +VMEY
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFA----------NSPWVVQLFY-AFQDDRYLYMVMEY 150
Query: 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254
GG L +++ + + ++ ++ +H IHRD+K N+LL
Sbjct: 151 MPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLD----- 202
Query: 255 EDLQFKTLKITDFGLAREVYKTTHM---SAAGTYAWMAPEVIKT----SIFSKASDVWSY 307
+ LK+ DFG ++ K + +A GT +++PEV+K+ + + D WS
Sbjct: 203 ---KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259
Query: 308 GVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST 345
GV L+E+L G+ P+ + + + +K +L P
Sbjct: 260 GVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 36/217 (16%)
Query: 125 IGEGGFGKVY-------KGIYEKQEVAIKVAHPNPDENILEN-----VKQEGKLLWLFDH 172
+G+G FGKV Y A+K+ E I+ E ++L H
Sbjct: 13 LGKGTFGKVILVREKATGRYY-----AMKILR---KEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 173 RNIVSLIGVCLQSP-KLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHC 230
+ +L Q+ +LC VMEYA GG L + R + + +I + YLH
Sbjct: 65 PFLTALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWM 288
+ +++RD+K N++L D +KITDFGL +E T + GT ++
Sbjct: 124 R---DVVYRDIKLENLML-------DKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 289 APEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
APEV++ + + +A D W GVV++E++ G +P+ + +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 63/208 (30%), Positives = 109/208 (52%), Gaps = 29/208 (13%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKVAHPNPDENIL-----ENVKQEGKLLWLFDHRNIVS 177
+G G FG+V+ + + + A+KV E ++ E+ E +L + H I+
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLK---KEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 178 LIGVCLQSP-KLCLVMEYARGGPLNRVLAGRKIR---PDVLVDWAIQIAEGMNYLHCQAP 233
+ G Q ++ ++M+Y GG L +L RK + V +A ++ + YLH +
Sbjct: 71 MWG-TFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALEYLHSK-- 125
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVI 293
+I+RDLK N+LL D +KITDFG A+ V T+ + GT ++APEV+
Sbjct: 126 -DIIYRDLKPENILL-------DKN-GHIKITDFGFAKYVPDVTY-TLCGTPDYIAPEVV 175
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPY 321
T ++K+ D WS+G++++E+L G P+
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYTPF 203
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 34/218 (15%)
Query: 125 IGEGGFGKVY----------KGIYEKQEVAIKV---AHPNPDENILENVKQEGKLLWLFD 171
+G+GG+GKV+ I+ A+KV A + + K E +L
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIF-----AMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 172 HRNIVSLIGVCLQSP-KLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLH 229
H IV LI Q+ KL L++EY GG L ++ D + +I+ + +LH
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAW 287
+ +I+RDLK N++L + Q +K+TDFGL +E T + GT +
Sbjct: 139 QK---GIIYRDLKPENIML-------NHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
MAPE++ S ++A D WS G +++++LTG P+ N
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 68/246 (27%), Positives = 125/246 (50%), Gaps = 32/246 (13%)
Query: 94 SSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVY----KGIYEKQEV-AIKVA 148
SI++I + V + + +L+ + +G+G FGKV+ + +++ A+KV
Sbjct: 3 GSIKEIAITHHVKEGHEKADPSQFELL--KVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 149 HPNPDENILEN----VKQEGKLLWLFDHRNIVSLIGVCLQSP-KLCLVMEYARGGPL-NR 202
+ K E +L +H IV L Q+ KL L++++ RGG L R
Sbjct: 61 K---KATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTR 116
Query: 203 VLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262
+ + + + ++A +++LH +I+RDLK N+LL D + +
Sbjct: 117 LSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILL-------DEE-GHI 165
Query: 263 KITDFGLARE---VYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEI 319
K+TDFGL++E K + S GT +MAPEV+ ++++D WS+GV+++E+LTG +
Sbjct: 166 KLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
Query: 320 PYKSIN 325
P++ +
Sbjct: 225 PFQGKD 230
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 33/216 (15%)
Query: 125 IGEGGFGKVY-------KGIYEKQEVAIKV---AHPNPDENILENVKQEGKLLWL-FDHR 173
+G+G FGKV +Y A+KV D+++ E E ++L L +H
Sbjct: 31 LGKGSFGKVMLARVKETGDLY-----AVKVLKKDVILQDDDV-ECTMTEKRILSLARNHP 84
Query: 174 NIVSLIGVCLQSP-KLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
+ L C Q+P +L VME+ GG L + R+ +A +I + +LH +
Sbjct: 85 FLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMA 289
+I+RDLK NVLL D + K+ DFG+ +E T + GT ++A
Sbjct: 144 ---GIIYRDLKLDNVLL-------DHE-GHCKLADFGMCKEGICNGVTTATFCGTPDYIA 192
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
PE+++ ++ A D W+ GV+L+E+L G P+++ N
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 35/255 (13%), Positives = 69/255 (27%), Gaps = 46/255 (18%)
Query: 122 GEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVS 177
G + ++ + ++VA+ P +++L+ L D +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLI 237
++ V +V E+ RGG L V P + +A + H +A +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAH-RAGV--A 151
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSI 297
S V +S + + +
Sbjct: 152 LSIDHPSRVRVSI--------DGDVVLAYPATMPDA------------------------ 179
Query: 298 FSKASDVWSYGVVLWELLTGEIPYKS---INAYAVAYGVAVNKLTLP--IPSTCPQLFKT 352
+ D+ G L+ LL P + A A + P I P
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238
Query: 353 LMEACWEADSHMRPS 367
+ + D +R +
Sbjct: 239 VAARSVQGDGGIRSA 253
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 41/225 (18%)
Query: 112 VEIDYNKLIFGEAIGEGGFGKVYKGI-YEKQEVAIK-VAHPNPDENILENVKQEGKLLWL 169
EI Y + IG G FG V++ E EVAIK V +N +E +++ +
Sbjct: 38 REIAYTNC---KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN------RELQIMRI 88
Query: 170 FDHRNIVSLIGVCLQS------PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI---- 219
H N+V L + L LV+EY + R + I
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 220 -QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH 278
Q+ + Y+H + HRD+K N+LL D LK+ DFG A+ +
Sbjct: 148 YQLLRSLAYIHSI---GICHRDIKPQNLLL-------DPPSGVLKLIDFGSAKILIAGEP 197
Query: 279 MSAAGTYA---WM-APEVIKTSI-FSKASDVWSYGVVLWELLTGE 318
+ Y + APE+I + ++ D+WS G V+ EL+ G+
Sbjct: 198 NVS---YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 33/216 (15%)
Query: 125 IGEGGFGKVY-------KGIYEKQEVAIKV---AHPNPDENILENVKQEGKLLWL-FDHR 173
+G+G FGKV +Y A+K+ D+++ E E ++L L
Sbjct: 349 LGKGSFGKVMLSERKGTDELY-----AVKILKKDVVIQDDDV-ECTMVEKRVLALPGKPP 402
Query: 174 NIVSLIGVCLQSP-KLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
+ L C Q+ +L VMEY GG L + + + V +A +IA G+ +L +
Sbjct: 403 FLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSAAGTYAWMA 289
+I+RDLK NV+L D + +KI DFG+ +E T + GT ++A
Sbjct: 462 ---GIIYRDLKLDNVML-------DSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIA 510
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
PE+I + K+ D W++GV+L+E+L G+ P++ +
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 45/225 (20%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEG-------- 164
Y ++ +GEG +G+VYK I + VAIK LE+ + EG
Sbjct: 35 RYRRI---TKLGEGTYGEVYKAIDTVTNETVAIKRIR-------LEHEE-EGVPGTAIRE 83
Query: 165 -KLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAG-----RKIRPDVLVDWA 218
LL HRNI+ L V + +L L+ EY L + V+ +
Sbjct: 84 VSLLKELQHRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFL 138
Query: 219 IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR----EVY 274
Q+ G+N+ H + +HRDLK N+LLS +E LKI DFGLAR +
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPV---LKIGDFGLARAFGIPIR 192
Query: 275 KTTHMSAAGTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
+ TH T + PE++ + +S + D+WS + E+L
Sbjct: 193 QFTHEII--TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 55/225 (24%), Positives = 88/225 (39%), Gaps = 41/225 (18%)
Query: 120 IFGEAIGEGGFGKVYKGIYE----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNI 175
G +G G +G VYK + ++ A+K I + +E LL H N+
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACREIALLRELKHPNV 80
Query: 176 VSLIGVCLQS--PKLCLVMEYA---------RGGPLNRVLAGRKIRPDVLVDWAIQIAEG 224
+SL V L K+ L+ +YA ++ ++ QI +G
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT 284
++YLH ++HRDLK +N+L+ +KI D G AR
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERG----RVKIADMGFARLFNSPLK-----P 188
Query: 285 YAWMAPEVIK-----------TSIFSKASDVWSYGVVLWELLTGE 318
A + P V+ ++KA D+W+ G + ELLT E
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 49/224 (21%)
Query: 125 IGEGGFGKVY-------KGIYEKQEVAIK------------VAHPNPDENILENVKQEGK 165
+G+G FGKV +Y A+K V ++ +L +
Sbjct: 28 LGKGSFGKVMLSERKGTDELY-----AVKILKKDVVIQDDDVECTMVEKRVLALPGK--- 79
Query: 166 LLWLFDHRNIVSLIGVCLQSP-KLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAE 223
+ L C Q+ +L VMEY GG L + + + V +A +IA
Sbjct: 80 ------PPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 224 GMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSA 281
G+ +L + +I+RDLK NV+L D + +KI DFG+ +E T +
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVML-------DSE-GHIKIADFGMCKENIWDGVTTKTF 181
Query: 282 AGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
GT ++APE+I + K+ D W++GV+L+E+L G+ P++ +
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 40/220 (18%)
Query: 123 EAIGEGGFGKVYKGIY-EKQEVAIK----VAHPNPDENILENVK------QEGKLLWLFD 171
I G +G V G+ E VAIK NIL + +E +LL F
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 172 HRNIVSLIGVCLQSPKLC------LVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----Q 220
H NI+ L + + LV E L +V+ + V+ I
Sbjct: 88 HPNILGLRDI-FVHFEEPAMHKLYLVTELM-RTDLAQVI---HDQRIVISPQHIQYFMYH 142
Query: 221 IAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMS 280
I G++ LH +A + +HRDL N+LL ++ + I DF LARE + +
Sbjct: 143 ILLGLHVLH-EAGV--VHRDLHPGNILL-----ADNND---ITICDFNLAREDTADANKT 191
Query: 281 A-AGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGE 318
+ APE++ F+K D+WS G V+ E+ +
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEG---KL 166
E+ Y + IG G FG VY+ + VAIK +L++ + + ++
Sbjct: 52 QEVSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIK--------KVLQDKRFKNRELQI 100
Query: 167 LWLFDHRNIVSLIGVCLQS------PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI- 219
+ DH NIV L S L LV++Y + RV L +
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVK 159
Query: 220 ----QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275
Q+ + Y+H + HRD+K N+LL D LK+ DFG A+++ +
Sbjct: 160 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLL-------DPDTAVLKLCDFGSAKQLVR 209
Query: 276 TTHMSAAGTYA---WM-APEVIKTSIF-SKASDVWSYGVVLWELLTGE 318
+Y + APE+I + + + DVWS G VL ELL G+
Sbjct: 210 GEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 49/224 (21%)
Query: 125 IGEGGFGKVY-------KGIYEKQEVAIK------------VAHPNPDENILENVKQEGK 165
+G+G FGKV+ + AIK V ++ +L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFF-----AIKALKKDVVLMDDDVECTMVEKRVLSLA----- 74
Query: 166 LLWLFDHRNIVSLIGVCLQSP-KLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAE 223
++H + + Q+ L VMEY GG L + + K +A +I
Sbjct: 75 ----WEHPFLTHMFC-TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 224 GMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE--VYKTTHMSA 281
G+ +LH + +++RDLK N+LL D +KI DFG+ +E + +
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILL-------DKD-GHIKIADFGMCKENMLGDAKTNTF 178
Query: 282 AGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
GT ++APE++ ++ + D WS+GV+L+E+L G+ P+ +
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQ----EGKLLW 168
Y L +GEG +G V K + + VAIK + D+ + VK+ E KLL
Sbjct: 26 KYENL---GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD---KMVKKIAMREIKLLK 79
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEY----------ARGGPLNRVLAGRKIRPDVLVDWA 218
H N+V+L+ VC + + LV E+ L+ V+ +
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLD---------YQVVQKYL 130
Query: 219 IQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE----VY 274
QI G+ + H ++IHRD+K N+L+S+ +K+ DFG AR
Sbjct: 131 FQIINGIGFCHSH---NIIHRDIKPENILVSQS--------GVVKLCDFGFARTLAAPGE 179
Query: 275 KTTHMSAAGTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
A T + APE++ + KA DVW+ G ++ E+ GE
Sbjct: 180 VYDDEVA--TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 57/280 (20%), Positives = 108/280 (38%), Gaps = 51/280 (18%)
Query: 97 EDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVY-------KGIY-----EKQEVA 144
E + + VK + + + IG G FG+V ++ K E+
Sbjct: 54 EYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML 113
Query: 145 IK--VAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-KLCLVMEYARGGPLN 201
+ A + ++L N D + I +L Q L LVM+Y GG L
Sbjct: 114 KRAETACFREERDVLVNG----------DSKWITTLHY-AFQDDNNLYLVMDYYVGGDLL 162
Query: 202 RVLAGRKIRPDVLVDWAI----QIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDL 257
+L K + + A ++ ++ +H +HRD+K N+L+ D+
Sbjct: 163 TLL--SKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILM-------DM 210
Query: 258 QFKTLKITDFGLAREVYK---TTHMSAAGTYAWMAPEVIKTSIFS-----KASDVWSYGV 309
+++ DFG ++ + A GT +++PE+++ D WS GV
Sbjct: 211 NGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV 269
Query: 310 VLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349
++E+L GE P+ + + + +K P+ +
Sbjct: 270 CMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 56/252 (22%), Positives = 100/252 (39%), Gaps = 49/252 (19%)
Query: 125 IGEGGFGKVY-------KGIY-----EKQEVAIK--VAHPNPDENILENVKQEGKLLWLF 170
IG G F +V +Y K ++ + V+ + ++L N
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG---------- 118
Query: 171 DHRNIVSLIGVCLQSP-KLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNY 227
D R I L Q L LVMEY GG L +L G +I ++ + +I ++
Sbjct: 119 DRRWITQLHF-AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY---KTTHMSAAGT 284
+H +HRD+K N+LL D +++ DFG ++ + A GT
Sbjct: 178 VHRL---GYVHRDIKPDNILL-------DRCGH-IRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 285 YAWMAPEVIK-------TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK 337
+++PE+++ T + D W+ GV +E+ G+ P+ + + + K
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286
Query: 338 LTLPIPSTCPQL 349
L +P +
Sbjct: 287 EHLSLPLVDEGV 298
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQ----EGKLLW 168
Y K+ IGEG +G V+K Q VAIK + D+ +K+ E ++L
Sbjct: 4 KYEKI---GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD---PVIKKIALREIRMLK 57
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMN 226
H N+V+L+ V + +L LV EY + L R + ++ Q + +N
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE------VYKTTHMS 280
+ H + IHRD+K N+L+++ +K+ DFG AR Y
Sbjct: 117 FCHKH---NCIHRDVKPENILITKH--------SVIKLCDFGFARLLTGPSDYY--DDEV 163
Query: 281 AAGTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
A Y +PE++ + + DVW+ G V ELL+G
Sbjct: 164 ATRWY--RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.9 bits (250), Expect = 1e-23
Identities = 64/221 (28%), Positives = 93/221 (42%), Gaps = 42/221 (19%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEKQE-VAIKVAHPNPDENILENVKQEG--------- 164
Y+ L E IGEG +G VYK E A+K ++ EG
Sbjct: 3 KYHGL---EKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--------EGIPSTTIREI 51
Query: 165 KLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIA 222
+L H NIV L V +L LV E+ L ++L + + +Q+
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR----EVYKTTH 278
G+ Y H + ++HRDLK N+L++ LKI DFGLAR V K TH
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINRE--------GELKIADFGLARAFGIPVRKYTH 159
Query: 279 MSAAGTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
Y AP+V+ + +S D+WS G + E++ G
Sbjct: 160 EIVTLWY--RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 67/221 (30%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEKQE-VAIKVAHPNPDENILENVKQEG--------- 164
Y KL E +GEG +G VYK + VA+K L+ EG
Sbjct: 22 KYQKL---EKVGEGTYGVVYKAKDSQGRIVALKRIR-------LDAED-EGIPSTAIREI 70
Query: 165 KLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIA 222
LL H NIVSLI V L LV E+ L +VL ++ + + Q+
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR----EVYKTTH 278
G+ + H ++HRDLK N+L++ LK+ DFGLAR V TH
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSD--------GALKLADFGLARAFGIPVRSYTH 178
Query: 279 MSAAGTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
Y AP+V+ + +S + D+WS G + E++TG+
Sbjct: 179 EVVTLWY--RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 72/247 (29%), Positives = 113/247 (45%), Gaps = 28/247 (11%)
Query: 89 PANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVY--KGIYEKQEVAIK 146
PA + + INL S K + + K+I G+G FGKV + E+ A+K
Sbjct: 15 PAPPPAPSQQINLGPSSNPHAKPSDFHFLKVI-----GKGSFGKVLLARHKAEEVFYAVK 69
Query: 147 V---AHPNPDENILENVKQEGKLLWL-FDHRNIVSLIGVCLQSP-KLCLVMEYARGGPL- 200
V + +++ E +L H +V L Q+ KL V++Y GG L
Sbjct: 70 VLQKKAILKKKEE-KHIMSERNVLLKNVKHPFLVGLHF-SFQTADKLYFVLDYINGGELF 127
Query: 201 NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260
+ R +A +IA + YLH ++++RDLK N+LL D Q
Sbjct: 128 YHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILL-------DSQ-G 176
Query: 261 TLKITDFGLARE--VYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGE 318
+ +TDFGL +E + +T + GT ++APEV+ + + D W G VL+E+L G
Sbjct: 177 HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
Query: 319 IPYKSIN 325
P+ S N
Sbjct: 237 PPFYSRN 243
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 125 IGEGGFGKVY----KGIYEKQEV-AIKV---AHPNPDENILENVKQEGKLLWLFDHRN-I 175
+G G +GKV+ ++ ++ A+KV A E+ + E ++L +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 176 VSLIGVCLQSP-KLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAP 233
V+L Q+ KL L+++Y GG L + + + + +I + +LH
Sbjct: 122 VTLHY-AFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL-- 178
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY----KTTHMSAAGTYAWMA 289
+I+RD+K N+LL D + +TDFGL++E + + GT +MA
Sbjct: 179 -GIIYRDIKLENILL-------DSN-GHVVLTDFGLSKEFVADETERAY-DFCGTIEYMA 228
Query: 290 PEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYKSIN 325
P++++ KA D WS GV+++ELLTG P+
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 6e-23
Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEG-------- 164
Y KL E IGEG +G V+K + + VA+K L++ EG
Sbjct: 3 KYEKL---EKIGEGTYGTVFKAKNRETHEIVALKRVR-------LDDDD-EGVPSSALRE 51
Query: 165 -KLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQI 221
LL H+NIV L V KL LV E+ L + + P+++ + Q+
Sbjct: 52 ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 222 AEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR----EVYKTT 277
+G+ + H + +++HRDLK N+L++ LK+ +FGLAR V +
Sbjct: 111 LKGLGFCHSR---NVLHRDLKPQNLLINRN--------GELKLANFGLARAFGIPVRCYS 159
Query: 278 HMSAAGTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGEIPY 321
Y P+V+ ++S + D+WS G + EL P
Sbjct: 160 AEVVTLWY--RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
Y KL + +GEG + VYKG + VA+K +E +E LL H
Sbjct: 3 TYIKL---DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 59
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA------GRKIRPDVLVDWAIQIAEGMN 226
NIV+L + L LV EY L++ L G I + + Q+ G+
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR----EVYKTTHMSAA 282
Y H Q ++HRDLK N+L++E LK+ DFGLAR +
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINER--------GELKLADFGLARAKSIPTKTYDNEVVT 163
Query: 283 GTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
Y P+++ ++ +S D+W G + +E+ TG
Sbjct: 164 LWY--RPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQ---EGKLLWLFDHRNIVS 177
+ IG G G V + VAIK P +N K+ E L+ +H+NI+S
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIS 125
Query: 178 LIGVCLQSPKLC------LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
L+ V L LVME L +V+ ++ + + Q+ G+ +LH
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-QMELDHERMSYLLYQMLCGIKHLHSA 183
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA-AGTYAWMAP 290
+IHRDLK SN+++ D TLKI DFGLAR + M+ T + AP
Sbjct: 184 ---GIIHRDLKPSNIVV-----KSDC---TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGEI 319
EVI + + D+WS G ++ E++ +I
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 29/217 (13%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
+ +L E +G G + VYKG+ + VA+K + +E +E L+ H
Sbjct: 6 QFKQL---EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARG------GPLNRVLAGRKIRPDVLVDWAIQIAEGMN 226
NIV L V KL LV E+ R + +++ + Q+ +G+
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR----EVYKTTHMSAA 282
+ H ++HRDLK N+L+++ LK+ DFGLAR V +
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKR--------GQLKLGDFGLARAFGIPVNTFSSEVV- 170
Query: 283 GTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
T + AP+V+ + +S + D+WS G +L E++TG+
Sbjct: 171 -TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 62/237 (26%), Positives = 98/237 (41%), Gaps = 61/237 (25%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQEG-------- 164
Y KL IG+G FG+V+K Q+VA+K + ++EN K EG
Sbjct: 18 KYEKL---AKIGQGTFGEVFKARHRKTGQKVALK-------KVLMENEK-EGFPITALRE 66
Query: 165 -KLLWLFDHRNIVSLIGVC--------LQSPKLCLVMEYARGGPLNRVLAG------RKI 209
K+L L H N+V+LI +C + LV ++ LAG K
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVKF 121
Query: 210 RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269
+ + G+ Y+H ++HRD+K++NVL++ + LK+ DFGL
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLIT----RD----GVLKLADFGL 170
Query: 270 AREVYKTTHMSAAGTYA------WM-APEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
AR + S Y W PE++ + D+W G ++ E+ T
Sbjct: 171 ARA-FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQ---EGKLLWLFDHRNIVS 177
+ IG G G V + VAIK P +N K+ E L+ +H+NI+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIG 88
Query: 178 LIGVCLQSPKLC------LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
L+ V L +VME L +V+ ++ + + Q+ G+ +LH
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-QMELDHERMSYLLYQMLCGIKHLHSA 146
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA-AGTYAWMAP 290
+IHRDLK SN+++ D LKI DFGLAR + M+ T + AP
Sbjct: 147 ---GIIHRDLKPSNIVV-----KSDCT---LKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGE 318
EVI + + D+WS G ++ E++ G
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQ----EGKLLW 168
Y KL + +GEG F VYK + Q VAIK + + + E KLL
Sbjct: 11 RYEKL---DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR--PDVLVDWAIQIAEGMN 226
H NI+ L+ + LV ++ L ++ + P + + + +G+
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR----EVYKTTHMSAA 282
YLH ++HRDLK +N+LL E LK+ DFGLA+ TH
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDE--NGV------LKLADFGLAKSFGSPNRAYTHQVVT 175
Query: 283 GTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLTGE 318
Y APE++ ++ D+W+ G +L ELL
Sbjct: 176 RWY--RAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 60/238 (25%), Positives = 97/238 (40%), Gaps = 67/238 (28%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNPDENILENVKQEG------- 164
Y + IGEG +GKV+K K + VA+K ++ + EG
Sbjct: 12 QYECV---AEIGEGAYGKVFKARDLKNGGRFVALKRVR-------VQTGE-EGMPLSTIR 60
Query: 165 -----KLLWLFDHRNIVSLIGVC-----LQSPKLCLVMEYARGGPLNRVLAG-------R 207
+ L F+H N+V L VC + KL LV E+ +++ L
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEP 115
Query: 208 KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267
+ + + D Q+ G+++LH ++HRDLK N+L++ +K+ DF
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS--------GQIKLADF 164
Query: 268 GLAREVYKTTHMSAAGTYA------WM-APEVIKTSIFSKASDVWSYGVVLWELLTGE 318
GLAR S W APEV+ S ++ D+WS G + E+ +
Sbjct: 165 GLARI------YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2rf0_A Mitogen-activated protein kinase kinase kinase 10; MAP3K10, MLK2, SH3 domain, TKL kinase, MKN28, structural GEN structural genomics consortium, SGC; 2.00A {Homo sapiens} Length = 89 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 6e-22
Identities = 33/61 (54%), Positives = 49/61 (80%), Gaps = 3/61 (4%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+W A++DY+A G +EL+LRRGD V+VLS+D A+SGD GWWTG++ +VG+FP+N+V
Sbjct: 31 VWTAVFDYEAAGDEELTLRRGDRVQVLSQDCAVSGDEGWWTGQLPSG---RVGVFPSNYV 87
Query: 94 S 94
+
Sbjct: 88 A 88
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQ---EGKLLWLFDHRNIVS 177
+ +G G +G V + + +VAIK P ++ L K+ E +LL H N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIK-KLYRPFQSELF-AKRAYRELRLLKHMRHENVIG 88
Query: 178 LIGVCLQSPKLC------LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
L+ V L LVM + G L +++ K+ D + Q+ +G+ Y+H
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH-A 146
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM-AP 290
A I IHRDLK N+ + NED + LKI DFGLAR+ + M+ W AP
Sbjct: 147 AGI--IHRDLKPGNLAV-----NEDCE---LKILDFGLARQA--DSEMTGYVVTRWYRAP 194
Query: 291 EVIKTS-IFSKASDVWSYGVVLWELLTGE 318
EVI +++ D+WS G ++ E++TG+
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
IGEG +G V VAIK P + + +E K+L F H NI+ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 181 VCLQSPKLC------LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
+ +++P + +V + L ++L + + D + + QI G+ Y+H A +
Sbjct: 93 I-IRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-SANV 149
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGT-YA---WM-A 289
+HRDLK SN+LL N LKI DFGLAR + T Y W A
Sbjct: 150 --LHRDLKPSNLLL-----NTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 290 PEVIKTS-IFSKASDVWSYGVVLWELLTGE 318
PE++ S ++K+ D+WS G +L E+L+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 45/210 (21%), Positives = 92/210 (43%), Gaps = 33/210 (15%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLL-WLFDHRNIVSLI 179
+G G + +V++ I ++V +K+ P + I +E K+L L NI++L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK----REIKILENLRGGPNIITLA 97
Query: 180 GVCL--QSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLHCQA 232
+ S LV E+ ++ L D+ I +I + ++Y H
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM- 149
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA-AGTYAWMAPE 291
++HRD+K NV++ D + + L++ D+GLA + + + + PE
Sbjct: 150 --GIMHRDVKPHNVMI-------DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 200
Query: 292 VIKTS-IFSKASDVWSYGVVLWELLTGEIP 320
++ ++ + D+WS G +L ++ + P
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 41/226 (18%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQ----EGKLL- 167
Y + IG G +G VYK VA+K + E LL
Sbjct: 10 RYEPV---AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 168 --WLFDHRNIVSLIGVCL-----QSPKLCLVMEYARGGPLNRVLAG-------RKIRPDV 213
F+H N+V L+ VC + K+ LV E+ +++ L + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAET 121
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273
+ D Q G+++LH ++HRDLK N+L++ T+K+ DFGLAR
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG--------GTVKLADFGLARIY 170
Query: 274 YKTTHMSAAGTYAWM-APEVIKTSIFSKASDVWSYGVVLWELLTGE 318
++ W APEV+ S ++ D+WS G + E+ +
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQ---EGKLLWLFDHRNIVS 177
+G G +G V K VA+K P ++I+ K+ E +LL H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVK-KLSRPFQSIIH-AKRTYRELRLLKHMKHENVIG 92
Query: 178 LIGVCLQSPKLC-------LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHC 230
L+ V + LV G LN ++ +K+ D + QI G+ Y+H
Sbjct: 93 LLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAW-MA 289
A I IHRDLK SN+ + NED + LKI DFGLAR M+ W A
Sbjct: 150 SADI--IHRDLKPSNLAV-----NEDCE---LKILDFGLARHT--ADEMTGYVATRWYRA 197
Query: 290 PEVIKTS-IFSKASDVWSYGVVLWELLTGE 318
PE++ +++ D+WS G ++ ELLTG
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 44/222 (19%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIG 180
+GEG +G V ++ + VAIK P +E K+L F H NI+++
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 181 VCLQSPKLC------LVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLH 229
+ + ++ E L+RV I +L D I Q + LH
Sbjct: 77 I-QRPDSFENFNEVYIIQELM-QTDLHRV-----ISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA--AGTYAW 287
+ + IHRDLK SN+L+ N + LK+ DFGLAR + ++ ++ G +
Sbjct: 130 -GSNV--IHRDLKPSNLLI-----NSNCD---LKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 288 M----------APEVIKTS-IFSKASDVWSYGVVLWELLTGE 318
M APEV+ TS +S+A DVWS G +L EL
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSLI 179
+G G +G V I ++ ++VAIK ++ P E + +E LL H N++ L+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 180 GVCLQSPKLC------LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAP 233
V + L LVM + L +++ G K + + Q+ +G+ Y+H A
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-GLKFSEEKIQYLVYQMLKGLKYIH-SAG 146
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAW-MAPEV 292
+ +HRDLK N+ + NED + LKI DFGLAR M+ W APEV
Sbjct: 147 V--VHRDLKPGNLAV-----NEDCE---LKILDFGLARHA--DAEMTGYVVTRWYRAPEV 194
Query: 293 IKTS-IFSKASDVWSYGVVLWELLTGE 318
I + +++ D+WS G ++ E+LTG+
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2jte_A CD2-associated protein; SH3 domain, coiled coil, cytoplasm, phosphorylation, SH3-binding, signaling protein; NMR {Mus musculus} PDB: 2kro_A Length = 64 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-21
Identities = 24/62 (38%), Positives = 36/62 (58%), Gaps = 7/62 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
R L+ Y DEL+ R G+I+ ++SK+ +G+ GWW G++ G K G+FP NF
Sbjct: 9 CRTLFPYTGTNEDELTFREGEIIHLISKE---TGEAGWWKGELNG----KEGVFPDNFAV 61
Query: 95 SI 96
I
Sbjct: 62 QI 63
|
| >2kbt_A Chimera of proto-oncogene VAV, linker, immunoglobulin G-binding protein G; sortase, protein ligation, intein, inset, solubility enhancement; NMR {Mus musculus} Length = 142 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 9e-21
Identities = 35/138 (25%), Positives = 57/138 (41%), Gaps = 16/138 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+A YD+ A ELSL+ GDI+++L+K G GWW G+I G ++G FP+N+V
Sbjct: 8 AKARYDFCARDRSELSLKEGDIIKILNKK----GQQGWWRGEIYG----RIGWFPSNYVE 59
Query: 95 SIEDINL-------VSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKV 147
L SS+ + L EA+ KV+K V +
Sbjct: 60 EDYSEYLPETGGGSGSSMTYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEW 119
Query: 148 AHPNPDENILENVKQEGK 165
+ + + + +
Sbjct: 120 TYDDATK-TFTVTEHSLE 136
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 42/221 (19%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIK-VAHPNPDENILENVKQ---EGKLLWLFDHRNIV 176
+ +G GG G V+ + + VAIK + +P ++VK E K++ DH NIV
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-----QSVKHALREIKIIRRLDHDNIV 71
Query: 177 SLIGVCLQSPKLC--------------LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIA 222
+ + S +V EY L VL + + + Q+
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLL 130
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAA 282
G+ Y+H +++HRDLK +N+ ++ EDL LKI DFGLAR +
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFIN----TEDLV---LKIGDFGLARIMDPHYSHKGH 180
Query: 283 GT-YA---WM-APEVIKTSI-FSKASDVWSYGVVLWELLTG 317
+ W +P ++ + ++KA D+W+ G + E+LTG
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >2dl7_A KIAA0769 protein; SH3 domain, FCHSD2, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 73 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-20
Identities = 22/64 (34%), Positives = 36/64 (56%), Gaps = 6/64 (9%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+ALYDY+ DELS G I+ +L+K++ D G+W G+ G ++G+FP+ V
Sbjct: 11 VKALYDYEGQTDDELSFPEGAIIRILNKEN--QDDDGFWEGEFNG----RIGVFPSVLVE 64
Query: 95 SIED 98
+
Sbjct: 65 ELSS 68
|
| >2ydl_A SH3 domain-containing kinase-binding protein 1; signaling protein; 2.05A {Homo sapiens} PDB: 2k6d_A Length = 69 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-20
Identities = 25/68 (36%), Positives = 41/68 (60%), Gaps = 7/68 (10%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
D + ++ Y+A DEL+++ GDIV +++KD DVGWW G++ G + G+FP N
Sbjct: 2 SDYCKVIFPYEAQNDDELTIKEGDIVTLINKD---CIDVGWWEGELNG----RRGVFPDN 54
Query: 92 FVSSIEDI 99
FV + +
Sbjct: 55 FVKLLPPL 62
|
| >2dm1_A Protein VAV-2; RHO family guanine nucleotide exchange factor, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 73 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-20
Identities = 26/70 (37%), Positives = 38/70 (54%), Gaps = 7/70 (10%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
A Y++ A + ELSLR GD+V + S+ I GD GWW G+ G ++G FP+ +V
Sbjct: 10 AVARYNFAARDMRELSLREGDVVRIYSR---IGGDQGWWKGETNG----RIGWFPSTYVE 62
Query: 95 SIEDINLVSS 104
+ SS
Sbjct: 63 EEGIQSGPSS 72
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 53/231 (22%), Positives = 94/231 (40%), Gaps = 60/231 (25%)
Query: 125 IGEGGFGKVYKG--IYEKQEVAIKVAHPNP-------DE-NILENVKQEG---------- 164
+G G F V+ + VA+K+ + DE +L+ V
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86
Query: 165 ---KLLWLFDHRNIVSLIGVCLQSPKLCLVME------YA-------RGGPLNRVLAGRK 208
KLL F+H+ + +V E A RG PL V ++
Sbjct: 87 HILKLLDHFNHKG--------PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV---KQ 135
Query: 209 IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268
I + Q+ G++Y+H + +IH D+K NVL+ E+ +KI D G
Sbjct: 136 I--------SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN--LIQIKIADLG 183
Query: 269 LAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEI 319
A + + ++ T + +PEV+ + + +D+WS +++EL+TG+
Sbjct: 184 NACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >1wyx_A CRK-associated substrate; beta sheets, cell adhesion; 1.14A {Homo sapiens} Length = 69 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-20
Identities = 27/70 (38%), Positives = 37/70 (52%), Gaps = 6/70 (8%)
Query: 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFP 89
H L +ALYD A DELS R+GDI+ VL +D+ G GWW + G + GI P
Sbjct: 1 HLNVLAKALYDNVAESPDELSFRKGDIMTVLEQDT--QGLDGWWLCSLHG----RQGIVP 54
Query: 90 ANFVSSIEDI 99
N + + +
Sbjct: 55 GNRLKILVGM 64
|
| >2da9_A SH3-domain kinase binding protein 1; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 70 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-20
Identities = 24/64 (37%), Positives = 39/64 (60%), Gaps = 7/64 (10%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+ ++ Y+A DEL+++ GDIV +++KD DVGWW G++ G + G+FP NFV
Sbjct: 10 CKVIFPYEAQNDDELTIKEGDIVTLINKD---CIDVGWWEGELNG----RRGVFPDNFVK 62
Query: 95 SIED 98
+
Sbjct: 63 LLSG 66
|
| >2cre_A HEF-like protein; SH3 domain, SRC homology 3 domain, beta barrel, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 71 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-19
Identities = 21/63 (33%), Positives = 30/63 (47%), Gaps = 6/63 (9%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYD DEL+ RGDI+ +L + GWW + G + G+ PAN +
Sbjct: 11 RALYDNCPDCSDELAFSRGDILTILEQHV--PESEGWWKCLLHG----RQGLAPANRLQI 64
Query: 96 IED 98
+
Sbjct: 65 LSG 67
|
| >1uff_A Intersectin 2; beta barrel, SH3 domain, endocytosis, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 93 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-19
Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 7/64 (10%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+RALY ++A DE+S GDI++V K G+ GW G +G G FP N+V
Sbjct: 8 YRALYPFEARNHDEMSFNSGDIIQVDEKT---VGEPGWLYGSFQG----NFGWFPCNYVE 60
Query: 95 SIED 98
+
Sbjct: 61 KMPS 64
|
| >2k9g_A SH3 domain-containing kinase-binding protein 1; CIN85, adaptor protein, downregulation, CBL, apoptosis, junction, cytoplasmic vesicle, cytoskeleton; NMR {Homo sapiens} Length = 73 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-19
Identities = 25/68 (36%), Positives = 40/68 (58%), Gaps = 7/68 (10%)
Query: 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPA 90
D + ++ Y+A DEL+++ GDIV +++KD DVGWW G++ G + G+FP
Sbjct: 8 SKDYCKVIFPYEAQNDDELTIKEGDIVTLINKD---CIDVGWWEGELNG----RRGVFPD 60
Query: 91 NFVSSIED 98
NFV +
Sbjct: 61 NFVKLLPP 68
|
| >1bb9_A Amphiphysin 2; transferase, SH3 domain; 2.20A {Rattus norvegicus} SCOP: b.34.2.1 PDB: 1muz_A 1mv0_B Length = 115 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 5e-19
Identities = 22/68 (32%), Positives = 31/68 (45%), Gaps = 6/68 (8%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEY------KVGIFP 89
+A +DY A DEL L+ GD+V V+ + D GW G E G+FP
Sbjct: 48 QAQHDYTATDTDELQLKAGDVVLVIPFQNPEEQDEGWLMGVKESDWNQHKELEKCRGVFP 107
Query: 90 ANFVSSIE 97
NF ++
Sbjct: 108 ENFTERVQ 115
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 7e-19
Identities = 58/242 (23%), Positives = 96/242 (39%), Gaps = 60/242 (24%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQ---EGKLLWLFDHRNIVS 177
IG G +G VY + + VAIK E++++ K+ E +L I+
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIK-KVNRMFEDLID-CKRILREITILNRLKSDYIIR 89
Query: 178 LIGVCLQSPKLC-----LVMEYARGGPLNRVLAGRKIR-PDVLVDWAI-----QIAEGMN 226
L + + L +V+E A L ++ + P L + I + G N
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIA-DSDLKKL-----FKTPIFLTEEHIKTILYNLLLGEN 143
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA 286
++H ++ I IHRDLK +N LL N+D ++K+ DFGLAR + +
Sbjct: 144 FIH-ESGI--IHRDLKPANCLL-----NQDC---SVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 287 WM------------------------APEVIKTS-IFSKASDVWSYGVVLWELLTGEIPY 321
APE+I ++K+ D+WS G + ELL +
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
Query: 322 KS 323
+
Sbjct: 253 IN 254
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 8e-19
Identities = 51/260 (19%), Positives = 98/260 (37%), Gaps = 78/260 (30%)
Query: 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVK---QEGKL 166
Y+ + +G G FG V + + + A+K +L++ + +E +
Sbjct: 5 SSKKYSLG---KTLGTGSFGIVCEVFDIESGKRFALK--------KVLQDPRYKNRELDI 53
Query: 167 LWLFDHRNIVSLIGV-------------------------------CLQSPK-------L 188
+ + DH NI+ L+ L
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 189 CLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLHCQAPISLIHRDLKS 243
++MEY L++VL + I Q+ + ++H + HRD+K
Sbjct: 114 NVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKP 169
Query: 244 SNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYA---WM-APEVIKTSI-F 298
N+L+ + + TLK+ DFG A+++ + A Y + APE++ + +
Sbjct: 170 QNLLV-------NSKDNTLKLCDFGSAKKLIPSEPSVA---YICSRFYRAPELMLGATEY 219
Query: 299 SKASDVWSYGVVLWELLTGE 318
+ + D+WS G V EL+ G+
Sbjct: 220 TPSIDLWSIGCVFGELILGK 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 8e-19
Identities = 50/240 (20%), Positives = 94/240 (39%), Gaps = 51/240 (21%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIK-VAHPNPDENILENVKQEGKLLWLFDHRNIVSLI 179
IG G +G V + + + VAIK + D + + +E +L +H ++V ++
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 180 GVCLQSPKLC-----LVMEYARGGPLNRVLAGRKIRPDVLVDWAI-QIAEGMNYLHCQAP 233
+ + +V+E A ++ ++ + + + G+ Y+H
Sbjct: 119 DIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA-- 175
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM----- 288
++HRDLK +N L+ N+D +K+ DFGLAR V + ++ +
Sbjct: 176 -GILHRDLKPANCLV-----NQDCS---VKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 289 ------------------------APEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKS 323
APE+I +++A DVWS G + ELL +
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
|
| >1uti_A GRB2-related adaptor protein 2; signaling protein regulator, SH3 domain/complex, adaptor protein (MONA); 1.5A {Mus musculus} SCOP: b.34.2.1 PDB: 1h3h_A 1oeb_A 2w10_A 2d0n_A Length = 58 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 1e-18
Identities = 26/61 (42%), Positives = 39/61 (63%), Gaps = 9/61 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYD++A+ DEL R G++VEVL + WWTG++ K+G+FPAN+V+
Sbjct: 5 RALYDFEALEEDELGFRSGEVVEVLDSS-----NPSWWTGRLHN----KLGLFPANYVAP 55
Query: 96 I 96
+
Sbjct: 56 M 56
|
| >2dl4_A Protein STAC; SH3 domain, STAC protein, SRC homology 3, cysteine-rich domain protein, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 68 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-18
Identities = 21/63 (33%), Positives = 32/63 (50%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALY + ++L +R GDI+ +L + WW GKI+ ++G FPANFV
Sbjct: 11 VALYKFVPQENEDLEMRPGDIITLLEDS-----NEDWWKGKIQD----RIGFFPANFVQR 61
Query: 96 IED 98
+
Sbjct: 62 LSG 64
|
| >2dlp_A KIAA1783 protein; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 85 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-18
Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 7/63 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
AL Y LS RGD++++L + + GW G G + G+FPA+ V
Sbjct: 12 IALRSYITDNCSLLSFHRGDLIKLLPVATL---EPGWQFGSAGG----RSGLFPADIVQP 64
Query: 96 IED 98
Sbjct: 65 AAA 67
|
| >2ed1_A 130 kDa phosphatidylinositol 4,5-biphosphate- dependent ARF1 GTPase-activating protein...; GTPase activation, membrane, metal-binding, SH3 domain; NMR {Homo sapiens} PDB: 2rqt_A 2rqu_A Length = 76 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-18
Identities = 22/63 (34%), Positives = 35/63 (55%), Gaps = 6/63 (9%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ +YD A DEL+ G+++ V ++ D WW G IEG+ E + G+FP +FV
Sbjct: 14 KTIYDCQADNDDELTFIEGEVIIVTGEE-----DQEWWIGHIEGQPE-RKGVFPVSFVHI 67
Query: 96 IED 98
+ D
Sbjct: 68 LSD 70
|
| >3u23_A CD2-associated protein; structural genomics, structural genomics consortium, SGC, BE barrel, adaptor protein, protein binding; 1.11A {Homo sapiens} PDB: 2krn_A Length = 65 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-18
Identities = 21/63 (33%), Positives = 36/63 (57%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ L++Y DEL L+ GDI+++ + + GWW+G + K+G+FP+NFV
Sbjct: 11 KVLFEYIPQNEDELELKVGDIIDINEEV-----EEGWWSGTLNN----KLGLFPSNFVKE 61
Query: 96 IED 98
+E
Sbjct: 62 LEV 64
|
| >1uhf_A Intersectin 2; beta barrel, SH3 domain, riken structural genomics/proteomics initiative, RSGI, structural genomics, signaling protein; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 69 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-18
Identities = 20/67 (29%), Positives = 32/67 (47%), Gaps = 10/67 (14%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
+ + ALY Y ++ +L+ G+ + V KD WWTG I + GIFP+N
Sbjct: 8 GEEYIALYPYSSVEPGDLTFTEGEEILVTQKDG------EWWTGSIGD----RSGIFPSN 57
Query: 92 FVSSIED 98
+V +
Sbjct: 58 YVKPKDS 64
|
| >1ue9_A Intersectin 2; beta barrel, SH3 domain, riken structural genomics/proteomics initiative, RSGI, structural genomics, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 80 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-18
Identities = 18/69 (26%), Positives = 35/69 (50%), Gaps = 6/69 (8%)
Query: 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIE-YKVGIFP 89
++ + Y A G ++LSL G ++ +L K+ GWW G+++ + + + G FP
Sbjct: 6 SGEIAQVTSAYVASGSEQLSLAPGQLILILKKN-----TSGWWQGELQARGKKRQKGWFP 60
Query: 90 ANFVSSIED 98
A+ V +
Sbjct: 61 ASHVKLLGP 69
|
| >2xmf_A Myosin 1E SH3; motor protein, SH3 domain; HET: DIA; 1.50A {Mus musculus} Length = 60 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-18
Identities = 26/61 (42%), Positives = 37/61 (60%), Gaps = 9/61 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ALY YDA DELS DI++++ +D GWWTG++ G K G+FP N+V+
Sbjct: 9 KALYAYDAQDTDELSFNANDIIDIIKED-----PSGWWTGRLRG----KQGLFPNNYVTK 59
Query: 96 I 96
I
Sbjct: 60 I 60
|
| >1x43_A Endophilin B1, SH3 domain GRB2-like protein B1; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 81 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-18
Identities = 18/63 (28%), Positives = 26/63 (41%), Gaps = 7/63 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
R LYDYDA ELSL +++ V S D W G+ + G P ++
Sbjct: 21 RVLYDYDAANSTELSLLADEVITVFSVVGM---DSDWLMGERGN----QKGKVPITYLEL 73
Query: 96 IED 98
+
Sbjct: 74 LNS 76
|
| >1wi7_A SH3-domain kinase binding protein 1; beta barrel, SH3KBP1, RUK, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} Length = 68 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-18
Identities = 21/63 (33%), Positives = 33/63 (52%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ + Y DEL L+ GDI+EV+ + + GWW G + G K G+FP+NF+
Sbjct: 11 QVAFSYLPQNDDELELKVGDIIEVVGEV-----EEGWWEGVLNG----KTGMFPSNFIKE 61
Query: 96 IED 98
+
Sbjct: 62 LSG 64
|
| >2j6f_A CD2-associated protein; metal-binding, immune response, SH3, SH2 domain, SH3 zinc-finger, SH3- binding, UBL conjugation pathway; 1.7A {Homo sapiens} PDB: 2j6k_A 2j6o_A 2j7i_A 2krm_A Length = 62 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 4e-18
Identities = 23/64 (35%), Positives = 36/64 (56%), Gaps = 8/64 (12%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+ YDYDA+ DEL++R G+I+ + K + GW G++ G + G+FP NFV
Sbjct: 4 YIVEYDYDAVHDDELTIRVGEIIRNVKK----LQEEGWLEGELNG----RRGMFPDNFVK 55
Query: 95 SIED 98
I+
Sbjct: 56 EIKR 59
|
| >2bz8_A SH3-domain kinase binding protein 1; SH3 domain, CIN85 adaptor protein, CBL ubiquitin ligase; 2.0A {Homo sapiens} Length = 58 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 4e-18
Identities = 23/62 (37%), Positives = 34/62 (54%), Gaps = 9/62 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+DY A DEL++ G+I+ + K+ D GWW G+I G + G+FP NFV
Sbjct: 5 IVEFDYQAQHDDELTISVGEIITNIRKE-----DGGWWEGQING----RRGLFPDNFVRE 55
Query: 96 IE 97
I+
Sbjct: 56 IK 57
|
| >2dil_A Proline-serine-threonine phosphatase-interacting protein 1; SH3 domain, PEST phosphatase-interacting protein 1, CD2- binding protein 1; NMR {Homo sapiens} Length = 69 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-18
Identities = 23/63 (36%), Positives = 33/63 (52%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYDY A DEL L GDI+EV+ + + GWWT + G + G P +++
Sbjct: 12 RALYDYTAQNPDELDLSAGDILEVILEG-----EDGWWTVERNG----QRGFVPGSYLEK 62
Query: 96 IED 98
+
Sbjct: 63 LSG 65
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 54/231 (23%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIK-VAHPNPDENILENVKQEGKLLWLF-DHRNIVSL 178
+ +G+G +G V+K I + + VA+K + + + +E +L H NIV+L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 179 IGVCLQSPK---LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAI-----QIAEGMNYLHC 230
+ V L++ + LV +Y L+ V IR ++L Q+ + + YLH
Sbjct: 75 LNV-LRADNDRDVYLVFDYM-ETDLHAV-----IRANILEPVHKQYVVYQLIKVIKYLH- 126
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM-- 288
+ +HRD+K SN+LL N + +K+ DFGL+R ++ +
Sbjct: 127 SGGL--LHRDMKPSNILL-----NAECH---VKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 289 ---------------------APEVIKTSI-FSKASDVWSYGVVLWELLTG 317
APE++ S ++K D+WS G +L E+L G
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
|
| >2d8h_A SH3YL1 protein; SH3 domain, hypothetical protein SH3YL1, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 80 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-18
Identities = 22/67 (32%), Positives = 34/67 (50%), Gaps = 7/67 (10%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
P ALY ++ +L+ + GD + V+SK + WW GK+ G + GIFPAN
Sbjct: 17 PIEVTALYSFEGQQPGDLNFQAGDRITVISKTDS---HFDWWEGKLRG----QTGIFPAN 69
Query: 92 FVSSIED 98
+V+
Sbjct: 70 YVTMNSG 76
|
| >1x2q_A Signal transducing adapter molecule 2; SH3 domain, signal transducing adaptor molecule, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 88 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-18
Identities = 22/63 (34%), Positives = 37/63 (58%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYD++A+ +EL+ + G+I+ VL D WW G+ +G+FP+NFV++
Sbjct: 21 RALYDFEAVEDNELTFKHGEIIIVLDDS-----DANWWKGENHR----GIGLFPSNFVTT 71
Query: 96 IED 98
+
Sbjct: 72 NLN 74
|
| >2fei_A CD2-associated protein; CMS SH3 domain, structural protein; NMR {Homo sapiens} Length = 65 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-18
Identities = 21/63 (33%), Positives = 36/63 (57%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ L++Y DEL L+ GDI+++ + + GWW+G + K+G+FP+NFV
Sbjct: 5 KVLFEYIPQNEDELELKVGDIIDINEEV-----EEGWWSGTLNN----KLGLFPSNFVKE 55
Query: 96 IED 98
+E
Sbjct: 56 LEL 58
|
| >2vwf_A Growth factor receptor-bound protein 2; polymorphism, phosphoprotein, golgi apparatus, alternative splicing, HOST-virus interaction, SH3C, signaling; 1.58A {Homo sapiens} PDB: 2w0z_A 1gcq_A 1gfc_A 1gfd_A 1io6_A 2vvk_A Length = 58 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 5e-18
Identities = 21/61 (34%), Positives = 32/61 (52%), Gaps = 9/61 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+AL+D+D EL RRGD + V+ D WW G G + G+FP N+V++
Sbjct: 6 QALFDFDPQEDGELGFRRGDFIHVMDNS-----DPNWWKGACHG----QTGMFPRNYVTA 56
Query: 96 I 96
+
Sbjct: 57 V 57
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 59/232 (25%), Positives = 91/232 (39%), Gaps = 72/232 (31%)
Query: 123 EAIGEGGFGKVYKGI--YEKQEVAIKVAHPNPD-------E-NILENVKQEG-------- 164
+ IG+G FG+V K Q VA+K+ E ILE+++++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 165 KLLWLFDHRNIVSLIGVCLQSPKLCLVMEY-------------ARGGPLNRVLAGRKIRP 211
+L F RN +C+ E +G L V RK
Sbjct: 163 HMLENFTFRN------------HICMTFELLSMNLYELIKKNKFQGFSLPLV---RKF-- 205
Query: 212 DVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271
A I + ++ LH +IH DLK N+LL + + +K+ DFG +
Sbjct: 206 ------AHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSG------IKVIDFGSSC 250
Query: 272 EVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEI 319
++ + TY + APEVI + + D+WS G +L ELLTG
Sbjct: 251 YEHQRVY-----TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >1uj0_A Signal transducing adaptor molecule (SH3 domain and ITAM motif) 2; STAM, SH3, GRB2, GADS, PXXP, HRS, endocytosis, early endosome, signaling protein/signaling protein complex; 1.70A {Mus musculus} SCOP: b.34.2.1 Length = 62 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-18
Identities = 21/62 (33%), Positives = 35/62 (56%), Gaps = 9/62 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYD++A+ +EL+ + G+++ VL D WW G+ G+FP+NFV++
Sbjct: 9 RALYDFEAVEDNELTFKHGELITVLDDS-----DANWWQGENHR----GTGLFPSNFVTT 59
Query: 96 IE 97
Sbjct: 60 DL 61
|
| >2eqi_A Phospholipase C, gamma 2; SH3 domain, PLCG2, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 69 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-18
Identities = 23/63 (36%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ALYDY A DEL+ RG ++ +SK+ GWW G +I+ FP+N+V
Sbjct: 11 KALYDYKAKRSDELTFCRGALIHNVSKE-----PGGWWKGDYGTRIQ---QYFPSNYVED 62
Query: 96 IED 98
I
Sbjct: 63 ISG 65
|
| >2yun_A Nostrin; nitric oxide synthase trafficker, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 79 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-18
Identities = 24/63 (38%), Positives = 33/63 (52%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ALY + A DEL+L +GDIV + K + GWW G + G K G FPA +V
Sbjct: 11 KALYSFQARQDDELNLEKGDIVIIHEKK-----EEGWWFGSLNG----KKGHFPAAYVEE 61
Query: 96 IED 98
+
Sbjct: 62 LPS 64
|
| >1zx6_A YPR154WP; SH3 domain, protein binding; 1.60A {Saccharomyces cerevisiae} PDB: 1ynz_A Length = 58 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 8e-18
Identities = 21/58 (36%), Positives = 29/58 (50%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALY +D +L L+ GD V++L K W+ G G + GIFPAN+V
Sbjct: 6 EALYQFDPQQDGDLGLKPGDKVQLLEKL-----SPEWYKGSCNG----RTGIFPANYV 54
|
| >1oot_A Hypothetical 40.4 kDa protein in PES4-His2 intergenic region; SH3 domain, sturctural genomics, structural genomics; 1.39A {Saccharomyces cerevisiae} SCOP: b.34.2.1 PDB: 1ssh_A 2a08_A Length = 60 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 8e-18
Identities = 21/61 (34%), Positives = 33/61 (54%), Gaps = 7/61 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALY + +L R+GD++ +L K + WWTG++ G + GIFPAN+V
Sbjct: 7 VALYSFAGEESGDLPFRKGDVITILKKSDS---QNDWWTGRVNG----REGIFPANYVEL 59
Query: 96 I 96
+
Sbjct: 60 V 60
|
| >1udl_A Intersectin 2, KIAA1256; beta barrel, SH3 domain, riken structural genomics/proteomics initiative, RSGI, structural genomics; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 98 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 8e-18
Identities = 27/69 (39%), Positives = 38/69 (55%), Gaps = 9/69 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A+YDY A DELS +G ++ V++KD D WW G+I G G+FP+N+V
Sbjct: 38 IAMYDYAANNEDELSFSKGQLINVMNKD-----DPDWWQGEING----VTGLFPSNYVKM 88
Query: 96 IEDINLVSS 104
D + SS
Sbjct: 89 TTDSSGPSS 97
|
| >2cub_A Cytoplasmic protein NCK1; SH3 domain, NCK1 adaptor, tyrosine kinase, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 88 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 8e-18
Identities = 23/64 (35%), Positives = 31/64 (48%), Gaps = 9/64 (14%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
++Y A DELSL +G V V+ K GWW G G +VG FP+N+V+
Sbjct: 20 AYVKFNYMAEREDELSLIKGTKVIVMEKC-----SDGWWRGSYNG----QVGWFPSNYVT 70
Query: 95 SIED 98
D
Sbjct: 71 EEGD 74
|
| >1sem_A SEM-5; SRC-homology 3 (SH3) domain, peptide-binding protein; 2.00A {Caenorhabditis elegans} SCOP: b.34.2.1 PDB: 2sem_A 3sem_A 1k76_A 1kfz_A Length = 58 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 1e-17
Identities = 20/58 (34%), Positives = 36/58 (62%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+AL+D++ EL+ +RGD++ +++KD D WW G++ + GIFP+N+V
Sbjct: 6 QALFDFNPQESGELAFKRGDVITLINKD-----DPNWWEGQLNN----RRGIFPSNYV 54
|
| >2yuo_A CIP85, RUN and TBC1 domain containing 3; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 78 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-17
Identities = 20/63 (31%), Positives = 33/63 (52%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+AL D++ DEL R+ DI+ ++S+ D W G++ G G FPA FV
Sbjct: 11 KALLDFERHDDDELGFRKNDIITIISQK-----DEHCWVGELNG----LRGWFPAKFVEV 61
Query: 96 IED 98
+++
Sbjct: 62 LDE 64
|
| >2ysq_A RHO guanine nucleotide exchange factor 9; SH3 domain, CDC42 guanine nucleotide exchange factor (GEF) 9, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 81 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-17
Identities = 18/63 (28%), Positives = 33/63 (52%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A++D+ + EL+ + GD+++VL + WW G+I+ + G FPA+FV
Sbjct: 14 EAVWDHVTMANRELAFKAGDVIKVLDAS-----NKDWWWGQIDD----EEGWFPASFVRL 64
Query: 96 IED 98
+
Sbjct: 65 WVN 67
|
| >1x2k_A OSTF1, osteoclast stimulating factor 1; SH3 domain, human osteoclast stimulating factor 1, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 68 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-17
Identities = 19/63 (30%), Positives = 29/63 (46%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALY ++ DEL GDI+ + D WW G +G + G+ P+N+V+
Sbjct: 11 RALYTFEPRTPDELYFEEGDIIYITDMS-----DTNWWKGTSKG----RTGLIPSNYVAE 61
Query: 96 IED 98
Sbjct: 62 QSG 64
|
| >2dnu_A RUH-061, SH3 multiple domains 1; RSGI, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 71 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-17
Identities = 17/64 (26%), Positives = 29/64 (45%), Gaps = 9/64 (14%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+ + Y + DE+ +G VEV+ K+ GWW + G K G PA+++
Sbjct: 11 YVTVQPYTSQSKDEIGFEKGVTVEVIRKN-----LEGWWYIRYLG----KEGWAPASYLK 61
Query: 95 SIED 98
+D
Sbjct: 62 KAKD 65
|
| >2a28_A BZZ1 protein; SH3 domain, signaling protein; 1.07A {Saccharomyces cerevisiae} Length = 54 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 1e-17
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 8/58 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A+Y Y+A G DE+S+ GDI+ V+ D GW G+ +G G+FP ++
Sbjct: 4 EAIYAYEAQGDDEISIDPGDIITVIRGDD----GSGWTYGECDG----LKGLFPTSYC 53
|
| >1ujy_A RHO guanine nucleotide exchange factor 6; structural genomics, SH3 domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 76 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-17
Identities = 20/63 (31%), Positives = 34/63 (53%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+A +++ DELS+ +GDI+ V + + GWW G + G + G FP+N+V
Sbjct: 14 KARFNFKQTNEDELSVCKGDIIYVTRVE-----EGGWWEGTLNG----RTGWFPSNYVRE 64
Query: 96 IED 98
I+
Sbjct: 65 IKS 67
|
| >2o2o_A SH3-domain kinase-binding protein 1; CIN85, protein binding; NMR {Homo sapiens} Length = 92 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-17
Identities = 21/63 (33%), Positives = 33/63 (52%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ + Y DEL L+ GDI+EV+ + + GWW G + G K G+FP+NF+
Sbjct: 22 QVAFSYLPQNDDELELKVGDIIEVVGEV-----EEGWWEGVLNG----KTGMFPSNFIKE 72
Query: 96 IED 98
+
Sbjct: 73 LSG 75
|
| >2dmo_A Neutrophil cytosol factor 2; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 68 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-17
Identities = 16/58 (27%), Positives = 26/58 (44%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
R L+ + +EL + G+IV VL K + W T G + G+ P N++
Sbjct: 11 RVLFGFVPETKEELQVMPGNIVFVLKKG-----NDNWATVMFNG----QKGLVPCNYL 59
|
| >2ak5_A RHO guanine nucleotide exchange factor 7; adaptor proteins, CIN85, PIX/COOL, protein-protein interaction, X-RAY, endocytosis; 1.85A {Rattus norvegicus} PDB: 1zsg_A Length = 64 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-17
Identities = 20/62 (32%), Positives = 32/62 (51%), Gaps = 9/62 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA +++ DELS +GD++ V + + GWW G G + G FP+N+V
Sbjct: 10 RAKFNFQQTNEDELSFSKGDVIHVTRVE-----EGGWWEGTHNG----RTGWFPSNYVRE 60
Query: 96 IE 97
I+
Sbjct: 61 IK 62
|
| >2ed0_A ABL interactor 2; coiled coil, cytoskeleton, nuclear protein, phosphorylation, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 78 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-17
Identities = 24/63 (38%), Positives = 33/63 (52%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A+YDY DELS + G I+ V+ K+ D GW+ G + G G+FP N+V S
Sbjct: 21 VAIYDYTKDKEDELSFQEGAIIYVIKKN-----DDGWYEGVMNG----VTGLFPGNYVES 71
Query: 96 IED 98
I
Sbjct: 72 ISG 74
|
| >4esr_A Jouberin; AHI-1, AHI1, AHI-1 SH3 domain, SH3 domain, dynamin-2, protei binding, chronic myeloid leukemia; 1.53A {Homo sapiens} Length = 69 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-17
Identities = 27/65 (41%), Positives = 33/65 (50%), Gaps = 8/65 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY A DEL++ RGDI+ V KD + WW G I + G FPAN V+S
Sbjct: 10 VALYDYTANRSDELTIHRGDIIRVFFKD-----NEDWWYGSIGKG---QEGYFPANHVAS 61
Query: 96 IEDIN 100
Sbjct: 62 ETLYQ 66
|
| >2ega_A SH3 and PX domain-containing protein 2A; SH3 domain, KIAA0418 protein, SH3MD1, SH3 multiple domains 1, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 70 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-17
Identities = 15/67 (22%), Positives = 30/67 (44%), Gaps = 9/67 (13%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
+ + + +Y ELSL+ G++V+V+ K+ + GWW + G PA
Sbjct: 8 LEQYVVVSNYKKQENSELSLQAGEVVDVIEKN-----ESGWWFVSTSE----EQGWVPAT 58
Query: 92 FVSSIED 98
++ +
Sbjct: 59 YLEAQNS 65
|
| >2g6f_X RHO guanine nucleotide exchange factor 7; SH3 domain, peptide interaction, signaling protein; HET: NCO; 0.92A {Rattus norvegicus} PDB: 2df6_A* 2p4r_A 2esw_A Length = 59 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-17
Identities = 20/61 (32%), Positives = 31/61 (50%), Gaps = 9/61 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA +++ DELS +GD++ V + + GWW G G + G FP+N+V
Sbjct: 8 RAKFNFQQTNEDELSFSKGDVIHVTRVE-----EGGWWEGTHNG----RTGWFPSNYVRE 58
Query: 96 I 96
I
Sbjct: 59 I 59
|
| >1x69_A Cortactin isoform A; SH3 domain, CTTN, oncogene EMS1, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 79 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-17
Identities = 24/63 (38%), Positives = 32/63 (50%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY A G DE+S DI+ + D GWW G +G + G+FPAN+V
Sbjct: 21 VALYDYQAAGDDEISFDPDDIITNIEMI-----DDGWWRGVCKG----RYGLFPANYVEL 71
Query: 96 IED 98
+
Sbjct: 72 RQS 74
|
| >1gbq_A GRB2; complex (signal transduction/peptide), SH3 domain; NMR {Mus musculus} SCOP: b.34.2.1 PDB: 1gbr_A 2gbq_A 3gbq_A 4gbq_A Length = 74 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-17
Identities = 21/63 (33%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A YD+ A DELS +RGDI++VL+++ D W+ ++ G K G P N++
Sbjct: 13 IAKYDFKATADDELSFKRGDILKVLNEEC----DQNWYKAELNG----KDGFIPKNYIEM 64
Query: 96 IED 98
Sbjct: 65 KPH 67
|
| >2drm_A Acanthamoeba myosin IB; SH3 domain, contractIle protein; 1.35A {Acanthamoeba} PDB: 2drk_A Length = 58 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-17
Identities = 27/61 (44%), Positives = 34/61 (55%), Gaps = 9/61 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ALYDYDA DEL+ + GD + V KD GWW G++ G K G PAN+V
Sbjct: 7 KALYDYDAQTGDELTFKEGDTIIVHQKD-----PAGWWEGELNG----KRGWVPANYVQD 57
Query: 96 I 96
I
Sbjct: 58 I 58
|
| >1uhc_A KIAA1010 protein; beta barrel, SH3, human cDNA, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 79 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-17
Identities = 16/66 (24%), Positives = 32/66 (48%), Gaps = 5/66 (7%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
++ A+Y + A +ELS+ +++L +G+ WW ++ G K G P+N
Sbjct: 13 NQVYFAVYTFKARNPNELSVSANQKLKILEFKDV-TGNTEWWLAEVNG----KKGYVPSN 67
Query: 92 FVSSIE 97
++ E
Sbjct: 68 YIRKTE 73
|
| >1x2p_A Protein arginine N-methyltransferase 2; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 68 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-17
Identities = 18/63 (28%), Positives = 25/63 (39%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A+ DY A +LS RG+ + +L + WW G+ G G PAN V
Sbjct: 11 VAIADYAATDETQLSFLRGEKILILRQT-----TADWWWGERAG----CCGYIPANHVGK 61
Query: 96 IED 98
Sbjct: 62 HSG 64
|
| >2dl3_A Sorbin and SH3 domain-containing protein 1; ponsin, C-CBL-associated protein, CAP, SH3 domain protein 5 SH3P12, structural genomics, NPPSFA; NMR {Homo sapiens} PDB: 2dlm_A Length = 68 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-17
Identities = 21/63 (33%), Positives = 33/63 (52%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA +D+ A L EL L++GDIV + + D W+ G+ G +VGIFP ++
Sbjct: 11 RAKFDFKAQTLKELPLQKGDIVYIYKQI-----DQNWYEGEHHG----RVGIFPRTYIEL 61
Query: 96 IED 98
+
Sbjct: 62 LSG 64
|
| >3ngp_A Spectrin alpha chain, brain; beta barrel, structural protein; 1.08A {Gallus gallus} PDB: 1e7o_A 1e6g_A 1e6h_A 1uue_A 1h8k_A 2lj3_A 1aey_A 1m8m_A 1shg_A 1u06_A 2nuz_A 2cdt_A 1hd3_A 2f2v_A 2f2w_A 2jm8_A 2jm9_A 2jma_A 3m0r_A 3m0p_A ... Length = 62 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-17
Identities = 16/62 (25%), Positives = 31/62 (50%), Gaps = 9/62 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
LYDY EL++++GDI+ +L+ + WW ++ G + G PA ++
Sbjct: 10 LVLYDYQEKSPRELTVKKGDILTLLNST-----NKDWWKIEVNG----RQGFVPAAYLKK 60
Query: 96 IE 97
++
Sbjct: 61 LD 62
|
| >2ecz_A Sorbin and SH3 domain-containing protein 1; glycoprotein, membrane, nuclear protein, phosphorylation, polymorphism, transport, structural genomics; NMR {Homo sapiens} Length = 70 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-17
Identities = 17/63 (26%), Positives = 31/63 (49%), Gaps = 7/63 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A ++++ E+S R+G+ + +L + D W+ G+I G + GIFP +V
Sbjct: 11 IAKFNFNGDTQVEMSFRKGERITLLRQV-----DENWYEGRIPG--TSRQGIFPITYVDV 63
Query: 96 IED 98
I
Sbjct: 64 ISG 66
|
| >3thk_A Spectrin alpha chain, brain; SH3 domain, chimera, structural protein; 1.70A {Rattus norvegicus} Length = 73 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-17
Identities = 16/64 (25%), Positives = 31/64 (48%), Gaps = 9/64 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY E+++++GDI+ +L+ + WW ++ + G PA +V
Sbjct: 9 LALYDYQEKSPREVTMKKGDILTLLNST-----NKDWWKVEVND----RQGFVPAAYVKK 59
Query: 96 IEDI 99
++
Sbjct: 60 LDPA 63
|
| >2l0a_A STAM-1, signal transducing adapter molecule 1; structural genomics, northeast structural genomics consortiu PSI-2, protein structure initiative; NMR {Homo sapiens} Length = 72 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-17
Identities = 21/58 (36%), Positives = 33/58 (56%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RA+YD++A +EL+ + G+I+ VL D WW G+ +G+FP+NFV
Sbjct: 21 RAIYDFEAAEDNELTFKAGEIITVLDDS-----DPNWWKGETHQ----GIGLFPSNFV 69
|
| >1ugv_A KIAA0621, olygophrenin-1 like protein; beta barrel, GRAF protein, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 72 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-17
Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 8/63 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ALY A ELS G + + + S + GW G + G K G+ P N+V
Sbjct: 14 KALYACKAEHDSELSFTAGTVFDNVHP----SQEPGWLEGTLNG----KTGLIPENYVEF 65
Query: 96 IED 98
+
Sbjct: 66 LSG 68
|
| >2djq_A SH3 domain containing ring finger 2; MUS musculus 0 DAY neonate head cDNA, riken FULL-length enriched library, clone:4831401O22, structural genomics; NMR {Mus musculus} Length = 68 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-17
Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+AL +Y +L +GD++ + + D W+ G+I G GIFPA+ V
Sbjct: 11 KALCNYRGKNPGDLKFNKGDVILLRRQL-----DENWYQGEING----VSGIFPASSVEV 61
Query: 96 IED 98
I
Sbjct: 62 ISG 64
|
| >1j3t_A Intersectin 2; beta barrel, SH3 domain, riken structural genomics/proteomics initiative, RSGI, structural genomics, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 74 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-17
Identities = 17/63 (26%), Positives = 28/63 (44%), Gaps = 10/63 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+AL + A + L+ + DI+ VL + WW G++ G G FP ++V
Sbjct: 14 QALCSWTAKKDNHLNFSKHDIITVLEQQE------NWWFGEVHG----GRGWFPKSYVKI 63
Query: 96 IED 98
I
Sbjct: 64 IPG 66
|
| >1k4u_S Phagocyte NADPH oxidase subunit P67PHOX; SH3-peptide complex, helix-turn-helix, hormone/growth factor complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 62 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 4e-17
Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
AL+ Y+A ++L + GDI+ VLSK + W G+ +G KVGIFP FV
Sbjct: 9 EALFSYEATQPEDLEFQEGDIILVLSKV-----NEEWLEGESKG----KVGIFPKVFV 57
|
| >3c0c_A Endophilin-A2; endocytosis, SH3, voltage-gated calcium channel, endosome, L binding, membrane, phosphoprotein, proto-oncogene, SH3 DOMA; 1.70A {Rattus norvegicus} Length = 73 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-17
Identities = 17/64 (26%), Positives = 32/64 (50%), Gaps = 9/64 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ALYD++ EL R GD++ + ++ D W+ G + G + G FP ++V
Sbjct: 17 KALYDFEPENDGELGFREGDLITLTNQI-----DENWYEGMLHG----QSGFFPLSYVQV 67
Query: 96 IEDI 99
+ +
Sbjct: 68 LVPL 71
|
| >1zlm_A Osteoclast stimulating factor 1; beta barrel, signaling protein; 1.07A {Homo sapiens} Length = 58 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 5e-17
Identities = 19/58 (32%), Positives = 28/58 (48%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RALY ++ DEL GDI+ + D WW G +G + G+ P+N+V
Sbjct: 7 RALYTFEPRTPDELYFEEGDIIYITDMS-----DTNWWKGTSKG----RTGLIPSNYV 55
|
| >1wxu_A Peroxisomal biogenesis factor 13; SH3 domain, PEX13, protein-protein interaction, structural genomics; NMR {Mus musculus} Length = 93 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 5e-17
Identities = 19/65 (29%), Positives = 33/65 (50%), Gaps = 4/65 (6%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA YD+ A+ +E+S R GD++ + K+ GW ++G+ G+ PAN+V
Sbjct: 21 RAEYDFVAVSDEEISFRAGDMLNLALKEQQ-PKVRGWLLASLDGQ---TTGLIPANYVKI 76
Query: 96 IEDIN 100
+
Sbjct: 77 LGKRR 81
|
| >2ew3_A SH3-containing GRB2-like protein 3; SH3GL3, solution structure, signaling protein; NMR {Homo sapiens} Length = 68 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-17
Identities = 20/64 (31%), Positives = 31/64 (48%), Gaps = 9/64 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
R LYD++ EL + GDI+ + ++ D W+ G I G + G FP N+V
Sbjct: 7 RGLYDFEPENQGELGFKEGDIITLTNQI-----DENWYEGMIHG----ESGFFPINYVEV 57
Query: 96 IEDI 99
I +
Sbjct: 58 IVPL 61
|
| >3ulr_B SRC substrate cortactin; SH3, protein-protein interaction, hydrolase, protein binding; 1.65A {Mus musculus} PDB: 2d1x_A Length = 65 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-17
Identities = 24/62 (38%), Positives = 32/62 (51%), Gaps = 9/62 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY A G DE+S DI+ + D GWW G +G + G+FPAN+V
Sbjct: 13 IALYDYQAAGDDEISFDPDDIITNIEMI-----DDGWWRGVCKG----RYGLFPANYVEL 63
Query: 96 IE 97
+
Sbjct: 64 RQ 65
|
| >1y0m_A 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 1; SH3 domain, hydrolase; 1.20A {Rattus norvegicus} PDB: 1ywp_A 1ywo_A Length = 61 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-17
Identities = 21/63 (33%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+AL+DY A DEL+ + I++ + K D GWW G GK + FP+N+V
Sbjct: 7 KALFDYKAQREDELTFTKSAIIQNVEKQ-----DGGWWRGDYGGKKQ---LWFPSNYVEE 58
Query: 96 IED 98
+ +
Sbjct: 59 MIN 61
|
| >2dbm_A SH3-containing GRB2-like protein 2; EC 2.3.1.-, SH3 domain protein 2A, endophilin 1, EEN-B1, structural genomics, NPPSFA; NMR {Homo sapiens} PDB: 2knb_B 3iql_A Length = 73 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-17
Identities = 19/63 (30%), Positives = 30/63 (47%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYD++ EL + GDI+ + ++ D W+ G + G G FP N+V
Sbjct: 11 RALYDFEPENEGELGFKEGDIITLTNQI-----DENWYEGMLHG----HSGFFPINYVEI 61
Query: 96 IED 98
+
Sbjct: 62 LVA 64
|
| >2ekh_A SH3 and PX domain-containing protein 2A; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 80 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 8e-17
Identities = 14/67 (20%), Positives = 25/67 (37%), Gaps = 9/67 (13%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
+ Y + E+S G V+VL K + GWW + G P++
Sbjct: 8 ATSYMTCSAYQKVQDSEISFPAGVEVQVLEKQ-----ESGWWYVRFGE----LEGWAPSH 58
Query: 92 FVSSIED 98
++ E+
Sbjct: 59 YLVLDEN 65
|
| >2i0n_A Class VII unconventional myosin; beta-sheet loop, structural protein; NMR {Dictyostelium discoideum} Length = 80 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-17
Identities = 19/63 (30%), Positives = 29/63 (46%), Gaps = 8/63 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RAL DY+ L +R DI+ + KD + W+ G++ G K G FP + V
Sbjct: 14 RALKDYNVSDTSLLPFKRNDIITITFKDQ----ENKWFMGQLNG----KEGSFPVDHVEI 65
Query: 96 IED 98
+
Sbjct: 66 LLS 68
|
| >2epd_A RHO GTPase-activating protein 4; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 76 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-17
Identities = 15/64 (23%), Positives = 25/64 (39%), Gaps = 9/64 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A + Y ELS RRGD++ + + WW G+ G G+ P +++
Sbjct: 14 VACFAYTGRTAQELSFRRGDVLRLHERA-----SSDWWRGEHNG----MRGLIPHKYITL 64
Query: 96 IEDI 99
Sbjct: 65 PAGT 68
|
| >2nwm_A Vinexin; cell adhesion; NMR {Homo sapiens} Length = 65 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 9e-17
Identities = 21/62 (33%), Positives = 33/62 (53%), Gaps = 9/62 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
R +D+ A EL+L++GDIV + + D W G+ G ++GIFPAN+V
Sbjct: 5 RLKFDFQAQSPKELTLQKGDIVYIHKEV-----DKNWLEGEHHG----RLGIFPANYVEV 55
Query: 96 IE 97
+
Sbjct: 56 LP 57
|
| >1z9q_A Neutrophil cytosol factor 4; oxidoreductase activator; NMR {Homo sapiens} Length = 79 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-16
Identities = 21/80 (26%), Positives = 38/80 (47%), Gaps = 13/80 (16%)
Query: 24 NHNRRNHRPDLW----RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEG 79
+H+ +H + AL+D+ EL+ + GD++ +LS+ + W G + G
Sbjct: 6 HHHHHHHMDRMAAPRAEALFDFTGNSKLELNFKAGDVIFLLSRI-----NKDWLEGTVRG 60
Query: 80 KIEYKVGIFPANFVSSIEDI 99
GIFP +FV ++D
Sbjct: 61 ----ATGIFPLSFVKILKDF 76
|
| >1w70_A Neutrophil cytosol factor 4; NADPH oxidase, P40PHOX, P47PHOX, SH3 domain, polyproline; 1.46A {Homo sapiens} PDB: 1w6x_A Length = 60 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 1e-16
Identities = 18/62 (29%), Positives = 31/62 (50%), Gaps = 9/62 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
AL+D+ EL+ + GD++ +LS+ + W G + G GIFP +FV
Sbjct: 8 EALFDFTGNSKLELNFKAGDVIFLLSRI-----NKDWLEGTVRG----ATGIFPLSFVKI 58
Query: 96 IE 97
++
Sbjct: 59 LK 60
|
| >1jqq_A PEX13P, peroxisomal membrane protein PAS20, PAS20P, roxin-13; compact beta-barrel of five anti-parrallel beta-strands; 2.65A {Saccharomyces cerevisiae} SCOP: b.34.2.1 PDB: 1n5z_A Length = 92 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 1e-16
Identities = 20/76 (26%), Positives = 40/76 (52%), Gaps = 4/76 (5%)
Query: 36 RALYDYDAIGLD-ELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
RALYD+ + E++L++GD++ +LSK + D WW + + +G P N++
Sbjct: 18 RALYDFVPENPEMEVALKKGDLMAILSKKDPLGRDSDWWKVRTKNG---NIGYIPYNYIE 74
Query: 95 SIEDINLVSSVINDVK 110
I+ + V ++ +
Sbjct: 75 IIKRRKKIEHVDDETR 90
|
| >1hsq_A Phospholipase C-gamma (SH3 domain); phosphoric diester hydrolase; NMR {Homo sapiens} SCOP: b.34.2.1 PDB: 2hsp_A Length = 71 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-16
Identities = 21/63 (33%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+AL+DY A DEL+ + I++ + K + GWW G GK K FP+N+V
Sbjct: 10 KALFDYKAQREDELTFIKSAIIQNVEKQ-----EGGWWRGDYGGK---KQLWFPSNYVEE 61
Query: 96 IED 98
+ +
Sbjct: 62 MVN 64
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 62/232 (26%), Positives = 90/232 (38%), Gaps = 70/232 (30%)
Query: 123 EAIGEGGFGKVYKGI--YEKQEVAIKVAHPNPD-------E-NILENVKQEG-------- 164
IG+G FG+V K E++ VAIK+ E +LE + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 165 KLLWLFDHRNIVSLIGVCLQSPKLCLVMEY-------------ARGGPLNRVLAGRKIRP 211
L F RN LCLV E RG LN RK
Sbjct: 120 HLKRHFMFRN------------HLCLVFEMLSYNLYDLLRNTNFRGVSLNLT---RKF-- 162
Query: 212 DVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271
A Q+ + +L +S+IH DLK N+LL P + +KI DFG +
Sbjct: 163 ------AQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSA------IKIVDFGSSC 209
Query: 272 EVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEI 319
++ + + Y + +PEV+ + A D+WS G +L E+ TGE
Sbjct: 210 QLGQRIY-----QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1nm7_A Peroxisomal membrane protein PAS20; yeast, PEX5P, PEX14P, PEX13P, import machine, SH3 domain, protein transport; NMR {Saccharomyces cerevisiae} SCOP: b.34.2.1 Length = 69 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-16
Identities = 21/71 (29%), Positives = 36/71 (50%), Gaps = 6/71 (8%)
Query: 28 RNHRPDLWRALYDYDAIGLD-ELSLRRGDIVEVLSKDSAISGDVGWWTGKI-EGKIEYKV 85
+H RALYD+ + E++L++GD++ +LSK + D WW + G +
Sbjct: 3 HHHHHHFARALYDFVPENPEMEVALKKGDLMAILSKKDPLGRDSDWWKVRTKNG----NI 58
Query: 86 GIFPANFVSSI 96
G P N++ I
Sbjct: 59 GYIPYNYIEII 69
|
| >1neg_A Spectrin alpha chain, brain; SH3-domain fold, five antiparallel beta sheets, structural protein; 2.30A {Gallus gallus} SCOP: b.34.2.1 Length = 83 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-16
Identities = 16/64 (25%), Positives = 30/64 (46%), Gaps = 9/64 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY E+++++GDI+ +L+ + WW ++ + G PA +V
Sbjct: 21 LALYDYQEKSPREVTMKKGDILTLLNST-----NKDWWKVEVND----RQGFVPAAYVKK 71
Query: 96 IEDI 99
+
Sbjct: 72 LAAA 75
|
| >3eg3_A Proto-oncogene tyrosine-protein kinase ABL1; beta, ATP-binding, cell adhesion, cytoskeleton, LIPO magnesium, manganese, metal-binding, myristate; 1.40A {Homo sapiens} PDB: 3egu_A 3eg0_A 3eg2_A 3eg1_A 1abo_A 1abq_A 1ju5_C* 2o88_A 1bbz_A 1awo_A Length = 63 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-16
Identities = 16/66 (24%), Positives = 33/66 (50%), Gaps = 8/66 (12%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
P+L+ ALYD+ A G + LS+ +G+ + VL + + W + + G P+
Sbjct: 5 PNLFVALYDFVASGDNTLSITKGEKLRVLGYNH----NGEWCEAQTKN----GQGWVPSA 56
Query: 92 FVSSIE 97
+++ +
Sbjct: 57 YITPVN 62
|
| >2dl8_A SLIT-ROBO RHO GTPase-activating protein 2; SH3 domain, formin-binding protein 2, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 72 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-16
Identities = 13/63 (20%), Positives = 24/63 (38%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A +DY ELS ++G + + + WW G+ G G+ P ++
Sbjct: 13 IAKFDYVGRTARELSFKKGASLLLYQRA-----SDDWWEGRHNG----IDGLIPHQYIVV 63
Query: 96 IED 98
+
Sbjct: 64 QDT 66
|
| >2cuc_A SH3 domain containing ring finger 2; structural genomics, ring finger 2 containing protein, NPPSFA; NMR {Mus musculus} Length = 70 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-16
Identities = 19/68 (27%), Positives = 33/68 (48%), Gaps = 7/68 (10%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
+++ AL+ Y A +EL L++G+ + VL K GW G + GIFP++
Sbjct: 7 GNMFVALHTYSAHRPEELDLQKGEGIRVLGKY-----QDGWLKGLSLLT--GRTGIFPSD 59
Query: 92 FVSSIEDI 99
+V +
Sbjct: 60 YVIPVSGP 67
|
| >3h0h_A Proto-oncogene tyrosine-protein kinase FYN; beta barrel, transferase; HET: PG4; 1.76A {Homo sapiens} PDB: 3h0i_A 3h0f_A* Length = 73 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-16
Identities = 19/67 (28%), Positives = 35/67 (52%), Gaps = 7/67 (10%)
Query: 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPA 90
L+ ALYDY+AI D+LS +G+ ++L+ + WW + + G P+
Sbjct: 14 GVTLFVALYDYEAITEDDLSFHKGEKFQILNSS-----EGDWWEARSLTT--GETGYIPS 66
Query: 91 NFVSSIE 97
N+V+ ++
Sbjct: 67 NYVAPVD 73
|
| >2ct3_A Vinexin; SH3 domian, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 70 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-16
Identities = 23/64 (35%), Positives = 32/64 (50%), Gaps = 7/64 (10%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+RA+Y Y DEL LR GD V+V+ + D GW+ G K G FP N+V+
Sbjct: 10 YRAMYQYRPQNEDELELREGDRVDVMQQC-----DDGWFVGVSRRT--QKFGTFPGNYVA 62
Query: 95 SIED 98
+
Sbjct: 63 PVSG 66
|
| >2o9s_A Ponsin; SH3 domain, signaling protein; 0.83A {Homo sapiens} PDB: 2o31_A 2o9v_A 2o2w_A Length = 67 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-16
Identities = 17/63 (26%), Positives = 32/63 (50%), Gaps = 7/63 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A ++++ E+S R+G+ + +L + D W+ G+I G + GIFP +V
Sbjct: 10 IAKFNFNGDTQVEMSFRKGERITLLRQV-----DENWYEGRIPG--TSRQGIFPITYVDV 62
Query: 96 IED 98
I+
Sbjct: 63 IKR 65
|
| >1b07_A Protein (proto-oncogene CRK (CRK)); SH3 domain, inhibitors, peptoids, protein-protein recognition, proline-rich motifs, signal transduction; 2.50A {Mus musculus} SCOP: b.34.2.1 Length = 65 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-16
Identities = 17/66 (25%), Positives = 31/66 (46%), Gaps = 10/66 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI-EGKIEYKVGIFPANFVS 94
RAL+D++ ++L ++GDI+ + K + WW + EG K G+ P +V
Sbjct: 7 RALFDFNGNDEEDLPFKKGDILRIRDKP-----EEQWWNAEDSEG----KRGMIPVPYVE 57
Query: 95 SIEDIN 100
+
Sbjct: 58 KYHHHH 63
|
| >1yn8_A NBP2, NAP1-binding protein 2; SH3 domain, unknown function; 1.70A {Saccharomyces cerevisiae} Length = 59 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-16
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 7/62 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYD++ +EL L GDIV + K GW E + K G+ P FVS
Sbjct: 5 VALYDFEPENDNELRLAEGDIVFISYKH-----GQGWLVA--ENESGSKTGLVPEEFVSY 57
Query: 96 IE 97
I+
Sbjct: 58 IQ 59
|
| >2lcs_A NAP1-binding protein 2; adaptor, transferase, signaling protein; NMR {Saccharomyces cerevisiae} Length = 73 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-16
Identities = 22/63 (34%), Positives = 29/63 (46%), Gaps = 7/63 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYD++ +EL L GDIV + K GW E + K G+ P FVS
Sbjct: 9 VALYDFEPENDNELRLAEGDIVFISYKH-----GQGWLVA--ENESGSKTGLVPEEFVSY 61
Query: 96 IED 98
I+
Sbjct: 62 IQP 64
|
| >2d8j_A FYN-related kinase; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 77 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 7e-16
Identities = 20/71 (28%), Positives = 32/71 (45%), Gaps = 10/71 (14%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGK-----IEGKIEYKVGIFP 89
+ AL+DY A ++LS R GD ++VL GWW + G + G P
Sbjct: 10 FVALFDYQARTAEDLSFRAGDKLQVLDTS-----HEGWWLARHLEKKGTGLGQQLQGYIP 64
Query: 90 ANFVSSIEDIN 100
+N+V+ +
Sbjct: 65 SNYVAEDSGPS 75
|
| >1tg0_A BBC1 protein, myosin tail region-interacting protein MTI1; yeast, SH3 domain, structural genomics, contractIle protein; 0.97A {Saccharomyces cerevisiae} PDB: 1zuk_A 1wdx_A Length = 68 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-16
Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 6/63 (9%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGK-IEYKVGIFPA 90
P A + Y + D+L+ + + V S + D W+ G+ + + GIFP
Sbjct: 7 PFKVVAQFPYKSDYEDDLNFEKDQEIIVTSVE-----DAEWYFGEYQDSNGDVIEGIFPK 61
Query: 91 NFV 93
+FV
Sbjct: 62 SFV 64
|
| >1u5s_A Cytoplasmic protein NCK2; protein-protein complex, beta barrel, beta sheet, zinc finger, metal binding protein; NMR {Homo sapiens} SCOP: b.34.2.1 PDB: 2fry_A Length = 71 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-16
Identities = 19/64 (29%), Positives = 33/64 (51%), Gaps = 8/64 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGK-IEGKIEYKVGIFPANFVS 94
+ LY + ++ +EL+ +G+ +EV+ K D WW K G +VG+ P N+V
Sbjct: 10 QTLYPFSSVTEEELNFEKGETMEVIEKP---ENDPEWWKCKNARG----QVGLVPKNYVV 62
Query: 95 SIED 98
+ D
Sbjct: 63 VLSD 66
|
| >2v1r_A Peroxisomal membrane protein PAS20; protein transport, translocation, transmembrane, peptide COM structural genomics, peroxisome; 2.1A {Saccharomyces cerevisiae} SCOP: b.34.2.1 Length = 80 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 9e-16
Identities = 20/65 (30%), Positives = 35/65 (53%), Gaps = 6/65 (9%)
Query: 36 RALYDYDAIGLD-ELSLRRGDIVEVLSKDSAISGDVGWWTGKI-EGKIEYKVGIFPANFV 93
RALYD+ + E++L++GD++ +LSK + D WW + G +G P N++
Sbjct: 18 RALYDFVPENPEMEVALKKGDLMAILSKKDPLGRDSDWWKVRTKNG----NIGYIPYNYI 73
Query: 94 SSIED 98
I+
Sbjct: 74 EIIKR 78
|
| >2gnc_A SLIT-ROBO RHO GTPase-activating protein 1; beta barrel, signaling protein; 1.80A {Mus musculus} Length = 60 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-16
Identities = 13/58 (22%), Positives = 23/58 (39%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A +DY ELS ++G + + + WW G+ G G+ P ++
Sbjct: 10 IAKFDYVGRSARELSFKKGASLLLYHRA-----SEDWWEGRHNG----IDGLVPHQYI 58
|
| >1wx6_A Cytoplasmic protein NCK2; SH3 domain, structural genomics, signal transduction, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} Length = 91 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-15
Identities = 19/65 (29%), Positives = 33/65 (50%), Gaps = 8/65 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGK-IEGKIEYKVGIFPANFVS 94
+ LY + ++ +EL+ +G+ +EV+ K D WW K G +VG+ P N+V
Sbjct: 21 QTLYPFSSVTEEELNFEKGETMEVIEKP---ENDPEWWKCKNARG----QVGLVPKNYVV 73
Query: 95 SIEDI 99
+ D
Sbjct: 74 VLSDG 78
|
| >2dbk_A CRK-like protein; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 88 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-15
Identities = 18/69 (26%), Positives = 28/69 (40%), Gaps = 11/69 (15%)
Query: 32 PDLWRALYDYD--AIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFP 89
P +A+ A L+L GDIV+V + G W G++ G + G+FP
Sbjct: 16 PVFAKAIQKRVPCAYDKTALALEVGDIVKVTRMN-----INGQWEGEVNG----RKGLFP 66
Query: 90 ANFVSSIED 98
V +
Sbjct: 67 FTHVKIFDP 75
|
| >3cqt_A P59-FYN, proto-oncogene tyrosine-protein kinase FYN; beta barrel, ATP-binding, developmental protein, lipoprotein, manganese, metal-binding; 1.60A {Gallus gallus} PDB: 2l2p_A Length = 79 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-15
Identities = 16/69 (23%), Positives = 35/69 (50%), Gaps = 7/69 (10%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
L+ ALYDY+A D+LS +G+ ++L+ + WW + + G P+
Sbjct: 5 STLFEALYDYEARTEDDLSFHKGEKFQILNSS-----EGDWWEARSLTT--GETGYIPSI 57
Query: 92 FVSSIEDIN 100
+++ ++ ++
Sbjct: 58 YLAPVDRLD 66
|
| >2e5k_A Suppressor of T-cell receptor signaling 1; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 94 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-15
Identities = 18/83 (21%), Positives = 34/83 (40%), Gaps = 7/83 (8%)
Query: 18 SDLLYGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI 77
S G+ + R + + +Y Y DEL L GD + + + + + GW G
Sbjct: 2 SSGSSGSRDIRFANHETLQVIYPYTPQNDDELELVPGDFIFMSPMEQTSTSE-GWIYGTS 60
Query: 78 E--GKIEYKVGIFPANFVSSIED 98
G G+ P N+++ ++
Sbjct: 61 LTTG----CSGLLPENYITKADE 79
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 62/244 (25%), Positives = 90/244 (36%), Gaps = 78/244 (31%)
Query: 123 EAIGEGGFGKVYKGI---YEKQEVAIKVAHPNPD-------E-NILENVKQEG------- 164
+ +GEG FGKV + I + VA+K+ E +LE++
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 165 -KLLWLFDHRNIVSLIGVCLQSPKLCLVME------YA-------RGGPLNRVLAGRKIR 210
++L F+H +C+V E Y L+ + RK+
Sbjct: 80 VQMLEWFEHHG------------HICIVFELLGLSTYDFIKENGFLPFRLDHI---RKM- 123
Query: 211 PDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT--------- 261
A QI + +N+LH L H DLK N+L + E K
Sbjct: 124 -------AYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 262 --LKITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELL 315
+K+ DFG A Y H S T + APEVI +S+ DVWS G +L E
Sbjct: 174 PDIKVVDFGSA--TYDDEHHS---TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228
Query: 316 TGEI 319
G
Sbjct: 229 LGFT 232
|
| >2ebp_A SAM and SH3 domain-containing protein 1; proline-glutamate repeat-containing protein, structural genomics, NPPSFA; NMR {Homo sapiens} PDB: 2kea_A Length = 73 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-15
Identities = 16/63 (25%), Positives = 27/63 (42%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ D L L++GDI++++SK +G W G + KVG F +V
Sbjct: 15 HTDFTPSPYDTDSLKLKKGDIIDIISKP-----PMGTWMGLLNN----KVGTFKFIYVDV 65
Query: 96 IED 98
+
Sbjct: 66 LSS 68
|
| >2eyx_A V-CRK sarcoma virus CT10 oncogene homolog isoform A; SH3, signaling protein; NMR {Homo sapiens} Length = 67 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-15
Identities = 17/67 (25%), Positives = 26/67 (38%), Gaps = 11/67 (16%)
Query: 36 RALYDYDAIGLD--ELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
R + D L+L G++V+V + G W G+ G K G FP V
Sbjct: 10 RVIQKRVPNAYDKTALALEVGELVKVTKIN-----VSGQWEGECNG----KRGHFPFTHV 60
Query: 94 SSIEDIN 100
++ N
Sbjct: 61 RLLDQQN 67
|
| >2x3w_D Syndapin I, protein kinase C and casein kinase substrate in N protein 1; endocytosis, N-WAsp, dynamin, pacsin I, transferase; 2.64A {Mus musculus} PDB: 2x3x_D Length = 60 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-15
Identities = 23/61 (37%), Positives = 37/61 (60%), Gaps = 7/61 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYDYD DELS + GD + L ++ + GW G+++ ++G++PAN+V +
Sbjct: 7 RALYDYDGQEQDELSFKAGDELTKLGEED----EQGWCRGRLDSG---QLGLYPANYVEA 59
Query: 96 I 96
I
Sbjct: 60 I 60
|
| >1jo8_A ABP1P, actin binding protein; SH3 domain actin-binding-protein, structural protein; 1.30A {Saccharomyces cerevisiae} SCOP: b.34.2.1 PDB: 2k3b_A 2rpn_A Length = 58 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-15
Identities = 19/58 (32%), Positives = 29/58 (50%), Gaps = 7/58 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A YDYDA +EL+ D + + D WW G++E + G+FP+N+V
Sbjct: 4 TAEYDYDAAEDNELTFVENDKIINIEFV-----DDDWWLGELEK--DGSKGLFPSNYV 54
|
| >2ke9_A Caskin-2; SH3 domain, ANK repeat, cytoplasm, phosphoprotein, protein binding; NMR {Homo sapiens} Length = 83 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-15
Identities = 18/66 (27%), Positives = 28/66 (42%), Gaps = 8/66 (12%)
Query: 36 RALYDY-DAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEY--KVGIFPANF 92
RAL D+ + L++R GD++ VL + G W G I ++G FP
Sbjct: 22 RALKDFWNLHDPTALNVRAGDVITVLEQH-----PDGRWKGHIHESQRGTDRIGYFPPGI 76
Query: 93 VSSIED 98
V +
Sbjct: 77 VEVVSK 82
|
| >4f14_A Nebulette; SH3 domain, heart muscle, actin-binding protein-peptide COMP; 1.20A {Homo sapiens} PDB: 1ark_A 1neb_A 3i35_A Length = 64 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-15
Identities = 20/62 (32%), Positives = 32/62 (51%), Gaps = 7/62 (11%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+RA+YDY A DE+S R GD + + D GW G ++ + G+ PAN++
Sbjct: 9 YRAMYDYSAQDEDEVSFRDGDYIVNVQPI-----DDGWMYGTVQRT--GRTGMLPANYIE 61
Query: 95 SI 96
+
Sbjct: 62 FV 63
|
| >2bzy_A CRK-like protein, CRKL SH3C; SH3 domain, dimer, nuclear export; 2.5A {Homo sapiens} PDB: 2bzx_A Length = 67 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-15
Identities = 18/69 (26%), Positives = 28/69 (40%), Gaps = 11/69 (15%)
Query: 32 PDLWRALYDYD--AIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFP 89
P +A+ A L+L GDIV+V + G W G++ G + G+FP
Sbjct: 1 PVFAKAIQKRVPCAYDKTALALEVGDIVKVTRMN-----INGQWEGEVNG----RKGLFP 51
Query: 90 ANFVSSIED 98
V +
Sbjct: 52 FTHVKIFDP 60
|
| >1cka_A C-CRK N-terminal SH3 domain; complex (oncogene protein/peptide); 1.50A {Mus musculus} SCOP: b.34.2.1 PDB: 1ckb_A 1m3c_A 1m30_A 1m3b_A 1m3a_A Length = 57 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-15
Identities = 17/59 (28%), Positives = 30/59 (50%), Gaps = 10/59 (16%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI-EGKIEYKVGIFPANFV 93
RAL+D++ ++L ++GDI+ + K + WW + EG K G+ P +V
Sbjct: 5 RALFDFNGNDEEDLPFKKGDILRIRDKP-----EEQWWNAEDSEG----KRGMIPVPYV 54
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 51/244 (20%), Positives = 84/244 (34%), Gaps = 78/244 (31%)
Query: 123 EAIGEGGFGKVYK---GIYEKQEVAIKVAHPNPD-------E-NILENVKQEG------- 164
+GEG FGKV + K +VA+K+ E N+L+ +K++
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 165 -KLLWLFDHRNIVSLIGVCLQSPKLCLVME------YA-------RGGPLNRVLAGRKIR 210
+ F+ +C+ E + + PL V R +
Sbjct: 85 VLMSDWFNFHG------------HMCIAFELLGKNTFEFLKENNFQPYPLPHV---RHM- 128
Query: 211 PDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK---------- 260
A Q+ + +LH L H DLK N+L
Sbjct: 129 -------AYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178
Query: 261 -TLKITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVLWELL 315
++++ DFG A + H + T + PEVI +++ DVWS G +L+E
Sbjct: 179 TSIRVADFGSA--TFDHEHHT---TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 316 TGEI 319
G
Sbjct: 234 RGFT 237
|
| >2egc_A SH3 and PX domain-containing protein 2A; SH3 domain, KIAA0418 protein, SH3MD1, SH3 multiple domains 1, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 75 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-15
Identities = 15/76 (19%), Positives = 33/76 (43%), Gaps = 6/76 (7%)
Query: 23 GNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIE 82
G+ + D++ ++ DY+ + + G +EVL ++ GWW +I ++
Sbjct: 1 GSSGSSGNLKDVYVSIADYEGDE-ETAGFQEGVSMEVLERN-----PNGWWYCQILDGVK 54
Query: 83 YKVGIFPANFVSSIED 98
G P+N++
Sbjct: 55 PFKGWVPSNYLEKKNS 70
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 57/248 (22%), Positives = 93/248 (37%), Gaps = 82/248 (33%)
Query: 123 EAIGEGGFGKVYKGI--YEKQEVAIKVAHPNP-------DE-NILENVKQEG-------K 165
+G+G FG+V K+ A+KV E +IL+ ++ + K
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVME------YA-------RGGPLNRVLAGRKIRPD 212
F + + +CL+ E Y G + + +
Sbjct: 101 YHGKFMYYD------------HMCLIFEPLGPSLYEIITRNNYNGFHIEDI---KLY--- 142
Query: 213 VLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK------------ 260
I+I + +NYL +SL H DLK N+LL +P + L
Sbjct: 143 -----CIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 261 -----TLKITDFGLAREVYKTTHMSAAGTYA----WMAPEVIKTSIFSKASDVWSYGVVL 311
+K+ DFG A +K+ + + + APEVI + +SD+WS+G VL
Sbjct: 195 RTKSTGIKLIDFGCA--TFKSDYHG---SIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249
Query: 312 WELLTGEI 319
EL TG +
Sbjct: 250 AELYTGSL 257
|
| >2yup_A Vinexin; sorbin and SH3 domain-containing protein 3, SH3-containing adapter molecule 1, SCAM-1, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 90 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-15
Identities = 18/63 (28%), Positives = 31/63 (49%), Gaps = 7/63 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A Y + ELS R+G+ + ++ K + W+ G+I G + GIFPA++V
Sbjct: 21 VAQYTFKGDLEVELSFRKGEHICLIRKV-----NENWYEGRITGT--GRQGIFPASYVQV 73
Query: 96 IED 98
+
Sbjct: 74 SRE 76
|
| >1s1n_A Nephrocystin 1; beta barrel, cell adhesion; NMR {Homo sapiens} Length = 68 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-15
Identities = 16/77 (20%), Positives = 36/77 (46%), Gaps = 10/77 (12%)
Query: 23 GNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGK-IEGKI 81
G+ + + + + A+ D+ A + +L+ ++G+I+ V+ K GWW K +G
Sbjct: 1 GSESHKWSTGEEYIAVGDFTAQQVGDLTFKKGEILLVIEKK-----PDGWWIAKDAKG-- 53
Query: 82 EYKVGIFPANFVSSIED 98
G+ P ++ +
Sbjct: 54 --NEGLVPRTYLEPYSE 68
|
| >1aww_A ATK, AMGX1, BPK, bruton'S tyrosine kinase; X-linked agammaglobulinemia, XLA, BTK, SH3 domain, transferase; NMR {Homo sapiens} SCOP: b.34.2.1 PDB: 1awx_A 1qly_A Length = 67 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-15
Identities = 19/63 (30%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY + ++L LR+GD +L + ++ WW + + + G P+N+V+
Sbjct: 12 VALYDYMPMNANDLQLRKGDEYFILEES-----NLPWWRARDKNG---QEGYIPSNYVTE 63
Query: 96 IED 98
ED
Sbjct: 64 AED 66
|
| >4ag1_C Fynomer; hydrolase-de novo protein complex, inhibitor, serine proteas; 1.40A {Synthetic construct} PDB: 4afz_C 4ag2_C* 4afq_C* 4afs_C 4afu_C 1azg_B 1nyf_A 1nyg_A 1a0n_B 1fyn_A 1m27_C* 1shf_A 1zbj_A 1efn_A 1avz_C 1nlo_C* 1nlp_C* 1qwe_A 1qwf_A 1prl_C ... Length = 84 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-15
Identities = 17/65 (26%), Positives = 30/65 (46%), Gaps = 7/65 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY+A +LS +G+ ++L WW + + G P+N+V+
Sbjct: 10 VALYDYNATRWTDLSFHKGEKFQILEFG-----PGDWWEARSLTT--GETGYIPSNYVAP 62
Query: 96 IEDIN 100
++ I
Sbjct: 63 VDSIQ 67
|
| >2kgt_A Tyrosine-protein kinase 6; SH3 domain, SRC kinase, PTK6, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; NMR {Homo sapiens} Length = 72 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-15
Identities = 16/65 (24%), Positives = 28/65 (43%), Gaps = 6/65 (9%)
Query: 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIE-GKIEYKVGIF 88
H + L+D+ + +ELS R GD+ V K+ + WW ++ G
Sbjct: 8 HLGPKYVGLWDFKSRTDEELSFRAGDVFHVARKE-----EQWWWATLLDEAGGAVAQGYV 62
Query: 89 PANFV 93
P N++
Sbjct: 63 PHNYL 67
|
| >2jt4_A Cytoskeleton assembly control protein SLA1; endocytosis, SH3, actin-binding, cytoplasm, cytoskeleton, phosphorylation, SH3 domain, DNA damage, DNA repair, nucleus; NMR {Saccharomyces cerevisiae} Length = 71 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-15
Identities = 18/65 (27%), Positives = 28/65 (43%), Gaps = 6/65 (9%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
YD+ A DEL+++ GD V +L WW ++ K G+ PA F+
Sbjct: 10 IVQYDFMAESQDELTIKSGDKVYILDDKK----SKDWWMCQLVDS--GKSGLVPAQFIEP 63
Query: 96 IEDIN 100
+ D
Sbjct: 64 VRDKK 68
|
| >2csi_A RIM-BP2, RIM binding protein 2; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 76 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-15
Identities = 19/70 (27%), Positives = 32/70 (45%), Gaps = 15/70 (21%)
Query: 36 RALYDYDA-------IGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIF 88
ALYDYD EL+ GDI+ V + + G++ G++ G + G+
Sbjct: 11 VALYDYDPRESSPNVDVEAELTFCTGDIITVFGE----IDEDGFYYGELNG----QKGLV 62
Query: 89 PANFVSSIED 98
P+NF+ +
Sbjct: 63 PSNFLEEVSG 72
|
| >2oaw_A Spectrin alpha chain, brain; SH3 domain, chimera, structural protein; 1.90A {Gallus gallus} PDB: 2rot_A 2rmo_A 2kr3_A Length = 65 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-15
Identities = 18/66 (27%), Positives = 33/66 (50%), Gaps = 9/66 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI----EGKIEYKVGIFPAN 91
ALYDY E+++++GDI+ +L+ + WW ++ GK + G PA
Sbjct: 5 LALYDYQEKSPREVTMKKGDILTLLNST-----NKDWWKVEVKITVNGKTYERQGFVPAA 59
Query: 92 FVSSIE 97
+V ++
Sbjct: 60 YVKKLD 65
|
| >1csk_A C-SRC SH3 domain; phosphotransferase; 2.50A {Homo sapiens} SCOP: b.34.2.1 Length = 71 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-15
Identities = 15/64 (23%), Positives = 29/64 (45%), Gaps = 7/64 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A Y++ +L +GD++ +++ D W+ K + + GI PAN+V
Sbjct: 15 IAKYNFHGTAEQDLPFCKGDVLTIVAVTK----DPNWYKAKNKVG---REGIIPANYVQK 67
Query: 96 IEDI 99
E +
Sbjct: 68 REGV 71
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 54/255 (21%), Positives = 98/255 (38%), Gaps = 70/255 (27%)
Query: 125 IGEGGFGKVY--KGIYEKQEVAIKV--AHPNPDE------NILENVKQEGKLLWLFDHRN 174
+G G F V+ I K+ VA+KV + + E +L++V+ + N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDP-----NDPN 99
Query: 175 ---IVSLIGV-CLQSPK---LCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEG 224
+V L+ + +C+V E G L + + + + + Q+ +G
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEP--------------------------------- 251
++YLH + I IH D+K N+LLS
Sbjct: 159 LDYLHTKCRI--IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 252 --------IENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASD 303
+E ++ + +KI D G A V+K T + + EV+ S ++ +D
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 304 VWSYGVVLWELLTGE 318
+WS + +EL TG+
Sbjct: 276 IWSTACMAFELATGD 290
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 70/293 (23%), Positives = 114/293 (38%), Gaps = 40/293 (13%)
Query: 117 NKLIFGEAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQEGKLL-WLFDHR 173
N+ G IG G FG +Y G I +EVAIK+ L E K+ +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI---ESKIYKMMQGGV 65
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGP-LN--RVLAGRKIRPDVLVDWAIQIAEGMNYLHC 230
I ++ + +VME GP L RK ++ A Q+ + Y+H
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY-KTTHM--------SA 281
+ + IHRD+K N L+ + + I DFGLA++ TH +
Sbjct: 124 K---NFIHRDVKPDNFLMGLGKKG-----NLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175
Query: 282 AGTYAWMAPEVIKTSIFSKAS---DVWSYGVVLWELLTGEIPYKSINAYAVAYG---VAV 335
GT + + I T + + S D+ S G VL G +P++ + A ++
Sbjct: 176 TGTARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232
Query: 336 NKLTLPIPSTC---PQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
K++ PI C P F T + C +P + + + N+ H +
Sbjct: 233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285
|
| >2rqv_A BUD emergence protein 1; BEM1P, SH3, CDC42P, cytoplasm, cytoskeleton, SH3 domain, SIG protein; NMR {Saccharomyces cerevisiae} PDB: 2rqw_A Length = 108 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-14
Identities = 17/78 (21%), Positives = 36/78 (46%), Gaps = 6/78 (7%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
LYD+ A DEL+ G+ + + + + W+ K G++ G+ P FVS
Sbjct: 9 IVLYDFKAEKADELTTYVGENLFICAHH-----NCEWFIAKPIGRLG-GPGLVPVGFVSI 62
Query: 96 IEDINLVSSVINDVKLVE 113
I+ ++ + ++ ++
Sbjct: 63 IDIATGYATGNDVIEDIK 80
|
| >2kxd_A 11-MER peptide, SH3 domain of spectrin alpha CHAI; alpha spectrin SH3 domain, SPC-S19P20S circular permutant, S protein; NMR {Synthetic} Length = 73 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-14
Identities = 15/63 (23%), Positives = 30/63 (47%), Gaps = 10/63 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
L Y A G E+++++GDI+ +L+ + WW ++ + G PA +V
Sbjct: 4 PPLPPYSAGG-REVTMKKGDILTLLNST-----NKDWWKVEVNDR----QGFVPAAYVKK 53
Query: 96 IED 98
++
Sbjct: 54 LDS 56
|
| >1gl5_A Tyrosine-protein kinase TEC; transferase, ATP-binding, SH3 domain, phosphorylation; NMR {Mus musculus} SCOP: b.34.2.1 Length = 67 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-14
Identities = 19/66 (28%), Positives = 31/66 (46%), Gaps = 8/66 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A+YD+ A +L L RG +L K+ D+ WW + + G P+N+V+
Sbjct: 6 VAMYDFQATEAHDLRLERGQEYIILEKN-----DLHWWRARDKYG---SEGYIPSNYVTG 57
Query: 96 IEDINL 101
+ NL
Sbjct: 58 KKSNNL 63
|
| >1x6b_A RHO guanine exchange factor (GEF) 16; SH3 domain, neuroblastoma, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 79 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-14
Identities = 17/63 (26%), Positives = 28/63 (44%), Gaps = 8/63 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ A DE++L++ D+V VL ++ GW G E + + G FP +F
Sbjct: 21 EITKAFFAKQADEVTLQQADVVLVLQQED------GWLYG--ERLRDGETGWFPEDFARF 72
Query: 96 IED 98
I
Sbjct: 73 ISG 75
|
| >1zuy_A Myosin-5 isoform; SH3 domain, contractIle protein; 1.39A {Saccharomyces cerevisiae} PDB: 1yp5_A Length = 58 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-14
Identities = 15/61 (24%), Positives = 28/61 (45%), Gaps = 8/61 (13%)
Query: 34 LWRALYDYDA-IGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
++ A YD+ EL L++GD++ + ++ GW GK+ K G P +
Sbjct: 2 MFEAAYDFPGSGSPSELPLKKGDVIYITREE-----PSGWSLGKLLD--GSKEGWVPTAY 54
Query: 93 V 93
+
Sbjct: 55 M 55
|
| >2v1q_A SLA1, cytoskeleton assembly control protein SLA1; structural genomics, phosphorylation, structural protein, yeast, SH3 domain; 1.2A {Saccharomyces cerevisiae} PDB: 1z9z_A Length = 60 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-14
Identities = 17/58 (29%), Positives = 26/58 (44%), Gaps = 6/58 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
YD+ A DEL+++ GD V +L WW ++ K G+ PA F+
Sbjct: 6 IVQYDFMAESQDELTIKSGDKVYILDDKK----SKDWWMCQLVDS--GKSGLVPAQFI 57
|
| >2yt6_A Adult MALE urinary bladder cDNA, riken FULL- length enriched library, clone:9530076O17...; SH3_1 domain; NMR {Mus musculus} Length = 109 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-14
Identities = 17/70 (24%), Positives = 34/70 (48%), Gaps = 7/70 (10%)
Query: 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFP 89
++ ALYDY+A ++LS ++G+ ++++ + WW + K G P
Sbjct: 25 GGVTIFVALYDYEARTTEDLSFKKGERFQIINNT-----EGDWWEARSIAT--GKSGYIP 77
Query: 90 ANFVSSIEDI 99
+N+V + I
Sbjct: 78 SNYVVPADSI 87
|
| >2kxc_A Brain-specific angiogenesis inhibitor 1-associate 2-like protein 1; IRTKS-SH3, espfu, complex structure, protein binding; NMR {Homo sapiens} Length = 67 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-14
Identities = 13/64 (20%), Positives = 29/64 (45%), Gaps = 7/64 (10%)
Query: 36 RALYDYDAI-GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+ ++ + A LS +GD++ +L + GW G+ + G FP+++
Sbjct: 10 KTIFPHTAGSNKTLLSFAQGDVITLLIPEE----KDGWLYGEHDVSK--ARGWFPSSYTK 63
Query: 95 SIED 98
+E+
Sbjct: 64 LLEE 67
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 63/294 (21%), Positives = 110/294 (37%), Gaps = 40/294 (13%)
Query: 117 NKLIFGEAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQEGKLL-WLFDHR 173
G IGEG FG +++G + Q+VAIK D L + E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD---EYRTYKLLAGCT 66
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGP-LNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHC 230
I ++ + LV++ GP L +L GRK + A Q+ + +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT----THM------S 280
+ SL++RD+K N L+ P + + DFG+ + Y+ H+ +
Sbjct: 125 K---SLVYRDIKPDNFLIGRP---NSKNANMIYVVDFGMVKF-YRDPVTKQHIPYREKKN 177
Query: 281 AAGTYAWMAPEVIKTSIFSKAS---DVWSYGVVLWELLTGEIP---YKSINAYAVAYGVA 334
+GT +M+ I T + + S D+ + G V L G +P K+ +
Sbjct: 178 LSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234
Query: 335 VNKLTLPIPSTC---PQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
K + P+ C P+ F M P + + + ++
Sbjct: 235 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 64/266 (24%), Positives = 99/266 (37%), Gaps = 41/266 (15%)
Query: 117 NKLIFGEAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQEGKLL-WLFDHR 173
G+ IG G FG++ G +Y + VAIK+ L E + L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL---EYRFYKQLGSGD 65
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGP-LN--RVLAGRKIRPDVLVDWAIQIAEGMNYLHC 230
I + +V+E GP L L R ++ AIQ+ M Y+H
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK--TTHM--------S 280
+ +LI+RD+K N L+ P + + + I DF LA+E Y T S
Sbjct: 124 K---NLIYRDVKPENFLIGRP---GNKTQQVIHIIDFALAKE-YIDPETKKHIPYREHKS 176
Query: 281 AAGTYAWMAPEVIKTSIFSKAS---DVWSYGVVLWELLTGEIP---YKSINAYAVAYGVA 334
GT +M+ I T + + S D+ + G + L G +P K+ +
Sbjct: 177 LTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233
Query: 335 VNKLTLPIPSTC---PQLFKTLMEAC 357
K PI C P+ T +
Sbjct: 234 DTKRATPIEVLCENFPE-MATYLRYV 258
|
| >2csq_A RIM-BP2, RIM binding protein 2; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 97 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 4e-14
Identities = 18/73 (24%), Positives = 33/73 (45%), Gaps = 16/73 (21%)
Query: 36 RALYDYDAIGL--------DELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGI 87
AL+DYD + + +EL + G I++V G++ G+ ++G+
Sbjct: 21 VALFDYDPLTMSPNPDAAEEELPFKEGQIIKVYGD----KDADGFYRGETCA----RLGL 72
Query: 88 FPANFVSSIEDIN 100
P N VS I+ +
Sbjct: 73 IPCNMVSEIQADD 85
|
| >4e6r_A Cytoplasmic protein NCK2; SH3 domain, protein binding, structural genomics, joint CENT structural genomics, JCSG, protein structure initiative; HET: MLY; 2.20A {Homo sapiens} PDB: 2frw_A 2js0_A Length = 58 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 4e-14
Identities = 21/63 (33%), Positives = 27/63 (42%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ Y A DELSL G V V+ GWW G G ++G FP+N+V
Sbjct: 5 FVXFAYVAEREDELSLVXGSRVTVMEXC-----SDGWWRGSYNG----QIGWFPSNYVLE 55
Query: 96 IED 98
D
Sbjct: 56 EVD 58
|
| >2vkn_A Protein SSU81; membrane, SH3 domain, transmembrane, membrane; 2.05A {Saccharomyces cerevisiae} Length = 70 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-14
Identities = 19/65 (29%), Positives = 31/65 (47%), Gaps = 11/65 (16%)
Query: 36 RALYDYDAIGLD--ELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ALY YDA D E+S + +I++V + WW + + GI P+N+V
Sbjct: 9 KALYPYDADDDDAYEISFEQNEILQVSDIEG------RWWKARRANG---ETGIIPSNYV 59
Query: 94 SSIED 98
I+
Sbjct: 60 QLIDG 64
|
| >2enm_A Sorting nexin-9; SH3-like barrel, protein transport, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 77 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-14
Identities = 18/65 (27%), Positives = 33/65 (50%), Gaps = 10/65 (15%)
Query: 36 RALYDYDA-IGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIE-GKIEYKVGIFPANFV 93
R +YD+ A G +EL++ G+I+ V + + GW GK G + G+ P ++V
Sbjct: 13 RVMYDFAAEPGNNELTVTEGEIITVTNPNV----GGGWLEGKNNKG----EQGLVPTDYV 64
Query: 94 SSIED 98
+ +
Sbjct: 65 EILPN 69
|
| >2iim_A Proto-oncogene tyrosine-protein kinase LCK; beta-barrels, signaling protein; HET: PG4; 1.00A {Homo sapiens} SCOP: b.34.2.1 PDB: 1h92_A 1kik_A Length = 62 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-14
Identities = 16/63 (25%), Positives = 29/63 (46%), Gaps = 8/63 (12%)
Query: 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPA 90
+ +L AL+ Y+ +L +G+ + +L + SG+ WW + + G P
Sbjct: 5 QDNLVIALHSYEPSHDGDLGFEKGEQLRILEQ----SGE--WWKAQ--SLTTGQEGFIPF 56
Query: 91 NFV 93
NFV
Sbjct: 57 NFV 59
|
| >2ege_A Uncharacterized protein KIAA1666; SH3 domain, KIAA1666 protein, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 75 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-14
Identities = 18/68 (26%), Positives = 28/68 (41%), Gaps = 15/68 (22%)
Query: 36 RALYDYDAIGL-------DELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIF 88
A DYD L+LR GD+V V D G++ G++ G G+
Sbjct: 11 IAALDYDPGDGQMGGQGKGRLALRAGDVVMVYGP----MDDQGFYYGELGG----HRGLV 62
Query: 89 PANFVSSI 96
PA+ + +
Sbjct: 63 PAHLLDHM 70
|
| >2kym_A BUD emergence protein 1; SH3 domain, BEM1P, SH3-CI, STE20P PRR, CDC42P-interacting, S signaling protein; NMR {Lodderomyces elongisporus} Length = 120 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-13
Identities = 14/65 (21%), Positives = 30/65 (46%), Gaps = 6/65 (9%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
LY++ A DEL + G+ + + + D W+ K ++ G+ P ++V
Sbjct: 7 VTLYEFKAERDDELDVSPGENLSICAHY-----DYEWFIAKPINRLG-GPGLVPVSYVRI 60
Query: 96 IEDIN 100
I+ ++
Sbjct: 61 IDLMD 65
|
| >2yuq_A Tyrosine-protein kinase ITK/TSK; T-cell-specific kinase, tyrosine-protein kinase LYK, kinase EMT, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 85 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-13
Identities = 17/66 (25%), Positives = 27/66 (40%), Gaps = 8/66 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY EL+LRR + +L ++ WW + G P++++
Sbjct: 23 IALYDYQTNDPQELALRRNEEYCLLDSS-----EIHWWRVQDRNG---HEGYVPSSYLVE 74
Query: 96 IEDINL 101
NL
Sbjct: 75 KSPNNL 80
|
| >1spk_A RSGI RUH-010, riken cDNA 1300006M19; structural genomics, SH3 domain, five-stranded barrel, mouse cDNA; NMR {Mus musculus} SCOP: b.34.2.1 Length = 72 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-13
Identities = 12/64 (18%), Positives = 27/64 (42%), Gaps = 7/64 (10%)
Query: 36 RALYDYDAI-GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+ ++ + A LS +GD++ +L + GW G+ + G FP+++
Sbjct: 11 KTIFPHTAGNNKTLLSFAQGDVLTLLIPEE----KDGWLYGEHDTTK--ARGWFPSSYTK 64
Query: 95 SIED 98
+
Sbjct: 65 LLSG 68
|
| >2oi3_A Tyrosine-protein kinase HCK; human HCK, SH3, SRC-type tyrosine kinase, transferase; NMR {Homo sapiens} PDB: 2oj2_A 4hck_A 5hck_A Length = 86 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-13
Identities = 22/64 (34%), Positives = 36/64 (56%), Gaps = 8/64 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY+AI ++LS ++GD + VL + SG+ WW K G P+N+V+
Sbjct: 29 VALYDYEAIHHEDLSFQKGDQMVVLEE----SGE--WWKA--RSLATRKEGYIPSNYVAR 80
Query: 96 IEDI 99
++ +
Sbjct: 81 VDSL 84
|
| >1ng2_A Neutrophil cytosolic factor 1; P47PHOX, autoinhibited, SH3 domain, NADPH oxidase, oxidoredu activator; 1.70A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 PDB: 1uec_A 1ov3_A 1wlp_B Length = 193 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 1e-13
Identities = 20/58 (34%), Positives = 32/58 (55%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RA+ DY+ E++L GD+VEV+ K + GWW +++ K G PA+F+
Sbjct: 15 RAIADYEKTSGSEMALSTGDVVEVVEKS-----ESGWWFCQMKA----KRGWIPASFL 63
|
| >1ng2_A Neutrophil cytosolic factor 1; P47PHOX, autoinhibited, SH3 domain, NADPH oxidase, oxidoredu activator; 1.70A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 PDB: 1uec_A 1ov3_A 1wlp_B Length = 193 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 8e-13
Identities = 20/84 (23%), Positives = 33/84 (39%), Gaps = 9/84 (10%)
Query: 15 EVDSDLLYGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWT 74
E N+ + + A+ Y A+ DE+SL G+ VEV+ K GWW
Sbjct: 64 EPLDSPDETEDPEPNYAGEPYVAIKAYTAVEGDEVSLLEGEAVEVIHKL-----LDGWWV 118
Query: 75 GKIEGKIEYKVGIFPANFVSSIED 98
+ + G FP+ ++
Sbjct: 119 IRKDD----VTGYFPSMYLQKSGQ 138
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 1e-13
Identities = 91/628 (14%), Positives = 174/628 (27%), Gaps = 215/628 (34%)
Query: 5 LDSMEHPYQNEVDSDLLYGNHNRR--------NHRPDLWRALY---DYDAI---GLDELS 50
++ Y+ D+L + D+ +++ + D I
Sbjct: 11 TGEHQYQYK-----DIL--SVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSG 63
Query: 51 LRR---------GDIVEVLSKDSAISGDVGWWTGKIEGK-----------IEYK------ 84
R ++V+ ++ + + + I+ + IE +
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEE-VLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 85 VGIFPANFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVA 144
+F VS ++ + L+E+ K + + G G GK VA
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQ-----ALLELRPAKNVLID--GVLGSGK--------TWVA 167
Query: 145 IKVAHPNPDENILENVKQEGKLLWL-FDHRNIVSLIGVCLQS------PKLCLVMEYARG 197
+ V + K + K+ WL + N + LQ P +++
Sbjct: 168 LDVCL---SYKVQC--KMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN 222
Query: 198 GP---------LNRVLAGRKIRPDVLV-D--WAIQIAEGMNYLHCQAPISLIHRDLKSSN 245
L R+L + +LV + N L C+ I L R + ++
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFN-LSCK--ILLTTRFKQVTD 279
Query: 246 VLLS---------------EPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAP 290
L + P E + L K L L REV T P
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT------------NP 327
Query: 291 EVIKTSIFSKA-SDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349
+ SI +++ D G+ W+ +K +N +KLT
Sbjct: 328 RRL--SIIAESIRD----GLATWD------NWKHVN---------CDKLT---------- 356
Query: 350 FKTLMEACWEA--DSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRVEI-EQVL 406
T++E+ + R F + + I +L
Sbjct: 357 --TIIESSLNVLEPAEYRKMF--------------------DRLSVFPPS--AHIPTILL 392
Query: 407 HELRVKEKELRSREEELTKAQMQQKLAEKELREREQAVAAREIDVLERELMIILQTAGPT 466
+ + + + KL + L E++ + I + EL
Sbjct: 393 SLIWFDVIK---SDVM----VVVNKLHKYSLVEKQPKESTISIPSIYLEL---KVKLENE 442
Query: 467 PTPHKRG-GKFNRSKLKVWKVHDISSPSDF--------RHTLTVQPTER----------- 506
H+ +N K + D+ P H ++ ER
Sbjct: 443 YALHRSIVDHYN--IPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF 500
Query: 507 -----KSRKATSPPGSPS--IPRLQAFK 527
K R ++ + + LQ K
Sbjct: 501 RFLEQKIRHDSTAWNASGSILNTLQQLK 528
|
| >1x6g_A Megakaryocyte-associated tyrosine-protein kinase; MATK, CTK, HYL, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 81 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-13
Identities = 11/65 (16%), Positives = 22/65 (33%), Gaps = 6/65 (9%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
++ EL+ R+GD+V +L + W+ K + G+ A +
Sbjct: 20 CITKCEHTRPKPGELAFRKGDVVTILEA----CENKSWYRVKHHTS--GQEGLLAAGALR 73
Query: 95 SIEDI 99
Sbjct: 74 ERSGP 78
|
| >1ruw_A Myosin-3 isoform, MYO3; SH3 domain, yeast, high-throughput, structural genomics, contractIle protein; 1.80A {Saccharomyces cerevisiae} PDB: 2btt_A 1va7_A Length = 69 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-13
Identities = 18/64 (28%), Positives = 28/64 (43%), Gaps = 8/64 (12%)
Query: 36 RALYDYDAIGL-DELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
A YD+ G EL L++GDIV + + GW K+ K G P +++
Sbjct: 6 EAAYDFPGSGSSSELPLKKGDIVFISRDE-----PSGWSLAKLLD--GSKEGWVPTAYMT 58
Query: 95 SIED 98
+D
Sbjct: 59 PYKD 62
|
| >1zuu_A BZZ1 protein; SH3 domain, unknown function; 0.97A {Saccharomyces cerevisiae} SCOP: b.34.2.1 Length = 58 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-13
Identities = 15/58 (25%), Positives = 29/58 (50%), Gaps = 6/58 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ LY Y DE+++ GD + ++++D +G GW KI + G+ P ++
Sbjct: 5 KVLYAYVQKDDDEITITPGDKISLVARD---TGS-GWT--KINNDTTGETGLVPTTYI 56
|
| >1wxb_A Epidermal growth factor receptor pathway substrate 8-like protein; SH3, EPS8, EPS8L2, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 68 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-13
Identities = 16/58 (27%), Positives = 26/58 (44%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ LYD+ A +ELS+ + +++EVL G W G + G P N +
Sbjct: 11 KILYDFTARNANELSVLKDEVLEVLED-----GRQWWKLRSRSG----QAGYVPCNIL 59
|
| >2dl5_A KIAA0769 protein; SH3 domain, FCHSD2, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 78 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-13
Identities = 12/63 (19%), Positives = 25/63 (39%), Gaps = 7/63 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ +Y Y A DEL++ +++EV+ + W + +VG P ++
Sbjct: 17 KVVYSYKASQPDELTIEEHEVLEVIEDG---DME-DWVKAR---NKVGQVGYVPEKYLQF 69
Query: 96 IED 98
Sbjct: 70 PTS 72
|
| >2ct4_A CDC42-interacting protein 4; thyroid receptor interacting protein 10, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 70 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-13
Identities = 12/63 (19%), Positives = 27/63 (42%), Gaps = 7/63 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A+Y ++ +S+ G+ + ++ +D GD GW + + E G P +++
Sbjct: 11 VAIYHFEGSSEGTISMAEGEDLSLMEED---KGD-GWTRVR---RKEGGEGYVPTSYLRV 63
Query: 96 IED 98
Sbjct: 64 TSG 66
|
| >3rnj_A Brain-specific angiogenesis inhibitor 1-associate 2; structural genomics, structural genomics consortium, SGC, BE barrel; HET: EDT; 1.50A {Homo sapiens} Length = 67 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-13
Identities = 14/63 (22%), Positives = 29/63 (46%), Gaps = 7/63 (11%)
Query: 36 RALYDYDAI-GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+A++ + A LS + GD++ +L ++ GW G+ E G FP ++
Sbjct: 11 KAIFSHAAGDNSTLLSFKEGDLITLLVPEA----RDGWHYGESEK--TKMRGWFPFSYTR 64
Query: 95 SIE 97
++
Sbjct: 65 VLD 67
|
| >3qwy_A Cell death abnormality protein 2; cell engulfment, signaling protein; 2.52A {Caenorhabditis elegans} Length = 308 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 4e-13
Identities = 16/92 (17%), Positives = 32/92 (34%), Gaps = 10/92 (10%)
Query: 2 PPLLDSMEHPYQNEVDSDLLYGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLS 61
P + + H + L + + + + +L +G+ +E+LS
Sbjct: 119 PDIPALLNHFKMRVLTEASLLAAYKKPIIEV--VVGTFKFTGERETDLPFEQGERLEILS 176
Query: 62 KDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
K + WW + G+ PAN+V
Sbjct: 177 KT-----NQDWWEARNALG---TTGLVPANYV 200
|
| >3qwy_A Cell death abnormality protein 2; cell engulfment, signaling protein; 2.52A {Caenorhabditis elegans} Length = 308 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 1e-09
Identities = 13/93 (13%), Positives = 30/93 (32%), Gaps = 11/93 (11%)
Query: 8 MEHPYQNEVDSDLLYGNHNRRNHRPDLWRALYDYDAIGLD--ELSLRRGDIVEVLSKDSA 65
+ + N + P + +D D +L +++G V V K
Sbjct: 223 SGGGAERFSSASTSSDNIELQPRLPAKAKVTFDRVPNAYDPTQLRVKKGQTVLVTQKM-- 280
Query: 66 ISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98
G + +++G+ +G P ++
Sbjct: 281 ---SNGMYKAELDGQ----IGSVPHTYLRFTAV 306
|
| >2gqi_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 71 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-13
Identities = 13/64 (20%), Positives = 25/64 (39%), Gaps = 8/64 (12%)
Query: 36 RALYDYDAIG-LDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
RA+ Y + DE+S +GD+ V ++ + GW + G+ + V
Sbjct: 11 RAILPYTKVPDTDEISFLKGDMFIVHNEL-----EDGWMWV--TNLRTDEQGLIVEDLVE 63
Query: 95 SIED 98
+
Sbjct: 64 EVSG 67
|
| >2fpe_A C-JUN-amino-terminal kinase interacting protein 1; SRC-homology 3 (SH3) domain, all beta structure, signaling protein; HET: P6G; 1.75A {Rattus norvegicus} PDB: 2fpd_A* Length = 62 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-13
Identities = 13/61 (21%), Positives = 23/61 (37%), Gaps = 7/61 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA++ + DEL L D + V + + W+ G+FPA +
Sbjct: 7 RAIFRFVPRHEDELELEVDDPLLVELQA-----EDYWYEA--YNMRTGARGVFPAYYAIE 59
Query: 96 I 96
+
Sbjct: 60 V 60
|
| >2fpf_A C-JUN-amino-terminal kinase interacting protein 1; scaffold protein 1, islet-brain-1, IB-1, mitogen-activated P kinase 8-interacting protein 1; 3.00A {Rattus norvegicus} Length = 71 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-13
Identities = 13/61 (21%), Positives = 22/61 (36%), Gaps = 7/61 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA++ + DEL L D + V + W+ G+FPA +
Sbjct: 10 RAIFRFVPRHEDELELEVDDPLLVELQAED-----YWYEA--YNMRTGARGVFPAYYAIE 62
Query: 96 I 96
+
Sbjct: 63 V 63
|
| >2cud_A SRC-like-adapter; SH3 domain, negative mitogenesis regulator, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 79 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-13
Identities = 14/68 (20%), Positives = 23/68 (33%), Gaps = 8/68 (11%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
D L DY + + RRG+ + V+S + GWW + P
Sbjct: 17 SDFLAVLSDYPSPDISPPIFRRGEKLRVISDEG------GWWKAIS--LSTGRESYIPGI 68
Query: 92 FVSSIEDI 99
V+ +
Sbjct: 69 CVARVSGP 76
|
| >1wxt_A Hypothetical protein FLJ21522; SH3 domain, EPS8-related protein 3, protein-protein interaction, structural genomics; NMR {Homo sapiens} Length = 68 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-13
Identities = 15/64 (23%), Positives = 28/64 (43%), Gaps = 9/64 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ LY+++A EL++ +G+ +EVL S W G + G P+N +
Sbjct: 11 QVLYEFEARNPRELTVVQGEKLEVLDH----SKR-WWLVKNEAG----RSGYIPSNILEP 61
Query: 96 IEDI 99
+
Sbjct: 62 LSGP 65
|
| >2rqr_A CED-12 homolog, engulfment and cell motility protein 1, linker, D of cytokinesis protein 2; KIAA0209, KIAA0281, apoptosis, membrane, phagocytosis; NMR {Homo sapiens} Length = 119 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 8e-13
Identities = 16/58 (27%), Positives = 28/58 (48%), Gaps = 7/58 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A+Y++ G +LSL+ GD+V + W+ G + + GIFP +F+
Sbjct: 63 VAIYNFQGSGAPQLSLQIGDVVRIQETCG------DWYRGYLIKH-KMLQGIFPKSFI 113
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 70/294 (23%), Positives = 117/294 (39%), Gaps = 42/294 (14%)
Query: 117 NKLIFGEAIGEGGFGKVYKG--IYEKQEVAIKVAHPNPDENILENVKQEGKLL-WLFDHR 173
NK G IG G FG++Y G I +EVAIK+ + L E K+ L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY---ESKIYRILQGGT 63
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGP-LN--RVLAGRKIRPDVLVDWAIQIAEGMNYLHC 230
I ++ ++ LVM+ GP L RK+ ++ A Q+ + ++H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK--TTHM--------S 280
+ S +HRD+K N L+ + I DFGLA++ Y+ +TH +
Sbjct: 122 K---SFLHRDIKPDNFLMGLGRRA-----NQVYIIDFGLAKK-YRDTSTHQHIPYRENKN 172
Query: 281 AAGTYAWMAPEVIKTSIFSKAS---DVWSYGVVLWELLTGEIP---YKSINAYAVAYGVA 334
GT + + + T + + S D+ S G VL L G +P K+ ++
Sbjct: 173 LTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229
Query: 335 VNKLTLPIPSTC---PQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
K+ I + C P F + C +P + + + ++ E Q
Sbjct: 230 EKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283
|
| >3o5z_A Phosphatidylinositol 3-kinase regulatory subunit; SRC homology 3 domain, protein binding; 2.01A {Homo sapiens} PDB: 2kt1_A Length = 90 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 1e-12
Identities = 18/82 (21%), Positives = 28/82 (34%), Gaps = 12/82 (14%)
Query: 25 HNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSK----------DSAISGDVGWWT 74
+ +RALY + ++L L GD++ V VGW
Sbjct: 4 GSMAGPEGFQYRALYPFRRERPEDLELLPGDVLVVSRAALQALGVAEGGERCPQSVGWMP 63
Query: 75 GKIEGKIEYKVGIFPANFVSSI 96
G E + G FP +V +
Sbjct: 64 GLNERT--RQRGDFPGTYVEFL 83
|
| >1awj_A ITK; transferase, regulatory intramolecular complex, kinase; NMR {Mus musculus} SCOP: b.34.2.1 PDB: 2rn8_A 2rna_A 2k79_A 2k7a_A Length = 77 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-12
Identities = 14/58 (24%), Positives = 25/58 (43%), Gaps = 8/58 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALYDY EL+LR + +L ++ WW + + G P++++
Sbjct: 24 IALYDYQTNDPQELALRCDEEYYLLDSS-----EIHWWRVQDKNG---HEGYAPSSYL 73
|
| >2eyz_A V-CRK sarcoma virus CT10 oncogene homolog isoform A; SH2, SH3, signaling protein; NMR {Homo sapiens} PDB: 2l3s_A 2l3p_A 2l3q_A 2ggr_A Length = 304 | Back alignment and structure |
|---|
Score = 67.3 bits (163), Expect = 2e-12
Identities = 18/94 (19%), Positives = 30/94 (31%), Gaps = 11/94 (11%)
Query: 7 SMEHPYQNEVDSDLLYGNHNRRNHRPDLWR--ALYDYDAIGLDELSLRRGDIVEVLSKDS 64
+ P + + P R +A L+L G++V+V +
Sbjct: 212 PLGGPEPGPYAQPSVNTPLPNLQNGPIYARVIQKRVPNAYDKTALALEVGELVKVTKIN- 270
Query: 65 AISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98
G W G+ G K G FP V ++
Sbjct: 271 ----VSGQWEGECNG----KRGHFPFTHVRLLDQ 296
|
| >2eyz_A V-CRK sarcoma virus CT10 oncogene homolog isoform A; SH2, SH3, signaling protein; NMR {Homo sapiens} PDB: 2l3s_A 2l3p_A 2l3q_A 2ggr_A Length = 304 | Back alignment and structure |
|---|
Score = 56.5 bits (135), Expect = 6e-09
Identities = 16/77 (20%), Positives = 30/77 (38%), Gaps = 8/77 (10%)
Query: 22 YGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKI 81
R + RAL+D++ ++L ++GDI+ + K + WW +
Sbjct: 124 GSGVILRQEEAEYVRALFDFNGNDEEDLPFKKGDILRIRDKP-----EEQWWNAEDSEG- 177
Query: 82 EYKVGIFPANFVSSIED 98
K G+ P +V
Sbjct: 178 --KRGMIPVPYVEKYRP 192
|
| >3qwx_X Cell death abnormality protein 2; cell engulfment, signaling protein; 2.01A {Caenorhabditis elegans} Length = 174 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 3e-12
Identities = 15/92 (16%), Positives = 32/92 (34%), Gaps = 10/92 (10%)
Query: 2 PPLLDSMEHPYQNEVDSDLLYGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLS 61
P + + H + + ++ + + +L +G+ +E+LS
Sbjct: 90 PDIPALLNHFKMRVLTEA--SLLAAYKKPIIEVVVGTFKFTGERETDLPFEQGERLEILS 147
Query: 62 KDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
K + WW + G+ PAN+V
Sbjct: 148 KT-----NQDWWEARNALG---TTGLVPANYV 171
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 65.1 bits (157), Expect = 3e-12
Identities = 26/101 (25%), Positives = 41/101 (40%), Gaps = 6/101 (5%)
Query: 2 PPLLDSMEHPYQNEVDSDLLYGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLS 61
++++ V+ G + +A +DY A DEL L+ GD+V V+
Sbjct: 112 AVVVETFPATVNGTVEGGSGAGRLDLPPGFMFKVQAQHDYTATDTDELQLKAGDVVLVIP 171
Query: 62 KDSAISGDVGWWTGKIEG------KIEYKVGIFPANFVSSI 96
+ D GW G E K+E G+FP NF +
Sbjct: 172 FQNPEEQDEGWLMGVKESDWNQHKKLEKCRGVFPENFTERV 212
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 4e-12
Identities = 35/208 (16%), Positives = 60/208 (28%), Gaps = 56/208 (26%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENI-------LENVKQEGKLL-- 167
KL E IGEG FG+V++ I + VAIK+ + + E + E +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 168 -------WLFDHRNIVSLIGVCL------------------------------QSPKLCL 190
+ L V + +L +
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 191 VMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSE 250
V+E+ GG + + Q+ + +A + HRDL NVLL +
Sbjct: 140 VLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL--AVAEASLRFEHRDLHWGNVLLKK 197
Query: 251 PIENEDLQFKTLKITDFGLAREVYKTTH 278
K+ + +
Sbjct: 198 --------TSLKKLHYTLNGKSSTIPSC 217
|
| >2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A* Length = 303 | Back alignment and structure |
|---|
Score = 65.8 bits (159), Expect = 5e-12
Identities = 18/99 (18%), Positives = 30/99 (30%), Gaps = 9/99 (9%)
Query: 2 PPLLDSMEHPYQNEVDSDLLYGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLS 61
P + + + + A L+L GDIV+V
Sbjct: 209 QPQTTTPLPAVSGSPGAAITPLPSTQNGPVFAKAIQKRVPCAYDKTALALEVGDIVKVTR 268
Query: 62 KDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDIN 100
+ G W G++ G + G+FP V + N
Sbjct: 269 MN-----INGQWEGEVNG----RKGLFPFTHVKIFDPQN 298
|
| >2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.8 bits (133), Expect = 1e-08
Identities = 16/84 (19%), Positives = 35/84 (41%), Gaps = 8/84 (9%)
Query: 10 HPYQNEVDSDLLYGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGD 69
Y + + N + R LYD+ ++L ++G+I+ ++ K +
Sbjct: 103 PRYPSPPMGSVSAPNLPTAEDNLEYVRTLYDFPGNDAEDLPFKKGEILVIIEKP-----E 157
Query: 70 VGWWTGKIEGKIEYKVGIFPANFV 93
WW+ + + +VG+ P +V
Sbjct: 158 EQWWSARNKDG---RVGMIPVPYV 178
|
| >2b86_A Cytoplasmic protein NCK2; NCK SH3 domain, signaling protein; NMR {Homo sapiens} PDB: 2js2_A Length = 67 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 5e-12
Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 9/66 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A +DY A EL +++ + + +L S WW + + G P+N+V
Sbjct: 8 IAKWDYTAQQDQELDIKKNERLWLLDD----SKT--WWRVRNAAN---RTGYVPSNYVER 58
Query: 96 IEDINL 101
+ +
Sbjct: 59 KLEHHH 64
|
| >1wie_A RIM binding protein 2; beta barrel, KIAA0318 protein, structural genomics, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 96 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 6e-12
Identities = 18/81 (22%), Positives = 33/81 (40%), Gaps = 13/81 (16%)
Query: 24 NHNRRNHRPDLWRALYDYDAI------GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI 77
+ R + + L A Y Y+ EL L G + V + G++ G++
Sbjct: 9 SKQRYSGKVHLCVARYSYNPFDGPNENPEAELPLTAGKYLYVYGDMD----EDGFYEGEL 64
Query: 78 EGKIEYKVGIFPANFVSSIED 98
+ G+ P+NFV ++D
Sbjct: 65 LDG---QRGLVPSNFVDFVQD 82
|
| >2jmc_A Spectrin alpha chain, brain and P41 peptide chimera; SPC-SH3, signaling protein; NMR {Gallus gallus} Length = 77 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 7e-12
Identities = 11/52 (21%), Positives = 26/52 (50%), Gaps = 9/52 (17%)
Query: 47 DELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98
E+++++GDI+ +L+ + WW ++ + G PA +V ++
Sbjct: 6 REVTMKKGDILTLLNST-----NKDWWKVEVND----RQGFVPAAYVKKLDS 48
|
| >1tuc_A Alpha-spectrin; capping protein, calcium-binding, duplication, repeat, SH3 domain, cytoskeleton; 2.02A {Gallus gallus} SCOP: b.34.2.1 Length = 63 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-12
Identities = 11/52 (21%), Positives = 26/52 (50%), Gaps = 9/52 (17%)
Query: 47 DELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98
E+++++GDI+ +L+ + WW ++ + G PA +V ++
Sbjct: 4 REVTMKKGDILTLLNST-----NKDWWKVEVNDR----QGFVPAAYVKKLDS 46
|
| >1i1j_A Melanoma derived growth regulatory protein; SH3 subdomain, hormone/growth factor complex; 1.39A {Homo sapiens} SCOP: b.34.2.1 PDB: 1k0x_A 1hjd_A Length = 108 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 9e-12
Identities = 19/67 (28%), Positives = 31/67 (46%), Gaps = 6/67 (8%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEG----KIEYKVGIFPAN 91
AL DY A L++ RG +V V SK +W G ++G + ++G FP++
Sbjct: 26 VALQDYMAPDCRFLTIHRGQVVYVFSKLKGRGRL--FWGGSVQGDYYGDLAARLGYFPSS 83
Query: 92 FVSSIED 98
V +
Sbjct: 84 IVREDQT 90
|
| >3reb_B Tyrosine-protein kinase HCK; HIV-1 NEF, SH3 domain binding, signaling, HCK SH3 domain, PR binding; 3.45A {Homo sapiens} Length = 90 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-11
Identities = 21/68 (30%), Positives = 34/68 (50%), Gaps = 8/68 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY + D+LS ++GD + VL + G+ WW + K G P+N+V+
Sbjct: 7 VALYDYVSWSPDDLSFQKGDQMVVLEES----GE--WWKAR--SLATRKEGYIPSNYVAR 58
Query: 96 IEDINLVS 103
++ S
Sbjct: 59 VDSGGGTS 66
|
| >1gri_A Growth factor bound protein 2; SH2, SH3, signal transduction adaptor; 3.10A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 d.93.1.1 PDB: 1aze_A 2a37_A 2azv_A 2a36_A 2azs_A Length = 217 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 1e-11
Identities = 21/63 (33%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A YD+ A DELS +RGDI++VL+++ D W+ ++ G K G P N++
Sbjct: 4 IAKYDFKATADDELSFKRGDILKVLNEE----CDQNWYKAELNG----KDGFIPKNYIEM 55
Query: 96 IED 98
Sbjct: 56 KPH 58
|
| >1gri_A Growth factor bound protein 2; SH2, SH3, signal transduction adaptor; 3.10A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 d.93.1.1 PDB: 1aze_A 2a37_A 2azv_A 2a36_A 2azs_A Length = 217 | Back alignment and structure |
|---|
Score = 61.2 bits (148), Expect = 7e-11
Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 11/99 (11%)
Query: 2 PPLLDSMEHPYQNEVD--SDLLYGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEV 59
L + +++ V + + + +P +AL+D+D EL RRGD + V
Sbjct: 126 NSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTYVQALFDFDPQEDGELGFRRGDFIHV 185
Query: 60 LSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98
+ D WW G G + G+FP N+V+ +
Sbjct: 186 MDNS-----DPNWWKGACHG----QTGMFPRNYVTPVNR 215
|
| >2jw4_A Cytoplasmic protein NCK1; SH3 domain, phosphorylation, SH2 domain, signaling protein; NMR {Homo sapiens} Length = 72 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-11
Identities = 15/69 (21%), Positives = 27/69 (39%), Gaps = 9/69 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A +DY A EL +++ + + +L S WW + K G P+N+V
Sbjct: 11 VAKFDYVAQQEQELDIKKNERLWLLDD----SKS--WWRVRNSMN---KTGFVPSNYVER 61
Query: 96 IEDINLVSS 104
++
Sbjct: 62 KNSARAAAN 70
|
| >2k2m_A EPS8-like protein 1; alternative splicing, coiled coil, cytoplasm, SH3 domain, signaling protein; NMR {Homo sapiens} PDB: 2rol_A Length = 68 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-11
Identities = 16/58 (27%), Positives = 25/58 (43%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
YD+ A ELS+++ D++EVL S WW + + G P N +
Sbjct: 12 LCNYDFQARNSSELSVKQRDVLEVLDD----SRK--WWKVRDPAG---QEGYVPYNIL 60
|
| >2dyb_A Neutrophil cytosol factor 4; P40(PHOX), NADPH oxidase, oxidoreductase; HET: CAF; 3.15A {Homo sapiens} Length = 341 | Back alignment and structure |
|---|
Score = 64.2 bits (155), Expect = 2e-11
Identities = 19/63 (30%), Positives = 32/63 (50%), Gaps = 9/63 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
AL+D+ EL+ + GD++ +LS+ + W G + G GIFP +FV
Sbjct: 178 EALFDFTGNSKLELNFKAGDVIFLLSRI-----NKDWLEGTVRG----ATGIFPLSFVKI 228
Query: 96 IED 98
++D
Sbjct: 229 LKD 231
|
| >1i07_A Epidermal growth factor receptor kinase substrate EPS8; hormone/growth factor; 1.80A {Mus musculus} SCOP: b.34.2.1 PDB: 1aoj_A 1i0c_A Length = 60 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-11
Identities = 14/64 (21%), Positives = 25/64 (39%), Gaps = 9/64 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
++ YD+ A ELS+ + D++E+L WW + G P N +
Sbjct: 5 KSKYDFVARNSSELSVMKDDVLEILDDRR------QWWKVRNASG---DSGFVPNNILDI 55
Query: 96 IEDI 99
+
Sbjct: 56 MRTP 59
|
| >3haj_A Human pacsin2 F-BAR; pacsin,syndapin,FAP52,F-BAR, alternative splicing, coiled coil, cytoplasmic vesicle, endocytosis, phosphoprotein, polymorphism; 2.78A {Homo sapiens} Length = 486 | Back alignment and structure |
|---|
Score = 64.0 bits (154), Expect = 5e-11
Identities = 24/97 (24%), Positives = 45/97 (46%), Gaps = 7/97 (7%)
Query: 1 MPPLLDSMEHPYQNEVDSDLLYGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVL 60
+S + + D + + + RALYDY+ DELS + GD + +
Sbjct: 397 DWSDDESNNPFSSTDANGDSNPFDDDATSGTEVRVRALYDYEGQEHDELSFKAGDELTKM 456
Query: 61 SKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97
+ + GW G+++ +VG++PAN+V +I+
Sbjct: 457 EDED----EQGWCKGRLDNG---QVGLYPANYVEAIQ 486
|
| >2j05_A RAS GTPase-activating protein 1; GTPase activation, SH3 domain, SH2 domain, SRC homology 3, RAS signaling pathway, proto- oncogene, phosphorylation; 1.5A {Homo sapiens} PDB: 2j06_A Length = 65 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-11
Identities = 14/70 (20%), Positives = 26/70 (37%), Gaps = 12/70 (17%)
Query: 30 HRPDLWRALYDYDAIG-LDELSLRRGDIVEVLSKDSAISGDVGWWTGKIE--GKIEYKVG 86
H RA+ Y + DE+S +GD+ V ++ + GW + G
Sbjct: 3 HMRRRVRAILPYTKVPDTDEISFLKGDMFIVHNEL-----EDGWMWVTNLRTD----EQG 53
Query: 87 IFPANFVSSI 96
+ + V +
Sbjct: 54 LIVEDLVEEV 63
|
| >2jxb_A T-cell surface glycoprotein CD3 epsilon chain, cytoplasmic protein NCK2; T-cell receptor, SH3 domain, immunology, SH2 domain; NMR {Homo sapiens} Length = 86 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-10
Identities = 14/58 (24%), Positives = 25/58 (43%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A +DY A EL +++ + + +L S WW + + G P+N+V
Sbjct: 35 IAKWDYTAQQDQELDIKKNERLWLLDD----SKT--WWRVR---NAANRTGYVPSNYV 83
|
| >1g2b_A Spectrin alpha chain; capping protein, calcium-binding, duplication, repeat, SH3 domain, cytoskeleton, metal binding protein; 1.12A {Gallus gallus} SCOP: b.34.2.1 PDB: 1tud_A Length = 62 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-10
Identities = 12/42 (28%), Positives = 23/42 (54%), Gaps = 5/42 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI 77
ALYDY E+++++GDI+ +L+ + WW ++
Sbjct: 25 LALYDYQEKSPREVTMKKGDILTLLNST-----NKDWWKVEV 61
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 39/294 (13%), Positives = 89/294 (30%), Gaps = 75/294 (25%)
Query: 117 NKLIFGEAIGEGGFGKVYKGI----------YEKQEVAIKVAHPNPDENILENVKQ---- 162
+ G +Y+ +KQ+ ++K+ + +N Q
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 163 -----EGKLLWLFDHRNIVSLIGVCLQSPKL-CLVMEYARGGP-LNRVLA--GRKI--RP 211
+ K L+ I + +G + K LV+ G L L + +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP--SLGRSLQSALDVSPKHVLSER 159
Query: 212 DVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271
VL A ++ + + +LH +H ++ + N+ + +++ + + +G A
Sbjct: 160 SVLQ-VACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQ------VTLAGYGFAF 209
Query: 272 EVYKTT----------HMSAAGT--YAWMAPEVIKTSI-------FSKASDVWSYGVVLW 312
Y + G + S+ S+ SD+ S G +
Sbjct: 210 R-YCPSGKHVAYVEGSRSPHEGDLEFI---------SMDLHKGCGPSRRSDLQSLGYCML 259
Query: 313 ELLTGEIPYKSINA--YAVAYG-VAVNKLTLPIPSTC------PQLFKTLMEAC 357
+ L G +P+ + + P C + + ++
Sbjct: 260 KWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVV 313
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 51/290 (17%), Positives = 97/290 (33%), Gaps = 77/290 (26%)
Query: 122 GEAIGEGGFGKVYKG-------IYEKQEVAIKVAHPN----PDENILENVKQEGKLLWLF 170
G IG+GGFG +Y + +KV + E + + + +
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 171 DHRNIVSLIGVCLQSPKL--------------CLVMEYARGGP-LNRVLA--GRKIRPDV 213
+ +GV PK ++M+ R G L ++ ++
Sbjct: 100 IRTRKLKYLGV----PKYWGSGLHDKNGKSYRFMIMD--RFGSDLQKIYEANAKRFSRKT 153
Query: 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273
++ +++I + + Y+H +H D+K+SN+LL+ + + + D+GLA
Sbjct: 154 VLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD------QVYLVDYGLAYR- 203
Query: 274 YKT--THM--------SAAGTYAWMAPEVIKTSI-------FSKASDVWSYGVVLWELLT 316
Y H GT + SI S+ D+ G + + LT
Sbjct: 204 YCPEGVHKAYAADPKRCHDGTIEFT-------SIDAHNGVAPSRRGDLEILGYCMIQWLT 256
Query: 317 GEIPYKSINAY--AVAYG-VAVNKLTLPIPSTC------PQLFKTLMEAC 357
G +P++ V + + + C P ME
Sbjct: 257 GHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETV 306
|
| >3i5r_A Phosphatidylinositol 3-kinase regulatory subunit alpha; SH3 domain, peptide complex, alternative splicing, disease mutation, HOST-virus interaction, phosphoprotein, polymorphism; 1.70A {Homo sapiens} PDB: 3i5s_A 1pht_A 1pnj_A 2pni_A 1pks_A 1pkt_A Length = 83 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 1e-09
Identities = 22/77 (28%), Positives = 31/77 (40%), Gaps = 12/77 (15%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISG----------DVGWWTGKIEGKIEYK 84
+RALYDY +++ L GDI+ V G ++GW G E E
Sbjct: 8 YRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGER- 66
Query: 85 VGIFPANFVSSIEDINL 101
G FP +V I +
Sbjct: 67 -GDFPGTYVEYIGRKKI 82
|
| >2dvj_A V-CRK sarcoma virus CT10 oncogene homolog, isoform A; SH3, SH2, signal transduction, adapter molecule, signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2eyy_A 2eyv_A 2eyw_A Length = 230 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 2e-09
Identities = 17/92 (18%), Positives = 31/92 (33%), Gaps = 8/92 (8%)
Query: 8 MEHPYQNEVDSDLLYGNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAIS 67
V R + RAL+D++ ++L ++GDI+ + K
Sbjct: 112 DTTTLIEPVSRSRQGSGVILRQEEAEYVRALFDFNGNDEEDLPFKKGDILRIRDKP---- 167
Query: 68 GDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99
+ WW + K G+ P +V
Sbjct: 168 -EEQWWNAEDSEG---KRGMIPVPYVEKYRPA 195
|
| >3a98_A DOCK2, dedicator of cytokinesis protein 2; protein-protein complex, DOCK2, ELMO1, SH3 domain, PH domain bundle, proline-rich sequence, cytoskeleton; 2.10A {Homo sapiens} Length = 184 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 6e-09
Identities = 18/65 (27%), Positives = 30/65 (46%), Gaps = 7/65 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A+Y++ G +LSL+ GD+V + W+ G + K + GIFP +F+
Sbjct: 21 VAIYNFQGSGAPQLSLQIGDVVRIQETCG------DWYRGYLI-KHKMLQGIFPKSFIHI 73
Query: 96 IEDIN 100
E
Sbjct: 74 KEVTV 78
|
| >1k1z_A VAV; SH3, proto-oncogene, signaling protein; NMR {Mus musculus} SCOP: b.34.2.1 Length = 78 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 1e-08
Identities = 19/76 (25%), Positives = 31/76 (40%), Gaps = 14/76 (18%)
Query: 26 NRRNHRPDLWR--ALYDYDAI------GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI 77
+++ + L + +Y I L L GDIVE+ ++ + WW G+
Sbjct: 4 DKKRNELGLPKMEVFQEYYGIPPPPGAFGGFLRLNPGDIVELTKAEA----EHNWWEGRN 59
Query: 78 EGKIEYKVGIFPANFV 93
+VG FP N V
Sbjct: 60 TAT--NEVGWFPCNRV 73
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 48/289 (16%), Positives = 93/289 (32%), Gaps = 78/289 (26%)
Query: 122 GEAIGEGGFGKVYKG--IYEKQEVAIKV----AHPNP---DENILENVKQEGKLLWLFDH 172
G+ IG GGFG +Y + ++ A V N E + + +
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 173 RNIVSLIGVCLQSPKL--------------CLVMEYARGGP-LNRVL-AGRKIRPDVLVD 216
R + +G+ P +VME R G L ++ + ++
Sbjct: 102 RKQLDYLGI----PLFYGSGLTEFKGRSYRFMVME--RLGIDLQKISGQNGTFKKSTVLQ 155
Query: 217 WAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT 276
I++ + + Y+H +H D+K++N+LL + + + D+GL+ Y
Sbjct: 156 LGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD------QVYLADYGLSYR-YCP 205
Query: 277 --THM--------SAAGT--YAWMAPEVIKTSI-------FSKASDVWSYGVVLWELLTG 317
H GT + S+ S+ SDV G + L G
Sbjct: 206 NGNHKQYQENPRKGHNGTIEFT---------SLDAHKGVALSRRSDVEILGYCMLRWLCG 256
Query: 318 EIPYKSINAYAVAYG------VAVNKLTLPIPSTC---PQLFKTLMEAC 357
++P++ VA + ++ + +
Sbjct: 257 KLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCA 305
|
| >1ug1_A KIAA1010 protein; structural genomics, SH3 domain, hypothetical protein BAA76854.1, riken structural genomics/proteomics initiative RSGI; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 92 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 6e-08
Identities = 15/72 (20%), Positives = 29/72 (40%), Gaps = 6/72 (8%)
Query: 27 RRNHRPD-LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKV 85
+ P+ L++A +++A ++SL GD+V V+ K G W
Sbjct: 11 LARYPPEKLFQAERNFNAAQDLDVSLLEGDLVGVIKK-KDPMGSQNRWLIDNGV----TK 65
Query: 86 GIFPANFVSSIE 97
G ++F+
Sbjct: 66 GFVYSSFLKPYN 77
|
| >1gcq_C VAV proto-oncogene; SH3 domain, protein-protein complex, GRB2,VAV, signaling protein/signaling protein complex; 1.68A {Mus musculus} SCOP: b.34.2.1 PDB: 1gcp_A Length = 70 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-07
Identities = 18/63 (28%), Positives = 25/63 (39%), Gaps = 12/63 (19%)
Query: 37 ALYDYDAI------GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPA 90
+Y I L L GDIVE+ ++ + WW G+ +VG FP
Sbjct: 9 VFQEYYGIPPPPGAFGPFLRLNPGDIVELTKAEA----EHNWWEGRNTA--TNEVGWFPC 62
Query: 91 NFV 93
N V
Sbjct: 63 NRV 65
|
| >1u3o_A Huntingtin-associated protein-interacting protein; SH3, CIS-proline,, signaling protein; NMR {Rattus norvegicus} Length = 82 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 4e-07
Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 3/62 (4%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
+L L D+ A ELS++ G VE+L + S GW + + + G+ P++
Sbjct: 17 CELTVVLQDFSAAHSSELSIQVGQTVELLERP---SERPGWCLVRTTERSPPQEGLVPSS 73
Query: 92 FV 93
+
Sbjct: 74 TL 75
|
| >2pz1_A RHO guanine nucleotide exchange factor 4; helical bundle, beta barrel, beta sandwich, signaling protei; 2.25A {Homo sapiens} PDB: 2dx1_A 3nmz_D 3nmx_D Length = 466 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 18/74 (24%), Positives = 33/74 (44%), Gaps = 9/74 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
AL+D+ + EL + GD++EV+ + WW G++ G FPA+FV
Sbjct: 34 EALWDHVTMDDQELGFKAGDVIEVMDAT-----NREWWWGRVADGE----GWFPASFVRL 84
Query: 96 IEDINLVSSVINDV 109
+ + + +
Sbjct: 85 RVNQDEPADDDAPL 98
|
| >2de0_X Alpha-(1,6)-fucosyltransferase; FUT8, glycosyltransferase, N-glycan, COR SH3 domain; 2.61A {Homo sapiens} Length = 526 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 4e-06
Identities = 13/73 (17%), Positives = 24/73 (32%), Gaps = 7/73 (9%)
Query: 27 RRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVG 86
A+Y + DE+ + GDI+ V G+ G + G
Sbjct: 437 FGGQNAHNQIAIYAHQPRTADEIPMEPGDIIGVAGNH-----WDGYSKGVNRK--LGRTG 489
Query: 87 IFPANFVSSIEDI 99
++P+ V +
Sbjct: 490 LYPSYKVREKIET 502
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* Length = 175 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 7e-06
Identities = 14/70 (20%), Positives = 28/70 (40%), Gaps = 8/70 (11%)
Query: 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPA 90
+ +L AL+ Y+ +L +G+ + +L + WW + + G P
Sbjct: 11 QDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSG------EWWKAQ--SLTTGQEGFIPF 62
Query: 91 NFVSSIEDIN 100
NFV+ +
Sbjct: 63 NFVAKANSLE 72
|
| >3jv3_A Intersectin-1; SH3 domain, DH domain, guanine nucleotide exchange factor, autoinhibition, domain-swapped, cell junction, cell project endocytosis; 2.40A {Mus musculus} PDB: 3gf9_A Length = 283 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 26/78 (33%), Positives = 44/78 (56%), Gaps = 9/78 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+YDY A DEL+ +G I+ VL+K+ D WW G++ G +VG+FP+N+V
Sbjct: 6 IGMYDYTAQNDDELAFSKGQIINVLNKE-----DPDWWKGEVSG----QVGLFPSNYVKL 56
Query: 96 IEDINLVSSVINDVKLVE 113
D++ +D+ L++
Sbjct: 57 TTDMDPSQQWCSDLHLLD 74
|
| >3kfv_A Tight junction protein ZO-3; structural genomics consortium, SGC, cell junction, cell membrane, membrane, SH3 domain; 2.80A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 1e-04
Identities = 14/63 (22%), Positives = 20/63 (31%), Gaps = 6/63 (9%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKD----SAISGDVGWWTGKIEGK--IEYKVGIFP 89
R ++ + L RGD+ VL G W G+ E + GI P
Sbjct: 8 RTHFELEPSPPSGLGFTRGDVFHVLDTLHPGPGQSHARGGHWLAVRMGRDLREQERGIIP 67
Query: 90 ANF 92
Sbjct: 68 NQS 70
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 2e-04
Identities = 16/74 (21%), Positives = 32/74 (43%), Gaps = 19/74 (25%)
Query: 385 QTPHESFHIMQDGWRVEIEQVLHEL----RVKEKELR------------SREEELTKAQM 428
+ E I + WR E + L EL +V E+E R + E++ K ++
Sbjct: 79 RLTQEPESIRK--WREEQRKRLQELDAASKVMEQEWREKAKKDLEEWNQRQSEQVEKNKI 136
Query: 429 QQKLAEKE-LRERE 441
++A+K ++ +
Sbjct: 137 NNRIADKAFYQQPD 150
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 527 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 2lx7_A | 60 | GAS-7, growth arrest-specific protein 7; structura | 99.59 | |
| 2lj0_A | 65 | Sorbin and SH3 domain-containing protein 1; R85FL, | 99.54 | |
| 1jo8_A | 58 | ABP1P, actin binding protein; SH3 domain actin-bin | 99.44 | |
| 2ed1_A | 76 | 130 kDa phosphatidylinositol 4,5-biphosphate- depe | 99.44 | |
| 2ew3_A | 68 | SH3-containing GRB2-like protein 3; SH3GL3, soluti | 99.44 | |
| 1tg0_A | 68 | BBC1 protein, myosin tail region-interacting prote | 99.44 | |
| 1w70_A | 60 | Neutrophil cytosol factor 4; NADPH oxidase, P40PHO | 99.43 | |
| 2g6f_X | 59 | RHO guanine nucleotide exchange factor 7; SH3 doma | 99.43 | |
| 1nm7_A | 69 | Peroxisomal membrane protein PAS20; yeast, PEX5P, | 99.43 | |
| 2b86_A | 67 | Cytoplasmic protein NCK2; NCK SH3 domain, signalin | 99.43 | |
| 2dl4_A | 68 | Protein STAC; SH3 domain, STAC protein, SRC homolo | 99.43 | |
| 2fei_A | 65 | CD2-associated protein; CMS SH3 domain, structural | 99.42 | |
| 2dmo_A | 68 | Neutrophil cytosol factor 2; SH3 domain, structura | 99.42 | |
| 1uti_A | 58 | GRB2-related adaptor protein 2; signaling protein | 99.42 | |
| 1ugv_A | 72 | KIAA0621, olygophrenin-1 like protein; beta barrel | 99.42 | |
| 2eyx_A | 67 | V-CRK sarcoma virus CT10 oncogene homolog isoform | 99.42 | |
| 2nwm_A | 65 | Vinexin; cell adhesion; NMR {Homo sapiens} | 99.41 | |
| 2xmf_A | 60 | Myosin 1E SH3; motor protein, SH3 domain; HET: DIA | 99.41 | |
| 1k4u_S | 62 | Phagocyte NADPH oxidase subunit P67PHOX; SH3-pepti | 99.41 | |
| 1sem_A | 58 | SEM-5; SRC-homology 3 (SH3) domain, peptide-bindin | 99.41 | |
| 2bz8_A | 58 | SH3-domain kinase binding protein 1; SH3 domain, C | 99.41 | |
| 3ulr_B | 65 | SRC substrate cortactin; SH3, protein-protein inte | 99.41 | |
| 2drm_A | 58 | Acanthamoeba myosin IB; SH3 domain, contractIle pr | 99.41 | |
| 1zx6_A | 58 | YPR154WP; SH3 domain, protein binding; 1.60A {Sacc | 99.41 | |
| 2ydl_A | 69 | SH3 domain-containing kinase-binding protein 1; si | 99.41 | |
| 1uhc_A | 79 | KIAA1010 protein; beta barrel, SH3, human cDNA, st | 99.4 | |
| 2i0n_A | 80 | Class VII unconventional myosin; beta-sheet loop, | 99.4 | |
| 2djq_A | 68 | SH3 domain containing ring finger 2; MUS musculus | 99.4 | |
| 2bzy_A | 67 | CRK-like protein, CRKL SH3C; SH3 domain, dimer, nu | 99.4 | |
| 2fpe_A | 62 | C-JUN-amino-terminal kinase interacting protein 1; | 99.4 | |
| 2x3w_D | 60 | Syndapin I, protein kinase C and casein kinase sub | 99.4 | |
| 1b07_A | 65 | Protein (proto-oncogene CRK (CRK)); SH3 domain, in | 99.4 | |
| 1s1n_A | 68 | Nephrocystin 1; beta barrel, cell adhesion; NMR {H | 99.4 | |
| 2vwf_A | 58 | Growth factor receptor-bound protein 2; polymorphi | 99.4 | |
| 2ak5_A | 64 | RHO guanine nucleotide exchange factor 7; adaptor | 99.4 | |
| 2eqi_A | 69 | Phospholipase C, gamma 2; SH3 domain, PLCG2, struc | 99.4 | |
| 2ekh_A | 80 | SH3 and PX domain-containing protein 2A; SH3 domai | 99.39 | |
| 2ysq_A | 81 | RHO guanine nucleotide exchange factor 9; SH3 doma | 99.39 | |
| 2egc_A | 75 | SH3 and PX domain-containing protein 2A; SH3 domai | 99.39 | |
| 2j05_A | 65 | RAS GTPase-activating protein 1; GTPase activation | 99.39 | |
| 1uj0_A | 62 | Signal transducing adaptor molecule (SH3 domain an | 99.39 | |
| 2ebp_A | 73 | SAM and SH3 domain-containing protein 1; proline-g | 99.39 | |
| 1x2p_A | 68 | Protein arginine N-methyltransferase 2; SH3 domain | 99.39 | |
| 1ujy_A | 76 | RHO guanine nucleotide exchange factor 6; structur | 99.39 | |
| 1cka_A | 57 | C-CRK N-terminal SH3 domain; complex (oncogene pro | 99.39 | |
| 2gnc_A | 60 | SLIT-ROBO RHO GTPase-activating protein 1; beta ba | 99.39 | |
| 1csk_A | 71 | C-SRC SH3 domain; phosphotransferase; 2.50A {Homo | 99.39 | |
| 2epd_A | 76 | RHO GTPase-activating protein 4; SH3 domain, struc | 99.39 | |
| 2j6f_A | 62 | CD2-associated protein; metal-binding, immune resp | 99.39 | |
| 1oot_A | 60 | Hypothetical 40.4 kDa protein in PES4-His2 interge | 99.38 | |
| 1y0m_A | 61 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 99.38 | |
| 1j3t_A | 74 | Intersectin 2; beta barrel, SH3 domain, riken stru | 99.38 | |
| 2iim_A | 62 | Proto-oncogene tyrosine-protein kinase LCK; beta-b | 99.38 | |
| 2l0a_A | 72 | STAM-1, signal transducing adapter molecule 1; str | 99.38 | |
| 1gl5_A | 67 | Tyrosine-protein kinase TEC; transferase, ATP-bind | 99.38 | |
| 1zlm_A | 58 | Osteoclast stimulating factor 1; beta barrel, sign | 99.38 | |
| 1z9q_A | 79 | Neutrophil cytosol factor 4; oxidoreductase activa | 99.38 | |
| 1x6g_A | 81 | Megakaryocyte-associated tyrosine-protein kinase; | 99.38 | |
| 2dl8_A | 72 | SLIT-ROBO RHO GTPase-activating protein 2; SH3 dom | 99.38 | |
| 2jte_A | 64 | CD2-associated protein; SH3 domain, coiled coil, c | 99.38 | |
| 1wyx_A | 69 | CRK-associated substrate; beta sheets, cell adhesi | 99.38 | |
| 3eg3_A | 63 | Proto-oncogene tyrosine-protein kinase ABL1; beta, | 99.37 | |
| 2ecz_A | 70 | Sorbin and SH3 domain-containing protein 1; glycop | 99.37 | |
| 2ege_A | 75 | Uncharacterized protein KIAA1666; SH3 domain, KIAA | 99.37 | |
| 2dl3_A | 68 | Sorbin and SH3 domain-containing protein 1; ponsin | 99.37 | |
| 2a28_A | 54 | BZZ1 protein; SH3 domain, signaling protein; 1.07A | 99.37 | |
| 1neg_A | 83 | Spectrin alpha chain, brain; SH3-domain fold, five | 99.37 | |
| 3c0c_A | 73 | Endophilin-A2; endocytosis, SH3, voltage-gated cal | 99.37 | |
| 2o2o_A | 92 | SH3-domain kinase-binding protein 1; CIN85, protei | 99.37 | |
| 1yn8_A | 59 | NBP2, NAP1-binding protein 2; SH3 domain, unknown | 99.37 | |
| 1x2k_A | 68 | OSTF1, osteoclast stimulating factor 1; SH3 domain | 99.37 | |
| 2dil_A | 69 | Proline-serine-threonine phosphatase-interacting p | 99.37 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 2lcs_A | 73 | NAP1-binding protein 2; adaptor, transferase, sign | 99.37 | |
| 2o9s_A | 67 | Ponsin; SH3 domain, signaling protein; 0.83A {Homo | 99.37 | |
| 2kxc_A | 67 | Brain-specific angiogenesis inhibitor 1-associate | 99.37 | |
| 1x2q_A | 88 | Signal transducing adapter molecule 2; SH3 domain, | 99.37 | |
| 4e6r_A | 58 | Cytoplasmic protein NCK2; SH3 domain, protein bind | 99.37 | |
| 2dl7_A | 73 | KIAA0769 protein; SH3 domain, FCHSD2, structural g | 99.37 | |
| 2dbm_A | 73 | SH3-containing GRB2-like protein 2; EC 2.3.1.-, SH | 99.36 | |
| 2gqi_A | 71 | RAS GTPase-activating protein 1; GAP, RAS P21 prot | 99.36 | |
| 1wxb_A | 68 | Epidermal growth factor receptor pathway substrate | 99.36 | |
| 3h0h_A | 73 | Proto-oncogene tyrosine-protein kinase FYN; beta b | 99.36 | |
| 3ngp_A | 62 | Spectrin alpha chain, brain; beta barrel, structur | 99.36 | |
| 1zuy_A | 58 | Myosin-5 isoform; SH3 domain, contractIle protein; | 99.36 | |
| 1uhf_A | 69 | Intersectin 2; beta barrel, SH3 domain, riken stru | 99.36 | |
| 2yun_A | 79 | Nostrin; nitric oxide synthase trafficker, structu | 99.36 | |
| 2cud_A | 79 | SRC-like-adapter; SH3 domain, negative mitogenesis | 99.36 | |
| 2k9g_A | 73 | SH3 domain-containing kinase-binding protein 1; CI | 99.36 | |
| 1wxt_A | 68 | Hypothetical protein FLJ21522; SH3 domain, EPS8-re | 99.36 | |
| 3cqt_A | 79 | P59-FYN, proto-oncogene tyrosine-protein kinase FY | 99.36 | |
| 2jw4_A | 72 | Cytoplasmic protein NCK1; SH3 domain, phosphorylat | 99.35 | |
| 2dlp_A | 85 | KIAA1783 protein; SH3 domain, structural genomics, | 99.35 | |
| 2csi_A | 76 | RIM-BP2, RIM binding protein 2; SH3 domain, struct | 99.35 | |
| 2v1q_A | 60 | SLA1, cytoskeleton assembly control protein SLA1; | 99.35 | |
| 1ruw_A | 69 | Myosin-3 isoform, MYO3; SH3 domain, yeast, high-th | 99.35 | |
| 1wi7_A | 68 | SH3-domain kinase binding protein 1; beta barrel, | 99.35 | |
| 3rnj_A | 67 | Brain-specific angiogenesis inhibitor 1-associate | 99.35 | |
| 2cre_A | 71 | HEF-like protein; SH3 domain, SRC homology 3 domai | 99.35 | |
| 2ct3_A | 70 | Vinexin; SH3 domian, structural genomics, NPPSFA, | 99.35 | |
| 1zuu_A | 58 | BZZ1 protein; SH3 domain, unknown function; 0.97A | 99.35 | |
| 2fpf_A | 71 | C-JUN-amino-terminal kinase interacting protein 1; | 99.35 | |
| 4esr_A | 69 | Jouberin; AHI-1, AHI1, AHI-1 SH3 domain, SH3 domai | 99.35 | |
| 2yuo_A | 78 | CIP85, RUN and TBC1 domain containing 3; structura | 99.35 | |
| 2dm1_A | 73 | Protein VAV-2; RHO family guanine nucleotide excha | 99.34 | |
| 2da9_A | 70 | SH3-domain kinase binding protein 1; structural ge | 99.34 | |
| 1spk_A | 72 | RSGI RUH-010, riken cDNA 1300006M19; structural ge | 99.34 | |
| 2k2m_A | 68 | EPS8-like protein 1; alternative splicing, coiled | 99.34 | |
| 2oaw_A | 65 | Spectrin alpha chain, brain; SH3 domain, chimera, | 99.34 | |
| 2rf0_A | 89 | Mitogen-activated protein kinase kinase kinase 10; | 99.34 | |
| 2jt4_A | 71 | Cytoskeleton assembly control protein SLA1; endocy | 99.34 | |
| 2dl5_A | 78 | KIAA0769 protein; SH3 domain, FCHSD2, structural g | 99.34 | |
| 2dnu_A | 71 | RUH-061, SH3 multiple domains 1; RSGI, structural | 99.34 | |
| 1u5s_A | 71 | Cytoplasmic protein NCK2; protein-protein complex, | 99.34 | |
| 1gbq_A | 74 | GRB2; complex (signal transduction/peptide), SH3 d | 99.34 | |
| 3thk_A | 73 | Spectrin alpha chain, brain; SH3 domain, chimera, | 99.34 | |
| 4ag1_C | 84 | Fynomer; hydrolase-de novo protein complex, inhibi | 99.33 | |
| 1x43_A | 81 | Endophilin B1, SH3 domain GRB2-like protein B1; st | 99.33 | |
| 2kbt_A | 142 | Chimera of proto-oncogene VAV, linker, immunoglobu | 99.33 | |
| 2d8j_A | 77 | FYN-related kinase; SH3 domain, structural genomic | 99.33 | |
| 1x69_A | 79 | Cortactin isoform A; SH3 domain, CTTN, oncogene EM | 99.33 | |
| 3u23_A | 65 | CD2-associated protein; structural genomics, struc | 99.33 | |
| 2pqh_A | 80 | Spectrin alpha chain, brain; SH3 domain, chimera, | 99.33 | |
| 1i07_A | 60 | Epidermal growth factor receptor kinase substrate | 99.32 | |
| 2ed0_A | 78 | ABL interactor 2; coiled coil, cytoskeleton, nucle | 99.32 | |
| 2ke9_A | 83 | Caskin-2; SH3 domain, ANK repeat, cytoplasm, phosp | 99.32 | |
| 4f14_A | 64 | Nebulette; SH3 domain, heart muscle, actin-binding | 99.32 | |
| 1uff_A | 93 | Intersectin 2; beta barrel, SH3 domain, endocytosi | 99.32 | |
| 1aww_A | 67 | ATK, AMGX1, BPK, bruton'S tyrosine kinase; X-linke | 99.32 | |
| 4glm_A | 72 | Dynamin-binding protein; SH3 domain, DNMBP, struct | 99.32 | |
| 1w1f_A | 65 | Tyrosine-protein kinase LYN; SH3-domain, SH3 domai | 99.32 | |
| 2dbk_A | 88 | CRK-like protein; structural genomics, NPPSFA, nat | 99.32 | |
| 2cuc_A | 70 | SH3 domain containing ring finger 2; structural ge | 99.32 | |
| 1ue9_A | 80 | Intersectin 2; beta barrel, SH3 domain, riken stru | 99.32 | |
| 2ct4_A | 70 | CDC42-interacting protein 4; thyroid receptor inte | 99.32 | |
| 2csq_A | 97 | RIM-BP2, RIM binding protein 2; SH3 domain, struct | 99.31 | |
| 2kgt_A | 72 | Tyrosine-protein kinase 6; SH3 domain, SRC kinase, | 99.31 | |
| 2yup_A | 90 | Vinexin; sorbin and SH3 domain-containing protein | 99.31 | |
| 2ega_A | 70 | SH3 and PX domain-containing protein 2A; SH3 domai | 99.31 | |
| 2d8h_A | 80 | SH3YL1 protein; SH3 domain, hypothetical protein S | 99.31 | |
| 2cub_A | 88 | Cytoplasmic protein NCK1; SH3 domain, NCK1 adaptor | 99.3 | |
| 1wie_A | 96 | RIM binding protein 2; beta barrel, KIAA0318 prote | 99.3 | |
| 2oi3_A | 86 | Tyrosine-protein kinase HCK; human HCK, SH3, SRC-t | 99.29 | |
| 2yuq_A | 85 | Tyrosine-protein kinase ITK/TSK; T-cell-specific k | 99.29 | |
| 2jxb_A | 86 | T-cell surface glycoprotein CD3 epsilon chain, cyt | 99.28 | |
| 1wx6_A | 91 | Cytoplasmic protein NCK2; SH3 domain, structural g | 99.28 | |
| 2rqv_A | 108 | BUD emergence protein 1; BEM1P, SH3, CDC42P, cytop | 99.28 | |
| 2enm_A | 77 | Sorting nexin-9; SH3-like barrel, protein transpor | 99.27 | |
| 2kxd_A | 73 | 11-MER peptide, SH3 domain of spectrin alpha CHAI; | 99.27 | |
| 1i1j_A | 108 | Melanoma derived growth regulatory protein; SH3 su | 99.26 | |
| 2vkn_A | 70 | Protein SSU81; membrane, SH3 domain, transmembrane | 99.26 | |
| 1x6b_A | 79 | RHO guanine exchange factor (GEF) 16; SH3 domain, | 99.26 | |
| 1awj_A | 77 | ITK; transferase, regulatory intramolecular comple | 99.26 | |
| 2v1r_A | 80 | Peroxisomal membrane protein PAS20; protein transp | 99.25 | |
| 2e5k_A | 94 | Suppressor of T-cell receptor signaling 1; SH3 dom | 99.25 | |
| 1u3o_A | 82 | Huntingtin-associated protein-interacting protein; | 99.25 | |
| 2m0y_A | 74 | Dedicator of cytokinesis protein 1; apoptosis; NMR | 99.25 | |
| 3reb_B | 90 | Tyrosine-protein kinase HCK; HIV-1 NEF, SH3 domain | 99.24 | |
| 1wxu_A | 93 | Peroxisomal biogenesis factor 13; SH3 domain, PEX1 | 99.24 | |
| 1jqq_A | 92 | PEX13P, peroxisomal membrane protein PAS20, PAS20P | 99.24 | |
| 2rqr_A | 119 | CED-12 homolog, engulfment and cell motility prote | 99.23 | |
| 1hsq_A | 71 | Phospholipase C-gamma (SH3 domain); phosphoric die | 99.23 | |
| 2kym_A | 120 | BUD emergence protein 1; SH3 domain, BEM1P, SH3-CI | 99.22 | |
| 3o5z_A | 90 | Phosphatidylinositol 3-kinase regulatory subunit; | 99.22 | |
| 3i5r_A | 83 | Phosphatidylinositol 3-kinase regulatory subunit a | 99.21 | |
| 1udl_A | 98 | Intersectin 2, KIAA1256; beta barrel, SH3 domain, | 99.2 | |
| 2yt6_A | 109 | Adult MALE urinary bladder cDNA, riken FULL- lengt | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.18 | |
| 1bb9_A | 115 | Amphiphysin 2; transferase, SH3 domain; 2.20A {Rat | 99.16 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 99.1 | |
| 1gcq_C | 70 | VAV proto-oncogene; SH3 domain, protein-protein co | 99.06 | |
| 1k1z_A | 78 | VAV; SH3, proto-oncogene, signaling protein; NMR { | 99.06 | |
| 3qwx_X | 174 | Cell death abnormality protein 2; cell engulfment, | 99.05 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 99.02 | |
| 1ng2_A | 193 | Neutrophil cytosolic factor 1; P47PHOX, autoinhibi | 99.0 | |
| 1gri_A | 217 | Growth factor bound protein 2; SH2, SH3, signal tr | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 3jv3_A | 283 | Intersectin-1; SH3 domain, DH domain, guanine nucl | 98.97 | |
| 1v1c_A | 71 | Obscurin; muscle, sarcomere, adapter, myogenesis, | 98.96 | |
| 3a98_A | 184 | DOCK2, dedicator of cytokinesis protein 2; protein | 98.95 | |
| 2dvj_A | 230 | V-CRK sarcoma virus CT10 oncogene homolog, isoform | 98.94 | |
| 1ng2_A | 193 | Neutrophil cytosolic factor 1; P47PHOX, autoinhibi | 98.93 | |
| 1g2b_A | 62 | Spectrin alpha chain; capping protein, calcium-bin | 98.93 | |
| 2dyb_A | 341 | Neutrophil cytosol factor 4; P40(PHOX), NADPH oxid | 98.87 | |
| 2de0_X | 526 | Alpha-(1,6)-fucosyltransferase; FUT8, glycosyltran | 98.84 | |
| 2eyz_A | 304 | V-CRK sarcoma virus CT10 oncogene homolog isoform | 98.84 | |
| 2eyz_A | 304 | V-CRK sarcoma virus CT10 oncogene homolog isoform | 98.81 | |
| 2pz1_A | 466 | RHO guanine nucleotide exchange factor 4; helical | 98.78 | |
| 1gri_A | 217 | Growth factor bound protein 2; SH2, SH3, signal tr | 98.78 | |
| 1tuc_A | 63 | Alpha-spectrin; capping protein, calcium-binding, | 98.77 | |
| 1ri9_A | 102 | FYN-binding protein; SH3-like, helically extended, | 98.77 | |
| 3qwy_A | 308 | Cell death abnormality protein 2; cell engulfment, | 98.74 | |
| 2jmc_A | 77 | Spectrin alpha chain, brain and P41 peptide chimer | 98.72 | |
| 1kjw_A | 295 | Postsynaptic density protein 95; protein-protein i | 98.71 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.7 | |
| 2lqn_A | 303 | CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT | 98.14 | |
| 3haj_A | 486 | Human pacsin2 F-BAR; pacsin,syndapin,FAP52,F-BAR, | 98.67 | |
| 2lqn_A | 303 | CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT | 98.11 | |
| 2gtj_A | 96 | FYN-binding protein; SH3, redox, signaling protein | 98.62 | |
| 3qwy_A | 308 | Cell death abnormality protein 2; cell engulfment, | 98.58 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.52 | |
| 4dey_A | 337 | Voltage-dependent L-type calcium channel subunit; | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.49 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.38 | |
| 1ug1_A | 92 | KIAA1010 protein; structural genomics, SH3 domain, | 98.36 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.24 | |
| 3pvl_A | 655 | Myosin VIIA isoform 1; protein complex, novel fold | 98.22 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 3tsz_A | 391 | Tight junction protein ZO-1; PDZ3-SH3-GUK, scaffol | 98.2 | |
| 3kfv_A | 308 | Tight junction protein ZO-3; structural genomics c | 98.17 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.17 | |
| 2xkx_A | 721 | Disks large homolog 4; structural protein, scaffol | 98.15 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.1 | |
| 3shw_A | 468 | Tight junction protein ZO-1; PDZ-SH3-GUK supramodu | 98.04 | |
| 3tvt_A | 292 | Disks large 1 tumor suppressor protein; DLG, SRC-h | 97.98 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 97.96 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.87 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 97.73 | |
| 3pe0_A | 283 | Plectin; cytoskeleton, plakin, spectrin repeat, SH | 97.53 | |
| 2dyb_A | 341 | Neutrophil cytosol factor 4; P40(PHOX), NADPH oxid | 97.5 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.48 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.44 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.43 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.42 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.31 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.06 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.03 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.97 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.87 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.78 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.71 | |
| 3r6n_A | 450 | Desmoplakin; spectrin repeat, SH3 domain, cell adh | 96.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.76 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.69 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.68 | |
| 2jmc_A | 77 | Spectrin alpha chain, brain and P41 peptide chimer | 91.94 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.52 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.68 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=469.91 Aligned_cols=257 Identities=38% Similarity=0.631 Sum_probs=228.7
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~ 182 (527)
+..+|+.+++++.+.||+|+||.||+|.+. ++.||||++.........+.|.+|+.++++++|||||+++|+|
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 456788999999999999999999999863 4679999998765555567899999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCc
Q psy6905 183 LQSPKLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSN 245 (527)
Q Consensus 183 ~~~~~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~N 245 (527)
.+++.+|||||||++|+|.++|.. ..+++..++.|+.||+.||+|||++ +||||||||+|
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~N 175 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRN 175 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccc
Confidence 999999999999999999999852 3488899999999999999999999 49999999999
Q ss_pred eecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCC
Q psy6905 246 VLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIP 320 (527)
Q Consensus 246 ILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~P 320 (527)
|||+.+ +.+||+|||+|+....... ....||+.|||||++.+..|+.++|||||||+||||+| |..|
T Consensus 176 ILl~~~--------~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~P 247 (308)
T 4gt4_A 176 VLVYDK--------LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247 (308)
T ss_dssp EEECGG--------GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eEECCC--------CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCC
Confidence 999975 6899999999987644322 24579999999999999999999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 321 YKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 321 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
|.+.+..++...+. .+..++.|..||+.+.+||.+||+.||.+||||.+|++.|+.+
T Consensus 248 f~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 248 YCGYSNQDVVEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCHHHHHHHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999888877775 4566789999999999999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-59 Score=465.68 Aligned_cols=259 Identities=36% Similarity=0.593 Sum_probs=221.4
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
..|||+++++.+.+.||+|+||+||+|.+++ .||||+++.. ......+.|.+|+.+|++++|||||+++|++.+ +.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 4599999999999999999999999999866 5999998754 344557889999999999999999999998865 568
Q ss_pred EEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 189 CLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
|||||||+||+|.++|. +..+++..++.|+.||+.||+|||++ +||||||||+||||+.+ +.+||+|
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~--------~~~Ki~D 175 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEG--------LTVKIGD 175 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETT--------EEEEECC
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCC--------CcEEEee
Confidence 99999999999999986 45799999999999999999999999 49999999999999875 6899999
Q ss_pred cCcchhhhcc----ccccCCCcccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 267 FGLAREVYKT----THMSAAGTYAWMAPEVIKT---SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 267 FGla~~~~~~----~~~~~~gt~~y~aPE~l~~---~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
||+|+..... .....+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.+.......+...+..
T Consensus 176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~ 255 (307)
T 3omv_A 176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA 255 (307)
T ss_dssp CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC
T ss_pred ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence 9999865432 1234579999999999964 45899999999999999999999999987766655555544443
Q ss_pred C----CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 340 L----PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 340 ~----~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
. ..+..||+.+.+||.+||+.||++|||+.+|++.|+.+.++
T Consensus 256 ~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 256 SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 3 34578999999999999999999999999999999877654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-58 Score=487.67 Aligned_cols=328 Identities=30% Similarity=0.568 Sum_probs=279.1
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc------c---c
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI------N---L 101 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~------~---~ 101 (527)
.+..++|+|||++++++||+|++||+|+|++++ .+++||.|+... |+.|+||+|||+....+ + .
T Consensus 10 ~~~~~~aly~~~~~~~~el~~~~gd~i~v~~~~----~~~~ww~~~~~~---g~~G~~P~~yv~~~~~~~~~~~~~~~~w 82 (450)
T 1k9a_A 10 SGTECIAKYNFHGTAEQDLPFCKGDVLTIVAVT----KDPNWYKAKNKV---GREGIIPANYVQKREGVKAGTKLSLMPW 82 (450)
T ss_dssp TTCEEEESSCBCCSSSSBCCBCTTCEEEEEEEC----SSTTEEEEECTT---CCEEEEEGGGEEECCCCCCCTTEESCTT
T ss_pred CCCEEEECCCcCccCCCcCCCCCCCEEEEeecc----CCCCceEEEECC---Cceeeechhccccccccccccccccccc
Confidence 456899999999999999999999999999973 377999999763 78999999999875432 0 0
Q ss_pred -----------------------eee------------------------------eec---------------------
Q psy6905 102 -----------------------VSS------------------------------VIN--------------------- 107 (527)
Q Consensus 102 -----------------------~~~------------------------------~~~--------------------- 107 (527)
++. .+.
T Consensus 83 yhg~i~r~~ae~~L~~~~~G~FlvR~S~~~~g~~~Lsv~~~~~v~H~~I~~~~~~~~i~~~~~F~sl~eLv~~y~~~~~~ 162 (450)
T 1k9a_A 83 FHGKITREQAERLLYPPETGLFLVRESTNYPGDYTLCVSCEGKVEHYRIMYHASKLSIDEEVYFENLMQLVEHYTTDADG 162 (450)
T ss_dssp BCTTCCHHHHHHHTCSCCTTEEEEEECSSSTTSEEEEEECSSSEEEEEEEEETTEEESSSSSCBSSHHHHHHHHHHCCTT
T ss_pred cccCcCHHHhhhhhccCCCceEEEEecCCCCCceEEEEEeCCeeeEEEEEecCCceEeccccccccHHHHHhhhcccccc
Confidence 000 000
Q ss_pred ----C-----------------ceeeEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHH
Q psy6905 108 ----D-----------------VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKL 166 (527)
Q Consensus 108 ----~-----------------~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~ 166 (527)
. ...|+++.++|++.+.||+|+||.||+|.++++.||||++.... ..+.+.+|+.+
T Consensus 163 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~ 239 (450)
T 1k9a_A 163 LCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASV 239 (450)
T ss_dssp SSSCCCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT---TSHHHHHHHHH
T ss_pred hhhhccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch---HHHHHHHHHHH
Confidence 0 12367889999999999999999999999999999999998654 24678899999
Q ss_pred HHhCCCCccceEEEEEEeCC-eEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q psy6905 167 LWLFDHRNIVSLIGVCLQSP-KLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLK 242 (527)
Q Consensus 167 l~~l~hpnIv~~~~~~~~~~-~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlk 242 (527)
|+.++||||+++++++.+.. .+|+|||||.+|+|.+++.. ..++...++.++.||+.||+|||+++ |||||||
T Consensus 240 l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlk 316 (450)
T 1k9a_A 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLA 316 (450)
T ss_dssp HHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred HHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCC
Confidence 99999999999999987765 79999999999999999872 23789999999999999999999994 9999999
Q ss_pred CCceecCCCCcccccccceeEEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCC
Q psy6905 243 SSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPY 321 (527)
Q Consensus 243 p~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf 321 (527)
|+|||++.+ +.+||+|||+++...... ....+++.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 317 p~Nill~~~--------~~~kl~DfG~a~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~ 387 (450)
T 1k9a_A 317 ARNVLVSED--------NVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387 (450)
T ss_dssp GGGEEECTT--------SCEEECCCTTCEECC-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred HhhEEECCC--------CCEEEeeCCCcccccccc-cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999875 689999999998553322 23367899999999999999999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 322 KSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 322 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.+.+..++...+. .+.+++.|..||+.+.+||..||..||.+|||+.+|++.|+.+...
T Consensus 388 ~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 388 PRIPLKDVVPRVE-KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TTSCTTTHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 9988777766654 4667888999999999999999999999999999999999887754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-59 Score=464.43 Aligned_cols=257 Identities=36% Similarity=0.639 Sum_probs=227.7
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
.+|++++|.+.+.||+|+||.||+|.+. +..||||+++.. .....+.|.+|+.+|++++|||||+++|+|.+
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 4688899999999999999999999863 467999999765 34457789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhcC--------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCC
Q psy6905 185 SPKLCLVMEYARGGPLNRVLAG--------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSE 250 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~~--------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~ 250 (527)
++.+|||||||+||+|.++|.. ..+++.+++.|+.||+.||.|||++ +||||||||+||||+.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGE 163 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECC
Confidence 9999999999999999999862 3689999999999999999999999 4999999999999987
Q ss_pred CCcccccccceeEEeccCcchhhhccccc----cCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q psy6905 251 PIENEDLQFKTLKITDFGLAREVYKTTHM----SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSIN 325 (527)
Q Consensus 251 ~~~~~~~~~~~vkL~DFGla~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~ 325 (527)
+ +.+||+|||+|+........ ...||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+
T Consensus 164 ~--------~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 164 N--------LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp G--------GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred C--------CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 5 68999999999876443222 2358999999999999999999999999999999999 999999999
Q ss_pred HHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 326 AYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 326 ~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
..++...+.. +..++.|..||+++.+||.+||+.||++|||+.+|...|+++...
T Consensus 236 ~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 236 NNEVIECITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 9888887765 455788999999999999999999999999999999999887653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=466.48 Aligned_cols=260 Identities=33% Similarity=0.595 Sum_probs=225.6
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~ 182 (527)
..+.|++++|.+.+.||+|+||.||+|.+. ++.||||++... .....+.|.+|+.+|++++|||||+++|+|
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 346788899999999999999999999864 467999999764 345578899999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHhcC----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCce
Q psy6905 183 LQSPKLCLVMEYARGGPLNRVLAG----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNV 246 (527)
Q Consensus 183 ~~~~~~~iv~Ey~~ggsL~~~l~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NI 246 (527)
.+.+.+|||||||++|+|.+++.. ..+++.+++.|+.||+.||+|||++ +||||||||+||
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NI 189 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNC 189 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhE
Confidence 999999999999999999999863 3488999999999999999999999 499999999999
Q ss_pred ecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCC
Q psy6905 247 LLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPY 321 (527)
Q Consensus 247 Ll~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf 321 (527)
||+.+ +.+||+|||+|+....... ....||+.|||||++.+..|+.++|||||||+||||+| |+.||
T Consensus 190 Ll~~~--------~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf 261 (329)
T 4aoj_A 190 LVGQG--------LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261 (329)
T ss_dssp EEETT--------TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EECCC--------CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCC
Confidence 99876 6999999999987643322 23569999999999999999999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 322 KSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 322 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
.+.+..++...+.. +.+++.|..||+++.+||.+||+.||++|||+.+|+++|+.+...+
T Consensus 262 ~~~~~~~~~~~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 262 YQLSNTEAIDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp CSSCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred CCCCHHHHHHHHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 99998888777764 5577889999999999999999999999999999999999887653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=471.33 Aligned_cols=262 Identities=31% Similarity=0.573 Sum_probs=231.6
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCC-CccceEEE
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFDH-RNIVSLIG 180 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~~~~ 180 (527)
.+.|||++++|++++.||+|+||.||+|.+.+ +.||||.+.........+.+.+|+.+|+++.| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 35699999999999999999999999998753 46999999887766667889999999999965 99999999
Q ss_pred EEEeC-CeEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q psy6905 181 VCLQS-PKLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLK 242 (527)
Q Consensus 181 ~~~~~-~~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlk 242 (527)
+|.+. ..+|||||||++|+|.++|+. ..+++..++.|+.||+.||+|||++ +|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence 99764 578999999999999999862 2478899999999999999999999 49999999
Q ss_pred CCceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-C
Q psy6905 243 SSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-G 317 (527)
Q Consensus 243 p~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g 317 (527)
|+|||++.+ +.+||+|||+|+.+..... ....||+.|||||++.+..|+.++|||||||+||||+| |
T Consensus 213 ~~NILl~~~--------~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 213 ARNILLSEK--------NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp GGGEEECGG--------GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred ccceeeCCC--------CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence 999999975 6899999999987644322 23468999999999999999999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 318 EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 318 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
+.||.+.+..+........+.+++.|..+|+++.+||..||+.||.+|||+.+|+++|++++..
T Consensus 285 ~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 285 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 9999998766666666666788899999999999999999999999999999999999887754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=486.72 Aligned_cols=328 Identities=31% Similarity=0.583 Sum_probs=278.7
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccccc---------
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDINL--------- 101 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~~--------- 101 (527)
.+.+|+|||||++++++||+|++||+|+|+++. .+++||.|+.. +..|+||+|||+....++.
T Consensus 42 ~~~~~~alyd~~~~~~~els~~~gd~~~v~~~~----~~~~w~~~~~~----~~~G~~P~~yv~~~~~le~~~wyhg~i~ 113 (495)
T 1opk_A 42 DPNLFVALYDFVASGDNTLSITKGEKLRVLGYN----HNGEWCEAQTK----NGQGWVPSNYITPVNSLEKHSWYHGPVS 113 (495)
T ss_dssp --CEEEESSCBCCCSTTBCCBCTTCEEEEEEEC----TTSSEEEEECS----SCEEEEEGGGEEESSSGGGSTTEEEECC
T ss_pred CCcEEEEeCCcCCCCCCCCCccCCCEEEEeecC----CCCCceeeeec----CCcceeccccccccccccchhhhccCCC
Confidence 346899999999999999999999999999874 36799999987 5679999999986532210
Q ss_pred -----------------eee-------------------------------------ee---------------------
Q psy6905 102 -----------------VSS-------------------------------------VI--------------------- 106 (527)
Q Consensus 102 -----------------~~~-------------------------------------~~--------------------- 106 (527)
++. .+
T Consensus 114 r~~ae~ll~~~~~G~fLvR~s~~~~~~~~lsv~~~~~v~h~~I~~~~~g~~~~~~~~~F~sl~eLv~~~~~~~~g~~~~l 193 (495)
T 1opk_A 114 RNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTL 193 (495)
T ss_dssp HHHHHHHGGGCCTTEEEEEECSSSTTCEEEEEEETTEEEEEECEECTTSCEESSTTSCBSSHHHHHHHHTTCCTTSSSCC
T ss_pred HHHHHHHhhCCCCceEEEEeCCCCCCceEEEEeeCCeEEEEEEEecCCCceEeccCccchhHHHHhhhhcccccccchhc
Confidence 000 00
Q ss_pred ----------------cCceeeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHH
Q psy6905 107 ----------------NDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLW 168 (527)
Q Consensus 107 ----------------~~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~ 168 (527)
.....|++...+|.+.+.||+|+||.||+|.+. +..||||++...... .+.+.+|+.+|+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~ 271 (495)
T 1opk_A 194 HYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMK 271 (495)
T ss_dssp CEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC--HHHHHHHHHHHH
T ss_pred cccccccccccccccCccccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc--hHHHHHHHHHHH
Confidence 001247888899999999999999999999985 678999998765432 567899999999
Q ss_pred hCCCCccceEEEEEEeCCeEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCc
Q psy6905 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSN 245 (527)
Q Consensus 169 ~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~N 245 (527)
.++||||++++++|.+...+|+|||||.+|+|.+++. ...+++..++.++.||+.||+|||++| ||||||||+|
T Consensus 272 ~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~N 348 (495)
T 1opk_A 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARN 348 (495)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred hcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhh
Confidence 9999999999999999999999999999999999986 345889999999999999999999995 9999999999
Q ss_pred eecCCCCcccccccceeEEeccCcchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCC
Q psy6905 246 VLLSEPIENEDLQFKTLKITDFGLAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPY 321 (527)
Q Consensus 246 ILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf 321 (527)
|||+.+ +.+||+|||+++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 349 Ill~~~--------~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~ 420 (495)
T 1opk_A 349 CLVGEN--------HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420 (495)
T ss_dssp EEECGG--------GCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred EEECCC--------CcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCC
Confidence 999875 6899999999987643322 23346789999999999899999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 322 KSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 322 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.+.+...+...+ ..+.+++.|..+|+.+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 421 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 421 PGIDLSQVYELL-EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 998877665544 4567788899999999999999999999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=479.42 Aligned_cols=327 Identities=31% Similarity=0.596 Sum_probs=278.0
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccccc----------
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDINL---------- 101 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~~---------- 101 (527)
..+++|+|||+++.++||+|++||+|.|+++ ++|||.|+.... |+.|+||+|||.....++.
T Consensus 8 ~~~~~al~~~~~~~~~el~~~~gd~~~v~~~------~~~W~~~~~~~~--g~~G~~P~~yv~~~~~le~~~W~~g~i~r 79 (454)
T 1qcf_A 8 RIIVVALYDYEAIHHEDLSFQKGDQMVVLEE------SGEWWKARSLAT--RKEGYIPSNYVARVDSLETEEWFFKGISR 79 (454)
T ss_dssp CCEEEESSCBCCCSTTBCCBCTTCEEEEEEC------CTTEEEEEETTT--CCEEEEEGGGEEETTCGGGSTTEETTCCH
T ss_pred CeEEEECcccCCcCCCcCcccCCCEEEEEec------CCCCeEEEECCC--CceEEecchhcccccccccccccccccch
Confidence 3589999999999999999999999999987 368999995221 7899999999985432210
Q ss_pred ------------------e---------------------eee-----e---c---------------------------
Q psy6905 102 ------------------V---------------------SSV-----I---N--------------------------- 107 (527)
Q Consensus 102 ------------------~---------------------~~~-----~---~--------------------------- 107 (527)
+ +.. + .
T Consensus 80 ~~ae~~L~~~~~~~G~FLvR~s~~~~g~y~lsv~~~~~~~~~~v~H~~I~~~~~g~~~i~~~~~F~sl~eLv~~y~~~~~ 159 (454)
T 1qcf_A 80 KDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGND 159 (454)
T ss_dssp HHHHHHHHSTTCCTTCEEEEECSSSTTSEEEEEEEEETTTEEEEEEEEEEECTTSCEESSSSSCBSSHHHHHHHHTSSCT
T ss_pred hhhhhhhhcCCCCCceEEEEECcCCCCeEEEEEEecccCCCCceEEEEEEEcCCCcEEEeCccccCCHHHHHHHHHhccC
Confidence 0 000 0 0
Q ss_pred -------------------CceeeEEeCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHH
Q psy6905 108 -------------------DVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLL 167 (527)
Q Consensus 108 -------------------~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l 167 (527)
....|+++.++|.+.+.||+|+||.||+|.++ +..||||++..... ..+.+.+|+.+|
T Consensus 160 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l 237 (454)
T 1qcf_A 160 GLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVM 237 (454)
T ss_dssp TSSSCCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHH
T ss_pred CccccccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc--cHHHHHHHHHHH
Confidence 01237888999999999999999999999985 56899999876532 257889999999
Q ss_pred HhCCCCccceEEEEEEeCCeEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q psy6905 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSS 244 (527)
Q Consensus 168 ~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~ 244 (527)
+.++||||+++++++. ...+|+|||||.+|+|.+++.. ..++...++.++.||+.||+|||+++ ||||||||+
T Consensus 238 ~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~ 313 (454)
T 1qcf_A 238 KTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAA 313 (454)
T ss_dssp TTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGG
T ss_pred hhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence 9999999999999986 5678999999999999999973 36889999999999999999999994 999999999
Q ss_pred ceecCCCCcccccccceeEEeccCcchhhhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCC
Q psy6905 245 NVLLSEPIENEDLQFKTLKITDFGLAREVYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIP 320 (527)
Q Consensus 245 NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~P 320 (527)
|||++.+ +.+||+|||+++...... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 314 Nill~~~--------~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P 385 (454)
T 1qcf_A 314 NILVSAS--------LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385 (454)
T ss_dssp GEEECTT--------CCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred HEEECCC--------CcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCC
Confidence 9999875 689999999998764322 223457889999999998999999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 321 YKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 321 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
|.+.+..++...+. .+.+++.|..+|+.+.+||.+||..||.+|||+.+|++.|+++...
T Consensus 386 ~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 386 YPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp STTCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 99998888777665 4567788999999999999999999999999999999999887654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=478.52 Aligned_cols=327 Identities=32% Similarity=0.570 Sum_probs=274.8
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccccc------------
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDINL------------ 101 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~~------------ 101 (527)
.++|+|||++++++||+|++||+|.|++++ ++|||.|+.... |+.|+||+|||+....++.
T Consensus 4 ~~~al~~~~~~~~~el~~~~gd~~~v~~~~-----~~~ww~~~~~~~--g~~G~~P~~yv~~~~~le~~~w~~g~~~r~~ 76 (452)
T 1fmk_A 4 TFVALYDYESRTETDLSFKKGERLQIVNNT-----EGDWWLAHSLST--GQTGYIPSNYVAPSDSIQAEEWYFGKITRRE 76 (452)
T ss_dssp EEEESSCBCCCSSSBCCBCTTCEEEESCCC-----SSSEEEEEETTT--CCEEEEEGGGEEETTSGGGSTTEEETCCHHH
T ss_pred EEEECCccCCCCCCCCCccCCCEEEEeccC-----CCCceEEEEcCC--CcccccCcccccccccccccccccCCccHHH
Confidence 689999999999999999999999999985 789999998311 7899999999986542210
Q ss_pred ------------------------------ee-------ee---------------------ec----------------
Q psy6905 102 ------------------------------VS-------SV---------------------IN---------------- 107 (527)
Q Consensus 102 ------------------------------~~-------~~---------------------~~---------------- 107 (527)
+. .. +.
T Consensus 77 ae~~L~~~~~~~G~FLvR~s~~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~~~~~~~~~F~Sl~~Li~~y~~~~~~l 156 (452)
T 1fmk_A 77 SERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGL 156 (452)
T ss_dssp HHHHHTCTTSCTTEEEEEECSSSTTCEEEEEEEEETTTEEEEEEEEEEECTTSCEESSTTSEESSHHHHHHHHTTCCTTS
T ss_pred HHHHhccCCCCCceEEEEeCCCCCCceEEEEEeeccCCCCcEEEEEEEEcCCCCEEEecCcccCCHHHHHHHhhhccccc
Confidence 00 00 00
Q ss_pred ------------------CceeeEEeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHH
Q psy6905 108 ------------------DVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLW 168 (527)
Q Consensus 108 ------------------~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~ 168 (527)
....|+++.++|.+.+.||+|+||.||+|.+.+ ..||||++...... .+.+.+|+.+|+
T Consensus 157 ~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~ 234 (452)
T 1fmk_A 157 CHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMK 234 (452)
T ss_dssp SSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHH
T ss_pred hhhccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC--HHHHHHHHHHHH
Confidence 012478889999999999999999999999865 57999999865422 467899999999
Q ss_pred hCCCCccceEEEEEEeCCeEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCc
Q psy6905 169 LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSN 245 (527)
Q Consensus 169 ~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~N 245 (527)
.++||||+++++++.+ ..+|+|||||.+|+|.+++. +..+++..++.++.||+.||+|||++| ||||||||+|
T Consensus 235 ~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~N 310 (452)
T 1fmk_A 235 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAAN 310 (452)
T ss_dssp HCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred hCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhh
Confidence 9999999999999876 67899999999999999997 356899999999999999999999994 9999999999
Q ss_pred eecCCCCcccccccceeEEeccCcchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCC
Q psy6905 246 VLLSEPIENEDLQFKTLKITDFGLAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPY 321 (527)
Q Consensus 246 ILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf 321 (527)
||++.+ +.+||+|||+++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 311 ill~~~--------~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~ 382 (452)
T 1fmk_A 311 ILVGEN--------LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382 (452)
T ss_dssp EEECGG--------GCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred EEECCC--------CCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCC
Confidence 999865 6899999999987643222 23457889999999999999999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 322 KSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 322 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
.+.+..+....+. .+.+++.|..+|+.+.+||.+||..||.+|||+.+|++.|+.+....
T Consensus 383 ~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 383 PGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp TTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 9998888777665 56678889999999999999999999999999999999999877543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-58 Score=462.64 Aligned_cols=247 Identities=26% Similarity=0.455 Sum_probs=215.3
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
.++|++++.||+|+||+||+|.+. ++.||||++.... .....+.+.+|+.+|+.|+|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999974 7899999987643 4455778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 193 EYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 193 Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||+||+|.+++. +..+++..++.|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~--------g~vKl~DFGl 171 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKD--------GTVQLGDFGI 171 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTT--------CCEEECSTTE
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCC--------CCEEEccccc
Confidence 9999999999985 235789999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCcc
Q psy6905 270 AREVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 270 a~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 347 (527)
|+...... ..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+....+ .+.+..+|
T Consensus 172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~~~~~~s 250 (350)
T 4b9d_A 172 ARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-PPVSLHYS 250 (350)
T ss_dssp ESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCCTTSC
T ss_pred ceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccCC
Confidence 98764432 2345799999999999999999999999999999999999999999999888888876554 36778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++.+||.+||..||.+|||+.+++++
T Consensus 251 ~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 251 YDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-58 Score=461.14 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=219.2
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.+.|++.+.||+|+||.||+|.+. |+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999984 689999998654322 24567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 194 YARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 194 y~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
||+||+|.+++.++.+++..+..|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+|+.+
T Consensus 152 y~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~--------g~vKl~DFGla~~~ 220 (346)
T 4fih_A 152 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHD--------GRVKLSDFGFCAQV 220 (346)
T ss_dssp CCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------CCEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCC--------CCEEEecCcCceec
Confidence 999999999999888999999999999999999999995 9999999999999876 78999999999877
Q ss_pred hcc--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCCCCCccHHH
Q psy6905 274 YKT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLF 350 (527)
Q Consensus 274 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~~ 350 (527)
... ...+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+....+..... ..+.+..+|+++
T Consensus 221 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 300 (346)
T 4fih_A 221 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 300 (346)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHH
T ss_pred CCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 443 23467899999999999999999999999999999999999999999988888777765322 334456789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+||.+||..||.+|||+.++++|
T Consensus 301 ~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 301 KGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-57 Score=484.34 Aligned_cols=327 Identities=32% Similarity=0.579 Sum_probs=278.8
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccccc-----------
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDINL----------- 101 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~~----------- 101 (527)
..++|||||++++++||+|++||+|.|++++ ++|||.|+.... |+.|+||+|||+....++.
T Consensus 86 ~~~~alyd~~~~~~~el~~~~gd~i~v~~~~-----~~~ww~~~~~~~--g~~G~~P~~yv~~~~~l~~~~wy~g~i~r~ 158 (535)
T 2h8h_A 86 TTFVALYDYESRTETDLSFKKGERLQIVNNT-----EGDWWLAHSLST--GQTGYIPSNYVAPSDSIQAEEWYFGKITRR 158 (535)
T ss_dssp -CEEESSCBCCCSSSBCCBCTTCEEEEEECS-----SSSEEEEEETTT--CCEEEEEGGGEEETTSGGGSTTBCCSCCHH
T ss_pred cEEEEccccCCcCCCcCCcCCCCEEEEEEec-----CCCceEEEECCC--CcceEecchhhcccccccccceeccccCHH
Confidence 4699999999999999999999999999985 789999998321 7899999999986432210
Q ss_pred -----------------eee-----------e-------------------------------ec---------------
Q psy6905 102 -----------------VSS-----------V-------------------------------IN--------------- 107 (527)
Q Consensus 102 -----------------~~~-----------~-------------------------------~~--------------- 107 (527)
++. + +.
T Consensus 159 ~ae~~L~~~~~~~G~FLvR~S~~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~~~i~~~~~F~SL~eLv~~y~~~~~~ 238 (535)
T 2h8h_A 159 ESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADG 238 (535)
T ss_dssp HHHHHHTCTTCCTTEEEEEECSSSTTCEEEEEEEEETTTEEEEEEEEEBC-CCSCEEEETTEEESSHHHHHHHHHHCCTT
T ss_pred HHHHHhccCCCCCCeEEEEecCCCCCcEEEEEEeeccCCCCceEEEEEEEcCCCcEEeeccccccChHHhheeeccccCc
Confidence 000 0 00
Q ss_pred -------------------CceeeEEeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHH
Q psy6905 108 -------------------DVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLL 167 (527)
Q Consensus 108 -------------------~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l 167 (527)
....|+|+.++|++.+.||+|+||.||+|.+.+ ..||||++...... .+.+.+|+.+|
T Consensus 239 ~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l 316 (535)
T 2h8h_A 239 LCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVM 316 (535)
T ss_dssp SSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHH
T ss_pred cccccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC--HHHHHHHHHHH
Confidence 012478889999999999999999999999865 57999999865422 46789999999
Q ss_pred HhCCCCccceEEEEEEeCCeEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q psy6905 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSS 244 (527)
Q Consensus 168 ~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~ 244 (527)
+.++||||+++++++.+ ..+|||||||.+|+|.+++. +..+++..++.|+.||+.||+|||+++ ||||||||+
T Consensus 317 ~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~ 392 (535)
T 2h8h_A 317 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAA 392 (535)
T ss_dssp HHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred HhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHh
Confidence 99999999999999876 67899999999999999997 256899999999999999999999994 999999999
Q ss_pred ceecCCCCcccccccceeEEeccCcchhhhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCC
Q psy6905 245 NVLLSEPIENEDLQFKTLKITDFGLAREVYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIP 320 (527)
Q Consensus 245 NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~P 320 (527)
||||+.+ +.+||+|||+++...... .....+++.|+|||++.+..++.++|||||||+||||++ |+.|
T Consensus 393 NIll~~~--------~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P 464 (535)
T 2h8h_A 393 NILVGEN--------LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464 (535)
T ss_dssp GEEECGG--------GCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCS
T ss_pred hEEEcCC--------CcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999865 689999999998764321 223457889999999999999999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 321 YKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 321 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
|.+....++...+. .+++++.|..|++.+.+||.+||..||++|||+.+|++.|+.+...
T Consensus 465 ~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 465 YPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp STTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 99998888777665 5667788999999999999999999999999999999999887654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=453.32 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=220.3
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
..++|++++.||+|+||+||+|.+ +++.||||++.... .....+.+.+|+.+|+.++|||||++++++.+++.+||
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 446899999999999999999997 46799999986431 12235678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||||+||+|.+++. .+.+++..+..|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~--------g~vKl~DFGl 178 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNED--------MHIQITDFGT 178 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------SCEEECCCTT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCC--------CCEEEEEcCC
Confidence 999999999999987 578999999999999999999999995 9999999999999875 7899999999
Q ss_pred chhhhcc----ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCC
Q psy6905 270 AREVYKT----THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST 345 (527)
Q Consensus 270 a~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 345 (527)
|+.+... ...+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+....+ .+|..
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--~~p~~ 256 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY--DFPEK 256 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTT
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCcc
Confidence 9876422 22356899999999999999999999999999999999999999999999888888876654 56788
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+|+++++||.+||..||.+|||+.+++.+
T Consensus 257 ~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 257 FFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp CCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred cCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 99999999999999999999999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=443.88 Aligned_cols=247 Identities=30% Similarity=0.471 Sum_probs=209.8
Q ss_pred eeeeeeeccCCceEEEEeeEc--CceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEe----CCeEEEE
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ----SPKLCLV 191 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----~~~~~iv 191 (527)
|++.+.||+|+||.||+|.+. +..||+|++... ......+.+.+|+.+|+.|+|||||+++++|.+ +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 478889999999999999985 578999988653 344456789999999999999999999999875 3568999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||||+||+|.+++. .+.+++..+..|+.||+.||+|||++++ +||||||||+||||+.. ++.+||+|||+|
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~-------~g~vKl~DFGla 179 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGP-------TGSVKIGDLGLA 179 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESST-------TSCEEECCTTGG
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECC-------CCCEEEEeCcCC
Confidence 99999999999997 5679999999999999999999999843 49999999999999752 268999999999
Q ss_pred hhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhCCccCCCCCCccHH
Q psy6905 271 REVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG-VAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 271 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~-i~~~~~~~~~p~~~~~~ 349 (527)
+........+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.+....... +.........+..++++
T Consensus 180 ~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (290)
T 3fpq_A 180 TLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp GGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred EeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHH
Confidence 8765555556789999999999875 599999999999999999999999987655444444 43333333456778899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+||.+||..||++|||+.++++|
T Consensus 259 ~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 259 VKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999873
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-57 Score=453.72 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=218.4
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
..+.|.+.++||+|+||.||+|.+. ++.||||++..... ..+|+.+++.++|||||++|+++.+++.+||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567899999999999999999984 68999999876432 236999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||+||+|.+++. .+.+++..+..|+.||+.||+|||++| ||||||||+||||+.+. ..+||+|||+|+
T Consensus 130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g-------~~vKl~DFGla~ 199 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDG-------SRAALCDFGHAL 199 (336)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTS-------CCEEECCCTTCE
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCC-------CEEEEeeCCCCe
Confidence 9999999999997 567999999999999999999999994 99999999999998751 269999999998
Q ss_pred hhhccc-------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC-CCC
Q psy6905 272 EVYKTT-------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL-PIP 343 (527)
Q Consensus 272 ~~~~~~-------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~-~~p 343 (527)
.+.... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+....... .+|
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 279 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP 279 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSC
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcC
Confidence 764321 123579999999999999999999999999999999999999999887777777776554432 467
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
..+|+.+.+||.+||..||.+|||+.+|+++|...+..
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 89999999999999999999999999999998876543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=463.80 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=220.8
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.+.|++.+.||+|+||.||+|.+. |+.||||++....... .+.+.+|+.+|+.++|||||++|++|.+++.+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 467999999999999999999984 6899999987653322 4568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 194 YARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 194 y~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
||+||+|.+++..+.+++..+..|+.||+.||+|||++| ||||||||+||||+.+ +.|||+|||+|+.+
T Consensus 229 y~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~--------g~vKl~DFGla~~~ 297 (423)
T 4fie_A 229 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHD--------GRVKLSDFGFCAQV 297 (423)
T ss_dssp CCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTT--------CCEEECCCTTCEEC
T ss_pred CCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCC--------CCEEEecCccceEC
Confidence 999999999999888999999999999999999999995 9999999999999876 78999999999876
Q ss_pred hcc--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCCCCCccHHH
Q psy6905 274 YKT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLF 350 (527)
Q Consensus 274 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~~ 350 (527)
... ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+..+.. .++.+..+|+++
T Consensus 298 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 377 (423)
T 4fie_A 298 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 377 (423)
T ss_dssp CSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHH
T ss_pred CCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHH
Confidence 433 23456899999999999999999999999999999999999999999988888777765432 345567899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++||.+||..||.+|||+.++++|
T Consensus 378 ~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 378 KGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=437.18 Aligned_cols=244 Identities=26% Similarity=0.433 Sum_probs=202.8
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|++.+.||+|+||+||+|.+ +++.||||++.... .......+.+|+.+++.++|||||++++++.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999987 47899999987542 2233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||| +|+|.+++. ++.+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~--------~~vkl~DFGla~ 160 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEH--------LNVKIADFGLSN 160 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTT--------CCEEECCSSCC-
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCC--------CCEEEeecCCCe
Confidence 999 678888775 778999999999999999999999995 9999999999999875 689999999998
Q ss_pred hhhccc-cccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 272 EVYKTT-HMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 272 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
...... ..+.+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+.......+.... .++|..+|++
T Consensus 161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~ 238 (275)
T 3hyh_A 161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--YTLPKFLSPG 238 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTSCHH
T ss_pred ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 764433 335689999999999998876 589999999999999999999999988888777776544 4567889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+||.+||..||++|||+.+++++
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHccCChhHCcCHHHHHcC
Confidence 9999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-57 Score=448.00 Aligned_cols=247 Identities=28% Similarity=0.427 Sum_probs=211.0
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE-----cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
++.++|++++.||+|+||+||+|.+ .++.||||++.... .......+.+|+.+|+.++|||||++++++.+++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 4568899999999999999999986 24689999986532 11113357789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|||||||+||+|.+++. .+.+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~--------g~vKl~D 169 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEE--------GHIKLTD 169 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTT--------SCEEEES
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCC--------CCEEecc
Confidence 999999999999999987 578999999999999999999999995 9999999999999876 7899999
Q ss_pred cCcchhhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 267 FGLAREVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 267 FGla~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
||+|+.... ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.... .+.|.
T Consensus 170 FGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~ 247 (304)
T 3ubd_A 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQ 247 (304)
T ss_dssp SEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCT
T ss_pred cccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCC
Confidence 999986533 23345789999999999999999999999999999999999999999999988888887654 46678
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSF-----KTILK 373 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~-----~~ll~ 373 (527)
.+|+++.+||.+||..||.+|||+ +++++
T Consensus 248 ~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 248 FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 899999999999999999999984 56654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=432.72 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=205.5
Q ss_pred CceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC----eEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP----KLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~----~~~iv~ 192 (527)
++|.+.+.||+|+||+||+|.++|+.||||++...... ......|+..+..++|||||+++|+|.+++ .+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 46889999999999999999999999999998654221 222335666667889999999999998754 589999
Q ss_pred eccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 193 EYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA-----PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 193 Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g-----~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|||+||+|.+++....+++..++.++.|++.||+|||+++ ..+||||||||+||||+.+ +.+||+||
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~--------~~~Ki~DF 152 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN--------GTCCIADL 152 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT--------SCEEECCC
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC--------CCEEEEeC
Confidence 9999999999999888999999999999999999999861 1259999999999999986 68999999
Q ss_pred Ccchhhhcccc------ccCCCccccccccccccC------CCCcccchHHHHHHHHHHHhCCCCCCC----------C-
Q psy6905 268 GLAREVYKTTH------MSAAGTYAWMAPEVIKTS------IFSKASDVWSYGVVLWELLTGEIPYKS----------I- 324 (527)
Q Consensus 268 Gla~~~~~~~~------~~~~gt~~y~aPE~l~~~------~~~~ksDvwSlGv~l~elltg~~Pf~~----------~- 324 (527)
|+|+....... ...+||+.|||||++.+. .++.++|||||||+||||+||..||.. .
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 99986643221 234799999999999764 367899999999999999999776532 1
Q ss_pred ----CHHHHHHHHHhCCccCCCCCC-----ccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 325 ----NAYAVAYGVAVNKLTLPIPST-----CPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 325 ----~~~~~~~~i~~~~~~~~~p~~-----~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
........+...+.+.++|.. ++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 123334444555666666643 456789999999999999999999999999887654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-54 Score=426.62 Aligned_cols=242 Identities=27% Similarity=0.401 Sum_probs=191.0
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC--------
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-------- 186 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-------- 186 (527)
++|++++.||+|+||+||+|.+. ++.||||++.....+...+.+.+|+.+|+.|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999974 68999999876666666778999999999999999999999987644
Q ss_pred ----eEEEEEeccCCCCHHHHhcCC-C---CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccc
Q psy6905 187 ----KLCLVMEYARGGPLNRVLAGR-K---IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258 (527)
Q Consensus 187 ----~~~iv~Ey~~ggsL~~~l~~~-~---~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~ 258 (527)
.+|||||||+||+|.+++... . .....++.|+.||+.||+|||++| ||||||||+||||+.+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~------- 154 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMD------- 154 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT-------
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCC-------
Confidence 379999999999999999743 2 334568899999999999999995 9999999999999876
Q ss_pred cceeEEeccCcchhhhccc--------------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q psy6905 259 FKTLKITDFGLAREVYKTT--------------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI 324 (527)
Q Consensus 259 ~~~vkL~DFGla~~~~~~~--------------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~ 324 (527)
+.+||+|||+|+...... ..+.+||+.|||||++.+..|+.++|||||||++|||++ ||.+.
T Consensus 155 -~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 155 -DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp -CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred -CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 689999999998764321 123479999999999999999999999999999999996 88654
Q ss_pred CHH-HHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 325 NAY-AVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 325 ~~~-~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
... .....+.. ....+.+...++.+.+||.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~-~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 231 MERVRTLTDVRN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHHHHT-TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cHHHHHHHHHhc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 322 22222221 1111222344567889999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=426.04 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=207.8
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe------CCe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ------SPK 187 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~------~~~ 187 (527)
++|++++.||+|+||+||+|.+ +|+.||||++.... .....+.+.+|+.+|+.|+|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999998 47899999987653 33446778899999999999999999999764 367
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|||||||+ |+|.+++. .+.+++..+..|+.||+.||.|||++| ||||||||+|||++.+ +.+||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~--------~~~Ki~D 201 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNEN--------CELKIGD 201 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT--------CCEEECC
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCC--------CCEEEee
Confidence 999999995 67888876 678999999999999999999999995 9999999999999976 7899999
Q ss_pred cCcchhhhc------cccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 267 FGLAREVYK------TTHMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 267 FGla~~~~~------~~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
||+|+.+.. ....+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+.......+......
T Consensus 202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~ 281 (398)
T 4b99_A 202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281 (398)
T ss_dssp CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999986532 122356899999999998875 5799999999999999999999999999887776665432111
Q ss_pred C------------------------CC-----CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 L------------------------PI-----PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ~------------------------~~-----p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. +. ...+++++.+||.+||..||.+|||+.++++|
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1 00 13468899999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=436.27 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=212.3
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC-----CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN-----PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~-----~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
+..++|.+++.||+|+||.||+|.+ +|+.||||++... ...........++.+++.++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 4467899999999999999999997 4689999998642 22222333445567777889999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.+|||||||+||+|.++|. .+.+++..+..|+.||+.||+|||++| ||||||||+||||+.+ +.|||+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~--------G~vKL~ 334 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEH--------GHVRIS 334 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTT--------SCEEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCC--------CCEEec
Confidence 9999999999999999987 578999999999999999999999995 9999999999999986 799999
Q ss_pred ccCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCccCC
Q psy6905 266 DFGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSIN---AYAVAYGVAVNKLTLP 341 (527)
Q Consensus 266 DFGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~ 341 (527)
|||+|+.+......+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+ .......+.. ....
T Consensus 335 DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~ 412 (689)
T 3v5w_A 335 DLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVE 412 (689)
T ss_dssp CCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCC
T ss_pred ccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCC
Confidence 999999876666667899999999999964 579999999999999999999999997643 3344444443 3446
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPS-----FKTILKA 374 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs-----~~~ll~~ 374 (527)
.|..+|+++++||.+||..||.+|++ +.+|++|
T Consensus 413 ~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 77889999999999999999999998 7888775
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=409.74 Aligned_cols=243 Identities=22% Similarity=0.357 Sum_probs=198.6
Q ss_pred CceeeeeeeccCCceEEEEeeEc-----CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~i 190 (527)
++|++.+.||+|+||+||+|.++ ++.||||.+..... ...+.+|+.+|+.+ +|||||++++++.+.+++||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 57999999999999999999863 46799998876543 34677899999988 69999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 191 VMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||||+||+|.+++. .+++.++..++.||+.||+|||++| ||||||||+|||++.+ .+.+||+|||+|
T Consensus 98 vmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~-------~~~~kl~DFGla 165 (361)
T 4f9c_A 98 AMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRR-------LKKYALVDFGLA 165 (361)
T ss_dssp EEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETT-------TTEEEECCCTTC
T ss_pred EEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCC-------CCeEEECcCCCC
Confidence 999999999999995 6999999999999999999999995 9999999999999864 268999999999
Q ss_pred hhhhccc------------------------------cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCC
Q psy6905 271 REVYKTT------------------------------HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEI 319 (527)
Q Consensus 271 ~~~~~~~------------------------------~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~ 319 (527)
+...... ..+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 7542211 1234799999999999875 58999999999999999999999
Q ss_pred CCCCC-CHHHHHHHHHh------------------------------------CC----------------ccCCCCCCc
Q psy6905 320 PYKSI-NAYAVAYGVAV------------------------------------NK----------------LTLPIPSTC 346 (527)
Q Consensus 320 Pf~~~-~~~~~~~~i~~------------------------------------~~----------------~~~~~p~~~ 346 (527)
||... +.......+.. .. ...+....+
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 99543 33333222210 00 001122457
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
|+++.+||.+||..||.+|||+.++++|
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 8899999999999999999999999873
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=436.13 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=220.4
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|++++.||+|+||.||+|.+ +|+.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.++..+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 6899999999999999999998 46899999987653 33357788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|+||+|.+++. .+.+++.++..++.||+.||+|||++| ||||||||+|||++.+. .+.+||+|||+|+.
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~------~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKR------SNELKLIDFGLTAH 306 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSS------CCCEEECCCSSCEE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCC------CCCEEEeeccceeE
Confidence 99999999885 457999999999999999999999995 99999999999998642 26899999999987
Q ss_pred hhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC--CCCCccHH
Q psy6905 273 VYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPSTCPQL 349 (527)
Q Consensus 273 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~ 349 (527)
+.... ....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+....+.++ .+..+|++
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 75433 2356899999999999999999999999999999999999999999999988888877665543 33678999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++||.+||..||.+|||+.++++|
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=387.87 Aligned_cols=266 Identities=64% Similarity=1.116 Sum_probs=225.0
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCCh---hHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDE---NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
.+++.++|.+.+.||+|+||.||+|.+.++.||||++...... ...+.+.+|+.+++.++||||+++++++.+++..
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CBCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred CccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 4678899999999999999999999999999999998764322 2256788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 189 CLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|+|||||++|+|.+++.++.+++..++.++.||+.||.|||++|..+|+||||||+|||++...++.+...+.+||+|||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999999999889999999999999999999999995334899999999999987544333345789999999
Q ss_pred cchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 269 LAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 269 la~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
+++...........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+.......+.|..+++
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (271)
T 3dtc_A 162 LAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE 241 (271)
T ss_dssp C-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCH
Confidence 99877655555678999999999999999999999999999999999999999999988888888888888889999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
.+.++|.+||+.||.+|||+.+++++|+.
T Consensus 242 ~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 242 PFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999999865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=393.43 Aligned_cols=265 Identities=35% Similarity=0.586 Sum_probs=225.7
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
...++++.++|.+.+.||+|+||.||+|.++++.||||++.... .....+.+.+|+.+++.++||||+++++++.+...
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34578899999999999999999999999999999999987654 34456788999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhcCCC----CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 188 LCLVMEYARGGPLNRVLAGRK----IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~~----~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
+|+|||||.+|+|.+++.... +++..++.++.||+.||.|||++|+ +|+||||||+|||++.+ +.+|
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~--------~~~k 179 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKK--------YTVK 179 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTT--------CCEE
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCC--------CcEE
Confidence 999999999999999997543 8999999999999999999999832 29999999999999875 6899
Q ss_pred EeccCcchhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 264 ITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 264 L~DFGla~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
|+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 180 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259 (309)
T ss_dssp ECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred ECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 99999997653322 2345799999999999999999999999999999999999999999988888777766677778
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
.|..+++.+.+||.+||..||.+|||+.++++.|+.+....
T Consensus 260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 89999999999999999999999999999999999887653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=396.65 Aligned_cols=259 Identities=34% Similarity=0.625 Sum_probs=227.3
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc---------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE---------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLI 179 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~ 179 (527)
..|++..++|.+++.||+|+||.||+|.+. +..||||++...........+.+|+.+++.+ +||||++++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 346788899999999999999999999863 2369999998776666678899999999999 899999999
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q psy6905 180 GVCLQSPKLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLK 242 (527)
Q Consensus 180 ~~~~~~~~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlk 242 (527)
+++.+.+.+|+|||||.+|+|.+++.. ..++...++.++.||+.||.|||++| |||||||
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlk 230 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA 230 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccc
Confidence 999999999999999999999999863 24788899999999999999999995 9999999
Q ss_pred CCceecCCCCcccccccceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-C
Q psy6905 243 SSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-G 317 (527)
Q Consensus 243 p~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g 317 (527)
|+||||+.+ +.+||+|||+++...... .....+|+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 231 p~NIll~~~--------~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g 302 (370)
T 2psq_A 231 ARNVLVTEN--------NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302 (370)
T ss_dssp GGGEEECTT--------CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred hhhEEECCC--------CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999875 689999999998664322 123457889999999999999999999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 318 EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 318 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
..||.+.+..+....+. .+...+.|..++..+.+||..||..||.+||++.++++.|+.++.
T Consensus 303 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 303 GSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp CCSSTTCCGGGHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 99999987776665554 455667888999999999999999999999999999999988764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=401.71 Aligned_cols=260 Identities=35% Similarity=0.640 Sum_probs=230.0
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
...|+++.++|.+.+.||+|+||.||+|.+. ++.||||++...........+.+|+.+++.++||||+++++++.+..
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 3468999999999999999999999999984 67899999987655555677889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.+|+|||||++|+|.+++. +..++...++.++.||+.||+|||++| |+||||||+|||++.+ +.+||
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~--------~~~kl 254 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEK--------NVLKI 254 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------CCEEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCC--------CcEEE
Confidence 9999999999999999987 346899999999999999999999995 9999999999999875 68999
Q ss_pred eccCcchhhhcccccc----CCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 265 TDFGLAREVYKTTHMS----AAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 265 ~DFGla~~~~~~~~~~----~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
+|||+++......... ..+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+. .+..
T Consensus 255 ~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~ 333 (377)
T 3cbl_A 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGR 333 (377)
T ss_dssp CCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCC
T ss_pred CcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 9999998654322221 235778999999998889999999999999999998 999999988877765554 4567
Q ss_pred CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 340 ~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
++.|..+|+.+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 78899999999999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=387.91 Aligned_cols=259 Identities=34% Similarity=0.574 Sum_probs=228.4
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc-----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
.++..++|.+.+.||+|+||.||+|.+. +..||||++.........+.+.+|+.+++.++||||+++++++.+..
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 5678899999999999999999999973 24599999987766666788999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.+|+|||||+||+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~--------~~~kl 192 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSN--------LVCKV 192 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------CCEEE
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCC--------CCEEE
Confidence 9999999999999999996 357999999999999999999999995 9999999999999875 68999
Q ss_pred eccCcchhhhccc-----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCc
Q psy6905 265 TDFGLAREVYKTT-----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 265 ~DFGla~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
+|||+++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+. ...
T Consensus 193 ~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~ 271 (325)
T 3kul_A 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGY 271 (325)
T ss_dssp CCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTC
T ss_pred CCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCC
Confidence 9999998664321 112346789999999998899999999999999999999 999999998888777665 356
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
..+.|..+++.+.+||..||..||.+|||+.++++.|+.+....
T Consensus 272 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 67888899999999999999999999999999999999887653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=384.13 Aligned_cols=247 Identities=28% Similarity=0.443 Sum_probs=219.4
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
..++|.+.+.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999997 57899999986542 444567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||||+||+|.+++. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~--------~~~kl~DFG~a 161 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDAD--------MNIKIADFGFS 161 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT--------SCEEECSTTCC
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCC--------CCEEEeeccCc
Confidence 99999999999886 678999999999999999999999995 9999999999999875 68999999999
Q ss_pred hhhhccc-cccCCCccccccccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 271 REVYKTT-HMSAAGTYAWMAPEVIKTSIFS-KASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 271 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~-~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
+...... ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+....+ ..|..+++
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~s~ 239 (328)
T 3fe3_A 162 NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--RIPFYMST 239 (328)
T ss_dssp GGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCH
T ss_pred eecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCH
Confidence 8764332 3356799999999999888765 899999999999999999999999998888877776554 56678999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.+||.+||..||.+|||+.+++++
T Consensus 240 ~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 240 DCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=381.25 Aligned_cols=248 Identities=30% Similarity=0.497 Sum_probs=217.3
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
...+|.+.+.||+|+||.||+|.+ +++.||||++....... .+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 346899999999999999999986 46789999886543222 466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 193 EYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 193 Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|||.||+|.+++....+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..
T Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~--------~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMD--------GSVKLTDFGFCAQ 165 (297)
T ss_dssp ECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------CCEEECCCTTCEE
T ss_pred ECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCC--------CCEEEeeCCCcee
Confidence 9999999999999888999999999999999999999995 9999999999999875 6899999999876
Q ss_pred hhcc--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CccCCCCCCccHH
Q psy6905 273 VYKT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLPIPSTCPQL 349 (527)
Q Consensus 273 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~ 349 (527)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ......|..+++.
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHH
T ss_pred cCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHH
Confidence 5432 223457999999999999999999999999999999999999999988877666555433 3345567789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+||.+||..||.+|||+.+++++
T Consensus 246 ~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 246 FRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHccCChhHCcCHHHHhhC
Confidence 9999999999999999999999873
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=371.60 Aligned_cols=258 Identities=33% Similarity=0.613 Sum_probs=226.7
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
..|.++.++|++.+.||+|+||.||+|.+ +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 35889999999999999999999999998 5678999998765432 35688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 189 CLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
|+|||||++|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~--------~~~kl~D 149 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGEN--------QVIKVSD 149 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGG--------GCEEECC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCC--------CCEEecc
Confidence 99999999999999996 345899999999999999999999995 9999999999999865 6899999
Q ss_pred cCcchhhhcc---ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 267 FGLAREVYKT---THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 267 FGla~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
||+++..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.. ......
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 228 (269)
T 4hcu_A 150 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYK 228 (269)
T ss_dssp TTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCC
T ss_pred ccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-CccCCC
Confidence 9999865332 2234457889999999999999999999999999999999 9999999888877766653 455677
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
|..+++.+.+++..||..||.+|||+.+++++|+.+..+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 888999999999999999999999999999999887754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=392.16 Aligned_cols=261 Identities=31% Similarity=0.583 Sum_probs=227.3
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEE
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIG 180 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~ 180 (527)
...|+++.++|.+.+.||+|+||.||+|.+. ++.||||++.........+.+.+|+.++..+ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 3468899999999999999999999999853 2679999998776666677899999999999 8999999999
Q ss_pred EEEeCC-eEEEEEeccCCCCHHHHhcCCC---------------------------------------------------
Q psy6905 181 VCLQSP-KLCLVMEYARGGPLNRVLAGRK--------------------------------------------------- 208 (527)
Q Consensus 181 ~~~~~~-~~~iv~Ey~~ggsL~~~l~~~~--------------------------------------------------- 208 (527)
++.+.+ .+++|||||.||+|.+++....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998754 4899999999999999987322
Q ss_pred ----------------CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 209 ----------------IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 209 ----------------~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
+++..++.++.||+.||.|||++| ||||||||+|||++.+ +.+||+|||+++.
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~--------~~~kl~Dfg~a~~ 242 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEK--------NVVKICDFGLARD 242 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG--------GCEEECCCGGGSC
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCC--------CcEEEEeccceee
Confidence 888899999999999999999995 9999999999999865 6899999999986
Q ss_pred hhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCcc
Q psy6905 273 VYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 273 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 347 (527)
..... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.................+.|..++
T Consensus 243 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (359)
T 3vhe_A 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 322 (359)
T ss_dssp TTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCC
T ss_pred ecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCC
Confidence 53322 223458899999999999999999999999999999998 9999998876666555555666778888999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
+.+.++|..||..||.+|||+.+++++|+.+..
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 999999999999999999999999999988764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=384.62 Aligned_cols=259 Identities=35% Similarity=0.613 Sum_probs=228.9
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCL 183 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~ 183 (527)
.+++..++|.+.+.||+|+||.||+|.+.+ +.||||++...........+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 367788999999999999999999999864 6899999987766666788999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHhcC-------------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceee
Q psy6905 184 QSPKLCLVMEYARGGPLNRVLAG-------------------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238 (527)
Q Consensus 184 ~~~~~~iv~Ey~~ggsL~~~l~~-------------------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiH 238 (527)
+.+.+|+|||||.+|+|.+++.. ..+++..++.++.||+.||.|||++| |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 99999999999999999999863 56889999999999999999999995 999
Q ss_pred cCCCCCceecCCCCcccccccceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHH
Q psy6905 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314 (527)
Q Consensus 239 rDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~el 314 (527)
|||||+|||++.+ +.+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 198 ~Dlkp~NIl~~~~--------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 269 (343)
T 1luf_A 198 RDLATRNCLVGEN--------MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269 (343)
T ss_dssp SCCSGGGEEECGG--------GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCcceEEECCC--------CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHH
Confidence 9999999999875 689999999998764322 1234688999999999998999999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 315 LT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 315 lt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
++ |..||.+.+..+....+.. +...+.|..+|+.+.+||..||..||.+|||+.++++.|+++...
T Consensus 270 ~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 270 FSYGLQPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HhcCCCcCCCCChHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 99 9999999888877766654 344567889999999999999999999999999999999887653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=390.22 Aligned_cols=265 Identities=34% Similarity=0.623 Sum_probs=233.1
Q ss_pred CceeeEEeCCceeeeeeeccCCceEEEEeeEcC---------ceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccce
Q psy6905 108 DVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK---------QEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVS 177 (527)
Q Consensus 108 ~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~---------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~ 177 (527)
....|++..++|.+.+.||+|+||.||+|.+.+ ..||||++...........+.+|+.+++.+ +||||++
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 345688999999999999999999999998632 469999998877666678899999999999 9999999
Q ss_pred EEEEEEeCCeEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecC
Q psy6905 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240 (527)
Q Consensus 178 ~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrD 240 (527)
+++++.+.+.+|+|||||.+|+|.+++.. ..+++..++.++.||+.||.|||++| |||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 216 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 216 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 99999999999999999999999999863 24899999999999999999999995 99999
Q ss_pred CCCCceecCCCCcccccccceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh
Q psy6905 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT 316 (527)
Q Consensus 241 lkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt 316 (527)
|||+||||+.+ +.+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 217 lkp~NIll~~~--------~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 288 (382)
T 3tt0_A 217 LAARNVLVTED--------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288 (382)
T ss_dssp CCGGGEEECTT--------CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCcceEEEcCC--------CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHh
Confidence 99999999875 689999999998664322 223457899999999999999999999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcccc
Q psy6905 317 -GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384 (527)
Q Consensus 317 -g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~~ 384 (527)
|..||.+.+..+....+. .+.....|..+++++.+||..||..||.+|||+.+++++|+.+......
T Consensus 289 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 289 LGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp TSCCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred CCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 999999988777665554 4556677889999999999999999999999999999999998865443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=387.32 Aligned_cols=260 Identities=34% Similarity=0.589 Sum_probs=224.5
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVC 182 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~ 182 (527)
.|+++.++|.+.+.||+|+||.||+|.+. +..||||++.........+.+.+|+.+++.+ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 48899999999999999999999999862 3479999998655444567889999999999 999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHhcCC------------------------CCChhHHHHHHHHHHHHHHHHHhcCCCceee
Q psy6905 183 LQSPKLCLVMEYARGGPLNRVLAGR------------------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238 (527)
Q Consensus 183 ~~~~~~~iv~Ey~~ggsL~~~l~~~------------------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiH 238 (527)
...+.+|+|||||++|+|.+++... .+++..++.++.||+.||.|||++| |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 9999999999999999999998732 2788899999999999999999995 999
Q ss_pred cCCCCCceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHH
Q psy6905 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314 (527)
Q Consensus 239 rDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~el 314 (527)
|||||+|||++.+ +.+||+|||++........ ....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 196 ~Dikp~NIll~~~--------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 267 (344)
T 1rjb_A 196 RDLAARNVLVTHG--------KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267 (344)
T ss_dssp TTCSGGGEEEETT--------TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCCChhhEEEcCC--------CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHH
Confidence 9999999999875 6899999999986643322 233478899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 315 LT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 315 lt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
++ |..||.+.+...........+...+.|..+++.+.+||..||..||.+|||+.+++++|+.+...
T Consensus 268 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 268 FSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 98 99999988766666666667777788899999999999999999999999999999999877653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=389.13 Aligned_cols=264 Identities=32% Similarity=0.539 Sum_probs=229.1
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~ 182 (527)
..+++..++|.+.+.||+|+||.||+|.+. +..||||++...........+.+|+.+++.++||||+++++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 346788899999999999999999999853 3579999998766666677889999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHhcC--------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcc
Q psy6905 183 LQSPKLCLVMEYARGGPLNRVLAG--------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254 (527)
Q Consensus 183 ~~~~~~~iv~Ey~~ggsL~~~l~~--------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~ 254 (527)
.+....|+|||||.||+|.+++.. ..++...++.++.||+.||.|||++| ||||||||+|||++.+..
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~- 219 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGP- 219 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSST-
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCC-
Confidence 999999999999999999999862 34889999999999999999999995 999999999999986421
Q ss_pred cccccceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy6905 255 EDLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAV 329 (527)
Q Consensus 255 ~~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~ 329 (527)
...+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+....
T Consensus 220 ----~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~ 295 (367)
T 3l9p_A 220 ----GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295 (367)
T ss_dssp ----TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ----CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 2469999999998664322 223457899999999999999999999999999999998 9999999888877
Q ss_pred HHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 330 ~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
...+.. +...+.|..++..+.+||..||+.||.+|||+.+++++|+.+....
T Consensus 296 ~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 296 LEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHHc-CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 766654 4456778889999999999999999999999999999998876643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=370.76 Aligned_cols=258 Identities=26% Similarity=0.497 Sum_probs=227.1
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--Ce
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS--PK 187 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~--~~ 187 (527)
.++++.++|.+.+.||+|+||.||+|.++++.||||++.... .....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 457888999999999999999999999999999999987653 444567899999999999999999999999876 78
Q ss_pred EEEEEeccCCCCHHHHhcCC---CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 188 LCLVMEYARGGPLNRVLAGR---KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~---~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.++|||||++|+|.+++... .+++..++.++.||+.||.|||++++ .++||||||+|||++.+ +.++|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~--------~~~~l 154 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDED--------MTARI 154 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTT--------SCEEE
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCC--------cceeE
Confidence 89999999999999999843 48999999999999999999999832 39999999999999875 57889
Q ss_pred eccCcchhhhccccccCCCccccccccccccCCCC---cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 265 TDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFS---KASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 265 ~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
+|||++.... .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+........
T Consensus 155 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (271)
T 3kmu_A 155 SMADVKFSFQ---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT 231 (271)
T ss_dssp EGGGSCCTTS---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred Eeccceeeec---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC
Confidence 8888765432 2345689999999999876544 489999999999999999999999998888888887888888
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.|..+++.+.++|..||+.||.+|||+.++++.|+.+..
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 899999999999999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=373.03 Aligned_cols=258 Identities=34% Similarity=0.614 Sum_probs=215.1
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc-----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
..+++..++|++.+.||+|+||.||+|.+. +..||+|+..........+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 347888999999999999999999999873 24699999887666666788999999999999999999999985
Q ss_pred CCeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
++..|+|||||.+|+|.+++. +..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~--------~~~ 155 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSN--------DCV 155 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET--------TEE
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCC--------CCE
Confidence 456899999999999999987 346899999999999999999999995 9999999999999865 689
Q ss_pred EEeccCcchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCc
Q psy6905 263 KITDFGLAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 263 kL~DFGla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
||+|||+++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.. ..
T Consensus 156 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~-~~ 234 (281)
T 1mp8_A 156 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GE 234 (281)
T ss_dssp EECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TC
T ss_pred EECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc-CC
Confidence 9999999987643322 23357789999999999999999999999999999997 9999998877766666553 44
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
..+.|..+|+.+.++|..||..||.+|||+.++++.|+.+..
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 567888999999999999999999999999999999987764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=370.24 Aligned_cols=258 Identities=30% Similarity=0.584 Sum_probs=225.0
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
..|+++.++|++.+.||+|+||.||+|.+.+ ..||||++...... .+.+.+|+.+++.++||||+++++++.+...+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 4688999999999999999999999999865 58999998865432 35688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 189 CLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
|+|||||.+|+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~--------~~~kl~D 163 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQ--------GVVKVSD 163 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTT--------SCEEECS
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCC--------CCEEEcc
Confidence 999999999999999874 67999999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 267 FGLAREVYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 267 FGla~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
||+++...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+.......+. .......
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~ 242 (283)
T 3gen_A 164 FGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYR 242 (283)
T ss_dssp TTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCC
T ss_pred ccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCC
Confidence 99998653322 223457889999999998899999999999999999998 999999988877776665 3455667
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
|..+++.+.++|..||+.||.+|||+.+++++|.++...
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 888999999999999999999999999999999887653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=376.28 Aligned_cols=260 Identities=34% Similarity=0.602 Sum_probs=227.6
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~ 182 (527)
..|++..++|.+.+.||+|+||.||+|.+. +..||||++.........+.+.+|+.+++.++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 357888999999999999999999999862 2679999998776666678899999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHhcCC-------------------------CCChhHHHHHHHHHHHHHHHHHhcCCCcee
Q psy6905 183 LQSPKLCLVMEYARGGPLNRVLAGR-------------------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLI 237 (527)
Q Consensus 183 ~~~~~~~iv~Ey~~ggsL~~~l~~~-------------------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~ii 237 (527)
.+.+..|+|||||.+|+|.+++... .+++..++.++.||+.||.|||++| |+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 9999999999999999999998631 2788899999999999999999995 99
Q ss_pred ecCCCCCceecCCCCcccccccceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHH
Q psy6905 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWE 313 (527)
Q Consensus 238 HrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~e 313 (527)
||||||+|||++.+ +.+||+|||+++...... .....+|+.|+|||++.+..++.++|||||||++|+
T Consensus 173 H~dikp~NIli~~~--------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 244 (314)
T 2ivs_A 173 HRDLAARNILVAEG--------RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244 (314)
T ss_dssp CCCCSGGGEEEETT--------TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred ccccchheEEEcCC--------CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHH
Confidence 99999999999875 689999999997653322 223457889999999999889999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 314 LLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 314 llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
|++ |..||.+.+.......+. .....+.|..+++.+.++|.+||..||.+|||+.+++++|+.+...
T Consensus 245 l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 245 IVTLGGNPYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHhCCCCCCCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 999 999999887766655544 4455677889999999999999999999999999999999887653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=378.23 Aligned_cols=262 Identities=33% Similarity=0.605 Sum_probs=229.7
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeE-------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEE
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIG 180 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~ 180 (527)
...|+++.++|.+.+.||+|+||.||+|.+ .++.||||++.........+.+.+|+.+++.+ +||||+++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 345889999999999999999999999985 23689999998776656678899999999999 9999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHhcCC-------------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCC
Q psy6905 181 VCLQSPKLCLVMEYARGGPLNRVLAGR-------------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDL 241 (527)
Q Consensus 181 ~~~~~~~~~iv~Ey~~ggsL~~~l~~~-------------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDl 241 (527)
++.+.+..++|||||++|+|.+++... .+++..++.++.||+.||.|||++| |+||||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 171 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDL 171 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 999999999999999999999998632 3889999999999999999999995 999999
Q ss_pred CCCceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-
Q psy6905 242 KSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT- 316 (527)
Q Consensus 242 kp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt- 316 (527)
||+|||++.+ +.+||+|||+++....... ....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 172 kp~Nil~~~~--------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 243 (313)
T 1t46_A 172 AARNILLTHG--------RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243 (313)
T ss_dssp SGGGEEEETT--------TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccceEEEcCC--------CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 9999999875 6899999999987644322 13347789999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 317 GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 317 g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
|..||.+...................+..+++.+.++|.+||..||.+|||+.++++.|+++...
T Consensus 244 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp TCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 99999988766655555555666677888999999999999999999999999999999887754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=382.19 Aligned_cols=248 Identities=26% Similarity=0.442 Sum_probs=217.4
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+..++|++++.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45678999999999999999999974 6789999986431 1122467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+|||||+||+|..++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~--------g~vkL~DFG 150 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKD--------GHIKITDFG 150 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT--------SCEEECCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCC--------CCEEEeecc
Confidence 9999999999998887 567999999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 269 LAREVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 269 la~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
+++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.... ...|..+
T Consensus 151 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~ 228 (337)
T 1o6l_A 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTL 228 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTS
T ss_pred chhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCC
Confidence 9986422 22335679999999999999999999999999999999999999999988887777776544 3567789
Q ss_pred cHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RP-----s~~~ll~~ 374 (527)
++++.+||.+||..||.+|| ++.+++++
T Consensus 229 s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 99999999999999999999 89998874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=387.72 Aligned_cols=259 Identities=34% Similarity=0.596 Sum_probs=218.0
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc-----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
.+++..+|.+.+.||+|+||.||+|.+. +..||||++.........+.+.+|+.+++.++||||+++++++.+..
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 4678889999999999999999999864 45799999987766666788999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.+|+|||||++|+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~--------~~~kl 188 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSN--------LVCKV 188 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT--------CCEEE
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCC--------CCEEE
Confidence 99999999999999999974 46899999999999999999999995 9999999999999875 68999
Q ss_pred eccCcchhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCc
Q psy6905 265 TDFGLAREVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 265 ~DFGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
+|||+++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.......+. .+.
T Consensus 189 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~ 267 (373)
T 2qol_A 189 SDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGY 267 (373)
T ss_dssp CCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTE
T ss_pred CcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCC
Confidence 99999987643221 12235788999999999999999999999999999998 999999988877766654 456
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
..+.+..++..+.+||..||..||.+||++.++++.|+.+....
T Consensus 268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 67788899999999999999999999999999999999887643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=384.11 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=217.3
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh-----hHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE-----NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+.|.+++.||+|+||.||+|.+. ++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 56999999999999999999984 678999988754321 12567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+|||||.||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+... ...+||+|||
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~----~~~vkl~DFG 164 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIP----IPHIKLIDFG 164 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSS----SCCEEECCCS
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCC----ccCEEEEecC
Confidence 9999999999999987 567999999999999999999999995 9999999999999865210 1279999999
Q ss_pred cchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC--CCCC
Q psy6905 269 LAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPST 345 (527)
Q Consensus 269 la~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~ 345 (527)
+++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....+.++ .+..
T Consensus 165 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (361)
T 2yab_A 165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244 (361)
T ss_dssp SCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred CceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence 998764432 3356799999999999999999999999999999999999999999988888877776555443 2367
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++.+.+||..||..||.+|||+.+++++
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 89999999999999999999999999873
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=382.51 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=219.5
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|.+.+.||+|+||.||+|.+. ++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 57999999999999999999984 6799999987643 34446778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||.||+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+.. .+.+||+|||++..
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~-----~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAK-----GAAVKLADFGLAIE 180 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSST-----TCCEEECCCTTCBC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCC-----CCCEEEeecCcceE
Confidence 999999988876 567899999999999999999999995 999999999999987532 24699999999987
Q ss_pred hhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCccHH
Q psy6905 273 VYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQL 349 (527)
Q Consensus 273 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~ 349 (527)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....+.++.+ ..++++
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 260 (362)
T 2bdw_A 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 260 (362)
T ss_dssp CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 65432 234679999999999999899999999999999999999999999998888888777766655544 467999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+||.+||..||.+||++.+++++
T Consensus 261 ~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 261 AKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=372.55 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=213.0
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-------------------------hhHHHHHHHHHHH
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-------------------------ENILENVKQEGKL 166 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-------------------------~~~~~~~~~e~~~ 166 (527)
+..++|.+.+.||+|+||.||+|.+ +++.||||++..... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3457899999999999999999987 467899999865421 1123568899999
Q ss_pred HHhCCCCccceEEEEEEe--CCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q psy6905 167 LWLFDHRNIVSLIGVCLQ--SPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSS 244 (527)
Q Consensus 167 l~~l~hpnIv~~~~~~~~--~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~ 244 (527)
++.++||||+++++++.+ ...+|+|||||++|+|.+++..+.+++..+..++.||+.||.|||++| |+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 999999999999999987 568999999999999999888888999999999999999999999995 999999999
Q ss_pred ceecCCCCcccccccceeEEeccCcchhhhccc--cccCCCccccccccccccCC---CCcccchHHHHHHHHHHHhCCC
Q psy6905 245 NVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSI---FSKASDVWSYGVVLWELLTGEI 319 (527)
Q Consensus 245 NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~--~~~~~gt~~y~aPE~l~~~~---~~~ksDvwSlGv~l~elltg~~ 319 (527)
|||++.+ +.+||+|||+++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus 167 Nil~~~~--------~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 167 NLLVGED--------GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GEEECTT--------SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HEEECCC--------CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999875 689999999998664322 23457999999999998765 3789999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 320 PYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 320 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
||.+.+.......+.......+.+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 239 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 239 PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 9999887777777766666666667899999999999999999999999999763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=376.90 Aligned_cols=258 Identities=30% Similarity=0.500 Sum_probs=216.9
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+.+..++|.+++.||+|+||.||+|.+. +..||+|++... +....+.+.+|+.+++.++||||+++++++.++...|
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4567889999999999999999999984 678999988654 3455788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+|||||.+|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~--------~~~kl~Df 152 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVREN--------KNVVVADF 152 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTT--------SCEEECCC
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCC--------CCEEEeec
Confidence 9999999999999997 467999999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhcccc----------------ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy6905 268 GLAREVYKTTH----------------MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY 331 (527)
Q Consensus 268 Gla~~~~~~~~----------------~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~ 331 (527)
|+++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~ 232 (310)
T 3s95_A 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232 (310)
T ss_dssp TTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred ccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence 99976532211 14569999999999999999999999999999999999999987643211100
Q ss_pred HH-HhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 332 GV-AVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 332 ~i-~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.. .........|..+|+.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 000111235678899999999999999999999999999999877654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=365.68 Aligned_cols=255 Identities=27% Similarity=0.559 Sum_probs=224.1
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
+++..++|++.+.||+|+||.||+|.+.+ ..||+|++...... ...+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 56788999999999999999999998865 47999998765432 3568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 191 VMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|||||++|+|.+++. +..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~--------~~~~l~Dfg 149 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRD--------LCVKVSDFG 149 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTT--------CCEEECCTT
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCC--------CCEEEccCc
Confidence 999999999999987 346999999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 269 LAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 269 la~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
++........ ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+.. ......|.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 228 (268)
T 3sxs_A 150 MTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-GHRLYRPH 228 (268)
T ss_dssp CEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCCT
T ss_pred cceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc-CCCCCCCC
Confidence 9976543322 23456788999999998889999999999999999999 9999999888777766653 44556778
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.+++.+.+++..||+.||.+|||+.+++++|+.+..
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 899999999999999999999999999999987754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=390.44 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=218.7
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|.+.+.||+|+||.||+|.+ +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 5799999999999999999987 468899999876542 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||.||+|.+.+. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+.. .+.+||+|||+++.
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~-----~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLK-----GAAVKLADFGLAIE 162 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSST-----TCCEEECCCSSCBC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCC-----CCcEEEccCceeEE
Confidence 999999988776 677999999999999999999999995 999999999999985421 26899999999977
Q ss_pred hhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCccH
Q psy6905 273 VYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQ 348 (527)
Q Consensus 273 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~ 348 (527)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....+.++.+ ..+++
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 64332 235679999999999999999999999999999999999999999999888888888776665554 47899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.+||.+||..||.+|||+.+++++
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999999999984
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=377.27 Aligned_cols=262 Identities=34% Similarity=0.620 Sum_probs=229.3
Q ss_pred CceeeEEeCCceeeeeeeccCCceEEEEeeEc---------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccce
Q psy6905 108 DVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE---------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVS 177 (527)
Q Consensus 108 ~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~ 177 (527)
....|+++.++|.+.+.||+|+||.||+|.+. +..||||++...........+.+|+.+++.+ +||||++
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 34568899999999999999999999999863 3579999998776666678899999999999 9999999
Q ss_pred EEEEEEeCCeEEEEEeccCCCCHHHHhcCC-----------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecC
Q psy6905 178 LIGVCLQSPKLCLVMEYARGGPLNRVLAGR-----------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRD 240 (527)
Q Consensus 178 ~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~~-----------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrD 240 (527)
+++++.+.+.+|+|||||.+|+|.+++... .+++..++.++.||+.||.|||++| |+|||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 182 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRD 182 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 999999999999999999999999998733 3788999999999999999999995 99999
Q ss_pred CCCCceecCCCCcccccccceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh
Q psy6905 241 LKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT 316 (527)
Q Consensus 241 lkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt 316 (527)
|||+|||++.+ +.+||+|||+++...... .....+|+.|+|||++.+..++.++|||||||++|+|++
T Consensus 183 lkp~NIll~~~--------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 254 (334)
T 2pvf_A 183 LAARNVLVTEN--------NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254 (334)
T ss_dssp CSGGGEEECTT--------CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred CccceEEEcCC--------CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHh
Confidence 99999999875 689999999998664322 223457889999999998889999999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 317 -GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 317 -g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
|..||.+.+..+....+.. +...+.|..++..+.++|..||..||.+|||+.++++.|+.+...
T Consensus 255 ~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 255 LGGSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp TSCCSSTTCCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcCcCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999887776655543 445667888999999999999999999999999999999887653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=375.05 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=217.0
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|.+.+.||+|+||.||+|.+. ++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 468999999999999999999984 6789999987543 335668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||+||+|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.+. .+.+||+|||+++
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~------~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRR------SSTIKIIEFGQAR 152 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSS------CCCEEECCCTTCE
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCC------CCCEEEEECCCCe
Confidence 9999999999974 46999999999999999999999995 99999999999998631 2689999999998
Q ss_pred hhhcccc-ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC--CCCccH
Q psy6905 272 EVYKTTH-MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI--PSTCPQ 348 (527)
Q Consensus 272 ~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~ 348 (527)
....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......++. ...+|+
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 7643322 3456899999999999988999999999999999999999999999888888777766554432 257899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.+||.+||..||.+|||+.+++++
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999999984
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=362.89 Aligned_cols=257 Identities=33% Similarity=0.614 Sum_probs=225.7
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
.|.++.++|++.+.||+|+||.||+|.+ ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 4788999999999999999999999998 4568999998865432 367889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+||||+++|+|.+++. ...+++..++.++.||+.||.|||++| ++||||||+|||++.+ +.+||+||
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~--------~~~kl~df 148 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGEN--------QVIKVSDF 148 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGG--------GCEEECCT
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCC--------CCEEEccc
Confidence 9999999999999987 356899999999999999999999995 9999999999999865 68999999
Q ss_pred Ccchhhhcc---ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 268 GLAREVYKT---THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 268 Gla~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|++...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+.. +.....|
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~ 227 (267)
T 3t9t_A 149 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKP 227 (267)
T ss_dssp TGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCC
T ss_pred ccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-CCcCCCC
Confidence 999865332 1223457889999999998899999999999999999999 9999999887777666653 4556677
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
..++..+.+++.+||..||.+|||+.++++.|+.+..+
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 88999999999999999999999999999999887754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=368.31 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=218.5
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCC--CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
-.++|++.+.||+|+||.||+|.+. +..||+|++... ......+.+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4578999999999999999999874 678999987543 344556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||||+||+|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~--------~~~kl~Dfg~ 157 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSN--------KTLKIFDFGI 157 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------SCEEECCCSS
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC--------CCEEEEeCCC
Confidence 999999999999987 567999999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc---CCCC
Q psy6905 270 AREVYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT---LPIP 343 (527)
Q Consensus 270 a~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~---~~~p 343 (527)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.............. ...+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237 (294)
T ss_dssp STTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSC
T ss_pred ccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcc
Confidence 98764322 22346999999999999999999999999999999999999999998877766555543322 1245
Q ss_pred CCccHHHHHHHHHhhhhCCCCCC-CHHHHHHHHhhhhhcc
Q psy6905 344 STCPQLFKTLMEACWEADSHMRP-SFKTILKALNNIVHSE 382 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RP-s~~~ll~~L~~~~~~~ 382 (527)
..+|+.+.++|.+||..||.+|| ++.++.+.|..+....
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 67899999999999999999999 8999999998877654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=377.88 Aligned_cols=260 Identities=32% Similarity=0.587 Sum_probs=227.7
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGV 181 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~ 181 (527)
..|+++.++|.+.+.||+|+||.||+|.+.+ ..||+|++...........+.+|+.+++.+ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3588999999999999999999999998743 369999998776666678899999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHhc---------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCce
Q psy6905 182 CLQSPKLCLVMEYARGGPLNRVLA---------------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNV 246 (527)
Q Consensus 182 ~~~~~~~~iv~Ey~~ggsL~~~l~---------------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NI 246 (527)
+.+.+.+|+|||||++|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 195 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 195 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGC
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceE
Confidence 999999999999999999999885 235789999999999999999999995 99999999999
Q ss_pred ecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCC
Q psy6905 247 LLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPY 321 (527)
Q Consensus 247 Ll~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf 321 (527)
|++.+ +.+||+|||+++....... ....||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 196 l~~~~--------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 267 (333)
T 2i1m_A 196 LLTNG--------HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267 (333)
T ss_dssp EEEGG--------GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred EECCC--------CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCC
Confidence 99865 6899999999986643322 23346789999999999999999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 322 KSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 322 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.+.........+.......+.|..+|+.+.+||..||+.||.+|||+.++++.|+.+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 268 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp TTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 98776666666666667777888899999999999999999999999999998876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=366.67 Aligned_cols=261 Identities=34% Similarity=0.603 Sum_probs=227.2
Q ss_pred eeEEeCCceeeee-eeccCCceEEEEeeE----cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC
Q psy6905 111 LVEIDYNKLIFGE-AIGEGGFGKVYKGIY----EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS 185 (527)
Q Consensus 111 ~~~i~~~~~~~~~-~iG~G~fg~Vy~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~ 185 (527)
.|.+..++|.+.+ .||+|+||.||+|.+ .+..||||++.........+.+.+|+.+++.++||||+++++++ ..
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 4677888898887 999999999999986 35679999998876666678899999999999999999999999 55
Q ss_pred CeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 186 PKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
+..|+|||||.+|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~--------~~~k 150 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNR--------HYAK 150 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEET--------TEEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCC--------CCEE
Confidence 67899999999999999986 456899999999999999999999995 9999999999999865 6899
Q ss_pred EeccCcchhhhccc-----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Q psy6905 264 ITDFGLAREVYKTT-----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK 337 (527)
Q Consensus 264 L~DFGla~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~ 337 (527)
|+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+.. +
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-~ 229 (287)
T 1u59_A 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-G 229 (287)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-T
T ss_pred ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-C
Confidence 99999998663322 123356899999999998889999999999999999998 9999998887776665553 4
Q ss_pred ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcccc
Q psy6905 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384 (527)
Q Consensus 338 ~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~~ 384 (527)
...+.|..+|+.+.++|..||..||.+||++.+++++|+.+..+...
T Consensus 230 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 230 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 45677889999999999999999999999999999999988776443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=378.98 Aligned_cols=258 Identities=26% Similarity=0.329 Sum_probs=212.6
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC---
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP--- 186 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~--- 186 (527)
..+.++.++|++.+.||+|+||.||+|.+.++.||||++.... ........|+.+++.++||||+++++++....
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 4577889999999999999999999999999999999986542 22345567899999999999999999998744
Q ss_pred -eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhc----------CCCceeecCCCCCceecCCCCccc
Q psy6905 187 -KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ----------APISLIHRDLKSSNVLLSEPIENE 255 (527)
Q Consensus 187 -~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~----------g~~~iiHrDlkp~NILl~~~~~~~ 255 (527)
.+|+|||||++|+|.+++....+++..++.++.||+.||.|||+. | |+||||||+|||++.+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~---- 167 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNN---- 167 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTT----
T ss_pred ceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCC----
Confidence 479999999999999999988899999999999999999999987 5 9999999999999875
Q ss_pred ccccceeEEeccCcchhhhccc----cccCCCccccccccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCC-
Q psy6905 256 DLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTS-----IFSKASDVWSYGVVLWELLTGEIPYKSIN- 325 (527)
Q Consensus 256 ~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~-----~~~~ksDvwSlGv~l~elltg~~Pf~~~~- 325 (527)
+.+||+|||+++...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..
T Consensus 168 ----~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 168 ----LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp ----CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred ----CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 689999999997653322 2235699999999999863 45678999999999999999999997632
Q ss_pred ---------------HHHHHHHHHhCCccCCCCC-----CccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 326 ---------------AYAVAYGVAVNKLTLPIPS-----TCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 326 ---------------~~~~~~~i~~~~~~~~~p~-----~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.......+.........+. .+++.+.+||.+||..||.+|||+.++++.|+.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1222222222333333332 245679999999999999999999999999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=373.73 Aligned_cols=259 Identities=33% Similarity=0.594 Sum_probs=223.2
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcC------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEK------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS 185 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~ 185 (527)
.+++.++|.+.+.||+|+||.||+|.+.. ..||||++...........+.+|+.+++.++||||+++++++.+.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 57888999999999999999999998743 259999998776666677899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 186 PKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
...|+|||||.+|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+|
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~--------~~~k 187 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSN--------LVCK 187 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT--------CCEE
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCC--------CcEE
Confidence 99999999999999999987 357999999999999999999999995 9999999999999875 6899
Q ss_pred EeccCcchhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Q psy6905 264 ITDFGLAREVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK 337 (527)
Q Consensus 264 L~DFGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~ 337 (527)
|+|||+++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+. .+
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~ 266 (333)
T 1mqb_A 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DG 266 (333)
T ss_dssp ECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TT
T ss_pred ECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CC
Confidence 999999987643221 12346789999999999999999999999999999999 999999888877766655 45
Q ss_pred ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 338 ~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
...+.+..++..+.++|.+||..||.+||++.++++.|+.+....
T Consensus 267 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 566778899999999999999999999999999999999887653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=373.38 Aligned_cols=262 Identities=32% Similarity=0.595 Sum_probs=229.2
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~ 182 (527)
..|++..++|.+.+.||+|+||.||+|.+. ++.||||++...........+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 457888899999999999999999999864 4679999998766656667889999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHhcC-----------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCC
Q psy6905 183 LQSPKLCLVMEYARGGPLNRVLAG-----------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEP 251 (527)
Q Consensus 183 ~~~~~~~iv~Ey~~ggsL~~~l~~-----------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~ 251 (527)
.+....|+|||||.+|+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 999999999999999999999862 45688999999999999999999995 9999999999999875
Q ss_pred CcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCH
Q psy6905 252 IENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINA 326 (527)
Q Consensus 252 ~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~ 326 (527)
+.+||+|||+++....... ....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 175 --------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 175 --------FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp --------CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred --------CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 6899999999986643321 23356889999999999999999999999999999999 9999999888
Q ss_pred HHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhccc
Q psy6905 327 YAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383 (527)
Q Consensus 327 ~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~ 383 (527)
......+... ...+.+..+++.+.+||..||..||.+|||+.+++++|+++....+
T Consensus 247 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~ 302 (322)
T 1p4o_A 247 EQVLRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302 (322)
T ss_dssp HHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred HHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence 7777666543 3456778899999999999999999999999999999988766443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=384.36 Aligned_cols=248 Identities=26% Similarity=0.432 Sum_probs=211.4
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCe
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~ 187 (527)
.+..++|++.+.||+|+||.||+|.+. ++.||||++.... .......+..|..++..+ +||||+++++++.+...
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 356688999999999999999999974 6789999986531 122346678899999988 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|+|||||.||+|..++. .+.+++..+..++.||+.||+|||++| ||||||||+||||+.+ +.+||+|
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~--------g~ikL~D 167 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHE--------GHCKLAD 167 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT--------SCEEECC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCC--------CCEEEcc
Confidence 999999999999999887 577999999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 267 FGLAREVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 267 FGla~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
||+++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+..... ..|.
T Consensus 168 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~p~ 245 (353)
T 3txo_A 168 FGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPT 245 (353)
T ss_dssp CTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCT
T ss_pred ccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCC
Confidence 999985422 223356799999999999988899999999999999999999999999998888888876544 4567
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCH------HHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSF------KTILK 373 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~------~~ll~ 373 (527)
.+++.+.+||++||..||.+||++ .++++
T Consensus 246 ~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 899999999999999999999998 66665
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=374.06 Aligned_cols=261 Identities=31% Similarity=0.584 Sum_probs=225.1
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGV 181 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~ 181 (527)
..|++..++|.+.+.||+|+||.||+|.+. ++.||||++...........+.+|+.++..+ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 357788899999999999999999999852 3679999998776666677899999999999 79999999999
Q ss_pred EEeCC-eEEEEEeccCCCCHHHHhcCCC-----------------CChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q psy6905 182 CLQSP-KLCLVMEYARGGPLNRVLAGRK-----------------IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKS 243 (527)
Q Consensus 182 ~~~~~-~~~iv~Ey~~ggsL~~~l~~~~-----------------~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp 243 (527)
+...+ .+|+|||||.+|+|.+++.... +++..++.++.||+.||.|||++| |+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence 88754 5899999999999999987432 788999999999999999999995 99999999
Q ss_pred CceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CC
Q psy6905 244 SNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GE 318 (527)
Q Consensus 244 ~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~ 318 (527)
+|||++.+ +.+||+|||+++....... ....||+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 177 ~Nil~~~~--------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 177 RNILLSEK--------NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp GGEEECGG--------GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ceEEECCC--------CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 99999864 6899999999986643221 23457889999999999999999999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 319 IPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 319 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.||.+.............+...+.|..+++.+.++|..||..||.+|||+.+++++|+.+...
T Consensus 249 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 249 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 999887655544444445556677888999999999999999999999999999999887754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=373.24 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=215.8
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh-----hHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE-----NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+.|.+.+.||+|+||.||+|.+. ++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56899999999999999999984 678999988654321 12567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+|||||.||+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+..+ ...+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~----~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVP----KPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSS----SCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCC----CCCEEEEECC
Confidence 9999999999999987 567999999999999999999999995 9999999999999875211 1379999999
Q ss_pred cchhhhcc-ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC--CCCC
Q psy6905 269 LAREVYKT-THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPST 345 (527)
Q Consensus 269 la~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~ 345 (527)
+++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......+ .+..
T Consensus 164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp TCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred CCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence 99876432 23345799999999999999999999999999999999999999999888777777665544333 2257
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++.+.+||.+||..||.+|||+.+++++
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 89999999999999999999999999873
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=369.99 Aligned_cols=259 Identities=34% Similarity=0.548 Sum_probs=214.8
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeE------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
+.++..++|++.+.||+|+||.||+|.+ +++.||||++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3467788999999999999999999985 45789999987653 4446788999999999999999999999865
Q ss_pred --CCeEEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccc
Q psy6905 185 --SPKLCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260 (527)
Q Consensus 185 --~~~~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~ 260 (527)
...+++|||||++|+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~--------~ 151 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENE--------N 151 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET--------T
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCC--------C
Confidence 3568999999999999999873 34899999999999999999999995 9999999999999875 6
Q ss_pred eeEEeccCcchhhhccc-----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-------
Q psy6905 261 TLKITDFGLAREVYKTT-----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYA------- 328 (527)
Q Consensus 261 ~vkL~DFGla~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~------- 328 (527)
.+||+|||+++...... .....+|..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 231 (295)
T 3ugc_A 152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231 (295)
T ss_dssp EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTT
T ss_pred eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCc
Confidence 89999999998764322 123357888999999999999999999999999999999999986532210
Q ss_pred --------HHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 329 --------VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 329 --------~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
............+.|..+|+.+.+||..||..||.+|||+.++++.|+.+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 232 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11222334556788899999999999999999999999999999999887643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=373.43 Aligned_cols=247 Identities=26% Similarity=0.434 Sum_probs=217.2
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+..++|++.+.||+|+||.||+|.+ +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 3567899999999999999999997 46799999986431 1112466788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+|||||.||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~--------g~~kL~Dfg 151 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKN--------GHIKITDFG 151 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTT--------SCEEECCCS
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCC--------CCEEEeecC
Confidence 9999999999999987 567999999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 269 LAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 269 la~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
+++.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.... ...|..+++
T Consensus 152 ~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~ 228 (318)
T 1fot_A 152 FAKYVPD-VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNE 228 (318)
T ss_dssp SCEECSS-CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCH
T ss_pred cceecCC-ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCH
Confidence 9986543 2345689999999999999999999999999999999999999999988888877777554 356778999
Q ss_pred HHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RP-----s~~~ll~~ 374 (527)
++.++|.+||..||.+|| ++.+++++
T Consensus 229 ~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 999999999999999999 88888763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=373.21 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=209.3
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeE-----cCceEEEEEcCCCC---ChhHHHHHHHHHHHHHhCCCCccceEEEEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNP---DENILENVKQEGKLLWLFDHRNIVSLIGVC 182 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~ 182 (527)
...+..++|++.+.||+|+||.||+|.+ .++.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 3456778999999999999999999986 46789999987642 122345678899999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 183 LQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 183 ~~~~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
..++.+|+|||||.||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~--------~~ 159 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQ--------GH 159 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTT--------SC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCC--------Cc
Confidence 99999999999999999999887 567899999999999999999999995 9999999999999875 68
Q ss_pred eEEeccCcchhhhcc--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 262 LKITDFGLAREVYKT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 262 vkL~DFGla~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
+||+|||+++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-- 237 (327)
T 3a62_A 160 VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-- 237 (327)
T ss_dssp EEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--
T ss_pred EEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--
Confidence 999999999765322 2234579999999999999999999999999999999999999999988888777776544
Q ss_pred CCCCCCccHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q psy6905 340 LPIPSTCPQLFKTLMEACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 340 ~~~p~~~~~~~~~li~~~l~~dp~~RP-----s~~~ll~~ 374 (527)
...|..+++.+.+||.+||..||.+|| ++.+++++
T Consensus 238 ~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 456778999999999999999999999 77788774
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=364.60 Aligned_cols=259 Identities=32% Similarity=0.590 Sum_probs=226.6
Q ss_pred CceeeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC
Q psy6905 108 DVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS 185 (527)
Q Consensus 108 ~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~ 185 (527)
....|++..++|++.+.||+|+||.||+|.+. +..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34568899999999999999999999999985 67899999876533 357788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 186 PKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
..+|+|||||.||+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~--------~~~ 150 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGEN--------HLV 150 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGG--------GCE
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCC--------CCE
Confidence 99999999999999999986 345899999999999999999999995 9999999999999865 689
Q ss_pred EEeccCcchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCc
Q psy6905 263 KITDFGLAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 263 kL~DFGla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
||+|||++........ ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+. ...
T Consensus 151 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~ 229 (288)
T 3kfa_A 151 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDY 229 (288)
T ss_dssp EECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTC
T ss_pred EEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccC
Confidence 9999999987643322 23346789999999999999999999999999999999 999999887766655544 455
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
..+.|..+|+.+.+||..||..||.+|||+.++++.|+.+..
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 667888999999999999999999999999999998876554
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=374.51 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=207.1
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|++.+.||+|+||.||+|.+. ++.||||++.........+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999874 678999998765444445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||.||+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~--------~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDER--------DNLKISDFGLATV 154 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------CCEEECCCTTCEE
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCC--------CCEEEEEeeccce
Confidence 999999999988 457999999999999999999999995 9999999999999875 6899999999976
Q ss_pred hhccc----cccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCccCCCCCCc
Q psy6905 273 VYKTT----HMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAV-AYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 273 ~~~~~----~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~-~~~i~~~~~~~~~p~~~ 346 (527)
..... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.... ...........+....+
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGS
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccC
Confidence 53221 234579999999999987765 7899999999999999999999987655422 22223233333444678
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.+.+||.+||..||.+|||+.+++++
T Consensus 235 ~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 235 DSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 9999999999999999999999999873
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=365.23 Aligned_cols=260 Identities=37% Similarity=0.638 Sum_probs=208.3
Q ss_pred CceeeEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 108 DVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 108 ~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
....++|..++|++.+.||+|+||.||+|.+.+ .||||++.... .....+.+.+|+.+++.++||||+++++++ ...
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 345789999999999999999999999998765 59999987654 444567889999999999999999999965 455
Q ss_pred eEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.+++|||||.+++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~--------~~~kl 161 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHED--------NTVKI 161 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETT--------TEEEE
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCC--------CCEEE
Confidence 6899999999999999986 456899999999999999999999995 9999999999999875 68999
Q ss_pred eccCcchhhhcc----ccccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hC
Q psy6905 265 TDFGLAREVYKT----THMSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA-VN 336 (527)
Q Consensus 265 ~DFGla~~~~~~----~~~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~-~~ 336 (527)
+|||+++..... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+......... ..
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 241 (289)
T 3og7_A 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG 241 (289)
T ss_dssp CCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT
T ss_pred ccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc
Confidence 999999765321 122346899999999986 6678899999999999999999999998866554444333 32
Q ss_pred CccCC---CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 337 KLTLP---IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 337 ~~~~~---~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
..... .+..+|+.+.+||.+||..||.+|||+.++++.|+.+..
T Consensus 242 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 242 SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 22222 345789999999999999999999999999999987653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=362.73 Aligned_cols=257 Identities=31% Similarity=0.573 Sum_probs=220.4
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcC-----ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-----QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS 185 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~ 185 (527)
.+.+..++|.+.+.||+|+||.||+|.+.+ ..||+|++.........+.+.+|+.+++.++||||+++++++.++
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 356788999999999999999999998743 259999998776666678899999999999999999999998754
Q ss_pred CeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 186 PKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
..|+||||+.+|+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+|
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~--------~~~k 153 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASP--------ECVK 153 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEET--------TEEE
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCC--------CcEE
Confidence 5689999999999999986 456899999999999999999999995 9999999999999875 6899
Q ss_pred EeccCcchhhhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 264 ITDFGLAREVYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 264 L~DFGla~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
|+|||++....... .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+.. ...
T Consensus 154 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~-~~~ 232 (281)
T 3cc6_A 154 LGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK-GDR 232 (281)
T ss_dssp ECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH-TCC
T ss_pred eCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc-CCC
Confidence 99999998664322 123457889999999998899999999999999999998 9999988776666555443 445
Q ss_pred CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 340 ~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.+.|..+++.+.++|.+||..||.+|||+.+++++|+.+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 67788899999999999999999999999999999877653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=372.73 Aligned_cols=255 Identities=33% Similarity=0.609 Sum_probs=214.9
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--Cc----eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQ----EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
+..++|++.+.||+|+||.||+|.+. ++ .||+|.+...........+.+|+.+++.++||||+++++++.++.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 45678999999999999999999873 33 468888876544444678899999999999999999999998765
Q ss_pred EEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.++|+||+.+|+|.+++. ...+++..++.|+.||+.||.|||++| ||||||||+|||++.+ +.+||+
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~--------~~~kl~ 159 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTP--------QHVKIT 159 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEET--------TEEEEC
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCC--------CCEEEc
Confidence 789999999999999886 456899999999999999999999995 9999999999999875 689999
Q ss_pred ccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 266 DFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
|||+++....... ....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+. .....
T Consensus 160 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~ 238 (327)
T 3poz_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERL 238 (327)
T ss_dssp CTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCC
T ss_pred cCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCC
Confidence 9999987643222 23356889999999999999999999999999999999 999999887766655444 45566
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
+.|..++..+.+++..||..||.+||++.+++++|+.+...
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 78889999999999999999999999999999999887653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=377.76 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=217.5
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
...++|.+.+.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45678999999999999999999984 6799999986431 1122467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+|||||.||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~--------g~~kL~DFg 186 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQ--------GYIQVTDFG 186 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------SCEEECCCT
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCC--------CCEEEcccc
Confidence 9999999999999987 467999999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 269 LAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 269 la~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ...|..+++
T Consensus 187 ~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~ 263 (350)
T 1rdq_E 187 FAKRVKGR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263 (350)
T ss_dssp TCEECSSC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCH
T ss_pred cceeccCC-cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCH
Confidence 99866432 345679999999999999999999999999999999999999999998888887777654 456788999
Q ss_pred HHHHHHHHhhhhCCCCCCC-----HHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPS-----FKTILK 373 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs-----~~~ll~ 373 (527)
.+.+||.+||..||.+||+ +.+|++
T Consensus 264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 9999999999999999998 777776
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=373.01 Aligned_cols=262 Identities=30% Similarity=0.564 Sum_probs=210.3
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcC--c---eEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEK--Q---EVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~--~---~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
.+.+..++|.+.+.||+|+||.||+|.+.. . .||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 456778899999999999999999998743 2 79999987653 33446788999999999999999999999987
Q ss_pred CCeE------EEEEeccCCCCHHHHhcC-------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCC
Q psy6905 185 SPKL------CLVMEYARGGPLNRVLAG-------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEP 251 (527)
Q Consensus 185 ~~~~------~iv~Ey~~ggsL~~~l~~-------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~ 251 (527)
.... ++|||||.+|+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 7655 999999999999998852 15899999999999999999999995 9999999999999875
Q ss_pred CcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCH
Q psy6905 252 IENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINA 326 (527)
Q Consensus 252 ~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~ 326 (527)
+.+||+|||+++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 174 --------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 245 (323)
T 3qup_A 174 --------MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245 (323)
T ss_dssp --------SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred --------CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence 6899999999987643221 23457889999999999999999999999999999999 9999999887
Q ss_pred HHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcccc
Q psy6905 327 YAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384 (527)
Q Consensus 327 ~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~~ 384 (527)
......+.. ....+.+..+++.+.+||.+||..||.+|||+.++++.|++++.....
T Consensus 246 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 246 AEIYNYLIG-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp GGHHHHHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred HHHHHHHhc-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 777666553 445677888999999999999999999999999999999999887654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=361.78 Aligned_cols=256 Identities=32% Similarity=0.575 Sum_probs=223.8
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
.|+++.++|++.+.||+|+||.||+|.+.+ ..||||++...... .+.+.+|+.+++.++||||+++++++.+ +..|
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 478899999999999999999999999865 58999998765422 4678899999999999999999999874 4589
Q ss_pred EEEeccCCCCHHHHhcCC---CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 190 LVMEYARGGPLNRVLAGR---KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~---~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|||||.+|+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~--------~~~kl~D 152 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDT--------LSCKIAD 152 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------SCEEECC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCC--------CCEEECC
Confidence 999999999999999743 6999999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 267 FGLAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 267 FGla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
||++........ ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+. .+.....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 231 (279)
T 1qpc_A 153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVR 231 (279)
T ss_dssp CTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCC
T ss_pred CcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCC
Confidence 999986643222 23457889999999998889999999999999999999 999999988777666654 4556677
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
|..+++.+.+++..||..||.+|||+.++++.|+++...
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 889999999999999999999999999999999887754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=390.08 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=217.9
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC--hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD--ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
+.+..++|.+.+.||+|+||.||+|.+. ++.||+|++..... ......+.+|+.+++.++|||||+++++|.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 4567789999999999999999999984 57899999864210 0012346789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 188 LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+|+|||||+||+|.+++.+..+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+||
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~--------g~ikL~DF 212 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--------GHLKLADF 212 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------SCEEECCC
T ss_pred EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCC--------CCEEEecc
Confidence 999999999999999999888999999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhccc---cccCCCccccccccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--c
Q psy6905 268 GLAREVYKTT---HMSAAGTYAWMAPEVIKTSI----FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK--L 338 (527)
Q Consensus 268 Gla~~~~~~~---~~~~~gt~~y~aPE~l~~~~----~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~--~ 338 (527)
|+++...... ..+.+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+.... .
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence 9998664332 23568999999999998665 7899999999999999999999999999888887776544 3
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHM--RPSFKTILKA 374 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~--RPs~~~ll~~ 374 (527)
.++.+..+++++++||.+||..+|.+ ||++.+|++|
T Consensus 293 ~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 34444579999999999999999988 9999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=369.57 Aligned_cols=260 Identities=35% Similarity=0.523 Sum_probs=221.8
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe-
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ- 184 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~- 184 (527)
..++.+.|++++.||+|+||.||++.+ +++.||||++...........+.+|+.+++.++||||+++++++.+
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 345556669999999999999988865 4578999999887666667889999999999999999999999988
Q ss_pred -CCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 185 -SPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 185 -~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
...+|+|||||++|+|.+++....+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~--------~~~k 174 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDND--------RLVK 174 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------CCEE
T ss_pred CCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCC--------CCEE
Confidence 467899999999999999999888999999999999999999999995 9999999999999875 6899
Q ss_pred EeccCcchhhhccc-----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-----------
Q psy6905 264 ITDFGLAREVYKTT-----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY----------- 327 (527)
Q Consensus 264 L~DFGla~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~----------- 327 (527)
|+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 254 (318)
T 3lxp_A 175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ 254 (318)
T ss_dssp ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHH
T ss_pred ECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccc
Confidence 99999998764322 22345888999999999988999999999999999999999999754321
Q ss_pred ---HHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 328 ---AVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 328 ---~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
.............+.+..+++.+.+||..||..||.+|||+.++++.|+.+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 255 MTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 1122233455667788999999999999999999999999999999998776543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=378.99 Aligned_cols=249 Identities=25% Similarity=0.450 Sum_probs=213.8
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCC
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSP 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~ 186 (527)
..+..++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+..|..++..+ +||||+++++++.+..
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3456789999999999999999999984 6789999986531 011245677888888876 9999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.+|+|||||+||+|.+++. .+.+++..+..++.||+.||.|||++| ||||||||+|||++.+ +.+||+
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~--------g~vkL~ 160 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKD--------GHIKIA 160 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT--------SCEEEC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCC--------CCEEEe
Confidence 9999999999999999987 467999999999999999999999995 9999999999999875 689999
Q ss_pred ccCcchhhh--ccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 266 DFGLAREVY--KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 266 DFGla~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|||+++... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.... ...|
T Consensus 161 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p 238 (345)
T 1xjd_A 161 DFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYP 238 (345)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCC
T ss_pred EChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--CCCC
Confidence 999998642 223345689999999999999999999999999999999999999999998888877776544 3467
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFK-TILK 373 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~-~ll~ 373 (527)
..+++++.+||.+||..||.+||++. ++++
T Consensus 239 ~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 239 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 78999999999999999999999986 5543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=364.05 Aligned_cols=256 Identities=33% Similarity=0.623 Sum_probs=216.7
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC-CeEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-PKLC 189 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-~~~~ 189 (527)
.|.++.++|++.+.||+|+||.||+|.++++.||||++.... ..+.+.+|+.+++.++||||+++++++.+. +.+|
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 467888999999999999999999999999999999987653 356788999999999999999999997654 4789
Q ss_pred EEEeccCCCCHHHHhcCC---CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 190 LVMEYARGGPLNRVLAGR---KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~---~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|||||++|+|.+++... .+++..++.++.||+.||.|||++| ++||||||+|||++.+ +.+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~--------~~~~l~D 160 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSED--------NVAKVSD 160 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT--------SCEEECC
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCC--------CcEEEee
Confidence 999999999999998732 3889999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCC
Q psy6905 267 FGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPST 345 (527)
Q Consensus 267 FGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 345 (527)
||++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+. .+.....+..
T Consensus 161 fg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (278)
T 1byg_A 161 FGLTKEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDG 238 (278)
T ss_dssp CCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTT
T ss_pred cccccccccc-ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCccc
Confidence 9999765432 223467899999999999999999999999999999998 999999887766655554 4456677889
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
+|+.+.++|..||+.||.+|||+.++++.|+.+....
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 9999999999999999999999999999998876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=362.08 Aligned_cols=259 Identities=32% Similarity=0.583 Sum_probs=215.3
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCCh---hH---HHHHHHHHHHHHhCCCCccceEEEEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDE---NI---LENVKQEGKLLWLFDHRNIVSLIGVCL 183 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~---~~---~~~~~~e~~~l~~l~hpnIv~~~~~~~ 183 (527)
..+..++|.+.+.||+|+||.||+|.+ +++.||||++...... .. .+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 346678999999999999999999998 4678999998664321 11 167889999999999999999999997
Q ss_pred eCCeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 184 QSPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 184 ~~~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
+.. ++|||||.+|+|.+++. ...+++..++.++.||+.||.|||++|+ +|+||||||+|||++.+..+ ....
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~---~~~~ 167 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDEN---APVC 167 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTT---CSCC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCC---Ccee
Confidence 765 79999999999988875 4568999999999999999999999831 29999999999999875211 1124
Q ss_pred eEEeccCcchhhhccccccCCCccccccccccc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhCC
Q psy6905 262 LKITDFGLAREVYKTTHMSAAGTYAWMAPEVIK--TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAV--AYGVAVNK 337 (527)
Q Consensus 262 vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~--~~~i~~~~ 337 (527)
+||+|||+++.... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+.... ...+....
T Consensus 168 ~kl~Dfg~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 168 AKVADFGLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp EEECCCTTCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred EEeCCCCccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 99999999975433 233467999999999994 45578999999999999999999999987654333 44555566
Q ss_pred ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 338 ~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
.....|..+|+.+.++|..||..||.+|||+.++++.|++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 7778889999999999999999999999999999998875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=376.07 Aligned_cols=251 Identities=29% Similarity=0.391 Sum_probs=204.3
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
..+.++|.+.+.||+|+||.||+|.+ +++.||||++...... ...+.+|+.+++.++||||+++++++.+...+|+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 45678999999999999999999998 4678999998764322 3567799999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||||.||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+. .+.+||+|||+
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~------~~~~kl~Dfg~ 164 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSP------APRLKICDFGY 164 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSS------SCCEEECCCCC
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCC------CceEEEeecCc
Confidence 999999999999886 567999999999999999999999995 99999999999998652 13599999999
Q ss_pred chhhhc-cccccCCCccccccccccccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCccCCCC
Q psy6905 270 AREVYK-TTHMSAAGTYAWMAPEVIKTSIFSKA-SDVWSYGVVLWELLTGEIPYKSINA----YAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 270 a~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k-sDvwSlGv~l~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~p 343 (527)
++.... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+. ......+.......+.+
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (361)
T 3uc3_A 165 SKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244 (361)
T ss_dssp C---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT
T ss_pred cccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc
Confidence 975432 22335579999999999988877655 9999999999999999999987543 34444555555555666
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+++.+.+||.+||..||.+|||+.+++++
T Consensus 245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 245 IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 6789999999999999999999999999885
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=367.70 Aligned_cols=245 Identities=27% Similarity=0.442 Sum_probs=213.5
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
.|...+.||+|+||.||+|.+ +++.||||++...... ..+.+.+|+.+++.++||||+++++++...+..|+|||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 467778999999999999987 4789999998765432 2567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 196 RGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 196 ~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
.||+|.+++....+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.....
T Consensus 125 ~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~--------~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 125 QGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLD--------GRVKLSDFGFCAQISK 193 (321)
T ss_dssp CSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------CCEEECCCTTCEECCS
T ss_pred CCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC--------CcEEEeeeeeeeeccc
Confidence 9999999999888999999999999999999999995 9999999999999875 6899999999976643
Q ss_pred c--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCCCCCccHHHHH
Q psy6905 276 T--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPSTCPQLFKT 352 (527)
Q Consensus 276 ~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~~~~ 352 (527)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..... ....+..+++.+.+
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 273 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRD 273 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHH
T ss_pred CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHH
Confidence 2 22345799999999999999999999999999999999999999998887776665554322 22334567899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q psy6905 353 LMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 353 li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+|.+||..||.+|||+.+++++
T Consensus 274 li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 274 FLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=372.67 Aligned_cols=242 Identities=24% Similarity=0.422 Sum_probs=207.9
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCC--CChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN--PDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~ 188 (527)
+..++|.+.+.||+|+||.||+|.+. ++.||||++... ........+.+|..++..+ +||||+++++++.+...+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 45678999999999999999999984 678999998754 2344567788999999987 899999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+|||||.||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+||
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~--------g~~kL~DF 154 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSE--------GHIKLTDY 154 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT--------SCEEECCG
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCC--------CCEEEEec
Confidence 99999999999999887 567999999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhC
Q psy6905 268 GLAREVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI---------NAYAVAYGVAVN 336 (527)
Q Consensus 268 Gla~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~---------~~~~~~~~i~~~ 336 (527)
|+++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+...
T Consensus 155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~ 234 (345)
T 3a8x_A 155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234 (345)
T ss_dssp GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred cccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence 99986422 2334568999999999999999999999999999999999999999752 222333334333
Q ss_pred CccCCCCCCccHHHHHHHHHhhhhCCCCCCCH
Q psy6905 337 KLTLPIPSTCPQLFKTLMEACWEADSHMRPSF 368 (527)
Q Consensus 337 ~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~ 368 (527)
....|..++..+.+||.+||..||.+||++
T Consensus 235 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 --QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 345678899999999999999999999995
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=363.09 Aligned_cols=258 Identities=33% Similarity=0.620 Sum_probs=220.2
Q ss_pred eeEEeCCceeeee-eeccCCceEEEEeeEc----CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 111 LVEIDYNKLIFGE-AIGEGGFGKVYKGIYE----KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 111 ~~~i~~~~~~~~~-~iG~G~fg~Vy~~~~~----~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
.+.++.++|.+.+ .||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 4667888999998 9999999999999653 4679999987653 233467899999999999999999999999 5
Q ss_pred CCeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
.+..|+||||+.+|+|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+|
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~--------~~~k 157 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQ--------HYAK 157 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET--------TEEE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCC--------CcEE
Confidence 667899999999999999987 556999999999999999999999995 9999999999999875 6899
Q ss_pred EeccCcchhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Q psy6905 264 ITDFGLAREVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK 337 (527)
Q Consensus 264 L~DFGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~ 337 (527)
|+|||++........ ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+.. .
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~ 236 (291)
T 1xbb_A 158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-G 236 (291)
T ss_dssp ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-T
T ss_pred EccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-C
Confidence 999999976533221 12346789999999998889999999999999999999 9999999888776665553 4
Q ss_pred ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 338 ~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
...+.|..+|+.+.++|..||+.||.+||++.++++.|+++...
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 237 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 45677889999999999999999999999999999999887654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=376.49 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=215.0
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCe
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~ 187 (527)
.+..++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+..|..++..+ +||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 456789999999999999999999985 4689999986531 112246678899999887 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|+|||||+||+|.+++. .+.+++..+..++.||+.||.|||++| ||||||||+|||++.+ +.+||+|
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~--------g~vkL~D 164 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSE--------GHIKIAD 164 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT--------SCEEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCC--------CcEEEEe
Confidence 999999999999999987 467999999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhh--ccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 267 FGLAREVY--KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 267 FGla~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
||+++... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+..... ..|.
T Consensus 165 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~p~ 242 (353)
T 2i0e_A 165 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AYPK 242 (353)
T ss_dssp CTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCT
T ss_pred CCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--CCCC
Confidence 99998642 2233456899999999999999999999999999999999999999999988888887776543 5677
Q ss_pred CccHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPS-----FKTILKA 374 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs-----~~~ll~~ 374 (527)
.+++++.+||.+||..||.+||+ +.+|+++
T Consensus 243 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 89999999999999999999995 5666653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=374.53 Aligned_cols=255 Identities=32% Similarity=0.582 Sum_probs=216.5
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--Cc----eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQ----EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
+..++|++.+.||+|+||.||+|.+. +. .||+|.+...........+.+|+.+++.++||||+++++++. +..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 45688999999999999999999874 33 388888765443333456678999999999999999999986 456
Q ss_pred EEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.++|||||.+|+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~--------~~~kl~ 157 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSP--------SQVQVA 157 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSS--------SCEEEC
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCC--------CeEEEC
Confidence 8999999999999999874 47899999999999999999999995 9999999999999875 689999
Q ss_pred ccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 266 DFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+. .....
T Consensus 158 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~ 236 (325)
T 3kex_A 158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERL 236 (325)
T ss_dssp SCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBC
T ss_pred CCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCC
Confidence 999998764322 123457889999999999999999999999999999999 999999887776665554 44566
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
..|..++..+.++|.+||..||.+|||+.+++++|+.+...
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 77888999999999999999999999999999999887653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=379.70 Aligned_cols=248 Identities=24% Similarity=0.401 Sum_probs=208.1
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCe
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~ 187 (527)
.+..++|++++.||+|+||.||+|.+. ++.||||++.... .......+..|..++..+ +||||+++++++.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 456788999999999999999999974 5789999987532 222345677899999876 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|+|||||+||+|..++. .+.+++..+..++.||+.||.|||++| ||||||||+||||+.+ +.+||+|
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~--------g~ikL~D 196 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSE--------GHIKLTD 196 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT--------SCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCC--------CCEEEee
Confidence 999999999999998887 567999999999999999999999995 9999999999999876 7899999
Q ss_pred cCcchhhh--ccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHh
Q psy6905 267 FGLAREVY--KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN---------AYAVAYGVAV 335 (527)
Q Consensus 267 FGla~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~---------~~~~~~~i~~ 335 (527)
||+++... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+..
T Consensus 197 FGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 197 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp CTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred cceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 99998632 233345689999999999999999999999999999999999999996432 1223333333
Q ss_pred CCccCCCCCCccHHHHHHHHHhhhhCCCCCCCH------HHHHH
Q psy6905 336 NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSF------KTILK 373 (527)
Q Consensus 336 ~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~------~~ll~ 373 (527)
.....|..+++++.+||++||..||.+||++ .++++
T Consensus 277 --~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 277 --KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred --cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 3456778899999999999999999999985 56655
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=399.89 Aligned_cols=258 Identities=34% Similarity=0.609 Sum_probs=221.7
Q ss_pred eEEeCCceeeee-eeccCCceEEEEeeEc----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 112 VEIDYNKLIFGE-AIGEGGFGKVYKGIYE----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 112 ~~i~~~~~~~~~-~iG~G~fg~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
+.+..+++.+.+ .||+|+||.||+|.+. +..||||+++........+.+.+|+.+|+.++|||||++++++.. +
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 556677777777 8999999999999874 346999999876544457889999999999999999999999976 5
Q ss_pred eEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.+|+|||||.+|+|.+++. ...+++..++.++.||+.||+|||+++ ||||||||+||||+.+ +.+||
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~--------~~vkL 477 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNR--------HYAKI 477 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET--------TEEEE
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCC--------CcEEE
Confidence 6899999999999999986 456899999999999999999999994 9999999999999875 68999
Q ss_pred eccCcchhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCc
Q psy6905 265 TDFGLAREVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 265 ~DFGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
+|||+++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. .+.
T Consensus 478 ~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~ 556 (613)
T 2ozo_A 478 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGK 556 (613)
T ss_dssp CCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTC
T ss_pred eeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCC
Confidence 99999987632211 12345789999999999999999999999999999998 999999988887776665 456
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
.++.|..+|+.+.+||..||..||.+||++.+|++.|+.+....
T Consensus 557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 77889999999999999999999999999999999998877654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=364.95 Aligned_cols=258 Identities=33% Similarity=0.534 Sum_probs=216.2
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeE------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
+..+....|++.+.||+|+||.||+|.+ .++.||||++...........+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 3456677899999999999999999984 4578999998866544446788999999999999999999999987
Q ss_pred C--CeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccc
Q psy6905 185 S--PKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260 (527)
Q Consensus 185 ~--~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~ 260 (527)
. ..+|+|||||.+|+|.+++. ...+++..++.++.||+.||+|||++| |+||||||+|||++.+ +
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~--------~ 163 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE--------H 163 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET--------T
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCC--------C
Confidence 6 67899999999999999985 567999999999999999999999995 9999999999999875 6
Q ss_pred eeEEeccCcchhhhccc-----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC-----------
Q psy6905 261 TLKITDFGLAREVYKTT-----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI----------- 324 (527)
Q Consensus 261 ~vkL~DFGla~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~----------- 324 (527)
.+||+|||++....... .....||..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 164 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 243 (302)
T 4e5w_A 164 QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243 (302)
T ss_dssp EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred CEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCc
Confidence 89999999998664322 22346888999999999988999999999999999999999876422
Q ss_pred ---CHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q psy6905 325 ---NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379 (527)
Q Consensus 325 ---~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~ 379 (527)
................+.|..+|+.+.+||.+||..||.+|||+.++++.|+.++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 244 HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2222333334456677888999999999999999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=379.10 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=211.6
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
..+..++|.+.+.||+|+||.||+|.+. ++.||+|++.... .......+.+|+.+++.++|||||++++++.+...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4567889999999999999999999874 5789999886431 11225678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|+|||||.||+|..++. ...+++..+..++.||+.||.|||++| ||||||||+||||+.+ +.+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~--------g~vkL~D 158 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEH--------GHVHITD 158 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------SCEEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCC--------CCEEEec
Confidence 999999999999999987 457999999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhcc-ccccCCCcccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCcc
Q psy6905 267 FGLAREVYKT-THMSAAGTYAWMAPEVIKT---SIFSKASDVWSYGVVLWELLTGEIPYKSIN---AYAVAYGVAVNKLT 339 (527)
Q Consensus 267 FGla~~~~~~-~~~~~~gt~~y~aPE~l~~---~~~~~ksDvwSlGv~l~elltg~~Pf~~~~---~~~~~~~i~~~~~~ 339 (527)
||+++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+ .......+.. ..
T Consensus 159 FG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~ 236 (384)
T 4fr4_A 159 FNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TV 236 (384)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CC
T ss_pred cceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cc
Confidence 9999876432 3345689999999999964 458999999999999999999999997543 3333333332 33
Q ss_pred CCCCCCccHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q psy6905 340 LPIPSTCPQLFKTLMEACWEADSHMRPS-FKTILK 373 (527)
Q Consensus 340 ~~~p~~~~~~~~~li~~~l~~dp~~RPs-~~~ll~ 373 (527)
...|..+++.+.+||.+||..||.+||+ +.++++
T Consensus 237 ~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 4677889999999999999999999998 777765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=377.57 Aligned_cols=249 Identities=21% Similarity=0.334 Sum_probs=216.7
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.+.|.+.+.||+|+||.||+|.+. ++.||+|++..... .....+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 367999999999999999999984 67899999876532 234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||.||+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+. .+.+||+|||+++
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~------~~~vkL~DFG~a~ 199 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKK------ASSVKIIDFGLAT 199 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTT------CCCEEECCCTTCE
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCC------CCceEEEecccce
Confidence 9999999999873 46899999999999999999999995 99999999999997531 2579999999998
Q ss_pred hhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC--CCCCccH
Q psy6905 272 EVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPSTCPQ 348 (527)
Q Consensus 272 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~ 348 (527)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......+ .+..+++
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 200 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 764332 2245799999999999999999999999999999999999999999888887777766554433 3457899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.+||.+||..||.+|||+.+++++
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=362.02 Aligned_cols=249 Identities=24% Similarity=0.449 Sum_probs=214.2
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC--hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD--ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
.+..++|.+.+.||+|+||.||+|.+. +..||+|++..... ......+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 345678999999999999999999885 46899998854321 11245688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+||||+++|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+||
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~--------~~~~l~Df 153 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSA--------GELKIADF 153 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTT--------SCEEECSC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCC--------CCEEEEec
Confidence 99999999999998887 567999999999999999999999995 9999999999999875 68999999
Q ss_pred CcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCcc
Q psy6905 268 GLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 268 Gla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 347 (527)
|++............||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+... ....|..++
T Consensus 154 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~ 231 (279)
T 3fdn_A 154 GWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVT 231 (279)
T ss_dssp CEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSC
T ss_pred cccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--CCCCCCcCC
Confidence 998766555555668999999999999999999999999999999999999999998887777666543 345678899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+.+||.+||..||.+|||+.+++++
T Consensus 232 ~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 232 EGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 999999999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=372.93 Aligned_cols=249 Identities=27% Similarity=0.391 Sum_probs=208.7
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC----ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP----DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
+.|++.+.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++.++..+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 57999999999999999999874 6799999875321 11124678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 191 VMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
|||||+||+|.+.+. +..+++..+..++.||+.||.|||++| |+||||||+|||++.+.. ...+||+
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~-----~~~vkl~ 175 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKEN-----SAPVKLG 175 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSST-----TCCEEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCC-----CCcEEEe
Confidence 999999999987764 235899999999999999999999995 999999999999986521 2469999
Q ss_pred ccCcchhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC-
Q psy6905 266 DFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI- 342 (527)
Q Consensus 266 DFGla~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~- 342 (527)
|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ......+....+..+.
T Consensus 176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred cCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence 999998764432 234579999999999999999999999999999999999999998753 3444455544443322
Q ss_pred -CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 343 -PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 343 -p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+++.+.+||.+||..||.+|||+.+++++
T Consensus 255 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 255 QWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 25689999999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=369.46 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=212.6
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~i 190 (527)
+..++|.+.+.||+|+||.||+|.+ +++.||||++..... ...+.+|+.+++.+ +||||+++++++......|+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 3457899999999999999999996 568999999865432 23577899999999 99999999999999999999
Q ss_pred EEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 191 VMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
||||| +|+|.+++. ++.+++..++.++.||+.||+|||++| ||||||||+|||++.+... ....+||+|||
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~---~~~~~kl~DFg 155 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNK---TQQVIHIIDFA 155 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGT---CTTSEEECCCT
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCC---CCceEEEEEcc
Confidence 99999 999999987 578999999999999999999999995 9999999999999875210 01239999999
Q ss_pred cchhhhccc---------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhC
Q psy6905 269 LAREVYKTT---------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN---AYAVAYGVAVN 336 (527)
Q Consensus 269 la~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~---~~~~~~~i~~~ 336 (527)
+++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ..+....+...
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 998653322 134579999999999999999999999999999999999999998753 33333333322
Q ss_pred CccCCC---CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 337 KLTLPI---PSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 337 ~~~~~~---p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
....+. ...+| ++.++|..||..||.+||++.+|++.|+++....
T Consensus 236 ~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 236 KRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 222221 23466 9999999999999999999999999998887653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=368.43 Aligned_cols=264 Identities=33% Similarity=0.544 Sum_probs=224.7
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeE-------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~ 182 (527)
...++..++|.+.+.||+|+||.||+|.+ .+..||||++...........+.+|+.+++.++||||+++++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 34578889999999999999999999984 24579999998666666677889999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHhcC--------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcc
Q psy6905 183 LQSPKLCLVMEYARGGPLNRVLAG--------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254 (527)
Q Consensus 183 ~~~~~~~iv~Ey~~ggsL~~~l~~--------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~ 254 (527)
.+....|+|||||++|+|.+++.. ..++...++.++.||+.||.|||++| |+||||||+|||++.+..
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~- 178 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGP- 178 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSST-
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCC-
Confidence 999999999999999999999873 24888899999999999999999995 999999999999985421
Q ss_pred cccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy6905 255 EDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAV 329 (527)
Q Consensus 255 ~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~ 329 (527)
...+||+|||+++....... ....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+....
T Consensus 179 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 254 (327)
T 2yfx_A 179 ----GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254 (327)
T ss_dssp ----TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ----cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH
Confidence 24799999999986643222 23457899999999999999999999999999999998 9999998887776
Q ss_pred HHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 330 ~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
...+.. +.....+..++..+.++|..||..||.+||++.+++++|+.+....
T Consensus 255 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 255 LEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHhc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 665553 4455677889999999999999999999999999999998877654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=379.29 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=197.0
Q ss_pred Cceeee-eeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHH-HhCCCCccceEEEEEEe----CCeE
Q psy6905 117 NKLIFG-EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLL-WLFDHRNIVSLIGVCLQ----SPKL 188 (527)
Q Consensus 117 ~~~~~~-~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l-~~l~hpnIv~~~~~~~~----~~~~ 188 (527)
++|.+. +.||.|+||.||+|.+. ++.||||++... ..+.+|+.++ +..+||||+++++++.. ...+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 456665 78999999999999984 678999998642 3456777776 45589999999999876 5678
Q ss_pred EEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 189 CLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
|+|||||.||+|.+++.. ..+++..+..|+.||+.||.|||++| ||||||||+|||++.+.. .+.+||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~-----~~~~kl~ 206 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRP-----NAILKLT 206 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSST-----TCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCC-----CccEEEE
Confidence 999999999999999974 35899999999999999999999995 999999999999987321 2689999
Q ss_pred ccCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCccC
Q psy6905 266 DFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYA----VAYGVAVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~----~~~~i~~~~~~~ 340 (527)
|||+++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+... ....+....+.+
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp CCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred ecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 999998654322 235678999999999999999999999999999999999999998754322 233444445544
Q ss_pred CCC--CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 341 PIP--STCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 341 ~~p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
+.+ ..+++++.+||..||..||.+|||+.+++++-
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 433 57899999999999999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=357.94 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=219.1
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
.++|.+.+.||+|+||.||+|.+. ++.||+|++.... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999874 6789999986543 3445677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||.+|+|.+.+. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+.. .+.+||+|||++.
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~-----~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAK-----GAAVKLADFGLAI 156 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSST-----TCCEEECCCTTCE
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCC-----CCcEEEeeceeeE
Confidence 9999999987765 667999999999999999999999995 999999999999986532 2469999999997
Q ss_pred hhhcccc-ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCccH
Q psy6905 272 EVYKTTH-MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQ 348 (527)
Q Consensus 272 ~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~ 348 (527)
....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......+.+ ..+++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 6643322 34579999999999999999999999999999999999999999998888887777666555544 57899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.+||..||..||.+|||+.+++++
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcC
Confidence 99999999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=372.63 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=216.4
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
..++..++|.+.+.||+|+||.||+|.+. +..||+|++...........+.+|+.+++.++||||+++++++.++..+
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 34677789999999999999999999985 6789999998776666678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+|||||+||+|.+++. .+.+++..+..++.||+.||.|||+.. +|+||||||+|||++.+ +.+||+||
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~--------~~~kl~Df 176 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSR--------GEIKLCDF 176 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTT--------CCEEECCC
T ss_pred EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCC--------CCEEEEEC
Confidence 99999999999999987 457999999999999999999999851 39999999999999875 68999999
Q ss_pred CcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------------
Q psy6905 268 GLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG--------------- 332 (527)
Q Consensus 268 Gla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~--------------- 332 (527)
|++............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 177 g~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3eqc_A 177 GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256 (360)
T ss_dssp CCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred CCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence 99987755555566899999999999999999999999999999999999999987665433211
Q ss_pred ---------------------------HHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 333 ---------------------------VAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 333 ---------------------------i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.........+..++.++.+||.+||..||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 111111122234578999999999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=368.29 Aligned_cols=258 Identities=33% Similarity=0.592 Sum_probs=219.3
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--Cc--eEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCe
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQ--EVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~ 187 (527)
.++.++|++.+.||+|+||.||+|.+. +. .+|+|.+...........+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 356789999999999999999999874 44 35999887654444567788999999999 99999999999999999
Q ss_pred EEEEEeccCCCCHHHHhcCC-----------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCC
Q psy6905 188 LCLVMEYARGGPLNRVLAGR-----------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSE 250 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~-----------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~ 250 (527)
+|+|||||++|+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcC
Confidence 99999999999999998743 5899999999999999999999995 999999999999986
Q ss_pred CCcccccccceeEEeccCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy6905 251 PIENEDLQFKTLKITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328 (527)
Q Consensus 251 ~~~~~~~~~~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~ 328 (527)
+ +.+||+|||+++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus 178 ~--------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~ 249 (327)
T 1fvr_A 178 N--------YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249 (327)
T ss_dssp G--------GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred C--------CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence 5 689999999997543222 223457889999999998889999999999999999998 999999988777
Q ss_pred HHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 329 ~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
....+. .+...+.|..+++.+.+||.+||..||.+|||+.+++++|+.+....
T Consensus 250 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 250 LYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHhh-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 666554 34556778889999999999999999999999999999999988754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=369.58 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=211.7
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCC--CccceEEEEEEeCC
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDH--RNIVSLIGVCLQSP 186 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h--pnIv~~~~~~~~~~ 186 (527)
.+++..+.|.+.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++| |||+++++++.++.
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 4567788999999999999999999987 45789999887543 44456788999999999976 99999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.+|+|||| .+|+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++. +.+||+
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~~---------~~~kl~ 149 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD---------GMLKLI 149 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET---------TEEEEC
T ss_pred EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEEC---------CcEEEe
Confidence 99999995 5889999887 567999999999999999999999995 999999999999974 589999
Q ss_pred ccCcchhhhccc----cccCCCcccccccccccc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCC-HHHH
Q psy6905 266 DFGLAREVYKTT----HMSAAGTYAWMAPEVIKT-----------SIFSKASDVWSYGVVLWELLTGEIPYKSIN-AYAV 329 (527)
Q Consensus 266 DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~-----------~~~~~ksDvwSlGv~l~elltg~~Pf~~~~-~~~~ 329 (527)
|||+++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 229 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH
Confidence 999998764322 224579999999999865 678999999999999999999999998754 3344
Q ss_pred HHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 330 ~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+.........|..++..+.+||..||..||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 455555566677888899999999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=363.93 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=204.1
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHh--CCCCccceEEEEEEe----CCe
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWL--FDHRNIVSLIGVCLQ----SPK 187 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~~~~~~~~----~~~ 187 (527)
+..++|++.+.||+|+||.||+|.++++.||||++.... ...+..|.+++.. ++||||+++++++.. ...
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 345789999999999999999999999999999986532 3445567777766 799999999999765 345
Q ss_pred EEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHH--------hcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 188 LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLH--------CQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH--------~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
+|+|||||++|+|.+++....+++..++.++.||+.||.||| +. +|+||||||+|||++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~-------- 149 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKN-------- 149 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTT--------
T ss_pred eEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCC--------
Confidence 899999999999999999889999999999999999999999 77 59999999999999875
Q ss_pred ceeEEeccCcchhhhccc------cccCCCccccccccccccC------CCCcccchHHHHHHHHHHHhC----------
Q psy6905 260 KTLKITDFGLAREVYKTT------HMSAAGTYAWMAPEVIKTS------IFSKASDVWSYGVVLWELLTG---------- 317 (527)
Q Consensus 260 ~~vkL~DFGla~~~~~~~------~~~~~gt~~y~aPE~l~~~------~~~~ksDvwSlGv~l~elltg---------- 317 (527)
+.+||+|||+++...... .....||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 689999999997653222 1234799999999999876 455799999999999999999
Q ss_pred CCCCCCCC----HHHHHHH-HHhCCccCCCC-----CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q psy6905 318 EIPYKSIN----AYAVAYG-VAVNKLTLPIP-----STCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378 (527)
Q Consensus 318 ~~Pf~~~~----~~~~~~~-i~~~~~~~~~p-----~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~ 378 (527)
..||.... ....... +.........| ..+++.+.+||..||+.||.+|||+.++++.|+.+
T Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 88886532 1222222 22233333333 23678899999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=367.44 Aligned_cols=261 Identities=23% Similarity=0.394 Sum_probs=210.7
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC--eEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP--KLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~--~~~ 189 (527)
+..++|.+.+.||+|+||.||+|.+. ++.||||++.........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 45678999999999999999999985 67999999876443333567789999999999999999999998755 789
Q ss_pred EEEeccCCCCHHHHhcCC----CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 190 LVMEYARGGPLNRVLAGR----KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~----~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
+|||||++|+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||+..... ..+.+||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~----~~~~~kL~ 158 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGED----GQSVYKLT 158 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTT----SCEEEEEC
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCC----CCceEEEc
Confidence 999999999999998732 3899999999999999999999995 999999999999821100 12579999
Q ss_pred ccCcchhhhccc-cccCCCccccccccccc--------cCCCCcccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHH
Q psy6905 266 DFGLAREVYKTT-HMSAAGTYAWMAPEVIK--------TSIFSKASDVWSYGVVLWELLTGEIPYKSIN----AYAVAYG 332 (527)
Q Consensus 266 DFGla~~~~~~~-~~~~~gt~~y~aPE~l~--------~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~----~~~~~~~ 332 (527)
|||+++...... .....||+.|+|||++. +..++.++|||||||++|+|++|..||.... ..+....
T Consensus 159 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred cCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 999998764433 23457999999999986 5678999999999999999999999997533 2334444
Q ss_pred HHhCCc-------------------cC----CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 333 VAVNKL-------------------TL----PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 333 i~~~~~-------------------~~----~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
+..... .+ .++..++..+.++|.+||..||.+|||+.+++++..+..+.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 432211 11 12234567899999999999999999999999998776653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=363.97 Aligned_cols=255 Identities=37% Similarity=0.684 Sum_probs=209.6
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
.++.++|++.+.||+|+||.||+|.+.++.||||.+... ...+.+.+|+.+++.++||||+++++++.+ ..|+||
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 467889999999999999999999999999999998654 335678899999999999999999998874 479999
Q ss_pred eccCCCCHHHHhcCC----CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 193 EYARGGPLNRVLAGR----KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 193 Ey~~ggsL~~~l~~~----~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|||+||+|.+++... .++...++.++.||+.||.|||+.+..+|+||||||+|||++.+. ..+||+|||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-------~~~kl~Dfg 151 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG-------TVLKICDFG 151 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT-------TEEEECCCC
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC-------CEEEEcccc
Confidence 999999999999743 368889999999999999999993212599999999999998651 358999999
Q ss_pred cchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCccCCCCCCc
Q psy6905 269 LAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA--YAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 269 la~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~ 346 (527)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+ ..+...+.+..+
T Consensus 152 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 229 (307)
T 2eva_A 152 TACDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-HNGTRPPLIKNL 229 (307)
T ss_dssp C-------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-HTTCCCCCBTTC
T ss_pred cccccccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-hcCCCCCccccc
Confidence 99765332 2234699999999999999999999999999999999999999986533 2333333 234556677889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
|+.+.+||.+||..||.+|||+.++++.|+.+...
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999887643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=387.28 Aligned_cols=250 Identities=28% Similarity=0.446 Sum_probs=209.6
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC--CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
..+..++|.+.+.||+|+||.||+|.+ +++.||||++... ........+.+|+.+++.++||||+++++++.+.+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 446678999999999999999999987 4678999998643 122334667889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHC-QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~-~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
+|+|||||+||+|.+++. .+.+++..+..++.||+.||+|||+ . +||||||||+||||+.+ +.+||+
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~--------~~~kl~ 291 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKD--------GHIKIT 291 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSS--------SCEEEC
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCC--------CCEEEc
Confidence 999999999999998886 5679999999999999999999998 6 49999999999999875 689999
Q ss_pred ccCcchhhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 266 DFGLAREVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 266 DFGla~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|||+++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..... ..|
T Consensus 292 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p 369 (446)
T 4ejn_A 292 DFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--RFP 369 (446)
T ss_dssp CCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCC
T ss_pred cCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--CCC
Confidence 9999986432 223356799999999999999999999999999999999999999999988888777765543 567
Q ss_pred CCccHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q psy6905 344 STCPQLFKTLMEACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RP-----s~~~ll~~ 374 (527)
..+++++.+||.+||..||.+|| ++.+++++
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 78999999999999999999999 99999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=387.12 Aligned_cols=252 Identities=21% Similarity=0.347 Sum_probs=215.6
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC--hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD--ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
+.+..++|.+.+.||+|+||.||+|.+. ++.||||++..... ......+.+|..++..++||||++++++|.+...
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 4566789999999999999999999984 57899999864210 0112347789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
+|+|||||.||+|.+++.. +.+++..+..++.||+.||.|||++| ||||||||+||||+.+ +.+||+
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~--------g~vkL~ 217 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMN--------GHIRLA 217 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------SCEEEC
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCC--------CCEEEc
Confidence 9999999999999999974 67999999999999999999999995 9999999999999876 689999
Q ss_pred ccCcchhhhcccc---ccCCCccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy6905 266 DFGLAREVYKTTH---MSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK 337 (527)
Q Consensus 266 DFGla~~~~~~~~---~~~~gt~~y~aPE~l~-----~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~ 337 (527)
|||+++....... ...+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence 9999976543222 2357999999999997 4568999999999999999999999999999888887776544
Q ss_pred ccCCCC---CCccHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q psy6905 338 LTLPIP---STCPQLFKTLMEACWEADSHM--RPSFKTILKA 374 (527)
Q Consensus 338 ~~~~~p---~~~~~~~~~li~~~l~~dp~~--RPs~~~ll~~ 374 (527)
.....| ..+++++.+||++||..+|++ ||++.+++++
T Consensus 298 ~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 444444 348999999999999888888 9999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=367.77 Aligned_cols=255 Identities=33% Similarity=0.610 Sum_probs=214.9
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--Cc----eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQ----EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
+..++|++.+.||+|+||.||+|.+. ++ .||+|.+...........+.+|+.+++.++||||+++++++..+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 55688999999999999999999973 33 368887765544445678899999999999999999999998765
Q ss_pred EEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.++|+||+.+|+|.+++. ...+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~--------~~~kL~ 159 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTP--------QHVKIT 159 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEET--------TEEEEC
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCC--------CCEEEc
Confidence 789999999999999986 456999999999999999999999995 9999999999999865 689999
Q ss_pred ccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 266 DFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+. .....
T Consensus 160 DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~ 238 (327)
T 3lzb_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERL 238 (327)
T ss_dssp CTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCC
T ss_pred cCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 999998763322 123457889999999999999999999999999999999 999999887776655554 45567
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
+.|..++..+.+||..||..||.+|||+.++++.|+.+...
T Consensus 239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 78889999999999999999999999999999999988754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=363.86 Aligned_cols=261 Identities=26% Similarity=0.476 Sum_probs=213.7
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEcC---------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK---------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCL 183 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~---------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~ 183 (527)
++..++|.+.+.||+|+||.||+|.+.. ..||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 5677899999999999999999998743 469999986543 233577899999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHhcCC--CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 184 QSPKLCLVMEYARGGPLNRVLAGR--KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 184 ~~~~~~iv~Ey~~ggsL~~~l~~~--~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
+++..|+|||||.||+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.+........+.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999999733 3899999999999999999999995 99999999999998763221122234
Q ss_pred eEEeccCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 262 LKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 262 vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+......... . .
T Consensus 160 ~kl~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-~--~ 234 (289)
T 4fvq_A 160 IKLSDPGISITVLPK--DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-D--R 234 (289)
T ss_dssp EEECCCCSCTTTSCH--HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-T--T
T ss_pred eeeccCcccccccCc--cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-c--c
Confidence 999999999765322 22457899999999987 678999999999999999999 566666665544433322 2 3
Q ss_pred CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 340 ~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
...|..+++.+.+||..||..||.+|||+.+++++|+.+..+.
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 3456667888999999999999999999999999999887643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=360.21 Aligned_cols=260 Identities=21% Similarity=0.327 Sum_probs=216.4
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~ 189 (527)
.+..++|.+.+.||+|+||.||+|.+ +++.||||++..... ...+.+|+.+++.+ +|+||+++++++.+....|
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 45678899999999999999999996 578999998865432 23467899999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+||||+ +|+|.+++. +..+++..++.++.||+.||.|||++| |+||||||+|||++.+... ..+.+||+||
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~---~~~~~kl~Df 155 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSK---NANMIYVVDF 155 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSST---TTTCEEECCC
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCC---CCCeEEEEEC
Confidence 999999 999999997 456999999999999999999999995 9999999999999875211 1245999999
Q ss_pred Ccchhhhccc---------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh
Q psy6905 268 GLAREVYKTT---------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN---AYAVAYGVAV 335 (527)
Q Consensus 268 Gla~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~---~~~~~~~i~~ 335 (527)
|+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+ .......+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 9998664321 234569999999999999999999999999999999999999998743 3333333332
Q ss_pred CCccCC---CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 336 NKLTLP---IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 336 ~~~~~~---~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
.....+ .+..+|+.+.+||..||..||.+||++.+|++.|+++....
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 222222 23578999999999999999999999999999999887653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=358.16 Aligned_cols=247 Identities=25% Similarity=0.351 Sum_probs=203.7
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999984 6789999887543 33446778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||.++.+..+.. ++.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~--------~~~kl~Dfg~~~~ 150 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRN--------GELKLANFGLARA 150 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------SCEEECCCTTCEE
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC--------CCEEEeeccccee
Confidence 997654444444 577999999999999999999999995 9999999999999875 6899999999986
Q ss_pred hhcc--ccccCCCccccccccccccCC-CCcccchHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCc----------
Q psy6905 273 VYKT--THMSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIP-YKSINAYAVAYGVAVNKL---------- 338 (527)
Q Consensus 273 ~~~~--~~~~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~elltg~~P-f~~~~~~~~~~~i~~~~~---------- 338 (527)
.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+.......+.....
T Consensus 151 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred cCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 5422 223457899999999997765 89999999999999999987766 566665555444432100
Q ss_pred -----------------cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 -----------------TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 -----------------~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.......+++.+.+||.+||..||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 011223578999999999999999999999999873
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=376.35 Aligned_cols=245 Identities=29% Similarity=0.458 Sum_probs=208.0
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999998 56799999876421 111135678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||| +|+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~--------~~~kl~DFG~s 155 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDN--------LNVKIADFGLS 155 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTT--------CCEEECCSSCT
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCC--------CCEEEEEeccc
Confidence 9999 678877765 678999999999999999999999995 9999999999999875 68999999999
Q ss_pred hhhhccc-cccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 271 REVYKTT-HMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 271 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
....... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+. ......|..+|+
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~ 233 (336)
T 3h4j_B 156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN--SCVYVMPDFLSP 233 (336)
T ss_dssp BTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC--SSCCCCCTTSCH
T ss_pred eeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH--cCCCCCcccCCH
Confidence 8764432 335679999999999988776 689999999999999999999998765433322221 223456788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.+||.+||..||.+|||+.+++++
T Consensus 234 ~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 234 GAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 99999999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=382.64 Aligned_cols=249 Identities=29% Similarity=0.437 Sum_probs=215.5
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 57999999999999999999984 6789999975321 11124678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||.||+|.+.+. .+.+++..+..++.||+.||.|||++| ||||||||+|||++.... .+.+||+|||+++.
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~-----~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEK-----DCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSST-----TCCEEECSCSCTTT
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCC-----CCCEEEEECCcCeE
Confidence 999999988775 678999999999999999999999995 999999999999975421 25799999999986
Q ss_pred hhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCccHH
Q psy6905 273 VYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQL 349 (527)
Q Consensus 273 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~ 349 (527)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....+..+.| ..+|+.
T Consensus 174 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp BCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred CCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 64332 234579999999999986 48999999999999999999999999999988888888776665554 568999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+||.+||..||.+|||+.+++++
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=374.46 Aligned_cols=243 Identities=28% Similarity=0.406 Sum_probs=204.2
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHH-HHhCCCCccceEEEEEEeCCeE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKL-LWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~-l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
+..++|++.+.||+|+||.||+|.+. ++.||||++.... .......+..|..+ ++.++||||+++++++.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 45678999999999999999999984 5689999986542 22234456667666 5678999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+|||||.||+|.+++. .+.+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+||
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~--------g~ikL~DF 183 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQ--------GHIVLTDF 183 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------SCEEECCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCC--------CCEEEeeC
Confidence 99999999999999887 567999999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCC
Q psy6905 268 GLAREVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST 345 (527)
Q Consensus 268 Gla~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 345 (527)
|+++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.... ...|..
T Consensus 184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~ 261 (373)
T 2r5t_A 184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPN 261 (373)
T ss_dssp CBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--CCCCSS
T ss_pred ccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--cCCCCC
Confidence 99986432 22345689999999999999999999999999999999999999999998888887777554 345678
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFK 369 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~ 369 (527)
++..+.+||.+||..||.+||++.
T Consensus 262 ~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 262 ITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCHHHHHHHHHHcccCHHhCCCCC
Confidence 999999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=357.41 Aligned_cols=253 Identities=36% Similarity=0.651 Sum_probs=216.6
Q ss_pred ceeeeeeeccCCceEEEEeeEc--C---ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE-EEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--K---QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL-CLV 191 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~-~iv 191 (527)
.|.+.+.||+|+||.||+|.+. + ..||+|++.........+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566799999999999999863 2 269999998766666678899999999999999999999999876655 999
Q ss_pred EeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 192 MEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||+.+|+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~--------~~~kl~Dfg~ 170 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDES--------FTVKVADFGL 170 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT--------CCEEECCTTS
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC--------CcEEeCcCCC
Confidence 999999999999873 56889999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhccc------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCC
Q psy6905 270 AREVYKTT------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPI 342 (527)
Q Consensus 270 a~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 342 (527)
++...... .....+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+. .....+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~ 249 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQ 249 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCC
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCC
Confidence 97653321 223457899999999999999999999999999999999 556666666655555444 4455677
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
|..+++.+.++|..||..||.+|||+.++++.|+.+....
T Consensus 250 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 250 PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 8889999999999999999999999999999999887654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=361.35 Aligned_cols=261 Identities=30% Similarity=0.591 Sum_probs=215.2
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEcC-----ceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEE
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-----QEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVC 182 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~ 182 (527)
...+.++.++|.+.+.||+|+||.||+|.+.. ..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 34567888999999999999999999998642 379999987653 444567889999999999999999999999
Q ss_pred EeCC-----eEEEEEeccCCCCHHHHhc-------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCC
Q psy6905 183 LQSP-----KLCLVMEYARGGPLNRVLA-------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSE 250 (527)
Q Consensus 183 ~~~~-----~~~iv~Ey~~ggsL~~~l~-------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~ 250 (527)
.+.. ..|+|||||.+|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence 8754 3599999999999999883 356899999999999999999999995 999999999999987
Q ss_pred CCcccccccceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q psy6905 251 PIENEDLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSIN 325 (527)
Q Consensus 251 ~~~~~~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~ 325 (527)
+ +.+||+|||+++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 183 ~--------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 183 D--------MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp T--------SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred C--------CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 5 689999999998664322 123357889999999999999999999999999999999 999999888
Q ss_pred HHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 326 AYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 326 ~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.......+. .+...+.|..+++.+.++|.+||..||.+|||+.+++++|+.+...
T Consensus 255 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 255 NHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp GGGHHHHHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 776665554 3445677888999999999999999999999999999999887653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=359.53 Aligned_cols=255 Identities=34% Similarity=0.634 Sum_probs=217.7
Q ss_pred CCceeeeeeeccCCceEEEEeeEcC-----ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEE-eCCeEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYEK-----QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCL-QSPKLC 189 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~-~~~~~~ 189 (527)
...|++.+.||+|+||.||+|.+.. ..||+|.+.........+.+.+|+.+++.++||||+++++++. .+...|
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468899999999999999998632 2589999887766666788999999999999999999999965 456789
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+|||||.+|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+||
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~--------~~~kl~Df 172 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEK--------FTVKVADF 172 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT--------CCEEECSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCC--------CCEEECcc
Confidence 9999999999999996 456889999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhccc------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 268 GLAREVYKTT------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 268 Gla~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
|+++...... .....||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+.. ....
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~ 251 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRL 251 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT-TCCC
T ss_pred cccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc-CCCC
Confidence 9998653322 223457889999999999999999999999999999999 7788887776666555543 4455
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
..|..+|+.+.+++..||..||.+|||+.++++.|+.+....
T Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 252 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 667889999999999999999999999999999999887643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=372.89 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=212.5
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCC--CCccceEEEEEEeCC
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNP-DENILENVKQEGKLLWLFD--HRNIVSLIGVCLQSP 186 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~--hpnIv~~~~~~~~~~ 186 (527)
...+....|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.+. ||||+++++++...+
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 35566778999999999999999999874 6789999986543 4455778999999999996 599999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.+|+||| |.+|+|.+++. ...+++..+..++.||+.||.|||++| ||||||||+|||++. +.+||+
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~---------~~~kl~ 196 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD---------GMLKLI 196 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEESS---------SCEEEC
T ss_pred EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEEC---------CeEEEE
Confidence 9999999 56889999987 567889999999999999999999995 999999999999964 589999
Q ss_pred ccCcchhhhccc----cccCCCcccccccccccc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCC-HHHH
Q psy6905 266 DFGLAREVYKTT----HMSAAGTYAWMAPEVIKT-----------SIFSKASDVWSYGVVLWELLTGEIPYKSIN-AYAV 329 (527)
Q Consensus 266 DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~-----------~~~~~ksDvwSlGv~l~elltg~~Pf~~~~-~~~~ 329 (527)
|||+++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ....
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 276 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH
Confidence 999998764322 234579999999999865 368999999999999999999999998754 3445
Q ss_pred HHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 330 ~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+.......+.|..++..+.+||.+||..||.+|||+.+++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 555555566677888889999999999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=369.99 Aligned_cols=249 Identities=32% Similarity=0.466 Sum_probs=209.7
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC----ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP----DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
++|.+.+.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 57999999999999999999874 5689999875431 23346788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcC-----------------------------------------CCCChhHHHHHHHHHHHHHHHHH
Q psy6905 191 VMEYARGGPLNRVLAG-----------------------------------------RKIRPDVLVDWAIQIAEGMNYLH 229 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~-----------------------------------------~~~~~~~~~~i~~qi~~~L~yLH 229 (527)
|||||+||+|.+++.. ..+++..+..++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999851 12356678889999999999999
Q ss_pred hcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccc------cccCCCcccccccccccc--CCCCcc
Q psy6905 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT------HMSAAGTYAWMAPEVIKT--SIFSKA 301 (527)
Q Consensus 230 ~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~------~~~~~gt~~y~aPE~l~~--~~~~~k 301 (527)
++| |+||||||+|||++.+. ...+||+|||+++...... .....||+.|+|||++.+ ..++.+
T Consensus 186 ~~~---ivH~Dlkp~NIll~~~~------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 186 NQG---ICHRDIKPENFLFSTNK------SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HTT---EECCCCCGGGEEESCSS------SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HCC---ccccCCChhhEEEecCC------CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 995 99999999999998642 1379999999998653311 224569999999999975 678999
Q ss_pred cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 302 SDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 302 sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+|||||||++|+|++|+.||.+.+.......+.......+.| ..+++.+.+||.+||..||.+||++.+++++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999999999999888888877666555444 3478999999999999999999999999884
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=375.54 Aligned_cols=255 Identities=33% Similarity=0.641 Sum_probs=210.5
Q ss_pred CceeeeeeeccCCceEEEEeeEc--C---ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe-CCeEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--K---QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ-SPKLCL 190 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~~~i 190 (527)
..|.+.+.||+|+||.||+|.+. + ..||+|.+.........+.+.+|+.+++.++||||+++++++.+ ++..|+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35778899999999999999863 1 35899998776665667889999999999999999999999754 557899
Q ss_pred EEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 191 VMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|||||.+|+|.+++.. ..++...++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~--------~~~kL~DFG 237 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEK--------FTVKVADFG 237 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT--------CCEEECCC-
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCC--------CCEEEeecc
Confidence 9999999999999973 45888999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhccc------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 269 LAREVYKTT------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 269 la~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
+++...... .....+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+. .+....
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~ 316 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLL 316 (373)
T ss_dssp --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCC
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 998663322 123457889999999999999999999999999999999 888998877665555554 344566
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhccc
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~ 383 (527)
.|..+|+.+.++|.+||..||.+|||+.++++.|+.+.....
T Consensus 317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 788899999999999999999999999999999998876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=362.63 Aligned_cols=250 Identities=28% Similarity=0.338 Sum_probs=204.0
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
+.-.++|++.+.||+|+||.||+|.+ +++.||+|++.... .......+.+|+.+++.++||||+++++++.++..+|+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 44557899999999999999999998 56789999987543 23345778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 191 VMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|||||.+ +|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~--------~~~kl~Dfg 164 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSD--------GALKLADFG 164 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------CCEEECCCT
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCC--------CCEEEccCc
Confidence 9999975 7777765 345899999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhcc--ccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC-----
Q psy6905 269 LAREVYKT--THMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL----- 340 (527)
Q Consensus 269 la~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~----- 340 (527)
+++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 165 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 165 LARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred CceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 99866422 2234578999999999876 568999999999999999999999998876655444432210000
Q ss_pred -----------------------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 -----------------------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 -----------------------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....+++++.+||.+||..||.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0123467889999999999999999999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=367.71 Aligned_cols=244 Identities=30% Similarity=0.465 Sum_probs=213.2
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
..|.+.+.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999986 46789999986543 2334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||. |+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~--------~~~kL~DfG~a 201 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEP--------GLVKLGDFGSA 201 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETT--------TEEEECCCTTC
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCC--------CCEEEeeccCc
Confidence 9996 67777764 667999999999999999999999995 9999999999999875 68999999999
Q ss_pred hhhhccccccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCcc
Q psy6905 271 REVYKTTHMSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 271 ~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 347 (527)
+.... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+.......+.........+..++
T Consensus 202 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (348)
T 1u5q_A 202 SIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 279 (348)
T ss_dssp BSSSS--BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred eecCC--CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Confidence 76533 23467999999999984 56789999999999999999999999999888777777776665555567899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+.+||..||..||.+|||+.+++++
T Consensus 280 ~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 280 EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 999999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=375.14 Aligned_cols=252 Identities=19% Similarity=0.339 Sum_probs=208.4
Q ss_pred eEEeCCceeeeeeeccC--CceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 112 VEIDYNKLIFGEAIGEG--GFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G--~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
+..+.++|++++.||+| +||.||+|.+. ++.||||++.... .......+.+|+.+++.++|||||++++++.+++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 44567889999999999 99999999985 6799999987543 3445677889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 187 KLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
.+|+|||||.+|+|.+++.. ..+++..+..++.||+.||.|||++| ||||||||+|||++.+ +.+|
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~--------~~~k 168 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVD--------GKVY 168 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------CCEE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC--------CCEE
Confidence 99999999999999999862 67999999999999999999999995 9999999999999875 6899
Q ss_pred EeccCcchhhhcc---------ccccCCCcccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy6905 264 ITDFGLAREVYKT---------THMSAAGTYAWMAPEVIKT--SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG 332 (527)
Q Consensus 264 L~DFGla~~~~~~---------~~~~~~gt~~y~aPE~l~~--~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 332 (527)
|+|||++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 248 (389)
T 3gni_B 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248 (389)
T ss_dssp ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999998654221 1123468999999999987 5789999999999999999999999988665444433
Q ss_pred HHhCCc--------------------------------------------cCCCCCCccHHHHHHHHHhhhhCCCCCCCH
Q psy6905 333 VAVNKL--------------------------------------------TLPIPSTCPQLFKTLMEACWEADSHMRPSF 368 (527)
Q Consensus 333 i~~~~~--------------------------------------------~~~~p~~~~~~~~~li~~~l~~dp~~RPs~ 368 (527)
+..... ..+.+..+++.+.+||.+||..||.+|||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 328 (389)
T 3gni_B 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328 (389)
T ss_dssp C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence 221111 112456688999999999999999999999
Q ss_pred HHHHHH
Q psy6905 369 KTILKA 374 (527)
Q Consensus 369 ~~ll~~ 374 (527)
.+++++
T Consensus 329 ~ell~h 334 (389)
T 3gni_B 329 STLLNH 334 (389)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=384.65 Aligned_cols=248 Identities=28% Similarity=0.482 Sum_probs=217.0
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+..++|.+++.||+|+||.||+|.+. ++.||||++.... ..+....+.+|+.+++.++||||+++++++.....+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34578999999999999999999974 7899999986431 1122467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+|||||.||+|.+++. ++.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~--------~~vkL~DFG 161 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAH--------MNAKIADFG 161 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTT--------CCEEECCCS
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecC--------CCeEEEecc
Confidence 9999999999999987 567999999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhccc-cccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 269 LAREVYKTT-HMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 269 la~~~~~~~-~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
+++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.... ...|..+
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~ 239 (476)
T 2y94_A 162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQYL 239 (476)
T ss_dssp SCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC--CCCCTTC
T ss_pred chhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--cCCCccC
Confidence 998764332 335679999999999988765 789999999999999999999999888777777666443 4567789
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.+.+||.+||..||.+|||+.+++++
T Consensus 240 s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 240 NPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 9999999999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=363.82 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=215.2
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh-----hHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE-----NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
.+.|.+.+.||+|+||.||+|.+. ++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 357999999999999999999984 678999988654321 1256788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+|||||.+|+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+... ...+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~----~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIP----IPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSS----SCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCC----cCCEEEccC
Confidence 99999999999999987 456899999999999999999999995 9999999999999875210 127999999
Q ss_pred Ccchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC--CCC
Q psy6905 268 GLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPS 344 (527)
Q Consensus 268 Gla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~ 344 (527)
|++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......+ .+.
T Consensus 164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 9998764432 2345799999999999999999999999999999999999999999888777776665443322 225
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+++.+.+||.+||..||.+|||+.+++++
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 788999999999999999999999999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=358.89 Aligned_cols=248 Identities=33% Similarity=0.552 Sum_probs=219.4
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.+.|.+.+.||+|+||.||+|.+. ++.||||++.........+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456899999999999999999874 678999998766544456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 194 YARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 194 y~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
||++++|.+++..+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++...
T Consensus 101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~--------~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEH--------GEVKLADFGVAGQL 169 (303)
T ss_dssp CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------SCEEECCCTTCEEC
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCC--------CCEEEeecccceec
Confidence 999999999999889999999999999999999999995 9999999999999875 68999999999766
Q ss_pred hccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHH
Q psy6905 274 YKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFK 351 (527)
Q Consensus 274 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 351 (527)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+... .....+..++..+.
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 248 (303)
T 3a7i_A 170 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEGNYSKPLK 248 (303)
T ss_dssp BTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCCSSCCHHHH
T ss_pred CccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-CCCCCccccCHHHH
Confidence 4322 23457999999999999999999999999999999999999999988877766655443 34456778999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 352 TLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 352 ~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
+||..||..||.+|||+.+++++.
T Consensus 249 ~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 249 EFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred HHHHHHcCCChhhCcCHHHHhhCh
Confidence 999999999999999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=358.06 Aligned_cols=250 Identities=23% Similarity=0.402 Sum_probs=218.0
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
..+..++|.+.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 3456688999999999999999999984 5689999885431 11124578899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
.|+|||||++|+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~--------~~~kl~D 157 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYK--------GELKIAD 157 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTT--------CCEEECC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCC--------CCEEEec
Confidence 999999999999999887 567999999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 267 FGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 267 FGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
||++............||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+... ....|..+
T Consensus 158 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~ 235 (284)
T 2vgo_A 158 FGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPFL 235 (284)
T ss_dssp CTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTS
T ss_pred ccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--ccCCCCcC
Confidence 9999766544445567999999999999999999999999999999999999999988877776666543 34567889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+..+.++|..||..||.+||++.+++++
T Consensus 236 ~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 236 SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 9999999999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=364.30 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=196.5
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.+.|.+.+.||+|+||.||+|.+. ++.||||++..... .+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD---KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh---HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 457999999999999999999985 56899999876532 3567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||.+|+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.... .+.+||+|||+++.
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~-----~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAP-----DAPLKIADFGLSKI 200 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSST-----TCCEEECCCC----
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCC-----CCCEEEccCccccc
Confidence 999999999887 556899999999999999999999995 999999999999985211 26899999999987
Q ss_pred hhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCccCC--CCCCccH
Q psy6905 273 VYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYA-VAYGVAVNKLTLP--IPSTCPQ 348 (527)
Q Consensus 273 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~--~p~~~~~ 348 (527)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.......+ ....++.
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 64332 234579999999999999999999999999999999999999998766554 4444444443332 3367899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.+||.+||..||.+|||+.+++++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999873
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=359.82 Aligned_cols=250 Identities=27% Similarity=0.365 Sum_probs=213.6
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|.+.+.||+|+||.||+|.+. ++.||+|++...... ....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 357999999999999999999974 688999998765322 24567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||++|+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||+..+.. .+.+||+|||++..
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~-----~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEE-----NSKIMITDFGLSKM 158 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSST-----TCCEEBCSCSTTCC
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCC-----CCCEEEccCCccee
Confidence 999999998876 567899999999999999999999995 999999999999943211 26899999999976
Q ss_pred hhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC--CCCCCccHHH
Q psy6905 273 VYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL--PIPSTCPQLF 350 (527)
Q Consensus 273 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~~~ 350 (527)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....... +.+..+++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (304)
T 2jam_A 159 EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA 238 (304)
T ss_dssp CCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred cCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence 54433334568999999999999999999999999999999999999999988877777776655443 3346789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.++|..||..||.+|||+.+++++
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=375.01 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=199.2
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC-CChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCC--eEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN-PDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSP--KLC 189 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~--~~~ 189 (527)
.++|++++.||+|+||.||+|.+ +++.||||++... ........+.+|+.+++.+. ||||+++++++...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 36899999999999999999987 4678999988654 33445677889999999997 999999999997644 799
Q ss_pred EEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
+|||||. |+|..++..+.+++..+..++.||+.||+|||+.| ||||||||+|||++.+ +.+||+|||+
T Consensus 88 lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~--------~~~kl~DFG~ 155 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAE--------CHVKVADFGL 155 (388)
T ss_dssp EEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------CCEEECCCTT
T ss_pred EEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCC--------CCEEecCCcc
Confidence 9999996 68999998888999999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhcc-----------------------ccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q psy6905 270 AREVYKT-----------------------THMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSIN 325 (527)
Q Consensus 270 a~~~~~~-----------------------~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~ 325 (527)
++..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9764220 1123479999999999986 678999999999999999999999999988
Q ss_pred HHHHHHHHHhCCccC----------------------------------------------CCCCCccHHHHHHHHHhhh
Q psy6905 326 AYAVAYGVAVNKLTL----------------------------------------------PIPSTCPQLFKTLMEACWE 359 (527)
Q Consensus 326 ~~~~~~~i~~~~~~~----------------------------------------------~~p~~~~~~~~~li~~~l~ 359 (527)
.......+... ... ..+..+++++.+||.+||.
T Consensus 236 ~~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 236 TMNQLERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HHHHHHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 76665554311 000 1123678999999999999
Q ss_pred hCCCCCCCHHHHHHH
Q psy6905 360 ADSHMRPSFKTILKA 374 (527)
Q Consensus 360 ~dp~~RPs~~~ll~~ 374 (527)
.||.+|||+.++++|
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999886
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=374.14 Aligned_cols=259 Identities=17% Similarity=0.238 Sum_probs=205.6
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhH----------HHHHHHHHHHHHhCCCCccc
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENI----------LENVKQEGKLLWLFDHRNIV 176 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~----------~~~~~~e~~~l~~l~hpnIv 176 (527)
+..++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 45678999999999999999999873 36799999876532110 11234566677788999999
Q ss_pred eEEEEEEeC----CeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCC
Q psy6905 177 SLIGVCLQS----PKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSE 250 (527)
Q Consensus 177 ~~~~~~~~~----~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~ 250 (527)
++++++... ...||||||| ||+|.+++. .+.+++..++.|+.||+.||.|||++| ||||||||+|||++.
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 999998774 4589999999 999999987 367999999999999999999999995 999999999999983
Q ss_pred CCcccccccceeEEeccCcchhhhcccc---------ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q psy6905 251 PIENEDLQFKTLKITDFGLAREVYKTTH---------MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY 321 (527)
Q Consensus 251 ~~~~~~~~~~~vkL~DFGla~~~~~~~~---------~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf 321 (527)
+. .+.+||+|||+++.+..... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 188 ~~------~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 188 KN------PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp SC------TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred CC------CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 21 26899999999976533211 2335999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCccC---------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 322 KSINAYAVAYGVAVNKLTL---------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 322 ~~~~~~~~~~~i~~~~~~~---------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
.+................. ..+..+|+++.++|..||..||.+||++.+|++.|++++...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 262 EDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp GGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 8643222211111111100 122578999999999999999999999999999999988754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=356.38 Aligned_cols=249 Identities=28% Similarity=0.445 Sum_probs=208.0
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|.+.+.||+|+||.||+|.+. +..||+|++.........+.+.+|+.+++.++||||+++++++.+...+|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57899999999999999999974 6789999887654333467788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 195 ARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 195 ~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|.+|+|.+++. +..+++..++.++.||+.||.|||++| |+||||||+|||++.+.. .+.+||+|||+
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~-----~~~~kl~Dfg~ 173 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSP-----HSPIKIIDFGL 173 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSST-----TCCEEECCCCC
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCC-----CCCEEEEeeec
Confidence 99999988874 467999999999999999999999995 999999999999965321 26799999999
Q ss_pred chhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC-CCCcc
Q psy6905 270 AREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI-PSTCP 347 (527)
Q Consensus 270 a~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~~~ 347 (527)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......... ...++
T Consensus 174 a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 174 AELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp CCC----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCC
T ss_pred ceecCCcccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCC
Confidence 97654332 234579999999999864 6899999999999999999999999998877776666544433322 24478
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+.+||.+||..||.+|||+.+++++
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999873
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=381.86 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=213.0
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
+.+..++|.+.+.||+|+||.||+|.+ +++.||||++.... .......+.+|..++..++||||+++++++.+.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 456778999999999999999999998 46899999986421 11123447789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
+|+|||||.||+|.+++. +..+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~--------g~vkL~ 204 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC--------GHIRLA 204 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------SCEEEC
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCC--------CCEEEe
Confidence 999999999999999987 357999999999999999999999995 9999999999999875 689999
Q ss_pred ccCcchhhhccc---cccCCCccccccccccc-------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6905 266 DFGLAREVYKTT---HMSAAGTYAWMAPEVIK-------TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV 335 (527)
Q Consensus 266 DFGla~~~~~~~---~~~~~gt~~y~aPE~l~-------~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 335 (527)
|||+++...... ....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+....+..
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 999998764322 22458999999999997 35689999999999999999999999999988887777764
Q ss_pred CCccCCC---CCCccHHHHHHHHHhhhhCCCCC---CCHHHHHHH
Q psy6905 336 NKLTLPI---PSTCPQLFKTLMEACWEADSHMR---PSFKTILKA 374 (527)
Q Consensus 336 ~~~~~~~---p~~~~~~~~~li~~~l~~dp~~R---Ps~~~ll~~ 374 (527)
....... +..+|+++++||++||. +|.+| |++.++++|
T Consensus 285 ~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 3333333 36799999999999999 99998 588888764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=396.51 Aligned_cols=257 Identities=33% Similarity=0.617 Sum_probs=219.3
Q ss_pred eeEEeCCceeeee-eeccCCceEEEEeeEc----CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 111 LVEIDYNKLIFGE-AIGEGGFGKVYKGIYE----KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 111 ~~~i~~~~~~~~~-~iG~G~fg~Vy~~~~~----~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
.|.++...+.+.. .||+|+||.||+|.+. ++.||||++.... +....+.+.+|+.+++.++|||||++++++..
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 441 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 441 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3566777776654 8999999999999763 3679999987642 33346789999999999999999999999965
Q ss_pred CCeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
+.+++|||||.+|+|.+++. ++.+++..++.|+.||+.||+|||++| ||||||||+||||+.+ +.+|
T Consensus 442 -~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~--------~~~k 509 (635)
T 4fl3_A 442 -ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQ--------HYAK 509 (635)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET--------TEEE
T ss_pred -CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCC--------CCEE
Confidence 46899999999999999987 567999999999999999999999995 9999999999999875 6899
Q ss_pred EeccCcchhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Q psy6905 264 ITDFGLAREVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK 337 (527)
Q Consensus 264 L~DFGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~ 337 (527)
|+|||+++.+..... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. .+
T Consensus 510 L~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~ 588 (635)
T 4fl3_A 510 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KG 588 (635)
T ss_dssp ECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TT
T ss_pred EEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 999999987643221 22346889999999999999999999999999999998 999999998887776665 45
Q ss_pred ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 338 ~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
...+.|..+|+++.+||..||..||.+||++.+|++.|+++..
T Consensus 589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 6778899999999999999999999999999999999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=370.65 Aligned_cols=247 Identities=26% Similarity=0.420 Sum_probs=207.8
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
.++|.+.+.||+|+||.||+|.+. ++.||||++...... ..+|+.++..+ +||||+++++++.++..+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 357999999999999999999984 678999998765322 23677777777 7999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||.||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||+..+.. ..+.+||+|||+++
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~----~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESG----NPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSC----SGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCC----CcCeEEEEECCCcc
Confidence 9999999998876 567999999999999999999999995 999999999999865311 12469999999998
Q ss_pred hhhcc--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhCCccCC--CCC
Q psy6905 272 EVYKT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKS---INAYAVAYGVAVNKLTLP--IPS 344 (527)
Q Consensus 272 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~---~~~~~~~~~i~~~~~~~~--~p~ 344 (527)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+ .+..+....+....+.++ .+.
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 66432 23356799999999999888889999999999999999999999986 345556666665555433 336
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+++++.+||.+||..||.+||++.+++++
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 789999999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=358.06 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=203.8
Q ss_pred CceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|.+.+.||+|+||.||+|.+. ++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999984 67899999866432 22246678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
+.+ +|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~--------~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINRE--------GELKIADFGLARA 149 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT--------SCEEECCTTHHHH
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCC--------CCEEEeECccccc
Confidence 965 8888876 367899999999999999999999995 9999999999999875 6899999999987
Q ss_pred hhcc--ccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Q psy6905 273 VYKT--THMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK------------ 337 (527)
Q Consensus 273 ~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~------------ 337 (527)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 150 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 6432 22345689999999999764 58999999999999999999999999988766655443210
Q ss_pred ----ccC-----------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 ----LTL-----------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 ----~~~-----------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.. .....+++.+.+||.+||..||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0124578999999999999999999999999873
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=370.97 Aligned_cols=245 Identities=28% Similarity=0.349 Sum_probs=206.5
Q ss_pred eeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEeccCC
Q psy6905 120 IFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARG 197 (527)
Q Consensus 120 ~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~~g 197 (527)
...+.||+|+||.||+|.+ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.+|+|||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 3467899999999999987 467899999876532 3457789999999999999999999999999999999999999
Q ss_pred CCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 198 GPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 198 gsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||+..+. .+.+||+|||+++....
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~------~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRD------AKQIKIIDFGLARRYKP 241 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETT------TTEEEECCCSSCEECCT
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCC------CCcEEEEeCCCceecCC
Confidence 99988875 346899999999999999999999995 99999999999994321 26899999999987643
Q ss_pred cc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC--CCCccHHHHH
Q psy6905 276 TT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI--PSTCPQLFKT 352 (527)
Q Consensus 276 ~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~~~~ 352 (527)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......+. ...+++++.+
T Consensus 242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 321 (373)
T 2x4f_A 242 REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKE 321 (373)
T ss_dssp TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHH
T ss_pred ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHH
Confidence 32 23456999999999999989999999999999999999999999999888887777765554332 2568999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q psy6905 353 LMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 353 li~~~l~~dp~~RPs~~~ll~~ 374 (527)
||.+||..||.+|||+.+++++
T Consensus 322 li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 322 FISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999884
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=365.67 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=208.6
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC---
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP--- 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~--- 186 (527)
.-.++|++.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 3457899999999999999999997 46789999987653 3445678899999999999999999999987654
Q ss_pred -eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 -KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 -~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
..|+|||||+||+|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~--------~~~kl 157 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISAT--------NAVKV 157 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETT--------SCEEE
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCC--------CCEEE
Confidence 3599999999999999987 567999999999999999999999995 9999999999999875 68999
Q ss_pred eccCcchhhhccc-----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 265 TDFGLAREVYKTT-----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 265 ~DFGla~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..............
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence 9999998664321 12346899999999999999999999999999999999999999998887777666554432
Q ss_pred CC--CCCCccHHHHHHHHHhhhhCCCCCCCHHHHH-HHHhhhh
Q psy6905 340 LP--IPSTCPQLFKTLMEACWEADSHMRPSFKTIL-KALNNIV 379 (527)
Q Consensus 340 ~~--~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll-~~L~~~~ 379 (527)
.+ .+..+|+.+.++|.+||..||.+||+..+++ ..+....
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 238 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 22 2356899999999999999999999766555 4454443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=365.57 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=194.0
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|++.+.||+|+||.||+|.+. ++.||||++...........+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999874 678999998765444345677899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcC-------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 194 YARGGPLNRVLAG-------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 194 y~~ggsL~~~l~~-------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
||. |+|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~--------~~~kl~D 151 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKR--------GQLKLGD 151 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------CCEEECC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCC--------CCEEECc
Confidence 997 689888752 35889999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhcc--ccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------
Q psy6905 267 FGLAREVYKT--THMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK------ 337 (527)
Q Consensus 267 FGla~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~------ 337 (527)
||+++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 152 fg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 152 FGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231 (317)
T ss_dssp CSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTT
T ss_pred CccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 9999876432 22345789999999999764 68999999999999999999999999988776655443210
Q ss_pred ----------c----------------cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 ----------L----------------TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 ----------~----------------~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+ ....+..++..+.+||.+||..||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 001223578899999999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=354.55 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=212.3
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|.+.+.||+|+||.||+|.+. +..||+|.+....... .+.+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 57999999999999999999985 4579999876543222 56788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|.+++|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||+..+.. .+.+||+|||++...
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~-----~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSP-----DSPLKLIDFGLAARF 159 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSST-----TCCEEECCCTTCEEC
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCC-----CCcEEEEecccceec
Confidence 99999988876 567899999999999999999999995 999999999999943211 268999999999766
Q ss_pred hccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCccHHH
Q psy6905 274 YKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQLF 350 (527)
Q Consensus 274 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~~ 350 (527)
.... .....||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+.......+.......+.. ..+++.+
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 160 KPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp CTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred cCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence 4322 2345799999999998765 8999999999999999999999999998888877777655443322 3689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+||.+||+.||.+|||+.+++++
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=355.09 Aligned_cols=252 Identities=29% Similarity=0.455 Sum_probs=210.8
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEe----CC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ----SP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----~~ 186 (527)
.+...|.+.+.||+|+||.||+|.+. +..||+|++... ......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 34567899999999999999999984 468999987654 234456788999999999999999999999875 45
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.+|+|||||++|+|.+++. .+.+++..++.++.||+.||.|||++|+ +|+||||||+|||++.. .+.+||+
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~-------~~~~kl~ 174 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGP-------TGSVKIG 174 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESST-------TSCEEEC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECC-------CCCEEEe
Confidence 6899999999999999997 4779999999999999999999999832 39999999999999732 2689999
Q ss_pred ccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhCCccCCCCC
Q psy6905 266 DFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY-GVAVNKLTLPIPS 344 (527)
Q Consensus 266 DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~-~i~~~~~~~~~p~ 344 (527)
|||++............||+.|+|||++.+ .++.++|||||||++|+|++|..||.......... .+.........+.
T Consensus 175 Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (290)
T 1t4h_A 175 DLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253 (290)
T ss_dssp CTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred eCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCC
Confidence 999997665554555679999999998875 58999999999999999999999998855544443 3333333334566
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+++.+.+||..||..||.+|||+.+++++
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 778999999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=357.58 Aligned_cols=257 Identities=34% Similarity=0.607 Sum_probs=215.3
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc---Cc--eEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE---KQ--EVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~---~~--~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
..+..++|++.+.||+|+||.||+|.+. ++ .||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 4567789999999999999999999863 22 58999987642 33456788999999999999999999999987
Q ss_pred CCeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
.. .++||||+.+|+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~--------~~~ 160 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATR--------DLV 160 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEET--------TEE
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCC--------CCE
Confidence 65 899999999999999887 356999999999999999999999995 9999999999999865 689
Q ss_pred EEeccCcchhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Q psy6905 263 KITDFGLAREVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVN 336 (527)
Q Consensus 263 kL~DFGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~ 336 (527)
||+|||++........ ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 240 (291)
T 1u46_A 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240 (291)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred EEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc
Confidence 9999999976643221 23457889999999998889999999999999999999 99999999988888888777
Q ss_pred CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 337 KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 337 ~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
....+.+..+|+.+.++|.+||..||.+|||+.++++.|+++..
T Consensus 241 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 77778888999999999999999999999999999999887654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=362.63 Aligned_cols=255 Identities=27% Similarity=0.493 Sum_probs=206.3
Q ss_pred CCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHh--CCCCccceEEEEEEeC----CeEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWL--FDHRNIVSLIGVCLQS----PKLC 189 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~~~~~~~~~----~~~~ 189 (527)
.++|++.+.||+|+||.||+|.++++.||||++.... ......|..++.. ++||||+++++++... ..+|
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 4689999999999999999999999999999986432 2334455555554 4999999999999887 7899
Q ss_pred EEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA-----PISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g-----~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
+|||||.+|+|.+++....+++..++.++.||+.||.|||+++ ..+||||||||+|||++.+ +.+||
T Consensus 112 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~--------~~~kl 183 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN--------GTCCI 183 (337)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT--------SCEEE
T ss_pred EEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC--------CCEEE
Confidence 9999999999999999888999999999999999999999871 0139999999999999875 68999
Q ss_pred eccCcchhhhcccc------ccCCCccccccccccccCCCCcc------cchHHHHHHHHHHHhC----------CCCCC
Q psy6905 265 TDFGLAREVYKTTH------MSAAGTYAWMAPEVIKTSIFSKA------SDVWSYGVVLWELLTG----------EIPYK 322 (527)
Q Consensus 265 ~DFGla~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~k------sDvwSlGv~l~elltg----------~~Pf~ 322 (527)
+|||+++....... ....||+.|+|||++.+..++.. +|||||||++|||++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999976533221 24579999999999988766654 9999999999999999 77776
Q ss_pred CCC-----HHHHHHHHHhCCccCCCCC-----CccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 323 SIN-----AYAVAYGVAVNKLTLPIPS-----TCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 323 ~~~-----~~~~~~~i~~~~~~~~~p~-----~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
... .......+.........|. .+++.+.+||.+||+.||.+|||+.+++++|+.+..+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 532 1222222333344444443 57788999999999999999999999999999887654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=367.30 Aligned_cols=254 Identities=31% Similarity=0.469 Sum_probs=210.9
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
..++|.+.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 4578999999999999999999974 67999998876543 346778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCC-----CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 194 YARGGPLNRVLAGR-----KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 194 y~~ggsL~~~l~~~-----~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
||++|+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~--------~~~kl~Dfg 184 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN--------FVPKITDFG 184 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTT--------CCEEECCCT
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCC--------CCEEEeecc
Confidence 99999999998633 4889999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hC-
Q psy6905 269 LAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYA------VAYGVA-VN- 336 (527)
Q Consensus 269 la~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~------~~~~i~-~~- 336 (527)
+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ...... ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 997643211 123458999999999998899999999999999999999999997643211 100110 00
Q ss_pred -------CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 337 -------KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 337 -------~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
......+..++..+.+++.+||..||.+|||+.+++++|+.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 11112334567789999999999999999999999999988765
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=354.13 Aligned_cols=257 Identities=23% Similarity=0.412 Sum_probs=206.6
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC--CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
...+|++.+.||+|+||.||+|.+ +++.||||++... ........+.+|+.+++.++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999987 4689999998753 244556788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 191 VMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
||||+.+|+|.+++. ...+++..++.++.||+.||.|||++| ++||||||+|||++.+ +.+||+
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~--------~~~kl~ 178 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITAT--------GVVKLG 178 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------SCEEEC
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCC--------CCEEEE
Confidence 999999999999885 456899999999999999999999995 9999999999999875 689999
Q ss_pred ccCcchhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCccCC
Q psy6905 266 DFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN--AYAVAYGVAVNKLTLP 341 (527)
Q Consensus 266 DFGla~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~--~~~~~~~i~~~~~~~~ 341 (527)
|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .......+........
T Consensus 179 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 258 (310)
T 2wqm_A 179 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 258 (310)
T ss_dssp CC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC
T ss_pred eccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC
Confidence 999997664322 223468999999999999999999999999999999999999997643 3344444444444333
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
.+..+++.+.+||..||..||.+|||+.++++.|+.+....
T Consensus 259 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 259 PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 34678999999999999999999999999999998876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=363.17 Aligned_cols=256 Identities=31% Similarity=0.495 Sum_probs=216.8
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEE--eC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCL--QS 185 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~--~~ 185 (527)
++.++|++.+.||+|+||.||+|.+ .+..||||++.... ....+.+.+|+.+++.++||||+++++++. +.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 5668899999999999999999984 35689999987653 344677899999999999999999999987 45
Q ss_pred CeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 186 PKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
..+|+|||||++|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~--------~~~k 167 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESE--------AHVK 167 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET--------TEEE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCC--------CCEE
Confidence 67999999999999999987 356999999999999999999999995 9999999999999875 6899
Q ss_pred EeccCcchhhhccc-----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-----------
Q psy6905 264 ITDFGLAREVYKTT-----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY----------- 327 (527)
Q Consensus 264 L~DFGla~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~----------- 327 (527)
|+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence 99999998653222 12345888999999999988999999999999999999999998654322
Q ss_pred ---HHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 328 ---AVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 328 ---~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.........+...+.+..+++.+.+||..||..||.+|||+.+++++|+.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 248 PALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp CHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred ccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 222333445666778889999999999999999999999999999999887654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=369.24 Aligned_cols=257 Identities=20% Similarity=0.306 Sum_probs=202.2
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc-----CceEEEEEcCCCCChhH----------HHHHHHHHHHHHhCCCCccce
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNPDENI----------LENVKQEGKLLWLFDHRNIVS 177 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~vaiK~~~~~~~~~~----------~~~~~~e~~~l~~l~hpnIv~ 177 (527)
++..++|.+.+.||+|+||.||+|.+. +..||||+......... ...+.+|+.+++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 345688999999999999999999983 46899999876543211 123567888999999999999
Q ss_pred EEEEEEe----CCeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCC
Q psy6905 178 LIGVCLQ----SPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPI 252 (527)
Q Consensus 178 ~~~~~~~----~~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~ 252 (527)
+++++.. ...+|+||||| +++|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9999988 77899999999 999999997 447999999999999999999999994 99999999999998752
Q ss_pred cccccccceeEEeccCcchhhhccc---------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q psy6905 253 ENEDLQFKTLKITDFGLAREVYKTT---------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKS 323 (527)
Q Consensus 253 ~~~~~~~~~vkL~DFGla~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~ 323 (527)
.+.+||+|||+++.+.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 189 ------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 189 ------PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp ------TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred ------CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 1389999999997653221 1345799999999999999999999999999999999999999965
Q ss_pred CCHHHHHHHHHhCCccCCCC---------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q psy6905 324 INAYAVAYGVAVNKLTLPIP---------STCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379 (527)
Q Consensus 324 ~~~~~~~~~i~~~~~~~~~p---------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~ 379 (527)
...................| ..+|+.+.++|..||..||.+|||+.+|++.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 263 NLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp GTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 32211111111111111222 278999999999999999999999999999997654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=379.48 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=218.1
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46799999999999999999998 46799999986532 122357788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||||.||+|.+++. .+.+++..+..++.||+.||.|||++| ||||||||+|||++.... .+.+||+|||++
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~-----~~~~kl~Dfg~a 176 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK-----DANIRIIDFGLS 176 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSST-----TCCEEECCTTHH
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCC-----CCcEEEEeeeee
Confidence 99999999988875 667999999999999999999999995 999999999999964321 268999999999
Q ss_pred hhhhcccc-ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCcc
Q psy6905 271 REVYKTTH-MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCP 347 (527)
Q Consensus 271 ~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~ 347 (527)
+....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....+.++.| ..+|
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 255 (484)
T 3nyv_A 177 THFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255 (484)
T ss_dssp HHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSC
T ss_pred EEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCC
Confidence 87643322 34579999999999976 58999999999999999999999999999998888888777666554 5689
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 256 ESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 999999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=382.85 Aligned_cols=249 Identities=29% Similarity=0.392 Sum_probs=212.5
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
+.|.+++.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 47999999999999999999984 5789999987542 12224678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||.||+|.+.+. ...+++..+..++.||+.||.|||++| ||||||||+|||++.... .+.+||+|||+++.
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~-----~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEK-----DALIKIVDFGLSAV 188 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSST-----TCCEEECCCTTCEE
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCC-----CCcEEEEECCCCeE
Confidence 999999988775 667999999999999999999999995 999999999999986421 25699999999987
Q ss_pred hhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCccHH
Q psy6905 273 VYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQL 349 (527)
Q Consensus 273 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~ 349 (527)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....+.++.| ..+|+.
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 189 FENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp CBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred CCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 64332 235579999999999874 58999999999999999999999999999988888887776665544 578999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+||.+||..||.+|||+.+++++
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHHCCCChhhCccHHHHhcC
Confidence 9999999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=354.56 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=197.6
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhH-HHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENI-LENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
+++..++|++.+.||+|+||.||+|.+ +++.||||++........ ...+..+...++.++||||+++++++.+.+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 467789999999999999999999998 578999999877644433 33445555668888999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCceecCCCCccccccccee
Q psy6905 189 CLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQ-APISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~-g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
|+|||||+ |+|.+++. +..+++..++.++.||+.||.|||++ | |+||||||+|||++.+ +.+
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~--------~~~ 149 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINAL--------GQV 149 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTT--------CCE
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCC--------CCE
Confidence 99999996 57777654 46799999999999999999999997 6 9999999999999875 689
Q ss_pred EEeccCcchhhhcccc-ccCCCcccccccccc----ccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC
Q psy6905 263 KITDFGLAREVYKTTH-MSAAGTYAWMAPEVI----KTSIFSKASDVWSYGVVLWELLTGEIPYKSI-NAYAVAYGVAVN 336 (527)
Q Consensus 263 kL~DFGla~~~~~~~~-~~~~gt~~y~aPE~l----~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~-~~~~~~~~i~~~ 336 (527)
||+|||+++....... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||... ............
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (290)
T 3fme_A 150 KMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 229 (290)
T ss_dssp EBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS
T ss_pred EEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc
Confidence 9999999987644322 234799999999996 5567899999999999999999999999874 344444444444
Q ss_pred CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
......+..+++.+.++|.+||..||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 230 PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 44444456789999999999999999999999999873
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=355.59 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=204.6
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|++++.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999984 6789999876654 33446778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||++++|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~--------~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKH--------SVIKLCDFGFARL 151 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------SCEEECCCTTCEE
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCC--------CCEEEeeCCCchh
Confidence 999999999887 567999999999999999999999995 9999999999999875 6899999999976
Q ss_pred hhccc--cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Q psy6905 273 VYKTT--HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------------- 336 (527)
Q Consensus 273 ~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------------- 336 (527)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 152 LTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp CC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 54322 234578999999999976 56899999999999999999999999998776655443211
Q ss_pred ------CccCCCC----------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ------KLTLPIP----------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ------~~~~~~p----------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+.+ ..++..+.+||.+||..||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1111111 3578889999999999999999999999873
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=352.20 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=212.7
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe--CCeEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--SPKLCL 190 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~i 190 (527)
.++|++.+.||+|+||.||+|.+. ++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999984 6789999987643 44456788999999999999999999998854 578999
Q ss_pred EEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCC--CceeecCCCCCceecCCCCcccccccceeE
Q psy6905 191 VMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAP--ISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~--~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
|||||++|+|.+++. ...+++..++.++.||+.||.|||++|. .+|+||||||+|||++.+ +.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~--------~~~k 156 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK--------QNVK 156 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS--------SCEE
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC--------CCEE
Confidence 999999999999986 2348999999999999999999999841 129999999999999875 6899
Q ss_pred EeccCcchhhhcccc--ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 264 ITDFGLAREVYKTTH--MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 264 L~DFGla~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
|+|||+++....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.... ...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~ 235 (279)
T 2w5a_A 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRR 235 (279)
T ss_dssp ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCC
T ss_pred EecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-ccc
Confidence 999999986643221 23468999999999999899999999999999999999999999988777766665443 346
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
+|..++..+.++|.+||..||.+|||+.++++++
T Consensus 236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 7788999999999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=351.88 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=209.1
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|++.+.||+|+||.||+|.+. ++.||||++.........+.+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57999999999999999999974 6789999987554445567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|++|+|.+++. ...+++..+..++.||+.||.|||++| ++||||||+|||++.+ +.+||+|||++...
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~--------~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDER--------DNLKISDFGLATVF 155 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------CCEEECCCTTCEEC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccC--------CCEEEeeCCCcccc
Confidence 99999999987 457999999999999999999999995 9999999999999875 68999999999765
Q ss_pred hccc----cccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCccCCCCCCcc
Q psy6905 274 YKTT----HMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYA-VAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 274 ~~~~----~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~ 347 (527)
.... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+... ............+.+..++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcC
Confidence 3221 234568999999999987665 789999999999999999999998765432 2222322233333445789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
+.+.+||.+||..||.+|||+.++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 236 SAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 99999999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=382.15 Aligned_cols=250 Identities=28% Similarity=0.397 Sum_probs=214.0
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh------------hHHHHHHHHHHHHHhCCCCccceEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE------------NILENVKQEGKLLWLFDHRNIVSLIGV 181 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~------------~~~~~~~~e~~~l~~l~hpnIv~~~~~ 181 (527)
.++|.+++.||+|+||.||+|.+. ++.||||++...... ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467999999999999999999984 578999998654211 235678899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccc
Q psy6905 182 CLQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260 (527)
Q Consensus 182 ~~~~~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~ 260 (527)
+.+...+|+|||||.||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+.. ..
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~-----~~ 186 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS-----LL 186 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC-----CS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC-----Cc
Confidence 999999999999999999988776 677999999999999999999999995 999999999999987521 13
Q ss_pred eeEEeccCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 261 TLKITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 261 ~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
.+||+|||+++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 69999999998764432 235679999999999875 5899999999999999999999999999998888888776655
Q ss_pred CCCC--CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 LPIP--STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ~~~p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.+ ..+|+.+.+||..||..||.+|||+.+++++
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 4433 6789999999999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=363.98 Aligned_cols=244 Identities=27% Similarity=0.372 Sum_probs=197.6
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC--------
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-------- 186 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-------- 186 (527)
++|++.+.||+|+||.||+|.+. ++.||||++.........+.+.+|+.+++.++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 57899999999999999999984 67899999876655556788999999999999999999999986643
Q ss_pred -------------------------------------------------eEEEEEeccCCCCHHHHhcCCC----CChhH
Q psy6905 187 -------------------------------------------------KLCLVMEYARGGPLNRVLAGRK----IRPDV 213 (527)
Q Consensus 187 -------------------------------------------------~~~iv~Ey~~ggsL~~~l~~~~----~~~~~ 213 (527)
.+|+|||||+||+|.+++.... .+...
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3899999999999999997432 34556
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc--------------ccc
Q psy6905 214 LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--------------THM 279 (527)
Q Consensus 214 ~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~--------------~~~ 279 (527)
++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++..... ...
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~--------~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMD--------DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------CCEEECCCTTCEECSCC--------------CCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCC--------CCEEEeecCcccccccchhhcccccccccccccc
Confidence 8899999999999999995 9999999999999875 68999999999866432 122
Q ss_pred cCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhh
Q psy6905 280 SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWE 359 (527)
Q Consensus 280 ~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~ 359 (527)
...||+.|+|||++.+..++.++|||||||++|+|++|..|+.. .......+.. ......+..+++.+.+||.+||.
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN-LKFPLLFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT-TCCCHHHHHHCHHHHHHHHHHHC
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc-cCCCcccccCChhHHHHHHHHcc
Confidence 34699999999999999999999999999999999998776532 1122222221 11111223456788999999999
Q ss_pred hCCCCCCCHHHHHHH
Q psy6905 360 ADSHMRPSFKTILKA 374 (527)
Q Consensus 360 ~dp~~RPs~~~ll~~ 374 (527)
.||.+|||+.+++++
T Consensus 312 ~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 312 PSPTERPEATDIIEN 326 (332)
T ss_dssp SSGGGSCCHHHHHHS
T ss_pred CCCCcCCCHHHHhhc
Confidence 999999999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=356.14 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=207.7
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
..++|.+.+.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++..++.+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4578999999999999999999974 6789999987542 33446788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||||+|++|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~--------~~~kl~Dfg~ 180 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSAD--------DFAYLVDFGI 180 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT--------SCEEECSCCC
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCC--------CCEEEecCcc
Confidence 999999999999987 467999999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCCCCC
Q psy6905 270 AREVYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPST 345 (527)
Q Consensus 270 a~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~ 345 (527)
+....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+..... ....+..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPG 260 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTT
T ss_pred CccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCC
Confidence 97664322 2245689999999999999999999999999999999999999998766544333332211 1234577
Q ss_pred ccHHHHHHHHHhhhhCCCCCC-CHHHHHHHHhhhhhc
Q psy6905 346 CPQLFKTLMEACWEADSHMRP-SFKTILKALNNIVHS 381 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RP-s~~~ll~~L~~~~~~ 381 (527)
+|+.+.++|.+||..||.+|| ++.++++.|+.++..
T Consensus 261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 261 IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 899999999999999999999 999999999876654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=365.08 Aligned_cols=262 Identities=29% Similarity=0.497 Sum_probs=218.4
Q ss_pred CceeeEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 108 DVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 108 ~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
....|+++.++|++.+.||+|+||.||+|.+.+ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 345689999999999999999999999999866 59999887542 2222355678999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcCC--CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLAGR--KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~--~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.+++|||||.|++|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++. +.+||
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~~---------~~~~l 170 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYDN---------GKVVI 170 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC-----------CCEE
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEeC---------CCEEE
Confidence 999999999999999999843 5899999999999999999999995 999999999999974 58999
Q ss_pred eccCcchhhhc-------cccccCCCcccccccccccc---------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6905 265 TDFGLAREVYK-------TTHMSAAGTYAWMAPEVIKT---------SIFSKASDVWSYGVVLWELLTGEIPYKSINAYA 328 (527)
Q Consensus 265 ~DFGla~~~~~-------~~~~~~~gt~~y~aPE~l~~---------~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~ 328 (527)
+|||+++.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 250 (319)
T 2y4i_B 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250 (319)
T ss_dssp CCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH
T ss_pred eecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999875421 11223458999999999874 457899999999999999999999999988887
Q ss_pred HHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 329 ~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
....+.........+..++..+.++|..||..||.+|||+.++++.|+.+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 251 IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 777766544443444578899999999999999999999999999998877543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=365.83 Aligned_cols=246 Identities=27% Similarity=0.384 Sum_probs=203.6
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC------C
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS------P 186 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~ 186 (527)
.++|.+.+.||+|+||.||+|.+ +++.||||++... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 36799999999999999999997 4678999998654 3444567889999999999999999999999765 3
Q ss_pred eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 187 KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
.+|+||||| +++|.+++....+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~--------~~~kl~D 171 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNED--------CELKILD 171 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------CCEEECC
T ss_pred eEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCC--------CCEEEEe
Confidence 469999999 899999998888999999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc------
Q psy6905 267 FGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT------ 339 (527)
Q Consensus 267 FGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~------ 339 (527)
||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 172 fg~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 172 FGLARQADS-EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CTTCEECCS-SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccccccc-ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 999986533 2335678999999999987 67999999999999999999999999998776655444321000
Q ss_pred -----------------------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 -----------------------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 -----------------------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
......+++.+.+||.+||..||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 01234678999999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=364.91 Aligned_cols=258 Identities=28% Similarity=0.403 Sum_probs=204.1
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHH--HHhCCCCccceEEEEEEe----
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKL--LWLFDHRNIVSLIGVCLQ---- 184 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~--l~~l~hpnIv~~~~~~~~---- 184 (527)
.+.++.++|++.+.||+|+||.||+|.++++.||||++.... ...+..|..+ +..++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 356788999999999999999999999999999999986532 2333444444 445899999999986643
Q ss_pred -CCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhc---------CCCceeecCCCCCceecCCCCcc
Q psy6905 185 -SPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ---------APISLIHRDLKSSNVLLSEPIEN 254 (527)
Q Consensus 185 -~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~---------g~~~iiHrDlkp~NILl~~~~~~ 254 (527)
...+|+|||||++|+|.+++.....++..++.++.||+.||.|||+. | ||||||||+|||++.+
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~--- 156 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKND--- 156 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTT---
T ss_pred CCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCC---
Confidence 23679999999999999999877889999999999999999999998 6 9999999999999875
Q ss_pred cccccceeEEeccCcchhhhcc----------ccccCCCcccccccccccc-------CCCCcccchHHHHHHHHHHHhC
Q psy6905 255 EDLQFKTLKITDFGLAREVYKT----------THMSAAGTYAWMAPEVIKT-------SIFSKASDVWSYGVVLWELLTG 317 (527)
Q Consensus 255 ~~~~~~~vkL~DFGla~~~~~~----------~~~~~~gt~~y~aPE~l~~-------~~~~~ksDvwSlGv~l~elltg 317 (527)
+.+||+|||+++..... ......||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 157 -----~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 157 -----GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp -----SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -----CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence 68999999999765321 1123469999999999987 3466899999999999999998
Q ss_pred CCCCCC-CC-----------------HHHHHHHHHhCCccCCCCCC------ccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 318 EIPYKS-IN-----------------AYAVAYGVAVNKLTLPIPST------CPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 318 ~~Pf~~-~~-----------------~~~~~~~i~~~~~~~~~p~~------~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
..||.. .. .......+........+|.. +++.+.+||.+||..||.+|||+.++++
T Consensus 232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 766532 21 11111122223334444443 4568999999999999999999999999
Q ss_pred HHhhhhhccc
Q psy6905 374 ALNNIVHSEF 383 (527)
Q Consensus 374 ~L~~~~~~~~ 383 (527)
.|+.+++...
T Consensus 312 ~L~~ll~~~~ 321 (336)
T 3g2f_A 312 RMAELMMIWE 321 (336)
T ss_dssp HHHHHHHCCC
T ss_pred HHHHHHHHHH
Confidence 9999887654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=370.55 Aligned_cols=258 Identities=27% Similarity=0.422 Sum_probs=206.4
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
+.+..++|.+.+.||+|+||.||+|.+ +++.||||++...........+.+|+.+++.++||||+++++++......++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 345668899999999999999999987 4678999998765433323468899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCC-----CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 191 VMEYARGGPLNRVLAGR-----KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~~-----~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
|||||.+|+|.+++... .+++..+..++.||+.||.|||++...+|+||||||+|||++.+ +.+||+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~--------~~~kl~ 176 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE--------FEAVVG 176 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT--------CCEEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC--------CCEEec
Confidence 99999999999998732 38899999999999999999999822239999999999999875 689999
Q ss_pred ccCcchhhhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Q psy6905 266 DFGLAREVYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN--------AYAVAYGVA 334 (527)
Q Consensus 266 DFGla~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~--------~~~~~~~i~ 334 (527)
|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .........
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999998653221 223459999999999998889999999999999999999999995211 011111110
Q ss_pred hC---------CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 335 VN---------KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 335 ~~---------~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
.. ......+..++..+.+++..||+.||.+|||+.+++++|+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00 11112233345789999999999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=363.60 Aligned_cols=256 Identities=27% Similarity=0.389 Sum_probs=208.6
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-----CCccceEEEEEEe
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFD-----HRNIVSLIGVCLQ 184 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----hpnIv~~~~~~~~ 184 (527)
..+-.++|.+.+.||+|+||.||+|.+ +++.||||++... ......+..|+.+++.+. ||||+++++++..
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 345568999999999999999999998 5678999998743 344567788999999986 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccc------
Q psy6905 185 SPKLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENE------ 255 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~------ 255 (527)
.+.+|+||||| +++|.+++.. ..+++..+..++.||+.||.|||++| ||||||||+|||++......
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchh
Confidence 99999999999 9999999873 34899999999999999999999995 99999999999998521000
Q ss_pred -----------ccccceeEEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q psy6905 256 -----------DLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI 324 (527)
Q Consensus 256 -----------~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~ 324 (527)
....+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 01136899999999976433 234567999999999999999999999999999999999999999988
Q ss_pred CHHHHHHHHHhCCccC------------------------CCCC--------------------CccHHHHHHHHHhhhh
Q psy6905 325 NAYAVAYGVAVNKLTL------------------------PIPS--------------------TCPQLFKTLMEACWEA 360 (527)
Q Consensus 325 ~~~~~~~~i~~~~~~~------------------------~~p~--------------------~~~~~~~~li~~~l~~ 360 (527)
+.......+....... ..|. ..++.+.+||.+||+.
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 7666554433211110 0111 1236788999999999
Q ss_pred CCCCCCCHHHHHHH
Q psy6905 361 DSHMRPSFKTILKA 374 (527)
Q Consensus 361 dp~~RPs~~~ll~~ 374 (527)
||.+|||+.+++++
T Consensus 343 dP~~Rpta~elL~h 356 (360)
T 3llt_A 343 DPTLRPSPAELLKH 356 (360)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=352.94 Aligned_cols=246 Identities=26% Similarity=0.409 Sum_probs=216.1
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCC--CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
.++|.+.+.||+|+||.||+|.+. ++.||+|++... ......+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999985 578999987654 2344567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||||++++|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~--------~~~kl~dfg~~ 162 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNED--------LEVKIGDFGLA 162 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------CCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCC--------CCEEEEeccCc
Confidence 99999999999887 467999999999999999999999995 9999999999999875 68999999999
Q ss_pred hhhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 271 REVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 271 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+... ....|..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~ 240 (294)
T 2rku_A 163 TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINP 240 (294)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCH
T ss_pred eecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--cCCCccccCH
Confidence 76532 2223456899999999999988999999999999999999999999998877766665543 3456788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.++|.+||+.||.+|||+.+++++
T Consensus 241 ~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 241 VAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhC
Confidence 99999999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=350.72 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=212.0
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC-----hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD-----ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
++|.+.+.||+|+||.||+|.+. ++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+....|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999985 67999998765421 112567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+||||+.+++|.+++. ...+++..+..++.||+.||.|||++| ++||||||+|||++.+.. ....+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~----~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNV----PNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSS----SSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCC----CCCceEEEecc
Confidence 9999999999999986 567999999999999999999999995 999999999999987521 12379999999
Q ss_pred cchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC--CCCC
Q psy6905 269 LAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPST 345 (527)
Q Consensus 269 la~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~ 345 (527)
++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......+ .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 997664322 2345689999999999999999999999999999999999999999888777666654433322 2357
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++.+.+||.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 88999999999999999999999999884
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=359.35 Aligned_cols=260 Identities=26% Similarity=0.439 Sum_probs=212.2
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe---
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--- 184 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--- 184 (527)
+.+.++.++|.+.+.||+|+||.||+|.+ +++.||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 45678889999999999999999999996 5689999988654 33456788999999999999999999999873
Q ss_pred -CCeEEEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccc
Q psy6905 185 -SPKLCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258 (527)
Q Consensus 185 -~~~~~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~ 258 (527)
....|+|||||.+|+|.+++. +..+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~------- 170 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDE------- 170 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT-------
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCC-------
Confidence 347899999999999998886 366999999999999999999999994 9999999999999875
Q ss_pred cceeEEeccCcchhhhccc-----------cccCCCccccccccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCC
Q psy6905 259 FKTLKITDFGLAREVYKTT-----------HMSAAGTYAWMAPEVIKTSI---FSKASDVWSYGVVLWELLTGEIPYKSI 324 (527)
Q Consensus 259 ~~~vkL~DFGla~~~~~~~-----------~~~~~gt~~y~aPE~l~~~~---~~~ksDvwSlGv~l~elltg~~Pf~~~ 324 (527)
+.+||+|||++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 171 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 249 (317)
T 2buj_A 171 -GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249 (317)
T ss_dssp -SCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHH
T ss_pred -CCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhh
Confidence 689999999986542211 11234799999999997654 688999999999999999999999642
Q ss_pred CH--HHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 325 NA--YAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 325 ~~--~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
.. .... .........+.+..++..+.++|.+||..||.+|||+.+++++|+.+....
T Consensus 250 ~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 250 FQKGDSVA-LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp HHTTSCHH-HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred hcccchhh-HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 11 1111 122234556667789999999999999999999999999999998876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=359.04 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=193.7
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
.+|.++.++|.+.+.||+|+||.||+|.+ +++.||||++...........+.+|+.+++.++||||+++++++...+.
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 46889999999999999999999999987 5679999998765444456778899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc---------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccc
Q psy6905 188 LCLVMEYARGGPLNRVLA---------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~---------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~ 258 (527)
.|+|||||.+|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~------- 157 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGED------- 157 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTT-------
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCC-------
Confidence 999999999999999885 345899999999999999999999995 9999999999999875
Q ss_pred cceeEEeccCcchhhhccc-------cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy6905 259 FKTLKITDFGLAREVYKTT-------HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVA 330 (527)
Q Consensus 259 ~~~vkL~DFGla~~~~~~~-------~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~ 330 (527)
+.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.....
T Consensus 158 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 236 (303)
T 2vwi_A 158 -GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 236 (303)
T ss_dssp -CCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH
T ss_pred -CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH
Confidence 689999999997653221 123468999999999875 56899999999999999999999999987766555
Q ss_pred HHHHhCCcc--------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 331 YGVAVNKLT--------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 331 ~~i~~~~~~--------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
......... ......++..+.+||.+||..||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 237 MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 444332211 1233567899999999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=361.36 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=216.4
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCC--CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
.++|.+.+.||+|+||.||+|.+. ++.||+|++... ......+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999984 578999987654 2334567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||||.+++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~--------~~~kl~Dfg~~ 188 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNED--------LEVKIGDFGLA 188 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT--------CCEEECCCTTC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCC--------CCEEEeeccCc
Confidence 99999999999887 567999999999999999999999995 9999999999999875 68999999999
Q ss_pred hhhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 271 REVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 271 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
+.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ...|..+++
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~ 266 (335)
T 2owb_A 189 TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINP 266 (335)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTTSCH
T ss_pred eecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--CCCCccCCH
Confidence 86532 22234579999999999999889999999999999999999999999888777666665443 356778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.+||.+||..||.+|||+.+++++
T Consensus 267 ~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 267 VAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=357.18 Aligned_cols=249 Identities=28% Similarity=0.455 Sum_probs=201.4
Q ss_pred Cceeee-eeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFG-EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~-~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
+.|.+. +.||+|+||.||+|.+ +++.||||++..... .....+.+|+.++..+ +||||+++++++.+.+.+|+||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 467774 7899999999999986 468999999876533 2356788999999885 7999999999999999999999
Q ss_pred eccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 193 EYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 193 Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|||+||+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+.. ...+||+|||++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~-----~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQ-----VSPVKICDFDLGS 162 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSS-----SCSEEECCTTCCC
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCC-----cCceEEEEccCcc
Confidence 9999999999987 567999999999999999999999995 999999999999987521 1349999999987
Q ss_pred hhhcc---------ccccCCCcccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCH-----------
Q psy6905 272 EVYKT---------THMSAAGTYAWMAPEVIKT-----SIFSKASDVWSYGVVLWELLTGEIPYKSINA----------- 326 (527)
Q Consensus 272 ~~~~~---------~~~~~~gt~~y~aPE~l~~-----~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~----------- 326 (527)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 65321 1123459999999999975 4578999999999999999999999987542
Q ss_pred ----HHHHHHHHhCCccCCCC--CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 327 ----YAVAYGVAVNKLTLPIP--STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 327 ----~~~~~~i~~~~~~~~~p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
......+......++.+ ..+++.+.+||.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 22334444444333321 4688999999999999999999999999883
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=359.42 Aligned_cols=260 Identities=33% Similarity=0.542 Sum_probs=215.1
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeE------cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEE
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC 182 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~ 182 (527)
..+..+..++|++++.||+|+||.||+|.+ .++.||||++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 33 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp ----CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 344567788999999999999999999984 467899999876543 4467889999999999999999999998
Q ss_pred EeCC--eEEEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccc
Q psy6905 183 LQSP--KLCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258 (527)
Q Consensus 183 ~~~~--~~~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~ 258 (527)
.... .+++|||||++|+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~------- 181 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENE------- 181 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEET-------
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCC-------
Confidence 7643 78999999999999999873 45899999999999999999999995 9999999999999865
Q ss_pred cceeEEeccCcchhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH------
Q psy6905 259 FKTLKITDFGLAREVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY------ 327 (527)
Q Consensus 259 ~~~vkL~DFGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~------ 327 (527)
+.+||+|||+++....... ....++..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 182 -~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~ 260 (326)
T 2w1i_A 182 -NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260 (326)
T ss_dssp -TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHC
T ss_pred -CcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhc
Confidence 6899999999986643221 2345788899999999888999999999999999999999998643111
Q ss_pred ---------HHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 328 ---------AVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 328 ---------~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.............+.|..+|+.+.+||.+||..||.+|||+.++++.|+.+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 261 NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp TTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01112233455667888999999999999999999999999999999887654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=353.85 Aligned_cols=245 Identities=29% Similarity=0.476 Sum_probs=188.3
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999997 56899999986431 111246788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 192 MEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
||||++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~--------~~~kl~dfg~ 158 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRN--------MNIKIADFGL 158 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTT--------CCEEECCCTT
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCC--------CCEEEEeecc
Confidence 999999999999874 56899999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhcc--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCcc
Q psy6905 270 AREVYKT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347 (527)
Q Consensus 270 a~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 347 (527)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... ....|..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (278)
T 3cok_A 159 ATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSFLS 236 (278)
T ss_dssp CEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS--CCCCCTTSC
T ss_pred eeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc--ccCCccccC
Confidence 9765322 223457899999999999988999999999999999999999999877655444433322 345677899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.++.+||.+||..||.+|||+.++++
T Consensus 237 ~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 237 IEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 99999999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=359.77 Aligned_cols=254 Identities=27% Similarity=0.359 Sum_probs=200.8
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
...++|.+.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+.+++.++||||+++++++.++..+|+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999987 467899999876532 2335667899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||||. |+|.+++. ...+++..+..++.||+.||.|||++| ||||||||+|||++.+..+ ..+.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~---~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDAS---ETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC--------CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCC---ccceEEECcCCC
Confidence 999997 58988887 567999999999999999999999995 9999999999999653211 135799999999
Q ss_pred chhhhcc--ccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC------
Q psy6905 270 AREVYKT--THMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL------ 340 (527)
Q Consensus 270 a~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~------ 340 (527)
++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 9876432 22345689999999999874 48999999999999999999999999988777666554311000
Q ss_pred ----------C------------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 ----------P------------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 ----------~------------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. .+..+++++.+||.+||..||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 011267899999999999999999999999873
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=361.74 Aligned_cols=247 Identities=24% Similarity=0.403 Sum_probs=213.8
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC-------hhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCC
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD-------ENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSP 186 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~ 186 (527)
++|.+.+.||+|+||.||+|.+. |+.||||++..... ....+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 57999999999999999999984 78999999876431 12356678999999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
..|+|||||+||+|.+++. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.+ +.+||+
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~--------~~ikl~ 242 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN--------MQIRLS 242 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------CCEEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC--------CCEEEE
Confidence 9999999999999999987 567999999999999999999999995 9999999999999875 689999
Q ss_pred ccCcchhhhccc-cccCCCcccccccccccc------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Q psy6905 266 DFGLAREVYKTT-HMSAAGTYAWMAPEVIKT------SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 266 DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~------~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
|||++..+.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 999998764332 334679999999999863 3578999999999999999999999999888777777766555
Q ss_pred cCCCC--CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 TLPIP--STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 ~~~~p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+.| ..++..+.+||.+||..||.+|||+.+++++
T Consensus 323 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 44433 5788999999999999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=353.42 Aligned_cols=247 Identities=31% Similarity=0.511 Sum_probs=208.1
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
..+.|++.+.||+|+||.||+|.+. +..||+|++...... ....+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH-HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3467999999999999999999985 678999998765332 3567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||++|+|.+++. ...+++..+..++.||+.||.|||++| ++||||||+|||++.+ +.+||+|||++
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~--------~~~kl~Dfg~~ 164 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLE--------GDIRLADFGVS 164 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTT--------SCEEECCCHHH
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCC--------CCEEEEECCCC
Confidence 9999999999876 567999999999999999999999995 9999999999999875 68999999998
Q ss_pred hhhhcc--ccccCCCcccccccccc-----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCC
Q psy6905 271 REVYKT--THMSAAGTYAWMAPEVI-----KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPI 342 (527)
Q Consensus 271 ~~~~~~--~~~~~~gt~~y~aPE~l-----~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~ 342 (527)
...... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||...+.......+..... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T 2j7t_A 165 AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT 244 (302)
T ss_dssp HHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS
T ss_pred ccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCC
Confidence 654321 22345799999999998 466789999999999999999999999999887777666654433 2344
Q ss_pred CCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 343 p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
+..++..+.++|..||..||.+|||+.++++
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 6778999999999999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=349.81 Aligned_cols=249 Identities=28% Similarity=0.473 Sum_probs=207.9
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
.+..++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 345678999999999999999999984 7899999986431 112245788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+|||||.+++|.+++. ...+++..+..++.||+.||.|||++| ++||||||+|||++.+ +.+||+||
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~--------~~~~l~df 155 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAH--------MNAKIADF 155 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTT--------SCEEECCC
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCC--------CCEEEeec
Confidence 99999999999999986 567899999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhccc-cccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCC
Q psy6905 268 GLAREVYKTT-HMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST 345 (527)
Q Consensus 268 Gla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 345 (527)
|++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+... ....|..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~ 233 (276)
T 2h6d_A 156 GLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY 233 (276)
T ss_dssp CGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTT
T ss_pred ccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchh
Confidence 9998764322 234568999999999988765 68999999999999999999999988877766665543 3356788
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++..+.++|.+||+.||.+|||+.+++++
T Consensus 234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 234 LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 99999999999999999999999999984
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=363.89 Aligned_cols=246 Identities=27% Similarity=0.344 Sum_probs=198.7
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|.+++.||+|+||.||+|.+. ++.||||++...........+.+|+.+++.++||||+++++++.+...+|+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999984 6789999987654333233455799999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|. |+|.+++. +..+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~--------~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINER--------GELKLADFGLARA 149 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTT--------CCEEECSSSEEEC
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCC--------CCEEEccCccccc
Confidence 96 58888776 456899999999999999999999995 9999999999999875 6899999999976
Q ss_pred hhcc--ccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc----------
Q psy6905 273 VYKT--THMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT---------- 339 (527)
Q Consensus 273 ~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~---------- 339 (527)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 150 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 150 KSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp C------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 5322 2224568999999999876 56899999999999999999999999998877665554321000
Q ss_pred ------------------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 ------------------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ------------------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+..+++++.+||.+||..||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 01123568899999999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=354.68 Aligned_cols=249 Identities=25% Similarity=0.334 Sum_probs=200.8
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC----ChhHHHHHHHHHHHHHhC---CCCccceEEEEEEe
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP----DENILENVKQEGKLLWLF---DHRNIVSLIGVCLQ 184 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l---~hpnIv~~~~~~~~ 184 (527)
+..++|++.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4457899999999999999999996 56789999876322 111123455666666655 59999999999987
Q ss_pred CC-----eEEEEEeccCCCCHHHHhcCC---CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccc
Q psy6905 185 SP-----KLCLVMEYARGGPLNRVLAGR---KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENED 256 (527)
Q Consensus 185 ~~-----~~~iv~Ey~~ggsL~~~l~~~---~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~ 256 (527)
.. .+++||||+. |+|.+++... .+++..+..++.||+.||+|||++| |+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~----- 156 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSG----- 156 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTT-----
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCC-----
Confidence 65 5899999996 6999988743 3899999999999999999999995 9999999999999875
Q ss_pred cccceeEEeccCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6905 257 LQFKTLKITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV 335 (527)
Q Consensus 257 ~~~~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 335 (527)
+.+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 157 ---~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 157 ---GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp ---SCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred ---CCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 689999999998664332 2345789999999999999999999999999999999999999999887776665542
Q ss_pred CCccCC-------------------------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 NKLTLP-------------------------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ~~~~~~-------------------------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....+ ....+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 110000 113578899999999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=389.84 Aligned_cols=258 Identities=34% Similarity=0.615 Sum_probs=223.2
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc-----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
..+++..++|.+.+.||+|+||.||+|.+. +..||||.+.........+.+.+|+.+++.++||||+++++++.+
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 462 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 346788899999999999999999999873 246999998876666667889999999999999999999999854
Q ss_pred CCeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
+..|+|||||.+|+|.+++. +..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~--------~~v 530 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSN--------DCV 530 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET--------TEE
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCC--------CCE
Confidence 56899999999999999987 336889999999999999999999995 9999999999999875 689
Q ss_pred EEeccCcchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCc
Q psy6905 263 KITDFGLAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 263 kL~DFGla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
||+|||+++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+.. +.
T Consensus 531 kL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-~~ 609 (656)
T 2j0j_A 531 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GE 609 (656)
T ss_dssp EECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-TC
T ss_pred EEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CC
Confidence 9999999987643222 12357789999999999999999999999999999997 9999999888777766654 44
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
..+.|..+|+.+.+||.+||..||.+|||+.++++.|+.+..
T Consensus 610 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 567888999999999999999999999999999999987764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=356.71 Aligned_cols=240 Identities=25% Similarity=0.392 Sum_probs=183.8
Q ss_pred eeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEEEeccCCCC
Q psy6905 123 EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLVMEYARGGP 199 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv~Ey~~ggs 199 (527)
+.||+|+||.||+|.+. ++.||||++... ....+.+|+.+++.+. ||||+++++++.++...|+|||||+||+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 78999999999999984 678999998643 2456778999999997 9999999999999999999999999999
Q ss_pred HHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc--
Q psy6905 200 LNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT-- 276 (527)
Q Consensus 200 L~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~-- 276 (527)
|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+.. ...+||+|||+++.....
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~-----~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDEND-----NLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC---------CEEEECCCTTCEECCC---
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCC-----cccEEEeccccceecCCCCC
Confidence 999887 567999999999999999999999995 999999999999976421 137999999999765322
Q ss_pred ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCccCCCC--CCcc
Q psy6905 277 THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA-------YAVAYGVAVNKLTLPIP--STCP 347 (527)
Q Consensus 277 ~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~p--~~~~ 347 (527)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. .+....+.......+.+ ..++
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 22345689999999999999999999999999999999999999986443 34444454433332221 3579
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++.+||..||..||.+|||+.+++++
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 999999999999999999999988763
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=353.98 Aligned_cols=245 Identities=20% Similarity=0.225 Sum_probs=197.1
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHh-CCCCccceEEEEEEeCCeEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWL-FDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~-l~hpnIv~~~~~~~~~~~~~ 189 (527)
+-.++|++.+.||+|+||+||+|.+. ++.||||++.... ..........|+..+.. .+||||++++++|.++..+|
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 33468999999999999999999984 6899999876543 22333444455555544 49999999999999999999
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+||||| +|+|.+++. +..+++..++.++.||+.||.|||++| ||||||||+|||++.+ +.+||+||
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~--------~~~kl~DF 201 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPR--------GRCKLGDF 201 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGG--------GCEEECCC
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCC--------CCEEEccc
Confidence 999999 778888776 456999999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 268 GLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 268 Gla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
|++....... .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+.... ..+.........+..+
T Consensus 202 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~ 277 (311)
T 3p1a_A 202 GLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTAGL 277 (311)
T ss_dssp TTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHHTTS
T ss_pred eeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccccCC
Confidence 9987664332 234569999999999886 6899999999999999999997766543322 2222222223345678
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.+.+||..||..||.+|||+.+++++
T Consensus 278 ~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 278 SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 9999999999999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=371.36 Aligned_cols=262 Identities=23% Similarity=0.400 Sum_probs=212.5
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC--eEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP--KLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~--~~~ 189 (527)
+..++|.+.+.||+|+||.||+|.+. ++.||||++.........+.+.+|+.+++.++||||+++++++.+.. ..|
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 45678999999999999999999985 67999999876443333567789999999999999999999998755 789
Q ss_pred EEEeccCCCCHHHHhcCC----CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 190 LVMEYARGGPLNRVLAGR----KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~----~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
+|||||+||+|.+++... .+++..++.++.||+.||.|||++| ||||||||+|||+..+.. ..+.+||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~----~~~~~kL~ 158 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGED----GQSVYKLT 158 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTT----SCEEEEEC
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCC----CceeEEEe
Confidence 999999999999999732 3899999999999999999999995 999999999999821100 12579999
Q ss_pred ccCcchhhhccc-cccCCCcccccccccccc--------CCCCcccchHHHHHHHHHHHhCCCCCCCC----CHHHHHHH
Q psy6905 266 DFGLAREVYKTT-HMSAAGTYAWMAPEVIKT--------SIFSKASDVWSYGVVLWELLTGEIPYKSI----NAYAVAYG 332 (527)
Q Consensus 266 DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~--------~~~~~ksDvwSlGv~l~elltg~~Pf~~~----~~~~~~~~ 332 (527)
|||+++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ...+....
T Consensus 159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred cCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 999998764332 235679999999999865 45788999999999999999999999753 23344444
Q ss_pred HHhCCcc-------------------CC----CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 333 VAVNKLT-------------------LP----IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 333 i~~~~~~-------------------~~----~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
+...... .+ ++..++..+.++|..||..||.+||++.++++.+.+++...
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 4432211 11 12345678899999999999999999999999999988764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=349.84 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=210.3
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEE-EeCCeEEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC-LQSPKLCLVM 192 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~-~~~~~~~iv~ 192 (527)
.++|++.+.||+|+||.||+|.+ +++.||||++...... ..+.+|+.+++.+.|++++..+..+ ......|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46899999999999999999996 5789999987665332 3577899999999988877666655 6677889999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||| +|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+. ..+.+||+|||++
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~-----~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK-----KGNLVYIIDFGLA 155 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGG-----GTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCC-----CCCeEEEeeCCCc
Confidence 999 999999987 567999999999999999999999995 99999999999996321 1268999999999
Q ss_pred hhhhcccc---------ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCc
Q psy6905 271 REVYKTTH---------MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA---YAVAYGVAVNKL 338 (527)
Q Consensus 271 ~~~~~~~~---------~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~i~~~~~ 338 (527)
+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. ......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 86643221 345799999999999999999999999999999999999999987432 222222222222
Q ss_pred cCC---CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcccc
Q psy6905 339 TLP---IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384 (527)
Q Consensus 339 ~~~---~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~~ 384 (527)
..+ .+..+|+.+.++|..||+.||.+|||+.++++.|+++......
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 222 2367899999999999999999999999999999998876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=354.85 Aligned_cols=248 Identities=30% Similarity=0.512 Sum_probs=207.4
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEe------
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQ------ 184 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~------ 184 (527)
...++|.+.+.||+|+||.||+|.+ .++.||||++...... ...+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 3567899999999999999999998 5789999998754332 35678999999998 89999999999987
Q ss_pred CCeEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 185 SPKLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
...+|+|||||++|+|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~--------~~ 167 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTEN--------AE 167 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTT--------CC
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCC--------CC
Confidence 4679999999999999999873 56899999999999999999999995 9999999999999875 68
Q ss_pred eEEeccCcchhhhcc--ccccCCCccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6905 262 LKITDFGLAREVYKT--THMSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA 334 (527)
Q Consensus 262 vkL~DFGla~~~~~~--~~~~~~gt~~y~aPE~l~-----~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 334 (527)
+||+|||++...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 168 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp EEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred EEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 999999999766432 223456999999999987 5668999999999999999999999999888777766666
Q ss_pred hCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 335 VNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 335 ~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
........+..++..+.+||.+||..||.+||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 5554444567789999999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=363.10 Aligned_cols=239 Identities=23% Similarity=0.384 Sum_probs=205.1
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-------hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-------ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
++|.+.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5799999999999999999986 467899998876431 1123456789999999999999999999999999
Q ss_pred EEEEEeccCCC-CHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGG-PLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~gg-sL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
+++||||+.+| +|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~--------~~~kL~ 172 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAED--------FTIKLI 172 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------SCEEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCC--------CcEEEe
Confidence 99999999777 9999987 457999999999999999999999995 9999999999999875 689999
Q ss_pred ccCcchhhhccc-cccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 266 DFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 266 DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .......|
T Consensus 173 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~ 244 (335)
T 3dls_A 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEAAIHPP 244 (335)
T ss_dssp CCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTTCCCCS
T ss_pred ecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------HhhccCCC
Confidence 999998664332 234579999999999988776 88999999999999999999999764321 12334567
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+++++.+||..||..||.+|||+.+++++
T Consensus 245 ~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 7799999999999999999999999999884
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=359.34 Aligned_cols=252 Identities=30% Similarity=0.494 Sum_probs=211.1
Q ss_pred CCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHh--CCCCccceEEEEEEeCC----eEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWL--FDHRNIVSLIGVCLQSP----KLC 189 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~~~~~~~~~~----~~~ 189 (527)
.++|.+.+.||+|+||.||+|.++++.||||++... ....+.+|+.++.. ++||||+++++++.... .+|
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 468999999999999999999999999999998643 24567788888887 79999999999998876 799
Q ss_pred EEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHH--------hcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLH--------CQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH--------~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
+|||||.+|+|.+++....+++..++.++.||+.||.||| +. +|+||||||+|||++.+ +.
T Consensus 117 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~--------~~ 185 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN--------GT 185 (342)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT--------SC
T ss_pred EEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC--------CC
Confidence 9999999999999999888999999999999999999999 66 59999999999999875 68
Q ss_pred eEEeccCcchhhhccc------cccCCCccccccccccccCC------CCcccchHHHHHHHHHHHhC----------CC
Q psy6905 262 LKITDFGLAREVYKTT------HMSAAGTYAWMAPEVIKTSI------FSKASDVWSYGVVLWELLTG----------EI 319 (527)
Q Consensus 262 vkL~DFGla~~~~~~~------~~~~~gt~~y~aPE~l~~~~------~~~ksDvwSlGv~l~elltg----------~~ 319 (527)
+||+|||++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999997654322 23447999999999998763 34789999999999999999 78
Q ss_pred CCCCCC-----HHHHHHHHHhCCccCCCCC-----CccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 320 PYKSIN-----AYAVAYGVAVNKLTLPIPS-----TCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 320 Pf~~~~-----~~~~~~~i~~~~~~~~~p~-----~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
||.... .......+........+|. .+++.+.+||.+||..||.+|||+.+++++|+.+....
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 987642 2333333444444444443 45678999999999999999999999999999887653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=352.45 Aligned_cols=248 Identities=28% Similarity=0.501 Sum_probs=208.7
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
....++|.+.+.||+|+||.||+|.+. ++.||||++..... ...+.+|+.+++.++||||+++++++.....+|+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 455678999999999999999999985 67899999876532 3567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 191 VMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|||||.+|+|.+++. ...+++..+..++.||+.||.|||+.| ++||||||+|||++.+ +.+||+|||
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~--------~~~kl~dfg 170 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTE--------GHAKLADFG 170 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------CCEEECCCT
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCC--------CCEEEeecc
Confidence 999999999999986 678999999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhcc--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-ccCCCCCC
Q psy6905 269 LAREVYKT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPST 345 (527)
Q Consensus 269 la~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~ 345 (527)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... .....+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T 3com_A 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL 250 (314)
T ss_dssp TCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred cchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCccc
Confidence 99765432 2234578999999999999899999999999999999999999999887766655544332 23345667
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++..+.+||.+||..||.+|||+.+++++
T Consensus 251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 251 WSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 89999999999999999999999999873
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=347.73 Aligned_cols=249 Identities=21% Similarity=0.306 Sum_probs=205.7
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+..+..+ +||||+++++++.+.+..|+||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999984 7899999987643 233456788999999999 9999999999999999999999
Q ss_pred eccCCCCHHHHhcC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcc-----------cc
Q psy6905 193 EYARGGPLNRVLAG-----RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN-----------ED 256 (527)
Q Consensus 193 Ey~~ggsL~~~l~~-----~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~-----------~~ 256 (527)
|||++|+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+... ..
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999863 66899999999999999999999995 9999999999999854210 00
Q ss_pred cccceeEEeccCcchhhhccccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6905 257 LQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV 335 (527)
Q Consensus 257 ~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 335 (527)
.....+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+....... .+.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~- 241 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIR- 241 (289)
T ss_dssp --CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HHH-
T ss_pred CCceEEEEcccccccccCCc--cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HHH-
Confidence 02357999999999876432 235699999999999876 56789999999999999999988776543322 222
Q ss_pred CCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 NKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.....|..+++.+.+||.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 334456778899999999999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=355.51 Aligned_cols=250 Identities=33% Similarity=0.485 Sum_probs=206.7
Q ss_pred eeeeeeeccCCceEEEEeeEcCceEEEEEcCCCC---ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP---DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
|..++.||+|+||.||+|.++++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+|||||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 4556899999999999999999999999886532 3345678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhc----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 196 RGGPLNRVLA----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 196 ~ggsL~~~l~----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
++|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~--------~~~kl~Dfg~~~ 181 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEA--------FTAKISDFGLAR 181 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT--------CCEEECCCTTCE
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCC--------CcEEEeeccccc
Confidence 9999999886 345899999999999999999999995 9999999999999875 689999999997
Q ss_pred hhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhC-------
Q psy6905 272 EVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYA----VAYGVAVN------- 336 (527)
Q Consensus 272 ~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~----~~~~i~~~------- 336 (527)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ....+...
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY 260 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred ccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence 653321 123468999999999875 47899999999999999999999998754321 11111110
Q ss_pred --CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 337 --KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 337 --~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
......+..++..+.+++..||+.||.+|||+.+++++|+.+..
T Consensus 261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11122344567889999999999999999999999999987653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=362.42 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=208.2
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC-----CeE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-----PKL 188 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~~~ 188 (527)
..+|.+++.||+|+||.||+|.+. +..||||++...........+.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 368999999999999999999874 6789999998766666678899999999999999999999999764 468
Q ss_pred EEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 189 CLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|+||||+. |+|.+++..+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~--------~~~kl~Dfg 173 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTT--------CDLKICDFG 173 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------CCEEECCCT
T ss_pred EEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCC--------CCEEEEeCc
Confidence 99999996 68999998888999999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhcccc-----ccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc----
Q psy6905 269 LAREVYKTTH-----MSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL---- 338 (527)
Q Consensus 269 la~~~~~~~~-----~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~---- 338 (527)
+++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9986643221 23479999999998754 4589999999999999999999999998776555444321000
Q ss_pred ----------------cC---------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 ----------------TL---------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 ----------------~~---------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. .....+++.+.+||.+||..||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0124578899999999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=375.87 Aligned_cols=246 Identities=27% Similarity=0.329 Sum_probs=198.5
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC------C
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS------P 186 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~ 186 (527)
.++|++++.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999987 46789999987542 344567888999999999999999999999654 4
Q ss_pred eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 187 KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
.+|+|||||+++ |.+.+. ..+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~--------~~~kl~D 207 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD--------CTLKILD 207 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------SCEEECC
T ss_pred eEEEEEeCCCCC-HHHHHh-hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCC--------CCEEEEE
Confidence 679999999765 656654 35899999999999999999999995 9999999999999975 6899999
Q ss_pred cCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc------
Q psy6905 267 FGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT------ 339 (527)
Q Consensus 267 FGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~------ 339 (527)
||+++...... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+......
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 208 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp CCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred EEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99998765432 23467999999999999999999999999999999999999999998876655554321000
Q ss_pred -------------------CC----CCCC-----------ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 -------------------LP----IPST-----------CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 -------------------~~----~p~~-----------~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. .|.. .++++.+||.+||..||.+|||+.++++|
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000 15679999999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=382.20 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=212.1
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+..++|.+.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++.+...+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 6678899999999999999999998 46899999985431 1112456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 190 LVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++| ||||||||+||||+.+ +.+||+|
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~--------g~vKL~D 329 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDH--------GHIRISD 329 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------SCEEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCC--------CCeEEEe
Confidence 99999999999998863 34899999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCccCC
Q psy6905 267 FGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN----AYAVAYGVAVNKLTLP 341 (527)
Q Consensus 267 FGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~ 341 (527)
||+++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ...+...+.. ....
T Consensus 330 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~ 407 (576)
T 2acx_A 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEE 407 (576)
T ss_dssp CTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCC
T ss_pred cccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--cccc
Confidence 99998764332 235689999999999999889999999999999999999999998753 2333333332 2345
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RP-----s~~~ll~~ 374 (527)
.|..+++++.+||.+||..||.+|| ++.++++|
T Consensus 408 ~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 6788999999999999999999999 78888875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=352.01 Aligned_cols=256 Identities=24% Similarity=0.374 Sum_probs=205.3
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEE-EeCCeEEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVC-LQSPKLCLVM 192 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~-~~~~~~~iv~ 192 (527)
.++|.+.+.||+|+||.||+|.+ .++.||||++..... ...+.+|+.+++.+.|++++..++.+ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 36799999999999999999996 567899998655432 23467899999999988877666655 6678899999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||| +|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+. ..+.+||+|||++
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~-----~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK-----KGNLVYIIDFGLA 155 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGG-----GTTCEEECCCTTC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccC-----CCCeEEEecCccc
Confidence 999 999999987 667999999999999999999999995 99999999999994221 1268999999999
Q ss_pred hhhhccc---------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCc
Q psy6905 271 REVYKTT---------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY---AVAYGVAVNKL 338 (527)
Q Consensus 271 ~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~---~~~~~i~~~~~ 338 (527)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. .....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 8664321 12456999999999999999999999999999999999999999875321 22222222222
Q ss_pred cCC---CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhccc
Q psy6905 339 TLP---IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383 (527)
Q Consensus 339 ~~~---~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~ 383 (527)
..+ ....+|+.+.+||..||+.||.+|||+.++++.|+++.....
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 222 226789999999999999999999999999999999887643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=359.46 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=207.5
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
.....++|++.+.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++.+...+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 3345678999999999999999999985 6789999876543 344466788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+|||||++++|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+||
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~--------~~~kl~Df 168 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQS--------GVVKLCDF 168 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------SCEEECCC
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCC--------CcEEEEeC
Confidence 99999999999988865 567999999999999999999999995 9999999999999875 68999999
Q ss_pred Ccchhhhcc--ccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Q psy6905 268 GLAREVYKT--THMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-------- 336 (527)
Q Consensus 268 Gla~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-------- 336 (527)
|+++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 169 g~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 169 GFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp TTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 999765432 22345789999999999875 6899999999999999999999999998876655444311
Q ss_pred -----------CccCC----------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 337 -----------KLTLP----------IPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 337 -----------~~~~~----------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
+...+ ....+++.+.+||.+||..||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111 11357899999999999999999999998877
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=347.58 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=214.5
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC--------hhHHHHHHHHHHHHHhCC-CCccceEEEEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD--------ENILENVKQEGKLLWLFD-HRNIVSLIGVCL 183 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~ 183 (527)
-.++|.+.+.||+|+||.||+|.+. ++.||||++..... ....+.+.+|+.+++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999984 57899999865431 123567789999999995 999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 184 QSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 184 ~~~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
.....|+|||||++|+|.+++. +..+++..+..++.||+.||.|||++| ++||||||+|||++.+ +.+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~--------~~~ 163 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDD--------MNI 163 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------CCE
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCC--------CcE
Confidence 9999999999999999999987 567999999999999999999999995 9999999999999875 689
Q ss_pred EEeccCcchhhhccc-cccCCCccccccccccc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6905 263 KITDFGLAREVYKTT-HMSAAGTYAWMAPEVIK------TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV 335 (527)
Q Consensus 263 kL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~------~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 335 (527)
||+|||++....... .....||+.|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 164 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 999999997664322 23457999999999985 45678999999999999999999999999888777777766
Q ss_pred CCccCCCC--CCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 336 NKLTLPIP--STCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 336 ~~~~~~~p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.....+.+ ..++..+.+||.+||..||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 65555444 468999999999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=391.73 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=215.1
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCC
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSP 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~ 186 (527)
..+..++|.+++.||+|+||.||+|.+. ++.||||++.... .......+..|..++..+ +||||+++++++.+.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 3466789999999999999999999984 5689999986421 112245677899999887 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.+|||||||.||+|..++. .+.+++..++.|+.||+.||+|||++| ||||||||+||||+.+ +.+||+
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~--------g~ikL~ 484 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSE--------GHIKIA 484 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSS--------SCEEEC
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCC--------CcEEEe
Confidence 9999999999999999987 477999999999999999999999995 9999999999999876 689999
Q ss_pred ccCcchhhh--ccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC
Q psy6905 266 DFGLAREVY--KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP 343 (527)
Q Consensus 266 DFGla~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p 343 (527)
|||+++... .......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+.... ...|
T Consensus 485 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p 562 (674)
T 3pfq_A 485 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYP 562 (674)
T ss_dssp CCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--CCCC
T ss_pred ecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCC
Confidence 999998642 223345689999999999999999999999999999999999999999999988888887554 4567
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPSF-----KTILK 373 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs~-----~~ll~ 373 (527)
..+++++.+||+.||..||.+||++ .+|++
T Consensus 563 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 7899999999999999999999997 66655
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=358.21 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=201.1
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh----hHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE----NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
..++|.+.+.||+|+||.||+|.+. ++.||||++...... .....+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3568999999999999999999974 678999998754221 1234678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 189 CLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
|+|||||.+ +|..++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~--------~~~kl~D 155 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDEN--------GVLKLAD 155 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------CCEEECC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCC--------CCEEEEe
Confidence 999999975 78888773 35899999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc--cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC---
Q psy6905 267 FGLAREVYKTT--HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL--- 340 (527)
Q Consensus 267 FGla~~~~~~~--~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~--- 340 (527)
||+++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 156 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 156 FGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235 (346)
T ss_dssp CGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 99998764322 2345789999999999764 58999999999999999999999999988776665554311000
Q ss_pred ------------------C-----CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 ------------------P-----IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 ------------------~-----~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. ....+++.+.+||.+||..||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 014567899999999999999999999999885
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=356.34 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=189.9
Q ss_pred cCceeeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHH-HHHhCCCCccceEEEEEE
Q psy6905 107 NDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGK-LLWLFDHRNIVSLIGVCL 183 (527)
Q Consensus 107 ~~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~hpnIv~~~~~~~ 183 (527)
.....|++..++|++.+.||+|+||.||+|.+. ++.||||++...........+..|+. +++.++||||+++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp CCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred ChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 344578899999999999999999999999985 78999999987655555556666665 777789999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHhc------CCCCChhHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCceecCCCCcccc
Q psy6905 184 QSPKLCLVMEYARGGPLNRVLA------GRKIRPDVLVDWAIQIAEGMNYLHCQ-APISLIHRDLKSSNVLLSEPIENED 256 (527)
Q Consensus 184 ~~~~~~iv~Ey~~ggsL~~~l~------~~~~~~~~~~~i~~qi~~~L~yLH~~-g~~~iiHrDlkp~NILl~~~~~~~~ 256 (527)
+.+..|+|||||.+ +|.+++. ...+++..+..++.|++.||.|||++ | |+||||||+|||++.+
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~----- 162 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRS----- 162 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETT-----
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCC-----
Confidence 99999999999975 7777764 56789999999999999999999998 6 9999999999999875
Q ss_pred cccceeEEeccCcchhhhcccc-ccCCCcccccccccc----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHH
Q psy6905 257 LQFKTLKITDFGLAREVYKTTH-MSAAGTYAWMAPEVI----KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY-AVA 330 (527)
Q Consensus 257 ~~~~~vkL~DFGla~~~~~~~~-~~~~gt~~y~aPE~l----~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~-~~~ 330 (527)
+.+||+|||+++....... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.. ...
T Consensus 163 ---~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 239 (327)
T 3aln_A 163 ---GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239 (327)
T ss_dssp ---TEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------
T ss_pred ---CCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH
Confidence 6899999999987644322 234799999999998 4566899999999999999999999999875432 222
Q ss_pred HHHHhCCccCCC----CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 331 YGVAVNKLTLPI----PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 331 ~~i~~~~~~~~~----p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+. .+..... +..+++.+.+||..||..||.+|||+.+++++
T Consensus 240 ~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 240 TQVV-KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCC-CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHh-cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1121 1111112 24689999999999999999999999999873
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=356.25 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=210.1
Q ss_pred Cceeee-eeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEE
Q psy6905 117 NKLIFG-EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 117 ~~~~~~-~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv 191 (527)
+.|.+. +.||+|+||.||+|.+. ++.||||++.... .......+.+|+.++..+ +||||+++++++.+...+|+|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 456666 89999999999999884 6899999887542 223356788999999998 569999999999999999999
Q ss_pred EeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 192 MEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
||||.+|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.... .+.+||+|||
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~-----~~~~kL~Dfg 179 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP-----LGDIKIVDFG 179 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTT-----BCCEEECCGG
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCC-----CCcEEEeeCc
Confidence 99999999999986 367899999999999999999999995 999999999999987321 2689999999
Q ss_pred cchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC--CCCCC
Q psy6905 269 LAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL--PIPST 345 (527)
Q Consensus 269 la~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~ 345 (527)
+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....... +.+..
T Consensus 180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259 (327)
T ss_dssp GCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred cccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence 998764332 234579999999999999999999999999999999999999999988887776665544333 34467
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++.+.+||..||..||.+|||+.+++++
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 89999999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=366.06 Aligned_cols=247 Identities=24% Similarity=0.414 Sum_probs=200.9
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe-----
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ----- 184 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----- 184 (527)
+++..++|.+++.||+|+||.||+|.+ +++.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345678999999999999999999987 468999998865432 12379999999999999999999844
Q ss_pred ---------------------------------CCeEEEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHH
Q psy6905 185 ---------------------------------SPKLCLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMN 226 (527)
Q Consensus 185 ---------------------------------~~~~~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~ 226 (527)
...+++|||||+ |+|.+.+. +..+++..+..++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 334899999997 57766654 567999999999999999999
Q ss_pred HHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhcc-ccccCCCccccccccccccCC-CCcccch
Q psy6905 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT-THMSAAGTYAWMAPEVIKTSI-FSKASDV 304 (527)
Q Consensus 227 yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~-~~~~~~gt~~y~aPE~l~~~~-~~~ksDv 304 (527)
|||++| |+||||||+|||++.. .+.+||+|||+++..... ......||+.|+|||++.+.. ++.++||
T Consensus 156 ~LH~~g---i~H~Dikp~Nil~~~~-------~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (383)
T 3eb0_A 156 FIHSLG---ICHRDIKPQNLLVNSK-------DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDL 225 (383)
T ss_dssp HHHTTT---EECSCCCGGGEEEETT-------TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred HHHHCc---CccCccCHHHEEEcCC-------CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence 999995 9999999999999742 268999999999866332 333567899999999987754 8999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------------------------CccCCCCCCccHHHHHHHHHh
Q psy6905 305 WSYGVVLWELLTGEIPYKSINAYAVAYGVAVN---------------------------KLTLPIPSTCPQLFKTLMEAC 357 (527)
Q Consensus 305 wSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~---------------------------~~~~~~p~~~~~~~~~li~~~ 357 (527)
|||||++|+|++|+.||.+.+.......+... .+....|..+|+++.+||.+|
T Consensus 226 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 99999999999999999998877666554321 001114566899999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q psy6905 358 WEADSHMRPSFKTILKA 374 (527)
Q Consensus 358 l~~dp~~RPs~~~ll~~ 374 (527)
|..||.+|||+.+++++
T Consensus 306 L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMAH 322 (383)
T ss_dssp CCSSGGGSCCHHHHHTS
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=355.81 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=197.8
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEE---
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCL--- 183 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~--- 183 (527)
..+++...+|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.++..+. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 35778888999999999999999999998 56799999885543 344677889999999995 999999999994
Q ss_pred -----eCCeEEEEEeccCCCCHHHHhc----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcc
Q psy6905 184 -----QSPKLCLVMEYARGGPLNRVLA----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN 254 (527)
Q Consensus 184 -----~~~~~~iv~Ey~~ggsL~~~l~----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~ 254 (527)
....+++|||||. |+|.+++. .+.+++..++.++.||+.||.|||++|+ +|+||||||+|||++.+
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~--- 174 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQ--- 174 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTT---
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCC---
Confidence 3445899999995 78888775 4569999999999999999999999832 39999999999999875
Q ss_pred cccccceeEEeccCcchhhhcccc--------------ccCCCcccccccccc---ccCCCCcccchHHHHHHHHHHHhC
Q psy6905 255 EDLQFKTLKITDFGLAREVYKTTH--------------MSAAGTYAWMAPEVI---KTSIFSKASDVWSYGVVLWELLTG 317 (527)
Q Consensus 255 ~~~~~~~vkL~DFGla~~~~~~~~--------------~~~~gt~~y~aPE~l---~~~~~~~ksDvwSlGv~l~elltg 317 (527)
+.+||+|||+++....... ....||+.|+|||++ .+..++.++|||||||++|+|++|
T Consensus 175 -----~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g 249 (337)
T 3ll6_A 175 -----GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249 (337)
T ss_dssp -----SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred -----CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhC
Confidence 6899999999976533211 134589999999998 566789999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 318 EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 318 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
..||........ .......+.+..++..+.+||..||..||.+|||+.+++++|..+....
T Consensus 250 ~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 250 QHPFEDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp SCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCcchhHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 999986554433 2334455666778889999999999999999999999999999887653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=370.68 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=196.8
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-------ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-------DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
.++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++. ..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 468999999999999999999874 5789999876431 1122345789999999999999999999975 45
Q ss_pred eEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 187 KLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
.+|+|||||.+|+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+.. ...+||+
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~-----~~~~kl~ 284 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE-----DCLIKIT 284 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSS-----SCCEEEC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCC-----cceEEEe
Confidence 6899999999999998876 567999999999999999999999995 999999999999976421 2469999
Q ss_pred ccCcchhhhccc-cccCCCcccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCccC
Q psy6905 266 DFGLAREVYKTT-HMSAAGTYAWMAPEVIKT---SIFSKASDVWSYGVVLWELLTGEIPYKSINAY-AVAYGVAVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~---~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~-~~~~~i~~~~~~~ 340 (527)
|||+++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+.......
T Consensus 285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~ 364 (419)
T 3i6u_A 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364 (419)
T ss_dssp CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence 999998764432 234579999999999863 56889999999999999999999999875433 2222333222222
Q ss_pred C--CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 P--IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 ~--~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. ....+++.+.+||.+||..||.+|||+.+++++
T Consensus 365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1 225688999999999999999999999999873
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=362.46 Aligned_cols=249 Identities=18% Similarity=0.308 Sum_probs=212.8
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCCh----------------hHHHHHHHHHHHHHhCCCCccce
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDE----------------NILENVKQEGKLLWLFDHRNIVS 177 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~e~~~l~~l~hpnIv~ 177 (527)
+..++|.+.+.||+|+||.||+|.++++.||||++...... .....+.+|+.+++.++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 45679999999999999999999998899999987643100 11277889999999999999999
Q ss_pred EEEEEEeCCeEEEEEeccCCCCHHHH------hc---CCCCChhHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcee
Q psy6905 178 LIGVCLQSPKLCLVMEYARGGPLNRV------LA---GRKIRPDVLVDWAIQIAEGMNYLHC-QAPISLIHRDLKSSNVL 247 (527)
Q Consensus 178 ~~~~~~~~~~~~iv~Ey~~ggsL~~~------l~---~~~~~~~~~~~i~~qi~~~L~yLH~-~g~~~iiHrDlkp~NIL 247 (527)
+++++.+.+.+|+|||||++|+|.++ +. ...+++..++.++.||+.||.|||+ + +|+||||||+|||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 99999999999999999999999998 55 3578999999999999999999999 7 4999999999999
Q ss_pred cCCCCcccccccceeEEeccCcchhhhccccccCCCccccccccccccC-CCCc-ccchHHHHHHHHHHHhCCCCCCCCC
Q psy6905 248 LSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTS-IFSK-ASDVWSYGVVLWELLTGEIPYKSIN 325 (527)
Q Consensus 248 l~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-ksDvwSlGv~l~elltg~~Pf~~~~ 325 (527)
++.+ +.+||+|||++............||+.|+|||++.+. .++. ++|||||||++|+|++|..||...+
T Consensus 185 ~~~~--------~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 185 MDKN--------GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp ECTT--------SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EcCC--------CcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9875 6899999999987655444566799999999999887 5666 9999999999999999999999877
Q ss_pred H-HHHHHHHHhCCccCCCC-----------------CCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 326 A-YAVAYGVAVNKLTLPIP-----------------STCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 326 ~-~~~~~~i~~~~~~~~~p-----------------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
. ......+.......+.. ..++..+.+||.+||..||.+|||+.++++
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 6 55555555443333321 668999999999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=347.85 Aligned_cols=253 Identities=28% Similarity=0.469 Sum_probs=209.2
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
..+.+..++|.....||+|+||.||+|.+ ++..||||++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 34566677777778999999999999997 457899998876533 345778899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhcCC----CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 188 LCLVMEYARGGPLNRVLAGR----KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~----~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
.++|||||++|+|.+++... .+++..+..++.||+.||.|||++| |+||||||+|||++.. .+.+|
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~-------~~~~k 163 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTY-------SGVLK 163 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT-------TCCEE
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECC-------CCCEE
Confidence 99999999999999998732 4568888999999999999999995 9999999999999862 26899
Q ss_pred EeccCcchhhhccc--cccCCCccccccccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCc
Q psy6905 264 ITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYKSINAYA-VAYGVAVNKL 338 (527)
Q Consensus 264 L~DFGla~~~~~~~--~~~~~gt~~y~aPE~l~~~~--~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~-~~~~i~~~~~ 338 (527)
|+|||++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ..........
T Consensus 164 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (295)
T 2clq_A 164 ISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV 243 (295)
T ss_dssp ECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC
T ss_pred EeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc
Confidence 99999997654322 23457899999999997653 8899999999999999999999997654332 2223323344
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
....|..+++.+.+||.+||..||.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 55678889999999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=347.98 Aligned_cols=249 Identities=29% Similarity=0.442 Sum_probs=214.2
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|.+.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 5799999999999999999998 46789999975432 12235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||.+++|.+++. ...+++..++.++.||+.||.|||++| ++||||||+|||++.+.. ...+||+|||++..
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~-----~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEK-----DCDIKIIDFGLSTC 173 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSST-----TCCEEECSTTGGGT
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCC-----cccEEEeccCccee
Confidence 999999988775 567999999999999999999999995 999999999999976421 24799999999986
Q ss_pred hhcccc-ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCC--CCccHH
Q psy6905 273 VYKTTH-MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQL 349 (527)
Q Consensus 273 ~~~~~~-~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~ 349 (527)
...... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+.......+.......+.| ..+++.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 174 FQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp BCCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred ecCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 643322 233589999999998764 8999999999999999999999999998888777777666555444 578999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.++|.+||..||.+|||+.+++++
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHcccChhhCcCHHHHhcC
Confidence 9999999999999999999999884
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=377.60 Aligned_cols=249 Identities=26% Similarity=0.364 Sum_probs=211.9
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC--hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD--ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
.+..++|.+.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+.+++.++||||+++++++.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 35668899999999999999999998 468999999864311 11245688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhcC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 189 CLVMEYARGGPLNRVLAG-----RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~-----~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
|+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++| ||||||||+||||+.+ +.+|
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~--------g~vk 329 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDD--------GNVR 329 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------SCEE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCC--------CCEE
Confidence 999999999999998863 35899999999999999999999995 9999999999999875 7899
Q ss_pred EeccCcchhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCC
Q psy6905 264 ITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN----AYAVAYGVAVNK 337 (527)
Q Consensus 264 L~DFGla~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~----~~~~~~~i~~~~ 337 (527)
|+|||+++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ .......+...
T Consensus 330 L~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~- 408 (543)
T 3c4z_A 330 ISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ- 408 (543)
T ss_dssp ECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-
T ss_pred EeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-
Confidence 99999998764332 234589999999999999999999999999999999999999998753 34444445433
Q ss_pred ccCCCCCCccHHHHHHHHHhhhhCCCCCCCH-----HHHHHH
Q psy6905 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSF-----KTILKA 374 (527)
Q Consensus 338 ~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~-----~~ll~~ 374 (527)
....|..+|+.+.+||.+||..||.+||++ .+|+++
T Consensus 409 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 409 -AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 345678899999999999999999999965 667653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=362.16 Aligned_cols=250 Identities=27% Similarity=0.370 Sum_probs=192.4
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-- 185 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-- 185 (527)
.|++. ++|.+.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 24 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp EEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 45554 6899999999999999999987 46789999987643 344567788999999999999999999999754
Q ss_pred ----CeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 186 ----PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 186 ----~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
..+|+||||+ +++|.+++..+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~--------~~ 170 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED--------CE 170 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------CC
T ss_pred cccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCC--------CC
Confidence 5689999999 789999998888999999999999999999999995 9999999999999875 68
Q ss_pred eEEeccCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---
Q psy6905 262 LKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK--- 337 (527)
Q Consensus 262 vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~--- 337 (527)
+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 171 ~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 171 LKILDFGLARHTADE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249 (367)
T ss_dssp EEECC----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred EEEeecccccccccc-CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999999875432 334579999999999987 678999999999999999999999999988765554433210
Q ss_pred -------------------c-cCC------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 -------------------L-TLP------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 -------------------~-~~~------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. ..+ ....+++.+.+||.+||..||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 000 113467889999999999999999999999885
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=359.01 Aligned_cols=261 Identities=15% Similarity=0.222 Sum_probs=208.5
Q ss_pred CceeeEEeCCceeeeeeeccCCceEEEEee-------EcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC---CCccce
Q psy6905 108 DVKLVEIDYNKLIFGEAIGEGGFGKVYKGI-------YEKQEVAIKVAHPNPDENILENVKQEGKLLWLFD---HRNIVS 177 (527)
Q Consensus 108 ~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~ 177 (527)
....+++..++|.+.+.||+|+||.||+|. ..++.||||++.... ...+..|+.++..++ |+||+.
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 345678888999999999999999999994 246789999997653 345677888888886 999999
Q ss_pred EEEEEEeCCeEEEEEeccCCCCHHHHhc------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCC
Q psy6905 178 LIGVCLQSPKLCLVMEYARGGPLNRVLA------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEP 251 (527)
Q Consensus 178 ~~~~~~~~~~~~iv~Ey~~ggsL~~~l~------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~ 251 (527)
+++++...+..|+|||||+||+|.+++. ...+++..++.|+.||+.||+|||++| ||||||||+||||+.+
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNG 208 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGG
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccc
Confidence 9999999999999999999999999985 456999999999999999999999995 9999999999999862
Q ss_pred Cc---ccccccceeEEeccCcchhhh----ccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q psy6905 252 IE---NEDLQFKTLKITDFGLAREVY----KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI 324 (527)
Q Consensus 252 ~~---~~~~~~~~vkL~DFGla~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~ 324 (527)
.. +.+...+.+||+|||+|+... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 10 001113689999999997553 12233567999999999999999999999999999999999999999654
Q ss_pred CHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCC-CCHHHHHHHHhhhhhc
Q psy6905 325 NAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMR-PSFKTILKALNNIVHS 381 (527)
Q Consensus 325 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~R-Ps~~~ll~~L~~~~~~ 381 (527)
..... .+ .. .+. ....++.+.+++..|++.+|.+| |++.++.+.|+.++..
T Consensus 289 ~~~~~--~~--~~-~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 289 EGGEC--KP--EG-LFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ETTEE--EE--CS-CCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCce--ee--ch-hcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 32100 00 00 011 11347789999999999999999 5788888888776654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.89 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=206.9
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE-----cCceEEEEEcCCCC---ChhHHHHHHHHHHHHHhC-CCCccceEEEEEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNP---DENILENVKQEGKLLWLF-DHRNIVSLIGVCL 183 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~ 183 (527)
.+..++|.+.+.||+|+||.||+|.+ .++.||||++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 34567899999999999999999987 56789999986532 111234566789999999 7999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 184 QSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 184 ~~~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
....+|+|||||++|+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~--------~~~ 198 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSN--------GHV 198 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------SCE
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC--------CcE
Confidence 9999999999999999999987 567999999999999999999999995 9999999999999875 689
Q ss_pred EEeccCcchhhhcc---ccccCCCccccccccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH
Q psy6905 263 KITDFGLAREVYKT---THMSAAGTYAWMAPEVIKTS--IFSKASDVWSYGVVLWELLTGEIPYKSIN----AYAVAYGV 333 (527)
Q Consensus 263 kL~DFGla~~~~~~---~~~~~~gt~~y~aPE~l~~~--~~~~ksDvwSlGv~l~elltg~~Pf~~~~----~~~~~~~i 333 (527)
||+|||+++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .......+
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 278 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence 99999999765322 22245799999999999863 47899999999999999999999997543 23333333
Q ss_pred HhCCccCCCCCCccHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q psy6905 334 AVNKLTLPIPSTCPQLFKTLMEACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 334 ~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RP-----s~~~ll~~ 374 (527)
.. ...+.|..++..+.+||.+||..||.+|| ++.+++++
T Consensus 279 ~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 279 LK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred hc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 32 23467788999999999999999999999 99999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=358.82 Aligned_cols=254 Identities=13% Similarity=0.197 Sum_probs=207.5
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc----------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccce------
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE----------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVS------ 177 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~------ 177 (527)
...++|.+.+.||+|+||.||+|.+. ++.||||++... ..+.+|+.+++.++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 34689999999999999999999874 568999998754 35678999999999999987
Q ss_pred ---------EEEEEEe-CCeEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q psy6905 178 ---------LIGVCLQ-SPKLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSS 244 (527)
Q Consensus 178 ---------~~~~~~~-~~~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~ 244 (527)
+++++.. +...|+||||| +|+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~ 188 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE 188 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence 6788876 78899999999 9999999973 67999999999999999999999995 999999999
Q ss_pred ceecCCCCcccccccceeEEeccCcchhhhcccc---------ccCCCccccccccccccCCCCcccchHHHHHHHHHHH
Q psy6905 245 NVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH---------MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELL 315 (527)
Q Consensus 245 NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~---------~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ell 315 (527)
|||++.+. ...+||+|||+++....... ....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 189 NIl~~~~~------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 189 NIFVDPED------QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp GEEEETTE------EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HEEEcCCC------CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99998751 02899999999976543211 2347999999999999999999999999999999999
Q ss_pred hCCCCCCCCC--HHHHHHHHHh-CCccCCCC------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhccc
Q psy6905 316 TGEIPYKSIN--AYAVAYGVAV-NKLTLPIP------STCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383 (527)
Q Consensus 316 tg~~Pf~~~~--~~~~~~~i~~-~~~~~~~p------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~ 383 (527)
+|+.||.+.. .......... .....+.+ ..+++.+.+||..||..||.+|||+.++++.|+.+.....
T Consensus 263 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 263 YGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 9999998764 2222221110 01111111 2468999999999999999999999999999999886643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=359.01 Aligned_cols=245 Identities=26% Similarity=0.341 Sum_probs=197.1
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC------
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP------ 186 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------ 186 (527)
.++|.+.+.||+|+||.||+|.+ .++.||||++... ........+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999987 4678999998754 33445677889999999999999999999997654
Q ss_pred eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 187 KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
.+|+|||||+ |+|.+++. ..+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~--------~~~kl~D 170 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD--------CTLKILD 170 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT--------SCEEECC
T ss_pred ceEEEEEcCC-CCHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCC--------CCEEEEE
Confidence 7899999996 56877775 46899999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC----
Q psy6905 267 FGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP---- 341 (527)
Q Consensus 267 FGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 341 (527)
||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... .+
T Consensus 171 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~ 249 (371)
T 2xrw_A 171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG-TPCPEF 249 (371)
T ss_dssp CCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CC-CCCHHH
T ss_pred eecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHH
Confidence 99998764332 2345799999999999999999999999999999999999999999887766555542111 00
Q ss_pred -------------------------------CCC------CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 342 -------------------------------IPS------TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 342 -------------------------------~p~------~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.|. .++..+.+||.+||..||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 010 125789999999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=347.07 Aligned_cols=243 Identities=30% Similarity=0.414 Sum_probs=205.9
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe----------
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ---------- 184 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~---------- 184 (527)
.+|++.+.||+|+||.||+|.+. ++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 57899999999999999999985 7899999987653 245689999999999999999999864
Q ss_pred ------CCeEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccc
Q psy6905 185 ------SPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENE 255 (527)
Q Consensus 185 ------~~~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~ 255 (527)
...+|+|||||++|+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~---- 158 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT---- 158 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET----
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC----
Confidence 445899999999999999986 357899999999999999999999995 9999999999999875
Q ss_pred ccccceeEEeccCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6905 256 DLQFKTLKITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA 334 (527)
Q Consensus 256 ~~~~~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 334 (527)
+.+||+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .....+.
T Consensus 159 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~ 232 (284)
T 2a19_B 159 ----KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR 232 (284)
T ss_dssp ----TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH
T ss_pred ----CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh
Confidence 689999999998764432 234569999999999999999999999999999999999998875321 1222222
Q ss_pred hCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 335 VNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 335 ~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
....+..++..+.++|.+||..||.+|||+.+++++|..+...
T Consensus 233 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 233 ----DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ----TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ----cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1235677899999999999999999999999999999876643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=372.65 Aligned_cols=241 Identities=14% Similarity=0.181 Sum_probs=194.4
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC--CChhHHHHHHHHH---HHHHhCCCCccceEE-------
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN--PDENILENVKQEG---KLLWLFDHRNIVSLI------- 179 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~--~~~~~~~~~~~e~---~~l~~l~hpnIv~~~------- 179 (527)
...++|.+.+.||+|+||.||+|.+ +++.||||++... ......+.+.+|+ .+++.++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3457899999999999999999996 4789999998643 2334567888999 555566899999998
Q ss_pred EEEEeCC-----------------eEEEEEeccCCCCHHHHhcC-CCCCh-------hHHHHHHHHHHHHHHHHHhcCCC
Q psy6905 180 GVCLQSP-----------------KLCLVMEYARGGPLNRVLAG-RKIRP-------DVLVDWAIQIAEGMNYLHCQAPI 234 (527)
Q Consensus 180 ~~~~~~~-----------------~~~iv~Ey~~ggsL~~~l~~-~~~~~-------~~~~~i~~qi~~~L~yLH~~g~~ 234 (527)
+++.+.+ ..|+||||| +|+|.+++.. +.+++ ..++.|+.||+.||+|||++|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 7766553 289999999 6899999872 33444 778889999999999999995
Q ss_pred ceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccccccCCCccccccccccccC-----------CCCcccc
Q psy6905 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTS-----------IFSKASD 303 (527)
Q Consensus 235 ~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~ksD 303 (527)
||||||||+||||+.+ +.+||+|||+++.... ......| +.|+|||++.+. .++.++|
T Consensus 227 -ivHrDikp~NIll~~~--------~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D 295 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQR--------GGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD 295 (377)
T ss_dssp -EECSCCCGGGEEECTT--------CCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred -eecCCCCHHHEEEcCC--------CCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence 9999999999999975 6899999999986433 2334567 999999999887 7999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 304 VWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 304 vwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
||||||++|||++|+.||.+.+.......+ ...+..+|+.+.+||.+||..||.+|||+.+++++
T Consensus 296 vwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 296 AWALGLVIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHHHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHHHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999999999999876543322222 23346789999999999999999999999999873
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=369.83 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=186.4
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCC-CChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC-----CeE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPN-PDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-----PKL 188 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~~~ 188 (527)
++|.+++.||+|+||.||+|.+ +++.||||++... ......+.+.+|+.+|+.++|||||++++++... ..+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6899999999999999999987 4678999988654 3344567889999999999999999999999543 569
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|+||||| +|+|.+++. ...+++..+..++.||+.||+|||++| ||||||||+||||+.+ +.+||+||
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~--------~~~kl~DF 200 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQD--------CSVKVCDF 200 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT--------CCEEECCC
T ss_pred EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCC--------CCEeeccc
Confidence 9999998 678988887 456999999999999999999999995 9999999999999876 68999999
Q ss_pred Ccchhhhcc-----------------------------ccccCCCcccccccccc-ccCCCCcccchHHHHHHHHHHHh-
Q psy6905 268 GLAREVYKT-----------------------------THMSAAGTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLT- 316 (527)
Q Consensus 268 Gla~~~~~~-----------------------------~~~~~~gt~~y~aPE~l-~~~~~~~ksDvwSlGv~l~ellt- 316 (527)
|+++..... .....+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 999865321 11234689999999986 56679999999999999999998
Q ss_pred ----------CCCCCCCCCHH--------------------HHHHHHHh----------------------CCcc-----
Q psy6905 317 ----------GEIPYKSINAY--------------------AVAYGVAV----------------------NKLT----- 339 (527)
Q Consensus 317 ----------g~~Pf~~~~~~--------------------~~~~~i~~----------------------~~~~----- 339 (527)
|+++|.+.+.. .....+.. ....
T Consensus 281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360 (458)
T ss_dssp STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence 77788765421 11111100 0000
Q ss_pred --CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 --LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 --~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
......+++++.+||.+||..||.+|||+.++++|
T Consensus 361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 01123568999999999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=355.89 Aligned_cols=247 Identities=26% Similarity=0.348 Sum_probs=207.0
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC-----CeE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-----PKL 188 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~~~ 188 (527)
.++|.+.+.||+|+||.||+|.+. ++.||||++...........+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999985 6789999997766566677888999999999999999999998764 678
Q ss_pred EEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 189 CLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
|+||||+. |+|.+++..+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 90 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~--------~~~kl~Dfg 157 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSN--------CDLKVCDFG 157 (353)
T ss_dssp EEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT--------CCEEECCCT
T ss_pred EEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCC--------CcEEEEecc
Confidence 99999996 68999998888999999999999999999999995 9999999999999875 689999999
Q ss_pred cchhhhccc------------cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6905 269 LAREVYKTT------------HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV 335 (527)
Q Consensus 269 la~~~~~~~------------~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 335 (527)
+++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 997653211 123468999999998764 6789999999999999999999999998876554433221
Q ss_pred C-C----------------------c-cCC------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 N-K----------------------L-TLP------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ~-~----------------------~-~~~------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. + . ..+ .+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0 0 000 124678999999999999999999999999885
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=346.74 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=210.7
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCC-CChhHHHHHHHHHHHHHhCC--CCccceEEEEEEeC
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPN-PDENILENVKQEGKLLWLFD--HRNIVSLIGVCLQS 185 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~--hpnIv~~~~~~~~~ 185 (527)
..+.+..++|.+.+.||+|+||.||+|.+. ++.||||++... ........+.+|+.++..+. ||||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 346778889999999999999999999874 678999998654 34455678899999999997 59999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 186 PKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
..+|+||| +.+++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++. +.+||
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~---------~~~kL 167 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD---------GMLKL 167 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET---------TEEEE
T ss_pred CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC---------CeEEE
Confidence 99999999 55889999987 567899999999999999999999995 999999999999964 58999
Q ss_pred eccCcchhhhcccc----ccCCCcccccccccccc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCC-HHH
Q psy6905 265 TDFGLAREVYKTTH----MSAAGTYAWMAPEVIKT-----------SIFSKASDVWSYGVVLWELLTGEIPYKSIN-AYA 328 (527)
Q Consensus 265 ~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~-----------~~~~~ksDvwSlGv~l~elltg~~Pf~~~~-~~~ 328 (527)
+|||+++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ...
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 99999986643221 23468999999999875 468899999999999999999999998764 334
Q ss_pred HHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 329 ~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+.........|..++..+.++|.+||..||.+||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 4444555556667788889999999999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=346.43 Aligned_cols=245 Identities=29% Similarity=0.484 Sum_probs=206.2
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC---ChhHHHHHHHHHHHHHhCCCCccceEEEEEE--eCCeE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP---DENILENVKQEGKLLWLFDHRNIVSLIGVCL--QSPKL 188 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~--~~~~~ 188 (527)
.++|.+.+.||+|+||.||+|.+ +++.||+|++.... .......+.+|+.+++.++||||+++++++. +...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36799999999999999999997 45789999987532 1223577899999999999999999999984 45678
Q ss_pred EEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 189 CLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
|+|||||.+| |.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~--------~~~kl~ 151 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTG--------GTLKIS 151 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------CCEEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCC--------CcEEee
Confidence 9999999877 666654 567999999999999999999999995 9999999999999875 689999
Q ss_pred ccCcchhhhc----cccccCCCccccccccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 266 DFGLAREVYK----TTHMSAAGTYAWMAPEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 266 DFGla~~~~~----~~~~~~~gt~~y~aPE~l~~~~--~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
|||++..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-- 229 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-- 229 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--
Confidence 9999976532 1122456999999999997644 4789999999999999999999999988877776665443
Q ss_pred CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.|..+++.+.++|.+||..||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 45678899999999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=362.94 Aligned_cols=247 Identities=24% Similarity=0.334 Sum_probs=196.7
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC-----Ce
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-----PK 187 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-----~~ 187 (527)
.++|.+.+.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 368999999999999999999874 5789999987643 334467889999999999999999999999776 57
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|+|||||. |+|.+++. ...+++..+..++.||+.||+|||++| |+||||||+||||+.+ +.+||+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~--------~~~kL~D 172 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQD--------CSVKVCD 172 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------CCEEECC
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCC--------CCEEEcc
Confidence 999999995 69999887 456999999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccc------------------------cccCCCcccccccccc-ccCCCCcccchHHHHHHHHHHHh-----
Q psy6905 267 FGLAREVYKTT------------------------HMSAAGTYAWMAPEVI-KTSIFSKASDVWSYGVVLWELLT----- 316 (527)
Q Consensus 267 FGla~~~~~~~------------------------~~~~~gt~~y~aPE~l-~~~~~~~ksDvwSlGv~l~ellt----- 316 (527)
||+++...... ....+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 99998653321 2345799999999986 55669999999999999999997
Q ss_pred ------CCCCCCCCCH-----------------HHHHHH------------------------HHhCCccCCCC-----C
Q psy6905 317 ------GEIPYKSINA-----------------YAVAYG------------------------VAVNKLTLPIP-----S 344 (527)
Q Consensus 317 ------g~~Pf~~~~~-----------------~~~~~~------------------------i~~~~~~~~~p-----~ 344 (527)
|.++|.+.+. ...... +.......+.+ .
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 4445544321 011100 00001111111 4
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+++++.+||.+||..||.+|||+.+++++
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 578999999999999999999999999885
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=361.79 Aligned_cols=248 Identities=22% Similarity=0.294 Sum_probs=204.6
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhC------CCCccceEEEEEEeC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLF------DHRNIVSLIGVCLQS 185 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~hpnIv~~~~~~~~~ 185 (527)
....+|++.+.||+|+||.||+|.+. ++.||||++... ......+.+|+.++..+ +|+||+++++++...
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 34567999999999999999999874 578999998754 33456677888888876 677999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 186 PKLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
..+|+|||||. |+|.+++.. ..+++..+..++.||+.||.|||++| ||||||||+||||+.+.. ..+
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~------~~v 241 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGR------SGI 241 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTS------CCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCC------cce
Confidence 99999999995 688888763 34899999999999999999999995 999999999999997521 239
Q ss_pred EEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc---
Q psy6905 263 KITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT--- 339 (527)
Q Consensus 263 kL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~--- 339 (527)
||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+......
T Consensus 242 kL~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 242 KVIDFGSSCYEHQ-RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp EECCCTTCEETTC-CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred EEeecccceecCC-cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 9999999975532 233567999999999999999999999999999999999999999998876655443311000
Q ss_pred ------------------------------------------------------CCCCCCccHHHHHHHHHhhhhCCCCC
Q psy6905 340 ------------------------------------------------------LPIPSTCPQLFKTLMEACWEADSHMR 365 (527)
Q Consensus 340 ------------------------------------------------------~~~p~~~~~~~~~li~~~l~~dp~~R 365 (527)
..++...++.+.+||.+||..||.+|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 00122347889999999999999999
Q ss_pred CCHHHHHHH
Q psy6905 366 PSFKTILKA 374 (527)
Q Consensus 366 Ps~~~ll~~ 374 (527)
||+.+++++
T Consensus 401 pta~e~L~H 409 (429)
T 3kvw_A 401 MTPGQALRH 409 (429)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhCC
Confidence 999999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=353.19 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=199.6
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-------ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-------DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 57999999999999999999874 5789999986532 1122345789999999999999999999987665
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
.|+|||||.+|+|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+.. ...+||+|
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~-----~~~~kl~D 160 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE-----DCLIKITD 160 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSS-----SCCEEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCC-----CCeEEEcc
Confidence 899999999999999887 567999999999999999999999995 999999999999987521 14699999
Q ss_pred cCcchhhhcccc-ccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCccC-
Q psy6905 267 FGLAREVYKTTH-MSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLTGEIPYKSINAY-AVAYGVAVNKLTL- 340 (527)
Q Consensus 267 FGla~~~~~~~~-~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~-~~~~~i~~~~~~~- 340 (527)
||+++....... ....||+.|+|||++. ...++.++|||||||++|+|++|..||...... .....+.......
T Consensus 161 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 161 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp CTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred CccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 999976543221 2346899999999974 466899999999999999999999999865432 2222333222221
Q ss_pred -CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 341 -PIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 341 -~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
..+..+++.+.+||.+||..||.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 122568899999999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=353.61 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=201.5
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEe--------
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQ-------- 184 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-------- 184 (527)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999998 467999998865432 2234567799999999999999999999987
Q ss_pred CCeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
.+.+|+|||||.+ +|.+.+. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~--------~~~ 163 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRD--------GVL 163 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------SCE
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCC--------CCE
Confidence 4468999999975 6666655 357999999999999999999999995 9999999999999875 689
Q ss_pred EEeccCcchhhhc------cccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6905 263 KITDFGLAREVYK------TTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAV 335 (527)
Q Consensus 263 kL~DFGla~~~~~------~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~ 335 (527)
||+|||+++.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999976532 11234568999999999876 4589999999999999999999999999887766555432
Q ss_pred CCccC--CCCCC----------------------------ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 336 NKLTL--PIPST----------------------------CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 336 ~~~~~--~~p~~----------------------------~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..... ..... .++.+.+||.+||..||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11111 11011 26779999999999999999999999884
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=349.71 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=175.9
Q ss_pred CCceeee-eeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe----CCeE
Q psy6905 116 YNKLIFG-EAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ----SPKL 188 (527)
Q Consensus 116 ~~~~~~~-~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----~~~~ 188 (527)
.++|.+. +.||+|+||.||+|.+. ++.||||++... .. ........++.+.||||+++++++.. ...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 3568875 46999999999999985 689999998653 12 22233344667799999999999976 4558
Q ss_pred EEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 189 CLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
|+|||||.||+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+.. .+.+||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~-----~~~~kl~ 173 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEK-----DAVLKLT 173 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSST-----TCCEEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCC-----CceEEEe
Confidence 999999999999999874 36899999999999999999999995 999999999999986421 2579999
Q ss_pred ccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCccC-
Q psy6905 266 DFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY----GVAVNKLTL- 340 (527)
Q Consensus 266 DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~----~i~~~~~~~- 340 (527)
|||+++...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+........ .+.......
T Consensus 174 Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3fhr_A 174 DFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253 (336)
T ss_dssp CCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred ccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence 999998765544456678999999999988889999999999999999999999998765443321 122222222
Q ss_pred -CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 -PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 -~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+....+++.+.+||..||..||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2335789999999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=347.25 Aligned_cols=244 Identities=18% Similarity=0.331 Sum_probs=201.2
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEe--CCeEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQ--SPKLC 189 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~--~~~~~ 189 (527)
+.++|++.+.||+|+||.||+|.+ +++.||||++.... .+.+.+|+.+++.+. ||||+++++++.+ ....+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 457899999999999999999987 46799999987542 456889999999997 9999999999988 67799
Q ss_pred EEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
+|||||.+++|.+++. .+++..+..++.||+.||.|||++| |+||||||+|||++.+ ...+||+|||+
T Consensus 110 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~-------~~~~kl~Dfg~ 177 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHE-------HRKLRLIDWGL 177 (330)
T ss_dssp EEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT-------TTEEEECCCTT
T ss_pred EEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCC-------CCEEEEEeCCC
Confidence 9999999999999985 4889999999999999999999995 9999999999999865 14899999999
Q ss_pred chhhhcc-ccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHH------------
Q psy6905 270 AREVYKT-THMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSI-NAYAVAYGVA------------ 334 (527)
Q Consensus 270 a~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~-~~~~~~~~i~------------ 334 (527)
++..... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||... +.......+.
T Consensus 178 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred ceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence 9865432 2334578999999999977 66899999999999999999999999543 3222221111
Q ss_pred -hCCc----------------------cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 335 -VNKL----------------------TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 335 -~~~~----------------------~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.... ....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 011123378999999999999999999999999873
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.33 Aligned_cols=242 Identities=26% Similarity=0.333 Sum_probs=197.7
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC------CeE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQS------PKL 188 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~------~~~ 188 (527)
.+|.+.+.||+|+||.||+|.+ +++.||||++..... ...+|+.+++.++|||||+++++|... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 4689999999999999999998 468999998865422 233799999999999999999998542 247
Q ss_pred EEEEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 189 CLVMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
++|||||.+ +|.+++. +..+++..+..++.||+.||.|||++| ||||||||+||||+.+ .+.+|
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~-------~~~~k 197 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPD-------TAVLK 197 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETT-------TTEEE
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCC-------CCeEE
Confidence 899999975 5555443 567999999999999999999999995 9999999999999854 25789
Q ss_pred EeccCcchhhhcc-ccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----
Q psy6905 264 ITDFGLAREVYKT-THMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN----- 336 (527)
Q Consensus 264 L~DFGla~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~----- 336 (527)
|+|||+++..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 198 l~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 198 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277 (420)
T ss_dssp ECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred eccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999999865332 23356799999999999765 6899999999999999999999999998876655544321
Q ss_pred ------------CccCC----------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ------------KLTLP----------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ------------~~~~~----------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+.++ ++..+++++.+||.+||..||.+||++.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 11111 234578999999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=346.55 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=201.2
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEE----------
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCL---------- 183 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~---------- 183 (527)
.++|.+.+.||+|+||.||+|.+. ++.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 578999999999999999999985 678999988754 3445678899999999999999999999873
Q ss_pred ----eCCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 184 ----QSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 184 ----~~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
+....|+||||+. |+|.+++..+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ .
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~-------~ 157 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTE-------D 157 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETT-------T
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCC-------C
Confidence 3467899999997 69999999888999999999999999999999995 9999999999999743 2
Q ss_pred ceeEEeccCcchhhhcc-----ccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6905 260 KTLKITDFGLAREVYKT-----THMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGV 333 (527)
Q Consensus 260 ~~vkL~DFGla~~~~~~-----~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i 333 (527)
+.+||+|||+++..... ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 58999999999865321 1123457899999998865 67899999999999999999999999998876655544
Q ss_pred HhCCcc----------------------C------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 334 AVNKLT----------------------L------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 334 ~~~~~~----------------------~------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...... . ..+..++..+.+||.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 321100 0 0124688999999999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=354.84 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=206.4
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
..|++. ++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 456665 68999999999999999999874 6799999987643 3445678889999999999999999999998766
Q ss_pred eE------EEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccc
Q psy6905 187 KL------CLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260 (527)
Q Consensus 187 ~~------~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~ 260 (527)
.. |+|||||. |+|.+++. ..+++..+..++.||+.||.|||++| |+||||||+|||++.+ +
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~--------~ 181 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNED--------C 181 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT--------C
T ss_pred CcccceeEEEEEcccc-ccHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCC--------C
Confidence 54 99999996 68888875 45999999999999999999999995 9999999999999875 6
Q ss_pred eeEEeccCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Q psy6905 261 TLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 261 ~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 339 (527)
.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 182 ~~kL~Dfg~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 260 (371)
T 4exu_A 182 ELKILDFGLARHADA-EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 260 (371)
T ss_dssp CEEECSTTCC---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred CEEEEecCccccccc-CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 899999999986533 2334678999999999987 67899999999999999999999999998876655554321000
Q ss_pred -----------------------------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 -----------------------------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 -----------------------------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 01124578999999999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=362.09 Aligned_cols=245 Identities=14% Similarity=0.135 Sum_probs=185.7
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC--hhHHHHHHHHHHHHHhC--CCCccceEE-------EEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD--ENILENVKQEGKLLWLF--DHRNIVSLI-------GVC 182 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l--~hpnIv~~~-------~~~ 182 (527)
...|.+.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+.++..| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45699999999999999999997 467899999887642 33456677885545444 699988755 555
Q ss_pred EeC-----------------CeEEEEEeccCCCCHHHHhc--CCCCChhHH------HHHHHHHHHHHHHHHhcCCCcee
Q psy6905 183 LQS-----------------PKLCLVMEYARGGPLNRVLA--GRKIRPDVL------VDWAIQIAEGMNYLHCQAPISLI 237 (527)
Q Consensus 183 ~~~-----------------~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~------~~i~~qi~~~L~yLH~~g~~~ii 237 (527)
... ..+|+|||||+ |+|.+++. +..+..... +.++.||+.||+|||++| ||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 433 34899999998 89999987 334555555 677899999999999995 99
Q ss_pred ecCCCCCceecCCCCcccccccceeEEeccCcchhhhccccccCCCcccccccccccc--CCCCcccchHHHHHHHHHHH
Q psy6905 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT--SIFSKASDVWSYGVVLWELL 315 (527)
Q Consensus 238 HrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDvwSlGv~l~ell 315 (527)
||||||+||||+.+ +.+||+|||+++....... ...+|+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 217 HrDikp~NIll~~~--------~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 217 HGHFTPDNLFIMPD--------GRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp ETTCSGGGEEECTT--------SCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEECCC--------CCEEEEecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 99999999999875 6899999999986643322 4557799999999987 67999999999999999999
Q ss_pred hCCCCCCCCCHHHHH-------HHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 316 TGEIPYKSINAYAVA-------YGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 316 tg~~Pf~~~~~~~~~-------~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
+|+.||.+....... .........++.+..+|+.+.+||.+||..||.+|||+.++++
T Consensus 288 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999876332110 0001112334444688999999999999999999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=348.35 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=206.4
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE---cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCc------cceEEEEEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY---EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN------IVSLIGVCL 183 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpn------Iv~~~~~~~ 183 (527)
++-.++|++.+.||+|+||.||+|.+ .++.||||++... ....+.+.+|+.+++.++|+| |+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 34567899999999999999999987 4578999998753 344577889999999886654 999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcc------
Q psy6905 184 QSPKLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN------ 254 (527)
Q Consensus 184 ~~~~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~------ 254 (527)
..+.+|+||||| +++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.....
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC--
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCc
Confidence 999999999999 8899988873 25889999999999999999999995 9999999999999864210
Q ss_pred -----cccccceeEEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy6905 255 -----EDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAV 329 (527)
Q Consensus 255 -----~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~ 329 (527)
.....+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccccccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 000125799999999976432 23356799999999999999999999999999999999999999998876654
Q ss_pred HHHHHhCCc------------------------------------------cCCCCCCccHHHHHHHHHhhhhCCCCCCC
Q psy6905 330 AYGVAVNKL------------------------------------------TLPIPSTCPQLFKTLMEACWEADSHMRPS 367 (527)
Q Consensus 330 ~~~i~~~~~------------------------------------------~~~~p~~~~~~~~~li~~~l~~dp~~RPs 367 (527)
...+..... ....+..+++.+.+||.+||..||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 433221100 01122345678999999999999999999
Q ss_pred HHHHHHH
Q psy6905 368 FKTILKA 374 (527)
Q Consensus 368 ~~~ll~~ 374 (527)
+.+++++
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=363.78 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=211.0
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCC-CccceEEEEEEeCCeEEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDH-RNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~~~~~~~~~~~~~iv 191 (527)
-.++|.+++.||+|+||.||+|.+. ++.||||++...... ..+..|+.+++.+.| ++|..+..++.+....|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 3578999999999999999999974 689999987654332 346789999999976 5666677777888899999
Q ss_pred EeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 192 MEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||| +++|.+++. .+.+++..++.|+.||+.||.|||++| ||||||||+||||+.+. ..+.+||+|||+
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~-----~~~~vkL~DFGl 152 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGR-----RANQVYIIDFGL 152 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGG-----GTTCEEECCCTT
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCC-----CCCeEEEEeCCc
Confidence 9999 999999997 678999999999999999999999995 99999999999995321 136899999999
Q ss_pred chhhhcccc---------ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC
Q psy6905 270 AREVYKTTH---------MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA---YAVAYGVAVNK 337 (527)
Q Consensus 270 a~~~~~~~~---------~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~i~~~~ 337 (527)
++....... ....||+.|+|||++.+..++.++|||||||+||+|++|+.||.+... ......+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 987643221 145799999999999999999999999999999999999999987543 23333332222
Q ss_pred ccC---CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhccc
Q psy6905 338 LTL---PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383 (527)
Q Consensus 338 ~~~---~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~ 383 (527)
... .++..+|+++.+||..||..||.+||++.+|++.|+.++....
T Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 211 2336789999999999999999999999999999999877543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=359.99 Aligned_cols=246 Identities=23% Similarity=0.303 Sum_probs=198.8
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC------
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP------ 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~------ 186 (527)
....+|.+.+.||+|+||.||+|.+. +..||+|.+..... ...+|+.+++.++||||+++++++....
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 34467999999999999999999984 45688887755422 1236999999999999999999996543
Q ss_pred eEEEEEeccCCCCHHHHhc----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 187 KLCLVMEYARGGPLNRVLA----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
.+|+|||||.++.+..+.. ...+++..+..++.||+.||+|||++| |+||||||+||||+.. .+.+
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~-------~~~~ 181 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPP-------SGVL 181 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETT-------TTEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCC-------CCcE
Confidence 3899999998765544332 567999999999999999999999995 9999999999999832 2689
Q ss_pred EEeccCcchhhhc-cccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---
Q psy6905 263 KITDFGLAREVYK-TTHMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK--- 337 (527)
Q Consensus 263 kL~DFGla~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~--- 337 (527)
||+|||+++.... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 182 kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp EECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999987633 333456789999999999765 58999999999999999999999999988766555443210
Q ss_pred --------------ccC----------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 --------------LTL----------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 --------------~~~----------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+ ..+..+++++.+||.+||..||.+|||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000 1234578999999999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=357.16 Aligned_cols=254 Identities=22% Similarity=0.290 Sum_probs=199.5
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC--------CCccceEEEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFD--------HRNIVSLIGVCL 183 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--------hpnIv~~~~~~~ 183 (527)
+-.++|.+.+.||+|+||.||+|.+ .++.||||++... ....+.+.+|+.+++.+. |+||+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 3457899999999999999999987 4678999998754 344677889999999885 788999999987
Q ss_pred ----eCCeEEEEEeccCCCCHHHHh-cC--CCCChhHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCceecCCCCc--
Q psy6905 184 ----QSPKLCLVMEYARGGPLNRVL-AG--RKIRPDVLVDWAIQIAEGMNYLHCQ-APISLIHRDLKSSNVLLSEPIE-- 253 (527)
Q Consensus 184 ----~~~~~~iv~Ey~~ggsL~~~l-~~--~~~~~~~~~~i~~qi~~~L~yLH~~-g~~~iiHrDlkp~NILl~~~~~-- 253 (527)
....+|+||||| +|+|.+.+ .. ..+++..++.++.||+.||.|||++ | ||||||||+||||+.+..
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 456899999999 55555544 43 5699999999999999999999998 5 999999999999986520
Q ss_pred ---------------------------------------ccccccceeEEeccCcchhhhccccccCCCccccccccccc
Q psy6905 254 ---------------------------------------NEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIK 294 (527)
Q Consensus 254 ---------------------------------------~~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~ 294 (527)
........+||+|||+++..... .....||+.|+|||++.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhhc
Confidence 00001237999999999866432 34567999999999999
Q ss_pred cCCCCcccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh--C----------Cc------------------
Q psy6905 295 TSIFSKASDVWSYGVVLWELLTGEIPYKSINA------YAVAYGVAV--N----------KL------------------ 338 (527)
Q Consensus 295 ~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~------~~~~~~i~~--~----------~~------------------ 338 (527)
+..++.++|||||||++|+|++|+.||.+.+. ......+.. + .+
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 99999999999999999999999999986542 111111110 0 00
Q ss_pred ----------cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 ----------TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 ----------~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+..++..+.+||.+||..||.+|||+.+++++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 011233456788999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.86 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=193.6
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhH-HHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENI-LENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
..+.+..++|.+.+.||+|+||.||+|.+. ++.||||++........ .+.+..+..+++.++||||+++++++.+.+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 346777889999999999999999999984 68999999877654433 334455556788889999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 187 KLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQ-APISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~-g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
.+|+||||| ++.+..+.. ...+++..+..++.||+.||.|||++ | |+||||||+|||++.+ +.+|
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~--------~~~k 165 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDER--------GQIK 165 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTT--------SCEE
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCC--------CCEE
Confidence 999999999 666666654 57799999999999999999999984 5 9999999999999875 6899
Q ss_pred EeccCcchhhhccc-cccCCCccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC
Q psy6905 264 ITDFGLAREVYKTT-HMSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGVVLWELLTGEIPYKSI-NAYAVAYGVAVN 336 (527)
Q Consensus 264 L~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~-----~~~~~~ksDvwSlGv~l~elltg~~Pf~~~-~~~~~~~~i~~~ 336 (527)
|+|||++....... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||... ........+...
T Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (318)
T 2dyl_A 166 LCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245 (318)
T ss_dssp ECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS
T ss_pred EEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc
Confidence 99999997664322 23456899999999994 456889999999999999999999999874 444444444433
Q ss_pred Cc-cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 KL-TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ~~-~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. ..+....+++.+.+||.+||..||.+||++.+++++
T Consensus 246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 22 223335689999999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=348.33 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=204.1
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
.|++. ++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 19 ~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 19 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 34543 57999999999999999999874 6799999987643 34446788999999999999999999999987653
Q ss_pred ------EEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccce
Q psy6905 188 ------LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKT 261 (527)
Q Consensus 188 ------~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~ 261 (527)
+|+||||+. |+|.+++. ..+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~--------~~ 164 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMG-LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNED--------CE 164 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTT--------CC
T ss_pred cccceeEEEEecccc-CCHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCC--------Cc
Confidence 599999996 68888775 35999999999999999999999995 9999999999999875 68
Q ss_pred eEEeccCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---
Q psy6905 262 LKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK--- 337 (527)
Q Consensus 262 vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~--- 337 (527)
+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 165 ~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 243 (353)
T 3coi_A 165 LKILDFGLARHADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243 (353)
T ss_dssp EEECSTTCTTC---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBC
T ss_pred EEEeecccccCCCCC-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999999865332 334578999999999877 678999999999999999999999999887665544432200
Q ss_pred --------------------------ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 --------------------------LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 --------------------------~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0012335678999999999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=348.89 Aligned_cols=249 Identities=24% Similarity=0.261 Sum_probs=189.4
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe----
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK---- 187 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~---- 187 (527)
...++|.+.+.||+|+||.||+|.+. ++.||||++...... .....+++..+..++||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 34578999999999999999999984 678999987554321 2345677888888999999999999976433
Q ss_pred ---EEEEEeccCCCCHHHHh---c-CCCCChhHHHHHHHHHHHHHHHHH--hcCCCceeecCCCCCceecCCCCcccccc
Q psy6905 188 ---LCLVMEYARGGPLNRVL---A-GRKIRPDVLVDWAIQIAEGMNYLH--CQAPISLIHRDLKSSNVLLSEPIENEDLQ 258 (527)
Q Consensus 188 ---~~iv~Ey~~ggsL~~~l---~-~~~~~~~~~~~i~~qi~~~L~yLH--~~g~~~iiHrDlkp~NILl~~~~~~~~~~ 258 (527)
+++|||||.++.+..+. . ...+++..+..++.||+.||.||| ++ +|+||||||+|||++..
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~------- 167 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA------- 167 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT-------
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC-------
Confidence 89999999765333222 2 567889999999999999999999 87 49999999999999862
Q ss_pred cceeEEeccCcchhhhccc-cccCCCccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6905 259 FKTLKITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN 336 (527)
Q Consensus 259 ~~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~ 336 (527)
.+.+||+|||+++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 2689999999998764332 33457899999999986654 899999999999999999999999998877666554321
Q ss_pred Cc------------------------------cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 KL------------------------------TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ~~------------------------------~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. ....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 011223367899999999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=352.55 Aligned_cols=248 Identities=27% Similarity=0.371 Sum_probs=196.7
Q ss_pred eCCceeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCC----------ChhHHHHHHHHHHHHHhCCCCccceEEEEEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNP----------DENILENVKQEGKLLWLFDHRNIVSLIGVCL 183 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~ 183 (527)
..++|.+.+.||+|+||.||+|.+ .+..||||++.... +....+.+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 357899999999999999999987 46789999875432 2233578899999999999999999999985
Q ss_pred e-----CCeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccc
Q psy6905 184 Q-----SPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENED 256 (527)
Q Consensus 184 ~-----~~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~ 256 (527)
. ...+|+|||||. |+|.+++. +..+++..+..++.||+.||.|||++| |+||||||+|||++.+
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~----- 170 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADN----- 170 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT-----
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCC-----
Confidence 4 336899999997 67777765 336899999999999999999999995 9999999999999875
Q ss_pred cccceeEEeccCcchhhhccc-cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6905 257 LQFKTLKITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVA 334 (527)
Q Consensus 257 ~~~~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~ 334 (527)
+.+||+|||+++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 171 ---~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 171 ---NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp ---CCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ---CCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 689999999997653322 234578999999999877 678999999999999999999999999887666555443
Q ss_pred hCC-----------------------c-c------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 335 VNK-----------------------L-T------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 335 ~~~-----------------------~-~------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
... . . ...+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 210 0 0 01224568889999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.28 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=201.2
Q ss_pred CCceeeeeeeccCCceEEEEeeEc---CceEEEEEcCCCCC-hhHHHHHHHHHHHHHhC---CCCccceEEEEEE-----
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE---KQEVAIKVAHPNPD-ENILENVKQEGKLLWLF---DHRNIVSLIGVCL----- 183 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~---~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l---~hpnIv~~~~~~~----- 183 (527)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... ......+.+|+.+++.+ .||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 368999999999999999999873 57899998764321 11122344666666655 8999999999987
Q ss_pred eCCeEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccc
Q psy6905 184 QSPKLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260 (527)
Q Consensus 184 ~~~~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~ 260 (527)
....+++||||+. |+|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.+ +
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~--------~ 157 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS--------G 157 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------C
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCC--------C
Confidence 4567899999997 699988862 34899999999999999999999995 9999999999999875 6
Q ss_pred eeEEeccCcchhhhcc-ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-
Q psy6905 261 TLKITDFGLAREVYKT-THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL- 338 (527)
Q Consensus 261 ~vkL~DFGla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~- 338 (527)
.+||+|||+++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 158 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 158 QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237 (326)
T ss_dssp CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred CEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 8999999999766432 23345789999999999999999999999999999999999999999887666555432100
Q ss_pred ------------------------cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 ------------------------TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 ------------------------~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+..++..+.+||.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001235688999999999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=338.94 Aligned_cols=241 Identities=27% Similarity=0.443 Sum_probs=194.4
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe----------
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ---------- 184 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~---------- 184 (527)
++|.+.+.||+|+||.||+|.+ +++.||||++... ......+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 5789999999999999999997 4678999998543 3446778999999999999999999999865
Q ss_pred ---CCeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 185 ---SPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 185 ---~~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
...+|+|||||++|+|.+++. +..+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~-------- 152 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDES-------- 152 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT--------
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCC--------
Confidence 356899999999999999997 335778899999999999999999995 9999999999999875
Q ss_pred ceeEEeccCcchhhhcc----------------ccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCC
Q psy6905 260 KTLKITDFGLAREVYKT----------------THMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYK 322 (527)
Q Consensus 260 ~~vkL~DFGla~~~~~~----------------~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~ 322 (527)
+.+||+|||++...... ......||+.|+|||++.+. .++.++|||||||++|+|++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 68999999999765321 11234689999999999865 68999999999999999998 665
Q ss_pred CC-CHHHHHHHHHhCCc--cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 323 SI-NAYAVAYGVAVNKL--TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 323 ~~-~~~~~~~~i~~~~~--~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.. +.......+..... ....+..++..+.++|.+||..||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp SHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 33 22333333332222 22345667888999999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=348.34 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=205.8
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCCh-----hHHHHHHHHHHHHHhCC--CCccceEE
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDE-----NILENVKQEGKLLWLFD--HRNIVSLI 179 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~--hpnIv~~~ 179 (527)
.+..+.-.++|++.+.||+|+||.||+|.+ +++.||||++...... .....+.+|+.+++.+. ||||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 344566778999999999999999999987 4678999988654211 11234567899999996 59999999
Q ss_pred EEEEeCCeEEEEEeccCC-CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccc
Q psy6905 180 GVCLQSPKLCLVMEYARG-GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDL 257 (527)
Q Consensus 180 ~~~~~~~~~~iv~Ey~~g-gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~ 257 (527)
+++...+..++||||+.+ ++|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~------ 185 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN------ 185 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT------
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCC------
Confidence 999999999999999976 89999887 567999999999999999999999995 9999999999999832
Q ss_pred ccceeEEeccCcchhhhccccccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6905 258 QFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN 336 (527)
Q Consensus 258 ~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~ 336 (527)
.+.+||+|||+++...........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... +...
T Consensus 186 -~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~ 258 (320)
T 3a99_A 186 -RGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG 258 (320)
T ss_dssp -TTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC
T ss_pred -CCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc
Confidence 2689999999998776555556679999999999987665 6889999999999999999999976432 1111
Q ss_pred CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 259 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 --QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 234567899999999999999999999999999873
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=354.88 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=180.7
Q ss_pred ceee-eeeeccCCceEEEEeeEc----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe--CCeEEE
Q psy6905 118 KLIF-GEAIGEGGFGKVYKGIYE----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--SPKLCL 190 (527)
Q Consensus 118 ~~~~-~~~iG~G~fg~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~i 190 (527)
.|.+ +++||+|+||.||+|.+. ++.||||++..... ...+.+|+.+++.++||||+++++++.. +..+|+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 4555 558999999999999964 56899999876533 2457789999999999999999999965 678999
Q ss_pred EEeccCCCCHHHHhc----------CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccc
Q psy6905 191 VMEYARGGPLNRVLA----------GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~----------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~ 260 (527)
|||||. |+|.+++. ...+++..++.++.||+.||.|||++| ||||||||+||||..+.. ..+
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~----~~~ 169 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP----ERG 169 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSST----TTT
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCC----CCC
Confidence 999996 57777664 124899999999999999999999995 999999999999953211 136
Q ss_pred eeEEeccCcchhhhcc-----ccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHH-------
Q psy6905 261 TLKITDFGLAREVYKT-----THMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAY------- 327 (527)
Q Consensus 261 ~vkL~DFGla~~~~~~-----~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~------- 327 (527)
.+||+|||+++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 8999999999876432 12345789999999999874 5899999999999999999999999765431
Q ss_pred --HHHHHHHh-CCccC-----------------------------------CCCCCccHHHHHHHHHhhhhCCCCCCCHH
Q psy6905 328 --AVAYGVAV-NKLTL-----------------------------------PIPSTCPQLFKTLMEACWEADSHMRPSFK 369 (527)
Q Consensus 328 --~~~~~i~~-~~~~~-----------------------------------~~p~~~~~~~~~li~~~l~~dp~~RPs~~ 369 (527)
.....+.. .+... ......++.+.+||.+||..||.+|||+.
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 12211111 00000 00112267789999999999999999999
Q ss_pred HHHHH
Q psy6905 370 TILKA 374 (527)
Q Consensus 370 ~ll~~ 374 (527)
+++++
T Consensus 330 e~L~h 334 (405)
T 3rgf_A 330 QAMQD 334 (405)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99884
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=342.62 Aligned_cols=245 Identities=24% Similarity=0.389 Sum_probs=197.5
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCCh-----hHHHHHHHHHHHHHhC----CCCccceEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDE-----NILENVKQEGKLLWLF----DHRNIVSLIG 180 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l----~hpnIv~~~~ 180 (527)
.+.-.++|.+.+.||+|+||.||+|.+ +++.||||++...... .....+.+|+.++..+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 445567899999999999999999987 4678999998764321 1123455788888888 8999999999
Q ss_pred EEEeCCeEEEEEec-cCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccc
Q psy6905 181 VCLQSPKLCLVMEY-ARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQ 258 (527)
Q Consensus 181 ~~~~~~~~~iv~Ey-~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~ 258 (527)
++...+..++|||| +.+++|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~------- 175 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLR------- 175 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETT-------
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCC-------
Confidence 99999999999999 78999999987 567999999999999999999999995 9999999999999832
Q ss_pred cceeEEeccCcchhhhccccccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy6905 259 FKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK 337 (527)
Q Consensus 259 ~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~ 337 (527)
.+.+||+|||+++...........||..|+|||++.+..+ +.++|||||||++|+|++|+.||..... +..
T Consensus 176 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~-- 247 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE-- 247 (312)
T ss_dssp TTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--
T ss_pred CCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh--
Confidence 2689999999998776555556679999999999987665 4599999999999999999999976422 111
Q ss_pred ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 ~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....+..++..+.++|.+||..||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2345678899999999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=347.83 Aligned_cols=253 Identities=20% Similarity=0.290 Sum_probs=201.1
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-----------CCccceEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFD-----------HRNIVSLI 179 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----------hpnIv~~~ 179 (527)
.+...+|.+.+.||+|+||.||+|.+ +++.||||++... ......+.+|+.+++.+. ||||++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 34567899999999999999999997 4679999998753 334567788999998876 89999999
Q ss_pred EEEEeCC----eEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCceecCCC
Q psy6905 180 GVCLQSP----KLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQ-APISLIHRDLKSSNVLLSEP 251 (527)
Q Consensus 180 ~~~~~~~----~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~-g~~~iiHrDlkp~NILl~~~ 251 (527)
+++.... .+++||||+ +++|.+++. ...+++..+..++.||+.||.|||++ | |+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEecc
Confidence 9998654 789999999 999999886 35599999999999999999999997 6 9999999999999642
Q ss_pred CcccccccceeEEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH----
Q psy6905 252 IENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAY---- 327 (527)
Q Consensus 252 ~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~---- 327 (527)
... ...+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 169 ~~~--~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 169 DSP--ENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp ETT--TTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCC--cCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 100 11258999999999766432 33457999999999999999999999999999999999999999865421
Q ss_pred --HHHHHHHh--C--------------------------------------CccCCCCCCccHHHHHHHHHhhhhCCCCC
Q psy6905 328 --AVAYGVAV--N--------------------------------------KLTLPIPSTCPQLFKTLMEACWEADSHMR 365 (527)
Q Consensus 328 --~~~~~i~~--~--------------------------------------~~~~~~p~~~~~~~~~li~~~l~~dp~~R 365 (527)
.....+.. + ......+..+++.+.+||.+||..||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111110 0 00123445667889999999999999999
Q ss_pred CCHHHHHHH
Q psy6905 366 PSFKTILKA 374 (527)
Q Consensus 366 Ps~~~ll~~ 374 (527)
||+.+++++
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999884
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=342.12 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=201.5
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--C-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCc------cceEEEEEEeC
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--K-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN------IVSLIGVCLQS 185 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpn------Iv~~~~~~~~~ 185 (527)
-.++|.+.+.||+|+||.||+|.+. + ..||||++... ......+.+|+.+++.+.|++ ++.+++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 4578999999999999999999873 3 58999998753 344567888999999987766 99999999999
Q ss_pred CeEEEEEeccCCCCHHHHhc-C--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcc--------
Q psy6905 186 PKLCLVMEYARGGPLNRVLA-G--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIEN-------- 254 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL~~~l~-~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~-------- 254 (527)
..+|+||||| +|+|.+++. . ..+++..++.++.||+.||.|||++| |+||||||+|||++.....
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 9999999999 566666554 2 46899999999999999999999995 9999999999999543100
Q ss_pred ---cccccceeEEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy6905 255 ---EDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY 331 (527)
Q Consensus 255 ---~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~ 331 (527)
.....+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccccCCCcEEEeecCccccccc-cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 001236899999999976432 2345679999999999999999999999999999999999999999887665443
Q ss_pred HHHhCCcc------------------------------------------CCCCCCccHHHHHHHHHhhhhCCCCCCCHH
Q psy6905 332 GVAVNKLT------------------------------------------LPIPSTCPQLFKTLMEACWEADSHMRPSFK 369 (527)
Q Consensus 332 ~i~~~~~~------------------------------------------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~ 369 (527)
.+...... .......+..+.+||.+||..||.+|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 33211000 011122356899999999999999999999
Q ss_pred HHHH
Q psy6905 370 TILK 373 (527)
Q Consensus 370 ~ll~ 373 (527)
++++
T Consensus 330 e~l~ 333 (355)
T 2eu9_A 330 EALL 333 (355)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=344.81 Aligned_cols=249 Identities=27% Similarity=0.353 Sum_probs=201.9
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CC-----ccceEEEEEEeCC
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HR-----NIVSLIGVCLQSP 186 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hp-----nIv~~~~~~~~~~ 186 (527)
-.++|.+.+.||+|+||.||+|.+. ++.||||++... ......+..|+.++..+. |+ +|+++++++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 3578999999999999999999874 678999998753 344567788888888874 55 4999999999999
Q ss_pred eEEEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 187 KLCLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
.+|+|||||. |+|.+++.. +.+++..+..++.||+.||.|||++. .+||||||||+||||+.+. .+.+|
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~------~~~~k 201 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPK------RSAIK 201 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTT------SCCEE
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCC------CCcEE
Confidence 9999999995 599988863 45899999999999999999999521 1599999999999996431 25899
Q ss_pred EeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC---
Q psy6905 264 ITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL--- 340 (527)
Q Consensus 264 L~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~--- 340 (527)
|+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 202 L~DFG~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 202 IVDFGSSCQLGQ-RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280 (382)
T ss_dssp ECCCTTCEETTC-CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred EEeccCceeccc-ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999999987643 2345679999999999999999999999999999999999999999988776655543210000
Q ss_pred --------------------------------CCC--C-------------------------CccHHHHHHHHHhhhhC
Q psy6905 341 --------------------------------PIP--S-------------------------TCPQLFKTLMEACWEAD 361 (527)
Q Consensus 341 --------------------------------~~p--~-------------------------~~~~~~~~li~~~l~~d 361 (527)
..| . ..++.+.+||.+||..|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 000 0 01147899999999999
Q ss_pred CCCCCCHHHHHHH
Q psy6905 362 SHMRPSFKTILKA 374 (527)
Q Consensus 362 p~~RPs~~~ll~~ 374 (527)
|.+|||+.+++++
T Consensus 361 P~~Rpta~e~L~h 373 (382)
T 2vx3_A 361 PKTRIQPYYALQH 373 (382)
T ss_dssp TTTSCCHHHHTTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=352.16 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=197.4
Q ss_pred eeeEEeCCceeeeeeeccCCceE-EEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCe
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGK-VYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~-Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~ 187 (527)
..+.+...+|.+.+.||+|+||+ ||++..+++.||||++..... ..+.+|+.+++.+ +|||||++++++.+...
T Consensus 17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp -CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred CcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 45677778899999999999998 556667889999999876432 2345799999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHhcCC--CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARGGPLNRVLAGR--KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~--~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
+|+|||||. |+|.+++... .+.+..++.++.||+.||.|||++| ||||||||+|||++.+..+ ....+||+
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~---~~~~~kL~ 165 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAH---GKIKAMIS 165 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTT---TBCCEEEC
T ss_pred EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCC---CceeEEEe
Confidence 999999995 6999998743 3556678899999999999999995 9999999999999753211 12368899
Q ss_pred ccCcchhhhcc-----ccccCCCccccccccccc---cCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Q psy6905 266 DFGLAREVYKT-----THMSAAGTYAWMAPEVIK---TSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVN 336 (527)
Q Consensus 266 DFGla~~~~~~-----~~~~~~gt~~y~aPE~l~---~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~ 336 (527)
|||+++..... ......||+.|+|||++. ...++.++|||||||++|+|++ |..||...............
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 245 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC 245 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC
Confidence 99999876432 122456999999999997 4567889999999999999999 99999766544443322222
Q ss_pred CccC-CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 KLTL-PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ~~~~-~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.... ..+...+..+.+||.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 2211 1223456778999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=346.19 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=188.6
Q ss_pred CceeeeeeeccCCceEEEEe-eEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKG-IYEKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+.|.+.+.||+|+||+||.+ ..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.++..+|+||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 34566789999999999654 457889999988653 235567899999876 899999999999999999999999
Q ss_pred cCCCCHHHHhcCCCC--------ChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCc-----ccccccce
Q psy6905 195 ARGGPLNRVLAGRKI--------RPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIE-----NEDLQFKT 261 (527)
Q Consensus 195 ~~ggsL~~~l~~~~~--------~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~-----~~~~~~~~ 261 (527)
|. |+|.+++..... ++..++.++.||+.||.|||++| ||||||||+|||++.+.. ........
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 699999974432 23346789999999999999995 999999999999975310 00011358
Q ss_pred eEEeccCcchhhhccc------cccCCCcccccccccccc-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCHH
Q psy6905 262 LKITDFGLAREVYKTT------HMSAAGTYAWMAPEVIKT-------SIFSKASDVWSYGVVLWELLT-GEIPYKSINAY 327 (527)
Q Consensus 262 vkL~DFGla~~~~~~~------~~~~~gt~~y~aPE~l~~-------~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~ 327 (527)
+||+|||+++...... .....||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998764321 123479999999999976 568999999999999999999 99999765443
Q ss_pred HHHHHHHhCCccCCC-----CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 328 AVAYGVAVNKLTLPI-----PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 328 ~~~~~i~~~~~~~~~-----p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. .+.......+. +..+++++.+||.+||..||.+|||+.+++++
T Consensus 247 ~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 32 22223322221 12356889999999999999999999999863
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=324.24 Aligned_cols=230 Identities=16% Similarity=0.147 Sum_probs=190.6
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC--hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD--ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+-.++|.+.+.||+|+||.||+|.+. ++.||||++..... ......+.+|+.++..++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44578999999999999999999985 68999999987542 445678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
+|||||+|++|.+++..+ ....++..++.||+.||.|||++| |+||||||+|||++.+ +.+||+++|.
T Consensus 108 lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~--------g~~kl~~~~~ 175 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSID--------GDVVLAYPAT 175 (286)
T ss_dssp EEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETT--------SCEEECSCCC
T ss_pred EEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCC--------CCEEEEeccc
Confidence 999999999999999755 466678899999999999999995 9999999999999875 6889985543
Q ss_pred chhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhCCccC--CCCC
Q psy6905 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY---GVAVNKLTL--PIPS 344 (527)
Q Consensus 270 a~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~---~i~~~~~~~--~~p~ 344 (527)
++ .++.++|||||||++|+|++|+.||.+.+...... ......... ..+.
T Consensus 176 ------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T 3uqc_A 176 ------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDR 230 (286)
T ss_dssp ------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCT
T ss_pred ------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhccc
Confidence 33 36899999999999999999999998765432110 111111110 1235
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.+|+.+.+||.+||..||.+| |+.++++.|+.+...
T Consensus 231 ~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 231 DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 789999999999999999999 999999999876643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=320.30 Aligned_cols=224 Identities=25% Similarity=0.390 Sum_probs=179.1
Q ss_pred Cceeee-eeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHH-HhCCCCccceEEEEEEe----CCeE
Q psy6905 117 NKLIFG-EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLL-WLFDHRNIVSLIGVCLQ----SPKL 188 (527)
Q Consensus 117 ~~~~~~-~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l-~~l~hpnIv~~~~~~~~----~~~~ 188 (527)
++|.+. +.||+|+||.||+|.+ +++.||||++... ..+.+|+.++ +.++||||+++++++.. ...+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456665 7899999999999987 4678999998642 3456788877 66699999999999987 6779
Q ss_pred EEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 189 CLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
|+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+.. .+.+||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~-----~~~~kl~ 162 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRP-----NAILKLT 162 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSST-----TCCEEEC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCC-----CCcEEEe
Confidence 999999999999999873 35999999999999999999999995 999999999999987321 2689999
Q ss_pred ccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CccCCCC
Q psy6905 266 DFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN--KLTLPIP 343 (527)
Q Consensus 266 DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~p 343 (527)
|||++.... +..++.++|||||||++|+|++|..||.+.+........... ......|
T Consensus 163 Dfg~a~~~~--------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 222 (299)
T 3m2w_A 163 DFGFAKETT--------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222 (299)
T ss_dssp CCTTCEECT--------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred ccccccccc--------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence 999986432 244678999999999999999999999876554432221111 1111222
Q ss_pred ----CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 344 ----STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 344 ----~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..+++.+.+||.+||..||.+|||+.+++++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 5689999999999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.51 Aligned_cols=241 Identities=22% Similarity=0.306 Sum_probs=197.8
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc---CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe--
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE---KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK-- 187 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~-- 187 (527)
++-.++|.+.+.||+|+||.||+|.+. ++.||||++...........+.+|+.+++.++||||+++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 345688999999999999999999873 578999998776666667788999999999999999999999987655
Q ss_pred ---EEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 188 ---LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 188 ---~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.|||||||+|++|.+++.. .+++..++.|+.||+.||.|||++| ||||||||+|||++. +.+||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~---------~~~kl 222 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTE---------EQLKL 222 (681)
T ss_dssp CEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECS---------SCEEE
T ss_pred CceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeC---------CcEEE
Confidence 7999999999999988765 7999999999999999999999995 999999999999986 37999
Q ss_pred eccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC-C
Q psy6905 265 TDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI-P 343 (527)
Q Consensus 265 ~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-p 343 (527)
+|||+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+.... ...... .
T Consensus 223 ~DFG~a~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~ 290 (681)
T 2pzi_A 223 IDLGAVSRINSF--GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPEDDPV 290 (681)
T ss_dssp CCCTTCEETTCC--SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCTTCHH
T ss_pred EecccchhcccC--CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------cccccccc
Confidence 999999876433 3457999999999998764 89999999999999999999998753210 000000 0
Q ss_pred CCccHHHHHHHHHhhhhCCCCCCC-HHHHHHHHhhh
Q psy6905 344 STCPQLFKTLMEACWEADSHMRPS-FKTILKALNNI 378 (527)
Q Consensus 344 ~~~~~~~~~li~~~l~~dp~~RPs-~~~ll~~L~~~ 378 (527)
..+++.+.+||.+||..||.+||+ +.++...|..+
T Consensus 291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 123578999999999999999995 56666655554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=356.52 Aligned_cols=258 Identities=25% Similarity=0.362 Sum_probs=202.8
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe------CCe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ------SPK 187 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~------~~~ 187 (527)
.++|.+.+.||+|+||.||+|.+ +++.||||++...........+.+|+.+++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 46899999999999999999987 4678999998876666667889999999999999999999999765 667
Q ss_pred EEEEEeccCCCCHHHHhcCC----CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 188 LCLVMEYARGGPLNRVLAGR----KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~----~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
.|+|||||+||+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.+.. ...+|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~-----~~~vK 164 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQ-----RLIHK 164 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSS-----SCEEE
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCC-----ceeEE
Confidence 89999999999999998732 5899999999999999999999995 999999999999986521 13589
Q ss_pred EeccCcchhhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------H
Q psy6905 264 ITDFGLAREVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG---------V 333 (527)
Q Consensus 264 L~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~---------i 333 (527)
|+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+......... .
T Consensus 165 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 165 IIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp ECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred EcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 99999998764433 2345799999999999999999999999999999999999999976533221100 0
Q ss_pred -----HhCCc----cCC----CCCCccHHHHHHHHHhhhhCCCCCCCHHHH-----HHHHhhhhhc
Q psy6905 334 -----AVNKL----TLP----IPSTCPQLFKTLMEACWEADSHMRPSFKTI-----LKALNNIVHS 381 (527)
Q Consensus 334 -----~~~~~----~~~----~p~~~~~~~~~li~~~l~~dp~~RPs~~~l-----l~~L~~~~~~ 381 (527)
..+.. ..+ .+..+++.+.++|..||..||.+|||+.++ .+.++.+...
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000 112 223467899999999999999999999773 3445554443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=339.80 Aligned_cols=248 Identities=18% Similarity=0.162 Sum_probs=191.1
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCC-------ChhHHHHHHHHHHHHHhCC---------CCccce
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP-------DENILENVKQEGKLLWLFD---------HRNIVS 177 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~---------hpnIv~ 177 (527)
+..++|++.+.||+|+||.||+|.++++.||||++.... .....+.+.+|+.+++.++ |||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 445789999999999999999999999999999987542 2223467889999998885 888888
Q ss_pred EEEEEE------------------------------eCCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHH
Q psy6905 178 LIGVCL------------------------------QSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNY 227 (527)
Q Consensus 178 ~~~~~~------------------------------~~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~y 227 (527)
+++++. +...+|+|||||.+|++.+.+.++.+++..+..++.||+.||.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 877753 26789999999999977666666789999999999999999999
Q ss_pred HH-hcCCCceeecCCCCCceecCCCCccc------------ccccceeEEeccCcchhhhccccccCCCccccccccccc
Q psy6905 228 LH-CQAPISLIHRDLKSSNVLLSEPIENE------------DLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIK 294 (527)
Q Consensus 228 LH-~~g~~~iiHrDlkp~NILl~~~~~~~------------~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~ 294 (527)
|| ++| ||||||||+||||+.+.... ......+||+|||+|+..... ...||+.|+|||++.
T Consensus 177 lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 177 AEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGC
T ss_pred HHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhc
Confidence 99 884 99999999999998752100 000128999999999866432 347999999999998
Q ss_pred cCCCCcccchHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhC-CccC----CCCCCccHHHHHHHHHhhhhCCCCCCC
Q psy6905 295 TSIFSKASDVWSYGVV-LWELLTGEIPYKSINA-YAVAYGVAVN-KLTL----PIPSTCPQLFKTLMEACWEADSHMRPS 367 (527)
Q Consensus 295 ~~~~~~ksDvwSlGv~-l~elltg~~Pf~~~~~-~~~~~~i~~~-~~~~----~~p~~~~~~~~~li~~~l~~dp~~RPs 367 (527)
+.. +.++||||||++ .+++++|..||.+... ......+... .... +.+..+++++.+||.+||..| |
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 776 899999998777 7778889999864321 1111222211 1111 112357889999999999976 9
Q ss_pred HHHHH-H
Q psy6905 368 FKTIL-K 373 (527)
Q Consensus 368 ~~~ll-~ 373 (527)
+.+++ +
T Consensus 325 a~e~l~~ 331 (336)
T 2vuw_A 325 ATDLLCQ 331 (336)
T ss_dssp HHHHHHH
T ss_pred HHHHHhc
Confidence 99888 5
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=339.79 Aligned_cols=239 Identities=16% Similarity=0.216 Sum_probs=186.2
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh--hHHHHHHHHHHHHHhCCC-Ccc---------c----
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE--NILENVKQEGKLLWLFDH-RNI---------V---- 176 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h-pnI---------v---- 176 (527)
....|.+.+.||+|+||.||+|.+. ++.||||++...... ...+.+.+|+.+++.+.| .|. +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 4456888999999999999999985 789999998844322 225678899999999977 221 1
Q ss_pred --------eEEEEEEe-----CCeEEEEEeccCCCCHHHHhc--------CCCCChhHHHHHHHHHHHHHHHHHhcCCCc
Q psy6905 177 --------SLIGVCLQ-----SPKLCLVMEYARGGPLNRVLA--------GRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235 (527)
Q Consensus 177 --------~~~~~~~~-----~~~~~iv~Ey~~ggsL~~~l~--------~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~ 235 (527)
.++.++.. ...++++|+++ +++|.+++. +..+++..++.++.||+.||+|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11111111 23467888877 789998884 344677788999999999999999995
Q ss_pred eeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccccccCCCcccccccccc----------ccCCCCcccchH
Q psy6905 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVI----------KTSIFSKASDVW 305 (527)
Q Consensus 236 iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~ksDvw 305 (527)
||||||||+||||+.+ +.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||
T Consensus 232 iiHrDiKp~NILl~~~--------~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQR--------GGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp EECSCCCGGGEEECTT--------CCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred cccCCcccceEEEecC--------CeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 9999999999999986 68999999998866443 345578 999999999 555688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 306 SYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 306 SlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
||||++|+|++|+.||.+.+.......+ +.....+|+.+.+||..||..||.+||++.++++
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHHCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999999999876544332222 2233467899999999999999999999998876
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=289.32 Aligned_cols=183 Identities=16% Similarity=0.082 Sum_probs=129.2
Q ss_pred eeeccCCceEEEEee--EcCceEEEEEcCCCC---------ChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCeEEE
Q psy6905 123 EAIGEGGFGKVYKGI--YEKQEVAIKVAHPNP---------DENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~--~~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~~~i 190 (527)
..++.|++|.+..+. +-|+.||+|++.... .+...+++.+|+.+|+++ .|+||++++++++++..+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 357778888777654 468899999886542 122356799999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||||+||+|.++|. ++.+++. .|+.||+.||+|||++| ||||||||+||||+.+ +.|||+|||+
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~d--------g~vKL~DFGl 385 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDAR--------QHARLIDFGS 385 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTT--------SCEEECCCTT
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCC--------CCEEEeeccc
Confidence 999999999999998 4556654 57899999999999995 9999999999999875 7899999999
Q ss_pred chhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCC
Q psy6905 270 AREVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP 320 (527)
Q Consensus 270 a~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~P 320 (527)
|+...... ..+.+||+.|+|||++.+. +..++|+||+|++++++.++..|
T Consensus 386 Ar~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 386 IVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp EESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 98764322 2345799999999999864 56789999999999887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-28 Score=262.18 Aligned_cols=182 Identities=22% Similarity=0.237 Sum_probs=145.3
Q ss_pred eeeeeccCCceEEEEeeEcCceEEEEEcCCCCC--h-----hHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 121 FGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPD--E-----NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 121 ~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~--~-----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
..+.||+|+||.||+|.+.+..+++|....... . ...+.+.+|+.+++.++||||+++..++......|||||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 357899999999999988889999997654321 1 124557899999999999999966666667777899999
Q ss_pred ccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 194 YARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 194 y~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
||+||+|.+++.. ++.++.||+.||.|||++| ||||||||+|||++. .+||+|||+++..
T Consensus 420 ~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~----------~~kL~DFGla~~~ 479 (540)
T 3en9_A 420 YINGKLAKDVIED-------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK----------DLYIIDFGLGKIS 479 (540)
T ss_dssp CCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS----------SEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC----------eEEEEECccCEEC
Confidence 9999999999875 5689999999999999995 999999999999984 6899999999876
Q ss_pred hccc---------cccCCCcccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCC
Q psy6905 274 YKTT---------HMSAAGTYAWMAPEVIKT--SIFSKASDVWSYGVVLWELLTGEIPYK 322 (527)
Q Consensus 274 ~~~~---------~~~~~gt~~y~aPE~l~~--~~~~~ksDvwSlGv~l~elltg~~Pf~ 322 (527)
.... ..+..||+.|+|||++.. ..|+..+|+||.++-..+-+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 4321 124579999999999986 568889999999999888888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-24 Score=211.92 Aligned_cols=144 Identities=19% Similarity=0.184 Sum_probs=114.8
Q ss_pred ceeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCCCh-----------------hHHHHHHHHHHHHHhCCCCccceEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDE-----------------NILENVKQEGKLLWLFDHRNIVSLI 179 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~hpnIv~~~ 179 (527)
.|.+++.||+|+||.||+|.+ +++.||||++...... .....+.+|+.+++.++ | ++++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 344669999999999999998 4679999998653211 13567889999999998 4 5666
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccc
Q psy6905 180 GVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQF 259 (527)
Q Consensus 180 ~~~~~~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~ 259 (527)
+++.. +..|+|||||+||+|.+ +. ......++.||+.||.|||++| ||||||||+|||++ +
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~-----~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~-------- 228 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR-----VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E-------- 228 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC-----CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T--------
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc-----hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C--------
Confidence 65544 45699999999999988 43 2345679999999999999995 99999999999998 4
Q ss_pred ceeEEeccCcchhhhccccccCCCccccccccccc
Q psy6905 260 KTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIK 294 (527)
Q Consensus 260 ~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~ 294 (527)
+.+||+|||+|+. +..++|||.+.
T Consensus 229 ~~vkl~DFG~a~~-----------~~~~~a~e~l~ 252 (282)
T 1zar_A 229 EGIWIIDFPQSVE-----------VGEEGWREILE 252 (282)
T ss_dssp TEEEECCCTTCEE-----------TTSTTHHHHHH
T ss_pred CcEEEEECCCCeE-----------CCCCCHHHHHH
Confidence 6899999999863 34578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.1e-20 Score=179.79 Aligned_cols=136 Identities=18% Similarity=0.186 Sum_probs=105.4
Q ss_pred eeeeeeeccCCceEEEEeeE--cCce--EEEEEcCCCCCh-----------------------hHHHHHHHHHHHHHhCC
Q psy6905 119 LIFGEAIGEGGFGKVYKGIY--EKQE--VAIKVAHPNPDE-----------------------NILENVKQEGKLLWLFD 171 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~--~~~~--vaiK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~ 171 (527)
|.+.+.||+|+||.||+|.+ +|+. ||||+++..... .....+.+|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999998 6788 999987553211 11236788999999998
Q ss_pred CCcc--ceEEEEEEeCCeEEEEEeccCC-C----CHHHHhcCCCCChhHHHHHHHHHHHHHHHHH-hcCCCceeecCCCC
Q psy6905 172 HRNI--VSLIGVCLQSPKLCLVMEYARG-G----PLNRVLAGRKIRPDVLVDWAIQIAEGMNYLH-CQAPISLIHRDLKS 243 (527)
Q Consensus 172 hpnI--v~~~~~~~~~~~~~iv~Ey~~g-g----sL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH-~~g~~~iiHrDlkp 243 (527)
|++| ..+++. ...++|||||.+ | +|.++... .++..+..++.||+.||.||| +.| ||||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCH
Confidence 8864 444442 245899999942 3 67766532 335678899999999999999 884 99999999
Q ss_pred CceecCCCCcccccccceeEEeccCcchhh
Q psy6905 244 SNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 244 ~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~----------~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID----------KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS----------SEEECCCTTCEET
T ss_pred HHEEEcC----------cEEEEECcccccC
Confidence 9999974 5899999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=169.58 Aligned_cols=144 Identities=16% Similarity=0.117 Sum_probs=99.9
Q ss_pred eeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCC----------------Ch-hH----HHHHHHHHHHHHhCCCCccc
Q psy6905 119 LIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNP----------------DE-NI----LENVKQEGKLLWLFDHRNIV 176 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~----------------~~-~~----~~~~~~e~~~l~~l~hpnIv 176 (527)
|.++..||+|+||.||+|.+ +|+.||||+++... .. .. .-...+|...|..+.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 78999999999999999987 57899999875421 00 00 01123566667776555443
Q ss_pred eEEEEEEeCCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccc
Q psy6905 177 SLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENED 256 (527)
Q Consensus 177 ~~~~~~~~~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~ 256 (527)
-..-+.... .+|||||++|++|..+.. ......++.||+.+|.|||..| ||||||||.|||++.+.+..+
T Consensus 177 vp~p~~~~~--~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 177 VPEPIAQSR--HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CCCEEEEET--TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSC
T ss_pred CCeeeeccC--ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCccc
Confidence 222222222 279999999998876543 2345678899999999999995 999999999999987532211
Q ss_pred cc--cceeEEeccCcchh
Q psy6905 257 LQ--FKTLKITDFGLARE 272 (527)
Q Consensus 257 ~~--~~~vkL~DFGla~~ 272 (527)
+. ...+.|+||+-+..
T Consensus 247 ~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TTSEEEEEEECCCTTCEE
T ss_pred ccccccceEEEEeCCccc
Confidence 11 12489999997643
|
| >2lx7_A GAS-7, growth arrest-specific protein 7; structural genomics, northeast structural genomics consortiu target HR8574A, PSI-biology; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.1e-15 Score=112.12 Aligned_cols=57 Identities=30% Similarity=0.606 Sum_probs=50.5
Q ss_pred CCCEEEEcccCCCCCCCC-CcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDE-LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~e-L~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
++..|+|||||+++.++| |+|++||+|.|++++ ++|||.|++.. |+.|+||+|||+.
T Consensus 2 sg~~~rAlydy~~~~~~e~Ls~~~Gd~i~v~~~~-----~~~Ww~g~~~~---G~~G~fP~nyVe~ 59 (60)
T 2lx7_A 2 SGARCRTLYPFSGERHGQGLRFAAGELITLLQVP-----DGGWWEGEKED---GLRGWFPASYVQL 59 (60)
T ss_dssp CSCEEEESCCCCSCCCSSCCCCCTTCEEEBSCCC-----TTSCEEEECTT---SCEEEECGGGEEE
T ss_pred CCCEEEECcccCCCCCCCCccCCCCCEEEEeEec-----CCCeEEEEeCC---CCEEEEcHHHEEE
Confidence 456899999999999887 999999999999885 78999999743 7899999999975
|
| >2lj0_A Sorbin and SH3 domain-containing protein 1; R85FL, ponsin, CAP, signaling protein; NMR {Homo sapiens} PDB: 2lj1_A | Back alignment and structure |
|---|
Probab=99.54 E-value=7.4e-15 Score=109.75 Aligned_cols=58 Identities=41% Similarity=0.723 Sum_probs=51.5
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
...++|||||+++.++||+|++||+|.|+++. ++|||.|++... ++.|+||+|||+.+
T Consensus 6 ~~~~~Alydy~a~~~~ELs~~~Gd~i~v~~~~-----~~gWw~g~~~~~--g~~G~~P~nyVe~l 63 (65)
T 2lj0_A 6 LFSYQALYSYIPQNDDELELRDGDIVDVMEKC-----DDGWFVGTSRRT--KQFGTFPGNYVKPL 63 (65)
T ss_dssp SCEEEESSCBCCSSTTBCCBCTTCEEEEEEEC-----TTSEEEEEETTT--CCEEEEETTSEEEC
T ss_pred CEEEEEceeECCCCcCCcCCCCCCEEEEeEeC-----CCCEEEEEECCC--CCEEEEehhHeEEE
Confidence 35789999999999999999999999999985 789999997543 78999999999864
|
| >1jo8_A ABP1P, actin binding protein; SH3 domain actin-binding-protein, structural protein; 1.30A {Saccharomyces cerevisiae} SCOP: b.34.2.1 PDB: 2k3b_A 2rpn_A | Back alignment and structure |
|---|
Probab=99.44 E-value=9.8e-14 Score=101.79 Aligned_cols=56 Identities=36% Similarity=0.576 Sum_probs=50.3
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.++|+|||+++.++||+|++||+|.|+++. +++||.|+.... ++.|+||+|||+.+
T Consensus 2 ~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~~--g~~G~~P~~yv~~~ 57 (58)
T 1jo8_A 2 WATAEYDYDAAEDNELTFVENDKIINIEFV-----DDDWWLGELEKD--GSKGLFPSNYVSLG 57 (58)
T ss_dssp CEEESSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEETTT--CCEEEEEGGGEEEC
T ss_pred EEEECceECCCCCCCcccCCCCEEEEEEec-----CCCcEEEEECCC--CCEEEechHHeEEC
Confidence 589999999999999999999999999984 789999998733 78999999999764
|
| >2ed1_A 130 kDa phosphatidylinositol 4,5-biphosphate- dependent ARF1 GTPase-activating protein...; GTPase activation, membrane, metal-binding, SH3 domain; NMR {Homo sapiens} PDB: 2rqt_A 2rqu_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.3e-13 Score=107.19 Aligned_cols=65 Identities=32% Similarity=0.700 Sum_probs=54.9
Q ss_pred CCCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 28 RNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 28 ~~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.......++|||||+++.++||+|++||+|.|+++. +++||.|++.++ .++.|+||+|||+.+..
T Consensus 6 ~~~~~~~~~alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~~~-~g~~G~~P~~yv~~~~~ 70 (76)
T 2ed1_A 6 SGNKVRRVKTIYDCQADNDDELTFIEGEVIIVTGEE-----DQEWWIGHIEGQ-PERKGVFPVSFVHILSD 70 (76)
T ss_dssp SSCCCEEEEESSCCCCSSSSBCCCCSSCEEEESSCC-----SSSEEEEEETTC-TTCEEEEEGGGEEECCC
T ss_pred CCCCCeEEEECccCCCCCcCCcCcCCCCEEEEEEec-----CCCEEEEEECCC-CCCEEEEehHHeEECCC
Confidence 334557899999999999999999999999999874 789999998641 14899999999987654
|
| >2ew3_A SH3-containing GRB2-like protein 3; SH3GL3, solution structure, signaling protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.4e-13 Score=104.35 Aligned_cols=59 Identities=32% Similarity=0.646 Sum_probs=52.9
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
+...++|+|||+++.++||+|++||+|.|+++. +++||.|+.+ ++.|+||+|||+....
T Consensus 2 ~~~~~~Alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 60 (68)
T 2ew3_A 2 DQPCCRGLYDFEPENQGELGFKEGDIITLTNQI-----DENWYEGMIH----GESGFFPINYVEVIVP 60 (68)
T ss_dssp CCCEEEESSCBCCCSTTBCCBCTTCEEEEEEES-----SSSEEEEEET----TEEEEEEGGGEEESCC
T ss_pred CCCEEEEeeeECCCCCCccCCCCCCEEEEEEec-----CCCEEEEEEC----CcEEEeeHHHEEEcCc
Confidence 346899999999999999999999999999985 7899999986 7899999999987544
|
| >1tg0_A BBC1 protein, myosin tail region-interacting protein MTI1; yeast, SH3 domain, structural genomics, contractIle protein; 0.97A {Saccharomyces cerevisiae} PDB: 1zuk_A 1wdx_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.2e-13 Score=104.82 Aligned_cols=58 Identities=28% Similarity=0.460 Sum_probs=51.6
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccc---eecccccCccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEY---KVGIFPANFVSSI 96 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~---~~G~~P~~yv~~~ 96 (527)
...++|+|||+++.++||+|++||+|.|+++. +++||.|++.+. + +.|+||+|||+..
T Consensus 7 ~~~~~Alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~~~--g~~~~~G~fP~~yv~~~ 67 (68)
T 1tg0_A 7 PFKVVAQFPYKSDYEDDLNFEKDQEIIVTSVE-----DAEWYFGEYQDS--NGDVIEGIFPKSFVAVQ 67 (68)
T ss_dssp SEEEEESSCBCCSCTTBCCBCTTCEEEEEEEC-----SSSEEEEEEECT--TSCEEEEEEEGGGEEEC
T ss_pred CEEEEECeeECcCCcCCCCCCCCCEEEEEEec-----CCCeEEEEECCC--CCCCEEEEEchHHEEEC
Confidence 35799999999999999999999999999874 789999998753 5 8999999999864
|
| >1w70_A Neutrophil cytosol factor 4; NADPH oxidase, P40PHOX, P47PHOX, SH3 domain, polyproline; 1.46A {Homo sapiens} PDB: 1w6x_A | Back alignment and structure |
|---|
Probab=99.43 E-value=1.5e-13 Score=101.58 Aligned_cols=57 Identities=30% Similarity=0.561 Sum_probs=51.5
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.+..++|+|||+++.++||+|++||+|.|+++. ++|||.|+.+ ++.|+||+|||+.+
T Consensus 3 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yv~~l 59 (60)
T 1w70_A 3 KHMRAEALFDFTGNSKLELNFKAGDVIFLLSRI-----NKDWLEGTVR----GATGIFPLSFVKIL 59 (60)
T ss_dssp CSCEEEESSCBCCSSTTBCCBCTTCEEEEEEEC-----SSSEEEEEET----TEEEEEEGGGEEEC
T ss_pred cCcEEEECccCCcCCCCCccCCCCCEEEEEEeC-----CCCeEEEEEC----CCEEEechHHEEEC
Confidence 356899999999999999999999999999984 7899999986 78999999999764
|
| >2g6f_X RHO guanine nucleotide exchange factor 7; SH3 domain, peptide interaction, signaling protein; HET: NCO; 0.92A {Rattus norvegicus} PDB: 2df6_A* 2p4r_A 2esw_A | Back alignment and structure |
|---|
Probab=99.43 E-value=1.6e-13 Score=101.00 Aligned_cols=56 Identities=32% Similarity=0.726 Sum_probs=51.0
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
.+..++|+|||+++.++||+|++||+|.|++++ +++||.++.+ ++.|+||+|||+.
T Consensus 3 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~ 58 (59)
T 2g6f_X 3 LGSVVRAKFNFQQTNEDELSFSKGDVIHVTRVE-----EGGWWEGTHN----GRTGWFPSNYVRE 58 (59)
T ss_dssp CCCEEEESSCBCCSSTTBCCBCTTCEEEEEEEC-----TTSEEEEEET----TEEEEEEGGGEEE
T ss_pred CCcEEEECceeCCCCcCCcCCCCCCEEEEEEec-----CCCEEEEEEC----CcEEEEeHHHEEE
Confidence 456899999999999999999999999999985 7899999986 7899999999975
|
| >1nm7_A Peroxisomal membrane protein PAS20; yeast, PEX5P, PEX14P, PEX13P, import machine, SH3 domain, protein transport; NMR {Saccharomyces cerevisiae} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.43 E-value=1.6e-13 Score=103.75 Aligned_cols=60 Identities=30% Similarity=0.700 Sum_probs=50.2
Q ss_pred CEEEEcccCCCCCCC-CCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLD-ELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~-eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
..++|+|||.+++++ ||+|++||+|.|+++++...++++||.+++.. ++.|+||+|||+.
T Consensus 8 ~~~~aly~y~a~~~~dELsf~~Gd~i~Vl~~~~~~~~~~gWW~g~~~~---G~~G~~PsnyV~~ 68 (69)
T 1nm7_A 8 HFARALYDFVPENPEMEVALKKGDLMAILSKKDPLGRDSDWWKVRTKN---GNIGYIPYNYIEI 68 (69)
T ss_dssp -CEEECSCCCCSSTTSCCCCCTTCEEEECCSSSSSCCSSSCEEEEETT---TEEEEECGGGEEE
T ss_pred eEEEEEecccCCCCCCccCCCCCCEEEEEecCCCCCCCCCeeEEEeCC---CCEEEecHHHEEE
Confidence 468999999999999 99999999999999852222356999999843 7899999999974
|
| >2b86_A Cytoplasmic protein NCK2; NCK SH3 domain, signaling protein; NMR {Homo sapiens} PDB: 2js2_A | Back alignment and structure |
|---|
Probab=99.43 E-value=1.5e-13 Score=103.57 Aligned_cols=58 Identities=22% Similarity=0.450 Sum_probs=50.1
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..+++|||||+++.++||+|++||+|.|+++ ++|||.++... ++.|+||+|||+....
T Consensus 4 ~~~~~Alydy~a~~~~ELsf~~Gd~i~vl~~------~~~Ww~~~~~~---g~~G~~Psnyv~~~~~ 61 (67)
T 2b86_A 4 EVIVIAKWDYTAQQDQELDIKKNERLWLLDD------SKTWWRVRNAA---NRTGYVPSNYVERKLE 61 (67)
T ss_dssp CEEEEESSCBCCSSTTSCCBCTTCEEEEEEC------SSSSCEEECTT---SCEEECCCCSEEEC--
T ss_pred CeEEEEeeeECCCCCCccccCCCCEEEEEec------CCCeEEEEeCC---CCEEEeChHHEeEcCC
Confidence 4689999999999999999999999999987 36999999543 7899999999987554
|
| >2dl4_A Protein STAC; SH3 domain, STAC protein, SRC homology 3, cysteine-rich domain protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.2e-13 Score=103.34 Aligned_cols=60 Identities=35% Similarity=0.796 Sum_probs=53.5
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.....++|+|||+++.++||+|++||+|.|+++. +++||.++.+ ++.|+||+|||+....
T Consensus 5 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 64 (68)
T 2dl4_A 5 SSGNTYVALYKFVPQENEDLEMRPGDIITLLEDS-----NEDWWKGKIQ----DRIGFFPANFVQRLSG 64 (68)
T ss_dssp SCCCEEEESSCCCCSSTTBCCCCTTCEEEEEECC-----CSSEEEEECS----SCEEEEETTTEEECCC
T ss_pred CCCCEEEEeeeECCCCcCCcCCCCCCEEEEEEeC-----CCCEEEEEEC----CcEEEEehHHeEECCC
Confidence 4457899999999999999999999999999974 7899999976 7899999999987653
|
| >2fei_A CD2-associated protein; CMS SH3 domain, structural protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.1e-13 Score=103.88 Aligned_cols=56 Identities=38% Similarity=0.846 Sum_probs=50.7
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.++|+|||+++.++||+|++||+|.|+++. ++|||.|+.+ ++.|+||+|||+....
T Consensus 3 ~~~Alydy~~~~~~eLs~~~Gd~i~v~~~~-----~~gWw~g~~~----g~~G~fP~~yv~~~~~ 58 (65)
T 2fei_A 3 QCKVLFEYIPQNEDELELKVGDIIDINEEV-----EEGWWSGTLN----NKLGLFPSNFVKELEL 58 (65)
T ss_dssp EEECSSCCCCCSTTBCCCCTTCEEECCCCS-----SSSEEEEESS----SCEEEEETTTSCBCCC
T ss_pred EEEECccCCcCCcCccCCCCCCEEEEEEec-----CCCEEEEEEC----CcEEEecHHHEEEcCC
Confidence 689999999999999999999999999874 7899999976 7899999999987543
|
| >2dmo_A Neutrophil cytosol factor 2; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.2e-13 Score=103.36 Aligned_cols=59 Identities=25% Similarity=0.454 Sum_probs=52.8
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.....++|||||+++.++||+|++||+|.|+++. +++||.++.+ ++.|+||+|||+.+.
T Consensus 5 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~ 63 (68)
T 2dmo_A 5 SSGEAHRVLFGFVPETKEELQVMPGNIVFVLKKG-----NDNWATVMFN----GQKGLVPCNYLEPVS 63 (68)
T ss_dssp CCSEEEEECSSCCCCSSSSCCCCTTCEEEECEEC-----SSSCEEEEET----TEEEEECSTTEEECC
T ss_pred CCCCEEEECcCCCcCCcCCCCCCCCCEEEEEEeC-----CCCEEEEEeC----CCEEEeehHHeEECC
Confidence 3456899999999999999999999999999985 6899999876 789999999998754
|
| >1uti_A GRB2-related adaptor protein 2; signaling protein regulator, SH3 domain/complex, adaptor protein (MONA); 1.5A {Mus musculus} SCOP: b.34.2.1 PDB: 1h3h_A 1oeb_A 2w10_A 2d0n_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1.9e-13 Score=100.21 Aligned_cols=54 Identities=48% Similarity=1.026 Sum_probs=49.8
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.++|+|||+++.++||+|++||+|.|+++. ++|||.|+.+ ++.|+||+|||+..
T Consensus 3 ~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~ 56 (58)
T 1uti_A 3 WARALYDFEALEEDELGFRSGEVVEVLDSS-----NPSWWTGRLH----NKLGLFPANYVAPM 56 (58)
T ss_dssp EEEESSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEEC
T ss_pred EEEECccCCCCCcCCCCCCCCCEEEEEEEC-----CCCEEEEEEC----CeEEEeeHHHeEEc
Confidence 689999999999999999999999999984 7899999986 78999999999864
|
| >1ugv_A KIAA0621, olygophrenin-1 like protein; beta barrel, GRAF protein, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.42 E-value=1.3e-13 Score=105.90 Aligned_cols=61 Identities=26% Similarity=0.457 Sum_probs=52.8
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+...++|||||+++.++||+|++||+|.|+.+. .+++||.|+.+ ++.|+||+|||+.+..
T Consensus 8 ~~~~~~~alydy~~~~~~eLsf~~Gd~i~v~~~~----~~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 68 (72)
T 1ugv_A 8 TPFRKAKALYACKAEHDSELSFTAGTVFDNVHPS----QEPGWLEGTLN----GKTGLIPENYVEFLSG 68 (72)
T ss_dssp CSCCCEEESSCBCCCSSSBCCBCTTCEEBSCCBC----SSTTEEEEESS----SCEEEEEGGGEEECCS
T ss_pred CCccEEEEccccCCcCCCEeCCcCCCEEEEEEec----CCCCeEEEEEC----CcEEEecHHHEEECCC
Confidence 4456899999999999999999999999998742 37899999976 7899999999987654
|
| >2eyx_A V-CRK sarcoma virus CT10 oncogene homolog isoform A; SH3, signaling protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.4e-13 Score=102.82 Aligned_cols=58 Identities=26% Similarity=0.378 Sum_probs=52.0
Q ss_pred CCCEEEEcccCCCC--CCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAI--GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~--~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.+..++|||||.++ .++||+|++||+|.|++++ ++|||.|+.+ ++.|+||+|||+.+.
T Consensus 5 ~~~~~~alydy~~~~~~~~eLs~~~Gd~i~v~~~~-----~~gWw~g~~~----g~~G~fP~~yv~~~~ 64 (67)
T 2eyx_A 5 GPIYARVIQKRVPNAYDKTALALEVGELVKVTKIN-----VSGQWEGECN----GKRGHFPFTHVRLLD 64 (67)
T ss_dssp CSCBEEECCCBCCCTTCSSBCCBCSSEEEEEEEEC-----TTSEEEEEET----TEEEEEEGGGBCCBC
T ss_pred CCEEEEEeEEECCCCCCCCccccCCCCEEEEEEec-----CCCEEEEEEC----CCEEEEehHhEEEcC
Confidence 34689999999999 8999999999999999984 7899999886 789999999998764
|
| >2nwm_A Vinexin; cell adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=2e-13 Score=102.39 Aligned_cols=55 Identities=36% Similarity=0.662 Sum_probs=50.3
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.++|+|||+++.++||+|++||+|.|+++. ++|||.|+.+ ++.|+||+|||+...
T Consensus 3 ~~~alydy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~fP~~yv~~~~ 57 (65)
T 2nwm_A 3 AARLKFDFQAQSPKELTLQKGDIVYIHKEV-----DKNWLEGEHH----GRLGIFPANYVEVLP 57 (65)
T ss_dssp EEEECSCBCCCSTTBCCBCTTCEEEEEECC-----TTTCEEEEET----TEEEEECGGGEEECC
T ss_pred EEEEeeeECCCCcCccCCcCCCEEEEEEec-----CCCEEEEEEC----CcEEEEehhhEEEcC
Confidence 689999999999999999999999999884 7899999976 789999999998754
|
| >2xmf_A Myosin 1E SH3; motor protein, SH3 domain; HET: DIA; 1.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.2e-13 Score=100.62 Aligned_cols=56 Identities=43% Similarity=0.899 Sum_probs=51.2
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
....++|+|||+++.++||+|++||+|.|++++ +++||.|+++ ++.|+||+|||+.
T Consensus 4 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~ 59 (60)
T 2xmf_A 4 GSPQCKALYAYDAQDTDELSFNANDIIDIIKED-----PSGWWTGRLR----GKQGLFPNNYVTK 59 (60)
T ss_dssp CSCEEEESSCBCCSSTTBCCBCTTCEEEEEEEC-----TTSEEEEEET----TEEEEEEGGGEEE
T ss_pred CCcEEEECccCCcCCcCCcCCCCCCEEEEEEec-----CCCEEEEEEC----CEEEEEcHHHEEE
Confidence 457899999999999999999999999999985 7899999985 7899999999975
|
| >1k4u_S Phagocyte NADPH oxidase subunit P67PHOX; SH3-peptide complex, helix-turn-helix, hormone/growth factor complex; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.41 E-value=1.9e-13 Score=101.65 Aligned_cols=57 Identities=39% Similarity=0.658 Sum_probs=51.6
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
....++|+|||+++.++||+|++||+|.|+++. +++||.|+.+ ++.|+||+|||+.+
T Consensus 4 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~ 60 (62)
T 1k4u_S 4 KGSQVEALFSYEATQPEDLEFQEGDIILVLSKV-----NEEWLEGESK----GKVGIFPKVFVEDS 60 (62)
T ss_dssp CCEEEECCSCBCCCSSSBCCBCSSCEEEEEEES-----SSSCEEEECS----SCEEEECGGGCCCS
T ss_pred CCeEEEECCCCCcCCCCCccCCCCCEEEEEEeC-----CCCEEEEEEC----CcEEEEeHHHEEEC
Confidence 446899999999999999999999999999984 7899999976 78999999999864
|
| >1sem_A SEM-5; SRC-homology 3 (SH3) domain, peptide-binding protein; 2.00A {Caenorhabditis elegans} SCOP: b.34.2.1 PDB: 2sem_A 3sem_A 1k76_A 1kfz_A | Back alignment and structure |
|---|
Probab=99.41 E-value=2.8e-13 Score=99.31 Aligned_cols=55 Identities=36% Similarity=0.912 Sum_probs=50.5
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
..++|+|||+++.++||+|++||+|.|+++. ++|||.|+.+ ++.|+||+|||+..
T Consensus 3 ~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~ 57 (58)
T 1sem_A 3 KFVQALFDFNPQESGELAFKRGDVITLINKD-----DPNWWEGQLN----NRRGIFPSNYVCPY 57 (58)
T ss_dssp CEEEESSCBCCSSTTBCCBCTTCEEEEEECS-----SSSEEEEEET----TEEEEEEGGGEEEC
T ss_pred eEEEECcCCCCCCCCCcCCCCCCEEEEEEec-----CCCEEEEEEC----CcEEEechHHeEEC
Confidence 5799999999999999999999999999984 7899999986 78999999999854
|
| >2bz8_A SH3-domain kinase binding protein 1; SH3 domain, CIN85 adaptor protein, CBL ubiquitin ligase; 2.0A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.1e-13 Score=99.94 Aligned_cols=54 Identities=41% Similarity=0.784 Sum_probs=49.7
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.++|+|||+++.++||+|++||+|.|++++ ++|||.|+.+ ++.|+||+|||+.+
T Consensus 3 ~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~ 56 (58)
T 2bz8_A 3 EAIVEFDYQAQHDDELTISVGEIITNIRKE-----DGGWWEGQIN----GRRGLFPDNFVREI 56 (58)
T ss_dssp CEEESSCBCCCSTTBCCBCTTCEEEEEECC-----TTTEEEEEET----TEEEEEEGGGEEEC
T ss_pred EEEECcccCCCCcCEeeECCCCEEEEEEeC-----CCCEEEEEEC----CeEEEEehHHeEEc
Confidence 589999999999999999999999999984 7899999986 78999999999864
|
| >3ulr_B SRC substrate cortactin; SH3, protein-protein interaction, hydrolase, protein binding; 1.65A {Mus musculus} SCOP: b.34.2.0 PDB: 2d1x_A | Back alignment and structure |
|---|
Probab=99.41 E-value=3.3e-13 Score=101.44 Aligned_cols=58 Identities=40% Similarity=0.646 Sum_probs=52.0
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
..+..++|+|||.++.++||+|++||+|.|+++. +++||.|+.+ ++.|+||+|||+.+
T Consensus 7 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~ 64 (65)
T 3ulr_B 7 DLGITAIALYDYQAAGDDEISFDPDDIITNIEMI-----DDGWWRGVCK----GRYGLFPANYVELR 64 (65)
T ss_dssp SCCSCEEECSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEEC
T ss_pred CCceEEEEEeeECCCCcCEeeEecCCEEEEEEec-----CCCEEEEEEC----CcEEEEehHHeEEC
Confidence 3456899999999999999999999999999984 7899999976 78999999999864
|
| >2drm_A Acanthamoeba myosin IB; SH3 domain, contractIle protein; 1.35A {Acanthamoeba} PDB: 2drk_A | Back alignment and structure |
|---|
Probab=99.41 E-value=2.5e-13 Score=99.61 Aligned_cols=56 Identities=45% Similarity=0.768 Sum_probs=51.0
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
++..++|+|||+++.++||+|++||+|.|++++ +++||.++.+ ++.|+||+|||+.
T Consensus 2 p~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yv~~ 57 (58)
T 2drm_A 2 PGIQVKALYDYDAQTGDELTFKEGDTIIVHQKD-----PAGWWEGELN----GKRGWVPANYVQD 57 (58)
T ss_dssp CCEEEEESSCBCCCSTTBCCBCTTCEEEEEECC-----TTSEEEEEET----TEEEEEEGGGEEE
T ss_pred CCcEEEECccCCCCCcCCcCCCCCCEEEEEEec-----CCCEEEEEEC----CcEEEEeHHHEEE
Confidence 456899999999999999999999999999984 7899999985 7899999999974
|
| >1zx6_A YPR154WP; SH3 domain, protein binding; 1.60A {Saccharomyces cerevisiae} PDB: 1ynz_A | Back alignment and structure |
|---|
Probab=99.41 E-value=2.5e-13 Score=99.61 Aligned_cols=54 Identities=37% Similarity=0.699 Sum_probs=49.9
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
..++|+|||+++.++||+|++||+|.|+++. +++||.|+.+ ++.|+||+|||+.
T Consensus 3 ~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~ 56 (58)
T 1zx6_A 3 EYVEALYQFDPQQDGDLGLKPGDKVQLLEKL-----SPEWYKGSCN----GRTGIFPANYVKP 56 (58)
T ss_dssp CEEEECSCBCCCSTTBCCBCTTCEEEEEEEC-----SSSEEEEEET----TEEEEEEGGGEEE
T ss_pred eEEEECceECCCCCCCccCCCCCEEEEEEec-----CCCEEEEEEC----CcEEEeeHHHEEE
Confidence 5799999999999999999999999999984 7899999985 7899999999975
|
| >2ydl_A SH3 domain-containing kinase-binding protein 1; signaling protein; 2.05A {Homo sapiens} PDB: 2k6d_A | Back alignment and structure |
|---|
Probab=99.41 E-value=2.5e-13 Score=103.14 Aligned_cols=59 Identities=41% Similarity=0.889 Sum_probs=51.8
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|||||+++.++||+|++||+|.|++++. .++|||.|+.+ ++.|+||+|||+....
T Consensus 3 ~~~~Alydy~a~~~~eLs~~~Gd~i~vl~~~~---~~~gWw~g~~~----g~~G~~P~~yV~~~~~ 61 (69)
T 2ydl_A 3 DYCKVIFPYEAQNDDELTIKEGDIVTLINKDC---IDVGWWEGELN----GRRGVFPDNFVKLLPP 61 (69)
T ss_dssp EEEEESSCBCCCSTTBCCBCTTCEEEEEESCC---SSTTEEEEEET----TEEEEEEGGGEEECCS
T ss_pred cEEEEcccCCCCCCCccccCCCCEEEEEEcCC---CCCCEEEEEEC----CcEEEecHHHEEECCC
Confidence 57999999999999999999999999998731 26799999986 7899999999987543
|
| >1uhc_A KIAA1010 protein; beta barrel, SH3, human cDNA, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.40 E-value=3.3e-13 Score=105.65 Aligned_cols=66 Identities=23% Similarity=0.547 Sum_probs=54.1
Q ss_pred CCCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 28 RNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 28 ~~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
......+++|||||+++.++||+|++||+|.|+.+.+. .++++||.++.+ ++.|+||+|||+....
T Consensus 9 ~~~~~~~~~Alydy~~~~~~eLs~~~Gd~i~vl~~~~~-~~~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 74 (79)
T 1uhc_A 9 EAEGNQVYFAVYTFKARNPNELSVSANQKLKILEFKDV-TGNTEWWLAEVN----GKKGYVPSNYIRKTES 74 (79)
T ss_dssp SCCSSCCEEESSCBCCCSSSBCCBCTTCEEEEEESCCT-TSCTTEEEEESS----SCEEEEEGGGEEECCS
T ss_pred cCCCCeEEEECccCCCCCCCccCCCCCCEEEEEECCCC-CCCCCeEEEEeC----CCEEEEchHHeEECCC
Confidence 33455789999999999999999999999999998410 013799999866 7899999999987543
|
| >2i0n_A Class VII unconventional myosin; beta-sheet loop, structural protein; NMR {Dictyostelium discoideum} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.8e-13 Score=105.52 Aligned_cols=61 Identities=30% Similarity=0.501 Sum_probs=53.1
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCc-eeEEEecCcccceecccccCcccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVG-WWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~-ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
.....++|||||+++.++||+|++||+|.|+++. +++ ||.|+.+ ++.|+||.|||+.....
T Consensus 8 ~~~~~~~alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~gWw~g~~~----g~~G~fP~~yv~~~~~~ 69 (80)
T 2i0n_A 8 EFAKYARALKDYNVSDTSLLPFKRNDIITITFKD-----QENKWFMGQLN----GKEGSFPVDHVEILLSD 69 (80)
T ss_dssp CCCCEEEESSCBCCCSSSSCCBCSSEEEEEEEES-----SSSSEEEEEET----TEEEEEEGGGEEEESSC
T ss_pred CCCeEEEECCCCCcCCCCCcCCCCCCEEEEEEec-----CCCCEEEEEEC----CcEEEechHHEEECCCC
Confidence 3447899999999999999999999999999985 445 9999976 78999999999876543
|
| >2djq_A SH3 domain containing ring finger 2; MUS musculus 0 DAY neonate head cDNA, riken FULL-length enriched library, clone:4831401O22, structural genomics; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=5.1e-13 Score=101.35 Aligned_cols=59 Identities=29% Similarity=0.510 Sum_probs=53.0
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|+|||+++.++||+|++||+|.|+++. +++||.++.+ ++.|+||+|||+....
T Consensus 6 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 64 (68)
T 2djq_A 6 SGPRAKALCNYRGKNPGDLKFNKGDVILLRRQL-----DENWYQGEIN----GVSGIFPASSVEVISG 64 (68)
T ss_dssp SCCEEEECSCCCSCCTTCCCCCTTCEEEEEECC-----CSSEEEEEET----TEEEEEESSSEETTCS
T ss_pred CceEEEECCCCCCCCcCCccCCCCCEEEEEEec-----CCCEEEEEEC----CcEEEeehHHEEEcCC
Confidence 446899999999999999999999999999884 7899999976 7899999999987654
|
| >2bzy_A CRK-like protein, CRKL SH3C; SH3 domain, dimer, nuclear export; 2.5A {Homo sapiens} PDB: 2bzx_A | Back alignment and structure |
|---|
Probab=99.40 E-value=2.1e-13 Score=103.14 Aligned_cols=57 Identities=26% Similarity=0.424 Sum_probs=51.5
Q ss_pred CEEEEcccCCCC--CCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAI--GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~--~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|||||.++ .++||+|++||+|.|+.+. ++|||.|+.+ ++.|+||+|||+....
T Consensus 2 ~~~~al~dy~~~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~fP~~yv~~~~~ 60 (67)
T 2bzy_A 2 VFAKAIQKRVPCAYDKTALALEVGDIVKVTRMN-----INGQWEGEVN----GRKGLFPFTHVKIFDP 60 (67)
T ss_dssp EEEEECSCBCSEEECTTBCCBCTTCEEEEEEEC-----SSSEEEEEET----TEEEEEEGGGEEECCS
T ss_pred cEEEEeeeECCCCCCCCccccCCCCEEEEEEec-----CCCeEEEEeC----CcEEEEehHHeEECCC
Confidence 579999999999 9999999999999999984 7899999887 7899999999987654
|
| >2fpe_A C-JUN-amino-terminal kinase interacting protein 1; SRC-homology 3 (SH3) domain, all beta structure, signaling protein; HET: P6G; 1.75A {Rattus norvegicus} PDB: 2fpd_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=2.8e-13 Score=100.82 Aligned_cols=58 Identities=22% Similarity=0.329 Sum_probs=50.6
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
...++|+|||+++.++||+|++||+|.|+.+. +++||.|+.... ++.|+||+|||+.+
T Consensus 3 ~~~~~al~~y~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~~~--g~~G~fP~~yv~~~ 60 (62)
T 2fpe_A 3 EQTHRAIFRFVPRHEDELELEVDDPLLVELQA-----EDYWYEAYNMRT--GARGVFPAYYAIEV 60 (62)
T ss_dssp CCCEEECSCBCCSSTTBCCBCTTCEEEEEEEC-----TTSEEEEEETTT--CCEEEEEGGGEEEC
T ss_pred CCEEEECccCCccCcCcCcCCCCCEEEEEEec-----CCCEEEEEECCC--CCEEEechHHEEEC
Confidence 35799999999999999999999999999874 789999995222 78999999999864
|
| >2x3w_D Syndapin I, protein kinase C and casein kinase substrate in N protein 1; endocytosis, N-WAsp, dynamin, pacsin I, transferase; 2.64A {Mus musculus} PDB: 2x3x_D | Back alignment and structure |
|---|
Probab=99.40 E-value=2.7e-13 Score=100.16 Aligned_cols=58 Identities=38% Similarity=0.774 Sum_probs=50.0
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
++..++|+|||+++.++||+|++||+|.|+++. ++++||.+++.. ++.|+||+|||+.
T Consensus 2 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~----~~~~W~~g~~~~---g~~G~~P~~yv~~ 59 (60)
T 2x3w_D 2 KGVRVRALYDYDGQEQDELSFKAGDELTKLGEE----DEQGWCRGRLDS---GQLGLYPANYVEA 59 (60)
T ss_dssp --CEEEECSCBCCSSSSBCCBCTTCEEEECSCC----CSSSEEEEECSS---CCEEEEEGGGEEC
T ss_pred CCCEEEECcccCccCCCcccCCCCCEEEEEEcc----CCCCceEEEeCC---CCEEEecHHHEEE
Confidence 356899999999999999999999999999874 356999999763 7899999999975
|
| >1b07_A Protein (proto-oncogene CRK (CRK)); SH3 domain, inhibitors, peptoids, protein-protein recognition, proline-rich motifs, signal transduction; 2.50A {Mus musculus} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.40 E-value=3.3e-13 Score=101.24 Aligned_cols=58 Identities=26% Similarity=0.638 Sum_probs=50.8
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|+|||+++.++||+|++||+|.|++++ +++||.|+... ++.|+||+|||+....
T Consensus 4 ~~~~Alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~~---g~~G~~P~~yv~~~~~ 61 (65)
T 1b07_A 4 EYVRALFDFNGNDEEDLPFKKGDILRIRDKP-----EEQWWNAEDSE---GKRGMIPVPYVEKYHH 61 (65)
T ss_dssp CEEEESSCBCCSSTTBCCBCTTCEEEEEECS-----SSSEEEEECTT---SCEEEEEGGGEEECC-
T ss_pred eEEEECCcCCCCCCCccCCcCCCEEEEEEec-----CCCeEEEEECC---CCEEEEChHHEeecCC
Confidence 5799999999999999999999999999985 68999999432 7899999999987543
|
| >1s1n_A Nephrocystin 1; beta barrel, cell adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.6e-13 Score=103.03 Aligned_cols=62 Identities=23% Similarity=0.520 Sum_probs=52.0
Q ss_pred CCCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 28 RNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 28 ~~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.......++|+|||.++.++||+|++||+|.|+.+. ++|||.|+... ++.|+||+|||+...
T Consensus 6 ~~~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~---g~~G~~P~~yv~~~~ 67 (68)
T 1s1n_A 6 KWSTGEEYIAVGDFTAQQVGDLTFKKGEILLVIEKK-----PDGWWIAKDAK---GNEGLVPRTYLEPYS 67 (68)
T ss_dssp ---CCEEEEECSCBCCSSSSCCCBCSSEEEEECSCC-----SSSEEEEECSS---SCEEEEESTTEEECC
T ss_pred CCCCCCEEEEcccCCCCCCCcCCCCCCCEEEEEEcC-----CCCeEEEEECC---CCEEEEehHHeEECc
Confidence 334557899999999999999999999999999984 67999999432 789999999998653
|
| >2vwf_A Growth factor receptor-bound protein 2; polymorphism, phosphoprotein, golgi apparatus, alternative splicing, HOST-virus interaction, SH3C, signaling; 1.58A {Homo sapiens} PDB: 2w0z_A 1gcq_A 1gfc_A 1gfd_A 1io6_A 2vvk_A | Back alignment and structure |
|---|
Probab=99.40 E-value=3.4e-13 Score=98.86 Aligned_cols=55 Identities=36% Similarity=0.834 Sum_probs=50.5
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
..++|+|||+++.++||+|++||+|.|+++. +++||.|+.+ ++.|+||+|||+.+
T Consensus 3 ~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~ 57 (58)
T 2vwf_A 3 TYVQALFDFDPQEDGELGFRRGDFIHVMDNS-----DPNWWKGACH----GQTGMFPRNYVTAV 57 (58)
T ss_dssp CEEEESSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEEC
T ss_pred eEEEECceECCCCcCCcCCCCCCEEEEEEcC-----CCCEEEEEEC----CcEEEEchHHeEEC
Confidence 5799999999999999999999999999984 7899999995 78999999999864
|
| >2ak5_A RHO guanine nucleotide exchange factor 7; adaptor proteins, CIN85, PIX/COOL, protein-protein interaction, X-RAY, endocytosis; 1.85A {Rattus norvegicus} PDB: 1zsg_A | Back alignment and structure |
|---|
Probab=99.40 E-value=4.1e-13 Score=100.60 Aligned_cols=58 Identities=33% Similarity=0.725 Sum_probs=52.4
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
+...++|+|||+++.++||+|++||+|.|+.+. +++||.|+.+ ++.|+||+|||+.+.
T Consensus 5 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~ 62 (64)
T 2ak5_A 5 SQLVVRAKFNFQQTNEDELSFSKGDVIHVTRVE-----EGGWWEGTHN----GRTGWFPSNYVREIK 62 (64)
T ss_dssp CCCEEEESSCBCCCSTTBCCBCTTCEEEEEECC-----TTSEEEEEET----TEEEEEEGGGEEECC
T ss_pred CCEEEEEccccCCcCcCcccCCCCCEEEEeEec-----CCCEEEEEEC----CCEEEEehHHeEEcC
Confidence 457899999999999999999999999999984 7899999986 789999999998754
|
| >2eqi_A Phospholipase C, gamma 2; SH3 domain, PLCG2, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.5e-13 Score=102.58 Aligned_cols=61 Identities=36% Similarity=0.662 Sum_probs=53.3
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+...++|||||+++.++||+|++||+|.|+.+. +++||.+++.+ +..|+||.|||+....
T Consensus 5 ~~~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~---~~~G~~P~~yv~~~~~ 65 (69)
T 2eqi_A 5 SSGRTVKALYDYKAKRSDELTFCRGALIHNVSKE-----PGGWWKGDYGT---RIQQYFPSNYVEDISG 65 (69)
T ss_dssp CCCCEEEESSCBCCCSSSCCCBCTTCEEESCCCC-----SSSCEEEEETT---EEEEEECGGGEEECCS
T ss_pred CCCcEEEECeeECCCCcCccCCCCCCEEEEEEcC-----CCCeEEEEECC---CCEEEEchHHcEECcc
Confidence 4557899999999999999999999999999874 77999999875 4569999999987543
|
| >2ekh_A SH3 and PX domain-containing protein 2A; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=4.3e-13 Score=105.19 Aligned_cols=60 Identities=23% Similarity=0.423 Sum_probs=53.8
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..+..|+|+|||+++.++||+|++||+|.|++++ +++||.+++. ++.|+||+|||+....
T Consensus 6 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~vl~~~-----~~gWw~g~~~----g~~G~~P~~yv~~~~~ 65 (80)
T 2ekh_A 6 SGATSYMTCSAYQKVQDSEISFPAGVEVQVLEKQ-----ESGWWYVRFG----ELEGWAPSHYLVLDEN 65 (80)
T ss_dssp CSCEEEEECSCBCCSSTTSCCBCTTCEEEEEEEC-----TTSEEEEEET----TEEEEEETTTEECCCC
T ss_pred CCCCEEEECCCCCCCCCCccCcCCCCEEEEEEeC-----CCCeEEEEEC----CCEEEEEhHHeEECCC
Confidence 3457899999999999999999999999999985 6899999987 7899999999997654
|
| >2ysq_A RHO guanine nucleotide exchange factor 9; SH3 domain, CDC42 guanine nucleotide exchange factor (GEF) 9, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=4.7e-13 Score=105.29 Aligned_cols=62 Identities=29% Similarity=0.547 Sum_probs=54.6
Q ss_pred CCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 29 NHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 29 ~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
......++|||||+++.++||+|++||+|.|++++ +++||.|+.. ++.|+||.|||+.+...
T Consensus 7 ~~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~~ 68 (81)
T 2ysq_A 7 GDSIVSAEAVWDHVTMANRELAFKAGDVIKVLDAS-----NKDWWWGQID----DEEGWFPASFVRLWVNQ 68 (81)
T ss_dssp CCCCEEEEESSCCCCSSSSSCCCCTTCEEEEEECC-----SSSEEEEECS----SCEEEEEGGGEEESSCC
T ss_pred CCCceEEEEeeeECCCCCCcCCCCCCCEEEEEEEc-----CcCEEEEEEC----CCEEEechHHEEEcCCc
Confidence 34557899999999999999999999999999985 7899999987 68999999999986543
|
| >2egc_A SH3 and PX domain-containing protein 2A; SH3 domain, KIAA0418 protein, SH3MD1, SH3 multiple domains 1, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=5e-13 Score=103.40 Aligned_cols=65 Identities=22% Similarity=0.479 Sum_probs=53.9
Q ss_pred CCCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 28 RNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 28 ~~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.......++|+|||+++ ++||+|++||+|.|++++ +++||.+++.....++.|+||+|||+....
T Consensus 6 ~~~~~~~~~alydy~~~-~~eLs~~~Gd~i~vl~~~-----~~gWw~g~~~~~~~g~~G~~P~~yv~~~~~ 70 (75)
T 2egc_A 6 SGNLKDVYVSIADYEGD-EETAGFQEGVSMEVLERN-----PNGWWYCQILDGVKPFKGWVPSNYLEKKNS 70 (75)
T ss_dssp CSSCCEEEEECSCBCCC-SSSCCBCTTCEEEECEEC-----TTSEEEEEECCSSSCEEEEEEGGGEEECCS
T ss_pred CCCCCeEEEECCCcCCC-CCcCCCCCCCEEEEEEcC-----CCCeEEEEeCCCCCCcEEEEehHHCEECCC
Confidence 34455789999999999 999999999999999985 789999997532115899999999987653
|
| >2j05_A RAS GTPase-activating protein 1; GTPase activation, SH3 domain, SH2 domain, SRC homology 3, RAS signaling pathway, proto- oncogene, phosphorylation; 1.5A {Homo sapiens} PDB: 2j06_A | Back alignment and structure |
|---|
Probab=99.39 E-value=4.1e-13 Score=100.90 Aligned_cols=59 Identities=22% Similarity=0.316 Sum_probs=51.2
Q ss_pred CCEEEEcccCCC-CCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 32 PDLWRALYDYDA-IGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 32 ~~~~~alyd~~~-~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
...++|||||.+ +.++||+|++||+|.|+.+. ++|||.|++... ++.|+||+|||+.++
T Consensus 5 ~~~~~alydy~~~~~~~eLs~~~Gd~i~v~~~~-----~~gW~~g~~~~~--g~~G~~P~~yv~~~~ 64 (65)
T 2j05_A 5 RRRVRAILPYTKVPDTDEISFLKGDMFIVHNEL-----EDGWMWVTNLRT--DEQGLIVEDLVEEVG 64 (65)
T ss_dssp TCEEEESSCBCCCTTSSBCCBCTTCEEEEEEEC-----TTSEEEEEETTT--CCEEEEEGGGEEECC
T ss_pred CcEEEEccccCCCCCCCcCcCCCCCEEEEeEec-----CCCEEEEEECCC--CCEEEEEhHHeEECc
Confidence 467999999999 99999999999999999884 779999994322 789999999998653
|
| >1uj0_A Signal transducing adaptor molecule (SH3 domain and ITAM motif) 2; STAM, SH3, GRB2, GADS, PXXP, HRS, endocytosis, early endosome, signaling protein/signaling protein complex; 1.70A {Mus musculus} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.39 E-value=3.8e-13 Score=100.06 Aligned_cols=56 Identities=38% Similarity=0.860 Sum_probs=50.8
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
....++|+|||+++.++||+|++||+|.|+++. +++||.|+.. ++.|+||+|||+.
T Consensus 4 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~ 59 (62)
T 1uj0_A 4 MARRVRALYDFEAVEDNELTFKHGELITVLDDS-----DANWWQGENH----RGTGLFPSNFVTT 59 (62)
T ss_dssp CCEEEEESSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEES
T ss_pred CCeEEEECccCCCCCcCCcCCCCCCEEEEEEeC-----CCCEEEEEEC----CCEEEechhHEEE
Confidence 346899999999999999999999999999974 7899999987 6799999999975
|
| >2ebp_A SAM and SH3 domain-containing protein 1; proline-glutamate repeat-containing protein, structural genomics, NPPSFA; NMR {Homo sapiens} PDB: 2kea_A | Back alignment and structure |
|---|
Probab=99.39 E-value=4e-13 Score=103.33 Aligned_cols=57 Identities=32% Similarity=0.599 Sum_probs=51.2
Q ss_pred CEEEEcccCCCC--CCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAI--GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~--~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|||||++. .++||+|++||+|.|+++. +++||.|+++ ++.|+||+|||+.+..
T Consensus 10 ~~~~alydy~~~~~~~~eLs~~~Gd~i~v~~~~-----~~gWw~g~~~----g~~G~fP~~yv~~~~~ 68 (73)
T 2ebp_A 10 GRARVHTDFTPSPYDTDSLKLKKGDIIDIISKP-----PMGTWMGLLN----NKVGTFKFIYVDVLSS 68 (73)
T ss_dssp EEEEECSCBCCCTTCCSBCCBCSSCEEEEEECC-----SSSCEEEECS----SCEEEECSTTEEECCC
T ss_pred eEEEEeeccCCCCCCCCccCCCCCCEEEEEEeC-----CCCeEEEEEC----CCEEEEeHHHEEECCC
Confidence 479999999976 9999999999999999984 7899999887 6899999999997654
|
| >1x2p_A Protein arginine N-methyltransferase 2; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=5.1e-13 Score=101.35 Aligned_cols=60 Identities=28% Similarity=0.492 Sum_probs=53.4
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..+..++|+|||+++.++||+|++||+|.|+++. +++||.++.. ++.|+||+|||+....
T Consensus 5 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 64 (68)
T 1x2p_A 5 SSGEEFVAIADYAATDETQLSFLRGEKILILRQT-----TADWWWGERA----GCCGYIPANHVGKHSG 64 (68)
T ss_dssp CSCCEEEESSCCCCSSTTBCCCCTTCEEEEEECC-----SSSEEEEECT----TCCEEEESSSEECCCC
T ss_pred CCCCEEEECceECCCCcCCcCCCCCCEEEEEEcC-----CCCEEEEEEC----CeEEEEehHHeEECCC
Confidence 3557899999999999999999999999999985 7899999976 7899999999987543
|
| >1ujy_A RHO guanine nucleotide exchange factor 6; structural genomics, SH3 domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.39 E-value=3.6e-13 Score=104.61 Aligned_cols=65 Identities=29% Similarity=0.641 Sum_probs=55.9
Q ss_pred CCCCCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 26 NRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 26 ~~~~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
.+.......++|+|||+++.++||+|++||+|.|+.+. +++||.|+.+ ++.|+||.|||+.....
T Consensus 4 ~~~~~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~~ 68 (76)
T 1ujy_A 4 GSSGSHQLIVKARFNFKQTNEDELSVCKGDIIYVTRVE-----EGGWWEGTLN----GRTGWFPSNYVREIKSS 68 (76)
T ss_dssp CCCSCCCEEEECCSCBCCSSTTSCCBCSSCCEEESSCC-----SSSCEEEEET----TEEEEECTTTSEECCHH
T ss_pred CCCCCCCEEEEECccCCcCCCCcccCCCCCEEEEEEec-----CCCEEEEEEC----CCEEEechHHEEECCcc
Confidence 33444557899999999999999999999999999874 7899999986 78999999999976543
|
| >1cka_A C-CRK N-terminal SH3 domain; complex (oncogene protein/peptide); 1.50A {Mus musculus} SCOP: b.34.2.1 PDB: 1ckb_A 1m3c_A 1m30_A 1m3b_A 1m3a_A | Back alignment and structure |
|---|
Probab=99.39 E-value=3.8e-13 Score=98.21 Aligned_cols=55 Identities=27% Similarity=0.672 Sum_probs=49.1
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
..++|+|||+++.++||+|++||+|.|+++. ++|||.|+... ++.|+||+|||+.
T Consensus 2 ~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~---g~~G~~P~~yv~~ 56 (57)
T 1cka_A 2 EYVRALFDFNGNDEEDLPFKKGDILRIRDKP-----EEQWWNAEDSE---GKRGMIPVPYVEK 56 (57)
T ss_dssp CEEEESSCBCCSSTTBCCBCTTCEEEEEECS-----SSSEEEEECTT---SCEEEEEGGGEEC
T ss_pred cEEEECCcCCCCCCCCCCCCCCCEEEEEEec-----CCCcEEEEeCC---CCEEEEeHHHEEE
Confidence 3689999999999999999999999999984 68999999433 7899999999975
|
| >2gnc_A SLIT-ROBO RHO GTPase-activating protein 1; beta barrel, signaling protein; 1.80A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.39 E-value=2.4e-13 Score=100.44 Aligned_cols=55 Identities=24% Similarity=0.564 Sum_probs=49.8
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~ 94 (527)
....++|+|||+++.++||+|++||+|.|+++. +++||.|+++ ++.|+||+|||+
T Consensus 5 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~ 59 (60)
T 2gnc_A 5 SPEFAIAKFDYVGRSARELSFKKGASLLLYHRA-----SEDWWEGRHN----GIDGLVPHQYIV 59 (60)
T ss_dssp -CEEEEESSCBCCSSTTBCCBCTTCEEEEEEEE-----ETTEEEEEET----TEEEEEEGGGEE
T ss_pred CCEEEEECCCCCcCCcCCcCCCCCCEEEEEEec-----CCCEEEEEEC----CeEEEEeHhhEE
Confidence 346899999999999999999999999999984 6799999986 789999999986
|
| >1csk_A C-SRC SH3 domain; phosphotransferase; 2.50A {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.39 E-value=3.4e-13 Score=103.27 Aligned_cols=60 Identities=25% Similarity=0.489 Sum_probs=50.2
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
++..++|+|||+++.++||+|++||+|.|+++. .++|||.|++.. ++.|+||+|||+..+
T Consensus 10 ~~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~~----~~~~Ww~g~~~~---g~~G~~P~~yv~~~~ 69 (71)
T 1csk_A 10 SGTECIAKYNFHGTAEQDLPFCKGDVLTIVAVT----KDPNWYKAKNKV---GREGIIPANYVQKRE 69 (71)
T ss_dssp -CEEEEESSCBCCSSTTBCCBCTTCEEEEEEEC----SSTTEEEEECTT---SCEEEEETTSEEC--
T ss_pred CCCEEEEceeECcCCCCcCCCCCCCEEEEeECC----CCCCCEEEEeCC---CCEEEEehHHeEEcc
Confidence 446899999999999999999999999999932 378999999432 789999999998754
|
| >2epd_A RHO GTPase-activating protein 4; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=2.6e-13 Score=105.37 Aligned_cols=61 Identities=23% Similarity=0.472 Sum_probs=53.9
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
.....++|||||+++.++||+|++||+|.|+++. +++||.++++ ++.|+||.|||+.....
T Consensus 8 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~~ 68 (76)
T 2epd_A 8 EGVVEAVACFAYTGRTAQELSFRRGDVLRLHERA-----SSDWWRGEHN----GMRGLIPHKYITLPAGT 68 (76)
T ss_dssp SCCEEEEESSCEECSSTTBCEECTTCEEEEEEEE-----ETTEEEEEET----TEEEEEESSSEECCSSC
T ss_pred CCCEEEEECcCCCCCCCCccCCCCCCEEEEEEeC-----CCCEEEEEEC----CcEEEEehHHEEEcCCC
Confidence 3446899999999999999999999999999985 6899999986 78999999999976543
|
| >2j6f_A CD2-associated protein; metal-binding, immune response, SH3, SH2 domain, SH3 zinc-finger, SH3- binding, UBL conjugation pathway; 1.7A {Homo sapiens} PDB: 2j6k_A 2j6o_A 2j7i_A 2krm_A | Back alignment and structure |
|---|
Probab=99.39 E-value=3.3e-13 Score=100.36 Aligned_cols=56 Identities=39% Similarity=0.751 Sum_probs=50.3
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.++|+|||+++.++||+|++||+|.|+.++ .++|||.|+.+ ++.|+||+|||+...
T Consensus 3 ~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~----~~~~Ww~g~~~----g~~G~~P~~yv~~~~ 58 (62)
T 2j6f_A 3 DYIVEYDYDAVHDDELTIRVGEIIRNVKKL----QEEGWLEGELN----GRRGMFPDNFVKEIK 58 (62)
T ss_dssp CEEECSCBCCSSTTBCCBCTTCEEEEEEEC----SSTTEEEEEET----TEEEEEEGGGEEECC
T ss_pred EEEECccCCcCCcCCcCCcCCCEEEEEEec----CCCCEEEEEEC----CcEEEechHHEEECC
Confidence 489999999999999999999999999982 37899999976 789999999998754
|
| >1oot_A Hypothetical 40.4 kDa protein in PES4-His2 intergenic region; SH3 domain, sturctural genomics, structural genomics; 1.39A {Saccharomyces cerevisiae} SCOP: b.34.2.1 PDB: 1ssh_A 2a08_A | Back alignment and structure |
|---|
Probab=99.38 E-value=4.8e-13 Score=98.81 Aligned_cols=57 Identities=35% Similarity=0.760 Sum_probs=50.5
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
...++|+|||+++.++||+|++||+|.|+++.. .+++||.|+.+ ++.|+||+|||+.
T Consensus 3 ~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~~---~~~~Ww~g~~~----g~~G~~P~~yv~~ 59 (60)
T 1oot_A 3 SPKAVALYSFAGEESGDLPFRKGDVITILKKSD---SQNDWWTGRVN----GREGIFPANYVEL 59 (60)
T ss_dssp CCEEEESSCBCCCSTTBCCBCTTCEEEEEECCS---CTTSEEEEEET----TEEEEEEGGGEEE
T ss_pred ccEEEECccCCcCCcCEeeEcCCCEEEEEEeCC---CCCCeEEEEEC----CEEEEEeHHHEEE
Confidence 468999999999999999999999999998741 26799999985 7899999999974
|
| >1y0m_A 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 1; SH3 domain, hydrolase; 1.20A {Rattus norvegicus} PDB: 1ywp_A 1ywo_A | Back alignment and structure |
|---|
Probab=99.38 E-value=4.9e-13 Score=99.08 Aligned_cols=57 Identities=35% Similarity=0.655 Sum_probs=50.1
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCccccee-cccccCccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKV-GIFPANFVSSI 96 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~-G~~P~~yv~~~ 96 (527)
++..++|+|||+++.++||+|++||+|.|+++. +++||.|++. +.. |+||+|||+.+
T Consensus 2 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~----g~~gG~~P~~yv~~~ 59 (61)
T 1y0m_A 2 FKSAVKALFDYKAQREDELTFTKSAIIQNVEKQ-----DGGWWRGDYG----GKKQLWFPSNYVEEM 59 (61)
T ss_dssp CCCCEEESSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEEGGGEEEC
T ss_pred CCCEEEECcCCCcCCCCCcCCcCCCEEEEEEec-----CCCEEEEEEC----CeEEEEEChHHcEEC
Confidence 346799999999999999999999999999984 7799999987 455 59999999864
|
| >1j3t_A Intersectin 2; beta barrel, SH3 domain, riken structural genomics/proteomics initiative, RSGI, structural genomics, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.38 E-value=5.3e-13 Score=103.06 Aligned_cols=62 Identities=26% Similarity=0.466 Sum_probs=54.0
Q ss_pred CCCCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 27 RRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 27 ~~~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
........++|+|||.++.++||+|++||+|.|+++ +++||.++++ ++.|+||.|||+....
T Consensus 5 ~~~~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~------~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 66 (74)
T 1j3t_A 5 SSGVENLKAQALCSWTAKKDNHLNFSKHDIITVLEQ------QENWWFGEVH----GGRGWFPKSYVKIIPG 66 (74)
T ss_dssp CCCCCCCEEEESSCBCCCSTTBCCBCTTCEEEEEEE------CSSEEEEEST----TCCCEEEGGGEEECCC
T ss_pred CCCCCCeEEEECCCCCCCCCCccCCCCCCEEEEEec------CCCEEEEEEC----CcEEEEchHHeEECCC
Confidence 334556789999999999999999999999999998 3689999986 7899999999987654
|
| >2iim_A Proto-oncogene tyrosine-protein kinase LCK; beta-barrels, signaling protein; HET: PG4; 1.00A {Homo sapiens} SCOP: b.34.2.1 PDB: 1h92_A 1kik_A | Back alignment and structure |
|---|
Probab=99.38 E-value=5.9e-13 Score=99.01 Aligned_cols=57 Identities=25% Similarity=0.511 Sum_probs=49.7
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
....++|+|||.++.++||+|++||+|.|++++ ++||.|+.... ++.|+||+|||+.
T Consensus 5 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~------~~Ww~g~~~~~--g~~G~~P~~yv~~ 61 (62)
T 2iim_A 5 QDNLVIALHSYEPSHDGDLGFEKGEQLRILEQS------GEWWKAQSLTT--GQEGFIPFNFVAK 61 (62)
T ss_dssp TTCEEEESSCBCCCSTTBCCBCTTCEEEEEECC------SSEEEEEETTT--CCEEEEEGGGEEE
T ss_pred CCcEEEEcccCCCCCCCCcCCCCCCEEEEEEcC------CCEEEEEECCC--CCEEEEEHHHEEE
Confidence 457899999999999999999999999999983 49999996211 7899999999975
|
| >2l0a_A STAM-1, signal transducing adapter molecule 1; structural genomics, northeast structural genomics consortiu PSI-2, protein structure initiative; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=4.4e-13 Score=102.48 Aligned_cols=55 Identities=38% Similarity=0.875 Sum_probs=50.0
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
...++|||||+++.++||+|++||+|.|+++. +++||.|++. ++.|+||+|||+.
T Consensus 17 ~~~~~Alydy~a~~~~eLsf~~Gd~i~Vl~~~-----~~gWw~g~~~----g~~G~fP~~yV~~ 71 (72)
T 2l0a_A 17 ARKVRAIYDFEAAEDNELTFKAGEIITVLDDS-----DPNWWKGETH----QGIGLFPSNFVTA 71 (72)
T ss_dssp CEEEEESSCBCCSSTTBCCBCTTCEEEEEEEE-----ETTEEEEECS----SCEEECTTCCEEE
T ss_pred CeEEEECCccCCCCCCccCCCCCCEEEEEEec-----CCCEEEEEEC----CCEEEechhhCcc
Confidence 36799999999999999999999999999874 7899999987 5799999999974
|
| >1gl5_A Tyrosine-protein kinase TEC; transferase, ATP-binding, SH3 domain, phosphorylation; NMR {Mus musculus} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.38 E-value=4.3e-13 Score=101.41 Aligned_cols=56 Identities=30% Similarity=0.631 Sum_probs=50.6
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
..++|+|||.++.++||+|++||+|.|+++. +++||.|+... ++.|+||+|||+..
T Consensus 3 ~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~---g~~G~~P~~yv~~~ 58 (67)
T 1gl5_A 3 EIVVAMYDFQATEAHDLRLERGQEYIILEKN-----DLHWWRARDKY---GSEGYIPSNYVTGK 58 (67)
T ss_dssp SCEEECSCBCCSSSSBCCBCTTCEEEEEECS-----SSSEEEEECSS---SCEEEEETTSEESS
T ss_pred eEEEECccCCCCCCCeecCCcCCEEEEEEcc-----CCCcEEEEECC---CCEEEEEhHhEEEc
Confidence 4789999999999999999999999999984 78999999432 78999999999986
|
| >1zlm_A Osteoclast stimulating factor 1; beta barrel, signaling protein; 1.07A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=4.5e-13 Score=98.21 Aligned_cols=54 Identities=33% Similarity=0.793 Sum_probs=49.6
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
..++|+|||+++.++||+|++||+|.|+++. +++||.|+.+ ++.|+||+|||+.
T Consensus 4 ~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~ 57 (58)
T 1zlm_A 4 KVFRALYTFEPRTPDELYFEEGDIIYITDMS-----DTNWWKGTSK----GRTGLIPSNYVAE 57 (58)
T ss_dssp EEEEESSCBCCSSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEE
T ss_pred EEEEECccCCCCCCCCccCCCCCEEEEEEeC-----CCCEEEEEEC----CCEEEEehHHEEe
Confidence 4799999999999999999999999999984 7899999985 7899999999974
|
| >1z9q_A Neutrophil cytosol factor 4; oxidoreductase activator; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=2e-13 Score=106.30 Aligned_cols=59 Identities=31% Similarity=0.577 Sum_probs=53.0
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|||||+++.++||+|++||+|.|+++. ++|||.|+.+ ++.|+||+|||+....
T Consensus 17 ~~~~~~Alydy~a~~~~eLsf~~Gd~I~Vl~~~-----~~gWw~g~~~----g~~G~fP~nyV~~~~~ 75 (79)
T 1z9q_A 17 AAPRAEALFDFTGNSKLELNFKAGDVIFLLSRI-----NKDWLEGTVR----GATGIFPLSFVKILKD 75 (79)
T ss_dssp SCCCEEESSCCCCSSTTBCCCCTTCCBCCCEES-----SSSEEEEEET----TEEEEEEGGGEEESSC
T ss_pred CceEEEEcCccCCCCCCcccccCCCEEEEeEec-----CCCEEEEEEC----CeEEEecHHHEEECCC
Confidence 346899999999999999999999999999984 7899999986 7899999999987654
|
| >1x6g_A Megakaryocyte-associated tyrosine-protein kinase; MATK, CTK, HYL, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=8.1e-13 Score=103.83 Aligned_cols=62 Identities=18% Similarity=0.253 Sum_probs=52.7
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+..|+|||||+++.++||+|++||+|.|+++. ++++||.+++... ++.|+||+|||+....
T Consensus 16 ~~~~~~Alydy~~~~~~eLsf~~Gd~i~v~~~~----~~~~Ww~g~~~~~--g~~G~~P~~yv~~~~~ 77 (81)
T 1x6g_A 16 PGTQCITKCEHTRPKPGELAFRKGDVVTILEAC----ENKSWYRVKHHTS--GQEGLLAAGALRERSG 77 (81)
T ss_dssp TTCEEEESSCBSSCCTTCCCBCTTCEEEEEECC----CSSSEEEEEETTT--CCEEEEEGGGEEECCC
T ss_pred CCCEEEECCCCCcCCCCCCCCCCCCEEEEEecc----CCCCeEEEEeCCC--CCEEEEehHHEEEccc
Confidence 446899999999999999999999999999974 3459999996422 7899999999987544
|
| >2dl8_A SLIT-ROBO RHO GTPase-activating protein 2; SH3 domain, formin-binding protein 2, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.4e-13 Score=102.40 Aligned_cols=59 Identities=22% Similarity=0.458 Sum_probs=52.9
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+..++|||||.++.++||+|++||+|.|+.+. +++||.|+++ ++.|+||.|||+....
T Consensus 8 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 66 (72)
T 2dl8_A 8 EPIEAIAKFDYVGRTARELSFKKGASLLLYQRA-----SDDWWEGRHN----GIDGLIPHQYIVVQDT 66 (72)
T ss_dssp SCEEEEESSCBCCSSSSBCCBCTTCEEEEEEEE-----ETTEEEEEET----TEEEEECSSSEEECCS
T ss_pred CCEEEEECccCCcCCCCEeccCCCCEEEEEeec-----CCCEEEEEEC----CEEEEEchHHeEEcCC
Confidence 446899999999999999999999999999984 6799999996 7899999999987543
|
| >2jte_A CD2-associated protein; SH3 domain, coiled coil, cytoplasm, phosphorylation, SH3-binding, signaling protein; NMR {Mus musculus} PDB: 2kro_A | Back alignment and structure |
|---|
Probab=99.38 E-value=5.4e-13 Score=99.90 Aligned_cols=58 Identities=40% Similarity=0.938 Sum_probs=51.0
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
...++|+|||+++.++||+|++||+|.|+.++ ..++|||.|+.+ ++.|+||+|||+.+
T Consensus 6 ~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~---~~~~~W~~g~~~----g~~G~~P~~yv~~l 63 (64)
T 2jte_A 6 KEYCRTLFPYTGTNEDELTFREGEIIHLISKE---TGEAGWWKGELN----GKEGVFPDNFAVQI 63 (64)
T ss_dssp SEEEEESSCBCCSSSSBCCBCTTCEEEEEESC---SSSTTEEEEEET----TEEEEEEGGGEEEC
T ss_pred CEEEEECccCCccCCCccCCCCCCEEEEEECC---CCCCCEEEEEEC----CeEEEEeHHHEEEC
Confidence 35799999999999999999999999999874 136799999986 78999999999864
|
| >1wyx_A CRK-associated substrate; beta sheets, cell adhesion; 1.14A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=3.9e-13 Score=102.35 Aligned_cols=61 Identities=41% Similarity=0.656 Sum_probs=52.4
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
+..++|+|||+++.++||+|++||+|.|+++... .++|||.|+.+ ++.|+||+|||+....
T Consensus 3 ~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~~~~--~~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 63 (69)
T 1wyx_A 3 NVLAKALYDNVAESPDELSFRKGDIMTVLEQDTQ--GLDGWWLCSLH----GRQGIVPGNRLKILVG 63 (69)
T ss_dssp EEEEEESSCBCCSSTTBCCBCTTCEEEEEETTGG--GCTTEEEEEET----TEEEEEEGGGEEEEEE
T ss_pred CEEEEECccCCcCCCCccCCcCCCEEEEeECCCC--CCCCcEEEEEC----CcEEEechhhEEECCC
Confidence 3579999999999999999999999999998310 15899999976 7899999999997654
|
| >3eg3_A Proto-oncogene tyrosine-protein kinase ABL1; beta, ATP-binding, cell adhesion, cytoskeleton, LIPO magnesium, manganese, metal-binding, myristate; 1.40A {Homo sapiens} PDB: 3egu_A 3eg0_A 3eg2_A 3eg1_A 1abo_A 1abq_A 1ju5_C* 2o88_A 1bbz_A 1awo_A | Back alignment and structure |
|---|
Probab=99.37 E-value=6.4e-13 Score=99.18 Aligned_cols=59 Identities=27% Similarity=0.600 Sum_probs=51.7
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.+..++|+|||.++.++||+|++||+|.|+.+. .+.+||.++.. ++.|+||+|||+.++
T Consensus 4 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~----~~~~W~~~~~~----g~~G~~P~~yv~~~~ 62 (63)
T 3eg3_A 4 DPNLFVALYDFVASGDNTLSITKGEKLRVLGYN----HNGEWCEAQTK----NGQGWVPSAYITPVN 62 (63)
T ss_dssp CTTEEEESSCBCCCSSSBCCBCTTCEEEEEEEC----TTSSEEEEEET----TEEEEEEGGGEEESC
T ss_pred CCEEEEEcceECCCCCCccCCCCCCEEEEEEeC----CCCCeEEEEEC----CCeEEEehHHeEECC
Confidence 356899999999999999999999999999853 36679999986 688999999998753
|
| >2ecz_A Sorbin and SH3 domain-containing protein 1; glycoprotein, membrane, nuclear protein, phosphorylation, polymorphism, transport, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=3.8e-13 Score=102.73 Aligned_cols=62 Identities=27% Similarity=0.564 Sum_probs=54.3
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..+..++|+|||+++.++||+|++||+|.|+++. +++||.+++.++ ++.|+||.|||+....
T Consensus 5 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~~--g~~G~~P~~yv~~~~~ 66 (70)
T 2ecz_A 5 SSGGEAIAKFNFNGDTQVEMSFRKGERITLLRQV-----DENWYEGRIPGT--SRQGIFPITYVDVISG 66 (70)
T ss_dssp CCCBCEEESSCCCCCSTTBCCCCTTCBCEEEEEE-----ETTEEEEEETTT--TEEEEECTTTEEESSS
T ss_pred CCCCEEEECccCCCCCcCCcCCCCCCEEEEEEec-----CCCeEEEEECCC--CCEEEEchHHEEECCC
Confidence 4456899999999999999999999999999974 679999998754 6899999999987543
|
| >2ege_A Uncharacterized protein KIAA1666; SH3 domain, KIAA1666 protein, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=5.7e-13 Score=103.12 Aligned_cols=58 Identities=29% Similarity=0.503 Sum_probs=51.2
Q ss_pred CCCEEEEcccCCCCC-------CCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 31 RPDLWRALYDYDAIG-------LDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 31 ~~~~~~alyd~~~~~-------~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
....++|||||+++. ++||+|++||+|.|+.+. .+++||.|+++ ++.|+||+|||+.+
T Consensus 6 ~~~~~~Alydy~~~~~~~~~~~~~eLsf~~Gd~i~v~~~~----~~~gWw~g~~~----g~~G~fP~~yv~~~ 70 (75)
T 2ege_A 6 SGKIMIAALDYDPGDGQMGGQGKGRLALRAGDVVMVYGPM----DDQGFYYGELG----GHRGLVPAHLLDHM 70 (75)
T ss_dssp CSEEEEESSCBCTTTTCCCSSSCCBCCBCTTCEEEEESCC----CTTCEEEEESS----SCEEEEETTTEEEC
T ss_pred CCcEEEECCCCCCCccccCCCCCCcceECCCCEEEEeEcc----CCCCEEEEEEC----CcEEEEChHHeEEc
Confidence 346899999999999 999999999999999742 37899999986 78999999999875
|
| >2dl3_A Sorbin and SH3 domain-containing protein 1; ponsin, C-CBL-associated protein, CAP, SH3 domain protein 5 SH3P12, structural genomics, NPPSFA; NMR {Homo sapiens} PDB: 2dlm_A | Back alignment and structure |
|---|
Probab=99.37 E-value=6.3e-13 Score=100.85 Aligned_cols=59 Identities=34% Similarity=0.642 Sum_probs=52.7
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.....++|+|||+++.++||+|++||+|.|+.+. +++||.++.+ ++.|+||.|||+...
T Consensus 5 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yv~~~~ 63 (68)
T 2dl3_A 5 SSGRPARAKFDFKAQTLKELPLQKGDIVYIYKQI-----DQNWYEGEHH----GRVGIFPRTYIELLS 63 (68)
T ss_dssp CCSEEEEESSCBCCSSTTBCCBCTTCEEEEEECC-----STTEEEEECS----SCEEEEETTTEEECC
T ss_pred CCCcEEEECccCCCCCcCCccCCCCCEEEEeEec-----CCCEEEEEEC----CCEEEEchHHEEECC
Confidence 3457899999999999999999999999999874 7899999966 789999999998754
|
| >2a28_A BZZ1 protein; SH3 domain, signaling protein; 1.07A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.37 E-value=5.4e-13 Score=96.22 Aligned_cols=53 Identities=36% Similarity=0.718 Sum_probs=47.9
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~ 94 (527)
.++|+|||+++.++||+|++||+|.|+.+. +.++||.++.+ ++.|+||+|||+
T Consensus 2 ~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~----~~~~W~~g~~~----g~~G~~P~~yv~ 54 (54)
T 2a28_A 2 AMEAIYAYEAQGDDEISIDPGDIITVIRGD----DGSGWTYGECD----GLKGLFPTSYCK 54 (54)
T ss_dssp EEEBCSCBCCCSTTBCCBCTTCEEEEEECC----CSSSEEEEEET----TEEEEEEGGGBC
T ss_pred EEEECccCCcCCCCCccCCCCCEEEEEEec----CCCCEEEEEEC----CeEEEeeHHHcC
Confidence 589999999999999999999999999985 23799999995 789999999985
|
| >1neg_A Spectrin alpha chain, brain; SH3-domain fold, five antiparallel beta sheets, structural protein; 2.30A {Gallus gallus} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.37 E-value=5.6e-13 Score=104.91 Aligned_cols=60 Identities=28% Similarity=0.668 Sum_probs=52.3
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.....++|||||+++.++||+|++||+|.|++++ ++|||.|+.+ ++.|+||+|||+....
T Consensus 15 ~~~~~~~Alydy~a~~~~eLsf~~Gd~i~Vl~~~-----~~gWw~g~~~----g~~G~~P~~yv~~~~~ 74 (83)
T 1neg_A 15 TGKELVLALYDYQEKSPREVTMKKGDILTLLNST-----NKDWWKVEVN----DRQGFVPAAYVKKLAA 74 (83)
T ss_dssp --CCEEEESSCBCCSSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEECCT
T ss_pred CCceEEEEccccCCCCCCccccCCCCEEEEEEec-----CCCEEEEEEC----CeEEEEEHHHEEECCC
Confidence 3447899999999999999999999999999984 7799999776 7899999999987643
|
| >3c0c_A Endophilin-A2; endocytosis, SH3, voltage-gated calcium channel, endosome, L binding, membrane, phosphoprotein, proto-oncogene, SH3 DOMA; 1.70A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.37 E-value=6.1e-13 Score=102.39 Aligned_cols=59 Identities=27% Similarity=0.603 Sum_probs=53.2
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|+|||+++.++||+|++||+|.|+++. +++||.|+.+ ++.|+||+|||+....
T Consensus 12 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yv~~~~~ 70 (73)
T 3c0c_A 12 DQPSCKALYDFEPENDGELGFREGDLITLTNQI-----DENWYEGMLH----GQSGFFPLSYVQVLVP 70 (73)
T ss_dssp CSCEEEESSCBCCSSTTBCCBCTTCEEEEEEEC-----SSSEEEEEET----TEEEEEEGGGEEEEEC
T ss_pred CCeEEEECccCCCCCCCCccCcCCCEEEEEEec-----CCCEEEEEEC----CCEEEeChHHEEECCC
Confidence 447899999999999999999999999999984 7899999986 7899999999987654
|
| >2o2o_A SH3-domain kinase-binding protein 1; CIN85, protein binding; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=4.5e-13 Score=107.65 Aligned_cols=60 Identities=35% Similarity=0.746 Sum_probs=53.5
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.....++|+|||+++.++||+|++||+|.|+++. ++|||.|+++ ++.|+||+|||+.+..
T Consensus 16 ~~~~~~~Alydy~a~~~~eLsf~~Gd~i~V~~~~-----~~gWw~g~~~----g~~G~fPsnyV~~~~~ 75 (92)
T 2o2o_A 16 RRRRRCQVAFSYLPQNDDELELKVGDIIEVVGEV-----EEGWWEGVLN----GKTGMFPSNFIKELSG 75 (92)
T ss_dssp CSSCEEEECSCBCCCSSSCCCBCSSCEEECCCGG-----GSSCBCCEET----TEECCBCSSSEECCSS
T ss_pred CCCeEEEEccccCCCCCccccccCCCEEEEeEec-----CCCEEEEEEC----CeEEEeehHHEEECCC
Confidence 3446899999999999999999999999999874 7899999986 7899999999997654
|
| >1yn8_A NBP2, NAP1-binding protein 2; SH3 domain, unknown function; 1.70A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.37 E-value=3.7e-13 Score=99.09 Aligned_cols=57 Identities=39% Similarity=0.581 Sum_probs=50.7
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
..++|+|||.++.++||+|++||+|.|+++. ++|||.++.... ++.|+||++||+.+
T Consensus 2 ~~~~al~d~~~~~~~eLs~~~Gd~i~v~~~~-----~~gW~~g~~~~~--g~~G~~P~~yv~~~ 58 (59)
T 1yn8_A 2 QRAVALYDFEPENDNELRLAEGDIVFISYKH-----GQGWLVAENESG--SKTGLVPEEFVSYI 58 (59)
T ss_dssp EEEEECSCBCCCSTTBCCBCTTCEEEEEEEE-----ETTEEEEECTTS--SCEEEEEGGGEEEC
T ss_pred CEEEECccCCCCCCCCcCCCCCCEEEEEEcC-----CCCeEEEEECCC--CCEEEEehHHeEEC
Confidence 4689999999999999999999999999984 789999997643 68999999999864
|
| >1x2k_A OSTF1, osteoclast stimulating factor 1; SH3 domain, human osteoclast stimulating factor 1, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=7.1e-13 Score=100.54 Aligned_cols=58 Identities=31% Similarity=0.719 Sum_probs=52.0
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
....++|+|||+++.++||+|++||+|.|+++. +++||.++.+ ++.|+||+|||+...
T Consensus 6 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~ 63 (68)
T 1x2k_A 6 SGKVFRALYTFEPRTPDELYFEEGDIIYITDMS-----DTNWWKGTSK----GRTGLIPSNYVAEQS 63 (68)
T ss_dssp CSEEEEESSCCCCCSTTBCCCCSSCEEEEEECS-----CSSEEEEESS----SCEEEEETTTEEECC
T ss_pred CcEEEEECceECCCCCCcccCCCCCEEEEEEcC-----CCCEEEEEEC----CcEEEEehHHeEEcC
Confidence 346899999999999999999999999999884 7899999985 789999999998753
|
| >2dil_A Proline-serine-threonine phosphatase-interacting protein 1; SH3 domain, PEST phosphatase-interacting protein 1, CD2- binding protein 1; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=9.1e-13 Score=100.25 Aligned_cols=60 Identities=37% Similarity=0.720 Sum_probs=53.5
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.....++|+|||+++.++||+|++||+|.|+.+. +++||.++++ ++.|+||.|||+....
T Consensus 6 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 65 (69)
T 2dil_A 6 SGAQEYRALYDYTAQNPDELDLSAGDILEVILEG-----EDGWWTVERN----GQRGFVPGSYLEKLSG 65 (69)
T ss_dssp CCCCEEECCSCBCCSSSSSCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGCCBCCC
T ss_pred CCCcEEEECccCCccCcCccCCCCCCEEEEEECC-----CCCEEEEEEC----CCEEEEehHHeEEcCC
Confidence 3457899999999999999999999999999984 7899999987 7899999999987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=2.8e-12 Score=124.24 Aligned_cols=141 Identities=17% Similarity=0.167 Sum_probs=110.2
Q ss_pred ceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEEEeccC
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLVMEYAR 196 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv~Ey~~ 196 (527)
.|.+...+|.|+++.||++...+..+++|+........ ...+.+|+.+++.+. +..+.++++++.+.+..|+||||++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC-HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 57778889999999999998778899999986421011 234778999999884 6778899999999889999999999
Q ss_pred CCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q psy6905 197 GGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ--------------------------------------------- 231 (527)
Q Consensus 197 ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~--------------------------------------------- 231 (527)
|.+|.+.+. +......++.+++.+|..||+.
T Consensus 94 G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 94 GVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp SEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred CeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 999987642 2233457788999999999981
Q ss_pred -----------CCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 232 -----------APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 232 -----------g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
.+..++|+|++|.|||++.+ +.+.|+||+.+.
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~--------~~~~lIDwe~a~ 212 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDG--------KVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETT--------EEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECC--------cEEEEEEchhcc
Confidence 01248999999999999753 356799998763
|
| >2lcs_A NAP1-binding protein 2; adaptor, transferase, signaling protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.37 E-value=4.3e-13 Score=103.08 Aligned_cols=59 Identities=37% Similarity=0.566 Sum_probs=52.3
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
...++|+|||+++.++||+|++||+|.|+++. ++|||.|++... ++.|+||+|||+...
T Consensus 5 ~~~~~Alydy~a~~~~eLs~~~Gd~i~v~~~~-----~~gWw~g~~~~~--g~~G~~P~~yv~~~~ 63 (73)
T 2lcs_A 5 NQRAVALYDFEPENDNELRLAEGDIVFISYKH-----GQGWLVAENESG--SKTGLVPEEFVSYIQ 63 (73)
T ss_dssp CEEEEESSCBCCSSTTBCCBCTTCEEEEEEEE-----TTTEEEEECTTS--SCEEEEESTTEEECC
T ss_pred CCEEEECccCCCCCCCccCCcCCCEEEEEEEc-----CCCEEEEEECCC--CCEEEeeHHHEEECC
Confidence 35799999999999999999999999999984 779999998633 789999999998754
|
| >2o9s_A Ponsin; SH3 domain, signaling protein; 0.83A {Homo sapiens} PDB: 2o31_A 2o9v_A 2o2w_A | Back alignment and structure |
|---|
Probab=99.37 E-value=5e-13 Score=101.06 Aligned_cols=58 Identities=29% Similarity=0.619 Sum_probs=51.9
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
..++|+|||+++.++||+|++||+|.|+++. +++||.|+..++ ++.|+||+|||+...
T Consensus 7 ~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~~--g~~G~~P~~yv~~~~ 64 (67)
T 2o9s_A 7 GEAIAKFNFNGDTQVEMSFRKGERITLLRQV-----DENWYEGRIPGT--SRQGIFPITYVDVIK 64 (67)
T ss_dssp EEEEECSCBCCSSTTBCCBCTTCEEEEEEEC-----SSSEEEEECTTS--SCEEEEEGGGEEEEE
T ss_pred EEEEECccCCcCCcCccCCCCCCEEEEEEec-----CCCEEEEEECCC--CCEEEEChHHeEECC
Confidence 4799999999999999999999999999984 789999998754 689999999998653
|
| >2kxc_A Brain-specific angiogenesis inhibitor 1-associate 2-like protein 1; IRTKS-SH3, espfu, complex structure, protein binding; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=6.5e-13 Score=100.45 Aligned_cols=61 Identities=21% Similarity=0.448 Sum_probs=52.3
Q ss_pred CCCEEEEcccCCC-CCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDA-IGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~-~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
....++|+|||+| +.++||+|++||+|.|+.++ .+++||.|++... ++.|+||+|||+.+.
T Consensus 5 ~~~~~~al~dy~a~~~~~eLs~~~Gd~i~v~~~~----~~~~Ww~g~~~~~--g~~G~~P~~yv~~~~ 66 (67)
T 2kxc_A 5 KKQKVKTIFPHTAGSNKTLLSFAQGDVITLLIPE----EKDGWLYGEHDVS--KARGWFPSSYTKLLE 66 (67)
T ss_dssp CCCEEEESSCBCCSSCSSBCCBCTTCEEEESSSS----CBTTEEEEEESSS--CCEEEEEGGGEEESC
T ss_pred CCEEEEEeecCCCCCCCCCCcCCCCCEEEEeECC----CCCCcEEEEECCC--CCEEEEehHHeEECC
Confidence 3468999999996 99999999999999999862 3789999998743 789999999998653
|
| >1x2q_A Signal transducing adapter molecule 2; SH3 domain, signal transducing adaptor molecule, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=104.80 Aligned_cols=61 Identities=38% Similarity=0.807 Sum_probs=53.9
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDIN 100 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~ 100 (527)
....++|||||+++.++||+|++||+|.|+++. +++||.|++. ++.|+||.|||+.....+
T Consensus 16 ~~~~~~Alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~~~ 76 (88)
T 1x2q_A 16 VARKVRALYDFEAVEDNELTFKHGEIIIVLDDS-----DANWWKGENH----RGIGLFPSNFVTTNLNIE 76 (88)
T ss_dssp CCEEEEESSCCCCCSSSCCCCCSSCEEEEEECS-----CSSSEEEEET----TEEEEECGGGEESCSSCC
T ss_pred CCeEEEEcccCCCCCcCccCCCCCCEEEEEEeC-----CCCEEEEEEC----CcEEEEehHHEEEcCCcC
Confidence 346899999999999999999999999999974 7899999987 679999999999765543
|
| >4e6r_A Cytoplasmic protein NCK2; SH3 domain, protein binding, structural genomics, joint CENT structural genomics, JCSG, protein structure initiative; HET: MLY; 2.20A {Homo sapiens} PDB: 2frw_A 2js0_A | Back alignment and structure |
|---|
Probab=99.37 E-value=5.9e-13 Score=97.58 Aligned_cols=55 Identities=35% Similarity=0.529 Sum_probs=49.7
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
..++|+|||.++.++||+|++||+|.|+++. +++||.|... ++.|+||+|||+..
T Consensus 2 ~~a~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yv~~~ 56 (58)
T 4e6r_A 2 IPAFVXFAYVAEREDELSLVXGSRVTVMEXC-----SDGWWRGSYN----GQIGWFPSNYVLEE 56 (58)
T ss_dssp EEEEECSCBCCCSTTBCCBCTTCEEEEEEEC-----TTSEEEEEET----TEEEEEEGGGEEEC
T ss_pred EEEEECccCCCCCCCEeeEeCCCEEEEeEcC-----CCCEEEEEEC----CcEEEEehHHEEEC
Confidence 3689999999999999999999999999984 7899999776 78999999999864
|
| >2dl7_A KIAA0769 protein; SH3 domain, FCHSD2, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=9e-13 Score=101.47 Aligned_cols=61 Identities=34% Similarity=0.738 Sum_probs=52.3
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
...++|||||+++.++||+|++||+|.|+++.. ..+++||.|+.+ ++.|+||.|||+....
T Consensus 8 ~~~~~alydy~~~~~~eLsf~~Gd~i~v~~~~~--~~~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 68 (73)
T 2dl7_A 8 VCFVKALYDYEGQTDDELSFPEGAIIRILNKEN--QDDDGFWEGEFN----GRIGVFPSVLVEELSS 68 (73)
T ss_dssp CEEEEESSCBCCSSTTBCCBCTTCEEEEEECCC--SSSSSCEEEEET----TEEEEECSSSEEECCS
T ss_pred CEEEEECccCCcCCCCcCCCCCCCEEEEEECCC--CCCCCcEEEEEC----CCEEEEChHHEEECCC
Confidence 367999999999999999999999999998721 026799999976 7899999999987654
|
| >2dbm_A SH3-containing GRB2-like protein 2; EC 2.3.1.-, SH3 domain protein 2A, endophilin 1, EEN-B1, structural genomics, NPPSFA; NMR {Homo sapiens} PDB: 2knb_B 3iql_A | Back alignment and structure |
|---|
Probab=99.36 E-value=8.5e-13 Score=101.60 Aligned_cols=60 Identities=30% Similarity=0.629 Sum_probs=53.7
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
....++|+|||+++.++||+|++||+|.|+.+. +++||.++++ ++.|+||.|||+.....
T Consensus 6 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~~ 65 (73)
T 2dbm_A 6 SGPCCRALYDFEPENEGELGFKEGDIITLTNQI-----DENWYEGMLH----GHSGFFPINYVEILVAL 65 (73)
T ss_dssp CCCEEEESSCBCCCSTTCCCBCTTCEEECCBCS-----SSSEEEEEET----TEEEEEESSSEEESSCC
T ss_pred CCCEEEEccccCCCCCCCccCCCCCEEEEEEec-----CCCEEEEEEC----CCEEEechHHEEEccCC
Confidence 446899999999999999999999999999985 7899999986 78999999999986553
|
| >2gqi_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=3.8e-13 Score=102.98 Aligned_cols=61 Identities=21% Similarity=0.305 Sum_probs=52.4
Q ss_pred CCCCEEEEcccCCC-CCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 30 HRPDLWRALYDYDA-IGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 30 ~~~~~~~alyd~~~-~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.....++|||||.+ +.++||+|++||+|.|+.+. +++||.|++... ++.|+||+|||+...
T Consensus 5 ~~~~~~~Alydy~~~~~~~eLsf~~Gd~i~v~~~~-----~~~W~~g~~~~~--g~~G~~P~~yv~~~~ 66 (71)
T 2gqi_A 5 SSGRRVRAILPYTKVPDTDEISFLKGDMFIVHNEL-----EDGWMWVTNLRT--DEQGLIVEDLVEEVS 66 (71)
T ss_dssp CSCCCEEESSCCCCCTTSSCCCCCTTCBCCCCEEC-----SSSCEEEECTTT--CCEEEECTTSEEECC
T ss_pred CCCCEEEECcccCCCCCCCCCCCCCCCEEEEEEec-----CCCEEEEEECCC--CCEEEeeHHHEEECC
Confidence 34568999999999 99999999999999999884 789999994322 789999999998754
|
| >1wxb_A Epidermal growth factor receptor pathway substrate 8-like protein; SH3, EPS8, EPS8L2, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=7.4e-13 Score=100.42 Aligned_cols=59 Identities=25% Similarity=0.529 Sum_probs=51.8
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
....+++|||||+++.++||+|++||+|.|+++ +++||.++... ++.|+||+|||+...
T Consensus 5 ~~~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~------~~~Ww~~~~~~---g~~G~~P~~yv~~~~ 63 (68)
T 1wxb_A 5 SSGKYVKILYDFTARNANELSVLKDEVLEVLED------GRQWWKLRSRS---GQAGYVPCNILGEAS 63 (68)
T ss_dssp SSCCCEECSSCBCCSSSSBCCBCTTCEEEEEEC------SSSEEEEECTT---SCEEEEETTTCCBCC
T ss_pred CCCEEEEECccCCCCCCCccCCCCCCEEEEEEc------CCCEEEEEECC---CCEEEEEHHHeEECC
Confidence 445689999999999999999999999999987 47999999632 789999999998754
|
| >3h0h_A Proto-oncogene tyrosine-protein kinase FYN; beta barrel, transferase; HET: PG4; 1.76A {Homo sapiens} SCOP: b.34.2.1 PDB: 3h0i_A 3h0f_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=8.5e-13 Score=101.65 Aligned_cols=59 Identities=32% Similarity=0.714 Sum_probs=51.8
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
...+++|+|||.++.++||+|++||+|.|+++. +++||.++.... ++.|+||.|||+.+
T Consensus 14 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~~--g~~G~~P~~yv~~~ 72 (73)
T 3h0h_A 14 GVTLFVALYDYEAITEDDLSFHKGEKFQILNSS-----EGDWWEARSLTT--GETGYIPSNYVAPV 72 (73)
T ss_dssp TTCEEEESSCBCCSSTTBCCBCTTCEEEEEECS-----SSSEEEEEETTT--CCEEEEEGGGEEEC
T ss_pred CCEEEEECccCCCCCCCcceEeCCCEEEEEEec-----CCCeEEEEECCC--CCEEEEEHHHeEEC
Confidence 347899999999999999999999999999985 789999998322 78999999999864
|
| >3ngp_A Spectrin alpha chain, brain; beta barrel, structural protein; 1.08A {Gallus gallus} PDB: 1e7o_A 1e6g_A 1e6h_A 1uue_A 1h8k_A 2lj3_A 1aey_A 1m8m_A 1shg_A 1u06_A 2nuz_A 2cdt_A 1hd3_A 2f2v_A 2f2w_A 2jm8_A 2jm9_A 2jma_A 3m0r_A 3m0p_A ... | Back alignment and structure |
|---|
Probab=99.36 E-value=8.2e-13 Score=98.24 Aligned_cols=56 Identities=29% Similarity=0.695 Sum_probs=51.1
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
...++|+|||.++.++||+|++||+|.|+++. +++||.++.. ++.|+||+|||+.+
T Consensus 6 ~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~~~~~----g~~G~~P~~yv~~~ 61 (62)
T 3ngp_A 6 KELVLVLYDYQEKSPRELTVKKGDILTLLNST-----NKDWWKIEVN----GRQGFVPAAYLKKL 61 (62)
T ss_dssp CCEEEECSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEEC
T ss_pred CEEEEECcCCCCCCCCCccCCCCCEEEEeEec-----CCCeEEEEEC----CEEEEEEHHHEEEC
Confidence 46899999999999999999999999999984 7899999976 78999999999864
|
| >1zuy_A Myosin-5 isoform; SH3 domain, contractIle protein; 1.39A {Saccharomyces cerevisiae} PDB: 1yp5_A | Back alignment and structure |
|---|
Probab=99.36 E-value=7.7e-13 Score=96.98 Aligned_cols=56 Identities=27% Similarity=0.599 Sum_probs=50.0
Q ss_pred CEEEEcccC-CCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDY-DAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~-~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
+.++|+||| .++.++||+|++||+|.|+.++ ++|||.|++... ++.|+||+|||+.
T Consensus 1 p~~~al~d~~~~~~~~eLs~~~Gd~i~v~~~~-----~~gW~~g~~~~~--g~~G~~P~~yv~~ 57 (58)
T 1zuy_A 1 PMFEAAYDFPGSGSPSELPLKKGDVIYITREE-----PSGWSLGKLLDG--SKEGWVPTAYMKP 57 (58)
T ss_dssp CEEEESSCBCCCSCTTBCCBCTTCEEEEEEEC-----TTSEEEEEESSC--SCEEEEEGGGEEC
T ss_pred CEEEEecccCCCCCCCcCCCCCCCEEEEEEec-----CCCeEEEEECCC--CCEEEecHHHEEE
Confidence 368999999 8999999999999999999985 789999998743 6899999999974
|
| >1uhf_A Intersectin 2; beta barrel, SH3 domain, riken structural genomics/proteomics initiative, RSGI, structural genomics, signaling protein; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.36 E-value=4.3e-13 Score=102.02 Aligned_cols=59 Identities=34% Similarity=0.707 Sum_probs=52.4
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..+..++|+|||+++.++||+|++||+|.|+++ +++||.|+.+ ++.|+||.|||+....
T Consensus 6 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~------~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 64 (69)
T 1uhf_A 6 SGGEEYIALYPYSSVEPGDLTFTEGEEILVTQK------DGEWWTGSIG----DRSGIFPSNYVKPKDS 64 (69)
T ss_dssp CCSEEEECSSCBCCSSSSBCCBCTTCEEEECEE------ETTEEEECST----TCCEEECGGGCEECCC
T ss_pred CCCCEEEEeeeECCCCcCccCCCCCCEEEEEEe------CCCEEEEEeC----CcEEEEchHHeEECCC
Confidence 345789999999999999999999999999987 5799999876 7899999999987654
|
| >2yun_A Nostrin; nitric oxide synthase trafficker, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=8.7e-13 Score=103.23 Aligned_cols=61 Identities=39% Similarity=0.739 Sum_probs=54.0
Q ss_pred CCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 29 NHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 29 ~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
+.++..++|||||+++.++||+|++||+|.|+.+. +++||.++.+ ++.|+||.|||+....
T Consensus 4 ~~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 64 (79)
T 2yun_A 4 GSSGRLCKALYSFQARQDDELNLEKGDIVIIHEKK-----EEGWWFGSLN----GKKGHFPAAYVEELPS 64 (79)
T ss_dssp CCCSEEEEESSCBCCSSTTBCCBCTTCEEEEEECC-----SSSCEEEESS----SCEEEECSTTEEEESS
T ss_pred CCCCCEEEECccCCcCCCCCcCCCCCCEEEEEEcC-----CCCEEEEEEC----CCEEEEEhHHeEECCC
Confidence 34567999999999999999999999999999884 7899999976 7899999999987554
|
| >2cud_A SRC-like-adapter; SH3 domain, negative mitogenesis regulator, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=1e-12 Score=102.69 Aligned_cols=60 Identities=23% Similarity=0.462 Sum_probs=51.8
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
....+++|||||+++.++||+|++||+|.|++. +++||.++.... ++.|+||+|||+...
T Consensus 15 ~~~~~~~Alydy~a~~~~eLs~~~Gd~i~v~~~------~~~Ww~~~~~~~--g~~G~~P~~yv~~~~ 74 (79)
T 2cud_A 15 LDSDFLAVLSDYPSPDISPPIFRRGEKLRVISD------EGGWWKAISLST--GRESYIPGICVARVS 74 (79)
T ss_dssp SCCCEEEESSCSSCTTTSCCSSCTTCEEEEEEE------ETTEEEEEETTT--CCEEEEEGGGEEEEC
T ss_pred CCCeEEEEccCCCCCCCCcCCCCCCCEEEEEec------CCCeEEEEECCC--CCEEEeeHHHeEEcc
Confidence 344789999999999999999999999999985 579999997432 789999999998653
|
| >2k9g_A SH3 domain-containing kinase-binding protein 1; CIN85, adaptor protein, downregulation, CBL, apoptosis, junction, cytoplasmic vesicle, cytoskeleton; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=1e-12 Score=101.15 Aligned_cols=60 Identities=40% Similarity=0.873 Sum_probs=52.5
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
....++|+|||+++.++||+|++||+|.|+.++ ..++|||.|+.+ ++.|+||+|||+.+.
T Consensus 8 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~---~~~~~W~~g~~~----g~~G~~P~~yv~~~~ 67 (73)
T 2k9g_A 8 SKDYCKVIFPYEAQNDDELTIKEGDIVTLINKD---CIDVGWWEGELN----GRRGVFPDNFVKLLP 67 (73)
T ss_dssp SCEEEEECSCBCCSSTTBCCBCTTCEEEEEECC---SSSTTEEEEEET----TEEEEEEGGGEEECC
T ss_pred CccEEEECccCCCCCCCeeeECCCCEEEEEECC---CCCCCEEEEEEC----CeEEEEchHHEEECC
Confidence 446899999999999999999999999999873 126899999986 789999999998754
|
| >1wxt_A Hypothetical protein FLJ21522; SH3 domain, EPS8-related protein 3, protein-protein interaction, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=9.5e-13 Score=99.80 Aligned_cols=59 Identities=27% Similarity=0.532 Sum_probs=51.8
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|||||+++.++||+|++||+|.|+++ +++||.++... ++.|+||.|||+....
T Consensus 6 ~~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~------~~~Ww~~~~~~---g~~G~~P~~yv~~~~~ 64 (68)
T 1wxt_A 6 SGLKMQVLYEFEARNPRELTVVQGEKLEVLDH------SKRWWLVKNEA---GRSGYIPSNILEPLSG 64 (68)
T ss_dssp CCEEEEESSCBCCCSSSBCCBCTTCEEEEEEC------SSSEEEEECTT---SCEEEEEGGGEECCCC
T ss_pred CCeEEEECceECCCCcCcCCCCCCCEEEEEEc------CCCEEEEEECC---CCEEEEEhHHcEECCC
Confidence 45689999999999999999999999999987 47999999432 7899999999987654
|
| >3cqt_A P59-FYN, proto-oncogene tyrosine-protein kinase FYN; beta barrel, ATP-binding, developmental protein, lipoprotein, manganese, metal-binding; 1.60A {Gallus gallus} PDB: 2l2p_A | Back alignment and structure |
|---|
Probab=99.36 E-value=6.8e-13 Score=103.68 Aligned_cols=63 Identities=25% Similarity=0.660 Sum_probs=51.7
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDINL 101 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~~ 101 (527)
...++|+|||+++.++||+|++||+|.|++++ ++|||.|+.... ++.|+||+|||+....++.
T Consensus 5 ~~~~~Alydy~~~~~~eLs~~~Gd~i~vl~~~-----~~~Ww~g~~~~~--g~~G~~P~~yv~~~~~~~~ 67 (79)
T 3cqt_A 5 STLFEALYDYEARTEDDLSFHKGEKFQILNSS-----EGDWWEARSLTT--GETGYIPSIYLAPVDRLDY 67 (79)
T ss_dssp CCCEEESSCBCCCSTTBCCBCTTCEEEEEECT-----TSSEEEEEETTT--CCEEEEEGGGEEEC-----
T ss_pred CcEEEECccCCCCCcCcCCCCCCCEEEEEEec-----CCCeEEEEECCC--CCEEEeehHHeEECCcccc
Confidence 35799999999999999999999999999884 789999998222 7899999999998766543
|
| >2jw4_A Cytoplasmic protein NCK1; SH3 domain, phosphorylation, SH2 domain, signaling protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=8.9e-13 Score=101.16 Aligned_cols=61 Identities=23% Similarity=0.428 Sum_probs=52.9
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDIN 100 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~ 100 (527)
.+..++|+|||.++.++||+|++||+|.|+++ +++||.++... ++.|+||+|||+....++
T Consensus 6 ~~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~------~~~Ww~g~~~~---g~~G~~P~~yv~~~~~~~ 66 (72)
T 2jw4_A 6 EEVVVVAKFDYVAQQEQELDIKKNERLWLLDD------SKSWWRVRNSM---NKTGFVPSNYVERKNSAR 66 (72)
T ss_dssp CCEEEECSSCCCCSSTTSCCCCTTCEEEEEEC------SSSSEEEECTT---SCEEEECTTSCEECCCCC
T ss_pred CCeEEEECcCCCcCCCCcccCCCCCEEEEEEC------CCCEEEEEECC---CCEEEEEhhHEEEcCCCc
Confidence 34689999999999999999999999999986 46999999632 789999999999876543
|
| >2dlp_A KIAA1783 protein; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=9.6e-13 Score=104.51 Aligned_cols=62 Identities=27% Similarity=0.430 Sum_probs=53.4
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
...+++|||||+++.++||+|++||+|.|++++ ..+++||.|+++ ++.|+||+|||+.+...
T Consensus 7 ~~~~~~al~dy~~~~~~eLsf~~Gd~i~v~~~~---~~~~~Ww~g~~~----g~~G~fP~~yv~~~~~~ 68 (85)
T 2dlp_A 7 GSGYVIALRSYITDNCSLLSFHRGDLIKLLPVA---TLEPGWQFGSAG----GRSGLFPADIVQPAAAP 68 (85)
T ss_dssp CCCEEEESSCBCCSSSSBCCBCTTCEEEECCCS---CCCTTEEEEESS----SCEEEEETTSEEECCCS
T ss_pred CCEEEEECCCCCccCcCCccCcCCCEEEEEEcc---CCCCCeEEEEEC----CEEEEechHHeEECCCc
Confidence 346899999999999999999999999999861 137899999986 78999999999986543
|
| >2csi_A RIM-BP2, RIM binding protein 2; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=9.8e-13 Score=102.08 Aligned_cols=60 Identities=30% Similarity=0.568 Sum_probs=52.2
Q ss_pred CCCCEEEEcccCCCCC-------CCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 30 HRPDLWRALYDYDAIG-------LDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~-------~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.....++|||||+++. .+||+|++||+|.|+.+. +++|||.|+++ ++.|+||+|||+.+.
T Consensus 5 ~~~~~~~Al~dy~~~~~~~~~~~~~eLsf~~Gd~i~v~~~~----~~~gWw~g~~~----g~~G~~P~~yv~~~~ 71 (76)
T 2csi_A 5 SSGRRMVALYDYDPRESSPNVDVEAELTFCTGDIITVFGEI----DEDGFYYGELN----GQKGLVPSNFLEEVS 71 (76)
T ss_dssp CCSEEEECSSCCCTTTTSCSSSTTTSCCCCTTCEEEEESSC----CSSSEEEEEET----TEEEEEEGGGCCBCC
T ss_pred CCccEEEEcccCCCCCcccCCCCCCcccCCCCCEEEEeEec----CCCCeEEEEEC----CcEEEEehHHEEECC
Confidence 3446899999999999 999999999999999884 23589999986 789999999998754
|
| >2v1q_A SLA1, cytoskeleton assembly control protein SLA1; structural genomics, phosphorylation, structural protein, yeast, SH3 domain; 1.2A {Saccharomyces cerevisiae} PDB: 1z9z_A | Back alignment and structure |
|---|
Probab=99.35 E-value=9.3e-13 Score=97.24 Aligned_cols=58 Identities=29% Similarity=0.554 Sum_probs=50.3
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
+..++|+|||+++.++||+|++||+|.|+++. .+++||.++.... ++.|+||+|||+.
T Consensus 2 ~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~----~~~~Ww~g~~~~~--g~~G~~P~~yv~~ 59 (60)
T 2v1q_A 2 MERGIVQYDFMAESQDELTIKSGDKVYILDDK----KSKDWWMCQLVDS--GKSGLVPAQFIEP 59 (60)
T ss_dssp CCEEEECSCBCCCSTTBCCBCTTCEEEEEESS----SCSSEEEEEETTT--CCEEEEEGGGEEE
T ss_pred CcEEEEeeeECCCCCCCccCCCCCEEEEEeCC----CCCCCEEEEECCC--CCEEEEEHHHEEE
Confidence 35899999999999999999999999999872 3789999998221 7899999999974
|
| >1ruw_A Myosin-3 isoform, MYO3; SH3 domain, yeast, high-throughput, structural genomics, contractIle protein; 1.80A {Saccharomyces cerevisiae} PDB: 2btt_A 1va7_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1e-12 Score=100.00 Aligned_cols=59 Identities=29% Similarity=0.532 Sum_probs=52.2
Q ss_pred CEEEEcccCC-CCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYD-AIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~-~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|||||+ ++.++||+|++||+|.|+++. ++|||.|+.... ++.|+||+|||+....
T Consensus 3 ~~~~alydy~~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~~~--g~~G~~P~~yv~~~~~ 62 (69)
T 1ruw_A 3 PKFEAAYDFPGSGSSSELPLKKGDIVFISRDE-----PSGWSLAKLLDG--SKEGWVPTAYMTPYKD 62 (69)
T ss_dssp SEEEESSCBCCCSCTTBCCBCTTCEEEEEEEC-----TTSEEEEEETTS--SCEEEEEGGGEEECCS
T ss_pred cEEEEccccCCCCCCCcccCCCCCEEEEEEec-----CCCeEEEEECCC--CCEEEEehHHeEEcCC
Confidence 5799999996 999999999999999999985 789999998743 6899999999987654
|
| >1wi7_A SH3-domain kinase binding protein 1; beta barrel, SH3KBP1, RUK, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.3e-13 Score=102.43 Aligned_cols=60 Identities=33% Similarity=0.710 Sum_probs=52.9
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.....++|+|||+++.++||+|++||+|.|+.+. +++||.|+.+ ++.|+||.|||+....
T Consensus 5 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 64 (68)
T 1wi7_A 5 SSGRRCQVAFSYLPQNDDELELKVGDIIEVVGEV-----EEGWWEGVLN----GKTGMFPSNFIKELSG 64 (68)
T ss_dssp CCCCCEEESSCBCCSSTTBCCBCTTCEECCCEEE-----ETTEEEECST----TCCEEEETTSEEECCS
T ss_pred CCCCEEEECccCCcCCCCCccCcCCCEEEEEEcC-----CCCeEEEEEC----CcEEEEchHHEEECCC
Confidence 3457899999999999999999999999999874 6899999975 7899999999987543
|
| >3rnj_A Brain-specific angiogenesis inhibitor 1-associate 2; structural genomics, structural genomics consortium, SGC, BE barrel; HET: EDT; 1.50A {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-12 Score=99.11 Aligned_cols=60 Identities=23% Similarity=0.419 Sum_probs=50.0
Q ss_pred CCCEEEEcccCCCCCCCC-CcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 31 RPDLWRALYDYDAIGLDE-LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~e-L~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
....++|+|||+++.+++ |+|++||+|.|+.+. .++|||.|++... ++.|+||+|||+.+
T Consensus 6 ~~~~~~al~dy~~~~~~e~Lsf~~Gd~i~v~~~~----~~~gW~~g~~~~~--g~~G~fP~~yv~~l 66 (67)
T 3rnj_A 6 GRMRVKAIFSHAAGDNSTLLSFKEGDLITLLVPE----ARDGWHYGESEKT--KMRGWFPFSYTRVL 66 (67)
T ss_dssp CCCEEEESSCBCCCSCTTBCCBCTTCEEEECSSS----CBTTEEEEEETTT--CCEEEEEGGGEEEC
T ss_pred CCeEEEEccccCCCCCCCCccCCCCCEEEEeecc----CCCCCEEEEECCC--CCEEEEEHHHeEEC
Confidence 346899999999998777 999999999999652 3679999995422 78999999999864
|
| >2cre_A HEF-like protein; SH3 domain, SRC homology 3 domain, beta barrel, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=9e-13 Score=100.92 Aligned_cols=63 Identities=33% Similarity=0.538 Sum_probs=53.4
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.....++|+|||+++.++||+|++||+|.|+.+.. ..+++||.++.+ ++.|+||.|||+....
T Consensus 5 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~~--~~~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 67 (71)
T 2cre_A 5 SSGLLARALYDNCPDCSDELAFSRGDILTILEQHV--PESEGWWKCLLH----GRQGLAPANRLQILSG 67 (71)
T ss_dssp CCCEEEEESSCCCCSSSSBCCCCSSCCEEEEESCC--TTSTTEEEEESS----SCCEEEETTTEEECCC
T ss_pred CCcEEEEECcccCcCCCCCCCCCCCCEEEEeEcCC--CCCCCcEEEEEC----CCEEEEehHHEEECCC
Confidence 34578999999999999999999999999998721 126899999965 7899999999987543
|
| >2ct3_A Vinexin; SH3 domian, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=1e-12 Score=100.37 Aligned_cols=62 Identities=37% Similarity=0.709 Sum_probs=54.1
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.++..++|+|||+++.++||+|++||+|.|+++. +++||.+++... ++.|+||.|||+....
T Consensus 5 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~gW~~g~~~~~--g~~G~~P~~yv~~~~~ 66 (70)
T 2ct3_A 5 SSGTPYRAMYQYRPQNEDELELREGDRVDVMQQC-----DDGWFVGVSRRT--QKFGTFPGNYVAPVSG 66 (70)
T ss_dssp CCCEEEEESSCBCCSSTTBCCBCTTEEEEEEEEC-----SSSCEEEEESSS--CCEEEECTTTEEETTC
T ss_pred CCCcEEEECccCCcCCcCCccCCCCCEEEEEEEC-----CCCEEEEEECCC--CCEEEechHHeEECCC
Confidence 4557899999999999999999999999999984 789999997532 7899999999987543
|
| >1zuu_A BZZ1 protein; SH3 domain, unknown function; 0.97A {Saccharomyces cerevisiae} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.35 E-value=5.5e-13 Score=97.75 Aligned_cols=56 Identities=21% Similarity=0.456 Sum_probs=48.2
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~ 94 (527)
..++|+|||+++.++||+|++||+|.|+.++ .+++||.++.... ++.|+||+|||+
T Consensus 2 ~~~~alydy~~~~~~eLs~~~Gd~i~v~~~~----~~~~W~~g~~~~~--g~~G~~P~~yv~ 57 (58)
T 1zuu_A 2 MENKVLYAYVQKDDDEITITPGDKISLVARD----TGSGWTKINNDTT--GETGLVPTTYIR 57 (58)
T ss_dssp -CCEECSCBCCCSTTBCCBCTTCCEEEEECC----SSSSEEEEEETTT--TEEEEEEGGGEE
T ss_pred CEEEEeeeECCcCCCcccCCCCCEEEEeEcC----CCCCCEEEEECCC--CCEEEEEHHHEE
Confidence 4589999999999999999999999999985 2379999998311 789999999986
|
| >2fpf_A C-JUN-amino-terminal kinase interacting protein 1; scaffold protein 1, islet-brain-1, IB-1, mitogen-activated P kinase 8-interacting protein 1; 3.00A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.35 E-value=8.7e-13 Score=100.95 Aligned_cols=60 Identities=22% Similarity=0.320 Sum_probs=51.4
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
...++|+|||.++.++||+|++||+|.|+.+. ++|||.|+.... ++.|+||+|||+....
T Consensus 6 ~~~~~al~~y~~~~~~eLs~~~Gd~i~v~~~~-----~~gW~~g~~~~~--g~~G~fP~~yv~~~~~ 65 (71)
T 2fpf_A 6 EQTHRAIFRFVPRHEDELELEVDDPLLVELQA-----EDYWYEAYNMRT--GARGVFPAYYAIEVTK 65 (71)
T ss_dssp CCCEEECSCBCCSSTTBCCBCTTCEEEEEEEC-----TTSEEEEEETTT--TEEEEEEGGGEEECC-
T ss_pred CeEEEECeeECccCCCcccCcCCcEEEEeEec-----CCCEEEEEECCC--CCEEEeehHHEEECCC
Confidence 35799999999999999999999999999874 789999995222 7899999999987543
|
| >4esr_A Jouberin; AHI-1, AHI1, AHI-1 SH3 domain, SH3 domain, dynamin-2, protei binding, chronic myeloid leukemia; 1.53A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=7e-13 Score=100.92 Aligned_cols=58 Identities=47% Similarity=0.722 Sum_probs=51.8
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|+|||.++.++||+|++||+|.|+++. ++|||.|+... ++.|+||+|||+....
T Consensus 7 ~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~---g~~G~~P~~yv~~~~~ 64 (69)
T 4esr_A 7 PTVVALYDYTANRSDELTIHRGDIIRVFFKD-----NEDWWYGSIGK---GQEGYFPANHVASETL 64 (69)
T ss_dssp CEEEESSCBCCCSTTBCCBCTTCEEEEEEEC-----SSSEEEEEEET---TEEEEEEGGGEEEHHH
T ss_pred CEEEECccCCCCCcCcCCCCCCCEEEEEEec-----CCCeEEEEeCC---CCEEEEchHHeEECcc
Confidence 5899999999999999999999999999984 78999999732 7899999999987544
|
| >2yuo_A CIP85, RUN and TBC1 domain containing 3; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-12 Score=102.37 Aligned_cols=59 Identities=32% Similarity=0.620 Sum_probs=53.0
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|||||+++.++||+|++||+|.|+++. +++||.++.+ ++.|+||.|||+....
T Consensus 6 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 64 (78)
T 2yuo_A 6 SGRRAKALLDFERHDDDELGFRKNDIITIISQK-----DEHCWVGELN----GLRGWFPAKFVEVLDE 64 (78)
T ss_dssp CCEEEEESSCBCCSSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEEECC
T ss_pred CceEEEECccCCCCCCCCccCCCCCEEEEEEec-----CCCEEEEEEC----CCEEEEehHHEEECCC
Confidence 446899999999999999999999999999974 7899999976 7899999999997654
|
| >2dm1_A Protein VAV-2; RHO family guanine nucleotide exchange factor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.2e-12 Score=100.80 Aligned_cols=61 Identities=36% Similarity=0.720 Sum_probs=53.0
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
..+..++|||||+++.++||+|++||+|.|+++. .++++||.++.+ ++.|+||.|||+...
T Consensus 5 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~---~~~~~Ww~g~~~----g~~G~~P~~yv~~~~ 65 (73)
T 2dm1_A 5 SSGGTAVARYNFAARDMRELSLREGDVVRIYSRI---GGDQGWWKGETN----GRIGWFPSTYVEEEG 65 (73)
T ss_dssp CSSSEEEESSCBCCCSTTBCCBCTTCEEECCBSS---SSSSSCEEEEET----TEEEEECSSSEEECC
T ss_pred CCCCEEEECccCCcCCCCcCCCCCCCEEEEEEec---CCCCCeEEEEEC----CeEEEeehHHEEEcC
Confidence 4557899999999999999999999999999874 125699999986 789999999998754
|
| >2da9_A SH3-domain kinase binding protein 1; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.34 E-value=9.8e-13 Score=100.38 Aligned_cols=60 Identities=40% Similarity=0.872 Sum_probs=52.3
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
....++|+|||+++.++||+|++||+|.|+.++. .+++||.|+.+ ++.|+||.|||+...
T Consensus 6 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~~---~~~~W~~g~~~----g~~G~~P~~yv~~~~ 65 (70)
T 2da9_A 6 SGDYCKVIFPYEAQNDDELTIKEGDIVTLINKDC---IDVGWWEGELN----GRRGVFPDNFVKLLS 65 (70)
T ss_dssp SSEEEEECSCCCCSSTTBCCCCTTEEEEEEECCC---SSTTEEEEECS----SCEEEEEGGGEEECC
T ss_pred CCcEEEECcCCCCCCcCEeeEcCCCEEEEEECCC---CCCCeEEEEEC----CcEEEechHHeEECC
Confidence 4468999999999999999999999999998731 26899999975 789999999998754
|
| >1spk_A RSGI RUH-010, riken cDNA 1300006M19; structural genomics, SH3 domain, five-stranded barrel, mouse cDNA; NMR {Mus musculus} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.34 E-value=1e-12 Score=100.83 Aligned_cols=62 Identities=19% Similarity=0.402 Sum_probs=53.1
Q ss_pred CCCEEEEcccCCC-CCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDA-IGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~-~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|||||++ +.++||+|++||+|.|+.++ .+++||.|++... ++.|+||+|||+.+..
T Consensus 6 ~~~~~~al~dy~a~~~~~eLs~~~Gd~i~v~~~~----~~~gWw~g~~~~~--g~~G~fP~~yv~~~~~ 68 (72)
T 1spk_A 6 SGQKVKTIFPHTAGNNKTLLSFAQGDVLTLLIPE----EKDGWLYGEHDTT--KARGWFPSSYTKLLSG 68 (72)
T ss_dssp CSCEEECSSCBCCSSCSSBCCBCTTCEEEECCSS----CBTTEEEEEETTT--CCEEEEEGGGCEECSS
T ss_pred CceEEEEeeeeCCCCCCCCCcCCCCCEEEEeEcc----CCCCcEEEEECCC--CCEEEEehHHeEECCC
Confidence 3468999999996 99999999999999999862 3789999998743 6899999999987643
|
| >2k2m_A EPS8-like protein 1; alternative splicing, coiled coil, cytoplasm, SH3 domain, signaling protein; NMR {Homo sapiens} PDB: 2rol_A | Back alignment and structure |
|---|
Probab=99.34 E-value=1.2e-12 Score=99.31 Aligned_cols=58 Identities=26% Similarity=0.456 Sum_probs=51.0
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
...+++|||||+++.++||+|++||+|.|+++ +++||.++... ++.|+||+|||+...
T Consensus 7 ~~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~------~~~Ww~~~~~~---g~~G~~P~~yv~~~~ 64 (68)
T 2k2m_A 7 ALKWVLCNYDFQARNSSELSVKQRDVLEVLDD------SRKWWKVRDPA---GQEGYVPYNILTPYP 64 (68)
T ss_dssp CCCEEEESSCBCCCSSSBCCBCTTCEEEEEEC------SSSEEEEECTT---SCCEEEEGGGEEECC
T ss_pred CCEEEEECccCCCCCCCcccCCCCCEEEEEEc------CCCeEEEEeCC---CCEEEEEhhhEEEcC
Confidence 34689999999999999999999999999997 37999998643 789999999998754
|
| >2oaw_A Spectrin alpha chain, brain; SH3 domain, chimera, structural protein; 1.90A {Gallus gallus} PDB: 2rot_A 2rmo_A 2kr3_A | Back alignment and structure |
|---|
Probab=99.34 E-value=9.9e-13 Score=98.80 Aligned_cols=59 Identities=32% Similarity=0.731 Sum_probs=50.4
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEec----CcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIE----GKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~----~k~~~~~G~~P~~yv~~~ 96 (527)
..++|+|||+++.++||+|++||+|.|+.+. +++||.|+.. +...++.|+||+|||+.+
T Consensus 2 ~~~~alydy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~~~~g~~~g~~G~~P~~yv~~l 64 (65)
T 2oaw_A 2 ELVLALYDYQEKSPREVTMKKGDILTLLNST-----NKDWWKVEVKITVNGKTYERQGFVPAAYVKKL 64 (65)
T ss_dssp EEEEECSCBCCSSTTBCCBCTTCEEEEEECC-----SSSEEEEEEEEEETTEEEEEEEEEEGGGEEEC
T ss_pred cEEEEcccCCccCCCCCCCCCCCEEEEEEcC-----CCCEEEEEEccccCCCcCCcEEEEchHHeEEc
Confidence 3689999999999999999999999999984 7899999865 211157999999999864
|
| >2rf0_A Mitogen-activated protein kinase kinase kinase 10; MAP3K10, MLK2, SH3 domain, TKL kinase, MKN28, structural GEN structural genomics consortium, SGC; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1e-12 Score=104.88 Aligned_cols=62 Identities=53% Similarity=1.092 Sum_probs=51.4
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
....++|||||+++.++||+|++||+|.|++++.....++|||.|+... ++.|+||+|||++
T Consensus 28 ~~~~~~Alydy~a~~~~ELsf~~GD~I~Vl~~~~~~~~~~gWw~g~~~~---g~~G~fP~nyV~p 89 (89)
T 2rf0_A 28 AGPVWTAVFDYEAAGDEELTLRRGDRVQVLSQDCAVSGDEGWWTGQLPS---GRVGVFPSNYVAP 89 (89)
T ss_dssp CCCEEEECSCBCCSSTTBCCBCTTCEEEEEECCHHHHSSTTEEEEECTT---CCEEEEEGGGEEC
T ss_pred CCcEEEECCccCCCCCCccccCCCCEEEEEeccCCcccCCCEEEEEECC---CCEEEEcHHHCcC
Confidence 4579999999999999999999999999999731001268999999832 7899999999974
|
| >2jt4_A Cytoskeleton assembly control protein SLA1; endocytosis, SH3, actin-binding, cytoplasm, cytoskeleton, phosphorylation, SH3 domain, DNA damage, DNA repair, nucleus; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.2e-12 Score=100.23 Aligned_cols=61 Identities=30% Similarity=0.569 Sum_probs=52.8
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
...++|+|||.++.++||+|++||+|.|+.+. .++|||.|+.... ++.|+||.|||+....
T Consensus 6 ~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~----~~~~Ww~g~~~~~--g~~G~~P~~yv~~~~~ 66 (71)
T 2jt4_A 6 KKRGIVQYDFMAESQDELTIKSGDKVYILDDK----KSKDWWMCQLVDS--GKSGLVPAQFIEPVRD 66 (71)
T ss_dssp CEEEEECSCBCCSSTTBCCBCTTCEEEEEESS----SCSSEEEEEETTT--CCEEEEEGGGEEETTT
T ss_pred CCEEEEcccCCCCCCCcccCCCCCEEEEEECC----CCCCCEEEEECCC--CCeEEechHHeEECCC
Confidence 46899999999999999999999999999973 3789999998211 7899999999987654
|
| >2dl5_A KIAA0769 protein; SH3 domain, FCHSD2, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-12 Score=101.55 Aligned_cols=60 Identities=22% Similarity=0.427 Sum_probs=52.5
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
+..++|||||+++.++||+|++||+|.|+++. ++++||.+++.. ++.|+||.|||+....
T Consensus 13 ~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~~----~~~~Ww~g~~~~---g~~G~~P~~yv~~~~~ 72 (78)
T 2dl5_A 13 PLTCKVVYSYKASQPDELTIEEHEVLEVIEDG----DMEDWVKARNKV---GQVGYVPEKYLQFPTS 72 (78)
T ss_dssp SEEEEECSCBCCCSTTBCCBCSSEEEEEEECC----SSSSEEEEECTT---CCEEEEETTTSCCSCC
T ss_pred CcEEEEceeECCCCCCCCCCCCCCEEEEEecc----CCCCcEEEEeCC---CCEEEEEhHHEEECCC
Confidence 36799999999999999999999999999984 248999999763 6899999999987643
|
| >2dnu_A RUH-061, SH3 multiple domains 1; RSGI, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.2e-12 Score=100.29 Aligned_cols=60 Identities=27% Similarity=0.496 Sum_probs=53.4
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.....++|+|||+++.++||+|++||+|.|++++ +++||.+++. ++.|+||.|||+....
T Consensus 6 ~~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 65 (71)
T 2dnu_A 6 SGEEKYVTVQPYTSQSKDEIGFEKGVTVEVIRKN-----LEGWWYIRYL----GKEGWAPASYLKKAKD 65 (71)
T ss_dssp CCSEEEECSSCBCCSSTTBCCBCTTCEEEECCCC-----SSSEEEEEET----TEEEEEEGGGCEECCC
T ss_pred CCCCEEEECCccCCCCCCCCcCCCCCEEEEeECC-----CCCeEEEEEC----CcEEEEEHHHeEEccC
Confidence 3446899999999999999999999999999884 6899999988 6899999999987654
|
| >1u5s_A Cytoplasmic protein NCK2; protein-protein complex, beta barrel, beta sheet, zinc finger, metal binding protein; NMR {Homo sapiens} SCOP: b.34.2.1 PDB: 2fry_A | Back alignment and structure |
|---|
Probab=99.34 E-value=1.3e-12 Score=100.06 Aligned_cols=60 Identities=30% Similarity=0.678 Sum_probs=51.6
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|+|||++..++||+|++||+|.|++++ ..++|||.|+... ++.|+||+|||+....
T Consensus 7 ~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~---~~~~~Ww~g~~~~---g~~G~~P~~yv~~~~~ 66 (71)
T 1u5s_A 7 HVVQTLYPFSSVTEEELNFEKGETMEVIEKP---ENDPEWWKCKNAR---GQVGLVPKNYVVVLSD 66 (71)
T ss_dssp SEEEESSCCCCCSSSBCCCCSSCCEEEEECC---CTTTCEEEEEETT---TEEEEEETTSEEECCC
T ss_pred EEEEEcccCCCCCCCcccCCCCCEEEEEECC---CCCCCCEEEEeCC---CCEEEEeHHHEEECCC
Confidence 5799999999999999999999999999982 1278999998433 7899999999987644
|
| >1gbq_A GRB2; complex (signal transduction/peptide), SH3 domain; NMR {Mus musculus} SCOP: b.34.2.1 PDB: 1gbr_A 2gbq_A 3gbq_A 4gbq_A | Back alignment and structure |
|---|
Probab=99.34 E-value=9e-13 Score=101.72 Aligned_cols=59 Identities=34% Similarity=0.582 Sum_probs=50.7
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
..+..++|||||+++.++||+|++||+|.|+++. .+.+||.++.+ ++.|+||+|||+..
T Consensus 7 ~~~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~~----~~~~Ww~g~~~----g~~G~~P~~yv~~~ 65 (74)
T 1gbq_A 7 VGSMEAIAKYDFKATADDELSFKRGDILKVLNEE----CDQNWYKAELN----GKDGFIPKNYIEMK 65 (74)
T ss_dssp ---CEEEESSCBCCSSTTBCCBCTTCEEECCBCS----SCSSEEEEEET----TEEEEEEGGGEEEE
T ss_pred CCCeEEEECccCCCCCCCeeeEcCCCEEEEeEec----CCCCEEEEEEC----CCEEEEehHhEEEc
Confidence 3457899999999999999999999999999874 35789999986 78999999999864
|
| >3thk_A Spectrin alpha chain, brain; SH3 domain, chimera, structural protein; 1.70A {Rattus norvegicus} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.3e-12 Score=100.53 Aligned_cols=59 Identities=29% Similarity=0.694 Sum_probs=52.5
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|+|||.++.++||+|++||+|.|+++. +++||.++.+ ++.|+||.|||+.+..
T Consensus 4 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 62 (73)
T 3thk_A 4 GKELVLALYDYQEKSPREVTMKKGDILTLLNST-----NKDWWKVEVN----DRQGFVPAAYVKKLDP 62 (73)
T ss_dssp -CCEEEECSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEECCC
T ss_pred CCEEEEECcCCCcCCCCccCCCCCCEEEEEECC-----CCCeEEEEEC----CcEEEEehHHeEECCC
Confidence 346899999999999999999999999999985 7899999976 6899999999987654
|
| >4ag1_C Fynomer; hydrolase-de novo protein complex, inhibitor, serine proteas; 1.40A {Synthetic construct} PDB: 4afz_C 4ag2_C* 4afq_C* 4afs_C 4afu_C 1azg_B 1nyf_A 1nyg_A 1a0n_B 3ua7_A 3ua6_A 1fyn_A 1m27_C* 1shf_A 1zbj_A 1efn_A 1avz_C 1nlo_C* 1nlp_C* 1qwe_A ... | Back alignment and structure |
|---|
Probab=99.33 E-value=1.2e-12 Score=103.60 Aligned_cols=63 Identities=29% Similarity=0.629 Sum_probs=54.3
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDIN 100 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~ 100 (527)
....++|+|||.++.++||+|++||+|.|+++. +++||.|+.... ++.|+||+|||+.+....
T Consensus 5 ~~~~~~Alydy~a~~~~eLsf~~Gd~i~vl~~~-----~~~Ww~g~~~~~--g~~G~~P~~yv~~~~~~~ 67 (84)
T 4ag1_C 5 GVTLFVALYDYNATRWTDLSFHKGEKFQILEFG-----PGDWWEARSLTT--GETGYIPSNYVAPVDSIQ 67 (84)
T ss_dssp -CCEEEESSCBCCSBTTBCCBCTTCEEEEEECC-----SSSEEEEEETTT--CCEEEEEGGGEEETTTCC
T ss_pred CCEEEEEcccCCCCCCCcccccCCCEEEEEEec-----CCCeEEEEECCC--CCEEEEehHHeEECCCcc
Confidence 346899999999999999999999999999984 789999998321 789999999999876654
|
| >1x43_A Endophilin B1, SH3 domain GRB2-like protein B1; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.7e-12 Score=102.01 Aligned_cols=61 Identities=30% Similarity=0.480 Sum_probs=53.0
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|||||+++.++||+|++||+|.|++++. .+++||.++.+ ++.|+||.|||+.+..
T Consensus 16 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~~---~~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 76 (81)
T 1x43_A 16 NNRKARVLYDYDAANSTELSLLADEVITVFSVVG---MDSDWLMGERG----NQKGKVPITYLELLNS 76 (81)
T ss_dssp CCEEEEESSCCCCSSTTBCCCCTTCEEEEECCTT---CCTTEEEEEET----TEEEEEEGGGEEECCC
T ss_pred CCeEEEEcccCCCCCCCcCCCCCCCEEEEEEcCC---CCCCcEEEEEC----CCEEEEehHHEEECCC
Confidence 4478999999999999999999999999999841 15799999976 7899999999987653
|
| >2kbt_A Chimera of proto-oncogene VAV, linker, immunoglobulin G-binding protein G; sortase, protein ligation, intein, inset, solubility enhancement; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.3e-12 Score=113.95 Aligned_cols=88 Identities=34% Similarity=0.582 Sum_probs=53.3
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccccceeeeecCceee
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDINLVSSVINDVKLV 112 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~~~~~~~~~~~~~ 112 (527)
..++|||||+++.++||+|++||+|.|+++. +++|||.|++. ++.|+||+|||+....-.
T Consensus 6 ~~~~Alydy~a~~~~ELsf~~Gd~i~Vl~~~----~~~gWw~g~~~----g~~G~fP~~yv~~~~~~~------------ 65 (142)
T 2kbt_A 6 GTAKARYDFCARDRSELSLKEGDIIKILNKK----GQQGWWRGEIY----GRIGWFPSNYVEEDYSEY------------ 65 (142)
T ss_dssp CEEEESSCCCCSSSSBCCCCTTCEEEEEECC----CSSSEEEEEET----TEEEEEETTSEEESSCCC------------
T ss_pred eEEEECCccCCCCCCcCCCCCCCEEEEEEec----CCCCeEEEEEC----CeeEEechHHEEEccccc------------
Confidence 5899999999999999999999999999873 37899999986 789999999998754311
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEc
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVA 148 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~ 148 (527)
.-...|.++++.++.+.+++..++-+..
T Consensus 66 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (142)
T 2kbt_A 66 --------LPETGGGSGSSMTYKLILNGKTLKGETT 93 (142)
T ss_dssp --------CCCC------------------------
T ss_pred --------CccccCCCcccccccccccccccCcccc
Confidence 1224677889999998887776665543
|
| >2d8j_A FYN-related kinase; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.5e-12 Score=101.47 Aligned_cols=64 Identities=31% Similarity=0.583 Sum_probs=53.6
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCccccee------cccccCcccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKV------GIFPANFVSSIEDI 99 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~------G~~P~~yv~~~~~~ 99 (527)
..+..++|||||+++.++||+|++||+|.|++++ +++||.++.... .++. |+||+|||+....+
T Consensus 5 ~~~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~~-~g~~~~~~~~G~~P~~yv~~~~~~ 74 (77)
T 2d8j_A 5 SSGQYFVALFDYQARTAEDLSFRAGDKLQVLDTS-----HEGWWLARHLEK-KGTGLGQQLQGYIPSNYVAEDSGP 74 (77)
T ss_dssp SCCEEEEESSCBCCSSSSBCCBCTTCCEEEEECC-----SSSEEEEEECSS-CCSSCCCCSEEEEETTTEEECCCC
T ss_pred CCCCEEEEccCCCCCCCCccCCCCCCEEEEEECC-----CCCeEEEEECCC-CCcCcccCCceEECHHHeeEcCCc
Confidence 4557999999999999999999999999999985 789999997621 0245 99999999976654
|
| >1x69_A Cortactin isoform A; SH3 domain, CTTN, oncogene EMS1, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-12 Score=101.95 Aligned_cols=59 Identities=39% Similarity=0.648 Sum_probs=53.0
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+..++|||||+++.++||+|++||+|.|+++. +++||.++.+ ++.|+||.|||+....
T Consensus 16 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 74 (79)
T 1x69_A 16 LGITAVALYDYQAAGDDEISFDPDDIITNIEMI-----DDGWWRGVCK----GRYGLFPANYVELRQS 74 (79)
T ss_dssp CCCCEEESSCCCCSSSSBCCCCTTCEEEEEEEC-----SSSEEEEEET----TEEEEEETTSEEECCC
T ss_pred CCeEEEECccCCCCCCCCcCcCCCCEEEEeEec-----CCCeEEEEEC----CcEEEechHHEEECCC
Confidence 446899999999999999999999999999884 7899999976 7899999999987654
|
| >3u23_A CD2-associated protein; structural genomics, structural genomics consortium, SGC, BE barrel, adaptor protein, protein binding; 1.11A {Homo sapiens} PDB: 2krn_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1e-12 Score=98.71 Aligned_cols=57 Identities=37% Similarity=0.849 Sum_probs=51.2
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
...++|+|||.++.++||+|++||+|.|+++. +++||.|+.+ ++.|+||+|||+.+.
T Consensus 7 ~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yv~~~~ 63 (65)
T 3u23_A 7 KRQCKVLFEYIPQNEDELELKVGDIIDINEEV-----EEGWWSGTLN----NKLGLFPSNFVKELE 63 (65)
T ss_dssp -CEEEECSCBCCSSTTBCCBCTTCEEEEEEEE-----ETTEEEEEET----TEEEEEEGGGEEECC
T ss_pred CeEEEEeeeeCCCCcCCcCCCCCCEEEEEEec-----CCCEEEEEEC----CCEEEeehHHEEECc
Confidence 46899999999999999999999999999884 7899999976 789999999998754
|
| >1i07_A Epidermal growth factor receptor kinase substrate EPS8; hormone/growth factor; 1.80A {Mus musculus} SCOP: b.34.2.1 PDB: 1aoj_A 1i0c_A | Back alignment and structure |
|---|
Probab=99.32 E-value=1.2e-12 Score=96.62 Aligned_cols=56 Identities=25% Similarity=0.519 Sum_probs=49.8
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.+++|+|||.++.++||+|++||+|.|+++ +++||.++... ++.|+||+|||+...
T Consensus 2 ~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~------~~~Ww~~~~~~---g~~G~~P~~yv~~~~ 57 (60)
T 1i07_A 2 KYAKSKYDFVARNSSELSVMKDDVLEILDD------RRQWWKVRNAS---GDSGFVPNNILDIMR 57 (60)
T ss_dssp CEEEESSCBCCSSTTBCCBCTTCEEEECGG------GCCEEEEECTT---SCEEEEEGGGEEEEC
T ss_pred eEEEECccCCCCCCCcccCCCCCEEEEEEc------CCCeEEEEECC---CCEEEEEHHHeEEcc
Confidence 478999999999999999999999999987 57999998543 789999999998754
|
| >2ed0_A ABL interactor 2; coiled coil, cytoskeleton, nuclear protein, phosphorylation, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.5e-12 Score=101.58 Aligned_cols=56 Identities=41% Similarity=0.755 Sum_probs=51.1
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
..++|+|||+++.++||+|++||+|.|+++. ++|||.++.+ ++.|+||.|||+.+.
T Consensus 18 ~~~~al~dy~~~~~~eLsf~~Gd~i~v~~~~-----~~gWw~g~~~----g~~G~~P~~yv~~~~ 73 (78)
T 2ed0_A 18 EKVVAIYDYTKDKEDELSFQEGAIIYVIKKN-----DDGWYEGVMN----GVTGLFPGNYVESIS 73 (78)
T ss_dssp EEEEECSCBCCSSTTBCCBCSSCEEEEEEEC-----SSSEEEEEET----TEEEEEETTSEEECS
T ss_pred EEEEECccCCccCcCcccccCCCEEEEEEeC-----CCCEEEEEEC----CcEEEeChHHEEEcC
Confidence 4799999999999999999999999999984 7899999976 789999999998754
|
| >2ke9_A Caskin-2; SH3 domain, ANK repeat, cytoplasm, phosphoprotein, protein binding; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.3e-12 Score=102.92 Aligned_cols=62 Identities=29% Similarity=0.536 Sum_probs=51.7
Q ss_pred CCCEEEEcccC-CCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecC--cccceecccccCcccccc
Q psy6905 31 RPDLWRALYDY-DAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEG--KIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~-~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~--k~~~~~G~~P~~yv~~~~ 97 (527)
....++|+||| .++.++||+|++||+|.|+++. +++||.|++.. ...++.|+||+|||+.+.
T Consensus 17 ~~~~~~Alydy~~a~~~~eLsf~~GDiI~V~~~~-----~~gWw~G~~~~~~~~tg~~G~fPsnyV~~~~ 81 (83)
T 2ke9_A 17 GSLKVRALKDFWNLHDPTALNVRAGDVITVLEQH-----PDGRWKGHIHESQRGTDRIGYFPPGIVEVVS 81 (83)
T ss_dssp CCEEEEESSCBCCCSCTTBCCBCTTCEEEESCSS-----CSSCEEEEECCSSTTSCCCEEECGGGEESSC
T ss_pred CCeEEEEccccCCCCCCCcccccCCCEEEEEEec-----CCCeEEEEECCCCCCCCCEEEechHHEEECC
Confidence 33679999999 8999999999999999999885 67899999752 001589999999998753
|
| >4f14_A Nebulette; SH3 domain, heart muscle, actin-binding protein-peptide COMP; 1.20A {Homo sapiens} PDB: 1ark_A 1neb_A 3i35_A | Back alignment and structure |
|---|
Probab=99.32 E-value=1.3e-12 Score=97.80 Aligned_cols=58 Identities=34% Similarity=0.674 Sum_probs=50.1
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
+..++|+|||.++.++||+|++||+|.|+.+. +++||.|+.... ++.|+||+|||+.+
T Consensus 6 ~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~~~--g~~G~~P~~yv~~~ 63 (64)
T 4f14_A 6 LRTYRAMYDYSAQDEDEVSFRDGDYIVNVQPI-----DDGWMYGTVQRT--GRTGMLPANYIEFV 63 (64)
T ss_dssp --CEEESSCBCCCSTTBCCBCTTCEEEEEEEC-----SSSEEEEEETTT--TEEEEEEGGGEEEC
T ss_pred CEEEEECeeeCCcCCCcCCCCCCCEEEEEEeC-----CCCeEEEEECCC--CCEEEEeHHHeEEC
Confidence 45799999999999999999999999999984 789999998422 78999999999864
|
| >1uff_A Intersectin 2; beta barrel, SH3 domain, endocytosis, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.32 E-value=1.8e-12 Score=104.70 Aligned_cols=62 Identities=35% Similarity=0.691 Sum_probs=53.7
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDIN 100 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~ 100 (527)
...++|||||+++..+||+|++||+|.|+++. .+++|||.|+++ ++.|+||.|||+.+...+
T Consensus 5 ~~~~~Alydy~a~~~~eLsf~~Gd~i~v~~~~---~~~~gWw~g~~~----g~~G~~P~~yv~~~~~~~ 66 (93)
T 1uff_A 5 SSGYRALYPFEARNHDEMSFNSGDIIQVDEKT---VGEPGWLYGSFQ----GNFGWFPCNYVEKMPSSE 66 (93)
T ss_dssp CCCEEESSCBCCCSSSCCCBCTTCEEEECSSC---CCSSSEEEEEET----TEEEEEETTTEEECCSSS
T ss_pred CEEEEECccCCCCCCCCcCCCCCCEEEEeEcc---CCCCCEEEEEEC----CCEEEechHHeEEcCCcc
Confidence 35799999999999999999999999999873 136799999977 789999999999876543
|
| >1aww_A ATK, AMGX1, BPK, bruton'S tyrosine kinase; X-linked agammaglobulinemia, XLA, BTK, SH3 domain, transferase; NMR {Homo sapiens} SCOP: b.34.2.1 PDB: 1awx_A 1qly_A | Back alignment and structure |
|---|
Probab=99.32 E-value=1.2e-12 Score=98.99 Aligned_cols=59 Identities=31% Similarity=0.624 Sum_probs=51.6
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
....++|+|||.++.++||+|++||+|.|+.+. +++||.++... ++.|+||+|||+..+
T Consensus 7 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~---g~~G~~P~~yv~~~~ 65 (67)
T 1aww_A 7 ELKKVVALYDYMPMNANDLQLRKGDEYFILEES-----NLPWWRARDKN---GQEGYIPSNYVTEAE 65 (67)
T ss_dssp CCCEEEBSSCCCCSSSSSCCCCSSCEEECCCCC-----SSSEECCBCTT---SCBCCEETTTBCCSC
T ss_pred CCeEEEECccCCCCCCCCccCCCCCEEEEEEcc-----CCCcEEEEECC---CCEEEEchHhEEEcC
Confidence 346899999999999999999999999999884 78999998432 789999999998754
|
| >4glm_A Dynamin-binding protein; SH3 domain, DNMBP, structural genomics, structural genomics consortium, SGC, SRC homology 3 domains, cell junctions; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.7e-12 Score=99.64 Aligned_cols=58 Identities=31% Similarity=0.576 Sum_probs=51.8
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
....++|+|||.++.++||+|++||+|.|+++. +++||.|+.+ ++.|+||.|||+.+.
T Consensus 12 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yv~~~~ 69 (72)
T 4glm_A 12 ALTYGVALYRFQALEPNELDFEVGDKIRILATL-----EDGWLEGSLK----GRTGIFPYRFVKLCP 69 (72)
T ss_dssp -CCEEEESSCBCCCSTTBCCBCTTCEEEEEEEC-----STTEEEEEET----TEEEEEEGGGEEEEC
T ss_pred CCeEEEECccCCCCCCCcCCCCCCCEEEEEEcc-----CCCEEEEEEC----CcEEEEChHHeEECC
Confidence 346899999999999999999999999999984 7899999976 789999999998754
|
| >2dbk_A CRK-like protein; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.6e-12 Score=103.95 Aligned_cols=58 Identities=28% Similarity=0.463 Sum_probs=51.4
Q ss_pred CCEEEEcccCCC--CCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDA--IGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~--~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..+++|||||++ +.++||+|++||+|.|+++. +++||.|+++ ++.|+||+|||+.+..
T Consensus 16 ~~~~~alydy~~~a~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~fP~~yv~~~~~ 75 (88)
T 2dbk_A 16 PVFAKAIQKRVPCAYDKTALALEVGDIVKVTRMN-----INGQWEGEVN----GRKGLFPFTHVKIFDP 75 (88)
T ss_dssp CEEEEECSCBCCCTTCSSBCCBCTTCEEEEEEEC-----TTSCEEEECS----SCEEEECTTTEEECCS
T ss_pred CEEEEEcccccCCCCCCCcccCCCCCEEEEEEec-----CCCEEEEEeC----CCEEEEehHHeEECCC
Confidence 368999999995 49999999999999999984 7899999887 7899999999997654
|
| >2cuc_A SH3 domain containing ring finger 2; structural genomics, ring finger 2 containing protein, NPPSFA; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.2e-12 Score=99.89 Aligned_cols=62 Identities=31% Similarity=0.544 Sum_probs=53.0
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....+++|+|||+++.++||+|++||+|.|+++. +++||.++.... ++.|+||+|||+....
T Consensus 5 ~~~~~~~al~~y~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~~--g~~G~~P~~yv~~~~~ 66 (70)
T 2cuc_A 5 SSGNMFVALHTYSAHRPEELDLQKGEGIRVLGKY-----QDGWLKGLSLLT--GRTGIFPSDYVIPVSG 66 (70)
T ss_dssp SSSCCEECCSCBCCCSTTBCCBCTTCEEEEEEEE-----ETTEEEEEETTT--CCEEEEEGGGCEECCC
T ss_pred CCCcEEEECeeECcCCCCcCCCCCCCEEEEEEec-----CCCeEEEEECCC--CCEEEEchHHeEECcC
Confidence 3456899999999999999999999999999984 679999994322 7899999999987543
|
| >1ue9_A Intersectin 2; beta barrel, SH3 domain, riken structural genomics/proteomics initiative, RSGI, structural genomics, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.32 E-value=2.1e-12 Score=101.29 Aligned_cols=63 Identities=29% Similarity=0.616 Sum_probs=53.5
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCc-ccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGK-IEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k-~~~~~G~~P~~yv~~~~~ 98 (527)
.+.+++|+|||+++.++||+|++||+|.|++++ +++||.|++... ..++.|+||.|||+.+..
T Consensus 6 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~gWw~g~~~~~g~~~~~G~fP~~yv~~~~~ 69 (80)
T 1ue9_A 6 SGEIAQVTSAYVASGSEQLSLAPGQLILILKKN-----TSGWWQGELQARGKKRQKGWFPASHVKLLGP 69 (80)
T ss_dssp CCEEEEECSCCCCCSTTBCCCCTTCEEEEEEEC-----SSSEEEEEECSCCSSCCEEEEETTSEEECCS
T ss_pred CCeEEEECcccCCCCCCCCCCCCCCEEEEEEec-----CCCcEEEEECCCCCCCcEEEEchHHeEECCC
Confidence 456899999999999999999999999999985 689999997632 013799999999997654
|
| >2ct4_A CDC42-interacting protein 4; thyroid receptor interacting protein 10, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.8e-12 Score=97.79 Aligned_cols=59 Identities=15% Similarity=0.355 Sum_probs=51.6
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|||||+++.++||+|++||+|.|++++ +++|||.++... ++.|+||.|||+....
T Consensus 8 ~~~~alydy~~~~~~eLs~~~Gd~i~vl~~~----~~~gW~~~~~~~---g~~G~~P~~yv~~~~~ 66 (70)
T 2ct4_A 8 GHCVAIYHFEGSSEGTISMAEGEDLSLMEED----KGDGWTRVRRKE---GGEGYVPTSYLRVTSG 66 (70)
T ss_dssp CEEEESSCBCCCSTTCCCBCTTCEEEEEECC----SSSCEEEEECSS---SCEEEEEGGGEEECCC
T ss_pred CEEEEcccCCCCCCCcCCCCCCCEEEEEecc----CCCCeEEEEeCC---CCEEEEEhHHeEEcCC
Confidence 5799999999999999999999999999874 346799999763 7899999999987543
|
| >2csq_A RIM-BP2, RIM binding protein 2; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.4e-12 Score=106.34 Aligned_cols=61 Identities=30% Similarity=0.657 Sum_probs=52.5
Q ss_pred CCCCEEEEcccCCCC--------CCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAI--------GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~--------~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....+++|||||+++ ..+||+|++||+|.|+++. +++|||.|+++ ++.|+||+|||+.+..
T Consensus 15 ~~~~~~~Alydy~~~~~~~~~~~~~~eLsf~~Gd~i~vl~~~----~~~gWw~g~~~----g~~G~~P~~yv~~~~~ 83 (97)
T 2csq_A 15 LPARIFVALFDYDPLTMSPNPDAAEEELPFKEGQIIKVYGDK----DADGFYRGETC----ARLGLIPCNMVSEIQA 83 (97)
T ss_dssp CCCEEEECSSCBCTTTTSSCHHHHTTBCCBCTTCEEEEEEEE----CTTCEEEEEET----TEEEEEETTTSEECCC
T ss_pred CCceEEEEccccCCCcccccCCCCCCccCCCCCCEEEEEEec----CCCCeEEEEEC----CcEEEEehHHeEECCC
Confidence 344689999999999 7999999999999999753 36789999986 7899999999997654
|
| >2kgt_A Tyrosine-protein kinase 6; SH3 domain, SRC kinase, PTK6, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.2e-12 Score=100.46 Aligned_cols=57 Identities=26% Similarity=0.575 Sum_probs=50.3
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEe---cCccccee---cccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI---EGKIEYKV---GIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~---~~k~~~~~---G~~P~~yv~~~~ 97 (527)
....++|||||+++.++||+|++||+|.| ++. ++|||.|+. + ++. |+||+|||+...
T Consensus 9 ~~~~~~alydy~~~~~~eLs~~~Gd~i~v-~~~-----~~~Ww~g~~~~~~----g~~~~~G~~P~~yv~~~~ 71 (72)
T 2kgt_A 9 LGPKYVGLWDFKSRTDEELSFRAGDVFHV-ARK-----EEQWWWATLLDEA----GGAVAQGYVPHNYLAERE 71 (72)
T ss_dssp CCCEEECCTTCBCSSTTSCBCCTTCCEEE-EEE-----CSSCEEEEEECTT----SCEEEEEEECTTTSEEEC
T ss_pred CCcEEEEcccCCCCCcCCcCCCCCCEEEE-eeC-----CCCEEEEEEcCCC----CCEeCCcEEcHhHEEEcc
Confidence 34689999999999999999999999999 874 789999998 5 577 999999998643
|
| >2yup_A Vinexin; sorbin and SH3 domain-containing protein 3, SH3-containing adapter molecule 1, SCAM-1, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.5e-12 Score=104.64 Aligned_cols=60 Identities=30% Similarity=0.523 Sum_probs=53.0
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
...++|||||+++.++||+|++||+|.|+++. +++||.|++... ++.|+||.|||+....
T Consensus 17 ~~~~~alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~~~--g~~G~fP~~yv~~~~~ 76 (90)
T 2yup_A 17 YGEAVAQYTFKGDLEVELSFRKGEHICLIRKV-----NENWYEGRITGT--GRQGIFPASYVQVSRE 76 (90)
T ss_dssp SEEEEECSCCCCCSSSBCCCCTTCEEEESSCC-----CSSEEEEECTTT--CCEEEEEGGGEEEEEC
T ss_pred ceEEEEeecCCcCCcCcCCCCCCCEEEEEEEc-----CCCeEEEEECCC--CCEEEEehHHeEEcCC
Confidence 35799999999999999999999999999874 789999998643 6899999999997654
|
| >2ega_A SH3 and PX domain-containing protein 2A; SH3 domain, KIAA0418 protein, SH3MD1, SH3 multiple domains 1, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.6e-12 Score=99.16 Aligned_cols=57 Identities=26% Similarity=0.609 Sum_probs=51.6
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|+|||+++.++||+|++||+|.|+.++ +++||.++.. ++.|+||+|||+....
T Consensus 9 ~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 65 (70)
T 2ega_A 9 EQYVVVSNYKKQENSELSLQAGEVVDVIEKN-----ESGWWFVSTS----EEQGWVPATYLEAQNS 65 (70)
T ss_dssp BCEECCSCCCCCSSSSCCCCTTCBCEEEEEC-----TTSEEEEECS----SCEEEEEGGGCEESCC
T ss_pred cEEEECceECCCCCCcccCCCCCEEEEEEcc-----CCCeEEEEEC----CCEEEEehHHcEECCC
Confidence 5699999999999999999999999999985 7899999976 6899999999987543
|
| >2d8h_A SH3YL1 protein; SH3 domain, hypothetical protein SH3YL1, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.8e-12 Score=101.65 Aligned_cols=60 Identities=35% Similarity=0.718 Sum_probs=52.3
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
....++|||||+++.++||+|++||+|.|+.+.. .+++||.|+++ ++.|+||.|||+...
T Consensus 16 ~~~~~~al~dy~~~~~~eLsf~~Gd~i~v~~~~~---~~~~Ww~g~~~----g~~G~~P~~yv~~~~ 75 (80)
T 2d8h_A 16 QPIEVTALYSFEGQQPGDLNFQAGDRITVISKTD---SHFDWWEGKLR----GQTGIFPANYVTMNS 75 (80)
T ss_dssp SCEEEECSSCEECSSTTBCEECTTCEEEEEECCS---CSSSEEEEEET----TEEEEEEGGGCCBCC
T ss_pred CCEEEEECccCCcCCCCeeeEcCCCEEEEeECcC---CCCCeEEEEEC----CEEEEEchhHeEEcC
Confidence 3468999999999999999999999999999841 14899999996 789999999998754
|
| >2cub_A Cytoplasmic protein NCK1; SH3 domain, NCK1 adaptor, tyrosine kinase, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.6e-12 Score=102.61 Aligned_cols=59 Identities=37% Similarity=0.557 Sum_probs=53.2
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+..++|||||+++.++||+|++||+|.|+++. +++||.++++ ++.|+||.|||+....
T Consensus 16 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~gWw~g~~~----g~~G~~P~~yv~~~~~ 74 (88)
T 2cub_A 16 LNMPAYVKFNYMAEREDELSLIKGTKVIVMEKC-----SDGWWRGSYN----GQVGWFPSNYVTEEGD 74 (88)
T ss_dssp CCEEEEESSCCCCCSTTBCCCCTTEEEEEEEEC-----TTSEEEEEET----TEEEEEEGGGEEECCC
T ss_pred CCCEEEEccccCCCCCCCcCCCCCCEEEEEEcc-----CCCeEEEEEC----CcEEEEehHHEEECCC
Confidence 346899999999999999999999999999985 7899999985 7899999999997654
|
| >1wie_A RIM binding protein 2; beta barrel, KIAA0318 protein, structural genomics, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.30 E-value=1.6e-12 Score=105.73 Aligned_cols=58 Identities=31% Similarity=0.570 Sum_probs=51.2
Q ss_pred CEEEEcccCCCCC------CCCCcccCCCEEEEe-ecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIG------LDELSLRRGDIVEVL-SKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~------~~eL~~~~gd~~~v~-~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..|+|||||+++. ++||+|++||+|.|+ +++ ++|||.|++.. ++.|+||+|||+.+..
T Consensus 18 ~~~~Alydy~~~~~~~~~~~~eLsf~~Gd~i~v~~~~~-----~~gWw~g~~~~---g~~G~~Psnyv~~~~~ 82 (96)
T 1wie_A 18 HLCVARYSYNPFDGPNENPEAELPLTAGKYLYVYGDMD-----EDGFYEGELLD---GQRGLVPSNFVDFVQD 82 (96)
T ss_dssp EEEEESSCCCGGGSSCSCTTTBCCCCTTCEEEEESSCC-----SSSCCEEEETT---CCBCBCCTTSEECCCS
T ss_pred cEEEECCccCCCcccCCCCCCeeeECCCCEEEEeEecC-----CCCEEEEEECC---CCEEEEchHHEEEcCC
Confidence 6899999999998 999999999999999 653 78999999832 7899999999997654
|
| >2oi3_A Tyrosine-protein kinase HCK; human HCK, SH3, SRC-type tyrosine kinase, transferase; NMR {Homo sapiens} PDB: 2oj2_A 4hck_A 5hck_A | Back alignment and structure |
|---|
Probab=99.29 E-value=3e-12 Score=101.95 Aligned_cols=61 Identities=33% Similarity=0.677 Sum_probs=52.8
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
....++|+|||.++.++||+|++||+|.|++++ ++||.|++... ++.|+||.|||+....+
T Consensus 24 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~------~~Ww~g~~~~~--g~~G~~P~~yv~~~~~~ 84 (86)
T 2oi3_A 24 EDIIVVALYDYEAIHHEDLSFQKGDQMVVLEES------GEWWKARSLAT--RKEGYIPSNYVARVDSL 84 (86)
T ss_dssp TSEEEEESSCCCCSSSSCCCCCTTCEEEEEEES------SSEEEEEETTT--CCEEEEEGGGEEEGGGC
T ss_pred CCcEEEECccCCCCCCCcCcCCCCCEEEEEEcC------CCeEEEEECCC--CCEEEEehHHcEEcccC
Confidence 346899999999999999999999999999983 49999998211 78999999999987654
|
| >2yuq_A Tyrosine-protein kinase ITK/TSK; T-cell-specific kinase, tyrosine-protein kinase LYK, kinase EMT, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=3.2e-12 Score=101.47 Aligned_cols=58 Identities=26% Similarity=0.508 Sum_probs=51.6
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
...+++|||||+++.++||+|++||+|.|++++ +++||.++... ++.|+||+|||+..
T Consensus 18 ~~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~~~~~~---g~~G~~P~~yv~~~ 75 (85)
T 2yuq_A 18 EETVVIALYDYQTNDPQELALRRNEEYCLLDSS-----EIHWWRVQDRN---GHEGYVPSSYLVEK 75 (85)
T ss_dssp SSCEEEESSCCCCSCSSBCCCCBTEEEEEEECC-----SSSEEEEECSS---SCEEEEETTTCEEC
T ss_pred CCeEEEECcCCCCCCCCcCCCCCCCEEEEEEec-----CCCeEEEEECC---CCEEEEehHHeEEc
Confidence 346899999999999999999999999999985 68999997532 78999999999975
|
| >2jxb_A T-cell surface glycoprotein CD3 epsilon chain, cytoplasmic protein NCK2; T-cell receptor, SH3 domain, immunology, SH2 domain; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=3e-12 Score=101.83 Aligned_cols=56 Identities=23% Similarity=0.481 Sum_probs=49.5
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
....++|||||+++.++||+|++||+|.|+++ ++|||.|+..+ ++.|+||+|||+.
T Consensus 30 ~~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~------~~~Ww~g~~~~---g~~G~~P~~yv~~ 85 (86)
T 2jxb_A 30 EEVIVIAKWDYTAQQDQELDIKKNERLWLLDD------SKTWWRVRNAA---NRTGYVPSNYVER 85 (86)
T ss_dssp CCEEEEESSCCCCCSSSBCCCCTTEEEEEEEC------CSSEEEEECTT---SCEEEEEGGGBCC
T ss_pred CceEEEECccCCCCCCCEeccCCCCEEEEEec------CCCeEEEEECC---CCEEEeehHHEEe
Confidence 34689999999999999999999999999986 46999999532 7899999999974
|
| >1wx6_A Cytoplasmic protein NCK2; SH3 domain, structural genomics, signal transduction, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=5.5e-12 Score=101.53 Aligned_cols=60 Identities=30% Similarity=0.678 Sum_probs=51.7
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|||||+++.++||+|++||+|.|++++. .+++||.++... ++.|+||.|||+.+..
T Consensus 18 ~~~~alydy~~~~~~eLs~~~Gd~i~v~~~~~---~~~~Ww~g~~~~---g~~G~~P~~yv~~~~~ 77 (91)
T 1wx6_A 18 HVVQTLYPFSSVTEEELNFEKGETMEVIEKPE---NDPEWWKCKNAR---GQVGLVPKNYVVVLSD 77 (91)
T ss_dssp EEEEESSCCCCSSSSBCCCCTTCEEEEEECCS---SCTTEEEEECTT---CCEEEEEGGGEEEEEE
T ss_pred EEEEEeecCCcCCCCcccCCCCCEEEEEECCC---CCCCcEEEEeCC---CCEEEEchHHEEECCC
Confidence 57999999999999999999999999999831 267999998432 7899999999997654
|
| >2rqv_A BUD emergence protein 1; BEM1P, SH3, CDC42P, cytoplasm, cytoskeleton, SH3 domain, SIG protein; NMR {Saccharomyces cerevisiae} PDB: 2rqw_A | Back alignment and structure |
|---|
Probab=99.28 E-value=1.2e-12 Score=108.04 Aligned_cols=60 Identities=28% Similarity=0.414 Sum_probs=51.2
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+++|||||+++.++||+|++||+|.|++++ +++||.|+.+++ .+..|+||+|||+....
T Consensus 6 ~~~~Alydy~a~~~~ELsf~~Gd~i~vl~~~-----~~~Ww~g~~~g~-~g~~G~fPsnYV~~~~~ 65 (108)
T 2rqv_A 6 LYAIVLYDFKAEKADELTTYVGENLFICAHH-----NCEWFIAKPIGR-LGGPGLVPVGFVSIIDI 65 (108)
T ss_dssp CCEEESSCCCCCSSSBCCCCSSEEECCCCEE-----TTTEEEECCSSS-SCCCEEEESTTCBCCCS
T ss_pred eEEEECCCcCCCCCCcCCcCCCCEEEEeEec-----CCCEEEEEECCc-cCCeeEeecceEEEecC
Confidence 5799999999999999999999999999874 789999998642 13459999999987543
|
| >2enm_A Sorting nexin-9; SH3-like barrel, protein transport, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.27 E-value=5.7e-12 Score=98.06 Aligned_cols=59 Identities=29% Similarity=0.588 Sum_probs=51.6
Q ss_pred CEEEEcccCCCC-CCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAI-GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~-~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|||||+++ .++||+|++||+|.|+.++ .++|||.|+... ++.|+||.|||+....
T Consensus 10 ~~~~al~dy~~~~~~~eLs~~~Gd~i~v~~~~----~~~gW~~g~~~~---g~~G~~P~~yv~~~~~ 69 (77)
T 2enm_A 10 TKARVMYDFAAEPGNNELTVTEGEIITVTNPN----VGGGWLEGKNNK---GEQGLVPTDYVEILPN 69 (77)
T ss_dssp EEEEESSCCCCCTTSSBCCCCTTCEEEEEESC----CSSSEEEEECTT---CCEEEEETTTEEEECC
T ss_pred cEEEECccCCCCCCCCeecCCCCCEEEEeEcc----CCCCeEEEEECC---CCEEEeehHHeEECCC
Confidence 689999999999 9999999999999999973 268999999432 7899999999997654
|
| >2kxd_A 11-MER peptide, SH3 domain of spectrin alpha CHAI; alpha spectrin SH3 domain, SPC-S19P20S circular permutant, S protein; NMR {Synthetic} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.5e-12 Score=98.97 Aligned_cols=54 Identities=28% Similarity=0.673 Sum_probs=48.8
Q ss_pred EEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 35 ~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
++|||||++ +++||+|++||+|.|+++. +++||.|+.+ ++.|+||+|||+....
T Consensus 3 a~alydy~~-~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 56 (73)
T 2kxd_A 3 APPLPPYSA-GGREVTMKKGDILTLLNST-----NKDWWKVEVN----DRQGFVPAAYVKKLDS 56 (73)
T ss_dssp CCCCCSSCC-CSCCCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEECCS
T ss_pred EEEeeeeCC-CCCEeeEcCCCEEEEEEec-----CCCEEEEEEC----CCEEEEehHHeEEcCC
Confidence 689999999 8999999999999999985 7899999976 7899999999987654
|
| >1i1j_A Melanoma derived growth regulatory protein; SH3 subdomain, hormone/growth factor complex; 1.39A {Homo sapiens} SCOP: b.34.2.1 PDB: 1k0x_A 1hjd_A | Back alignment and structure |
|---|
Probab=99.26 E-value=3.3e-12 Score=105.53 Aligned_cols=63 Identities=32% Similarity=0.579 Sum_probs=51.5
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCc--eeEEEecC----cccceecccccCcccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVG--WWTGKIEG----KIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~--ww~~~~~~----k~~~~~G~~P~~yv~~~~~~ 99 (527)
..++|||||.++..+||+|++||+|.|+++. ++.| ||.|++.+ ...++.|+||+|||+.....
T Consensus 23 ~~~~Alydy~a~~~~ELsf~~GDiI~Vl~k~----~~~g~dWW~G~~~~~~~~~~~g~~G~fPsnYV~~~~~~ 91 (108)
T 1i1j_A 23 SMAVALQDYMAPDCRFLTIHRGQVVYVFSKL----KGRGRLFWGGSVQGDYYGDLAARLGYFPSSIVREDQTL 91 (108)
T ss_dssp EEEEESSCBCCSSTTBCCBCTTCEEEEEEEE----CGGGTTEEEEEEBCSSTTCBCSCCEEEEGGGEEEEEEC
T ss_pred eEEEECCccCCCCCCccccCCCCEEEEEEec----CCCCCCEEEEEECCccccCCCCCEEEEchhHEEEcccc
Confidence 5799999999999999999999999999882 1334 99999762 11257999999999976654
|
| >2vkn_A Protein SSU81; membrane, SH3 domain, transmembrane, membrane; 2.05A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.26 E-value=4.4e-12 Score=96.73 Aligned_cols=57 Identities=33% Similarity=0.616 Sum_probs=48.8
Q ss_pred CEEEEcccCCCCCCC--CCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLD--ELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~--eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|||||+++.++ ||+|++||+|.|+++ ++|||.|+..+ ++.|+||+|||+....
T Consensus 6 ~~~~alydy~~~~~~~~eLsf~~Gd~i~v~~~------~~~Ww~g~~~~---g~~G~~P~~yv~~~~~ 64 (70)
T 2vkn_A 6 YKAKALYPYDADDDDAYEISFEQNEILQVSDI------EGRWWKARRAN---GETGIIPSNYVQLIDG 64 (70)
T ss_dssp EEEEESSCBCCCSSSTTBCCBCTTCEEEEECT------TSSEEEEECTT---SCEEEEEGGGEEEEEE
T ss_pred EEEEECccCCCCCCCCCcccCCCCCEEEEEEc------CCCeEEEEECC---CCEEEEehHHEEECCC
Confidence 568999999999766 999999999999875 57999998533 7899999999987543
|
| >1x6b_A RHO guanine exchange factor (GEF) 16; SH3 domain, neuroblastoma, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=4.3e-12 Score=99.21 Aligned_cols=60 Identities=27% Similarity=0.396 Sum_probs=51.9
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|||||+++.++||+|++||+|.|+.+ +++||.|++... ++.|+||.|||+.+..
T Consensus 16 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~------~~gW~~g~~~~~--g~~G~fP~~yv~~~~~ 75 (79)
T 1x6b_A 16 DLPQVEITKAFFAKQADEVTLQQADVVLVLQQ------EDGWLYGERLRD--GETGWFPEDFARFISG 75 (79)
T ss_dssp SCCEEEESSCCCCCSSSBCCCCTTEEEEEEEE------ETTEEEEEETTT--CCEEEECGGGCEEEES
T ss_pred CCCEEEECeeECCCCcCCcCCCCCCEEEEEEe------CCCEEEEEECCC--CCEEEEchHHEEECCC
Confidence 34689999999999999999999999999987 579999998322 7899999999987543
|
| >1awj_A ITK; transferase, regulatory intramolecular complex, kinase; NMR {Mus musculus} SCOP: b.34.2.1 PDB: 2rn8_A 2rna_A 2k79_A 2k7a_A | Back alignment and structure |
|---|
Probab=99.26 E-value=6.9e-13 Score=103.24 Aligned_cols=57 Identities=26% Similarity=0.492 Sum_probs=50.5
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
...+++|||||+++..+||+|++||+|.|++++ ++|||.|+..+ ++.|+||+|||+.
T Consensus 19 ~~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~~~~~~---g~~G~~P~~yv~~ 75 (77)
T 1awj_A 19 EETLVIALYDYQTNDPQELALRCDEEYYLLDSS-----EIHWWRVQDKN---GHEGYAPSSYLVE 75 (77)
T ss_dssp SSSCCCCCCCBCCCCTTSCCBCSSSCCSCCCTT-----SSSBCCCCCSS---SCCCCCBSTTCCC
T ss_pred CceEEEECccCCCCCcCCcCCCCCCEEEEEEec-----CCCCEEEEECC---CCEEEEehHHEEE
Confidence 346899999999999999999999999999884 67999998632 7899999999986
|
| >2v1r_A Peroxisomal membrane protein PAS20; protein transport, translocation, transmembrane, peptide COM structural genomics, peroxisome; 2.1A {Saccharomyces cerevisiae} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.25 E-value=3.2e-12 Score=100.30 Aligned_cols=62 Identities=31% Similarity=0.717 Sum_probs=50.6
Q ss_pred CEEEEcccCCCCCCC-CCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 33 DLWRALYDYDAIGLD-ELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 33 ~~~~alyd~~~~~~~-eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
..++|||||+++.++ ||+|++||+|.|+++......++|||.|++.+ ++.|+||+|||+.+.
T Consensus 15 ~~~~alydy~~~~~~~eLs~~~Gd~i~v~~~~~~~~~~~~Ww~g~~~~---g~~G~~P~~yv~~~~ 77 (80)
T 2v1r_A 15 EFARALYDFVPENPEMEVALKKGDLMAILSKKDPLGRDSDWWKVRTKN---GNIGYIPYNYIEIIK 77 (80)
T ss_dssp EEEEESSCBCCSSTTTBCCBCTTCEEEEEEEECTTSCEEEEEEEECTT---SCEEEEEGGGEEEC-
T ss_pred EEEEECccCCCCCCCCEecCCCCCEEEEEECCCCCCCCCCcEEEEeCC---CCeEEEEHHHeEEcC
Confidence 679999999999999 99999999999999851111124999999832 789999999998754
|
| >2e5k_A Suppressor of T-cell receptor signaling 1; SH3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=7.6e-12 Score=101.32 Aligned_cols=65 Identities=23% Similarity=0.454 Sum_probs=52.4
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|||||+++.++||+|++||+|.|+.++.. ..++|||.|++... ++.|+||.|||+....
T Consensus 15 ~~~~~~Alydy~~~~~~eLs~~~Gd~i~v~~~~~~-~~~~gWw~g~~~~~--g~~G~fP~~yv~~~~~ 79 (94)
T 2e5k_A 15 NHETLQVIYPYTPQNDDELELVPGDFIFMSPMEQT-STSEGWIYGTSLTT--GCSGLLPENYITKADE 79 (94)
T ss_dssp CCEEEEECSCBCCSSSSBCCBCTTCEEEECGGGCC-STTTTEEEEEESSS--CCEEEEEGGGEEECCS
T ss_pred CCeEEEECCcCCCCCCCCcCCCCCCEEEEEECcCC-CCCCCcEEEEECCC--CCEEEechHHeEEccc
Confidence 44689999999999999999999999999987310 01289999994211 7899999999997653
|
| >1u3o_A Huntingtin-associated protein-interacting protein; SH3, CIS-proline,, signaling protein; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.25 E-value=6.9e-12 Score=96.02 Aligned_cols=59 Identities=27% Similarity=0.441 Sum_probs=50.1
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~ 94 (527)
.+++|+|||.|+..+||+|++||+|+|++.. .++++||.++......+..|++|.|||.
T Consensus 18 e~~valydF~Ar~~~ELS~~kGd~vevle~~---~~~peW~lvr~~~~~~~qeGlVPsnyl~ 76 (82)
T 1u3o_A 18 ELTVVLQDFSAAHSSELSIQVGQTVELLERP---SERPGWCLVRTTERSPPQEGLVPSSTLC 76 (82)
T ss_dssp EEEECSSCBCCCSTTCCCBCTTCEEEESSCT---TSSTTEEEEEESSSSSCEEEEEEGGGSC
T ss_pred eEEEEEeeecCCCCCeeeEcCCCEEEEEecC---CCCCCEEEEEECCCCCCcEeeccccEEe
Confidence 5799999999999999999999999999874 2468999999754322468999999993
|
| >2m0y_A Dedicator of cytokinesis protein 1; apoptosis; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.25 E-value=4.3e-12 Score=97.94 Aligned_cols=60 Identities=43% Similarity=0.697 Sum_probs=50.7
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..+++|+|||.++.++||+|++||+|.|+++ ++|||.|+.... .++.|+||+|||+....
T Consensus 11 ~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~------~~~W~~g~~~~~-~g~~G~~P~~yv~~~~~ 70 (74)
T 2m0y_A 11 EKYGVAFYNYDARGADELSLQIGDTVHILET------YEGWYRGYTLRK-KSKKGIFPASYIHLKEA 70 (74)
T ss_dssp CSCEEECSEECCCSSSBCCEETTEEEEEEEB------SSSCEEEEESSC-SSCCEEECGGGEEECCC
T ss_pred CeEEEEceeeCCCCcCcccCCCCCEEEEEEc------CCCeEEEEECCC-CCCEEEEehHHEEEecc
Confidence 4689999999999999999999999999987 368999997210 16899999999986543
|
| >3reb_B Tyrosine-protein kinase HCK; HIV-1 NEF, SH3 domain binding, signaling, HCK SH3 domain, PR binding; 3.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=7.5e-12 Score=100.49 Aligned_cols=60 Identities=32% Similarity=0.594 Sum_probs=51.1
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
..+++|+|||.++.++||+|++||+|.|+++ ++|||.|+.... ++.|+||+|||+.....
T Consensus 3 ~~~~~Alydy~~~~~~eLs~~~Gd~i~v~~~------~~~Ww~g~~~~~--g~~G~~P~~yv~~~~~~ 62 (90)
T 3reb_B 3 DIIVVALYDYVSWSPDDLSFQKGDQMVVLEE------SGEWWKARSLAT--RKEGYIPSNYVARVDSG 62 (90)
T ss_dssp CCEEEESSCBCCSSTTBCCBCTTCEEEEEEC------SSSEEEEEETTT--CCEEEEEGGGEEEECC-
T ss_pred cEEEEECCccCcCCcCcCCCCCCCEEEEEEe------CCCEEEEEECCC--CCEEEEehhheEECCCC
Confidence 4689999999999999999999999999987 358999997221 78999999999976543
|
| >1wxu_A Peroxisomal biogenesis factor 13; SH3 domain, PEX13, protein-protein interaction, structural genomics; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.24 E-value=6.3e-12 Score=101.58 Aligned_cols=64 Identities=30% Similarity=0.578 Sum_probs=52.3
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|||||+++.++||+|++||+|.|+.++.. ..+++||.|++.+ .+.|+||.|||+.+..
T Consensus 16 ~~~~~~alydy~a~~~~eLsf~~Gd~i~v~~~~~~-~~~~gWw~g~~~~---~~~G~~P~~yv~~~~~ 79 (93)
T 1wxu_A 16 DHVVARAEYDFVAVSDEEISFRAGDMLNLALKEQQ-PKVRGWLLASLDG---QTTGLIPANYVKILGK 79 (93)
T ss_dssp CBBCEEESSCBCCSSSSBCCBCSSCBCEECCTTTS-CSCSSCEEEESSS---SSCEEECSTTEEECCC
T ss_pred CCEEEEECccCCCCCCCccCcCCCCEEEEEECCCC-CCCCCcEEEEeCC---cCEEEEehHHEEEcCC
Confidence 34689999999999999999999999999998510 0016999999874 3499999999997654
|
| >1jqq_A PEX13P, peroxisomal membrane protein PAS20, PAS20P, roxin-13; compact beta-barrel of five anti-parrallel beta-strands; 2.65A {Saccharomyces cerevisiae} SCOP: b.34.2.1 PDB: 1n5z_A | Back alignment and structure |
|---|
Probab=99.24 E-value=8.8e-12 Score=100.54 Aligned_cols=65 Identities=29% Similarity=0.685 Sum_probs=52.7
Q ss_pred CCCEEEEcccCCCCCCC-CCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLD-ELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~-eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|+|||+++.++ ||+|++||+|.|++++.....++|||.|++.+ ++.|+||.|||+....
T Consensus 13 ~~~~~~alydy~~~~~~~eLsf~~Gd~i~v~~~~~~~~~~~gWw~g~~~~---g~~G~~P~~yv~~~~~ 78 (92)
T 1jqq_A 13 KLEFARALYDFVPENPEMEVALKKGDLMAILSKKDPLGRDSDWWKVRTKN---GNIGYIPYNYIEIIKR 78 (92)
T ss_dssp TCEEEEESSBBCCSSTTTBCCBCTTCEEEEEEEECTTSCEEEEEEEEETT---SCEEEEEGGGEEECCC
T ss_pred cCEEEEECccCCCCCCCCCcCCCCCCEEEEEECCCCCCCCCCCeEEEeCC---CCEEEEehHHeEECCC
Confidence 33689999999999999 99999999999999851111124999999832 7899999999997654
|
| >2rqr_A CED-12 homolog, engulfment and cell motility protein 1, linker, D of cytokinesis protein 2; KIAA0209, KIAA0281, apoptosis, membrane, phagocytosis; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.4e-11 Score=103.97 Aligned_cols=58 Identities=31% Similarity=0.557 Sum_probs=50.4
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecC-cccceecccccCcccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEG-KIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~-k~~~~~G~~P~~yv~~~~ 97 (527)
..+++|||||+++.++||+|++||+|.|+++ ++|||.|++.. . ++.|+||+|||+...
T Consensus 59 ~~~~~Alydy~a~~~~eLsf~~Gd~i~vl~~------~~gWw~g~~~~~~--g~~G~fP~nyV~~~~ 117 (119)
T 2rqr_A 59 ERHGVAIYNFQGSGAPQLSLQIGDVVRIQET------CGDWYRGYLIKHK--MLQGIFPKSFIHIKE 117 (119)
T ss_dssp CEEEEBCSCBCCCSTTBCCBCTTCEEEEEEE------ETTEEEEEESSCT--TCEEEEEGGGBCCCC
T ss_pred ceEEEEccccCCCCCCcccCcCCCEEEEEEc------CCCEEEEEECCCC--CCEEEeChhHEEEec
Confidence 3679999999999999999999999999998 35999999821 1 789999999998654
|
| >1hsq_A Phospholipase C-gamma (SH3 domain); phosphoric diester hydrolase; NMR {Homo sapiens} SCOP: b.34.2.1 PDB: 2hsp_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.3e-12 Score=100.06 Aligned_cols=58 Identities=33% Similarity=0.638 Sum_probs=50.7
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceec-ccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVG-IFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G-~~P~~yv~~~~~ 98 (527)
...++|+|||+++.++||+|++||+|.|+.+. +++||.|+++ ++.| +||+|||+....
T Consensus 6 ~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~gG~~P~~yv~~~~~ 64 (71)
T 1hsq_A 6 KCAVKALFDYKAQREDELTFIKSAIIQNVEKQ-----EGGWWRGDYG----GKKQLWFPSNYVEEMVN 64 (71)
T ss_dssp SSCCCCSSCCCCSSSSSCCCCTTCCCBSCCCB-----TTTEECCBCS----SSCSCCEETTTCCSCSC
T ss_pred CeEEEECCCCCcCCCCccCCCCCCEEEEEEec-----CCCEEEEEEC----CeEEeEEChHHcEECCC
Confidence 45789999999999999999999999999884 7799999986 4555 999999997654
|
| >2kym_A BUD emergence protein 1; SH3 domain, BEM1P, SH3-CI, STE20P PRR, CDC42P-interacting, S signaling protein; NMR {Lodderomyces elongisporus} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.1e-11 Score=104.99 Aligned_cols=61 Identities=25% Similarity=0.422 Sum_probs=52.1
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..+++|||||+++.++||+|++||+|.|+++. ++|||.|+..+. .++.|+||+|||+....
T Consensus 3 ~~~~~Alydy~a~~~~ELsf~~Gd~i~vl~~~-----~~~Ww~g~~~~~-~g~~G~~P~nyv~~~~~ 63 (120)
T 2kym_A 3 PLFAVTLYEFKAERDDELDVSPGENLSICAHY-----DYEWFIAKPINR-LGGPGLVPVSYVRIIDL 63 (120)
T ss_dssp CCEEEECSCBCCCSTTCCCBCTTCEEEEEEEE-----TTTEEEEEESSS-CSCCCCEEGGGEEEECS
T ss_pred CEEEEEcccCCCCCCCccCCCCCCEEEEEEec-----CCCEEEEEECCC-CCCEEEEchHHEEEccC
Confidence 35799999999999999999999999999984 789999986321 16889999999987643
|
| >3o5z_A Phosphatidylinositol 3-kinase regulatory subunit; SRC homology 3 domain, protein binding; 2.01A {Homo sapiens} SCOP: b.34.2.0 PDB: 2kt1_A | Back alignment and structure |
|---|
Probab=99.22 E-value=6.6e-12 Score=100.64 Aligned_cols=66 Identities=27% Similarity=0.444 Sum_probs=51.6
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecC----------CCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKD----------SAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~----------~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+..++|||||.++.++||+|++||+|.|+++. ....++.|||.|++... ++.|+||+|||+.+..
T Consensus 10 ~~~~~~Alydy~a~~~~ELsf~~GD~I~V~~~~~~~l~~~~~~~~~~~~~gW~~G~~~~~--g~~G~fP~nyVe~i~~ 85 (90)
T 3o5z_A 10 EGFQYRALYPFRRERPEDLELLPGDVLVVSRAALQALGVAEGGERCPQSVGWMPGLNERT--RQRGDFPGTYVEFLGP 85 (90)
T ss_dssp SEEEEEECSCBCCCSTTBCCBCTTCEEEEEHHHHHHTTCCTTGGGCHHHHCEEEEEETTT--CCEEEEEGGGEEEEEE
T ss_pred CCcEEEEeeeECCCCCCccCCcCCCEEEEEeccccccccccccccCCCCCCceEEEeCCC--CCEEEeehHHEEEecc
Confidence 446899999999999999999999999998430 00012348999987432 7899999999987654
|
| >3i5r_A Phosphatidylinositol 3-kinase regulatory subunit alpha; SH3 domain, peptide complex, alternative splicing, disease mutation, HOST-virus interaction, phosphoprotein, polymorphism; 1.70A {Homo sapiens} SCOP: b.34.2.1 PDB: 3i5s_A 1pht_A 1pnj_A 2pni_A 1pks_A 1pkt_A | Back alignment and structure |
|---|
Probab=99.21 E-value=3.8e-12 Score=100.58 Aligned_cols=65 Identities=32% Similarity=0.539 Sum_probs=51.3
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecC----------CCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKD----------SAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~----------~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
+..++|+|||.++.++||+|++||+|.|+++. ....+++|||.|+.... ++.|+||.|||+.+..
T Consensus 5 ~~~~~Alydy~~~~~~eLs~~~Gd~I~V~~~~~~~~~~~~~~e~~~~~~gW~~g~~~~~--g~~G~fP~~yV~~~~~ 79 (83)
T 3i5r_A 5 GYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETT--GERGDFPGTYVEYIGR 79 (83)
T ss_dssp EEEEEECSCBCCCSTTBCCBCTTCEEEEEHHHHHHHTCTTTGGGCHHHHCEEEEEETTT--TEEEEEEGGGEEEEEE
T ss_pred CcEEEEccccCCCCCCccccCCCCEEEEeeccccccccccccccCCCCCccEEEEeCCC--CCEEEEehHHEEECCc
Confidence 46799999999999999999999999999541 00112449999986533 7899999999987543
|
| >1udl_A Intersectin 2, KIAA1256; beta barrel, SH3 domain, riken structural genomics/proteomics initiative, RSGI, structural genomics; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.20 E-value=8.7e-12 Score=101.79 Aligned_cols=58 Identities=41% Similarity=0.791 Sum_probs=51.9
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
...++|||||+++.++||+|++||+|.|++++ +++||.++.+ ++.|+||.|||+....
T Consensus 34 ~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 91 (98)
T 1udl_A 34 VCQVIAMYDYAANNEDELSFSKGQLINVMNKD-----DPDWWQGEIN----GVTGLFPSNYVKMTTD 91 (98)
T ss_dssp SEEEEESSCCCCSSTTSCCCCTTCEEEECBCC-----SSSEEBCBSS----SCBCCEETTSEEECCC
T ss_pred ceEEEECCCCCCCCCCccCCcCCCEEEEEEec-----CCCEEEEEEC----CcEEEEehHHeEEcCC
Confidence 46799999999999999999999999999984 7899999865 7899999999987654
|
| >2yt6_A Adult MALE urinary bladder cDNA, riken FULL- length enriched library, clone:9530076O17...; SH3_1 domain; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.20 E-value=4.4e-11 Score=99.66 Aligned_cols=62 Identities=27% Similarity=0.661 Sum_probs=53.8
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
....++|+|||+++.++||+|++||+|.|++++ +++||.++.... ++.|+||.|||+....+
T Consensus 26 ~~~~~~al~dy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~~~--g~~G~~P~~yv~~~~~~ 87 (109)
T 2yt6_A 26 GVTIFVALYDYEARTTEDLSFKKGERFQIINNT-----EGDWWEARSIAT--GKSGYIPSNYVVPADSI 87 (109)
T ss_dssp SCCEEEESSCCCCSSTTSCCCCTTCEEEEEECS-----CTTCEEEEESSS--CCEEEECTTTEEESSSC
T ss_pred CCEEEEECccCCCCCCCccCCCCCCEEEEEEcc-----CCCcEEEEECCC--CCEEEechHHcEECCcc
Confidence 347899999999999999999999999999985 789999996221 78999999999987654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=3.9e-11 Score=115.53 Aligned_cols=134 Identities=13% Similarity=0.160 Sum_probs=96.1
Q ss_pred eeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCc--cceEEEEEEeCCeEEEEEecc
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN--IVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~~~~~~~~~~~~~iv~Ey~ 195 (527)
+.+....+.|..+.||++... +..+++|+..... ...+..|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 333333345667999998764 5679999976541 234668888888885444 556899888888899999999
Q ss_pred CCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q psy6905 196 RGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA------------------------------------------- 232 (527)
Q Consensus 196 ~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g------------------------------------------- 232 (527)
+|.+|. .. ... ...++.+++..|..||...
T Consensus 98 ~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 98 PGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp SSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred CCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 998884 22 111 2356777888888888642
Q ss_pred ------------CCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 233 ------------PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 233 ------------~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+..++|+|++|.|||++.+ +.+.|+|||.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~--------~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENG--------RFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETT--------EEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECC--------cEEEEEcchhcc
Confidence 1129999999999999753 356799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.18 E-value=9.4e-11 Score=119.02 Aligned_cols=144 Identities=13% Similarity=0.173 Sum_probs=106.6
Q ss_pred eeeeccCCceEEEEeeEcCceEEEEEcC--CCCChhHHHHHHHHHHHHHhCC--CCccceEEEEEEeC---CeEEEEEec
Q psy6905 122 GEAIGEGGFGKVYKGIYEKQEVAIKVAH--PNPDENILENVKQEGKLLWLFD--HRNIVSLIGVCLQS---PKLCLVMEY 194 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~~~vaiK~~~--~~~~~~~~~~~~~e~~~l~~l~--hpnIv~~~~~~~~~---~~~~iv~Ey 194 (527)
.+.|+.|.++.||+....+..+++|+.. ..........+.+|+.+++.|. +..+.+++.++.+. +..|+||||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 4678999999999998877889999876 4322122356778999999886 45578999988776 347999999
Q ss_pred cCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q psy6905 195 ARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA------------------------------------------ 232 (527)
Q Consensus 195 ~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g------------------------------------------ 232 (527)
++|..+.+.. -..++......++.+++..|..||...
T Consensus 123 v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (359)
T 3dxp_A 123 VSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLM 201 (359)
T ss_dssp CCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHH
T ss_pred cCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHH
Confidence 9998874321 124677888889999999999999731
Q ss_pred -------------CCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 233 -------------PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 233 -------------~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
+..++|||++|.|||++.+. ...+.|+||+.+..
T Consensus 202 ~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~------~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 202 DWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE------PRVLAVLDWELSTL 248 (359)
T ss_dssp HHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS------SCEEEECCCTTCEE
T ss_pred HHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC------CcEEEEECcccccc
Confidence 23699999999999998641 12468999998753
|
| >1bb9_A Amphiphysin 2; transferase, SH3 domain; 2.20A {Rattus norvegicus} SCOP: b.34.2.1 PDB: 1muz_A 1mv0_B | Back alignment and structure |
|---|
Probab=99.16 E-value=1.8e-11 Score=102.49 Aligned_cols=64 Identities=36% Similarity=0.561 Sum_probs=50.6
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecC------cccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEG------KIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~------k~~~~~G~~P~~yv~~~ 96 (527)
..++|||||+++.++||+|++||+|.|+.++.....++|||.|++.. ...++.|+||+|||+.+
T Consensus 45 ~~~~Alydy~a~~~dELsf~~GDiI~Vl~~~~~~~~~~gWw~G~~~~t~~~~~~~~g~~G~fPsnyV~~l 114 (115)
T 1bb9_A 45 FKVQAQHDYTATDTDELQLKAGDVVLVIPFQNPEEQDEGWLMGVKESDWNQHKELEKCRGVFPENFTERV 114 (115)
T ss_dssp EEEEESSCBCCSSTTBCCBCTTCEEEEECCSCGGGCCTTEEEEEEHHHHHTTCCHHHHCEEEEGGGEEEE
T ss_pred eEEEECCccCCCCCCccCcCCCCEEEEeeccCCcccCCCeEEEEeCCCcccccccCCCEEEechHHEEEC
Confidence 56999999999999999999999999999311111478999998631 11267999999999864
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.10 E-value=5.5e-11 Score=109.78 Aligned_cols=64 Identities=38% Similarity=0.571 Sum_probs=50.4
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecC------cccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEG------KIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~------k~~~~~G~~P~~yv~~~ 96 (527)
..|+|||||.++..+||+|++||+|.|+........++|||.|++.. ...++.|+||.|||+.+
T Consensus 143 ~~~rALYdY~a~~~dELSf~~GDiI~Vl~~~~~~~~ddgWw~G~~~~t~~~~~d~~G~~G~FPsnYVe~l 212 (213)
T 1mv3_A 143 FKVQAQHDYTATDTDELQLKAGDVVLVIPFQNPEEQDEGWLMGVKESDWNQHKKLEKCRGVFPENFTERV 212 (213)
T ss_dssp EEEEESSCBCCCSTTCCCBCSSCEEEECCCSCGGGSCTTEEEEEEHHHHHTGGGGGGTCEEEESTTEEEE
T ss_pred eEEEECCCcCCCCCCcCCcCCCCEEEEeecCCCCccCCCeeEEEeCCcccccccCCCCEEEecHHHeEEC
Confidence 47999999999999999999999999998211111378999999631 11278999999999854
|
| >1gcq_C VAV proto-oncogene; SH3 domain, protein-protein complex, GRB2,VAV, signaling protein/signaling protein complex; 1.68A {Mus musculus} SCOP: b.34.2.1 PDB: 1gcp_A | Back alignment and structure |
|---|
Probab=99.06 E-value=1.9e-10 Score=87.49 Aligned_cols=50 Identities=32% Similarity=0.518 Sum_probs=39.5
Q ss_pred CCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 41 YDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 41 ~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
|.++..+||+|++||+|.|++++ .+++||.|++... ++.|+||+|||+..
T Consensus 19 ~~~~~~~eLsf~~Gd~i~v~~~~----~~~~Ww~g~~~~~--g~~G~fP~~yv~~~ 68 (70)
T 1gcq_C 19 PPGAFGPFLRLNPGDIVELTKAE----AEHNWWEGRNTAT--NEVGWFPCNRVHPY 68 (70)
T ss_dssp CGGGCSCBCCBCTTCEEEEEECC----TTCSEEEEEETTT--TEEEEEEGGGEEEC
T ss_pred CCCCCCCcCCcCCCCEEEEEeCC----CCCCCeEEEeCCC--CCEeEeehHHeEEC
Confidence 33334559999999999999983 3789999974432 78999999999863
|
| >1k1z_A VAV; SH3, proto-oncogene, signaling protein; NMR {Mus musculus} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=99.06 E-value=3.5e-10 Score=88.05 Aligned_cols=57 Identities=30% Similarity=0.569 Sum_probs=44.2
Q ss_pred EEEEcccCCCCC---CCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 34 LWRALYDYDAIG---LDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 34 ~~~alyd~~~~~---~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.+.|+|+|.++. .+||+|++||+|.|++++ .++|||.|++... ++.|+||+|||+..
T Consensus 17 ~~~a~~~~~~~~~~~~~eLsf~~Gd~i~v~~~~----~~~gWw~g~~~~~--g~~G~fP~nyV~~~ 76 (78)
T 1k1z_A 17 VFQEYYGIPPPPGAFGGFLRLNPGDIVELTKAE----AEHNWWEGRNTAT--NEVGWFPCNRVHPY 76 (78)
T ss_dssp ECSCBSSCSCCSSSSCCCCCBCTTCEEEEEECC----SSCSCEEEEETTT--TEEEEECSTTEEES
T ss_pred EEEECCCCCCCCCCCCCccCCCCCCEEEEEEcC----CCCCeEEEEECCC--CCEEEEehHHeEEC
Confidence 344556666642 599999999999999983 2789999996321 78999999999863
|
| >3qwx_X Cell death abnormality protein 2; cell engulfment, signaling protein; 2.01A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.4e-10 Score=105.21 Aligned_cols=56 Identities=23% Similarity=0.527 Sum_probs=49.9
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
...++|+|||+++.++||+|++||+|.|+++. ++|||.|+... ++.|+||+|||+.
T Consensus 118 ~~~~~alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~~---g~~G~~P~nyv~~ 173 (174)
T 3qwx_X 118 IEVVVGTFKFTGERETDLPFEQGERLEILSKT-----NQDWWEARNAL---GTTGLVPANYVQI 173 (174)
T ss_dssp SEEEEESSCBCCSSTTBCCBCTTCEEEEEECC-----SSSEEEEECTT---CCEEEEEGGGEEE
T ss_pred ccEEEEecCcccCCCCccccccCCEEEEEEcc-----CCCeEEEEECC---CCEEEEChHHEEe
Confidence 35799999999999999999999999999984 78999999522 7899999999973
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=2.4e-10 Score=103.80 Aligned_cols=62 Identities=23% Similarity=0.493 Sum_probs=52.2
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDIN 100 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~ 100 (527)
....++|+|||++++++||+|++||+|.|+++ +++||.|+.... ++.|+||.|||+....++
T Consensus 11 ~~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~------~~~Ww~~~~~~~--g~~G~vP~~yv~~~~~l~ 72 (175)
T 4d8k_A 11 QDNLVIALHSYEPSHDGDLGFEKGEQLRILEQ------SGEWWKAQSLTT--GQEGFIPFNFVAKANSLE 72 (175)
T ss_dssp --CEEEESSCBCCCSSSBCCBCTTCEEEEEEC------CSSEEEEEETTT--CCEEEEEGGGEEETTCST
T ss_pred CCcEEEEccCcCCcCCcccccccCCEEEEEcc------CCCEEEEEECCC--Cceeeecccccccccccc
Confidence 34689999999999999999999999999987 458999997322 789999999999765543
|
| >1ng2_A Neutrophil cytosolic factor 1; P47PHOX, autoinhibited, SH3 domain, NADPH oxidase, oxidoredu activator; 1.70A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 PDB: 1uec_A 1ov3_A 1wlp_B | Back alignment and structure |
|---|
Probab=99.00 E-value=2.8e-10 Score=104.92 Aligned_cols=59 Identities=31% Similarity=0.530 Sum_probs=53.1
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+..++|+|||+++.++||+|++||+|.|+++. ++|||.|+.+ ++.|+||.|||+....
T Consensus 80 ~~~~~~al~dy~a~~~~eLs~~~Gd~i~vl~~~-----~~gWw~g~~~----g~~G~~P~~yv~~~~~ 138 (193)
T 1ng2_A 80 AGEPYVAIKAYTAVEGDEVSLLEGEAVEVIHKL-----LDGWWVIRKD----DVTGYFPSMYLQKSGQ 138 (193)
T ss_dssp TCEEEEESSCBCCCSTTBCCBCTTCEEEEEECC-----TTSEEEEEET----TEEEEEEGGGEEETTS
T ss_pred cceeeeeccccCCCCCCcccccCCCEEEEEEec-----CCCeEEEEEC----CCEEEEehHHeEECCC
Confidence 446899999999999999999999999999984 7899999986 7899999999987654
|
| >1gri_A Growth factor bound protein 2; SH2, SH3, signal transduction adaptor; 3.10A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 d.93.1.1 PDB: 1aze_A 2a37_A 2azv_A 2a36_A 2azs_A | Back alignment and structure |
|---|
Probab=98.99 E-value=3.6e-10 Score=106.32 Aligned_cols=58 Identities=36% Similarity=0.845 Sum_probs=52.6
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
....++|+|||+++.++||+|++||+|.|+++. ++|||.|+++ ++.|+||+|||+.+.
T Consensus 157 ~~~~~~al~~y~~~~~~eL~~~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yv~~~~ 214 (217)
T 1gri_A 157 QPTYVQALFDFDPQEDGELGFRRGDFIHVMDNS-----DPNWWKGACH----GQTGMFPRNYVTPVN 214 (217)
T ss_dssp CCCEEEESSCCCCSSTTBCCCCTTCEEEEEECC-----SSSEEEEECS----SCEEEEEGGGEEEEC
T ss_pred CceEEEecCCccCCCCCcCCCCCCCEEEEEEeC-----CCCeEEEEEC----CeEEEEeHHHeEECC
Confidence 447899999999999999999999999999984 7899999986 789999999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=4.9e-10 Score=110.98 Aligned_cols=184 Identities=18% Similarity=0.192 Sum_probs=120.9
Q ss_pred eeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCc--cceEEEEEEeCC---eEEEEEeccC
Q psy6905 123 EAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRN--IVSLIGVCLQSP---KLCLVMEYAR 196 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpn--Iv~~~~~~~~~~---~~~iv~Ey~~ 196 (527)
+.++.|.+..||+.. ..+++|+.... .....+.+|+.+++.+ .+.. +.+++....... ..|+||++++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458999999999864 57999986543 3456788999999887 3333 345555543333 2489999999
Q ss_pred CCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q psy6905 197 GGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ--------------------------------------------- 231 (527)
Q Consensus 197 ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~--------------------------------------------- 231 (527)
|.+|..... ..++..+...++.+++..|..||+.
T Consensus 100 G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 100 GVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp CEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred CeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 988864322 3467777788888888888888861
Q ss_pred ----------CCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhccccccCCCcccc---ccccccc---c
Q psy6905 232 ----------APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAW---MAPEVIK---T 295 (527)
Q Consensus 232 ----------g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y---~aPE~l~---~ 295 (527)
.+..++|+|++|.|||++.+. ...+.|+||+.+......... .....+ ..|+... .
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~------~~~~~~iD~~~~~~~~~~~Dl--~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEK------NTICGIIDFGDAAISDPDNDF--ISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTT------TEEEEECCCTTCEEECTTHHH--HTTCCTTTSCCHHHHHHHHH
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCC------CCEEEEEeCCCCccCChHHHH--HHHHhhccccCHHHHHHHHH
Confidence 112479999999999998631 146789999987543111000 000000 1222111 0
Q ss_pred --CC---------CCcccchHHHHHHHHHHHhCCCCC
Q psy6905 296 --SI---------FSKASDVWSYGVVLWELLTGEIPY 321 (527)
Q Consensus 296 --~~---------~~~ksDvwSlGv~l~elltg~~Pf 321 (527)
+. .....+.|++|.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 112368999999999999998776
|
| >3jv3_A Intersectin-1; SH3 domain, DH domain, guanine nucleotide exchange factor, autoinhibition, domain-swapped, cell junction, cell project endocytosis; 2.40A {Mus musculus} PDB: 3gf9_A | Back alignment and structure |
|---|
Probab=98.97 E-value=4.1e-10 Score=110.48 Aligned_cols=59 Identities=39% Similarity=0.814 Sum_probs=52.9
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
+..++|+|||.+++++||+|++||+|.|+++. ++|||.|+.+ |+.|+||+|||+.....
T Consensus 2 ~~~~~a~~~~~~~~~~el~~~~gd~i~v~~~~-----~~~w~~~~~~----g~~G~~P~~~v~~~~~~ 60 (283)
T 3jv3_A 2 SCQVIGMYDYTAQNDDELAFSKGQIINVLNKE-----DPDWWKGEVS----GQVGLFPSNYVKLTTDM 60 (283)
T ss_dssp CEEEEESSCBCCSSTTBCCBCTTCEEEEEECC-----STTEEEEEET----TEEEEEEGGGEEEGGGS
T ss_pred CeEEEEccccCCCCCCcCCCCCCCEEEEEecC-----CCCEEEEEEC----CCCCcCCCccccccCcc
Confidence 45799999999999999999999999999984 7899999977 78999999999976543
|
| >3a98_A DOCK2, dedicator of cytokinesis protein 2; protein-protein complex, DOCK2, ELMO1, SH3 domain, PH domain bundle, proline-rich sequence, cytoskeleton; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=4.3e-10 Score=102.63 Aligned_cols=60 Identities=28% Similarity=0.533 Sum_probs=50.2
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..+++|+|||.++.++||+|++||+|.|+++. + |||.|+.... .++.|+||+|||+....
T Consensus 17 ~~~~~Alydf~~~~~~eLs~~~Gd~i~v~~~~-----~-~W~~g~~~~~-~g~~G~fP~nyV~~~~~ 76 (184)
T 3a98_A 17 ERHGVAIYNFQGSGAPQLSLQIGDVVRIQETC-----G-DWYRGYLIKH-KMLQGIFPKSFIHIKEV 76 (184)
T ss_dssp CCEEEESSCBCCSSTTBCCBCTTCEEEEEEEE-----T-TEEEEEETTE-EEEEEEEEGGGEEEECC
T ss_pred ceEEEEeeeeCCCCCCCCCcCCCCEEEEEecC-----C-CEEEEEEecC-CCceEEECcceEEEecc
Confidence 36899999999999999999999999999984 3 6999997210 16899999999987543
|
| >2dvj_A V-CRK sarcoma virus CT10 oncogene homolog, isoform A; SH3, SH2, signal transduction, adapter molecule, signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2eyy_A 2eyv_A 2eyw_A | Back alignment and structure |
|---|
Probab=98.94 E-value=2.6e-10 Score=108.22 Aligned_cols=62 Identities=24% Similarity=0.595 Sum_probs=53.6
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDIN 100 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~ 100 (527)
....++|+|||+++.++||+|++||+|.|++++ ++|||.|+..+ ++.|+||+|||+......
T Consensus 135 ~~~~~~al~dy~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~~---g~~G~~P~~yv~~~~~~~ 196 (230)
T 2dvj_A 135 EAEYVRALFDFNGNDEEDLPFKKGDILRIRDKP-----EEQWWNAEDSE---GKRGMIPVPYVEKYRPAS 196 (230)
T ss_dssp CCCCCBCCSCCCCSSSSSCCCCSSCBCCCCBCS-----CSSEEEEECTT---SCEEEEEGGGSCCCCSSC
T ss_pred cceeEEEeeeecCCCCCCccCcCCCEEEEEEcc-----CCCcEEEEeCC---CCEEEEehHHeEEcCCCC
Confidence 346799999999999999999999999999985 78999999432 789999999999876543
|
| >1ng2_A Neutrophil cytosolic factor 1; P47PHOX, autoinhibited, SH3 domain, NADPH oxidase, oxidoredu activator; 1.70A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 PDB: 1uec_A 1ov3_A 1wlp_B | Back alignment and structure |
|---|
Probab=98.93 E-value=6.6e-10 Score=102.41 Aligned_cols=58 Identities=34% Similarity=0.748 Sum_probs=52.3
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
...|+|+|||.+..++||+|++||+|.|++++ ++|||.|+.+ ++.|+||.|||+....
T Consensus 11 ~~~~~al~dy~~~~~~eLs~~~Gd~i~vl~~~-----~~gWw~g~~~----g~~G~~P~~yv~~~~~ 68 (193)
T 1ng2_A 11 LQTYRAIADYEKTSGSEMALSTGDVVEVVEKS-----ESGWWFCQMK----AKRGWIPASFLEPLDS 68 (193)
T ss_dssp CEEEECSSCBCCSSTTCCCBCTTCEEEEEECC-----TTSCCEEEEC----CCCCCCCGGGCCCSSC
T ss_pred CcEEEEcCCcCCCCCCcCCCCCCCEEEEEEec-----CCCeEEEEEC----CeeeEechheEEeecc
Confidence 35799999999999999999999999999985 7899999965 7899999999997654
|
| >1g2b_A Spectrin alpha chain; capping protein, calcium-binding, duplication, repeat, SH3 domain, cytoskeleton, metal binding protein; 1.12A {Gallus gallus} SCOP: b.34.2.1 PDB: 1tud_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.3e-09 Score=80.77 Aligned_cols=43 Identities=30% Similarity=0.725 Sum_probs=38.7
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEec
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIE 78 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~ 78 (527)
....++|||||+++.++||+|++||+|.|+++. +++||.|+++
T Consensus 20 ~~~~~~alydy~a~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~n 62 (62)
T 1g2b_A 20 GKELVLALYDYQEKSPREVTMKKGDILTLLNST-----NKDWWKVEVN 62 (62)
T ss_dssp SSCEEEECSCBCCSSTTBCCBCTTCEEEEEECC-----SSSEEEEEEC
T ss_pred CceEEEEeeeECCCCCCccCCCCCCEEEEEEec-----CCCEEEEEeC
Confidence 346899999999999999999999999999984 7899999863
|
| >2dyb_A Neutrophil cytosol factor 4; P40(PHOX), NADPH oxidase, oxidoreductase; HET: CAF; 3.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.87 E-value=2e-09 Score=108.22 Aligned_cols=59 Identities=31% Similarity=0.577 Sum_probs=53.3
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|+|||+++.++||+|++||+|.|+++. ++|||.|+.+ |+.|+||+|||+....
T Consensus 173 ~~~~~~alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 231 (341)
T 2dyb_A 173 AAPRAEALFDFTGNSKLELNFKAGDVIFLLSRI-----NKDWLEGTVR----GATGIFPLSFVKILKD 231 (341)
T ss_dssp CCCEEEESSCBCCSSSSBCCBCTTCEEEEEEEC-----SSSEEEEEET----TEEEEEEGGGEEEEEC
T ss_pred CCcEEEEEEeeCCCCCCcCCccCCCEEEEEEec-----CCCEEEEEEC----CcEEEechHHeEEcCC
Confidence 457899999999999999999999999999984 7899999976 7899999999987654
|
| >2de0_X Alpha-(1,6)-fucosyltransferase; FUT8, glycosyltransferase, N-glycan, COR SH3 domain; 2.61A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.84 E-value=2.4e-09 Score=112.77 Aligned_cols=62 Identities=21% Similarity=0.280 Sum_probs=53.5
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
....++|||||++++++||+|++||+|.|+++. ++|||.|+.... |+.|+||+|||+.....
T Consensus 441 ~~~~~~aly~y~a~~~dELs~~~GD~i~v~~~~-----~~gW~~G~~~~~--g~~G~fPsnyV~~~~~~ 502 (526)
T 2de0_X 441 NAHNQIAIYAHQPRTADEIPMEPGDIIGVAGNH-----WDGYSKGVNRKL--GRTGLYPSYKVREKIET 502 (526)
T ss_dssp CCCEEEECSCBCCSSTTBCCBCTTCEEEEEEEC-----SSSEEEEEETTT--TEEEEEEGGGEEECCCE
T ss_pred cccceEEeecCCCCCCCcCCcCCCCEEEEcccc-----CCCeeEEEeCCC--CCEEEECchheeEcccC
Confidence 447899999999999999999999999999884 789999995322 78999999999876543
|
| >2eyz_A V-CRK sarcoma virus CT10 oncogene homolog isoform A; SH2, SH3, signaling protein; NMR {Homo sapiens} PDB: 2l3s_A 2l3p_A 2l3q_A 2ggr_A | Back alignment and structure |
|---|
Probab=98.84 E-value=1.2e-09 Score=107.94 Aligned_cols=58 Identities=26% Similarity=0.358 Sum_probs=52.1
Q ss_pred CEEEEcccCC--CCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 33 DLWRALYDYD--AIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 33 ~~~~alyd~~--~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
..++|||||. +..++||+|++||+|.|++++ ++|||.|+++ ++.|+||+|||+.+...
T Consensus 238 ~~~~al~d~~~~a~~~~eL~~~~Gd~i~v~~~~-----~~gWw~g~~~----g~~G~fP~~yv~~~~~~ 297 (304)
T 2eyz_A 238 IYARVIQKRVPNAYDKTALALEVGELVKVTKIN-----VSGQWEGECN----GKRGHFPFTHVRLLDQQ 297 (304)
T ss_dssp CCSCCSSCBCCCTTCSSCCCBCTTSCCEEEEEC-----TTSCEEEEET----TEEEECCCTTSCCCSSC
T ss_pred EEEEEeeeecCCCCCCCeecccCCCEEEEEEec-----CCCeEEEEEC----CceEEechHHEEECCCC
Confidence 5789999999 779999999999999999985 7899999988 68999999999986543
|
| >2eyz_A V-CRK sarcoma virus CT10 oncogene homolog isoform A; SH2, SH3, signaling protein; NMR {Homo sapiens} PDB: 2l3s_A 2l3p_A 2l3q_A 2ggr_A | Back alignment and structure |
|---|
Probab=98.81 E-value=4.4e-09 Score=104.00 Aligned_cols=60 Identities=25% Similarity=0.614 Sum_probs=52.7
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|||||.++.++||+|++||+|.|++++ +++||.|+..+ ++.|+||+|||+....
T Consensus 133 ~~~~~~alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~~---g~~G~~P~~yv~~~~~ 192 (304)
T 2eyz_A 133 EAEYVRALFDFNGNDEEDLPFKKGDILRIRDKP-----EEQWWNAEDSE---GKRGMIPVPYVEKYRP 192 (304)
T ss_dssp CCCEEEECSCCCCSCSSSCCCCTTCEEEEEECC-----SSSEEEEECTT---SCEEEEESTTEEECCC
T ss_pred cceeEEEEeeecCCCCCcCcccCCCEEEEEEec-----CCCcEEEEeCC---CceeccchhccccccC
Confidence 346899999999999999999999999999985 78999999432 7899999999997654
|
| >2pz1_A RHO guanine nucleotide exchange factor 4; helical bundle, beta barrel, beta sandwich, signaling protei; 2.25A {Homo sapiens} PDB: 2dx1_A 3nmz_D 3nmx_D | Back alignment and structure |
|---|
Probab=98.78 E-value=4.7e-09 Score=110.35 Aligned_cols=59 Identities=31% Similarity=0.564 Sum_probs=53.1
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....++|+|||.+..++||+|++||+|.|+++. ++|||.|+.+ |+.|+||+|||+....
T Consensus 29 ~~~~~~al~~~~~~~~~eL~~~~gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 87 (466)
T 2pz1_A 29 SVVCAEALWDHVTMDDQELGFKAGDVIEVMDAT-----NREWWWGRVA----DGEGWFPASFVRLRVN 87 (466)
T ss_dssp CCEEEEESSCBCCCCTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEECSC
T ss_pred CccEEEEccccCCCCCCcCCCCCCCEEEEEEec-----CCCEEEEEEC----CcEEEEehhHeeeccC
Confidence 357899999999999999999999999999984 7899999987 6899999999987544
|
| >1gri_A Growth factor bound protein 2; SH2, SH3, signal transduction adaptor; 3.10A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 d.93.1.1 PDB: 1aze_A 2a37_A 2azv_A 2a36_A 2azs_A | Back alignment and structure |
|---|
Probab=98.78 E-value=3.4e-09 Score=99.67 Aligned_cols=55 Identities=36% Similarity=0.658 Sum_probs=45.3
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.++|+|||+++.++||+|++||+|.|+++. .+++||.++.+ ++.|+||.|||+..
T Consensus 2 ~~~al~~~~~~~~~eLs~~~Gd~i~v~~~~----~~~~W~~~~~~----g~~G~~P~~yv~~~ 56 (217)
T 1gri_A 2 EAIAKYDFKATADDELSFKRGDILKVLNEE----CDQNWYKAELN----GKDGFIPKNYIEMK 56 (217)
T ss_dssp EEEECSCBCCCSSSCCCBCTTCEEEC----------CCEEEEESS----SCEEEEEGGGEECC
T ss_pred EEEEeeccCCcCCCcCCCCCCCEEEEEecc----CCCCeEeeccC----CccceECCcccccc
Confidence 589999999999999999999999999874 36799999976 78999999999854
|
| >1tuc_A Alpha-spectrin; capping protein, calcium-binding, duplication, repeat, SH3 domain, cytoskeleton; 2.02A {Gallus gallus} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=98.77 E-value=5.8e-09 Score=77.38 Aligned_cols=45 Identities=27% Similarity=0.773 Sum_probs=39.7
Q ss_pred CCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 45 GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 45 ~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
+++||+|++||+|.|+++. +++||.|+.+ ++.|+||+|||+....
T Consensus 2 ~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 46 (63)
T 1tuc_A 2 GPREVTMKKGDILTLLNST-----NKDWWKVEVN----DRQGFVPAAYVKKLDS 46 (63)
T ss_dssp CCCCCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEECSC
T ss_pred CccccCCCCCCEEEEEEec-----CCCEEEEEEC----CcEEEEeHHHEEEcCC
Confidence 5789999999999999985 7899999876 7899999999987644
|
| >1ri9_A FYN-binding protein; SH3-like, helically extended, signaling protein; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=98.77 E-value=3.3e-09 Score=83.95 Aligned_cols=57 Identities=16% Similarity=0.170 Sum_probs=49.1
Q ss_pred CEEEEcccC--CCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 33 DLWRALYDY--DAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 33 ~~~~alyd~--~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
..++|+|+| ...+..||+|++|++++|+..+ +++||.+++.. |+.|++|.|||...+
T Consensus 40 ~~~~a~~~f~~~k~g~~DLpfkkGE~LeVI~~~-----e~~wwLcRNs~---GkyGyVP~~yl~~~d 98 (102)
T 1ri9_A 40 YSTKVTTSITSKKWGTRDLQVKPGESLEVIQTT-----DDTKVLCRNEE---GKYGYVLRSYLADND 98 (102)
T ss_dssp SCCBCCTTSCSSCCCTTBCCCCTTCBCEEEEES-----SSSEEEEEETT---TEEEEEEGGGSCC--
T ss_pred EEEEEeeccccccCCcccCCcCCCCEEEEEEeC-----CCCEEEEECCC---CCCCceeHHHhcccc
Confidence 357789999 7778999999999999999996 56999999875 899999999998654
|
| >3qwy_A Cell death abnormality protein 2; cell engulfment, signaling protein; 2.52A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=98.74 E-value=6.6e-09 Score=102.97 Aligned_cols=56 Identities=23% Similarity=0.531 Sum_probs=50.2
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
..++|+|||+++.++||+|++||+|.|++++ +++||.|+..+ ++.|+||+|||+..
T Consensus 148 ~~~~al~dy~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~~---g~~G~~P~~yv~~~ 203 (308)
T 3qwy_A 148 EVVVGTFKFTGERETDLPFEQGERLEILSKT-----NQDWWEARNAL---GTTGLVPANYVQIQ 203 (308)
T ss_dssp EEEEESSCBCCSSTTBCCBCTTCEEEEEECC-----SSSEEEEECTT---SCEEEEEGGGEEEC
T ss_pred eeEEEeceEcCCCCCcCcCCCCCEEEEEEcC-----CCCeEEEEeCC---CCeeEecccccccc
Confidence 5799999999999999999999999999985 78999999622 78999999999943
|
| >2jmc_A Spectrin alpha chain, brain and P41 peptide chimera; SPC-SH3, signaling protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.72 E-value=5.9e-09 Score=80.73 Aligned_cols=47 Identities=28% Similarity=0.775 Sum_probs=41.5
Q ss_pred CCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 43 AIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 43 ~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
++..+||+|++||+|.|+++. +++||.|+.+ ++.|+||.|||+....
T Consensus 2 a~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~~~~ 48 (77)
T 2jmc_A 2 AMGPREVTMKKGDILTLLNST-----NKDWWKVEVN----DRQGFVPAAYVKKLDS 48 (77)
T ss_dssp CSSSCCCCCCTTCEEECCCCC-----CSSCCCEEET----TEEECCCGGGEEECCC
T ss_pred CcCCCccCCCCCCEEEEEEec-----CCCEEEEEEC----CcEEEEEeeEEEEcCC
Confidence 578899999999999999985 7899999976 7899999999987643
|
| >1kjw_A Postsynaptic density protein 95; protein-protein interaction, scaffold, neuropeptide; 1.80A {Rattus norvegicus} SCOP: b.34.2.1 c.37.1.1 PDB: 1jxm_A* 1jxo_A | Back alignment and structure |
|---|
Probab=98.71 E-value=2.5e-09 Score=105.08 Aligned_cols=59 Identities=29% Similarity=0.509 Sum_probs=50.2
Q ss_pred EEEEcccCCCCCCC-----CCcccCCCEEEEeecCCCCCCCCceeEEEecCcc--cceecccccCcccccc
Q psy6905 34 LWRALYDYDAIGLD-----ELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKI--EYKVGIFPANFVSSIE 97 (527)
Q Consensus 34 ~~~alyd~~~~~~~-----eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~--~~~~G~~P~~yv~~~~ 97 (527)
+++|+|||+++.++ ||+|++||++.|+++. ++|||.|+..+.. .+..|+||+||+....
T Consensus 3 ~vrAlydy~~~~~~~~p~~eLsf~~GDil~V~~~~-----d~~WW~a~~~~~~~~~~~~G~iPsny~~e~~ 68 (295)
T 1kjw_A 3 YIRALFDYDKTKDCGFLSQALSFRFGDVLHVIDAG-----DEEWWQARRVHSDSETDDIGFIPSKRRVERR 68 (295)
T ss_dssp EEEESSCBCHHHHHCCCSSBCCBCTTCEEEEEECC-----SSSEEEEEECCSSCCCSCCEEEECHHHHHHH
T ss_pred EEEEeeccCCCCCCCCCCcCCcCCCCCEEEEEEeC-----CCCeEEEEECCCCCccCceeEeecHHHHHHH
Confidence 68999999999888 9999999999999984 7899999976421 1378999999997643
|
| >2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.9e-09 Score=106.49 Aligned_cols=59 Identities=27% Similarity=0.445 Sum_probs=51.2
Q ss_pred CCEEEEcccCCCCC--CCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 32 PDLWRALYDYDAIG--LDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 32 ~~~~~alyd~~~~~--~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
...++|||||.++. ++||+|++||+|.|++++ ++|||.|+++ |+.|+||+|||+.+...
T Consensus 237 ~~~~~alydy~~~~~~~~eLs~~~Gd~i~v~~~~-----~~gWw~g~~~----g~~G~fP~~yv~~~~~~ 297 (303)
T 2lqn_A 237 PVFAKAIQKRVPCAYDKTALALEVGDIVKVTRMN-----INGQWEGEVN----GRKGLFPFTHVKIFDPQ 297 (303)
Confidence 46799999998555 779999999999999884 7899999987 78999999999986543
|
| >3haj_A Human pacsin2 F-BAR; pacsin,syndapin,FAP52,F-BAR, alternative splicing, coiled coil, cytoplasmic vesicle, endocytosis, phosphoprotein, polymorphism; 2.78A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.67 E-value=2.3e-09 Score=113.07 Aligned_cols=58 Identities=38% Similarity=0.773 Sum_probs=0.0
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
+..++|||||.++.++||+|++||+|.|+.+. +++|||.|++.+ |+.|+||+|||+.+
T Consensus 428 ~~~~~alydy~~~~~~eLsf~~Gd~i~vl~~~----~~~~Ww~g~~~~---g~~G~~P~nyv~~i 485 (486)
T 3haj_A 428 EVRVRALYDYEGQEHDELSFKAGDELTKMEDE----DEQGWCKGRLDN---GQVGLYPANYVEAI 485 (486)
T ss_dssp -----------------------------------------------------------------
T ss_pred CeEEEEccccCCCCCCcCccCCCCEEEEEEec----CCCCeeEEEeCC---CCEEEEeHHHceeC
Confidence 46799999999999999999999999999874 356999999873 68999999999864
|
| >2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=2.5e-09 Score=105.67 Aligned_cols=59 Identities=24% Similarity=0.678 Sum_probs=52.2
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
..++|||||+++.++||+|++||+|.|++++ +++||.|+..+ ++.|+||+|||+.....
T Consensus 126 ~~~~alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~~~~~~---g~~G~~P~~yv~~~~~~ 184 (303)
T 2lqn_A 126 EYVRTLYDFPGNDAEDLPFKKGEILVIIEKP-----EEQWWSARNKD---GRVGMIPVPYVEKLVRS 184 (303)
Confidence 5799999999999999999999999999985 78999999532 78999999999976543
|
| >2gtj_A FYN-binding protein; SH3, redox, signaling protein; NMR {Homo sapiens} PDB: 2gto_A | Back alignment and structure |
|---|
Probab=98.62 E-value=2.5e-08 Score=78.28 Aligned_cols=56 Identities=25% Similarity=0.389 Sum_probs=48.5
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
..++|+|+ ...+..||+|++|++++|+..+ ..++|||.+++.. |..|++|.+||+.
T Consensus 29 ~~a~a~~~-~k~g~~dLp~~~GE~LeII~~~---e~p~g~Wl~RN~~---G~~GyVp~~~v~v 84 (96)
T 2gtj_A 29 HLAKACCD-VKGGKNELSFKQGEQIEIIRIT---DNPEGKWLGRTAR---GSYGYIKTTAVEI 84 (96)
T ss_dssp EEEEESSC-EECTTSCCEECTTCCEEEEECT---TCSSSCCEEECTT---CCBCCCCGGGEEE
T ss_pred EEEEEeec-CCCCcccCCcCCCCEEEEEEcc---CCCCCeEEEECCC---CCCCccchhhEEE
Confidence 36899999 5679999999999999999996 2357999999875 8999999999875
|
| >3qwy_A Cell death abnormality protein 2; cell engulfment, signaling protein; 2.52A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=98.58 E-value=6.4e-09 Score=103.10 Aligned_cols=58 Identities=19% Similarity=0.369 Sum_probs=0.0
Q ss_pred CCEEEEcccC--CCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDY--DAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~--~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
...++|+||| ++..++||+|++||+|.|+.+. ++|||.|+++ |+.|+||+|||+.++.
T Consensus 247 ~~~a~alyd~~~~~~~~~ELs~~~Gd~i~v~~~~-----~~~ww~g~~~----g~~G~fP~~yv~~~~~ 306 (308)
T 3qwy_A 247 PAKAKVTFDRVPNAYDPTQLRVKKGQTVLVTQKM-----SNGMYKAELD----GQIGSVPHTYLRFTAV 306 (308)
T ss_dssp ---------------------------------------------------------------------
T ss_pred ccccccccccccccCCcccceeCCCCEEEEEEEc-----CCCcEEEEEC----CeeEEechHHeEEecC
Confidence 3578999999 4555699999999999999984 6899999887 6899999999997654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.3e-06 Score=86.24 Aligned_cols=139 Identities=22% Similarity=0.156 Sum_probs=95.2
Q ss_pred eeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCC---ccceEEEEEE-eCCeEEEEEeccCC
Q psy6905 122 GEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHR---NIVSLIGVCL-QSPKLCLVMEYARG 197 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hp---nIv~~~~~~~-~~~~~~iv~Ey~~g 197 (527)
.+.++.|....||+. +..+++|+... ......+..|+.+|..+.+. .+.+.+.++. ..+..|+||||++|
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 345888999999987 67899998532 23456788999999998653 3567777764 34557899999999
Q ss_pred CCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q psy6905 198 GPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQ---------------------------------------------- 231 (527)
Q Consensus 198 gsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~---------------------------------------------- 231 (527)
.+|....- ..++......++.++...|..||+.
T Consensus 98 ~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 176 (306)
T 3tdw_A 98 QILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF 176 (306)
T ss_dssp EECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred eECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence 88865321 2334555555556666666666542
Q ss_pred -----------CCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 232 -----------APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 232 -----------g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
.+..++|+|++|.|||++.+..+ ...+.|+||+.+.
T Consensus 177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~----~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQ----TPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSS----CCEEEECCCTTCE
T ss_pred HHHHhCcccccCCCeeEeCCCCcccEEEecCCCC----CceEEEEehhhcC
Confidence 12246999999999999862100 1345899999874
|
| >4dey_A Voltage-dependent L-type calcium channel subunit; maguk, voltage dependent calcium channel, transport protein; 1.95A {Oryctolagus cuniculus} PDB: 4dex_A 1t3l_A 1t3s_A 1vyv_A 1vyu_A 1vyt_A 1t0h_B 1t0j_B 1t0h_A 1t0j_A | Back alignment and structure |
|---|
Probab=98.49 E-value=6.6e-08 Score=94.87 Aligned_cols=55 Identities=24% Similarity=0.463 Sum_probs=47.0
Q ss_pred CEEEEcccCCCCCCCC-------CcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcc
Q psy6905 33 DLWRALYDYDAIGLDE-------LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93 (527)
Q Consensus 33 ~~~~alyd~~~~~~~e-------L~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv 93 (527)
.+++|+|||++..+++ |+|++||++.|++++ +++||.|+..+. .+..|++|+++.
T Consensus 39 ~~vrAlfdY~~~~d~d~P~~e~~LsF~~GDiL~V~~~~-----d~~WWqar~~~~-~g~~GlIPS~~~ 100 (337)
T 4dey_A 39 FAVRTNVSYSAAHEDDVPVPGMAISFEAKDFLHVKEKF-----NNDWWIGRLVKE-GCEIGFIPSPVK 100 (337)
T ss_dssp EEEEESSCBCCCGGGCCSSTTCBCCBCTTCEEEEEEEC-----SSSEEEEEESST-TCCCEEEECHHH
T ss_pred EEEEEccccCCCCCCCCCcccccccccCCCEEEEEecC-----CCCeEEEEECCC-CCCccEecCHHH
Confidence 5899999999998876 999999999999985 789999997431 157899999883
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=4.4e-06 Score=80.60 Aligned_cols=132 Identities=18% Similarity=0.172 Sum_probs=94.0
Q ss_pred eccCCce-EEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEEEeccCCCCH
Q psy6905 125 IGEGGFG-KVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLVMEYARGGPL 200 (527)
Q Consensus 125 iG~G~fg-~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv~Ey~~ggsL 200 (527)
+..|..| .||+.... +..+++|+.... ....+.+|+..|+.|. +--+.++++++.+.+..|+|||+++|.++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 4455555 68986653 457999986543 3556788999998874 33367889999999999999999999888
Q ss_pred HHHhcCCCCChhHHHHHHHHHHHHHHHHHhcC------------------------------------------------
Q psy6905 201 NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA------------------------------------------------ 232 (527)
Q Consensus 201 ~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g------------------------------------------------ 232 (527)
.+.... .......++.++...|.-||...
T Consensus 108 ~~~~~~---~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 108 FQVLEE---YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHHH---CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred cccccC---CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 766431 22334455666677777777421
Q ss_pred -------CCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 233 -------PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 233 -------~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+..++|+|+.+.|||++.. +.+-|+||+.+.
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~~~--------~~~~viDwe~a~ 222 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFDEG--------KLIGCIDVGRVG 222 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEETT--------EEEEECCCTTCE
T ss_pred hcccccCCcEEEcCCCCCCeEEEECC--------eEEEEEECcccc
Confidence 1137999999999999864 456799999874
|
| >1ug1_A KIAA1010 protein; structural genomics, SH3 domain, hypothetical protein BAA76854.1, riken structural genomics/proteomics initiative RSGI; NMR {Homo sapiens} SCOP: b.34.2.1 | Back alignment and structure |
|---|
Probab=98.36 E-value=6.2e-07 Score=69.24 Aligned_cols=64 Identities=20% Similarity=0.366 Sum_probs=53.7
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDIN 100 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~ 100 (527)
..+|.+..+|.+...-||++++||+|.|+.+.+...+...||..+ . ++.|++|++|++......
T Consensus 17 ~~LY~~t~~~~~tq~~dl~l~~GdlVAVl~k~Dp~Gn~srW~Vdt-g----g~~GyvPs~yLe~~~~~~ 80 (92)
T 1ug1_A 17 EKLFQAERNFNAAQDLDVSLLEGDLVGVIKKKDPMGSQNRWLIDN-G----VTKGFVYSSFLKPYNPRR 80 (92)
T ss_dssp GGEEEESSCCCCCSSSCCCCCTTCEEEEEESCCTTSCSSEEEEEC-S----SSEEEEEGGGEEECCCCS
T ss_pred hheEEeccCcCCCCceeeeecCCCEEEEEecCCCCCCCcceEEEC-C----CcEEeeEhhhceEcccCC
Confidence 468889999999999999999999999999987777766677444 3 899999999999876544
|
| >3pvl_A Myosin VIIA isoform 1; protein complex, novel folding, protein cargo binding, cargo proteins, motor protein-protein transport complex; 2.80A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.22 E-value=5.7e-07 Score=97.50 Aligned_cols=67 Identities=24% Similarity=0.310 Sum_probs=50.4
Q ss_pred CCCEEEEcccCC---CCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 31 RPDLWRALYDYD---AIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 31 ~~~~~~alyd~~---~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
...+++|||||. +.++++|+|++||+|.++........++|||.|++.-+ |+.|.||++||..+..+
T Consensus 572 rs~~~~Al~d~~~~~~~~~~~L~f~kGDlI~l~~~~~~~~~~~~W~~G~~~~~--g~~G~fP~~~V~~lptl 641 (655)
T 3pvl_A 572 RSKYVVALQDNPNPAGEESGFLSFAKGDLIILDHDTGEQVMNSGWANGINERT--KQRGDFPTDCVYVMPTV 641 (655)
T ss_dssp HCCEEEESSCCCC-----CCBCCCCTTCEEEESSCCHHHHHHSSEEEEEETTT--CCEEEEEGGGEEECCCS
T ss_pred cchhhhHHhhcccCCCCCCCcccccCCCEEEEccccCcccCCCCeEEEEeCCC--CceEEeEhhhEEECCCC
Confidence 346899999999 67888999999999999876211112579999996432 89999999999876554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=6.8e-06 Score=82.77 Aligned_cols=80 Identities=11% Similarity=0.063 Sum_probs=54.7
Q ss_pred eeee-ccCCceEEEEeeEc--------CceEEEEEcCCCCC--hhHHHHHHHHHHHHHhCC-C--CccceEEEEEEeC--
Q psy6905 122 GEAI-GEGGFGKVYKGIYE--------KQEVAIKVAHPNPD--ENILENVKQEGKLLWLFD-H--RNIVSLIGVCLQS-- 185 (527)
Q Consensus 122 ~~~i-G~G~fg~Vy~~~~~--------~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h--pnIv~~~~~~~~~-- 185 (527)
.+.| +.|....+|+.... +..+++|+...... ......+..|+.+++.|. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4568 88999999998765 67899998754320 000134567888887773 2 3567888887655
Q ss_pred -CeEEEEEeccCCCCHH
Q psy6905 186 -PKLCLVMEYARGGPLN 201 (527)
Q Consensus 186 -~~~~iv~Ey~~ggsL~ 201 (527)
...|+||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999886653
|
| >3tsz_A Tight junction protein ZO-1; PDZ3-SH3-GUK, scaffolding, JAM, tight junction, cell adhesio; 2.50A {Homo sapiens} PDB: 3tsw_A 3lh5_A | Back alignment and structure |
|---|
Probab=98.20 E-value=8.3e-07 Score=90.50 Aligned_cols=64 Identities=23% Similarity=0.387 Sum_probs=50.1
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcc--cceecccccCccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKI--EYKVGIFPANFVSSI 96 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~--~~~~G~~P~~yv~~~ 96 (527)
+..+++|+|||++..+++|+|++||++.|++.. ..++.+||.|+..+.. ....|++|+||+...
T Consensus 105 ~~~~vral~dy~~~~~~~Lsf~~Gdil~V~~~~--~~~d~~wW~a~~~~~~~~~~~~G~IPs~~~~e~ 170 (391)
T 3tsz_A 105 DSFYIRTHFEYEKESPYGLSFNKGEVFRVVDTL--YNGKLGSWLAIRIGKNHKEVERGIIPNKNRAEQ 170 (391)
T ss_dssp CCEEEEECSCBCCSSTTBCCBCTTCEEEEEESS--GGGSSSEEEEEEECGGGCEEEEEEEECHHHHHH
T ss_pred cccccccccccCCCCCCcceEccCCEEEEEecc--CCCCCCeEEEEEeCCCCCcccCCEecCHHHHHH
Confidence 345677999999999999999999999999871 0126799999965431 125899999999863
|
| >3kfv_A Tight junction protein ZO-3; structural genomics consortium, SGC, cell junction, cell membrane, membrane, SH3 domain; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.17 E-value=9.6e-07 Score=86.27 Aligned_cols=64 Identities=22% Similarity=0.315 Sum_probs=46.3
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCC----CCCCceeEEEecCcc--cceecccccCcccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAI----SGDVGWWTGKIEGKI--EYKVGIFPANFVSS 95 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~----~~~~~ww~~~~~~k~--~~~~G~~P~~yv~~ 95 (527)
.-+++|+|||+++.+++|+|++||++.|++....- .+..|||.+..-+.. ....|++|.+|+..
T Consensus 4 sfyVRalfdy~~~~~~eL~F~kGDil~V~dt~~~~~~~~~~~~gwW~A~~~~~~~~~~~~G~IPs~~~ae 73 (308)
T 3kfv_A 4 SFYIRTHFELEPSPPSGLGFTRGDVFHVLDTLHPGPGQSHARGGHWLAVRMGRDLREQERGIIPNQSRAE 73 (308)
T ss_dssp CEEEEECSCBCCCSSSBCCBCTTCEEEEEEC-------------CEEEEEECTTSCEEEEEEECCHHHHH
T ss_pred cEEEEEecCcCCCCcccCCCccCCEEEEccccCCCcccccccCceEEEEecCCCCCcCCCCeeechHHHH
Confidence 34677999999999999999999999999874100 001359999964321 13689999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=4.6e-06 Score=85.46 Aligned_cols=75 Identities=17% Similarity=0.160 Sum_probs=48.8
Q ss_pred eeeeccCCceEEEEeeE--cCceEEEEEcCCCCC------hhHHHHHHHHHHHHHhCCC--C-ccceEEEEEEeCCeEEE
Q psy6905 122 GEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD------ENILENVKQEGKLLWLFDH--R-NIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~h--p-nIv~~~~~~~~~~~~~i 190 (527)
.+.||.|.++.||++.. .+..|+||....... ......+..|+.+++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 45799999999999964 457899997653211 0112345678888887632 3 34466654 3445589
Q ss_pred EEeccCCC
Q psy6905 191 VMEYARGG 198 (527)
Q Consensus 191 v~Ey~~gg 198 (527)
||||+.|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2xkx_A Disks large homolog 4; structural protein, scaffold protein, membrane associated GU kinase; 22.9A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.15 E-value=1.4e-06 Score=96.31 Aligned_cols=60 Identities=28% Similarity=0.460 Sum_probs=50.3
Q ss_pred CCEEEEcccCCCCCCCC-----CcccCCCEEEEeecCCCCCCCCceeEEEecCcc--cceecccccCccccc
Q psy6905 32 PDLWRALYDYDAIGLDE-----LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKI--EYKVGIFPANFVSSI 96 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~e-----L~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~--~~~~G~~P~~yv~~~ 96 (527)
..+++|+|||++..+++ |+|++||++.|+++. +++||.|+..+.. .+..|++|+||+...
T Consensus 427 ~~~vrAl~dy~~~~d~~~p~~~LsF~~GDil~v~~~~-----~~~WW~a~~~~~~~~~~~~G~iPs~~~~e~ 493 (721)
T 2xkx_A 427 GFYIRALFDYDKTKDCGFLSQALSFRFGDVLHVIDAG-----DEEWWQARRVHSDSETDDIGFIPSKRRVER 493 (721)
T ss_pred ceeEEEeeccCcCCCCCCccccccccCCCEEEEeecC-----CCCeEEEEECCCCCccCccceeecHHHHHH
Confidence 36778999999999999 999999999999985 7899999976421 135799999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.10 E-value=2.5e-05 Score=77.79 Aligned_cols=73 Identities=18% Similarity=0.189 Sum_probs=42.3
Q ss_pred eeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhC-----CCCccceEE-E--EEEeCCeEEEEEec
Q psy6905 123 EAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLF-----DHRNIVSLI-G--VCLQSPKLCLVMEY 194 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~hpnIv~~~-~--~~~~~~~~~iv~Ey 194 (527)
+.|+.|..+.||++...+..+++|+.... . ..+..|..++..| ..|.++... | +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~--~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP--E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC--H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC--H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 45677789999998877667999998763 2 2233344444433 234444310 1 12346678999999
Q ss_pred cCCCCH
Q psy6905 195 ARGGPL 200 (527)
Q Consensus 195 ~~ggsL 200 (527)
++|..+
T Consensus 113 i~G~~~ 118 (346)
T 2q83_A 113 IEGRPF 118 (346)
T ss_dssp CCCBCC
T ss_pred ecCccC
Confidence 998654
|
| >3shw_A Tight junction protein ZO-1; PDZ-SH3-GUK supramodule, cell adhesion; 2.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.04 E-value=2.6e-06 Score=88.23 Aligned_cols=63 Identities=24% Similarity=0.395 Sum_probs=49.5
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcc--cceecccccCccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKI--EYKVGIFPANFVSSI 96 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~--~~~~G~~P~~yv~~~ 96 (527)
..+++|+|||++..+.+|+|++||++.|++.. ..++.+||.|+.-+.. ....|++|+||+...
T Consensus 98 s~yVralfdy~~~~~~~LsF~~GDIL~V~d~~--~~~d~~wW~A~~~~~~~~~~~~GlIPs~~~~e~ 162 (468)
T 3shw_A 98 SFYIRTHFEYEKESPYGLSFNKGEVFRVVDTL--YNGKLGSWLAIRIGKNHKEVERGIIPNKNRAEQ 162 (468)
T ss_dssp CEEEEECSCBCCSSTTBCCBCTTCEEEEEESS--GGGCTTEEEEEEECTTSCEEEEEEEECHHHHHH
T ss_pred ccccccccCcCCCCCCCceEccCCEEEEeecc--cCCCCCeEEEEEcCCCCcccccceecCHHHHHH
Confidence 45778999999999999999999999999871 0026799999964321 126899999999763
|
| >3tvt_A Disks large 1 tumor suppressor protein; DLG, SRC-homology-3, guanylate kinase, phosphorylation-depen cell membrane; 1.60A {Drosophila melanogaster} PDB: 3uat_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=4.4e-06 Score=81.47 Aligned_cols=59 Identities=31% Similarity=0.548 Sum_probs=40.3
Q ss_pred CCEEEEcccCCCCCCC-----CCcccCCCEEEEeecCCCCCCCCceeEEEec--CcccceecccccCcccc
Q psy6905 32 PDLWRALYDYDAIGLD-----ELSLRRGDIVEVLSKDSAISGDVGWWTGKIE--GKIEYKVGIFPANFVSS 95 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~-----eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~--~k~~~~~G~~P~~yv~~ 95 (527)
..+++|+|||++..++ .|+|++||++.|++.+ +++||.|+.- +......|++|+.....
T Consensus 5 s~yvRa~fdY~~~~D~~~P~~gL~F~~gDiL~V~~~~-----d~~wWqA~~v~~~~~~~~~GlIPS~~~~e 70 (292)
T 3tvt_A 5 SLYVRALFDYDPNRDDGLPSRGLPFKHGDILHVTNAS-----DDEWWQARRVLGDNEDEQIGIVPSKRRWE 70 (292)
T ss_dssp CCEEEECSCBCC---------CCCBCTTCEEEEEECC-----SSSEEEECCCCC--------EEECHHHHH
T ss_pred eEEEEEeccCCCCCCCCCCCCcCCcCCCCEEEEeecC-----CCCeEEEEEeCCCCCccceeEEeChHHHH
Confidence 3689999999998776 4999999999999985 8899999953 11124589999976543
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=97.96 E-value=6.4e-06 Score=78.00 Aligned_cols=60 Identities=25% Similarity=0.631 Sum_probs=50.2
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..+.|+|||.+..+.+|.|++|++++|+.+... ++.+||.++.. ++.|+||.+||+....
T Consensus 171 ~~~~al~d~~~~~~~eLa~~~G~~i~vl~~~~~--~~~~Ww~~~~~----~~~G~~P~~yv~~~~~ 230 (239)
T 1ycs_B 171 GVIYALWDYEPQNDDELPMKEGDCMTIIHREDE--DEIEWWWARLN----DKEGYVPRNLLGLYPR 230 (239)
T ss_dssp GEEEESSCBCCSSTTBCCBCSSCEEEECCCCTT--SCSSEEEEEET----TEEEEEEGGGEECCC-
T ss_pred ceEEEEeccCCCCCCcccccCCCEEEEEEecCC--CCCCEEEEEEC----CcEEEeehHHeeECCc
Confidence 578999999999999999999999999988521 22359999987 7899999999987543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.94 E-value=7e-05 Score=73.95 Aligned_cols=75 Identities=17% Similarity=0.155 Sum_probs=60.9
Q ss_pred eeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC---CCccceEEEEEEeCCeEEEEEeccCCC
Q psy6905 122 GEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFD---HRNIVSLIGVCLQSPKLCLVMEYARGG 198 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~~~~~~~~~~~~~iv~Ey~~gg 198 (527)
.+.|+.|.+..+|+....+..+++|+.... ....+..|+..|+.|. ...+.+.+.++...+..|+||||++|.
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 467999999999998877788999987543 2456788988888873 356889999888888899999999988
Q ss_pred CH
Q psy6905 199 PL 200 (527)
Q Consensus 199 sL 200 (527)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.87 E-value=7.9e-05 Score=76.86 Aligned_cols=74 Identities=12% Similarity=0.098 Sum_probs=44.8
Q ss_pred eeeeccCCceEEEEeeEcCceEEEEEcCC-----CCC-h--hHHHHHHHHHHHHH-hCCCCccceEEEEEEeCCeEEEEE
Q psy6905 122 GEAIGEGGFGKVYKGIYEKQEVAIKVAHP-----NPD-E--NILENVKQEGKLLW-LFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~-----~~~-~--~~~~~~~~e~~~l~-~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
.+.||.|..+.||++...+..++||.... ... . .....+..|+..+. ......+.+++.+. .+..++||
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 35689999999999977677899993221 100 0 01122223332222 22334567777765 45569999
Q ss_pred ecc-CC
Q psy6905 193 EYA-RG 197 (527)
Q Consensus 193 Ey~-~g 197 (527)
||+ +|
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 77
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=97.73 E-value=2.1e-05 Score=73.29 Aligned_cols=55 Identities=33% Similarity=0.772 Sum_probs=49.9
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.+++|+|||+++.+++|+|++||++.|.+.. +.+||.+... ++.|++|.+|+...
T Consensus 15 ~~~~al~d~~~~~~~el~~~~Gd~~~v~~~~-----~~~w~~~~~~----g~~gl~p~~~v~~~ 69 (222)
T 3ehr_A 15 KVFRALYTFEPRTPDELYIEEGDIIYITDMS-----DTNWWKGTSK----GRTGLIPSNYVAEQ 69 (222)
T ss_dssp EEEEESSCCCCSSTTBCCCCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEHHHHHHH
T ss_pred eEEEEeCCcCCCCCCcccccCCCEEEEeccc-----cchhHhcccC----Ccceeechhhcccc
Confidence 6899999999999999999999999998874 7899999987 68999999998754
|
| >3pe0_A Plectin; cytoskeleton, plakin, spectrin repeat, SH3, structural prote intermediate filament, crosslinking; 2.95A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.53 E-value=6.1e-05 Score=73.17 Aligned_cols=56 Identities=14% Similarity=0.204 Sum_probs=45.5
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.+..++|+|||.+. ++++++||.+.+++.. +..||.++..+ |..|++|++|+....
T Consensus 197 ~~~~v~al~dy~~~---e~~~~kge~~~l~~~s-----~~~wW~v~~~~---G~~g~vPs~~~~ip~ 252 (283)
T 3pe0_A 197 GRLPLLAVCDYKQV---EVTVHKGDECQLVGPA-----QPSHWKVLSSS---GSEAAVPSVCFLVPP 252 (283)
T ss_dssp SCEEEEECSCEECS---SCEECTTCEEEEEEEC-----STTEEEEECC------EEEEEGGGEECCS
T ss_pred CCceEEeecCccCC---cccccCCCEEEEeeCC-----CCCceEEEcCC---CCEeeccceEEeeCC
Confidence 44789999999774 7999999999999973 67899999754 789999999998643
|
| >2dyb_A Neutrophil cytosol factor 4; P40(PHOX), NADPH oxidase, oxidoreductase; HET: CAF; 3.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.50 E-value=1.2e-06 Score=87.82 Aligned_cols=61 Identities=21% Similarity=0.347 Sum_probs=46.7
Q ss_pred CEEEEcccCCC----CCCCCCcc--cCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccC-cccccccc
Q psy6905 33 DLWRALYDYDA----IGLDELSL--RRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN-FVSSIEDI 99 (527)
Q Consensus 33 ~~~~alyd~~~----~~~~eL~~--~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~-yv~~~~~~ 99 (527)
..+.|+|||.+ .++.+|+| +.||+|.|+++. ++|||.|+.+|+ .|++|+||.+ ||+...+.
T Consensus 267 ~~~~a~yd~~~~~~~~~e~eL~~~~~~GD~I~v~~~~-----d~gWw~Ge~~g~-~G~~glfP~~~~v~~~~~~ 334 (341)
T 2dyb_A 267 PLLKDLLELTRREFQREDIALNYRDAEGDLVRLLSDE-----DVALMVRQARGL-PSQKRLFPWKLHITQKDNY 334 (341)
T ss_dssp CCHHHHHHHHHHHHTCSCEEEEEECSSSCEEECCSHH-----HHHHHHHHHTTS-CCBTTBCSSCEEEEECC--
T ss_pred cchhhhhhhhhhhcCCCcccccCCCCCCCEEEEeeec-----CCCEeEEEECCC-CCCCceecceeEEEecCCc
Confidence 45578999988 45555666 899999999984 789999997753 2678899999 77765554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00038 Score=69.16 Aligned_cols=74 Identities=5% Similarity=-0.034 Sum_probs=38.5
Q ss_pred eeeccCCceE-EEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCC--CCccceEEEEEEeCCeEEEEEeccCCC
Q psy6905 123 EAIGEGGFGK-VYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFD--HRNIVSLIGVCLQSPKLCLVMEYARGG 198 (527)
Q Consensus 123 ~~iG~G~fg~-Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--hpnIv~~~~~~~~~~~~~iv~Ey~~gg 198 (527)
+.|+.|+... +|+.... +..+++|....... ..+..|+.++..+. .-.+.+++.+..+.. +++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 3465555444 6676653 67788887655421 12334555555553 223566776644333 7899999776
Q ss_pred CHHH
Q psy6905 199 PLNR 202 (527)
Q Consensus 199 sL~~ 202 (527)
.+.+
T Consensus 98 ~l~~ 101 (333)
T 3csv_A 98 LFTE 101 (333)
T ss_dssp BHHH
T ss_pred chHH
Confidence 6643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.44 E-value=0.001 Score=61.16 Aligned_cols=138 Identities=12% Similarity=0.099 Sum_probs=89.0
Q ss_pred CCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhhc
Q psy6905 198 GPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK 275 (527)
Q Consensus 198 gsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~ 275 (527)
-+|.++|. +.++++++++.++.|.+.+|.-+-... .-..+=+.|..|++..+ |.|-+.+ +.+
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~d--------G~V~f~~-~~s----- 96 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRD--------GAVTLAP-AAD----- 96 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETT--------SCEEECC-C-------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecC--------Cceeccc-ccc-----
Confidence 36899987 889999999999999999987662111 01122345677887765 5666553 111
Q ss_pred cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHH
Q psy6905 276 TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLME 355 (527)
Q Consensus 276 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~ 355 (527)
......+.|||... ...+.+.=|||||+++|..+--..| ...+..+|+.+.+||.
T Consensus 97 -----~~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~ 151 (229)
T 2yle_A 97 -----DAGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLID 151 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHH
T ss_pred -----cccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHH
Confidence 11234567888764 2346788899999999998863222 1234568899999999
Q ss_pred Hhhhh-------------------------CCCCCCCHHHHHHHHh
Q psy6905 356 ACWEA-------------------------DSHMRPSFKTILKALN 376 (527)
Q Consensus 356 ~~l~~-------------------------dp~~RPs~~~ll~~L~ 376 (527)
.|... .+..|+++.++++.=.
T Consensus 152 ~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 152 HMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp HHTTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred HHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 99755 2467889999987543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0015 Score=63.35 Aligned_cols=79 Identities=13% Similarity=0.115 Sum_probs=54.7
Q ss_pred CceeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCC---CccceEEEEEEeCCeEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH---RNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h---pnIv~~~~~~~~~~~~~iv~ 192 (527)
.++.-++.+|.|..+.||+... +|+.|++|+....... ....+..|+..|+.|.- --+.+.+++ +.. ++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~--~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDR--TLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETT--EEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEec--cCc--eEEE
Confidence 3445567899999999999987 5789999987654221 12456789998888742 234555554 333 7899
Q ss_pred eccCCCCH
Q psy6905 193 EYARGGPL 200 (527)
Q Consensus 193 Ey~~ggsL 200 (527)
||+.++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00083 Score=66.18 Aligned_cols=140 Identities=16% Similarity=0.161 Sum_probs=76.5
Q ss_pred eeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCc--cceEEEE------EEeCCeEEEEE
Q psy6905 121 FGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN--IVSLIGV------CLQSPKLCLVM 192 (527)
Q Consensus 121 ~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~~~~~------~~~~~~~~iv~ 192 (527)
-.+.|+.|....||+....+..+++|+...... ...+..|+.++..|...+ +.+++.. ....+..+++|
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEECC---EEEEEEEESSCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred EeeccCCCcccceEEEEeCCccEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 345688898899999887666899999876311 123345666665552111 2233311 12345679999
Q ss_pred eccCCCCHHH-----------Hh---c--CCCCCh-----hHHHHH------------------HHHHHHHHHHHHhc--
Q psy6905 193 EYARGGPLNR-----------VL---A--GRKIRP-----DVLVDW------------------AIQIAEGMNYLHCQ-- 231 (527)
Q Consensus 193 Ey~~ggsL~~-----------~l---~--~~~~~~-----~~~~~i------------------~~qi~~~L~yLH~~-- 231 (527)
+|++|..+.. .+ . ...+.. .....| ...+...+.+++..
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9998865311 11 0 111110 000001 01134445555532
Q ss_pred --CCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 232 --APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 232 --g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
.+..++|+|+.+.|||++.+ +.+.|+||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~--------~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGD--------ELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETT--------EEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEeCC--------ceEEEecchhcc
Confidence 23358999999999999863 345799998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00054 Score=67.06 Aligned_cols=71 Identities=11% Similarity=0.116 Sum_probs=44.2
Q ss_pred eeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCcc-ceEEEEEEeCCeEEEEEecc-CCCC
Q psy6905 122 GEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNI-VSLIGVCLQSPKLCLVMEYA-RGGP 199 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~~~~~~~~~~~~~iv~Ey~-~ggs 199 (527)
.+.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++ .+++++. ...-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 567989999999998 67999988754211 1122457777766632223 4666543 32347899999 6554
Q ss_pred H
Q psy6905 200 L 200 (527)
Q Consensus 200 L 200 (527)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0014 Score=67.66 Aligned_cols=71 Identities=17% Similarity=0.198 Sum_probs=48.5
Q ss_pred eeeeccCCceEEEEeeEc---------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCcc-ceEEEEEEeCCeEEEE
Q psy6905 122 GEAIGEGGFGKVYKGIYE---------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNI-VSLIGVCLQSPKLCLV 191 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~~~~~~~~~~~~~iv 191 (527)
.+.|+.|....||++... +..+++|+...... ...+..|+.+++.|...++ .++++.+. + .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence 456888989999998864 36799999854222 1344578888887743333 57777654 2 389
Q ss_pred EeccCCCC
Q psy6905 192 MEYARGGP 199 (527)
Q Consensus 192 ~Ey~~ggs 199 (527)
+||++|.+
T Consensus 151 ~e~l~G~~ 158 (429)
T 1nw1_A 151 EEYIPSRP 158 (429)
T ss_dssp ECCCCEEE
T ss_pred EEEeCCcc
Confidence 99998644
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0036 Score=65.03 Aligned_cols=73 Identities=21% Similarity=0.192 Sum_probs=48.3
Q ss_pred eeeeccCCceEEEEeeEcC--ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCcc-ceEEEEEEeCCeEEEEEeccCCC
Q psy6905 122 GEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNI-VSLIGVCLQSPKLCLVMEYARGG 198 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~~~~~~~~~~~~~iv~Ey~~gg 198 (527)
.+.|+.|-...+|++...+ ..+++|+....... .-....|..++..|...++ .++++++. + .+||||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 4568889899999998865 78999987653211 1112478888888865444 57777763 3 3599999875
Q ss_pred CH
Q psy6905 199 PL 200 (527)
Q Consensus 199 sL 200 (527)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0014 Score=66.01 Aligned_cols=72 Identities=17% Similarity=0.167 Sum_probs=43.7
Q ss_pred eeeeccCCceEEEEeeEcC----------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCc-cceEEEEEEeCCeEEE
Q psy6905 122 GEAIGEGGFGKVYKGIYEK----------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN-IVSLIGVCLQSPKLCL 190 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~~~~~~~~~~~~~i 190 (527)
.+.|+.|....+|++...+ ..+++|+....... ......|..+++.+...+ +.++++.. .+ ++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence 3467888889999987643 67999987654211 112356777777764333 44676554 23 78
Q ss_pred EEeccCCCC
Q psy6905 191 VMEYARGGP 199 (527)
Q Consensus 191 v~Ey~~ggs 199 (527)
||||++|..
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0093 Score=58.67 Aligned_cols=74 Identities=11% Similarity=0.121 Sum_probs=46.1
Q ss_pred eeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCC--ccceEEEE-----EEeCCeEEEEEec
Q psy6905 123 EAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHR--NIVSLIGV-----CLQSPKLCLVMEY 194 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~~~~~-----~~~~~~~~iv~Ey 194 (527)
..|+ |....||+.... |+.+++|+....... ...+..|..++..|... .+++++.. ....+..+++|+|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~--~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC--HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3466 888899987764 557999998743211 23455677777666321 23444432 2234567899999
Q ss_pred cCCCC
Q psy6905 195 ARGGP 199 (527)
Q Consensus 195 ~~ggs 199 (527)
++|..
T Consensus 109 i~G~~ 113 (328)
T 1zyl_A 109 VGGRQ 113 (328)
T ss_dssp CCCEE
T ss_pred cCCCC
Confidence 98754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0037 Score=63.29 Aligned_cols=139 Identities=19% Similarity=0.279 Sum_probs=78.6
Q ss_pred eeeccCCceEEEEeeEc---------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEEE
Q psy6905 123 EAIGEGGFGKVYKGIYE---------KQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 123 ~~iG~G~fg~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv~ 192 (527)
+.|..|-...+|++... +..|++++...... ....+.+|..+++.|. +.-..++++++.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~--~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ--GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C--CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc--hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 46777888999998763 36799998654221 1345568888888774 2223567766543 3999
Q ss_pred eccCCCCHHH--------------Hhc---CC------CCC--hhHHHHHHHHHHH-------------------HHHHH
Q psy6905 193 EYARGGPLNR--------------VLA---GR------KIR--PDVLVDWAIQIAE-------------------GMNYL 228 (527)
Q Consensus 193 Ey~~ggsL~~--------------~l~---~~------~~~--~~~~~~i~~qi~~-------------------~L~yL 228 (527)
||++|..|.. .|. .- ... ...+..|..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998765421 111 11 111 2344455444321 23333
Q ss_pred H----h-cCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 229 H----C-QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 229 H----~-~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
. . ..+..++|+|+.+.|||++.+.. ..+.+.|+||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~----~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPE----NADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC-------CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCC----ccCcEEEEecccCC
Confidence 2 2 12345899999999999976410 12478999998774
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.013 Score=58.36 Aligned_cols=68 Identities=13% Similarity=0.064 Sum_probs=42.0
Q ss_pred ccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhC---CCCccceEEEE------EEeCCeEEEEEeccC
Q psy6905 126 GEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLF---DHRNIVSLIGV------CLQSPKLCLVMEYAR 196 (527)
Q Consensus 126 G~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l---~hpnIv~~~~~------~~~~~~~~iv~Ey~~ 196 (527)
|.|....||+....+..+++|+...... ..|+.++..| .-|++++.+.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g~~vLK~~~~~~~-------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESKSYFIKLKYGYHD-------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSCEEEEEEEECSSC-------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCCCEEEEEecCccc-------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444689999886555899998766532 2344444443 22324444432 233567899999999
Q ss_pred CCCH
Q psy6905 197 GGPL 200 (527)
Q Consensus 197 ggsL 200 (527)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8755
|
| >3r6n_A Desmoplakin; spectrin repeat, SH3 domain, cell adhesion, desmosome; 2.95A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0018 Score=66.76 Aligned_cols=57 Identities=21% Similarity=0.267 Sum_probs=48.8
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
..+..++|||||.. +++++.+||.+++++.. +..||.....+ |..|++|++|+....
T Consensus 281 ~~~~~V~alcdy~~---~e~~i~kge~~~L~~ns-----~~~~W~V~~~~---G~~~~vPavcf~ipp 337 (450)
T 3r6n_A 281 NKPIILRALCDYKQ---DQKIVHKGDECILKDNN-----ERSKWYVTGPG---GVDMLVPSVGLIIPP 337 (450)
T ss_dssp SSCCEEEESSCEEE---TTEEECTTCEEEEEECS-----SSSEEEEECSS---SCCEEEEGGGEECCS
T ss_pred CCCceEEEeccccC---CeeeEecCCEEEEecCC-----CCCceEEecCC---CCeeccceeEEecCC
Confidence 34578999999994 78999999999999984 78999999776 899999999987643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.69 E-value=0.023 Score=58.20 Aligned_cols=73 Identities=12% Similarity=0.129 Sum_probs=47.5
Q ss_pred eeeeccCCceEEEEeeEc---------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEE
Q psy6905 122 GEAIGEGGFGKVYKGIYE---------KQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv 191 (527)
.+.|..|-...+|+.... +..|++++....... .-...+|..+++.+. +.-..++++.+ .+ ++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~--~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK--FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C--CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch--hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence 356777888999998875 578999997654211 112346777777764 22245666543 23 789
Q ss_pred EeccCCCCH
Q psy6905 192 MEYARGGPL 200 (527)
Q Consensus 192 ~Ey~~ggsL 200 (527)
|||++|..|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.68 E-value=0.019 Score=58.46 Aligned_cols=34 Identities=29% Similarity=0.444 Sum_probs=25.0
Q ss_pred eeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 236 iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
++|+|+.+.|||+..+.. ....+.+.++||-+|.
T Consensus 246 fcHnDl~~gNil~~~~~~--~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRE--NSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGG--GCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcc--cCcCCeEEEechHhcc
Confidence 679999999999965321 1123679999998874
|
| >2jmc_A Spectrin alpha chain, brain and P41 peptide chimera; SPC-SH3, signaling protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=91.94 E-value=0.097 Score=39.55 Aligned_cols=23 Identities=35% Similarity=0.423 Sum_probs=20.7
Q ss_pred CCEEEEcccCCCCCCCCCcccCC
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRG 54 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~g 54 (527)
...++|+|||+++.++||+|.+.
T Consensus 52 ~~~~~alydy~a~~~dElsf~~~ 74 (77)
T 2jmc_A 52 KELVLALYDYQESGDNAPSYSPP 74 (77)
T ss_dssp CCEEEESSCCCCSSCCCCCSCCC
T ss_pred CceEEECCCcCCCCCCccccCCC
Confidence 36899999999999999999874
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.52 E-value=0.06 Score=55.86 Aligned_cols=61 Identities=11% Similarity=0.042 Sum_probs=18.6
Q ss_pred eeeeeccCCceEEEEeeEcC--ceEEE------EEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe
Q psy6905 121 FGEAIGEGGFGKVYKGIYEK--QEVAI------KVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ 184 (527)
Q Consensus 121 ~~~~iG~G~fg~Vy~~~~~~--~~vai------K~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~ 184 (527)
+.+.|| ||.||+|.+.+ .+||+ |...... ..+....+.+++.+++.++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 456776 99999999865 47888 6555422 22334567889999999999999999988654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.68 E-value=2.8 Score=38.25 Aligned_cols=115 Identities=9% Similarity=0.100 Sum_probs=78.8
Q ss_pred CCCccceEEEEEEeCCeEEEEEeccCCC-CHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecC
Q psy6905 171 DHRNIVSLIGVCLQSPKLCLVMEYARGG-PLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLS 249 (527)
Q Consensus 171 ~hpnIv~~~~~~~~~~~~~iv~Ey~~gg-sL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~ 249 (527)
.||+.+.. .+-.+++.+.+.++.-..+ ++.. + +.++....++++.+|+....+++. =+|--|+|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i--k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I--KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G--GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H--HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEEc
Confidence 78988876 5666777777766665422 3433 2 357788889999999887766654 37889999999999
Q ss_pred CCCcccccccceeEEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCC
Q psy6905 250 EPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYK 322 (527)
Q Consensus 250 ~~~~~~~~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~ 322 (527)
.+ +.+++.-.|+-..+ +|. .++...=+-.+=|++..+++++..|.
T Consensus 114 ~~--------~~p~i~~RGik~~l---------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 114 RD--------GLPIAKTRGLQNVV---------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TT--------SCEEESCCEETTTB---------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CC--------CCEEEEEccCccCC---------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 86 67899877764222 221 11222223357788999999988874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 527 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-73 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-65 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-64 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-54 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-53 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-51 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-46 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-19 | |
| d1bb9a_ | 83 | b.34.2.1 (A:) Amphiphysin 2 {Rat (Rattus norvegicu | 1e-16 | |
| d1gcqa_ | 56 | b.34.2.1 (A:) Growth factor receptor-bound protein | 7e-16 | |
| d1uhfa_ | 69 | b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Hom | 9e-16 | |
| d2hspa_ | 71 | b.34.2.1 (A:) Phospholipase C, SH3 domain {Human ( | 1e-15 | |
| d1ujya_ | 76 | b.34.2.1 (A:) Rac/CDC42 GEF 6 {Human (Homo sapiens | 2e-15 | |
| d1sema_ | 58 | b.34.2.1 (A:) Growth factor receptor-bound protein | 2e-15 | |
| d1utia_ | 57 | b.34.2.1 (A:) Grb2-related adaptor protein 2 (Mona | 3e-15 | |
| d1udla_ | 98 | b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Hom | 4e-15 | |
| d1uj0a_ | 58 | b.34.2.1 (A:) Signal transducing adaptor molecule | 5e-15 | |
| d1k4us_ | 62 | b.34.2.1 (S:) p67phox {Human (Homo sapiens) [TaxId | 6e-15 | |
| d1uhca_ | 79 | b.34.2.1 (A:) Hypothetical protein Baa76854.1 (KIA | 1e-14 | |
| d1awwa_ | 67 | b.34.2.1 (A:) Bruton's tyrosine kinase {Human (Hom | 1e-14 | |
| d1u06a1 | 55 | b.34.2.1 (A:7-61) alpha-Spectrin, SH3 domain {Chic | 2e-14 | |
| d1gria1 | 56 | b.34.2.1 (A:1-56) Growth factor receptor-bound pro | 3e-14 | |
| d1uffa_ | 93 | b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Hom | 3e-14 | |
| d1opka1 | 57 | b.34.2.1 (A:83-139) Abl tyrosine kinase, SH3 domai | 3e-14 | |
| d1j3ta_ | 74 | b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Hom | 4e-14 | |
| d1ycsb2 | 63 | b.34.2.1 (B:457-519) 53BP2 {Human (Homo sapiens) [ | 4e-14 | |
| d2v1ra1 | 67 | b.34.2.1 (A:10-76) Peroxisomal membrane protein Pe | 4e-14 | |
| d1efna_ | 57 | b.34.2.1 (A:) Fyn proto-oncogene tyrosine kinase, | 5e-14 | |
| d1oota_ | 58 | b.34.2.1 (A:) Hypothetical protein YFR024c {Baker' | 7e-14 | |
| d1ckaa_ | 57 | b.34.2.1 (A:) C-Crk, N-terminal SH3 domain {Mouse | 8e-14 | |
| d1ue9a_ | 80 | b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Hom | 9e-14 | |
| d1u5sa1 | 71 | b.34.2.1 (A:1-71) Nck-2 {Human (Homo sapiens) [Tax | 2e-13 | |
| d1jo8a_ | 58 | b.34.2.1 (A:) Actin binding protein ABP1 {Baker's | 2e-13 | |
| d1ng2a2 | 118 | b.34.2.1 (A:215-332) p47pox (neutrophil cytosolic | 2e-13 | |
| d1gl5a_ | 67 | b.34.2.1 (A:) tyrosine kinase tec {Mouse (Mus musc | 3e-13 | |
| d1fmka1 | 64 | b.34.2.1 (A:82-145) c-src protein tyrosine kinase | 3e-13 | |
| d1arka_ | 60 | b.34.2.1 (A:) SH3 domain from nebulin {Human (Homo | 4e-13 | |
| d1qcfa1 | 65 | b.34.2.1 (A:80-145) Hemapoetic cell kinase Hck {Hu | 5e-13 | |
| d1k9aa1 | 71 | b.34.2.1 (A:6-76) Carboxyl-terminal src kinase (cs | 5e-13 | |
| d2iima1 | 62 | b.34.2.1 (A:58-119) p56-lck tyrosine kinase, SH3 d | 1e-12 | |
| d1phta_ | 83 | b.34.2.1 (A:) Phosphatidylinositol 3-kinase (p85-a | 2e-12 | |
| d1ugva_ | 72 | b.34.2.1 (A:) Olygophrenin-1 like protein (KIAA062 | 5e-12 | |
| d1spka_ | 72 | b.34.2.1 (A:) BAI1-associated protein 2-like 1 (RI | 5e-12 | |
| d1zuua1 | 56 | b.34.2.1 (A:2-57) BZZ1 {Baker's yeast (Saccharomyc | 2e-11 | |
| d1i1ja_ | 106 | b.34.2.1 (A:) Melanoma inhibitory activity protein | 2e-11 | |
| d1gcqc_ | 69 | b.34.2.1 (C:) Vav N-terminal SH3 domain {Mouse (Mu | 4e-11 | |
| d2rn8a1 | 53 | b.34.2.1 (A:176-228) Bruton's tyrosine kinase {Mus | 6e-11 | |
| d1ng2a1 | 58 | b.34.2.1 (A:157-214) p47pox (neutrophil cytosolic | 7e-11 | |
| d1i07a_ | 59 | b.34.2.1 (A:) EPS8 SH3 domain {Mouse (Mus musculus | 2e-10 | |
| d1wlpb1 | 53 | b.34.2.1 (B:229-281) p47pox (neutrophil cytosolic | 3e-10 | |
| d1wiea_ | 96 | b.34.2.1 (A:) RIM binding protein 2, RIMBP2 {Human | 1e-09 | |
| d1kjwa1 | 96 | b.34.2.1 (A:430-525) Psd-95 {Rat (Rattus norvegicu | 2e-08 | |
| d1wfwa_ | 74 | b.34.2.1 (A:) Kalirin-9a {Mouse (Mus musculus) [Ta | 2e-08 | |
| d1ug1a_ | 92 | b.34.2.1 (A:) Hypothetical protein Baa76854.1 (KIA | 6e-08 | |
| d1t0ha_ | 96 | b.34.2.1 (A:) SH3-like domain of the L-type calciu | 2e-07 | |
| d1vyva1 | 145 | b.34.2.1 (A:71-215) SH3-like domain of the L-type | 1e-05 | |
| d1vyua1 | 136 | b.34.2.1 (A:39-174) SH3-like domain of the L-type | 1e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 9e-73
Identities = 97/283 (34%), Positives = 144/283 (50%), Gaps = 27/283 (9%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPN-PDENILENVKQEGKLLWLFD 171
EI ++ G+ IG G FG VYKG + +VA+K+ + P L+ K E +L
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLH 229
H NI+ +G +P+L +V ++ G L L K L+D A Q A+GM+YLH
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK----TTHMSAAGTY 285
+ S+IHRDLKS+N+ L E T+KI DFGLA + +G+
Sbjct: 122 AK---SIIHRDLKSNNIFLHED--------LTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 286 AWMAPEVIKT---SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP- 341
WMAPEVI+ + +S SDV+++G+VL+EL+TG++PY +IN + P
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 342 ---IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381
+ S CP+ K LM C + RP F IL ++ + S
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-67
Identities = 84/271 (30%), Positives = 130/271 (47%), Gaps = 21/271 (7%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
++ +L + IG+G FG V G Y +VA+K ++ + E ++ H
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK---NDATAQAFLAEASVMTQLRH 59
Query: 173 RNIVSLIGVCLQSP-KLCLVMEYARGGPLNRVLAGRKIRP---DVLVDWAIQIAEGMNYL 228
N+V L+GV ++ L +V EY G L L R D L+ +++ + E M YL
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM 288
+ +HRDL + NVL+SE K++DFGL +E +T + W
Sbjct: 120 EGN---NFVHRDLAARNVLVSED--------NVAKVSDFGLTKEAS-STQDTGKLPVKWT 167
Query: 289 APEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347
APE ++ FS SDVWS+G++LWE+ + G +PY I V V + P CP
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCP 226
Query: 348 QLFKTLMEACWEADSHMRPSFKTILKALNNI 378
+M+ CW D+ MRPSF + + L +I
Sbjct: 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 3e-65
Identities = 96/296 (32%), Positives = 144/296 (48%), Gaps = 26/296 (8%)
Query: 110 KLVEIDYNKLIFGEA-IGEGGFGKVYKGIY----EKQEVAIKVAHPNPDENILENVKQEG 164
K + + + L+ + +G G FG V +G+Y ++ +VAIKV ++ E + +E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 165 KLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIA 222
+++ D+ IV LIGVC Q+ L LVME A GGPL++ L G++ I + + Q++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 223 EGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-----YKTT 277
GM YL + + +HRDL + NVLL KI+DFGL++ + Y T
Sbjct: 120 MGMKYLEEK---NFVHRDLAARNVLLVN--------RHYAKISDFGLSKALGADDSYYTA 168
Query: 278 HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVN 336
+ W APE I FS SDVWSYGV +WE L+ G+ PYK + V +
Sbjct: 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 228
Query: 337 KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFH 392
K + P CP LM CW RP F T+ + + +S + H
Sbjct: 229 K-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHH 283
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 4e-64
Identities = 91/301 (30%), Positives = 136/301 (45%), Gaps = 48/301 (15%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGI-------YEKQEVAIKVAHPNPDENILENVKQEGK 165
E L FG+ +G G FGKV +VA+K+ D + E + E K
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92
Query: 166 LLW-LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK---------------- 208
++ L H NIV+L+G C S + L+ EY G L L ++
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 209 --------IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260
+ + L+ +A Q+A+GM +L + S +HRDL + NVL++ K
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHG--------K 201
Query: 261 TLKITDFGLAREVYK----TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT 316
+KI DFGLAR++ +A WMAPE + I++ SDVWSYG++LWE+ +
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261
Query: 317 -GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
G PY I A Y + N + P + +M++CW DS RPSF + L
Sbjct: 262 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 376 N 376
Sbjct: 322 G 322
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-63
Identities = 61/258 (23%), Positives = 116/258 (44%), Gaps = 18/258 (6%)
Query: 121 FGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIV 176
G +G+G FG VY + K +A+KV + +++E ++ H NI+
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L G + ++ L++EYA G + R L K + ++A ++Y H +
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---R 126
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT 295
+IHRD+K N+LL LKI DFG + + + GT ++ PE+I+
Sbjct: 127 VIHRDIKPENLLLGSA--------GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 178
Query: 296 SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLME 355
+ + D+WS GV+ +E L G+ P+++ ++++ P + + L+
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK--RISRVEFTFPDFVTEGARDLIS 236
Query: 356 ACWEADSHMRPSFKTILK 373
+ + RP + +L+
Sbjct: 237 RLLKHNPSQRPMLREVLE 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-63
Identities = 80/273 (29%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFD 171
E+ L E +G G FG+V+ G Y +VA+K + E L+
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQ 66
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL---AGRKIRPDVLVDWAIQIAEGMNYL 228
H+ +V L V Q P + ++ EY G L L +G K+ + L+D A QIAEGM ++
Sbjct: 67 HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM---SAAGTY 285
+ + IHRDL+++N+L+S+ + KI DFGLAR + + A
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSC--------KIADFGLARLIEDNEYTAREGAKFPI 174
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST 345
W APE I F+ SDVWS+G++L E++T + P
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234
Query: 346 CPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
CP+ LM CW+ RP+F + L +
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (528), Expect = 2e-63
Identities = 77/311 (24%), Positives = 130/311 (41%), Gaps = 33/311 (10%)
Query: 125 IGEGGFGKVYKGIYEK--QEVAIKVAHPN--PDENILENVKQEGKLLWLFDHRNIVSLIG 180
IG G FG VY + + VAIK + +++ +E + L H N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 181 VCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGMNYLHCQAPISLIHR 239
L+ LVMEY G + + +K ++ + +G+ YLH ++IHR
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHR 139
Query: 240 DLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTS--- 296
D+K+ N+LLSEP +K+ DFG A + GT WMAPEVI
Sbjct: 140 DVKAGNILLSEP--------GLVKLGDFGSASIMAPANSF--VGTPYWMAPEVILAMDEG 189
Query: 297 IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEA 356
+ DVWS G+ EL + P ++NA + Y +A N+ + F+ +++
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 357 CWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLHELRVKEKEL 416
C + RP+ + +LK F+ IM I++ +R +
Sbjct: 250 CLQKIPQDRPTSEVLLK-------HRFVLRERPPTVIMD-----LIQRTKDAVRELDNLQ 297
Query: 417 RSREEELTKAQ 427
+ +++ +
Sbjct: 298 YRKMKKILFQE 308
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-63
Identities = 74/264 (28%), Positives = 116/264 (43%), Gaps = 18/264 (6%)
Query: 119 LIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHP-NPDENILENVKQEGKLLWLFDHRNI 175
L F IG G F VYKG+ + EVA ++ + K+E ++L H NI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 176 VSLIGVCLQSPK----LCLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGMNYLHC 230
V + K + LV E G L L K ++ VL W QI +G+ +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAP 290
+ P +IHRDLK N+ ++ P ++KI D GLA + + GT +MAP
Sbjct: 131 RTP-PIIHRDLKCDNIFITGP-------TGSVKIGDLGLATLKRASFAKAVIGTPEFMAP 182
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT-LPIPSTCPQL 349
E+ + + ++ DV+++G+ + E+ T E PY A Y + +
Sbjct: 183 EMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 350 FKTLMEACWEADSHMRPSFKTILK 373
K ++E C + R S K +L
Sbjct: 242 VKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-63
Identities = 88/294 (29%), Positives = 134/294 (45%), Gaps = 30/294 (10%)
Query: 112 VEIDYNKLIFGE-AIGEGGFGKVYKGIYEK----QEVAIKVAHPNP-DENILENVKQEGK 165
V +D L + +G G FG V KG Y+ + VA+K+ D + + + E
Sbjct: 1 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEG 224
++ D+ IV +IG+C ++ LVME A GPLN+ L R ++ +++ Q++ G
Sbjct: 61 VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-----YKTTHM 279
M YL + +HRDL + NVLL KI+DFGL++ + Y
Sbjct: 120 MKYLEES---NFVHRDLAARNVLLVTQ--------HYAKISDFGLSKALRADENYYKAQT 168
Query: 280 SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338
W APE I FS SDVWS+GV++WE + G+ PY+ + V +
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGE 227
Query: 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFH 392
+ P+ CP+ LM CW D RP F + L N + +E H
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY----YYDVVNEGHH 277
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 7e-63
Identities = 77/272 (28%), Positives = 130/272 (47%), Gaps = 21/272 (7%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
ID L F + +G G FG V G + + +VAIK+ + +E K++ H
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSH 58
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR--PDVLVDWAIQIAEGMNYLHC 230
+V L GVC + + ++ EY G L L + R L++ + E M YL
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK---TTHMSAAGTYAW 287
+ +HRDL + N L+++ +K++DFGL+R V T+ + + W
Sbjct: 119 K---QFLHRDLAARNCLVNDQ--------GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346
PEV+ S FS SD+W++GV++WE+ + G++PY+ A + L L P
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLA 226
Query: 347 PQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
+ T+M +CW + RP+FK +L + ++
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 3e-62
Identities = 67/283 (23%), Positives = 125/283 (44%), Gaps = 16/283 (5%)
Query: 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWL 169
+E+ + +G G G V+K ++ +A K+ H I + +E ++L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGMNYL 228
+ IV G ++ + ME+ GG L++VL +I +L +I + +G+ YL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM 288
+ I +HRD+K SN+L++ +K+ DFG++ ++ + S GT ++M
Sbjct: 121 REKHKI--MHRDVKPSNILVNSR--------GEIKLCDFGVSGQLIDSMANSFVGTRSYM 170
Query: 289 APEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348
+PE ++ + +S SD+WS G+ L E+ G P +A + + + P
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE--LMFGCQVEGDAAETPP 228
Query: 349 LFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESF 391
+T RP I + L+ IV+ + P F
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMA-IFELLDYIVNEPPPKLPSGVF 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-61
Identities = 83/276 (30%), Positives = 117/276 (42%), Gaps = 21/276 (7%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFD 171
EI L +G+G FG+V+ G + VAIK P E QE +++
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLR 70
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRP---DVLVDWAIQIAEGMNYL 228
H +V L V + P + +V EY G L L G + LVD A QIA GM Y+
Sbjct: 71 HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK---TTHMSAAGTY 285
+ +HRDL+++N+L+ E K+ DFGLAR + T A
Sbjct: 130 ERM---NYVHRDLRAANILVGEN--------LVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPST 345
W APE F+ SDVWS+G++L EL T +P P
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238
Query: 346 CPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381
CP+ LM CW + RP+F+ + L + S
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (514), Expect = 2e-61
Identities = 87/285 (30%), Positives = 132/285 (46%), Gaps = 27/285 (9%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDENILENVKQEGKLL 167
EID + + + IG G FG+V G + VAIK E + E ++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV--LVDWAIQIAEGM 225
FDH N++ L GV +S + ++ E+ G L+ L + V LV IA GM
Sbjct: 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-------YKTTH 278
YL + +HRDL + N+L++ K++DFGL+R + T+
Sbjct: 142 KYLADM---NYVHRDLAARNILVNSN--------LVCKVSDFGLSRFLEDDTSDPTYTSA 190
Query: 279 MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNK 337
+ W APE I+ F+ ASDVWSYG+V+WE+++ GE PY + V +
Sbjct: 191 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQD 249
Query: 338 LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
LP P CP LM CW+ D + RP F I+ L+ ++ +
Sbjct: 250 YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-61
Identities = 74/262 (28%), Positives = 120/262 (45%), Gaps = 17/262 (6%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN 174
K E IG+G G VY + QEVAI+ + + E + E ++ + N
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPN 78
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPI 234
IV+ + L +L +VMEY GG L V+ + + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 235 SLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV--YKTTHMSAAGTYAWMAPEV 292
+IHRD+KS N+LL ++K+TDFG ++ ++ + GT WMAPEV
Sbjct: 136 QVIHRDIKSDNILLGMD--------GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 293 IKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLPIPSTCPQLFK 351
+ + D+WS G++ E++ GE PY + N Y +A N L P +F+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 352 TLMEACWEADSHMRPSFKTILK 373
+ C + D R S K +L+
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 6e-61
Identities = 80/274 (29%), Positives = 125/274 (45%), Gaps = 19/274 (6%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDH 172
ID ++L F + IG G FG V+ G + K +VAIK E+ +E +++ H
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSH 59
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR--PDVLVDWAIQIAEGMNYLHC 230
+V L GVCL+ +CLV E+ G L+ L ++ + L+ + + EGM YL
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK---TTHMSAAGTYAW 287
+IHRDL + N L+ E + +K++DFG+ R V T+ W
Sbjct: 120 A---CVIHRDLAARNCLVGEN--------QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 168
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCP 347
+PEV S +S SDVWS+GV++WE+ + + + L P
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS 228
Query: 348 QLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381
+M CW+ RP+F +L+ L I S
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 9e-61
Identities = 94/296 (31%), Positives = 145/296 (48%), Gaps = 29/296 (9%)
Query: 103 SSVINDVKLVEIDYNKLI--FGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNPDEN 155
++ V+ V I + LI F E IG G FG VY G +K A+K + D
Sbjct: 11 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 70
Query: 156 ILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-KLCLVMEYARGGPLNRVLAGRKIRPDV- 213
+ EG ++ F H N++SL+G+CL+S +V+ Y + G L + P V
Sbjct: 71 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 214 -LVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272
L+ + +Q+A+GM +L + +HRDL + N +L E T+K+ DFGLAR+
Sbjct: 131 DLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKF--------TVKVADFGLARD 179
Query: 273 VYK------TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSIN 325
+Y A WMA E ++T F+ SDVWS+GV+LWEL+T G PY +N
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239
Query: 326 AYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381
+ + + + L P CP +M CW + MRPSF ++ ++ I +
Sbjct: 240 TFDITVYL-LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-60
Identities = 77/265 (29%), Positives = 121/265 (45%), Gaps = 24/265 (9%)
Query: 121 FGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
+G+G FGKVYK ++ A KV E LE+ E +L DH NIV L
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKL 74
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
+ L +++E+ GG ++ V+ R + + Q + +NYLH +
Sbjct: 75 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KI 131
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK--TTHMSAAGTYAWMAPEVI- 293
IHRDLK+ N+L + +K+ DFG++ + + S GT WMAPEV+
Sbjct: 132 IHRDLKAGNILFTLD--------GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 294 ----KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPSTCPQ 348
K + +DVWS G+ L E+ E P+ +N V +A ++ TL PS
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243
Query: 349 LFKTLMEACWEADSHMRPSFKTILK 373
FK ++ C E + R + +L+
Sbjct: 244 NFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (501), Expect = 1e-59
Identities = 83/281 (29%), Positives = 133/281 (47%), Gaps = 21/281 (7%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLF 170
E++ + +G G +G+VY+G+++K VA+K + E +E +E ++
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEI 70
Query: 171 DHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNY 227
H N+V L+GVC + P ++ E+ G L L +++ VL+ A QI+ M Y
Sbjct: 71 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK---TTHMSAAGT 284
L + + IHRDL + N L+ E +K+ DFGL+R + T H A
Sbjct: 131 LEKK---NFIHRDLAARNCLVGEN--------HLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 285 YAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344
W APE + + FS SDVW++GV+LWE+ T + + Y + + P
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 239
Query: 345 TCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
CP+ LM ACW+ + RPSF I +A + I
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 2e-59
Identities = 67/273 (24%), Positives = 114/273 (41%), Gaps = 26/273 (9%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHP-NPDENILENVKQEGKLLWLFD 171
DY L IG G +G+ K + + + K + E + + E LL
Sbjct: 5 DYEVL---YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 172 HRNIVSLIGVCL--QSPKLCLVMEYARGGPLNRVLAGRK-----IRPDVLVDWAIQIAEG 224
H NIV + + L +VMEY GG L V+ + + ++ Q+
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 225 MNYLHCQAPIS--LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM--S 280
+ H ++ ++HRDLK +NV L + +K+ DFGLAR + T +
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGK--------QNVKLGDFGLARILNHDTSFAKA 173
Query: 281 AAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL 340
GT +M+PE + +++ SD+WS G +L+EL P+ + + +A + K
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-R 232
Query: 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
IP ++ + RPS + IL+
Sbjct: 233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-59
Identities = 87/277 (31%), Positives = 128/277 (46%), Gaps = 27/277 (9%)
Query: 114 IDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNP--DENILENVKQEGKL 166
I L E +G+G FG V +G + + VA+K P+ +++ +E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR--PDVLVDWAIQIAEG 224
+ DHRN++ L GV +P + +V E A G L L + L +A+Q+AEG
Sbjct: 65 MHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-----YKTTHM 279
M YL + IHRDL + N+LL+ +KI DFGL R + +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLA--------TRDLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 280 SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338
+AW APE +KT FS ASD W +GV LWE+ T G+ P+ +N + + +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232
Query: 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
LP P CPQ +M CW RP+F + L
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-59
Identities = 87/294 (29%), Positives = 128/294 (43%), Gaps = 36/294 (12%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY----EKQEVAIKVAHPNPDENILENVKQEGKLLW 168
+D+N + F + IGEG FG+V K + + AIK ++ + E ++L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 169 -LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL-----------------AGRKIR 210
L H NI++L+G C L L +EYA G L L +
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 211 PDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270
L+ +A +A GM+YL + IHRDL + N+L+ E KI DFGL+
Sbjct: 126 SQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY--------VAKIADFGLS 174
Query: 271 REVY-KTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYA 328
R WMA E + S+++ SDVWSYGV+LWE+++ G PY +
Sbjct: 175 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234
Query: 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
+ + L P C LM CW + RPSF IL +LN ++
Sbjct: 235 LYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 9e-59
Identities = 94/280 (33%), Positives = 135/280 (48%), Gaps = 22/280 (7%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEKQE-----VAIKVAHPNPDENILENVKQEGKLL 167
EI ++ G IGEG FG V++GIY E VAIK +++ E QE +
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 168 WLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDV--LVDWAIQIAEGM 225
FDH +IV LIGV ++P + ++ME G L L RK D+ L+ +A Q++ +
Sbjct: 63 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA---A 282
YL + +HRD+ + NVL+S +K+ DFGL+R + +T+ A
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSS--------NDCVKLGDFGLSRYMEDSTYYKASKGK 170
Query: 283 GTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI 342
WMAPE I F+ ASDVW +GV +WE+L + G N LP+
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 230
Query: 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382
P CP +LM CW D RP F + L+ I+ E
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 8e-58
Identities = 81/282 (28%), Positives = 125/282 (44%), Gaps = 24/282 (8%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKL 166
EI + + + IG G FG+VYKG+ ++ VAIK E + E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK--IRPDVLVDWAIQIAEG 224
+ F H NI+ L GV + + ++ EY G L++ L + LV IA G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-----TTHM 279
M YL + +HRDL + N+L++ + K++DFGL+R + T
Sbjct: 123 MKYLANM---NYVHRDLAARNILVNSNL--------VCKVSDFGLSRVLEDDPEATYTTS 171
Query: 280 SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT 339
W APE I F+ ASDVWS+G+V+WE++T + +
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231
Query: 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381
LP P CP LM CW+ + RP F I+ L+ ++ +
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 194 bits (493), Expect = 9e-58
Identities = 63/264 (23%), Positives = 111/264 (42%), Gaps = 17/264 (6%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN 174
+ E +G G FG V++ A K P E+ E V++E + + + H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHPT 84
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
+V+L ++ ++ E+ GG L + K+ D V++ Q+ +G+ ++H
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN- 143
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-YKTTHMSAAGTYAWMAPE 291
+ +H DLK N++ + NE LK+ DFGL + K + GT + APE
Sbjct: 144 --NYVHLDLKPENIMFTTKRSNE------LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 195
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPSTCPQL 349
V + +D+WS GV+ + LL+G P+ N V + S +
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255
Query: 350 FKTLMEACWEADSHMRPSFKTILK 373
K + AD + R + L+
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 1e-57
Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 20/262 (7%)
Query: 121 FGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
+ +GEG +G+V + + VA+K+ + EN+K+E + + +H N+V
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 179 IGVCLQSPKLCLVMEYARGG-PLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLI 237
G + L +EY GG +R+ + + Q+ G+ YLH +
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GIT 125
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV----YKTTHMSAAGTYAWMAPEVI 293
HRD+K N+LL E LKI+DFGLA + GT ++APE++
Sbjct: 126 HRDIKPENLLLDER--------DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 294 KTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK-LTLPIPSTCPQLFK 351
K F ++ DVWS G+VL +L GE+P+ + Y K L
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 352 TLMEACWEADSHMRPSFKTILK 373
L+ + R + I K
Sbjct: 238 ALLHKILVENPSARITIPDIKK 259
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 6e-57
Identities = 88/299 (29%), Positives = 138/299 (46%), Gaps = 43/299 (14%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGK 165
E N+L FG+ +G G FGKV + VA+K+ P+ E + E K
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 166 LLW-LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK---------------- 208
+L L +H NIV+L+G C ++ EY G L L ++
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 209 ---IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265
+ + L+ ++ Q+A+GM +L + + IHRDL + N+LL+ + KI
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG--------RITKIC 187
Query: 266 DFGLAREVYK----TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIP 320
DFGLAR++ +A WMAPE I +++ SDVWSYG+ LWEL + G P
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 321 YKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
Y + + Y + + P P +M+ CW+AD RP+FK I++ + +
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-56
Identities = 75/310 (24%), Positives = 125/310 (40%), Gaps = 51/310 (16%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIV 176
++ E+IG+G FG+V++G + +EVA+K+ + + + E + H NI+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFR--EAEIYQTVMLRHENIL 60
Query: 177 SLIGVCLQS----PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
I + +L LV +Y G L L + + ++ A+ A G+ +LH +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 233 PISL-----IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL------AREVYKTTHMSA 281
+ HRDLKS N+L+ + T I D GL A +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKN--------GTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 282 AGTYAWMAPEVIKTSI------FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAY---- 331
GT +MAPEV+ SI K +D+++ G+V WE+ Y + Y
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
Query: 332 -----------GVAVNKLTLPIPST-----CPQLFKTLMEACWEADSHMRPSFKTILKAL 375
V KL IP+ ++ +M CW A+ R + I K L
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
Query: 376 NNIVHSEFIQ 385
+ + E I+
Sbjct: 293 SQLSQQEGIK 302
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-56
Identities = 86/278 (30%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY------EKQEVAIKVAHPNPDENILENVKQEGKL 166
E ++ K+ + +G G FG VYKG++ K VAIK + + E +
Sbjct: 8 ETEFKKI---KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 167 LWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRP-DVLVDWAIQIAEGM 225
+ D+ ++ L+G+CL S + G L+ V + L++W +QIA+GM
Sbjct: 65 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV----YKTTHMSA 281
NYL + L+HRDL + NVL+ P + +KITDFGLA+ + +
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTP--------QHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 282 AGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340
WMA E I I++ SDVWSYGV +WEL+T G PY I A + + L
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERL 232
Query: 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNI 378
P P C +M CW D+ RP F+ ++ + +
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 190 bits (483), Expect = 2e-56
Identities = 64/341 (18%), Positives = 133/341 (39%), Gaps = 30/341 (8%)
Query: 121 FGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
E +G G FG V++ + + + K + P VK E ++ H +++L
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFIN-TPYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISL 236
++ L++E+ GG L +A K+ ++++ Q EG+ ++H S+
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 148
Query: 237 IHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-TTHMSAAGTYAWMAPEVIKT 295
+H D+K N++ + ++KI DFGLA ++ T + APE++
Sbjct: 149 VHLDIKPENIMCETKKAS------SVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 296 SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPSTCPQLFKTL 353
+D+W+ GV+ + LL+G P+ + V S+ K
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262
Query: 354 MEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGWRV-EIEQVLHELRVK 412
++ + + R + L+ +++ H + R +I Q ++K
Sbjct: 263 IKNLLQKEPRKRLTVHDALE-------HPWLKGDHSNLTSRIPSSRYNKIRQ-----KIK 310
Query: 413 EKELRSREEELTKAQMQQKLAEKELREREQAVAAREIDVLE 453
EK + ++ + ++ R +E + D E
Sbjct: 311 EKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 351
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (472), Expect = 2e-55
Identities = 89/303 (29%), Positives = 129/303 (42%), Gaps = 49/303 (16%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E N + + IGEG FG+V++ VA+K+ ++ + ++E
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK----------------- 208
L+ FD+ NIV L+GVC +CL+ EY G LN L
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 209 --------IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260
+ + A Q+A GM YL + +HRDL + N L+ E
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN--------M 177
Query: 261 TLKITDFGLAREV----YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT 316
+KI DFGL+R + Y + A WM PE I + ++ SDVW+YGVVLWE+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 317 GEI-PYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKAL 375
+ PY + V Y V + L P CP LM CW RPSF +I + L
Sbjct: 238 YGLQPYYGMAHEEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
Query: 376 NNI 378
+
Sbjct: 297 QRM 299
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-55
Identities = 70/272 (25%), Positives = 116/272 (42%), Gaps = 22/272 (8%)
Query: 121 FGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIV 176
FG+ +GEG F V +E AIK+ EN + V +E ++ DH V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L KL + YA+ G L + + + +I + YLH +
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---G 128
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR----EVYKTTHMSAAGTYAWMAPE 291
+IHRDLK N+LL+E ++ITDFG A+ E + S GT +++PE
Sbjct: 129 IIHRDLKPENILLNED--------MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFK 351
++ K+SD+W+ G ++++L+ G P+++ N Y + + KL P +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFFPKAR 238
Query: 352 TLMEACWEADSHMRPSFKTILKALNNIVHSEF 383
L+E D+ R + + H F
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-54
Identities = 87/307 (28%), Positives = 138/307 (44%), Gaps = 38/307 (12%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIY-------EKQEVAIKVAHPNPDENILENVKQEGK 165
E+ K+ +G+G FG VY+G+ + VAIK + E
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75
Query: 166 LLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK-----------IRPDVL 214
++ F+ ++V L+GV Q ++ME G L L + +
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 215 VDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV- 273
+ A +IA+GM YL+ +HRDL + N +++E T+KI DFG+ R++
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED--------FTVKIGDFGMTRDIY 184
Query: 274 ---YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTG-EIPYKSINAYAV 329
Y WM+PE +K +F+ SDVWS+GVVLWE+ T E PY+ ++ V
Sbjct: 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244
Query: 330 AYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHE 389
V L L P CP + LM CW+ + MRPSF I+ ++ + F +
Sbjct: 245 LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV--- 300
Query: 390 SFHIMQD 396
SF+ ++
Sbjct: 301 SFYYSEE 307
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 8e-54
Identities = 66/259 (25%), Positives = 110/259 (42%), Gaps = 14/259 (5%)
Query: 121 FGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSL 178
F + +G G F +V ++ + VAIK E +++ E +L H NIV+L
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 179 IGVCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGMNYLHCQAPISLI 237
+ L L+M+ GG L + + Q+ + + YLH ++
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIV 129
Query: 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHM-SAAGTYAWMAPEVIKTS 296
HRDLK N+L E+ + I+DFGL++ + + +A GT ++APEV+
Sbjct: 130 HRDLKPENLLYYSLDEDS-----KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 297 IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIP--STCPQLFKTLM 354
+SKA D WS GV+ + LL G P+ N + + + P K +
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244
Query: 355 EACWEADSHMRPSFKTILK 373
E D R + + L+
Sbjct: 245 RHLMEKDPEKRFTCEQALQ 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-53
Identities = 91/299 (30%), Positives = 142/299 (47%), Gaps = 44/299 (14%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK---------QEVAIKVAHPNPDENILENVKQE 163
E+ ++L+ G+ +GEG FG+V +VA+K+ + E L ++ E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 164 GKLLW-LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK-------------- 208
+++ + H+NI++L+G C Q L +++EYA G L L R+
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 209 ---IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265
+ LV A Q+A GM YL + IHRDL + NVL++E KI
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVM--------KIA 177
Query: 266 DFGLAREV----YKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIP 320
DFGLAR++ Y + WMAPE + I++ SDVWS+GV+LWE+ T G P
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 321 YKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379
Y + + + + + PS C +M CW A RP+FK +++ L+ IV
Sbjct: 238 YPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-53
Identities = 55/265 (20%), Positives = 111/265 (41%), Gaps = 18/265 (6%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHR 173
Y K + E +G G FG V++ + K+ K + +L VK+E +L + HR
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHR 61
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGMNYLHCQ 231
NI+ L +L ++ E+ G + + + ++ +V + Q+ E + +LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-YKTTHMSAAGTYAWMAP 290
++ H D++ N++ + T+KI +FG AR++ + AP
Sbjct: 122 ---NIGHFDIRPENIIYQTR------RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
Query: 291 EVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPSTCPQ 348
EV + + S A+D+WS G +++ LL+G P+ + + + + T
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 349 LFKTLMEACWEADSHMRPSFKTILK 373
++ + R + L+
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-52
Identities = 74/335 (22%), Positives = 139/335 (41%), Gaps = 44/335 (13%)
Query: 120 IFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLW-LFDHRNIV 176
+ + +G G GKV + ++ ++ A+K+ P ++E +L W +IV
Sbjct: 15 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQCPHIV 68
Query: 177 SLIGVC----LQSPKLCLVMEYARGGPLNRVLAGRKIRP---DVLVDWAIQIAEGMNYLH 229
++ V L +VME GG L + R + + I E + YLH
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-TTHMSAAGTYAWM 288
++ HRD+K N+L + N LK+TDFG A+E + + T ++
Sbjct: 129 SI---NIAHRDVKPENLLYTSKRPN-----AILKLTDFGFAKETTSHNSLTTPCYTPYYV 180
Query: 289 APEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------KLTLPI 342
APEV+ + K+ D+WS GV+++ LL G P+ S + A++ G+ + P
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 343 PSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI------QTPHESFHIMQD 396
S + K L+ + + R + + H + QTP + ++++
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN------HPWIMQSTKVPQTPLHTSRVLKE 294
Query: 397 GWRVEIEQVLHELRVKEKELRSREEELTKAQMQQK 431
+ E V E+ +R E++ +++
Sbjct: 295 -DKERWEDVKEEMTSALATMRVDYEQIKIKKIEDA 328
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 9e-52
Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 42/300 (14%)
Query: 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGK 165
E ++L G+ +G G FG+V + + VA+K+ + + E K
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68
Query: 166 LLWLFDHR-NIVSLIGVCLQSP-KLCLVMEYARGGPLNRVLAGRK--------------- 208
+L H N+V+L+G C + L +++E+ + G L+ L ++
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 209 --IRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266
+ + L+ ++ Q+A+GM +L + IHRDL + N+LLSE +KI D
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK--------NVVKICD 177
Query: 267 FGLAREVYK----TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTG-EIPY 321
FGLAR++YK A WMAPE I +++ SDVWS+GV+LWE+ + PY
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237
Query: 322 KSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381
+ + P M CW + RP+F +++ L N++ +
Sbjct: 238 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-51
Identities = 62/268 (23%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP---DENILENVKQEGKLLWL 169
D+ I + +G+G FGKV+ ++K Q AIK + D+++ + ++ L
Sbjct: 3 DF---ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 59
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYL 228
++H + + L VMEY GG L + + K +A +I G+ +L
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY--KTTHMSAAGTYA 286
H + +++RDLK N+LL + KI DFG+ +E + GT
Sbjct: 120 HSK---GIVYRDLKLDNILLDKDGHI--------KIADFGMCKENMLGDAKTNTFCGTPD 168
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346
++APE++ ++ + D WS+GV+L+E+L G+ P+ + + + + ++ P
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWL 226
Query: 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374
+ K L+ + + R + ++
Sbjct: 227 EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 4e-51
Identities = 61/264 (23%), Positives = 109/264 (41%), Gaps = 18/264 (6%)
Query: 121 FGEAIGEGGFGKVYKGIYEK--QEVAIKV-----AHPNPDENILENVKQEGKLLWLFDHR 173
GE +G G F V K + + A K + E++++E +L H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGPL-NRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
N+++L V + L++E GG L + + + + ++ QI G+ YLH
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL- 132
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV-YKTTHMSAAGTYAWMAPE 291
+ H DLK N++L + ++ +KI DFGLA ++ + + GT ++APE
Sbjct: 133 --QIAHFDLKPENIMLL----DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 292 VIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPSTCPQL 349
++ +D+WS GV+ + LL+G P+ V+ S L
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 350 FKTLMEACWEADSHMRPSFKTILK 373
K + D R + + L+
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 173 bits (440), Expect = 6e-51
Identities = 59/279 (21%), Positives = 107/279 (38%), Gaps = 32/279 (11%)
Query: 116 YNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP--------DENILENVKQEGK 165
Y E +G G V + I++ +E A+K+ + + E +E
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 166 LLW-LFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAE 223
+L + H NI+ L + LV + + G L L + + + E
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121
Query: 224 GMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA-A 282
+ LH +++HRDLK N+LL + +K+TDFG + ++ +
Sbjct: 122 VICALHKL---NIVHRDLKPENILLDDD--------MNIKLTDFGFSCQLDPGEKLREVC 170
Query: 283 GTYAWMAPEVIKTSI------FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN 336
GT +++APE+I+ S+ + K D+WS GV+++ LL G P+ + +
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
Query: 337 KLTLPIP--STCPQLFKTLMEACWEADSHMRPSFKTILK 373
P K L+ R + + L
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 168 bits (427), Expect = 4e-49
Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 18/274 (6%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP--DENILENVKQEGKLLWLFDH 172
++ GE +G GG +V+ + ++VA+KV + D + ++E + +H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 173 RNIVSLIGVCL----QSPKLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNY 227
IV++ P +VMEY G L ++ + P ++ + +N+
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAW 287
H +IHRD+K +N+++S + + F + T + GT +
Sbjct: 127 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS---GNSVTQTAAVIGTAQY 180
Query: 288 MAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPST 345
++PE + SDV+S G VL+E+LTGE P+ + +VAY P
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 346 CPQLFKTLMEACWEADSHMRP-SFKTILKALNNI 378
++ + R + + L +
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (426), Expect = 5e-48
Identities = 61/261 (23%), Positives = 115/261 (44%), Gaps = 21/261 (8%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP-----DENILENVKQEGKLLWL 169
N IG GGFG+VY + A+K E + N + L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 170 FDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYL 228
D IV + KL +++ GG L+ L+ + +A +I G+ ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM 288
H + +++RDLK +N+LL E ++I+D GLA + K ++ GT+ +M
Sbjct: 124 HNR---FVVYRDLKPANILLDE--------HGHVRISDLGLACDFSKKKPHASVGTHGYM 172
Query: 289 APEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLPIPSTC 346
APEV++ + + ++D +S G +L++LL G P++ + + + +P +
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 347 PQLFKTLMEACWEADSHMRPS 367
++L+E + D + R
Sbjct: 233 SPELRSLLEGLLQRDVNRRLG 253
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 7e-48
Identities = 57/269 (21%), Positives = 105/269 (39%), Gaps = 30/269 (11%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPN-----PDENILENVKQEGKLLWL 169
++ G +G GGFG VY GI VAIK + + V E LL
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 170 FD--HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL--AGRKIRPDVLVDWAIQIAEGM 225
++ L+ + L++E ++ ++ + Q+ E +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 226 NYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTY 285
+ H ++HRD+K N+L+ DL LK+ DFG + T + GT
Sbjct: 124 RHCHNC---GVLHRDIKDENILI-------DLNRGELKLIDFGSGALLKDTVYTDFDGTR 173
Query: 286 AWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344
+ PE I+ +++ VWS G++L++++ G+IP++ + + +
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRGQVFFRQ 225
Query: 345 TCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ L+ C RP+F+ I
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (413), Expect = 1e-46
Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 19/252 (7%)
Query: 121 FGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIV 176
+G G FG+V+ + A+KV +E+ E +L + H I+
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLV-DWAIQIAEGMNYLHCQAPIS 235
+ G + ++ ++M+Y GG L +L + P+ + +A ++ + YLH +
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---D 124
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT 295
+I+RDLK N+LL + +KITDFG A+ V + GT ++APEV+ T
Sbjct: 125 IIYRDLKPENILLDK--------NGHIKITDFGFAKYV-PDVTYTLCGTPDYIAPEVVST 175
Query: 296 SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLME 355
++K+ D WS+G++++E+L G P+ N + L P + K L+
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE--KILNAELRFPPFFNEDVKDLLS 233
Query: 356 ACWEADSHMRPS 367
D R
Sbjct: 234 RLITRDLSQRLG 245
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (409), Expect = 2e-46
Identities = 55/287 (19%), Positives = 103/287 (35%), Gaps = 26/287 (9%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN 174
G IGEG FG +++G Q+VAIK D L + + KLL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA--GCTG 62
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAP 233
I ++ + LV++ + + GRK + A Q+ + +H +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK-- 120
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR---------EVYKTTHMSAAGT 284
SL++RD+K N L+ P + + DFG+ + + + +GT
Sbjct: 121 -SLVYRDIKPDNFLIGRPNSKNA---NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 285 YAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG---VAVNKLTLP 341
+M+ S+ D+ + G V L G +P++ + A + K + P
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236
Query: 342 I---PSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
+ + P+ F M P + + + ++
Sbjct: 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 3e-46
Identities = 61/288 (21%), Positives = 102/288 (35%), Gaps = 30/288 (10%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN 174
N+ G IG G FG +Y G +EVAIK+ + E K+ +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGV 63
Query: 175 IVSLIGVCLQSPK-LCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEGMNYLHCQA 232
+ I C +VME + RK ++ A Q+ + Y+H +
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK- 122
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV---------YKTTHMSAAG 283
+ IHRD+K N L + + I DFGLA++ + + G
Sbjct: 123 --NFIHRDVKPDNFL-----MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 284 TYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN---KLTL 340
T + + S+ D+ S G VL G +P++ + A K++
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235
Query: 341 PIP---STCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQ 385
PI P F T + C +P + + + N+ H +
Sbjct: 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-43
Identities = 63/258 (24%), Positives = 119/258 (46%), Gaps = 20/258 (7%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP--DENILENVKQEGKLLWLFDH 172
N + + +G+G FGKV + + A+K+ ++ + + E ++L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 173 RNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIRP-DVLVDWAIQIAEGMNYLHCQ 231
+ +L +LC VMEYA GG L L+ ++ + + +I + YLH +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 232 APISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK--TTHMSAAGTYAWMA 289
+++RD+K N++L + +KITDFGL +E T + GT ++A
Sbjct: 125 ---DVVYRDIKLENLMLDKD--------GHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349
PEV++ + + +A D W GVV++E++ G +P+ + + + + + P T
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE--LILMEEIRFPRTLSPE 231
Query: 350 FKTLMEACWEADSHMRPS 367
K+L+ + D R
Sbjct: 232 AKSLLAGLLKKDPKQRLG 249
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-40
Identities = 62/287 (21%), Positives = 100/287 (34%), Gaps = 47/287 (16%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAHPN----PDENILENVKQEGKLLWLFDHRNIV 176
+ +GEG F VYK + Q VAIK + I +E KLL H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 177 SLIGVCLQSPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPIS 235
L+ + LV ++ + + P + + + +G+ YLH +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL- 122
Query: 236 LIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--THMSAAGTYAWMAPEVI 293
HRDLK +N+LL E LK+ DFGLA+ + T + APE++
Sbjct: 123 --HRDLKPNNLLLDEN--------GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172
Query: 294 KT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP----------- 341
++ D+W+ G +L ELL + + T
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 342 ---------------IPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
I S L++ + + R + LK
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 4e-40
Identities = 67/293 (22%), Positives = 112/293 (38%), Gaps = 51/293 (17%)
Query: 121 FGEAIGEGGFGKVYKGIYEK---QEVAIKVAHPNP-DENILENVKQE---GKLLWLFDHR 173
IGEG +GKV+K K + VA+K +E + + +E + L F+H
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 174 NIVSLIGVCLQSP-----KLCLVMEYARGGPLN--RVLAGRKIRPDVLVDWAIQIAEGMN 226
N+V L VC S KL LV E+ + + + + D Q+ G++
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130
Query: 227 YLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYK-TTHMSAAGTY 285
+LH ++HRDLK N+L++ +K+ DFGLAR S T
Sbjct: 131 FLHSH---RVVHRDLKPQNILVTSS--------GQIKLADFGLARIYSFQMALTSVVVTL 179
Query: 286 AWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPY------------------------ 321
+ APEV+ S ++ D+WS G + E+ + +
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 322 -KSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ + A+ + + +L K L+ C + R S + L
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 7e-39
Identities = 68/349 (19%), Positives = 129/349 (36%), Gaps = 58/349 (16%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN 174
+ IGEG +G V VAIK P + + +E K+L F H N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 175 IVSLIGVC----LQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHC 230
I+ + + ++ K ++ + G L ++L + + D + + QI G+ Y+H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 127
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR-----EVYKTTHMSAAGTY 285
+++HRDLK SN+LL+ + LKI DFGLAR + T
Sbjct: 128 A---NVLHRDLKPSNLLLNTTCD--------LKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 286 AWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--- 341
+ APE++ S ++K+ D+WS G +L E+L+ + + + +
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 342 --------------------------IPSTCPQLFKTLMEACWEADSHMRPSFKTIL--- 372
+ L++ + H R + L
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296
Query: 373 --KALNNIVHSEFIQTPHESFHIMQDGWRVEIEQVLH-ELRVKEKELRS 418
+ + + P + + D + ++++++ E + RS
Sbjct: 297 YLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS 345
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (347), Expect = 1e-37
Identities = 64/290 (22%), Positives = 103/290 (35%), Gaps = 44/290 (15%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHP-NPDENILENVKQEGKLLWLFDHRN 174
K E IGEG +G VYK + A+K DE I +E +L H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 175 IVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRK-IRPDVLVDWAIQIAEGMNYLHCQAP 233
IV L V +L LV E+ + + + +Q+ G+ Y H +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKT--THMSAAGTYAWMAPE 291
++HRDLK N+L++ LKI DFGLAR + T + AP+
Sbjct: 120 -RVLHRDLKPQNLLINRE--------GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
Query: 292 VI-KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--------- 341
V+ + +S D+WS G + E++ G + ++ + T
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 342 ------------------IPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ L+ + D + R + K L+
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 2e-37
Identities = 64/293 (21%), Positives = 120/293 (40%), Gaps = 34/293 (11%)
Query: 91 NFVSSIEDINLVSSVINDVKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVA 148
+F+ E + ++ ++ ++ +G G FG+V +++ A+K+
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 149 HPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVL-A 205
+E+ E ++L + +V L + L +VMEY GG + L
Sbjct: 75 DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 206 GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265
+ +A QI YLH LI+RDLK N+L+ + +++T
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQ--------GYIQVT 183
Query: 266 DFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSIN 325
DFG A+ K + GT +APE+I + ++KA D W+ GV+++E+ G P+ +
Sbjct: 184 DFGFAK-RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 326 AYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEAD-----SHMRPSFKTILK 373
+ + K + PS K L+ + D +++ I
Sbjct: 243 PIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 59/305 (19%), Positives = 98/305 (32%), Gaps = 59/305 (19%)
Query: 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLL 167
+ E+ Y + IG G FG VY+ + VAIK + +E +++
Sbjct: 16 RPQEVSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIM 67
Query: 168 WLFDHRNIVSLIGVCLQSPK------LCLVMEYARGGPLNRVL----AGRKIRPDVLVDW 217
DH NIV L S + L LV++Y A + + + +
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 218 AIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT 277
Q+ + Y+H + HRD+K N+LL LK+ DFG A+++ +
Sbjct: 128 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDP-------DTAVLKLCDFGSAKQLVRGE 177
Query: 278 HM--SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGV-- 333
Y + + ++ + DVWS G VL ELL G+ + + +
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 334 -------------------------AVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSF 368
+ T P L E R +
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
Query: 369 KTILK 373
Sbjct: 298 LEACA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-36
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 49/294 (16%)
Query: 115 DYNKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNP-DENILENVKQEGKLLWLFD 171
++ K+ E IGEG +G VYK + + VA+K + E + +E LL +
Sbjct: 3 NFQKV---EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 172 HRNIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLH 229
H NIV L+ V KL LV E+ + A I ++ + Q+ +G+ + H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 230 CQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT--HMSAAGTYAW 287
++HRDLK N+L++ +K+ DFGLAR + T +
Sbjct: 120 SH---RVLHRDLKPQNLLINT--------EGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 288 MAPEVI-KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP----- 341
APE++ +S A D+WS G + E++T + + + + T
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 342 ----------------------IPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ + ++L+ D + R S K L
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-36
Identities = 64/264 (24%), Positives = 107/264 (40%), Gaps = 28/264 (10%)
Query: 121 FGEAIGEGGFGKVYKGI-----YEKQEVAIKVAHP---NPDENILENVKQEGKLLWLFDH 172
+ +G G +GKV+ + A+KV E+ + E ++L
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 173 R-NIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGR-KIRPDVLVDWAIQIAEGMNYLHC 230
+V+L KL L+++Y GG L L+ R + + + +I + +LH
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 231 QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV---YKTTHMSAAGTYAW 287
+I+RD+K N+LL + +TDFGL++E GT +
Sbjct: 148 L---GIIYRDIKLENILLDSN--------GHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 288 MAPEVIKTSI--FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT--LPIP 343
MAP++++ KA D WS GV+++ELLTG P+ ++ L P P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256
Query: 344 STCPQLFKTLMEACWEADSHMRPS 367
L K L++ D R
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLG 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-36
Identities = 58/306 (18%), Positives = 103/306 (33%), Gaps = 60/306 (19%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHP-NPDENILENVKQEGKLLWLFDHR 173
+K IG+G FG+V+K + K Q+VA+K N E +E K+L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 174 NIVSLIGVCLQSP--------KLCLVMEYARGGPLNRVL-AGRKIRPDVLVDWAIQIAEG 224
N+V+LI +C + LV ++ + K + + G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 225 MNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV------YKTTH 278
+ Y+H ++HRD+K++NVL++ LK+ DFGLAR +
Sbjct: 130 LYYIHRN---KILHRDMKAANVLITRD--------GVLKLADFGLARAFSLAKNSQPNRY 178
Query: 279 MSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK 337
+ T + PE++ + D+W G ++ E+ T + ++
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 338 LTLP------------------------------IPSTCPQLFKTLMEACWEADSHMRPS 367
++ L++ D R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 368 FKTILK 373
L
Sbjct: 299 SDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 9e-35
Identities = 59/292 (20%), Positives = 106/292 (36%), Gaps = 46/292 (15%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHP-NPDENILENVKQEGKLLWLFDHR 173
K E IGEG +G V+K + + VA+K + DE + + +E LL H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 174 NIVSLIGVCLQSPKLCLVMEYARGGPLNRVLAGRKIR-PDVLVDWAIQIAEGMNYLHCQA 232
NIV L V KL LV E+ + P+++ + Q+ +G+ + H +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 233 PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY---KTTHMSAAGTYAWMA 289
+++HRDLK N+L++ E K+ +FGLAR + +
Sbjct: 121 --NVLHRDLKPQNLLINRNGEL--------KLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 290 PEVIKTSIFSKASDVWSYGVVLWELLTGEIPY---------------------------- 321
+ ++S + D+WS G + EL P
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 322 KSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ Y + + + L++ + + R S + L+
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-34
Identities = 64/306 (20%), Positives = 115/306 (37%), Gaps = 57/306 (18%)
Query: 123 EAIGEGGFGKVYKGIYEK--QEVAIKVAH-PNPDENILENVKQEGKLLWLFDHRNIVSLI 179
+ +G G +G V + + +VAIK + P E + +E +LL H N++ L+
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 180 GVCLQSPKL------CLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAP 233
V L LVM + G L +++ K+ D + Q+ +G+ Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 142
Query: 234 ISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVI 293
I HRDLK N+ ++E E KI DFGLAR+ + ++
Sbjct: 143 I---HRDLKPGNLAVNEDCEL--------KILDFGLARQADSEMTGYVVTRWYRAPEVIL 191
Query: 294 KTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP------------ 341
+++ D+WS G ++ E++TG+ +K + + T P
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 342 -----------------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFI 384
I + L L+E D+ R + L +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA-------HPYF 304
Query: 385 QTPHES 390
++ H++
Sbjct: 305 ESLHDT 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (320), Expect = 1e-33
Identities = 47/286 (16%), Positives = 111/286 (38%), Gaps = 26/286 (9%)
Query: 108 DVKLVEIDYNKL---IFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQ 162
D + +++ +G G + +V++ I ++V +K+ P + I +K
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKI 82
Query: 163 EGKLLWLFDHRNIVSLIGVCLQ--SPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQ 220
L L NI++L + S LV E+ ++ + + + + +
Sbjct: 83 ---LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYE 137
Query: 221 IAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY-KTTHM 279
I + ++Y H ++HRD+K NV++ D + + L++ D+GLA + +
Sbjct: 138 ILKALDYCHSM---GIMHRDVKPHNVMI-------DHEHRKLRLIDWGLAEFYHPGQEYN 187
Query: 280 SAAGTYAWMAPEV-IKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL 338
+ + PE+ + ++ + D+WS G +L ++ + P+ + L
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247
Query: 339 TLPIPSTCPQLFKTLMEACWE--ADSHMRPSFKTILKALNNIVHSE 382
+ ++ + H R ++ + + N + S
Sbjct: 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 293
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-31
Identities = 71/346 (20%), Positives = 128/346 (36%), Gaps = 36/346 (10%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAH-PNPDENILENVKQEGKLLWLFDHR 173
+ + IG G G V + VAIK P ++ + +E L+ +H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 174 NIVSLIGVCLQSPK------LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNY 227
NI+SL+ V + LVME + ++ + + Q+ G+ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 134
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSA-AGTYA 286
LH I HRDLK SN+++ TLKI DFGLAR + M+ T
Sbjct: 135 LHSAGII---HRDLKPSNIVVKSD--------CTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 287 WMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346
+ APEVI + + D+WS G ++ E++ +I + + V + +L P P
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV-IEQLGTPCPEFM 242
Query: 347 PQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHESFHIMQDGW-------R 399
+L T+ + +F + SE + + R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 400 VEIEQVL-----HELRVKEKELRSREEELTKAQMQQKLAEKELRER 440
+ ++ L + + + K +++ +E +E
Sbjct: 303 ISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 348
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 63/294 (21%), Positives = 103/294 (35%), Gaps = 48/294 (16%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAH-PNPDENILENVKQEGKLLWLFDHR 173
+ +G G +G V K VA+K P + +E +LL H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 174 NIVSLIGVC-----LQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYL 228
N++ L+ V L+ ++ + G LN ++ +K+ D + QI G+ Y+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 229 HCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAWM 288
H +IHRDLK SN+ ++E E KI DFGLAR A +
Sbjct: 138 HSA---DIIHRDLKPSNLAVNEDCEL--------KILDFGLARHTDDEMTGYVATRWYRA 186
Query: 289 APEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP------- 341
++ +++ D+WS G ++ ELLTG + + + T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 342 ----------------------IPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373
+ L L+E DS R + L
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (265), Expect = 7e-26
Identities = 53/296 (17%), Positives = 106/296 (35%), Gaps = 29/296 (9%)
Query: 117 NKLIFGEAIGEGGFGKVYKGIYEK--QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN 174
+ I +G G F V+ VA+K+ D+ E + E KLL + +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDAD 70
Query: 175 IVSLIGVCLQSP---------------KLCLVMEYARGGPLNRVLAGRKIRP--DVLVDW 217
+ + +V E L + +
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 218 AIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT 277
+ Q+ G++Y+H + I IH D+K NVL+ E+L +KI D G A +
Sbjct: 131 SKQLLLGLDYMHRRCGI--IHTDIKPENVLMEIVDSPENL--IQIKIADLGNACWYDEHY 186
Query: 278 HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK 337
S T + +PEV+ + + +D+WS +++EL+TG+ ++ ++
Sbjct: 187 TNSI-QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 338 LTLPIPSTCPQLF---KTLMEACWEADSHMRPSFKTILKALNNIVHSEFIQTPHES 390
+ + P + + +R K L +++ ++ + E+
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 1e-19
Identities = 33/202 (16%), Positives = 59/202 (29%), Gaps = 39/202 (19%)
Query: 122 GEAIGEGGFGKVYKGIYEK-QEVAIKVAHPN---------PDENILENVKQEGKLLWLFD 171
G+ +GEG V+ EK E +K + + +
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 172 HRNIVSLIGVCLQSP----KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNY 227
R + L G+ + ++ME ++R + + I E +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKE------LYRVRVENPDEVLDMILEEVAK 118
Query: 228 LHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTHMSAAGTYAW 287
+ + ++H DL NVL+SE + I DF + E
Sbjct: 119 FYHR---GIVHGDLSQYNVLVSEE---------GIWIIDFPQSVE---VGEEGWR-EILE 162
Query: 288 MAPEVIKTSI---FSKASDVWS 306
I T + D+ S
Sbjct: 163 RDVRNIITYFSRTYRTEKDINS 184
|
| >d1bb9a_ b.34.2.1 (A:) Amphiphysin 2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 83 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Amphiphysin 2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 73.1 bits (179), Expect = 1e-16
Identities = 22/68 (32%), Positives = 31/68 (45%), Gaps = 6/68 (8%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEY------KVGIFP 89
+A +DY A DEL L+ GD+V V+ + D GW G E G+FP
Sbjct: 16 QAQHDYTATDTDELQLKAGDVVLVIPFQNPEEQDEGWLMGVKESDWNQHKELEKCRGVFP 75
Query: 90 ANFVSSIE 97
NF ++
Sbjct: 76 ENFTERVQ 83
|
| >d1gcqa_ b.34.2.1 (A:) Growth factor receptor-bound protein 2 (GRB2), N- and C-terminal domains {Human (Homo sapiens) [TaxId: 9606]} Length = 56 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Growth factor receptor-bound protein 2 (GRB2), N- and C-terminal domains species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.7 bits (171), Expect = 7e-16
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 9/61 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+AL+D+D EL RRGD + V+ D WW G G + G+FP N+V+
Sbjct: 5 QALFDFDPQEDGELGFRRGDFIHVMDNS-----DPNWWKGACHG----QTGMFPRNYVTP 55
Query: 96 I 96
+
Sbjct: 56 V 56
|
| >d1uhfa_ b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Homo sapiens) [TaxId: 9606]} Length = 69 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Intersectin 2 (KIAA1256) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.8 bits (171), Expect = 9e-16
Identities = 20/63 (31%), Positives = 30/63 (47%), Gaps = 10/63 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALY Y ++ +L+ G+ + V KD WWTG I + GIFP+N+V
Sbjct: 12 IALYPYSSVEPGDLTFTEGEEILVTQKDG------EWWTGSIGD----RSGIFPSNYVKP 61
Query: 96 IED 98
+
Sbjct: 62 KDS 64
|
| >d2hspa_ b.34.2.1 (A:) Phospholipase C, SH3 domain {Human (Homo sapiens) [TaxId: 9606]} Length = 71 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Phospholipase C, SH3 domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.4 bits (170), Expect = 1e-15
Identities = 21/63 (33%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+AL+DY A DEL+ + I++ + K + GWW G GK K FP+N+V
Sbjct: 10 KALFDYKAQREDELTFIKSAIIQNVEKQ-----EGGWWRGDYGGK---KQLWFPSNYVEE 61
Query: 96 IED 98
+ +
Sbjct: 62 MVN 64
|
| >d1ujya_ b.34.2.1 (A:) Rac/CDC42 GEF 6 {Human (Homo sapiens) [TaxId: 9606]} Length = 76 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Rac/CDC42 GEF 6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (169), Expect = 2e-15
Identities = 20/68 (29%), Positives = 35/68 (51%), Gaps = 9/68 (13%)
Query: 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPA 90
+ +A +++ DELS+ +GDI+ V + + GWW G + G + G FP+
Sbjct: 9 HQLIVKARFNFKQTNEDELSVCKGDIIYVTRVE-----EGGWWEGTLNG----RTGWFPS 59
Query: 91 NFVSSIED 98
N+V I+
Sbjct: 60 NYVREIKS 67
|
| >d1sema_ b.34.2.1 (A:) Growth factor receptor-bound protein 2 (GRB2), N- and C-terminal domains {Caenorhabditis elegans, SEM-5 [TaxId: 6239]} Length = 58 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Growth factor receptor-bound protein 2 (GRB2), N- and C-terminal domains species: Caenorhabditis elegans, SEM-5 [TaxId: 6239]
Score = 68.5 bits (168), Expect = 2e-15
Identities = 20/58 (34%), Positives = 36/58 (62%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+AL+D++ EL+ +RGD++ +++KD D WW G++ + GIFP+N+V
Sbjct: 6 QALFDFNPQESGELAFKRGDVITLINKD-----DPNWWEGQLNN----RRGIFPSNYV 54
|
| >d1utia_ b.34.2.1 (A:) Grb2-related adaptor protein 2 (Mona/Gads) {Mouse (Mus musculus) [TaxId: 10090]} Length = 57 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Grb2-related adaptor protein 2 (Mona/Gads) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.8 bits (166), Expect = 3e-15
Identities = 26/61 (42%), Positives = 39/61 (63%), Gaps = 9/61 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYD++A+ DEL R G++VEVL + WWTG++ K+G+FPAN+V+
Sbjct: 5 RALYDFEALEEDELGFRSGEVVEVLDSS-----NPSWWTGRLHN----KLGLFPANYVAP 55
Query: 96 I 96
+
Sbjct: 56 M 56
|
| >d1udla_ b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Homo sapiens) [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Intersectin 2 (KIAA1256) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.8 bits (168), Expect = 4e-15
Identities = 27/69 (39%), Positives = 38/69 (55%), Gaps = 9/69 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A+YDY A DELS +G ++ V++KD D WW G+I G G+FP+N+V
Sbjct: 38 IAMYDYAANNEDELSFSKGQLINVMNKD-----DPDWWQGEING----VTGLFPSNYVKM 88
Query: 96 IEDINLVSS 104
D + SS
Sbjct: 89 TTDSSGPSS 97
|
| >d1uj0a_ b.34.2.1 (A:) Signal transducing adaptor molecule Stam2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 58 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Signal transducing adaptor molecule Stam2 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.0 bits (164), Expect = 5e-15
Identities = 22/64 (34%), Positives = 36/64 (56%), Gaps = 11/64 (17%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RALYD++A+ +EL+ + G+++ VL D WW G+ G+FP+NFV+
Sbjct: 6 RALYDFEAVEDNELTFKHGELITVLDDS-----DANWWQGENHR----GTGLFPSNFVT- 55
Query: 96 IEDI 99
D+
Sbjct: 56 -TDL 58
|
| >d1k4us_ b.34.2.1 (S:) p67phox {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: p67phox species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.1 bits (164), Expect = 6e-15
Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 9/58 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
AL+ Y+A ++L + GDI+ VLSK + W G+ +G KVGIFP FV
Sbjct: 9 EALFSYEATQPEDLEFQEGDIILVLSKV-----NEEWLEGESKG----KVGIFPKVFV 57
|
| >d1uhca_ b.34.2.1 (A:) Hypothetical protein Baa76854.1 (KIAA1010) {Human (Homo sapiens) [TaxId: 9606]} Length = 79 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Hypothetical protein Baa76854.1 (KIAA1010) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (163), Expect = 1e-14
Identities = 17/75 (22%), Positives = 34/75 (45%), Gaps = 5/75 (6%)
Query: 23 GNHNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIE 82
G+ ++ A+Y + A +ELS+ +++L +G+ WW ++ G
Sbjct: 4 GSSGSEAEGNQVYFAVYTFKARNPNELSVSANQKLKILEFKDV-TGNTEWWLAEVNG--- 59
Query: 83 YKVGIFPANFVSSIE 97
K G P+N++ E
Sbjct: 60 -KKGYVPSNYIRKTE 73
|
| >d1awwa_ b.34.2.1 (A:) Bruton's tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 67 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Bruton's tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (162), Expect = 1e-14
Identities = 19/63 (30%), Positives = 33/63 (52%), Gaps = 8/63 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY + ++L LR+GD +L + ++ WW + + + G P+N+V+
Sbjct: 12 VALYDYMPMNANDLQLRKGDEYFILEES-----NLPWWRARDKNG---QEGYIPSNYVTE 63
Query: 96 IED 98
ED
Sbjct: 64 AED 66
|
| >d1u06a1 b.34.2.1 (A:7-61) alpha-Spectrin, SH3 domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 55 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: alpha-Spectrin, SH3 domain species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 65.5 bits (160), Expect = 2e-14
Identities = 17/64 (26%), Positives = 32/64 (50%), Gaps = 9/64 (14%)
Query: 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
+L ALYDY E+++++GDI+ +L+ + WW ++ + G PA +
Sbjct: 1 ELVLALYDYQEKSPREVTMKKGDILTLLNST-----NKDWWKVEVND----RQGFVPAAY 51
Query: 93 VSSI 96
V +
Sbjct: 52 VKKL 55
|
| >d1gria1 b.34.2.1 (A:1-56) Growth factor receptor-bound protein 2 (GRB2), N- and C-terminal domains {Human (Homo sapiens) [TaxId: 9606]} Length = 56 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Growth factor receptor-bound protein 2 (GRB2), N- and C-terminal domains species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (159), Expect = 3e-14
Identities = 21/58 (36%), Positives = 33/58 (56%), Gaps = 8/58 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
A YD+ A DELS +RGDI++VL+++ D W+ ++ G K G P N++
Sbjct: 4 IAKYDFKATADDELSFKRGDILKVLNEEC----DQNWYKAELNG----KDGFIPKNYI 53
|
| >d1uffa_ b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Homo sapiens) [TaxId: 9606]} Length = 93 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Intersectin 2 (KIAA1256) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (160), Expect = 3e-14
Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 7/64 (10%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+RALY ++A DE+S GDI++V K G+ GW G +G G FP N+V
Sbjct: 8 YRALYPFEARNHDEMSFNSGDIIQVDEKT---VGEPGWLYGSFQG----NFGWFPCNYVE 60
Query: 95 SIED 98
+
Sbjct: 61 KMPS 64
|
| >d1opka1 b.34.2.1 (A:83-139) Abl tyrosine kinase, SH3 domain {Mouse (Mus musculus) [TaxId: 10090]} Length = 57 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Abl tyrosine kinase, SH3 domain species: Mouse (Mus musculus) [TaxId: 10090]
Score = 64.8 bits (158), Expect = 3e-14
Identities = 16/64 (25%), Positives = 33/64 (51%), Gaps = 8/64 (12%)
Query: 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
+L+ ALYD+ A G + LS+ +G+ + VL + + W + + G P+N+
Sbjct: 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNH----NGEWCEAQTKN----GQGWVPSNY 52
Query: 93 VSSI 96
++ +
Sbjct: 53 ITPV 56
|
| >d1j3ta_ b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Homo sapiens) [TaxId: 9606]} Length = 74 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Intersectin 2 (KIAA1256) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (159), Expect = 4e-14
Identities = 17/63 (26%), Positives = 28/63 (44%), Gaps = 10/63 (15%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+AL + A + L+ + DI+ VL + WW G++ G G FP ++V
Sbjct: 14 QALCSWTAKKDNHLNFSKHDIITVLEQQE------NWWFGEVHG----GRGWFPKSYVKI 63
Query: 96 IED 98
I
Sbjct: 64 IPG 66
|
| >d1ycsb2 b.34.2.1 (B:457-519) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 63 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (158), Expect = 4e-14
Identities = 15/58 (25%), Positives = 27/58 (46%), Gaps = 6/58 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
AL+DY+ DEL ++ GD + ++ ++ WW ++ K G P N +
Sbjct: 8 YALWDYEPQNDDELPMKEGDCMTIIHREDEDEI--EWWWARLND----KEGYVPRNLL 59
|
| >d2v1ra1 b.34.2.1 (A:10-76) Peroxisomal membrane protein Pex13p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 67 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Peroxisomal membrane protein Pex13p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 64.9 bits (158), Expect = 4e-14
Identities = 19/62 (30%), Positives = 34/62 (54%), Gaps = 4/62 (6%)
Query: 36 RALYDYDAIGLD-ELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
RALYD+ + E++L++GD++ +LSK + D WW + + +G P N++
Sbjct: 9 RALYDFVPENPEMEVALKKGDLMAILSKKDPLGRDSDWWKVRTKNG---NIGYIPYNYIE 65
Query: 95 SI 96
I
Sbjct: 66 II 67
|
| >d1efna_ b.34.2.1 (A:) Fyn proto-oncogene tyrosine kinase, SH3 domain {Human (Homo sapiens) [TaxId: 9606]} Length = 57 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Fyn proto-oncogene tyrosine kinase, SH3 domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (157), Expect = 5e-14
Identities = 19/63 (30%), Positives = 33/63 (52%), Gaps = 7/63 (11%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
L+ ALYDY+AI D+LS +G+ ++L+ + WW + G P+N+V
Sbjct: 2 LFVALYDYEAITEDDLSFHKGEKFQILNSS-----EGDWWEA--RSLTTGETGYIPSNYV 54
Query: 94 SSI 96
+ +
Sbjct: 55 APV 57
|
| >d1oota_ b.34.2.1 (A:) Hypothetical protein YFR024c {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 58 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Hypothetical protein YFR024c species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 64.0 bits (156), Expect = 7e-14
Identities = 21/61 (34%), Positives = 32/61 (52%), Gaps = 7/61 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALY + +L R+GD++ +L K WWTG++ G + GIFPAN+V
Sbjct: 5 VALYSFAGEESGDLPFRKGDVITILKKS---DSQNDWWTGRVNG----REGIFPANYVEL 57
Query: 96 I 96
+
Sbjct: 58 V 58
|
| >d1ckaa_ b.34.2.1 (A:) C-Crk, N-terminal SH3 domain {Mouse (Mus musculus) [TaxId: 10090]} Length = 57 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: C-Crk, N-terminal SH3 domain species: Mouse (Mus musculus) [TaxId: 10090]
Score = 64.0 bits (156), Expect = 8e-14
Identities = 16/58 (27%), Positives = 29/58 (50%), Gaps = 8/58 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
RAL+D++ ++L ++GDI+ + K + WW + E K G+ P +V
Sbjct: 5 RALFDFNGNDEEDLPFKKGDILRIRDKP-----EEQWWNAED---SEGKRGMIPVPYV 54
|
| >d1ue9a_ b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Homo sapiens) [TaxId: 9606]} Length = 80 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Intersectin 2 (KIAA1256) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.6 bits (157), Expect = 9e-14
Identities = 19/70 (27%), Positives = 36/70 (51%), Gaps = 6/70 (8%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKI-EYKVGIFPANFVS 94
+ Y A G ++LSL G ++ +L K+ GWW G+++ + + + G FPA+ V
Sbjct: 11 QVTSAYVASGSEQLSLAPGQLILILKKN-----TSGWWQGELQARGKKRQKGWFPASHVK 65
Query: 95 SIEDINLVSS 104
+ + +S
Sbjct: 66 LLGPSSERAS 75
|
| >d1u5sa1 b.34.2.1 (A:1-71) Nck-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 71 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Nck-2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (154), Expect = 2e-13
Identities = 16/63 (25%), Positives = 30/63 (47%), Gaps = 6/63 (9%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ LY + ++ +EL+ +G+ +EV+ K WW +VG+ P N+V
Sbjct: 10 QTLYPFSSVTEEELNFEKGETMEVIEKPENDP---EWWKC---KNARGQVGLVPKNYVVV 63
Query: 96 IED 98
+ D
Sbjct: 64 LSD 66
|
| >d1jo8a_ b.34.2.1 (A:) Actin binding protein ABP1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 58 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Actin binding protein ABP1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 62.9 bits (153), Expect = 2e-13
Identities = 20/61 (32%), Positives = 30/61 (49%), Gaps = 7/61 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A YDYDA +EL+ D + + D WW G++E + G+FP+N+VS
Sbjct: 4 TAEYDYDAAEDNELTFVENDKIINIEFV-----DDDWWLGELEK--DGSKGLFPSNYVSL 56
Query: 96 I 96
Sbjct: 57 G 57
|
| >d1ng2a2 b.34.2.1 (A:215-332) p47pox (neutrophil cytosolic factor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 118 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: p47pox (neutrophil cytosolic factor 1) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (157), Expect = 2e-13
Identities = 19/70 (27%), Positives = 32/70 (45%), Gaps = 9/70 (12%)
Query: 29 NHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIF 88
N+ + + A+ Y A+ DE+SL G+ VEV+ K GWW + + G F
Sbjct: 11 NYAGEPYVAIKAYTAVEGDEVSLLEGEAVEVIHKL-----LDGWWVIRKDD----VTGYF 61
Query: 89 PANFVSSIED 98
P+ ++
Sbjct: 62 PSMYLQKSGQ 71
|
| >d1gl5a_ b.34.2.1 (A:) tyrosine kinase tec {Mouse (Mus musculus) [TaxId: 10090]} Length = 67 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: tyrosine kinase tec species: Mouse (Mus musculus) [TaxId: 10090]
Score = 62.5 bits (152), Expect = 3e-13
Identities = 19/69 (27%), Positives = 33/69 (47%), Gaps = 8/69 (11%)
Query: 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANF 92
++ A+YD+ A +L L RG +L K+ D+ WW + + G P+N+
Sbjct: 3 EIVVAMYDFQATEAHDLRLERGQEYIILEKN-----DLHWWRARDKYG---SEGYIPSNY 54
Query: 93 VSSIEDINL 101
V+ + NL
Sbjct: 55 VTGKKSNNL 63
|
| >d1fmka1 b.34.2.1 (A:82-145) c-src protein tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 64 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: c-src protein tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.5 bits (152), Expect = 3e-13
Identities = 15/65 (23%), Positives = 32/65 (49%), Gaps = 7/65 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY++ +LS ++G+ +++++ + WW + G P+N+V+
Sbjct: 6 VALYDYESRTETDLSFKKGERLQIVNNT-----EGDWWLAHSLST--GQTGYIPSNYVAP 58
Query: 96 IEDIN 100
+ I
Sbjct: 59 SDSIQ 63
|
| >d1arka_ b.34.2.1 (A:) SH3 domain from nebulin {Human (Homo sapiens) [TaxId: 9606]} Length = 60 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: SH3 domain from nebulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (151), Expect = 4e-13
Identities = 21/61 (34%), Positives = 32/61 (52%), Gaps = 7/61 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA+YDY A DE+S + GD + + D GW G ++ + G+ PAN+V +
Sbjct: 7 RAMYDYMAADADEVSFKDGDAIINVQAI-----DEGWMYGTVQR--TGRTGMLPANYVEA 59
Query: 96 I 96
I
Sbjct: 60 I 60
|
| >d1qcfa1 b.34.2.1 (A:80-145) Hemapoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} Length = 65 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Hemapoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (150), Expect = 5e-13
Identities = 20/64 (31%), Positives = 33/64 (51%), Gaps = 8/64 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
ALYDY+AI ++LS ++GD + VL + WW K G P+N+V+
Sbjct: 8 VALYDYEAIHHEDLSFQKGDQMVVLEESG------EWWKA--RSLATRKEGYIPSNYVAR 59
Query: 96 IEDI 99
++ +
Sbjct: 60 VDSL 63
|
| >d1k9aa1 b.34.2.1 (A:6-76) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 71 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (150), Expect = 5e-13
Identities = 15/64 (23%), Positives = 29/64 (45%), Gaps = 7/64 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
A Y++ +L +GD++ +++ D W+ K + + GI PAN+V
Sbjct: 10 IAKYNFHGTAEQDLPFCKGDVLTIVAVTK----DPNWYKAKNKVG---REGIIPANYVQK 62
Query: 96 IEDI 99
E +
Sbjct: 63 REGV 66
|
| >d2iima1 b.34.2.1 (A:58-119) p56-lck tyrosine kinase, SH3 domain {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: p56-lck tyrosine kinase, SH3 domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (147), Expect = 1e-12
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 8/62 (12%)
Query: 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPAN 91
+L AL+ Y+ +L +G+ + +L + WW + + G P N
Sbjct: 6 DNLVIALHSYEPSHDGDLGFEKGEQLRILEQSG------EWWKA--QSLTTGQEGFIPFN 57
Query: 92 FV 93
FV
Sbjct: 58 FV 59
|
| >d1phta_ b.34.2.1 (A:) Phosphatidylinositol 3-kinase (p85-alpha subunit, pi3k), SH3 domain {Human (Homo sapiens) [TaxId: 9606]} Length = 83 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Phosphatidylinositol 3-kinase (p85-alpha subunit, pi3k), SH3 domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (146), Expect = 2e-12
Identities = 21/73 (28%), Positives = 30/73 (41%), Gaps = 12/73 (16%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISG----------DVGWWTGKIEGKIEYK 84
+RALYDY +++ L GDI+ V G ++GW G E +
Sbjct: 6 YRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETT--GE 63
Query: 85 VGIFPANFVSSIE 97
G FP +V I
Sbjct: 64 RGDFPGTYVEYIG 76
|
| >d1ugva_ b.34.2.1 (A:) Olygophrenin-1 like protein (KIAA0621) {Human (Homo sapiens) [TaxId: 9606]} Length = 72 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Olygophrenin-1 like protein (KIAA0621) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (143), Expect = 5e-12
Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 8/63 (12%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
+ALY A ELS G + + + S + GW G + G K G+ P N+V
Sbjct: 14 KALYACKAEHDSELSFTAGTVFDNVH----PSQEPGWLEGTLNG----KTGLIPENYVEF 65
Query: 96 IED 98
+
Sbjct: 66 LSG 68
|
| >d1spka_ b.34.2.1 (A:) BAI1-associated protein 2-like 1 (RIKEN cDNA 1300006m19) {Mouse (Mus musculus) [TaxId: 10090]} Length = 72 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: BAI1-associated protein 2-like 1 (RIKEN cDNA 1300006m19) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 59.1 bits (143), Expect = 5e-12
Identities = 12/64 (18%), Positives = 27/64 (42%), Gaps = 7/64 (10%)
Query: 36 RALYDYDAI-GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94
+ ++ + A LS +GD++ +L + GW G+ + G FP+++
Sbjct: 11 KTIFPHTAGNNKTLLSFAQGDVLTLLIPE----EKDGWLYGEHDTT--KARGWFPSSYTK 64
Query: 95 SIED 98
+
Sbjct: 65 LLSG 68
|
| >d1zuua1 b.34.2.1 (A:2-57) BZZ1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 56 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: BZZ1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 56.8 bits (137), Expect = 2e-11
Identities = 12/58 (20%), Positives = 26/58 (44%), Gaps = 6/58 (10%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ LY Y DE+++ GD + ++++D +G I + G+ P ++
Sbjct: 3 KVLYAYVQKDDDEITITPGDKISLVARD---TGSGWTK---INNDTTGETGLVPTTYI 54
|
| >d1i1ja_ b.34.2.1 (A:) Melanoma inhibitory activity protein {Human (Homo sapiens) [TaxId: 9606]} Length = 106 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Melanoma inhibitory activity protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (141), Expect = 2e-11
Identities = 22/83 (26%), Positives = 34/83 (40%), Gaps = 5/83 (6%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGW--WTGKIEGKIEYKVGIFPANFV 93
AL DY A L++ RG +V V SK G G + ++G FP++ V
Sbjct: 25 VALQDYMAPDCRFLTIHRGQVVYVFSKLKGRGRLFWGGSVQGDYYGDLAARLGYFPSSIV 84
Query: 94 SSIEDINLVSSVINDVKLVEIDY 116
+ + DVK + D+
Sbjct: 85 ---REDQTLKPGKVDVKTDKWDF 104
|
| >d1gcqc_ b.34.2.1 (C:) Vav N-terminal SH3 domain {Mouse (Mus musculus) [TaxId: 10090]} Length = 69 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Vav N-terminal SH3 domain species: Mouse (Mus musculus) [TaxId: 10090]
Score = 56.8 bits (137), Expect = 4e-11
Identities = 18/65 (27%), Positives = 25/65 (38%), Gaps = 12/65 (18%)
Query: 35 WRALYDYDAI------GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIF 88
+Y I L L GDIVE+ ++ + WW G+ +VG F
Sbjct: 7 MEVFQEYYGIPPPPGAFGPFLRLNPGDIVELTKAEA----EHNWWEGRNTAT--NEVGWF 60
Query: 89 PANFV 93
P N V
Sbjct: 61 PCNRV 65
|
| >d2rn8a1 b.34.2.1 (A:176-228) Bruton's tyrosine kinase {Mus musculus [TaxId: 10090]} Length = 53 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Bruton's tyrosine kinase species: Mus musculus [TaxId: 10090]
Score = 55.7 bits (134), Expect = 6e-11
Identities = 14/58 (24%), Positives = 24/58 (41%), Gaps = 8/58 (13%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
ALYDY EL+LR + +L ++ WW + G P++++
Sbjct: 2 IALYDYQTNDPQELALRCDEEYYLLDSS-----EIHWWRVQ---DKNGHEGYAPSSYL 51
|
| >d1ng2a1 b.34.2.1 (A:157-214) p47pox (neutrophil cytosolic factor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 58 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: p47pox (neutrophil cytosolic factor 1) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.3 bits (133), Expect = 7e-11
Identities = 20/62 (32%), Positives = 34/62 (54%), Gaps = 9/62 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
RA+ DY+ E++L GD+VEV+ K + GWW +++ K G PA+F+
Sbjct: 6 RAIADYEKTSGSEMALSTGDVVEVVEKS-----ESGWWFCQMKAKR----GWIPASFLEP 56
Query: 96 IE 97
++
Sbjct: 57 LD 58
|
| >d1i07a_ b.34.2.1 (A:) EPS8 SH3 domain {Mouse (Mus musculus) [TaxId: 10090]} Length = 59 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: EPS8 SH3 domain species: Mouse (Mus musculus) [TaxId: 10090]
Score = 54.5 bits (131), Expect = 2e-10
Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 9/62 (14%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95
++ YD+ A ELS+ + D++E+L WW G P N +
Sbjct: 5 KSKYDFVARNSSELSVMKDDVLEILDDRR------QWWKV---RNASGDSGFVPNNILDI 55
Query: 96 IE 97
+
Sbjct: 56 MR 57
|
| >d1wlpb1 b.34.2.1 (B:229-281) p47pox (neutrophil cytosolic factor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 53 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: p47pox (neutrophil cytosolic factor 1) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (129), Expect = 3e-10
Identities = 18/59 (30%), Positives = 29/59 (49%), Gaps = 9/59 (15%)
Query: 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
+ A+ Y A+ DE+SL G+ VEV+ K GWW + + G FP+ ++
Sbjct: 3 YVAIKAYTAVEGDEVSLLEGEAVEVIHKL-----LDGWWVIRKDD----VTGYFPSMYL 52
|
| >d1wiea_ b.34.2.1 (A:) RIM binding protein 2, RIMBP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 96 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: RIM binding protein 2, RIMBP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (128), Expect = 1e-09
Identities = 18/81 (22%), Positives = 33/81 (40%), Gaps = 13/81 (16%)
Query: 24 NHNRRNHRPDLWRALYDYDAIGL------DELSLRRGDIVEVLSKDSAISGDVGWWTGKI 77
+ R + + L A Y Y+ EL L G + V + G++ G++
Sbjct: 9 SKQRYSGKVHLCVARYSYNPFDGPNENPEAELPLTAGKYLYVYGDMD----EDGFYEGEL 64
Query: 78 EGKIEYKVGIFPANFVSSIED 98
+ G+ P+NFV ++D
Sbjct: 65 LDG---QRGLVPSNFVDFVQD 82
|
| >d1kjwa1 b.34.2.1 (A:430-525) Psd-95 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 96 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Psd-95 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 2e-08
Identities = 16/65 (24%), Positives = 23/65 (35%), Gaps = 12/65 (18%)
Query: 36 RALYDYDA-----IGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKI--EGKIEYKVGIF 88
RAL+DYD LS R GD++ V+ WW + +G
Sbjct: 5 RALFDYDKTKDCGFLSQALSFRFGDVLHVIDAGDEE-----WWQARRVHSDSETDDIGFI 59
Query: 89 PANFV 93
P+
Sbjct: 60 PSKRR 64
|
| >d1wfwa_ b.34.2.1 (A:) Kalirin-9a {Mouse (Mus musculus) [TaxId: 10090]} Length = 74 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Kalirin-9a species: Mouse (Mus musculus) [TaxId: 10090]
Score = 49.4 bits (117), Expect = 2e-08
Identities = 10/63 (15%), Positives = 24/63 (38%), Gaps = 7/63 (11%)
Query: 36 RALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEY--KVGIFPANFV 93
+ DY A+ +E+ + +G++V+VL+ + G P + +
Sbjct: 11 TVIKDYYALKENEICVSQGEVVQVLAVN-----QQNMCLVYQPASDHSPAAEGWVPGSIL 65
Query: 94 SSI 96
+
Sbjct: 66 APF 68
|
| >d1ug1a_ b.34.2.1 (A:) Hypothetical protein Baa76854.1 (KIAA1010) {Human (Homo sapiens) [TaxId: 9606]} Length = 92 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Hypothetical protein Baa76854.1 (KIAA1010) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (114), Expect = 6e-08
Identities = 14/72 (19%), Positives = 27/72 (37%), Gaps = 5/72 (6%)
Query: 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93
L++A +++A ++SL GD+V V+ K D + G ++F+
Sbjct: 19 LFQAERNFNAAQDLDVSLLEGDLVGVIKKK-----DPMGSQNRWLIDNGVTKGFVYSSFL 73
Query: 94 SSIEDINLVSSV 105
S
Sbjct: 74 KPYNPRRSHSDA 85
|
| >d1t0ha_ b.34.2.1 (A:) SH3-like domain of the L-type calcium channel {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 96 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: SH3-like domain of the L-type calcium channel species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 47.2 bits (112), Expect = 2e-07
Identities = 13/65 (20%), Positives = 23/65 (35%), Gaps = 13/65 (20%)
Query: 36 RALYDYDAIGLDE-------LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIF 88
R Y A D+ +S D + V K + WW G++ + ++G
Sbjct: 25 RTNVRYSAAQEDDVPVPGMAISFEAKDFLHVKEKF-----NNDWWIGRLVKE-GCEIGFI 78
Query: 89 PANFV 93
P+
Sbjct: 79 PSPVK 83
|
| >d1vyva1 b.34.2.1 (A:71-215) SH3-like domain of the L-type calcium channel {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 145 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: SH3-like domain of the L-type calcium channel species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 1e-05
Identities = 9/65 (13%), Positives = 21/65 (32%), Gaps = 13/65 (20%)
Query: 36 RALYDYDA-------IGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIF 88
+ Y + +S D + + K + WW G++ + ++G
Sbjct: 27 KTNVSYCGALDEDVPVPSSAVSFDAKDFLHIKEKY-----NNDWWIGRLVKE-GCEIGFI 80
Query: 89 PANFV 93
P+
Sbjct: 81 PSPLR 85
|
| >d1vyua1 b.34.2.1 (A:39-174) SH3-like domain of the L-type calcium channel {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 136 | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: SH3-like domain of the L-type calcium channel species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.6 bits (92), Expect = 1e-04
Identities = 8/65 (12%), Positives = 18/65 (27%), Gaps = 13/65 (20%)
Query: 36 RALYDYDA-------IGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIF 88
R Y + ++ D + + K WW G++ + +
Sbjct: 27 RTNVSYCGVLDEECPVQGSGVNFEAKDFLHIKEKY-----SNDWWIGRLVKE-GGDIAFI 80
Query: 89 PANFV 93
P+
Sbjct: 81 PSPQR 85
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 527 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1sema_ | 58 | Growth factor receptor-bound protein 2 (GRB2), N- | 99.55 | |
| d1gcqa_ | 56 | Growth factor receptor-bound protein 2 (GRB2), N- | 99.55 | |
| d1utia_ | 57 | Grb2-related adaptor protein 2 (Mona/Gads) {Mouse | 99.54 | |
| d1u06a1 | 55 | alpha-Spectrin, SH3 domain {Chicken (Gallus gallus | 99.54 | |
| d1k4us_ | 62 | p67phox {Human (Homo sapiens) [TaxId: 9606]} | 99.54 | |
| d1jo8a_ | 58 | Actin binding protein ABP1 {Baker's yeast (Sacchar | 99.52 | |
| d1uj0a_ | 58 | Signal transducing adaptor molecule Stam2 {Mouse ( | 99.52 | |
| d2rn8a1 | 53 | Bruton's tyrosine kinase {Mus musculus [TaxId: 100 | 99.51 | |
| d1ujya_ | 76 | Rac/CDC42 GEF 6 {Human (Homo sapiens) [TaxId: 9606 | 99.51 | |
| d1arka_ | 60 | SH3 domain from nebulin {Human (Homo sapiens) [Tax | 99.51 | |
| d1ckaa_ | 57 | C-Crk, N-terminal SH3 domain {Mouse (Mus musculus) | 99.51 | |
| d1opka1 | 57 | Abl tyrosine kinase, SH3 domain {Mouse (Mus muscul | 99.5 | |
| d1j3ta_ | 74 | Intersectin 2 (KIAA1256) {Human (Homo sapiens) [Ta | 99.5 | |
| d1wlpb1 | 53 | p47pox (neutrophil cytosolic factor 1) {Human (Hom | 99.5 | |
| d1efna_ | 57 | Fyn proto-oncogene tyrosine kinase, SH3 domain {Hu | 99.5 | |
| d1ng2a1 | 58 | p47pox (neutrophil cytosolic factor 1) {Human (Hom | 99.49 | |
| d1fmka1 | 64 | c-src protein tyrosine kinase {Human (Homo sapiens | 99.49 | |
| d1k9aa1 | 71 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.49 | |
| d1gria1 | 56 | Growth factor receptor-bound protein 2 (GRB2), N- | 99.49 | |
| d1ugva_ | 72 | Olygophrenin-1 like protein (KIAA0621) {Human (Hom | 99.48 | |
| d1ycsb2 | 63 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.48 | |
| d2v1ra1 | 67 | Peroxisomal membrane protein Pex13p {Baker's yeast | 99.48 | |
| d1qcfa1 | 65 | Hemapoetic cell kinase Hck {Human (Homo sapiens) [ | 99.47 | |
| d1spka_ | 72 | BAI1-associated protein 2-like 1 (RIKEN cDNA 13000 | 99.47 | |
| d1gl5a_ | 67 | tyrosine kinase tec {Mouse (Mus musculus) [TaxId: | 99.47 | |
| d1oota_ | 58 | Hypothetical protein YFR024c {Baker's yeast (Sacch | 99.45 | |
| d1uhfa_ | 69 | Intersectin 2 (KIAA1256) {Human (Homo sapiens) [Ta | 99.44 | |
| d1i07a_ | 59 | EPS8 SH3 domain {Mouse (Mus musculus) [TaxId: 1009 | 99.43 | |
| d1udla_ | 98 | Intersectin 2 (KIAA1256) {Human (Homo sapiens) [Ta | 99.43 | |
| d1ue9a_ | 80 | Intersectin 2 (KIAA1256) {Human (Homo sapiens) [Ta | 99.43 | |
| d1uhca_ | 79 | Hypothetical protein Baa76854.1 (KIAA1010) {Human | 99.42 | |
| d1u5sa1 | 71 | Nck-2 {Human (Homo sapiens) [TaxId: 9606]} | 99.42 | |
| d1awwa_ | 67 | Bruton's tyrosine kinase {Human (Homo sapiens) [Ta | 99.42 | |
| d1wfwa_ | 74 | Kalirin-9a {Mouse (Mus musculus) [TaxId: 10090]} | 99.41 | |
| d2iima1 | 62 | p56-lck tyrosine kinase, SH3 domain {Human (Homo s | 99.41 | |
| d1ng2a2 | 118 | p47pox (neutrophil cytosolic factor 1) {Human (Hom | 99.41 | |
| d2hspa_ | 71 | Phospholipase C, SH3 domain {Human (Homo sapiens) | 99.4 | |
| d1bb9a_ | 83 | Amphiphysin 2 {Rat (Rattus norvegicus) [TaxId: 101 | 99.37 | |
| d1wiea_ | 96 | RIM binding protein 2, RIMBP2 {Human (Homo sapiens | 99.36 | |
| d1uffa_ | 93 | Intersectin 2 (KIAA1256) {Human (Homo sapiens) [Ta | 99.35 | |
| d1zuua1 | 56 | BZZ1 {Baker's yeast (Saccharomyces cerevisiae) [Ta | 99.35 | |
| d1ug1a_ | 92 | Hypothetical protein Baa76854.1 (KIAA1010) {Human | 99.34 | |
| d1gcqc_ | 69 | Vav N-terminal SH3 domain {Mouse (Mus musculus) [T | 99.33 | |
| d1phta_ | 83 | Phosphatidylinositol 3-kinase (p85-alpha subunit, | 99.31 | |
| d1t0ha_ | 96 | SH3-like domain of the L-type calcium channel {Rab | 99.3 | |
| d1kjwa1 | 96 | Psd-95 {Rat (Rattus norvegicus) [TaxId: 10116]} | 99.28 | |
| d1i1ja_ | 106 | Melanoma inhibitory activity protein {Human (Homo | 99.25 | |
| d1vyva1 | 145 | SH3-like domain of the L-type calcium channel {Rat | 99.05 | |
| d1vyua1 | 136 | SH3-like domain of the L-type calcium channel {Rat | 98.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.45 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.86 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.73 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.57 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.51 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.08 | |
| d1ri9a_ | 77 | Fyn-binding protein (T-cell adapter protein adap) | 93.49 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-57 Score=443.90 Aligned_cols=258 Identities=37% Similarity=0.603 Sum_probs=219.2
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
.|||+.++|++.+.||+|+||.||+|.+++ .||||+++... .....+.+.+|+.++++++|||||++++++.+ +.+|
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 489999999999999999999999998765 59999987542 44557889999999999999999999998754 5689
Q ss_pred EEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 190 LVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
||||||+||+|.+++. +..+++..++.++.||+.||+|||++ +||||||||+||||+.+ +.+||+||
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~--------~~~Kl~DF 148 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHED--------LTVKIGDF 148 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT--------SSEEECCC
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCC--------CCEEEccc
Confidence 9999999999999985 45699999999999999999999999 49999999999999875 68999999
Q ss_pred Ccchhhhccc----cccCCCcccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 268 GLAREVYKTT----HMSAAGTYAWMAPEVIKT---SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 268 Gla~~~~~~~----~~~~~gt~~y~aPE~l~~---~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
|+|+...... ..+..||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+.+...........+...
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 228 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence 9997764321 224579999999999964 358999999999999999999999999887665555554444433
Q ss_pred ----CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 341 ----PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 341 ----~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
..+..+|+.+.+||.+||+.||++|||+.+|+++|+.+..+
T Consensus 229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 35678999999999999999999999999999999877653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-56 Score=442.13 Aligned_cols=258 Identities=32% Similarity=0.594 Sum_probs=224.9
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
...|||+.++|++.+.||+|+||.||+|.+. ++.||||++...... .+.+.+|+.+|+.++|||||+++|+|.+++
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch--HHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 4569999999999999999999999999984 678999998765432 567899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 187 KLCLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
.+|||||||++|+|.+++. ...+++..++.++.||+.||+|||++| ||||||||+||||+.+ +.+|
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~--------~~~K 155 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGEN--------HLVK 155 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG--------GCEE
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCC--------CcEE
Confidence 9999999999999999985 356899999999999999999999994 9999999999999875 6899
Q ss_pred EeccCcchhhhccccc---cCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCcc
Q psy6905 264 ITDFGLAREVYKTTHM---SAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIP-YKSINAYAVAYGVAVNKLT 339 (527)
Q Consensus 264 L~DFGla~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~P-f~~~~~~~~~~~i~~~~~~ 339 (527)
|+|||+|+........ ...||+.|+|||++.+..|+.++|||||||++|||++|..| |.+.+... .......+..
T Consensus 156 l~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~~~~ 234 (287)
T d1opja_ 156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYR 234 (287)
T ss_dssp ECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCC
T ss_pred EccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhcCCC
Confidence 9999999876443222 33578999999999999999999999999999999996555 45555444 4445556778
Q ss_pred CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 340 LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 340 ~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
++.|..+|+.+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 88999999999999999999999999999999998877654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=450.96 Aligned_cols=256 Identities=35% Similarity=0.598 Sum_probs=225.2
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGV 181 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~ 181 (527)
..|||++++|++++.||+|+||+||+|.+.+ ..||+|.+...........+.+|+.++.++ +|||||+++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 3599999999999999999999999998743 259999987765555567789999999998 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHhcCC------------------------CCChhHHHHHHHHHHHHHHHHHhcCCCcee
Q psy6905 182 CLQSPKLCLVMEYARGGPLNRVLAGR------------------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLI 237 (527)
Q Consensus 182 ~~~~~~~~iv~Ey~~ggsL~~~l~~~------------------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~ii 237 (527)
+.+.+.+|+|||||+||+|.+++... .+++..++.++.||+.||+|||++ +||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~Ii 186 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 186 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 99999999999999999999998632 378889999999999999999999 499
Q ss_pred ecCCCCCceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHH
Q psy6905 238 HRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWE 313 (527)
Q Consensus 238 HrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~e 313 (527)
||||||+|||++.+ +.+||+|||+|+....... .+..||+.|+|||++.+..|+.++|||||||++||
T Consensus 187 HRDlKp~Nill~~~--------~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~e 258 (325)
T d1rjba_ 187 HRDLAARNVLVTHG--------KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258 (325)
T ss_dssp ETTCSGGGEEEETT--------TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred eccCchhccccccC--------CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHH
Confidence 99999999999875 6999999999987654332 23457999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q psy6905 314 LLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALN 376 (527)
Q Consensus 314 llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~ 376 (527)
|+| |..||.+.+.......+..++.+++.|..+|+++.+||.+||+.||++|||+.+|+++|.
T Consensus 259 mlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 259 IFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 998 999999988777777888888889999999999999999999999999999999999885
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=436.28 Aligned_cols=246 Identities=25% Similarity=0.464 Sum_probs=220.3
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
.++|++++.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999984 6789999886431 112356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||||+||+|.+++. .+.+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~--------~~~kl~DFG~a 153 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSA--------GELKIADFGWS 153 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------SCEEECCCCSC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCC--------CCEeeccccee
Confidence 99999999999987 568999999999999999999999994 9999999999999875 68999999999
Q ss_pred hhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHH
Q psy6905 271 REVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLF 350 (527)
Q Consensus 271 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 350 (527)
+...........||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.... ..+|..+|+++
T Consensus 154 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~ 231 (263)
T d2j4za1 154 VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGA 231 (263)
T ss_dssp SCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHH
T ss_pred eecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCccCCHHH
Confidence 8776655566789999999999999999999999999999999999999999998888877776443 46778899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+||.+||..||.+|||+.+++++
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHHHccCCHhHCcCHHHHHcC
Confidence 999999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-56 Score=440.95 Aligned_cols=258 Identities=33% Similarity=0.605 Sum_probs=220.7
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--C---ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--K---QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
.+++.++|++.+.||+|+||+||+|.+. + ..||||.+.........+.+.+|+.+|++++|||||+++|++.+++
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 3678889999999999999999999874 2 2589999887767777788999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.+|+|||||++|+|.+++. .+.+++.+++.++.||+.||+|||++ +||||||||+||||+.+ +.+||
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~--------~~~Kl 169 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSN--------LVCKV 169 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT--------CCEEE
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCC--------CcEEE
Confidence 9999999999999999887 34689999999999999999999999 49999999999999876 68999
Q ss_pred eccCcchhhhcccc-------ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Q psy6905 265 TDFGLAREVYKTTH-------MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVN 336 (527)
Q Consensus 265 ~DFGla~~~~~~~~-------~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~ 336 (527)
+|||+|+....... ....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....+. .
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~ 248 (299)
T d1jpaa_ 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-Q 248 (299)
T ss_dssp CCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-T
T ss_pred CCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 99999987643221 12357899999999999999999999999999999998 999999998888777765 4
Q ss_pred CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 337 KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 337 ~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
+.+++.|..+|+.+.+||.+||+.||.+|||+.+|++.|+.++.+
T Consensus 249 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 249 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 667788999999999999999999999999999999999887754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=434.82 Aligned_cols=257 Identities=35% Similarity=0.619 Sum_probs=225.2
Q ss_pred eEEeCCceeeeee-eccCCceEEEEeeEc----CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 112 VEIDYNKLIFGEA-IGEGGFGKVYKGIYE----KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~-iG~G~fg~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
+-++.++|.+.+. ||+|+||.||+|.+. +..||||++.........+.+.+|+.+|++++|||||+++|++.. +
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 4567788999885 999999999999863 246999999877666667889999999999999999999999865 4
Q ss_pred eEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.+|+|||||++|+|.+++. +..+++..++.++.||+.||+|||++ +||||||||+||||+.+ +.+||
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~--------~~~Kl 150 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNR--------HYAKI 150 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEET--------TEEEE
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccC--------Cceee
Confidence 6899999999999999875 45799999999999999999999999 49999999999999875 68999
Q ss_pred eccCcchhhhccc-----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCc
Q psy6905 265 TDFGLAREVYKTT-----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 265 ~DFGla~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
+|||+++...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+. .+.
T Consensus 151 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~ 229 (285)
T d1u59a_ 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGK 229 (285)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTC
T ss_pred ccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCC
Confidence 9999998764322 123468999999999999999999999999999999998 999999988877766665 466
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
+++.|..+|+++.+||..||+.||++|||+.+|.+.|+....+
T Consensus 230 ~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 7788999999999999999999999999999999998776543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-56 Score=438.18 Aligned_cols=247 Identities=30% Similarity=0.499 Sum_probs=219.1
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|++.+.||+|+||+||+|.+ +|+.||||++....... .+.+.+|+.+++.++|||||++++++.+++.+|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 35799999999999999999987 47899999986543322 4678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 194 YARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 194 y~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
||+||+|.+++.++.+++.++..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+.+
T Consensus 98 y~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~--------~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMD--------GSVKLTDFGFCAQI 166 (293)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------CCEEECCCTTCEEC
T ss_pred ecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCC--------CcEeeccchhheee
Confidence 999999999998888999999999999999999999995 9999999999999875 68999999999876
Q ss_pred hcc--ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CccCCCCCCccHHH
Q psy6905 274 YKT--THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-KLTLPIPSTCPQLF 350 (527)
Q Consensus 274 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~~ 350 (527)
... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+... ....+.|..+|+++
T Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 246 (293)
T d1yhwa1 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (293)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHH
T ss_pred ccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHH
Confidence 432 234567999999999999999999999999999999999999999998877776666544 33456678899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++||.+||..||.+|||+.++++|
T Consensus 247 ~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 247 RDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=430.70 Aligned_cols=254 Identities=33% Similarity=0.625 Sum_probs=216.1
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
|+.++|++.+.||+|+||.||+|.+. ++.||||++...... .+.+.+|+.+++.++|||||+++|+|.+++.+|+||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 57789999999999999999999985 568999998765432 467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||++|+|.+++. ...+++..++.++.||+.||+|||+++ ||||||||+||||+.+ +.+||+|||++
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~--------~~~Kl~DFGla 148 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGEN--------QVIKVSDFGMT 148 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGG--------GCEEECSCC--
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCC--------CCeEecccchh
Confidence 9999999999886 356889999999999999999999994 9999999999999975 68999999999
Q ss_pred hhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 271 REVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 271 ~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
+....... ....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+....+.. +...+.|..+
T Consensus 149 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~ 227 (263)
T d1sm2a_ 149 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLA 227 (263)
T ss_dssp ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCCCTTS
T ss_pred eeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCCcccc
Confidence 87644322 23568999999999999999999999999999999999 6778887777777766654 5667888999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
|+++.+||..||+.||++|||+.+|+++|+++.++
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999887653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-56 Score=434.33 Aligned_cols=256 Identities=32% Similarity=0.577 Sum_probs=223.4
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
..|||++++|++.+.||+|+||.||+|.+++ +.||||++...... .+.+.+|+.++++++|||||+++|++.+ +.+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~ 82 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence 4699999999999999999999999999864 68999998765332 4678999999999999999999998765 567
Q ss_pred EEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 189 CLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
|+|||||++|+|.+++.. ..+++..++.|+.||+.||.|||++ +||||||||+||||+.+ +.+||+
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~--------~~~Kl~ 151 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDT--------LSCKIA 151 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT--------SCEEEC
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecc--------cceeec
Confidence 999999999999998762 3589999999999999999999999 49999999999999976 689999
Q ss_pred ccCcchhhhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 266 DFGLAREVYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 266 DFGla~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
|||+|+...... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+....+. .+.+.+
T Consensus 152 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~ 230 (272)
T d1qpca_ 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMV 230 (272)
T ss_dssp CCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCC
T ss_pred cccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCC
Confidence 999998764332 224568999999999999999999999999999999999 566677777666665554 567778
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.|..+|+++.+||.+||+.||++|||+.+|++.|++++.
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 899999999999999999999999999999999987654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=431.81 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=208.9
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe--CCeEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ--SPKLCL 190 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~--~~~~~i 190 (527)
.++|++.+.||+|+||.||+|.+. ++.||||++.... .+...+.+.+|+.+++.++|||||++++++.+ ++.+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 468999999999999999999874 6789999987653 44556778999999999999999999999965 456899
Q ss_pred EEeccCCCCHHHHhc-----CCCCChhHHHHHHHHHHHHHHHHHhcCC--CceeecCCCCCceecCCCCcccccccceeE
Q psy6905 191 VMEYARGGPLNRVLA-----GRKIRPDVLVDWAIQIAEGMNYLHCQAP--ISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-----~~~~~~~~~~~i~~qi~~~L~yLH~~g~--~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
|||||+||+|.+++. +..+++..++.++.||+.||.|||+.|. .+||||||||+||||+.+ +.+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~--------~~vk 154 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK--------QNVK 154 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT--------SCEE
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC--------CcEE
Confidence 999999999999885 4679999999999999999999998741 149999999999999875 6899
Q ss_pred EeccCcchhhhccc--cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 264 ITDFGLAREVYKTT--HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 264 L~DFGla~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
|+|||+|+...... ..+..||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+..... .+
T Consensus 155 l~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-~~ 233 (269)
T d2java1 155 LGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-RR 233 (269)
T ss_dssp ECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CC
T ss_pred EeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CC
Confidence 99999998775432 2356799999999999999999999999999999999999999999998888877765544 36
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+|..+|+++.+||.+||..||.+|||+.+++++
T Consensus 234 ~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 788899999999999999999999999999873
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-56 Score=432.82 Aligned_cols=246 Identities=28% Similarity=0.415 Sum_probs=207.8
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|++++.||+|+||+||+|.+. ++.||||++......+..+.+.+|+.+++.++|||||++++++.+++.+||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999984 6799999987665444556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|+||+|.+++. .+.+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+..
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~--------~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDER--------DNLKISDFGLATVF 153 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT--------CCEEECCCTTCEEC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCC--------CCEEEccchhheee
Confidence 99999999987 567999999999999999999999995 9999999999999875 68999999999876
Q ss_pred hcc----ccccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhCCccCCCCCCcc
Q psy6905 274 YKT----THMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAVAY-GVAVNKLTLPIPSTCP 347 (527)
Q Consensus 274 ~~~----~~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~-~i~~~~~~~~~p~~~~ 347 (527)
... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+...... .........+.+..+|
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 233 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCC
Confidence 332 2235679999999999988775 678999999999999999999998765433333 3333333334446789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 348 QLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 348 ~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
+++.+||.+||+.||.+|||+.++++
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 234 SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=428.38 Aligned_cols=257 Identities=33% Similarity=0.598 Sum_probs=220.5
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEcC------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
||+.+.|++.++||+|+||.||+|.+++ ..||||.+...........+.+|+.+++.++|||||+++|++.+.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 6788999999999999999999998753 3699999987766666778999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.+++|||||.+|++.+++. ...+++..++.++.||+.||+|||++ +||||||||+||||+.+ +.+||
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~--------~~~Kl 151 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSN--------LVCKV 151 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT--------CCEEE
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCC--------CeEEE
Confidence 9999999999999988876 46799999999999999999999999 49999999999999986 68999
Q ss_pred eccCcchhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCc
Q psy6905 265 TDFGLAREVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 265 ~DFGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
+|||+++....... ....||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++...+ ..+.
T Consensus 152 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i-~~~~ 230 (283)
T d1mqba_ 152 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGF 230 (283)
T ss_dssp CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTC
T ss_pred cccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH-hccC
Confidence 99999987643221 23458999999999999999999999999999999999 55566666666665555 4567
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
+.+.|..+|..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 7889999999999999999999999999999999999887764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-55 Score=424.66 Aligned_cols=250 Identities=30% Similarity=0.599 Sum_probs=223.9
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVM 192 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 192 (527)
++.++|++++.||+|+||+||+|.++ ++.||||+++..... .+.+.+|+.+++.++|||||+++|+|.+++.+++||
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 46789999999999999999999985 458999998765432 467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 193 EYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 193 Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
|||.+|+|..++. ...+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~--------~~~kl~DfG~a 147 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQ--------GVVKVSDFGLS 147 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTT--------CCEEECCCSSC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCC--------CcEEECcchhh
Confidence 9999999998865 557889999999999999999999995 9999999999999975 68999999999
Q ss_pred hhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 271 REVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 271 ~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
+....... ....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+. .+.+.+.|..+
T Consensus 148 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~ 226 (258)
T d1k2pa_ 148 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLA 226 (258)
T ss_dssp CBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTC
T ss_pred eeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccc
Confidence 86643322 23568999999999999999999999999999999998 899999999988887776 46678899999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
|+.+.+||.+||+.||++|||+.+|+++|.+
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 9999999999999999999999999999865
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-55 Score=428.86 Aligned_cols=256 Identities=35% Similarity=0.629 Sum_probs=217.7
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcC-----ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEK-----QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
|||++++|++++.||+|+||.||+|.+.. ..||||.+.........+.+.+|+.++++++|||||+++|++. ++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 89999999999999999999999998742 3589999877666666788999999999999999999999996 45
Q ss_pred eEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.+|+|||||.+|+|.+++. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.+ +.+||
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~--------~~~Kl 149 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSN--------DCVKL 149 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET--------TEEEE
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCC--------CcEEE
Confidence 7899999999999998865 456899999999999999999999994 9999999999999875 68999
Q ss_pred eccCcchhhhcccc---ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccC
Q psy6905 265 TDFGLAREVYKTTH---MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTL 340 (527)
Q Consensus 265 ~DFGla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 340 (527)
+|||+|+....... ....||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++...+. .+...
T Consensus 150 ~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~ 228 (273)
T d1mp8a_ 150 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERL 228 (273)
T ss_dssp CC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCC
T ss_pred ccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 99999987643222 23468999999999999999999999999999999998 999999998888777765 45667
Q ss_pred CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 341 PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 341 ~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
+.|..+|+.+.+||.+||+.||.+|||+.+|+++|+.++.
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 8899999999999999999999999999999999877654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=439.40 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=213.9
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEE
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~i 190 (527)
||..++|++++.||+|+||+||+|.+. ++.||+|++...........+.+|+.+|+.++|||||+++++|.+...+||
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 466789999999999999999999984 678999998876555667789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 191 VMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
|||||+||+|.+++. .+.+++..+..++.||+.||.|||+.. +||||||||+||||+.+ +.+||+|||+
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~--------~~vkl~DFGl 151 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSR--------GEIKLCDFGV 151 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTT--------CCEEECCCCC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCC--------CCEEEeeCCC
Confidence 999999999999986 567999999999999999999999741 39999999999999875 6899999999
Q ss_pred chhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----------------
Q psy6905 270 AREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGV---------------- 333 (527)
Q Consensus 270 a~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i---------------- 333 (527)
|+........+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+........
T Consensus 152 a~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 152 SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp CHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred ccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 9988766666779999999999999999999999999999999999999999875432211100
Q ss_pred -------------------------HhCCccCCCC-CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 334 -------------------------AVNKLTLPIP-STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 334 -------------------------~~~~~~~~~p-~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.........| ..+|.++.+||.+||..||.+|||+.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0011111122 3468899999999999999999999999884
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-55 Score=434.37 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=204.1
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+.|++.+.||+|+||+||+|.+. ++.||||++...........+.+|+.+|+.++|||||++++++.+++.+||||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56999999999999999999984 6789999987654444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
|+||+|.+++. .+.+++..+..++.||+.||+|||++| ||||||||+|||+....+ .+.+||+|||+|+..
T Consensus 89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~-----~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDE-----DSKIMISDFGLSKME 160 (307)
T ss_dssp CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSST-----TCCEEECCC------
T ss_pred cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCC-----CceEEEeccceeEEc
Confidence 99999999886 567999999999999999999999995 999999999999975321 268999999999876
Q ss_pred hccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC--CCCCccHHH
Q psy6905 274 YKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPSTCPQLF 350 (527)
Q Consensus 274 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~~ 350 (527)
.... ..+.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+......++ .+..+|+++
T Consensus 161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 4433 3356799999999999999999999999999999999999999999988888888877666544 446799999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+||.+||..||.+|||+.+++++
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcC
Confidence 999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-55 Score=431.62 Aligned_cols=245 Identities=31% Similarity=0.492 Sum_probs=215.4
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
+.|++++.||+|+||.||+|.+. ++.||||++...... ..+.+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG-GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH-HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 45899999999999999999984 678999998765433 356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|+||+|.+++. ++.+++..+..++.||+.||.|||++| ||||||||+|||++.+ +.+||+|||+|+.
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~--------~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLD--------GDIKLADFGVSAK 159 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------SCEEECCCTTCEE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCC--------CCEEEEechhhhc
Confidence 99999999875 567999999999999999999999995 9999999999999976 6899999999976
Q ss_pred hhcc--ccccCCCccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-cCCCCC
Q psy6905 273 VYKT--THMSAAGTYAWMAPEVIK-----TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-TLPIPS 344 (527)
Q Consensus 273 ~~~~--~~~~~~gt~~y~aPE~l~-----~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~ 344 (527)
.... ...+..||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+....+..... ..+.|.
T Consensus 160 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (288)
T d2jfla1 160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 239 (288)
T ss_dssp CHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGG
T ss_pred cCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 5432 223568999999999984 45689999999999999999999999999888888777776543 345567
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.+|+++.+||.+||+.||.+|||+.++++
T Consensus 240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 89999999999999999999999999876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=424.74 Aligned_cols=250 Identities=29% Similarity=0.446 Sum_probs=210.7
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe----CCeE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ----SPKL 188 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~----~~~~ 188 (527)
...|++.+.||+|+||+||+|.+. +..||+|.+.... .....+.+.+|+++|++++|||||++++++.+ ...+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 334578889999999999999985 5689999876542 44456788999999999999999999999875 3568
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|||||||+||+|.+++. ...+++..+..|+.||+.||+|||++++ +||||||||+||||+.+ ++.+||+||
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~-------~~~~Kl~DF 159 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGP-------TGSVKIGDL 159 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESST-------TSCEEECCT
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCC-------CCCEEEeec
Confidence 99999999999999987 5679999999999999999999999842 39999999999999743 268999999
Q ss_pred CcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCccCCCCCCc
Q psy6905 268 GLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVA-YGVAVNKLTLPIPSTC 346 (527)
Q Consensus 268 Gla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~-~~i~~~~~~~~~p~~~ 346 (527)
|+|+........+.+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....... ..+..+......+..+
T Consensus 160 Gla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (270)
T d1t4ha_ 160 GLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238 (270)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred CcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccC
Confidence 9998765555556789999999999876 5899999999999999999999999876554444 4444333334456778
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++++.+||.+||..||++|||+.++++|
T Consensus 239 ~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 9999999999999999999999999873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=425.57 Aligned_cols=252 Identities=33% Similarity=0.631 Sum_probs=213.9
Q ss_pred eCCceeee-eeeccCCceEEEEeeEcC----ceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 115 DYNKLIFG-EAIGEGGFGKVYKGIYEK----QEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 115 ~~~~~~~~-~~iG~G~fg~Vy~~~~~~----~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
+...+.+. +.||+|+||.||+|.+.+ +.||||++.... +....+.+.+|+.+|++++|||||+++|+|.. +..
T Consensus 4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~ 82 (277)
T d1xbba_ 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESW 82 (277)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSE
T ss_pred chhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCE
Confidence 34444554 469999999999998742 479999987543 33446789999999999999999999999865 467
Q ss_pred EEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 189 CLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|||||||++|+|.+++. ...+++..++.|+.||+.||+|||++ +||||||||+||||+.+ +.+||+||
T Consensus 83 ~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~--------~~~kl~DF 151 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQ--------HYAKISDF 151 (277)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET--------TEEEECCC
T ss_pred EEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhccccc--------Ccccccch
Confidence 99999999999999987 56799999999999999999999999 49999999999999875 68999999
Q ss_pred Ccchhhhccc-----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 268 GLAREVYKTT-----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 268 Gla~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
|+++...... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. .+.+++
T Consensus 152 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~ 230 (277)
T d1xbba_ 152 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMG 230 (277)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCC
T ss_pred hhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 9998663322 123468999999999999999999999999999999998 999999998887766665 466778
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~ 379 (527)
.|..+|+++.+||.+||+.||++|||+.+|.+.|++..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 89999999999999999999999999999998886654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=432.72 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=218.0
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
+..++|++++.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.++++++|||||++++++.+++.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 34578999999999999999999984 6789999986431 1223567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+|||||+||+|.+++. .+.+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~--------~~vkl~DFG 153 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNED--------MHIQITDFG 153 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------SCEEECCCT
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCC--------ceEEecccc
Confidence 9999999999999877 678999999999999999999999994 9999999999999875 689999999
Q ss_pred cchhhhcc----ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 269 LAREVYKT----THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 269 la~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
+|+.+... ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.... ..+|.
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~ 231 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPE 231 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--CCCCT
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--CCCCc
Confidence 99876422 2234579999999999999999999999999999999999999999999888888877544 45678
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKAL 375 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L 375 (527)
.+++++.+||.+||..||.+|||+.+++++.
T Consensus 232 ~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 8999999999999999999999999987653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-54 Score=430.38 Aligned_cols=244 Identities=30% Similarity=0.454 Sum_probs=216.9
Q ss_pred ceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.|++++.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 489999999999999999997 46789999987653 23445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
||.||+|..++. ++.+++..+..++.||+.||.|||++| ||||||||+||||+.+ +.+||+|||+|+.
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~--------~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEP--------GLVKLGDFGSASI 164 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETT--------TEEEECCCTTCBS
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCC--------CCEEEeecccccc
Confidence 999999977655 678999999999999999999999995 9999999999999875 6999999999986
Q ss_pred hhccccccCCCcccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHH
Q psy6905 273 VYKTTHMSAAGTYAWMAPEVIKT---SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQL 349 (527)
Q Consensus 273 ~~~~~~~~~~gt~~y~aPE~l~~---~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 349 (527)
... .....||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+....+..+......+..+|++
T Consensus 165 ~~~--~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 242 (309)
T d1u5ra_ 165 MAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242 (309)
T ss_dssp SSS--BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHH
T ss_pred cCC--CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHH
Confidence 543 335689999999999864 458999999999999999999999999998888888887776666667789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+||.+||..||.+|||+.++++|
T Consensus 243 ~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 243 FRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHCcCChhHCcCHHHHHhC
Confidence 9999999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=421.56 Aligned_cols=254 Identities=33% Similarity=0.624 Sum_probs=219.1
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe-CCeEEE
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ-SPKLCL 190 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~~~i 190 (527)
|+|+.++|++.+.||+|+||.||+|.++++.||||+++... ..+.+.+|+.++++++|||||+++|+|.+ .+.+|+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 89999999999999999999999999999999999997643 34678899999999999999999999965 456899
Q ss_pred EEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 191 VMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|||||++|+|.+++.. ..+++..++.|+.||+.||.|||++ +||||||||+|||++.+ +.+||+||
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~--------~~~kl~df 147 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSED--------NVAKVSDF 147 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT--------SCEEECCC
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCC--------CCEeeccc
Confidence 9999999999999863 2489999999999999999999999 49999999999999986 68999999
Q ss_pred CcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 268 GLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 268 Gla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
|+++..... .....+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..+....+. .+.+.+.|..+
T Consensus 148 g~s~~~~~~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~ 225 (262)
T d1byga_ 148 GLTKEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGC 225 (262)
T ss_dssp CC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTC
T ss_pred ccceecCCC-CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccC
Confidence 999876433 334568999999999999999999999999999999998 899999988877777764 56778899999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 347 PQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
++.+++||.+||..||.+|||+.+|+++|+.+...
T Consensus 226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999877543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=430.09 Aligned_cols=262 Identities=30% Similarity=0.560 Sum_probs=218.2
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEE
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIG 180 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~ 180 (527)
.+.|+|++++|++++.||+|+||.||+|.+.+ +.||||++.........+.+.+|..++.++ +|+|||.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 35699999999999999999999999998742 479999998766666677788888888776 7899999999
Q ss_pred EEEeC-CeEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q psy6905 181 VCLQS-PKLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLK 242 (527)
Q Consensus 181 ~~~~~-~~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlk 242 (527)
++... ..+++|||||++|+|.+++.. ..+++..++.++.||+.||+|||++ +|||||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence 98764 468999999999999999852 2478899999999999999999999 49999999
Q ss_pred CCceecCCCCcccccccceeEEeccCcchhhhccc----cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhC-
Q psy6905 243 SSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTT----HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTG- 317 (527)
Q Consensus 243 p~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg- 317 (527)
|+||||+.+ +.+||+|||+|+...... .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 162 p~NILl~~~--------~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~ 233 (299)
T d1ywna1 162 ARNILLSEK--------NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233 (299)
T ss_dssp GGGEEECGG--------GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccceeECCC--------CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCC
Confidence 999999875 689999999998654322 2245699999999999999999999999999999999985
Q ss_pred CCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 318 EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 318 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.+||.+.+...........+..++.|..+|+++.+||.+||+.||++|||+.+++++|++++.+
T Consensus 234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 234 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 6789887766666666666778889999999999999999999999999999999999887653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-54 Score=422.09 Aligned_cols=257 Identities=33% Similarity=0.567 Sum_probs=218.5
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
+.|+|++++|++++.||+|+||.||+|.+++ +.||||++...... .+.+.+|+.++++++|||||+++|++.+ +.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence 4699999999999999999999999999855 57999998765432 4678999999999999999999999865 467
Q ss_pred EEEEeccCCCCHHHHhc---CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 189 CLVMEYARGGPLNRVLA---GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~---~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
|+|||||++|+|..++. ...+++.+++.++.||+.||+|||++| |+||||||+||||+.+ +.+||+
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~--------~~~kl~ 155 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN--------LVCKVA 155 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG--------GCEEEC
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCC--------CcEEEc
Confidence 99999999999998876 356999999999999999999999995 9999999999999875 689999
Q ss_pred ccCcchhhhccc---cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 266 DFGLAREVYKTT---HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTG-EIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 266 DFGla~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
|||+++...... .....||+.|+|||++.+..++.++|||||||++|||++| .+||.+....+....+. .+...+
T Consensus 156 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~ 234 (285)
T d1fmka3 156 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMP 234 (285)
T ss_dssp CCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCC
T ss_pred ccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCC
Confidence 999998764322 2235689999999999999999999999999999999995 55566666666665554 466778
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
.|..+|+++.+||.+||+.||++|||+.+|++.|++...+
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 9999999999999999999999999999999998876654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-53 Score=424.09 Aligned_cols=257 Identities=35% Similarity=0.601 Sum_probs=228.4
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCL 183 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~ 183 (527)
.+|+++++|++.+.||+|+||.||+|.+.+ +.||||++......+..+.+.+|+.+++.++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 378899999999999999999999998753 5799999987777777788999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHhcC-------------------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceee
Q psy6905 184 QSPKLCLVMEYARGGPLNRVLAG-------------------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIH 238 (527)
Q Consensus 184 ~~~~~~iv~Ey~~ggsL~~~l~~-------------------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiH 238 (527)
.....+++||||.+|+|.+++.. ..++...++.++.||+.||+|||++ +|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence 99999999999999999998852 1378889999999999999999999 4999
Q ss_pred cCCCCCceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHH
Q psy6905 239 RDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWEL 314 (527)
Q Consensus 239 rDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~el 314 (527)
|||||+||||+.+ +.+||+|||+|+....... .+..||+.|+|||.+.+..|+.++|||||||++|||
T Consensus 164 rDlKp~NILld~~--------~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~el 235 (301)
T d1lufa_ 164 RDLATRNCLVGEN--------MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235 (301)
T ss_dssp SCCSGGGEEECGG--------GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred eEEcccceEECCC--------CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHH
Confidence 9999999999875 6899999999987643322 245688999999999999999999999999999999
Q ss_pred HhC-CCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q psy6905 315 LTG-EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIV 379 (527)
Q Consensus 315 ltg-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~ 379 (527)
++| .+||.+.+..+....+.. +...+.|..+|+++.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus 236 l~~~~~p~~~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 236 FSYGLQPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HccCCCCCCCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 997 578999998888877764 4467789999999999999999999999999999999998765
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-53 Score=431.38 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=219.5
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|++++.||+|+||.||+|.+. |+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++.+||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57999999999999999999974 78999999876543 3467789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|+||+|.+++. .+.+++..+..|+.||+.||+|||++| ||||||||+|||++.+. .+.+||+|||+|+.
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~------~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKR------SNELKLIDFGLTAH 175 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTT------SCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCC------CCeEEEeecchhee
Confidence 99999999885 457999999999999999999999995 99999999999997532 26899999999987
Q ss_pred hhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC--CCCccHH
Q psy6905 273 VYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI--PSTCPQL 349 (527)
Q Consensus 273 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~ 349 (527)
+.... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.......+. +..+|++
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 64433 33568999999999999999999999999999999999999999999988888888766655443 2568999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 350 FKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 350 ~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+++||.+||..||++|||+.+++++
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999884
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=419.97 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=219.5
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-----ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-----DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-----~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
++|++++.||+|+||+||+|.+. |+.||||++.... .....+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46999999999999999999984 6799999875432 1223678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
||||||+||+|.+++. .+.+++..++.++.||+.||+|||+++ ||||||||+|||++.+... ...+||+|||
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~----~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVP----KPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSS----SCCEEECCCT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCc----ccceEecchh
Confidence 9999999999999987 567999999999999999999999995 9999999999999875311 2369999999
Q ss_pred cchhhhcc-ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC--CCCC
Q psy6905 269 LAREVYKT-THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPST 345 (527)
Q Consensus 269 la~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~ 345 (527)
+|+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......++ .+..
T Consensus 163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (293)
T d1jksa_ 163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242 (293)
T ss_dssp TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence 99876543 33456799999999999999999999999999999999999999999999888888876655443 3467
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+|+.+.+||++||..||.+|||+.+++++
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=419.77 Aligned_cols=260 Identities=34% Similarity=0.639 Sum_probs=226.4
Q ss_pred ceeeEEeCCceeeeeeeccCCceEEEEeeEcC---------ceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceE
Q psy6905 109 VKLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK---------QEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSL 178 (527)
Q Consensus 109 ~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~---------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~ 178 (527)
.+.|+|+.++|.+++.||+|+||.||+|.+.+ ..||||++...........+.+|+..+.++ +|||||++
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 34599999999999999999999999998632 369999998877766678889999999888 89999999
Q ss_pred EEEEEeCCeEEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCC
Q psy6905 179 IGVCLQSPKLCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDL 241 (527)
Q Consensus 179 ~~~~~~~~~~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDl 241 (527)
+++|.+++.+|+|||||++|+|.+++.. ..+++.+++.++.||+.||+|||+++ ||||||
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDi 161 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDL 161 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeee
Confidence 9999999999999999999999999862 34899999999999999999999994 999999
Q ss_pred CCCceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-
Q psy6905 242 KSSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT- 316 (527)
Q Consensus 242 kp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt- 316 (527)
||+|||++.+ +.+||+|||+++....... ....||+.|+|||.+.+..|+.++|||||||++|||++
T Consensus 162 Kp~NiLl~~~--------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 162 AARNVLVTED--------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp SGGGEEECTT--------CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cccceeecCC--------CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence 9999999986 6899999999987754332 23568999999999999999999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 317 GEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 317 g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
|.+||.+.+...+...+. .+..++.|..+|+++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 234 g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 234 GGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp SCCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 899999888877665554 577888999999999999999999999999999999999987753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-53 Score=429.56 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=219.2
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
.++|++++.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35799999999999999999997 468999999876543 235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||+||+|.+++. +..+++.+++.|+.||+.||+|||++| ||||||||+||||+... .+.+||+|||+|+
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~------~~~vkL~DFGla~ 177 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKK------ASSVKIIDFGLAT 177 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTT------CCCEEECCCTTCE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccC------CCeEEEeecccce
Confidence 999999988876 346999999999999999999999995 99999999999997431 2689999999998
Q ss_pred hhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCC--CCCCccH
Q psy6905 272 EVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLP--IPSTCPQ 348 (527)
Q Consensus 272 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~ 348 (527)
.+.... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+......++ .+..+|+
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 775433 3356799999999999999999999999999999999999999999999888888877665443 4467899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.+||.+||..||.+|||+.++++|
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999873
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=426.43 Aligned_cols=248 Identities=26% Similarity=0.440 Sum_probs=219.6
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLC 189 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~ 189 (527)
|..++|++++.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 4557899999999999999999997 46899999986431 1123567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 190 LVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
+|||||+||+|.+++. .+.+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~--------g~vkl~DFG 150 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKD--------GHIKITDFG 150 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT--------SCEEECCCT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCC--------CCEEEeecc
Confidence 9999999999999887 578999999999999999999999995 9999999999999876 799999999
Q ss_pred cchhhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCc
Q psy6905 269 LAREVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTC 346 (527)
Q Consensus 269 la~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 346 (527)
+|+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+.... ...|..+
T Consensus 151 ~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~ 228 (337)
T d1o6la_ 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTL 228 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTS
T ss_pred cccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CCCCccC
Confidence 9987643 22345689999999999999999999999999999999999999999999888887776554 4678889
Q ss_pred cHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q psy6905 347 PQLFKTLMEACWEADSHMRPS-----FKTILKA 374 (527)
Q Consensus 347 ~~~~~~li~~~l~~dp~~RPs-----~~~ll~~ 374 (527)
|+++.+||.+||..||.+||+ +.++++|
T Consensus 229 s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 999999999999999999995 7888764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=416.16 Aligned_cols=252 Identities=35% Similarity=0.623 Sum_probs=214.7
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEcC-----ceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYEK-----QEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP 186 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~ 186 (527)
|+.++|++.+.||+|+||.||+|.+.+ ..||||++.... .....+.+.+|+.+|++++|||||++||++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 567889999999999999999998642 268999887642 33456789999999999999999999999965 4
Q ss_pred eEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEE
Q psy6905 187 KLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKI 264 (527)
Q Consensus 187 ~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL 264 (527)
.+++|||||++|+|.+++. .+.+++..++.++.||+.||.|||++ +|+||||||+||||+.+ +.+||
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~--------~~vkl 152 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATR--------DLVKI 152 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEET--------TEEEE
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccc--------cceee
Confidence 6799999999999988765 45799999999999999999999999 49999999999999875 68999
Q ss_pred eccCcchhhhcccc-----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCc
Q psy6905 265 TDFGLAREVYKTTH-----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKL 338 (527)
Q Consensus 265 ~DFGla~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 338 (527)
+|||+++....... ....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....+...+.
T Consensus 153 ~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~ 232 (273)
T d1u46a_ 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232 (273)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred ccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC
Confidence 99999987643322 12357889999999999999999999999999999998 8999999999999999988888
Q ss_pred cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q psy6905 339 TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNN 377 (527)
Q Consensus 339 ~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~ 377 (527)
+++.|..+|+.+.+||.+||+.||++|||+.+|++.|.+
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 889999999999999999999999999999999988765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=419.63 Aligned_cols=253 Identities=33% Similarity=0.609 Sum_probs=216.0
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--Cc----eEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQ----EVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKL 188 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~ 188 (527)
..++|++++.||+|+||+||+|.+. ++ .||+|.+.........+.+.+|+.++++++|||||+++|+|.++ ..
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 4467999999999999999999874 32 58999887655555577899999999999999999999999875 56
Q ss_pred EEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 189 CLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+++||||.+|+|.+++. ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.+ +.+||+|
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~--------~~~kl~D 154 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTP--------QHVKITD 154 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEET--------TEEEECC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCC--------CCeEeec
Confidence 88899999999988776 567999999999999999999999994 9999999999999875 6899999
Q ss_pred cCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCccCC
Q psy6905 267 FGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-GEIPYKSINAYAVAYGVAVNKLTLP 341 (527)
Q Consensus 267 FGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 341 (527)
||+|+....... ....||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..++...+. .+.+++
T Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~ 233 (317)
T d1xkka_ 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLP 233 (317)
T ss_dssp CSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCC
T ss_pred cccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 999987643222 23358999999999999999999999999999999998 899999988777655554 466778
Q ss_pred CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 342 IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 342 ~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.|..+|+.+.+||.+||+.||.+|||+.+|+++|..+..
T Consensus 234 ~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999999999999887754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-53 Score=419.94 Aligned_cols=260 Identities=33% Similarity=0.608 Sum_probs=231.9
Q ss_pred eeeEEeCCceeeeeeeccCCceEEEEeeEcC-------ceEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEE
Q psy6905 110 KLVEIDYNKLIFGEAIGEGGFGKVYKGIYEK-------QEVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGV 181 (527)
Q Consensus 110 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~ 181 (527)
..|+|+.++|++++.||+|+||.||+|.+.+ +.||||++...........+.+|+.+++.+ +|||||+++|+
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3699999999999999999999999998632 479999998876666677899999999999 79999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHhcCC-------------------CCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q psy6905 182 CLQSPKLCLVMEYARGGPLNRVLAGR-------------------KIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLK 242 (527)
Q Consensus 182 ~~~~~~~~iv~Ey~~ggsL~~~l~~~-------------------~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlk 242 (527)
|.+.+.+|+|||||++|+|.+++... .+++..++.++.||+.||+|||+++ +||||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLK 172 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccc
Confidence 99999999999999999999998622 4888999999999999999999995 9999999
Q ss_pred CCceecCCCCcccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHh-C
Q psy6905 243 SSNVLLSEPIENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLT-G 317 (527)
Q Consensus 243 p~NILl~~~~~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~ellt-g 317 (527)
|+|||++.+ +.+||+|||+++....... ....||+.|+|||++.+..++.++|||||||++|||+| |
T Consensus 173 p~NIl~~~~--------~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g 244 (311)
T d1t46a_ 173 ARNILLTHG--------RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (311)
T ss_dssp GGGEEEETT--------TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccc--------CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCC
Confidence 999999875 6899999999987643222 23468999999999999999999999999999999998 7
Q ss_pred CCCCCCCCHHHHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhh
Q psy6905 318 EIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVH 380 (527)
Q Consensus 318 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~ 380 (527)
.+||.+.+..+....+...+.+...|..+|+.+.+||.+||+.||.+|||+.+|++.|+.++.
T Consensus 245 ~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp CCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 788888887777777777788888999999999999999999999999999999999987654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=417.89 Aligned_cols=261 Identities=33% Similarity=0.593 Sum_probs=231.3
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeEc-------CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEE
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIYE-------KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCL 183 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~ 183 (527)
.|+|+.++|++++.||+|+||.||+|.+. ++.||||+++..........+.+|+.++++++|||||+++|++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 59999999999999999999999999874 35799999987666666678999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHhcC-----------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCC
Q psy6905 184 QSPKLCLVMEYARGGPLNRVLAG-----------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPI 252 (527)
Q Consensus 184 ~~~~~~iv~Ey~~ggsL~~~l~~-----------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~ 252 (527)
.++..++|||||.+|+|.+++.. ..++...+..++.||+.||.|||++ +||||||||+||||+.+
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~- 169 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED- 169 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT-
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC-
Confidence 99999999999999999998751 2467888999999999999999999 59999999999999976
Q ss_pred cccccccceeEEeccCcchhhhcccc----ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhC-CCCCCCCCHH
Q psy6905 253 ENEDLQFKTLKITDFGLAREVYKTTH----MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTG-EIPYKSINAY 327 (527)
Q Consensus 253 ~~~~~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg-~~Pf~~~~~~ 327 (527)
+.+||+|||+++....... ....||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..
T Consensus 170 -------~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~ 242 (308)
T d1p4oa_ 170 -------FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242 (308)
T ss_dssp -------CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred -------ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 6899999999987644322 234689999999999999999999999999999999996 6899999888
Q ss_pred HHHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhccc
Q psy6905 328 AVAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSEF 383 (527)
Q Consensus 328 ~~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~~ 383 (527)
+....+. .+..++.|..+|+.+.+||.+||+.||++|||+.+|++.|++..++.+
T Consensus 243 ~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~ 297 (308)
T d1p4oa_ 243 QVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297 (308)
T ss_dssp HHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred HHHHHHH-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 8877765 455678899999999999999999999999999999999988776544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-52 Score=418.45 Aligned_cols=245 Identities=26% Similarity=0.437 Sum_probs=217.6
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
.++|++++.||+|+||+||+|.+. |+.||||++.... .....+.+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 367999999999999999999974 6899999986431 112256788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||||.||+|..++. +..+++..+..++.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+|
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~--------g~vkL~DFG~a 151 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKN--------GHIKITDFGFA 151 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTT--------SCEEECCCSSC
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCC--------CCEEEecCccc
Confidence 99999999998887 667899999999999999999999995 9999999999999875 68999999999
Q ss_pred hhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHH
Q psy6905 271 REVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLF 350 (527)
Q Consensus 271 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 350 (527)
+.... ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.... ...|..+|+++
T Consensus 152 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~ 228 (316)
T d1fota_ 152 KYVPD-VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDV 228 (316)
T ss_dssp EECSS-CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHH
T ss_pred eEecc-ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCCCCHHH
Confidence 87643 3345789999999999999999999999999999999999999999999888888877654 45678899999
Q ss_pred HHHHHHhhhhCCCCCC-----CHHHHHHH
Q psy6905 351 KTLMEACWEADSHMRP-----SFKTILKA 374 (527)
Q Consensus 351 ~~li~~~l~~dp~~RP-----s~~~ll~~ 374 (527)
.++|.+||..||.+|+ |++++++|
T Consensus 229 ~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 229 KDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 9999999999999996 88888764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=416.38 Aligned_cols=258 Identities=33% Similarity=0.584 Sum_probs=221.9
Q ss_pred EEeCCceeeeeeeccCCceEEEEeeEcC--c--eEEEEEcCCCCChhHHHHHHHHHHHHHhC-CCCccceEEEEEEeCCe
Q psy6905 113 EIDYNKLIFGEAIGEGGFGKVYKGIYEK--Q--EVAIKVAHPNPDENILENVKQEGKLLWLF-DHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 113 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~--~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~~~~~~~~~~~ 187 (527)
.|+.++|++.+.||+|+||.||+|.+++ . .||||.+......+..+.+.+|+.+|+.+ +|||||+++|+|.+++.
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 4688999999999999999999999843 2 57888876554444567899999999998 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHhcC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCC
Q psy6905 188 LCLVMEYARGGPLNRVLAG-----------------RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSE 250 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~ 250 (527)
+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++ +||||||||+|||++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcC
Confidence 9999999999999999852 4689999999999999999999999 4999999999999987
Q ss_pred CCcccccccceeEEeccCcchhhhcccc-ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhC-CCCCCCCCHHH
Q psy6905 251 PIENEDLQFKTLKITDFGLAREVYKTTH-MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTG-EIPYKSINAYA 328 (527)
Q Consensus 251 ~~~~~~~~~~~vkL~DFGla~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg-~~Pf~~~~~~~ 328 (527)
+ +.+||+|||+++....... ....||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+
T Consensus 163 ~--------~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~ 234 (309)
T d1fvra_ 163 N--------YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234 (309)
T ss_dssp G--------GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred C--------CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH
Confidence 5 6899999999986644332 245689999999999999999999999999999999995 56898888888
Q ss_pred HHHHHHhCCccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 329 VAYGVAVNKLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 329 ~~~~i~~~~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
....+. .+.+++.|..+|+++.+||.+||+.||++|||+.+|+++|+.+.+..
T Consensus 235 ~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 235 LYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHH-hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 777765 45677889999999999999999999999999999999999988654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=416.47 Aligned_cols=248 Identities=22% Similarity=0.338 Sum_probs=218.5
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
+++|.+++.||+|+||+||+|.+. ++.||||++...... ...+.+|+.+|+.++|||||++++++.+++.+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 578999999999999999999974 678999999765422 3567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||+||+|.+++.. ..+++.++..|+.||+.||+|||++| ||||||||+|||++.+. ...+||+|||+++
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~------~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRR------SSTIKIIEFGQAR 152 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSS------CCCEEECCCTTCE
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCC------ceEEEEcccchhh
Confidence 9999999999973 36899999999999999999999995 99999999999998642 2589999999998
Q ss_pred hhhccc-cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCC--CCCccH
Q psy6905 272 EVYKTT-HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPI--PSTCPQ 348 (527)
Q Consensus 272 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~ 348 (527)
...... .....||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+.......+....+.++. +..+|+
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 764332 33457899999999999999999999999999999999999999999998888888766655432 247899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
++.+||.+||..||.+|||+.++++|
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-51 Score=405.07 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=213.9
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC----e
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP----K 187 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~----~ 187 (527)
.++|++.+.||+|+||.||+|.+ +++.||||++.... +......+.+|+.+++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999997 47899999987643 4455678999999999999999999999997654 3
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|+|||||+||+|.+++. .+.+++.+++.++.||+.||+|||++| ||||||||+|||++.+ +.++|+|
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~--------~~~~l~d 154 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISAT--------NAVKVMD 154 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT--------SCEEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCcc--------ccceeeh
Confidence 899999999999998876 668999999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhcc-----ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC-
Q psy6905 267 FGLAREVYKT-----THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL- 340 (527)
Q Consensus 267 FGla~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~- 340 (527)
||.+...... .....+||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234 (277)
T ss_dssp CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC
Confidence 9998654322 2234579999999999999999999999999999999999999999999888887777655443
Q ss_pred -CCCCCccHHHHHHHHHhhhhCCCCCC-CHHHHHHHHhhhh
Q psy6905 341 -PIPSTCPQLFKTLMEACWEADSHMRP-SFKTILKALNNIV 379 (527)
Q Consensus 341 -~~p~~~~~~~~~li~~~l~~dp~~RP-s~~~ll~~L~~~~ 379 (527)
..+..+|+.+.++|.+||..||.+|| |+++++..|..+.
T Consensus 235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 23467899999999999999999999 8999988876653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-51 Score=404.37 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=216.6
Q ss_pred CCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCC--------hhHHHHHHHHHHHHHhCC-CCccceEEEEEEe
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPD--------ENILENVKQEGKLLWLFD-HRNIVSLIGVCLQ 184 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~ 184 (527)
+++|++.+.||+|+||+||+|.+ +++.||||++..... ....+.+.+|+.+++.++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999997 568999999865431 123456889999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
++.+|||||||+||+|.+++. .+.+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~--------~~~k 150 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDD--------MNIK 150 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT--------CCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCC--------CCeE
Confidence 999999999999999999996 668999999999999999999999995 9999999999999875 6899
Q ss_pred EeccCcchhhhcc-ccccCCCcccccccccccc------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6905 264 ITDFGLAREVYKT-THMSAAGTYAWMAPEVIKT------SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN 336 (527)
Q Consensus 264 L~DFGla~~~~~~-~~~~~~gt~~y~aPE~l~~------~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~ 336 (527)
|+|||+++.+... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 151 l~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230 (277)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence 9999999876443 2334679999999999853 34688999999999999999999999999988888777776
Q ss_pred CccCCCC--CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 KLTLPIP--STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ~~~~~~p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...++.+ ..+|+++++||.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 6554443 4789999999999999999999999998763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.7e-52 Score=420.64 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=209.4
Q ss_pred eCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-----ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCe
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-----DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPK 187 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~ 187 (527)
..++|++++.||+|+||.||+|.+ +|+.||||++.... ..........++.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 356899999999999999999998 46899999975421 12222333455777888899999999999999999
Q ss_pred EEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEec
Q psy6905 188 LCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITD 266 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~D 266 (527)
+|+|||||+||+|.+++. ...+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~--------g~iKl~D 150 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEH--------GHVRISD 150 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS--------SCEEECC
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCC--------CcEEEee
Confidence 999999999999999986 667899999999999999999999995 9999999999999875 6899999
Q ss_pred cCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhCCccCCCCC
Q psy6905 267 FGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYG-VAVNKLTLPIPS 344 (527)
Q Consensus 267 FGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~-i~~~~~~~~~p~ 344 (527)
||+|+...........||+.|+|||++.. ..|+.++|||||||++|||++|+.||.+.+....... ..........|.
T Consensus 151 FGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 230 (364)
T d1omwa3 151 LGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230 (364)
T ss_dssp CTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS
T ss_pred eceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Confidence 99998776665666789999999999964 5689999999999999999999999987543322211 112344556778
Q ss_pred CccHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPS-----FKTILKA 374 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs-----~~~ll~~ 374 (527)
.+|+++.+||.+||..||.+||| +.++++|
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 89999999999999999999999 7888875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-52 Score=419.85 Aligned_cols=244 Identities=26% Similarity=0.376 Sum_probs=216.8
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC--ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEE
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP--DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
.++|++++.||+|+||.||+|.++ |+.||||++.... .....+.+.+|+.+|+.++|||||++++++.+...+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 468999999999999999999984 7899999886421 112256788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||||.||+|..++. .+.+++..+..++.||+.||.|||++| ||||||||+||||+.+ +.+||+|||+|
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~--------g~ikL~DFG~a 188 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQ--------GYIQVTDFGFA 188 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT--------SCEEECCCTTC
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCC--------CCEEeeeceee
Confidence 99999999988876 568999999999999999999999994 9999999999999875 68999999999
Q ss_pred hhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccHHH
Q psy6905 271 REVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQLF 350 (527)
Q Consensus 271 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 350 (527)
+.+.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ...|..+|+++
T Consensus 189 ~~~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~ 265 (350)
T d1rdqe_ 189 KRVKG-RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDL 265 (350)
T ss_dssp EECSS-CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHH
T ss_pred eeccc-ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHH
Confidence 87643 2345679999999999999999999999999999999999999999998888888777554 45678899999
Q ss_pred HHHHHHhhhhCCCCCC-----CHHHHHH
Q psy6905 351 KTLMEACWEADSHMRP-----SFKTILK 373 (527)
Q Consensus 351 ~~li~~~l~~dp~~RP-----s~~~ll~ 373 (527)
.+||++||..||.+|+ |+.+|++
T Consensus 266 ~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHhhhCHHhccccccccHHHHHc
Confidence 9999999999999994 8888876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=412.79 Aligned_cols=244 Identities=25% Similarity=0.446 Sum_probs=212.0
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC--ChhHHHHHHHHHHHHH-hCCCCccceEEEEEEeCCeEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP--DENILENVKQEGKLLW-LFDHRNIVSLIGVCLQSPKLCLV 191 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~-~l~hpnIv~~~~~~~~~~~~~iv 191 (527)
++|.+++.||+|+||+||+|.+ +++.||||++.... .....+.+..|..++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999998 46899999986431 1112345566666654 68999999999999999999999
Q ss_pred EeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcc
Q psy6905 192 MEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLA 270 (527)
Q Consensus 192 ~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla 270 (527)
||||+||+|.+++. ...+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||++
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~--------~~~kl~DFG~a 150 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKD--------GHIKIADFGMC 150 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT--------SCEEECCCTTC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCC--------Cceeccccchh
Confidence 99999999999987 677999999999999999999999995 9999999999999975 68999999999
Q ss_pred hhhhc--cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCCCccH
Q psy6905 271 REVYK--TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPSTCPQ 348 (527)
Q Consensus 271 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 348 (527)
+.... .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+.... ...|..+|+
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~ 228 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEK 228 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCH
T ss_pred hhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCccCCH
Confidence 86533 22234579999999999999999999999999999999999999999999888888776554 466788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHH-HHHH
Q psy6905 349 LFKTLMEACWEADSHMRPSFK-TILK 373 (527)
Q Consensus 349 ~~~~li~~~l~~dp~~RPs~~-~ll~ 373 (527)
++.+||.+||..||.+||++. ++++
T Consensus 229 ~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 229 EAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 999999999999999999985 5654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-51 Score=404.81 Aligned_cols=250 Identities=33% Similarity=0.625 Sum_probs=211.5
Q ss_pred eeeeeccCCceEEEEeeEcC-----ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe-CCeEEEEEec
Q psy6905 121 FGEAIGEGGFGKVYKGIYEK-----QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ-SPKLCLVMEY 194 (527)
Q Consensus 121 ~~~~iG~G~fg~Vy~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-~~~~~iv~Ey 194 (527)
+.++||+|+||+||+|.+.. ..||||.+....+....+.+.+|+.+|++++|||||+++|++.+ +...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 36789999999999998732 25899998876666677889999999999999999999999876 4689999999
Q ss_pred cCCCCHHHHhcC--CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 195 ARGGPLNRVLAG--RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 195 ~~ggsL~~~l~~--~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
|++|+|.+++.. ..++...++.++.|++.||.|||+. +|+||||||+||||+.+ +.+||+|||+++.
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~--------~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEK--------FTVKVADFGLARD 179 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT--------CCEEECSSGGGCC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCC--------CCEEEecccchhh
Confidence 999999998874 3467788999999999999999999 49999999999999875 6899999999987
Q ss_pred hhcccc------ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCccCCCCCC
Q psy6905 273 VYKTTH------MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSI-NAYAVAYGVAVNKLTLPIPST 345 (527)
Q Consensus 273 ~~~~~~------~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~ 345 (527)
...... ....||+.|+|||.+.+..++.++||||||+++|||+||..||... +..+....+. .+.+++.|..
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~ 258 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEY 258 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTT
T ss_pred ccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCccc
Confidence 643221 1346899999999999999999999999999999999976666544 3444444443 4567788899
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 346 CPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 346 ~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
+++.+.+||.+||+.||++|||+.+++++|+.+..+.
T Consensus 259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 9999999999999999999999999999999988653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=408.10 Aligned_cols=244 Identities=26% Similarity=0.428 Sum_probs=200.6
Q ss_pred Cceeee-eeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHH-hCCCCccceEEEEEEe----CCeE
Q psy6905 117 NKLIFG-EAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLW-LFDHRNIVSLIGVCLQ----SPKL 188 (527)
Q Consensus 117 ~~~~~~-~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~hpnIv~~~~~~~~----~~~~ 188 (527)
++|.+. +.||+|+||.||+|.+ +++.||||++... ..+.+|+.++. .++|||||+++++|.+ +..+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 578876 4699999999999997 4679999998643 45668888865 4589999999999876 4678
Q ss_pred EEEEeccCCCCHHHHhcC---CCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 189 CLVMEYARGGPLNRVLAG---RKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 189 ~iv~Ey~~ggsL~~~l~~---~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
|||||||+||+|.+++.. ..+++.++..|+.||+.||+|||++| ||||||||+|||++.+.+ .+.+||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~-----~~~~Kl~ 156 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRP-----NAILKLT 156 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSST-----TCCEEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccc-----ccccccc
Confidence 999999999999999863 36899999999999999999999995 999999999999987532 2579999
Q ss_pred ccCcchhhhcc-ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhCCccC
Q psy6905 266 DFGLAREVYKT-THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGV----AVNKLTL 340 (527)
Q Consensus 266 DFGla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i----~~~~~~~ 340 (527)
|||+|+..... .....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+.......+ ....+.+
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 99999876443 334567999999999999999999999999999999999999999876654443332 2223333
Q ss_pred CCC--CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 PIP--STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 ~~p--~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
+.+ ..+|+++.+||.+||..||++|||+.+++++
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 322 3578999999999999999999999999885
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=399.36 Aligned_cols=242 Identities=26% Similarity=0.328 Sum_probs=200.8
Q ss_pred eeeeccCCceEEEEeeE--cCceEEEEEcCCCCCh----hHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEecc
Q psy6905 122 GEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDE----NILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEYA 195 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey~ 195 (527)
+++||+|+||+||+|.+ +++.||||++...... ...+.+.+|+.+++.++|||||++++++.+++.+|||||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999997 4678999998754321 22356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhhh
Q psy6905 196 RGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREVY 274 (527)
Q Consensus 196 ~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~~ 274 (527)
.||++..+.. +..+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+...
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~--------~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDEN--------GVLKLADFGLAKSFG 151 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------CCEEECCCGGGSTTT
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCC--------CccccccCccccccC
Confidence 9988877776 567999999999999999999999995 9999999999999875 689999999998765
Q ss_pred ccc--cccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc------------
Q psy6905 275 KTT--HMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT------------ 339 (527)
Q Consensus 275 ~~~--~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~------------ 339 (527)
... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+......
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 432 234579999999999865 45899999999999999999999999998887776655421000
Q ss_pred --------C-C-----CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 --------L-P-----IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 --------~-~-----~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. . ....+++++.+||.+||..||++|||+.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 0 013567899999999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=399.77 Aligned_cols=240 Identities=23% Similarity=0.396 Sum_probs=203.6
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCCh-----hHHHHHHHHHHHHHhCC--CCccceEEEEEEeCCe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDE-----NILENVKQEGKLLWLFD--HRNIVSLIGVCLQSPK 187 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~--hpnIv~~~~~~~~~~~ 187 (527)
++|++++.||+|+||.||+|.+. ++.||||++...... .....+.+|+.+++.++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999984 679999987643110 11234568999999986 8999999999999999
Q ss_pred EEEEEeccCC-CCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 188 LCLVMEYARG-GPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 188 ~~iv~Ey~~g-gsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
+|+|||||.+ +++.+++. +..+++..+..++.||+.||+|||++| ||||||||+|||++.+ .+.+||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~-------~~~vkl~ 153 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN-------RGELKLI 153 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETT-------TTEEEEC
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecC-------CCeEEEC
Confidence 9999999976 57777776 678999999999999999999999995 9999999999999854 2689999
Q ss_pred ccCcchhhhccccccCCCccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccCCCCC
Q psy6905 266 DFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIF-SKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTLPIPS 344 (527)
Q Consensus 266 DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 344 (527)
|||+|+........+..||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+. +... ....+.
T Consensus 154 DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~--~~~~~~ 225 (273)
T d1xwsa_ 154 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--QVFFRQ 225 (273)
T ss_dssp CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--CCCCSS
T ss_pred ccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhc--ccCCCC
Confidence 999998776555566789999999999987664 6789999999999999999999986431 2222 235677
Q ss_pred CccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 345 TCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 345 ~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.+|+++.+||.+||..||.+|||+.+++++
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 899999999999999999999999999873
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=393.93 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=203.5
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCC-hhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPD-ENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|++++.||+|+||+||+|.+. ++.||||++..... +.....+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999984 68999999865432 2235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
||.++.+..+.. .+.+++..+..++.||+.||.|||++| ||||||||+|||++.+ +.+||+|||+|+
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~--------~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTE--------GAIKLADFGLAR 150 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT--------SCEEECSTTHHH
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeeccc--------CcceeccCCcce
Confidence 997665544433 567999999999999999999999995 9999999999999875 689999999998
Q ss_pred hhhccc--cccCCCccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Q psy6905 272 EVYKTT--HMSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK----------- 337 (527)
Q Consensus 272 ~~~~~~--~~~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~----------- 337 (527)
...... .....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 151 ~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 151 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp HHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred eccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 774432 23457999999999976655 5789999999999999999999999988776665543210
Q ss_pred -----ccCCC-----------CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 -----LTLPI-----------PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 -----~~~~~-----------p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
..... ...+++++.+||.+||..||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00001 12467889999999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=395.64 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=202.8
Q ss_pred CceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC----eEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP----KLCLVM 192 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~----~~~iv~ 192 (527)
++|.+.+.||+|+||.||+|.++|+.||||++...... ......|+..+..++|||||++++++.+.+ .+|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 57899999999999999999999999999998654221 122234555556789999999999998654 589999
Q ss_pred eccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 193 EYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA-----PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 193 Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g-----~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
|||++|+|.++++...+++..++.++.|++.||.|||+.+ ..+||||||||+||||+.+ +.+||+||
T Consensus 81 Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~--------~~~Kl~DF 152 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN--------GTCCIADL 152 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT--------SCEEECCC
T ss_pred ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC--------CCeEEEec
Confidence 9999999999999888999999999999999999999731 1169999999999999876 69999999
Q ss_pred Ccchhhhccc------cccCCCccccccccccccCC------CCcccchHHHHHHHHHHHhCCCCCCCC-----------
Q psy6905 268 GLAREVYKTT------HMSAAGTYAWMAPEVIKTSI------FSKASDVWSYGVVLWELLTGEIPYKSI----------- 324 (527)
Q Consensus 268 Gla~~~~~~~------~~~~~gt~~y~aPE~l~~~~------~~~ksDvwSlGv~l~elltg~~Pf~~~----------- 324 (527)
|+++...... .....||+.|+|||++.+.. ++.++|||||||+||||+||..||...
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 9998764322 12356999999999987643 567999999999999999998877431
Q ss_pred ----CHHHHHHHHHhCCccCCCCCC-----ccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhc
Q psy6905 325 ----NAYAVAYGVAVNKLTLPIPST-----CPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHS 381 (527)
Q Consensus 325 ----~~~~~~~~i~~~~~~~~~p~~-----~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~ 381 (527)
........+...+.+.++|.. ++..+.+||.+||..||.+|||+.+|++.|..+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 122333333444444445433 345689999999999999999999999999877654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.7e-49 Score=387.38 Aligned_cols=247 Identities=26% Similarity=0.325 Sum_probs=206.8
Q ss_pred CceeeeeeeccCCceEEEEeeEc-CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEec
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE-KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVMEY 194 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~Ey 194 (527)
++|++++.||+|+||+||+|.++ ++.||||++.... .+...+.+.+|+.+|+.++|||||++++++.+++..|++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999984 6899999987653 233356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchhh
Q psy6905 195 ARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAREV 273 (527)
Q Consensus 195 ~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~~ 273 (527)
+.++++..+.. .+.+++..+..++.||+.||+|||++ +||||||||+|||++.+ +.+||+|||++...
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~--------~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINRE--------GELKIADFGLARAF 150 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT--------SCEEECCTTHHHHH
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCC--------CCEEecccccceec
Confidence 98888777766 67799999999999999999999999 49999999999999876 68999999999876
Q ss_pred hccc--cccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc-----------
Q psy6905 274 YKTT--HMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLT----------- 339 (527)
Q Consensus 274 ~~~~--~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~----------- 339 (527)
.... .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 4432 2344689999999998754 5789999999999999999999999988876665554321000
Q ss_pred ----------------CCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 340 ----------------LPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 340 ----------------~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+..+++.+.+||++||..||++|||+.++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01235678899999999999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=390.41 Aligned_cols=247 Identities=26% Similarity=0.359 Sum_probs=200.8
Q ss_pred CceeeeeeeccCCceEEEEeeEc---CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhC---CCCccceEEEEEEe-----
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE---KQEVAIKVAHPNP-DENILENVKQEGKLLWLF---DHRNIVSLIGVCLQ----- 184 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~---~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l---~hpnIv~~~~~~~~----- 184 (527)
++|++++.||+|+||+||+|.+. ++.||||++.... .......+.+|+.+++.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999973 4579999875432 111123345666666554 89999999999863
Q ss_pred CCeEEEEEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
...+|++||||.+|++..... ...+++..+..++.||+.||+|||+++ ||||||||+|||++.+ +.+
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~--------~~~ 155 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS--------GQI 155 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------CCE
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCC--------CCe
Confidence 346899999999887754443 567899999999999999999999995 9999999999999875 689
Q ss_pred EEeccCcchhhhc-cccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----
Q psy6905 263 KITDFGLAREVYK-TTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNK---- 337 (527)
Q Consensus 263 kL~DFGla~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~---- 337 (527)
||+|||+++.... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 156 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence 9999999986643 33345689999999999999999999999999999999999999999988777665543210
Q ss_pred ---------------------ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 338 ---------------------LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 338 ---------------------~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.....+..+++.+.+||.+||..||.+|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0011345678999999999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=392.15 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=205.1
Q ss_pred eEEeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC--
Q psy6905 112 VEIDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-- 186 (527)
Q Consensus 112 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-- 186 (527)
|++ .++|++++.||+|+||+||+|.+. ++.||||++.... .....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 14 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 565 578999999999999999999974 7899999997643 4455678899999999999999999999997654
Q ss_pred ----eEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 187 ----KLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 187 ----~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
.+|+||||| +++|..+++.+.+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~--------~~~ 160 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNED--------CEL 160 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------CCE
T ss_pred cccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccc--------ccc
Confidence 579999999 778988888889999999999999999999999995 9999999999999986 689
Q ss_pred EEeccCcchhhhccccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---
Q psy6905 263 KITDFGLAREVYKTTHMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL--- 338 (527)
Q Consensus 263 kL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~--- 338 (527)
||+|||+|+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 161 kl~Dfg~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 161 KILDFGLARQADS-EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp EECCCTTCEECCS-SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccceeccCC-ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 9999999987643 2345679999999999876 4578999999999999999999999998876555433221100
Q ss_pred --------------------------cCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 --------------------------TLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 --------------------------~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.......+++++.+||.+||..||.+|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 011235678999999999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=387.41 Aligned_cols=246 Identities=26% Similarity=0.362 Sum_probs=200.8
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCC-----eEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQSP-----KLC 189 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 189 (527)
++|.+++.||+|+||+||+|.+. ++.||||++.........+.+.+|+.+|+.++||||+++++++.... .+|
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 45999999999999999999974 78999999987666666788999999999999999999999997643 345
Q ss_pred EEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
++ +|+.||+|.+++..+.+++..+..++.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+
T Consensus 88 l~-~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~--------~~~kl~DfG~ 155 (345)
T d1pmea_ 88 LV-THLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTT--------CDLKICDFGL 155 (345)
T ss_dssp EE-EECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------CCEEECCCTT
T ss_pred EE-EeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCC--------CCEEEcccCc
Confidence 54 5566999999998888999999999999999999999995 9999999999999875 6899999999
Q ss_pred chhhhccc-----cccCCCccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Q psy6905 270 AREVYKTT-----HMSAAGTYAWMAPEVIK-TSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------- 336 (527)
Q Consensus 270 a~~~~~~~-----~~~~~gt~~y~aPE~l~-~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------- 336 (527)
++...... ....+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+...........
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 97653321 22456999999999984 456789999999999999999999999887755444332110
Q ss_pred -----------------CccC-----CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 -----------------KLTL-----PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 -----------------~~~~-----~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.... .....+++++.+||.+||..||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0123567889999999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-47 Score=379.15 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=202.3
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCcc-ceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNI-VSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~~~~~~~~~~~~~iv~E 193 (527)
++|++++.||+|+||.||+|.+. ++.||||++...... ..+..|+.+++.++|+|+ +.+++++.+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 57999999999999999999974 679999987765332 346789999999977765 455566678889999999
Q ss_pred ccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 194 YARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 194 y~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
|| +|+|...+. .+.+++..++.++.|++.||+|||++| ||||||||+|||++.... ...+||+|||+|+
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~-----~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKK-----GNLVYIIDFGLAK 154 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGG-----TTCEEECCCSSCE
T ss_pred Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCC-----CceeeeeccCcce
Confidence 99 556655544 668999999999999999999999995 999999999999875421 2579999999998
Q ss_pred hhhccc---------cccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCcc
Q psy6905 272 EVYKTT---------HMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGV---AVNKLT 339 (527)
Q Consensus 272 ~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i---~~~~~~ 339 (527)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 764321 22457999999999999999999999999999999999999999876554333222 111112
Q ss_pred CC---CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 340 LP---IPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 340 ~~---~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
.+ .+..+|+++.++|..||+.||++||++.+|.+.|+++....
T Consensus 235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 22 34678999999999999999999999999999888876543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.8e-47 Score=375.17 Aligned_cols=259 Identities=21% Similarity=0.316 Sum_probs=212.0
Q ss_pred EeCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCC-CccceEEEEEEeCCeEEE
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDH-RNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~~~~~~~~~~~~~i 190 (527)
|-.++|++++.||+|+||+||+|.+. ++.||||++....+. ..+.+|++.++.+.| +||+.+++++.++...|+
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 34678999999999999999999974 678999998654332 345678889988865 899999999999999999
Q ss_pred EEeccCCCCHHHHhc--CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccC
Q psy6905 191 VMEYARGGPLNRVLA--GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFG 268 (527)
Q Consensus 191 v~Ey~~ggsL~~~l~--~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFG 268 (527)
||||| +|+|.+++. +..++..++..++.|++.||+|||++| ||||||||+|||++.+... ..+.+||+|||
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~---~~~~vkl~DFG 151 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSK---NANMIYVVDFG 151 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSST---TTTCEEECCCT
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccc---cCCceEEcccc
Confidence 99999 789988876 457999999999999999999999995 9999999999999864211 13689999999
Q ss_pred cchhhhcc---------ccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC
Q psy6905 269 LAREVYKT---------THMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINA---YAVAYGVAVN 336 (527)
Q Consensus 269 la~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~i~~~ 336 (527)
+|+..... ...+..||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 99865321 12245799999999999999999999999999999999999999986532 2222233222
Q ss_pred CccC---CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhhcc
Q psy6905 337 KLTL---PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKALNNIVHSE 382 (527)
Q Consensus 337 ~~~~---~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~L~~~~~~~ 382 (527)
+... .++..+|+++.++|..||..+|++||+++.+.+.|++++...
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 2222 234678999999999999999999999999999988877654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=379.70 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=200.4
Q ss_pred CCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe--------
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ-------- 184 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~-------- 184 (527)
.++|++++.||+|+||+||+|.+. ++.||||++.... .+.....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999984 6799999986543 23345678899999999999999999999855
Q ss_pred CCeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
...+|+|||||.++++..+.. ...+++..+..++.||+.||.|||++| ||||||||+|||++.+ +.+|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~--------~~~k 157 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRD--------GVLK 157 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT--------SCEE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCC--------CcEE
Confidence 346899999998887766655 567999999999999999999999995 9999999999999976 6899
Q ss_pred EeccCcchhhhc------cccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6905 264 ITDFGLAREVYK------TTHMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN 336 (527)
Q Consensus 264 L~DFGla~~~~~------~~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~ 336 (527)
|+|||+++.... ....+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.......+...
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 999999976532 122345799999999998765 6899999999999999999999999988776665544321
Q ss_pred CccCC--CC----------------------------CCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 KLTLP--IP----------------------------STCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ~~~~~--~p----------------------------~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
....+ .. ...++++.+||.+||..||++|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11100 00 0125678899999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=387.20 Aligned_cols=242 Identities=24% Similarity=0.300 Sum_probs=198.2
Q ss_pred ceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCccceEEEEEEe------CCeEE
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNIVSLIGVCLQ------SPKLC 189 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~------~~~~~ 189 (527)
+|+.+++||+|+||+||+|.+. ++.||||++..... ...+|+.+|+.++||||++++++|.. ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 6888999999999999999984 67899999876532 22379999999999999999999854 33589
Q ss_pred EEEeccCCCCHHHHhc----CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEe
Q psy6905 190 LVMEYARGGPLNRVLA----GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKIT 265 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~----~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~ 265 (527)
||||||++|++..+.. ...+++..+..|+.||+.||+|||++| ||||||||+|||++.+. ..+||+
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~-------~~~kl~ 165 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDT-------AVLKLC 165 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTT-------CCEEEC
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCC-------CceeEe
Confidence 9999998775444432 557999999999999999999999995 99999999999998751 479999
Q ss_pred ccCcchhhhcc-ccccCCCcccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Q psy6905 266 DFGLAREVYKT-THMSAAGTYAWMAPEVIKT-SIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN------- 336 (527)
Q Consensus 266 DFGla~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~------- 336 (527)
|||+++..... ...+..||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 166 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 99999876433 3345689999999998865 46899999999999999999999999988876655544310
Q ss_pred ----------CccC----------CCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ----------KLTL----------PIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ----------~~~~----------~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
...+ .....+++++.+||.+||..||.+|||+.++++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 1123578899999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=387.83 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=207.1
Q ss_pred EeCCceeeeeeeccCCceEEEEeeE-----cCceEEEEEcCCCC---ChhHHHHHHHHHHHHHhCCC-CccceEEEEEEe
Q psy6905 114 IDYNKLIFGEAIGEGGFGKVYKGIY-----EKQEVAIKVAHPNP---DENILENVKQEGKLLWLFDH-RNIVSLIGVCLQ 184 (527)
Q Consensus 114 i~~~~~~~~~~iG~G~fg~Vy~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h-pnIv~~~~~~~~ 184 (527)
+..++|++++.||+|+||+||+|.+ +|+.||||++.... +....+.+.+|+.++++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 3457899999999999999999976 35789999886532 22234567899999999966 899999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeE
Q psy6905 185 SPKLCLVMEYARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLK 263 (527)
Q Consensus 185 ~~~~~iv~Ey~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vk 263 (527)
...+|++||||.||+|.+++. .+.+++..+..++.||+.||+|||++ +||||||||+|||++.+ +.+|
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~--------~~vk 169 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN--------GHVV 169 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT--------SCEE
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCC--------CCEE
Confidence 999999999999999999887 66788999999999999999999999 59999999999999986 6899
Q ss_pred EeccCcchhhhcc---ccccCCCccccccccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Q psy6905 264 ITDFGLAREVYKT---THMSAAGTYAWMAPEVIKTS--IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVN-- 336 (527)
Q Consensus 264 L~DFGla~~~~~~---~~~~~~gt~~y~aPE~l~~~--~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~-- 336 (527)
|+|||+++.+... ......|++.|+|||.+.+. .++.++|||||||+||+|++|+.||.+.+.......+...
T Consensus 170 L~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~ 249 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249 (322)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence 9999999865322 22345799999999999764 4688999999999999999999999876544333333221
Q ss_pred CccCCCCCCccHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q psy6905 337 KLTLPIPSTCPQLFKTLMEACWEADSHMRPS-----FKTILK 373 (527)
Q Consensus 337 ~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs-----~~~ll~ 373 (527)
....+.|..+|+++.+||.+||..||.+||| ++++++
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 2345677889999999999999999999995 788875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=380.95 Aligned_cols=251 Identities=25% Similarity=0.318 Sum_probs=206.4
Q ss_pred eeEEeCCceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeC--
Q psy6905 111 LVEIDYNKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQS-- 185 (527)
Q Consensus 111 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~-- 185 (527)
.|+|+ ++|++++.||+|+||+||+|.+ +++.||||++.... +....+.+.+|+.+|+.++|||||++++++...
T Consensus 13 ~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 13 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp EEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 47774 6799999999999999999987 47899999987653 334466788999999999999999999998642
Q ss_pred ---CeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccccccee
Q psy6905 186 ---PKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTL 262 (527)
Q Consensus 186 ---~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~v 262 (527)
...+++|+||.||+|.+++..+.+++..+..++.||+.||+|||++| ||||||||+|||++.+ +.+
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~--------~~~ 160 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED--------CEL 160 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT--------CCE
T ss_pred cccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccc--------ccc
Confidence 33466677788999999999889999999999999999999999995 9999999999999876 689
Q ss_pred EEeccCcchhhhccccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccC-
Q psy6905 263 KITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKLTL- 340 (527)
Q Consensus 263 kL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~- 340 (527)
|++|||++..... ...+..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 161 kl~dfg~a~~~~~-~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 161 KILDFGLARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239 (348)
T ss_dssp EECCC----CCTG-GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccchhcccCc-ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999999976533 33456799999999987665 46899999999999999999999999988766655543211110
Q ss_pred --------------------C--------CCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 341 --------------------P--------IPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 341 --------------------~--------~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
. ....+++++.+||.+||..||.+|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0 113578899999999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=367.45 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=205.7
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEeCCeEEEEEe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQSPKLCLVME 193 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~~~~~~iv~E 193 (527)
++|++++.||+|+||+||+|.+ +++.||||+++... .......+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999998 45789999986543 34457888999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhc-CCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCcchh
Q psy6905 194 YARGGPLNRVLA-GRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLARE 272 (527)
Q Consensus 194 y~~ggsL~~~l~-~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~~ 272 (527)
++.+++|..++. .+.+++..+..++.|++.||+|||++ +||||||||+|||++.+ +.+||+|||.++.
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~--------~~~kl~DFG~a~~ 150 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRN--------GELKLANFGLARA 150 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT--------CCEEECCCTTCEE
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccC--------Cceeeeecchhhc
Confidence 999999988876 66789999999999999999999999 49999999999999875 6899999999987
Q ss_pred hhcccc--ccCCCccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhC------------
Q psy6905 273 VYKTTH--MSAAGTYAWMAPEVIKTSI-FSKASDVWSYGVVLWELLTGEIPY-KSINAYAVAYGVAVN------------ 336 (527)
Q Consensus 273 ~~~~~~--~~~~gt~~y~aPE~l~~~~-~~~ksDvwSlGv~l~elltg~~Pf-~~~~~~~~~~~i~~~------------ 336 (527)
...... ....+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+..+....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred ccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhh
Confidence 644322 2345788999999987655 689999999999999999999885 444544443332210
Q ss_pred ---------------CccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 337 ---------------KLTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 337 ---------------~~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
......+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112334568899999999999999999999999873
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.4e-46 Score=374.38 Aligned_cols=243 Identities=18% Similarity=0.312 Sum_probs=198.8
Q ss_pred eCCceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEe--CCeEE
Q psy6905 115 DYNKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQ--SPKLC 189 (527)
Q Consensus 115 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~--~~~~~ 189 (527)
+.++|++++.||+|+||+||+|.+. ++.||||++.... .+.+.+|+.+|+.+. ||||+++++++.. ...+|
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 3468999999999999999999974 6899999987543 456789999999995 9999999999974 45699
Q ss_pred EEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEeccCc
Q psy6905 190 LVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGL 269 (527)
Q Consensus 190 iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGl 269 (527)
+|||||.+|+|..+. +.+++..+..++.||+.||.|||++| ||||||||+||||+.+ .+.+||+|||+
T Consensus 109 ~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~-------~~~vkl~DFG~ 176 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHE-------HRKLRLIDWGL 176 (328)
T ss_dssp EEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT-------TTEEEECCGGG
T ss_pred EEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCC-------CCeeeeccccc
Confidence 999999999998764 46999999999999999999999995 9999999999999864 25799999999
Q ss_pred chhhhcc-ccccCCCccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh-----------
Q psy6905 270 AREVYKT-THMSAAGTYAWMAPEVIKTS-IFSKASDVWSYGVVLWELLTGEIPYKSINAY-AVAYGVAV----------- 335 (527)
Q Consensus 270 a~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~-~~~~~i~~----------- 335 (527)
|+..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .....+..
T Consensus 177 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 177 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred ceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 9876443 33456799999999998765 4799999999999999999999999765422 11111100
Q ss_pred --CC----------------------ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHHHH
Q psy6905 336 --NK----------------------LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTILK 373 (527)
Q Consensus 336 --~~----------------------~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~ 373 (527)
.. ...+....+++++.+||++||..||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 001122346889999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-46 Score=376.45 Aligned_cols=245 Identities=25% Similarity=0.285 Sum_probs=193.0
Q ss_pred CceeeeeeeccCCceEEEEeeEc--CceEEEEEcCCCC-ChhHHHHHHHHHHHHHhCCCCccceEEEEEEe------CCe
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIYE--KQEVAIKVAHPNP-DENILENVKQEGKLLWLFDHRNIVSLIGVCLQ------SPK 187 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~~~~~~~~------~~~ 187 (527)
++|++++.||+|+||+||+|.+. |+.||||++.... .......+.+|+.+++.++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999984 7899999987653 34456678999999999999999999999963 468
Q ss_pred EEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccceeEEecc
Q psy6905 188 LCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDF 267 (527)
Q Consensus 188 ~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DF 267 (527)
+|+|||||.++++..+ ...+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+|++||
T Consensus 97 ~~iv~Ey~~~~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~--------~~~kl~df 163 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD--------CTLKILDF 163 (355)
T ss_dssp EEEEEECCSEEHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT--------CCEEECCC
T ss_pred eEEEEeccchHHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccc--------cceeeech
Confidence 9999999976655444 356899999999999999999999995 9999999999999976 68999999
Q ss_pred Ccchhhhcccc-ccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--------
Q psy6905 268 GLAREVYKTTH-MSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYAVAYGVAVNKL-------- 338 (527)
Q Consensus 268 Gla~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~~~~~i~~~~~-------- 338 (527)
|+++....... ....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp CC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 99887644333 345799999999999999999999999999999999999999998876555443321000
Q ss_pred --------------cC------------CC------CCCccHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q psy6905 339 --------------TL------------PI------PSTCPQLFKTLMEACWEADSHMRPSFKTILKA 374 (527)
Q Consensus 339 --------------~~------------~~------p~~~~~~~~~li~~~l~~dp~~RPs~~~ll~~ 374 (527)
.. .. +...++++.+||++||..||++|||++++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00 01236778999999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5e-40 Score=334.28 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=188.6
Q ss_pred CceeeeeeeccCCceEEEEeeE--cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-----------CCccceEEEEEE
Q psy6905 117 NKLIFGEAIGEGGFGKVYKGIY--EKQEVAIKVAHPNPDENILENVKQEGKLLWLFD-----------HRNIVSLIGVCL 183 (527)
Q Consensus 117 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----------hpnIv~~~~~~~ 183 (527)
.+|++++.||+|+||+||+|++ +++.||||+++.. ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 5699999999999999999987 4789999998754 233566778888888775 578999999886
Q ss_pred e--CCeEEEEEeccCCCCHHH-Hh---cCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCccccc
Q psy6905 184 Q--SPKLCLVMEYARGGPLNR-VL---AGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDL 257 (527)
Q Consensus 184 ~--~~~~~iv~Ey~~ggsL~~-~l---~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~ 257 (527)
. ....+++|+++..+.... .. ....+++..+..++.||+.||.|||+.. +|+||||||+||||+.+... .
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~--~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP--E 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT--T
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcc--c
Confidence 4 456677777776554322 22 2567899999999999999999999832 59999999999999764211 1
Q ss_pred ccceeEEeccCcchhhhccccccCCCccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH------HHH
Q psy6905 258 QFKTLKITDFGLAREVYKTTHMSAAGTYAWMAPEVIKTSIFSKASDVWSYGVVLWELLTGEIPYKSINAYA------VAY 331 (527)
Q Consensus 258 ~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDvwSlGv~l~elltg~~Pf~~~~~~~------~~~ 331 (527)
....++|+|||.+..... .....+||+.|+|||++.+..++.++|||||||++++|++|+.||...+... ...
T Consensus 167 ~~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp TEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred ccceeeEeeccccccccc-ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 123589999999976543 3345679999999999999999999999999999999999999997643211 110
Q ss_pred HHHh--C------------------------C--------------ccCCCCCCccHHHHHHHHHhhhhCCCCCCCHHHH
Q psy6905 332 GVAV--N------------------------K--------------LTLPIPSTCPQLFKTLMEACWEADSHMRPSFKTI 371 (527)
Q Consensus 332 ~i~~--~------------------------~--------------~~~~~p~~~~~~~~~li~~~l~~dp~~RPs~~~l 371 (527)
.... + . .....+...++++.+||.+||..||.+|||+.++
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 0000 0 0 0111223356789999999999999999999999
Q ss_pred HHH
Q psy6905 372 LKA 374 (527)
Q Consensus 372 l~~ 374 (527)
++|
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=4e-25 Score=203.05 Aligned_cols=164 Identities=19% Similarity=0.181 Sum_probs=120.8
Q ss_pred eeeeeeeccCCceEEEEeeE-cCceEEEEEcCCCCC-----------------hhHHHHHHHHHHHHHhCCCCccceEEE
Q psy6905 119 LIFGEAIGEGGFGKVYKGIY-EKQEVAIKVAHPNPD-----------------ENILENVKQEGKLLWLFDHRNIVSLIG 180 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~-~~~~vaiK~~~~~~~-----------------~~~~~~~~~e~~~l~~l~hpnIv~~~~ 180 (527)
+.+++.||+|+||.||+|.+ +|+.||||+++.... .........|...+..+.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35788999999999999986 578999998764211 011234456888999999999999887
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCceecCCCCcccccccc
Q psy6905 181 VCLQSPKLCLVMEYARGGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQAPISLIHRDLKSSNVLLSEPIENEDLQFK 260 (527)
Q Consensus 181 ~~~~~~~~~iv~Ey~~ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g~~~iiHrDlkp~NILl~~~~~~~~~~~~ 260 (527)
+. . .+++|||++++.+.. ++......++.|++.+|.|||++| |+||||||+|||++.+
T Consensus 82 ~~--~--~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~--------- 139 (191)
T d1zara2 82 WE--G--NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE--------- 139 (191)
T ss_dssp EE--T--TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT---------
T ss_pred ec--C--CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC---------
Confidence 63 2 279999998876543 456667789999999999999995 9999999999999863
Q ss_pred eeEEeccCcchhhhccccccCCCccccccc------cccccCCCCcccchHHHHHHH
Q psy6905 261 TLKITDFGLAREVYKTTHMSAAGTYAWMAP------EVIKTSIFSKASDVWSYGVVL 311 (527)
Q Consensus 261 ~vkL~DFGla~~~~~~~~~~~~gt~~y~aP------E~l~~~~~~~ksDvwSlGv~l 311 (527)
.++|+|||+|+....... ..|... +.+ ...|+.++|+||+.--+
T Consensus 140 ~~~liDFG~a~~~~~~~~------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 140 GIWIIDFPQSVEVGEEGW------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEEECCCTTCEETTSTTH------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CEEEEECCCcccCCCCCc------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 689999999865532111 111111 111 24578899999976544
|
| >d1sema_ b.34.2.1 (A:) Growth factor receptor-bound protein 2 (GRB2), N- and C-terminal domains {Caenorhabditis elegans, SEM-5 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Growth factor receptor-bound protein 2 (GRB2), N- and C-terminal domains species: Caenorhabditis elegans, SEM-5 [TaxId: 6239]
Probab=99.55 E-value=3.1e-15 Score=107.21 Aligned_cols=56 Identities=36% Similarity=0.896 Sum_probs=51.3
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
..+++|||||.+++++||+|++||+|.|+++. ++|||.|+.+ ++.|+||+|||++.
T Consensus 2 ~~~~~Alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yvep~ 57 (58)
T d1sema_ 2 TKFVQALFDFNPQESGELAFKRGDVITLINKD-----DPNWWEGQLN----NRRGIFPSNYVCPY 57 (58)
T ss_dssp CCEEEESSCBCCSSTTBCCBCTTCEEEEEECS-----SSSEEEEEET----TEEEEEEGGGEEEC
T ss_pred CEEEEECCCCCcCCcCCcCCCCCCEEEEeEEc-----CCCEEEEEEC----CeEEEEEhhhEEEC
Confidence 36899999999999999999999999999985 7899999987 78999999999864
|
| >d1gcqa_ b.34.2.1 (A:) Growth factor receptor-bound protein 2 (GRB2), N- and C-terminal domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Growth factor receptor-bound protein 2 (GRB2), N- and C-terminal domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=2.3e-15 Score=107.11 Aligned_cols=55 Identities=36% Similarity=0.830 Sum_probs=50.3
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.+++|||||.+++++||+|++||+|.|+++. ++|||.|+.+ ++.|+||+|||+++
T Consensus 2 tyv~Alydy~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yv~~v 56 (56)
T d1gcqa_ 2 TYVQALFDFDPQEDGELGFRRGDFIHVMDNS-----DPNWWKGACH----GQTGMFPRNYVTPV 56 (56)
T ss_dssp EEEEESSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEEC
T ss_pred EEEEECcCCCcCCcCCcCCCCCCEEEEEEec-----CCCEEEEEEC----CeEEEEEHhHEEEC
Confidence 4789999999999999999999999999985 7899999987 78999999999863
|
| >d1utia_ b.34.2.1 (A:) Grb2-related adaptor protein 2 (Mona/Gads) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Grb2-related adaptor protein 2 (Mona/Gads) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.54 E-value=3.1e-15 Score=106.78 Aligned_cols=55 Identities=47% Similarity=1.005 Sum_probs=50.3
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.+++|||||++++++||+|++||.|.|++.. ++|||.|+.+ ++.|+||+|||+.+
T Consensus 2 ~yarAlydy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yve~i 56 (57)
T d1utia_ 2 RWARALYDFEALEEDELGFRSGEVVEVLDSS-----NPSWWTGRLH----NKLGLFPANYVAPM 56 (57)
T ss_dssp CEEEESSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEEC
T ss_pred EEEEECcCCCCCCcCCcCCCCCCEEEEeEEc-----CCCEEEEEEC----CcEEEEEHHHEEEc
Confidence 3789999999999999999999999999985 7799999986 78999999999863
|
| >d1u06a1 b.34.2.1 (A:7-61) alpha-Spectrin, SH3 domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: alpha-Spectrin, SH3 domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.54 E-value=3.3e-15 Score=105.91 Aligned_cols=53 Identities=32% Similarity=0.735 Sum_probs=49.4
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
+++|||||+++.++||+|++||.|.|+++. ++|||.|+.. ++.|+||+|||+.
T Consensus 2 ~~vAl~dy~~~~~~eLs~~~Gd~v~v~~~~-----~~~Ww~g~~~----g~~G~~P~~yv~~ 54 (55)
T d1u06a1 2 LVLALYDYQEKSPREVTMKKGDILTLLNST-----NKDWWKVEVN----DRQGFVPAAYVKK 54 (55)
T ss_dssp EEEECSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEEE
T ss_pred EEEECCCCCCCCcCCccCCCCCEEEEeEEc-----CCCEEEEEEC----CeEEEEeHHHEEE
Confidence 789999999999999999999999999985 7799999987 7899999999975
|
| >d1k4us_ b.34.2.1 (S:) p67phox {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: p67phox species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=2.3e-15 Score=109.55 Aligned_cols=58 Identities=38% Similarity=0.646 Sum_probs=52.4
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.+..++|||||+++.++||+|++||+|+|++.. ++|||.|+.+ ++.|+||+|||++..
T Consensus 4 ~g~~v~Aly~y~a~~~~eLsf~~Gd~i~vl~~~-----~~~Ww~g~~~----g~~G~~P~~yVe~~~ 61 (62)
T d1k4us_ 4 KGSQVEALFSYEATQPEDLEFQEGDIILVLSKV-----NEEWLEGESK----GKVGIFPKVFVEDSA 61 (62)
T ss_dssp CCEEEECCSCBCCCSSSBCCBCSSCEEEEEEES-----SSSCEEEECS----SCEEEECGGGCCCSC
T ss_pred CCCEEEECCCCCCCCcCCcCCCCCCEEEEeEEc-----CCCEEEEEEC----CcEEEEchHHeEECC
Confidence 457899999999999999999999999999984 7899999986 789999999998753
|
| >d1jo8a_ b.34.2.1 (A:) Actin binding protein ABP1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Actin binding protein ABP1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.52 E-value=5.2e-15 Score=106.29 Aligned_cols=57 Identities=35% Similarity=0.561 Sum_probs=51.1
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
++++|||||+++.++||+|++||+|.|+++. +++||.|++... ++.|+||+|||+.+
T Consensus 1 P~~~Alydy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~~~~~~~--g~~G~~P~~yVe~i 57 (58)
T d1jo8a_ 1 PWATAEYDYDAAEDNELTFVENDKIINIEFV-----DDDWWLGELEKD--GSKGLFPSNYVSLG 57 (58)
T ss_dssp CCEEESSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEETTT--CCEEEEEGGGEEEC
T ss_pred CEEEEccCCCCCCcCCcCCCCCCEEEEEEEc-----CCCEEEEEECCC--CCEEEEchHHEEEc
Confidence 4799999999999999999999999999985 789999997654 78999999999854
|
| >d1uj0a_ b.34.2.1 (A:) Signal transducing adaptor molecule Stam2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Signal transducing adaptor molecule Stam2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.52 E-value=5.6e-15 Score=105.82 Aligned_cols=54 Identities=39% Similarity=0.901 Sum_probs=49.7
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
..++|||||.++.++||+|++||+|.|+++. ++|||.|+++ ++.|+||+|||+.
T Consensus 3 rr~~Alydy~~~~~~eLsf~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yV~~ 56 (58)
T d1uj0a_ 3 RRVRALYDFEAVEDNELTFKHGELITVLDDS-----DANWWQGENH----RGTGLFPSNFVTT 56 (58)
T ss_dssp EEEEESSCBCCCSTTBCCBCTTCEEEEEECC-----SSSEEEEEET----TEEEEEEGGGEES
T ss_pred CEEEECCCCCCCCcCCcCCCCCCEEEEeEEe-----CCCEEEEEEC----CeEEEEehHhEee
Confidence 4689999999999999999999999999984 7899999986 7899999999974
|
| >d2rn8a1 b.34.2.1 (A:176-228) Bruton's tyrosine kinase {Mus musculus [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Bruton's tyrosine kinase species: Mus musculus [TaxId: 10090]
Probab=99.51 E-value=5.4e-15 Score=103.91 Aligned_cols=52 Identities=27% Similarity=0.513 Sum_probs=47.1
Q ss_pred EEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccc
Q psy6905 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94 (527)
Q Consensus 35 ~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~ 94 (527)
++|||||+++.++||+|++||+|.|+++. +++||.++... ++.|+||+|||+
T Consensus 1 V~Alydy~a~~~~eLs~~~Gd~~~vl~~~-----~~~Ww~~~~~~---g~~G~vP~~yv~ 52 (53)
T d2rn8a1 1 VIALYDYQTNDPQELALRCDEEYYLLDSS-----EIHWWRVQDKN---GHEGYAPSSYLV 52 (53)
T ss_dssp EEESSCCCCSSTTBCCCCTTCEEEECCCS-----CSSCEEEECTT---SCEEEECGGGEE
T ss_pred CEEeeeECCCCCCeeeECCCCEEEEeEEc-----CCCeEEEEeCC---CCEEEEeHHHEe
Confidence 68999999999999999999999999874 78999998543 789999999996
|
| >d1ujya_ b.34.2.1 (A:) Rac/CDC42 GEF 6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Rac/CDC42 GEF 6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=7.1e-15 Score=111.76 Aligned_cols=63 Identities=30% Similarity=0.669 Sum_probs=54.7
Q ss_pred CCCCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 27 RRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 27 ~~~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..+..+.+++|||||+++.++||+|++||+|.|+++. +++||.++++ ++.|+||.|||+.+..
T Consensus 5 ~~g~~~~~~rAlydy~a~~~~eLs~~~Gd~i~v~~~~-----~~~W~~g~~~----g~~G~~P~~yv~~i~~ 67 (76)
T d1ujya_ 5 SSGSHQLIVKARFNFKQTNEDELSVCKGDIIYVTRVE-----EGGWWEGTLN----GRTGWFPSNYVREIKS 67 (76)
T ss_dssp CCSCCCEEEECCSCBCCSSTTSCCBCSSCCEEESSCC-----SSSCEEEEET----TEEEEECTTTSEECCH
T ss_pred CCCCCCEEEEECccCCCCCCCCccCCCCCEEEEeEEc-----CCCEEEEEEC----CcEEEEchHHEEECCC
Confidence 3334456899999999999999999999999999984 7899999987 6899999999987654
|
| >d1arka_ b.34.2.1 (A:) SH3 domain from nebulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: SH3 domain from nebulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=3.7e-15 Score=107.88 Aligned_cols=58 Identities=34% Similarity=0.692 Sum_probs=52.1
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
++..++|||||+++.++||+|++||+|.|+++. +++||.+++... ++.|+||+|||+.
T Consensus 2 ~G~~~rAl~df~~~~~~eLs~~~Gd~i~v~~~~-----~~~W~~~~~~~~--g~~G~vP~nyve~ 59 (60)
T d1arka_ 2 AGKIFRAMYDYMAADADEVSFKDGDAIINVQAI-----DEGWMYGTVQRT--GRTGMLPANYVEA 59 (60)
T ss_dssp CCCCEECCSCCCCSSSSBCCCCTTCEECCSEEC-----SSSEEEEECTTT--CCEEEEETTTCEE
T ss_pred CCcEEEECccCCCCCCCCcCCCCCCEEEEEEEc-----CCCEEEEEECCC--CCEEEEcHHHEEE
Confidence 567899999999999999999999999999985 789999997543 7899999999985
|
| >d1ckaa_ b.34.2.1 (A:) C-Crk, N-terminal SH3 domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: C-Crk, N-terminal SH3 domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.51 E-value=9.2e-15 Score=104.37 Aligned_cols=55 Identities=27% Similarity=0.672 Sum_probs=49.8
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
.+++|||||+++.++||+|++||+|.|+++. +++||.++... ++.|+||+|||++
T Consensus 2 ~~v~Alydy~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~~~~~~---g~~G~vP~~yve~ 56 (57)
T d1ckaa_ 2 EYVRALFDFNGNDEEDLPFKKGDILRIRDKP-----EEQWWNAEDSE---GKRGMIPVPYVEK 56 (57)
T ss_dssp CEEEESSCBCCSSTTBCCBCTTCEEEEEECS-----SSSEEEEECTT---SCEEEEEGGGEEC
T ss_pred CEEEECCCCCcCCcCCcCCCCCCEEEEEEEc-----CCCeEEEEECC---CCEEEEcHHHeEE
Confidence 4789999999999999999999999999985 78999998643 6899999999985
|
| >d1opka1 b.34.2.1 (A:83-139) Abl tyrosine kinase, SH3 domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Abl tyrosine kinase, SH3 domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.50 E-value=9e-15 Score=104.41 Aligned_cols=56 Identities=29% Similarity=0.608 Sum_probs=48.8
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.+++|||||+++.++||+|++||+|.|++++ .+++||.++.. ++.|+||+|||++.
T Consensus 1 n~~vAlydy~a~~~~eLs~~~Gd~i~vl~~~----~~~~W~~~~~~----g~~G~~P~~yv~~v 56 (57)
T d1opka1 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYN----HNGEWCEAQTK----NGQGWVPSNYITPV 56 (57)
T ss_dssp CEEEESSCBCCCSTTBCCBCTTCEEEEEEEC----TTSSEEEEECS----SCEEEEEGGGEEES
T ss_pred CEEEECccCCCCCcCCcCCCCCCEEEEeEec----CCCCEEEEEEC----CCEeEEchhheEEC
Confidence 3789999999999999999999999999875 34568888876 67899999999864
|
| >d1j3ta_ b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Intersectin 2 (KIAA1256) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.3e-14 Score=109.58 Aligned_cols=65 Identities=25% Similarity=0.436 Sum_probs=55.9
Q ss_pred CCCCCCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 25 HNRRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 25 ~~~~~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
..+.+.....++|||||.++.++||+|++||+|+|+++ +++||.++++ ++.|+||.|||+.+...
T Consensus 3 sgs~~~~~~~~~alydy~a~~~~ELs~~~Gd~i~vl~~------~~~ww~g~~~----g~~G~fP~~yve~i~~~ 67 (74)
T d1j3ta_ 3 SGSSGVENLKAQALCSWTAKKDNHLNFSKHDIITVLEQ------QENWWFGEVH----GGRGWFPKSYVKIIPGS 67 (74)
T ss_dssp SCCCCCCCCEEEESSCBCCCSTTBCCBCTTCEEEEEEE------CSSEEEEEST----TCCCEEEGGGEEECCCS
T ss_pred CCCCCCCCeEEEEccCCCCCCCCEecCCCCCEEEEEEc------cCCeEEEEEC----CcEEEEchhhEEECCCC
Confidence 34445567899999999999999999999999999987 4689999986 78999999999976543
|
| >d1wlpb1 b.34.2.1 (B:229-281) p47pox (neutrophil cytosolic factor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: p47pox (neutrophil cytosolic factor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=9.7e-15 Score=102.42 Aligned_cols=52 Identities=35% Similarity=0.608 Sum_probs=47.9
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~ 94 (527)
.++|+|||+++.++||+|++||+|.|+++. ++|||.|+.+ ++.|+||+|||+
T Consensus 2 ~yval~~y~a~~~~eLs~~~Gd~v~vl~~~-----~~gWw~g~~~----g~~G~~P~~yve 53 (53)
T d1wlpb1 2 PYVAIKAYTAVEGDEVSLLEGEAVEVIHKL-----LDGWWVIRKD----DVTGYFPSMYLQ 53 (53)
T ss_dssp EEEECSCBCCCSSSBCCBCTTCEEEEEECC-----TTSSEEEESS----SCEEEECSTTEE
T ss_pred eEEEeeeECCCCCCEecCCCCCEEEEEeec-----CCceEEEEEC----CcEeEecHHhCC
Confidence 478999999999999999999999999984 7899999976 789999999985
|
| >d1efna_ b.34.2.1 (A:) Fyn proto-oncogene tyrosine kinase, SH3 domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Fyn proto-oncogene tyrosine kinase, SH3 domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.2e-14 Score=104.17 Aligned_cols=55 Identities=35% Similarity=0.764 Sum_probs=49.4
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
+++|||||++++++||+|++||+|.|++++ +++||.++.... ++.|+||+|||++
T Consensus 2 l~vAl~dy~a~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~~~~~~~--g~~G~vP~~yv~p 56 (57)
T d1efna_ 2 LFVALYDYEAITEDDLSFHKGEKFQILNSS-----EGDWWEARSLTT--GETGYIPSNYVAP 56 (57)
T ss_dssp EEEESSCBCCSSTTBCCBCTTCEEEEEECS-----SCSEEEEEETTT--TEEEEEEGGGEEE
T ss_pred EEEECCCCCCCCcCCcCCCCCCEEEEEEec-----CCCCEEEEECCC--CCEEEEeHHHeEE
Confidence 689999999999999999999999999985 678999986443 7899999999985
|
| >d1ng2a1 b.34.2.1 (A:157-214) p47pox (neutrophil cytosolic factor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: p47pox (neutrophil cytosolic factor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.1e-14 Score=104.58 Aligned_cols=54 Identities=37% Similarity=0.792 Sum_probs=49.8
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSI 96 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~ 96 (527)
.++|+|||.+++++||+|++||+|.|+++. +++||.++.. ++.|+||+|||+.+
T Consensus 4 ~~~al~dy~~~~~~eLs~~~Gd~i~vl~~~-----~~~Ww~~~~~----g~~G~~P~~yve~l 57 (58)
T d1ng2a1 4 TYRAIADYEKTSGSEMALSTGDVVEVVEKS-----ESGWWFCQMK----AKRGWIPASFLEPL 57 (58)
T ss_dssp EEECSSCBCCSSTTCCCBCTTCEEEEEECC-----TTSCCEEEEC----CCCCCCCGGGCCCS
T ss_pred EEEECccCcCCCCCCcCCCCCCEEEEEEec-----CCCeEEEEEC----CCCcEEcHhHEEEC
Confidence 589999999999999999999999999984 7899999987 68999999999864
|
| >d1fmka1 b.34.2.1 (A:82-145) c-src protein tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: c-src protein tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1e-14 Score=107.05 Aligned_cols=59 Identities=25% Similarity=0.643 Sum_probs=52.3
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
.++|||||++++++||+|++||+|.|+++. +++||.++.... ++.|+||.|||+....+
T Consensus 4 ~~vAlydf~~~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~~~~~~~--g~~G~vP~~yv~~~~s~ 62 (64)
T d1fmka1 4 TFVALYDYESRTETDLSFKKGERLQIVNNT-----EGDWWLAHSLST--GQTGYIPSNYVAPSDSI 62 (64)
T ss_dssp EEEESSCBCCCSSSBCCBCTTCEEEESCCC-----SSSEEEEEETTT--CCEEEEEGGGEEETTSG
T ss_pred EEEECccCCCcCcCCcCCCCCCEEEEEEEc-----CCCcEEEEECCC--CCEEEEehHHeEECccC
Confidence 689999999999999999999999999874 678999987543 78999999999987654
|
| >d1k9aa1 b.34.2.1 (A:6-76) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.5e-14 Score=108.39 Aligned_cols=61 Identities=25% Similarity=0.482 Sum_probs=53.4
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
++..|+|||||++++++||+|++||+|.|+++. .+.+||.+++.. ++.|+||.|||+....
T Consensus 5 ~g~~~~Alydy~a~~~~ELs~~~Gd~i~vl~~~----~~~~W~~~~~~~---g~~G~~P~~yve~~~~ 65 (71)
T d1k9aa1 5 SGTECIAKYNFHGTAEQDLPFCKGDVLTIVAVT----KDPNWYKAKNKV---GREGIIPANYVQKREG 65 (71)
T ss_dssp TTCEEEESSCBCCSSSSBCCBCTTCEEEEEEEC----SSTTEEEEECTT---CCEEEEEGGGEEECCC
T ss_pred CCCEEEEccCCCCCCCCCccCCCCCEEEEeEec----cCCCEEEEEeCC---CCEEEEchHHeEEccc
Confidence 567899999999999999999999999999874 466899998764 7899999999987654
|
| >d1gria1 b.34.2.1 (A:1-56) Growth factor receptor-bound protein 2 (GRB2), N- and C-terminal domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Growth factor receptor-bound protein 2 (GRB2), N- and C-terminal domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=9.1e-15 Score=103.99 Aligned_cols=53 Identities=38% Similarity=0.705 Sum_probs=43.8
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~ 94 (527)
.++|||||+++.++||+|++||.|+|+++. .+++||.++.+ |+.|+||+|||+
T Consensus 2 ~a~Alydy~a~~~~ELs~~~Gd~v~v~~~~----~~~~W~~~~~~----g~~G~vP~nyve 54 (56)
T d1gria1 2 EAIAKYDFKATADDELSFKRGDILKVLNEE----CDQNWYKAELN----GKDGFIPKNYIE 54 (56)
T ss_dssp EEEECSCBCCCSSSCCCBCTTCEEEC----------CCEEEEESS----SCEEEEEGGGEE
T ss_pred EEEEeeCCCCCCCCCcCCCCCCEEEEEecc----CCCCeEEEEEC----CcEEEEehhhEE
Confidence 589999999999999999999999998874 46789999876 689999999996
|
| >d1ugva_ b.34.2.1 (A:) Olygophrenin-1 like protein (KIAA0621) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Olygophrenin-1 like protein (KIAA0621) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.2e-14 Score=109.24 Aligned_cols=64 Identities=25% Similarity=0.436 Sum_probs=54.0
Q ss_pred CCCCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 27 RRNHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 27 ~~~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
+...+...++|||||+++.++||+|++||+|+|+++. .+++||.++.+ ++.|+||.|||+.+..
T Consensus 5 s~~~p~~~~~alydy~~~~~~eLs~~~Gd~i~v~~~~----~~~~W~~g~~~----g~~G~~P~~yve~i~~ 68 (72)
T d1ugva_ 5 SSGTPFRKAKALYACKAEHDSELSFTAGTVFDNVHPS----QEPGWLEGTLN----GKTGLIPENYVEFLSG 68 (72)
T ss_dssp SSCCSCCCEEESSCBCCCSSSBCCBCTTCEEBSCCBC----SSTTEEEEESS----SCEEEEEGGGEEECCS
T ss_pred CCCCCCEEEEEcccCCCCCCCEecCCCCCEEEEeecc----CCCCEEEEEeC----CCEEEEchHHEEECCC
Confidence 3444557899999999999999999999999999874 35679999876 7899999999987643
|
| >d1ycsb2 b.34.2.1 (B:457-519) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.7e-14 Score=105.11 Aligned_cols=56 Identities=27% Similarity=0.684 Sum_probs=48.9
Q ss_pred EEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 34 LWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 34 ~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
.++|||||+++.++||+|++||+|.|+++++. ++.|||.|+++ ++.|+||+|||+.
T Consensus 6 ~v~Alydy~a~~~~ELs~~~Gd~i~vl~~~~~--~~~gW~~g~~~----g~~G~~P~~yv~~ 61 (63)
T d1ycsb2 6 VIYALWDYEPQNDDELPMKEGDCMTIIHREDE--DEIEWWWARLN----DKEGYVPRNLLGL 61 (63)
T ss_dssp EEEESSCBCCSSTTBCCBCSSCEEEECCCCTT--SCSSEEEEEET----TEEEEEEGGGEEC
T ss_pred EEEEeeCCCCCCCCCcCCCCCCEEEEEEecCC--CCCCEEEEEEC----CeEEEEchHHhEe
Confidence 68999999999999999999999999977421 24589999986 7899999999975
|
| >d2v1ra1 b.34.2.1 (A:10-76) Peroxisomal membrane protein Pex13p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Peroxisomal membrane protein Pex13p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.48 E-value=1e-14 Score=107.79 Aligned_cols=60 Identities=30% Similarity=0.712 Sum_probs=50.1
Q ss_pred CEEEEcccCCCCCCC-CCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLD-ELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~-eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
.+++|||||.+++++ ||+|++||+|.|+++.+....++|||.|+... |+.|+||+|||+.
T Consensus 6 ~~~~Alydy~~~~~~~ELs~~~Gd~i~vl~~~d~~~~~~~Ww~g~~~~---G~~G~~P~nyve~ 66 (67)
T d2v1ra1 6 EFARALYDFVPENPEMEVALKKGDLMAILSKKDPLGRDSDWWKVRTKN---GNIGYIPYNYIEI 66 (67)
T ss_dssp EEEEESSCBCCSSTTTBCCBCTTCEEEEEEEECTTSCEEEEEEEECTT---SCEEEEEGGGEEE
T ss_pred EEEEECccCCCCCCCCEeCCCCCCEEEEEEeecCCCcCCCeEEEEeCC---CCEEEEEHHHEEE
Confidence 579999999998875 99999999999998753333457999998643 7899999999975
|
| >d1qcfa1 b.34.2.1 (A:80-145) Hemapoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Hemapoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=2.7e-14 Score=105.22 Aligned_cols=61 Identities=33% Similarity=0.678 Sum_probs=52.2
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDIN 100 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~~ 100 (527)
..+++|||||+++.++||+|++||+|.|+++ +++||.+..... ++.|+||.|||+..+.++
T Consensus 4 ~~~vvAlydy~~~~~~eLs~~~Gd~i~v~~~------~~~ww~~~~~~~--g~~G~vP~~yv~~~~~~e 64 (65)
T d1qcfa1 4 RIIVVALYDYEAIHHEDLSFQKGDQMVVLEE------SGEWWKARSLAT--RKEGYIPSNYVARVDSLE 64 (65)
T ss_dssp CCEEEESSCBCCCSTTBCCBCTTCEEEEEEC------CTTEEEEEETTT--CCEEEEEGGGEEETTCGG
T ss_pred cEEEEECCcCCCCCcCccCCCCCCEEEEEEE------CCCCEEEEEccC--CCEEEEchHHeEECccCC
Confidence 4689999999999999999999999999986 457888875433 789999999999876654
|
| >d1spka_ b.34.2.1 (A:) BAI1-associated protein 2-like 1 (RIKEN cDNA 1300006m19) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: BAI1-associated protein 2-like 1 (RIKEN cDNA 1300006m19) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.47 E-value=2.3e-14 Score=107.54 Aligned_cols=63 Identities=19% Similarity=0.385 Sum_probs=52.3
Q ss_pred CCCCEEEEcccCCCC-CCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAI-GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~-~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..+..|+|||||++. .++||+|++||+|+|+.+. .+++||.++++.. ++.|+||.|||+.+..
T Consensus 5 ~~~~~~~Alydy~~~~~~deLsf~~Gd~i~vl~~~----~~~gW~~g~~~~~--g~~G~fP~nyVe~i~~ 68 (72)
T d1spka_ 5 SSGQKVKTIFPHTAGNNKTLLSFAQGDVLTLLIPE----EKDGWLYGEHDTT--KARGWFPSSYTKLLSG 68 (72)
T ss_dssp SCSCEEECSSCBCCSSCSSBCCBCTTCEEEECCSS----CBTTEEEEEETTT--CCEEEEEGGGCEECSS
T ss_pred CCCCEEEEeeccCCCCCCCEeeEcCCCEEEEEEee----cCCCeEEEEECCC--CCEEEEchhhEEECCC
Confidence 455789999999985 5788999999999999764 3668999987644 7899999999997643
|
| >d1gl5a_ b.34.2.1 (A:) tyrosine kinase tec {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: tyrosine kinase tec species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.47 E-value=2.3e-14 Score=106.07 Aligned_cols=58 Identities=29% Similarity=0.619 Sum_probs=51.5
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+++|||||+++.++||+|++||+|.|+++. +++||.++... ++.|+||+|||+....
T Consensus 3 ~~v~Alydf~a~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~~~~~~---g~~G~~P~~yV~~~~~ 60 (67)
T d1gl5a_ 3 EIVVAMYDFQATEAHDLRLERGQEYIILEKN-----DLHWWRARDKY---GSEGYIPSNYVTGKKS 60 (67)
T ss_dssp SCEEECSCBCCSSSSBCCBCTTCEEEEEECS-----SSSEEEEECSS---SCEEEEETTSEESSTT
T ss_pred EEEEECCCCCCCCcCCcCCCCCCEEEEEEec-----CCCcEEEEECC---CCEEEEEhHHeEEecC
Confidence 5799999999999999999999999999985 77999998543 6899999999987554
|
| >d1oota_ b.34.2.1 (A:) Hypothetical protein YFR024c {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Hypothetical protein YFR024c species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.45 E-value=5.1e-14 Score=100.82 Aligned_cols=56 Identities=36% Similarity=0.771 Sum_probs=49.1
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
+.++|||||.+++++||+|++||+|.|+++.. .+.+||.++.+ ++.|+||+|||+.
T Consensus 2 P~~~Alydy~a~~~~ELs~~~Gd~v~vl~~~~---~~~~W~~~~~~----g~~G~vP~~yve~ 57 (58)
T d1oota_ 2 PKAVALYSFAGEESGDLPFRKGDVITILKKSD---SQNDWWTGRVN----GREGIFPANYVEL 57 (58)
T ss_dssp CEEEESSCBCCCSTTBCCBCTTCEEEEEECCS---CTTSEEEEEET----TEEEEEEGGGEEE
T ss_pred CeEEEccCCCCCCCCCccCCCCCEEEEEEeec---CCCCEEEEEEC----CcEEEEcHHHEEE
Confidence 36999999999999999999999999998752 24689999886 7899999999974
|
| >d1uhfa_ b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Intersectin 2 (KIAA1256) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=2.8e-14 Score=105.81 Aligned_cols=57 Identities=35% Similarity=0.730 Sum_probs=51.0
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.+..|+|||||+++.++||+|++||+|.|+++ +++||.++++ ++.|+||.|||+...
T Consensus 7 ~~~~~vAl~~y~~~~~~eLs~~~Gd~v~vl~~------~~~Ww~~~~~----g~~G~vP~~yv~~~~ 63 (69)
T d1uhfa_ 7 GGEEYIALYPYSSVEPGDLTFTEGEEILVTQK------DGEWWTGSIG----DRSGIFPSNYVKPKD 63 (69)
T ss_dssp CSEEEECSSCBCCSSSSBCCBCTTCEEEECEE------ETTEEEECST----TCCEEECGGGCEECC
T ss_pred CCcEEEECccCCCCCcCCcCCCCCCEEEEEEe------cCCEEEEEEC----CcEEEEchhhEEECC
Confidence 34789999999999999999999999999987 4589999976 789999999998754
|
| >d1i07a_ b.34.2.1 (A:) EPS8 SH3 domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: EPS8 SH3 domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.43 E-value=4.5e-14 Score=101.55 Aligned_cols=56 Identities=25% Similarity=0.519 Sum_probs=49.2
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
.+++|+|||.+++++||+|++||+|.|+++ +++||.++... ++.|+||+|||+.+.
T Consensus 2 ~~a~alydf~a~~~~ELs~~~Gd~i~v~~~------~~~ww~~~~~~---g~~G~~P~nyve~i~ 57 (59)
T d1i07a_ 2 KYAKSKYDFVARNSSELSVMKDDVLEILDD------RRQWWKVRNAS---GDSGFVPNNILDIMR 57 (59)
T ss_dssp CEEEESSCBCCSSTTBCCBCTTCEEEECGG------GCCEEEEECTT---SCEEEEEGGGEEEEC
T ss_pred eEEEEccCCCCCCCCeeeEcCCCEEEEEEE------cCCcEEEEEcC---CCEEEECHHHeEECC
Confidence 478999999999999999999999999986 45899998543 789999999998754
|
| >d1udla_ b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Intersectin 2 (KIAA1256) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=4.4e-14 Score=113.36 Aligned_cols=57 Identities=42% Similarity=0.815 Sum_probs=51.7
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|||||+++.++||+|++||+|.|+++. ++|||.|+++ ++.|+||.|||+.+..
T Consensus 35 ~~~~Alydy~a~~~~ELsf~~Gd~i~Vl~~~-----~~gWw~g~~~----g~~G~~P~nyVe~~~~ 91 (98)
T d1udla_ 35 CQVIAMYDYAANNEDELSFSKGQLINVMNKD-----DPDWWQGEIN----GVTGLFPSNYVKMTTD 91 (98)
T ss_dssp EEEEESSCCCCSSTTSCCCCTTCEEEECBCC-----SSSEEBCBSS----SCBCCEETTSEEECCC
T ss_pred cEEEEccCCCCCCCCEeeEcCCCEEEEeEec-----CCCeEEEEEC----CeEEEEchHHEEECCC
Confidence 5799999999999999999999999999985 7899999976 7899999999987554
|
| >d1ue9a_ b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Intersectin 2 (KIAA1256) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=9.6e-14 Score=106.89 Aligned_cols=66 Identities=27% Similarity=0.580 Sum_probs=55.4
Q ss_pred CCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCc-ccceecccccCcccccccc
Q psy6905 29 NHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGK-IEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 29 ~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k-~~~~~G~~P~~yv~~~~~~ 99 (527)
...+..++|||||+++.++||+|++||+|.|+++. +++||.|++.++ ..++.|+||.|||+.+...
T Consensus 4 ~~~g~~~~al~~y~~~~~~eLs~~~Gd~i~Vl~~~-----~~~Ww~g~~~~~~~~~~~G~~P~~yv~~~~~~ 70 (80)
T d1ue9a_ 4 GSSGEIAQVTSAYVASGSEQLSLAPGQLILILKKN-----TSGWWQGELQARGKKRQKGWFPASHVKLLGPS 70 (80)
T ss_dssp SSCCEEEEECSCCCCCSTTBCCCCTTCEEEEEEEC-----SSSEEEEEECSCCSSCCEEEEETTSEEECCSC
T ss_pred CCCCCEEEECcCCCCCCCCEeeEcCCCEEEEEEEe-----CCCeEEEEEccCCCCCCEeEEEheeEEECCCC
Confidence 34567999999999999999999999999999985 789999987542 1256899999999876543
|
| >d1uhca_ b.34.2.1 (A:) Hypothetical protein Baa76854.1 (KIAA1010) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Hypothetical protein Baa76854.1 (KIAA1010) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1e-13 Score=106.06 Aligned_cols=64 Identities=23% Similarity=0.579 Sum_probs=53.5
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
....+++|||||.++.++||+|++||+|.|+++.. ...+++||.++.. ++.|+||.|||+.+..
T Consensus 11 ~~~~~~~Alydy~a~~~~ELs~~~Gd~i~vl~~~~-~~~~~~W~~g~~~----g~~G~vP~~yv~~~~~ 74 (79)
T d1uhca_ 11 EGNQVYFAVYTFKARNPNELSVSANQKLKILEFKD-VTGNTEWWLAEVN----GKKGYVPSNYIRKTES 74 (79)
T ss_dssp CSSCCEEESSCBCCCSSSBCCBCTTCEEEEEESCC-TTSCTTEEEEESS----SCEEEEEGGGEEECCS
T ss_pred CCCEEEEECccCCCCCCCCccCCCCCEEEEEEeec-CCCCCCEEEEEEC----CCEEEEehhhEEECCC
Confidence 34468999999999999999999999999998631 1235799999976 7899999999987654
|
| >d1u5sa1 b.34.2.1 (A:1-71) Nck-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Nck-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=8.8e-14 Score=104.10 Aligned_cols=60 Identities=30% Similarity=0.678 Sum_probs=51.3
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
.+++|||||+++.++||+|++||+|.|+++. .+++|||.++... |+.|+||+|||+.+..
T Consensus 7 ~~~~Alydf~~~~~~eLs~~~Gd~i~vl~~~---~~~~~Ww~~~~~~---G~~G~vP~~yv~~~~~ 66 (71)
T d1u5sa1 7 HVVQTLYPFSSVTEEELNFEKGETMEVIEKP---ENDPEWWKCKNAR---GQVGLVPKNYVVVLSD 66 (71)
T ss_dssp SEEEESSCCCCCSSSBCCCCSSCCEEEEECC---CTTTCEEEEEETT---TEEEEEETTSEEECCC
T ss_pred EEEEECccCCCCCCCEeeECCCCEEEEEEcc---cCCCCeEEEEECC---CCEEEEChHHEEECCC
Confidence 5799999999999999999999999999874 1346899998542 7899999999987654
|
| >d1awwa_ b.34.2.1 (A:) Bruton's tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Bruton's tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=6.3e-14 Score=103.65 Aligned_cols=58 Identities=33% Similarity=0.672 Sum_probs=51.1
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
..++|||||+++.++||+|++||+|.|+++. +++||.++... ++.|+||+|||+...+
T Consensus 9 ~~v~Alydy~a~~~~eLs~~~Gd~i~v~~~~-----~~~Ww~~~~~~---g~~G~vP~~yv~~~~~ 66 (67)
T d1awwa_ 9 KKVVALYDYMPMNANDLQLRKGDEYFILEES-----NLPWWRARDKN---GQEGYIPSNYVTEAED 66 (67)
T ss_dssp CEEEBSSCCCCSSSSSCCCCSSCEEECCCCC-----SSSEECCBCTT---SCBCCEETTTBCCSCC
T ss_pred EEEEECcCCCCCCcCCcCCCCCCEEEEEEEc-----CCCeEEEEECC---CCEEEEcHHHeEECcC
Confidence 5799999999999999999999999999874 78999997543 7899999999987643
|
| >d1wfwa_ b.34.2.1 (A:) Kalirin-9a {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Kalirin-9a species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.41 E-value=1.4e-13 Score=104.06 Aligned_cols=65 Identities=15% Similarity=0.250 Sum_probs=54.9
Q ss_pred CCCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCc--ccceecccccCccccccc
Q psy6905 29 NHRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGK--IEYKVGIFPANFVSSIED 98 (527)
Q Consensus 29 ~~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k--~~~~~G~~P~~yv~~~~~ 98 (527)
+..+..++|||||.+..++||+|++||+|+|+++. +++||.++.... ..++.|+||.|||+.+..
T Consensus 4 ~s~g~~~~al~dy~~~~~~eLs~~~Gd~i~vl~~~-----~~~Ww~v~~~~~~~~~g~~G~vP~~yve~~~~ 70 (74)
T d1wfwa_ 4 GSSGSTMTVIKDYYALKENEICVSQGEVVQVLAVN-----QQNMCLVYQPASDHSPAAEGWVPGSILAPFSG 70 (74)
T ss_dssp CCCSCEEECCSCBCCCSSSCCCBCTTCEEEEEEEC-----TTSEEEEEECSCSSSSSEEEEEEGGGCCBCCS
T ss_pred CCCCCEEEEeEEECCCCCCCccCccCCEEEEEEEc-----CCCCEEEEeCccCCcCCeeeEEchHHeEECCC
Confidence 34568999999999999999999999999999984 789999986432 226899999999987543
|
| >d2iima1 b.34.2.1 (A:58-119) p56-lck tyrosine kinase, SH3 domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: p56-lck tyrosine kinase, SH3 domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.4e-13 Score=100.19 Aligned_cols=57 Identities=25% Similarity=0.511 Sum_probs=48.4
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
+...++|||||+++.++||+|++||+|.|+++. ++||.+..... ++.|+||+|||+.
T Consensus 5 ~~~~~~al~dy~a~~~~eLs~~~Gd~i~v~~~~------~~ww~~~~~~~--g~~G~~P~~yV~~ 61 (62)
T d2iima1 5 QDNLVIALHSYEPSHDGDLGFEKGEQLRILEQS------GEWWKAQSLTT--GQEGFIPFNFVAK 61 (62)
T ss_dssp TTCEEEESSCBCCCSTTBCCBCTTCEEEEEECC------SSEEEEEETTT--CCEEEEEGGGEEE
T ss_pred CCcEEEECCCCCcCCcCCcCCCCCCEEEEeEEc------CCCEEEEeccC--CeEeEEcHHHEEe
Confidence 457899999999999999999999999999873 46777664332 7899999999975
|
| >d1ng2a2 b.34.2.1 (A:215-332) p47pox (neutrophil cytosolic factor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: p47pox (neutrophil cytosolic factor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.3e-13 Score=114.79 Aligned_cols=59 Identities=31% Similarity=0.513 Sum_probs=53.2
Q ss_pred CCCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccc
Q psy6905 30 HRPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIE 97 (527)
Q Consensus 30 ~~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~ 97 (527)
..+..++|||||.++.++||+|++||+|+|+++. ++|||.|+.+ ++.|+||.|||+...
T Consensus 12 ~~g~~~~alydy~a~~~dELs~~~Gd~i~Vl~~~-----~~gWw~g~~~----g~~G~~P~~yv~~~~ 70 (118)
T d1ng2a2 12 YAGEPYVAIKAYTAVEGDEVSLLEGEAVEVIHKL-----LDGWWVIRKD----DVTGYFPSMYLQKSG 70 (118)
T ss_dssp TTCEEEEESSCBCCCSTTBCCBCTTCEEEEEECC-----TTSEEEEEET----TEEEEEEGGGEEETT
T ss_pred CCCcEEEECcCCCCCCCCEecCCCCCEEEEeEec-----CCCeEEEEEC----CeEEEEehhhEEECC
Confidence 4557899999999999999999999999999985 7899999986 789999999998654
|
| >d2hspa_ b.34.2.1 (A:) Phospholipase C, SH3 domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Phospholipase C, SH3 domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=3.7e-14 Score=106.09 Aligned_cols=59 Identities=34% Similarity=0.646 Sum_probs=52.1
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
..++|||||+++.++||+|++||+|.|+++. ++|||.|++++ +..|+||+|||+.+...
T Consensus 7 ~~v~Aly~f~a~~~~eLsf~~Gd~i~v~~~~-----~~~Ww~g~~~~---~~~G~fP~~yv~~~~~~ 65 (71)
T d2hspa_ 7 CAVKALFDYKAQREDELTFIKSAIIQNVEKQ-----EGGWWRGDYGG---KKQLWFPSNYVEEMVNP 65 (71)
T ss_dssp SCEECCSCCCCSSSSSCCCCTTCEEBSCCCB-----TTTEECCBCSS---CCSCCEETTTCCSCSCC
T ss_pred EEEEEcccCCcCCcCCccCCCCCEEEEEEec-----CCCEEEEEECC---eEEEEEchHHeEEcCCc
Confidence 5799999999999999999999999999985 78999998775 56789999999976543
|
| >d1bb9a_ b.34.2.1 (A:) Amphiphysin 2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Amphiphysin 2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.37 E-value=1.4e-13 Score=106.29 Aligned_cols=64 Identities=36% Similarity=0.557 Sum_probs=51.8
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCc------ccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGK------IEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k------~~~~~G~~P~~yv~~~ 96 (527)
..++|||||+++.++||+|++||+|.|+++.+.-..++|||.|.+.+. ..++.|+||+|||+.+
T Consensus 13 ~~~~Alydy~a~~~~ELs~~~Gd~i~Vl~~~~~~~~~dgWw~G~~~~~~~~~~~~~g~~G~fP~nyVe~i 82 (83)
T d1bb9a_ 13 FKVQAQHDYTATDTDELQLKAGDVVLVIPFQNPEEQDEGWLMGVKESDWNQHKELEKCRGVFPENFTERV 82 (83)
T ss_dssp EEEEESSCBCCSSTTBCCBCTTCEEEEECCSCGGGCCTTEEEEEEHHHHHTTCCHHHHCEEEEGGGEEEE
T ss_pred EEEEEceeECCCCCCEecCcCCCEEEEEEccCCCcccCCEeEEEecCCccccccCCCCEEEEchhHeEEc
Confidence 368999999999999999999999999988543334678999985421 1257899999999865
|
| >d1wiea_ b.34.2.1 (A:) RIM binding protein 2, RIMBP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: RIM binding protein 2, RIMBP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=3.8e-13 Score=106.37 Aligned_cols=61 Identities=28% Similarity=0.486 Sum_probs=49.7
Q ss_pred CCEEEEcccCCCCC------CCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 32 PDLWRALYDYDAIG------LDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 32 ~~~~~alyd~~~~~------~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
..+|+|||||+++. ++||+|++||+|.|+++. ++++||.+.... ++.|+||+|||+.+...
T Consensus 17 ~~~~~Alydy~~~~~~~~~~e~ELsf~~Gd~i~v~~~~----~~~gW~~~~~~~---G~~G~~P~nyve~~~~~ 83 (96)
T d1wiea_ 17 VHLCVARYSYNPFDGPNENPEAELPLTAGKYLYVYGDM----DEDGFYEGELLD---GQRGLVPSNFVDFVQDN 83 (96)
T ss_dssp EEEEEESSCCCGGGSSCSCTTTBCCCCTTCEEEEESSC----CSSSCCEEEETT---CCBCBCCTTSEECCCSC
T ss_pred ceEEEEeeeecCcccCCCCCCcEeeEcCCCEEEEEEee----CCCceEEEEeCC---CCEEEEehHHeEECCCc
Confidence 36899999998864 588999999999999874 355788887543 78999999999976543
|
| >d1uffa_ b.34.2.1 (A:) Intersectin 2 (KIAA1256) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Intersectin 2 (KIAA1256) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=4.2e-13 Score=106.56 Aligned_cols=61 Identities=36% Similarity=0.697 Sum_probs=52.5
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~~ 99 (527)
...|+|||||.++.++||+|++||+|.|++++ ..+.+||.++.+ ++.|+||.|||+.....
T Consensus 5 ~~~~rAlydy~~~~~~ELs~~~Gd~v~Vl~~~---~~~~~w~~~~~~----g~~G~~P~~Yve~~~~~ 65 (93)
T d1uffa_ 5 SSGYRALYPFEARNHDEMSFNSGDIIQVDEKT---VGEPGWLYGSFQ----GNFGWFPCNYVEKMPSS 65 (93)
T ss_dssp CCCEEESSCBCCCSSSCCCBCTTCEEEECSSC---CCSSSEEEEEET----TEEEEEETTTEEECCSS
T ss_pred CeEEEECccCCCCCCCCccCcCCCEEEEEEec---cCCCCEEEEEeC----CcEEEEchHHEEECCCC
Confidence 35799999999999999999999999999875 135689999876 78999999999876543
|
| >d1zuua1 b.34.2.1 (A:2-57) BZZ1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: BZZ1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.35 E-value=3.5e-13 Score=95.89 Aligned_cols=54 Identities=22% Similarity=0.509 Sum_probs=44.9
Q ss_pred EEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccc
Q psy6905 35 WRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVS 94 (527)
Q Consensus 35 ~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~ 94 (527)
.+|||||+++.++||+|++||+|.|+++. ..++||.+..... ++.|+||+|||+
T Consensus 2 aralydf~a~~~~ELs~~~Gd~i~v~~~~----~~~~w~~~~~~~~--g~~G~~P~nyve 55 (56)
T d1zuua1 2 NKVLYAYVQKDDDEITITPGDKISLVARD----TGSGWTKINNDTT--GETGLVPTTYIR 55 (56)
T ss_dssp CEECSCBCCCSTTBCCBCTTCCEEEEECC----SSSSEEEEEETTT--TEEEEEEGGGEE
T ss_pred CEEeeeeCCCCCCEeeECCCCEEEEEEEe----cCCCcEEEeCCCC--ceEEEEehhhEE
Confidence 47999999999999999999999999874 3455666654433 789999999996
|
| >d1ug1a_ b.34.2.1 (A:) Hypothetical protein Baa76854.1 (KIAA1010) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Hypothetical protein Baa76854.1 (KIAA1010) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=3.7e-13 Score=105.97 Aligned_cols=63 Identities=22% Similarity=0.348 Sum_probs=53.2
Q ss_pred CCCEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 31 RPDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 31 ~~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
++.+|+|+|||+++.++||+|++||+|+|+++.+. .++.+||.++.+ ++.|+||.|||+....
T Consensus 16 ~~~~~~a~~~f~a~~~~eLs~~~Gd~v~vl~~~d~-~~~~~Ww~~~~~----g~~G~~P~~yv~~~~~ 78 (92)
T d1ug1a_ 16 PEKLFQAERNFNAAQDLDVSLLEGDLVGVIKKKDP-MGSQNRWLIDNG----VTKGFVYSSFLKPYNP 78 (92)
T ss_dssp GGGEEEESSCCCCCSSSCCCCCTTCEEEEEESCCT-TSCSSEEEEECS----SSEEEEEGGGEEECCC
T ss_pred CCeEEEEcCCcCCCCCCeEEEecccEEEEEEcccc-cccCCceEEEec----ccEEEEEhhhceecCC
Confidence 44689999999999999999999999999987421 134789999986 6899999999997554
|
| >d1gcqc_ b.34.2.1 (C:) Vav N-terminal SH3 domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Vav N-terminal SH3 domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.33 E-value=5.7e-13 Score=98.43 Aligned_cols=57 Identities=30% Similarity=0.508 Sum_probs=47.9
Q ss_pred CEEEEcccCCC------CCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDA------IGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~------~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
+.++|+|+|.+ ++.+||+|++||+|+|++++ .++|||.|++... ++.|+||+|||++
T Consensus 5 Pk~~a~~~y~~~~~~~~~~~~eLsf~~GD~i~Vl~~~----~~~gWw~G~~~~~--g~~G~fP~nyVeP 67 (69)
T d1gcqc_ 5 PKMEVFQEYYGIPPPPGAFGPFLRLNPGDIVELTKAE----AEHNWWEGRNTAT--NEVGWFPCNRVHP 67 (69)
T ss_dssp CEEEECSCBSSSSCCGGGCSCBCCBCTTCEEEEEECC----TTCSEEEEEETTT--TEEEEEEGGGEEE
T ss_pred CcEEEeeeEeccCCCCCCCCCEeeEcCCCEEEEEEEe----cCCCEEEEEECCC--CCEEEEeHHHEEE
Confidence 46788888865 67899999999999999864 3679999997543 7999999999986
|
| >d1phta_ b.34.2.1 (A:) Phosphatidylinositol 3-kinase (p85-alpha subunit, pi3k), SH3 domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Phosphatidylinositol 3-kinase (p85-alpha subunit, pi3k), SH3 domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=2.6e-13 Score=104.07 Aligned_cols=65 Identities=31% Similarity=0.515 Sum_probs=52.4
Q ss_pred CCEEEEcccCCCCCCCCCcccCCCEEEEeecCCC----------CCCCCceeEEEecCcccceecccccCccccccc
Q psy6905 32 PDLWRALYDYDAIGLDELSLRRGDIVEVLSKDSA----------ISGDVGWWTGKIEGKIEYKVGIFPANFVSSIED 98 (527)
Q Consensus 32 ~~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~----------~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~~~~ 98 (527)
+..++|||||.++.++||+|++||+|.|+.+.+. ...++|||.|++... ++.|+||+|||+.+..
T Consensus 3 G~~~raly~y~~~~~~eLs~~~Gd~i~V~~~~~~~~~~~~~~~~~~~~~GW~~G~~~~~--g~~G~FP~nYVe~i~~ 77 (83)
T d1phta_ 3 GYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETT--GERGDFPGTYVEYIGR 77 (83)
T ss_dssp EEEEEECSCBCCSSTTBCCBCTTCEEEEEHHHHHTTTCCTTGGGCHHHHCEEEEEETTT--TEEEEEEGGGEEEEEE
T ss_pred CCEEEEcCccCCCCCCcccccCCCEEEEEeccccccccccccccccCCCCeEEEEECCC--CcEeeEehhhEEEcCC
Confidence 4579999999999999999999999999975211 112468999987432 7999999999987654
|
| >d1t0ha_ b.34.2.1 (A:) SH3-like domain of the L-type calcium channel {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: SH3-like domain of the L-type calcium channel species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.30 E-value=5.5e-13 Score=104.42 Aligned_cols=57 Identities=23% Similarity=0.434 Sum_probs=49.3
Q ss_pred CEEEEcccCCCCCCCC-------CcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 33 DLWRALYDYDAIGLDE-------LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 33 ~~~~alyd~~~~~~~e-------L~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
..++|||||++..+++ |+|++||+|.|++++ +++||.|++.+. .+++|+||++|+..
T Consensus 22 ~~vrAlydY~~~~dd~~P~~~~~LsF~~GDii~v~~~~-----d~~WW~gr~~~~-~g~~G~~PS~~~~e 85 (96)
T d1t0ha_ 22 FAVRTNVRYSAAQEDDVPVPGMAISFEAKDFLHVKEKF-----NNDWWIGRLVKE-GCEIGFIPSPVKLE 85 (96)
T ss_dssp EEEEESSCBCCCGGGCCSSTTCBCCBCTTCEEEEEEEC-----SSSEEEEEESST-TCCCEEEECHHHHH
T ss_pred EEEEEeeccCCCCCCCCccccccccCCCCCEEEEeeee-----CCCceEEEEcCC-CCCEEEecCcHHHH
Confidence 5799999999999999 999999999999995 889999998422 26899999998543
|
| >d1kjwa1 b.34.2.1 (A:430-525) Psd-95 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Psd-95 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.28 E-value=2.5e-13 Score=108.46 Aligned_cols=59 Identities=29% Similarity=0.511 Sum_probs=48.6
Q ss_pred CEEEEcccCCCCCC-----CCCcccCCCEEEEeecCCCCCCCCceeEEEecC--cccceecccccCccccc
Q psy6905 33 DLWRALYDYDAIGL-----DELSLRRGDIVEVLSKDSAISGDVGWWTGKIEG--KIEYKVGIFPANFVSSI 96 (527)
Q Consensus 33 ~~~~alyd~~~~~~-----~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~--k~~~~~G~~P~~yv~~~ 96 (527)
-+++|||||+++.+ .||+|++||+|+|+++. +++||.|+..+ ...++.|+||+|||...
T Consensus 2 ~~vrAlydy~~~~d~~~~~~eLsf~kGdil~V~~~~-----d~~WW~~~~~~~~~~~g~~G~~Psnyv~e~ 67 (96)
T d1kjwa1 2 FYIRALFDYDKTKDCGFLSQALSFRFGDVLHVIDAG-----DEEWWQARRVHSDSETDDIGFIPSKRRVER 67 (96)
T ss_dssp EEEEESSCBCHHHHHCCCSSBCCBCTTCEEEEEECC-----SSSEEEEEECCSSCCCSCCEEEECHHHHHH
T ss_pred EEEEEcccCcCCcCCCCCCccceEcCCCEEEEeeec-----cCceEEEEEccCCCCCCCEeEEeccceeee
Confidence 36789999999864 48999999999999984 78999998522 22378999999999753
|
| >d1i1ja_ b.34.2.1 (A:) Melanoma inhibitory activity protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Melanoma inhibitory activity protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=2.2e-12 Score=104.03 Aligned_cols=65 Identities=29% Similarity=0.509 Sum_probs=53.2
Q ss_pred CEEEEcccCCCCCCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCc----ccceecccccCcccccccc
Q psy6905 33 DLWRALYDYDAIGLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGK----IEYKVGIFPANFVSSIEDI 99 (527)
Q Consensus 33 ~~~~alyd~~~~~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k----~~~~~G~~P~~yv~~~~~~ 99 (527)
.+++|||||.++.++||+|++||+|.|+.+.. .++++||.|.+.++ ..++.|+||+|||+.....
T Consensus 22 ~~~~Alydy~~~~~~eL~f~~Gd~i~Vl~k~~--~~~~~WW~g~~~g~~~~~~~g~~G~fP~nyV~~~~~~ 90 (106)
T d1i1ja_ 22 SMAVALQDYMAPDCRFLTIHRGQVVYVFSKLK--GRGRLFWGGSVQGDYYGDLAARLGYFPSSIVREDQTL 90 (106)
T ss_dssp EEEEESSCBCCSSTTBCCBCTTCEEEEEEEEC--GGGTTEEEEEEBCSSTTCBCSCCEEEEGGGEEEEEEC
T ss_pred eEEEEccccCCCCCCCccCCCCCEEEEEEecC--CCCcceEEEEecCccccccCCcccccccccEEEcccc
Confidence 47999999999999999999999999998631 13678999997753 2356899999999976544
|
| >d1vyva1 b.34.2.1 (A:71-215) SH3-like domain of the L-type calcium channel {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: SH3-like domain of the L-type calcium channel species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.05 E-value=4.1e-11 Score=102.68 Aligned_cols=56 Identities=16% Similarity=0.396 Sum_probs=48.4
Q ss_pred EEEEcccCCCCCCCC-------CcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 34 LWRALYDYDAIGLDE-------LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 34 ~~~alyd~~~~~~~e-------L~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
.|+|+|||++..+++ |+|++||+|.|++++ +++||.|++.+. .++.|+||++|+..
T Consensus 25 ~vra~~dy~~~~d~~~p~~~~~LsF~kGDii~V~~~~-----d~~WW~gr~~~~-~g~~G~iPS~~~~e 87 (145)
T d1vyva1 25 AVKTNVSYCGALDEDVPVPSSAVSFDAKDFLHIKEKY-----NNDWWIGRLVKE-GCEIGFIPSPLRLE 87 (145)
T ss_dssp EEEESSCBCTTSCCSCSSTTCBCCBCTTCEEEEEEEE-----ETTEEEEEESST-TCCCEEEECHHHHH
T ss_pred EEEEeeeeCCccCCcCCcccccccCcCCCEEEEeecc-----CCCcEEEEEcCC-CCceeEeCCchhhh
Confidence 599999999999998 999999999999995 889999997321 27899999988654
|
| >d1vyua1 b.34.2.1 (A:39-174) SH3-like domain of the L-type calcium channel {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: SH3-like domain of the L-type calcium channel species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.89 E-value=2.7e-10 Score=95.51 Aligned_cols=56 Identities=16% Similarity=0.335 Sum_probs=47.5
Q ss_pred EEEEcccCCCCCCCC-------CcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcccc
Q psy6905 34 LWRALYDYDAIGLDE-------LSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFVSS 95 (527)
Q Consensus 34 ~~~alyd~~~~~~~e-------L~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv~~ 95 (527)
.++|+|||++..+++ |+|++||+|.|++++ |++||.|++-.. .+..|++|++|+..
T Consensus 25 ~vra~~~Y~~~~d~~~P~~~~~LsF~~gdil~v~~~~-----d~~WW~~r~~~~-~~~~G~iPs~~~lE 87 (136)
T d1vyua1 25 AVRTNVSYCGVLDEECPVQGSGVNFEAKDFLHIKEKY-----SNDWWIGRLVKE-GGDIAFIPSPQRLE 87 (136)
T ss_dssp EEEESSCEEGGGCTTCSSTTCBCEECTTCEEEEEEEC-----SSSEEEEEESST-TCCCEEEECHHHHH
T ss_pred EEEEeeccCCCCCCCCcccCcccCCCCCCEEEEEecc-----CCCcEEEEeccC-CCceeccCchHHHh
Confidence 589999999999888 899999999999995 889999996321 16799999998543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.45 E-value=6e-07 Score=83.98 Aligned_cols=141 Identities=17% Similarity=0.167 Sum_probs=94.3
Q ss_pred ceeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCC-CCccceEEEEEEeCCeEEEEEeccC
Q psy6905 118 KLIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFD-HRNIVSLIGVCLQSPKLCLVMEYAR 196 (527)
Q Consensus 118 ~~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~~~~~~~~~~~~~iv~Ey~~ 196 (527)
.|.+.+..+-|+.+.||+....++.+++|+........ ...+.+|...+..+. +--+.+++.++.+++..|+||++++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence 45555555445567899988777888999876432211 234567777777663 3336788888888889999999999
Q ss_pred CCCHHHHhcCCCCChhHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q psy6905 197 GGPLNRVLAGRKIRPDVLVDWAIQIAEGMNYLHCQA-------------------------------------------- 232 (527)
Q Consensus 197 ggsL~~~l~~~~~~~~~~~~i~~qi~~~L~yLH~~g-------------------------------------------- 232 (527)
|.++...... ......++.+++..|..||+..
T Consensus 94 G~~~~~~~~~----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T d1j7la_ 94 GVLCSEEYED----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp SEEHHHHTTT----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHH
T ss_pred cccccccccc----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHH
Confidence 9888665431 1222334455555566666321
Q ss_pred ------------CCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 233 ------------PISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 233 ------------~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+..++|+|+.|.|||++.+ +.+-|+||+.+.
T Consensus 170 ~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~--------~~~~lIDwe~a~ 212 (263)
T d1j7la_ 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDG--------KVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHSCCCCCEEEECSCCCTTSEEEETT--------EEEEECCCTTCE
T ss_pred HHHHHHhcCCcCCcEEEEeeccCcceeecCC--------ceEEEeechhcc
Confidence 1137999999999999864 345699998874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.86 E-value=5.1e-05 Score=69.90 Aligned_cols=72 Identities=13% Similarity=0.102 Sum_probs=50.3
Q ss_pred eccCC-ceEEEEeeEcC-ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCC--CccceEEEEEEeCCeEEEEEeccCCCCH
Q psy6905 125 IGEGG-FGKVYKGIYEK-QEVAIKVAHPNPDENILENVKQEGKLLWLFDH--RNIVSLIGVCLQSPKLCLVMEYARGGPL 200 (527)
Q Consensus 125 iG~G~-fg~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~~~~~~~~~~~~~iv~Ey~~ggsL 200 (527)
+..|. -+.||+....+ ..+++|+....... .+..|+..++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 44454 36789987754 46888987665322 34567777766632 3367788888888889999999987665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.73 E-value=7.7e-05 Score=73.80 Aligned_cols=76 Identities=18% Similarity=0.175 Sum_probs=46.9
Q ss_pred eeeeccCCceEEEEeeEc--CceEEEEEcCCC-----C-ChhHHHHHHHHHHHHHhC-CC--CccceEEEEEEeCCeEEE
Q psy6905 122 GEAIGEGGFGKVYKGIYE--KQEVAIKVAHPN-----P-DENILENVKQEGKLLWLF-DH--RNIVSLIGVCLQSPKLCL 190 (527)
Q Consensus 122 ~~~iG~G~fg~Vy~~~~~--~~~vaiK~~~~~-----~-~~~~~~~~~~e~~~l~~l-~h--pnIv~~~~~~~~~~~~~i 190 (527)
.+.||.|....||+.... ++.|+||..... . ..........|...|+.+ .+ ..+.++|.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999998753 567899954321 0 011123345677777665 22 345667655 3444589
Q ss_pred EEeccCCCC
Q psy6905 191 VMEYARGGP 199 (527)
Q Consensus 191 v~Ey~~ggs 199 (527)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.57 E-value=0.0057 Score=59.77 Aligned_cols=77 Identities=18% Similarity=0.216 Sum_probs=50.7
Q ss_pred CCceeeeeeeccCCceEEEEeeEcC---------ceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCc-cceEEEEEEeC
Q psy6905 116 YNKLIFGEAIGEGGFGKVYKGIYEK---------QEVAIKVAHPNPDENILENVKQEGKLLWLFDHRN-IVSLIGVCLQS 185 (527)
Q Consensus 116 ~~~~~~~~~iG~G~fg~Vy~~~~~~---------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~~~~~~~~~ 185 (527)
.+++.+ +.|+.|-.-.+|++.... ..|.+++...... .....+|..+++.+.--+ ..++++++.+
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 344444 568888899999987532 4577787663222 234557888888774334 4578887643
Q ss_pred CeEEEEEeccCCCCH
Q psy6905 186 PKLCLVMEYARGGPL 200 (527)
Q Consensus 186 ~~~~iv~Ey~~ggsL 200 (527)
.+|+||++|..|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 689999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.51 E-value=0.0052 Score=58.37 Aligned_cols=67 Identities=10% Similarity=0.158 Sum_probs=42.9
Q ss_pred eEEEEeeE-cCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCCCcc--ceEE-----EEEEeCCeEEEEEeccCCCC
Q psy6905 131 GKVYKGIY-EKQEVAIKVAHPNPDENILENVKQEGKLLWLFDHRNI--VSLI-----GVCLQSPKLCLVMEYARGGP 199 (527)
Q Consensus 131 g~Vy~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~hpnI--v~~~-----~~~~~~~~~~iv~Ey~~ggs 199 (527)
-.||++.. +|..|++|+.++.... .+++..|...+..|...+| +..+ ..+..+...+.+++++.|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 58999886 5678999998775322 3556678777776632222 1111 12244667899999997643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.08 E-value=0.034 Score=51.92 Aligned_cols=142 Identities=15% Similarity=0.093 Sum_probs=71.4
Q ss_pred eeeeeeeccCCceEEEEeeEcCceEEEEEcCCCCChhHHHHHHHHHHHHHhCCC-----CccceEE-E--EEEeCCeEEE
Q psy6905 119 LIFGEAIGEGGFGKVYKGIYEKQEVAIKVAHPNPDENILENVKQEGKLLWLFDH-----RNIVSLI-G--VCLQSPKLCL 190 (527)
Q Consensus 119 ~~~~~~iG~G~fg~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-----pnIv~~~-~--~~~~~~~~~i 190 (527)
+.-.+.|..|---+.|+...++..+++|+.....+. ..+..|..++..|.. |..+... | +.......+.
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~ 96 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 96 (316)
T ss_dssp EEEEEEECC---EEEEEEEESSCCEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred ceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCH---HHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence 333456777877889998887778999998654322 233345555555432 2222110 0 1122345566
Q ss_pred EEeccCCCCHHH-----------Hh---c--CCC--------C------------------ChhHHHHHHHHHHHHHHHH
Q psy6905 191 VMEYARGGPLNR-----------VL---A--GRK--------I------------------RPDVLVDWAIQIAEGMNYL 228 (527)
Q Consensus 191 v~Ey~~ggsL~~-----------~l---~--~~~--------~------------------~~~~~~~i~~qi~~~L~yL 228 (527)
++.+..|..... .+ . ... . ....+...+..+...+.-.
T Consensus 97 ~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 176 (316)
T d2ppqa1 97 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 176 (316)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred eeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhcc
Confidence 666665543211 00 0 000 0 0011122222222222222
Q ss_pred Hh-cCCCceeecCCCCCceecCCCCcccccccceeEEeccCcch
Q psy6905 229 HC-QAPISLIHRDLKSSNVLLSEPIENEDLQFKTLKITDFGLAR 271 (527)
Q Consensus 229 H~-~g~~~iiHrDlkp~NILl~~~~~~~~~~~~~vkL~DFGla~ 271 (527)
+. .-+.++||+|+.++|||++.+ ..+-|+||+.+.
T Consensus 177 ~~~~L~~giIHgDl~~dNvl~~~~--------~v~gvIDF~~~~ 212 (316)
T d2ppqa1 177 WPKDLPAGVIHADLFQDNVFFLGD--------ELSGLIDFYFAC 212 (316)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETT--------EEEEECCCTTCE
T ss_pred CccccccccccCCcchhhhhcccc--------cceeEecccccc
Confidence 21 123469999999999999875 355799999874
|
| >d1ri9a_ b.34.2.1 (A:) Fyn-binding protein (T-cell adapter protein adap) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: SH3-domain family: SH3-domain domain: Fyn-binding protein (T-cell adapter protein adap) species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.49 E-value=0.031 Score=39.98 Aligned_cols=41 Identities=22% Similarity=0.310 Sum_probs=34.8
Q ss_pred CCCCCcccCCCEEEEeecCCCCCCCCceeEEEecCcccceecccccCcc
Q psy6905 45 GLDELSLRRGDIVEVLSKDSAISGDVGWWTGKIEGKIEYKVGIFPANFV 93 (527)
Q Consensus 45 ~~~eL~~~~gd~~~v~~~~~~~~~~~~ww~~~~~~k~~~~~G~~P~~yv 93 (527)
+..+|+++.||.|.|+... ++|=|.+++.. |+-|+++.+++
T Consensus 35 g~~dL~vk~GE~ldVIr~t-----~~~k~LcRN~~---GkYGYV~~~~l 75 (77)
T d1ri9a_ 35 GTRDLQVKPGESLEVIQTT-----DDTKVLCRNEE---GKYGYVLRSYL 75 (77)
T ss_dssp CTTBCCCCTTCBCEEEEES-----SSSEEEEEETT---TEEEEEEGGGS
T ss_pred CcccCCcCCCCEEEEEEeC-----CCCeEEEEcCC---CcEEEEEeeee
Confidence 4568999999999999985 68889999875 89999887665
|